<SEC-DOCUMENT>0001636282-25-000049.txt : 20250508
<SEC-HEADER>0001636282-25-000049.hdr.sgml : 20250508
<ACCEPTANCE-DATETIME>20250508160112
ACCESSION NUMBER:		0001636282-25-000049
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		83
CONFORMED PERIOD OF REPORT:	20250331
FILED AS OF DATE:		20250508
DATE AS OF CHANGE:		20250508

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Spyre Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001636282
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				464312787
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37722
		FILM NUMBER:		25925806

	BUSINESS ADDRESS:	
		STREET 1:		221 CRESCENT STREET
		STREET 2:		BUILDING 23, SUITE 105
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02453
		BUSINESS PHONE:		6176515940

	MAIL ADDRESS:	
		STREET 1:		221 CRESCENT STREET
		STREET 2:		BUILDING 23, SUITE 105
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02453

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Aeglea BioTherapeutics, Inc.
		DATE OF NAME CHANGE:	20150311
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>syre-20250331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:00f29609-870c-422a-b8be-61cf7b074069,g:31b3bfa9-c84d-47fe-82f5-b77ff3f965cb,d:d1024c8efdf34cb8889d12b6bf18881e-->
<html xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:srt="http://fasb.org/srt/2024" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:syre="http://spyre.com/20250331" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>syre-20250331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-27">0001636282</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="f-28">12-31</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-29">false</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-30">2025</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-31">Q1</ix:nonNumeric><ix:nonFraction unitRef="usd" contextRef="c-243" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" scale="0" id="f-781">0</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="c-172" decimals="3" name="syre:RoyaltyStepDownPercent" scale="-2" id="f-782">33</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="c-219" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="0" id="f-783">0</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="syre-20250331.xsd"/></ix:references><ix:resources><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="segment"><xbrli:measure>syre:segment</xbrli:measure></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="bank"><xbrli:measure>syre:bank</xbrli:measure></xbrli:unit><xbrli:unit id="seat"><xbrli:measure>syre:seat</xbrli:measure></xbrli:unit><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesANonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesANonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:PreferredStockExcludingSeriesAAndBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:PreferredStockExcludingSeriesAAndBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesANonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesANonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesANonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesANonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesANonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesANonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">syre:SpyreTherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-22</xbrli:startDate><xbrli:endDate>2023-06-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:CommonStockAndSeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-20</xbrli:startDate><xbrli:endDate>2024-03-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-20</xbrli:startDate><xbrli:endDate>2024-03-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">syre:ConversionOfSeriesANonVotingConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesANonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-23</xbrli:startDate><xbrli:endDate>2024-04-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesANonVotingConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">syre:AssetAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-23</xbrli:startDate><xbrli:endDate>2024-04-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesANonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">syre:ConversionOfSeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-14</xbrli:startDate><xbrli:endDate>2024-05-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">syre:ConversionOfSeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-14</xbrli:startDate><xbrli:endDate>2024-05-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">syre:AtTheMarketOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">syre:AtTheMarketOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">syre:AtTheMarketOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">syre:AtTheMarketOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">syre:UnderwrittenOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-11-20</xbrli:startDate><xbrli:endDate>2024-11-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-11-29</xbrli:startDate><xbrli:endDate>2024-11-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">syre:UnderwrittenOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-11-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">syre:AtTheMarketOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">syre:AtTheMarketOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2015-03-10</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">syre:ContingentValueRightLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">syre:ContingentValueRightLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">syre:ContingentValueRightLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">syre:ContingentValueRightLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">syre:ContingentValueRightLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">syre:ContingentValueRightLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">syre:ContingentValueRightLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">syre:ContingentValueRightLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">syre:MeasurementInputProabilityOfSuccessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">syre:ContingentValueRightLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">syre:MeasurementInputProabilityOfSuccessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">syre:ContingentValueRightLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">syre:ContingentValueRightLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">syre:MeasurementInputReimbursementRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">syre:ContingentValueRightLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">syre:MeasurementInputReimbursementRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">syre:ContingentValueRightLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">syre:ContingentValueRightLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">syre:ContingentValueRightLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">syre:ContingentValueRightLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">syre:ContingentValueRightLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">syre:USBankingInstitutionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:SPY003LicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-10-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:Spy001LicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:SPY002LicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:SPY003LicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-11</xbrli:startDate><xbrli:endDate>2024-10-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:SPY002LicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-14</xbrli:startDate><xbrli:endDate>2024-05-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:ParagonAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:SPY002LicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:ParagonAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:ParagonAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:ParagonAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:ParagonAgreementLicenseMilestonePaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:ParagonAgreementLicenseMilestonePaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">syre:ParagonTherapeuticsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:ParagonAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">syre:FairmountFundsManagementLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:ParagonAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:AppointOfBoardMembersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:ParagonAgreementLicenseMilestonePaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:ParagonAndLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:ParagonAndLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:ParapyreLiabilityLicenseAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:ParapyreLiabilityLicenseAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-186"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:ParagonAgreementSubsequentToAssetAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-187"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">syre:ParapyreOptionObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">syre:ParapyreOptionObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:ConsultingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-22</xbrli:startDate><xbrli:endDate>2023-11-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-190"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:ConsultingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-191"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:ConsultingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-22</xbrli:startDate><xbrli:endDate>2023-11-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:ConsultingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-193"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:ConsultingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-194"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">syre:ParapyreWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">syre:A2024ParapyreOptionObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-195"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">syre:ParapyreWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">syre:A2024ParapyreOptionObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-196"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">syre:ParapyreWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-197"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesANonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-198"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesANonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-23</xbrli:startDate><xbrli:endDate>2024-04-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesANonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-200"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-11</xbrli:startDate><xbrli:endDate>2023-12-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-18</xbrli:startDate><xbrli:endDate>2024-03-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:CommonStockAndSeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">syre:ConversionOfSeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">syre:ConversionOfSeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">syre:AtTheMarketOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">syre:TwoThousandAndFifteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">syre:TwoThousandAndSixteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-01-01</xbrli:startDate><xbrli:endDate>2016-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">syre:TwoThousandAndSixteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">syre:TwoThousandAndSixteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">syre:TwoThousandAndSixteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">syre:TwoThousandAndEighteenEquityInducementPlanAmendedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">syre:TwoThousandAndEighteenEquityInducementPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">syre:ServiceBasedAwardsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">syre:TwoThousandAndFifteenAndTwoThousandAndSixteenEquityIncentivePlanAndTwoThousandAndEighteenEquityInducementPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">syre:Spyre2023EquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">syre:AssetAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-22</xbrli:startDate><xbrli:endDate>2023-06-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">syre:TwoThousandAndSixteenEmployeeStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">syre:A2016ESPPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">syre:TwoThousandAndSixteenEmployeeStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">syre:TwoThousandAndSixteenEmployeeStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">syre:A2016ESPPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">syre:AegleaEmployeesAndDirectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">syre:TwoThousandAndSixteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">syre:TwoThousandAndSixteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">syre:TwoThousandAndSixteenEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">syre:TwoThousandAndSixteenEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syre:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syre:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syre:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-232"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syre:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-233"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syre:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-234"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syre:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-235"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-236"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-237"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-238"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-239"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-240"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-241"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">syre:ParapyreWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-242"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">syre:ParapyreWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-243"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:ParagonAgreementSubsequentToAssetAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-110 f-111" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"/><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-112 f-113" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"/></ix:resources></ix:header></div><div id="id1024c8efdf34cb8889d12b6bf18881e_1"></div><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:17pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:17pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WASHINGTON, DC 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:17pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-Q</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________________________</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Mark One)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.264%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="f-2">x</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3">March 31, 2025</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.264%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-4">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; to &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-37722</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________________________</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:22pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-6">SPYRE THERAPEUTICS, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact Name of Registrant as Specified in its Charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________________________</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-7">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-8">46-4312787</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(I.R.S. Employer<br/>Identification No.)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-9">221 Crescent Street</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine2" id="f-10">Building 23</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine3" id="f-11">Suite 105</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-12">Waltham</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-13">MA</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-14">02453</ix:nonNumeric></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address of principal executive offices including zip code)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code: (<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-15">617</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-16">651-5940</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Former name, former address and former fiscal year, if changed since last report: N/A</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________________________</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Exchange Act:</span></div><div style="margin-top:6pt;text-align:center"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Title of each class</span></td><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:0.5pt solid #000;border-right:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000;border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-17">Common Stock, $0.0001 Par Value Per Share</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:0.5pt solid #000;border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-18">SYRE</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:0.5pt solid #000;border-left:0.5pt solid #000;border-right:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">The Nasdaq Stock Market LLC</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Nasdaq Global Select Market)</span></div></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-20">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-21">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.203%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.203%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-22">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="f-23">o</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-24">o</ix:nonNumeric></span></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-25">x</ix:nonNumeric></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of May&#160;2, 2025, the registrant had <ix:nonFraction unitRef="shares" contextRef="c-2" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-26">60,353,561</ix:nonFraction> shares of common stock, $0.0001 par value per share, outstanding.</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:18pt;padding-left:3pt;padding-right:3pt;text-align:center"><span><br/></span></div></div></div><div id="id1024c8efdf34cb8889d12b6bf18881e_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SPYRE THERAPEUTICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUARTERLY REPORT ON FORM 10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE QUARTER ENDED MARCH 31, 2025</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:79.657%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.992%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Page No.</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#id1024c8efdf34cb8889d12b6bf18881e_13">PART I. FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#id1024c8efdf34cb8889d12b6bf18881e_13">1</a></span></div></td></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#id1024c8efdf34cb8889d12b6bf18881e_16">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#id1024c8efdf34cb8889d12b6bf18881e_16">Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#id1024c8efdf34cb8889d12b6bf18881e_16">1</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id1024c8efdf34cb8889d12b6bf18881e_19">Condensed Consolidated Balance Sheets as of March 31, 2025 and December 31, 2024</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#id1024c8efdf34cb8889d12b6bf18881e_19">1</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id1024c8efdf34cb8889d12b6bf18881e_22">Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2025 and 2024</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#id1024c8efdf34cb8889d12b6bf18881e_22">2</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id1024c8efdf34cb8889d12b6bf18881e_25">Condensed Consolidated Statements of Comprehensive Loss for the Three Months Ended March 31, 2025 and 2024</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#id1024c8efdf34cb8889d12b6bf18881e_25">3</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id1024c8efdf34cb8889d12b6bf18881e_28">Condensed Consolidated Statements of Changes in Convertible Preferred Stock and Stockholders&#8217; Equity for the Three Months Ended March 31, 2025 and 2024</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#id1024c8efdf34cb8889d12b6bf18881e_28">4</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id1024c8efdf34cb8889d12b6bf18881e_34">Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2025 and 2024</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#id1024c8efdf34cb8889d12b6bf18881e_34">5</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id1024c8efdf34cb8889d12b6bf18881e_37">Notes to Unaudited Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#id1024c8efdf34cb8889d12b6bf18881e_37">6</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#id1024c8efdf34cb8889d12b6bf18881e_91">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#id1024c8efdf34cb8889d12b6bf18881e_91">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#id1024c8efdf34cb8889d12b6bf18881e_91">22</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#id1024c8efdf34cb8889d12b6bf18881e_124">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#id1024c8efdf34cb8889d12b6bf18881e_124">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#id1024c8efdf34cb8889d12b6bf18881e_124">37</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#id1024c8efdf34cb8889d12b6bf18881e_127">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#id1024c8efdf34cb8889d12b6bf18881e_127">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#id1024c8efdf34cb8889d12b6bf18881e_127">37</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#id1024c8efdf34cb8889d12b6bf18881e_130">PART II. OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#id1024c8efdf34cb8889d12b6bf18881e_130">39</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#id1024c8efdf34cb8889d12b6bf18881e_133">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#id1024c8efdf34cb8889d12b6bf18881e_133">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#id1024c8efdf34cb8889d12b6bf18881e_133">39</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#id1024c8efdf34cb8889d12b6bf18881e_136">Item 1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#id1024c8efdf34cb8889d12b6bf18881e_136">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#id1024c8efdf34cb8889d12b6bf18881e_136">39</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#id1024c8efdf34cb8889d12b6bf18881e_139">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#id1024c8efdf34cb8889d12b6bf18881e_139">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#id1024c8efdf34cb8889d12b6bf18881e_139">79</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#id1024c8efdf34cb8889d12b6bf18881e_142">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#id1024c8efdf34cb8889d12b6bf18881e_142">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#id1024c8efdf34cb8889d12b6bf18881e_142">79</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#id1024c8efdf34cb8889d12b6bf18881e_145">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#id1024c8efdf34cb8889d12b6bf18881e_145">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#id1024c8efdf34cb8889d12b6bf18881e_145">79</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#id1024c8efdf34cb8889d12b6bf18881e_148">Item 5.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#id1024c8efdf34cb8889d12b6bf18881e_148">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#id1024c8efdf34cb8889d12b6bf18881e_148">79</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#id1024c8efdf34cb8889d12b6bf18881e_154">Item 6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#id1024c8efdf34cb8889d12b6bf18881e_154">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#id1024c8efdf34cb8889d12b6bf18881e_154">80</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#id1024c8efdf34cb8889d12b6bf18881e_157">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#id1024c8efdf34cb8889d12b6bf18881e_157">82</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:18pt;padding-left:3pt;padding-right:3pt;text-align:center"><span><br/></span></div></div></div><div id="id1024c8efdf34cb8889d12b6bf18881e_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE ABOUT FORWARD-LOOKING STATEMENTS</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q for the quarter ended March&#160;31, 2025 (this &#8220;Quarterly Report&#8221;) contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and Section 27A of the Securities Act of 1933, as amended (the "Securities Act"). All statements contained in this Quarterly Report other than statements of historical fact, including statements regarding any future payouts under our contingent value rights ("CVRs") issued in connection with the acquisition of Spyre Therapeutics, Inc. ("Pre-Merger Spyre") (the "Asset Acquisition"); our future results of operations and financial position; our business strategy, including our ability to develop best-in-class therapeutics for inflammatory bowel disease ("IBD") or rheumatoid arthritis ("RA") that meaningfully improve both efficacy and convenience compared to today's standard of care and our ability to develop first-in-class therapeutics for RA; our plans to expand the development of our product candidates, including SPY002, to indications beyond IBD and RA; the SPY001 Phase 1 trial final data readouts not being consistent with or being different than the interim Phase 1 results; the planned dosing regimen for SPY001 and our other product candidates, including the potential for a Q3M-Q6M dosing profile; the potential for increased or accelerated efficacy; the expected design and timing of the platform Phase 2 trial of SPY001, SPY002, SPY003 and combinations thereof, including timing of each cohort and data readouts; the expected advancement of one or more SPY002 candidates to Phase 2 trials; potential alignment with regulatory authorities and anticipated regulatory submissions; expected timing for regulatory feedback; the length of time that we believe our existing cash resources will fund operations; estimated market sizes and potential growth opportunities; our nonclinical and clinical development activities, including clinical trial designs, submission of investigational new drug ("IND") applications and foreign equivalents and further clinical evaluation of therapeutic combinations, and related regulatory feedback; the potential efficacy, tolerability, convenience, commercial viability and safety profile of our product candidates, including in combinations; the potential therapeutic benefits and economic value of our product candidates as monotherapies or in combinations and their extended half-life, including the expected duration of half-life in comparison to competitor products; the timing and results of nonclinical studies and clinical trials, including Phase 2 trials in UC and RA and timing of data readouts for Phase 1 and Phase 2 trials; our ability to achieve the expected benefits or opportunities and related timing with respect to the Asset Acquisition; the expected impact of macroeconomic conditions, including inflation, increasing interest rates and volatile market conditions, current or potential bank failures, as well as global events, including the ongoing military conflict in Ukraine, the conflicts in the Middle East, and geopolitical tensions between the United States and other countries, including China, on our operations, and the implementation of changes in law, tariffs, sanctions, export or import controls, and other government measures that could impact our business operations, including restricting international trade by the United States, China or other countries; and the receipt and timing of potential regulatory designations, approvals and commercialization of product candidates, are forward-looking statements. The words &#8220;believe,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;potentially,&#8221; &#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;anticipate,&#8221; &#8220;predict,&#8221; &#8220;target,&#8221; &#8220;intend,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;should,&#8221; &#8220;project,&#8221; &#8220;plan,&#8221; &#8220;expect,&#8221; and similar expressions that convey uncertainty of future events or outcomes are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including those described in Item 1A, &#8220;Risk Factors&#8221; included in this Quarterly Report. Moreover, we operate in a very competitive and rapidly changing environment, and new risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties, and assumptions, the forward-looking events and circumstances discussed in this Quarterly Report may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that the future results, levels of activity, performance or events and circumstances reflected in the forward-looking statements will be achieved or occur. We undertake no obligation to update publicly any forward-looking statements for any reason after the date of this report to conform these statements to actual results or to changes in our expectations, except as required by law. You should read this Quarterly Report with the understanding that our actual future results, levels of activity, performance and events and circumstances may be materially different from what we expect.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:18pt;padding-left:3pt;padding-right:3pt;text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless the context indicates otherwise, as used in this Quarterly Report, the terms &#8220;Spyre,&#8221; &#8220;the Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; refer to Spyre Therapeutics, Inc., a Delaware corporation, and its consolidated subsidiaries taken as a whole. &#8220;Spyre&#8221; and all product candidate names are our common law trademarks. This Quarterly Report contains additional trade names, trademarks and service marks of other companies, which are the property of their respective owners. We do not intend our use or display of other companies&#8217; trade names, trademarks or service marks to imply a relationship with, or endorsement or sponsorship of us by, these other companies.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All references to &#8220;our product candidates,&#8221; &#8220;our programs&#8221; and &#8220;our pipeline&#8221; in this Quarterly Report refer to the research programs with respect to which we have signed a license agreement for or have the option to acquire intellectual property license rights to pursuant to that certain antibody discovery and option agreement, dated May 25, 2023 and subsequently amended and restated on September 29, 2023 and May 14, 2024, by and among us, Paragon Therapeutics, Inc. (&#8220;Paragon&#8221;) and Parapyre Holding LLC (&#8220;Parapyre&#8221;) (as amended, the &#8220;Paragon Agreement&#8221;).</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:18pt;padding-left:3pt;padding-right:3pt;text-align:center"><span><br/></span></div></div></div><div id="id1024c8efdf34cb8889d12b6bf18881e_13"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I. &#8211; Financial Information</span></div><div id="id1024c8efdf34cb8889d12b6bf18881e_16"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Financial Statements (Unaudited).</span></div><div id="id1024c8efdf34cb8889d12b6bf18881e_19"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Spyre Therapeutics, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited, in thousands, except share and per share amounts)</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">CURRENT ASSETS</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-32">48,493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-33">89,423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-34">516,327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-35">513,665</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-36">4,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-37">5,386</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-38">569,768</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-39">608,474</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="f-40">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="f-41">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">TOTAL ASSETS</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-42">569,778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-43">608,484</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">CURRENT LIABILITIES</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-44">3,689</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AccountsPayableCurrent" scale="3" id="f-45">666</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">CVR liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DerivativeLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-46">42,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DerivativeLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-47">25,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accrued and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-48">21,631</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-49">27,711</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Related party accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-50">2,548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" scale="3" id="f-51">603</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-52">70,678</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-53">54,060</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Non-current CVR liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DerivativeLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-54">16,490</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DerivativeLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-55">36,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">TOTAL LIABILITIES</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-56">87,168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-57">90,680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Commitments and Contingencies (Note 6 and 7)</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-3" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-58"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-4" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-59"></ix:nonFraction></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Series A non-voting convertible preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-9" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-60"><ix:nonFraction unitRef="usdPerShare" contextRef="c-10" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-61">0.0001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="c-10" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-62"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-63">1,086,341</ix:nonFraction></ix:nonFraction> shares authorized as of March&#160;31, 2025 and December&#160;31, 2024; <ix:nonFraction unitRef="shares" contextRef="c-10" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-64"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-65"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-66"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-67">346,045</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding as of March&#160;31, 2025 and December&#160;31, 2024.</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:num-dot-decimal" scale="3" id="f-68">146,425</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:num-dot-decimal" scale="3" id="f-69">146,425</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Series B non-voting convertible preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-11" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-70"><ix:nonFraction unitRef="usdPerShare" contextRef="c-12" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-71">0.0001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="c-12" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-72"><ix:nonFraction unitRef="shares" contextRef="c-11" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-73">271,625</ix:nonFraction></ix:nonFraction> shares authorized and <ix:nonFraction unitRef="shares" contextRef="c-11" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-74"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-75"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-76"><ix:nonFraction unitRef="shares" contextRef="c-11" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-77">16,667</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding as of March&#160;31, 2025 and December 31, 2024.</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:num-dot-decimal" scale="3" id="f-78">9,395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:num-dot-decimal" scale="3" id="f-79">9,395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-13" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-80"><ix:nonFraction unitRef="usdPerShare" contextRef="c-14" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-81">0.0001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="c-13" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-82"><ix:nonFraction unitRef="shares" contextRef="c-14" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-83">8,642,034</ix:nonFraction></ix:nonFraction> shares authorized as of March&#160;31, 2025 and December&#160;31, 2024; <ix:nonFraction unitRef="shares" contextRef="c-13" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-84"><ix:nonFraction unitRef="shares" contextRef="c-13" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="f-85"><ix:nonFraction unitRef="shares" contextRef="c-14" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-86"><ix:nonFraction unitRef="shares" contextRef="c-14" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="f-87">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding as of March&#160;31, 2025 and December&#160;31, 2024.</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-88">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-89">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-90"><ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-91">0.0001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-92"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-93">400,000,000</ix:nonFraction></ix:nonFraction> shares authorized as of March&#160;31, 2025 and December&#160;31, 2024; <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-94"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-95">60,275,561</ix:nonFraction></ix:nonFraction> shares and <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-96"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-97">60,257,023</ix:nonFraction></ix:nonFraction> shares issued and outstanding as of March&#160;31, 2025 and December&#160;31, 2024, respectively.</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-98">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-99">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-100">1,343,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-101">1,334,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-102">682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-103">180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-104">1,017,205</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-105">972,432</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">TOTAL STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-106">482,610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-107">517,804</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">TOTAL LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#8217; EQUITY</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-108">569,778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-109">608,484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="id1024c8efdf34cb8889d12b6bf18881e_22"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Spyre Therapeutics, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Operations</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited, in thousands, except share and per share amounts)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.795%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.797%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research and development </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" format="ixt:num-dot-decimal" scale="3" id="f-110">41,623</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" format="ixt:num-dot-decimal" scale="3" id="f-111">34,928</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">General and administrative </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-112">11,944</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-113">12,846</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-114">53,567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-115">47,774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Loss from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-116">53,567</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-117">47,774</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other income:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InvestmentIncomeNet" format="ixt:num-dot-decimal" scale="3" id="f-118">6,493</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:InvestmentIncomeNet" format="ixt:num-dot-decimal" scale="3" id="f-119">4,432</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-120">2,286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="f-121">483</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total other income </span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-122">8,779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-123">3,949</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Loss before income tax expense</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-124">44,788</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-125">43,825</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="f-126">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="f-127">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net loss</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-128">44,773</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-129">43,857</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net loss per share, basic and diluted, Series A Preferred Stock</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-16" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-130"><ix:nonFraction unitRef="usdPerShare" contextRef="c-16" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-131">23.95</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-17" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-132"><ix:nonFraction unitRef="usdPerShare" contextRef="c-17" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-133">28.93</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted-average Series A non-voting convertible preferred stock outstanding, basic and diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-16" decimals="INF" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-134"><ix:nonFraction unitRef="shares" contextRef="c-16" decimals="INF" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-135">346,045</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-17" decimals="INF" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-136"><ix:nonFraction unitRef="shares" contextRef="c-17" decimals="INF" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-137">437,037</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net loss per share, basic and diluted, Series B Preferred Stock</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-18" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-138"><ix:nonFraction unitRef="usdPerShare" contextRef="c-18" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-139">23.95</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-19" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-140"><ix:nonFraction unitRef="usdPerShare" contextRef="c-19" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-141">28.93</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted-average Series B non-voting convertible preferred stock outstanding, basic and diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-18" decimals="INF" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-142"><ix:nonFraction unitRef="shares" contextRef="c-18" decimals="INF" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-143">16,667</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-19" decimals="INF" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-144"><ix:nonFraction unitRef="shares" contextRef="c-19" decimals="INF" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-145">166,261</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net loss per share, basic and diluted, common</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-20" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-146"><ix:nonFraction unitRef="usdPerShare" contextRef="c-20" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-147">0.60</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-21" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-148"><ix:nonFraction unitRef="usdPerShare" contextRef="c-21" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-149">0.72</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted-average common stock outstanding, basic and diluted</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-20" decimals="INF" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-150"><ix:nonFraction unitRef="shares" contextRef="c-20" decimals="INF" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-151">60,265,932</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-21" decimals="INF" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-152"><ix:nonFraction unitRef="shares" contextRef="c-21" decimals="INF" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-153">36,512,662</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><ix:footnote id="fn-1" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Includes $<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" scale="6" id="f-154">2.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" scale="6" id="f-155">17.1</ix:nonFraction> million in related party expenses for the three months ended March&#160;31, 2025 and 2024, respectively.</span></ix:footnote></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><ix:footnote id="fn-2" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Includes $<ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" scale="6" id="f-156"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" scale="6" id="f-157">0.3</ix:nonFraction></ix:nonFraction> million in related party expenses for the three months ended March&#160;31, 2025 and 2024.</span></ix:footnote></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="id1024c8efdf34cb8889d12b6bf18881e_25"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Spyre Therapeutics, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Comprehensive Loss</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited, in thousands)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.263%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.265%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net loss</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-158">44,773</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-159">43,857</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other comprehensive income (loss):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="3" id="f-160">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="3" id="f-161">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unrealized gain (loss) on marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="f-162">488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="f-163">681</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total comprehensive loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-164">44,271</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-165">44,522</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="id1024c8efdf34cb8889d12b6bf18881e_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Spyre Therapeutics, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Changes in </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Convertible Preferred Stock and Stockholders&#8217; Equity</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited, in thousands)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.219%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.200%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.423%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.914%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.914%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.792%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.768%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.768%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.965%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="57" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended March 31, 2025</span></div></td></tr><tr style="height:32pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Series A <br/>Non-Voting Convertible<br/>Preferred Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Series B <br/>Non-Voting Convertible<br/>Preferred Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Additional</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Paid-In</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Capital </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Comprehensive</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Income</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Deficit </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stockholders'</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Equity</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Balances - December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-26" decimals="-3" name="us-gaap:PreferredStockSharesOutstanding" scale="3" id="f-166">346</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-167">146,425</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-27" decimals="-3" name="us-gaap:PreferredStockSharesOutstanding" scale="3" id="f-168">17</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-169">9,395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-28" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-170">60,257</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-171">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-172">1,334,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-173">180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-174">972,432</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-175">517,804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Issuance of common stock in connection with exercise of stock options and employee stock purchase plan</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-32" decimals="-3" name="syre:StockIssuedDuringPeriodSharesOptionsExercisedAndEmployeeStockOwnershipPlan" scale="3" id="f-176">19</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="syre:StockIssuedDuringPeriodValueOptionsExercisedAndEmployeeStockOwnershipPlan" scale="3" id="f-177">335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="syre:StockIssuedDuringPeriodValueOptionsExercisedAndEmployeeStockOwnershipPlan" scale="3" id="f-178">335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-179">8,859</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-180">8,859</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Cash settlement of stock option award</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="syre:ShareBasedPaymentArrangementSettlementOptionsCash" scale="3" id="f-181">117</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="syre:ShareBasedPaymentArrangementSettlementOptionsCash" scale="3" id="f-182">117</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Foreign currency translation adjustment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="3" id="f-183">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="3" id="f-184">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Unrealized gain on marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="f-185">488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="f-186">488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-187">44,773</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-188">44,773</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Balances - March 31, 2025</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-36" decimals="-3" name="us-gaap:PreferredStockSharesOutstanding" scale="3" id="f-189">346</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-190">146,425</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-37" decimals="-3" name="us-gaap:PreferredStockSharesOutstanding" scale="3" id="f-191">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-192">9,395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-38" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-193">60,276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-194">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-195">1,343,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-196">682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-197">1,017,205</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-198">482,610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div id="id1024c8efdf34cb8889d12b6bf18881e_31"></div><div style="padding-right:-13.5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.443%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.244%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.211%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.197%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.211%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.374%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.211%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.197%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.211%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.319%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.211%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.833%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.211%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.888%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.211%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.211%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.211%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.024%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="57" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended March 31, 2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:32pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Series B <br/>Non-Voting Convertible Preferred Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Series A <br/>Non-Voting Convertible<br/>Preferred Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Additional</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Paid-In</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Capital </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Comprehensive</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Income (Loss)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Deficit </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stockholders'</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Equity</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Balances - December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-42" decimals="-3" name="us-gaap:TemporaryEquitySharesOutstanding" scale="3" id="f-199">150</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-200">84,555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-43" decimals="-3" name="us-gaap:PreferredStockSharesOutstanding" scale="3" id="f-201">437</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-202">184,927</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-44" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-203">36,057</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-204">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-205">763,191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-206">302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-207">764,414</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-208">184,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Issuance of Series B non-voting convertible preferred stock in connection with private placement, net of financing costs</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-49" decimals="-3" name="syre:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" scale="3" id="f-209">122</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-210">168,850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Issuance of common stock in connection with exercise of stock options and employee stock purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-50" decimals="-3" name="syre:StockIssuedDuringPeriodSharesOptionsExercisedAndEmployeeStockOwnershipPlan" scale="3" id="f-211">572</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-3" name="syre:StockIssuedDuringPeriodValueOptionsExercisedAndEmployeeStockOwnershipPlan" format="ixt:num-dot-decimal" scale="3" id="f-212">4,390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="syre:StockIssuedDuringPeriodValueOptionsExercisedAndEmployeeStockOwnershipPlan" format="ixt:num-dot-decimal" scale="3" id="f-213">4,390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-214">8,385</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-215">8,385</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Foreign currency translation adjustment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="3" id="f-216">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="3" id="f-217">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Unrealized loss on marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="f-218">681</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="f-219">681</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-220">43,857</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-221">43,857</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Balances - March 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-54" decimals="-3" name="us-gaap:TemporaryEquitySharesOutstanding" scale="3" id="f-222">272</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-223">253,405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-55" decimals="-3" name="us-gaap:PreferredStockSharesOutstanding" scale="3" id="f-224">437</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-225">184,927</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-56" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-226">36,629</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-227">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-228">775,966</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-229">363</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-230">808,271</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-231">152,269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt;padding-right:-13.5pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="id1024c8efdf34cb8889d12b6bf18881e_34"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Spyre Therapeutics, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited, in thousands)</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:120%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:120%">&#160;</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:120%">CASH FLOWS FROM OPERATING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-232">44,773</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-233">43,857</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-234">8,859</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-235">13,835</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Change in fair value of CVR liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" format="ixt:num-dot-decimal" scale="3" id="f-236">2,400</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="3" id="f-237">430</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Net accretion of discount on marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" format="ixt:num-dot-decimal" scale="3" id="f-238">2,642</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" format="ixt:num-dot-decimal" scale="3" id="f-239">2,423</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Interest proceeds from maturities of zero coupon US Treasury Bills</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="syre:InterestProceedsDebtSecurities" scale="3" id="f-240">530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="syre:InterestProceedsDebtSecurities" format="ixt:fixed-zero" scale="3" id="f-241">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" format="ixt:num-dot-decimal" scale="3" id="f-242">3,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" format="ixt:num-dot-decimal" scale="3" id="f-243">2,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Accrued and other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-244">5,998</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-245">8,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Related party accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="f-246">1,945</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="f-247">6,507</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="f-248">462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="f-249">381</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Net cash used in operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-250">40,994</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-251">28,542</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:120%">CASH FLOWS FROM INVESTING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Proceeds from maturities and sales of marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="3" id="f-252">71,383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="3" id="f-253">47,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Purchases of marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="3" id="f-254">71,444</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="3" id="f-255">152,713</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="f-256">61</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-257">104,963</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:120%">CASH FLOWS FROM FINANCING ACTIVITIES</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Proceeds from issuance of Series B non-voting convertible preferred stock in connection with private placement, net of placement and other offering costs </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" format="ixt:fixed-zero" scale="3" id="f-258">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" format="ixt:num-dot-decimal" scale="3" id="f-259">169,205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Payments related to CVR</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-260">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-261">1,430</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Payment of deferred offering costs in connection with shelf registration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="syre:PaymentForDeferredOfferingCosts" scale="3" id="f-262">93</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="syre:PaymentForDeferredOfferingCosts" format="ixt:fixed-zero" scale="3" id="f-263">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Proceeds from employee stock option exercises and employee stock plan purchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="3" id="f-264">335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" format="ixt:num-dot-decimal" scale="3" id="f-265">4,390</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Cash settlement of employee stock option award</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="syre:PaymentForSettlementOfShareBasedPaymentArrangement" scale="3" id="f-266">117</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="syre:PaymentForSettlementOfShareBasedPaymentArrangement" format="ixt:fixed-zero" scale="3" id="f-267">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="f-268">125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-269">172,165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Effect of exchange rate on cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:fixed-zero" scale="3" id="f-270">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="f-271">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">NET (DECREASE) INCREASE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-272">40,930</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-273">38,656</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:120%">CASH, CASH EQUIVALENTS, AND RESTRICTED CASH</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-274">89,423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-275">189,215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">End of period</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-276">48,493</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-277">227,871</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Supplemental Disclosure of Non-Cash Financing Information:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Unpaid deferred offering costs in connection with shelf registration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="syre:DeferredOfferingCostsUnpaidAmount" scale="3" id="f-278">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="syre:DeferredOfferingCostsUnpaidAmount" format="ixt:fixed-zero" scale="3" id="f-279">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Unpaid amounts related to issuance of Series B non-voting convertible preferred stock in connection with private placement</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="syre:IssuanceOfConvertiblePreferredStockRelatedToPrivatePlacementUnpaidAmount" format="ixt:fixed-zero" scale="3" id="f-280">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="syre:IssuanceOfConvertiblePreferredStockRelatedToPrivatePlacementUnpaidAmount" scale="3" id="f-281">355</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Reconciliation of Cash, Cash Equivalents, and Restricted Cash Reported in the Statement of Financial Position:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-282">48,493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-283">227,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:RestrictedCash" format="ixt:fixed-zero" scale="3" id="f-284">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-3" name="us-gaap:RestrictedCash" scale="3" id="f-285">319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Total cash, cash equivalents, and restricted cash shown in the statement of cash flows</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-286">48,493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-287">227,871</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:3pt;text-align:center"><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="id1024c8efdf34cb8889d12b6bf18881e_37"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Spyre Therapeutics, Inc.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Unaudited Condensed Consolidated Financial Statements</span></div><div id="id1024c8efdf34cb8889d12b6bf18881e_40"></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. <ix:nonNumeric contextRef="c-1" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="f-288" continuedAt="f-288-1" escape="true">The Company and Basis of Presentation</ix:nonNumeric></span></div><ix:continuation id="f-288-1" continuedAt="f-288-2"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Spyre Therapeutics, Inc., formerly Aeglea BioTherapeutics, Inc. (&#8220;Spyre&#8221; or the &#8220;Company&#8221;), is a clinical stage biotechnology company focused on developing next generation therapeutics for patients living with inflammatory bowel disease and other immune-mediated diseases. The Company was formed as a Limited Liability Company in Delaware on December 16, 2013 under the name Aeglea BioTherapeutics Holdings, LLC and was converted from a Delaware LLC to a Delaware corporation on March 10, 2015. On November 27, 2023, the Company completed its corporate rebranding, changing the name of the Company to Spyre Therapeutics, Inc. The Company operates in <ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="f-289">one</ix:nonFraction> segment and has its principal offices in Waltham, Massachusetts.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 22, 2023, the Company acquired, in accordance with the terms of the Agreement and Plan of Merger (the "Acquisition Agreement"), the assets of Spyre Therapeutics, Inc. (&#8220;Pre-Merger Spyre&#8221;), a privately held biotechnology company advancing a pipeline of antibody therapeutics with the potential to transform the treatment of inflammatory bowel disease through a research and development option agreement (as amended, the "Paragon Agreement") with Paragon Therapeutics, Inc. ("Paragon") and Parapyre Holding LLC (&#8220;Parapyre&#8221;) (the "Asset Acquisition"). The Asset Acquisition was accomplished through a two-step reverse triangular merger whereby Aspen Merger Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of the Company ("First Merger Sub"), merged with and into Pre-Merger Spyre, which existed at the time the Acquisition Agreement was entered into, and became a wholly owned subsidiary of the Company in accordance with the terms of the Acquisition Agreement. Immediately following this merger, Pre-Merger Spyre merged with and into Sequoia Merger Sub II, LLC, a Delaware limited liability company and a wholly subsidiary of the Company (&#8220;Second Merger Sub&#8221;), in accordance with the terms of the Acquisition Agreement and Pre-Merger Spyre ceased to exist. Subsequently, Aeglea BioTherapeutics, Inc. was renamed Spyre Therapeutics, Inc. and is a different entity than Pre-Merger Spyre, which ceased to exist upon merging with Second Merger Sub.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Asset Acquisition, a non-transferable contingent value right ("CVR") was distributed to stockholders of record of the Company as of the close of business on July 3, 2023 (the "Legacy Stockholders"). Holders of the CVRs will be entitled to receive cash payments from proceeds received by the Company for a <ix:nonNumeric contextRef="c-61" name="syre:AssetAcquisitionStockholderPaymentPeriod" format="ixt-sec:durwordsen" id="f-290">three-year</ix:nonNumeric> period related to the disposition or monetization of its legacy assets for a period of <ix:nonNumeric contextRef="c-61" name="syre:AssetAcquisitionCashPaymentThresholdPeriod" format="ixt-sec:durwordsen" id="f-291">one-year</ix:nonNumeric> following the closing of the Asset Acquisition.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 20, 2024, the Company completed a private placement of Series B non-voting convertible preferred stock, par value of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-62" decimals="4" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" id="f-292">0.0001</ix:nonFraction> per share ("Series B Preferred Stock") (convertible on a <ix:nonFraction unitRef="number" contextRef="c-63" decimals="0" name="us-gaap:PreferredStockConvertibleConversionRatio" scale="0" id="f-293">40</ix:nonFraction> to 1 basis) (the &#8220;March 2024 PIPE&#8221;) to a group of investors. The Company sold <ix:nonFraction unitRef="shares" contextRef="c-64" decimals="INF" name="syre:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-294">121,625</ix:nonFraction> shares of Series B Preferred Stock at $<ix:nonFraction unitRef="usdPerShare" contextRef="c-65" decimals="2" name="us-gaap:SaleOfStockPricePerShare" format="ixt:num-dot-decimal" scale="0" id="f-295">1,480</ix:nonFraction> per share. The net proceeds from this offering were approximately $<ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="f-296">168.9</ix:nonFraction> million after deducting placement and offering costs of $<ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-5" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="6" id="f-297">11.2</ix:nonFraction> million.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 23, 2024, the Company entered into an exchange agreement with Fairmount Healthcare Fund II L.P. (the &#8220;Stockholder&#8221;), pursuant to which the Stockholder agreed to exchange an aggregate of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-67" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="f-298">90,992</ix:nonFraction></span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shares of Series A non-voting convertible preferred stock, par val</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ue of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-68" decimals="4" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-299">0.0001</ix:nonFraction> per share ("Se</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ries A Preferred Stock"), par value of  for an aggregate of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-69" decimals="INF" name="syre:StockIssuedDuringPeriodSharesExchangeOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="f-300">3,639,680</ix:nonFraction></span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shares of the Company's common stock (the &#8220;April 2024 Exchange&#8221;). The common stock issued in connection with the April 2024 Exchange was issued without registration under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;) in reliance on the exemption from registration contained in Section 3(a)(9) of the Securities Act. The April 2024 Exchange closed on April 25, 2024, with </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-70" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-301">346,045</ix:nonFraction></span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shares of Series A Preferred Stock remaining outstanding following the April 2024 Exchange.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 14, 2024, the Company's stockholders approved the issuance of its common stock upon conversion of the Company's Series B Preferred Stock to common stock. A total of <ix:nonFraction unitRef="shares" contextRef="c-71" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="f-302">254,958</ix:nonFraction> shares of Series B </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><ix:continuation id="f-288-2" continuedAt="f-288-3"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preferred Stock automatically converted to <ix:nonFraction unitRef="shares" contextRef="c-72" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="f-303">10,198,320</ix:nonFraction> shares of common stock; <ix:nonFraction unitRef="shares" contextRef="c-12" decimals="INF" name="syre:PreferredStockSharesNotAutomaticallyConvertedOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-304">16,667</ix:nonFraction> shares of Series B Preferred Stock did not automatically convert and remained outstanding as of March&#160;31, 2025.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 6, 2024, the Company filed a new shelf registration statement on Form S-3 that was declared effective by the SEC for the potential offering, issuance and sale by the Company of up to $<ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-5" name="syre:SaleOfStockAuthorizedAmount" format="ixt:num-dot-decimal" scale="6" id="f-305">500.0</ix:nonFraction>&#160;million of its common stock, preferred stock, debt securities, warrants and/or units consisting of all or some of these securities. Concurrent with the filing of the shelf-registration statement, the Company entered into a sales agreement, dated September 6, 2024, with TD Securities (USA) LLC (&#8220;TD Cowen&#8221;) ("Sales Agreement"), as its sales agent, pursuant to which the Company may issue and sell shares of its common stock for an aggregate offering price of up to $<ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-5" name="syre:SaleOfStockAggregateOfferingPrice" format="ixt:num-dot-decimal" scale="6" id="f-306">200.0</ix:nonFraction>&#160;million under an at-the-market (&#8220;ATM&#8221;) offering program included in the shelf registration. During the year ended December 31, 2024, the Company sold an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-75" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-307">777,432</ix:nonFraction> shares of common stock under the ATM at an average price per share of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-76" decimals="3" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-308">26.935</ix:nonFraction>, resulting in aggregate net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="f-309">20.5</ix:nonFraction> million after deducting $<ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-5" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="6" id="f-310">0.4</ix:nonFraction> million in commissions paid to TD Cowen as sales agent and other offering costs. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 18, 2024, the Company entered into an underwriting agreement (the "Underwriting Agreement") with Jefferies LLC, Goldman Sachs &amp; Co. LLC, Evercore Group L.L.C. and Guggenheim Securities, LLC as representatives of the several underwriters (collectively, the "Underwriters"), pursuant to which the Company sold an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-77" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-311">8,366,250</ix:nonFraction> shares of its common stock, inclusive of <ix:nonFraction unitRef="shares" contextRef="c-78" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-312">1,091,250</ix:nonFraction> shares pursuant to the full exercise of the Underwriters' over-allotment option, at a public offering price per share of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-79" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-313">27.50</ix:nonFraction>, resulting in net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="6" id="f-314">215.9</ix:nonFraction>&#160;million after deducting approximately $<ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-5" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="f-315">14.2</ix:nonFraction>&#160;million of underwriting discounts and other offering costs (the "November 2024 Offering"). The November 2024 Offering closed on November 20, 2024 and the over-allotment option was exercised in full on November 26, 2024 and closed on November 29, 2024. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2025, the Company filed a new shelf registration statement on Form S-3 (the "February 2025 Shelf Registration Statement") that was declared effective by the SEC for the potential offering, issuance and sale of up to $<ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-5" name="syre:SaleOfStockAuthorizedAmount" format="ixt:num-dot-decimal" scale="6" id="f-316">500.0</ix:nonFraction>&#160;million of shares of common stock, preferred stock, debt securities, warrants and/or units consisting of all or some of these securities. Concurrent with the effectiveness of the February 2025 Shelf Registration Statement, the offering of unsold securities under a previous shelf registration statement on Form S-3 (File No. 333-281975), which was initially filed with the SEC on September 6, 2024 and became effective on September 18, 2024, was deemed terminated pursuant to Rule 415(a)(6) under the Securities Act. The February 2025 Shelf Registration Statement contains a sales agreement prospectus supplement covering the offering, issuance and sale by the Company of up to $<ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-5" name="syre:SaleOfStockAggregateOfferingPrice" format="ixt:num-dot-decimal" scale="6" id="f-317">179.1</ix:nonFraction>&#160;million of shares of common stock that may be issued and sold under the Sales Agreement in connection with the ATM offering program. No shares were sold under the ATM offering program during the three months ended March 31, 2025.  As of March 31, 2025, $<ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-5" name="syre:SaleOfStockRemainingAuthorizedAmount" format="ixt:num-dot-decimal" scale="6" id="f-318">179.1</ix:nonFraction>&#160;million remained available for sale under the Sales Agreement. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a clinical stage biotechnology company with a limited operating history, and due to its significant research and development expenditures, the Company has generated operating losses since its inception and has not generated any revenue from the commercial sale of any products. There can be no assurance that profitable operations will ever be achieved, and, if achieved, whether profitability can be sustained on a continuing basis.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since its inception and through March&#160;31, 2025, the Company has funded its operations by raising an aggregate of approximately $<ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-8" name="syre:ProceedsFromRaisingCapital" format="ixt:num-dot-decimal" scale="9" id="f-319">1.3</ix:nonFraction>&#160;billion of gross proceeds from the sale and issuance of convertible preferred stock and common stock, pre-funded warrants, the collection of grant proceeds, and the licensing of its product rights for commercialization of pegzilarginase in Europe and certain countries in the Middle East. As of March&#160;31, 2025, Spyre had an accumulated deficit of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-8" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="9" id="f-320">1.0</ix:nonFraction>&#160;billion, and cash, cash equivalents, and marketable securities of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="6" id="f-321">564.8</ix:nonFraction>&#160;million.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on its current operating plans, the Company has sufficient resources to fund operations for at least one year from the issuance date of these financial statements with existing cash, cash equivalents, and marketable securities. The Company will need to secure additional financing in the future to fund additional research and development, and before a commercial drug can be produced, marketed and sold. If the Company </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><ix:continuation id="f-288-3"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is unable to obtain additional financing or generate license or product revenue, the lack of liquidity could have a material adverse effect on the Company.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="f-322" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States (&#8220;U.S. GAAP&#8221;) as defined by the Financial Accounting Standards Board and include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.</span></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unaudited Interim Financial Information</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interim condensed consolidated financial statements included in this Quarterly Report on Form 10-Q are unaudited. The unaudited interim financial statements have been prepared on the same basis as the annual financial statements and reflect, in the opinion of management, all adjustments of a normal and recurring nature that are necessary for a fair statement of the Company&#8217;s financial position as of March&#160;31, 2025, and its results of operations for the three months ended March&#160;31, 2025 and 2024, changes in convertible preferred stock and stockholders&#8217; equity for the three months ended March&#160;31, 2025 and 2024, and cash flows for the three months ended March&#160;31, 2025 and 2024. The results of operations for the three months ended March&#160;31, 2025, are not necessarily indicative of the results to be expected for the year ending December&#160;31, 2025 or for any other future annual or interim period. The December&#160;31, 2024 balance sheet was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP for complete financial statements. These financial statements should be read in conjunction with the audited financial statements included in the Company&#8217;s Form 10-K for the year ended December&#160;31, 2024 (the "Annual Report") as filed with the SEC on February 27, 2025.</span></div></ix:continuation><div id="id1024c8efdf34cb8889d12b6bf18881e_46"></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="c-1" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="f-323" continuedAt="f-323-1" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="f-323-1" continuedAt="f-323-2"><div style="margin-top:18pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These interim condensed consolidated financial statements have been prepared in accordance with U.S. GAAP and SEC instructions for interim financial information, and should be read in conjunction with the Company's Annual Report. Significant accounting policies and other disclosures normally provided have been omitted since such items are disclosed in the Company's Annual Report. The Company uses the same accounting policies in preparing quarterly and annual financial statements.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no significant changes from the significant accounting policies and estimates disclosed in the Notes titled &#8220;1. The Company and Basis of Presentation&#8221; and "2. Summary of Significant Accounting Policies&#8221; of the Company's Annual Report.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-324" continuedAt="f-324-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no recent accounting pronouncements or changes in accounting pronouncements during the three months ended March&#160;31, 2025 that are of significance or potential significance to the Company.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Not Yet Adopted Accounting Pronouncements</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the Financial Accounting Standards Board&#8217;s ("FASB") issued Accounting Standards Update 2023-09 ("ASU 2023-09"), Income Taxes (Topic 740): Improvements to Income Tax Disclosures. ASU 2023-09 expands disclosures in an entity&#8217;s income tax rate reconciliation table and disclosures regarding taxes paid both in the U.S. and foreign jurisdictions. This update is effective for fiscal years beginning after December 15, 2024. ASU 2023-09 will have no impact on the Company&#8217;s consolidated financial condition or results of operations. The Company is currently evaluating the impact to its income tax disclosures.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, the Financial Accounting Standards Board issued Accounting Standards Update 2024-03 ("ASU 2024-03") Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses to require more detailed information about specified categories of expenses (purchases of inventory, employee compensation, depreciation, amortization, and depletion) included in certain expense captions presented on the face of the </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><ix:continuation id="f-324-1"><ix:continuation id="f-323-2"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">income statement. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and for interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. The amendments may be applied either (1) prospectively to financial statements issued for reporting periods after the effective date of this ASU or (2) retrospectively to all prior periods presented in the financial statements. The Company is currently evaluating the impact ASU 2024-03 will have on its disclosures.</span></div></ix:continuation></ix:continuation><div id="id1024c8efdf34cb8889d12b6bf18881e_49"></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3. <ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueDisclosuresTextBlock" id="f-325" continuedAt="f-325-1" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><ix:continuation id="f-325-1" continuedAt="f-325-2"><div style="margin-top:18pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures and reports certain financial instruments as assets and liabilities at fair value on a recurring basis. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="f-326" continuedAt="f-326-1" escape="true">The following tables set forth the fair value of the Company&#8217;s financial assets and liabilities at fair value on a recurring basis based on the three-tier fair value hierarchy (in thousands):</ix:nonNumeric></span></div><ix:continuation id="f-326-1"><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31, 2025</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 3</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-327">46,800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-328">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-329">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-330">46,800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 15.4pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government treasury securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-331">223,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-332">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-333">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-334">223,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 15.4pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-335">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-336">72,730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-337">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-338">72,730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 15.4pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-339">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-340">147,450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-341">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-342">147,450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 15.4pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-343">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-344">72,647</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-345">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-346">72,647</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total financial assets</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-347">270,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-348">292,827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-349">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-350">563,127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVR liability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-351">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-352">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-353">59,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-354">59,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-355">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-356">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-357">59,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-358">59,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 3</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-359">65,902</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-360">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-361">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-362">65,902</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government treasury securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-363">227,244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-364">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-365">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-366">227,244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-367">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-368">86,681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-369">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-370">86,681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 15.4pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-371">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-372">165,130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-373">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-374">165,130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 15.4pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-375">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-376">56,448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-377">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-378">56,448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total financial assets</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-379">293,146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-380">308,259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-381">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-382">601,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVR liability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-383">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-384">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-385">61,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-386">61,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-387">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-388">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-389">61,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-390">61,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures the fair value of money market funds and U.S. government treasury securities on quoted prices in active markets for identical assets or liabilities. The Level 2 assets include U.S. government agency securities, commercial paper and corporate bonds, and are valued based on quoted prices for similar assets in active markets and inputs other than quoted prices that are derived from observable market data. The Company evaluates transfers between levels at the end of each reporting period. There were no transfers between Level 1, Level 2, or Level 3 during the periods presented.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CVR Liability </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Asset Acquisition, a non-transferable CVR was distributed to the Legacy Stockholders. Holders of the CVR will be entitled to receive certain cash payments from proceeds received by </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><ix:continuation id="f-325-2"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company for a <ix:nonNumeric contextRef="c-61" name="syre:AssetAcquisitionStockholderPaymentPeriod" format="ixt-sec:durwordsen" id="f-391">three-year</ix:nonNumeric> period, if any, related to the disposition or monetization of the Company&#8217;s legacy assets for a period of <ix:nonNumeric contextRef="c-61" name="syre:AssetAcquisitionCashPaymentThresholdPeriod" format="ixt-sec:durwordsen" id="f-392">one year</ix:nonNumeric> following the closing of the Asset Acquisition.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the CVR liability was determined using the probability weighted discounted cash flow method to estimate future cash flows associated with the sale of the legacy assets. Analogous to a dividend being declared/approved in one period and paid out in another, the liability was recorded at the date of approval, June 22, 2023, as a common stock dividend, returning capital to the Legacy Stockholders. Changes in fair value of the liability will be recognized as a component of Other income (expense), net in the consolidated statement of operations and comprehensive loss in each reporting period. The liability value is based on significant inputs not observable in the market such as estimated cash flows, estimated probabilities of regulatory success, and discount rates, which represent a Level 3 measurement within the fair value hierarchy. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="f-393" continuedAt="f-393-1" escape="true">The significant inputs used to estimate the fair value of the CVR liability were as follows:</ix:nonNumeric></span></div><ix:continuation id="f-393-1"><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.748%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.052%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated cash flow dates</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">08/28/25 - 06/22/26</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated probability of success</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-139" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="f-394">72</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="c-140" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="f-395">100</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated reimbursement rate compared to reimbursement target</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-141" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="f-396">49</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="c-142" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="f-397">100</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk-adjusted discount rates</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-143" decimals="4" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="f-398">7.78</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="c-144" decimals="4" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="f-399">7.90</ix:nonFraction>%</span></div></td></tr></table></div></ix:continuation><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in fair value between December&#160;31, 2024 and March&#160;31, 2025 was a $<ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:num-dot-decimal" scale="6" id="f-400">2.4</ix:nonFraction>&#160;million decrease, primarily driven by changes in the likelihood of achievement of certain milestones and an increase in risk-adjusted discount rates, partially offset by  time value of money adjustments.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="f-401" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents changes in the CVR liability for the periods presented (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.082%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">CVR Liability</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning balance as of December 31, 2024</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="f-402">61,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of the CVR liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-3" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:num-dot-decimal" scale="3" id="f-403">2,400</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" format="ixt:fixed-zero" scale="3" id="f-404">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ending Balance as of March 31, 2025</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="f-405">59,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div id="id1024c8efdf34cb8889d12b6bf18881e_52"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. <ix:nonNumeric contextRef="c-1" name="us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock" id="f-406" continuedAt="f-406-1" escape="true">Cash Equivalents and Marketable Securities</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" id="f-407" continuedAt="f-407-1" escape="true"><ix:continuation id="f-406-1" continuedAt="f-406-2"><div style="margin-top:18pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the estimated fair value of the Company&#8217;s cash equivalents and marketable securities and the gross unrealized gains and losses (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31, 2025</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cost</span></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gains</span></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Losses</span></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Estimated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-3" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-408">46,800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-3" name="syre:CashEquivalentsUnrealizedGains" format="ixt:fixed-zero" scale="3" id="f-409">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-3" name="syre:CashEquivalentsUnrealizedLosses" format="ixt:fixed-zero" scale="3" id="f-410">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-411">46,800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total cash equivalents</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-412">46,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="syre:CashEquivalentsUnrealizedGains" format="ixt:fixed-zero" scale="3" id="f-413">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="syre:CashEquivalentsUnrealizedLosses" format="ixt:fixed-zero" scale="3" id="f-414">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-415">46,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-416">147,448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-417">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-418">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-419">147,450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-420">72,618</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-421">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-422">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-423">72,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government treasury securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-424">222,942</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-425">638</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-426">80</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-427">223,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.68pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-428">72,673</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-429">94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-430">37</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-431">72,730</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-432">515,681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-433">807</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-434">161</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-435">516,327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div style="margin-top:6pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><ix:continuation id="f-406-2" continuedAt="f-406-3"><ix:continuation id="f-407-1"><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cost</span></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gains</span></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Losses </span></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Estimated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-436">65,902</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" name="syre:CashEquivalentsUnrealizedGains" format="ixt:fixed-zero" scale="3" id="f-437">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" name="syre:CashEquivalentsUnrealizedLosses" format="ixt:fixed-zero" scale="3" id="f-438">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-439">65,902</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-440">21,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" name="syre:CashEquivalentsUnrealizedGains" scale="3" id="f-441">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" name="syre:CashEquivalentsUnrealizedLosses" format="ixt:fixed-zero" scale="3" id="f-442">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-443">21,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total cash equivalents</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-444">87,734</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="syre:CashEquivalentsUnrealizedGains" scale="3" id="f-445">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="syre:CashEquivalentsUnrealizedLosses" format="ixt:fixed-zero" scale="3" id="f-446">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-447">87,740</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-448">143,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-449">104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-450">77</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-451">143,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-452">56,471</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-453">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-454">48</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-455">56,448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government treasury securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-456">227,155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-457">385</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-458">296</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-459">227,244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.68pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-460">86,616</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-461">137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-462">72</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-463">86,681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-464">513,507</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-465">651</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-466">493</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-467">513,665</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" id="f-468" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the available-for-sale securities in an unrealized loss position for which an allowance for credit losses has not been recorded as of March&#160;31, 2025 and December&#160;31, 2024, aggregated by major security type and length of time in a continuous unrealized loss position:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.506%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.964%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31, 2025</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Less Than 12 Months</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">12 Months or Longer</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Losses </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Losses</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Losses </span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="3" id="f-469">36,057</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="f-470">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:fixed-zero" scale="3" id="f-471">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="3" id="f-472">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="3" id="f-473">36,057</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="f-474">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="3" id="f-475">13,129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="f-476">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:fixed-zero" scale="3" id="f-477">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="3" id="f-478">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="3" id="f-479">13,129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="f-480">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government treasury securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="3" id="f-481">32,810</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="f-482">80</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:fixed-zero" scale="3" id="f-483">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="3" id="f-484">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="3" id="f-485">32,810</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="f-486">80</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="3" id="f-487">23,154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="f-488">37</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:fixed-zero" scale="3" id="f-489">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="3" id="f-490">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="3" id="f-491">23,154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="f-492">37</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="3" id="f-493">105,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="f-494">161</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:fixed-zero" scale="3" id="f-495">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="3" id="f-496">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="3" id="f-497">105,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="f-498">161</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Less Than 12 Months</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">12 Months or Longer</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Losses </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Losses</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Losses </span></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="3" id="f-499">67,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="f-500">77</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:fixed-zero" scale="3" id="f-501">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="3" id="f-502">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="3" id="f-503">67,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="f-504">77</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="3" id="f-505">42,916</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="f-506">48</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:fixed-zero" scale="3" id="f-507">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="3" id="f-508">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="3" id="f-509">42,916</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="f-510">48</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government treasury securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="3" id="f-511">126,588</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="f-512">296</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:fixed-zero" scale="3" id="f-513">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="3" id="f-514">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="3" id="f-515">126,588</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="f-516">296</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="3" id="f-517">12,560</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="f-518">72</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-157" xsi:nil="true" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" id="f-519"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-157" xsi:nil="true" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" id="f-520"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="3" id="f-521">12,560</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="f-522">72</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="3" id="f-523">249,264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="f-524">493</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:fixed-zero" scale="3" id="f-525">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="3" id="f-526">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="3" id="f-527">249,264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="f-528">493</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluated its securities for credit losses and considered the decline in market value to be primarily attributable to current economic and market conditions and not to a credit loss or other factors. Additionally, the Company does not intend to sell the securities in an unrealized loss position and does not expect it will be required to sell the securities before recovery of the unamortized cost basis. As of March&#160;31, 2025 and December&#160;31, 2024, an allowance for credit losses had <ix:nonFraction unitRef="usd" contextRef="c-158" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="0" id="f-529"><ix:nonFraction unitRef="usd" contextRef="c-159" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="0" id="f-530">not</ix:nonFraction></ix:nonFraction> been recognized. Given the Company's intent and ability to hold such securities until recovery, and the lack of significant change in credit risk of these </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><ix:continuation id="f-406-3"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">investments, the Company does <ix:nonFraction unitRef="usd" contextRef="c-160" decimals="INF" name="syre:ImpairmentOfMarketableSecurities" format="ixt:fixed-zero" scale="0" id="f-531"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="INF" name="syre:ImpairmentOfMarketableSecurities" format="ixt:fixed-zero" scale="0" id="f-532">not</ix:nonFraction></ix:nonFraction> consider these marketable securities to be impaired as of March&#160;31, 2025 and December&#160;31, 2024. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial instruments that potentially subject the Company to a concentration of credit risk consist principally of cash deposits. Accounts at each of our <ix:nonFraction unitRef="bank" contextRef="c-3" decimals="INF" name="syre:NumberOfDomesticBankingInstitutions" format="ixt-sec:numwordsen" scale="0" id="f-533">two</ix:nonFraction> U.S. banking institutions are insured by the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) up to $<ix:nonFraction unitRef="usd" contextRef="c-162" decimals="INF" name="us-gaap:CashFDICInsuredAmount" format="ixt:num-dot-decimal" scale="0" id="f-534">250,000</ix:nonFraction> per depositor. As of March&#160;31, 2025 and December&#160;31, 2024, cash deposits at the Company's U.S. banking institutions exceeded the FDIC limits.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="c-161" decimals="INF" name="us-gaap:MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments" format="ixt:fixed-zero" scale="0" id="f-535"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="INF" name="us-gaap:MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments" format="ixt:fixed-zero" scale="0" id="f-536">no</ix:nonFraction></ix:nonFraction> realized gains or losses on marketable securities for the three months ended March&#160;31, 2025 and 2024. Interest on marketable securities is included in interest income. Accrued interest receivable on available-for-sale debt securities as of March&#160;31, 2025 and December&#160;31, 2024, was $<ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-5" name="us-gaap:InterestReceivable" scale="6" id="f-537"><ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-5" name="us-gaap:InterestReceivable" scale="6" id="f-538">3.4</ix:nonFraction></ix:nonFraction> million and is reflected in Prepaid expenses and other current assets.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="f-539" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the contractual maturities of the Company&#8217;s marketable securities at estimated fair value (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due in one year or less</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" format="ixt:num-dot-decimal" scale="3" id="f-540">367,106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" format="ixt:num-dot-decimal" scale="3" id="f-541">338,442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due in 1 - 2 years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="syre:DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOne" format="ixt:num-dot-decimal" scale="3" id="f-542">149,221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="syre:DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOne" format="ixt:num-dot-decimal" scale="3" id="f-543">175,223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-544">516,327</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-545">513,665</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may sell investments at any time for use in current operations even if they have not yet reached maturity. As a result, the Company classifies marketable securities, including securities with maturities beyond twelve months as current assets.</span></div></ix:continuation><div id="id1024c8efdf34cb8889d12b6bf18881e_55"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="c-1" name="syre:AccruedAndOtherCurrentLiabilitiesTextBlock" id="f-546" continuedAt="f-546-1" escape="true">Accrued and Other Current Liabilities </ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="f-547" escape="true"><ix:continuation id="f-546-1"><div style="margin-top:18pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued and other current liabilities consist of the following (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued compensation</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccruedSalariesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-548">1,561</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedSalariesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-549">5,688</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued contracted research and development costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="syre:AccruedContractedResearchAndDevelopmentCosts" format="ixt:num-dot-decimal" scale="3" id="f-550">19,078</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="syre:AccruedContractedResearchAndDevelopmentCosts" format="ixt:num-dot-decimal" scale="3" id="f-551">20,861</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued professional and consulting fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="f-552">621</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="f-553">661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="f-554">371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="f-555">501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total accrued and other current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-556">21,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-557">27,711</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div id="id1024c8efdf34cb8889d12b6bf18881e_61"></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. <ix:nonNumeric contextRef="c-1" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" id="f-558" continuedAt="f-558-1" escape="true">Licensing Agreements</ix:nonNumeric></span></div><ix:continuation id="f-558-1" continuedAt="f-558-2"><div style="margin-top:18pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 12, 2023, December 14, 2023, and June 5, 2024, the Company exercised the Option available under the Paragon Agreement with respect to the SPY001, SPY002, and SPY003 research programs, respectively. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 14, 2024, the Company and Paragon entered into (i) a license agreement (the &#8220;SPY001 License Agreement&#8221;), pursuant to which Paragon granted the Company a royalty-bearing, world-wide, exclusive license to develop, manufacture, commercialize or otherwise exploit certain antibodies and products targeting &#945;4&#223;7 integrin and (ii) a license agreement (the &#8220;SPY002 License Agreement&#8221;), pursuant to which Paragon granted the Company a royalty-bearing, world-wide, exclusive license to develop, manufacture, commercialize or otherwise exploit certain antibodies and products targeting TL1A, respectively.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 11, 2024, the Company and Paragon entered into a license agreement (as amended, the "SPY003 License Agreement", and together with the SPY001 License Agreement and the SPY002 License Agreement, the "License Agreements"), pursuant to which Paragon granted the Company a royalty-bearing, </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><ix:continuation id="f-558-2"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">world-wide, exclusive license to develop, manufacture, commercialize or otherwise exploit certain antibodies and products targeting IL-23 in the field of IBD.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 24, 2025, the SPY003 License Agreement was amended and restated to, among other things, clarify each party's rights and obligations with respect to license exclusivity and patent prosecution.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of each License Agreement, the Company is obligated to pay Paragon up to $<ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-5" name="syre:AmountToBePaidUnderAgreement" scale="6" id="f-559"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-5" name="syre:AmountToBePaidUnderAgreement" scale="6" id="f-560"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-5" name="syre:AmountToBePaidUnderAgreement" scale="6" id="f-561">22.0</ix:nonFraction></ix:nonFraction></ix:nonFraction> million based on specific development, regulatory and clinical milestones for the first product under each agreement, respectively, that achieves such specified milestones, including a milestone payment of $<ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-5" name="syre:PaymentOfMilestone" scale="6" id="f-562"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-5" name="syre:PaymentOfMilestone" scale="6" id="f-563"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-5" name="syre:PaymentOfMilestone" scale="6" id="f-564">3.0</ix:nonFraction></ix:nonFraction></ix:nonFraction> million upon the first dosing of a human patient in a Phase 2 trial. In addition, the following summarizes other key terms of each License Agreement:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Paragon will provide the Company with an exclusive license (such license, with respect to the SPY003 License Agreement only, being limited to the field of IBD) to its patents covering the related antibody, the method of use and its method of manufacture.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Paragon will not conduct any new campaigns that generate anti-&#945;4&#223;7 or anti-TL1A monospecific antibodies in any field or anti-IL-23 monospecific antibodies in the field of IBD, in each case for at least <ix:nonNumeric contextRef="c-169" name="syre:CampaignTimelineMinimumTerm" format="ixt-sec:duryear" id="f-565">5</ix:nonNumeric> years.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">The Company will pay Paragon a low single-digit percentage royalty for single antibody products and a mid single-digit percentage royalty for products containing more than one antibody from Paragon.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">There is a royalty step-down of 1/3rd if there is no Paragon patent in effect during the royalty term.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">The royalty term ends on the later of (i) the last-to-expire licensed patent or Company patent directed to the manufacture, use or sale of a licensed antibody in the country at issue or (ii) <ix:nonNumeric contextRef="c-169" name="syre:RoyaltyTermExpirationPeriod" format="ixt-sec:duryear" id="f-566">12</ix:nonNumeric> years from the date of first sale of a Company product. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Agreement may be terminated on <ix:nonNumeric contextRef="c-169" name="syre:TerminationNoticePeriod" format="ixt-sec:durday" id="f-567">60</ix:nonNumeric> days&#8217; notice by the Company; on material breach without cure; and to the extent permitted by law, on a party&#8217;s insolvency or bankruptcy.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">With respect to the SPY002 License Agreement only, on a product by product basis, the Company will pay sublicensing fees of up to approximately $<ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-5" name="syre:SublicensingFee" scale="6" id="f-568">20</ix:nonFraction> million upon the achievement of mostly commercial milestones.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes the expense associated with each milestone when the achievement of the milestone is deemed probable. During the three months ended March&#160;31, 2025, the Company recognized expense of $<ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-5" name="syre:LicenseAgreementMilestoneExpenseAmountRecognized" scale="6" id="f-569">2.5</ix:nonFraction> million related to Paragon license milestone payments recorded within Research and development expenses in the accompanying condensed statement of operations. There was <ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-5" name="syre:LicenseAgreementMilestoneExpenseAmountRecognized" format="ixt:fixed-zero" scale="0" id="f-570">no</ix:nonFraction> such expense for the three months ended March&#160;31, 2024. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2025 and 2024, there were <ix:nonFraction unitRef="usd" contextRef="c-171" decimals="INF" name="syre:LicenseAgreementMilestonePayments" format="ixt:fixed-zero" scale="0" id="f-571"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="INF" name="syre:LicenseAgreementMilestonePayments" format="ixt:fixed-zero" scale="0" id="f-572">no</ix:nonFraction></ix:nonFraction> cash milestone payments to Paragon. As of March&#160;31, 2025 and December 31, 2024, there were $<ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-5" name="syre:LicenseAgreementMilestonePaymentsOutstandingAndPayable" scale="6" id="f-573">2.5</ix:nonFraction> million and <ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-5" name="syre:LicenseAgreementMilestonePaymentsOutstandingAndPayable" format="ixt:fixed-zero" scale="0" id="f-574">nil</ix:nonFraction>, respectively, of Paragon license milestone payments outstanding and payable to Paragon. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Additionally, there were <ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-5" name="syre:SublicensingFee" format="ixt:fixed-zero" scale="0" id="f-575"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-5" name="syre:SublicensingFee" format="ixt:fixed-zero" scale="0" id="f-576">no</ix:nonFraction></ix:nonFraction> expenses recognized related to sublicensing fees for the three months ended March&#160;31, 2025 and 2024. For the three months ended March&#160;31, 2025 and 2024, the Company made sublicensing fees payments to Paragon totaling $<ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-5" name="syre:PaymentForSublicensingFee" scale="6" id="f-577">0.5</ix:nonFraction> million and <ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-5" name="syre:PaymentForSublicensingFee" format="ixt:fixed-zero" scale="0" id="f-578">nil</ix:nonFraction>, respectively.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2025 and December 31, 2024, <ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-5" name="syre:SublicensingFeeOutstandingAndPayable" format="ixt:fixed-zero" scale="0" id="f-579">nil</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-5" name="syre:SublicensingFeeOutstandingAndPayable" scale="6" id="f-580">0.5</ix:nonFraction> million in sublicensing fees were outstanding and payable to Paragon, respectively.</span></div></ix:continuation><div id="id1024c8efdf34cb8889d12b6bf18881e_67"></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7. <ix:nonNumeric contextRef="c-1" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="f-581" continuedAt="f-581-1" escape="true">Related Party Transactions</ix:nonNumeric></span></div><ix:continuation id="f-581-1" continuedAt="f-581-2"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Paragon and Parapyre each beneficially own less than <ix:nonFraction unitRef="number" contextRef="c-176" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="f-582">5</ix:nonFraction>% of a class of the Company's voting securities through their respective holdings of the Company's common stock. Fairmount Funds Management LLC ("Fairmount") beneficially owns more than <ix:nonFraction unitRef="number" contextRef="c-177" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="f-583">5</ix:nonFraction>% of a class of the Company's voting securities, has <ix:nonFraction unitRef="seat" contextRef="c-178" decimals="0" name="syre:RelatedPartyTransactionNumberOfBoardSeats" format="ixt-sec:numwordsen" scale="0" id="f-584">two</ix:nonFraction> seats on the Board (held by Peter Harwin and Tomas Kiselak) and beneficially owns more than <ix:nonFraction unitRef="number" contextRef="c-177" decimals="2" name="syre:MinorityInterestOwnershipPercentageByNoncontrollingOwnersHeldInThirdParty" scale="-2" id="f-585">5</ix:nonFraction>% of Paragon. Fairmount appointed Paragon's board of directors and has the contractual right to approve the appointment of </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><ix:continuation id="f-581-2" continuedAt="f-581-3"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any executive officers of Paragon. Parapyre is an entity formed by Paragon as a vehicle to hold equity in Spyre in order to share profits with certain employees of Paragon and will not perform any substantive role under the Paragon Agreement other than to receive warrants granted to Parapyre under the Paragon Agreement. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock" id="f-586" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is the summary of expenses related to the Paragon Agreement and License Agreements, which are ultimately settled in cash (in millions) and recorded within Research and development in the consolidated statement of operations for the periods presented:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.629%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:27pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reimbursable costs under the Paragon Agreement</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" format="ixt:fixed-zero" scale="6" id="f-587">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="6" id="f-588">11.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">License Agreements milestone and sublicensing fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="6" id="f-589">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" format="ixt:fixed-zero" scale="6" id="f-590">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total related party expense (excludes stock-based compensation)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="6" id="f-591">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="6" id="f-592">11.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="syre:ScheduleOfBalancesDueToAffiliatesTableTextBlock" id="f-593" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is the summary of Related party accounts payable and other current liabilities (in millions):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reimbursable costs under the Paragon Agreement</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-5" name="us-gaap:AccountsPayableOtherCurrent" format="ixt:fixed-zero" scale="6" id="f-594">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-5" name="us-gaap:AccountsPayableOtherCurrent" scale="6" id="f-595">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">License Agreements development milestone liability (see Note 6)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-5" name="us-gaap:AccountsPayableOtherCurrent" scale="6" id="f-596">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-5" name="us-gaap:AccountsPayableOtherCurrent" scale="6" id="f-597">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total related party accounts payable</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:AccountsPayableOtherCurrent" scale="6" id="f-598">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:AccountsPayableOtherCurrent" scale="6" id="f-599">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Paragon Agreement</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Asset Acquisition, the Company assumed the rights and obligations of Pre-Merger Spyre under the Paragon Agreement. Spyre is obligated to compensate Paragon for its services performed under each research program based on the actual costs incurred with mark-up costs pursuant to the terms of the Paragon Agreement. Spyre was also obligated under the Paragon Agreement to issue Parapyre annual equity grants of warrants in accordance with the Parapyre Option Obligation (as defined below). </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 12, 2023, December 14, 2023, and June 5, 2024, the Company exercised the Option available under the Paragon Agreement with respect to the SPY001, SPY002 and SPY003 research programs, respectively. Please refer to Note 6 for additional information on the License Agreements.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 14, 2024, the Company, Paragon and Parapyre entered into a second amended and restated antibody discovery and option agreement that amends and restates that certain amended and restated antibody discovery and option agreement, dated September 29, 2023, by and between Paragon, Parapyre and Spyre Therapeutics, LLC, in order to, among other things, (i) replace the Company&#8217;s subsidiary with the Company as a party to the agreement and (ii) amend certain terms related to the SPY003 research program, including without limitation, (a) establishing an SPY003 antibody selection process pursuant to which the Company and Paragon shall alternate in turn to select a project antibody to be included and excluded, respectively, from the Company&#8217;s rights under its option to license certain intellectual property rights related to SPY003 from Paragon until all project antibodies under the SPY003 research program have been selected; (b) reducing the development costs invoiced to the Company for the SPY003 research program incurred from and after April 1, 2024 through completion of the SPY003 antibody selection process by <ix:nonFraction unitRef="number" contextRef="c-184" decimals="2" name="syre:DevelopmentCostReductionPercentage" scale="-2" id="f-600">50</ix:nonFraction>%; (c) requiring Paragon to reimburse the Company for <ix:nonFraction unitRef="number" contextRef="c-185" decimals="2" name="syre:DevelopmentCostReimbursementPercentage" scale="-2" id="f-601">50</ix:nonFraction>% of the development costs for the SPY003 research program incurred prior to April 1, 2024; provided, that Paragon receives rights to at least one SPY003 project antibody following completion of the SPY003 antibody selection process; (d) obligating the Company to exercise its option to license the intellectual property rights to SPY003 project antibodies and technology following the completion of the SPY003 antibody selection process; and (e) establishing a license agreement term sheet for the SPY003 research program with substantially similar milestone payment terms and royalty payment terms as the SPY001 License Agreement. Please refer to Note 6 for additional disclosures. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2025 and 2024, the Company recognized de minimis and $<ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" scale="6" id="f-602">17.1</ix:nonFraction> million, respectively, expenses related to services provided by Paragon, of which <ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-5" name="us-gaap:ShareBasedCompensation" format="ixt:fixed-zero" scale="0" id="f-603">nil</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="f-604">5.4</ix:nonFraction> million, </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><ix:continuation id="f-581-3" continuedAt="f-581-4"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">respectively, of related stock-based compensation expense were recorded as Research and development expenses in the consolidated statements of operations. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2025 and 2024, the Company made payments totaling $<ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" scale="6" id="f-605">0.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" scale="6" id="f-606">18.2</ix:nonFraction> million respectively, in connection with the Paragon Agreement. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Parapyre Option Obligation</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Paragon Agreement, the Company agreed to issue Parapyre an annual equity grant of warrants, on the last business day of each of the years ended December 31, 2023 and December 31, 2024, to purchase <ix:nonFraction unitRef="number" contextRef="c-172" decimals="2" name="syre:CommonStockSharesOutstandingPercentageAvailableToPurchaseOnADilutedBasis" scale="-2" id="f-607">1</ix:nonFraction>% of the then outstanding shares of the Company's common stock, on a fully diluted basis, during the term of the Paragon Agreement (the "Parapyre Option Obligation"). See Note 9 for disclosures related to the Parapyre Option Obligation.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Paragon License Agreements</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 6 for disclosures related to the License Agreements entered into with Paragon.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mark McKenna Option Grant</span></div></ix:continuation><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-581-4">On February 1, 2024, the Board appointed Mark McKenna as a Class I director. Mr. McKenna and the Company are parties to a consulting agreement, pursuant to which Mr. McKenna agreed to continue to provide consulting services as an independent contractor to the Company, with an effective date of August 1, 2023 (the &#8220;Vesting Commencement Date&#8221;). As compensation for Mr. McKenna&#8217;s consulting services, on November 22, 2023, he was granted non-qualified stock options to purchase <ix:nonFraction unitRef="shares" contextRef="c-189" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-608">477,000</ix:nonFraction> shares of the Company&#8217;s common stock under the 2016 Plan (as defined in Note 8) with an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-190" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" scale="0" id="f-609">10.39</ix:nonFraction> per share, which vest as to <ix:nonFraction unitRef="number" contextRef="c-191" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-610">25</ix:nonFraction>% on the <ix:nonNumeric contextRef="c-191" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-611">one year</ix:nonNumeric> anniversary of the Vesting Commencement Date and thereafter vest and become exercisable in <ix:nonNumeric contextRef="c-189" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durmonth" id="f-612">36</ix:nonNumeric> equal monthly installments, subject to Mr. McKenna&#8217;s continued service to the Company through each applicable vesting date. For the three months ended March&#160;31, 2025 and 2024, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="c-192" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="f-613"><ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="f-614">0.3</ix:nonFraction></ix:nonFraction>&#160;million in stock-based compensation expense related to Mr. McKenna's consulting agreement.</ix:continuation> </span></div><div id="id1024c8efdf34cb8889d12b6bf18881e_70"></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8. <ix:nonNumeric contextRef="c-1" name="us-gaap:PreferredStockTextBlock" id="f-615" continuedAt="f-615-1" escape="true">Convertible Preferred Stock and Stockholders&#8217; Equity</ix:nonNumeric></span></div><ix:continuation id="f-615-1" continuedAt="f-615-2"><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Parapyre Warrants</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, the Company settled its obligations under the Parapyre Option Obligation by issuing Parapyre <ix:nonFraction unitRef="shares" contextRef="c-194" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-616">848,184</ix:nonFraction> warrants to purchase the Company's common stock at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-194" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-617">23.28</ix:nonFraction>.  As of March&#160;31, 2025, a total of <ix:nonFraction unitRef="shares" contextRef="c-195" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-618">1,532,591</ix:nonFraction> warrants with a weighted-average exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-195" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-619">22.49</ix:nonFraction> had been issued to Parapyre under the Parapyre Option Obligation.  As of March 31, 2025, <ix:nonFraction unitRef="shares" contextRef="c-196" decimals="INF" name="syre:ClassOfWarrantOrRightNumberOfSecuritiesExercised" format="ixt:fixed-zero" scale="0" id="f-620">none</ix:nonFraction> of the warrants issued under the Parapyre Option Obligation have been exercised and all remain outstanding. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Series A Non-Voting Convertible Preferred Stock</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Company's Certificate of Designation of Preferences, Rights and Limitations of the Series A Non-Voting Convertible Preferred Stock (the "Series A Certificate of Designation"), holders of Series A Preferred Stock are entitled to receive dividends on shares of Series A Preferred Stock equal to, on an as-if-converted-to-common stock basis, and in the same form as, dividends actually paid on shares of common stock. Except as provided in the Series A Certificate of Designation or as otherwise required by law, the Series A Preferred Stock does not have voting rights. However, as long as any shares of Series A Preferred Stock are outstanding, the Company will not, without the affirmative vote of the holders of a majority of the then outstanding shares of the Series A Preferred Stock: (a) alter or change adversely the powers, preferences or rights given to the Series A Preferred Stock, or alter or amend the Series A Certificate of Designation, amend or repeal any provision of, or add any provision to, the Company&#8217;s Certificate of Incorporation or its Bylaws, or file any articles of amendment, certificate of designations, preferences, limitations and relative rights of any series of preferred stock, if such action would adversely alter or change the preferences, rights, privileges or powers of, or restrictions provided for the benefit of the Series A Preferred Stock, regardless of whether any of the foregoing actions will be by means of amendment to the Certificate of Incorporation or by merger, consolidation, </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><ix:continuation id="f-615-2" continuedAt="f-615-3"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recapitalization, reclassification, conversion or otherwise, (b) issue further shares of Series A Preferred Stock or increase or decrease (other than by conversion) the number of authorized shares of Series A Preferred Stock, (c) prior to the stockholder approval of the conversion of the Series A Preferred Stock into shares of common stock in accordance with Nasdaq Stock Market Rules (the &#8220;Series A Conversion Proposal&#8221;) or at any time while at least <ix:nonFraction unitRef="number" contextRef="c-197" decimals="2" name="syre:PreferredStockRemainsIssuedAndOutstandingPercentage" scale="-2" id="f-621">30</ix:nonFraction>% of the originally issued Series A Preferred Stock remains issued and outstanding, consummate (x) any Fundamental Transaction (as defined in the Series A Certificate of Designation) or (y) any merger or consolidation of the Company with or into another entity or any stock sale to, or other business combination in which our stockholders immediately before such transaction do not hold at least a majority of our capital stock immediately after such transaction or (d) enter into any agreement with respect to any of the foregoing. The Series A Preferred Stock does not have a preference upon any liquidation, dissolution or winding-up of the Company. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 23, 2024, in connection with the April 2024 Exchange, the Stockholder agreed to exchange an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-198" decimals="INF" name="syre:StockIssuedDuringPeriodSharesExchangeOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="f-622">90,992</ix:nonFraction> shares of Series A Preferred Stock for an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-69" decimals="INF" name="syre:StockIssuedDuringPeriodSharesExchangeOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="f-623">3,639,680</ix:nonFraction> shares of the Company's common stock. This exchange was recorded as a reclassification between Series A Preferred Stock and common stock based on the historical per-share contributed capital amount, inclusive of any forward-contract valuation adjustments, of the Series A Preferred Stock. Following the April 2024 Exchange, <ix:nonFraction unitRef="shares" contextRef="c-199" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-624">346,045</ix:nonFraction> shares of Series A Preferred Stock remained outstanding and are convertible into <ix:nonFraction unitRef="shares" contextRef="c-199" decimals="INF" name="us-gaap:PreferredStockConvertibleSharesIssuable" format="ixt:num-dot-decimal" scale="0" id="f-625">13,841,800</ix:nonFraction> common shares.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Series B Non-Voting Convertible Preferred Stock</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Company's Certificate of Designation of Preferences, Rights and Limitations of Series B Non-Voting Convertible Preferred Stock (as amended, the "Series B Certificate of Designation"), holders of Series B Preferred Stock are entitled to receive dividends on shares of Series B Preferred Stock equal to, on an as-if-converted-to-common stock basis, and in the same form as, dividends actually paid on shares of common stock. Except as provided in the Series B Certificate of Designation or as otherwise required by law, the Series B Preferred Stock does not have voting rights. However, as long as any shares of Series B Preferred Stock are outstanding, the Company will not, without the affirmative vote of the holders of a majority of the then outstanding shares of the Series B Preferred Stock, alter or change adversely the powers, preferences or rights given to the Series B Preferred Stock, or alter or amend the Series B Certificate of Designation, amend or repeal any provision of, or add any provision to, the Company&#8217;s Certificate of Incorporation or its Bylaws, or file any articles of amendment, certificate of designations, preferences, limitations and relative rights of any series of preferred stock, if such action would adversely alter or change the preferences, rights, privileges or powers of, or restrictions provided for the benefit of the Series B Preferred Stock, regardless of whether any of the foregoing actions will be by means of amendment to the Certificate of Incorporation or by merger, consolidation, recapitalization, reclassification, conversion or otherwise. The Series B Preferred Stock does not have a preference upon any liquidation, dissolution or winding-up of the Company.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 18, 2024, in connection with the March 2024 PIPE, the Company filed a certificate of amendment to its Series B Certificate of Designation to increase the number of authorized shares of Series B Preferred Stock from <ix:nonFraction unitRef="shares" contextRef="c-200" decimals="INF" name="syre:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-626">150,000</ix:nonFraction> to <ix:nonFraction unitRef="shares" contextRef="c-201" decimals="INF" name="syre:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-627">271,625</ix:nonFraction>.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 20, 2024, as part of the March 2024 PIPE, the Company completed a private placement of <ix:nonFraction unitRef="shares" contextRef="c-64" decimals="INF" name="syre:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-628">121,625</ix:nonFraction> shares of Series B Preferred Stock at $<ix:nonFraction unitRef="usdPerShare" contextRef="c-65" decimals="2" name="us-gaap:SaleOfStockPricePerShare" format="ixt:num-dot-decimal" scale="0" id="f-629">1,480.00</ix:nonFraction> per share in exchange for net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="6" id="f-630">168.9</ix:nonFraction>&#160;million, after deducting placement agent fees and offering costs of $<ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-5" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="f-631">11.2</ix:nonFraction>&#160;million.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 14, 2024, the Company's stockholders approved the issuance of common stock upon the conversion of all issued and outstanding Series B Preferred Stock into shares of common stock in accordance with the Nasdaq Stock Market Rules (the "Series B Conversion Proposal"), among other matters, at its 2024 annual meeting of stockholders. As a result of the approval of the Series B Conversion Proposal, all conditions that could have required cash redemption of the Series B Preferred Stock were satisfied. Since the Series B Preferred Stock is no longer redeemable, the associated balances of the Series B Preferred Stock were reclassified from mezzanine equity to permanent equity during the second quarter of 2024. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following stockholder approval of the Series B Conversion Proposal, each share of Series B Preferred Stock automatically converted into <ix:nonFraction unitRef="number" contextRef="c-202" decimals="0" name="us-gaap:PreferredStockConvertibleConversionRatio" scale="0" id="f-632">40</ix:nonFraction> shares of common stock, subject to certain limitations, including that a holder of Series B Preferred Stock is prohibited from converting shares of Series B Preferred Stock into shares of common stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><ix:continuation id="f-615-3" continuedAt="f-615-4"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">own more than a specified percentage (established by the holder between <ix:nonFraction unitRef="number" contextRef="c-203" decimals="0" name="syre:BeneficialHoldersOwnedPercentage" scale="-2" id="f-633">0</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-204" decimals="4" name="syre:BeneficialHoldersOwnedPercentage" scale="-2" id="f-634">19.9</ix:nonFraction>%) of the total number of shares of common stock issued and outstanding immediately after giving effect to such conversion. <ix:nonFraction unitRef="shares" contextRef="c-205" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="f-635">254,958</ix:nonFraction> shares of Series B Preferred Stock automatically converted to <ix:nonFraction unitRef="shares" contextRef="c-206" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="f-636">10,198,320</ix:nonFraction> shares of common stock; <ix:nonFraction unitRef="shares" contextRef="c-12" decimals="INF" name="syre:PreferredStockSharesNotAutomaticallyConvertedOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-637">16,667</ix:nonFraction> shares of Series B Preferred Stock did not automatically convert and remain outstanding as of March&#160;31, 2025 due to beneficial ownership limitations. This conversion was recorded as a reclassification between Series B Preferred Stock and common stock based on the historical per-share contributed capital amount of the Series B Preferred Stock. The remaining outstanding Series B Preferred Stock is convertible into <ix:nonFraction unitRef="shares" contextRef="c-12" decimals="INF" name="us-gaap:PreferredStockConvertibleSharesIssuable" format="ixt:num-dot-decimal" scale="0" id="f-638">666,680</ix:nonFraction> common shares as of March&#160;31, 2025.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">September 2024 ATM Facility</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 6, 2024, the Company filed a new shelf registration statement on Form S-3 that was declared effective by the SEC for the potential offering, issuance and sale of up to $<ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-5" name="syre:SaleOfStockAuthorizedAmount" format="ixt:num-dot-decimal" scale="6" id="f-639">500.0</ix:nonFraction>&#160;million of the Company's common stock, preferred stock, debt securities, warrants and/or units consisting of all or some of these securities. Concurrent with the filing of the shelf-registration statement, the Company entered into the Sales Agreement, pursuant to which the Company may issue and sell up to $<ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-5" name="syre:SaleOfStockAggregateOfferingPrice" format="ixt:num-dot-decimal" scale="6" id="f-640">200.0</ix:nonFraction>&#160;million of shares of common stock under an ATM offering program included in the registration statement. During the twelve months ended December 31, 2024, the Company sold an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-75" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-641">777,432</ix:nonFraction> shares of common stock under the ATM offering program at an average price per share of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-76" decimals="3" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-642">26.935</ix:nonFraction> resulting in net proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="f-643">20.5</ix:nonFraction> million, after deducting sales agent commissions and other offering costs of $<ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-5" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="6" id="f-644">0.4</ix:nonFraction> million. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2025, the Company filed a new shelf registration statement on Form S-3 that was declared effective by the SEC for the potential offering, issuance and sale of up to $<ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-5" name="syre:SaleOfStockAuthorizedAmount" format="ixt:num-dot-decimal" scale="6" id="f-645">500.0</ix:nonFraction>&#160;million of the Company's common stock, preferred stock, debt securities, warrants and/or units consisting of all or some of these securities. Concurrent with the effectiveness of the February 2025 Shelf Registration Statement, the offering of unsold securities under the previous shelf registration statement on Form S-3 (described above), was deemed terminated pursuant to Rule 415(a)(6) under the Securities Act. The February 2025 Shelf Registration Statement contains a prospectus supplement covering the offering, issuance and sale by the Company of up to $<ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-5" name="syre:SaleOfStockAggregateOfferingPrice" format="ixt:num-dot-decimal" scale="6" id="f-646">179.1</ix:nonFraction>&#160;million of shares of common stock that may be issued and sold under the Sales Agreement in connection with the ATM program. <ix:nonFraction unitRef="shares" contextRef="c-207" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:fixed-zero" scale="0" id="f-647">No</ix:nonFraction> shares were sold under the ATM program during the three months ended March 31, 2025. As of March 31, 2025, $<ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-5" name="syre:SaleOfStockRemainingAuthorizedAmount" format="ixt:num-dot-decimal" scale="6" id="f-648">179.1</ix:nonFraction>&#160;million remained available for sale under the Sales Agreement. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">November 2024 Underwritten Offering</span></div></ix:continuation><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-615-4">On November 18, 2024, the Company entered into the Underwriting Agreement with the Underwriters, pursuant to which the Company sold an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-77" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-649">8,366,250</ix:nonFraction> shares of common stock, at a public offering price per share of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-79" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-650">27.50</ix:nonFraction>, resulting in net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="6" id="f-651">215.9</ix:nonFraction>&#160;million after deducting approximately $<ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-5" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="f-652">14.2</ix:nonFraction>&#160;million of underwriting discounts and other offering costs. The November 2024 Offering closed on November 20, 2024 and the over-allotment option was exercised in full on November 26, 2024 and closed on November 29, 2024.</ix:continuation> </span></div><div id="id1024c8efdf34cb8889d12b6bf18881e_73"></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9. <ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="f-653" continuedAt="f-653-1" escape="true">Stock-Based Compensation</ix:nonNumeric></span></div><ix:continuation id="f-653-1" continuedAt="f-653-2"><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2015 Equity Incentive Plan</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2015, the Company adopted the 2015 Equity Incentive Plan (&#8220;2015 Plan&#8221;), administered by the board of directors, and provides for the Company to sell or issue shares of common stock or restricted common stock, or to grant incentive stock options or nonqualified stock options for the purchase of common stock, to employees, members of the board of directors and consultants of the Company. The Company granted options under the 2015 Plan until April 2016 when it was terminated as to future awards, although it continues to govern the terms of options that remain outstanding under the 2015 Plan.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2025, a total of <ix:nonFraction unitRef="shares" contextRef="c-208" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" scale="0" id="f-654">952</ix:nonFraction> shares of common stock are subject to options outstanding under the 2015 Plan and will become available under the 2016 Equity Incentive Plan (&#8220;2016 Plan&#8221;) to the extent the options are forfeited or lapse unexercised.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><ix:continuation id="f-653-2" continuedAt="f-653-3"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2016 Equity Incentive Plan</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2016 Plan became effective in April 2016 and serves as the successor to the 2015 Plan. Under the 2016 Plan, the Company may grant stock options, stock appreciation rights, restricted stock awards, restricted stock units, performance awards, and stock bonuses. The 2016 Plan, as amended, provides for an automatic increase in the number of shares reserved for issuance thereunder on January 1 of each year for the remaining term of the plan equal to (a) <ix:nonFraction unitRef="number" contextRef="c-209" decimals="3" name="syre:AnnualPercentageOfAdditionalSharesWhichEqualsToIssuedAndOutstandingShares" scale="-2" id="f-655">5.0</ix:nonFraction>% of the number of issued and outstanding shares of common stock </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(including such shares issuable pursuant to the exercise or conversion, as applicable, of any outstanding pre-funded warrants and nonvoting convertible preferred stock) on December 31 of the immediately preceding year, or (b) a lesser amount as approved by the board each year (the &#8220;Evergreen Provision&#8221;). As a result of the Evergreen Provision, on January 1, 2025 and 2024, an additional <ix:nonFraction unitRef="shares" contextRef="c-210" decimals="INF" name="syre:ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-656">3,814,905</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-211" decimals="INF" name="syre:ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-657">3,023,650</ix:nonFraction> shares, respectively, became available for issuance under the 2016 Plan.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2025, the 2016 Plan had <ix:nonFraction unitRef="shares" contextRef="c-212" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-658">11,007,869</ix:nonFraction> shares available for future issuance, of which <ix:nonFraction unitRef="shares" contextRef="c-212" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-659">4,817,317</ix:nonFraction> shares were subject to outstanding option awards.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2018 Equity Inducement Plan</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2018 Equity Inducement Plan (&#8220;2018 Plan&#8221;) became effective in February 2018.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2024, the Company amended the 2018 Plan to increase the number of shares of common stock reserved for issuance by <ix:nonFraction unitRef="shares" contextRef="c-213" decimals="INF" name="syre:CommonStockCapitalSharesReservedForFutureIssuanceIncreasedAmount" format="ixt:num-dot-decimal" scale="0" id="f-660">1,000,000</ix:nonFraction>. After this amendment and as of March&#160;31, 2025, the 2018 Plan had <ix:nonFraction unitRef="shares" contextRef="c-214" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-661">6,856,811</ix:nonFraction> shares available for future issuance, of which <ix:nonFraction unitRef="shares" contextRef="c-214" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-662">6,300,368</ix:nonFraction> shares were subject to outstanding option awards and restricted unit awards.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service-based awards granted under the 2018 Plan, 2016 Plan, and 2015 Plan generally vest over <ix:nonNumeric contextRef="c-215" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-663">four years</ix:nonNumeric> and expire after <ix:nonNumeric contextRef="c-215" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="f-664">ten years</ix:nonNumeric>, although awards have been granted with vesting terms less than <ix:nonNumeric contextRef="c-215" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-665">four years</ix:nonNumeric>. Under the 2016 Plan and 2018 Plan, the Company may grant stock-based awards with service conditions (&#8220;service-based&#8221; awards), performance conditions (&#8220;performance-based&#8221; awards), and market conditions (&#8220;market-based&#8221; awards). </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Spyre 2023 Equity Incentive Plan</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;22, 2023, in connection with the Asset Acquisition, the Company assumed the Amended and Restated Spyre 2023 Equity Incentive Plan (the "2023 Plan") and its outstanding and unexercised stock options, which were converted to options to purchase <ix:nonFraction unitRef="shares" contextRef="c-216" decimals="INF" name="syre:OutstandingAndUnexercisedStockOptions" format="ixt:num-dot-decimal" scale="0" id="f-666">2,734</ix:nonFraction> shares of common stock. The acquisition-date fair value of these grants will be recognized as an expense on a pro-rata basis over the vesting period. As of March 31, 2025 none of the stock options under the 2023 Plan remained outstanding.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" id="f-667" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s stock awards granted under all equity incentive and inducement plans for each of the periods indicated:</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.515%"><tr><td style="width:1.0%"/><td style="width:42.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.353%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.353%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.774%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Grants</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted Average Grant Date Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Grants</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted Average Grant Date Fair Value</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-668">1,897,917</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-669">21.45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-15" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-670">1,044,658</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-15" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-671">26.50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Parapyre Option Obligation</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, the Company settled its obligations under the Parapyre Option Obligation by issuing Parapyre <ix:nonFraction unitRef="shares" contextRef="c-194" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-672">848,184</ix:nonFraction> warrants to purchase the Company's common stock at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-194" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-673">23.28</ix:nonFraction>.  As of March&#160;31, 2025, a total of <ix:nonFraction unitRef="shares" contextRef="c-195" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-674">1,532,591</ix:nonFraction> warrants with a weighted-average exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-195" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-675">22.49</ix:nonFraction> had been </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><ix:continuation id="f-653-3"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">issued to Parapyre under the Parapyre Option Obligation.  As of March 31, 2025 <ix:nonFraction unitRef="shares" contextRef="c-196" decimals="INF" name="syre:ClassOfWarrantOrRightNumberOfSecuritiesExercised" format="ixt:fixed-zero" scale="0" id="f-676">none</ix:nonFraction> of the warrants issued under the Parapyre Option Obligation have been exercised and all remain outstanding. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2024, $<ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="f-677">5.4</ix:nonFraction> million was recognized as stock compensation expense related to the Parapyre Option Obligation. There are no ongoing obligations under the Parapyre Option Obligation as of January 1, 2025.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2016 Employee Stock Purchase Plan</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Company&#8217;s 2016 Employee Stock Purchase Plan (&#8220;2016 ESPP&#8221;), the Company issued and sold <ix:nonFraction unitRef="shares" contextRef="c-217" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-678"><ix:nonFraction unitRef="shares" contextRef="c-218" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-679">16,877</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-219" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-680">2,330</ix:nonFraction> shares during the three months ended March&#160;31, 2025 and 2024, respectively. The aggregate cash proceeds were $<ix:nonFraction unitRef="usd" contextRef="c-217" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="f-681">0.3</ix:nonFraction> million and de minimis for the three months ended March&#160;31, 2025 and 2024, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-based Compensation Expense</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" id="f-682" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation expense recognized from the Company&#8217;s equity incentive plans, 2018 Plan, 2016 ESPP and Parapyre Option Obligation during the periods presented was as follows (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.748%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.869%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.869%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.408%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-220" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-683">3,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-221" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-684">6,857</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-222" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-685">5,347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-223" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-686">6,978</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation expense </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-687">8,859</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-688">13,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:9pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2024, $<ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="f-689">5.4</ix:nonFraction> million was recognized as stock compensation expense related to the Parapyre Option Obligation.</span></div><div style="margin-top:9pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Of the total $<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="f-690">13.8</ix:nonFraction> million of stock-based compensation expense for the three months ended March&#160;31, 2024, $<ix:nonFraction unitRef="usd" contextRef="c-224" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="f-691">2.9</ix:nonFraction> million is related to legacy Aeglea employees and directors who had been terminated as of the end of the period.</span></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify"><span><br/></span></div></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="f-692" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the weighted-average Black-Scholes option pricing model assumptions used to estimate the fair value of stock options granted under the Company's equity incentive plans, and the shares purchasable under the 2016 ESPP during the periods presented: </span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.484%"><tr><td style="width:1.0%"/><td style="width:64.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.696%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock Options Granted</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-225" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-693">6.03</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-226" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-694">6.03</ix:nonNumeric></span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-225" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-695">76</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-226" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-696">105</ix:nonFraction>%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk-free interest</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-225" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-697">4.46</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-226" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-698">3.88</ix:nonFraction>%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-225" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="f-699">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-226" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="f-700">&#8212;</ix:nonFraction></span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2016 ESPP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-227" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-701">0.50</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-228" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-702">0.50</ix:nonNumeric></span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-227" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-703">69</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-228" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-704">98</ix:nonFraction>%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk-free interest</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-227" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-705">4.23</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-228" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-706">5.31</ix:nonFraction>%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-227" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="f-707">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-228" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="f-708">&#8212;</ix:nonFraction></span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><div id="id1024c8efdf34cb8889d12b6bf18881e_1099511628468"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10. &#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingDisclosureTextBlock" id="f-709" continuedAt="f-709-1" escape="true">Segment Reporting</ix:nonNumeric></span></div><ix:continuation id="f-709-1" continuedAt="f-709-2"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates under a single operating and reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated diseases. The Company's Chief Operating Decision Maker ("CODM") is the Company's Chief Executive Officer. The Company's CODM uses consolidated Net loss as the measure of segment profit or loss and uses consolidated Total Assets as reported on the balance sheet as the measure of segment assets. The Company's CODM compares Net loss against budgeted and/or forecasted amounts to track the Company's financial performance against expectations and to inform, along with development timelines and scientific and commercial considerations, their decisions regarding resource allocations to fund the Company's development of its pipeline. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" id="f-710" continuedAt="f-710-1" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table sets forth the significant expenses provided to the CODM on a regular basis (in thousands):</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.545%"><tr><td style="width:1.0%"/><td style="width:71.807%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.142%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.143%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-3" name="us-gaap:CompensationExpenseExcludingCostOfGoodAndServiceSold" format="ixt:num-dot-decimal" scale="3" id="f-711">6,991</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-3" name="us-gaap:CompensationExpenseExcludingCostOfGoodAndServiceSold" format="ixt:num-dot-decimal" scale="3" id="f-712">4,174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-713">8,859</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-714">13,835</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development, excluding compensation and stock-based compensation </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2) (3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-715">33,551</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-716">26,103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other segment items </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-3" sign="-" name="us-gaap:SegmentReportingOtherItemAmount" format="ixt:num-dot-decimal" scale="3" id="f-717">4,628</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-3" sign="-" name="us-gaap:SegmentReportingOtherItemAmount" scale="3" id="f-718">255</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-719">44,773</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-720">43,857</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reconciliation of net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjustments and reconciling items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:fixed-zero" scale="3" id="f-721">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-232" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:fixed-zero" scale="3" id="f-722">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated net loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-233" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-723">44,773</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-234" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-724">43,857</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes $<ix:nonFraction unitRef="usd" contextRef="c-235" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="f-725">0.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-236" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="f-726">5.7</ix:nonFraction> million in related party expenses for the three months ended March 31, 2025 and 2024, respectively. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes non-clinical study, clinical trial, and manufacturing expenses. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes $<ix:nonFraction unitRef="usd" contextRef="c-235" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-727">2.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-236" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-728">11.7</ix:nonFraction> million in related party expenses for the three months ended March 31, 2025 and 2024, respectively. </span></div></ix:nonNumeric></ix:continuation><div style="margin-top:6pt;text-align:justify"><ix:continuation id="f-710-1" continuedAt="f-710-2"><ix:continuation id="f-709-2" continuedAt="f-709-3"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="f-710-2"><ix:continuation id="f-709-3"> Includes general and administrative expenses such as audit, legal, and other professional fees, interest income, and other expense, net.</ix:continuation></ix:continuation> </span></div><div id="id1024c8efdf34cb8889d12b6bf18881e_82"></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11. <ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerShareTextBlock" id="f-729" continuedAt="f-729-1" escape="true">Net Loss Per Share</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerSharePolicyTextBlock" id="f-730" continuedAt="f-730-1" escape="true"><ix:continuation id="f-729-1" continuedAt="f-729-2"><div style="margin-top:18pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company computes net loss per share of common stock, Series A Preferred Stock, and Series B Preferred Stock using the two-class method required for multiple classes of common stock and other participating securities.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The two-class method is an earnings (loss) allocation method under which earnings (loss) per share is calculated for each class of common stock. The Company has determined that the Series A Preferred Stock and Series B Preferred Stock do not have preferential rights when compared to the Company's common stock and therefore it must allocate losses to these other classes of common stock, as illustrated in the table below.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted net loss per share is computed by dividing the net loss by the weighted-average number of shares and pre-funded warrants outstanding during the period, without consideration of potential dilutive securities. The pre-funded warrants are included in the computation of basic net loss per share as the exercise price is negligible and they are fully vested and exercisable. For periods in which the Company generated a net loss, the Company does not include potential shares of common stock in diluted net loss per share when the impact of these items is anti-dilutive. The Company has generated a net loss for all periods </span></div></ix:continuation></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><ix:continuation id="f-729-2"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-730-1">presented, therefore diluted net loss per share is the same as basic net loss per share since the inclusion of potential shares of common stock would be anti-dilutive.</ix:continuation>  </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" id="f-731" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net loss per share of common stock, Series A Preferred Stock, and Series B Preferred Stock (in thousands, except share and per share amounts):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.445%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.445%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.445%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.445%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.445%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.449%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="15" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="15" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Series A Preferred Stock</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Series B Preferred Stock</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Common<br/>Stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Series A Preferred Stock</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Series B Preferred Stock</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Common<br/>Stock</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net loss per share, basic and diluted:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Numerator</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Allocation of losses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-732">8,288</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="f-733">399</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-734">36,086</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-735">12,642</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-736">4,810</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-737">26,405</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Denominator</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Weighted-average shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-16" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesIssuedBasic" format="ixt:num-dot-decimal" scale="0" id="f-738">346,045</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-18" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesIssuedBasic" format="ixt:num-dot-decimal" scale="0" id="f-739">16,667</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-20" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesIssuedBasic" format="ixt:num-dot-decimal" scale="0" id="f-740">60,265,932</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-17" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesIssuedBasic" format="ixt:num-dot-decimal" scale="0" id="f-741">437,037</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-19" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesIssuedBasic" format="ixt:num-dot-decimal" scale="0" id="f-742">166,261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-21" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesIssuedBasic" format="ixt:num-dot-decimal" scale="0" id="f-743">36,262,662</ix:nonFraction></span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Weighted-average pre-funded warrants outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-16" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" format="ixt:fixed-zero" scale="0" id="f-744">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-18" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" format="ixt:fixed-zero" scale="0" id="f-745">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-20" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" format="ixt:fixed-zero" scale="0" id="f-746">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-17" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" format="ixt:fixed-zero" scale="0" id="f-747">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-19" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" format="ixt:fixed-zero" scale="0" id="f-748">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-21" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" format="ixt:num-dot-decimal" scale="0" id="f-749">250,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Number of shares used in per share computation</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-16" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-750"><ix:nonFraction unitRef="shares" contextRef="c-16" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-751">346,045</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-18" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-752"><ix:nonFraction unitRef="shares" contextRef="c-18" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-753">16,667</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-20" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-754"><ix:nonFraction unitRef="shares" contextRef="c-20" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-755">60,265,932</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-17" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-756"><ix:nonFraction unitRef="shares" contextRef="c-17" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-757">437,037</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-19" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-758"><ix:nonFraction unitRef="shares" contextRef="c-19" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-759">166,261</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-21" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-760"><ix:nonFraction unitRef="shares" contextRef="c-21" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-761">36,512,662</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net loss per share, basic and diluted</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-16" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-762"><ix:nonFraction unitRef="usdPerShare" contextRef="c-16" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-763">23.95</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-18" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-764"><ix:nonFraction unitRef="usdPerShare" contextRef="c-18" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-765">23.95</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-20" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-766"><ix:nonFraction unitRef="usdPerShare" contextRef="c-20" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-767">0.60</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-17" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-768"><ix:nonFraction unitRef="usdPerShare" contextRef="c-17" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-769">28.93</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-19" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-770"><ix:nonFraction unitRef="usdPerShare" contextRef="c-19" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-771">28.93</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-21" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-772"><ix:nonFraction unitRef="usdPerShare" contextRef="c-21" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-773">0.72</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following weighted-average equity instruments were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive for the periods presented:</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="f-774" escape="true"><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.121%"><tr><td style="width:1.0%"/><td style="width:65.320%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.951%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.951%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options to purchase common stock</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-237" decimals="INF" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-775">1,866,235</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-238" decimals="INF" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-776">3,200,918</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unvested restricted stock units</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-239" decimals="INF" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-777">22,622</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-240" decimals="INF" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-778">61,253</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding Parapyre warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-241" decimals="INF" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-779">1,532,591</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-242" decimals="INF" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-780">684,407</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="padding-left:9pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><div id="id1024c8efdf34cb8889d12b6bf18881e_91"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-top:18pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">You should read the following discussion and analysis of our financial condition and results of operations in conjunction with our unaudited condensed consolidated financial statements and related notes included in Part I, Item 1 of this Quarterly Report on Form 10-Q for the quarterly period ended March&#160;31, 2025 (this "Quarterly Report") as well as the audited consolidated financial statements and notes and Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations, included in our Annual Report on Form 10-K for the year ended December 31, 2024 (the "Annual Report") filed with the U.S. Securities and Exchange Commission (the "SEC") on February 27, 2025. This discussion and other parts of this Quarterly Report contain forward-looking statements that involve risks and uncertainties, such as statements regarding our expected results, outcomes, and the timing of these results and outcomes, plans, objectives, expectations and intentions. As a result of many factors, including those factors set forth in the &#8220;Risk Factors&#8221; section of this Quarterly Report, our actual results could differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis. As used in this report, unless the context suggests otherwise, &#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221;, &#8220;the Company,&#8221; or &#8220;Spyre&#8221; refers to Spyre Therapeutics, Inc. and its consolidated subsidiaries taken as a whole.</span></div><div id="id1024c8efdf34cb8889d12b6bf18881e_94"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisition of Pre-Merger Spyre </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 22, 2023, we acquired Pre-Merger Spyre pursuant to that certain Agreement and Plan of Merger (the &#8220;Acquisition Agreement&#8221;), dated June 22, 2023, by and among us, Aspen Merger Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of the Company, Sequoia Merger Sub II, LLC, a Delaware limited liability company and one of our wholly owned subsidiaries, and Pre-Merger Spyre. Pre-Merger Spyre was a pre-clinical stage biotechnology company that was incorporated on April 28, 2023 under the direction of Peter Harwin, a Managing Member of Fairmount, for the purpose of holding rights to certain intellectual property being developed by Paragon. Fairmount is a founder of Paragon. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through the Asset Acquisition, we received the option to license certain intellectual property rights related to certain research programs (collectively, the "Option"). On July 12, 2023, we exercised the Option with respect to one of these research programs to be granted an exclusive license to all of Paragon's rights, title and interest in and to intellectual property rights, including inventions, patents, sequence information and results, under SPY001, our &#945;4&#946;7 integrin program, to develop and commercialize antibodies and products worldwide in all therapeutics disorders. We expect any patents pursued non-provisionally and that mature into issued patents to expire no earlier than 2044, subject to any disclaimers or extensions. On December 14, 2023, we exercised the Option under the Paragon Agreement to be granted an exclusive license to all of Paragon&#8217;s rights, title and interest in and to intellectual property rights, including inventions, patents, sequence information and results, under SPY002, our TL1A program, to develop and commercialize antibodies and products worldwide in all therapeutics disorders. We expect any patents pursued non-provisionally and that mature into issued patents to expire no earlier than 2044, subject to any disclaimers or extensions. On June 5, 2024, we exercised the Option under the Paragon Agreement to be granted an exclusive license to all of Paragon&#8217;s rights, title and interest in and to intellectual property rights, including inventions, patents, sequence information and results, under SPY003, our IL-23 program, to develop and commercialize antibodies and products worldwide solely in inflammatory bowel disease ("IBD") indications. We expect any patents pursued non-provisionally and that mature into issued patents to expire no earlier than 2045, subject to any disclaimers or extensions. The License Agreements pertaining to SPY001 and SPY002 between the Company and Paragon were executed in the second quarter of 2024, and the License Agreement pertaining to SPY003 was executed in October 2024 and subsequently amended and restated on February 24, 2025. </span></div><div id="id1024c8efdf34cb8889d12b6bf18881e_97"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the Asset Acquisition, we have significantly reshaped the business into a clinical stage biotechnology company focused on developing next generation therapeutics for patients living with IBD, including ulcerative colitis ("UC") and Crohn's disease ("CD"), and other immune-mediated diseases. Our portfolio of novel and proprietary monoclonal antibody product candidates has the potential to address unmet needs in IBD and rheumatoid arthritis ("RA") care by improving efficacy, safety, and/or dosing convenience relative to products currently available or product candidates in development. We have engineered our product candidates with the aim to bind potently and selectively to their target epitopes and to exhibit extended pharmacokinetic half-lives through modifications in the Fc domain, which modifications are designed to increase </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">affinity to human FcRn and increase antibody recycling. We anticipate that half-life extension will enable less frequent administration as compared to marketed or development-stage mAbs that do not incorporate half-life extension modifications. In addition to the development of our product candidates as potential monotherapies, we plan to investigate combinations of our proprietary antibodies in nonclinical studies and clinical trials in order to evaluate whether combination therapy (co-administration or co-formulation of multiple monoclonal antibodies) can lead to greater efficacy, as compared to monotherapies in IBD. We intend to deliver our product candidates through convenient, infrequently self-administered, subcutaneous maintenance injections, although the specific delivery mechanism or technology has not been selected given our early stage.</span></div><div id="id1024c8efdf34cb8889d12b6bf18881e_100"></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Portfolio</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are advancing a pipeline of monoclonal antibodies (&#8220;mAbs&#8221;) for the treatment of IBD and other immune-mediated diseases. The following table summarizes our programs and strategy:</span></div><div style="margin-top:12pt;text-align:center;text-indent:36pt"><img src="syre-20250331_g1.jpg" alt="Pipeline.jpg" style="height:260px;margin-bottom:5pt;vertical-align:text-bottom;width:612px" id="i-1"/></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through the Asset Acquisition, we received the Option pursuant to the Paragon Agreement, and subsequently executed license agreements for our &#945;4&#946;7, TL1A, and IL-23 programs. As of the date of this Quarterly Report on Form 10-Q, we have exercised our Option with respect to and nominated development candidates for our SPY001, SPY002, and SPY003 programs. We executed license agreements with Paragon for SPY001 (the "SPY001 License Agreement") and SPY002 (the "SPY002 License Agreement") in the second quarter of 2024 and we executed a license agreement with Paragon for SPY003 (the "SPY003 License Agreement" and, together with the SPY001 License Agreement and the SPY002 License Agreement, the "License Agreements") in the fourth quarter of 2024. The SPY001 and SPY002 licenses are indication agnostic, and the SPY003 license is restricted to IBD.  See the section titled &#8220;Paragon Agreement&#8221; in this Quarterly Report on Form 10-Q for more discussion about the Paragon Agreement and the License Agreements.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SPY001 &#8211; anti-&#945;4&#946;7 mAb</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our most advanced product candidate, SPY001, is a highly potent, highly selective, and humanized monoclonal immunoglobulin G1 antibody designed to bind selectively to the &#945;4&#946;7 integrin being developed for the treatment of IBD (UC and CD). The &#945;4&#946;7 integrin is a protein found on the surface of immune cells. This integrin regulates the migration of immune cells to the gut where they contribute to the inflammatory process in IBD. By selectively binding to the &#945;4&#946;7 integrin, SPY001 is designed to prevent the interaction of these immune cells with MAdCAM-1, a molecule expressed on endothelial cells lining the blood vessels in the gut. This interaction is responsible for guiding lymphocytes from the bloodstream into the gut tissue, where they cause inflammation. By blocking the interaction between &#945;4&#946;7 integrin and MAdCAM-1, SPY001 aims to reduce the recruitment of immune cells to the gut, leading to a decrease in inflammation. Since it specifically targets the gut immune system, SPY001 is designed to minimize systemic immunosuppressive effects unrelated to IBD pathology.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> SPY001 preclinical characterization studies were conducted in-house with support from third party vendors. SPY001 demonstrates similar potency and selectivity as synthesized vedolizumab in preclinical </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> models including surface plasmon residence (n=5 concentrations) and cellular adhesion assays (see Figure 1, n=6 replicates per group). </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company initiated a first-in-human ("FIH") Phase 1 trial for SPY001 in June 2024. The SPY001 Phase 1 trial is a double blind, placebo-controlled trial in healthy volunteers and consists of a single-ascending dose ("SAD") component and a multi-ascending dose ("MAD") component. The trial design includes enrolling 56 healthy adult participants into five SAD cohorts and two MAD cohorts in the main portion of the study. The primary endpoint is safety, with pharmacokinetics ("PK") and anti-drug antibodies ("ADA") serving as secondary endpoints. Additional cohorts have been added to the study to evaluate pharmacokinetics in healthy volunteers of various ethnicities to facilitate subsequent global clinical trials. Trial enrollment is now complete.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interim results were initially presented in November 2024, with additional data presented in May 2025 with up to eight months of follow up. Findings from the interim SAD and MAD portions of the Phase 1 trial were as follows:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Safety (See Figure 2) - SPY001 was well tolerated across all dose groups (single doses of up to 1,000 mg and multiple doses of up to 600 mg) with a favorable safety profile. The most common treatment-emergent adverse events were headache and nasopharyngitis.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">PK (See Figure 3) - SPY001 demonstrated a meaningfully differentiated PK profile relative to vedolizumab. SPY001 has a half-life estimate of ~80 days based on population PK modeling, more than three times that of vedolizumab's 25-day human half-life in a cross-trial comparison, supporting the potential for Q3M-Q6M SC maintenance dosing.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Pharmacodynamics ("PD") (see Figure 4) - saturation of occupancy of &#945;4&#946;7 receptors was observed with a single dose of 600 mg up to 32 weeks of follow up, which was the longest follow-up available at data cutoff.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Based on these interim results, we plan to advance SPY001 to a Phase 2 clinical trial in UC patients in mid-2025. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Figure 1. Potency and selectivity of SPY001 relative to synthesized vedolizumab in cellular assays (Data on file). </span></div><div style="margin-top:12pt;text-align:center"><img src="syre-20250331_g2.jpg" alt="Figure1.jpg" style="height:363px;margin-bottom:5pt;vertical-align:text-bottom;width:660px" id="i-2"/></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Figure 2. Interim SPY001 Phase 1 safety data. </span></div><div style="margin-top:12pt;text-align:center"><img src="syre-20250331_g3.jpg" alt="SPY001 Safety.jpg" style="height:272px;margin-bottom:5pt;vertical-align:text-bottom;width:660px" id="i-3"/></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Figure 3. Interim SPY001 simulated concentration-time profile compared to vedolizumab.</span></div><div style="margin-top:18pt;padding-left:18pt;padding-right:18pt;text-align:center"><img src="syre-20250331_g4.jpg" alt="SPY001 PK simulation.jpg" style="height:257px;margin-bottom:5pt;vertical-align:text-bottom;width:612px" id="i-4"/></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Figure 4. Interim SPY001 pharmacodynamic data.</span></div><div style="margin-top:18pt;padding-left:18pt;padding-right:18pt;text-align:center"><img src="syre-20250331_g5.jpg" alt="SPY001 PD.jpg" style="height:247px;margin-bottom:5pt;vertical-align:text-bottom;width:612px" id="i-5"/></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SPY002 &#8211; anti-TL1A mAb</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our SPY002 program, we nominated two highly potent, highly selective, and fully human mAb candidates designed to bind to tumor necrosis factor-like ligand 1A (&#8220;TL1A&#8221;), both of which are being developed for the treatment of IBD (UC and CD) and RA. TL1A is a protein that plays a role in regulating the immune system and is elevated in the gut tissue of individuals with IBD and synovial tissue of individuals with RA. TL1A interacts with its receptor, death receptor 3 (&#8220;DR3&#8221;), which is expressed in various immune cells, including T cells. This interaction triggers signaling pathways that contribute to inflammation and immune system activation, leading to IBD or RA symptomology. The SPY002 candidates have been designed to block the interaction between TL1A and DR3, and thereby inhibit the downstream signaling events and dampen the inflammatory response. By neutralizing TL1A, we believe the SPY002 candidates have the potential to modulate the immune response in IBD and RA patients, potentially reducing disease activity.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SPY002 preclinical characterization studies were conducted in-house with support from third party vendors. Our extensive discovery campaign has identified two lead candidates which bind TL1A monomers and trimers and have subnanomolar potency in cellular assays (see Figure 5, n=4 replicates per group per study). The candidates also exhibited extended pharmacokinetic half-lives of greater than two to three-fold relative to synthesized competitor molecules in clinical development that do not incorporate half-life extending modifications, based on head-to-head preclinical studies in non-human primates ("NHPs") (see Figure 6, n=5 per group).</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company initiated two FIH trials in healthy volunteers in the fourth quarter of 2024, one for each of our SPY002 candidates, with interim safety and PK data from these trials expected in the second quarter of 2025. If successful, one or more SPY002 candidates will advance to Phase 2 clinical trials (UC and RA).</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Figure 5. Inhibition of TL1A induced TF-1 cell apoptosis (left) and IFN&#947; secretion in primary human whole blood 1 donor of 4 donors profiled (right) (Data on file. Duvakitug was not benchmarked in IFN&#947; secretion assay; Duvakitug, RO7790121, and tulisokibart are synthesized comparator antibodies). </span></div><div style="margin-top:12pt;text-align:center;text-indent:36pt"><img src="syre-20250331_g6.jpg" alt="fg 5mage 4 v2 -Screenshot 2024-11-05 130337.jpg" style="height:338px;margin-bottom:5pt;vertical-align:text-bottom;width:612px" id="i-6"/></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Figure 6. Pharmacokinetic concentration-time curves of SPY002 candidates compared to synthesized competing anti-TL1A molecules in non-human primates (Data on file. Group size was n=5 for SPY002 mAbs and tulisokibart at final endpoints for half-life determination; No RO7790121 detected after day 28. Duvakitug not compared in these models given low human half-life (7-10 days).</span></div><div style="margin-top:12pt;text-align:center;text-indent:36pt"><img src="syre-20250331_g7.jpg" alt="Figure6.jpg" style="height:252px;margin-bottom:5pt;vertical-align:text-bottom;width:660px" id="i-7"/></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SPY003 &#8211; anti-IL-23 mAb</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SPY003 is a clinical-stage program designed to bind to Interleukin 23 (&#8220;IL-23&#8221;) and incorporates half-life extending modifications. IL-23 is a cytokine that is produced by immune cells and is involved in immune response regulation. IL-23 promotes the survival, expansion, and activity of Th17 cells. Th17 cells produce inflammatory cytokines, such as IL-17, which contribute to the inflammation seen in IBD. IL-23 also helps in the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recruitment and activation of other immune cells, such as neutrophils, which further contribute to tissue damage in the gut. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SPY003 preclinical characterization studies were conducted in-house with support from third party vendors. Our extensive discovery campaign has identified a lead candidate which binds to the p19 subunit of IL-23 with subnanomolar potency in cellular assays (see Figure 7, n=2 and n=3 for pSTAT assay and IL-17 assay, respectively). The development candidate also exhibited extended pharmacokinetic half-life of greater than three-fold relative to a synthesized risankizumab comparator that does not incorporate half-life extending modifications, based on head-to-head preclinical studies in NHPs (see Figure 8, n=4 per group with n=4 and n=3 at the final timepoint for half-life determination for SPY003 and risankizumab, respectively). </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company initiated a FIH trial in healthy volunteers in March 2025, with interim safety and PK data from this trial expected in the second half of 2025. If successful, SPY003 will advance to Phase 2 clinical trials.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Figure 7. Inhibition of IL-23 induced STAT3 phosphorylation in a human lymphoma cell line (DB) (left) and IL-23 induced IL-17 secretion in human peripheral blood mononuclear cells (right) by SPY003 and synthesized risankizumab (Data on file).</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><img src="syre-20250331_g8.jpg" alt="Image 7 -Screenshot 2024-11-05 130807.jpg" style="height:352px;margin-bottom:5pt;vertical-align:text-bottom;width:612px" id="i-8"/><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Figure 8. Pharmacokinetic concentration-time curves of SPY003 candidate compared to synthesized risankizumab comparator in non-human primates (Data on file. Group size was n=4 in the NHP studies with n=4 and n=3 at the final timepoint for half-life determination for SPY003 and risankizumab, respectively).</span></div><div style="margin-top:12pt;text-align:center;text-indent:36pt"><img src="syre-20250331_g9.jpg" alt="FG 8. Screenshot 2024-11-06 160912-Image 6.jpg" style="height:245px;margin-bottom:5pt;vertical-align:text-bottom;width:612px" id="i-9"/></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SPY120 - combination, anti-&#945;4&#946;7 and anti-TL1A mAbs</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SPY120 combines SPY001 (anti-&#945;4&#946;7) and SPY002 (anti-TL1A) antibodies, pairing two mechanisms studied in third-party clinical trials targeting non-overlapping sites of action. We are currently evaluating SPY120 in nonclinical studies, and have initiated combination toxicology studies. Subject to regulatory feedback, we intend to initiate clinical trials in 2025 that will include SPY120.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February and May 2025, the Company presented new preclinical data demonstrating that combination therapy resulted in additive or greater than additive in vivo biological activity relative to either monotherapy in mouse hapten reagent 2,4,6-trinitrobenzene sulfonic acid (TNBS) and anti-CD40 colitis models (Figure 9). In addition, coadministration of SPY001 and SPY002 in NHPs demonstrated no drug effects on PK (Figure 10). </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Figure 9. Combined inhibition of anti-TL1A and anti-&#223;7 (anti-&#945;4&#946;7 mouse surrogate) is superior to either monotherapy in mouse models of colitis.</span></div><div style="margin-top:12pt;text-align:center;text-indent:36pt"><img src="syre-20250331_g10.jpg" alt="FG 9. SPY120 Mouse model.jpg" style="height:179px;margin-bottom:5pt;vertical-align:text-bottom;width:612px" id="i-10"/></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Figure 10. Coadministration of SPY001 and SPY002 demonstrates no drug-drug effects on exposure in NHPs.</span></div><div style="margin-top:12pt;text-align:center;text-indent:36pt"><img src="syre-20250331_g11.jpg" alt="FG 10. SPY120 PK.jpg" style="height:299px;margin-bottom:5pt;vertical-align:text-bottom;width:612px" id="i-11"/></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SPY130 - combination anti-&#945;4&#946;7 and anti-IL-23 mAbs</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SPY130 combines SPY001 (anti-&#945;4&#946;7) and SPY003 (anti-IL-23) antibodies, pairing two commercially validated mechanisms targeting non-overlapping sites of action. We are currently evaluating SPY130 in nonclinical studies and initiated combination toxicology studies in 2024. Subject to regulatory feedback, we intend to initiate clinical trials in 2025 that will include SPY130.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2024, the Company presented new preclinical data, demonstrating in a T-cell transfer model of IBD, that combination therapy with anti-IL-23 and anti-&#945;4&#223;7 improved body weight and reduced colonic CD4+ infiltration and IL-17 levels relative to monotherapy (Figure 11). </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2025, the Company presented additional preclinical data, demonstrating that combination therapy resulted in additive or greater than additive in vivo biological activity relative to either monotherapy in mouse TNBS model (Figure 12).</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Figure 11. Combination of anti-&#223;7 (anti-&#945;4&#946;7 murine surrogate) and anti-IL-23 increases efficacy and PD in T-cell transfer colitis model.</span></div><div style="margin-top:12pt;text-align:center;text-indent:36pt"><img src="syre-20250331_g12.jpg" alt="FG11 - SPY130.jpg" style="height:176px;margin-bottom:5pt;vertical-align:text-bottom;width:612px" id="i-12"/></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Figure 12. Combined inhibition of anti-IL-23 and anti-&#223;7 (anti-&#945;4&#946;7 mouse surrogate) is superior to either monotherapy in mouse TNBS models of colitis (*P&lt;0.05, **P&lt;0.01, ***P&lt;0.001, ****P&lt;0.0001 vs. vehicle (2-way ANOVA with Dunnett&#8217;s correction). N=8 per group).</span></div><div style="margin-top:12pt;text-align:center;text-indent:36pt"><img src="syre-20250331_g13.jpg" alt="SPY130 TNBS model.jpg" style="height:407px;margin-bottom:5pt;vertical-align:text-bottom;width:432px" id="i-13"/></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SPY230 &#8211; combination anti-TL1A and anti-IL-23 mAbs</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SPY230 combines SPY002 (anti-TL1A) and SPY003 (anti-IL-23) antibodies, pairing two complementary mechanisms of action with potential to address overlapping and non-overlapping triggers of inflammation. We are currently evaluating SPY230 in nonclinical studies and initiated combination toxicology studies in 2024. Subject to regulatory feedback, we intend to initiate clinical trials in 2025 that will include SPY230.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2024, the Company presented new preclinical data, demonstrating that anti-IL-23 and anti-TL1A have a synergistic effect on promoting IL-17 secretion from human and mouse cells, and that the combination of anti-IL-23 and anti-TL1A suppressed IL-17 secretion more effectively than either agent alone (Figure 13).</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2025, the Company presented additional preclinical data, demonstrating that combination therapy resulted in additive in vivo biological activity relative to either monotherapy in mouse TNBS model (Figure 14).</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Figure 13. Combination of anti-TL1A and anti-IL-23 offers superior inhibition of IL-17 release in vitro.</span></div><div style="margin-top:12pt;text-align:center;text-indent:36pt"><img src="syre-20250331_g14.jpg" alt="FG12 - SPY230.jpg" style="height:331px;margin-bottom:5pt;vertical-align:text-bottom;width:612px" id="i-14"/></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Figure 14. Combined inhibition of anti-IL-23 and anti-TL1A  is superior to either monotherapy in mouse TNBS model of colitis (*P&lt;0.05, **P&lt;0.01, ***P&lt;0.001, ****P&lt;0.0001 vs. vehicle (2-way ANOVA with Dunnett&#8217;s correction). N=8 per group.</span></div><div style="margin-top:12pt;text-align:center;text-indent:36pt"><img src="syre-20250331_g15.jpg" alt="SPY230 TNBS model.jpg" style="height:372px;margin-bottom:5pt;vertical-align:text-bottom;width:432px" id="i-15"/></div><div style="margin-top:12pt;text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Phase 2 Platform Trial in UC and Phase 2 Trial in RA</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We plan to initiate in mid-2025 (i) a Phase 2 platform trial of our product candidates in IBD beginning with monotherapies in mid-2025 and subsequent planned addition of combination arms and (ii) a Phase 2 clinical trial of anti-TL1A in RA, each subject to regulatory feedback and with initial topline Phase 2 results expected to be received in 2026.</span></div><div id="id1024c8efdf34cb8889d12b6bf18881e_103"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Paragon Agreement</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2023, Pre-Merger Spyre entered into the Paragon Agreement with Paragon and Parapyre. Pursuant to the Paragon Agreement, the Option provided for the right to acquire the intellectual property rights related to certain research programs from Paragon in accordance with a license agreement to be entered into following each exercise of the Option. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 12, 2023, December 14, 2023 and June 5, 2024, we exercised our Option available under the Paragon Agreement with respect to the SPY001, SPY002 and SPY003 research programs, respectively. In May 2024, we signed license agreements with Paragon for rights to royalty-bearing, world-wide, exclusive licenses to develop, manufacture, commercialize or otherwise exploit certain antibodies and products targeting &#593;4&#946;7 integrin (SPY001 program) and TL1A (SPY002 program) and, in October 2024, we signed a license agreement for rights to a royalty-bearing, world-wide, exclusive license to develop, manufacture, commercialize or otherwise exploit certain antibodies and products targeting IL-23 (SPY003 program) in the field of IBD. The SPY003 License Agreement was subsequently amended and restated in February 2025 to, among other things, clarify each party's rights and obligations with respect to license exclusivity and patent prosecution.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of each License Agreement, we are obligated to pay Paragon up to $22.0&#160;million upon the achievement of specific development, regulatory and clinical milestones for the first product under each agreement, respectively, that achieves such specified milestones, including a milestone payment of $3 million upon the first dosing of a human patient in a Phase 2 trial. With respect to the SPY002 License Agreement only, on a product by product basis, we are obligated to pay sublicensing fees of up to approximately $20&#160;million upon the achievement of mostly commercial milestones.</span></div><div id="id1024c8efdf34cb8889d12b6bf18881e_106"></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our condensed consolidated financial statements are prepared in accordance with generally accepted accounting principles in the United States ("U.S. GAAP"). The preparation of these condensed consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, costs and expenses, and related disclosures. These estimates form the basis for judgments we make about the carrying values of our assets, liabilities and equity and the amount of revenues and expenses, which are not readily apparent from other sources. We base our estimates on historical experience and on various other assumptions that we believe are reasonable under the circumstances. On an ongoing basis, we evaluate our estimates and assumptions. Our actual results may differ materially from these estimates under different assumptions or conditions. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our critical accounting policies are those policies which require the most significant judgments and estimates in the preparation of our consolidated financial statements. The most significant estimates and assumptions that management considers in the preparation of our financial statements relate to accrued research and development costs; the discount rate, probabilities of success, and timing of estimated cash flows in the valuation of the contingent value right ("CVR") liability and inputs used in the Black-Scholes model for stock-based compensation expense. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We define our critical accounting policies as those accounting principles generally accepted in the United States that require us to make subjective estimates and judgments about matters that are uncertain and are likely to have a material impact on our financial condition and results of operations, as well as the specific manner in which we apply those principles. There have been no significant changes to our critical accounting policies and estimates as compared to the critical accounting policies and estimates disclosed in "Management&#8217;s Discussion and Analysis of Financial Condition and Operations" included in our Annual Report.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><div id="id1024c8efdf34cb8889d12b6bf18881e_109"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Comparison of the Three Months Ended March&#160;31, 2025 and 2024</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our results of operations for the three months ended March&#160;31, 2025 and 2024, together with the changes in those items in dollars and as a percentage:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.839%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.263%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.263%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.263%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.054%"/><td style="width:0.1%"/></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Increase/(Decrease)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">% Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating expenses:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">41,623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">34,928&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6,695&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11,944&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12,846&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(902)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">53,567&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">47,774&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5,793&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Loss from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(53,567)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(47,774)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5,793&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other income:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6,493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,432&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,061&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(483)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,769&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total other income </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8,779&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,949&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,830&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Loss before income tax expense</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(44,788)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(43,825)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">963&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(44,773)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(43,857)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">916&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.11pt">Percentage not meaningful</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expenses</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Research and development expenses increased by $6.7 million, or 19%, to $41.6 million for the three months ended March&#160;31, 2025, from $34.9 million for the three months ended March&#160;31, 2024. The increase was primarily driven by $13.5 million and $5.3 million increases in clinical and preclinical development activities, respectively, a $4.7 million increase in compensation costs, and a $2.5 million increase in intellectual property license fees, partially offset by $17.1 million and $3.5 million decreases in antibody discovery costs and manufacturing costs, respectively.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">External research and development expenses include costs associated with third parties contracted to conduct research and development activities on behalf of the Company, including through Paragon, CROs, CMOs, and third-party laboratories. For the three months ended March&#160;31, 2025 and 2024, external research and development costs accounted for $33.5 million and $31.3 million, respectively. The increase was primarily due to increased clinical and preclinical development activities, intellectual property license fees, partially offset by decreases in antibody discovery and manufacturing costs associated with our pipeline candidates as described above.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Internal research and development expenses include compensation and related costs associated with our research and development employees. For the three months ended March&#160;31, 2025 and 2024, internal research and development costs accounted for $8.1 million and $3.6 million, respectively. The increase was primarily driven by an increase in research and development headcount.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and Administrative Expenses.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> General and administrative expenses decreased by $0.9 million, or 7%, to $11.9 million for the three months ended March&#160;31, 2025, from $12.8 million for the three months ended March&#160;31, 2024. The decrease was primarily attributable to a $1.6 million decrease in stock-based compensation, partially offset by a $0.8 million increase in professional services fees.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Income.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Interest income was $6.5 million and $4.4 million for the three months ended March&#160;31, 2025 and 2024, respectively. The increase was primarily due to higher investment balances. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other income (expense), net. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net for the three months ended  March&#160;31, 2025 increased by $2.8 million versus the three months ended March&#160;31, 2024 primarily driven by a $2.4 million decrease in fair value of the CVR liability during the current period compared to a $0.4 million increase in fair value of the contingent right liability during the prior period.</span></div><div id="id1024c8efdf34cb8889d12b6bf18881e_658"></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a clinical stage biotechnology company with a limited operating history, and due to our significant research and development expenditures, we have generated operating losses since our inception and have not generated any revenue from the commercial sale of any products. There can be no assurance that profitable operations will ever be achieved, and, if achieved, whether profitability can be sustained on a continuing basis. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since our inception and through March&#160;31, 2025, we have funded our operations by raising an aggregate of approximately $1.3 billion of gross proceeds from the sale and issuance of convertible preferred stock and common stock, pre-funded warrants, the collection of grant proceeds, and the licensing of our product rights for commercialization of pegzilarginase in Europe and certain countries in the Middle East. As of March&#160;31, 2025, we had an accumulated deficit of $1.0 billion.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary use of cash is to fund the development of our product candidates, and advance our pipeline. This includes both the research and development costs and the general and administrative expenses required to support those operations. Since we are a clinical stage biotechnology company, we have incurred significant operating losses since our inception and we anticipate such losses, in absolute dollar terms, to increase as we continue to pursue clinical development of our product candidates, prepare for the potential commercialization of our product candidates, and expand our development efforts in our pipeline of nonclinical candidates. Based on current operating plans, we have sufficient resources to fund operations for at least one year from the issuance date of the financial statements included in this Quarterly Report with existing cash, cash equivalents, and marketable securities. We will need to secure additional financing in the future to fund additional research and development, and before a commercial drug can be produced, marketed and sold. If the Company is unable to obtain additional financing or generate license or product revenue, the lack of liquidity could have a material adverse effect on the Company.</span></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sources of Liquidity</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2024, we completed a private placement of 121,625 shares of Series B Preferred Stock at $1,480.00 per share resulting in net proceeds of approximately $168.9&#160;million after deducting approximately $11.2 million of placement agent and other offering costs. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2024 and December 2024, we sold an aggregate of 777,432 shares of common stock under an ATM offering program at an average price per share of $26.935 resulting in net proceeds of approximately $20.5&#160;million after deducting approximately $0.4&#160;million of sales agent commissions and other offering costs. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, we sold 8,366,250 shares of our common stock in an underwritten public offering, inclusive of 1,091,250 shares pursuant to the full exercise of the underwriters' over-allotment option, under our shelf registration statement on Form S-3 at a price per share of $27.50, resulting in net proceeds of $215.9 million after deducting approximately $14.2&#160;million of underwriting discounts and other offering costs.</span></div><div id="id1024c8efdf34cb8889d12b6bf18881e_115"></div><div style="margin-top:18pt;text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our cash flows for the periods indicated (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash, cash equivalents, and restricted cash (used in) provided by:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(40,994)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(28,542)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(61)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(104,963)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">172,165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effect of exchange rate on cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net (decrease) increase in cash, cash equivalents, and restricted cash</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(40,930)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38,656&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Used in Operating Activities</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used in operating activities for the three months ended March&#160;31, 2025 was $41.0 million and reflected a net loss of $44.8 million coupled with $2.6 million in net accretion of discount on marketable securities and a $2.4 million non-cash gain from the decrease of the CVR liability fair value, partially offset by stock-based compensation of $8.9 million.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used in operating activities for the three months ended March&#160;31, 2024 was $28.5 million and reflected a net loss of $43.9 million and $2.4 million in net accretion of discount on marketable securities, partially offset by stock-based compensation of $13.8 million and a $3.5 million decrease in net operating assets and liabilities driven by timing of payments.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Used in Investing Activities</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used in investing activities for the three months ended March&#160;31, 2025 was $0.1 million.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used in investing activities for the three months ended March&#160;31, 2024, was $105.0 million and primarily consisted of $152.7 million in purchases of marketable securities, partially offset by $47.8 million in maturities and sales of marketable securities.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Provided by Financing Activities</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash provided by financing activities for the three months ended March&#160;31, 2025 was $0.1 million.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash provided by financing activities for the three months ended March&#160;31, 2024, was $172.2 million, which primarily consisted of the net proceeds from the issuance of the Series B Preferred Stock in the March 2024 PIPE of $169.2 million and $4.4 million from proceeds from stock option exercises and sales of common stock under our Employee Stock Purchase Plan.</span></div><div id="id1024c8efdf34cb8889d12b6bf18881e_118"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Contractual Obligations</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through the Asset Acquisition, we received the Option to license certain intellectual property rights related to certain research programs. The exercise of the Option allows for us to enter into an exclusive license agreement with Paragon for the respective research program. Thus far we have exercised the Option and entered into license agreements with respect to SPY001, SPY002, and SPY003. Under the terms of each License Agreement, we are obligated to pay Paragon up to $22.0 million based on specific development, regulatory and clinical milestones for the first product under each agreement. As of March 31, 2025, we have incurred a total of $12.0 million of milestone fees out of a total maximum of $66.0 million in potential milestone fees across all License Agreements. As of March 31, 2025 $2.5 million of milestone fees remain outstanding and payable.  With respect to the SPY002 License Agreement only, on a product by product basis, we are obligated to pay sublicensing fees of up to approximately $20 million upon the achievement of mostly </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">commercial milestones. As of March 31, 2025 we have incurred $0.7 million of sublicensing fees of which nil remain outstanding and payable.</span></div><div id="id1024c8efdf34cb8889d12b6bf18881e_121"></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no recent accounting pronouncements that have had a material effect on the Company&#8217;s financial position or results of operations.</span></div><div id="id1024c8efdf34cb8889d12b6bf18881e_124"></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Quantitative and Qualitative Disclosures About Market Risk.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to market risks in the ordinary course of our business. These risks primarily include interest rate sensitivities related to our interest-earning investments, foreign currency exchange rates and inflation risk affecting labor costs and clinical trial costs.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Rate Risk</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary exposure to market risk is interest rate sensitivity, which is affected by changes in the general level of United States interest rates, particularly because our investments are in marketable securities. As of March&#160;31, 2025, we held $564.8 million in cash, cash equivalents, and marketable securities, all of which were denominated in U.S. dollars, and consisted primarily of investments in money market funds, commercial paper, U.S. government obligations, and corporate bonds. Our marketable securities are subject to interest rate risk and could fall in value if market interest rates increase. However, we believe that our exposure to interest rate risk is not significant as the majority of our investments are short-term in duration and have a low risk profile. A hypothetical 10% change in interest rates during any of the periods presented would not have had a material effect on the total market value of our cash equivalents and marketable securities as of March&#160;31, 2025. To date, we have not experienced a loss of principal on any of our investments and as of March&#160;31, 2025, we did not record any allowance for credit loss from our investments.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Risk</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also exposed to market risk related to changes in foreign currency exchange rates as a result of our entering into transactions denominated in currencies other than U.S. dollars. Due to the uncertain timing of expected payments in foreign currencies, we do not utilize any forward exchange contracts. All foreign transactions settle on the applicable spot exchange basis at the time such payments are made. Volatile market conditions arising from the macroeconomic environment (including financial conditions affecting the banking system and financial institutions), inflation, tariff/trade policy, or global political instability may result in significant changes in exchange rates, and in particular, a weakening of the U.S. dollar relative to foreign currencies may negatively affect our expenses and net income as expressed in U.S. dollars. An adverse movement in foreign exchange rates could have a material effect on payments made to foreign suppliers. For the three months ended March&#160;31, 2025, a majority of our expenditures were denominated in U.S. dollars. A hypothetical 10% change in foreign exchange rates during any of the periods presented would not have had a material impact on our consolidated financial statements.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inflation Fluctuation Risk</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inflation generally affects us by increasing our costs, such as the cost of labor and research and development contract costs. We do not believe inflation has had a material adverse effect on the results of our operations during the three months ended March&#160;31, 2025.</span></div><div id="id1024c8efdf34cb8889d12b6bf18881e_127"></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Controls and Procedures.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, with the participation of our principal executive officer and principal financial officer, evaluated, as of the end of the period covered by this Quarterly Report on Form 10-Q, the effectiveness of our disclosure controls and procedures. Based on the foregoing evaluation of our disclosure controls and procedures, as of March&#160;31, 2025, our principal executive officer and principal financial officer concluded that </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">our disclosure controls and procedures were effective at the reasonable assurance level. The term &#8220;disclosure controls and procedures,&#8221; as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act are recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting during the quarter ended March&#160;31, 2025, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><div id="id1024c8efdf34cb8889d12b6bf18881e_130"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II. &#8211; Other Information</span></div><div id="id1024c8efdf34cb8889d12b6bf18881e_133"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Legal Proceedings</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may become involved in legal proceedings relating to claims arising from the ordinary course of business. Our management believes that there are currently no claims or actions pending against us, the ultimate disposition of which could have a material adverse effect on our results of operations, financial condition or cash flows.</span></div><div id="id1024c8efdf34cb8889d12b6bf18881e_136"></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. Risk Factors</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following summarizes the principal factors that make an investment in the Company speculative or risky, all of which are more fully described in the Risk Factors section below. This summary should be read in conjunction with the Risk Factors section and should not be relied upon as an exhaustive summary of the material risks facing our business. Some of the factors, events and contingencies discussed below may have occurred in the past, but the disclosures below are not representations as to whether or not the factors, events or contingencies have occurred in the past, and instead reflect our beliefs and opinions as to the factors, events or contingencies that could materially and adversely affect us in the future. The occurrence of any of these risks, could harm our business, financial condition, results of operations and/or growth prospects or cause our actual results to differ materially from those contained in forward-looking statements we have made in this Quarterly Report on Form 10-Q and those we may make from time to time. You should consider all of the risk factors described in our public filings when evaluating our business.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk Factor Summary </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks Related to Our Financial Condition and Capital Requirements</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We will not be able to continue as a going concern if we are unable to raise additional capital when needed and raising additional capital may cause dilution to our stockholders and restrict our operations.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have never generated any revenue from product sales and may never be profitable. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We anticipate that we will continue to incur significant losses for the foreseeable future.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks Related to Discovery, Development and Commercialization</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our programs are in clinical and nonclinical stages of development and may fail or suffer delays or may be more costly than anticipated for various reasons, including but not limited to delays or failures in achieving alignment with regulatory authorities on trial designs and interpretation of data and its sufficiency to support safety and efficacy of our product candidates, patient recruitment or other clinical trial challenges, or unanticipated drug supply disruptions.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are substantially dependent on the success of the SPY001, SPY002 and SPY003 programs, alone or in combination, and may fail to achieve our projected development goals in the time frames we expect.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Any drug delivery device used may have its own regulatory development, supply, and other risks.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may not be successful in building a pipeline of product candidates with commercial value.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our studies and trials may be insufficient to support regulatory approval of any product candidates.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may not be successful in discovering, developing and commercializing our intraportfolio investigational drug combinations to achieve superior outcomes relative to the use of other therapies.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Preliminary or &#8220;topline&#8221; data from our clinical trials may change as more data becomes available.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our current or future clinical trials may reveal significant adverse events or undesirable side effects.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may fail to capitalize on more profitable or potentially successful product candidates.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our products may not achieve regulatory approval, market acceptance or commercial success.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our programs may compete with each other and they face third-party program competition.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Regulatory authorities may not accept data from clinical trials we conduct at sites outside the United States or other jurisdiction.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks Related to Government Regulation</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may not be able to achieve our timelines or obtain timely regulatory approvals of product candidates.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may not be able to meet requirements for chemistry, manufacturing and control of our programs.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our product candidates may face competition sooner than anticipated based on rules and regulations that may apply or government decisions with respect to our intellectual property.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Even if we receive regulatory approval, we will be subject to extensive ongoing regulatory obligations.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may be negatively impacted by healthcare legislative reform measures and other changes in law.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our potential revenue may be adversely affected due to unfavorable regulations, laws and/or policies.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may face criminal liability or other consequences if we violate U.S. and foreign trade regulations.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Any accelerated review designations we may pursue may not hasten development or regulatory review.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks Related to Our Intellectual Property</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may fail in obtaining, maintaining and protecting our patents and other proprietary rights. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may be subject to patent infringement claims or may need to file such claims.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may be subject to claims of wrongful hiring of employees or wrongful use of confidential information.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our patents and our ability to protect our products may be impaired by changes to patent laws.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our patent protection could be reduced or eliminated for non-compliance with legal requirements.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may fail to identify or interpret relevant third-party patents.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may become subject to claims challenging the inventorship or ownership of our intellectual property.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Patent terms may be inadequate to protect our competitive position of our programs.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our technology licensed from various third parties may be subject to retained rights.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks Related to Our Reliance on Third Parties</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may fail to maintain collaborations and licensing arrangements with third parties that we rely on.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Third parties we rely on for nonclinical studies and clinical trials may fail to satisfy contractual duties.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may be unable to use third-party manufacturing sites, our third-party manufacturers may encounter difficulties in production or we may need to switch or create third-party manufacturer redundancies.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks Related to Employee Matters, Managing Growth and Other Risks Related to Our Business</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may experience difficulties in managing the growth of our organization.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may fail to attract or retain highly qualified personnel.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to operate in foreign markets is subject to regulatory burdens, risks and uncertainties.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our estimates of market opportunity may be inaccurate and our business may not grow at similar rates. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our employees or third parties may engage in misconduct or other improper activities.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may be impacted by security or data breaches or other improper access to our data.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to use our net operating loss carryforwards and certain other tax attributes may be limited.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may fail to comply with privacy, data security, safety and other regulations despite compliance efforts.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may be subject to adverse legislative or regulatory tax changes.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may fail to realize the benefits of our business or product acquisitions or our strategic alliances.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks Related to Our Common Stock</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The market price of our common stock has historically been volatile and may drop in the future.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our certificate of incorporation, Delaware law and certain contracts include anti-takeover provisions. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We do not anticipate paying any dividends in the foreseeable future.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Future sales and issuances of equity/debt may dilute stockholders and/or result in a drop in our stock price.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our principal stockholders own a significant percentage of our stock. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General Risk Factors</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our product liability insurance may be insufficient to cover costly and damaging liability claims.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Litigation costs and the outcome of litigation could have a material adverse effect on our business.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We continue to incur significant costs for compliance with public company laws and regulations.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our failure to maintain proper and effective internal controls may adversely affect our ability to report our financial condition and results of operations in a timely and accurate manner, decrease investor confidence in us, and reduce the value of our common stock. For example, in the fourth quarter of 2024, we identified a </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">material weakness in our internal control over financial reporting which resulted in restatements of our previously-issued financial statements to amend certain net loss per share disclosures.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our business could be adversely affected by macroeconomic conditions.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Financial Condition and Capital Requirements</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We will need to raise additional capital, and if we are unable to do so when needed, we will not be able to continue as a going concern.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2025, we had $564.8 million of cash, cash equivalents, and marketable securities. We will need to raise additional capital to continue to fund our operations in the future. If we are unable to raise additional capital when needed, we will not be able to continue as a going concern.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Developing our product candidates requires a substantial amount of capital. We expect our research and development expenses to increase in connection with our ongoing activities, particularly as we advance our product candidates through clinical trials. We will need to raise additional capital to fund our operations and such funding may not be available to us on acceptable terms, or at all, and such funding may become even more difficult to obtain due to macroeconomic conditions, including rising interest rates, tariffs and trade restrictions and downturns in the U.S. capital markets and the biotechnology sector in general. Competition for additional capital among biotechnology companies may be particularly intense during economic downturns. We may be unable to raise capital through public offerings of our common stock and may need to turn to alternative financing arrangements. Such arrangements, if we pursue them, could involve issuances of one or more types of securities, including common stock, preferred stock, convertible debt, warrants to acquire common stock or other securities. These securities could be issued at or below the then prevailing market price for our common stock. In addition, if we issue debt securities, the holders of the debt would have a claim to our assets that would be superior to the rights of stockholders until the principal, accrued and unpaid interest and any premium or make-whole has been paid. Interest on any newly-issued debt securities and/or newly-incurred borrowings would increase our operating costs and reduce our net income (or increase our net loss), and these impacts may be material. If the issuance of new securities results in diminished rights to holders of our common stock, the market price of our common stock could be materially and adversely affected.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not currently have any products approved for sale and do not generate any revenue from product sales. Accordingly, we expect to rely primarily on equity and/or debt financings to fund our continued operations. Our ability to raise additional funds will depend, in part, on the success of our nonclinical studies and clinical trials and other product development activities, regulatory events, our ability to identify and enter into licensing or other strategic arrangements, and other events or conditions that may affect our value or prospects, as well as factors related to financial, economic and market conditions, many of which are beyond our control. There can be no assurances that sufficient funds will be available to us when required or on acceptable terms, if at all. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to raise additional capital when required or on acceptable terms, we may be required to:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">significantly delay, scale back, or discontinue the development or commercialization of our product candidates;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">seek strategic partnerships, or amend existing partnerships, for research and development programs at an earlier stage than otherwise would be desirable or that we otherwise would have sought to develop independently, or on terms that are less favorable than might otherwise be available in the future;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">dispose of technology assets, or relinquish or license on unfavorable terms, our rights to technologies or any of our product candidates that we otherwise would seek to develop or commercialize ourselves;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pursue the sale of our company to a third party at a price that may result in a loss on investment for our stockholders; or</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">file for bankruptcy or cease operations altogether (and face any related legal proceedings).</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any of these events could have a material adverse effect on our business, operating results and prospects. Even if successful in raising new capital, we could be limited in the amount of capital we raise due to investor demand restrictions placed on the amount of capital we raise or other reasons.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, any capital raising efforts are subject to significant risks and contingencies, as described in more detail under the risk factor titled &#8220;Raising additional capital may cause dilution to our stockholders, restrict our operations, or require us to relinquish rights.&#8221;</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have never generated any revenue from product sales and may never be profitable.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have no products approved for commercialization and have never generated any revenue from product sales. Our ability to generate revenue and achieve profitability depends on our ability, alone or with strategic collaborators, to successfully complete the development of, and obtain the regulatory and marketing approvals necessary to commercialize one or more of our product candidates. We do not anticipate generating revenue from product sales for the foreseeable future. Our ability to generate future revenue from product sales depends heavily on our success in many areas, including but not limited to:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">completing research and development of our product candidates; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">obtaining regulatory and marketing approvals for our product candidates for which we complete clinical trials; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">manufacturing product candidates and establishing and maintaining supply and manufacturing relationships with third parties that are commercially feasible, meet regulatory requirements and our supply needs in sufficient quantities to meet market demand for our product candidates, if approved; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">qualify for adequate coverage and reimbursement by government and third-party payors for any product candidates for which we obtain regulatory and marketing approval;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">marketing, launching, and commercializing product candidates for which we obtain regulatory and marketing approval, either directly or with a collaborator or distributor; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">gaining market acceptance of our product candidates as treatment options;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">addressing any competing products and technological and market developments;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">implementing internal systems and infrastructure, as needed;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">protecting and enforcing our intellectual property rights, including patents, trade secrets, and know-how;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">negotiating favorable terms in any collaboration, licensing, or other arrangements into which we may enter;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">obtaining coverage and adequate reimbursement from third-party payors and maintaining pricing for our product candidates that supports profitability; and </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">attracting, hiring, and retaining qualified personnel. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if one or more of the product candidates that we develop is approved for commercial sale, we anticipate incurring significant costs associated with commercializing any approved product candidate. Our expenses could increase beyond expectations if we are required by regulatory authorities to perform clinical and other studies in addition to those that we anticipate. Even if we are able to generate revenues from the sale of any approved products, we may not become profitable and may need to obtain additional funding to continue operations. Portions of our research programs may be in-licensed from third parties, which make the commercial sale of such in-licensed products potentially subject to additional royalty and milestone payments to such third parties. We will also have to develop or acquire manufacturing capabilities or continue to contract with contract manufacturers in order to continue development and potential commercialization of our product candidates. For instance, if the costs of manufacturing our drug product are not commercially feasible, we will need to develop or procure our drug product in a commercially feasible manner in order to successfully commercialize a future approved product, if any. Additionally, if we are not able to generate revenue from the sale of any approved products, we may never become profitable.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have historically incurred losses, have a limited operating history on which to assess our business, and anticipate that we will continue to incur significant losses for the foreseeable future.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a biopharmaceutical company with a limited operating history. Since inception, we have incurred significant operating losses. For the years ended December 31, 2024, 2023 and 2022, we reported a net loss of $208.0 million, $338.8 million and $83.8 million, respectively. As of December 31, 2024, we had an </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">accumulated deficit of $972.4 million. We will need to raise substantial additional capital to continue to fund our operations in the future.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Failure to raise capital as and when needed, on favorable terms or at all, would have a negative impact on our financial condition and our ability to develop our product candidates. Changing circumstances may cause us to consume capital significantly faster or slower than we currently anticipate. If we are unable to acquire additional capital or resources, we will be required to modify our operational plans to complete future milestones and we may be required to delay, limit, reduce or eliminate development or future commercialization efforts of product candidates and/or programs. We have based these estimates on assumptions that may prove to be wrong, and we could exhaust our available financial resources sooner than we currently anticipate. We may be forced to reduce our operating expenses and raise additional funds to meet our working capital needs, principally through the additional sales of our securities or debt financings or entering into strategic collaborations. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have devoted substantially all of our financial resources to identify, acquire, and develop our product candidates, including conducting nonclinical and clinical development of the legacy rare disease clinical trials conducted by us prior to the Asset Acquisition and the nonclinical and clinical development of our current pipeline, and providing general and administrative support for our operations. To date, we have funded our operations primarily from the sale and issuance of convertible preferred and common equity securities, pre-funded warrants, the collection of grant proceeds, and the licensing of our product rights for commercialization of pegzilarginase in Europe and certain countries in the Middle East. The amount of our future net losses will depend, in part, on the rate of our future expenditures and our ability to obtain funding through equity or debt financings, strategic collaborations, or grants. Biopharmaceutical product development is a highly speculative undertaking and involves a substantial degree of risk. We expect our losses to increase as our product candidates enter more advanced clinical trials. It may be several years, if ever, before we complete pivotal clinical trials or have a product candidate approved for commercialization. We expect to invest significant funds into the research and development of our current product candidates to determine the potential to advance these product candidates to regulatory approval. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we obtain regulatory approval to market a product candidate, our future revenue will depend upon the size of any markets in which our product candidates may receive approval, and our ability to achieve sufficient market acceptance, pricing, coverage and adequate reimbursement from third-party payors, and adequate market share for our product candidates in those markets. Even if we obtain adequate market share for our product candidates, because the potential markets in which our product candidates may ultimately receive regulatory approval could be very small, we may never become profitable despite obtaining such market share and acceptance of our products.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to continue to incur significant expenses and increasing operating losses for the foreseeable future and our expenses will increase substantially if and as we:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continue the nonclinical and clinical development of our product candidates; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continue efforts to discover and develop new product candidates;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continue the manufacturing of our product candidates or increase volumes manufactured by third parties;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">advance our product candidates into larger, more expensive clinical trials;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">initiate additional nonclinical studies or clinical trials for our product candidates;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">seek regulatory and marketing approvals and reimbursement for our product candidates;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">establish a sales, marketing, and distribution infrastructure to commercialize any products for which we may obtain marketing approval and market for ourselves;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">seek to identify, assess, acquire, and/or develop other product candidates;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">make milestone, royalty, or other payments under third-party license agreements;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">seek to maintain, protect, and expand our intellectual property portfolio;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">seek to attract and retain skilled personnel; and</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">experience any delays or encounter issues with the development and potential for regulatory approval of our clinical and product candidates such as safety issues, manufacturing delays, clinical trial accrual delays, longer follow-up for planned studies or trials, additional major studies or trials, or supportive trials necessary to support marketing approval.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, the net losses we incur may fluctuate significantly from quarter to quarter and year to year, such that a period-to-period comparison of our results of operations may not be a good indication of our future performance.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Raising additional capital may cause dilution to our stockholders, restrict our operations, or require us to relinquish rights. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Until such time, if ever, as we can generate substantial revenue from the sale of our product candidates, we expect to finance our cash needs through a combination of equity offerings, debt financings and license and development agreements. To the extent that we raise additional capital through the sale of equity securities or convertible debt securities, the ownership interest of our stockholders will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect your rights as a holder of common stock. Debt financing and preferred equity financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures, or declaring dividends. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we raise additional funds through collaborations, strategic alliances or marketing, distribution or licensing arrangements with third parties, we may be required to relinquish valuable rights to our research programs or product candidates or grant licenses on terms that may not be favorable to us. If we are unable to raise additional funds through equity or debt financings or other arrangements with third parties when needed, we may be required to delay, limit, reduce or terminate our product development or future commercialization efforts or grant rights to third parties to develop and market product candidates that we would otherwise prefer to develop and market ourselves. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent that we raise additional capital through the sale of equity, including pursuant to any sales under convertible debt or other securities convertible into equity, the ownership interest of our stockholders will be diluted, and the terms of these new securities may include liquidation or other preferences that adversely affect the rights of our stockholders. For instance, in December 2023, we sold an aggregate of 6,000,000 shares of our common stock and 150,000 shares of our Series B Preferred Stock pursuant to a private placement to certain investors for gross proceeds of approximately $180 million and in March 2024, we sold an aggregate of 121,625 shares of our Series B Preferred Stock pursuant to a private placement to certain investors for gross proceeds of approximately $180 million. Subject to certain beneficial ownership limitations set by each holder of Series B Preferred Stock, each share of Series B Preferred Stock is convertible into an aggregate of 40 shares of our common stock. Following stockholder approval of the Series B Conversion Proposal, 254,958 shares of Series B Preferred Stock automatically converted to 10,198,320 shares of common stock; 16,667 shares of Series B Preferred Stock did not automatically convert and remain outstanding as of March 31, 2025 due to beneficial ownership limitations.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt financing, if available, would likely involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures, making additional product acquisitions, or declaring dividends. If we raise additional funds through strategic collaborations or licensing arrangements with third parties, we may have to relinquish valuable rights to our product candidates or future revenue streams or grant licenses on terms that are not favorable to us. We cannot be assured that we will be able to obtain additional funding if and when necessary to fund our entire portfolio of product candidates to meet our projected plans. If we are unable to obtain funding on a timely basis, we may be required to delay or discontinue one or more of our development programs or the commercialization of any product candidates or be unable to expand our operations or otherwise capitalize on potential business opportunities, which could materially harm our business, financial condition, and results of operations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Discovery, Development and Commercialization</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face competition from entities that have developed or may develop programs for the diseases addressed by our product candidates. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The development and commercialization of drugs is highly competitive. Our product candidates, if approved, will face significant competition and our failure to effectively compete may prevent us from achieving significant market penetration. We compete with a variety of multinational biopharmaceutical companies, specialized biotechnology companies and emerging biotechnology companies, as well as academic institutions, governmental agencies, and public and private research institutions, among others. Many of the companies with which we are currently competing or will compete against in the future have significantly greater financial resources and expertise in research and development, manufacturing, nonclinical testing, clinical trial conduct, regulatory approvals, and marketing than we do. Mergers and acquisitions in the pharmaceutical and biotechnology industry may result in even more resources being concentrated among a smaller number of our competitors. Smaller or early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. These competitors also compete with us in recruiting and retaining qualified scientific and management personnel, establishing clinical trial sites, recruiting participants for clinical trials, as well as in acquiring technologies complementary to, or necessary for, our product candidates. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our competitors have developed, are developing or will develop programs and processes competitive with our programs and processes. Competitive therapeutic treatments include those that have already been approved and accepted by the medical community and any new treatments. Our success will depend partially on our ability to develop and commercialize products that have a competitive safety, efficacy, dosing and/or presentation profile. Our commercial opportunity and success will be reduced or eliminated if competing products are safer, more effective, have a more attractive dosing profile or presentation or are less expensive than the products we develop, or if our competitors develop competing products or if biosimilars enter the market more quickly than we do and are able to gain market acceptance. See the section titled &#8220;Business &#8211; Competition&#8221; in our Annual Report on Form 10-K for more discussion about our competitors.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, because of the competitive landscape for inflammatory and immunology ("I&amp;I") indications, we may also face competition for clinical trial enrollment. Clinical trial enrollment will depend on many factors, including if potential clinical trial participants choose to undergo treatment with approved products or enroll in competitors&#8217; ongoing clinical trials for programs that are under development for the same indications as our programs. An increase in the number of approved products for the indications we are targeting with our programs may further exacerbate this competition. Our inability to enroll a sufficient number of participants could, among other things, delay our development timeline, which may further harm our competitive position.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our product candidates are in clinical and nonclinical stages of development and may fail in development or suffer delays that materially and adversely affect their commercial viability. If we or our current or future collaborators are unable to complete development of, or commercialize our product candidates, or experience significant delays in doing so, our business will be materially harmed.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have no products on the market and all of our product candidates are in clinical or nonclinical stages of development, and we have not completed any clinical trials. As a result, we expect it will be many years before we commercialize any product candidate, if ever. Our ability to achieve and sustain profitability depends on obtaining regulatory approvals for, and successfully commercializing, our product candidates, either alone or with third parties, and we cannot guarantee that we will ever obtain regulatory approval for any of our product candidates. We have not yet demonstrated our ability to complete any clinical trials, obtain regulatory approvals, manufacture a commercial-scale product or arrange for a third party to do so on our behalf, or conduct sales and marketing activities necessary for successful product commercialization. Before obtaining regulatory approval for the commercial distribution of our product candidates, we or an existing or future collaborator must conduct extensive nonclinical tests and clinical trials to demonstrate the safety and efficacy in humans of our programs and future product candidates.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We or our collaborators may experience delays in initiating or completing nonclinical studies or clinical trials. We or our collaborators also may experience numerous unforeseen events during, or as a result of, any current or future nonclinical studies and clinical trials that we could conduct that could delay or prevent our ability to achieve our development timelines, receive marketing approval or commercialize our current product candidates or any future product candidates, including:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulators, such as the U.S. Food and Drug Administration ("FDA"), or ethics committees (&#8220;ECs&#8221;)/institutional review boards (&#8220;IRBs&#8221;) may not authorize us or our investigators to commence a clinical trial or conduct a clinical trial at a prospective trial site; </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may experience delays in reaching, or fail to reach, agreement on acceptable terms with prospective trial sites and prospective contract research organizations (&#8220;CROs&#8221;), the terms of which can be subject to extensive negotiation and may vary significantly among different CROs and trial sites;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">clinical trial sites may deviate from trial protocol or drop out of a clinical trial;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">clinical trials of any product candidates may fail to demonstrate safety or efficacy, or produce negative or inconclusive results, and we may decide, or regulators may require us, to conduct additional nonclinical studies or clinical trials, or we may decide to abandon product development programs;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the number of participants required for clinical trials of any product candidates may be larger than we anticipate and enrollment in these clinical trials may be slower than we anticipate or participants may drop out of these clinical trials or fail to return for post-treatment follow-up at a higher rate than we anticipate;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our third-party contractors may fail to comply with regulatory requirements or meet their contractual obligations to us in a timely manner, or at all, or may deviate from the clinical trial protocol or drop out of the trial, which may require that we add new clinical trial sites or investigators;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may elect to, or regulators and/or ECs/IRBs may require that we or our investigators materially modify, suspend or terminate clinical research or trials for various reasons, including noncompliance with regulatory requirements or a finding that the participants in our trials are being exposed to unacceptable health risks;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost of clinical trials of any of our programs may be greater than we anticipate;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the quality of our product candidates or other materials necessary to conduct clinical trials of our product candidates may be inadequate to initiate or complete a given clinical trial;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may be unable to manufacture sufficient quantities of our product candidates for use in clinical trials;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reports from clinical testing of other therapies may raise safety or efficacy concerns about our programs;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the FDA or other regulatory authorities may not agree with our interpretation of the results of clinical trials or non-clinical studies or our clinical trial designs and plans;  </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may fail to establish an appropriate safety profile for a product candidate based on clinical or nonclinical data for such product candidates as well as data emerging from other therapies in the same class as our product candidates; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the FDA or other regulatory authorities may require us to submit additional data such as long-term toxicology studies, additional clinical data or additional manufacturing data or impose other requirements before permitting us to initiate clinical trials or approving marketing/commercial sales.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commencing clinical trials in the United States is subject to acceptance by the FDA of an IND or similar application and finalizing the trial design based on discussions with the FDA and other regulatory authorities. In the event that the FDA requires us to complete additional nonclinical studies or clinical trials or we are required to satisfy other FDA requests prior to commencing future planned clinical trials, the start of such planned clinical trials may be delayed or such planned clinical trials may be commenced in a modified manner. Even after we receive and incorporate guidance from these regulatory authorities, the FDA or other regulatory authorities could disagree that we have satisfied their requirements to commence any future clinical trial or change their position on the acceptability of our trial design or the clinical endpoints selected, which may require us to complete additional nonclinical studies or clinical trials, delay the enrollment of our clinical trials or impose stricter approval conditions than we currently expect. Even if we conduct such additional nonclinical studies or clinical trials, the FDA or other regulatory authorities could determine that the data from our nonclinical studies or clinical trials are insufficient to support the safety and efficacy of our product candidates. There are equivalent processes and risks applicable to clinical trial applications in other countries outside of the United States., which may require us to complete additional nonclinical studies or clinical trials, delay the enrollment of our clinical trials or impose stricter approval conditions than we currently expect.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not have the financial resources to continue development of, or to modify existing or enter into new collaborations for, a product candidate if we experience any issues that delay or prevent regulatory approval of, or our ability to commercialize, our product candidates. We or our current or future collaborators&#8217; </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">inability to complete development of, or commercialize our product candidates, or significant delays in doing so, could have a material and adverse effect on our business, financial condition, results of operations and prospects.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are substantially dependent on the success of our three most advanced programs, SPY001, SPY002 and SPY003, alone or in combination, and our current and planned clinical trials of such programs may not be successful.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future success is substantially dependent on our ability to timely obtain marketing approval for, and then successfully commercialize, our three most advanced programs, SPY001, SPY002 and SPY003, alone or in combination. We exercised our Option with respect to the SPY001, SPY002 and SPY003 programs on July 12, 2023, December 14, 2023, and June 5, 2024, respectively. Additionally, in May 2024, we signed license agreements with Paragon for rights to royalty-bearing, world-wide, exclusive licenses to develop, manufacture, commercialize or otherwise exploit certain antibodies and products targeting &#593;4&#946;7 integrin (SPY001 program) and TL1A (SPY002 program) and, in October 2024, we signed a license agreement for rights to a royalty-bearing, world-wide, exclusive license to develop, manufacture, commercialize or otherwise exploit certain antibodies and products targeting IL-23 (SPY003 program) in the field of IBD. The SPY003 License Agreement was subsequently amended and restated in February 2025 to, among other things, clarify each party's rights and obligations with respect to license exclusivity and patent prosecution. We are investing a majority of our efforts and financial resources into the research and development of these programs. We initiated a Phase 1 clinical trial in healthy volunteers of SPY001 and announced the dosing of our first participant in June 2024.  We also initiated a Phase 1 clinical trial in healthy volunteers of SPY002 in the fourth quarter of 2024 and a Phase 1 clinical trial in healthy volunteers of SPY003 in the first quarter of 2025. We also plan to initiate a Phase 2 platform trial of our product candidates in IBD beginning with monotherapies in mid-2025 and subsequent planned addition of combination arms as well as a Phase 2 clinical trial of SPY002 in RA in mid-2025, each subject to regulatory feedback and approval. The success of our programs is dependent on observing longer half-lives of our product candidates in humans and comparable or better safety and efficacy profiles than other mAbs currently marketed or in development. We believe these longer half-lives have the potential to result in more favorable dosing schedules for our product candidates, assuming they successfully complete clinical development and obtain marketing approval. This is based in part on the assumption that the longer half-lives observed in NHPs will translate into extended half-lives of our product candidates in humans. To the extent we do not observe these extended half-lives with favorable safety and efficacy profiles when we dose humans with our product candidates, it would significantly and adversely affect the clinical and commercial potential of our product candidates. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our programs will require additional clinical development, evaluation of clinical, nonclinical and manufacturing activities, product development, marketing approval in multiple jurisdictions, substantial investment and significant marketing efforts before we generate any revenues from product sales. We are not permitted to market or promote these programs, or any other programs, before we receive marketing approval from the FDA and comparable foreign regulatory authorities, and we may never receive such marketing approvals. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of our product candidates will depend on a variety of factors. We do not have complete control over many of these factors, including certain aspects of clinical development and the regulatory submission process, potential threats to our intellectual property rights and the manufacturing, marketing, distribution and sales efforts of any current or future collaborator. Accordingly, we cannot assure you that we will ever be able to generate revenue through the sale of these product candidates, even if approved. If we are not successful in commercializing SPY001, SPY002 or SPY003, alone or in combination, or are significantly delayed in doing so, our business will be materially harmed.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we do not achieve our projected development goals in the time frames we announce and expect, the commercialization of our product candidates may be delayed and our expenses may increase and, as a result, our stock price may decline.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we estimate the timing of the anticipated accomplishment of various scientific, clinical, regulatory and other product development goals, which we sometimes refer to as milestones. These milestones may include the commencement or completion of nonclinical studies and clinical trials, such as the expected timing for the anticipated completion of our Phase 1 clinical trials in healthy volunteers and topline </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">data from our planned Phase 2 clinical trials in IBD and RA, as well as the submission of regulatory filings. From time to time, we may publicly announce the expected timing of some of these milestones. All of these milestones are and will be based on numerous assumptions. The actual timing of these milestones can vary dramatically compared to our estimates, in some cases for reasons beyond our control, including positions that may be taken by or requirements of regulatory authorities. If we do not meet these milestones as publicly announced, or at all, the commercialization of our product candidates may be delayed or never achieved and, as a result, our stock price may decline. Additionally, delays relative to our projected timelines are likely to cause overall expenses to increase, which may require us to raise additional capital sooner than expected and prior to achieving targeted development milestones.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Any drug delivery device that we potentially use to deliver our product candidates may have its own regulatory, development, supply and other risks.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to deliver our product candidates via a drug delivery device, such as an injector or other delivery system. There may be unforeseen technical complications related to the development activities required to bring such a product to market, including primary container compatibility and/or dose volume requirements. If our product candidates are intended to be used with drug delivery devices, we expect to utilize drug delivery devices authorized for marketing under clearances of approvals held by third parties. Our product candidates may not be approved or may be substantially delayed in receiving approval if the devices that we choose to develop do not gain and/or maintain their own regulatory approvals or clearances. Where approval of the drug product and device is sought under a single application, the increased complexity of the review process may delay approval. In addition, some drug delivery devices are provided by single-source unaffiliated third-party companies. We may be dependent on the sustained cooperation and effort of those third-party companies both to supply the devices and, in some cases, to conduct the studies required for approval or other regulatory clearance of the devices. Even if approval is obtained for our products, we may also be dependent on those third-party companies continuing to maintain such approvals or clearances, if required, for their drug delivery devices once they have been received. Failure of third-party companies to supply the devices, to successfully complete studies on the devices in a timely manner, or to obtain or maintain required approvals or clearances of the devices could result in increased development costs, delays in or failure to obtain regulatory approval and delays in product candidates reaching the market or in gaining approval or clearance for expanded labels for new indications.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our approach to the discovery and development of our programs is unproven, and we may not be successful in our efforts to build a pipeline of programs with commercial value.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our approach to the discovery and development of our research programs leverages clinically validated mechanisms of action and incorporates advanced antibody engineering to optimize half-life and other properties designed to overcome limitations of existing therapies. Our programs are purposefully designed to improve upon existing product candidates and products while maintaining the same well-established mechanisms of action. However, the scientific research that forms the basis of our efforts to develop programs using half-life extension technologies, including YTE and LS amino acid substitutions, is ongoing and may not result in viable programs. We have limited clinical data on product candidates utilizing YTE and LS half-life extension technologies, especially in I&amp;I indications, demonstrating whether they are safe or effective for long-term treatment in humans. The long-term safety and efficacy of these technologies and the extended half-lives and exposure profiles of our programs compared to currently approved products are unknown.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may ultimately discover that our investigational products developed with half-life extension technologies do not possess certain properties required for therapeutic effectiveness and could lead to adverse effects. We currently have only interim clinical or nonclinical data regarding the increased half-life properties of our programs and the anticipated half-life extension for each of our product candidates may not be seen in humans in our clinical trials. In addition, programs using half-life extension technologies may demonstrate different chemical and pharmacological properties in participants than they do in laboratory studies. This technology and any programs resulting therefrom may not demonstrate the same chemical and pharmacological properties in humans and may interact with human biological systems in unforeseen, ineffective or harmful ways. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we may in the future seek to discover and develop programs that are based on novel targets and technologies that are unproven. If our discovery activities fail to identify novel targets or </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">technologies for drug discovery, or such targets prove to be unsuitable for treating human disease, we may not be able to develop viable additional programs. We and our existing or future collaborators may never receive approval to market and commercialize any product candidate. Even if we or an existing or future collaborator obtains regulatory approval, the approval may be for targets, disease indications or patient populations that are not as broad as we intended or desired or may require labeling that includes significant use or distribution restrictions or safety warnings. If the products resulting from our research programs  prove to be ineffective, unsafe or commercially unviable, our programs and pipeline would have little, if any, value, which would have a material and adverse effect on our business, financial condition, results of operations and prospects.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nonclinical and clinical development involve lengthy and expensive processes that are subject to delays and may result in uncertain outcomes, and results of earlier studies and trials may not be predictive of future clinical trial results. If our nonclinical studies and clinical trials are not sufficient to support regulatory approval of any of our product candidates, we may incur additional costs or experience delays in completing, or ultimately be unable to complete, the development of such product candidate. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Before obtaining marketing approval from regulatory authorities for the sale of any product candidate, we must complete nonclinical studies and then conduct extensive clinical trials to demonstrate the safety and efficacy of our product candidate in humans. Our clinical trials may not be conducted as planned or completed on schedule, if at all, and failure can occur at any time during the nonclinical study or clinical trial process. For example, we depend on the availability of NHPs to conduct certain nonclinical studies that we are required to complete prior to submitting an IND or foreign equivalent and initiating clinical development. There is no guarantee that we will always be able to source NHPs for our drug development activities on our preferred timelines. The cost of obtaining NHPs for our future nonclinical development activities could increase significantly if short or long term shortages occur in their availability. If we are unable to source NHPs on our preferred timelines, it could result in delays to our development timelines. Similarly, we may experience difficulty in conducting our clinical trials as planned if we are unable to enroll a sufficient number of participants in any such trial as a result of variables outside of our control. See the risk factor titled &#8220;If we encounter difficulties enrolling participants in our current and future clinical trials, our clinical development activities could be delayed or otherwise adversely affected.&#8221;  </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, a failure of one or more clinical trials can occur at any stage of testing. The outcome of nonclinical studies and early-stage clinical trials may not be predictive of the success of later stage clinical trials. Moreover, nonclinical and clinical data are often susceptible to varying interpretations and analyses, and many companies that have believed their product candidates performed satisfactorily in nonclinical studies and clinical trials have nonetheless failed to obtain marketing approval of their product candidates. In addition, we expect to rely on participants to provide feedback on measures such as measures of disease activity and measures of quality of life, which are subjective and inherently difficult to evaluate. These measures can be influenced by factors outside of our control and can vary widely from day to day for a particular participant, and from participant to participant and from site to site within a clinical trial. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot be sure that the FDA, or comparable foreign regulatory authority, as applicable, will agree with our clinical development plans. We plan to use the data from our ongoing Phase 1 trials of our SPY001, SPY002 and SPY003 programs in healthy volunteers to support Phase 2 trials in IBD, RA and other I&amp;I indications. If the FDA and/or comparable foreign regulatory authority requires us to materially modify our proposed trial designs, conduct additional trials or enroll additional participants, our development timelines may be delayed. We cannot be sure that submission of an IND, clinical trial application or similar application will result in the FDA or comparable foreign regulatory authorities, as applicable, allowing clinical trials to begin in a timely manner, if at all. Moreover, even if these trials begin, issues may arise that could cause regulatory authorities to suspend or terminate them. Events that may prevent successful or timely initiation or completion of clinical trials include: inability to generate sufficient nonclinical, toxicology or other in vivo or in vitro data; delays in reaching a consensus with regulatory authorities on trial design or implementation of the clinical trials; delays or failure in obtaining regulatory authorization to commence a trial; delays in reaching agreement on acceptable terms with current and prospective CROs and clinical trial sites, the terms of which can be subject to extensive negotiation and may vary significantly among different CROs and clinical trial sites; CRO personnel changes which could lead to operational delays or complications; delays in identifying, recruiting and training suitable clinical investigators and their study teams; delays in obtaining required EC/IRB approval at each clinical trial site; delays in manufacturing, testing, releasing, validating or importing/exporting sufficient stable </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">quantities of our product candidates or other supplies for use in clinical trials or the inability to do any of the foregoing; failure by our CROs, other third parties or us to adhere to clinical trial protocols; failure to perform in accordance with the FDA&#8217;s or any other regulatory authority&#8217;s good clinical practice requirements (&#8220;GCPs&#8221;) or applicable regulatory guidelines in other countries; changes to the clinical trial protocols; clinical sites deviating from trial protocol or dropping out of a trial; changes in regulatory requirements and guidance that require amending or submitting new clinical protocols; selection of clinical endpoints that require prolonged periods of observation or analyses of resulting data; transfer of manufacturing processes to facilities operated by a contract manufacturing organization (&#8220;CMO&#8221;) and delays or failure by our CMOs or us to make any necessary changes to such manufacturing process; and third parties being unwilling or unable to satisfy their contractual obligations to us.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We could also encounter delays if a planned clinical trial is required to be materially modified or suspended or terminated by us, by the ECs/IRBs of the institutions in which such clinical trials are being conducted, by the external Data Monitoring Committee, if any, for such clinical trial or by the FDA or comparable foreign regulatory authorities. Such authorities may suspend, put on clinical hold or terminate a clinical trial due to a number of factors, including not aligning with or supporting our clinical trial designs or our failure to conduct the clinical trial in accordance with regulatory requirements or our clinical trial protocols, inspection of the clinical trial operations or trial site by the FDA or comparable foreign regulatory authorities resulting in the imposition of a clinical hold, unforeseen safety issues or adverse side effects, failure to demonstrate a benefit from the programs, changes in governmental regulations or administrative actions or lack of adequate funding to continue the clinical trial. If we are required to conduct additional clinical trials or other testing of our product candidates beyond those that we currently contemplate, if we are unable to successfully complete clinical trials of our product candidates, if the results of these trials are not positive or are only moderately positive or if there are safety concerns, our business and results of operations may be adversely affected and we may incur significant additional costs.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A key element of our strategy is the development of intra-portfolio investigational drug combinations. If we are not successful in discovering, developing and commercializing investigational products that take advantage of different mechanisms of action to achieve superior outcomes relative to the use of monotherapies or other combination therapies, our ability to achieve our strategic objectives would likely be impaired. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A key element of our strategy is to build a broad portfolio of investigational products that will allow for the development of intra-portfolio combinations. We believe that by developing or licensing these investigational products, we can control the combinations we pursue and, if and when approved, maximize the commercial potential of these combinations. However, these combinations have not been tested before and may fail to achieve superior outcomes relative to the use of single agents or other combination therapies, may exacerbate adverse events associated with one of the investigational products when used as monotherapy, may yield new adverse events not observed with either of the monotherapies, or may fail to demonstrate sufficient safety or efficacy in clinical trials to enable us to complete those clinical trials or obtain marketing approval for the combination therapy. In addition, demonstrating that our combinations are superior to our single agents is likely necessary for marketing authorization of the combinations. However, comparing active treatments may be difficult to do in a controlled manner in our clinical trials, and we may be unable to interpret the results of comparisons between our combinations and single agents in a manner that satisfies regulatory requirements. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if we are successful in developing combination therapies, competition from other investigational products in the same class which are either already approved or further along in development than ours may prevent us from realizing the commercial potential of our combination therapies and prevent us from achieving our strategic objectives. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Development of combination therapies may present more or different challenges than development of monotherapies.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We plan to pursue development of our investigational products in combination with one or more additional products or investigational products. The development of combination therapies may be more complex than the development of monotherapies and generally requires that sponsors demonstrate the contribution of each investigational product to the claimed effect and the safety and efficacy of the combination as a whole. Regulatory authority requirements for the development of combination therapies may make the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">design and conduct of clinical trials more complex and/or burdensome, requiring more clinical trial participants and additional time and cost to complete than we plan or anticipate. We also may not be able to meet the FDA&#8217;s current or future approval standards required for combination therapies or combination products, if we decided to administer or package a combination therapy as a single drug product. For example, under the "combination rule", the FDA may not file or approve a fixed-dose combination product unless each component of a proposed drug product is shown to make a contribution to the claimed effects and the dosage of each component (amount, frequency, duration) is safe and effective for the intended population. To satisfy these requirements, the FDA typically requires a clinical factorial trial, designed to assess the effects attributable to each drug in the combination product. This is particularly true when the ingredients are directed at the same sign or symptom of the disease or condition. The FDA has accepted a variety of approaches to satisfy the combination rule but the FDA has stated that factorial studies may be unethical (e.g., omitting a drug known to improve survival) or impractical (there may be too many components to conduct a factorial trial, meaning the trial cannot be conducted). The FDA has also stated that it may be possible to use other types of clinical and nonclinical data and mechanistic information available to demonstrate the contributions of the individual active ingredients to the effect of the combination. In addition, combination products may require dose selection for each agent in the combination, which may require more and/or larger groups of participants than single agents. Our clinical trial and research efforts may not satisfy regulators' expectations of adequate exploration of dose ranging required for drug approval. Moreover, the applicable requirements for approval of a combination therapy may differ from country to country.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that one of our investigational products were to fail to demonstrate sufficient safety and efficacy data or establish its contribution to the claimed effects of a combination therapy or if we are unable to meet the FDA&#8217;s current or future approval standards required for combination therapies or combination products in a timely manner, we would need to identify and research alternative monotherapy or combination treatments, run additional trials to produce supportive data or modify existing clinical trial plans. In the event we are unable to do so or are unable to do so on commercially reasonable terms or we are unable to continue development of one or more of investigational products, our business and prospects would be materially harmed.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we encounter difficulties enrolling participants in our current and future clinical trials, our clinical development activities could be delayed or otherwise adversely affected.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may experience difficulties in participant enrollment in our current and future clinical trials for a variety of reasons. The timely completion of clinical trials in accordance with their protocols depends, among other things, on our ability to enroll a sufficient number of participants who remain in the trial until its conclusion. The enrollment of participants will depend on many factors, including if participants choose to enroll in clinical trials, rather than using approved products, or if our competitors have ongoing clinical trials for programs that are under development for the same indications as our programs, and participants instead enroll in such clinical trials. Additionally, the number of participants required for clinical trials of our programs may be larger than we anticipate. Even if we are able to enroll a sufficient number of participants for our current or future clinical trials, we may have difficulty maintaining participants in our clinical trials. Our inability to enroll or maintain a sufficient number of participants would result in significant delays in completing clinical trials or receipt of marketing approvals, increased development costs or our cessation of one or more clinical trials altogether.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preliminary, &#8220;topline&#8221; or interim data from our clinical trials that we announce or publish from time to time may change as more participant data become available and are subject to audit and verification procedures.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may publicly disclose preliminary or topline data from our nonclinical studies and clinical trials, which are based on a preliminary analysis of then-available data. The results and related findings and conclusions are subject to change following a more comprehensive review or taking into account additional data that becomes available. In reviewing preliminary or topline data, we also make assumptions, estimations, calculations and conclusions as part of our analyses that may change once a complete data set is available. As a result, the preliminary or topline results that we report may differ from future results of the same studies, or different conclusions or considerations may qualify such results, once additional data have been received and fully evaluated or subsequently made subject to audit and verification procedures. Any preliminary or topline data should be viewed with caution until the final data are available.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, others, including regulatory agencies, may not accept or agree with our assumptions, estimates, calculations, conclusions or analyses or may interpret or weigh the importance of data differently, which could impact the value of the particular product candidate, the approvability or commercialization of the particular product candidate and our company in general. In addition, the information we choose to publicly disclose regarding a particular nonclinical study or clinical trial is based on what is typically extensive information, and you or others may not agree with what we determine is material or otherwise appropriate information to include in our disclosure. If the preliminary, topline or interim data that we report differ from actual results, or if others, including regulatory authorities, disagree with the conclusions reached, our ability to obtain approval for, and commercialize, our product candidates may be harmed, which could harm our business, operating results, prospects or financial condition.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our current and future clinical trials or those of our future collaborators may reveal significant adverse events or undesirable side effects not seen in our nonclinical studies and may result in a safety profile that could halt clinical development, inhibit regulatory approval or limit commercial potential or market acceptance of any of our product candidates.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Results of our non-clinical studies or clinical trials could reveal a high and unacceptable severity and prevalence of side effects, adverse events or unexpected characteristics at any point in time during the development process for our product candidates. We cannot assure you that the future results of our nonclinical studies or clinical trials will not reveal such characteristics. If significant adverse events or undesirable side effects are observed in any of our current or future non-clinical studies or clinical trials, we may have difficulty recruiting participants to such trials, participants may drop out of our trials, or we may be required to cease or materially modify our development efforts of one or more programs. We, the FDA or other applicable regulatory authorities, or an EC/IRB, may suspend or require the material modification of any clinical trials of any program at any time for various reasons, including a belief that participants in such trials are being exposed to unacceptable health risks or adverse side effects. Some potential products developed in the biotechnology industry that initially showed therapeutic promise in early-stage studies and trials have later been found to cause side effects that prevented their further development. Other potential products have shown side effects in nonclinical studies, which side effects do not present themselves in clinical trials in humans. Even if the side effects do not preclude the product candidate from obtaining or maintaining marketing approval, undesirable side effects may inhibit market acceptance of the approved product due to its tolerability versus other therapies. In addition, an extended half-life could prolong the duration of undesirable side effects, which could also inhibit market acceptance. Treatment-emergent adverse events could also affect participant recruitment or the ability of enrolled participants to complete our clinical trials or could result in potential product liability claims. Potential side effects associated with our product candidates may not be appropriately recognized or managed by the treating medical staff, as toxicities resulting from our product candidates may not be normally encountered in the general patient population and by medical personnel. Any of these occurrences could harm our business, financial condition, results of operations and prospects significantly.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our product candidates have mechanisms of action that have been associated with certain adverse reactions in patients.  For example, nasopharyngitis, headache, arthralgia, nausea, pyrexia, upper respiratory tract infection, fatigue, cough, bronchitis, influenza, back pain, rash, pruritus, sinusitis, oropharyngeal pain, and pain in extremities are the most common adverse reactions noted with Entyvio, which is in the same drug class as SPY001 and is approved for the treatment of moderately to severely active UC in adults and of moderately to severely active CD in adults.  In addition, mAbs targeting TL1A such as our product candidate SPY002 in clinical research are associated with patient adverse reactions that most commonly include headache, nasopharyngitis, arthralgia, and back pain.  Finally, for Skyrizi, which is in the same drug class as SPY003 and is approved for the treatment of moderately to severely active UC in adults and of moderately to severely active CD in adults, the most common adverse reactions are upper respiratory infections, headache, arthralgia, injection site reactions, abdominal pain, anemia, pyrexia, back pain, arthropathy, and urinary tract infection in patients with CD and arthralgia, pyrexia, injection site reactions, and rash in patients with UC.  Participants in our clinical trials for SPY001, SPY002 and SPY003, or combinations thereof, may experience similar or additional adverse reactions.  </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, even if we successfully advance our product candidates or any future product candidates through clinical trials, such trials will only include a limited number of participants and limited duration of exposure to our product candidates. As a result, we cannot be assured that adverse effects of our product candidates will not be uncovered when a significantly larger number of participants are exposed to the product </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">after approval. Further, any clinical trials may not be sufficient to determine the effect and safety consequences of using any of our products over a multi-year period.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of the foregoing events occur or if one or more of our research programs pursuant to the Paragon Agreement prove to be unsafe, our entire pipeline could be affected, which would have a material adverse effect on our business, financial condition, results of operations and prospects.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may expend our limited resources to pursue a particular program and fail to capitalize on programs that may be more profitable or for which there is a greater likelihood of success.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because we have limited financial and managerial resources, we focus our research and development efforts on certain selected programs. For example, we are initially focused on our most advanced programs, SPY001, SPY002 and SPY003, including combinations thereof. As a result, we may forgo or delay pursuit of opportunities with other programs that later prove to have greater commercial potential. Our resource allocation decisions may cause us to fail to capitalize on viable commercial products or profitable market opportunities. Our spending on current and future research and development programs for specific indications may not yield any commercially viable product candidates. If we do not accurately evaluate the commercial potential or target market for a particular product candidate, we may relinquish valuable rights to that product candidate through collaboration, licensing or other royalty arrangements in cases in which it would have been more advantageous for us to retain sole development and commercialization rights to such product candidate.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Any approved products resulting from our current programs or any future program may not achieve adequate market acceptance among clinicians, patients, healthcare third-party payors and others in the medical community necessary for commercial success and we may not generate any future revenue from the sale or licensing of such products.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if regulatory approval is obtained for a product candidate resulting from one of our current or future programs, they may not gain market acceptance among physicians, patients, healthcare payors or the medical community. We may not generate or sustain revenue from sales of the product due to factors such as whether the product can be sold at a competitive cost and whether it will otherwise be accepted in the market. There are several approved products and product candidates in later stages of development for the treatment of IBD and the treatment of RA. However, our programs incorporate advanced antibody engineering to optimize the half-life and formulation of antibodies; to date, no such antibody has been approved by the FDA for the treatment of IBD or RA. Market participants with significant influence over acceptance of new treatments, such as clinicians and third-party payors, may not adopt a biologic that incorporates half-life extension for our targeted indications, and we may not be able to convince the medical community and third-party payors to accept and use, or to provide favorable reimbursement for, any programs developed by us or our existing or future collaborators. An extended half-life may make it more difficult for patients to change treatments and there is a perception that half-life extension could exacerbate side effects, each of which may adversely affect our ability to gain market acceptance. Market acceptance of our product candidates will depend on many factors, including factors that are not within our control.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales of medical products also depend on the willingness of clinicians to prescribe the treatment. We cannot predict whether clinicians, clinicians&#8217; organizations, hospitals, other healthcare providers, government agencies or private insurers will determine that our product is safe, therapeutically effective, cost effective or less burdensome as compared with competing treatments. If any current or future product candidate is approved but does not achieve an adequate level of acceptance by such parties, we may not generate or derive sufficient revenue from that product candidate and may not become or remain profitable.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Some of our programs may compete with our other programs, which could negatively impact our business and reduce our future revenue.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have multiple product candidates in development for the same indication, IBD, and are planning to develop one product candidate (SPY002) for RA. We may in the future develop our programs for other I&amp;I indications. Each such program targets a different mechanism of action. However, developing multiple programs for a single indication may negatively impact our business if the programs compete with each other. For example, if multiple programs are conducting clinical trials at the same time, they could compete for the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">enrollment of participants. In addition, if multiple product candidates are approved for the same indication, they may compete for market share, which could limit our future revenue. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are conducting and may conduct future clinical trials for our programs at sites outside the United States or other jurisdiction, and the FDA and comparable foreign regulatory authorities may not accept data from such trials.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are conducting and may conduct future clinical trials in the United States and various other countries. The acceptance of trial data from clinical trials conducted outside the United States or other jurisdiction by the FDA or comparable foreign regulatory authority may be subject to conditions imposed by such regulatory authority or may not be accepted at all. For example, in cases where data from foreign clinical trials are intended to serve as the basis for marketing approval in the United States, the FDA will generally not approve the applicable clinical trial data on the basis of foreign data alone unless, among other conditions, (i) the clinical trial is well-designed and conducted and performed by qualified investigators in accordance with ethical principles, (ii) the trial population adequately represents the U.S. population, and (iii) the data is applicable to the U.S. population and U.S. medical practice in ways that the FDA deems clinically meaningful. Many foreign regulatory authorities have similar approval requirements. In addition, clinical trials are subject to the applicable local laws of the jurisdictions where the trials are conducted and acceptance of the data by the FDA or any comparable foreign regulatory authority may depend on its determination that the trials also complied with all applicable local laws and regulations. There can be no assurance that the FDA or any comparable foreign regulatory authority will accept data from trials conducted outside of the United States or the applicable jurisdiction. If the FDA or any comparable foreign regulatory authority does not accept such data, it would likely result in the need for additional trials, which would be costly and time-consuming and would delay or permanently halt our development of the applicable product candidates. Even if the FDA or any comparable foreign regulatory authority accepted such data, it could require us to modify our planned clinical trials to receive clearance to initiate such trials in the applicable jurisdiction or to continue such trials once initiated. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, conducting international clinical trials presents additional risks that may delay completion of our clinical trials. These risks include the failure of enrolled participants in foreign countries to adhere to clinical protocol as a result of differences in healthcare services or cultural customs that could restrict or limit our ability to conduct our clinical trials, the administrative burdens of conducting clinical trials under multiple sets of foreign regulations, foreign exchange fluctuations, as well as political and economic risks relevant to foreign countries.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Government Regulation </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The regulatory approval processes of the FDA and other comparable foreign regulatory authorities are lengthy, time-consuming and inherently unpredictable. If we are not able to obtain, or if there are delays in obtaining, required regulatory approvals for our product candidates, we will not be able to commercialize, or will be delayed in commercializing, our product candidates, and our ability to generate revenue will be materially impaired.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The process of obtaining regulatory approvals, both in the United States and abroad, is unpredictable, expensive and typically takes many years following commencement of clinical trials, if approval is obtained at all, and can vary substantially based upon a variety of factors, including the type, complexity and novelty of the product candidates involved. We cannot commercialize product candidates in the United States without first obtaining regulatory approval from the FDA. Similarly, we cannot commercialize product candidates outside of the United States without obtaining regulatory approval from comparable foreign regulatory authorities. Before obtaining regulatory approvals for the commercial sale of our product candidates, including our most advanced product candidates, SPY001, SPY002 and SPY003, we must demonstrate through lengthy, complex and expensive nonclinical studies and clinical trials that our product candidates are both safe and effective for each targeted indication. Securing regulatory approval also requires the submission of information about the drug manufacturing process to, and inspection of manufacturing facilities by, the relevant regulatory authority. Further, our product candidates may not be effective, may be only moderately effective or may prove to have undesirable or unintended side effects, toxicities or other characteristics that may preclude our obtaining marketing approval. The FDA and comparable foreign regulatory authorities have substantial discretion in the approval process and may refuse to accept any application or may decide that our data are insufficient for approval and require additional nonclinical, clinical or other data. Our product candidates could be delayed in receiving, or fail to receive, regulatory approval for many reasons, including: the FDA or comparable foreign </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">regulatory authorities may disagree with the design or implementation of our clinical trials; we may be unable to demonstrate to the satisfaction of the FDA or comparable foreign regulatory authorities that a product candidate is safe and effective for its proposed indication; the results of clinical trials may not meet the level of statistical significance required by the FDA or comparable foreign regulatory authorities for approval; serious and unexpected drug-related side effects may be experienced by participants in our clinical trials or by individuals using drugs similar to our product candidates; we may be unable to demonstrate that a product candidate&#8217;s clinical and other benefits outweigh its safety risks; the FDA or comparable foreign regulatory authorities may disagree with our interpretation of data from nonclinical studies or clinical trials; the data collected from clinical trials of our product candidates may not be acceptable or sufficient to support the submission of a BLA or other submission or to obtain regulatory approval in the United States or elsewhere, and we may be required to conduct additional clinical trials; the FDA or the applicable foreign regulatory authority may disagree regarding the formulation, labeling and/or the specifications of our product candidates; the FDA or comparable foreign regulatory authorities may fail to approve the manufacturing processes or facilities of third-party manufacturers with which we contract for clinical and commercial supplies; and the approval policies or regulations of the FDA or comparable foreign regulatory authorities may significantly change in a manner rendering our clinical data insufficient for approval. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Of the large number of drugs in development, only a small percentage successfully complete the FDA or foreign regulatory approval processes and are commercialized. The lengthy approval process as well as the unpredictability of future clinical trial results may result in our failing to obtain regulatory approval to market our product candidates, which would significantly harm our business, results of operations and prospects. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we were to obtain approval, regulatory authorities may approve any of our product candidates for fewer or more limited indications than we request, including failing to approve the most commercially promising indications, may grant approval contingent on the performance of costly post-marketing clinical trials, or may approve a product candidate with a label that does not include the labeling claims necessary or desirable for the successful commercialization of that product candidate. If we are not able to obtain, or if there are delays in obtaining, required regulatory approvals for our product candidates, we will not be able to commercialize, or will be delayed in commercializing, our product candidates and our ability to generate revenue will be materially impaired.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to meet requirements for the chemistry, manufacturing and control of our programs.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to receive approval of our products by the FDA and comparable foreign regulatory authorities, we must show that we and our contract manufacturing partners are able to characterize, control and manufacture our drug products and drug delivery devices safely and in accordance with regulatory requirements. This includes manufacturing the active ingredient, developing an acceptable formulation and drug delivery device, manufacturing the drug product and drug delivery device, performing tests to adequately characterize the formulated product, documenting a repeatable manufacturing process, meeting facility, process, testing validation and commercialization requirements, and demonstrating that our drug products meet standards for parenteral administration as well as stability and quality requirements. Meeting these chemistry, manufacturing and control requirements is a complex task that requires specialized expertise. If we are not able to meet the chemistry, manufacturing and control requirements, we may not be successful in getting our products approved.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our product candidates for which we intend to seek approval as biologics may face competition sooner than anticipated</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Patient Protection and Affordable Care Act, as amended by the Healthcare and Education Reconciliation Act, includes a subtitle called the Biologics Price Competition and Innovation Act of 2009 (&#8220;BPCIA&#8221;), which created an abbreviated approval pathway for biological products that are biosimilar to or interchangeable with an FDA-licensed reference biological product. Under the BPCIA, an application for a highly similar or &#8220;biosimilar&#8221; product may not be submitted to the FDA until four years following the date that the reference product was first approved by the FDA. In addition, the approval of a biosimilar product may not be made effective by the FDA until 12 years from the date on which the reference product was first approved. During this 12-year period of exclusivity, another company may still market a competing version of the reference product if the FDA approves a full BLA for the competing product containing the sponsor&#8217;s own nonclinical data </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and data from adequate and well-controlled clinical trials to demonstrate the safety, purity and potency of their product. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that any of our product candidates approved as biologics under a BLA should qualify for the 12-year period of exclusivity. However, there is a risk that this exclusivity could be shortened due to congressional action or otherwise, or that the FDA will not accord our product candidates reference product exclusivity relative to biosimilar products, potentially creating the opportunity for competition sooner than anticipated. Other aspects of the BPCIA, some of which may impact the BPCIA exclusivity provisions, have also been the subject of recent litigation. Moreover, the extent to which a biosimilar, once approved, will be substituted for any reference products in a way that is similar to traditional generic substitution for non-biological products is not yet clear, and will depend on a number of marketplace and regulatory factors that are still developing.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Even if we receive regulatory approval of our product candidates, we will be subject to extensive ongoing regulatory obligations and continued regulatory review, which may result in significant additional expense and we may be subject to penalties if we fail to comply with regulatory requirements or experience unanticipated problems with our product candidates.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any regulatory approvals that we may receive for our product candidates will require the submission of reports to regulatory authorities and surveillance to monitor the safety and efficacy of the product candidate, may contain significant limitations related to use restrictions for specified age groups, warnings, precautions or contraindications, and may include burdensome post-approval trial or risk management requirements. For example, the FDA may require a risk evaluation and mitigation strategy in order to approve our product candidates, which could entail requirements for a medication guide, physician training and communication plans or additional elements to ensure safe use, such as restricted distribution methods, patient registries and other risk minimization tools. In addition, if the FDA or comparable foreign regulatory authorities approve our product candidates, our product candidates and the activities associated with their development and commercialization, including their design, testing, manufacture, safety, efficacy, recordkeeping, labeling, storage, approval, advertising, promotion, sale, distribution, import and export will be subject to comprehensive regulation by the FDA and other regulatory agencies in the United States and by comparable foreign regulatory authorities. These requirements include submissions of safety and other post-marketing information and reports, registration, as well as on-going compliance with current cGMPs, good pharmacovigilance practices (&#8220;GVPs&#8221;) and GCPs for any post-approval trials that we conduct following approval. In addition, manufacturers of drug products and their facilities are subject to continual review and periodic, unannounced inspections by the FDA and other regulatory authorities for compliance with cGMPs. Following approval, sponsors are also subject to continual review and periodic, unannounced inspections for compliance with GVPs.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we or a regulatory authority discover previously unknown problems with a product, such as adverse events of unanticipated severity or frequency, or problems with the facilities where the product is manufactured, a regulatory authority may impose restrictions on that product, the manufacturing facility or us, including requiring recall or withdrawal of the product from the market or suspension of manufacturing, restrictions on our ability to conduct post-approval trials, including full or partial holds on ongoing or planned trials, restrictions on the manufacturing process, warning or untitled letters, civil and criminal penalties, injunctions, product seizures, detentions or import bans, voluntary or mandatory publicity requirements and imposition of restrictions on operations, including costly new manufacturing requirements. The occurrence of any event or penalty described above may inhibit our ability to commercialize our product candidates and generate revenue and could require us to expend significant time and resources in response and could generate negative publicity.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be negatively impacted by healthcare legislative reform measures and other changes in law</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Existing regulatory policies may change, and additional government regulations may be enacted that could prevent, limit or delay development of or regulatory approval of our product candidates and/or increase our manufacturing costs, general operating costs or other costs. We cannot predict the likelihood, nature or extent of government regulation that may arise from future legislation or administrative action, either in the United States or abroad. If we fail to adequately prepare for the impacts of or are slow or unable to adapt to changes in existing requirements or the adoption of new requirements or policies, or if we are not able to maintain regulatory compliance, our product candidates may be delayed in obtaining regulatory approval or may lose any marketing approval that we may have obtained and we may not achieve or sustain profitability. In </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">addition, the impact of legislative, executive, and administrative actions and any future healthcare measures and agency rules implemented by the current presidential administration on us and the pharmaceutical industry as a whole is unclear. These government actions could cause delays in our business plans, increase the cost of execution of our business plans or otherwise have a material adverse effect on our business. For example, the federal government recently announced tariffs on goods imported from China and other countries, which have been followed by threatened or enacted counter-measures by certain countries. These measures could impact the cost of manufacturing our product candidates for our ongoing and planned clinical trials and may increase other costs such as  import and export costs across different jurisdictions, costs of drug product and clinical trial supplies, and other costs of running our trials and executing on our business plans, which could negatively impact our financial position. We may seek alternative or additional sources for our drug substance or drug product for our clinical trials, clinical trial sites, or service providers, which could negatively impact our expected timelines and business plan. Additionally, if legislation similar to the BIOSECURE Act is passed with terms that require us to switch or move development of our product candidates from one CMO to another or if we undertake such actions to mitigate the effects of such legislation prior to its enactment, we may incur additional development costs or delays in manufacturing product for clinical trials or commercialization. See the section titled &#8220;Business &#8211; Government Regulation &#8211; Healthcare Reform&#8221; in our Annual Report on Form 10-K for a more detailed description of healthcare reform measures that may prevent us from being able to generate revenue, attain profitability, or commercialize our product candidates. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business operations and current and future arrangements with investigators, healthcare professionals, consultants, third-party payors, patient organizations and customers will be subject to applicable healthcare regulatory laws, which could expose us to penalties.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business operations and current and future arrangements with investigators, healthcare professionals, consultants, third-party payors, patient organizations and customers may expose us to broadly applicable fraud and abuse and other healthcare laws and regulations. These laws may constrain the business or financial arrangements and relationships through which we conduct our operations, including how we research, market, sell and distribute our product candidates, if approved. See the section titled &#8220;Business &#8211; Government Regulation &#8211; Other Healthcare Laws and Compliance Requirements&#8221; in our Annual Report on Form 10-K for a more detailed description of the laws that may affect our ability to operate.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ensuring that our internal operations and future business arrangements with third parties comply with applicable healthcare laws and regulations will involve substantial costs. If our operations are found to be in violation of any of these laws or any other governmental laws and regulations that may apply to us, we may be subject to significant penalties, including civil, criminal and administrative penalties, damages, fines, exclusion from government-funded healthcare programs, integrity oversight and reporting obligations to resolve allegations of non-compliance, disgorgement, individual imprisonment, contractual damages, reputational harm, diminished profits and the curtailment or restructuring of our operations. Further, defending against any such actions can be costly and time-consuming and may require significant personnel resources. Therefore, even if we are successful in defending against any such actions that may be brought against us, our business may be impaired.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Even if we are able to commercialize any product candidates, due to unfavorable pricing regulations and/or third-party coverage and reimbursement policies, we may not be able to offer such product candidates at competitive prices, which would seriously harm our business.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to seek approval to market our product candidates in both the United States and in selected foreign jurisdictions. If we obtain approval in one or more foreign jurisdictions for our product candidates, we will be subject to rules and regulations in those jurisdictions. Our ability to successfully commercialize any product candidates that we may develop will depend in part on the extent to which reimbursement for these product candidates and related treatments will be available from government health administration authorities, private health insurers and other organizations. Government authorities and other third-party payors, such as private health insurers and health maintenance organizations, decide which medications they will pay for and establish reimbursement levels. Government authorities and other third-party payors have attempted to control costs by limiting coverage and the amount of reimbursement for particular medications. These entities may create preferential access policies for a competitor&#8217;s product, including a branded or generic/biosimilar product, over our products in an attempt to reduce their costs, which may reduce our commercial opportunity. Additionally, if any of our product candidates are approved and we are found to have improperly promoted off-label uses of </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">those product candidates, we may become subject to significant liability, which would materially adversely affect our business and financial condition. See the sections titled &#8220;Business &#8211; Government Regulation &#8211; Coverage and Reimbursement&#8221; and &#8220;Business &#8211; Government Regulation &#8211; Regulation in the European Union&#8221; in our Annual Report on Form 10-K for a more detailed description of the government regulations and third-party payor practices that may affect our ability to commercialize our product candidates.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to U.S. and certain foreign export and import controls, sanctions, embargoes, anti-corruption laws, and anti-money laundering laws and regulations. We can face criminal liability and other serious consequences for violations, which can harm our business.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to export control and import laws and regulations, including the U.S. Export Administration Regulations, U.S. Customs regulations, various economic and trade sanctions regulations administered by the U.S. Treasury Department&#8217;s Office of Foreign Assets Controls, the U.S. Foreign Corrupt Practices Act of 1977, as amended, the U.S. domestic bribery statute contained in 18 U.S.C. &#167; 201, the U.S. Travel Act, the USA PATRIOT Act and other state and national anti-bribery and anti-money laundering laws in the countries in which we conduct activities. Anti-corruption laws are interpreted broadly and prohibit companies and their employees, agents, contractors, and other collaborators from authorizing, promising, offering, or providing, directly or indirectly, improper payments or anything else of value to or from recipients in the public or private sector. We may engage third parties to sell our products outside the United States, to conduct clinical trials, and/or to obtain necessary permits, licenses, patent registrations, and other regulatory approvals. We have direct or indirect interactions with officials and employees of government agencies or government-affiliated hospitals, universities, and other organizations. We can be held liable for the corrupt or other illegal activities of our employees, agents, contractors, and other collaborators, even if we do not explicitly authorize or have actual knowledge of such activities. Any violations of the laws and regulations described above may result in substantial civil and criminal fines and penalties, imprisonment, the loss of export or import privileges, debarment, tax reassessments, breach of contract and fraud litigation, reputational harm, and other consequences.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Governments outside the United States tend to impose strict price controls, which may adversely affect our revenue, if any.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some countries, particularly member states of the EU, the pricing of prescription drugs is subject to governmental control. In these countries, pricing negotiations with governmental authorities can take considerable time after receipt of marketing approval for a therapeutic. In addition, there can be considerable pressure by governments and other stakeholders on prices and reimbursement levels, including as part of cost containment measures. Political, economic and regulatory developments may further complicate pricing negotiations, and pricing negotiations may continue after reimbursement has been obtained. Reference pricing used by various EU member states and parallel distribution, or arbitrage between low-priced and high-priced member states, can further reduce prices. To obtain coverage and reimbursement or pricing approvals in some countries, we or current or future collaborators may be required to conduct a clinical trial or other studies that compare the cost-effectiveness of our product candidates to other available therapies in order to obtain or maintain reimbursement or pricing approval. Publication of discounts by third-party payors or authorities may lead to further pressure on the prices or reimbursement levels within the country of publication and other countries. If reimbursement of any product candidate approved for marketing is unavailable or limited in scope or amount, or if pricing is set at unsatisfactory levels, our business, financial condition, results of operations or prospects could be materially and adversely affected. If the UK or certain EU member states were to significantly alter their regulations affecting the pricing of prescription pharmaceuticals, we could face significant new costs.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A breakthrough therapy, fast track, or other expedited designation for our product candidates may not lead to a faster development or regulatory review or approval process, and it does not increase the likelihood that those product candidates will receive marketing approval.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may seek a breakthrough therapy, fast track, or other designation for appropriate product candidates. Designations such as these are within the discretion of the FDA, or other comparable regulatory authorities. The receipt of a designation for a product candidate may not result in a faster development process, review or approval compared to products considered for approval under conventional FDA procedures and does not assure ultimate approval by the FDA. In addition, even if one or more of our product candidates qualify </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">under one of FDA&#8217;s designation programs, the FDA may later decide that the products no longer meet the conditions for qualification or decide that the time period for FDA review or approval will not be shortened. See the section titled &#8220;Business &#8211; Government Regulation &#8211; United States Biologics Regulation &#8211; Expedited Development and Review Programs&#8221; in our Annual Report on Form 10-K for a more detailed description of the process for seeking expedited designations such as fast track or breakthrough therapy designations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Intellectual Property</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to obtain and protect our patents and other proprietary rights is uncertain, exposing us to the possible loss of competitive advantage.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely upon a combination of patents, trademarks, trade secret protection, confidentiality agreements, license agreements, including the License Agreements, and the Paragon Agreement to protect the intellectual property related to our programs and technologies and to prevent third parties from competing unfairly with us. Our success depends in large part on our ability to obtain and maintain patent protection for our platform technologies, programs and their uses, as well as our ability to operate without infringing on or violating the proprietary rights of others. We own and have licensed rights to pending patent applications and expect to continue to file patent applications in the United States and abroad related to our novel discoveries and technologies that are important to our business. However, we may not be able to protect our intellectual property rights throughout the world and the legal systems in certain countries may not favor enforcement or protection of patents, trade secrets and other intellectual property. Filing, prosecuting and defending patents on programs worldwide would be expensive and our intellectual property rights in some foreign jurisdictions can be less extensive than those in the United States; the reverse may also occur. As such, we may not have patents in all countries or all major markets and may not be able to obtain patents in all jurisdictions even if we apply for them. Our competitors may operate in countries where we do not have patent protection and can freely use our technologies and discoveries in such countries to the extent such technologies and discoveries are publicly known or disclosed in countries where we do have patent protection or pending patent applications.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our pending and future patent applications may not result in patents being issued. Any issued patents may not afford sufficient protection of our programs or their intended uses against competitors, nor can there be any assurance that the patents issued will not be infringed, designed around, invalidated by third parties, or effectively prevent others from commercializing competitive technologies, products or programs. Even if these patents are granted, they may be difficult to enforce. Further, any issued patents that we may license or own covering our programs could be narrowed or found invalid or unenforceable if challenged in court or before administrative bodies in the United States or abroad, including the United States Patent and Trademark Office (&#8220;USPTO&#8221;). Further, if we encounter delays in our clinical trials or delays in obtaining regulatory approval, the period of time during which we could market our product candidates under patent protection would be reduced. Thus, the patents that we may own or license may not afford us any meaningful competitive advantage. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to seeking patents for some of our technology and programs, we may also rely on trade secrets, including unpatented know-how, technology and other proprietary information, to maintain our competitive position. Any disclosure, either intentional or unintentional, by our employees, the employees of third parties with whom we share our facilities or third-party consultants and vendors that we engage to perform research, clinical trials or manufacturing activities, or misappropriation by third parties (such as through a cybersecurity breach) of our trade secrets or proprietary information could enable competitors to duplicate or surpass our technological achievements, thus eroding our competitive position in our market. In order to protect our proprietary technology and processes, we rely in part on confidentiality agreements with our collaborators, employees, consultants, outside scientific collaborators and sponsored researchers and other advisors. These agreements may not effectively prevent disclosure of confidential information and may not provide an adequate remedy in the event of unauthorized disclosure of confidential information. We may need to share our proprietary information, including trade secrets, with future business partners, collaborators, contractors and others located in countries at heightened risk of theft of trade secrets, including through direct intrusion by private parties or state actors and those affiliated with or controlled by state actors. In addition, while we undertake efforts to protect our trade secrets and other confidential information from disclosure, others may independently discover trade secrets and proprietary information, and in such cases, we may not be able to assert any trade secret rights against such party. Costly and time-consuming litigation could be necessary to enforce and determine the scope of our proprietary rights and failure to obtain or maintain trade secret protection could adversely affect our competitive business position. Enforcing a claim that a party illegally </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">obtained and is using our trade secrets is challenging and the outcome is unpredictable. In addition, courts outside of the U.S. may be less willing to protect trade secrets.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lastly, if our trademarks and trade names are not registered or adequately protected, then we may not be able to build name recognition in our markets of interest and our business may be adversely affected.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be successful in obtaining or maintaining necessary rights to our programs through acquisitions and in-licenses.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because our development programs currently do and may in the future require the use of proprietary rights held by third parties, the growth of our business may depend in part on our ability to acquire, in-license, or use these third-party proprietary rights. We may be unable to acquire or in-license any compositions, methods of use, processes or other third-party intellectual property rights from third parties that we identify as necessary for our programs. The licensing and acquisition of third-party intellectual property rights is a competitive area, and a number of more established companies may pursue strategies to license or acquire third-party intellectual property rights that we may consider attractive or necessary. These established companies may have a competitive advantage over us due to their size, capital resources and greater clinical development and commercialization capabilities. In addition, companies that perceive us to be a competitor may be unwilling to assign or license rights to us. We also may be unable to license or acquire third-party intellectual property rights on terms that would allow us to make an appropriate return on our investment or at all. If we are unable to successfully obtain rights to required third-party intellectual property rights or maintain the existing intellectual property rights we have, we may have to abandon development of the relevant program, which could have a material adverse effect on our business, financial condition, results of operations, and prospects. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we normally seek to obtain the right to control prosecution, maintenance and enforcement of the patents relating to our programs, there may be times when the filing and prosecution activities for patents and patent applications relating to our programs are controlled by our current and future licensors or collaboration partners. If any of our current and future licensors or collaboration partners fail to prosecute, maintain and enforce such patents and patent applications in a manner consistent with the best interests of our business, including by payment of all applicable fees for patents covering our product candidates, we could lose our rights to the intellectual property or our exclusivity with respect to those rights, our ability to develop and commercialize those product candidates may be adversely affected and we may not be able to prevent competitors from making, using and selling competing products. In addition, even where we have the right to control patent prosecution of patents and patent applications we have licensed to and from third parties, we may still be adversely affected or prejudiced by actions or inactions of our licensees, our current and future licensors and their counsel that took place prior to the date upon which we assumed control over patent prosecution. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current and future licensors may rely on third-party consultants or collaborators or on funds from third parties such that our current and future licensors are not the sole and exclusive owners of the patents we in-license. If other third parties have ownership rights to our current and future in-licensed patents, they may be able to license such patents to our competitors, and our competitors could market competing products and technology. This could have a material adverse effect on our competitive position, business, financial conditions, results of operations, and prospects.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is possible that we may be unable to obtain licenses at a reasonable cost or on reasonable terms, if at all. Even if we are able to obtain a license, it may be non-exclusive, thereby giving our competitors access to the same technologies licensed to us. In that event, we may be required to expend significant time and resources to redesign our technology, programs, or the methods for manufacturing them or to develop or license replacement technology, all of which may not be feasible on a technical or commercial basis. If we are unable to do so, we may be unable to develop or commercialize the affected product candidates, which could harm our business, financial condition, results of operations, and prospects significantly. We cannot provide any assurances that third-party patents do not exist which might be enforced against our current technology, manufacturing methods, programs, or future methods or products resulting in either an injunction prohibiting our manufacture or future sales, or, with respect to our future sales, an obligation on our part to pay royalties and/or other forms of compensation to third parties, which could be significant. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disputes may arise between us and our current and future licensors regarding intellectual property subject to a license agreement, including: the scope of rights granted under the license agreement and other </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">interpretation-related issues; whether and the extent to which our technology and processes infringe on intellectual property of the licensor that is not subject to the licensing agreement; our right to sublicense patents and other rights to third parties; our right to transfer or assign the license; the inventorship and ownership of inventions and know-how resulting from the joint creation or use of intellectual property by our current and future licensors and us and our partners; and the priority of invention of patented technology.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to patent infringement claims or may need to file claims to protect our intellectual property, which could result in substantial costs and liability and prevent us from commercializing our potential products.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because the intellectual property landscape in the biotechnology industry is rapidly evolving and interdisciplinary, it is difficult to conclusively assess our freedom to operate and guarantee that we can operate without infringing on or violating third-party rights. If certain of our product candidates are ultimately granted regulatory approval, patent rights held by third parties, if found to be valid and enforceable, could be alleged to render one or more of our product candidates infringing. If a third party successfully brings a claim against us, we may be required to pay substantial damages, be forced to abandon any affected product candidate and/or seek a license from the patent holder. In addition, any intellectual property claims (e.g. patent infringement or trade secret theft) brought against us, whether or not successful, may cause us to incur significant legal expenses and divert the attention of our management and key personnel from other business concerns. We cannot be certain that patents owned or licensed by us will not be challenged by others in the course of litigation. Some of our competitors may be able to sustain the costs of complex intellectual property litigation more effectively than we can because they have substantially greater resources. In addition, any uncertainties resulting from the initiation and continuation of any litigation could have a material adverse effect on our ability to raise funds and on the market price of our common stock. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Competitors may infringe or otherwise violate our patents, trademarks, copyrights or other intellectual property. To counter infringement or other violations, we may be required to file claims, which can be expensive and time-consuming. Any such claims could provoke these parties to assert counterclaims against us, including claims alleging that we infringe their patents or other intellectual property rights. In addition, in a patent infringement proceeding, a court or administrative body may decide that one or more of the patents we assert is invalid or unenforceable, in whole or in part, construe the patent&#8217;s claims narrowly or refuse to prevent the other party from using the technology at issue on the grounds that our patents do not cover the technology. Similarly, if we assert trademark infringement claims, a court or administrative body may determine that the marks we have asserted are invalid or unenforceable or that the party against whom we have asserted trademark infringement has superior rights to the marks in question. In such a case, we could ultimately be forced to cease use of such marks. In any intellectual property litigation, even if we are successful, any award of monetary damages or other remedy we receive may not be commercially valuable.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, we may be required to protect our patents through procedures created to attack the validity of a patent at the USPTO. An adverse determination in any such submission or proceeding could reduce the scope or enforceability of, or invalidate, our patent rights, which could adversely affect our competitive position. Because of a lower evidentiary standard in USPTO proceedings compared to the evidentiary standard in United States federal courts necessary to invalidate a patent claim, a third party could potentially provide evidence in a USPTO proceeding sufficient for the USPTO to hold a claim invalid even though the same evidence would be insufficient to invalidate the claim if first presented in a district court action. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, if our programs are found to infringe the intellectual property rights of third parties, these third parties may assert infringement claims against our future licensees and other parties with whom we have business relationships and we may be required to indemnify those parties for any damages they suffer as a result of these claims, which may require us to initiate or defend protracted and costly litigation on behalf of licensees and other parties regardless of the merits of such claims. If any of these claims succeed, we may be forced to pay damages on behalf of those parties or may be required to obtain licenses for the products they use. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation or other legal proceedings relating to our intellectual property rights, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation or other proceedings.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to claims that we have wrongfully hired an employee from a competitor or that our employees, consultants or independent contractors have wrongfully used or disclosed confidential information of third parties</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As is common in the biotechnology industry, in addition to our employees, we engage the services of consultants to assist us in the development of our programs. Many of these consultants, and many of our employees, were previously employed at, or may have previously provided or may be currently providing consulting services to, other biotechnology or pharmaceutical companies including our competitors or potential competitors. Despite our training and compliance efforts, we could in the future be subject to claims that we or our employees have inadvertently or otherwise used or disclosed alleged trade secrets or other confidential information of former employers or competitors. Although we try to ensure that our employees and consultants do not use the intellectual property, proprietary information, know-how or trade secrets of others in their work for us, we may become subject to claims that we caused an employee to breach the terms of his or her non-competition or non-solicitation agreement, or that we or these individuals have, inadvertently or otherwise, used or disclosed the alleged trade secrets or other proprietary information of a former employer or competitor. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we may litigate to defend ourselves against these claims, even if we are successful, litigation could result in substantial costs and could be a distraction to management. If our defenses to these claims fail, in addition to requiring us to pay monetary damages, a court could prohibit us from using technologies or features that are essential to our programs, if such technologies or features are found to incorporate or be derived from the trade secrets or other proprietary information of the former employers. Moreover, any such litigation or the threat thereof may adversely affect our reputation, our ability to form strategic alliances or sublicense our rights to collaborators, engage with scientific advisors or hire employees or consultants, each of which would have an adverse effect on our business, results of operations and financial condition. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes to patent laws in the United States and other jurisdictions could diminish the value of patents in general, thereby impairing our ability to protect our products.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in either the patent laws or interpretation of patent laws in the United States, including patent reform legislation such as the Leahy-Smith America Invents Act (the &#8220;Leahy-Smith Act&#8221;) could increase the uncertainties and costs surrounding the prosecution of our owned and in-licensed patent applications and the maintenance, enforcement or defense of our owned and in-licensed issued patents. The Leahy-Smith Act includes a number of significant changes to United States patent law. These changes include provisions that affect the way patent applications are prosecuted, redefine prior art, provide more efficient and cost-effective avenues for competitors to challenge the validity of patents, and enable third-party submission of prior art to the USPTO during patent prosecution and additional procedures to attack the validity of a patent at USPTO-administered post-grant proceedings, including post-grant review, inter partes review and derivation proceedings. Assuming that other requirements for patentability are met, prior to March 2013, in the United States, the first to invent the claimed invention was entitled to the patent, while outside the United States, the first to file a patent application was entitled to the patent. After March 2013, under the Leahy-Smith Act, the United States transitioned to a first-to-file system in which, assuming that the other statutory requirements for patentability are met, the first inventor to file a patent application will be entitled to the patent on an invention regardless of whether a third party was the first to invent the claimed invention. As such, the Leahy-Smith Act and its implementation could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents, all of which could have a material adverse effect on our business, financial condition, results of operations and prospects. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the patent positions of companies in the development and commercialization of biologics and pharmaceuticals are particularly uncertain. U.S. Supreme Court and U.S. Court of Appeals for the Federal Circuit rulings have narrowed the scope of patent protection available in certain circumstances and weakened the rights of patent owners in certain situations, including in the antibody arts. For example, the United States Supreme Court in </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amgen, Inc. v. Sanofi (Amgen)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> recently held that Amgen&#8217;s patent claims to a class of antibodies functionally defined by their ability to bind a particular antigen were invalid for lack of enablement where the patent specification provided twenty-six exemplary antibodies, but the claimed class of antibodies covered a &#8220;vast number&#8221; of additional antibodies not disclosed in the specification. The Court stated that if patent claims are directed to an entire class of compositions of matter, then the patent specification must enable </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a person skilled in the art to make and use the entire class of compositions. This decision makes it unlikely that we will be granted U.S. patents with composition of matter claims directed to antibodies functionally defined by their ability to bind a particular antigen. Even if we are granted claims directed to functionally defined antibodies, it is possible that a third party may challenge our patents, when issued, relying on the reasoning in </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amgen</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or other recent precedential court decisions. Additionally, there have been proposals for additional changes to the patent laws of the United States and other countries that, if adopted, could impact our ability to enforce our proprietary technology. This combination of events has created uncertainty with respect to the validity and enforceability of patents once obtained. Depending on future actions by the U.S. Congress, the federal courts, the USPTO and the relevant law-making bodies in other countries, the laws and regulations governing patents could change in ways that could have a material adverse effect on our patent rights and weaken our ability to protect, defend and enforce our patent rights in the future. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Geopolitical instability in the United States and in foreign countries could increase the uncertainties and costs surrounding the prosecution or maintenance of patent applications and the maintenance, enforcement or defense of issued patents. For example, the United States and foreign government actions related to Russia&#8217;s invasion of Ukraine may limit or prevent filing, prosecution and maintenance of patent applications in Russia. Government actions may also prevent maintenance of issued patents in Russia. These actions could result in abandonment or lapse of patents or patent applications, resulting in partial or complete loss of patent rights in Russia. If such an event were to occur, it could have a material adverse effect on our business. In addition, a decree was adopted by the Russian government in March 2022, allowing Russian companies and individuals to exploit inventions owned by patentees that have citizenship or nationality in, are registered in, or have predominately primary place of business or profit-making activities in the United States and other countries that Russia has deemed unfriendly without consent or compensation. Consequently, we would not be able to prevent third parties from practicing our inventions in Russia or from selling or importing products made using our inventions in and into Russia. Accordingly, our competitive position may be impaired, and our business, financial condition, results of operations and prospects may be adversely affected. In addition, a European Unified Patent Court (&#8220;UPC&#8221;) entered into force on June 1, 2023. The UPC is a common patent court that hears patent infringement and revocation proceedings effective for member states of the EU. This could enable third parties to seek revocation of a European patent in a single proceeding at the UPC rather than through multiple proceedings in each of the jurisdictions in which the European patent is validated. Although we do not currently own any European patents or applications for our current pipeline, if we obtain such patents and applications in the future, any such revocation and loss of patent protection could have a material adverse impact on our business and our ability to commercialize or license our technology and products. Moreover, the controlling laws and regulations of the UPC will develop over time, and may adversely affect our ability to enforce or defend the validity of any European patents we may obtain. We may decide to opt out from the UPC any future European patent applications that we may file and any patents we may obtain. If certain formalities and requirements are not met, however, such European patents and patent applications could be challenged for non-compliance and brought under the jurisdiction of the UPC. We cannot be certain that future European patents and patent applications will avoid falling under the jurisdiction of the UPC, if we decide to opt out of the UPC, or that we will have the ability to opt out of the UPC in the future.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Obtaining and maintaining patent protection depends on compliance with various procedural, document submissions, fee payment and other requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for non-compliance with these requirements.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periodic maintenance fees, renewal fees, annuities fees and various other governmental fees on patents and/or patent applications are due to be paid to the USPTO and foreign patent agencies in several stages over the lifetime of the patent and/or patent application. The USPTO and various foreign governmental patent agencies also require compliance with a number of procedural, documentary, fee payment and other similar provisions during the patent application process. While an inadvertent lapse can in many cases be cured by payment of a late fee or by other means in accordance with the applicable rules, there are situations in which noncompliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. Non-compliance events that could result in abandonment or lapse of a patent or patent application include, but are not limited to, failure to respond to official actions within prescribed time limits, non-payment of fees and failure to properly legalize and submit formal documents. If we fail to maintain the patents and patent applications covering our programs, our competitive position would be adversely affected.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not identify relevant third-party patents or may incorrectly interpret the relevance, scope or expiration of a third-party patent, which might adversely affect our ability to develop and market our products.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot guarantee that any of our patent searches or analyses, including the identification of relevant patents, the scope of patent claims or the expiration of relevant patents, are complete or thorough, nor can we be certain that we have identified each and every third-party patent and pending application in the United States and abroad that is relevant to or necessary for the commercialization of our product candidates in any jurisdiction. The scope of a patent claim is determined by an interpretation of the law, the written disclosure in a patent and the patent&#8217;s prosecution history. Our interpretation of the relevance or the scope of a patent or a pending application may be incorrect. For example, we may incorrectly determine that our products are not covered by a third-party patent or may incorrectly predict whether a third party&#8217;s pending application will issue with claims of relevant scope. Our determination of the expiration date of any patent in the United States or abroad that we consider relevant may be incorrect. Our failure to identify and correctly interpret relevant patents may negatively impact our ability to develop and market our products. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, because some patent applications in the United States may be maintained in secrecy until the patents are issued, patent applications in the United States and many foreign jurisdictions are typically not published until 18 months after priority filing, and publications in the scientific literature often lag behind actual discoveries, we cannot be certain that others have not filed patent applications for technology covered by our issued patents or our pending applications, or that we were the first to invent the technology. Our competitors may have filed, and may in the future file, patent applications covering our products or technology similar to ours. Any such patent application may have priority over our patent applications or patents, which could require us to obtain rights to issued patents covering such technologies.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may become subject to claims challenging the inventorship or ownership of our patents and other intellectual property.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be subject to claims that former employees, collaborators or other third parties have an interest in our patents or other intellectual property as an inventor or co-inventor. The failure to name the proper inventors on a patent application can result in the patents issuing thereon being unenforceable. Inventorship disputes may arise from conflicting views regarding the contributions of different individuals named as inventors, the effects of foreign laws where foreign nationals are involved in the development of the subject matter of the patent, conflicting obligations of third parties involved in developing our programs or as a result of questions regarding co-ownership of potential joint inventions. Litigation may be necessary to resolve these and other claims challenging inventorship and/or ownership. Alternatively, or additionally, we may enter into agreements to clarify the scope of our rights in such intellectual property. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights, such as exclusive ownership of, or right to use, valuable intellectual property. Such an outcome could have a material adverse effect on our business. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current and future licensors may have relied on third-party consultants or collaborators or on funds from third parties, such as the U.S. government, such that our licensors are not the sole and exclusive owners of the patents we in-licensed. The U.S. government has certain rights in such inventions under the applicable funding agreements and under applicable law. If other third parties have ownership rights or other rights to our in-licensed patents, they may be able to license such patents to our competitors, and our competitors could market competing products and technology. This could have a material adverse effect on our competitive position, business, financial conditions, results of operations, and prospects.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Patent terms may be inadequate to protect the competitive position of our product candidates for an adequate amount of time.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patents have a limited lifespan. In the United States, if all maintenance fees are timely paid, the natural expiration of a patent is generally 20 years from its earliest United States non-provisional filing date. Various extensions may be available, but the life of a patent, and the protection it affords, is limited. Even if patents covering our product candidates are obtained, once the patent life has expired, we may be open to competition from competitive products, including generics or biosimilars. Given the amount of time required for the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">development, testing and regulatory review of new product candidates, patents protecting such product candidates might expire before or shortly after such product candidates are commercialized. As a result, our owned and licensed patent portfolio may not provide us with sufficient rights to exclude others from commercializing products similar or identical to ours.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our technology licensed from various third parties may be subject to retained rights.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current or future licensors may retain certain rights under the relevant agreements with us, including the right to use the underlying technology for noncommercial academic and research use, to publish general scientific findings from research related to the technology, and to make customary scientific and scholarly disclosures of information relating to the technology. It is difficult to monitor whether our licensors limit their use of the technology to these uses, and we could incur substantial expenses to enforce our rights to our licensed technology in the event of misuse.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Reliance on Third Parties</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely on collaborations and licensing arrangements with third parties, including our arrangement with Paragon. If we are unable to maintain these collaborations or licensing arrangements, or if these collaborations or licensing arrangements are not successful, our business could be negatively impacted.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently rely on our collaborations and licensing arrangements with third parties, including Paragon, for a substantial portion of our discovery capabilities and in-licenses. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Collaborations or licensing arrangements that we enter into may not be successful, and any success will depend heavily on the efforts and activities of such collaborators or licensors. If any of our collaborators or licensors experiences delays in performance of, or fails to perform its obligations under their agreement with us, disagrees with our interpretation of the terms of such agreement or terminates their agreement with us, our research programs and development timeline could be adversely affected. If we fail to comply with any of the obligations under our collaborations or license agreements, including payment terms and diligence terms, our collaborators or licensors may have the right to terminate such agreements, in which event we may lose intellectual property rights and may not be able to develop, manufacture, market or sell the products covered by our agreements or may face other penalties under our agreements. Our collaborators and licensors may also fail to properly maintain or defend the intellectual property we have licensed from them, if required by our agreement with them, or even infringe upon, our intellectual property rights, leading to the potential invalidation of our intellectual property or subjecting us to litigation or arbitration, any of which would be time-consuming and expensive and could harm our ability to commercialize our product candidates. In addition, collaborators could independently develop, or develop with third parties, products that compete directly or indirectly with our programs and products if the collaborators believe that the competitive products are more likely to be successfully developed or can be commercialized under terms that are more economically attractive than ours. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our strategy, we plan to evaluate additional opportunities to enhance our capabilities and expand our development pipeline or provide development or commercialization capabilities that complement our own. We may not realize the benefits of such collaborations, alliances or licensing arrangements. Any of these relationships may require us to incur non-recurring and other charges, increase our near and long-term expenditures, issue securities that dilute our existing stockholders or disrupt our management and business.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may face significant competition in attracting appropriate collaborators, and more established companies may also be pursuing strategies to license or acquire third-party intellectual property rights that we consider attractive. These companies may have a competitive advantage over us due to their size, financial resources and greater clinical development and commercialization capabilities. In addition, companies that perceive us to be a competitor may be unwilling to assign or license rights to us. Whether we reach a definitive agreement for a collaboration will depend upon, among other things, our assessment of the collaborator&#8217;s resources and expertise, the terms and conditions of the proposed collaboration and the proposed collaborator&#8217;s evaluation of a number of factors. Collaborations are complex and time-consuming to negotiate, document and execute. In addition, consolidation among large pharmaceutical and biotechnology companies has reduced the number of potential future collaborators. We may not be able to negotiate additional collaborations on a timely basis, on acceptable terms or at all. If we fail to enter into collaborations and do not </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">have sufficient funds or expertise to undertake the necessary development and commercialization activities, we may not be able to further develop our product candidates or bring them to market.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We currently rely, and plan to rely in the future, on third parties to conduct and support our nonclinical studies and clinical trials. If these third parties do not properly and successfully carry out their contractual duties or meet expected deadlines, we may not be able to obtain regulatory approval of or commercialize our product candidates.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have utilized and plan to continue to utilize and depend upon independent investigators and collaborators, such as medical institutions, CROs, contract testing labs and strategic partners, to conduct and support our nonclinical studies and clinical trials under agreements with us. We will rely heavily on these third parties over the course of our nonclinical studies and clinical trials, and we control only certain aspects of their activities. As a result, we will have less direct control over the conduct, timing and completion of these nonclinical studies and clinical trials and the management of data developed through nonclinical studies and clinical trials than would be the case if we were relying entirely upon our own staff. Nevertheless, we are responsible for ensuring that each of our studies and trials is conducted in accordance with the applicable protocol, legal, regulatory and scientific standards, and our reliance on these third parties does not relieve us of our regulatory responsibilities. We and our third-party contractors and CROs are required to comply with GLP, GCP and GVP regulations, which are regulations and guidelines enforced by the FDA and comparable foreign regulatory authorities for all of our programs in clinical development. If we or any of these third parties fail to comply with applicable GLP, GCP and GVP regulations, the nonclinical and clinical data generated in our nonclinical studies and clinical trials may be deemed unreliable and the FDA or comparable foreign regulatory authorities may require us to perform additional nonclinical and clinical trials before approving our marketing applications. We cannot assure you that upon inspection by a given regulatory authority, such regulatory authority will determine that any of our nonclinical studies and clinical trials comply with GLP, GCP and GVP regulations. In addition, our nonclinical studies and clinical trials must be conducted with products produced under cGMP regulations. Our failure to comply with these regulations may require us to repeat nonclinical studies and clinical trials, which would delay the regulatory approval process. Moreover, our business may be implicated if any of these third parties violates federal or state fraud and abuse or false claims laws and regulations or healthcare privacy and security laws.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any third parties conducting our nonclinical studies and clinical trials will not be our employees and, except for remedies available to us under our agreements with such third parties, we cannot control whether they devote sufficient time and resources to our programs. These third parties may be involved in mergers, acquisitions or similar transactions and may have relationships with other commercial entities, including our competitors, for whom they may also be conducting nonclinical studies, clinical trials or other product development activities, which could negatively affect their performance on our behalf and the timing thereof and could lead to products that compete directly or indirectly with our current or future product candidates. If these third parties do not successfully carry out their contractual duties or obligations or meet expected deadlines, if they need to be replaced or if the quality or accuracy of the clinical data they obtain is compromised due to the failure to adhere to our nonclinical and clinical protocols or regulatory requirements or for other reasons, our nonclinical studies and clinical trials may be extended, delayed or terminated and we may not be able to complete development of, obtain regulatory approval of or successfully commercialize our product candidates.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we currently rely on foreign CROs and CMOs, including WuXi Biologics, and will likely continue to rely on foreign CROs and CMOs in the future. We or the foreign CROs or CMOs we work with may be subject to U.S. legislation, including the potential passing of an act similar to the previously proposed BIOSECURE Act, sanctions, trade restrictions and other foreign regulatory requirements which could increase the cost or reduce the supply of material available to us, delay the procurement or supply of such material or have an adverse effect on our ability to secure significant commitments from governments to purchase our potential therapies or disrupt our supply chain. For example, in April 2025, the United States government imposed significant tariffs on imports from China and other countries and may impose more restrictions on goods, including biologically derived substances, manufactured in or imported from China or impose other restrictions on companies&#8217; ability to work with Chinese biotechnology companies. To the extent these or future tariffs are applicable to the material we import from China and other countries or if we are not able to secure supply of our product candidates as a result of applicable legislation, our business and financial condition could be adversely affected.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, the biopharmaceutical industry in China is strictly regulated by the Chinese government. Changes to Chinese regulations or government policies affecting biopharmaceutical companies are unpredictable and may have a material adverse effect on our collaborators in China which could have an adverse effect on our business, financial condition, results of operations and prospects. Evolving changes in China&#8217;s public health, economic, political, and social conditions and the uncertainty around China&#8217;s relationship with other governments, such as the United States and the UK, could also negatively impact our ability to manufacture our product candidates for our planned clinical trials or have an adverse effect on our ability to secure government funding, which could adversely affect our financial condition and cause us to delay our clinical development programs.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We currently rely and expect to rely in the future on the use of manufacturing suites in third-party facilities or on third parties to manufacture our product candidates, and we may rely on third parties to produce and process our products, if approved. Our business could be adversely affected if we are unable to use third-party manufacturing suites or if the third-party manufacturers encounter difficulties in production.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not currently own any facility that may be used as our clinical or commercial manufacturing and processing facility and must currently rely on CMOs to manufacture our product candidates. We have not yet caused our product candidates to be manufactured on a commercial scale and may not be able to do so for any of our programs, if approved. We currently have a sole source relationship for our supply of the SPY001 and SPY003 programs and one of the molecules in our SPY002 program. If there should be any disruption in such supply arrangement, including any adverse events affecting our suppliers, it could have a negative effect on the clinical development of our programs and other operations while we work to identify and qualify alternate supply sources. We may not control the manufacturing process of, and may be completely dependent on, our contract manufacturing partners for compliance with cGMP requirements and any other regulatory requirements of the FDA or comparable foreign regulatory authorities for the manufacture of our product candidates. Beyond periodic audits, we have limited control over the ability of our CMOs to maintain adequate quality control, quality assurance and other qualified personnel. If the FDA or a comparable foreign regulatory authority does not approve these facilities for the manufacture of our product candidates or if it withdraws any approval in the future, we may need to find alternative manufacturing facilities, which would require the incurrence of significant additional costs and delays, and materially adversely affect our ability to develop, obtain regulatory approval for or market our product candidates, if approved. Similarly, our failure, or the failure of our CMOs, to comply with applicable regulations could result in sanctions being imposed on us, including fines, injunctions, civil penalties, delays, suspension or withdrawal of approvals, license revocation, seizures or recalls of product candidates or drugs, operating restrictions and criminal prosecutions, any of which could significantly and adversely affect supplies of our product candidates or drugs and harm our business and results of operations. In addition, the FDA and comparable foreign regulatory authorities may undergo leadership changes, change their policies, issue additional regulations or revise existing regulations, or take other actions, such as those implemented by the recently established Department of Government Efficiency, which may impact our clinical development plans or prevent or delay approval of our programs under development on a timely basis. Such policy or regulatory changes could impose additional requirements upon us that could delay our ability to obtain approvals and increase the costs of compliance.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, our CMOs may experience manufacturing difficulties due to resource constraints, supply chain issues, proposed or actual legislative changes or requirements, or as a result of labor disputes or unstable political environments. If any CMOs on which we will rely fail to manufacture quantities of our product candidates at quality levels necessary to meet regulatory requirements and at a scale sufficient to meet anticipated demand at a cost that allows us to achieve profitability, our business, financial condition and prospects could be materially and adversely affected. In addition, our CMOs and other third parties are responsible for transporting temperature-controlled materials that can be inadvertently degraded during transport due to several factors, rendering certain batches unsuitable for trial use for failure to meet, among others, our integrity and purity specifications. We and any of our CMOs may also face product seizure or detention or refusal to permit the import or export of products. Our business could be materially adversely affected by business disruptions to our third-party providers that could materially adversely affect our anticipated timelines, potential future revenue and financial condition and increase our costs and expenses. Each of these risks could delay or prevent the completion of our nonclinical studies and clinical trials or the approval of any of our product candidates by the FDA, resulting in higher costs or adversely impact commercialization of our product candidates. See the section titled &#8220;Business &#8211; Manufacturing and Supply&#8221; in our Annual Report on Form </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-K for a more detailed description of our manufacturing plans and assumptions and the factors that may affect the success of our programs.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disruptions at the FDA and other government agencies could negatively affect the review of our regulatory submissions, which could negatively impact our business.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ability of the FDA to review and approve regulatory submissions can be affected by a variety of factors, including statutory, regulatory and policy changes, inadequate government budget funding levels or a reduction in the FDA&#8217;s workforce and its ability to hire and retain key personnel, disruptions caused by government shutdowns and public health crises. There have been mass layoffs of federal employees since the start of the current presidential administration in January 2025, the full impact of which is unclear at this time. Such disruptions could significantly impact the ability of the FDA or other regulatory authorities to timely review and process our regulatory submissions, which could have a material adverse effect on our business. In addition, the presidential administration has made and is expected to continue to make changes in the leadership of various U.S. federal regulatory agencies and changes to U.S. federal government policy that have led to, in some cases, legal challenges and uncertainty around the funding, functioning and policy priorities of the U.S. federal regulatory agencies, including the FDA.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are unable to predict the extent to which the presidential administration may impose or seek to impose leadership or policy changes at the FDA or changes to rules and policies impacting our business and operations. It is unclear how these executive actions or other potential actions by the federal government will impact the FDA or other regulatory authorities that oversee our business. Government proposals to reduce or eliminate budgetary deficits may include reduced allocations to the FDA and other related government agencies. These budgetary pressures may reduce the FDA&#8217;s ability to perform its responsibilities, which could result in delays in our clinical trial timelines. If a significant reduction in the FDA&#8217;s workforce occurs, the FDA&#8217;s budget is significantly reduced or a prolonged government shutdown occurs, it could significantly impact the ability of the FDA to timely review and process our regulatory submissions or take other actions critical to the development or manufacturing of our product candidates, which could have a material adverse effect on our business.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Employee Matters, Managing Growth and Other Risks Related to Our Business</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">In order to successfully implement our plans and strategies, we will need to grow the size of our organization and we may experience difficulties in managing this growth.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to experience significant growth in the number of our employees and the scope of our operations, particularly in the areas of nonclinical and clinical drug development, technical operations, clinical operations, regulatory affairs and, potentially, sales and marketing. To manage our anticipated future growth, we must continue to implement and improve our managerial, operational and financial personnel and systems, expand our facilities and continue to recruit and train additional qualified personnel. Due to our limited financial resources and the limited experience of our management team working together in managing a company with such anticipated growth, we may not be able to effectively manage the expansion of our operations or recruit and train additional qualified personnel.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are highly dependent on our key personnel and anticipate hiring new key personnel. If we are not successful in attracting and retaining highly qualified personnel, we may not be able to successfully implement our business strategy.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a clinical stage biotechnology company with a limited operating history, and, as of March 31, 2025, we had 73 employees. We have been and will continue to be highly dependent on the research and development, clinical and business development expertise of our executive officers, as well as the other principal members of our management, scientific and clinical team. Any such officers and other principal members may terminate their employment with us at any time. We do not maintain &#8220;key person&#8221; insurance for any of our executives or other employees.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attracting and retaining qualified personnel will also be critical to our success, including with respect to any strategic transaction that we may pursue. The loss of the services of our executive officers or other key employees could impede the achievement of our research, development and commercialization objectives and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">seriously harm our ability to successfully implement our business strategy. Furthermore, replacing executive officers and key personnel may be difficult and may take an extended period of time because of the limited number of individuals in our industry with the breadth of skills and experience required to successfully develop, facilitate regulatory approval of and commercialize product candidates. Competition to hire from this limited pool is intense, and we may be unable to hire, train, retain or motivate these key personnel on acceptable terms given the competition among numerous pharmaceutical and biotechnology companies for similar personnel. We also experience competition for the hiring of scientific and clinical personnel from universities and research institutions.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we rely on consultants and advisors, including scientific and clinical advisors, to assist us in formulating our discovery and nonclinical and clinical development and commercialization strategy. Our consultants and advisors may be employed by employers other than us and may have commitments under consulting or advisory contracts with other entities that may limit their availability to us. If we are unable to continue to attract and retain high quality personnel, our ability to pursue our growth strategy will be limited.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our future growth may depend, in part, on our ability to operate in foreign markets, where we would be subject to additional regulatory burdens and other risks and uncertainties.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future growth may depend, in part, on our ability to develop and commercialize our product candidates in foreign markets for which we may rely on collaboration with third parties. We are not permitted to market or promote any of our product candidates before we receive regulatory approval from the applicable foreign regulatory authority, and may never receive such regulatory approval for any of our product candidates. To obtain separate regulatory approval in many other countries, we must comply with numerous and varying regulatory requirements of such countries regarding safety and efficacy and governing, among other things, clinical trials and commercial sales, pricing and distribution of our product candidates, and we cannot predict success in these jurisdictions. If we fail to comply with the regulatory requirements in international markets and receive applicable marketing approvals, our target market will be reduced and our ability to realize the full market potential of our product candidates will be harmed and our business will be adversely affected. Moreover, even if we obtain approval of our product candidates and ultimately commercialize our product candidates in foreign markets, we would be subject to the risks and uncertainties, including the burden of complying with complex and changing foreign regulatory, tax, accounting and legal requirements and reduced protection of intellectual property rights in some foreign countries.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our estimates of market opportunity and forecasts of market growth may prove to be inaccurate, and even if the markets in which we compete achieve the forecasted growth, our business may not grow at similar rates, or at all. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our market opportunity estimates and growth forecasts are subject to significant uncertainty and are based on assumptions and estimates which may not prove to be accurate. Our estimates and forecasts relating to size and expected growth of our target market may prove to be inaccurate. Even if the markets in which we compete meet our size estimates and growth forecasts, our business may not grow at similar rates, or at all. Our growth is subject to many factors, including our success in implementing our business strategy, which is subject to many risks and uncertainties.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue will be dependent, in part, upon the size of the markets in the territories for which we gain regulatory approval, the accepted price for the product, the ability to obtain coverage and reimbursement and whether we own the commercial rights for that territory. If the number of our addressable patients is not as significant as we estimate, the indication approved by regulatory authorities is narrower than we expect or the treatment population is narrowed by competition, physician choice or treatment guidelines, we may not generate significant revenue from sales of such products, even if approved.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our employees, independent contractors, consultants, commercial collaborators, principal investigators, CROs, CMOs, suppliers and vendors may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Despite our employee training and compliance programs, we are exposed to the risk that our employees, independent contractors, consultants, commercial collaborators, principal investigators, CROs, CMOs, suppliers and vendors acting for or on our behalf may engage in misconduct or other improper activities. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have adopted a code of conduct and ethics, policies, standard operating procedures and other compliance efforts but it is not always possible to identify and deter misconduct by these parties and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to comply with these laws or regulations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our internal information technology systems, or those of any of our CROs, manufacturers, other contractors or consultants, third-party service providers, or potential future collaborators, may fail or suffer security or data privacy breaches or other unauthorized or improper access to, use of, or destruction of our proprietary or confidential data, employee data or personal data, which could result in additional costs, loss of revenue, significant liabilities, harm to our brand and material disruption of our operations.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of our business, we and the third parties upon which we rely collect, receive, store, process, generate, use, transfer, disclose, make accessible, protect, secure, dispose of, transmit, and share (collectively, process) proprietary, confidential, and sensitive data, including personal data, intellectual property, trade secrets, and other sensitive data (collectively, sensitive information).</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Despite the implementation of security measures in an effort to protect systems that store our information, given their size and complexity and the increasing amounts of information maintained on our internal information technology systems and those of our third-party CROs, other contractors (including sites performing our clinical trials), third-party service providers and supply chain companies, and consultants, these systems are potentially vulnerable to breakdown or other damage or interruption from service interruptions, system malfunction, natural disasters, terrorism, war and telecommunication and electrical failures, as well as security breaches from inadvertent or intentional actions by our employees, contractors, consultants, business partners and/or other third parties, or from cyber-attacks by malicious third parties, which may compromise our system infrastructure or lead to the loss, destruction, alteration or dissemination of, or damage to, our data. The growing use of artificial intelligence (AI) by malicious actors is expected to further escalate cybersecurity threats. For example, AI may be used to develop adaptive malware, generate highly convincing phishing or impersonation attacks (such as deepfakes), or automate the discovery and exploitation of software vulnerabilities, thereby increasing the likelihood and sophistication of future attacks.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some actors now engage and are expected to continue to engage in cyber-attacks, including without limitation nation-state actors for geopolitical reasons and in conjunction with military conflicts and defense activities. During times of war and other major conflicts, we, and the third parties upon which we rely, may be vulnerable to a heightened risk of these attacks, including retaliatory cyber-attacks, that could materially disrupt our systems and operations, supply chain, and ability to produce, sell and distribute our goods and services. In particular, severe ransomware attacks are becoming increasingly prevalent and can lead to significant interruptions in our operations, ability to provide our products or services, loss of sensitive data and income, reputational harm, and diversion of funds. Extortion payments may alleviate the negative impact of a ransomware attack, but we may be unwilling or unable to make such payments due to, for example, applicable laws or regulations prohibiting such payments.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent that any disruption or security breach were to result in loss, destruction, unavailability, alteration or dissemination of, or damage to, our data or applications, or for it to be believed or reported that any of these occurred, we could incur liability and reputational damage and the development and commercialization of our product candidates could be delayed. The use of AI by attackers may also contribute to faster, more coordinated attacks that evade traditional detection methods, placing additional pressure on our security infrastructure and incident response capabilities. Further, our insurance policies may not be adequate to compensate us for the potential losses arising from any such disruption in, or failure or security breach of, our systems or third-party systems where information important to our business operations or commercial development is stored. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fully-remote workforce may create additional risks for our information technology systems and data because our employees work remotely and utilize network connections, computers, and devices working at home, while in transit and in public locations. Additionally, business transactions (such as acquisitions or integrations) could expose us to additional cybersecurity risks and vulnerabilities, as our systems could be negatively affected by vulnerabilities present in acquired or integrated entities&#8217; systems and technologies.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we have implemented security measures designed to protect against security incidents, there can be no assurance that these measures will be effective. We may be unable in the future to detect vulnerabilities in our information technology systems because such threats and techniques change frequently, are often sophisticated in nature, and may not be detected until after a security incident has occurred. Further, we may experience delays in developing and deploying remedial measures designed to address any such identified vulnerabilities. Applicable data privacy and security obligations may require us to notify relevant stakeholders of security incidents. Such disclosures are costly, and the disclosure or the failure to comply with such requirements could lead to adverse consequences. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on third-party service providers and technologies to operate critical business systems to process sensitive information in a variety of contexts. Certain third-party platforms or vendors may incorporate AI-driven automation or analytics into their offerings, which may expose us to new categories of risk, such as data being repurposed for AI training, unexplainable outputs generated by machine learning models, or unintended reliance on automated decision-making systems that lack transparency or auditability. Our ability to monitor these third parties&#8217; information security practices is limited, and these third parties may not have adequate information security measures in place. If our third-party service providers experience a security incident or other interruption, we could experience adverse consequences. While we may be entitled to damages if our third-party service providers fail to satisfy their privacy or security-related obligations to us, any award may be insufficient to cover our damages, or we may be unable to recover such award. In addition, supply-chain attacks have increased in frequency and severity, and we cannot guarantee that third parties&#8217; infrastructure in our supply chain or our third-party partners&#8217; supply chains have not been compromised. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Internally, we are also evaluating and, in some cases, implementing AI-enabled technologies to support business operations, data analysis, and other workflow efficiencies. Although these tools offer potential benefits, they also present new and evolving risks, including exposure to biased outputs, regulatory uncertainty around AI governance, and the possibility that sensitive data could inadvertently be incorporated into AI model training datasets or disclosed through model inference. As global laws and guidance surrounding AI systems continue to evolve, noncompliance could result in restrictions on our use of AI, reputational consequences, or enforcement activity.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we (or a third party upon whom we rely) experience a security incident or are perceived to have experienced a security incident, we may experience adverse consequences, such as government enforcement actions (for example, investigations, fines, penalties, audits, and inspections); additional reporting requirements and/or oversight; restrictions on processing sensitive information (including personal data); litigation (including class claims); indemnification obligations; negative publicity; reputational harm; monetary fund diversions; interruptions in our operations (including availability of data); financial loss; and other similar harms. Security incidents and attendant consequences may cause stakeholders (including investors and potential customers) to stop supporting our platform, deter new customers from products, and negatively impact our ability to grow and operate our business. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contracts may not contain limitations of liability, and even where they do, there can be no assurance that limitations of liability in our contracts are sufficient to protect us from liabilities, damages, or claims related to our data privacy and security obligations. We cannot be sure that our insurance coverage will be adequate or sufficient to protect us from or to mitigate liabilities arising out of our privacy and security practices, that such coverage will continue to be available on commercially reasonable terms or at all, or that such coverage will pay future claims.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to use our net operating loss carryforwards and certain other tax attributes may be limited.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Sections 382 and 383 of the Internal Revenue Code of 1986, as amended, if a corporation undergoes an &#8220;ownership change,&#8221; generally defined as a greater than 50% change (by value) in its equity ownership over a three-year period, the corporation&#8217;s ability to use its pre-change net operating loss carryforwards, or NOLs, and other pre-change tax attributes (such as research tax credits) to offset its post-change income or taxes may be limited. Upon certain events since our conversion from a Delaware limited liability company to a Delaware corporation in 2015, it is possible that we may have triggered an &#8220;ownership change&#8221; limitation. We may also experience ownership changes in the future as a result of subsequent shifts in our stock ownership (some of which are outside of our control). As a result, if we earn net taxable income, our ability to use our pre-change NOLs and other pre-change tax attributes to offset U.S. federal taxable income or </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">taxes may be subject to limitations, which could potentially result in increased future tax liability to us. In addition, at the state level, there may be periods during which the use of NOLs is suspended or otherwise limited, which could accelerate or permanently increase state taxes owed.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to stringent and changing laws, regulations and standards, and contractual obligations relating to privacy, data protection, and data security. The actual or perceived failure to comply with such obligations could lead to government enforcement actions (which could include civil or criminal penalties), fines and sanctions, private litigation and/or adverse publicity and could negatively affect our operating results and business.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We, and third parties who we work with, are or may become subject to numerous domestic and foreign laws, regulations, and standards relating to privacy, data protection, and data security, the scope of which is changing, subject to differing applications and interpretations, and may be inconsistent among countries, or conflict with other rules. We are or may become subject to the terms of contractual obligations related to privacy, data protection and data security. Our obligations may also change or expand as our business grows. The actual or perceived failure by us or third parties related to us to comply with such laws, regulations and obligations could increase our compliance and operational costs, expose us to regulatory scrutiny, actions, fines and penalties, result in reputational harm, lead to a loss of customers, result in litigation and liability, and otherwise cause a material adverse effect on our business, financial condition and results of operations. See the section titled &#8220;Business &#8211; Government Regulation &#8211; Data Privacy and Security&#8221; in our Annual Report on Form 10-K for a more detailed description of the laws that may affect our ability to operate.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to comply with environmental, health and safety laws and regulations, we could become subject to fines or penalties or incur costs that could have a material adverse effect on the success of our business.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to numerous environmental, health and safety laws and regulations, including those governing laboratory procedures and the handling, use, storage, treatment and disposal of hazardous materials and wastes. Our operations may involve the use of hazardous and flammable materials, including chemicals and biological and radioactive materials. In addition, we may incur substantial costs in order to comply with current or future environmental, health and safety laws and regulations. These current or future laws and regulations may impair our research, development or commercialization efforts. Failure to comply with these laws and regulations also may result in substantial fines, penalties or other sanctions.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to adverse legislative or regulatory tax changes that could negatively impact our financial condition.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rules dealing with U.S. federal, state and local income taxation are constantly under review by persons involved in the legislative process and by the Internal Revenue Service and the U.S. Treasury Department. Changes to tax laws (which changes may have retroactive application) could adversely affect our stockholders or us. We assess the impact of various tax reform proposals and modifications to existing tax treaties in all jurisdictions where we have operations to determine the potential effect on our business and any assumptions we have made about our future taxable income. We cannot predict whether any specific proposals will be enacted, the terms of any such proposals or what effect, if any, such proposals would have on our business if they were to be enacted. For example, the United States enacted the Inflation Reduction Act of 2022, which implements, among other changes, a 1% excise tax on certain stock buybacks. In addition, beginning in 2022, the Tax Cuts and Jobs Act eliminated the previously available option to deduct research and development expenditures and requires taxpayers to amortize them generally over five years for research activities conducted in the United States and over 15 years for research activities conducted outside the United States. Such changes, among others, may adversely affect our effective tax rate, results of operation and general business condition.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may acquire businesses or products, or form strategic alliances, in the future, and may not realize the benefits of such acquisitions.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may acquire additional businesses or products, form strategic alliances, or create joint ventures with third parties that we believe will complement or augment our existing business. If we acquire businesses with promising markets or technologies, we may not be able to realize the benefit of acquiring such businesses if we </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are unable to successfully integrate them with our existing operations and company culture. We may encounter numerous difficulties in developing, manufacturing and marketing any new product candidates or products resulting from a strategic alliance or acquisition that delay or prevent us from realizing their expected benefits or enhancing our business. There is no assurance that, following any such acquisition, we will achieve the synergies expected in order to justify the transaction, which could result in a material adverse effect on our business and prospects.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We maintain our cash at financial institutions, often in balances that exceed federally-insured limits. The failure of financial institutions could adversely affect our ability to pay our operational expenses or make other payments.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash held in non-interest-bearing and interest-bearing accounts exceeds the Federal Deposit Insurance Corporation ("FDIC") insurance limits. If such banking institutions were to fail, we could lose all or a portion of those amounts held in excess of such insurance limitations. For example, the FDIC took control of Silicon Valley Bank on March 10, 2023. The Federal Reserve subsequently announced that account holders would be made whole. However, the FDIC may not make all account holders whole in the event of future bank failures. In addition, even if account holders are ultimately made whole with respect to a future bank failure, account holders&#8217; access to their accounts and assets held in their accounts may be substantially delayed. Any material loss that we may experience in the future or inability for a material time period to access our cash and cash equivalents could have an adverse effect on our ability to pay our operational expenses or make other payments, which could adversely affect our business.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Common Stock</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The market price of our common stock has historically been volatile, and the market price of our common stock may decline in the future.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market price of our common stock has been, and may continue to be, subject to significant fluctuations. Market prices for securities of early-stage pharmaceutical, biotechnology, and other life sciences companies have historically been particularly volatile. Some of the factors that may cause the market price of our common stock to fluctuate include:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to obtain regulatory approvals for our product candidates, and delays or failures to obtain such approvals; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure of any of our product candidates, if approved, to achieve commercial success; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure to maintain our existing third-party license and supply agreements; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in laws or regulations applicable to our product candidates;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any inability to obtain adequate supply of our product candidates or the inability to do so at acceptable prices;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">adverse regulatory authority decisions;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">introduction of new products, services, or technologies by our competitors;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure to meet or exceed financial and development projections we may provide to the public and the investment community;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the perception of the pharmaceutical industry by the public, legislatures, regulators, and the investment community;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">announcements of significant acquisitions, strategic collaborations, joint ventures, or capital commitments by us or our competitors;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disputes or other developments relating to proprietary rights, including patents, litigation matters, and our ability to obtain patent protection for our technologies;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">additions or departures of key personnel;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">significant lawsuits, including patent or stockholder litigation;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if securities or industry analysts do not publish research or reports about our business, or if they issue an adverse or misleading opinion regarding our business and stock;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the market valuations of similar companies;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general market or macroeconomic conditions, including global inflationary pressures, rising interest rates, general economic slowdown or a recession, changes in tariff/trade and monetary policies, instability in financial institutions and the prospect of a shutdown of the U.S. federal government;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">geopolitical instability and government actions, including the ongoing military conflict in Ukraine, conflicts in the middle east, geopolitical tensions between the United States and other countries, including China, and the implementation of measures that restrict international trade by the United States, China or other governments; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">sales of our common stock by us or our stockholders in the future; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">trading volume of our common stock;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">announcements by commercial partners or competitors of new commercial products, clinical progress or the lack thereof, significant contracts, commercial relationships, or capital commitments;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the introduction of technological innovations or new therapies that compete with our potential products; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the structure of health care payment systems; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">period-to-period fluctuations in our financial results.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, the capital markets in general have experienced substantial volatility that has often been unrelated to the operating performance of individual companies. These broad market fluctuations may also adversely affect the trading price of our common stock. For example, escalating trade tensions, elevated interest rates and regulatory uncertainty have caused significant market volatility in recent months, and particularly in the biotechnology and biopharmaceutical industries.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the past, following periods of volatility in the market price of a company&#8217;s securities, stockholders have often instituted class action securities litigation against those companies. Such litigation, if instituted, could result in substantial costs and diversion of management attention and resources, which could significantly harm our profitability and reputation.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Anti-takeover provisions in our charter documents and under Delaware law and the terms of some of our contracts could make an acquisition of us more difficult and may prevent attempts by our stockholders to replace or remove our management.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provisions in our Certificate of Incorporation and Bylaws may delay or prevent an acquisition or a change in management. These provisions include a prohibition on actions by written consent of our stockholders and the ability of our board of directors to issue preferred stock without stockholder approval. In addition, because we are incorporated in Delaware, we are governed by the provisions of Section 203 of the DGCL, which prohibits stockholders owning in excess of 15% of our outstanding voting stock from merging or combining with us. Although we believe these provisions collectively will provide for an opportunity to receive higher bids by requiring potential acquirers to negotiate with our board of directors, they would apply even if the offer may be considered beneficial by some stockholders. In addition, these provisions may frustrate or prevent any attempts by our stockholders to replace or remove then current management by making it more difficult for stockholders to replace members of the board of directors, which is responsible for appointing the members of management.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Certificate of Designation of Preferences, Rights and Limitations of the Series A Preferred Stock (the &#8220;Series A Certificate of Designation&#8221;) relating to our Series A Preferred Stock may delay or prevent a change in control of our company. At any time while at least 30% of the originally issued Series A Preferred Stock remains issued and outstanding, we may not consummate a Fundamental Transaction (as defined in the Series A Certificate of Designation) or any merger or consolidation of the Company with or into another entity or any stock sale to, or other business combination in which our stockholders immediately before such transaction do not hold at least a majority of our capital stock immediately after such transaction, without the affirmative vote of the holders of a majority of the then outstanding shares of the Series A Preferred Stock. This provision of the Series A Certificate of Designation may make it more difficult for us to enter into any of the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">aforementioned transactions as it would require the separate consent of a majority of the holders of the Series A Preferred Stock.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Certificate of Incorporation and Bylaws provide that the Court of Chancery of the State of Delaware is the exclusive forum certain types of actions and proceedings that may be initiated by our stockholders, and our Bylaws designate the federal courts of the United States as the exclusive forum for actions arising under the Securities Act, each of which could limit our stockholders&#8217; ability to obtain a favorable judicial forum for disputes with us or our directors, officers, employees or agents</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Certificate of Incorporation and Bylaws provide that, unless we consent in writing to an alternative forum, the Court of Chancery of the State of Delaware will be the sole and exclusive forum for any derivative action or proceeding brought on our behalf, any action asserting a claim of breach of a fiduciary duty owed by any of our directors, officers, employees or agents to us or our stockholders, any action asserting a claim arising pursuant to any provision of the DGCL, our Certificate of Incorporation or our Bylaws or any action asserting a claim that is governed by the internal affairs doctrine, in each case subject to the Court of Chancery having personal jurisdiction over the indispensable parties named as defendants therein and the claim not being one which is vested in the exclusive jurisdiction of a court or forum other than the Court of Chancery or for which the Court of Chancery does not have subject matter jurisdiction. Any person purchasing or otherwise acquiring any interest in any shares of our capital stock shall be deemed to have notice of and to have consented to this provision of our Certificate of Incorporation and Bylaws. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Bylaws provide that the federal district courts of the United States of America will, to the fullest extent permitted by law, be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act (a &#8220;Federal Forum Provision&#8221;). Our decision to adopt a Federal Forum Provision followed a decision by the Supreme Court of the State of Delaware holding that such provisions are facially valid under Delaware law. While there can be no assurance that federal or state courts will follow the holding of the Delaware Supreme Court or determine that the Federal Forum Provision should be enforced in a particular case, application of the Federal Forum Provision means that suits brought by our stockholders to enforce any duty or liability created by the Securities Act must be brought in federal court and cannot be brought in state court. In addition, investors cannot waive compliance with the federal securities laws and the rules and regulations thereunder.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These choice of forum provisions will not apply to claims brought to enforce a duty or liability created by the Exchange Act</span><span style="color:#008080;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These choice of forum provisions may limit our stockholders&#8217; ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers, employees or agents, which may discourage such lawsuits against us and our directors, officers, employees and agents even though an action, if successful, might benefit our stockholders. Stockholders who do bring a claim in the specified courts could face additional litigation costs in pursuing any such claim. The specified courts may also reach different judgments or results than would other courts, including courts where a stockholder considering an action may be located or would otherwise choose to bring the action, and such judgments or results may be more favorable to us than to our stockholders. Alternatively, if a court were to find these provisions of our governance documents inapplicable to, or unenforceable in respect of, one or more of the specified types of actions or proceedings, we may incur additional costs associated with resolving such matters in other jurisdictions, which could have a material adverse effect on our business, financial condition or results of operations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We do not anticipate that we will pay any cash dividends in the foreseeable future.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current expectation is that we will retain our future earnings, if any, to fund the development and growth of our business. As a result, capital appreciation, if any, of our common stock will be your sole source of gain, if any, for the foreseeable future.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future sales of shares by existing stockholders could cause our stock price to decline. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our stockholders sell, or indicate an intention to sell, substantial amounts of our common stock in the public market after legal restrictions on resale lapse, the trading price of our common stock could decline. In addition, shares of our common stock that are subject to our outstanding options and restricted stock units will become eligible for sale in the public market to the extent permitted by the provisions of various vesting agreements and Rules 144 and 701 under the Securities Act</span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future sales and issuances of equity and debt could result in additional dilution to our stockholders.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that we will need significant additional capital to fund our current and future operations, including to complete potential clinical trials for our product candidates. To raise capital, we may sell common stock, convertible securities, or other equity securities in one or more transactions at prices and in a manner we determine from time to time. As a result, our stockholders may experience additional dilution, which could cause our stock price to fall. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to our equity incentive plans, we may grant equity awards and issue additional shares of our common stock to our employees, directors and consultants, and the number of shares of our common stock reserved for future issuance under certain of these plans will be subject to automatic annual increases in accordance with the terms of the plans. To the extent that new options or other stock-based equity awards are granted and, if applicable, exercised, or we issue additional shares of common stock in the future, our stockholders may experience additional dilution, which could cause our stock price to fall.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our principal stockholders own a significant percentage of our stock and are able to exert significant control over matters subject to stockholder approval.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our directors, officers, 5% stockholders, and their affiliates currently beneficially own a substantial portion of our outstanding voting stock. Therefore, these stockholders have the ability and may continue to have the ability to influence us through this ownership position. These stockholders may be able to determine some or all matters requiring stockholder approval. For example, these stockholders, acting together, may be able to control elections of directors, amendments of organizational documents, or approval of any merger, sale of assets, or other major corporate transaction. This may prevent or discourage unsolicited acquisition proposals or offers for our common stock that you may believe are in your best interest as one of our stockholders.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Risk Factors</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may become exposed to costly and damaging liability claims, either when testing our programs in the clinic or at the commercial stage, and our product liability insurance may not cover all damages from such claims.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to potential product liability and professional indemnity risks that are inherent in the research, development, manufacturing, marketing and use of pharmaceutical products. While we currently have no products that have been approved for commercial sale, the use of our product candidates in clinical trials, and the sale of any approved products in the future, may expose us to liability claims. These claims may be made by participants or patients that use the product candidate or product, healthcare providers, pharmaceutical companies, or others selling such products. Any claims against us, regardless of their merit, could be difficult and costly to defend and could materially and adversely affect the market for our products or any prospects for commercialization of our products. Although we currently maintain adequate product liability insurance for our product candidates, it is possible that our liabilities could exceed our insurance coverage or that in the future we may not be able to maintain insurance coverage at a reasonable cost or obtain insurance coverage that will be adequate to satisfy any liability that may arise. If a successful product liability claim or series of claims is brought against us for uninsured liabilities or in excess of insured liabilities, our assets may not be sufficient to cover such claims and our business operations could be impaired.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation costs and the outcome of litigation could have a material adverse effect on our business.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time we may be subject to litigation claims through the ordinary course of our business operations regarding, but not limited to, securities litigation, employment matters, security of patient and employee personal information, contractual relations with collaborators and licensors and intellectual property rights. Litigation to defend ourselves against claims by third parties, or to enforce any rights that we may have against third parties, could result in substantial costs and diversion of our resources, causing a material adverse effect on our business, financial condition, results of operations or cash flows.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We continue to incur significant costs and demands upon management as a result of complying with the laws and regulations regulating public companies.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a public company, and particularly after December 31, 2024, when we ceased to be a &#8220;smaller reporting company&#8221; and &#8220;non-accelerated filer,&#8221; and became a &#8220;large accelerated filer,&#8221; we have and will continue to incur significant legal, accounting and other expenses associated with public company reporting requirements, including costs associated with corporate governance requirements, such as requirements under the Sarbanes-Oxley Act, the Dodd-Frank Wall Street Reform and Consumer Protection Act, as well as rules implemented by the SEC and Nasdaq. Stockholder activism, the current political environment and the current high level of government intervention and regulatory reform may lead to substantial new regulations and disclosure obligations, which may lead to additional compliance costs and impact (in ways we cannot currently anticipate) the manner in which we operate our business. In addition, changing laws, regulations, and standards relating to corporate governance and public disclosure, including those related to climate change and other environmental, social and governance focused disclosures, are creating uncertainty for public companies, increasing legal and financial compliance costs, and making some activities more time-consuming. These rules and regulations increase our legal and financial compliance costs and make some activities more time-consuming and costly. These rules and regulations may also make it difficult and expensive for us to obtain directors&#8217; and officers&#8217; liability insurance. Our management and other personnel will continue to devote a substantial amount of time to these compliance initiatives, and we will continue to incur increased legal and financial compliance costs. As a result, it may be more difficult for us to attract and retain qualified individuals to serve on our board of directors or as our executive officers, which may adversely affect investor confidence and could cause our business or stock price to suffer. In addition, the increased costs may require us to reduce costs in other areas of our business or increase the prices of our product candidates, once commercialized. Moreover, these rules and regulations are often subject to varying interpretations, in many cases due to their lack of specificity, and, as a result, their application in practice may evolve over time as new guidance is provided by regulatory and governing bodies. This could result in continuing uncertainty regarding compliance matters and higher costs necessitated by ongoing revisions to disclosure and governance practices.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are no longer a &#8220;smaller reporting company&#8221; within the meaning of the Securities Act and as a result we are or will be subject to certain enhanced disclosure requirements which will require us to incur significant expenses and expend time and resources. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are no longer a &#8220;smaller reporting company,&#8221; as of January 1, 2025 and, as a result, we are or will be required to comply with various disclosure and compliance requirements that did not previously apply, such as the auditor attestation requirements of Section 404(b) of the Sarbanes-Oxley Act, the requirement that we hold a nonbinding advisory vote on executive compensation and obtain stockholder approval of any golden parachute payments not previously approved, the requirement to provide full and more detailed executive compensation disclosure and the reduction in the amount of time for filing our periodic and annual reports. Compliance with these additional requirements increases our legal and financial compliance costs and causes management and other personnel to divert attention from operational and other business matters to these additional public company reporting requirements. In addition, if we are not able to comply with changing requirements in a timely manner, the market price of our stock could decline and we could be subject to delisting proceedings by the stock exchange on which our common shares are listed, or sanctions or investigations by the SEC or other regulatory authorities, which would require additional financial and management resources.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will reassess, as of June 30, 2025, whether we continue to qualify as a large accelerated filer for filings beyond the fiscal year ending December 31, 2025.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If equity research analysts do not publish research or reports, or publish unfavorable research or reports, about us, our business, or our market, our stock price and trading volume could decline.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading market for our common stock is influenced by the research and reports that equity research analysts publish about us and our business. Equity research analysts may elect not to provide research coverage of our common stock and such lack of research coverage may adversely affect the market price of our common stock. In the event we do have equity research analyst coverage, we will not have any control over the analysts or the content and opinions included in their reports. The price of our common stock could decline if one or more equity research analysts downgrade our stock or issue other unfavorable commentary or research. If one or more equity research analysts ceases coverage of us or fails to publish reports on us regularly, demand for our common stock could decrease, which in turn could cause our stock price or trading volume to decline.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to maintain proper and effective internal controls, our ability to produce accurate financial statements on a timely basis could be impaired, investors may lose confidence in the accuracy and completeness of our financial reports and the market price of our common stock may be negatively affected.  For example, in the fourth quarter of 2024, we identified a material weakness in our internal control over financial reporting which resulted in restatements of our previously-issued financial statements to amend certain net loss per share disclosures.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the reporting requirements of the Exchange Act, the Sarbanes-Oxley Act, and the rules and regulations of Nasdaq. The Sarbanes-Oxley Act requires, among other things, that we maintain effective disclosure controls and procedures and internal control over financial reporting.  In addition to our management&#8217;s report on the effectiveness of our internal controls over financial reporting, our independent registered public accounting firm is required to attest to the effectiveness of our internal control over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act. The rules governing the standards that must be met for management to assess our internal control over financial reporting are complex and require significant documentation, testing, and possible remediation. We must perform system and process evaluation and testing of our internal control over financial reporting to allow management to report on the effectiveness of our internal controls over financial reporting in our annual report filing for that year, as required by Section 404 of the Sarbanes-Oxley Act.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are not able to comply with the requirements of Section 404 of the Sarbanes-Oxley Act, or if we are unable to maintain proper and effective internal controls, it could result in a material misstatement of our financial statements that would not be prevented or detected on a timely basis, which could require a restatement, cause us to be subject to sanctions or investigations by Nasdaq, the SEC, or other regulatory authorities, cause investors to lose confidence in our financial information, or cause our stock price to decline.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim consolidated financial statements will not be prevented or detected on a timely basis.  As described in our Annual Report for the year ended December 31, 2024, we identified a material weakness in our internal control over financial reporting in connection with our net earnings (loss) per share disclosures, which resulted in the restatement of our consolidated financial statements as of and for the year ended December 31, 2023, as well as the quarterly condensed consolidated financial information for the interim periods ended March 31, 2024, June 30, 2024, and September 30, 2024. We have implemented measures designed to improve our disclosure controls and procedures and internal control over financial reporting to address the underlying causes of this material weakness, including enhancing the design of controls relevant to the preparation and presentation of financial reporting matters related to net earnings (loss) per share calculations and disclosures to ensure that economic substance beyond the legal form of our capital structure is considered when preparing disclosures related to net earnings (loss) per share. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our internal control over financial reporting will not prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system&#8217;s objectives will be met. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud will be detected. In addition, we may encounter problems or delays in completing the implementation of any requested improvements and receiving a favorable attestation in connection with the attestation provided by our independent registered public accounting firm.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a public company, we incur significant legal, accounting, insurance, and other expenses, and our management and other personnel have and will need to continue to devote a substantial amount of time to compliance initiatives resulting from operating as a public company. We may experience difficulty in meeting these reporting requirements in a timely manner for each period.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business could be adversely affected by economic downturns, inflation, increases in interest rates, natural disasters, public health crises, political crises, U.S. elections, international or geopolitical events, such as the conflict between Russia and Ukraine, and conflicts in the middle east, the implementation of measures that restrict international trade or other macroeconomic conditions, which could have a material and adverse effect on our results of operations and financial condition.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The global economy, including credit and financial markets, has experienced extreme volatility and disruptions, including, among other things, diminished liquidity and credit availability, declines in consumer confidence, declines in economic growth, supply chain shortages, increases in inflation rates, higher interest rates, and uncertainty about economic stability. Adverse macroeconomic conditions, including inflation, slower growth or recession, new or increased tariffs and other barriers to trade, especially in light of recent comments and executive orders made by the Trump administration, changes to fiscal and monetary policy or government budget dynamics (particularly in the pharmaceutical and biotechnology areas), tighter credit, higher interest rates, volatility in financial markets, high unemployment, labor availability constraints, currency fluctuations and other challenges in the global economy have in the past adversely affected, and may in the future adversely affect, us and our business partners and suppliers. In recent months, the United States has announced tariffs on imports from most countries, including significant tariffs on imports from Canada, Mexico and China. Historically, tariffs have led to increased trade and political tensions. In response to tariffs, other countries have implemented retaliatory tariffs on U.S. goods. Political tensions as a result of trade policies could reduce trade volume, investment, technological exchange and other economic activities between major international economies, resulting in a material adverse effect on global economic conditions and the stability of global financial markets. There is substantial uncertainty about the duration of existing tariffs and whether additional tariffs may be imposed, modified or suspended. The Federal Reserve has raised interest rates multiple times in response to concerns about inflation and it may raise them again. Higher interest rates, coupled with reduced government spending and volatility in financial markets, may increase economic uncertainty and affect consumer spending. Similarly, geopolitical uncertainties, international conflicts and government actions, including the ongoing military conflicts between Russia and Ukraine, and conflicts in the middle east involving Israel and various other parties, including Iran, Hamas and Hezbollah, as well as other conflicts in the region, rising tensions with China and the implementation of tariffs, sanctions, export or import controls, and other measures that restrict international trade by the United States, China or other governments, have created extreme volatility in the global capital markets and may have further global economic consequences, including disruptions of the global supply chain. Any such volatility and disruptions may adversely affect our business or the third parties on whom we rely. If the equity and credit markets deteriorate, including as a result of political unrest or war, it may make any necessary debt or equity financing more costly, more dilutive, or more difficult to obtain in a timely manner or on favorable terms, if at all. Increased inflation rates can adversely affect us by increasing our costs, including labor and employee benefit costs.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may in the future experience disruptions as a result of such macroeconomic conditions, including delays or difficulties in initiating or expanding clinical trials and manufacturing sufficient quantities of materials. Any one or a combination of these events could have a material and adverse effect on our results of operations and financial condition.</span></div><div id="id1024c8efdf34cb8889d12b6bf18881e_139"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">None. </span></div><div id="id1024c8efdf34cb8889d12b6bf18881e_142"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Defaults Upon Senior Securities.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None. </span></div><div id="id1024c8efdf34cb8889d12b6bf18881e_145"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Mine Safety Disclosures.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="id1024c8efdf34cb8889d12b6bf18881e_148"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5. Other Information.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trading Plans </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fiscal quarter ended March 31, 2025, no director or Section 16 officer <ix:nonNumeric contextRef="c-1" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-784"><ix:nonNumeric contextRef="c-1" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-785">adopted</ix:nonNumeric></ix:nonNumeric> or <ix:nonNumeric contextRef="c-1" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-786"><ix:nonNumeric contextRef="c-1" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-787">terminated</ix:nonNumeric></ix:nonNumeric> any Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (in each case, as defined in Item 408(a) of Regulation S-K).</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><div id="id1024c8efdf34cb8889d12b6bf18881e_154"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. Exhibits.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exhibits filed or furnished as part of this Quarterly Report on Form 10-Q are set forth below.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:8.748%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.415%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.869%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.172%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.415%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.933%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Form</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">File No</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Date of Filing</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exhibit<br/>No.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Filed<br/>Herewith</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1636282/000119312523302158/d518298dex21.htm">Agreement and Plan of Merger, dated June 22, 2023, by and among Aeglea BioTherapeutics, Inc. Aspen Merger Sub I, Inc., Sequoia Merger Sub II, LLC and Spyre Therapeutics, Inc.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-1</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">333-276251</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12/22/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1636282/000119312524138893/d839821dex32.htm">Second Amended and Restated Certificate of Incorporation of the Company, effective as of May 14, 2024</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-37722</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">05/15/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1636282/000119312524023071/d518298dex32.htm">Amended and Restated Bylaws</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-1/A</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">333-276251</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">02/05/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1636282/000119312523302158/d518298dex33.htm">Certificate of Designation of Series A Non-Voting Convertible Preferred Stock</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-1</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">333-276251</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12/22/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.4</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1636282/000119312523302158/d518298dex34.htm">Certificate of Designation of Series B Non-Voting Convertible Preferred Stock</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-1</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">333-276251</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12/22/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.4</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1636282/000119312524069693/d784263dex32.htm">Certificate of Amendment to Certificate of Designation of Series B Non-Voting Convertible Preferred Stock</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-37722</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">03/18/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.1#</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1636282/000163628225000020/exhibit1025-paragonxspyrex.htm">Amended and Restated IL-23 (SPY003) License Agreement, dated February 24, 2025, by and between the Company and Paragon Therapeutics, Inc</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-37722</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">02/27/2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.25</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="spyre-2050331xex311.htm">Certification of the Principal Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="spyre-20250331xex312.htm">Certification of the Principal Financial Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32.1(1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="spyre-20250331xex321.htm">Certification of the Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.INS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Instance Document &#8211; the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Schema Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:6pt;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:8.748%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.415%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.869%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.172%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.415%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.933%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Form</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">File No</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Date of Filing</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exhibit<br/>No.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Filed<br/>Herewith</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cover page from this Quarterly Report formatted in Inline XBRL and contained in Exhibit 101</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+&#160;&#160;&#160;&#160;Indicates management contract or compensatory plan. </span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">#&#160;&#160;&#160;&#160;Portions of this exhibit have been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">The certifications on Exhibit 32 hereto are deemed furnished and not &#8220;filed&#8221; for purposes of Section 18 of the Exchange Act or otherwise subject to the liability of that Section. Such certifications will not be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><div id="id1024c8efdf34cb8889d12b6bf18881e_157"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Signatures</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date: May&#160;8, 2025</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:46.851%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.997%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:46.852%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Spyre Therapeutics, Inc.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Scott Burrows</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Scott Burrows</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Chief Financial Officer</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Principal Financial Officer and Principal Accounting Officer)</span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>2
<FILENAME>spyre-20250331xex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i6e012b773851450c81f7425649044072_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="-sec-extract:summary;margin-top:6pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Scott Burrows, certify that&#58;</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">I have reviewed this Quarterly Report on Form 10-Q of Spyre Therapeutics, Inc.&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.23pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and </font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; May&#160;8, 2025</font></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.203%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:53.597%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#47;s&#47; Scott Burrows</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Scott Burrows</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:114%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial Officer and Principal Accounting Officer)</font></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>3
<FILENAME>spyre-20250331xex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="ic1a287511f37489484667aaaa331efd5_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="-sec-extract:summary;margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certifications of the</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principal Executive Officer and Principal Financial Officer</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant To 18 U.S.C. Section 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As Adopted Pursuant To</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 906 of The Sarbanes-Oxley Act Of 2002</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of Spyre Therapeutics, Inc. (the &#8220;Company&#8221;) on Form 10-Q for the quarterly period ended March&#160;31, 2025, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), each of the undersigned officers of the Company hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge&#58;</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.11pt">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.11pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.787%"><tr><td style="width:1.0%"></td><td style="width:43.225%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.575%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Date&#58; May&#160;8, 2025</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#47;s&#47; Cameron Turtle, D.Phil</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cameron Turtle, D.Phil</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:114%">Chief Executive Officer</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Principal Executive Officer)</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#47;s&#47; Scott Burrows</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Scott Burrows</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:114%">Chief Financial Officer</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:114%">(Principal Financial Officer and Principal Accounting Officer)</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>spyre-2050331xex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="id2b1ff8efb634d81b587f7cbaa8465ce_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="-sec-extract:summary;margin-top:6pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Cameron Turtle, certify that&#58;</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">I have reviewed this Quarterly Report on Form 10-Q of Spyre Therapeutics, Inc.&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.23pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and </font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; May&#160;8, 2025</font></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#47;s&#47; Cameron Turtle, D.Phil</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cameron Turtle, D.Phil</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:114%">Chief Executive Officer</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:114%">(Principal Executive Officer)</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>syre-20250331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:00f29609-870c-422a-b8be-61cf7b074069,g:31b3bfa9-c84d-47fe-82f5-b77ff3f965cb-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:syre="http://spyre.com/20250331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://spyre.com/20250331">
  <xs:import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="syre-20250331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="syre-20250331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="syre-20250331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="syre-20250331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://spyre.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://spyre.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>9952151 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://spyre.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>9952152 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperations" roleURI="http://spyre.com/role/CondensedConsolidatedStatementsofOperations">
        <link:definition>9952153 - Statement - Condensed Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperationsParenthetical" roleURI="http://spyre.com/role/CondensedConsolidatedStatementsofOperationsParenthetical">
        <link:definition>9952154 - Statement - Condensed Consolidated Statements of Operations (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveLoss" roleURI="http://spyre.com/role/CondensedConsolidatedStatementsofComprehensiveLoss">
        <link:definition>9952155 - Statement - Condensed Consolidated Statements of Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofChangesinConvertiblePreferredStockandStockholdersEquity" roleURI="http://spyre.com/role/CondensedConsolidatedStatementsofChangesinConvertiblePreferredStockandStockholdersEquity">
        <link:definition>9952156 - Statement - Condensed Consolidated Statements of Changes in Convertible Preferred Stock and Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows">
        <link:definition>9952157 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TheCompanyandBasisofPresentation" roleURI="http://spyre.com/role/TheCompanyandBasisofPresentation">
        <link:definition>9952158 - Disclosure - The Company and Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://spyre.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>9952159 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://spyre.com/role/FairValueMeasurements">
        <link:definition>9952160 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashEquivalentsandMarketableSecurities" roleURI="http://spyre.com/role/CashEquivalentsandMarketableSecurities">
        <link:definition>9952161 - Disclosure - Cash Equivalents and Marketable Securities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedandOtherCurrentLiabilities" roleURI="http://spyre.com/role/AccruedandOtherCurrentLiabilities">
        <link:definition>9952162 - Disclosure - Accrued and Other Current Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LicensingAgreements" roleURI="http://spyre.com/role/LicensingAgreements">
        <link:definition>9952163 - Disclosure - Licensing Agreements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactions" roleURI="http://spyre.com/role/RelatedPartyTransactions">
        <link:definition>9952164 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertiblePreferredStockandStockholdersEquity" roleURI="http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquity">
        <link:definition>9952165 - Disclosure - Convertible Preferred Stock and Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensation" roleURI="http://spyre.com/role/StockBasedCompensation">
        <link:definition>9952166 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReporting" roleURI="http://spyre.com/role/SegmentReporting">
        <link:definition>9952167 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShare" roleURI="http://spyre.com/role/NetLossPerShare">
        <link:definition>9952168 - Disclosure - Net Loss Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://spyre.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>9955511 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementTables" roleURI="http://spyre.com/role/FairValueMeasurementTables">
        <link:definition>9955512 - Disclosure - Fair Value Measurement (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashEquivalentsandMarketableSecuritiesTables" roleURI="http://spyre.com/role/CashEquivalentsandMarketableSecuritiesTables">
        <link:definition>9955513 - Disclosure - Cash Equivalents and Marketable Securities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedandOtherCurrentLiabilitiesTables" roleURI="http://spyre.com/role/AccruedandOtherCurrentLiabilitiesTables">
        <link:definition>9955514 - Disclosure - Accrued and Other Current Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsTables" roleURI="http://spyre.com/role/RelatedPartyTransactionsTables">
        <link:definition>9955515 - Disclosure - Related Party Transactions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationTables" roleURI="http://spyre.com/role/StockBasedCompensationTables">
        <link:definition>9955516 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingTables" roleURI="http://spyre.com/role/SegmentReportingTables">
        <link:definition>9955517 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareTables" roleURI="http://spyre.com/role/NetLossPerShareTables">
        <link:definition>9955518 - Disclosure - Net Loss Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TheCompanyandBasisofPresentationDetails" roleURI="http://spyre.com/role/TheCompanyandBasisofPresentationDetails">
        <link:definition>9955519 - Disclosure - The Company and Basis of Presentation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" roleURI="http://spyre.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails">
        <link:definition>9955520 - Disclosure - Fair Value Measurements - Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://spyre.com/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>9955521 - Disclosure - Fair Value Measurements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsSignificantInputsusedtoEstimatetheFairValueofDerivativeLiabilityDetails" roleURI="http://spyre.com/role/FairValueMeasurementsSignificantInputsusedtoEstimatetheFairValueofDerivativeLiabilityDetails">
        <link:definition>9955522 - Disclosure - Fair Value Measurements - Significant Inputs used to Estimate the Fair Value of Derivative Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsChangesinDerivativeLiabilitiesDetails" roleURI="http://spyre.com/role/FairValueMeasurementsChangesinDerivativeLiabilitiesDetails">
        <link:definition>9955523 - Disclosure - Fair Value Measurements - Changes in Derivative Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashEquivalentsandMarketableSecuritiesEstimatedFairValueofCashEquivalentsandMarketableSecuritiesandtheGrossUnrealizedGainsandLossesDetails" roleURI="http://spyre.com/role/CashEquivalentsandMarketableSecuritiesEstimatedFairValueofCashEquivalentsandMarketableSecuritiesandtheGrossUnrealizedGainsandLossesDetails">
        <link:definition>9955524 - Disclosure - Cash Equivalents and Marketable Securities - Estimated Fair Value of Cash Equivalents and Marketable Securities and the Gross Unrealized Gains and Losses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashEquivalentsandMarketableSecuritiesAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails" roleURI="http://spyre.com/role/CashEquivalentsandMarketableSecuritiesAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails">
        <link:definition>9955525 - Disclosure - Cash Equivalents and Marketable Securities - Available-for-Sale Securities in an Unrealized Loss Position (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashEquivalentsandMarketableSecuritiesNarrativeDetails" roleURI="http://spyre.com/role/CashEquivalentsandMarketableSecuritiesNarrativeDetails">
        <link:definition>9955526 - Disclosure - Cash Equivalents and Marketable Securities - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashEquivalentsandMarketableSecuritiesContractualMaturitiesofMarketableSecuritiesatEstimatedFairValueDetails" roleURI="http://spyre.com/role/CashEquivalentsandMarketableSecuritiesContractualMaturitiesofMarketableSecuritiesatEstimatedFairValueDetails">
        <link:definition>9955527 - Disclosure - Cash Equivalents and Marketable Securities - Contractual Maturities of Marketable Securities at Estimated Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedandOtherCurrentLiabilitiesDetails" roleURI="http://spyre.com/role/AccruedandOtherCurrentLiabilitiesDetails">
        <link:definition>9955528 - Disclosure - Accrued and Other Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LicensingAgreementsDetails" roleURI="http://spyre.com/role/LicensingAgreementsDetails">
        <link:definition>9955529 - Disclosure - Licensing Agreements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsNarrativeDetails" roleURI="http://spyre.com/role/RelatedPartyTransactionsNarrativeDetails">
        <link:definition>9955530 - Disclosure - Related Party Transactions - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsExpensesrelatedtoRelatedPartywhichwereSettledinCashDetails" roleURI="http://spyre.com/role/RelatedPartyTransactionsExpensesrelatedtoRelatedPartywhichwereSettledinCashDetails">
        <link:definition>9955531 - Disclosure - Related Party Transactions - Expenses related to Related Party which were Settled in Cash (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsRelatedPartyAccountsPayableDetails" roleURI="http://spyre.com/role/RelatedPartyTransactionsRelatedPartyAccountsPayableDetails">
        <link:definition>9955532 - Disclosure - Related Party Transactions - Related Party Accounts Payable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertiblePreferredStockandStockholdersEquityNarrativeDetails" roleURI="http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails">
        <link:definition>9955533 - Disclosure - Convertible Preferred Stock and Stockholders' Equity - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationNarrativeDetails" roleURI="http://spyre.com/role/StockBasedCompensationNarrativeDetails">
        <link:definition>9955534 - Disclosure - Stock-Based Compensation - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationStockAwardsGrantedDetails" roleURI="http://spyre.com/role/StockBasedCompensationStockAwardsGrantedDetails">
        <link:definition>9955535 - Disclosure - Stock-Based Compensation - Stock Awards Granted (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationStockBasedCompensationExpenseDetails" roleURI="http://spyre.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails">
        <link:definition>9955536 - Disclosure - Stock-Based Compensation - Stock-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationAssumptionsusedtoEstimatetheFairValueofStockOptionsGrantedDetails" roleURI="http://spyre.com/role/StockBasedCompensationAssumptionsusedtoEstimatetheFairValueofStockOptionsGrantedDetails">
        <link:definition>9955537 - Disclosure - Stock-Based Compensation - Assumptions used to Estimate the Fair Value of Stock Options Granted (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingSummaryofSignificantSegmentExpensesDetails" roleURI="http://spyre.com/role/SegmentReportingSummaryofSignificantSegmentExpensesDetails">
        <link:definition>9955538 - Disclosure - Segment Reporting -Summary of Significant Segment Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails" roleURI="http://spyre.com/role/NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails">
        <link:definition>9955539 - Disclosure - Net Loss Per Share - Reconciliation of Basic and Diluted Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareWeightedAverageEquityInstrumentsExcludedfromCalculationofDilutedNetLossPerShareDetails" roleURI="http://spyre.com/role/NetLossPerShareWeightedAverageEquityInstrumentsExcludedfromCalculationofDilutedNetLossPerShareDetails">
        <link:definition>9955540 - Disclosure - Net Loss Per Share - Weighted-Average Equity Instruments Excluded from Calculation of Diluted Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="syre_SeriesANonVotingConvertiblePreferredStockMember" abstract="true" name="SeriesANonVotingConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syre_SeriesBNonVotingConvertiblePreferredStockMember" abstract="true" name="SeriesBNonVotingConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syre_PreferredStockExcludingSeriesAAndBNonVotingConvertiblePreferredStockMember" abstract="true" name="PreferredStockExcludingSeriesAAndBNonVotingConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syre_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" abstract="false" name="TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="syre_StockIssuedDuringPeriodSharesOptionsExercisedAndEmployeeStockOwnershipPlan" abstract="false" name="StockIssuedDuringPeriodSharesOptionsExercisedAndEmployeeStockOwnershipPlan" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="syre_StockIssuedDuringPeriodValueOptionsExercisedAndEmployeeStockOwnershipPlan" abstract="false" name="StockIssuedDuringPeriodValueOptionsExercisedAndEmployeeStockOwnershipPlan" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syre_ShareBasedPaymentArrangementSettlementOptionsCash" abstract="false" name="ShareBasedPaymentArrangementSettlementOptionsCash" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syre_InterestProceedsDebtSecurities" abstract="false" name="InterestProceedsDebtSecurities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syre_PaymentForDeferredOfferingCosts" abstract="false" name="PaymentForDeferredOfferingCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syre_PaymentForSettlementOfShareBasedPaymentArrangement" abstract="false" name="PaymentForSettlementOfShareBasedPaymentArrangement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syre_DeferredOfferingCostsUnpaidAmount" abstract="false" name="DeferredOfferingCostsUnpaidAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syre_IssuanceOfConvertiblePreferredStockRelatedToPrivatePlacementUnpaidAmount" abstract="false" name="IssuanceOfConvertiblePreferredStockRelatedToPrivatePlacementUnpaidAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syre_AccruedAndOtherCurrentLiabilitiesTextBlock" abstract="false" name="AccruedAndOtherCurrentLiabilitiesTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="syre_LicensingAgreementsAbstract" abstract="true" name="LicensingAgreementsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="syre_ScheduleOfBalancesDueToAffiliatesTableTextBlock" abstract="false" name="ScheduleOfBalancesDueToAffiliatesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="syre_CompanyAndBasisOfPresentationTable" abstract="true" name="CompanyAndBasisOfPresentationTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="syre_SpyreTherapeuticsIncMember" abstract="true" name="SpyreTherapeuticsIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syre_AssetAcquisitionMember" abstract="true" name="AssetAcquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syre_CommonStockAndSeriesBNonVotingConvertiblePreferredStockMember" abstract="true" name="CommonStockAndSeriesBNonVotingConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syre_AtTheMarketOfferingMember" abstract="true" name="AtTheMarketOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syre_UnderwrittenOfferingMember" abstract="true" name="UnderwrittenOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syre_ConversionOfSeriesANonVotingConvertiblePreferredStockMember" abstract="true" name="ConversionOfSeriesANonVotingConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syre_ConversionOfSeriesBNonVotingConvertiblePreferredStockMember" abstract="true" name="ConversionOfSeriesBNonVotingConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syre_CompanyAndBasisOfPresentationLineItems" abstract="true" name="CompanyAndBasisOfPresentationLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="syre_AssetAcquisitionStockholderPaymentPeriod" abstract="false" name="AssetAcquisitionStockholderPaymentPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="syre_AssetAcquisitionCashPaymentThresholdPeriod" abstract="false" name="AssetAcquisitionCashPaymentThresholdPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="syre_StockIssuedDuringPeriodSharesExchangeOfConvertibleSecurities" abstract="false" name="StockIssuedDuringPeriodSharesExchangeOfConvertibleSecurities" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="syre_PreferredStockSharesNotAutomaticallyConvertedOutstanding" abstract="false" name="PreferredStockSharesNotAutomaticallyConvertedOutstanding" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="syre_SaleOfStockAuthorizedAmount" abstract="false" name="SaleOfStockAuthorizedAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syre_SaleOfStockAggregateOfferingPrice" abstract="false" name="SaleOfStockAggregateOfferingPrice" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syre_SaleOfStockRemainingAuthorizedAmount" abstract="false" name="SaleOfStockRemainingAuthorizedAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syre_ProceedsFromRaisingCapital" abstract="false" name="ProceedsFromRaisingCapital" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syre_ContingentValueRightLiabilityMember" abstract="true" name="ContingentValueRightLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syre_MeasurementInputProabilityOfSuccessMember" abstract="true" name="MeasurementInputProabilityOfSuccessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syre_MeasurementInputReimbursementRateMember" abstract="true" name="MeasurementInputReimbursementRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syre_CashEquivalentsUnrealizedGains" abstract="false" name="CashEquivalentsUnrealizedGains" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syre_CashEquivalentsUnrealizedLosses" abstract="false" name="CashEquivalentsUnrealizedLosses" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syre_CashEquivalentsAndMarketableSecuritiesTable" abstract="true" name="CashEquivalentsAndMarketableSecuritiesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="syre_USBankingInstitutionMember" abstract="true" name="USBankingInstitutionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syre_CashEquivalentsAndMarketableSecuritiesLineItems" abstract="true" name="CashEquivalentsAndMarketableSecuritiesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="syre_ImpairmentOfMarketableSecurities" abstract="false" name="ImpairmentOfMarketableSecurities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syre_NumberOfDomesticBankingInstitutions" abstract="false" name="NumberOfDomesticBankingInstitutions" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="syre_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOne" abstract="false" name="DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOne" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syre_AccruedContractedResearchAndDevelopmentCosts" abstract="false" name="AccruedContractedResearchAndDevelopmentCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syre_ParagonAgreementMember" abstract="true" name="ParagonAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syre_Spy001LicenseAgreementMember" abstract="true" name="Spy001LicenseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syre_SPY002LicenseAgreementMember" abstract="true" name="SPY002LicenseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syre_SPY003LicenseAgreementMember" abstract="true" name="SPY003LicenseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syre_ParagonAgreementLicenseMilestonePaymentsMember" abstract="true" name="ParagonAgreementLicenseMilestonePaymentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syre_AmountToBePaidUnderAgreement" abstract="false" name="AmountToBePaidUnderAgreement" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syre_PaymentOfMilestone" abstract="false" name="PaymentOfMilestone" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syre_CampaignTimelineMinimumTerm" abstract="false" name="CampaignTimelineMinimumTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="syre_RoyaltyStepDownPercent" abstract="false" name="RoyaltyStepDownPercent" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="syre_RoyaltyTermExpirationPeriod" abstract="false" name="RoyaltyTermExpirationPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="syre_TerminationNoticePeriod" abstract="false" name="TerminationNoticePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="syre_SublicensingFee" abstract="false" name="SublicensingFee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syre_LicenseAgreementMilestoneExpenseAmountRecognized" abstract="false" name="LicenseAgreementMilestoneExpenseAmountRecognized" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syre_LicenseAgreementMilestonePayments" abstract="false" name="LicenseAgreementMilestonePayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syre_LicenseAgreementMilestonePaymentsOutstandingAndPayable" abstract="false" name="LicenseAgreementMilestonePaymentsOutstandingAndPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syre_PaymentForSublicensingFee" abstract="false" name="PaymentForSublicensingFee" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syre_SublicensingFeeOutstandingAndPayable" abstract="false" name="SublicensingFeeOutstandingAndPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syre_ParagonTherapeuticsIncMember" abstract="true" name="ParagonTherapeuticsIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syre_FairmountFundsManagementLlcMember" abstract="true" name="FairmountFundsManagementLlcMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syre_AppointOfBoardMembersMember" abstract="true" name="AppointOfBoardMembersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syre_ParagonAgreementSubsequentToAssetAcquisitionMember" abstract="true" name="ParagonAgreementSubsequentToAssetAcquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syre_ConsultingAgreementMember" abstract="true" name="ConsultingAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syre_ParapyreOptionObligationMember" abstract="true" name="ParapyreOptionObligationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syre_RelatedPartyTransactionNumberOfBoardSeats" abstract="false" name="RelatedPartyTransactionNumberOfBoardSeats" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="syre_MinorityInterestOwnershipPercentageByNoncontrollingOwnersHeldInThirdParty" abstract="false" name="MinorityInterestOwnershipPercentageByNoncontrollingOwnersHeldInThirdParty" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="syre_DevelopmentCostReductionPercentage" abstract="false" name="DevelopmentCostReductionPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="syre_DevelopmentCostReimbursementPercentage" abstract="false" name="DevelopmentCostReimbursementPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="syre_CommonStockSharesOutstandingPercentageAvailableToPurchaseOnADilutedBasis" abstract="false" name="CommonStockSharesOutstandingPercentageAvailableToPurchaseOnADilutedBasis" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="syre_ParagonAndLicenseAgreementMember" abstract="true" name="ParagonAndLicenseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syre_ParapyreLiabilityLicenseAgreementsMember" abstract="true" name="ParapyreLiabilityLicenseAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syre_ParapyreWarrantsMember" abstract="true" name="ParapyreWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syre_A2024ParapyreOptionObligationMember" abstract="true" name="A2024ParapyreOptionObligationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syre_ClassOfWarrantOrRightNumberOfSecuritiesExercised" abstract="false" name="ClassOfWarrantOrRightNumberOfSecuritiesExercised" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="syre_PreferredStockRemainsIssuedAndOutstandingPercentage" abstract="false" name="PreferredStockRemainsIssuedAndOutstandingPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="syre_BeneficialHoldersOwnedPercentage" abstract="false" name="BeneficialHoldersOwnedPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="syre_TwoThousandAndFifteenAndTwoThousandAndSixteenEquityIncentivePlanAndTwoThousandAndEighteenEquityInducementPlanMember" abstract="true" name="TwoThousandAndFifteenAndTwoThousandAndSixteenEquityIncentivePlanAndTwoThousandAndEighteenEquityInducementPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syre_TwoThousandAndFifteenEquityIncentivePlanMember" abstract="true" name="TwoThousandAndFifteenEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syre_TwoThousandAndSixteenEquityIncentivePlanMember" abstract="true" name="TwoThousandAndSixteenEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syre_TwoThousandAndEighteenEquityInducementPlanMember" abstract="true" name="TwoThousandAndEighteenEquityInducementPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syre_TwoThousandAndEighteenEquityInducementPlanAmendedMember" abstract="true" name="TwoThousandAndEighteenEquityInducementPlanAmendedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syre_Spyre2023EquityIncentivePlanMember" abstract="true" name="Spyre2023EquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syre_TwoThousandAndSixteenEmployeeStockPurchasePlanMember" abstract="true" name="TwoThousandAndSixteenEmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syre_ServiceBasedAwardsMember" abstract="true" name="ServiceBasedAwardsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syre_A2016ESPPMember" abstract="true" name="A2016ESPPMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syre_AnnualPercentageOfAdditionalSharesWhichEqualsToIssuedAndOutstandingShares" abstract="false" name="AnnualPercentageOfAdditionalSharesWhichEqualsToIssuedAndOutstandingShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="syre_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalNumberOfSharesAvailableForGrant" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalNumberOfSharesAvailableForGrant" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="syre_CommonStockCapitalSharesReservedForFutureIssuanceIncreasedAmount" abstract="false" name="CommonStockCapitalSharesReservedForFutureIssuanceIncreasedAmount" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="syre_OutstandingAndUnexercisedStockOptions" abstract="false" name="OutstandingAndUnexercisedStockOptions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="syre_AegleaEmployeesAndDirectorsMember" abstract="true" name="AegleaEmployeesAndDirectorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syre_ReportableSegmentMember" abstract="true" name="ReportableSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>syre-20250331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:00f29609-870c-422a-b8be-61cf7b074069,g:31b3bfa9-c84d-47fe-82f5-b77ff3f965cb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://spyre.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="syre-20250331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://spyre.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_7ca839a2-ca94-4efe-b7b6-3f4d551f7db8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_16c7d0e7-3135-4288-94ff-3aa0f7b1b18b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_7ca839a2-ca94-4efe-b7b6-3f4d551f7db8" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_16c7d0e7-3135-4288-94ff-3aa0f7b1b18b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_c0a91459-7a87-4314-a70a-f1ba937d6c78" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_7ca839a2-ca94-4efe-b7b6-3f4d551f7db8" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_c0a91459-7a87-4314-a70a-f1ba937d6c78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_96aec0c2-0f6f-4e07-bcc4-fd3fa58a13b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_7ca839a2-ca94-4efe-b7b6-3f4d551f7db8" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_96aec0c2-0f6f-4e07-bcc4-fd3fa58a13b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_53f7742f-f1cb-4089-946a-7e7738df9854" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_f06318a3-2e05-42c2-9c97-3726f0511a42" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_53f7742f-f1cb-4089-946a-7e7738df9854" xlink:to="loc_us-gaap_AccountsPayableCurrent_f06318a3-2e05-42c2-9c97-3726f0511a42" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_b5cb4ba8-e5b3-49b4-9bf1-74ecf5bc4283" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_53f7742f-f1cb-4089-946a-7e7738df9854" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_b5cb4ba8-e5b3-49b4-9bf1-74ecf5bc4283" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_244e104e-bfc5-422c-8887-0f30f912bf25" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_53f7742f-f1cb-4089-946a-7e7738df9854" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_244e104e-bfc5-422c-8887-0f30f912bf25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_1650c685-4e97-4ec8-b636-61001e5c67b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_53f7742f-f1cb-4089-946a-7e7738df9854" xlink:to="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_1650c685-4e97-4ec8-b636-61001e5c67b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_894442ec-de17-4ff5-a986-6524f90801e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_2530c439-b36d-4b33-add0-87c6e77bde65" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_894442ec-de17-4ff5-a986-6524f90801e7" xlink:to="loc_us-gaap_PreferredStockValue_2530c439-b36d-4b33-add0-87c6e77bde65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_7c01b5e6-023f-447f-8d30-998c3a4df537" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_894442ec-de17-4ff5-a986-6524f90801e7" xlink:to="loc_us-gaap_CommonStockValue_7c01b5e6-023f-447f-8d30-998c3a4df537" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_be546e1e-9fc5-45d1-9e15-5a595efe42bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_894442ec-de17-4ff5-a986-6524f90801e7" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_be546e1e-9fc5-45d1-9e15-5a595efe42bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a58a44d8-aa62-4b69-845f-2dc8fffea26e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_894442ec-de17-4ff5-a986-6524f90801e7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a58a44d8-aa62-4b69-845f-2dc8fffea26e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9b34a409-945c-4c0f-b85b-e8a87ae1d15c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_894442ec-de17-4ff5-a986-6524f90801e7" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9b34a409-945c-4c0f-b85b-e8a87ae1d15c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_76920927-f40b-4e1c-8d2c-566dda5c446f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_6c5799fc-b94e-4e23-8a0b-ab75b20515b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_76920927-f40b-4e1c-8d2c-566dda5c446f" xlink:to="loc_us-gaap_Liabilities_6c5799fc-b94e-4e23-8a0b-ab75b20515b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_afeabdd9-9b65-4daf-a69f-36ede1f72e6b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_76920927-f40b-4e1c-8d2c-566dda5c446f" xlink:to="loc_us-gaap_CommitmentsAndContingencies_afeabdd9-9b65-4daf-a69f-36ede1f72e6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_68a5eca6-9b71-4928-ab36-defcd66dd645" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_76920927-f40b-4e1c-8d2c-566dda5c446f" xlink:to="loc_us-gaap_StockholdersEquity_68a5eca6-9b71-4928-ab36-defcd66dd645" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_9c29efcb-74db-4ac7-924f-25966b6e01e9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_7ead0768-079c-4ea9-a524-df9f88d7f6e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_9c29efcb-74db-4ac7-924f-25966b6e01e9" xlink:to="loc_us-gaap_LiabilitiesCurrent_7ead0768-079c-4ea9-a524-df9f88d7f6e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent_233c8c41-c4f9-4f9b-8ecc-29c4868e564d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_9c29efcb-74db-4ac7-924f-25966b6e01e9" xlink:to="loc_us-gaap_DerivativeLiabilitiesNoncurrent_233c8c41-c4f9-4f9b-8ecc-29c4868e564d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_b6fc4f9f-a952-48fb-990b-3128ff2635cf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_1cbce55f-a521-436c-8d13-986bc556ce37" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b6fc4f9f-a952-48fb-990b-3128ff2635cf" xlink:to="loc_us-gaap_AssetsCurrent_1cbce55f-a521-436c-8d13-986bc556ce37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_3e549327-2725-487b-9858-fbd264e6a53d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b6fc4f9f-a952-48fb-990b-3128ff2635cf" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_3e549327-2725-487b-9858-fbd264e6a53d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://spyre.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="syre-20250331.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://spyre.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_734ec1a3-16a9-4108-a0ed-cc611105b743" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2adbdc70-e6f5-4154-8ab4-b5ce3220a2dc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_734ec1a3-16a9-4108-a0ed-cc611105b743" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2adbdc70-e6f5-4154-8ab4-b5ce3220a2dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_3dfd33a5-ce9d-4296-81ba-6628ce35ae7c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_734ec1a3-16a9-4108-a0ed-cc611105b743" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_3dfd33a5-ce9d-4296-81ba-6628ce35ae7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_faf9dbc9-f776-465f-9b79-cce15d11a6cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_fdac0af5-60bf-4da0-aed6-f34482719f26" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_faf9dbc9-f776-465f-9b79-cce15d11a6cc" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_fdac0af5-60bf-4da0-aed6-f34482719f26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_40ef4bf3-02ea-41e0-bf37-b1c3658ab35d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_faf9dbc9-f776-465f-9b79-cce15d11a6cc" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_40ef4bf3-02ea-41e0-bf37-b1c3658ab35d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_7fe9e13d-b45e-4c83-ad44-2a62f4d90917" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_ff58b03d-aef0-4998-aacb-0bf131d47e61" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_7fe9e13d-b45e-4c83-ad44-2a62f4d90917" xlink:to="loc_us-gaap_InvestmentIncomeNet_ff58b03d-aef0-4998-aacb-0bf131d47e61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_d41259fa-8a70-4589-9e5f-e38ba3faa566" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_7fe9e13d-b45e-4c83-ad44-2a62f4d90917" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_d41259fa-8a70-4589-9e5f-e38ba3faa566" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c2b659d5-f55a-4462-9c6a-1bcd16e1b917" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_3e48d0a5-3970-48a1-8b60-1eac8441d70f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c2b659d5-f55a-4462-9c6a-1bcd16e1b917" xlink:to="loc_us-gaap_OperatingIncomeLoss_3e48d0a5-3970-48a1-8b60-1eac8441d70f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_08cbd7eb-76cf-4945-81b3-8de85d59b215" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c2b659d5-f55a-4462-9c6a-1bcd16e1b917" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_08cbd7eb-76cf-4945-81b3-8de85d59b215" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_246dcde0-9a39-4fc1-9321-3db75200d3d9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_3b12ba66-975c-4eb6-a761-e3ff8189bdc0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_246dcde0-9a39-4fc1-9321-3db75200d3d9" xlink:to="loc_us-gaap_OperatingExpenses_3b12ba66-975c-4eb6-a761-e3ff8189bdc0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://spyre.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="syre-20250331.xsd#CondensedConsolidatedStatementsofComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://spyre.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_ddffdc34-0e0e-4d37-8092-44089c93a7d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_24b80f68-ca4c-48e1-8f4a-0968eeee9bc8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_ddffdc34-0e0e-4d37-8092-44089c93a7d2" xlink:to="loc_us-gaap_NetIncomeLoss_24b80f68-ca4c-48e1-8f4a-0968eeee9bc8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_49af1b4d-0fcb-4bf4-a890-91370042a168" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_ddffdc34-0e0e-4d37-8092-44089c93a7d2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_49af1b4d-0fcb-4bf4-a890-91370042a168" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_d31fff13-de97-4de0-bf7b-a3a146b89320" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_ddffdc34-0e0e-4d37-8092-44089c93a7d2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_d31fff13-de97-4de0-bf7b-a3a146b89320" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="syre-20250331.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c66f9cfc-853b-408c-8214-cba250b7c12c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_f7838701-86ec-4917-ba25-0dd7ecd95112" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c66f9cfc-853b-408c-8214-cba250b7c12c" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_f7838701-86ec-4917-ba25-0dd7ecd95112" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_a7e5e99e-b19f-495d-b570-ab4e6086f89c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c66f9cfc-853b-408c-8214-cba250b7c12c" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_a7e5e99e-b19f-495d-b570-ab4e6086f89c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d3ded58c-2d61-4619-8433-5de07e7ccff1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_d0cb9fc1-0f56-49d3-b391-b97f6e5f6e26" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d3ded58c-2d61-4619-8433-5de07e7ccff1" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_d0cb9fc1-0f56-49d3-b391-b97f6e5f6e26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_ffee19b0-6ec3-4865-b917-c442c2eab6a8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d3ded58c-2d61-4619-8433-5de07e7ccff1" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_ffee19b0-6ec3-4865-b917-c442c2eab6a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_PaymentForSettlementOfShareBasedPaymentArrangement_8b9942e1-5f2d-4809-b065-c1d4c56df4c6" xlink:href="syre-20250331.xsd#syre_PaymentForSettlementOfShareBasedPaymentArrangement"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d3ded58c-2d61-4619-8433-5de07e7ccff1" xlink:to="loc_syre_PaymentForSettlementOfShareBasedPaymentArrangement_8b9942e1-5f2d-4809-b065-c1d4c56df4c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_PaymentForDeferredOfferingCosts_c095b231-2b0c-4cb0-ac21-6633951bb313" xlink:href="syre-20250331.xsd#syre_PaymentForDeferredOfferingCosts"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d3ded58c-2d61-4619-8433-5de07e7ccff1" xlink:to="loc_syre_PaymentForDeferredOfferingCosts_c095b231-2b0c-4cb0-ac21-6633951bb313" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_c50c22cd-9bbf-49a7-b9c5-080eb5f0845a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d3ded58c-2d61-4619-8433-5de07e7ccff1" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_c50c22cd-9bbf-49a7-b9c5-080eb5f0845a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_10c7dd66-e313-49e8-902b-d0cc9f80d5ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_InterestProceedsDebtSecurities_31080b6d-1309-4214-b705-251043121625" xlink:href="syre-20250331.xsd#syre_InterestProceedsDebtSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_10c7dd66-e313-49e8-902b-d0cc9f80d5ef" xlink:to="loc_syre_InterestProceedsDebtSecurities_31080b6d-1309-4214-b705-251043121625" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_545725c9-0071-4a16-a2fa-7ba247e4f518" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_10c7dd66-e313-49e8-902b-d0cc9f80d5ef" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_545725c9-0071-4a16-a2fa-7ba247e4f518" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0a523e02-4723-4875-98d4-89d77b4edfea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_10c7dd66-e313-49e8-902b-d0cc9f80d5ef" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0a523e02-4723-4875-98d4-89d77b4edfea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherAccountsPayable_49e5c0df-87e8-4615-b777-05121674e2a5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayable"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_10c7dd66-e313-49e8-902b-d0cc9f80d5ef" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherAccountsPayable_49e5c0df-87e8-4615-b777-05121674e2a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_6230ca8a-9a34-4724-9aa2-a213d834f0d9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_10c7dd66-e313-49e8-902b-d0cc9f80d5ef" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_6230ca8a-9a34-4724-9aa2-a213d834f0d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_28278059-d2d7-4178-bc2f-3f5b364f2c7b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_10c7dd66-e313-49e8-902b-d0cc9f80d5ef" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_28278059-d2d7-4178-bc2f-3f5b364f2c7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_f8053e57-7de2-4351-a122-6cd1a8ba3986" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_10c7dd66-e313-49e8-902b-d0cc9f80d5ef" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_f8053e57-7de2-4351-a122-6cd1a8ba3986" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1df80c97-6c86-414a-87b5-573a87d2786b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_10c7dd66-e313-49e8-902b-d0cc9f80d5ef" xlink:to="loc_us-gaap_NetIncomeLoss_1df80c97-6c86-414a-87b5-573a87d2786b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_51c3b232-fc44-46ae-abd9-e16064b8dd33" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_10c7dd66-e313-49e8-902b-d0cc9f80d5ef" xlink:to="loc_us-gaap_ShareBasedCompensation_51c3b232-fc44-46ae-abd9-e16064b8dd33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6f0009fd-7b03-4eb9-af17-a4cff5f7a874" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_470a9164-13e7-4f72-a43b-303b1e57a0cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6f0009fd-7b03-4eb9-af17-a4cff5f7a874" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_470a9164-13e7-4f72-a43b-303b1e57a0cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_a40c5e0d-984d-4def-834d-b80c20f8821c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCash"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6f0009fd-7b03-4eb9-af17-a4cff5f7a874" xlink:to="loc_us-gaap_RestrictedCash_a40c5e0d-984d-4def-834d-b80c20f8821c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9a102802-7cd0-48cb-b080-25b3c8ffac28" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_431776f0-0b45-489b-8d84-57b2c65ecd22" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9a102802-7cd0-48cb-b080-25b3c8ffac28" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_431776f0-0b45-489b-8d84-57b2c65ecd22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_836352fa-f2ee-4667-bf2f-934dba484ca3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9a102802-7cd0-48cb-b080-25b3c8ffac28" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_836352fa-f2ee-4667-bf2f-934dba484ca3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_53694d35-5fa8-4f99-a627-5e481e1f400a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9a102802-7cd0-48cb-b080-25b3c8ffac28" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_53694d35-5fa8-4f99-a627-5e481e1f400a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e6b56b3e-a5c4-4ff8-89bd-f9287e91a2a0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9a102802-7cd0-48cb-b080-25b3c8ffac28" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e6b56b3e-a5c4-4ff8-89bd-f9287e91a2a0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://spyre.com/role/CashEquivalentsandMarketableSecuritiesEstimatedFairValueofCashEquivalentsandMarketableSecuritiesandtheGrossUnrealizedGainsandLossesDetails" xlink:type="simple" xlink:href="syre-20250331.xsd#CashEquivalentsandMarketableSecuritiesEstimatedFairValueofCashEquivalentsandMarketableSecuritiesandtheGrossUnrealizedGainsandLossesDetails"/>
  <link:calculationLink xlink:role="http://spyre.com/role/CashEquivalentsandMarketableSecuritiesEstimatedFairValueofCashEquivalentsandMarketableSecuritiesandtheGrossUnrealizedGainsandLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_4b64358a-f74d-431f-9ab0-b47ce8b1f1c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_CashEquivalentsUnrealizedLosses_b37babae-7c45-4ef8-935a-1764fddbab2a" xlink:href="syre-20250331.xsd#syre_CashEquivalentsUnrealizedLosses"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashEquivalentsAtCarryingValue_4b64358a-f74d-431f-9ab0-b47ce8b1f1c7" xlink:to="loc_syre_CashEquivalentsUnrealizedLosses_b37babae-7c45-4ef8-935a-1764fddbab2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_CashEquivalentsUnrealizedGains_1408ec55-8abe-4200-8c63-ed87878bfd05" xlink:href="syre-20250331.xsd#syre_CashEquivalentsUnrealizedGains"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashEquivalentsAtCarryingValue_4b64358a-f74d-431f-9ab0-b47ce8b1f1c7" xlink:to="loc_syre_CashEquivalentsUnrealizedGains_1408ec55-8abe-4200-8c63-ed87878bfd05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_1bc7cf77-15e7-48fb-9a94-4ef88e13bda9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashEquivalentsAtCarryingValue_4b64358a-f74d-431f-9ab0-b47ce8b1f1c7" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_1bc7cf77-15e7-48fb-9a94-4ef88e13bda9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_fdde0e2e-70c2-4428-95fe-640408eea116" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0a0db442-0fc9-4a58-9dc1-94999d15915f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_fdde0e2e-70c2-4428-95fe-640408eea116" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0a0db442-0fc9-4a58-9dc1-94999d15915f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_9672452f-74c8-41c0-a8ec-75ddc94ee413" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_fdde0e2e-70c2-4428-95fe-640408eea116" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_9672452f-74c8-41c0-a8ec-75ddc94ee413" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_ad4f06a0-50d7-4dae-8842-673bf5e1c09e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_fdde0e2e-70c2-4428-95fe-640408eea116" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_ad4f06a0-50d7-4dae-8842-673bf5e1c09e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://spyre.com/role/CashEquivalentsandMarketableSecuritiesAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="syre-20250331.xsd#CashEquivalentsandMarketableSecuritiesAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails"/>
  <link:calculationLink xlink:role="http://spyre.com/role/CashEquivalentsandMarketableSecuritiesAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_48521e4b-4dd4-450a-be55-8683f6ec3daf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_bf242e96-3787-47fa-9145-93dde9a1cb09" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_48521e4b-4dd4-450a-be55-8683f6ec3daf" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_bf242e96-3787-47fa-9145-93dde9a1cb09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_b3d9fbd0-4eb1-48ea-9fdb-b4afe0a5989f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_48521e4b-4dd4-450a-be55-8683f6ec3daf" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_b3d9fbd0-4eb1-48ea-9fdb-b4afe0a5989f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_a92461a4-4fb6-4daa-90ce-f93c8cf25c50" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_7daccf93-38dd-4805-848b-a28885908d00" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_a92461a4-4fb6-4daa-90ce-f93c8cf25c50" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_7daccf93-38dd-4805-848b-a28885908d00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_231ec504-4e70-4883-98df-d8848354121d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_a92461a4-4fb6-4daa-90ce-f93c8cf25c50" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_231ec504-4e70-4883-98df-d8848354121d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://spyre.com/role/CashEquivalentsandMarketableSecuritiesContractualMaturitiesofMarketableSecuritiesatEstimatedFairValueDetails" xlink:type="simple" xlink:href="syre-20250331.xsd#CashEquivalentsandMarketableSecuritiesContractualMaturitiesofMarketableSecuritiesatEstimatedFairValueDetails"/>
  <link:calculationLink xlink:role="http://spyre.com/role/CashEquivalentsandMarketableSecuritiesContractualMaturitiesofMarketableSecuritiesatEstimatedFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_f97845cf-5433-40c3-98f6-cf961f0f2018" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_4acb3233-2ccd-4551-9b91-e889b0e4619b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_f97845cf-5433-40c3-98f6-cf961f0f2018" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_4acb3233-2ccd-4551-9b91-e889b0e4619b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOne_5db3f9fd-c214-4301-b56c-2b43096608d1" xlink:href="syre-20250331.xsd#syre_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOne"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_f97845cf-5433-40c3-98f6-cf961f0f2018" xlink:to="loc_syre_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOne_5db3f9fd-c214-4301-b56c-2b43096608d1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://spyre.com/role/AccruedandOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="syre-20250331.xsd#AccruedandOtherCurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://spyre.com/role/AccruedandOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_3eb4d783-3d28-4fb5-a91b-9998c2022e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent_192b3daf-367a-4eeb-9085-9d9ca9864fd0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_3eb4d783-3d28-4fb5-a91b-9998c2022e1b" xlink:to="loc_us-gaap_AccruedSalariesCurrent_192b3daf-367a-4eeb-9085-9d9ca9864fd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_AccruedContractedResearchAndDevelopmentCosts_8023d18a-5a3a-46ab-8047-4ad4f10a9729" xlink:href="syre-20250331.xsd#syre_AccruedContractedResearchAndDevelopmentCosts"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_3eb4d783-3d28-4fb5-a91b-9998c2022e1b" xlink:to="loc_syre_AccruedContractedResearchAndDevelopmentCosts_8023d18a-5a3a-46ab-8047-4ad4f10a9729" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_25e1b24a-2383-4d75-a5f6-207bddb3b097" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_3eb4d783-3d28-4fb5-a91b-9998c2022e1b" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_25e1b24a-2383-4d75-a5f6-207bddb3b097" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_b99eda09-841c-4819-84a3-12431717f859" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_3eb4d783-3d28-4fb5-a91b-9998c2022e1b" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_b99eda09-841c-4819-84a3-12431717f859" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://spyre.com/role/SegmentReportingSummaryofSignificantSegmentExpensesDetails" xlink:type="simple" xlink:href="syre-20250331.xsd#SegmentReportingSummaryofSignificantSegmentExpensesDetails"/>
  <link:calculationLink xlink:role="http://spyre.com/role/SegmentReportingSummaryofSignificantSegmentExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b0b64469-ad4b-488a-a2ad-ac8e42c10bc0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_b97b39ee-3694-4413-9543-fea9c1777d37" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_b0b64469-ad4b-488a-a2ad-ac8e42c10bc0" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_b97b39ee-3694-4413-9543-fea9c1777d37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_414dcb6a-8829-4906-81cf-fee72cbe6901" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_b0b64469-ad4b-488a-a2ad-ac8e42c10bc0" xlink:to="loc_us-gaap_ShareBasedCompensation_414dcb6a-8829-4906-81cf-fee72cbe6901" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_5b3490c5-494f-4d5a-ab78-a4bba4a3ac05" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_b0b64469-ad4b-488a-a2ad-ac8e42c10bc0" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_5b3490c5-494f-4d5a-ab78-a4bba4a3ac05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold_39004ab8-4396-4528-8742-4b0d9441198b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_b0b64469-ad4b-488a-a2ad-ac8e42c10bc0" xlink:to="loc_us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold_39004ab8-4396-4528-8742-4b0d9441198b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://spyre.com/role/NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails" xlink:type="simple" xlink:href="syre-20250331.xsd#NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails"/>
  <link:calculationLink xlink:role="http://spyre.com/role/NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_11400f4a-2a4e-43b5-8019-96bb5a5bca17" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_925b21bf-e612-4c40-9b43-34d721f2e16b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_11400f4a-2a4e-43b5-8019-96bb5a5bca17" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_925b21bf-e612-4c40-9b43-34d721f2e16b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_3ee55999-5216-47fb-950c-0c8d92956067" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_11400f4a-2a4e-43b5-8019-96bb5a5bca17" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_3ee55999-5216-47fb-950c-0c8d92956067" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cc94489d-fbd5-479e-ac1c-9acaff0ca861" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_23bd9caa-c4b2-444a-895b-64ffa2703b74" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cc94489d-fbd5-479e-ac1c-9acaff0ca861" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_23bd9caa-c4b2-444a-895b-64ffa2703b74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_a0fbb0f6-cda4-47b1-ba35-9ca9269c2941" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cc94489d-fbd5-479e-ac1c-9acaff0ca861" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_a0fbb0f6-cda4-47b1-ba35-9ca9269c2941" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>syre-20250331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:00f29609-870c-422a-b8be-61cf7b074069,g:31b3bfa9-c84d-47fe-82f5-b77ff3f965cb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://spyre.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="syre-20250331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:definitionLink xlink:role="http://spyre.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_355e7a7c-6823-47f6-9bb0-0cda17d69f09" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ab639c28-81fa-4244-95cb-33d22e3b572f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_355e7a7c-6823-47f6-9bb0-0cda17d69f09" xlink:to="loc_us-gaap_StatementTable_ab639c28-81fa-4244-95cb-33d22e3b572f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_033fb7f8-fa7a-4990-a106-ddf377539715" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_ab639c28-81fa-4244-95cb-33d22e3b572f" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_033fb7f8-fa7a-4990-a106-ddf377539715" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_033fb7f8-fa7a-4990-a106-ddf377539715_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_033fb7f8-fa7a-4990-a106-ddf377539715" xlink:to="loc_us-gaap_RelatedPartyDomain_033fb7f8-fa7a-4990-a106-ddf377539715_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_9813fa79-f850-49d3-aadb-39acc7dc9472" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_033fb7f8-fa7a-4990-a106-ddf377539715" xlink:to="loc_us-gaap_RelatedPartyDomain_9813fa79-f850-49d3-aadb-39acc7dc9472" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_d39cb380-9518-4b94-839b-8dfa081c6e83" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_9813fa79-f850-49d3-aadb-39acc7dc9472" xlink:to="loc_us-gaap_RelatedPartyMember_d39cb380-9518-4b94-839b-8dfa081c6e83" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrelatedPartyMember_e5947c75-3362-4d2d-a595-5572060860a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonrelatedPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_9813fa79-f850-49d3-aadb-39acc7dc9472" xlink:to="loc_us-gaap_NonrelatedPartyMember_e5947c75-3362-4d2d-a595-5572060860a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_fe614276-d335-40a0-8bea-0c9b6c1cac90" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_ab639c28-81fa-4244-95cb-33d22e3b572f" xlink:to="loc_us-gaap_StatementClassOfStockAxis_fe614276-d335-40a0-8bea-0c9b6c1cac90" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_fe614276-d335-40a0-8bea-0c9b6c1cac90_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_fe614276-d335-40a0-8bea-0c9b6c1cac90" xlink:to="loc_us-gaap_ClassOfStockDomain_fe614276-d335-40a0-8bea-0c9b6c1cac90_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_3a3d0dee-e4c0-47e8-a472-06aeb09f6f43" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_fe614276-d335-40a0-8bea-0c9b6c1cac90" xlink:to="loc_us-gaap_ClassOfStockDomain_3a3d0dee-e4c0-47e8-a472-06aeb09f6f43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SeriesANonVotingConvertiblePreferredStockMember_a6a8c7f5-af9e-4c7e-a397-707d692a33e0" xlink:href="syre-20250331.xsd#syre_SeriesANonVotingConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3a3d0dee-e4c0-47e8-a472-06aeb09f6f43" xlink:to="loc_syre_SeriesANonVotingConvertiblePreferredStockMember_a6a8c7f5-af9e-4c7e-a397-707d692a33e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SeriesBNonVotingConvertiblePreferredStockMember_92713604-e9f6-4f52-b52b-685a8a9dd14d" xlink:href="syre-20250331.xsd#syre_SeriesBNonVotingConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3a3d0dee-e4c0-47e8-a472-06aeb09f6f43" xlink:to="loc_syre_SeriesBNonVotingConvertiblePreferredStockMember_92713604-e9f6-4f52-b52b-685a8a9dd14d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_PreferredStockExcludingSeriesAAndBNonVotingConvertiblePreferredStockMember_91f1e491-c0a0-4c56-847f-61a9e029b78e" xlink:href="syre-20250331.xsd#syre_PreferredStockExcludingSeriesAAndBNonVotingConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3a3d0dee-e4c0-47e8-a472-06aeb09f6f43" xlink:to="loc_syre_PreferredStockExcludingSeriesAAndBNonVotingConvertiblePreferredStockMember_91f1e491-c0a0-4c56-847f-61a9e029b78e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_f58ecdde-99a4-4e25-938a-b1c19220219c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_355e7a7c-6823-47f6-9bb0-0cda17d69f09" xlink:to="loc_us-gaap_AssetsAbstract_f58ecdde-99a4-4e25-938a-b1c19220219c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_7827970d-8347-4c0c-a29d-1cc763759507" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_f58ecdde-99a4-4e25-938a-b1c19220219c" xlink:to="loc_us-gaap_AssetsCurrentAbstract_7827970d-8347-4c0c-a29d-1cc763759507" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6ece282e-ded1-49df-a0a1-007588241cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7827970d-8347-4c0c-a29d-1cc763759507" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6ece282e-ded1-49df-a0a1-007588241cf8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_79daa0c6-5980-423b-9b05-3cd4cdfc532a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7827970d-8347-4c0c-a29d-1cc763759507" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_79daa0c6-5980-423b-9b05-3cd4cdfc532a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_df03b08f-e730-44ea-a8b2-e1fbbd02511b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7827970d-8347-4c0c-a29d-1cc763759507" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_df03b08f-e730-44ea-a8b2-e1fbbd02511b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3514349d-3b94-4d44-b497-a4799eb235bb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7827970d-8347-4c0c-a29d-1cc763759507" xlink:to="loc_us-gaap_AssetsCurrent_3514349d-3b94-4d44-b497-a4799eb235bb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_3d6ae967-28a2-4b2d-9ced-016ea9db1507" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_f58ecdde-99a4-4e25-938a-b1c19220219c" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_3d6ae967-28a2-4b2d-9ced-016ea9db1507" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_9e5b5bd4-82bf-4717-a97d-19432e366f7e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_f58ecdde-99a4-4e25-938a-b1c19220219c" xlink:to="loc_us-gaap_Assets_9e5b5bd4-82bf-4717-a97d-19432e366f7e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4477719a-173a-427c-aced-de480e699b84" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_355e7a7c-6823-47f6-9bb0-0cda17d69f09" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4477719a-173a-427c-aced-de480e699b84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_c99e87b8-fa19-4531-bfa6-4a50764f65bc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4477719a-173a-427c-aced-de480e699b84" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_c99e87b8-fa19-4531-bfa6-4a50764f65bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_d4a31228-8f05-4692-9f2e-5f237489df69" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c99e87b8-fa19-4531-bfa6-4a50764f65bc" xlink:to="loc_us-gaap_AccountsPayableCurrent_d4a31228-8f05-4692-9f2e-5f237489df69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_00f706e4-5596-4a52-84ea-1feb76f20211" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c99e87b8-fa19-4531-bfa6-4a50764f65bc" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_00f706e4-5596-4a52-84ea-1feb76f20211" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_76ac749d-c275-41c5-8372-21b895676895" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c99e87b8-fa19-4531-bfa6-4a50764f65bc" xlink:to="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_76ac749d-c275-41c5-8372-21b895676895" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_8a595a27-7220-44df-92bb-dd616bfaee9b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c99e87b8-fa19-4531-bfa6-4a50764f65bc" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_8a595a27-7220-44df-92bb-dd616bfaee9b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_bfedece4-2069-4410-b8cd-9cd91a4016c9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c99e87b8-fa19-4531-bfa6-4a50764f65bc" xlink:to="loc_us-gaap_LiabilitiesCurrent_bfedece4-2069-4410-b8cd-9cd91a4016c9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent_e7d8c1e2-9868-40e7-ac14-082aec1bcd65" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4477719a-173a-427c-aced-de480e699b84" xlink:to="loc_us-gaap_DerivativeLiabilitiesNoncurrent_e7d8c1e2-9868-40e7-ac14-082aec1bcd65" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_38c1bcb3-d4c9-47fc-befb-ac12810b0e1d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4477719a-173a-427c-aced-de480e699b84" xlink:to="loc_us-gaap_Liabilities_38c1bcb3-d4c9-47fc-befb-ac12810b0e1d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_a6d367e0-6b3c-4be4-825d-48290a3d773b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4477719a-173a-427c-aced-de480e699b84" xlink:to="loc_us-gaap_CommitmentsAndContingencies_a6d367e0-6b3c-4be4-825d-48290a3d773b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_1c00983b-79bc-41d4-803b-3b80328e62ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4477719a-173a-427c-aced-de480e699b84" xlink:to="loc_us-gaap_StockholdersEquityAbstract_1c00983b-79bc-41d4-803b-3b80328e62ba" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_b49680eb-bc8d-43bf-bfbf-a59ad6742f7c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1c00983b-79bc-41d4-803b-3b80328e62ba" xlink:to="loc_us-gaap_PreferredStockValue_b49680eb-bc8d-43bf-bfbf-a59ad6742f7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_17e7be81-8aff-4cb8-8aa1-b81fe8bda99d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1c00983b-79bc-41d4-803b-3b80328e62ba" xlink:to="loc_us-gaap_CommonStockValue_17e7be81-8aff-4cb8-8aa1-b81fe8bda99d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_34289178-7170-4684-ac6b-2b8cb32ecfb0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1c00983b-79bc-41d4-803b-3b80328e62ba" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_34289178-7170-4684-ac6b-2b8cb32ecfb0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_31e2ae97-3d63-4887-8852-879ee967225b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1c00983b-79bc-41d4-803b-3b80328e62ba" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_31e2ae97-3d63-4887-8852-879ee967225b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_0a9ef4ef-8bb6-4728-8b99-ab9b0a22a323" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1c00983b-79bc-41d4-803b-3b80328e62ba" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_0a9ef4ef-8bb6-4728-8b99-ab9b0a22a323" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e7f2d602-fbce-4a3f-a1bb-7febe353bf9f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1c00983b-79bc-41d4-803b-3b80328e62ba" xlink:to="loc_us-gaap_StockholdersEquity_e7f2d602-fbce-4a3f-a1bb-7febe353bf9f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_dd2e5003-ce2e-42bf-b772-4d8a3f2df370" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4477719a-173a-427c-aced-de480e699b84" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_dd2e5003-ce2e-42bf-b772-4d8a3f2df370" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://spyre.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="syre-20250331.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:definitionLink xlink:role="http://spyre.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_bde6a39a-7280-4d03-aacd-3b864e9de3f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_c4a297d3-f1e7-45ec-8a9f-6ea527a497f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_bde6a39a-7280-4d03-aacd-3b864e9de3f0" xlink:to="loc_us-gaap_StatementTable_c4a297d3-f1e7-45ec-8a9f-6ea527a497f4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_268e283d-1cd1-4bdf-9cb5-9c03624efc4f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_c4a297d3-f1e7-45ec-8a9f-6ea527a497f4" xlink:to="loc_us-gaap_StatementClassOfStockAxis_268e283d-1cd1-4bdf-9cb5-9c03624efc4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_268e283d-1cd1-4bdf-9cb5-9c03624efc4f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_268e283d-1cd1-4bdf-9cb5-9c03624efc4f" xlink:to="loc_us-gaap_ClassOfStockDomain_268e283d-1cd1-4bdf-9cb5-9c03624efc4f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_df3b7eca-6243-4ce7-b961-2ac37ed9ccad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_268e283d-1cd1-4bdf-9cb5-9c03624efc4f" xlink:to="loc_us-gaap_ClassOfStockDomain_df3b7eca-6243-4ce7-b961-2ac37ed9ccad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SeriesANonVotingConvertiblePreferredStockMember_a8f2f07b-f5d6-4681-9568-b603dbc2c3f9" xlink:href="syre-20250331.xsd#syre_SeriesANonVotingConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_df3b7eca-6243-4ce7-b961-2ac37ed9ccad" xlink:to="loc_syre_SeriesANonVotingConvertiblePreferredStockMember_a8f2f07b-f5d6-4681-9568-b603dbc2c3f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SeriesBNonVotingConvertiblePreferredStockMember_2841807f-8fb4-49ba-b560-ed1a14dc9b7f" xlink:href="syre-20250331.xsd#syre_SeriesBNonVotingConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_df3b7eca-6243-4ce7-b961-2ac37ed9ccad" xlink:to="loc_syre_SeriesBNonVotingConvertiblePreferredStockMember_2841807f-8fb4-49ba-b560-ed1a14dc9b7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_PreferredStockExcludingSeriesAAndBNonVotingConvertiblePreferredStockMember_590193af-2bfe-4874-b203-ab542ef8828f" xlink:href="syre-20250331.xsd#syre_PreferredStockExcludingSeriesAAndBNonVotingConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_df3b7eca-6243-4ce7-b961-2ac37ed9ccad" xlink:to="loc_syre_PreferredStockExcludingSeriesAAndBNonVotingConvertiblePreferredStockMember_590193af-2bfe-4874-b203-ab542ef8828f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_f141d69e-922c-4998-836a-d7791cb66767" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bde6a39a-7280-4d03-aacd-3b864e9de3f0" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_f141d69e-922c-4998-836a-d7791cb66767" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_947ddf35-6dc3-48f0-8996-e587bd373a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bde6a39a-7280-4d03-aacd-3b864e9de3f0" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_947ddf35-6dc3-48f0-8996-e587bd373a7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_4ed328d4-ec84-4fde-b197-ff7ea9e2f056" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bde6a39a-7280-4d03-aacd-3b864e9de3f0" xlink:to="loc_us-gaap_PreferredStockSharesIssued_4ed328d4-ec84-4fde-b197-ff7ea9e2f056" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_39e7baf2-3f36-4be0-9c13-980d7236bd7a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bde6a39a-7280-4d03-aacd-3b864e9de3f0" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_39e7baf2-3f36-4be0-9c13-980d7236bd7a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_92b9e734-b79a-4e55-9e5a-29a0c9421f0e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bde6a39a-7280-4d03-aacd-3b864e9de3f0" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_92b9e734-b79a-4e55-9e5a-29a0c9421f0e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_42937dcc-d6cf-4d03-b6d9-06fa97360b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bde6a39a-7280-4d03-aacd-3b864e9de3f0" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_42937dcc-d6cf-4d03-b6d9-06fa97360b2b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_15dd4f0c-59d7-4dd3-b8c6-947854822381" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bde6a39a-7280-4d03-aacd-3b864e9de3f0" xlink:to="loc_us-gaap_CommonStockSharesIssued_15dd4f0c-59d7-4dd3-b8c6-947854822381" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_612907e9-6cd1-4860-8087-86d75df5a43b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bde6a39a-7280-4d03-aacd-3b864e9de3f0" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_612907e9-6cd1-4860-8087-86d75df5a43b" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://spyre.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="syre-20250331.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:definitionLink xlink:role="http://spyre.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b7327ba1-93d3-4357-a08a-38dd75578c3c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_8091966a-6704-44d3-9d27-c6fc438077aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_b7327ba1-93d3-4357-a08a-38dd75578c3c" xlink:to="loc_us-gaap_StatementTable_8091966a-6704-44d3-9d27-c6fc438077aa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_cac8a679-b60e-4d23-972d-e58c4eb10d20" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_8091966a-6704-44d3-9d27-c6fc438077aa" xlink:to="loc_us-gaap_StatementClassOfStockAxis_cac8a679-b60e-4d23-972d-e58c4eb10d20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_cac8a679-b60e-4d23-972d-e58c4eb10d20_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_cac8a679-b60e-4d23-972d-e58c4eb10d20" xlink:to="loc_us-gaap_ClassOfStockDomain_cac8a679-b60e-4d23-972d-e58c4eb10d20_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_9024cc06-5a5d-4ef7-84cd-6d2e38e071df" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_cac8a679-b60e-4d23-972d-e58c4eb10d20" xlink:to="loc_us-gaap_ClassOfStockDomain_9024cc06-5a5d-4ef7-84cd-6d2e38e071df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SeriesANonVotingConvertiblePreferredStockMember_69869b63-3407-478e-b7b9-cbbb93bf9177" xlink:href="syre-20250331.xsd#syre_SeriesANonVotingConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_9024cc06-5a5d-4ef7-84cd-6d2e38e071df" xlink:to="loc_syre_SeriesANonVotingConvertiblePreferredStockMember_69869b63-3407-478e-b7b9-cbbb93bf9177" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SeriesBNonVotingConvertiblePreferredStockMember_2c5da0df-c34a-4ae9-a45a-508c9cd7e301" xlink:href="syre-20250331.xsd#syre_SeriesBNonVotingConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_9024cc06-5a5d-4ef7-84cd-6d2e38e071df" xlink:to="loc_syre_SeriesBNonVotingConvertiblePreferredStockMember_2c5da0df-c34a-4ae9-a45a-508c9cd7e301" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_b8504131-359a-4c28-8d31-5de2c1539013" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_9024cc06-5a5d-4ef7-84cd-6d2e38e071df" xlink:to="loc_us-gaap_CommonStockMember_b8504131-359a-4c28-8d31-5de2c1539013" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_130de1ba-0b63-4f16-9eaf-a252bfef2d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_8091966a-6704-44d3-9d27-c6fc438077aa" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_130de1ba-0b63-4f16-9eaf-a252bfef2d4a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_130de1ba-0b63-4f16-9eaf-a252bfef2d4a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_130de1ba-0b63-4f16-9eaf-a252bfef2d4a" xlink:to="loc_us-gaap_RelatedPartyDomain_130de1ba-0b63-4f16-9eaf-a252bfef2d4a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_af005428-ec3a-401e-9d05-a3b22531da7a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_130de1ba-0b63-4f16-9eaf-a252bfef2d4a" xlink:to="loc_us-gaap_RelatedPartyDomain_af005428-ec3a-401e-9d05-a3b22531da7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_cc63819a-d144-4daf-8355-79c2830feafb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_af005428-ec3a-401e-9d05-a3b22531da7a" xlink:to="loc_us-gaap_RelatedPartyMember_cc63819a-d144-4daf-8355-79c2830feafb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_7382ba0c-0748-4298-84af-26cf055d99f1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b7327ba1-93d3-4357-a08a-38dd75578c3c" xlink:to="loc_us-gaap_OperatingExpensesAbstract_7382ba0c-0748-4298-84af-26cf055d99f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_6ae8e036-15d6-45b3-8b95-3e4d4f81b844" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7382ba0c-0748-4298-84af-26cf055d99f1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_6ae8e036-15d6-45b3-8b95-3e4d4f81b844" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_ac9247d1-4a41-4746-a920-9130a3c4416b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7382ba0c-0748-4298-84af-26cf055d99f1" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_ac9247d1-4a41-4746-a920-9130a3c4416b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_ca437523-ad0a-4c71-9941-8a35a54d54ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7382ba0c-0748-4298-84af-26cf055d99f1" xlink:to="loc_us-gaap_OperatingExpenses_ca437523-ad0a-4c71-9941-8a35a54d54ce" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_055801cf-4c2b-4275-80a1-f8dbbbbdb141" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b7327ba1-93d3-4357-a08a-38dd75578c3c" xlink:to="loc_us-gaap_OperatingIncomeLoss_055801cf-4c2b-4275-80a1-f8dbbbbdb141" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9ecab2a3-c26f-48ec-b22e-72e5628be8e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b7327ba1-93d3-4357-a08a-38dd75578c3c" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9ecab2a3-c26f-48ec-b22e-72e5628be8e7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_6f3fc839-9a62-4d68-8187-3a3f29a1faac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9ecab2a3-c26f-48ec-b22e-72e5628be8e7" xlink:to="loc_us-gaap_InvestmentIncomeNet_6f3fc839-9a62-4d68-8187-3a3f29a1faac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_da5354b0-f08b-4439-8a43-2796b84ac059" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9ecab2a3-c26f-48ec-b22e-72e5628be8e7" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_da5354b0-f08b-4439-8a43-2796b84ac059" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_5a12cb8b-e2fd-4d2b-9050-59eb1edd3c92" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9ecab2a3-c26f-48ec-b22e-72e5628be8e7" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_5a12cb8b-e2fd-4d2b-9050-59eb1edd3c92" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f27edd2f-8f68-4168-b32c-32de11d38693" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b7327ba1-93d3-4357-a08a-38dd75578c3c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f27edd2f-8f68-4168-b32c-32de11d38693" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_646af020-a5e9-4c2d-a49c-ac48c3c30a21" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b7327ba1-93d3-4357-a08a-38dd75578c3c" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_646af020-a5e9-4c2d-a49c-ac48c3c30a21" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d4d667c0-6c55-4e95-a2e1-7e69de541419" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b7327ba1-93d3-4357-a08a-38dd75578c3c" xlink:to="loc_us-gaap_NetIncomeLoss_d4d667c0-6c55-4e95-a2e1-7e69de541419" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_fadfc290-9ab2-48aa-a10c-7046f99b1e2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b7327ba1-93d3-4357-a08a-38dd75578c3c" xlink:to="loc_us-gaap_EarningsPerShareBasic_fadfc290-9ab2-48aa-a10c-7046f99b1e2f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_2f410c0f-e9e0-4ead-8cb0-d50d9d61a34f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b7327ba1-93d3-4357-a08a-38dd75578c3c" xlink:to="loc_us-gaap_EarningsPerShareDiluted_2f410c0f-e9e0-4ead-8cb0-d50d9d61a34f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_26aaf676-be77-4893-b1af-d175f0d8a36d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b7327ba1-93d3-4357-a08a-38dd75578c3c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_26aaf676-be77-4893-b1af-d175f0d8a36d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f6dc6b2a-304c-4bc8-bb6f-93b16ac8a4be" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b7327ba1-93d3-4357-a08a-38dd75578c3c" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f6dc6b2a-304c-4bc8-bb6f-93b16ac8a4be" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://spyre.com/role/CondensedConsolidatedStatementsofOperationsParenthetical" xlink:type="simple" xlink:href="syre-20250331.xsd#CondensedConsolidatedStatementsofOperationsParenthetical"/>
  <link:definitionLink xlink:role="http://spyre.com/role/CondensedConsolidatedStatementsofOperationsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5694b7c1-b50b-4b24-b49c-62195b7e3ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_840fc961-88f4-4a37-b077-54f7f8743cc1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_5694b7c1-b50b-4b24-b49c-62195b7e3ce2" xlink:to="loc_us-gaap_StatementTable_840fc961-88f4-4a37-b077-54f7f8743cc1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5c006855-25cf-4e56-9d02-06f2be3b35b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_840fc961-88f4-4a37-b077-54f7f8743cc1" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5c006855-25cf-4e56-9d02-06f2be3b35b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_5c006855-25cf-4e56-9d02-06f2be3b35b5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5c006855-25cf-4e56-9d02-06f2be3b35b5" xlink:to="loc_us-gaap_RelatedPartyDomain_5c006855-25cf-4e56-9d02-06f2be3b35b5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_0bda7699-1fe1-4e6a-800c-622d5b9fcfc2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5c006855-25cf-4e56-9d02-06f2be3b35b5" xlink:to="loc_us-gaap_RelatedPartyDomain_0bda7699-1fe1-4e6a-800c-622d5b9fcfc2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_c5827515-3a5b-4df3-bfa0-451a1915af02" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_0bda7699-1fe1-4e6a-800c-622d5b9fcfc2" xlink:to="loc_us-gaap_RelatedPartyMember_c5827515-3a5b-4df3-bfa0-451a1915af02" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_4d283685-377d-4d23-ad65-ca6c260b741f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_840fc961-88f4-4a37-b077-54f7f8743cc1" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_4d283685-377d-4d23-ad65-ca6c260b741f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_4d283685-377d-4d23-ad65-ca6c260b741f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_4d283685-377d-4d23-ad65-ca6c260b741f" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_4d283685-377d-4d23-ad65-ca6c260b741f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_43b06e7c-bf79-4968-a183-e6e1b93a00b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_4d283685-377d-4d23-ad65-ca6c260b741f" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_43b06e7c-bf79-4968-a183-e6e1b93a00b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_8d71cde5-8572-4d84-a210-cac3183612c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_43b06e7c-bf79-4968-a183-e6e1b93a00b6" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_8d71cde5-8572-4d84-a210-cac3183612c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_a5aa48a0-c243-42ef-909c-d81903d2cabd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_43b06e7c-bf79-4968-a183-e6e1b93a00b6" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_a5aa48a0-c243-42ef-909c-d81903d2cabd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_e90db06b-3c1b-4211-87d8-8d7d44d04cfd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5694b7c1-b50b-4b24-b49c-62195b7e3ce2" xlink:to="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_e90db06b-3c1b-4211-87d8-8d7d44d04cfd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://spyre.com/role/CondensedConsolidatedStatementsofChangesinConvertiblePreferredStockandStockholdersEquity" xlink:type="simple" xlink:href="syre-20250331.xsd#CondensedConsolidatedStatementsofChangesinConvertiblePreferredStockandStockholdersEquity"/>
  <link:definitionLink xlink:role="http://spyre.com/role/CondensedConsolidatedStatementsofChangesinConvertiblePreferredStockandStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_7048e6d0-dcb6-4fbf-9fda-c5e2970e27b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2deb3d74-3c8b-49f1-9cd5-79a3d699a90d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_7048e6d0-dcb6-4fbf-9fda-c5e2970e27b6" xlink:to="loc_us-gaap_StatementTable_2deb3d74-3c8b-49f1-9cd5-79a3d699a90d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d48209f6-bcc7-4cbe-a4fe-f8a292f43f06" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2deb3d74-3c8b-49f1-9cd5-79a3d699a90d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d48209f6-bcc7-4cbe-a4fe-f8a292f43f06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d48209f6-bcc7-4cbe-a4fe-f8a292f43f06_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d48209f6-bcc7-4cbe-a4fe-f8a292f43f06" xlink:to="loc_us-gaap_EquityComponentDomain_d48209f6-bcc7-4cbe-a4fe-f8a292f43f06_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8a297ec5-c92d-44b5-a365-6bdd739cf936" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d48209f6-bcc7-4cbe-a4fe-f8a292f43f06" xlink:to="loc_us-gaap_EquityComponentDomain_8a297ec5-c92d-44b5-a365-6bdd739cf936" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_ec21641f-a3e8-4316-ac46-d324eac0fcd3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8a297ec5-c92d-44b5-a365-6bdd739cf936" xlink:to="loc_us-gaap_PreferredStockMember_ec21641f-a3e8-4316-ac46-d324eac0fcd3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_60aa7736-dc04-4e73-b243-6476a4caefaa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8a297ec5-c92d-44b5-a365-6bdd739cf936" xlink:to="loc_us-gaap_CommonStockMember_60aa7736-dc04-4e73-b243-6476a4caefaa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_22d8519a-9e1d-40ad-8397-3e92ca20f4e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8a297ec5-c92d-44b5-a365-6bdd739cf936" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_22d8519a-9e1d-40ad-8397-3e92ca20f4e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_61bb57b7-42f3-4b11-8217-2821573b3b30" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8a297ec5-c92d-44b5-a365-6bdd739cf936" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_61bb57b7-42f3-4b11-8217-2821573b3b30" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_79eb45a4-7d8e-45c1-bc68-25aa25b1e7fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8a297ec5-c92d-44b5-a365-6bdd739cf936" xlink:to="loc_us-gaap_RetainedEarningsMember_79eb45a4-7d8e-45c1-bc68-25aa25b1e7fd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_a527197b-a071-4f26-8332-36337cce6d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2deb3d74-3c8b-49f1-9cd5-79a3d699a90d" xlink:to="loc_us-gaap_StatementClassOfStockAxis_a527197b-a071-4f26-8332-36337cce6d2b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a527197b-a071-4f26-8332-36337cce6d2b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a527197b-a071-4f26-8332-36337cce6d2b" xlink:to="loc_us-gaap_ClassOfStockDomain_a527197b-a071-4f26-8332-36337cce6d2b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f0753bfe-d6d7-449c-8994-d1c86ab5c68f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a527197b-a071-4f26-8332-36337cce6d2b" xlink:to="loc_us-gaap_ClassOfStockDomain_f0753bfe-d6d7-449c-8994-d1c86ab5c68f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SeriesANonVotingConvertiblePreferredStockMember_cc492604-9ebb-4793-8253-95aded4da0c1" xlink:href="syre-20250331.xsd#syre_SeriesANonVotingConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_f0753bfe-d6d7-449c-8994-d1c86ab5c68f" xlink:to="loc_syre_SeriesANonVotingConvertiblePreferredStockMember_cc492604-9ebb-4793-8253-95aded4da0c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SeriesBNonVotingConvertiblePreferredStockMember_71e29110-1f1c-47f5-92de-c5743467c6c0" xlink:href="syre-20250331.xsd#syre_SeriesBNonVotingConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_f0753bfe-d6d7-449c-8994-d1c86ab5c68f" xlink:to="loc_syre_SeriesBNonVotingConvertiblePreferredStockMember_71e29110-1f1c-47f5-92de-c5743467c6c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_704a39cc-f8c1-4977-bf4f-e051759c2778" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7048e6d0-dcb6-4fbf-9fda-c5e2970e27b6" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_704a39cc-f8c1-4977-bf4f-e051759c2778" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_dcabf33e-90ce-41fa-9239-65465236440c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_704a39cc-f8c1-4977-bf4f-e051759c2778" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_dcabf33e-90ce-41fa-9239-65465236440c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_05536040-2d4d-477a-89b9-a3772241305d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_704a39cc-f8c1-4977-bf4f-e051759c2778" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_05536040-2d4d-477a-89b9-a3772241305d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_89cf7ef0-97e7-438a-bddf-396a0cfb2053" xlink:href="syre-20250331.xsd#syre_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_704a39cc-f8c1-4977-bf4f-e051759c2778" xlink:to="loc_syre_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_89cf7ef0-97e7-438a-bddf-396a0cfb2053" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_64afc06b-b499-444d-bacc-4afa73415f15" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_704a39cc-f8c1-4977-bf4f-e051759c2778" xlink:to="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_64afc06b-b499-444d-bacc-4afa73415f15" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_11106c8a-2d7a-4962-a096-c731d6309641" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_47b45851-049e-4e37-9b20-b978936533e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4340884f-2678-4a37-80d4-6f47b49d629a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7048e6d0-dcb6-4fbf-9fda-c5e2970e27b6" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4340884f-2678-4a37-80d4-6f47b49d629a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_1302cceb-73a1-40fe-9b79-0ba16462576f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4340884f-2678-4a37-80d4-6f47b49d629a" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_1302cceb-73a1-40fe-9b79-0ba16462576f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ddd00b90-7206-4c78-b0c1-a8f55b5baf7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4340884f-2678-4a37-80d4-6f47b49d629a" xlink:to="loc_us-gaap_StockholdersEquity_ddd00b90-7206-4c78-b0c1-a8f55b5baf7d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_ef811386-0f6c-4de1-99cb-c24429206a84" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4340884f-2678-4a37-80d4-6f47b49d629a" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_ef811386-0f6c-4de1-99cb-c24429206a84" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_StockIssuedDuringPeriodSharesOptionsExercisedAndEmployeeStockOwnershipPlan_ae7f569d-cbf5-4166-aa28-35b02869583e" xlink:href="syre-20250331.xsd#syre_StockIssuedDuringPeriodSharesOptionsExercisedAndEmployeeStockOwnershipPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4340884f-2678-4a37-80d4-6f47b49d629a" xlink:to="loc_syre_StockIssuedDuringPeriodSharesOptionsExercisedAndEmployeeStockOwnershipPlan_ae7f569d-cbf5-4166-aa28-35b02869583e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_StockIssuedDuringPeriodValueOptionsExercisedAndEmployeeStockOwnershipPlan_0edddc0f-618d-4d22-a577-68a362ff0e90" xlink:href="syre-20250331.xsd#syre_StockIssuedDuringPeriodValueOptionsExercisedAndEmployeeStockOwnershipPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4340884f-2678-4a37-80d4-6f47b49d629a" xlink:to="loc_syre_StockIssuedDuringPeriodValueOptionsExercisedAndEmployeeStockOwnershipPlan_0edddc0f-618d-4d22-a577-68a362ff0e90" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_4cadbe39-1463-41b0-b704-cd78405ef743" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4340884f-2678-4a37-80d4-6f47b49d629a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_4cadbe39-1463-41b0-b704-cd78405ef743" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ShareBasedPaymentArrangementSettlementOptionsCash_31fea1a3-db85-40b0-9a6c-e744f1aa992e" xlink:href="syre-20250331.xsd#syre_ShareBasedPaymentArrangementSettlementOptionsCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4340884f-2678-4a37-80d4-6f47b49d629a" xlink:to="loc_syre_ShareBasedPaymentArrangementSettlementOptionsCash_31fea1a3-db85-40b0-9a6c-e744f1aa992e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_f20a0f62-2030-49f5-894e-77fb594896da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4340884f-2678-4a37-80d4-6f47b49d629a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_f20a0f62-2030-49f5-894e-77fb594896da" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2b7e2351-66cc-4ae7-8b5a-fd30ed9e6221" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4340884f-2678-4a37-80d4-6f47b49d629a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2b7e2351-66cc-4ae7-8b5a-fd30ed9e6221" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3b3aaea1-1819-45d4-9e78-5d5f30ef3643" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4340884f-2678-4a37-80d4-6f47b49d629a" xlink:to="loc_us-gaap_NetIncomeLoss_3b3aaea1-1819-45d4-9e78-5d5f30ef3643" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_dd897e5d-e99c-470e-b276-339b5b56f78c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4cc2d205-4cdb-4539-b7cc-bb08504a7479" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_4c22a569-1055-4d9e-812a-4d5a2e57f27e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://spyre.com/role/TheCompanyandBasisofPresentationDetails" xlink:type="simple" xlink:href="syre-20250331.xsd#TheCompanyandBasisofPresentationDetails"/>
  <link:definitionLink xlink:role="http://spyre.com/role/TheCompanyandBasisofPresentationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_syre_CompanyAndBasisOfPresentationLineItems_a567ca30-df4d-465b-b131-53e48ff2f6d5" xlink:href="syre-20250331.xsd#syre_CompanyAndBasisOfPresentationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_CompanyAndBasisOfPresentationTable_0e7c0225-fe6b-4318-8e58-ecbe46576a86" xlink:href="syre-20250331.xsd#syre_CompanyAndBasisOfPresentationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_syre_CompanyAndBasisOfPresentationLineItems_a567ca30-df4d-465b-b131-53e48ff2f6d5" xlink:to="loc_syre_CompanyAndBasisOfPresentationTable_0e7c0225-fe6b-4318-8e58-ecbe46576a86" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_a17d6c56-4a70-4c74-b6e2-7cdfe5b05c15" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_syre_CompanyAndBasisOfPresentationTable_0e7c0225-fe6b-4318-8e58-ecbe46576a86" xlink:to="loc_us-gaap_AssetAcquisitionAxis_a17d6c56-4a70-4c74-b6e2-7cdfe5b05c15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_a17d6c56-4a70-4c74-b6e2-7cdfe5b05c15_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AssetAcquisitionAxis_a17d6c56-4a70-4c74-b6e2-7cdfe5b05c15" xlink:to="loc_us-gaap_AssetAcquisitionDomain_a17d6c56-4a70-4c74-b6e2-7cdfe5b05c15_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_5e7ffd0c-aaff-4a98-a6fa-74d2289a1bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AssetAcquisitionAxis_a17d6c56-4a70-4c74-b6e2-7cdfe5b05c15" xlink:to="loc_us-gaap_AssetAcquisitionDomain_5e7ffd0c-aaff-4a98-a6fa-74d2289a1bf9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SpyreTherapeuticsIncMember_87dbb632-1064-4a76-af0a-29b695e8260d" xlink:href="syre-20250331.xsd#syre_SpyreTherapeuticsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_5e7ffd0c-aaff-4a98-a6fa-74d2289a1bf9" xlink:to="loc_syre_SpyreTherapeuticsIncMember_87dbb632-1064-4a76-af0a-29b695e8260d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_AssetAcquisitionMember_cf7133ab-52ba-4261-9978-f58ac240dcf9" xlink:href="syre-20250331.xsd#syre_AssetAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_5e7ffd0c-aaff-4a98-a6fa-74d2289a1bf9" xlink:to="loc_syre_AssetAcquisitionMember_cf7133ab-52ba-4261-9978-f58ac240dcf9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_c51f2db9-b908-40f4-b41e-ab6e7010c396" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_syre_CompanyAndBasisOfPresentationTable_0e7c0225-fe6b-4318-8e58-ecbe46576a86" xlink:to="loc_us-gaap_StatementClassOfStockAxis_c51f2db9-b908-40f4-b41e-ab6e7010c396" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_c51f2db9-b908-40f4-b41e-ab6e7010c396_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_c51f2db9-b908-40f4-b41e-ab6e7010c396" xlink:to="loc_us-gaap_ClassOfStockDomain_c51f2db9-b908-40f4-b41e-ab6e7010c396_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_e0bd3be9-98df-4ad8-b469-218770ce8c5a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_c51f2db9-b908-40f4-b41e-ab6e7010c396" xlink:to="loc_us-gaap_ClassOfStockDomain_e0bd3be9-98df-4ad8-b469-218770ce8c5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_CommonStockAndSeriesBNonVotingConvertiblePreferredStockMember_d9b6e1de-6a9b-4bf1-a78e-86e6a48e6667" xlink:href="syre-20250331.xsd#syre_CommonStockAndSeriesBNonVotingConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e0bd3be9-98df-4ad8-b469-218770ce8c5a" xlink:to="loc_syre_CommonStockAndSeriesBNonVotingConvertiblePreferredStockMember_d9b6e1de-6a9b-4bf1-a78e-86e6a48e6667" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SeriesBNonVotingConvertiblePreferredStockMember_e709b792-4a2f-48d2-9e01-fbef421b2aa2" xlink:href="syre-20250331.xsd#syre_SeriesBNonVotingConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e0bd3be9-98df-4ad8-b469-218770ce8c5a" xlink:to="loc_syre_SeriesBNonVotingConvertiblePreferredStockMember_e709b792-4a2f-48d2-9e01-fbef421b2aa2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SeriesANonVotingConvertiblePreferredStockMember_983d6cd5-17a9-4ff3-8760-5f209ef73dc6" xlink:href="syre-20250331.xsd#syre_SeriesANonVotingConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e0bd3be9-98df-4ad8-b469-218770ce8c5a" xlink:to="loc_syre_SeriesANonVotingConvertiblePreferredStockMember_983d6cd5-17a9-4ff3-8760-5f209ef73dc6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_7d6da930-69c4-4189-b8a6-c3e9d6014d8f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e0bd3be9-98df-4ad8-b469-218770ce8c5a" xlink:to="loc_us-gaap_CommonStockMember_7d6da930-69c4-4189-b8a6-c3e9d6014d8f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_56eb9c27-bfdb-4ade-a1d4-98f7abe69544" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_syre_CompanyAndBasisOfPresentationTable_0e7c0225-fe6b-4318-8e58-ecbe46576a86" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_56eb9c27-bfdb-4ade-a1d4-98f7abe69544" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_56eb9c27-bfdb-4ade-a1d4-98f7abe69544_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_56eb9c27-bfdb-4ade-a1d4-98f7abe69544" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_56eb9c27-bfdb-4ade-a1d4-98f7abe69544_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_fd68c38d-03a5-4a8e-9070-2adf47fa39be" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_56eb9c27-bfdb-4ade-a1d4-98f7abe69544" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_fd68c38d-03a5-4a8e-9070-2adf47fa39be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_9fc58a91-0c09-434b-b79e-abc2e40a1057" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_fd68c38d-03a5-4a8e-9070-2adf47fa39be" xlink:to="loc_us-gaap_PrivatePlacementMember_9fc58a91-0c09-434b-b79e-abc2e40a1057" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_AtTheMarketOfferingMember_2504281e-3240-41e7-8d50-9432df9b16dd" xlink:href="syre-20250331.xsd#syre_AtTheMarketOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_fd68c38d-03a5-4a8e-9070-2adf47fa39be" xlink:to="loc_syre_AtTheMarketOfferingMember_2504281e-3240-41e7-8d50-9432df9b16dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_UnderwrittenOfferingMember_4560d235-89ef-49be-b4c8-6247c328d0dc" xlink:href="syre-20250331.xsd#syre_UnderwrittenOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_fd68c38d-03a5-4a8e-9070-2adf47fa39be" xlink:to="loc_syre_UnderwrittenOfferingMember_4560d235-89ef-49be-b4c8-6247c328d0dc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_7b085fb6-6d3b-4357-8078-f4ec8fa9a500" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_fd68c38d-03a5-4a8e-9070-2adf47fa39be" xlink:to="loc_us-gaap_OverAllotmentOptionMember_7b085fb6-6d3b-4357-8078-f4ec8fa9a500" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_71a1038c-1c0f-42f6-acff-34c22e44e27c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_syre_CompanyAndBasisOfPresentationTable_0e7c0225-fe6b-4318-8e58-ecbe46576a86" xlink:to="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_71a1038c-1c0f-42f6-acff-34c22e44e27c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_71a1038c-1c0f-42f6-acff-34c22e44e27c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_71a1038c-1c0f-42f6-acff-34c22e44e27c" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_71a1038c-1c0f-42f6-acff-34c22e44e27c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_23fe7dd4-aa41-4e65-a852-787a9ffddd13" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_71a1038c-1c0f-42f6-acff-34c22e44e27c" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_23fe7dd4-aa41-4e65-a852-787a9ffddd13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ConversionOfSeriesANonVotingConvertiblePreferredStockMember_4394b3ad-d122-48cd-9855-463391d836e0" xlink:href="syre-20250331.xsd#syre_ConversionOfSeriesANonVotingConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_23fe7dd4-aa41-4e65-a852-787a9ffddd13" xlink:to="loc_syre_ConversionOfSeriesANonVotingConvertiblePreferredStockMember_4394b3ad-d122-48cd-9855-463391d836e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ConversionOfSeriesBNonVotingConvertiblePreferredStockMember_575defac-5146-49d7-9ae3-5fd59be31367" xlink:href="syre-20250331.xsd#syre_ConversionOfSeriesBNonVotingConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_23fe7dd4-aa41-4e65-a852-787a9ffddd13" xlink:to="loc_syre_ConversionOfSeriesBNonVotingConvertiblePreferredStockMember_575defac-5146-49d7-9ae3-5fd59be31367" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_21dbe31f-51b5-4d8f-8da6-ed24a6279667" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_syre_CompanyAndBasisOfPresentationTable_0e7c0225-fe6b-4318-8e58-ecbe46576a86" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_21dbe31f-51b5-4d8f-8da6-ed24a6279667" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_21dbe31f-51b5-4d8f-8da6-ed24a6279667_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_21dbe31f-51b5-4d8f-8da6-ed24a6279667" xlink:to="loc_us-gaap_EquityComponentDomain_21dbe31f-51b5-4d8f-8da6-ed24a6279667_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4b37ed10-f7f3-444e-aeb4-20933bb752ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_21dbe31f-51b5-4d8f-8da6-ed24a6279667" xlink:to="loc_us-gaap_EquityComponentDomain_4b37ed10-f7f3-444e-aeb4-20933bb752ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_e17231dd-622e-4332-a65b-a3ccc440b933" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_4b37ed10-f7f3-444e-aeb4-20933bb752ec" xlink:to="loc_us-gaap_PreferredStockMember_e17231dd-622e-4332-a65b-a3ccc440b933" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_62658dc1-e196-4b22-8e46-ad0abccb4452" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_4b37ed10-f7f3-444e-aeb4-20933bb752ec" xlink:to="loc_us-gaap_CommonStockMember_62658dc1-e196-4b22-8e46-ad0abccb4452" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4fbde19e-fab3-4efd-9202-5f09647c8019" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_syre_CompanyAndBasisOfPresentationTable_0e7c0225-fe6b-4318-8e58-ecbe46576a86" xlink:to="loc_srt_RangeAxis_4fbde19e-fab3-4efd-9202-5f09647c8019" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4fbde19e-fab3-4efd-9202-5f09647c8019_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_4fbde19e-fab3-4efd-9202-5f09647c8019" xlink:to="loc_srt_RangeMember_4fbde19e-fab3-4efd-9202-5f09647c8019_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_17521379-4b62-499b-bd82-5766d73839d2" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_4fbde19e-fab3-4efd-9202-5f09647c8019" xlink:to="loc_srt_RangeMember_17521379-4b62-499b-bd82-5766d73839d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_80a9039a-6c30-416c-8a5d-f67286e041de" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_17521379-4b62-499b-bd82-5766d73839d2" xlink:to="loc_srt_MaximumMember_80a9039a-6c30-416c-8a5d-f67286e041de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_4da8b657-525f-4519-8a12-3c9d8d1e0396" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_syre_CompanyAndBasisOfPresentationLineItems_a567ca30-df4d-465b-b131-53e48ff2f6d5" xlink:to="loc_us-gaap_NumberOfOperatingSegments_4da8b657-525f-4519-8a12-3c9d8d1e0396" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_AssetAcquisitionStockholderPaymentPeriod_80d3c411-980d-44b8-94bc-0c2219222ac0" xlink:href="syre-20250331.xsd#syre_AssetAcquisitionStockholderPaymentPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_syre_CompanyAndBasisOfPresentationLineItems_a567ca30-df4d-465b-b131-53e48ff2f6d5" xlink:to="loc_syre_AssetAcquisitionStockholderPaymentPeriod_80d3c411-980d-44b8-94bc-0c2219222ac0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_AssetAcquisitionCashPaymentThresholdPeriod_c99262d1-8fc6-41ea-8a21-8497e2a24c49" xlink:href="syre-20250331.xsd#syre_AssetAcquisitionCashPaymentThresholdPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_syre_CompanyAndBasisOfPresentationLineItems_a567ca30-df4d-465b-b131-53e48ff2f6d5" xlink:to="loc_syre_AssetAcquisitionCashPaymentThresholdPeriod_c99262d1-8fc6-41ea-8a21-8497e2a24c49" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_647d86db-3f19-407e-a1cf-7b4ddd475c78" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_syre_CompanyAndBasisOfPresentationLineItems_a567ca30-df4d-465b-b131-53e48ff2f6d5" xlink:to="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_647d86db-3f19-407e-a1cf-7b4ddd475c78" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockConvertibleConversionRatio_b6fc3759-0a4c-40e4-b264-4d35b048e37a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockConvertibleConversionRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_syre_CompanyAndBasisOfPresentationLineItems_a567ca30-df4d-465b-b131-53e48ff2f6d5" xlink:to="loc_us-gaap_PreferredStockConvertibleConversionRatio_b6fc3759-0a4c-40e4-b264-4d35b048e37a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_ea59864a-dd60-440b-986a-12065d765775" xlink:href="syre-20250331.xsd#syre_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_syre_CompanyAndBasisOfPresentationLineItems_a567ca30-df4d-465b-b131-53e48ff2f6d5" xlink:to="loc_syre_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_ea59864a-dd60-440b-986a-12065d765775" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_cf7f56b6-7d65-4d0f-aaa3-eb8752e5f14c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_syre_CompanyAndBasisOfPresentationLineItems_a567ca30-df4d-465b-b131-53e48ff2f6d5" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_cf7f56b6-7d65-4d0f-aaa3-eb8752e5f14c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_898a36cb-05fc-41a8-9596-f9dc410341e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_syre_CompanyAndBasisOfPresentationLineItems_a567ca30-df4d-465b-b131-53e48ff2f6d5" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_898a36cb-05fc-41a8-9596-f9dc410341e2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_f0b3be75-c8b1-4bf1-b91d-2f555dec8a20" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_syre_CompanyAndBasisOfPresentationLineItems_a567ca30-df4d-465b-b131-53e48ff2f6d5" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_f0b3be75-c8b1-4bf1-b91d-2f555dec8a20" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_d09e3cde-e30e-435d-93fb-76723b931fbc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_syre_CompanyAndBasisOfPresentationLineItems_a567ca30-df4d-465b-b131-53e48ff2f6d5" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_d09e3cde-e30e-435d-93fb-76723b931fbc" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_StockIssuedDuringPeriodSharesExchangeOfConvertibleSecurities_47acff1f-dcd1-4f06-b2fd-6fe68b977b8c" xlink:href="syre-20250331.xsd#syre_StockIssuedDuringPeriodSharesExchangeOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_syre_CompanyAndBasisOfPresentationLineItems_a567ca30-df4d-465b-b131-53e48ff2f6d5" xlink:to="loc_syre_StockIssuedDuringPeriodSharesExchangeOfConvertibleSecurities_47acff1f-dcd1-4f06-b2fd-6fe68b977b8c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_0d226a8a-9aac-47f3-a495-51ffa3173e3f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_syre_CompanyAndBasisOfPresentationLineItems_a567ca30-df4d-465b-b131-53e48ff2f6d5" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_0d226a8a-9aac-47f3-a495-51ffa3173e3f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c328a92e-2b2b-4f96-b4fe-37c197bc142d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_syre_CompanyAndBasisOfPresentationLineItems_a567ca30-df4d-465b-b131-53e48ff2f6d5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c328a92e-2b2b-4f96-b4fe-37c197bc142d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_PreferredStockSharesNotAutomaticallyConvertedOutstanding_be479b84-d83b-4438-affe-94ec7b2eb7be" xlink:href="syre-20250331.xsd#syre_PreferredStockSharesNotAutomaticallyConvertedOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_syre_CompanyAndBasisOfPresentationLineItems_a567ca30-df4d-465b-b131-53e48ff2f6d5" xlink:to="loc_syre_PreferredStockSharesNotAutomaticallyConvertedOutstanding_be479b84-d83b-4438-affe-94ec7b2eb7be" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SaleOfStockAuthorizedAmount_beb9a49e-d643-49b3-84a8-18e33b9831d3" xlink:href="syre-20250331.xsd#syre_SaleOfStockAuthorizedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_syre_CompanyAndBasisOfPresentationLineItems_a567ca30-df4d-465b-b131-53e48ff2f6d5" xlink:to="loc_syre_SaleOfStockAuthorizedAmount_beb9a49e-d643-49b3-84a8-18e33b9831d3" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SaleOfStockAggregateOfferingPrice_9b0ba7c6-aed9-454c-ba54-b59c0ada9907" xlink:href="syre-20250331.xsd#syre_SaleOfStockAggregateOfferingPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_syre_CompanyAndBasisOfPresentationLineItems_a567ca30-df4d-465b-b131-53e48ff2f6d5" xlink:to="loc_syre_SaleOfStockAggregateOfferingPrice_9b0ba7c6-aed9-454c-ba54-b59c0ada9907" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_53518521-bb4a-47b7-82f8-2cbd13931d60" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_syre_CompanyAndBasisOfPresentationLineItems_a567ca30-df4d-465b-b131-53e48ff2f6d5" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_53518521-bb4a-47b7-82f8-2cbd13931d60" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SaleOfStockRemainingAuthorizedAmount_8086e13a-22d5-4c7a-8380-8cba13a1e4c2" xlink:href="syre-20250331.xsd#syre_SaleOfStockRemainingAuthorizedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_syre_CompanyAndBasisOfPresentationLineItems_a567ca30-df4d-465b-b131-53e48ff2f6d5" xlink:to="loc_syre_SaleOfStockRemainingAuthorizedAmount_8086e13a-22d5-4c7a-8380-8cba13a1e4c2" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ProceedsFromRaisingCapital_429af177-ef92-4034-a5ea-7b1c1099d028" xlink:href="syre-20250331.xsd#syre_ProceedsFromRaisingCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_syre_CompanyAndBasisOfPresentationLineItems_a567ca30-df4d-465b-b131-53e48ff2f6d5" xlink:to="loc_syre_ProceedsFromRaisingCapital_429af177-ef92-4034-a5ea-7b1c1099d028" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_13bc4dda-272e-4107-8cea-a49a9f50e2db" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_syre_CompanyAndBasisOfPresentationLineItems_a567ca30-df4d-465b-b131-53e48ff2f6d5" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_13bc4dda-272e-4107-8cea-a49a9f50e2db" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_c09b2d7b-44dd-458e-9027-1eba987344d0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_syre_CompanyAndBasisOfPresentationLineItems_a567ca30-df4d-465b-b131-53e48ff2f6d5" xlink:to="loc_us-gaap_MarketableSecurities_c09b2d7b-44dd-458e-9027-1eba987344d0" xlink:type="arc" order="20"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://spyre.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="syre-20250331.xsd#FairValueMeasurementsFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://spyre.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d26bfe5c-f5cb-4d21-abf6-b0c98881a4c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0b83aceb-0352-464d-a1b4-6f81a2ab79a4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d26bfe5c-f5cb-4d21-abf6-b0c98881a4c8" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0b83aceb-0352-464d-a1b4-6f81a2ab79a4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_32c7eaaf-c86f-498e-9a35-e1c620bad630" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0b83aceb-0352-464d-a1b4-6f81a2ab79a4" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_32c7eaaf-c86f-498e-9a35-e1c620bad630" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_32c7eaaf-c86f-498e-9a35-e1c620bad630_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_32c7eaaf-c86f-498e-9a35-e1c620bad630" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_32c7eaaf-c86f-498e-9a35-e1c620bad630_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_afc1f777-8e02-437d-bfe4-12e35265bbf3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_32c7eaaf-c86f-498e-9a35-e1c620bad630" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_afc1f777-8e02-437d-bfe4-12e35265bbf3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_ecd53281-3e1e-40c8-966f-c160b94a3a4d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_afc1f777-8e02-437d-bfe4-12e35265bbf3" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_ecd53281-3e1e-40c8-966f-c160b94a3a4d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_aa54790c-a655-400c-a17e-c3dfecd1a448" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0b83aceb-0352-464d-a1b4-6f81a2ab79a4" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_aa54790c-a655-400c-a17e-c3dfecd1a448" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_aa54790c-a655-400c-a17e-c3dfecd1a448_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_aa54790c-a655-400c-a17e-c3dfecd1a448" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_aa54790c-a655-400c-a17e-c3dfecd1a448_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_ed146ca3-ebf7-46ec-ae21-e780a866b433" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_aa54790c-a655-400c-a17e-c3dfecd1a448" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_ed146ca3-ebf7-46ec-ae21-e780a866b433" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_6156dbab-3d59-4fb2-8fcb-2efb47c0c013" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_ed146ca3-ebf7-46ec-ae21-e780a866b433" xlink:to="loc_us-gaap_MoneyMarketFundsMember_6156dbab-3d59-4fb2-8fcb-2efb47c0c013" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_de92a715-8f07-4f34-8aa5-168d94bc2f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0b83aceb-0352-464d-a1b4-6f81a2ab79a4" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_de92a715-8f07-4f34-8aa5-168d94bc2f7d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_de92a715-8f07-4f34-8aa5-168d94bc2f7d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_de92a715-8f07-4f34-8aa5-168d94bc2f7d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_de92a715-8f07-4f34-8aa5-168d94bc2f7d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c177d214-2eb0-4cb3-93fd-896d2b83f6b8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_de92a715-8f07-4f34-8aa5-168d94bc2f7d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c177d214-2eb0-4cb3-93fd-896d2b83f6b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_5e3af458-e829-4a38-90b4-8ebf770bb77e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c177d214-2eb0-4cb3-93fd-896d2b83f6b8" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_5e3af458-e829-4a38-90b4-8ebf770bb77e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_4c8850fe-f416-4d1a-9e5f-846171e67d37" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c177d214-2eb0-4cb3-93fd-896d2b83f6b8" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_4c8850fe-f416-4d1a-9e5f-846171e67d37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_47a42a3c-72c6-409b-8d93-089ef7206ab3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c177d214-2eb0-4cb3-93fd-896d2b83f6b8" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_47a42a3c-72c6-409b-8d93-089ef7206ab3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_adda3617-eb0a-4204-b518-965ffed3750b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0b83aceb-0352-464d-a1b4-6f81a2ab79a4" xlink:to="loc_us-gaap_FinancialInstrumentAxis_adda3617-eb0a-4204-b518-965ffed3750b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_adda3617-eb0a-4204-b518-965ffed3750b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_adda3617-eb0a-4204-b518-965ffed3750b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_adda3617-eb0a-4204-b518-965ffed3750b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9f0e33f6-f3d9-4698-b8ca-aa9e91d8cf53" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_adda3617-eb0a-4204-b518-965ffed3750b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9f0e33f6-f3d9-4698-b8ca-aa9e91d8cf53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_f3e11777-31e1-40bf-b188-275f20e3292d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9f0e33f6-f3d9-4698-b8ca-aa9e91d8cf53" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_f3e11777-31e1-40bf-b188-275f20e3292d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_c295393c-5e2b-4eab-a7ba-c69ea08e037b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9f0e33f6-f3d9-4698-b8ca-aa9e91d8cf53" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_c295393c-5e2b-4eab-a7ba-c69ea08e037b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_c8729c72-18ef-4a22-9faf-d1a56d2cd06a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9f0e33f6-f3d9-4698-b8ca-aa9e91d8cf53" xlink:to="loc_us-gaap_CommercialPaperMember_c8729c72-18ef-4a22-9faf-d1a56d2cd06a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_e3affcd1-3efb-4f11-857c-9d5d08b4f0a8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9f0e33f6-f3d9-4698-b8ca-aa9e91d8cf53" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_e3affcd1-3efb-4f11-857c-9d5d08b4f0a8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ContingentValueRightLiabilityMember_19a8f813-79ac-4231-83ec-bbbca66f859d" xlink:href="syre-20250331.xsd#syre_ContingentValueRightLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9f0e33f6-f3d9-4698-b8ca-aa9e91d8cf53" xlink:to="loc_syre_ContingentValueRightLiabilityMember_19a8f813-79ac-4231-83ec-bbbca66f859d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_a6d05888-9b8e-48f8-9f8d-8a1ed819555f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d26bfe5c-f5cb-4d21-abf6-b0c98881a4c8" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_a6d05888-9b8e-48f8-9f8d-8a1ed819555f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_b2be4c69-573c-41c8-adb8-346236e688fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_a6d05888-9b8e-48f8-9f8d-8a1ed819555f" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_b2be4c69-573c-41c8-adb8-346236e688fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_2a42534e-3a42-4852-87f7-0ff8c32d8af4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d26bfe5c-f5cb-4d21-abf6-b0c98881a4c8" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_2a42534e-3a42-4852-87f7-0ff8c32d8af4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_2ca93093-23ba-4ac4-8b94-c20afee848b8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_2a42534e-3a42-4852-87f7-0ff8c32d8af4" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_2ca93093-23ba-4ac4-8b94-c20afee848b8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://spyre.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="syre-20250331.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://spyre.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_05cd8ed8-8f37-416b-a446-fa05065ce2c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3eb14b17-bc9d-4c34-bcf9-2b85fea41678" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_05cd8ed8-8f37-416b-a446-fa05065ce2c5" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3eb14b17-bc9d-4c34-bcf9-2b85fea41678" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_a96e1993-307c-48be-8894-db71021e3bea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3eb14b17-bc9d-4c34-bcf9-2b85fea41678" xlink:to="loc_us-gaap_AssetAcquisitionAxis_a96e1993-307c-48be-8894-db71021e3bea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_a96e1993-307c-48be-8894-db71021e3bea_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AssetAcquisitionAxis_a96e1993-307c-48be-8894-db71021e3bea" xlink:to="loc_us-gaap_AssetAcquisitionDomain_a96e1993-307c-48be-8894-db71021e3bea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_5cab2a28-694c-4ac1-bffd-6a0cd01ac0e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AssetAcquisitionAxis_a96e1993-307c-48be-8894-db71021e3bea" xlink:to="loc_us-gaap_AssetAcquisitionDomain_5cab2a28-694c-4ac1-bffd-6a0cd01ac0e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SpyreTherapeuticsIncMember_00f6db92-25f1-4e5c-906b-33f184c1bcac" xlink:href="syre-20250331.xsd#syre_SpyreTherapeuticsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_5cab2a28-694c-4ac1-bffd-6a0cd01ac0e8" xlink:to="loc_syre_SpyreTherapeuticsIncMember_00f6db92-25f1-4e5c-906b-33f184c1bcac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_b0861d08-2709-4395-b938-ab6806372508" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3eb14b17-bc9d-4c34-bcf9-2b85fea41678" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_b0861d08-2709-4395-b938-ab6806372508" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b0861d08-2709-4395-b938-ab6806372508_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_b0861d08-2709-4395-b938-ab6806372508" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b0861d08-2709-4395-b938-ab6806372508_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3b23ea28-809a-4138-acbb-9c9f41fb4193" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_b0861d08-2709-4395-b938-ab6806372508" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3b23ea28-809a-4138-acbb-9c9f41fb4193" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ContingentValueRightLiabilityMember_cbbc8b1f-8f7f-49c4-b01f-baf5f12d5393" xlink:href="syre-20250331.xsd#syre_ContingentValueRightLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3b23ea28-809a-4138-acbb-9c9f41fb4193" xlink:to="loc_syre_ContingentValueRightLiabilityMember_cbbc8b1f-8f7f-49c4-b01f-baf5f12d5393" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_AssetAcquisitionStockholderPaymentPeriod_3bb414d8-3cd0-4aeb-a434-e545a86237a2" xlink:href="syre-20250331.xsd#syre_AssetAcquisitionStockholderPaymentPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_05cd8ed8-8f37-416b-a446-fa05065ce2c5" xlink:to="loc_syre_AssetAcquisitionStockholderPaymentPeriod_3bb414d8-3cd0-4aeb-a434-e545a86237a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_AssetAcquisitionCashPaymentThresholdPeriod_3accfd0a-eed3-40eb-ad49-db82f28e8d27" xlink:href="syre-20250331.xsd#syre_AssetAcquisitionCashPaymentThresholdPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_05cd8ed8-8f37-416b-a446-fa05065ce2c5" xlink:to="loc_syre_AssetAcquisitionCashPaymentThresholdPeriod_3accfd0a-eed3-40eb-ad49-db82f28e8d27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_b528e6fe-e142-4d17-a8e9-fbb3f3531cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_05cd8ed8-8f37-416b-a446-fa05065ce2c5" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_b528e6fe-e142-4d17-a8e9-fbb3f3531cfb" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://spyre.com/role/FairValueMeasurementsSignificantInputsusedtoEstimatetheFairValueofDerivativeLiabilityDetails" xlink:type="simple" xlink:href="syre-20250331.xsd#FairValueMeasurementsSignificantInputsusedtoEstimatetheFairValueofDerivativeLiabilityDetails"/>
  <link:definitionLink xlink:role="http://spyre.com/role/FairValueMeasurementsSignificantInputsusedtoEstimatetheFairValueofDerivativeLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_49dce2fa-bba7-402a-8605-d60721b7dc40" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_8faadaa3-deef-475d-994e-99ae08fb2347" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_49dce2fa-bba7-402a-8605-d60721b7dc40" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_8faadaa3-deef-475d-994e-99ae08fb2347" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_66247193-57cf-4add-919c-e27c827474df" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_8faadaa3-deef-475d-994e-99ae08fb2347" xlink:to="loc_srt_RangeAxis_66247193-57cf-4add-919c-e27c827474df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_66247193-57cf-4add-919c-e27c827474df_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_66247193-57cf-4add-919c-e27c827474df" xlink:to="loc_srt_RangeMember_66247193-57cf-4add-919c-e27c827474df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_37ee0014-7815-48dd-8929-117f4da4c5bd" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_66247193-57cf-4add-919c-e27c827474df" xlink:to="loc_srt_RangeMember_37ee0014-7815-48dd-8929-117f4da4c5bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_3d8bd844-8e56-4932-a53e-88c218284c37" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_37ee0014-7815-48dd-8929-117f4da4c5bd" xlink:to="loc_srt_MinimumMember_3d8bd844-8e56-4932-a53e-88c218284c37" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b206534a-29f4-4b00-adb7-fc09e14628f8" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_37ee0014-7815-48dd-8929-117f4da4c5bd" xlink:to="loc_srt_MaximumMember_b206534a-29f4-4b00-adb7-fc09e14628f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_feb5418d-737e-4a7f-b273-94ac5ebcdfd4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_8faadaa3-deef-475d-994e-99ae08fb2347" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_feb5418d-737e-4a7f-b273-94ac5ebcdfd4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_feb5418d-737e-4a7f-b273-94ac5ebcdfd4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_feb5418d-737e-4a7f-b273-94ac5ebcdfd4" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_feb5418d-737e-4a7f-b273-94ac5ebcdfd4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5ed3145c-6e57-4380-8c87-4d25fb4e0b0d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_feb5418d-737e-4a7f-b273-94ac5ebcdfd4" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5ed3145c-6e57-4380-8c87-4d25fb4e0b0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_de4b3855-7d41-4d33-8cc2-50f235c8824a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5ed3145c-6e57-4380-8c87-4d25fb4e0b0d" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_de4b3855-7d41-4d33-8cc2-50f235c8824a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_006209f6-859a-48a7-8977-b1ddd9457dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_8faadaa3-deef-475d-994e-99ae08fb2347" xlink:to="loc_us-gaap_FinancialInstrumentAxis_006209f6-859a-48a7-8977-b1ddd9457dc4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_006209f6-859a-48a7-8977-b1ddd9457dc4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_006209f6-859a-48a7-8977-b1ddd9457dc4" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_006209f6-859a-48a7-8977-b1ddd9457dc4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0cd48bde-c8c5-4ea0-a5e3-ff0b871cac82" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_006209f6-859a-48a7-8977-b1ddd9457dc4" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0cd48bde-c8c5-4ea0-a5e3-ff0b871cac82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ContingentValueRightLiabilityMember_c7f0068e-e85c-4132-8973-ee051470e8ba" xlink:href="syre-20250331.xsd#syre_ContingentValueRightLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0cd48bde-c8c5-4ea0-a5e3-ff0b871cac82" xlink:to="loc_syre_ContingentValueRightLiabilityMember_c7f0068e-e85c-4132-8973-ee051470e8ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_50fe9839-06ae-413c-b5fc-a9a8b7998470" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_8faadaa3-deef-475d-994e-99ae08fb2347" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_50fe9839-06ae-413c-b5fc-a9a8b7998470" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_50fe9839-06ae-413c-b5fc-a9a8b7998470_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_50fe9839-06ae-413c-b5fc-a9a8b7998470" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_50fe9839-06ae-413c-b5fc-a9a8b7998470_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_ce4100d9-fe98-4eb0-b91d-45519eca7973" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_50fe9839-06ae-413c-b5fc-a9a8b7998470" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_ce4100d9-fe98-4eb0-b91d-45519eca7973" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_MeasurementInputProabilityOfSuccessMember_3548bb38-555f-40f8-9613-dad032ad5c47" xlink:href="syre-20250331.xsd#syre_MeasurementInputProabilityOfSuccessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ce4100d9-fe98-4eb0-b91d-45519eca7973" xlink:to="loc_syre_MeasurementInputProabilityOfSuccessMember_3548bb38-555f-40f8-9613-dad032ad5c47" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_MeasurementInputReimbursementRateMember_88840654-5d9e-431b-97f6-65eff7b9a518" xlink:href="syre-20250331.xsd#syre_MeasurementInputReimbursementRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ce4100d9-fe98-4eb0-b91d-45519eca7973" xlink:to="loc_syre_MeasurementInputReimbursementRateMember_88840654-5d9e-431b-97f6-65eff7b9a518" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_d4973fb8-26dd-4e87-b63c-9fd0aa220607" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ce4100d9-fe98-4eb0-b91d-45519eca7973" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_d4973fb8-26dd-4e87-b63c-9fd0aa220607" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_5eed6530-3a6c-409c-948a-dff7715afe9b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_8faadaa3-deef-475d-994e-99ae08fb2347" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_5eed6530-3a6c-409c-948a-dff7715afe9b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_5eed6530-3a6c-409c-948a-dff7715afe9b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_5eed6530-3a6c-409c-948a-dff7715afe9b" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_5eed6530-3a6c-409c-948a-dff7715afe9b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_0fb33324-0502-4fbb-9a9a-beeb6084d644" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_5eed6530-3a6c-409c-948a-dff7715afe9b" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_0fb33324-0502-4fbb-9a9a-beeb6084d644" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ContingentValueRightLiabilityMember_72edce2d-9fee-453c-9b0d-f58bfad3ef2a" xlink:href="syre-20250331.xsd#syre_ContingentValueRightLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_0fb33324-0502-4fbb-9a9a-beeb6084d644" xlink:to="loc_syre_ContingentValueRightLiabilityMember_72edce2d-9fee-453c-9b0d-f58bfad3ef2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityMeasurementInput_bc418533-4e0e-4fdd-9f58-e890186cb2ad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_49dce2fa-bba7-402a-8605-d60721b7dc40" xlink:to="loc_us-gaap_DerivativeLiabilityMeasurementInput_bc418533-4e0e-4fdd-9f58-e890186cb2ad" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://spyre.com/role/FairValueMeasurementsChangesinDerivativeLiabilitiesDetails" xlink:type="simple" xlink:href="syre-20250331.xsd#FairValueMeasurementsChangesinDerivativeLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://spyre.com/role/FairValueMeasurementsChangesinDerivativeLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_a0db25e5-1362-4ec5-b222-ee3e81911853" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_bf424118-4e5f-4473-8ef5-e220d5c9ee9f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_a0db25e5-1362-4ec5-b222-ee3e81911853" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_bf424118-4e5f-4473-8ef5-e220d5c9ee9f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_7503309c-1282-45ca-9424-ba0edf405176" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_bf424118-4e5f-4473-8ef5-e220d5c9ee9f" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_7503309c-1282-45ca-9424-ba0edf405176" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7503309c-1282-45ca-9424-ba0edf405176_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7503309c-1282-45ca-9424-ba0edf405176" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7503309c-1282-45ca-9424-ba0edf405176_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f175ee72-f664-4083-b8e8-404f2cc6b7f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7503309c-1282-45ca-9424-ba0edf405176" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f175ee72-f664-4083-b8e8-404f2cc6b7f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ContingentValueRightLiabilityMember_420cb6e2-a221-49bd-8a7f-5d8d9ee0c12d" xlink:href="syre-20250331.xsd#syre_ContingentValueRightLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f175ee72-f664-4083-b8e8-404f2cc6b7f9" xlink:to="loc_syre_ContingentValueRightLiabilityMember_420cb6e2-a221-49bd-8a7f-5d8d9ee0c12d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_93c745c6-cce5-4cdd-a415-56595099b357" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_a0db25e5-1362-4ec5-b222-ee3e81911853" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_93c745c6-cce5-4cdd-a415-56595099b357" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_168ee38d-cea3-4f26-b967-a872738dca66" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_93c745c6-cce5-4cdd-a415-56595099b357" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_168ee38d-cea3-4f26-b967-a872738dca66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_0439a01d-c0e7-4b5c-8fb3-bd8e7345c67a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_93c745c6-cce5-4cdd-a415-56595099b357" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_0439a01d-c0e7-4b5c-8fb3-bd8e7345c67a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_22ef14a4-5491-44ed-be6f-46c758bf173f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_93c745c6-cce5-4cdd-a415-56595099b357" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_22ef14a4-5491-44ed-be6f-46c758bf173f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_15cbb33b-0882-4d32-851a-b548aea5b557" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://spyre.com/role/CashEquivalentsandMarketableSecuritiesEstimatedFairValueofCashEquivalentsandMarketableSecuritiesandtheGrossUnrealizedGainsandLossesDetails" xlink:type="simple" xlink:href="syre-20250331.xsd#CashEquivalentsandMarketableSecuritiesEstimatedFairValueofCashEquivalentsandMarketableSecuritiesandtheGrossUnrealizedGainsandLossesDetails"/>
  <link:definitionLink xlink:role="http://spyre.com/role/CashEquivalentsandMarketableSecuritiesEstimatedFairValueofCashEquivalentsandMarketableSecuritiesandtheGrossUnrealizedGainsandLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_51b8777a-0f62-4362-ad96-cac9a095055d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_2d29574c-de43-4360-8664-452e6767b134" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_51b8777a-0f62-4362-ad96-cac9a095055d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_2d29574c-de43-4360-8664-452e6767b134" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_79b75ac4-405c-4dba-b831-7750c46df391" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_2d29574c-de43-4360-8664-452e6767b134" xlink:to="loc_us-gaap_FinancialInstrumentAxis_79b75ac4-405c-4dba-b831-7750c46df391" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_79b75ac4-405c-4dba-b831-7750c46df391_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_79b75ac4-405c-4dba-b831-7750c46df391" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_79b75ac4-405c-4dba-b831-7750c46df391_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cee16247-503a-4583-9d70-a551e745e791" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_79b75ac4-405c-4dba-b831-7750c46df391" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cee16247-503a-4583-9d70-a551e745e791" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_75fc2697-90c4-4f79-a367-bc3e5f951583" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cee16247-503a-4583-9d70-a551e745e791" xlink:to="loc_us-gaap_MoneyMarketFundsMember_75fc2697-90c4-4f79-a367-bc3e5f951583" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_7b9cbef8-4d6e-4e61-a193-949cdf9dc78f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cee16247-503a-4583-9d70-a551e745e791" xlink:to="loc_us-gaap_CommercialPaperMember_7b9cbef8-4d6e-4e61-a193-949cdf9dc78f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_2adceef2-522b-4cb8-9022-64d5504d8cdd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cee16247-503a-4583-9d70-a551e745e791" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_2adceef2-522b-4cb8-9022-64d5504d8cdd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_784a28f4-648d-4528-bc37-6b3d39d581ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cee16247-503a-4583-9d70-a551e745e791" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_784a28f4-648d-4528-bc37-6b3d39d581ba" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_bbf9375a-3a19-4ab3-a423-110a451182fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cee16247-503a-4583-9d70-a551e745e791" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_bbf9375a-3a19-4ab3-a423-110a451182fe" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_b503e5d4-f071-4d1b-83fb-5b5fecb38710" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_51b8777a-0f62-4362-ad96-cac9a095055d" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_b503e5d4-f071-4d1b-83fb-5b5fecb38710" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_CashEquivalentsUnrealizedGains_7fcda4ac-c669-46a6-8256-882c4cf3f566" xlink:href="syre-20250331.xsd#syre_CashEquivalentsUnrealizedGains"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_51b8777a-0f62-4362-ad96-cac9a095055d" xlink:to="loc_syre_CashEquivalentsUnrealizedGains_7fcda4ac-c669-46a6-8256-882c4cf3f566" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_CashEquivalentsUnrealizedLosses_44f4b7b4-1dbe-439b-bd26-b4599640f6b1" xlink:href="syre-20250331.xsd#syre_CashEquivalentsUnrealizedLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_51b8777a-0f62-4362-ad96-cac9a095055d" xlink:to="loc_syre_CashEquivalentsUnrealizedLosses_44f4b7b4-1dbe-439b-bd26-b4599640f6b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_4e7c56be-5846-4599-9944-be8b6cb8d38d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_51b8777a-0f62-4362-ad96-cac9a095055d" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_4e7c56be-5846-4599-9944-be8b6cb8d38d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_5e19230c-5000-47db-a4f7-e1b29f629896" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_51b8777a-0f62-4362-ad96-cac9a095055d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_5e19230c-5000-47db-a4f7-e1b29f629896" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_d76f8a4f-eb64-47b7-b3aa-30f29bd8dd9d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_51b8777a-0f62-4362-ad96-cac9a095055d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_d76f8a4f-eb64-47b7-b3aa-30f29bd8dd9d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_3e3325ee-aaa6-4cc3-9a9e-f548119c9ca4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_51b8777a-0f62-4362-ad96-cac9a095055d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_3e3325ee-aaa6-4cc3-9a9e-f548119c9ca4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_91dceea7-3a29-442e-958b-e442f389fec4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_51b8777a-0f62-4362-ad96-cac9a095055d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_91dceea7-3a29-442e-958b-e442f389fec4" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://spyre.com/role/CashEquivalentsandMarketableSecuritiesAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="syre-20250331.xsd#CashEquivalentsandMarketableSecuritiesAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails"/>
  <link:definitionLink xlink:role="http://spyre.com/role/CashEquivalentsandMarketableSecuritiesAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f6b05e9e-d899-4992-b6d5-f099696585a5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_86a4ec57-e29d-4023-9a8b-db69ecc7a02e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f6b05e9e-d899-4992-b6d5-f099696585a5" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_86a4ec57-e29d-4023-9a8b-db69ecc7a02e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_23fad563-8e38-4bd8-b18e-7c7228b263fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_86a4ec57-e29d-4023-9a8b-db69ecc7a02e" xlink:to="loc_us-gaap_FinancialInstrumentAxis_23fad563-8e38-4bd8-b18e-7c7228b263fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_23fad563-8e38-4bd8-b18e-7c7228b263fe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_23fad563-8e38-4bd8-b18e-7c7228b263fe" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_23fad563-8e38-4bd8-b18e-7c7228b263fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2eb907d4-78e0-4838-aa1c-47924d1fb6e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_23fad563-8e38-4bd8-b18e-7c7228b263fe" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2eb907d4-78e0-4838-aa1c-47924d1fb6e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_e5e45131-3697-42fc-b301-3e19ec715dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2eb907d4-78e0-4838-aa1c-47924d1fb6e2" xlink:to="loc_us-gaap_CommercialPaperMember_e5e45131-3697-42fc-b301-3e19ec715dfc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_ad650488-1b47-4e1d-bcff-0f642d8d5e74" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2eb907d4-78e0-4838-aa1c-47924d1fb6e2" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_ad650488-1b47-4e1d-bcff-0f642d8d5e74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_b29349b0-4ac7-46d8-99f3-4280f2c64b1d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2eb907d4-78e0-4838-aa1c-47924d1fb6e2" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_b29349b0-4ac7-46d8-99f3-4280f2c64b1d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_40f63275-c547-450d-b674-7b2b0165d88d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2eb907d4-78e0-4838-aa1c-47924d1fb6e2" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_40f63275-c547-450d-b674-7b2b0165d88d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_62ad76b8-33ac-427a-a3fb-ec0bca7af70e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f6b05e9e-d899-4992-b6d5-f099696585a5" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_62ad76b8-33ac-427a-a3fb-ec0bca7af70e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_ff3f4276-528f-45a9-b52f-07e4088fb83d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_62ad76b8-33ac-427a-a3fb-ec0bca7af70e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_ff3f4276-528f-45a9-b52f-07e4088fb83d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_f4ce9528-91e3-4a2e-85ac-57590176f085" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_62ad76b8-33ac-427a-a3fb-ec0bca7af70e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_f4ce9528-91e3-4a2e-85ac-57590176f085" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_5eb884df-fcda-4c3d-8994-4f5a0dd15fac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_62ad76b8-33ac-427a-a3fb-ec0bca7af70e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_5eb884df-fcda-4c3d-8994-4f5a0dd15fac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableforSaleUnrealizedLossPositionAbstract_e4c9b20f-e703-4d7b-94f7-9b3bfa160d71" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableforSaleUnrealizedLossPositionAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f6b05e9e-d899-4992-b6d5-f099696585a5" xlink:to="loc_us-gaap_DebtSecuritiesAvailableforSaleUnrealizedLossPositionAbstract_e4c9b20f-e703-4d7b-94f7-9b3bfa160d71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_f152b8b6-d8ac-4926-83d1-59446e69b1de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforSaleUnrealizedLossPositionAbstract_e4c9b20f-e703-4d7b-94f7-9b3bfa160d71" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_f152b8b6-d8ac-4926-83d1-59446e69b1de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_c4c179dd-aa4d-40e1-848f-d81c46a5a1b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforSaleUnrealizedLossPositionAbstract_e4c9b20f-e703-4d7b-94f7-9b3bfa160d71" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_c4c179dd-aa4d-40e1-848f-d81c46a5a1b3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_82c2a392-1cad-4ef5-8f29-bed6d84990f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforSaleUnrealizedLossPositionAbstract_e4c9b20f-e703-4d7b-94f7-9b3bfa160d71" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_82c2a392-1cad-4ef5-8f29-bed6d84990f9" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://spyre.com/role/CashEquivalentsandMarketableSecuritiesNarrativeDetails" xlink:type="simple" xlink:href="syre-20250331.xsd#CashEquivalentsandMarketableSecuritiesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://spyre.com/role/CashEquivalentsandMarketableSecuritiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_syre_CashEquivalentsAndMarketableSecuritiesLineItems_96906b74-4e2a-44f6-8154-ba447dba8b77" xlink:href="syre-20250331.xsd#syre_CashEquivalentsAndMarketableSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_CashEquivalentsAndMarketableSecuritiesTable_385729d3-59a0-45cf-8d2f-33f484ee4186" xlink:href="syre-20250331.xsd#syre_CashEquivalentsAndMarketableSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_syre_CashEquivalentsAndMarketableSecuritiesLineItems_96906b74-4e2a-44f6-8154-ba447dba8b77" xlink:to="loc_syre_CashEquivalentsAndMarketableSecuritiesTable_385729d3-59a0-45cf-8d2f-33f484ee4186" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_d9a713d2-cd20-4a15-8c33-e36d92993d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_syre_CashEquivalentsAndMarketableSecuritiesTable_385729d3-59a0-45cf-8d2f-33f484ee4186" xlink:to="loc_us-gaap_FinancialInstrumentAxis_d9a713d2-cd20-4a15-8c33-e36d92993d3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d9a713d2-cd20-4a15-8c33-e36d92993d3e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_d9a713d2-cd20-4a15-8c33-e36d92993d3e" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d9a713d2-cd20-4a15-8c33-e36d92993d3e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2a5af159-30ec-492a-b032-8c4391277993" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_d9a713d2-cd20-4a15-8c33-e36d92993d3e" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2a5af159-30ec-492a-b032-8c4391277993" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_e84c46f9-33a0-4a1f-b1fb-b5c280c7faf7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2a5af159-30ec-492a-b032-8c4391277993" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_e84c46f9-33a0-4a1f-b1fb-b5c280c7faf7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_USBankingInstitutionMember_2c490142-44fe-4ddd-a55b-93db313b2100" xlink:href="syre-20250331.xsd#syre_USBankingInstitutionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2a5af159-30ec-492a-b032-8c4391277993" xlink:to="loc_syre_USBankingInstitutionMember_2c490142-44fe-4ddd-a55b-93db313b2100" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_aca45c8a-65de-4028-97fb-fb7c84b9ee81" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_syre_CashEquivalentsAndMarketableSecuritiesTable_385729d3-59a0-45cf-8d2f-33f484ee4186" xlink:to="loc_srt_RangeAxis_aca45c8a-65de-4028-97fb-fb7c84b9ee81" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_aca45c8a-65de-4028-97fb-fb7c84b9ee81_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_aca45c8a-65de-4028-97fb-fb7c84b9ee81" xlink:to="loc_srt_RangeMember_aca45c8a-65de-4028-97fb-fb7c84b9ee81_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_819b90f8-b5c9-4b13-b324-7cbb78a6dedd" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_aca45c8a-65de-4028-97fb-fb7c84b9ee81" xlink:to="loc_srt_RangeMember_819b90f8-b5c9-4b13-b324-7cbb78a6dedd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ea2f97f9-8d5e-4ce2-8f08-887023c69b02" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_819b90f8-b5c9-4b13-b324-7cbb78a6dedd" xlink:to="loc_srt_MaximumMember_ea2f97f9-8d5e-4ce2-8f08-887023c69b02" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_c8dedc78-728d-4d08-8565-e63dedd3e3b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_syre_CashEquivalentsAndMarketableSecuritiesLineItems_96906b74-4e2a-44f6-8154-ba447dba8b77" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_c8dedc78-728d-4d08-8565-e63dedd3e3b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ImpairmentOfMarketableSecurities_8242afe3-125b-4fc2-92ad-49cb33e8c9b9" xlink:href="syre-20250331.xsd#syre_ImpairmentOfMarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_syre_CashEquivalentsAndMarketableSecuritiesLineItems_96906b74-4e2a-44f6-8154-ba447dba8b77" xlink:to="loc_syre_ImpairmentOfMarketableSecurities_8242afe3-125b-4fc2-92ad-49cb33e8c9b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_NumberOfDomesticBankingInstitutions_692d7abf-191d-4500-a790-b4951bd48a4b" xlink:href="syre-20250331.xsd#syre_NumberOfDomesticBankingInstitutions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_syre_CashEquivalentsAndMarketableSecuritiesLineItems_96906b74-4e2a-44f6-8154-ba447dba8b77" xlink:to="loc_syre_NumberOfDomesticBankingInstitutions_692d7abf-191d-4500-a790-b4951bd48a4b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFDICInsuredAmount_343f1059-125b-42db-a262-8dbc13cd2898" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFDICInsuredAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_syre_CashEquivalentsAndMarketableSecuritiesLineItems_96906b74-4e2a-44f6-8154-ba447dba8b77" xlink:to="loc_us-gaap_CashFDICInsuredAmount_343f1059-125b-42db-a262-8dbc13cd2898" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments_7c5f260a-55d7-4b74-881c-7d98f72150c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_syre_CashEquivalentsAndMarketableSecuritiesLineItems_96906b74-4e2a-44f6-8154-ba447dba8b77" xlink:to="loc_us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments_7c5f260a-55d7-4b74-881c-7d98f72150c4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivable_36e8ad78-4701-4adf-a3df-7ca87e2c9e13" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_syre_CashEquivalentsAndMarketableSecuritiesLineItems_96906b74-4e2a-44f6-8154-ba447dba8b77" xlink:to="loc_us-gaap_InterestReceivable_36e8ad78-4701-4adf-a3df-7ca87e2c9e13" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://spyre.com/role/LicensingAgreementsDetails" xlink:type="simple" xlink:href="syre-20250331.xsd#LicensingAgreementsDetails"/>
  <link:definitionLink xlink:role="http://spyre.com/role/LicensingAgreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_d9060080-65d4-42ea-83a5-9d732701d3c2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_b621ffcf-f318-43be-b892-6e4c9a3de04b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d9060080-65d4-42ea-83a5-9d732701d3c2" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_b621ffcf-f318-43be-b892-6e4c9a3de04b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8cb8fb4f-797f-4e28-bcac-f16201ee0af9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_b621ffcf-f318-43be-b892-6e4c9a3de04b" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8cb8fb4f-797f-4e28-bcac-f16201ee0af9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_8cb8fb4f-797f-4e28-bcac-f16201ee0af9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8cb8fb4f-797f-4e28-bcac-f16201ee0af9" xlink:to="loc_us-gaap_RelatedPartyDomain_8cb8fb4f-797f-4e28-bcac-f16201ee0af9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_f8e4c432-f819-4b57-9435-511347a95063" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8cb8fb4f-797f-4e28-bcac-f16201ee0af9" xlink:to="loc_us-gaap_RelatedPartyDomain_f8e4c432-f819-4b57-9435-511347a95063" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_e254df44-be81-45f3-81b6-8d3218ed5bbd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_f8e4c432-f819-4b57-9435-511347a95063" xlink:to="loc_us-gaap_RelatedPartyMember_e254df44-be81-45f3-81b6-8d3218ed5bbd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_2c295680-6734-448c-995b-084b890b64a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_b621ffcf-f318-43be-b892-6e4c9a3de04b" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_2c295680-6734-448c-995b-084b890b64a9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_2c295680-6734-448c-995b-084b890b64a9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_2c295680-6734-448c-995b-084b890b64a9" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_2c295680-6734-448c-995b-084b890b64a9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_3b220e27-2766-43ee-905e-78fae4ba864a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_2c295680-6734-448c-995b-084b890b64a9" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_3b220e27-2766-43ee-905e-78fae4ba864a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ParagonAgreementMember_00c3daf5-d9f3-4e53-961a-895c88287939" xlink:href="syre-20250331.xsd#syre_ParagonAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_3b220e27-2766-43ee-905e-78fae4ba864a" xlink:to="loc_syre_ParagonAgreementMember_00c3daf5-d9f3-4e53-961a-895c88287939" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_Spy001LicenseAgreementMember_da5f6f74-0247-445e-864e-0028c75c0afa" xlink:href="syre-20250331.xsd#syre_Spy001LicenseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_syre_ParagonAgreementMember_00c3daf5-d9f3-4e53-961a-895c88287939" xlink:to="loc_syre_Spy001LicenseAgreementMember_da5f6f74-0247-445e-864e-0028c75c0afa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SPY002LicenseAgreementMember_a12b6e98-6b1a-4d21-bdc1-330e9adce975" xlink:href="syre-20250331.xsd#syre_SPY002LicenseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_syre_ParagonAgreementMember_00c3daf5-d9f3-4e53-961a-895c88287939" xlink:to="loc_syre_SPY002LicenseAgreementMember_a12b6e98-6b1a-4d21-bdc1-330e9adce975" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SPY003LicenseAgreementMember_646ab207-c44d-4d09-a335-297c01d4730d" xlink:href="syre-20250331.xsd#syre_SPY003LicenseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_syre_ParagonAgreementMember_00c3daf5-d9f3-4e53-961a-895c88287939" xlink:to="loc_syre_SPY003LicenseAgreementMember_646ab207-c44d-4d09-a335-297c01d4730d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ParagonAgreementLicenseMilestonePaymentsMember_578c3460-93c3-47cd-b5fd-47b994a972ec" xlink:href="syre-20250331.xsd#syre_ParagonAgreementLicenseMilestonePaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_syre_ParagonAgreementMember_00c3daf5-d9f3-4e53-961a-895c88287939" xlink:to="loc_syre_ParagonAgreementLicenseMilestonePaymentsMember_578c3460-93c3-47cd-b5fd-47b994a972ec" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0dbd4ce2-c1dd-4d14-b791-c967cd2002d2" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_b621ffcf-f318-43be-b892-6e4c9a3de04b" xlink:to="loc_srt_RangeAxis_0dbd4ce2-c1dd-4d14-b791-c967cd2002d2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0dbd4ce2-c1dd-4d14-b791-c967cd2002d2_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_0dbd4ce2-c1dd-4d14-b791-c967cd2002d2" xlink:to="loc_srt_RangeMember_0dbd4ce2-c1dd-4d14-b791-c967cd2002d2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_15e3bceb-f36f-43c4-9ea4-ccb164c9561c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_0dbd4ce2-c1dd-4d14-b791-c967cd2002d2" xlink:to="loc_srt_RangeMember_15e3bceb-f36f-43c4-9ea4-ccb164c9561c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_700f97e4-0e4c-4158-a49a-e019885d1478" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_15e3bceb-f36f-43c4-9ea4-ccb164c9561c" xlink:to="loc_srt_MaximumMember_700f97e4-0e4c-4158-a49a-e019885d1478" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_AmountToBePaidUnderAgreement_1e281a54-085f-4010-ad9f-38ebff1d4ff9" xlink:href="syre-20250331.xsd#syre_AmountToBePaidUnderAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d9060080-65d4-42ea-83a5-9d732701d3c2" xlink:to="loc_syre_AmountToBePaidUnderAgreement_1e281a54-085f-4010-ad9f-38ebff1d4ff9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_PaymentOfMilestone_651bdebe-16b6-4628-be68-2ffedd54c1b4" xlink:href="syre-20250331.xsd#syre_PaymentOfMilestone"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d9060080-65d4-42ea-83a5-9d732701d3c2" xlink:to="loc_syre_PaymentOfMilestone_651bdebe-16b6-4628-be68-2ffedd54c1b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_CampaignTimelineMinimumTerm_6eba0faa-4654-4193-b8cc-f38bebde23bc" xlink:href="syre-20250331.xsd#syre_CampaignTimelineMinimumTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d9060080-65d4-42ea-83a5-9d732701d3c2" xlink:to="loc_syre_CampaignTimelineMinimumTerm_6eba0faa-4654-4193-b8cc-f38bebde23bc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_RoyaltyStepDownPercent_b1d9ede5-16da-4884-b8a2-9ccf6fa87a69" xlink:href="syre-20250331.xsd#syre_RoyaltyStepDownPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d9060080-65d4-42ea-83a5-9d732701d3c2" xlink:to="loc_syre_RoyaltyStepDownPercent_b1d9ede5-16da-4884-b8a2-9ccf6fa87a69" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_RoyaltyTermExpirationPeriod_161587ea-ac46-4ecb-9c36-b5cd9948d62e" xlink:href="syre-20250331.xsd#syre_RoyaltyTermExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d9060080-65d4-42ea-83a5-9d732701d3c2" xlink:to="loc_syre_RoyaltyTermExpirationPeriod_161587ea-ac46-4ecb-9c36-b5cd9948d62e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_TerminationNoticePeriod_6b2527f3-1bfd-4aad-8379-00c8f30a97a9" xlink:href="syre-20250331.xsd#syre_TerminationNoticePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d9060080-65d4-42ea-83a5-9d732701d3c2" xlink:to="loc_syre_TerminationNoticePeriod_6b2527f3-1bfd-4aad-8379-00c8f30a97a9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SublicensingFee_636e1b95-8692-41a5-93d7-1ee21f15396f" xlink:href="syre-20250331.xsd#syre_SublicensingFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d9060080-65d4-42ea-83a5-9d732701d3c2" xlink:to="loc_syre_SublicensingFee_636e1b95-8692-41a5-93d7-1ee21f15396f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_LicenseAgreementMilestoneExpenseAmountRecognized_9cfde962-157d-4843-9559-31a37d2d83c8" xlink:href="syre-20250331.xsd#syre_LicenseAgreementMilestoneExpenseAmountRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d9060080-65d4-42ea-83a5-9d732701d3c2" xlink:to="loc_syre_LicenseAgreementMilestoneExpenseAmountRecognized_9cfde962-157d-4843-9559-31a37d2d83c8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_LicenseAgreementMilestonePayments_dd2fa04c-a0d4-4d96-a5cd-a736c3c8b6f6" xlink:href="syre-20250331.xsd#syre_LicenseAgreementMilestonePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d9060080-65d4-42ea-83a5-9d732701d3c2" xlink:to="loc_syre_LicenseAgreementMilestonePayments_dd2fa04c-a0d4-4d96-a5cd-a736c3c8b6f6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_LicenseAgreementMilestonePaymentsOutstandingAndPayable_0214bd17-bb7d-49ce-a567-f264659128b4" xlink:href="syre-20250331.xsd#syre_LicenseAgreementMilestonePaymentsOutstandingAndPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d9060080-65d4-42ea-83a5-9d732701d3c2" xlink:to="loc_syre_LicenseAgreementMilestonePaymentsOutstandingAndPayable_0214bd17-bb7d-49ce-a567-f264659128b4" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_PaymentForSublicensingFee_fbcfc7bc-83e4-46fd-b964-78bc9c366faf" xlink:href="syre-20250331.xsd#syre_PaymentForSublicensingFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d9060080-65d4-42ea-83a5-9d732701d3c2" xlink:to="loc_syre_PaymentForSublicensingFee_fbcfc7bc-83e4-46fd-b964-78bc9c366faf" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SublicensingFeeOutstandingAndPayable_e3ea7b41-214c-4994-97be-733774a2bfb7" xlink:href="syre-20250331.xsd#syre_SublicensingFeeOutstandingAndPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d9060080-65d4-42ea-83a5-9d732701d3c2" xlink:to="loc_syre_SublicensingFeeOutstandingAndPayable_e3ea7b41-214c-4994-97be-733774a2bfb7" xlink:type="arc" order="11"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://spyre.com/role/RelatedPartyTransactionsNarrativeDetails" xlink:type="simple" xlink:href="syre-20250331.xsd#RelatedPartyTransactionsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://spyre.com/role/RelatedPartyTransactionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_f8927fe6-a392-47e8-b63e-19e596a38a84" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_fab21d49-b362-4ca8-8008-754a688bbd7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_f8927fe6-a392-47e8-b63e-19e596a38a84" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_fab21d49-b362-4ca8-8008-754a688bbd7d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_31eed31d-96a4-4537-b129-58d30851dc89" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_fab21d49-b362-4ca8-8008-754a688bbd7d" xlink:to="loc_srt_OwnershipAxis_31eed31d-96a4-4537-b129-58d30851dc89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_31eed31d-96a4-4537-b129-58d30851dc89_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_31eed31d-96a4-4537-b129-58d30851dc89" xlink:to="loc_srt_OwnershipDomain_31eed31d-96a4-4537-b129-58d30851dc89_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_ba0e348e-c2a8-44bd-b64a-5e1c298cc534" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_31eed31d-96a4-4537-b129-58d30851dc89" xlink:to="loc_srt_OwnershipDomain_ba0e348e-c2a8-44bd-b64a-5e1c298cc534" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ParagonTherapeuticsIncMember_de10426b-4077-4caa-908a-413fef74750e" xlink:href="syre-20250331.xsd#syre_ParagonTherapeuticsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_ba0e348e-c2a8-44bd-b64a-5e1c298cc534" xlink:to="loc_syre_ParagonTherapeuticsIncMember_de10426b-4077-4caa-908a-413fef74750e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_FairmountFundsManagementLlcMember_aa41d8f2-07f3-4ca9-a95e-51efca247553" xlink:href="syre-20250331.xsd#syre_FairmountFundsManagementLlcMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_ba0e348e-c2a8-44bd-b64a-5e1c298cc534" xlink:to="loc_syre_FairmountFundsManagementLlcMember_aa41d8f2-07f3-4ca9-a95e-51efca247553" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_df2a7799-fb71-4b83-ac52-0960e964d3be" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_fab21d49-b362-4ca8-8008-754a688bbd7d" xlink:to="loc_srt_RangeAxis_df2a7799-fb71-4b83-ac52-0960e964d3be" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_df2a7799-fb71-4b83-ac52-0960e964d3be_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_df2a7799-fb71-4b83-ac52-0960e964d3be" xlink:to="loc_srt_RangeMember_df2a7799-fb71-4b83-ac52-0960e964d3be_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a42a4031-58d2-4a90-a10d-820fe9df7df7" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_df2a7799-fb71-4b83-ac52-0960e964d3be" xlink:to="loc_srt_RangeMember_a42a4031-58d2-4a90-a10d-820fe9df7df7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3d4a245f-1074-438e-b5d9-eb7ae0da7c9c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a42a4031-58d2-4a90-a10d-820fe9df7df7" xlink:to="loc_srt_MaximumMember_3d4a245f-1074-438e-b5d9-eb7ae0da7c9c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_bf45e046-bc8a-4489-9c76-6c7cc97e21f0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a42a4031-58d2-4a90-a10d-820fe9df7df7" xlink:to="loc_srt_MinimumMember_bf45e046-bc8a-4489-9c76-6c7cc97e21f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_8fe14d85-d0c5-4c19-806c-ca342e2ac936" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_fab21d49-b362-4ca8-8008-754a688bbd7d" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_8fe14d85-d0c5-4c19-806c-ca342e2ac936" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_8fe14d85-d0c5-4c19-806c-ca342e2ac936_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_8fe14d85-d0c5-4c19-806c-ca342e2ac936" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_8fe14d85-d0c5-4c19-806c-ca342e2ac936_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_0cb7f186-f230-49ff-9dd4-66c251e7392a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_8fe14d85-d0c5-4c19-806c-ca342e2ac936" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_0cb7f186-f230-49ff-9dd4-66c251e7392a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ParagonAgreementMember_1a1f7d21-0c50-4ee1-ab96-a12d6727d118" xlink:href="syre-20250331.xsd#syre_ParagonAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_0cb7f186-f230-49ff-9dd4-66c251e7392a" xlink:to="loc_syre_ParagonAgreementMember_1a1f7d21-0c50-4ee1-ab96-a12d6727d118" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_AppointOfBoardMembersMember_c14e5da0-9d68-4872-833d-569ec11b4654" xlink:href="syre-20250331.xsd#syre_AppointOfBoardMembersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_0cb7f186-f230-49ff-9dd4-66c251e7392a" xlink:to="loc_syre_AppointOfBoardMembersMember_c14e5da0-9d68-4872-833d-569ec11b4654" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ParagonAgreementSubsequentToAssetAcquisitionMember_780774e4-7f19-43c1-b8db-4e30bea1df28" xlink:href="syre-20250331.xsd#syre_ParagonAgreementSubsequentToAssetAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_0cb7f186-f230-49ff-9dd4-66c251e7392a" xlink:to="loc_syre_ParagonAgreementSubsequentToAssetAcquisitionMember_780774e4-7f19-43c1-b8db-4e30bea1df28" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ConsultingAgreementMember_453a23c8-c963-403f-ae65-bd063fa7a5f7" xlink:href="syre-20250331.xsd#syre_ConsultingAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_0cb7f186-f230-49ff-9dd4-66c251e7392a" xlink:to="loc_syre_ConsultingAgreementMember_453a23c8-c963-403f-ae65-bd063fa7a5f7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_12c9c6f1-d2b5-49a0-8e37-4dcd2586e191" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_fab21d49-b362-4ca8-8008-754a688bbd7d" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_12c9c6f1-d2b5-49a0-8e37-4dcd2586e191" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_12c9c6f1-d2b5-49a0-8e37-4dcd2586e191_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_12c9c6f1-d2b5-49a0-8e37-4dcd2586e191" xlink:to="loc_us-gaap_RelatedPartyDomain_12c9c6f1-d2b5-49a0-8e37-4dcd2586e191_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_c421efe2-175e-4d71-8eea-2d03b43ee7f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_12c9c6f1-d2b5-49a0-8e37-4dcd2586e191" xlink:to="loc_us-gaap_RelatedPartyDomain_c421efe2-175e-4d71-8eea-2d03b43ee7f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_8495c46c-5369-4238-b0bb-9e8f7618bf80" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_c421efe2-175e-4d71-8eea-2d03b43ee7f6" xlink:to="loc_us-gaap_RelatedPartyMember_8495c46c-5369-4238-b0bb-9e8f7618bf80" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_d017568f-82de-43f7-a1cc-01cdaba7578f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_fab21d49-b362-4ca8-8008-754a688bbd7d" xlink:to="loc_us-gaap_PlanNameAxis_d017568f-82de-43f7-a1cc-01cdaba7578f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_d017568f-82de-43f7-a1cc-01cdaba7578f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_d017568f-82de-43f7-a1cc-01cdaba7578f" xlink:to="loc_us-gaap_PlanNameDomain_d017568f-82de-43f7-a1cc-01cdaba7578f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_1470e276-f484-4deb-a140-0eab52afbb20" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_d017568f-82de-43f7-a1cc-01cdaba7578f" xlink:to="loc_us-gaap_PlanNameDomain_1470e276-f484-4deb-a140-0eab52afbb20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ParapyreOptionObligationMember_a6755b5d-81a6-4c6f-aac3-0baf8a4c132c" xlink:href="syre-20250331.xsd#syre_ParapyreOptionObligationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_1470e276-f484-4deb-a140-0eab52afbb20" xlink:to="loc_syre_ParapyreOptionObligationMember_a6755b5d-81a6-4c6f-aac3-0baf8a4c132c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_79e95d17-2d12-4507-87b5-0f07f972fe4f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_fab21d49-b362-4ca8-8008-754a688bbd7d" xlink:to="loc_us-gaap_VestingAxis_79e95d17-2d12-4507-87b5-0f07f972fe4f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_79e95d17-2d12-4507-87b5-0f07f972fe4f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_79e95d17-2d12-4507-87b5-0f07f972fe4f" xlink:to="loc_us-gaap_VestingDomain_79e95d17-2d12-4507-87b5-0f07f972fe4f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_368b862d-05b9-4f21-92f9-0d6394863433" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_79e95d17-2d12-4507-87b5-0f07f972fe4f" xlink:to="loc_us-gaap_VestingDomain_368b862d-05b9-4f21-92f9-0d6394863433" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_00d978c8-7ee1-40d0-a38e-9315df8850fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_368b862d-05b9-4f21-92f9-0d6394863433" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_00d978c8-7ee1-40d0-a38e-9315df8850fd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_48ac1301-87af-4013-9623-c177250a5bed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_f8927fe6-a392-47e8-b63e-19e596a38a84" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_48ac1301-87af-4013-9623-c177250a5bed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_RelatedPartyTransactionNumberOfBoardSeats_01af8638-7d07-411e-ab38-aab43fe72f8d" xlink:href="syre-20250331.xsd#syre_RelatedPartyTransactionNumberOfBoardSeats"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_f8927fe6-a392-47e8-b63e-19e596a38a84" xlink:to="loc_syre_RelatedPartyTransactionNumberOfBoardSeats_01af8638-7d07-411e-ab38-aab43fe72f8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_MinorityInterestOwnershipPercentageByNoncontrollingOwnersHeldInThirdParty_688e7eca-2556-4f54-989e-26a02604e794" xlink:href="syre-20250331.xsd#syre_MinorityInterestOwnershipPercentageByNoncontrollingOwnersHeldInThirdParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_f8927fe6-a392-47e8-b63e-19e596a38a84" xlink:to="loc_syre_MinorityInterestOwnershipPercentageByNoncontrollingOwnersHeldInThirdParty_688e7eca-2556-4f54-989e-26a02604e794" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_DevelopmentCostReductionPercentage_ee1c42d8-8852-43f5-a9a8-3101a57791bf" xlink:href="syre-20250331.xsd#syre_DevelopmentCostReductionPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_f8927fe6-a392-47e8-b63e-19e596a38a84" xlink:to="loc_syre_DevelopmentCostReductionPercentage_ee1c42d8-8852-43f5-a9a8-3101a57791bf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_DevelopmentCostReimbursementPercentage_f884d062-fcd1-4449-b63a-0758608ec16f" xlink:href="syre-20250331.xsd#syre_DevelopmentCostReimbursementPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_f8927fe6-a392-47e8-b63e-19e596a38a84" xlink:to="loc_syre_DevelopmentCostReimbursementPercentage_f884d062-fcd1-4449-b63a-0758608ec16f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_80db7726-3eba-4704-88ab-2a3520c41722" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_f8927fe6-a392-47e8-b63e-19e596a38a84" xlink:to="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_80db7726-3eba-4704-88ab-2a3520c41722" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_470533e6-4a29-4df5-b662-dbd943859151" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_f8927fe6-a392-47e8-b63e-19e596a38a84" xlink:to="loc_us-gaap_ShareBasedCompensation_470533e6-4a29-4df5-b662-dbd943859151" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_CommonStockSharesOutstandingPercentageAvailableToPurchaseOnADilutedBasis_b6dec537-e507-4b1f-8d6a-f1ad2ff7a5d9" xlink:href="syre-20250331.xsd#syre_CommonStockSharesOutstandingPercentageAvailableToPurchaseOnADilutedBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_f8927fe6-a392-47e8-b63e-19e596a38a84" xlink:to="loc_syre_CommonStockSharesOutstandingPercentageAvailableToPurchaseOnADilutedBasis_b6dec537-e507-4b1f-8d6a-f1ad2ff7a5d9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_4108edcd-b5a7-46e9-8ec1-12b9f6f1e595" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_f8927fe6-a392-47e8-b63e-19e596a38a84" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_4108edcd-b5a7-46e9-8ec1-12b9f6f1e595" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_09575457-df9a-45b7-8a38-12f4f32b3826" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_f8927fe6-a392-47e8-b63e-19e596a38a84" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_09575457-df9a-45b7-8a38-12f4f32b3826" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_c46fc1dc-0185-482b-9335-58e3d6e0d852" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_f8927fe6-a392-47e8-b63e-19e596a38a84" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_c46fc1dc-0185-482b-9335-58e3d6e0d852" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_3beaa0ae-ece9-44c8-8c80-6cc5f340d663" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_f8927fe6-a392-47e8-b63e-19e596a38a84" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_3beaa0ae-ece9-44c8-8c80-6cc5f340d663" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_98df3fb5-3c2e-43f3-97be-b7178eb1f0ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_f8927fe6-a392-47e8-b63e-19e596a38a84" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_98df3fb5-3c2e-43f3-97be-b7178eb1f0ce" xlink:type="arc" order="12"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://spyre.com/role/RelatedPartyTransactionsExpensesrelatedtoRelatedPartywhichwereSettledinCashDetails" xlink:type="simple" xlink:href="syre-20250331.xsd#RelatedPartyTransactionsExpensesrelatedtoRelatedPartywhichwereSettledinCashDetails"/>
  <link:definitionLink xlink:role="http://spyre.com/role/RelatedPartyTransactionsExpensesrelatedtoRelatedPartywhichwereSettledinCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_6bdd169f-7f6e-4b83-aac1-edd9a7fe211a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d8400dff-7493-4190-b561-ce05d786e767" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_6bdd169f-7f6e-4b83-aac1-edd9a7fe211a" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d8400dff-7493-4190-b561-ce05d786e767" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_801240b7-63d0-42a6-b459-a45103af08ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d8400dff-7493-4190-b561-ce05d786e767" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_801240b7-63d0-42a6-b459-a45103af08ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_801240b7-63d0-42a6-b459-a45103af08ba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_801240b7-63d0-42a6-b459-a45103af08ba" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_801240b7-63d0-42a6-b459-a45103af08ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_05ab35a3-eb21-4674-b921-b80ace7a278e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_801240b7-63d0-42a6-b459-a45103af08ba" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_05ab35a3-eb21-4674-b921-b80ace7a278e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ParagonAndLicenseAgreementMember_847bbb31-d82a-4f84-af58-ea0801d750dc" xlink:href="syre-20250331.xsd#syre_ParagonAndLicenseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_05ab35a3-eb21-4674-b921-b80ace7a278e" xlink:to="loc_syre_ParagonAndLicenseAgreementMember_847bbb31-d82a-4f84-af58-ea0801d750dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ParagonAgreementMember_b8ad9b22-98d9-42d0-b430-799549ce2cbf" xlink:href="syre-20250331.xsd#syre_ParagonAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_syre_ParagonAndLicenseAgreementMember_847bbb31-d82a-4f84-af58-ea0801d750dc" xlink:to="loc_syre_ParagonAgreementMember_b8ad9b22-98d9-42d0-b430-799549ce2cbf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ParagonAgreementLicenseMilestonePaymentsMember_85abaa3c-e402-493f-bb49-07efb91aab74" xlink:href="syre-20250331.xsd#syre_ParagonAgreementLicenseMilestonePaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_syre_ParagonAndLicenseAgreementMember_847bbb31-d82a-4f84-af58-ea0801d750dc" xlink:to="loc_syre_ParagonAgreementLicenseMilestonePaymentsMember_85abaa3c-e402-493f-bb49-07efb91aab74" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dbcfdc4d-2ccc-41da-98d0-b364a7829504" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d8400dff-7493-4190-b561-ce05d786e767" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dbcfdc4d-2ccc-41da-98d0-b364a7829504" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_dbcfdc4d-2ccc-41da-98d0-b364a7829504_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dbcfdc4d-2ccc-41da-98d0-b364a7829504" xlink:to="loc_us-gaap_RelatedPartyDomain_dbcfdc4d-2ccc-41da-98d0-b364a7829504_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_f55c314c-7d6e-4ef7-ba99-d0059e25bd6a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dbcfdc4d-2ccc-41da-98d0-b364a7829504" xlink:to="loc_us-gaap_RelatedPartyDomain_f55c314c-7d6e-4ef7-ba99-d0059e25bd6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_4aa10e21-6802-402b-84c9-a09614206874" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_f55c314c-7d6e-4ef7-ba99-d0059e25bd6a" xlink:to="loc_us-gaap_RelatedPartyMember_4aa10e21-6802-402b-84c9-a09614206874" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_e967f517-e7c9-429d-a51e-458dd7d8be5b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_6bdd169f-7f6e-4b83-aac1-edd9a7fe211a" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_e967f517-e7c9-429d-a51e-458dd7d8be5b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://spyre.com/role/RelatedPartyTransactionsRelatedPartyAccountsPayableDetails" xlink:type="simple" xlink:href="syre-20250331.xsd#RelatedPartyTransactionsRelatedPartyAccountsPayableDetails"/>
  <link:definitionLink xlink:role="http://spyre.com/role/RelatedPartyTransactionsRelatedPartyAccountsPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_9c85934b-ea83-403a-92ec-95e1bad747a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9bcaf180-0f59-4b22-883e-49a8efd2f644" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9c85934b-ea83-403a-92ec-95e1bad747a7" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9bcaf180-0f59-4b22-883e-49a8efd2f644" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_40f9e319-2666-41e3-ab7e-00fcef848e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9bcaf180-0f59-4b22-883e-49a8efd2f644" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_40f9e319-2666-41e3-ab7e-00fcef848e5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_40f9e319-2666-41e3-ab7e-00fcef848e5b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_40f9e319-2666-41e3-ab7e-00fcef848e5b" xlink:to="loc_us-gaap_RelatedPartyDomain_40f9e319-2666-41e3-ab7e-00fcef848e5b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_6d8bf421-fcd7-4676-9cd5-3692c644d15f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_40f9e319-2666-41e3-ab7e-00fcef848e5b" xlink:to="loc_us-gaap_RelatedPartyDomain_6d8bf421-fcd7-4676-9cd5-3692c644d15f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_293e5c59-b43b-4f39-a4c5-471fd809b6e9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_6d8bf421-fcd7-4676-9cd5-3692c644d15f" xlink:to="loc_us-gaap_RelatedPartyMember_293e5c59-b43b-4f39-a4c5-471fd809b6e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_3bd3bf03-74d5-401d-818a-8f666f977234" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9bcaf180-0f59-4b22-883e-49a8efd2f644" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_3bd3bf03-74d5-401d-818a-8f666f977234" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_3bd3bf03-74d5-401d-818a-8f666f977234_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_3bd3bf03-74d5-401d-818a-8f666f977234" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_3bd3bf03-74d5-401d-818a-8f666f977234_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_628b3d82-0181-49cc-931a-e5a4c6440349" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_3bd3bf03-74d5-401d-818a-8f666f977234" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_628b3d82-0181-49cc-931a-e5a4c6440349" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ParagonAgreementMember_02bc3aa6-88ac-4c20-bf8e-c9fc60e80e5a" xlink:href="syre-20250331.xsd#syre_ParagonAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_628b3d82-0181-49cc-931a-e5a4c6440349" xlink:to="loc_syre_ParagonAgreementMember_02bc3aa6-88ac-4c20-bf8e-c9fc60e80e5a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ParapyreLiabilityLicenseAgreementsMember_43f31f18-8e54-4e2a-a789-787c1def6a61" xlink:href="syre-20250331.xsd#syre_ParapyreLiabilityLicenseAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_628b3d82-0181-49cc-931a-e5a4c6440349" xlink:to="loc_syre_ParapyreLiabilityLicenseAgreementsMember_43f31f18-8e54-4e2a-a789-787c1def6a61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableOtherCurrent_08c69c9e-bb39-4cea-b584-8d0463a0981b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableOtherCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9c85934b-ea83-403a-92ec-95e1bad747a7" xlink:to="loc_us-gaap_AccountsPayableOtherCurrent_08c69c9e-bb39-4cea-b584-8d0463a0981b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="syre-20250331.xsd#ConvertiblePreferredStockandStockholdersEquityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_1106da3b-2fcf-4a74-b550-939f14d4735a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_00983c02-afe3-442e-9518-643d98bc6455" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_1106da3b-2fcf-4a74-b550-939f14d4735a" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_00983c02-afe3-442e-9518-643d98bc6455" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_5d5d7107-0c72-4bc3-9df5-fc13a8eb2427" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_00983c02-afe3-442e-9518-643d98bc6455" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_5d5d7107-0c72-4bc3-9df5-fc13a8eb2427" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_5d5d7107-0c72-4bc3-9df5-fc13a8eb2427_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_5d5d7107-0c72-4bc3-9df5-fc13a8eb2427" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_5d5d7107-0c72-4bc3-9df5-fc13a8eb2427_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_481890d7-5922-40cb-9466-26a6394b0a48" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_5d5d7107-0c72-4bc3-9df5-fc13a8eb2427" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_481890d7-5922-40cb-9466-26a6394b0a48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ParapyreWarrantsMember_5bb784da-f857-45ba-8499-b7d28c56fb04" xlink:href="syre-20250331.xsd#syre_ParapyreWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_481890d7-5922-40cb-9466-26a6394b0a48" xlink:to="loc_syre_ParapyreWarrantsMember_5bb784da-f857-45ba-8499-b7d28c56fb04" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_df491008-b9a1-4f32-a838-d22e0b71b6b4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_00983c02-afe3-442e-9518-643d98bc6455" xlink:to="loc_us-gaap_PlanNameAxis_df491008-b9a1-4f32-a838-d22e0b71b6b4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_df491008-b9a1-4f32-a838-d22e0b71b6b4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_df491008-b9a1-4f32-a838-d22e0b71b6b4" xlink:to="loc_us-gaap_PlanNameDomain_df491008-b9a1-4f32-a838-d22e0b71b6b4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_1beb7b5b-c632-44a5-87aa-9c471acd34ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_df491008-b9a1-4f32-a838-d22e0b71b6b4" xlink:to="loc_us-gaap_PlanNameDomain_1beb7b5b-c632-44a5-87aa-9c471acd34ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_A2024ParapyreOptionObligationMember_4c7acfae-3ee0-4e2e-8fef-f62d223220cd" xlink:href="syre-20250331.xsd#syre_A2024ParapyreOptionObligationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_1beb7b5b-c632-44a5-87aa-9c471acd34ae" xlink:to="loc_syre_A2024ParapyreOptionObligationMember_4c7acfae-3ee0-4e2e-8fef-f62d223220cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_024550c6-2a2d-405a-8619-ebce65fa4237" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_00983c02-afe3-442e-9518-643d98bc6455" xlink:to="loc_us-gaap_StatementClassOfStockAxis_024550c6-2a2d-405a-8619-ebce65fa4237" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_024550c6-2a2d-405a-8619-ebce65fa4237_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_024550c6-2a2d-405a-8619-ebce65fa4237" xlink:to="loc_us-gaap_ClassOfStockDomain_024550c6-2a2d-405a-8619-ebce65fa4237_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_2fe42cb9-64bb-4e09-8ee4-04248cf42694" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_024550c6-2a2d-405a-8619-ebce65fa4237" xlink:to="loc_us-gaap_ClassOfStockDomain_2fe42cb9-64bb-4e09-8ee4-04248cf42694" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SeriesANonVotingConvertiblePreferredStockMember_eb9cccd0-bb4d-4f12-b20d-5e56506661d0" xlink:href="syre-20250331.xsd#syre_SeriesANonVotingConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_2fe42cb9-64bb-4e09-8ee4-04248cf42694" xlink:to="loc_syre_SeriesANonVotingConvertiblePreferredStockMember_eb9cccd0-bb4d-4f12-b20d-5e56506661d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_5c65d2b2-35f7-4b32-88aa-62b1484e3fee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_2fe42cb9-64bb-4e09-8ee4-04248cf42694" xlink:to="loc_us-gaap_CommonStockMember_5c65d2b2-35f7-4b32-88aa-62b1484e3fee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SeriesBNonVotingConvertiblePreferredStockMember_28f16fe2-6766-4634-a57c-d21c02e47da0" xlink:href="syre-20250331.xsd#syre_SeriesBNonVotingConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_2fe42cb9-64bb-4e09-8ee4-04248cf42694" xlink:to="loc_syre_SeriesBNonVotingConvertiblePreferredStockMember_28f16fe2-6766-4634-a57c-d21c02e47da0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_CommonStockAndSeriesBNonVotingConvertiblePreferredStockMember_05ee4d78-1ac2-4d99-ab21-54ea8ff20329" xlink:href="syre-20250331.xsd#syre_CommonStockAndSeriesBNonVotingConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_2fe42cb9-64bb-4e09-8ee4-04248cf42694" xlink:to="loc_syre_CommonStockAndSeriesBNonVotingConvertiblePreferredStockMember_05ee4d78-1ac2-4d99-ab21-54ea8ff20329" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_96ce7cbd-0b8d-4e00-b586-cf7b0f184e8e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_00983c02-afe3-442e-9518-643d98bc6455" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_96ce7cbd-0b8d-4e00-b586-cf7b0f184e8e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_96ce7cbd-0b8d-4e00-b586-cf7b0f184e8e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_96ce7cbd-0b8d-4e00-b586-cf7b0f184e8e" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_96ce7cbd-0b8d-4e00-b586-cf7b0f184e8e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1b7abb6c-0e1c-4a1a-88ba-d36d347bb3a6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_96ce7cbd-0b8d-4e00-b586-cf7b0f184e8e" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1b7abb6c-0e1c-4a1a-88ba-d36d347bb3a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_1f7cc62c-e0ba-4d15-8cfb-e77bb58b07a5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1b7abb6c-0e1c-4a1a-88ba-d36d347bb3a6" xlink:to="loc_us-gaap_PrivatePlacementMember_1f7cc62c-e0ba-4d15-8cfb-e77bb58b07a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_AtTheMarketOfferingMember_ec719759-db9b-47fc-a6a5-486b13c97a2b" xlink:href="syre-20250331.xsd#syre_AtTheMarketOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1b7abb6c-0e1c-4a1a-88ba-d36d347bb3a6" xlink:to="loc_syre_AtTheMarketOfferingMember_ec719759-db9b-47fc-a6a5-486b13c97a2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_UnderwrittenOfferingMember_7b87a98f-f8da-4aa7-8eb5-d36fa5ebccd2" xlink:href="syre-20250331.xsd#syre_UnderwrittenOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1b7abb6c-0e1c-4a1a-88ba-d36d347bb3a6" xlink:to="loc_syre_UnderwrittenOfferingMember_7b87a98f-f8da-4aa7-8eb5-d36fa5ebccd2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a4310037-4c07-4755-b969-ec52ff3d7b5e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_00983c02-afe3-442e-9518-643d98bc6455" xlink:to="loc_srt_RangeAxis_a4310037-4c07-4755-b969-ec52ff3d7b5e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a4310037-4c07-4755-b969-ec52ff3d7b5e_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a4310037-4c07-4755-b969-ec52ff3d7b5e" xlink:to="loc_srt_RangeMember_a4310037-4c07-4755-b969-ec52ff3d7b5e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_72bcfa3a-762d-4b78-9f95-33da27a874b4" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a4310037-4c07-4755-b969-ec52ff3d7b5e" xlink:to="loc_srt_RangeMember_72bcfa3a-762d-4b78-9f95-33da27a874b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c09df570-2cee-41cc-bc52-3971947ab709" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_72bcfa3a-762d-4b78-9f95-33da27a874b4" xlink:to="loc_srt_MinimumMember_c09df570-2cee-41cc-bc52-3971947ab709" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2eb7b31c-4c72-41c0-9a44-632767d64c63" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_72bcfa3a-762d-4b78-9f95-33da27a874b4" xlink:to="loc_srt_MaximumMember_2eb7b31c-4c72-41c0-9a44-632767d64c63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_0e609c01-1395-4827-83c2-8004cc0a3f76" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_00983c02-afe3-442e-9518-643d98bc6455" xlink:to="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_0e609c01-1395-4827-83c2-8004cc0a3f76" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_0e609c01-1395-4827-83c2-8004cc0a3f76_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_0e609c01-1395-4827-83c2-8004cc0a3f76" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_0e609c01-1395-4827-83c2-8004cc0a3f76_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_8d3ade70-ccb1-4153-b967-c159a8f6331f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_0e609c01-1395-4827-83c2-8004cc0a3f76" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_8d3ade70-ccb1-4153-b967-c159a8f6331f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ConversionOfSeriesBNonVotingConvertiblePreferredStockMember_f1a226b6-97c4-463c-882d-8dcacde9f715" xlink:href="syre-20250331.xsd#syre_ConversionOfSeriesBNonVotingConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_8d3ade70-ccb1-4153-b967-c159a8f6331f" xlink:to="loc_syre_ConversionOfSeriesBNonVotingConvertiblePreferredStockMember_f1a226b6-97c4-463c-882d-8dcacde9f715" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_7d511b79-4e7f-4b61-b456-b84e2655c880" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_00983c02-afe3-442e-9518-643d98bc6455" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_7d511b79-4e7f-4b61-b456-b84e2655c880" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7d511b79-4e7f-4b61-b456-b84e2655c880_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7d511b79-4e7f-4b61-b456-b84e2655c880" xlink:to="loc_us-gaap_EquityComponentDomain_7d511b79-4e7f-4b61-b456-b84e2655c880_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_95ef33b6-3418-4d92-8c15-f1df2dd7e0ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7d511b79-4e7f-4b61-b456-b84e2655c880" xlink:to="loc_us-gaap_EquityComponentDomain_95ef33b6-3418-4d92-8c15-f1df2dd7e0ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_83f31fdf-127c-4c90-90b4-1e710ca728fc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_95ef33b6-3418-4d92-8c15-f1df2dd7e0ec" xlink:to="loc_us-gaap_PreferredStockMember_83f31fdf-127c-4c90-90b4-1e710ca728fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_89fc4d06-901b-4721-9119-624396e9fa95" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1106da3b-2fcf-4a74-b550-939f14d4735a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_89fc4d06-901b-4721-9119-624396e9fa95" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_59a0473b-6e71-4e8a-98f4-d6edc5eccc5f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1106da3b-2fcf-4a74-b550-939f14d4735a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_59a0473b-6e71-4e8a-98f4-d6edc5eccc5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ClassOfWarrantOrRightNumberOfSecuritiesExercised_1923467f-1707-4ba2-8cc0-9bcb43359e50" xlink:href="syre-20250331.xsd#syre_ClassOfWarrantOrRightNumberOfSecuritiesExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1106da3b-2fcf-4a74-b550-939f14d4735a" xlink:to="loc_syre_ClassOfWarrantOrRightNumberOfSecuritiesExercised_1923467f-1707-4ba2-8cc0-9bcb43359e50" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_PreferredStockRemainsIssuedAndOutstandingPercentage_a0963e41-7887-415b-aa0d-8f88615559b5" xlink:href="syre-20250331.xsd#syre_PreferredStockRemainsIssuedAndOutstandingPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1106da3b-2fcf-4a74-b550-939f14d4735a" xlink:to="loc_syre_PreferredStockRemainsIssuedAndOutstandingPercentage_a0963e41-7887-415b-aa0d-8f88615559b5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_StockIssuedDuringPeriodSharesExchangeOfConvertibleSecurities_c6990dc8-3629-482d-be50-2d4507102b0d" xlink:href="syre-20250331.xsd#syre_StockIssuedDuringPeriodSharesExchangeOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1106da3b-2fcf-4a74-b550-939f14d4735a" xlink:to="loc_syre_StockIssuedDuringPeriodSharesExchangeOfConvertibleSecurities_c6990dc8-3629-482d-be50-2d4507102b0d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_c65adb30-4274-4912-80b1-44ea334a7bee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1106da3b-2fcf-4a74-b550-939f14d4735a" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_c65adb30-4274-4912-80b1-44ea334a7bee" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockConvertibleSharesIssuable_8acca36b-3281-4e9a-a8c3-965c5845d324" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockConvertibleSharesIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1106da3b-2fcf-4a74-b550-939f14d4735a" xlink:to="loc_us-gaap_PreferredStockConvertibleSharesIssuable_8acca36b-3281-4e9a-a8c3-965c5845d324" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_dd1e63a3-1507-4392-853e-95f1e880b621" xlink:href="syre-20250331.xsd#syre_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1106da3b-2fcf-4a74-b550-939f14d4735a" xlink:to="loc_syre_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_dd1e63a3-1507-4392-853e-95f1e880b621" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_cfde6cac-078d-4244-af8b-23d6c82654fb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1106da3b-2fcf-4a74-b550-939f14d4735a" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_cfde6cac-078d-4244-af8b-23d6c82654fb" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_4d6493a7-7e67-42a5-9a9d-2fbd1a8bd516" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1106da3b-2fcf-4a74-b550-939f14d4735a" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_4d6493a7-7e67-42a5-9a9d-2fbd1a8bd516" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_329b8d61-a49d-46d8-8f0a-7ba25ebdf8dc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1106da3b-2fcf-4a74-b550-939f14d4735a" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_329b8d61-a49d-46d8-8f0a-7ba25ebdf8dc" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockConvertibleConversionRatio_35dd6743-50e9-4c53-baef-cf366b68e3a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockConvertibleConversionRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1106da3b-2fcf-4a74-b550-939f14d4735a" xlink:to="loc_us-gaap_PreferredStockConvertibleConversionRatio_35dd6743-50e9-4c53-baef-cf366b68e3a9" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_BeneficialHoldersOwnedPercentage_2fbea9f3-9b97-4d00-b494-d0099a7d4e98" xlink:href="syre-20250331.xsd#syre_BeneficialHoldersOwnedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1106da3b-2fcf-4a74-b550-939f14d4735a" xlink:to="loc_syre_BeneficialHoldersOwnedPercentage_2fbea9f3-9b97-4d00-b494-d0099a7d4e98" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_29035007-b4c5-46ed-a2ce-87e2444f41fc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1106da3b-2fcf-4a74-b550-939f14d4735a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_29035007-b4c5-46ed-a2ce-87e2444f41fc" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_PreferredStockSharesNotAutomaticallyConvertedOutstanding_c6d562d5-dab9-47b9-8ed3-a0b91b2f5ac2" xlink:href="syre-20250331.xsd#syre_PreferredStockSharesNotAutomaticallyConvertedOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1106da3b-2fcf-4a74-b550-939f14d4735a" xlink:to="loc_syre_PreferredStockSharesNotAutomaticallyConvertedOutstanding_c6d562d5-dab9-47b9-8ed3-a0b91b2f5ac2" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SaleOfStockAuthorizedAmount_1c9ad9f3-43b5-4e07-ac09-723300061aaa" xlink:href="syre-20250331.xsd#syre_SaleOfStockAuthorizedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1106da3b-2fcf-4a74-b550-939f14d4735a" xlink:to="loc_syre_SaleOfStockAuthorizedAmount_1c9ad9f3-43b5-4e07-ac09-723300061aaa" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SaleOfStockAggregateOfferingPrice_e2d1bb32-1cc3-4d3e-a2dd-0fe5276a9f17" xlink:href="syre-20250331.xsd#syre_SaleOfStockAggregateOfferingPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1106da3b-2fcf-4a74-b550-939f14d4735a" xlink:to="loc_syre_SaleOfStockAggregateOfferingPrice_e2d1bb32-1cc3-4d3e-a2dd-0fe5276a9f17" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_e4069eaa-0b8c-4ae6-bc58-5dc38b3c090f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1106da3b-2fcf-4a74-b550-939f14d4735a" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_e4069eaa-0b8c-4ae6-bc58-5dc38b3c090f" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SaleOfStockRemainingAuthorizedAmount_c59dd9c0-7757-4b98-8deb-9d6acda06e31" xlink:href="syre-20250331.xsd#syre_SaleOfStockRemainingAuthorizedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1106da3b-2fcf-4a74-b550-939f14d4735a" xlink:to="loc_syre_SaleOfStockRemainingAuthorizedAmount_c59dd9c0-7757-4b98-8deb-9d6acda06e31" xlink:type="arc" order="18"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://spyre.com/role/StockBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="syre-20250331.xsd#StockBasedCompensationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://spyre.com/role/StockBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d580a91-c3eb-4d47-a767-b1d81416d376" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_86033456-cae2-48dc-929c-a21d1b71427d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d580a91-c3eb-4d47-a767-b1d81416d376" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_86033456-cae2-48dc-929c-a21d1b71427d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_3e3cfe83-355a-4312-8b5c-28a893ccb464" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_86033456-cae2-48dc-929c-a21d1b71427d" xlink:to="loc_us-gaap_PlanNameAxis_3e3cfe83-355a-4312-8b5c-28a893ccb464" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_3e3cfe83-355a-4312-8b5c-28a893ccb464_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_3e3cfe83-355a-4312-8b5c-28a893ccb464" xlink:to="loc_us-gaap_PlanNameDomain_3e3cfe83-355a-4312-8b5c-28a893ccb464_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_a6632908-1fac-485b-9236-34d2612b467b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_3e3cfe83-355a-4312-8b5c-28a893ccb464" xlink:to="loc_us-gaap_PlanNameDomain_a6632908-1fac-485b-9236-34d2612b467b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_TwoThousandAndFifteenAndTwoThousandAndSixteenEquityIncentivePlanAndTwoThousandAndEighteenEquityInducementPlanMember_adfcfa8e-19d3-4883-b0b2-d24950404bf3" xlink:href="syre-20250331.xsd#syre_TwoThousandAndFifteenAndTwoThousandAndSixteenEquityIncentivePlanAndTwoThousandAndEighteenEquityInducementPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_a6632908-1fac-485b-9236-34d2612b467b" xlink:to="loc_syre_TwoThousandAndFifteenAndTwoThousandAndSixteenEquityIncentivePlanAndTwoThousandAndEighteenEquityInducementPlanMember_adfcfa8e-19d3-4883-b0b2-d24950404bf3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_TwoThousandAndFifteenEquityIncentivePlanMember_6bd6cdc5-14a0-44f0-842a-4758d0e02baa" xlink:href="syre-20250331.xsd#syre_TwoThousandAndFifteenEquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_syre_TwoThousandAndFifteenAndTwoThousandAndSixteenEquityIncentivePlanAndTwoThousandAndEighteenEquityInducementPlanMember_adfcfa8e-19d3-4883-b0b2-d24950404bf3" xlink:to="loc_syre_TwoThousandAndFifteenEquityIncentivePlanMember_6bd6cdc5-14a0-44f0-842a-4758d0e02baa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_TwoThousandAndSixteenEquityIncentivePlanMember_f7767a49-e420-4afd-907d-c4f13a2af10a" xlink:href="syre-20250331.xsd#syre_TwoThousandAndSixteenEquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_syre_TwoThousandAndFifteenAndTwoThousandAndSixteenEquityIncentivePlanAndTwoThousandAndEighteenEquityInducementPlanMember_adfcfa8e-19d3-4883-b0b2-d24950404bf3" xlink:to="loc_syre_TwoThousandAndSixteenEquityIncentivePlanMember_f7767a49-e420-4afd-907d-c4f13a2af10a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_TwoThousandAndEighteenEquityInducementPlanMember_db62913d-db71-45da-8ac8-213a28a065e7" xlink:href="syre-20250331.xsd#syre_TwoThousandAndEighteenEquityInducementPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_syre_TwoThousandAndFifteenAndTwoThousandAndSixteenEquityIncentivePlanAndTwoThousandAndEighteenEquityInducementPlanMember_adfcfa8e-19d3-4883-b0b2-d24950404bf3" xlink:to="loc_syre_TwoThousandAndEighteenEquityInducementPlanMember_db62913d-db71-45da-8ac8-213a28a065e7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_TwoThousandAndEighteenEquityInducementPlanAmendedMember_e69b84e7-1c1f-4eff-b97b-2e6368c47579" xlink:href="syre-20250331.xsd#syre_TwoThousandAndEighteenEquityInducementPlanAmendedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_syre_TwoThousandAndEighteenEquityInducementPlanMember_db62913d-db71-45da-8ac8-213a28a065e7" xlink:to="loc_syre_TwoThousandAndEighteenEquityInducementPlanAmendedMember_e69b84e7-1c1f-4eff-b97b-2e6368c47579" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_Spyre2023EquityIncentivePlanMember_9da4b39e-9cb0-4f1f-8f77-0dfdf873a5cc" xlink:href="syre-20250331.xsd#syre_Spyre2023EquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_a6632908-1fac-485b-9236-34d2612b467b" xlink:to="loc_syre_Spyre2023EquityIncentivePlanMember_9da4b39e-9cb0-4f1f-8f77-0dfdf873a5cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ParapyreOptionObligationMember_6c85c6c2-8b22-45f0-8ec2-473606786e0d" xlink:href="syre-20250331.xsd#syre_ParapyreOptionObligationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_a6632908-1fac-485b-9236-34d2612b467b" xlink:to="loc_syre_ParapyreOptionObligationMember_6c85c6c2-8b22-45f0-8ec2-473606786e0d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_A2024ParapyreOptionObligationMember_1b0095c2-f2ff-4528-b3a4-d0971a6a5524" xlink:href="syre-20250331.xsd#syre_A2024ParapyreOptionObligationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_syre_ParapyreOptionObligationMember_6c85c6c2-8b22-45f0-8ec2-473606786e0d" xlink:to="loc_syre_A2024ParapyreOptionObligationMember_1b0095c2-f2ff-4528-b3a4-d0971a6a5524" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_TwoThousandAndSixteenEmployeeStockPurchasePlanMember_a8e61cba-e6e8-48c9-bc55-6b52a9904f76" xlink:href="syre-20250331.xsd#syre_TwoThousandAndSixteenEmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_a6632908-1fac-485b-9236-34d2612b467b" xlink:to="loc_syre_TwoThousandAndSixteenEmployeeStockPurchasePlanMember_a8e61cba-e6e8-48c9-bc55-6b52a9904f76" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_fdb0c319-47b3-483f-925e-773f9adf852a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_86033456-cae2-48dc-929c-a21d1b71427d" xlink:to="loc_us-gaap_AwardTypeAxis_fdb0c319-47b3-483f-925e-773f9adf852a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fdb0c319-47b3-483f-925e-773f9adf852a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_fdb0c319-47b3-483f-925e-773f9adf852a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fdb0c319-47b3-483f-925e-773f9adf852a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_06ab76d4-cdec-4e4e-8e6b-574dbeba4256" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_fdb0c319-47b3-483f-925e-773f9adf852a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_06ab76d4-cdec-4e4e-8e6b-574dbeba4256" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ServiceBasedAwardsMember_dfa8daee-9ca6-430d-98ac-0459c6b0cfc3" xlink:href="syre-20250331.xsd#syre_ServiceBasedAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_06ab76d4-cdec-4e4e-8e6b-574dbeba4256" xlink:to="loc_syre_ServiceBasedAwardsMember_dfa8daee-9ca6-430d-98ac-0459c6b0cfc3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_0f89bc98-bd0a-460f-9fd8-f0fd1233f4f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_86033456-cae2-48dc-929c-a21d1b71427d" xlink:to="loc_us-gaap_AssetAcquisitionAxis_0f89bc98-bd0a-460f-9fd8-f0fd1233f4f5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_0f89bc98-bd0a-460f-9fd8-f0fd1233f4f5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AssetAcquisitionAxis_0f89bc98-bd0a-460f-9fd8-f0fd1233f4f5" xlink:to="loc_us-gaap_AssetAcquisitionDomain_0f89bc98-bd0a-460f-9fd8-f0fd1233f4f5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_f86d1235-2aa8-45f6-be46-b80d7a15a4c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AssetAcquisitionAxis_0f89bc98-bd0a-460f-9fd8-f0fd1233f4f5" xlink:to="loc_us-gaap_AssetAcquisitionDomain_f86d1235-2aa8-45f6-be46-b80d7a15a4c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_AssetAcquisitionMember_a7a43d3e-b244-48d5-bf2e-aaa19cd1213b" xlink:href="syre-20250331.xsd#syre_AssetAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_f86d1235-2aa8-45f6-be46-b80d7a15a4c6" xlink:to="loc_syre_AssetAcquisitionMember_a7a43d3e-b244-48d5-bf2e-aaa19cd1213b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_164de455-fbe9-457d-8435-a9725e1c2ae6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_86033456-cae2-48dc-929c-a21d1b71427d" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_164de455-fbe9-457d-8435-a9725e1c2ae6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_164de455-fbe9-457d-8435-a9725e1c2ae6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_164de455-fbe9-457d-8435-a9725e1c2ae6" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_164de455-fbe9-457d-8435-a9725e1c2ae6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_dc49f355-b05f-47b4-aaba-9b259db99308" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_164de455-fbe9-457d-8435-a9725e1c2ae6" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_dc49f355-b05f-47b4-aaba-9b259db99308" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_A2016ESPPMember_85002e28-89f7-42fa-bd13-456a8d645b7d" xlink:href="syre-20250331.xsd#syre_A2016ESPPMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_dc49f355-b05f-47b4-aaba-9b259db99308" xlink:to="loc_syre_A2016ESPPMember_85002e28-89f7-42fa-bd13-456a8d645b7d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_3a9208bd-9c5b-40c1-ad6b-50774c2cc456" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_86033456-cae2-48dc-929c-a21d1b71427d" xlink:to="loc_us-gaap_StatementClassOfStockAxis_3a9208bd-9c5b-40c1-ad6b-50774c2cc456" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_3a9208bd-9c5b-40c1-ad6b-50774c2cc456_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_3a9208bd-9c5b-40c1-ad6b-50774c2cc456" xlink:to="loc_us-gaap_ClassOfStockDomain_3a9208bd-9c5b-40c1-ad6b-50774c2cc456_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f042e8e2-f323-4a66-903c-3cbacd904474" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_3a9208bd-9c5b-40c1-ad6b-50774c2cc456" xlink:to="loc_us-gaap_ClassOfStockDomain_f042e8e2-f323-4a66-903c-3cbacd904474" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_35c382de-ab1b-4a69-9923-d11050f2ab3a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_f042e8e2-f323-4a66-903c-3cbacd904474" xlink:to="loc_us-gaap_EmployeeStockMember_35c382de-ab1b-4a69-9923-d11050f2ab3a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_45506d47-0378-4020-822a-ebe8f1d772b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_86033456-cae2-48dc-929c-a21d1b71427d" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_45506d47-0378-4020-822a-ebe8f1d772b1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_45506d47-0378-4020-822a-ebe8f1d772b1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_45506d47-0378-4020-822a-ebe8f1d772b1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_45506d47-0378-4020-822a-ebe8f1d772b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_04a1caa5-c05b-489e-9003-3daf1ca57432" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_45506d47-0378-4020-822a-ebe8f1d772b1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_04a1caa5-c05b-489e-9003-3daf1ca57432" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ParapyreWarrantsMember_e01367f3-8e65-4747-b1e6-44889ee798ba" xlink:href="syre-20250331.xsd#syre_ParapyreWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_04a1caa5-c05b-489e-9003-3daf1ca57432" xlink:to="loc_syre_ParapyreWarrantsMember_e01367f3-8e65-4747-b1e6-44889ee798ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease_901e0733-6980-4138-85bf-6dbe0f40e60e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d580a91-c3eb-4d47-a767-b1d81416d376" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease_901e0733-6980-4138-85bf-6dbe0f40e60e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_AnnualPercentageOfAdditionalSharesWhichEqualsToIssuedAndOutstandingShares_85c2ad52-5645-48ec-bc3a-cbd09cf2e2d5" xlink:href="syre-20250331.xsd#syre_AnnualPercentageOfAdditionalSharesWhichEqualsToIssuedAndOutstandingShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d580a91-c3eb-4d47-a767-b1d81416d376" xlink:to="loc_syre_AnnualPercentageOfAdditionalSharesWhichEqualsToIssuedAndOutstandingShares_85c2ad52-5645-48ec-bc3a-cbd09cf2e2d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalNumberOfSharesAvailableForGrant_5473dbad-4aab-4fc9-8fc6-7977016b5785" xlink:href="syre-20250331.xsd#syre_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d580a91-c3eb-4d47-a767-b1d81416d376" xlink:to="loc_syre_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalNumberOfSharesAvailableForGrant_5473dbad-4aab-4fc9-8fc6-7977016b5785" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_fd07ae4f-7615-4e0b-bb9b-36e6d0930a55" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d580a91-c3eb-4d47-a767-b1d81416d376" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_fd07ae4f-7615-4e0b-bb9b-36e6d0930a55" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d987eef0-dca5-4bdc-9ca9-e4292392eab2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d580a91-c3eb-4d47-a767-b1d81416d376" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d987eef0-dca5-4bdc-9ca9-e4292392eab2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_CommonStockCapitalSharesReservedForFutureIssuanceIncreasedAmount_cf70e14a-8ba9-443e-9474-546c519d24a5" xlink:href="syre-20250331.xsd#syre_CommonStockCapitalSharesReservedForFutureIssuanceIncreasedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d580a91-c3eb-4d47-a767-b1d81416d376" xlink:to="loc_syre_CommonStockCapitalSharesReservedForFutureIssuanceIncreasedAmount_cf70e14a-8ba9-443e-9474-546c519d24a5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_14bbabb6-82cc-44b6-8075-f523586dbf82" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d580a91-c3eb-4d47-a767-b1d81416d376" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_14bbabb6-82cc-44b6-8075-f523586dbf82" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_570598cf-aa4e-4292-b756-d0fae08822aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d580a91-c3eb-4d47-a767-b1d81416d376" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_570598cf-aa4e-4292-b756-d0fae08822aa" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_OutstandingAndUnexercisedStockOptions_0494f5e8-482b-4cef-b582-6686f7288dee" xlink:href="syre-20250331.xsd#syre_OutstandingAndUnexercisedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d580a91-c3eb-4d47-a767-b1d81416d376" xlink:to="loc_syre_OutstandingAndUnexercisedStockOptions_0494f5e8-482b-4cef-b582-6686f7288dee" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_9ebfa596-2972-4705-88ea-2734a62c07f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d580a91-c3eb-4d47-a767-b1d81416d376" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_9ebfa596-2972-4705-88ea-2734a62c07f0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_51d2deba-1c60-4d10-864b-de5580814e42" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d580a91-c3eb-4d47-a767-b1d81416d376" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_51d2deba-1c60-4d10-864b-de5580814e42" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_089df1c1-99d6-42b5-8036-26e368232573" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d580a91-c3eb-4d47-a767-b1d81416d376" xlink:to="loc_us-gaap_ShareBasedCompensation_089df1c1-99d6-42b5-8036-26e368232573" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_ea4c3047-2049-4a67-bb5c-286c177d8261" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d580a91-c3eb-4d47-a767-b1d81416d376" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_ea4c3047-2049-4a67-bb5c-286c177d8261" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_e22bbe9c-23b0-4f67-8603-7dd3295f9b9f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d580a91-c3eb-4d47-a767-b1d81416d376" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_e22bbe9c-23b0-4f67-8603-7dd3295f9b9f" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_bd7cffa6-4d0e-47dc-9d30-94ac460829c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d580a91-c3eb-4d47-a767-b1d81416d376" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_bd7cffa6-4d0e-47dc-9d30-94ac460829c5" xlink:type="arc" order="14"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://spyre.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="syre-20250331.xsd#StockBasedCompensationStockBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://spyre.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0850ef9d-8323-49fc-88c9-14e29d5a64d0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_54b7952d-0674-41dc-a51c-8c5bb3c53010" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0850ef9d-8323-49fc-88c9-14e29d5a64d0" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_54b7952d-0674-41dc-a51c-8c5bb3c53010" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_298b08dc-daba-47c1-8ea2-eae7536c84a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_54b7952d-0674-41dc-a51c-8c5bb3c53010" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_298b08dc-daba-47c1-8ea2-eae7536c84a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_298b08dc-daba-47c1-8ea2-eae7536c84a7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_298b08dc-daba-47c1-8ea2-eae7536c84a7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_298b08dc-daba-47c1-8ea2-eae7536c84a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_509cb56a-878f-4dd4-96b6-94332a896cf1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_298b08dc-daba-47c1-8ea2-eae7536c84a7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_509cb56a-878f-4dd4-96b6-94332a896cf1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_a0593770-dbe7-4b83-9da8-3c375565facd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_509cb56a-878f-4dd4-96b6-94332a896cf1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_a0593770-dbe7-4b83-9da8-3c375565facd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_33e1c84b-115c-4d63-a50a-f5cd4039a444" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_509cb56a-878f-4dd4-96b6-94332a896cf1" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_33e1c84b-115c-4d63-a50a-f5cd4039a444" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_31718cd1-a8a1-437d-932c-54e82241387d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_54b7952d-0674-41dc-a51c-8c5bb3c53010" xlink:to="loc_us-gaap_PlanNameAxis_31718cd1-a8a1-437d-932c-54e82241387d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_31718cd1-a8a1-437d-932c-54e82241387d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_31718cd1-a8a1-437d-932c-54e82241387d" xlink:to="loc_us-gaap_PlanNameDomain_31718cd1-a8a1-437d-932c-54e82241387d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_cbe917ba-4854-4b79-a812-e18d44c6b718" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_31718cd1-a8a1-437d-932c-54e82241387d" xlink:to="loc_us-gaap_PlanNameDomain_cbe917ba-4854-4b79-a812-e18d44c6b718" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ParapyreOptionObligationMember_e40a8fe2-99e9-4d6f-bbcd-31d354a24c96" xlink:href="syre-20250331.xsd#syre_ParapyreOptionObligationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_cbe917ba-4854-4b79-a812-e18d44c6b718" xlink:to="loc_syre_ParapyreOptionObligationMember_e40a8fe2-99e9-4d6f-bbcd-31d354a24c96" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_656205a4-939e-4902-9074-20e8533adcd3" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_54b7952d-0674-41dc-a51c-8c5bb3c53010" xlink:to="loc_srt_TitleOfIndividualAxis_656205a4-939e-4902-9074-20e8533adcd3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_656205a4-939e-4902-9074-20e8533adcd3_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_656205a4-939e-4902-9074-20e8533adcd3" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_656205a4-939e-4902-9074-20e8533adcd3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_eeedb6d6-8574-4b96-a3d4-e59ce1347a5a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_656205a4-939e-4902-9074-20e8533adcd3" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_eeedb6d6-8574-4b96-a3d4-e59ce1347a5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_AegleaEmployeesAndDirectorsMember_7583122b-96d4-4afa-a775-b2af0fb495a6" xlink:href="syre-20250331.xsd#syre_AegleaEmployeesAndDirectorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_eeedb6d6-8574-4b96-a3d4-e59ce1347a5a" xlink:to="loc_syre_AegleaEmployeesAndDirectorsMember_7583122b-96d4-4afa-a775-b2af0fb495a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_a5a13077-531e-4d79-aac5-dea3d9ce6a93" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0850ef9d-8323-49fc-88c9-14e29d5a64d0" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_a5a13077-531e-4d79-aac5-dea3d9ce6a93" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_79c281e9-31f1-47c5-8b93-42026be337bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0850ef9d-8323-49fc-88c9-14e29d5a64d0" xlink:to="loc_us-gaap_ShareBasedCompensation_79c281e9-31f1-47c5-8b93-42026be337bf" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://spyre.com/role/StockBasedCompensationAssumptionsusedtoEstimatetheFairValueofStockOptionsGrantedDetails" xlink:type="simple" xlink:href="syre-20250331.xsd#StockBasedCompensationAssumptionsusedtoEstimatetheFairValueofStockOptionsGrantedDetails"/>
  <link:definitionLink xlink:role="http://spyre.com/role/StockBasedCompensationAssumptionsusedtoEstimatetheFairValueofStockOptionsGrantedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_b3d82768-1da7-4b28-a8a0-fb5a5a6d7d2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_4508c9c4-c423-44f2-965d-7c1757507f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_b3d82768-1da7-4b28-a8a0-fb5a5a6d7d2f" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_4508c9c4-c423-44f2-965d-7c1757507f7d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_d3314663-351c-414d-8756-619c232b4c00" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_4508c9c4-c423-44f2-965d-7c1757507f7d" xlink:to="loc_us-gaap_PlanNameAxis_d3314663-351c-414d-8756-619c232b4c00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_d3314663-351c-414d-8756-619c232b4c00_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_d3314663-351c-414d-8756-619c232b4c00" xlink:to="loc_us-gaap_PlanNameDomain_d3314663-351c-414d-8756-619c232b4c00_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_19ac9f6a-ba68-4b5b-b5f6-4431a0c5b90b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_d3314663-351c-414d-8756-619c232b4c00" xlink:to="loc_us-gaap_PlanNameDomain_19ac9f6a-ba68-4b5b-b5f6-4431a0c5b90b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_TwoThousandAndSixteenEquityIncentivePlanMember_f08ad179-7941-4509-9871-4a550f4f2011" xlink:href="syre-20250331.xsd#syre_TwoThousandAndSixteenEquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_19ac9f6a-ba68-4b5b-b5f6-4431a0c5b90b" xlink:to="loc_syre_TwoThousandAndSixteenEquityIncentivePlanMember_f08ad179-7941-4509-9871-4a550f4f2011" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_TwoThousandAndSixteenEmployeeStockPurchasePlanMember_2254006f-2dbf-4869-b7cd-84d45155aa0d" xlink:href="syre-20250331.xsd#syre_TwoThousandAndSixteenEmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_19ac9f6a-ba68-4b5b-b5f6-4431a0c5b90b" xlink:to="loc_syre_TwoThousandAndSixteenEmployeeStockPurchasePlanMember_2254006f-2dbf-4869-b7cd-84d45155aa0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_be58f49d-f008-4769-8744-f228367e4e85" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_b3d82768-1da7-4b28-a8a0-fb5a5a6d7d2f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_be58f49d-f008-4769-8744-f228367e4e85" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_6659ee56-dc0d-4650-a8ba-4c9b41644625" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_b3d82768-1da7-4b28-a8a0-fb5a5a6d7d2f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_6659ee56-dc0d-4650-a8ba-4c9b41644625" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_7fc32531-0074-404f-82d8-e473f2b6e486" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_b3d82768-1da7-4b28-a8a0-fb5a5a6d7d2f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_7fc32531-0074-404f-82d8-e473f2b6e486" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_aa260dc4-3c59-4313-9b01-138581123eb2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_b3d82768-1da7-4b28-a8a0-fb5a5a6d7d2f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_aa260dc4-3c59-4313-9b01-138581123eb2" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://spyre.com/role/SegmentReportingSummaryofSignificantSegmentExpensesDetails" xlink:type="simple" xlink:href="syre-20250331.xsd#SegmentReportingSummaryofSignificantSegmentExpensesDetails"/>
  <link:definitionLink xlink:role="http://spyre.com/role/SegmentReportingSummaryofSignificantSegmentExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_65201786-daca-41a6-9491-690f9d57a4bc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_5ae70802-b1ea-46b3-9274-7ba786a7bcb7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_65201786-daca-41a6-9491-690f9d57a4bc" xlink:to="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_5ae70802-b1ea-46b3-9274-7ba786a7bcb7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e9ca5493-eb37-4ebb-ab2b-71a3613c9c56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_5ae70802-b1ea-46b3-9274-7ba786a7bcb7" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e9ca5493-eb37-4ebb-ab2b-71a3613c9c56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e9ca5493-eb37-4ebb-ab2b-71a3613c9c56_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e9ca5493-eb37-4ebb-ab2b-71a3613c9c56" xlink:to="loc_us-gaap_SegmentDomain_e9ca5493-eb37-4ebb-ab2b-71a3613c9c56_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b1338c13-431c-4cbb-a932-7fcd7e0acddd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e9ca5493-eb37-4ebb-ab2b-71a3613c9c56" xlink:to="loc_us-gaap_SegmentDomain_b1338c13-431c-4cbb-a932-7fcd7e0acddd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ReportableSegmentMember_2f21e6e3-a26c-4c31-a466-bf12fa2cb1f2" xlink:href="syre-20250331.xsd#syre_ReportableSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b1338c13-431c-4cbb-a932-7fcd7e0acddd" xlink:to="loc_syre_ReportableSegmentMember_2f21e6e3-a26c-4c31-a466-bf12fa2cb1f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_45c88ead-3b41-4f56-b105-144df9b5c464" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_5ae70802-b1ea-46b3-9274-7ba786a7bcb7" xlink:to="loc_srt_ConsolidationItemsAxis_45c88ead-3b41-4f56-b105-144df9b5c464" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_45c88ead-3b41-4f56-b105-144df9b5c464_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_45c88ead-3b41-4f56-b105-144df9b5c464" xlink:to="loc_srt_ConsolidationItemsDomain_45c88ead-3b41-4f56-b105-144df9b5c464_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_7e3d69e1-6ae9-4767-b866-048a9132de10" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_45c88ead-3b41-4f56-b105-144df9b5c464" xlink:to="loc_srt_ConsolidationItemsDomain_7e3d69e1-6ae9-4767-b866-048a9132de10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_f7e7cb3c-e4ef-4ab3-8261-bf56565c4061" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_7e3d69e1-6ae9-4767-b866-048a9132de10" xlink:to="loc_us-gaap_OperatingSegmentsMember_f7e7cb3c-e4ef-4ab3-8261-bf56565c4061" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_088166fc-91f1-414d-a70c-617a4183ac6d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_7e3d69e1-6ae9-4767-b866-048a9132de10" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_088166fc-91f1-414d-a70c-617a4183ac6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1f30dbb4-6979-45f0-a087-b15430d9e244" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_5ae70802-b1ea-46b3-9274-7ba786a7bcb7" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1f30dbb4-6979-45f0-a087-b15430d9e244" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_1f30dbb4-6979-45f0-a087-b15430d9e244_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1f30dbb4-6979-45f0-a087-b15430d9e244" xlink:to="loc_us-gaap_RelatedPartyDomain_1f30dbb4-6979-45f0-a087-b15430d9e244_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_ce466c12-e53d-4b5f-8267-7e6819016abf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1f30dbb4-6979-45f0-a087-b15430d9e244" xlink:to="loc_us-gaap_RelatedPartyDomain_ce466c12-e53d-4b5f-8267-7e6819016abf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_e5b675b9-cc80-4ab4-bdfd-d0b2b836f6b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_ce466c12-e53d-4b5f-8267-7e6819016abf" xlink:to="loc_us-gaap_RelatedPartyMember_e5b675b9-cc80-4ab4-bdfd-d0b2b836f6b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold_2baac8d3-fa6e-4008-93dd-86143cb869d1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_65201786-daca-41a6-9491-690f9d57a4bc" xlink:to="loc_us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold_2baac8d3-fa6e-4008-93dd-86143cb869d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_00321fcc-9ceb-4f26-85f9-70045cff7363" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_65201786-daca-41a6-9491-690f9d57a4bc" xlink:to="loc_us-gaap_ShareBasedCompensation_00321fcc-9ceb-4f26-85f9-70045cff7363" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_62829913-61bb-4808-8d37-ac1e015e8d9f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_65201786-daca-41a6-9491-690f9d57a4bc" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_62829913-61bb-4808-8d37-ac1e015e8d9f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_1d678260-b754-4d1b-8231-d74f97fd3ae9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_65201786-daca-41a6-9491-690f9d57a4bc" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_1d678260-b754-4d1b-8231-d74f97fd3ae9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d540ea64-35a4-4cf3-8b1a-5d397aa23bca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_65201786-daca-41a6-9491-690f9d57a4bc" xlink:to="loc_us-gaap_NetIncomeLoss_d540ea64-35a4-4cf3-8b1a-5d397aa23bca" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_22331d47-3aaa-4e9c-b557-5835705ddd68" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_65201786-daca-41a6-9491-690f9d57a4bc" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_22331d47-3aaa-4e9c-b557-5835705ddd68" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4039399d-34cc-402b-b220-6afccf978153" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a6f03f60-98fe-4ce2-887f-e57cb1a5def5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://spyre.com/role/NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails" xlink:type="simple" xlink:href="syre-20250331.xsd#NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails"/>
  <link:definitionLink xlink:role="http://spyre.com/role/NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_48402543-90da-4ac4-a002-22a6e3ab2dd9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_b32d06c5-5f28-45b4-987c-ee3deec11c09" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_48402543-90da-4ac4-a002-22a6e3ab2dd9" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_b32d06c5-5f28-45b4-987c-ee3deec11c09" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_9e901c07-d23c-48ce-83dc-3c8ce6914024" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_b32d06c5-5f28-45b4-987c-ee3deec11c09" xlink:to="loc_us-gaap_StatementClassOfStockAxis_9e901c07-d23c-48ce-83dc-3c8ce6914024" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_9e901c07-d23c-48ce-83dc-3c8ce6914024_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_9e901c07-d23c-48ce-83dc-3c8ce6914024" xlink:to="loc_us-gaap_ClassOfStockDomain_9e901c07-d23c-48ce-83dc-3c8ce6914024_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_aba02781-42e3-4d1c-9b7e-a099d437861b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_9e901c07-d23c-48ce-83dc-3c8ce6914024" xlink:to="loc_us-gaap_ClassOfStockDomain_aba02781-42e3-4d1c-9b7e-a099d437861b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SeriesANonVotingConvertiblePreferredStockMember_d0474122-9129-40ff-83fb-482256964e54" xlink:href="syre-20250331.xsd#syre_SeriesANonVotingConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_aba02781-42e3-4d1c-9b7e-a099d437861b" xlink:to="loc_syre_SeriesANonVotingConvertiblePreferredStockMember_d0474122-9129-40ff-83fb-482256964e54" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SeriesBNonVotingConvertiblePreferredStockMember_4266818c-7a00-4fcd-9475-94ac3f81c235" xlink:href="syre-20250331.xsd#syre_SeriesBNonVotingConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_aba02781-42e3-4d1c-9b7e-a099d437861b" xlink:to="loc_syre_SeriesBNonVotingConvertiblePreferredStockMember_4266818c-7a00-4fcd-9475-94ac3f81c235" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_0c6051f3-bcff-4a25-85fd-9f809b8522f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_aba02781-42e3-4d1c-9b7e-a099d437861b" xlink:to="loc_us-gaap_CommonStockMember_0c6051f3-bcff-4a25-85fd-9f809b8522f8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e4ff8497-f6e2-46c0-9fce-840e9bb19f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_48402543-90da-4ac4-a002-22a6e3ab2dd9" xlink:to="loc_us-gaap_NetIncomeLoss_e4ff8497-f6e2-46c0-9fce-840e9bb19f4c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_0f6396d7-aad7-417e-b007-db55438cfcb4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_48402543-90da-4ac4-a002-22a6e3ab2dd9" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_0f6396d7-aad7-417e-b007-db55438cfcb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_bb0c2818-3935-48c8-8ef9-cb60741fa2d4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_48402543-90da-4ac4-a002-22a6e3ab2dd9" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_bb0c2818-3935-48c8-8ef9-cb60741fa2d4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0a92ddc1-88fb-4ca9-8da2-d2b4428481fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_48402543-90da-4ac4-a002-22a6e3ab2dd9" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0a92ddc1-88fb-4ca9-8da2-d2b4428481fd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d3a02d72-a722-4d0d-b012-c1845accef7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_48402543-90da-4ac4-a002-22a6e3ab2dd9" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d3a02d72-a722-4d0d-b012-c1845accef7d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_995864d1-5447-4ac4-976d-2cc5aabdcb06" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_48402543-90da-4ac4-a002-22a6e3ab2dd9" xlink:to="loc_us-gaap_EarningsPerShareBasic_995864d1-5447-4ac4-976d-2cc5aabdcb06" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_82de753a-735b-4c0e-a9d0-09bf069ef625" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_48402543-90da-4ac4-a002-22a6e3ab2dd9" xlink:to="loc_us-gaap_EarningsPerShareDiluted_82de753a-735b-4c0e-a9d0-09bf069ef625" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://spyre.com/role/NetLossPerShareWeightedAverageEquityInstrumentsExcludedfromCalculationofDilutedNetLossPerShareDetails" xlink:type="simple" xlink:href="syre-20250331.xsd#NetLossPerShareWeightedAverageEquityInstrumentsExcludedfromCalculationofDilutedNetLossPerShareDetails"/>
  <link:definitionLink xlink:role="http://spyre.com/role/NetLossPerShareWeightedAverageEquityInstrumentsExcludedfromCalculationofDilutedNetLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6daf562a-8337-488d-8155-4e6e753cd37d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_203bcb7f-0c33-47c0-a521-630b35295bfb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6daf562a-8337-488d-8155-4e6e753cd37d" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_203bcb7f-0c33-47c0-a521-630b35295bfb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_374aac3b-fc11-4094-ae2c-feb39a835fa8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_203bcb7f-0c33-47c0-a521-630b35295bfb" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_374aac3b-fc11-4094-ae2c-feb39a835fa8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_374aac3b-fc11-4094-ae2c-feb39a835fa8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_374aac3b-fc11-4094-ae2c-feb39a835fa8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_374aac3b-fc11-4094-ae2c-feb39a835fa8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d9d94a4d-587c-45a9-ab17-427d0824f632" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_374aac3b-fc11-4094-ae2c-feb39a835fa8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d9d94a4d-587c-45a9-ab17-427d0824f632" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_3ac9f8aa-9a7a-4608-bf8c-94be9b8a2e4d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d9d94a4d-587c-45a9-ab17-427d0824f632" xlink:to="loc_us-gaap_EmployeeStockOptionMember_3ac9f8aa-9a7a-4608-bf8c-94be9b8a2e4d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_aeb0a5d2-f628-4ef5-b947-b1fe82e18952" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d9d94a4d-587c-45a9-ab17-427d0824f632" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_aeb0a5d2-f628-4ef5-b947-b1fe82e18952" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ParapyreWarrantsMember_e98e585d-3316-45e2-bb55-b049a0d72404" xlink:href="syre-20250331.xsd#syre_ParapyreWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d9d94a4d-587c-45a9-ab17-427d0824f632" xlink:to="loc_syre_ParapyreWarrantsMember_e98e585d-3316-45e2-bb55-b049a0d72404" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SeriesANonVotingConvertiblePreferredStockMember_ce42ac20-fc20-4805-af6d-1b1d42d4f5ad" xlink:href="syre-20250331.xsd#syre_SeriesANonVotingConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d9d94a4d-587c-45a9-ab17-427d0824f632" xlink:to="loc_syre_SeriesANonVotingConvertiblePreferredStockMember_ce42ac20-fc20-4805-af6d-1b1d42d4f5ad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SeriesBNonVotingConvertiblePreferredStockMember_f70b341e-fb97-4f1e-8086-038e7ef3a187" xlink:href="syre-20250331.xsd#syre_SeriesBNonVotingConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d9d94a4d-587c-45a9-ab17-427d0824f632" xlink:to="loc_syre_SeriesBNonVotingConvertiblePreferredStockMember_f70b341e-fb97-4f1e-8086-038e7ef3a187" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_40f6d1a6-9679-4168-a81a-ef7ec03ac0c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6daf562a-8337-488d-8155-4e6e753cd37d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_40f6d1a6-9679-4168-a81a-ef7ec03ac0c5" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>syre-20250331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:00f29609-870c-422a-b8be-61cf7b074069,g:31b3bfa9-c84d-47fe-82f5-b77ff3f965cb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_5a453fa6-b72a-4996-beb0-b4249566872d_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">U.S. government agency securities</link:label>
    <link:label id="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_441987b8-96a3-4a45-a5e3-af45b59970f8_verboseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">U.S. government agency securities</link:label>
    <link:label id="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">US Government Corporations and Agencies Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_ParagonAgreementMember_0eb8dbd8-43ab-4699-85b8-3dfbdeac5706_terseLabel_en-US" xlink:label="lab_syre_ParagonAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Paragon Agreement</link:label>
    <link:label id="lab_syre_ParagonAgreementMember_label_en-US" xlink:label="lab_syre_ParagonAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Paragon Agreement [Member]</link:label>
    <link:label id="lab_syre_ParagonAgreementMember_documentation_en-US" xlink:label="lab_syre_ParagonAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Paragon agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ParagonAgreementMember" xlink:href="syre-20250331.xsd#syre_ParagonAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_ParagonAgreementMember" xlink:to="lab_syre_ParagonAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_af7a5d13-6d75-48c8-826d-067233ee0098_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_68620f79-fd5d-42b8-b66d-91898d3647dc_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_b798f1b2-41c5-45fa-9a60-4c8e8c4e2c56_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_1ff13b9e-ec1c-4c68-a997-bb6657c74791_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transactions</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_7f0509e9-d2ac-4b13-8982-f10756319396_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Marketable securities, gross unrealized losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_a25f68fb-76a4-481a-81f4-dac3c0679063_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated Fair Value of Cash Equivalents and Marketable Securities and the Gross Unrealized Gains and Losses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents and Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_38d4ca38-d98e-4296-a282-32c3603fb0de_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7927a0a1-351b-482f-9e3a-75afce7764c0_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">NET (DECREASE) INCREASE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_b13f1037-2226-4c91-9f85-65566c264dcf_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk-adjusted discount rates</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_8f1eeb64-7139-421c-b5ef-2b32f03746cf_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllTradingArrangementsMember_terseLabel_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Trading Arrangements</link:label>
    <link:label id="lab_ecd_AllTradingArrangementsMember_label_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Trading Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllTradingArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="lab_ecd_AllTradingArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonNeosMember_terseLabel_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-NEOs</link:label>
    <link:label id="lab_ecd_NonNeosMember_label_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-NEOs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonNeosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonNeosMember" xlink:to="lab_ecd_NonNeosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_38667230-125b-4f17-b0e4-66052fb5e3c2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vest period grant date</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:to="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_1a867d88-3dcb-49ba-9199-c20ae0019c3b_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Issued, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_c56e5a2b-a3a7-4411-8d4f-d301322b038b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-Based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Cost by Plan [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_2356bd8f-622e-495c-985c-46fce91dfa62_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares converted (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_CompanyAndBasisOfPresentationTable_c7f2aa53-ea46-4ff7-83ac-975be9c1f87f_terseLabel_en-US" xlink:label="lab_syre_CompanyAndBasisOfPresentationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company and Basis of Presentation [Table]</link:label>
    <link:label id="lab_syre_CompanyAndBasisOfPresentationTable_label_en-US" xlink:label="lab_syre_CompanyAndBasisOfPresentationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company and Basis of Presentation [Table]</link:label>
    <link:label id="lab_syre_CompanyAndBasisOfPresentationTable_documentation_en-US" xlink:label="lab_syre_CompanyAndBasisOfPresentationTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Company and basis of presentation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_CompanyAndBasisOfPresentationTable" xlink:href="syre-20250331.xsd#syre_CompanyAndBasisOfPresentationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_CompanyAndBasisOfPresentationTable" xlink:to="lab_syre_CompanyAndBasisOfPresentationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PayVsPerformanceDisclosureLineItems_label_en-US" xlink:label="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_0f65ebd9-9c23-4cd2-886e-57b65e131303_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_adc995f1-2ab4-4e8a-98e7-5efb16f02b12_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">The Company and Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_ParapyreOptionObligationMember_9f1532ba-e9fc-40e5-ac1d-0b1a7a191c19_terseLabel_en-US" xlink:label="lab_syre_ParapyreOptionObligationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Parapyre Option Obligation</link:label>
    <link:label id="lab_syre_ParapyreOptionObligationMember_label_en-US" xlink:label="lab_syre_ParapyreOptionObligationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Parapyre Option Obligation [Member]</link:label>
    <link:label id="lab_syre_ParapyreOptionObligationMember_documentation_en-US" xlink:label="lab_syre_ParapyreOptionObligationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Parapyre Option Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ParapyreOptionObligationMember" xlink:href="syre-20250331.xsd#syre_ParapyreOptionObligationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_ParapyreOptionObligationMember" xlink:to="lab_syre_ParapyreOptionObligationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:to="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_434a6c86-e926-4955-b538-6e8c6addcbf4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_LicenseAgreementMilestonePayments_e66aa706-0938-40a3-9fba-7ca1f82ae60c_terseLabel_en-US" xlink:label="lab_syre_LicenseAgreementMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Milestone payments</link:label>
    <link:label id="lab_syre_LicenseAgreementMilestonePayments_label_en-US" xlink:label="lab_syre_LicenseAgreementMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License Agreement, Milestone Payments</link:label>
    <link:label id="lab_syre_LicenseAgreementMilestonePayments_documentation_en-US" xlink:label="lab_syre_LicenseAgreementMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">License Agreement, Milestone Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_LicenseAgreementMilestonePayments" xlink:href="syre-20250331.xsd#syre_LicenseAgreementMilestonePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_LicenseAgreementMilestonePayments" xlink:to="lab_syre_LicenseAgreementMilestonePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_896269b1-0727-4856-9260-826a2795b75c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrealized gain (loss) on marketable securities</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_ee95396b-5e04-4bfe-8bcd-6002a16aab76_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Unrealized gain (loss) on marketable securities</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgDiscLineItems_label_en-US" xlink:label="lab_ecd_AwardTmgDiscLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="lab_ecd_AwardTmgDiscLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_label_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OtherPerfMeasureAmt" xlink:to="lab_ecd_OtherPerfMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_3f49bd28-3955-4f37-8d94-578162d3d2d7_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_4411f73b-1225-437f-9c46-a74528f23f44_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance, common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_3aefa88e-4b0e-41b7-977d-a37c2f2d15b6_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance, common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_3b446864-3dea-4652-be41-59b87760130e_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:to="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestReceivable_45022106-8850-4bbd-98d5-30024f67b680_terseLabel_en-US" xlink:label="lab_us-gaap_InterestReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued interest receivable on available-for-sale debt securities</link:label>
    <link:label id="lab_us-gaap_InterestReceivable_label_en-US" xlink:label="lab_us-gaap_InterestReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestReceivable" xlink:to="lab_us-gaap_InterestReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_ParapyreLiabilityLicenseAgreementsMember_e1ea00d6-ecb7-46c6-989a-66a1f8c23518_terseLabel_en-US" xlink:label="lab_syre_ParapyreLiabilityLicenseAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">License Agreements development milestone liability (see Note 6)</link:label>
    <link:label id="lab_syre_ParapyreLiabilityLicenseAgreementsMember_label_en-US" xlink:label="lab_syre_ParapyreLiabilityLicenseAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Parapyre Liability, License Agreements [Member]</link:label>
    <link:label id="lab_syre_ParapyreLiabilityLicenseAgreementsMember_documentation_en-US" xlink:label="lab_syre_ParapyreLiabilityLicenseAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Parapyre Liability, License Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ParapyreLiabilityLicenseAgreementsMember" xlink:href="syre-20250331.xsd#syre_ParapyreLiabilityLicenseAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_ParapyreLiabilityLicenseAgreementsMember" xlink:to="lab_syre_ParapyreLiabilityLicenseAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_a1e60077-a453-467b-a198-260578a6d15c_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_138ada47-8709-4bdd-9a22-4557a922e755_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of stock, price per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_afb7dfb4-2eb7-4bbd-9791-0c1ea8a4cd94_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_01856580-c8aa-48db-9d74-fc0c1da273ce_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_5c672b5a-94ba-4191-9dd9-9debe2ed6daa_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateBondSecuritiesMember_987c8748-a2f5-4e69-9ee5-32dc131bf719_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateBondSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Corporate bonds</link:label>
    <link:label id="lab_us-gaap_CorporateBondSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateBondSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Corporate Bond Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateBondSecuritiesMember" xlink:to="lab_us-gaap_CorporateBondSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_fc7760e0-014c-48e4-a482-3c33d553d145_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_a0f609a5-d1e1-4d96-b0a4-664cc189af98_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_5ede8c62-1f5c-4875-a6b7-ac7bdd05627c_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_c34708ec-c7d0-411c-a408-3eee87e4ea67_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of stock, proceeds received</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c67a102a-f288-4f96-8273-48c89364a885_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_6b04a8b3-119b-44ff-be63-9497f6790333_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">U.S. government treasury securities</link:label>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">US Treasury Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasurySecuritiesMember" xlink:to="lab_us-gaap_USTreasurySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_LicensingAgreementsAbstract_label_en-US" xlink:label="lab_syre_LicensingAgreementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Licensing Agreements [Abstract]</link:label>
    <link:label id="lab_syre_LicensingAgreementsAbstract_documentation_en-US" xlink:label="lab_syre_LicensingAgreementsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Licensing Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_LicensingAgreementsAbstract" xlink:href="syre-20250331.xsd#syre_LicensingAgreementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_LicensingAgreementsAbstract" xlink:to="lab_syre_LicensingAgreementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_bd89b4cf-6d89-48b7-aba5-872978fd1430_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_c04502d0-b8be-43ba-ac98-6efa5f034cc1_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_2c1a9c65-ae37-41de-bec8-835c9b0b0730_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Service Share Based Compensation Allocation of Recognized Period Costs [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Method</link:label>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMethodTextBlock" xlink:to="lab_ecd_AwardTmgMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_ReportableSegmentMember_1478f29b-5adb-4f14-8898-00313d9a5bde_terseLabel_en-US" xlink:label="lab_syre_ReportableSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reportable Segment</link:label>
    <link:label id="lab_syre_ReportableSegmentMember_label_en-US" xlink:label="lab_syre_ReportableSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reportable Segment [Member]</link:label>
    <link:label id="lab_syre_ReportableSegmentMember_documentation_en-US" xlink:label="lab_syre_ReportableSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Reportable Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ReportableSegmentMember" xlink:href="syre-20250331.xsd#syre_ReportableSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_ReportableSegmentMember" xlink:to="lab_syre_ReportableSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrByIndTable_terseLabel_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual</link:label>
    <link:label id="lab_ecd_TradingArrByIndTable_label_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="lab_ecd_TradingArrByIndTable" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_PreferredStockRemainsIssuedAndOutstandingPercentage_94dcc364-fcc7-4400-a8be-25bbe466a7c9_terseLabel_en-US" xlink:label="lab_syre_PreferredStockRemainsIssuedAndOutstandingPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock issued and outstanding percentage</link:label>
    <link:label id="lab_syre_PreferredStockRemainsIssuedAndOutstandingPercentage_label_en-US" xlink:label="lab_syre_PreferredStockRemainsIssuedAndOutstandingPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock Remains Issued and Outstanding Percentage.</link:label>
    <link:label id="lab_syre_PreferredStockRemainsIssuedAndOutstandingPercentage_documentation_en-US" xlink:label="lab_syre_PreferredStockRemainsIssuedAndOutstandingPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Preferred stock remains issued and outstanding percentage.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_PreferredStockRemainsIssuedAndOutstandingPercentage" xlink:href="syre-20250331.xsd#syre_PreferredStockRemainsIssuedAndOutstandingPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_PreferredStockRemainsIssuedAndOutstandingPercentage" xlink:to="lab_syre_PreferredStockRemainsIssuedAndOutstandingPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_692de54f-b843-4104-a2a9-080a917427de_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_4909b350-047b-4f80-b22a-34063cd0d8c5_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingPoliciesProcLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_MeasurementInputReimbursementRateMember_8560ccf3-c9ed-4ac2-b335-c1a2e18fb007_terseLabel_en-US" xlink:label="lab_syre_MeasurementInputReimbursementRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated reimbursement rate compared to reimbursement target</link:label>
    <link:label id="lab_syre_MeasurementInputReimbursementRateMember_label_en-US" xlink:label="lab_syre_MeasurementInputReimbursementRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Reimbursement Rate [Member]</link:label>
    <link:label id="lab_syre_MeasurementInputReimbursementRateMember_documentation_en-US" xlink:label="lab_syre_MeasurementInputReimbursementRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Measurement Input, Reimbursement Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_MeasurementInputReimbursementRateMember" xlink:href="syre-20250331.xsd#syre_MeasurementInputReimbursementRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_MeasurementInputReimbursementRateMember" xlink:to="lab_syre_MeasurementInputReimbursementRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_PaymentForSettlementOfShareBasedPaymentArrangement_16791332-14b7-4267-ad55-4145f09c41ae_negatedTerseLabel_en-US" xlink:label="lab_syre_PaymentForSettlementOfShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Cash settlement of employee stock option award</link:label>
    <link:label id="lab_syre_PaymentForSettlementOfShareBasedPaymentArrangement_label_en-US" xlink:label="lab_syre_PaymentForSettlementOfShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payment For Settlement Of Share-Based Payment Arrangement</link:label>
    <link:label id="lab_syre_PaymentForSettlementOfShareBasedPaymentArrangement_documentation_en-US" xlink:label="lab_syre_PaymentForSettlementOfShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payment For Settlement Of Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_PaymentForSettlementOfShareBasedPaymentArrangement" xlink:href="syre-20250331.xsd#syre_PaymentForSettlementOfShareBasedPaymentArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_PaymentForSettlementOfShareBasedPaymentArrangement" xlink:to="lab_syre_PaymentForSettlementOfShareBasedPaymentArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
    <link:label id="lab_ecd_AdjToCompAmt_label_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAmt" xlink:to="lab_ecd_AdjToCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_0db7f144-cf83-490c-9913-2ec848aa0795_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryCompAmt" xlink:to="lab_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_b9899c26-4b3f-4afc-af6f-d11065022b42_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureAmt" xlink:to="lab_ecd_CoSelectedMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TabularListTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tabular List, Table</link:label>
    <link:label id="lab_ecd_TabularListTableTextBlock_label_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tabular List [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TabularListTableTextBlock" xlink:to="lab_ecd_TabularListTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_d3e8fa1e-e7a7-42a5-b8d1-cd4eb54b07fa_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_813d4c59-9079-4ef9-97e5-9ec8c3d2b15c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_LicenseAgreementMilestoneExpenseAmountRecognized_4bcf9471-971a-4bca-af54-7ee63d9aec78_terseLabel_en-US" xlink:label="lab_syre_LicenseAgreementMilestoneExpenseAmountRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Milestone expense recognized</link:label>
    <link:label id="lab_syre_LicenseAgreementMilestoneExpenseAmountRecognized_label_en-US" xlink:label="lab_syre_LicenseAgreementMilestoneExpenseAmountRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License Agreement, Milestone Expense, Amount Recognized</link:label>
    <link:label id="lab_syre_LicenseAgreementMilestoneExpenseAmountRecognized_documentation_en-US" xlink:label="lab_syre_LicenseAgreementMilestoneExpenseAmountRecognized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">License Agreement, Milestone Expense, Amount Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_LicenseAgreementMilestoneExpenseAmountRecognized" xlink:href="syre-20250331.xsd#syre_LicenseAgreementMilestoneExpenseAmountRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_LicenseAgreementMilestoneExpenseAmountRecognized" xlink:to="lab_syre_LicenseAgreementMilestoneExpenseAmountRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_a91f8ddc-c334-4492-a8f8-5248d109dff8_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants to purchase shares (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_DeferredOfferingCostsUnpaidAmount_873b2eb4-07e9-44c8-89ea-f45c376fe8f9_terseLabel_en-US" xlink:label="lab_syre_DeferredOfferingCostsUnpaidAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unpaid deferred offering costs in connection with shelf registration</link:label>
    <link:label id="lab_syre_DeferredOfferingCostsUnpaidAmount_label_en-US" xlink:label="lab_syre_DeferredOfferingCostsUnpaidAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Offering Costs, Unpaid Amount</link:label>
    <link:label id="lab_syre_DeferredOfferingCostsUnpaidAmount_documentation_en-US" xlink:label="lab_syre_DeferredOfferingCostsUnpaidAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Offering Costs, Unpaid Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_DeferredOfferingCostsUnpaidAmount" xlink:href="syre-20250331.xsd#syre_DeferredOfferingCostsUnpaidAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_DeferredOfferingCostsUnpaidAmount" xlink:to="lab_syre_DeferredOfferingCostsUnpaidAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_705262d4-6339-4928-98a7-1b038d97c564_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_977302a6-9867-46f0-a2eb-dc7ebda42173_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive securities excluded from computation of earnings per share (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_3ae2a1c1-b068-43ad-a26e-ff9e9fb89f9b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Tranche One</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Tranche One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_TwoThousandAndFifteenEquityIncentivePlanMember_da98b103-a5e9-4e9b-bd4f-f9ed454fc29d_terseLabel_en-US" xlink:label="lab_syre_TwoThousandAndFifteenEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2015 Equity Incentive Plan</link:label>
    <link:label id="lab_syre_TwoThousandAndFifteenEquityIncentivePlanMember_label_en-US" xlink:label="lab_syre_TwoThousandAndFifteenEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Two Thousand And Fifteen Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_syre_TwoThousandAndFifteenEquityIncentivePlanMember_documentation_en-US" xlink:label="lab_syre_TwoThousandAndFifteenEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Two thousand and fifteen equity incentive plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_TwoThousandAndFifteenEquityIncentivePlanMember" xlink:href="syre-20250331.xsd#syre_TwoThousandAndFifteenEquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_TwoThousandAndFifteenEquityIncentivePlanMember" xlink:to="lab_syre_TwoThousandAndFifteenEquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockConvertibleSharesIssuable_baf61968-4866-4b54-9762-7c03c2280ae7_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockConvertibleSharesIssuable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of common shares issuable upon conversion (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockConvertibleSharesIssuable_label_en-US" xlink:label="lab_us-gaap_PreferredStockConvertibleSharesIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Convertible, Shares Issuable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockConvertibleSharesIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockConvertibleSharesIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockConvertibleSharesIssuable" xlink:to="lab_us-gaap_PreferredStockConvertibleSharesIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_ClassOfWarrantOrRightNumberOfSecuritiesExercised_2bb7d77a-4ed6-4157-83f0-3f68264dbd5b_terseLabel_en-US" xlink:label="lab_syre_ClassOfWarrantOrRightNumberOfSecuritiesExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of warrants exercised (in shares)</link:label>
    <link:label id="lab_syre_ClassOfWarrantOrRightNumberOfSecuritiesExercised_label_en-US" xlink:label="lab_syre_ClassOfWarrantOrRightNumberOfSecuritiesExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Number of Securities Exercised</link:label>
    <link:label id="lab_syre_ClassOfWarrantOrRightNumberOfSecuritiesExercised_documentation_en-US" xlink:label="lab_syre_ClassOfWarrantOrRightNumberOfSecuritiesExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Number of Securities Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ClassOfWarrantOrRightNumberOfSecuritiesExercised" xlink:href="syre-20250331.xsd#syre_ClassOfWarrantOrRightNumberOfSecuritiesExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_ClassOfWarrantOrRightNumberOfSecuritiesExercised" xlink:to="lab_syre_ClassOfWarrantOrRightNumberOfSecuritiesExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_5b37c7ae-1fd7-448c-b258-e7d7e02aa5ee_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionAxis" xlink:to="lab_us-gaap_AssetAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_3f5d5c1f-dd7c-4862-bdb6-88624ceab753_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total, fair value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_31f68e45-4126-4913-8ccb-f5d3be579626_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_61d5bc7c-5132-48f4-ad69-bb6f731d7392_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">End of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6c06adec-3961-4a13-b4dd-5a36a081d7df_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total cash, cash equivalents, and restricted cash shown in the statement of cash flows</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_AssetAcquisitionMember_cff0f96a-4c99-4d15-bccb-04dd2e0f2732_terseLabel_en-US" xlink:label="lab_syre_AssetAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset Acquisition</link:label>
    <link:label id="lab_syre_AssetAcquisitionMember_label_en-US" xlink:label="lab_syre_AssetAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition [Member]</link:label>
    <link:label id="lab_syre_AssetAcquisitionMember_documentation_en-US" xlink:label="lab_syre_AssetAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Asset acquisition.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_AssetAcquisitionMember" xlink:href="syre-20250331.xsd#syre_AssetAcquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_AssetAcquisitionMember" xlink:to="lab_syre_AssetAcquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_a9112d1b-03b1-4db8-811d-2da928f1773a_negatedLabel_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Net accretion of discount on marketable securities</link:label>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_label_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_CashEquivalentsUnrealizedLosses_e3864d59-0507-49dc-af9a-b508e7ae5ae6_negatedLabel_en-US" xlink:label="lab_syre_CashEquivalentsUnrealizedLosses" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Cash equivalents, gross unrealized losses</link:label>
    <link:label id="lab_syre_CashEquivalentsUnrealizedLosses_label_en-US" xlink:label="lab_syre_CashEquivalentsUnrealizedLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Equivalents Unrealized Losses</link:label>
    <link:label id="lab_syre_CashEquivalentsUnrealizedLosses_documentation_en-US" xlink:label="lab_syre_CashEquivalentsUnrealizedLosses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash equivalents unrealized losses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_CashEquivalentsUnrealizedLosses" xlink:href="syre-20250331.xsd#syre_CashEquivalentsUnrealizedLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_CashEquivalentsUnrealizedLosses" xlink:to="lab_syre_CashEquivalentsUnrealizedLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_43d5e0ba-6274-4545-8a6e-6060bc860be6_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CURRENT ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold_38b8b120-f0a3-4fcd-8203-a00391fc6e14_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation</link:label>
    <link:label id="lab_us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold_label_en-US" xlink:label="lab_us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Expense, Excluding Cost of Good and Service Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold" xlink:to="lab_us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_a3c14400-c608-45b5-802f-d9d304f092b1_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_PreferredStockExcludingSeriesAAndBNonVotingConvertiblePreferredStockMember_28baef50-ea46-4ec1-933f-5157f8b56a9b_terseLabel_en-US" xlink:label="lab_syre_PreferredStockExcludingSeriesAAndBNonVotingConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred Stock, Excluding Series A Non Voting Convertible Preferred Stock</link:label>
    <link:label id="lab_syre_PreferredStockExcludingSeriesAAndBNonVotingConvertiblePreferredStockMember_label_en-US" xlink:label="lab_syre_PreferredStockExcludingSeriesAAndBNonVotingConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Excluding Series A and B Non Voting Convertible Preferred Stock [Member]</link:label>
    <link:label id="lab_syre_PreferredStockExcludingSeriesAAndBNonVotingConvertiblePreferredStockMember_documentation_en-US" xlink:label="lab_syre_PreferredStockExcludingSeriesAAndBNonVotingConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Preferred Stock, Excluding Series A and B Non Voting Convertible Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_PreferredStockExcludingSeriesAAndBNonVotingConvertiblePreferredStockMember" xlink:href="syre-20250331.xsd#syre_PreferredStockExcludingSeriesAAndBNonVotingConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_PreferredStockExcludingSeriesAAndBNonVotingConvertiblePreferredStockMember" xlink:to="lab_syre_PreferredStockExcludingSeriesAAndBNonVotingConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_AccruedAndOtherCurrentLiabilitiesTextBlock_0802948f-1841-46cd-b5f1-a4b1c85a7061_terseLabel_en-US" xlink:label="lab_syre_AccruedAndOtherCurrentLiabilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued and Other Current Liabilities</link:label>
    <link:label id="lab_syre_AccruedAndOtherCurrentLiabilitiesTextBlock_label_en-US" xlink:label="lab_syre_AccruedAndOtherCurrentLiabilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued And Other Current Liabilities [Text Block]</link:label>
    <link:label id="lab_syre_AccruedAndOtherCurrentLiabilitiesTextBlock_documentation_en-US" xlink:label="lab_syre_AccruedAndOtherCurrentLiabilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The entire disclosure for accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_AccruedAndOtherCurrentLiabilitiesTextBlock" xlink:href="syre-20250331.xsd#syre_AccruedAndOtherCurrentLiabilitiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_AccruedAndOtherCurrentLiabilitiesTextBlock" xlink:to="lab_syre_AccruedAndOtherCurrentLiabilitiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalNumberOfSharesAvailableForGrant_d6a62420-4043-4963-bf09-aaba5cb3a6b0_terseLabel_en-US" xlink:label="lab_syre_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional number of shares available for issuance (in shares)</link:label>
    <link:label id="lab_syre_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_syre_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Additional Number Of Shares Available For Grant</link:label>
    <link:label id="lab_syre_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalNumberOfSharesAvailableForGrant_documentation_en-US" xlink:label="lab_syre_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-based compensation arrangement by share-based payment award, additional number of shares available for grant.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalNumberOfSharesAvailableForGrant" xlink:href="syre-20250331.xsd#syre_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalNumberOfSharesAvailableForGrant" xlink:to="lab_syre_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_ee7420a2-aef2-4d8e-b583-ff2f948d7e37_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Options to purchase common stock</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_d0b9eac9-da51-4358-a438-74712c0e1029_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_140ce884-6366-4bcc-9067-e13dd7ce37c7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_86976e3a-4990-4bd8-a9c8-b45c73c961a1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_f604864c-7f91-47ba-ba2c-62ef30ab5fad_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Security, Excluded EPS Calculation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_SaleOfStockAuthorizedAmount_a7997f9a-7f16-48fa-8828-ef1e1e73f8d1_terseLabel_en-US" xlink:label="lab_syre_SaleOfStockAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of stock, authorized amount</link:label>
    <link:label id="lab_syre_SaleOfStockAuthorizedAmount_label_en-US" xlink:label="lab_syre_SaleOfStockAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Authorized Amount</link:label>
    <link:label id="lab_syre_SaleOfStockAuthorizedAmount_documentation_en-US" xlink:label="lab_syre_SaleOfStockAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sale of Stock, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SaleOfStockAuthorizedAmount" xlink:href="syre-20250331.xsd#syre_SaleOfStockAuthorizedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_SaleOfStockAuthorizedAmount" xlink:to="lab_syre_SaleOfStockAuthorizedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_a78cea05-55cc-4876-a936-7e446fdac454_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_AccruedContractedResearchAndDevelopmentCosts_41d30e81-698f-4a87-b6ec-ca915002f9fe_terseLabel_en-US" xlink:label="lab_syre_AccruedContractedResearchAndDevelopmentCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued contracted research and development costs</link:label>
    <link:label id="lab_syre_AccruedContractedResearchAndDevelopmentCosts_label_en-US" xlink:label="lab_syre_AccruedContractedResearchAndDevelopmentCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Contracted Research And Development Costs</link:label>
    <link:label id="lab_syre_AccruedContractedResearchAndDevelopmentCosts_documentation_en-US" xlink:label="lab_syre_AccruedContractedResearchAndDevelopmentCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued contracted research and development costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_AccruedContractedResearchAndDevelopmentCosts" xlink:href="syre-20250331.xsd#syre_AccruedContractedResearchAndDevelopmentCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_AccruedContractedResearchAndDevelopmentCosts" xlink:to="lab_syre_AccruedContractedResearchAndDevelopmentCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_51569cd7-6f39-4807-88b0-d386f9a07d00_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_7cffc051-7ca7-4042-b967-12ea9a297cfe_periodStartLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance, preferred stock (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_23fa6bb5-3050-4d34-ab3d-f93f17d20879_periodEndLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance, preferred stock (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_889599f1-d0c9-4c94-8fe2-fa8a9f487238_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_3c314c06-24d8-4016-aaad-199878c51d84_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contractual Maturities of Marketable Securities at Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_39012c43-36ff-4350-a6f0-4f80ac321d65_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_SpyreTherapeuticsIncMember_6cd44708-6fb2-44c9-925f-f3b4c08284a8_terseLabel_en-US" xlink:label="lab_syre_SpyreTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Spyre Therapeutics, Inc.</link:label>
    <link:label id="lab_syre_SpyreTherapeuticsIncMember_label_en-US" xlink:label="lab_syre_SpyreTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Spyre Therapeutics, Inc. [Member]</link:label>
    <link:label id="lab_syre_SpyreTherapeuticsIncMember_documentation_en-US" xlink:label="lab_syre_SpyreTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Spyre Therapeutics, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SpyreTherapeuticsIncMember" xlink:href="syre-20250331.xsd#syre_SpyreTherapeuticsIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_SpyreTherapeuticsIncMember" xlink:to="lab_syre_SpyreTherapeuticsIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_c75ff04d-8a07-4205-9343-7155a6c5c126_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_d1847ca3-395b-4a4a-9f64-ca31ff128004_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">TOTAL LIABILITIES</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_90c52f11-94c0-4a68-9fa5-a3caf6d3cb4d_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_67fcdd47-aea9-4886-b10b-6b7ea51d36f3_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_3819609f-c477-468e-8e4e-d7be2a7d63d4_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development, excluding compensation and share-based compensation</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_TwoThousandAndSixteenEquityIncentivePlanMember_e98b3d25-f72c-4bf9-b272-4b312e1cf95f_terseLabel_en-US" xlink:label="lab_syre_TwoThousandAndSixteenEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2016 Equity Incentive Plan</link:label>
    <link:label id="lab_syre_TwoThousandAndSixteenEquityIncentivePlanMember_0cd501ff-ee09-4a9c-b4f8-3b2d1d440162_verboseLabel_en-US" xlink:label="lab_syre_TwoThousandAndSixteenEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Stock Options Granted</link:label>
    <link:label id="lab_syre_TwoThousandAndSixteenEquityIncentivePlanMember_label_en-US" xlink:label="lab_syre_TwoThousandAndSixteenEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Two Thousand And Sixteen Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_syre_TwoThousandAndSixteenEquityIncentivePlanMember_documentation_en-US" xlink:label="lab_syre_TwoThousandAndSixteenEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Two thousand and sixteen equity incentive plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_TwoThousandAndSixteenEquityIncentivePlanMember" xlink:href="syre-20250331.xsd#syre_TwoThousandAndSixteenEquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_TwoThousandAndSixteenEquityIncentivePlanMember" xlink:to="lab_syre_TwoThousandAndSixteenEquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_93c5ada5-200e-4bd7-b4c7-5316bb65cdaa_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrExpirationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expiration Date</link:label>
    <link:label id="lab_ecd_TrdArrExpirationDate_label_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Expiration Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrExpirationDate" xlink:to="lab_ecd_TrdArrExpirationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_aa3e436d-e6d1-4519-a95d-2c9a500e1ef1_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnAmt" xlink:to="lab_ecd_TotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_ca006b7b-24fc-4df2-94e5-ba4e242f4c07_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:to="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOne_da91a65d-25d3-46aa-8541-0f8e011ff5ea_terseLabel_en-US" xlink:label="lab_syre_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOne" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Due in 1 - 2 years</link:label>
    <link:label id="lab_syre_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOne_label_en-US" xlink:label="lab_syre_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-For-Sale, Fair Value, Maturity, Allocated And Single Maturity Date, After Year One</link:label>
    <link:label id="lab_syre_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOne_documentation_en-US" xlink:label="lab_syre_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-For-Sale, Fair Value, Maturity, Allocated And Single Maturity Date, After Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOne" xlink:href="syre-20250331.xsd#syre_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOne" xlink:to="lab_syre_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOne" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_9f17a223-7568-499d-a05b-8bb76924a2c4_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Total, unrealized losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_label_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_0d862726-8309-4531-b008-97b554e9c8b3_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and Development Expense</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_3db6c3d9-6e89-40f1-a489-0a3ab579d77c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_1be37438-a479-4511-b9d2-37941c133a45_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e00a4918-75da-49f9-9961-92f40d97b0d5_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average common stock outstanding, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_933fbdc0-d752-4a13-a02c-2250c23b0986_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total diluted weighed average shares (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_2ed9ce00-b7af-47ff-a978-b78a4f5e191a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_terseLabel_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_label_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:to="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_61fac84d-d50a-4e25-8c42-67ce6167b05b_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">TOTAL STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_3dcf79fd-65f7-4af3-8135-88533f10ff00_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_5d44cac2-872d-4658-a49d-9e694394119c_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_CommonStockSharesOutstandingPercentageAvailableToPurchaseOnADilutedBasis_18964c3d-cfc3-4953-99f3-1cc47943165f_terseLabel_en-US" xlink:label="lab_syre_CommonStockSharesOutstandingPercentageAvailableToPurchaseOnADilutedBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares outstanding, percentage available to purchase on a diluted basis</link:label>
    <link:label id="lab_syre_CommonStockSharesOutstandingPercentageAvailableToPurchaseOnADilutedBasis_label_en-US" xlink:label="lab_syre_CommonStockSharesOutstandingPercentageAvailableToPurchaseOnADilutedBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Outstanding, Percentage Available to Purchase on a Diluted Basis</link:label>
    <link:label id="lab_syre_CommonStockSharesOutstandingPercentageAvailableToPurchaseOnADilutedBasis_documentation_en-US" xlink:label="lab_syre_CommonStockSharesOutstandingPercentageAvailableToPurchaseOnADilutedBasis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Outstanding, Percentage Available to Purchase on a Diluted Basis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_CommonStockSharesOutstandingPercentageAvailableToPurchaseOnADilutedBasis" xlink:href="syre-20250331.xsd#syre_CommonStockSharesOutstandingPercentageAvailableToPurchaseOnADilutedBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_CommonStockSharesOutstandingPercentageAvailableToPurchaseOnADilutedBasis" xlink:to="lab_syre_CommonStockSharesOutstandingPercentageAvailableToPurchaseOnADilutedBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityMeasurementInput_17f816c3-f141-45b8-b4ef-85819f87d5a7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative liability, measurement input</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityMeasurementInput_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Liability, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilityMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityMeasurementInput" xlink:to="lab_us-gaap_DerivativeLiabilityMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_13bec03e-79bf-4ed1-93cd-91beca581231_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Licensing Agreements</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyMember_743d7959-ed52-406b-845d-e7fac7e58728_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyMember_label_en-US" xlink:label="lab_us-gaap_RelatedPartyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyMember" xlink:to="lab_us-gaap_RelatedPartyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_61d02fb9-0252-4766-8ab0-78e87ea27335_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Due in one year or less</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedSalariesCurrent_fcf293bb-66eb-4256-98af-e2c5623c0393_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedSalariesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_us-gaap_AccruedSalariesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedSalariesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Salaries, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedSalariesCurrent" xlink:to="lab_us-gaap_AccruedSalariesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_b7ba2a0a-a84c-41a1-8fa0-6b13e0327a32_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payments related to CVR</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payment for Contingent Consideration Liability, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeNet_00ef05af-5246-4539-ae91-54edec9c293e_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeNet_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment Income, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeNet" xlink:to="lab_us-gaap_InvestmentIncomeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_ConversionOfSeriesBNonVotingConvertiblePreferredStockMember_b61a910f-10c0-4245-8580-6b5285f42292_terseLabel_en-US" xlink:label="lab_syre_ConversionOfSeriesBNonVotingConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion Of Series B Non-Voting Convertible Preferred Stock</link:label>
    <link:label id="lab_syre_ConversionOfSeriesBNonVotingConvertiblePreferredStockMember_label_en-US" xlink:label="lab_syre_ConversionOfSeriesBNonVotingConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Conversion Of Series B Non-Voting Convertible Preferred Stock [Member]</link:label>
    <link:label id="lab_syre_ConversionOfSeriesBNonVotingConvertiblePreferredStockMember_documentation_en-US" xlink:label="lab_syre_ConversionOfSeriesBNonVotingConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Conversion Of Series B Non-Voting Convertible Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ConversionOfSeriesBNonVotingConvertiblePreferredStockMember" xlink:href="syre-20250331.xsd#syre_ConversionOfSeriesBNonVotingConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_ConversionOfSeriesBNonVotingConvertiblePreferredStockMember" xlink:to="lab_syre_ConversionOfSeriesBNonVotingConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_bcffa6fc-2769-4b20-bf1c-577b9cd33554_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Measurements, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_47e515e6-1976-40ad-8ac6-d234c889417f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_a25b4a3c-19a1-46f8-b4dc-0fd50e197121_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Grants (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis_e66671b2-7741-4f54-9557-5836c2814638_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Conversion Description [Axis]</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Conversion Description [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:to="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_d2881306-d91e-4786-b2a6-8a18d0aa7528_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">12 Months or Longer</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_13dc57f0-d3f3-4636-aef9-afb908ef25b0_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_6a4b2cea-7f5a-4e12-94f2-9161fdbcfee0_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_80b852bb-0a99-41b3-b0c7-f4e3c7cd8721_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_fc86bede-6c79-43be-8db8-244880024274_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_CommonStockCapitalSharesReservedForFutureIssuanceIncreasedAmount_d1d4a156-f9ff-4f5c-9ed2-c4d73da9786a_terseLabel_en-US" xlink:label="lab_syre_CommonStockCapitalSharesReservedForFutureIssuanceIncreasedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock available for future issuance, additional amount authorized (in shares)</link:label>
    <link:label id="lab_syre_CommonStockCapitalSharesReservedForFutureIssuanceIncreasedAmount_label_en-US" xlink:label="lab_syre_CommonStockCapitalSharesReservedForFutureIssuanceIncreasedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance, Increased Amount</link:label>
    <link:label id="lab_syre_CommonStockCapitalSharesReservedForFutureIssuanceIncreasedAmount_documentation_en-US" xlink:label="lab_syre_CommonStockCapitalSharesReservedForFutureIssuanceIncreasedAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance, Additional Amount Reserved</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_CommonStockCapitalSharesReservedForFutureIssuanceIncreasedAmount" xlink:href="syre-20250331.xsd#syre_CommonStockCapitalSharesReservedForFutureIssuanceIncreasedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_CommonStockCapitalSharesReservedForFutureIssuanceIncreasedAmount" xlink:to="lab_syre_CommonStockCapitalSharesReservedForFutureIssuanceIncreasedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_CampaignTimelineMinimumTerm_43053540-eab1-4575-b362-4d4f2b842352_terseLabel_en-US" xlink:label="lab_syre_CampaignTimelineMinimumTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Campaign timeline, minimum term</link:label>
    <link:label id="lab_syre_CampaignTimelineMinimumTerm_label_en-US" xlink:label="lab_syre_CampaignTimelineMinimumTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Campaign Timeline, Minimum Term</link:label>
    <link:label id="lab_syre_CampaignTimelineMinimumTerm_documentation_en-US" xlink:label="lab_syre_CampaignTimelineMinimumTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Campaign Timeline, Minimum Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_CampaignTimelineMinimumTerm" xlink:href="syre-20250331.xsd#syre_CampaignTimelineMinimumTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_CampaignTimelineMinimumTerm" xlink:to="lab_syre_CampaignTimelineMinimumTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:to="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_c1efdbf6-fdf1-445f-8f94-3303a6531f76_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_terseLabel_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Executive Categories</link:label>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_label_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Executive Categories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="lab_ecd_AllExecutiveCategoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_label_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:to="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_9e0ae582-4980-415d-8a6d-2d14660349cc_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_599ca6df-b1fd-4e67-93a1-800475baf641_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_PaymentOfMilestone_c963616e-2309-45e4-a8df-1cea16a47661_terseLabel_en-US" xlink:label="lab_syre_PaymentOfMilestone" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">First milestone payment</link:label>
    <link:label id="lab_syre_PaymentOfMilestone_label_en-US" xlink:label="lab_syre_PaymentOfMilestone" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payment Of Milestone</link:label>
    <link:label id="lab_syre_PaymentOfMilestone_documentation_en-US" xlink:label="lab_syre_PaymentOfMilestone" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payment of milestone.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_PaymentOfMilestone" xlink:href="syre-20250331.xsd#syre_PaymentOfMilestone"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_PaymentOfMilestone" xlink:to="lab_syre_PaymentOfMilestone" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_9f03b3de-23f0-4026-90dd-5d7f378c2dcc_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_31755ac0-3258-45c6-b298-ec4b50946b4a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_06c06bd8-c044-4944-95ee-e5918bf646e6_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_ba13e1c5-fa01-4f9d-8886-0d60b701ee57_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Change in fair value of CVR liability</link:label>
    <link:label id="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_label_en-US" xlink:label="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Derivative Instruments, Net, Pretax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:to="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:to="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_ConversionOfSeriesANonVotingConvertiblePreferredStockMember_9c25cbfa-278f-4df0-a723-ed3d7f520377_terseLabel_en-US" xlink:label="lab_syre_ConversionOfSeriesANonVotingConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion Of Series A Non-Voting Convertible Preferred Stock</link:label>
    <link:label id="lab_syre_ConversionOfSeriesANonVotingConvertiblePreferredStockMember_label_en-US" xlink:label="lab_syre_ConversionOfSeriesANonVotingConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Conversion Of Series A Non-Voting Convertible Preferred Stock [Member]</link:label>
    <link:label id="lab_syre_ConversionOfSeriesANonVotingConvertiblePreferredStockMember_documentation_en-US" xlink:label="lab_syre_ConversionOfSeriesANonVotingConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Conversion Of Series A Non-Voting Convertible Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ConversionOfSeriesANonVotingConvertiblePreferredStockMember" xlink:href="syre-20250331.xsd#syre_ConversionOfSeriesANonVotingConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_ConversionOfSeriesANonVotingConvertiblePreferredStockMember" xlink:to="lab_syre_ConversionOfSeriesANonVotingConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_SeriesBNonVotingConvertiblePreferredStockMember_6e01d725-a62e-4349-ab8b-73265bb8ddc7_terseLabel_en-US" xlink:label="lab_syre_SeriesBNonVotingConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Series B Non Voting Convertible Preferred Stock</link:label>
    <link:label id="lab_syre_SeriesBNonVotingConvertiblePreferredStockMember_6d717431-c7d9-4017-9158-a954c0f4d4ed_verboseLabel_en-US" xlink:label="lab_syre_SeriesBNonVotingConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Series B Preferred Stock</link:label>
    <link:label id="lab_syre_SeriesBNonVotingConvertiblePreferredStockMember_label_en-US" xlink:label="lab_syre_SeriesBNonVotingConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series B Non Voting Convertible Preferred Stock [Member]</link:label>
    <link:label id="lab_syre_SeriesBNonVotingConvertiblePreferredStockMember_documentation_en-US" xlink:label="lab_syre_SeriesBNonVotingConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Series B Non Voting Convertible Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SeriesBNonVotingConvertiblePreferredStockMember" xlink:href="syre-20250331.xsd#syre_SeriesBNonVotingConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_SeriesBNonVotingConvertiblePreferredStockMember" xlink:to="lab_syre_SeriesBNonVotingConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonrelatedPartyMember_aa1e4175-ef7a-4397-9688-ebc7e3171140_terseLabel_en-US" xlink:label="lab_us-gaap_NonrelatedPartyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Nonrelated Party</link:label>
    <link:label id="lab_us-gaap_NonrelatedPartyMember_label_en-US" xlink:label="lab_us-gaap_NonrelatedPartyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonrelated Party [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrelatedPartyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonrelatedPartyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonrelatedPartyMember" xlink:to="lab_us-gaap_NonrelatedPartyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_090640ec-b434-4af3-967d-6bd81c9744d7_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Marketable securities, amortized cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_d93bc34a-52bc-497b-a2a8-e209203189dd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_RelatedPartyTransactionNumberOfBoardSeats_1965af6b-8b1e-41b0-b4da-3de8e9e0c83a_terseLabel_en-US" xlink:label="lab_syre_RelatedPartyTransactionNumberOfBoardSeats" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of board seats held by related party</link:label>
    <link:label id="lab_syre_RelatedPartyTransactionNumberOfBoardSeats_label_en-US" xlink:label="lab_syre_RelatedPartyTransactionNumberOfBoardSeats" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction, Number Of Board Seats</link:label>
    <link:label id="lab_syre_RelatedPartyTransactionNumberOfBoardSeats_documentation_en-US" xlink:label="lab_syre_RelatedPartyTransactionNumberOfBoardSeats" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Related Party Transaction, Number Of Board Seats</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_RelatedPartyTransactionNumberOfBoardSeats" xlink:href="syre-20250331.xsd#syre_RelatedPartyTransactionNumberOfBoardSeats"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_RelatedPartyTransactionNumberOfBoardSeats" xlink:to="lab_syre_RelatedPartyTransactionNumberOfBoardSeats" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_f344bdc8-cf12-45c4-bdc9-98941d21af04_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk-free interest</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_SaleOfStockAggregateOfferingPrice_fa6891cf-80ba-4227-8dfe-42f5225fe5d8_terseLabel_en-US" xlink:label="lab_syre_SaleOfStockAggregateOfferingPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of stock, aggregate offering price</link:label>
    <link:label id="lab_syre_SaleOfStockAggregateOfferingPrice_label_en-US" xlink:label="lab_syre_SaleOfStockAggregateOfferingPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Aggregate Offering Price</link:label>
    <link:label id="lab_syre_SaleOfStockAggregateOfferingPrice_documentation_en-US" xlink:label="lab_syre_SaleOfStockAggregateOfferingPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sale of Stock, Aggregate Offering Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SaleOfStockAggregateOfferingPrice" xlink:href="syre-20250331.xsd#syre_SaleOfStockAggregateOfferingPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_SaleOfStockAggregateOfferingPrice" xlink:to="lab_syre_SaleOfStockAggregateOfferingPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_533f008b-8f49-4b6a-a956-8b25f3adddb0_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_6a0a0019-9e56-4037-9f24-4838cb651ac2_verboseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_label_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_AppointOfBoardMembersMember_0099cd39-c9b8-44a9-90b1-1f9d96db21d5_terseLabel_en-US" xlink:label="lab_syre_AppointOfBoardMembersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Appoint Of Board Members</link:label>
    <link:label id="lab_syre_AppointOfBoardMembersMember_label_en-US" xlink:label="lab_syre_AppointOfBoardMembersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Appoint Of Board Members [Member]</link:label>
    <link:label id="lab_syre_AppointOfBoardMembersMember_documentation_en-US" xlink:label="lab_syre_AppointOfBoardMembersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Appoint Of Board Members</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_AppointOfBoardMembersMember" xlink:href="syre-20250331.xsd#syre_AppointOfBoardMembersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_AppointOfBoardMembersMember" xlink:to="lab_syre_AppointOfBoardMembersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_8a0c92fc-ef28-40d7-a7eb-0436bc0bea8a_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_c2af11ba-9451-43f2-b21f-e7b1a00667df_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_c0075b80-24b9-4d51-9345-371b1b4277a9_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_30b68d91-2c30-4f70-a308-7740347ae91f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_InterestProceedsDebtSecurities_f4a3b61f-169e-49ea-9239-8914cc62b04e_terseLabel_en-US" xlink:label="lab_syre_InterestProceedsDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest proceeds from maturities of zero coupon US Treasury Bills</link:label>
    <link:label id="lab_syre_InterestProceedsDebtSecurities_label_en-US" xlink:label="lab_syre_InterestProceedsDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Proceeds, Debt Securities</link:label>
    <link:label id="lab_syre_InterestProceedsDebtSecurities_documentation_en-US" xlink:label="lab_syre_InterestProceedsDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Interest Proceeds, Debt Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_InterestProceedsDebtSecurities" xlink:href="syre-20250331.xsd#syre_InterestProceedsDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_InterestProceedsDebtSecurities" xlink:to="lab_syre_InterestProceedsDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_8ba49d7b-2db7-49e7-ab9f-c849ecc4d231_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assumptions used to Estimate the Fair Value of Stock Options Granted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_RoyaltyTermExpirationPeriod_54573463-81e2-4ef5-978f-19aeb0cb40a5_terseLabel_en-US" xlink:label="lab_syre_RoyaltyTermExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalty term expiration period</link:label>
    <link:label id="lab_syre_RoyaltyTermExpirationPeriod_label_en-US" xlink:label="lab_syre_RoyaltyTermExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalty Term, Expiration Period</link:label>
    <link:label id="lab_syre_RoyaltyTermExpirationPeriod_documentation_en-US" xlink:label="lab_syre_RoyaltyTermExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Royalty Term, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_RoyaltyTermExpirationPeriod" xlink:href="syre-20250331.xsd#syre_RoyaltyTermExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_RoyaltyTermExpirationPeriod" xlink:to="lab_syre_RoyaltyTermExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_a9baa03d-d987-4e7e-a86e-79bc117e759a_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction_6d021b00-2507-4760-ab4d-a54dfa2bc3e2_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount of related party transaction</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction, Amounts of Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:to="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_c3447131-2df8-4571-b852-8d40a77c2239_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related party accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable and Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_b4a307b7-9a7d-4ee8-9761-1086766e7ed6_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoName_terseLabel_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:label id="lab_ecd_PeoName_label_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoName" xlink:to="lab_ecd_PeoName" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:to="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a8251175-24f5-4c95-91ba-e4a63e610586_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Loss before income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_45b0e00d-3272-4740-9a88-cd203eeaf9f1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_ConsultingAgreementMember_6728ad52-4725-440f-9095-813630bd1bbd_terseLabel_en-US" xlink:label="lab_syre_ConsultingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consulting Agreement</link:label>
    <link:label id="lab_syre_ConsultingAgreementMember_label_en-US" xlink:label="lab_syre_ConsultingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consulting Agreement [Member]</link:label>
    <link:label id="lab_syre_ConsultingAgreementMember_documentation_en-US" xlink:label="lab_syre_ConsultingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Consulting Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ConsultingAgreementMember" xlink:href="syre-20250331.xsd#syre_ConsultingAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_ConsultingAgreementMember" xlink:to="lab_syre_ConsultingAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d4930a12-f696-4079-8916-5fca4858bb98_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingAxis_5f3b321b-84da-4191-98ce-a94a07593b31_terseLabel_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:label id="lab_us-gaap_VestingAxis_label_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingAxis" xlink:to="lab_us-gaap_VestingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryIndName" xlink:to="lab_ecd_OutstandingRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_b966b5ef-9fd7-4100-a8ef-ea29f7c9f864_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-Average Equity Instruments Excluded from Calculation of Diluted Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoMember_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO</link:label>
    <link:label id="lab_ecd_NonPeoNeoMember_label_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoMember" xlink:to="lab_ecd_NonPeoNeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_db80ec10-c437-4faf-bb01-28c9d5bd656f_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title and Position [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title and Position [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare_d841beb0-a19e-4c45-9931-0a033d06de1f_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Series B non-voting convertible preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:to="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities_c1219405-ed51-4f31-98c7-a7fd28902b84_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued and other current liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities_1cf86245-ee0e-4284-bf21-97d4638342ca_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total accrued and other current liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Liabilities and Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_11949b54-be15-43bc-a25b-3bbcd8e3f4b9_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined</link:label>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_label_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgPredtrmndFlag" xlink:to="lab_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_StockIssuedDuringPeriodSharesOptionsExercisedAndEmployeeStockOwnershipPlan_7e1c75ee-2e0d-4062-9ed5-eb2e8e8f2eed_terseLabel_en-US" xlink:label="lab_syre_StockIssuedDuringPeriodSharesOptionsExercisedAndEmployeeStockOwnershipPlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock in connection with exercise of stock options and employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_syre_StockIssuedDuringPeriodSharesOptionsExercisedAndEmployeeStockOwnershipPlan_label_en-US" xlink:label="lab_syre_StockIssuedDuringPeriodSharesOptionsExercisedAndEmployeeStockOwnershipPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Options Exercised And Employee Stock Ownership Plan</link:label>
    <link:label id="lab_syre_StockIssuedDuringPeriodSharesOptionsExercisedAndEmployeeStockOwnershipPlan_documentation_en-US" xlink:label="lab_syre_StockIssuedDuringPeriodSharesOptionsExercisedAndEmployeeStockOwnershipPlan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Options Exercised And Employee Stock Ownership Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_StockIssuedDuringPeriodSharesOptionsExercisedAndEmployeeStockOwnershipPlan" xlink:href="syre-20250331.xsd#syre_StockIssuedDuringPeriodSharesOptionsExercisedAndEmployeeStockOwnershipPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_StockIssuedDuringPeriodSharesOptionsExercisedAndEmployeeStockOwnershipPlan" xlink:to="lab_syre_StockIssuedDuringPeriodSharesOptionsExercisedAndEmployeeStockOwnershipPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_586acde9-33ca-4f1a-8cc9-a5f7510970b8_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_CashEquivalentsAndMarketableSecuritiesLineItems_14e42294-7e6d-472c-81c1-89da20f0ed38_terseLabel_en-US" xlink:label="lab_syre_CashEquivalentsAndMarketableSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash Equivalents And Marketable Securities [Line Items]</link:label>
    <link:label id="lab_syre_CashEquivalentsAndMarketableSecuritiesLineItems_label_en-US" xlink:label="lab_syre_CashEquivalentsAndMarketableSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Equivalents And Marketable Securities [Line Items]</link:label>
    <link:label id="lab_syre_CashEquivalentsAndMarketableSecuritiesLineItems_documentation_en-US" xlink:label="lab_syre_CashEquivalentsAndMarketableSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash equivalents and marketable securities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_CashEquivalentsAndMarketableSecuritiesLineItems" xlink:href="syre-20250331.xsd#syre_CashEquivalentsAndMarketableSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_CashEquivalentsAndMarketableSecuritiesLineItems" xlink:to="lab_syre_CashEquivalentsAndMarketableSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_a55ac022-1e3e-496a-9878-99e2e28ac652_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recently Adopted and Not Yet Adopted Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_2d000acb-49fe-4a6a-9dc7-f10ab64f8bf8_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss per share, diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_99f08022-2d00-49fd-a203-3ade6137bdb9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_f549f010-689f-45ad-bc7e-bfba847b2251_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment, Reconciliation of Other Items from Segments to Consolidated [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment, Reconciliation of Other Items from Segments to Consolidated [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems" xlink:to="lab_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_07a88b79-280f-4d4b-bc8b-bdd2467ee788_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title and Position [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title and Position [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_256f33ff-30c5-401e-b90d-43ab48285d49_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of Series A/B non-voting convertible preferred stock in connection with private placement, net of financing costs</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_RoyaltyStepDownPercent_20575347-4650-4bfa-9ad3-c098d7b9a234_terseLabel_en-US" xlink:label="lab_syre_RoyaltyStepDownPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalty step-down percentage</link:label>
    <link:label id="lab_syre_RoyaltyStepDownPercent_label_en-US" xlink:label="lab_syre_RoyaltyStepDownPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalty Step-Down, Percent</link:label>
    <link:label id="lab_syre_RoyaltyStepDownPercent_documentation_en-US" xlink:label="lab_syre_RoyaltyStepDownPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Royalty Step-Down, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_RoyaltyStepDownPercent" xlink:href="syre-20250331.xsd#syre_RoyaltyStepDownPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_RoyaltyStepDownPercent" xlink:to="lab_syre_RoyaltyStepDownPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_a8d7b0c4-a2ea-4ba1-bd5f-170e7486b336_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of Basic and Diluted Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Weighted Average Number of Shares [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureName_terseLabel_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_MeasureName_label_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureName" xlink:to="lab_ecd_MeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_391e45f1-1c41-488c-879b-032d04db18ba_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_terseLabel_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement does not require Recovery</link:label>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_label_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_8dd5f70c-352c-4f6b-ac81-23c88379a1aa_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment, Reconciliation of Other Items from Segments to Consolidated [Table]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment, Reconciliation of Other Items from Segments to Consolidated [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable" xlink:to="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_ba3becbd-af76-4f3f-94ab-dece67f31e4c_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_e9b80ce0-3bae-4311-bfd3-d7a0cb483db4_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting percentage</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_bb451d3a-0abd-4dd6-9824-f007c6ef78a1_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_UnderwrittenOfferingMember_b115d35d-7a9d-4186-be9c-0b24ae047cdd_terseLabel_en-US" xlink:label="lab_syre_UnderwrittenOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underwritten Offering</link:label>
    <link:label id="lab_syre_UnderwrittenOfferingMember_label_en-US" xlink:label="lab_syre_UnderwrittenOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Underwritten Offering [Member]</link:label>
    <link:label id="lab_syre_UnderwrittenOfferingMember_documentation_en-US" xlink:label="lab_syre_UnderwrittenOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Underwritten Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_UnderwrittenOfferingMember" xlink:href="syre-20250331.xsd#syre_UnderwrittenOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_UnderwrittenOfferingMember" xlink:to="lab_syre_UnderwrittenOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_eaa6d4b8-b47f-44bb-bf6b-006254578c1f_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_d3ceffae-fe66-4fc0-8581-5a24b13a1f2a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Assets and Liabilities Measured at Fair Value on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_OutstandingAndUnexercisedStockOptions_a4c78624-550f-4c18-a258-63fff775997f_terseLabel_en-US" xlink:label="lab_syre_OutstandingAndUnexercisedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of outstanding and unexercised stock options to purchase (in shares)</link:label>
    <link:label id="lab_syre_OutstandingAndUnexercisedStockOptions_label_en-US" xlink:label="lab_syre_OutstandingAndUnexercisedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding and Unexercised Stock Options</link:label>
    <link:label id="lab_syre_OutstandingAndUnexercisedStockOptions_documentation_en-US" xlink:label="lab_syre_OutstandingAndUnexercisedStockOptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Outstanding and unexercised stock options.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_OutstandingAndUnexercisedStockOptions" xlink:href="syre-20250331.xsd#syre_OutstandingAndUnexercisedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_OutstandingAndUnexercisedStockOptions" xlink:to="lab_syre_OutstandingAndUnexercisedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_98d3aa73-efdf-4959-85e3-32f02150c9d3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock_9b02dc4f-4b01-4e25-8ad5-e5b4b31438e5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Awards Granted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_a89c9f0d-75ac-4068-a459-daedc6bef142_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_95f628ba-0424-48b1-90be-07e84583ca4d_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_PaymentForSublicensingFee_adfc3894-b11e-459c-bad2-541f242a6c98_terseLabel_en-US" xlink:label="lab_syre_PaymentForSublicensingFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payment for sublicensing fee</link:label>
    <link:label id="lab_syre_PaymentForSublicensingFee_label_en-US" xlink:label="lab_syre_PaymentForSublicensingFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payment For Sublicensing Fee</link:label>
    <link:label id="lab_syre_PaymentForSublicensingFee_documentation_en-US" xlink:label="lab_syre_PaymentForSublicensingFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payment For Sublicensing Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_PaymentForSublicensingFee" xlink:href="syre-20250331.xsd#syre_PaymentForSublicensingFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_PaymentForSublicensingFee" xlink:to="lab_syre_PaymentForSublicensingFee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_badb9d8a-cff5-4963-859f-af5f851b468c_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Income tax benefit (expense)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_117cedf9-92b0-49b6-8bfc-67b1ff1390b9_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other income:</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_9df39201-831d-446a-a45d-9753d406b83c_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_f5a53c0c-a532-40a3-a047-8f7078c16edd_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Marketable securities, estimated fair value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_9f8466b1-888b-49de-ad69-767c08ade494_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total marketable securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_ef2c6805-865b-4276-89ff-dfb89fc7c153_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other income</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_491cb00b-57d8-4538-86ab-77ecc5b0e2c8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_5a06e48a-632e-435d-b534-0b31b934a5f5_totalLabel_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Cash equivalents, amortized cost</link:label>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_26b91a62-eb8c-4ea8-b42b-436c66532eef_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_8930c7b6-a80a-4507-ba95-a5510067ea25_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_00ca3c2f-e83f-4aed-8a24-f82773f9179f_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of Series B non-voting convertible preferred stock in connection with private placement, net of placement and other offering costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Private Placement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_87e5f907-e1fe-47db-b09a-61fb60dc71d5_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense (Excluding Acquired in Process Cost)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_99fbc833-9849-450f-bd92-c1836534d4a5_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">TOTAL LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:to="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllAdjToCompMember_terseLabel_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation</link:label>
    <link:label id="lab_ecd_AllAdjToCompMember_label_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="lab_ecd_AllAdjToCompMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_DevelopmentCostReductionPercentage_c5003ce2-825b-459e-b811-0b0eaa53c51b_terseLabel_en-US" xlink:label="lab_syre_DevelopmentCostReductionPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Development cost reduction, percent</link:label>
    <link:label id="lab_syre_DevelopmentCostReductionPercentage_label_en-US" xlink:label="lab_syre_DevelopmentCostReductionPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Development Cost Reduction, Percentage</link:label>
    <link:label id="lab_syre_DevelopmentCostReductionPercentage_documentation_en-US" xlink:label="lab_syre_DevelopmentCostReductionPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Development Cost Reduction, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_DevelopmentCostReductionPercentage" xlink:href="syre-20250331.xsd#syre_DevelopmentCostReductionPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_DevelopmentCostReductionPercentage" xlink:to="lab_syre_DevelopmentCostReductionPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_6ebdadb8-2f91-48c6-a8a5-691f25807fa0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2eec18ec-2338-4930-88a6-ee2e3ed7ef39_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_TwoThousandAndFifteenAndTwoThousandAndSixteenEquityIncentivePlanAndTwoThousandAndEighteenEquityInducementPlanMember_83a2662a-f43f-4027-9cf0-ff976dd4a504_terseLabel_en-US" xlink:label="lab_syre_TwoThousandAndFifteenAndTwoThousandAndSixteenEquityIncentivePlanAndTwoThousandAndEighteenEquityInducementPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2015 and 2016 and 2018 Equity Inducement Plan</link:label>
    <link:label id="lab_syre_TwoThousandAndFifteenAndTwoThousandAndSixteenEquityIncentivePlanAndTwoThousandAndEighteenEquityInducementPlanMember_label_en-US" xlink:label="lab_syre_TwoThousandAndFifteenAndTwoThousandAndSixteenEquityIncentivePlanAndTwoThousandAndEighteenEquityInducementPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Two Thousand And Fifteen And Two Thousand And Sixteen Equity Incentive Plan And Two Thousand And Eighteen Equity Inducement Plan [Member]</link:label>
    <link:label id="lab_syre_TwoThousandAndFifteenAndTwoThousandAndSixteenEquityIncentivePlanAndTwoThousandAndEighteenEquityInducementPlanMember_documentation_en-US" xlink:label="lab_syre_TwoThousandAndFifteenAndTwoThousandAndSixteenEquityIncentivePlanAndTwoThousandAndEighteenEquityInducementPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Two thousand and fifteen and two thousand and sixteen equity incentive plan and two thousand and eighteen equity inducement plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_TwoThousandAndFifteenAndTwoThousandAndSixteenEquityIncentivePlanAndTwoThousandAndEighteenEquityInducementPlanMember" xlink:href="syre-20250331.xsd#syre_TwoThousandAndFifteenAndTwoThousandAndSixteenEquityIncentivePlanAndTwoThousandAndEighteenEquityInducementPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_TwoThousandAndFifteenAndTwoThousandAndSixteenEquityIncentivePlanAndTwoThousandAndEighteenEquityInducementPlanMember" xlink:to="lab_syre_TwoThousandAndFifteenAndTwoThousandAndSixteenEquityIncentivePlanAndTwoThousandAndEighteenEquityInducementPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesCurrent_41e9b320-d4bb-46fc-b863-a05910086424_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CVR liability</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilitiesCurrent" xlink:to="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_e05c1a9e-f953-4c94-a1d3-c91f4c8fab4b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic, by Common Class, Including Two-Class Method [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic, by Common Class, Including Two-Class Method [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_AnnualPercentageOfAdditionalSharesWhichEqualsToIssuedAndOutstandingShares_7c3ad66c-ae41-4dff-89b1-bcf4a1992a9a_terseLabel_en-US" xlink:label="lab_syre_AnnualPercentageOfAdditionalSharesWhichEqualsToIssuedAndOutstandingShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Annual percentage of additional shares</link:label>
    <link:label id="lab_syre_AnnualPercentageOfAdditionalSharesWhichEqualsToIssuedAndOutstandingShares_label_en-US" xlink:label="lab_syre_AnnualPercentageOfAdditionalSharesWhichEqualsToIssuedAndOutstandingShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Annual Percentage Of Additional Shares Which Equals To Issued And Outstanding Shares</link:label>
    <link:label id="lab_syre_AnnualPercentageOfAdditionalSharesWhichEqualsToIssuedAndOutstandingShares_documentation_en-US" xlink:label="lab_syre_AnnualPercentageOfAdditionalSharesWhichEqualsToIssuedAndOutstandingShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Annual percentage of additional shares which equals to the issued and outstanding shares.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_AnnualPercentageOfAdditionalSharesWhichEqualsToIssuedAndOutstandingShares" xlink:href="syre-20250331.xsd#syre_AnnualPercentageOfAdditionalSharesWhichEqualsToIssuedAndOutstandingShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_AnnualPercentageOfAdditionalSharesWhichEqualsToIssuedAndOutstandingShares" xlink:to="lab_syre_AnnualPercentageOfAdditionalSharesWhichEqualsToIssuedAndOutstandingShares" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_terseLabel_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change</link:label>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_label_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:to="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_1dcd872e-1f3b-47af-ba01-53bf901198c6_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_IndividualAxis_terseLabel_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Individual:</link:label>
    <link:label id="lab_ecd_IndividualAxis_label_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_IndividualAxis" xlink:to="lab_ecd_IndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_97d3dca2-1aef-4625-81ec-fd696bbae955_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ae752693-141f-49f9-8675-d63dbb378fef_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_TerminationNoticePeriod_de356c23-4a77-4154-9aa0-8ba343b5640c_terseLabel_en-US" xlink:label="lab_syre_TerminationNoticePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Termination notice period</link:label>
    <link:label id="lab_syre_TerminationNoticePeriod_label_en-US" xlink:label="lab_syre_TerminationNoticePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Termination Notice Period</link:label>
    <link:label id="lab_syre_TerminationNoticePeriod_documentation_en-US" xlink:label="lab_syre_TerminationNoticePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Termination Notice Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_TerminationNoticePeriod" xlink:href="syre-20250331.xsd#syre_TerminationNoticePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_TerminationNoticePeriod" xlink:to="lab_syre_TerminationNoticePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCash_990f3a97-c359-499f-bdc8-c7e618168a70_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCash_label_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCash" xlink:to="lab_us-gaap_RestrictedCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_67731cf7-e73b-4584-8483-989ba1fa7a67_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_SeriesANonVotingConvertiblePreferredStockMember_00d26f39-69d2-4d90-9817-db8bc6d1bdcd_terseLabel_en-US" xlink:label="lab_syre_SeriesANonVotingConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Series A Non Voting Convertible Preferred Stock</link:label>
    <link:label id="lab_syre_SeriesANonVotingConvertiblePreferredStockMember_3b81fa15-3144-4358-9b31-0dbd65f88392_verboseLabel_en-US" xlink:label="lab_syre_SeriesANonVotingConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Series A Preferred Stock</link:label>
    <link:label id="lab_syre_SeriesANonVotingConvertiblePreferredStockMember_label_en-US" xlink:label="lab_syre_SeriesANonVotingConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series A Non Voting Convertible Preferred Stock [Member]</link:label>
    <link:label id="lab_syre_SeriesANonVotingConvertiblePreferredStockMember_documentation_en-US" xlink:label="lab_syre_SeriesANonVotingConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Series A non voting convertible preferred stock.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SeriesANonVotingConvertiblePreferredStockMember" xlink:href="syre-20250331.xsd#syre_SeriesANonVotingConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_SeriesANonVotingConvertiblePreferredStockMember" xlink:to="lab_syre_SeriesANonVotingConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_321dd752-799c-418a-9efe-48c3e324f488_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">US Government Agencies Debt Securities</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_7273d900-0299-4260-8a07-9c707eca1878_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_75613ccc-8eaa-4358-b092-fd838b29a269_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_4059f769-6a6d-4ba2-83ff-7d706a20fcc9_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_A2024ParapyreOptionObligationMember_dd8c3496-c69b-4284-ab9d-86c4bc6fe2d2_terseLabel_en-US" xlink:label="lab_syre_A2024ParapyreOptionObligationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2024 Parapyre Option Obligation</link:label>
    <link:label id="lab_syre_A2024ParapyreOptionObligationMember_label_en-US" xlink:label="lab_syre_A2024ParapyreOptionObligationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2024 Parapyre Option Obligation [Member]</link:label>
    <link:label id="lab_syre_A2024ParapyreOptionObligationMember_documentation_en-US" xlink:label="lab_syre_A2024ParapyreOptionObligationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2024 Parapyre Option Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_A2024ParapyreOptionObligationMember" xlink:href="syre-20250331.xsd#syre_A2024ParapyreOptionObligationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_A2024ParapyreOptionObligationMember" xlink:to="lab_syre_A2024ParapyreOptionObligationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_label_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompAnalysisTextBlock" xlink:to="lab_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_22cb2cba-7622-4e8c-a4ef-2536a8ee8ccf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expenses related to Related Party which were Settled in Cash</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Related Party Transactions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_1e2d640a-17cd-4446-9edf-91d126b63d79_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Significant Segment Expenses</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_f1292647-3528-472e-a633-03a1a8450cc3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_CommonStockAndSeriesBNonVotingConvertiblePreferredStockMember_9d9bd939-cc58-4f14-806b-3226d25a4739_terseLabel_en-US" xlink:label="lab_syre_CommonStockAndSeriesBNonVotingConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock and Series B Non Voting Convertible Preferred Stock</link:label>
    <link:label id="lab_syre_CommonStockAndSeriesBNonVotingConvertiblePreferredStockMember_label_en-US" xlink:label="lab_syre_CommonStockAndSeriesBNonVotingConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock and Series B Non Voting Convertible Preferred Stock [Member]</link:label>
    <link:label id="lab_syre_CommonStockAndSeriesBNonVotingConvertiblePreferredStockMember_documentation_en-US" xlink:label="lab_syre_CommonStockAndSeriesBNonVotingConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Common Stock and Series B Non Voting Convertible Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_CommonStockAndSeriesBNonVotingConvertiblePreferredStockMember" xlink:href="syre-20250331.xsd#syre_CommonStockAndSeriesBNonVotingConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_CommonStockAndSeriesBNonVotingConvertiblePreferredStockMember" xlink:to="lab_syre_CommonStockAndSeriesBNonVotingConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_11aa190b-1113-47f7-979a-a7592d13342a_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingDomain_a62c8dee-b844-47c3-8aff-4b3cd7122a6f_terseLabel_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:label id="lab_us-gaap_VestingDomain_label_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingDomain" xlink:to="lab_us-gaap_VestingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_LicenseAgreementMilestonePaymentsOutstandingAndPayable_40242886-19dd-4a01-b61c-aad060d5b9d8_terseLabel_en-US" xlink:label="lab_syre_LicenseAgreementMilestonePaymentsOutstandingAndPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Milestone payments, outstanding and payable</link:label>
    <link:label id="lab_syre_LicenseAgreementMilestonePaymentsOutstandingAndPayable_label_en-US" xlink:label="lab_syre_LicenseAgreementMilestonePaymentsOutstandingAndPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License Agreement, Milestone Payments Outstanding and Payable</link:label>
    <link:label id="lab_syre_LicenseAgreementMilestonePaymentsOutstandingAndPayable_documentation_en-US" xlink:label="lab_syre_LicenseAgreementMilestonePaymentsOutstandingAndPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">License Agreement, Milestone Payments Outstanding and Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_LicenseAgreementMilestonePaymentsOutstandingAndPayable" xlink:href="syre-20250331.xsd#syre_LicenseAgreementMilestonePaymentsOutstandingAndPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_LicenseAgreementMilestonePaymentsOutstandingAndPayable" xlink:to="lab_syre_LicenseAgreementMilestonePaymentsOutstandingAndPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_AtTheMarketOfferingMember_31432381-b761-4ace-b6ff-6c045c3ec9f5_terseLabel_en-US" xlink:label="lab_syre_AtTheMarketOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">At-The-Market Offering</link:label>
    <link:label id="lab_syre_AtTheMarketOfferingMember_label_en-US" xlink:label="lab_syre_AtTheMarketOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">At-The-Market Offering [Member]</link:label>
    <link:label id="lab_syre_AtTheMarketOfferingMember_documentation_en-US" xlink:label="lab_syre_AtTheMarketOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">At-The-Market Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_AtTheMarketOfferingMember" xlink:href="syre-20250331.xsd#syre_AtTheMarketOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_AtTheMarketOfferingMember" xlink:to="lab_syre_AtTheMarketOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9f7c913b-e381-4e4c-a7d8-9c8f027ff7f5_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_707aa7cc-c976-46e0-9b5a-1089a2abb9a0_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2b5d0f2d-06f3-4cc2-b458-36cf383f2054_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_ShareBasedPaymentArrangementSettlementOptionsCash_0d79ac93-bd30-421f-bb30-8a3e2941fe46_negatedTerseLabel_en-US" xlink:label="lab_syre_ShareBasedPaymentArrangementSettlementOptionsCash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Cash settlement of stock option award</link:label>
    <link:label id="lab_syre_ShareBasedPaymentArrangementSettlementOptionsCash_label_en-US" xlink:label="lab_syre_ShareBasedPaymentArrangementSettlementOptionsCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Settlement, Options, Cash</link:label>
    <link:label id="lab_syre_ShareBasedPaymentArrangementSettlementOptionsCash_documentation_en-US" xlink:label="lab_syre_ShareBasedPaymentArrangementSettlementOptionsCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Settlement, Options, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ShareBasedPaymentArrangementSettlementOptionsCash" xlink:href="syre-20250331.xsd#syre_ShareBasedPaymentArrangementSettlementOptionsCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_ShareBasedPaymentArrangementSettlementOptionsCash" xlink:to="lab_syre_ShareBasedPaymentArrangementSettlementOptionsCash" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_165c7ef4-7757-4fa6-9bfb-c0af37e576e8_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDeterminationDate_terseLabel_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:label id="lab_ecd_RestatementDeterminationDate_label_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDeterminationDate" xlink:to="lab_ecd_RestatementDeterminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrAdoptionDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adoption Date</link:label>
    <link:label id="lab_ecd_TrdArrAdoptionDate_label_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Adoption Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrAdoptionDate" xlink:to="lab_ecd_TrdArrAdoptionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTable_terseLabel_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure</link:label>
    <link:label id="lab_ecd_PvpTable_label_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTable" xlink:to="lab_ecd_PvpTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_b122d6d7-7b44-4b92-ae58-51825cf69d6a_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompRecoveryTable_terseLabel_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery</link:label>
    <link:label id="lab_ecd_ErrCompRecoveryTable_label_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="lab_ecd_ErrCompRecoveryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8d29361a-e79c-4ee8-b457-fe46665f9b6f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding option awards (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_e178f1a1-aba9-4dc6-ac8d-9bfe77a8cfc3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</link:label>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:to="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_8ae1b7db-9650-4fb6-8013-613d8038e847_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardExrcPrice_terseLabel_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise Price</link:label>
    <link:label id="lab_ecd_AwardExrcPrice_label_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardExrcPrice" xlink:to="lab_ecd_AwardExrcPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableforSaleUnrealizedLossPositionAbstract_99f88a64-d640-4f66-819b-6d7846a46082_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableforSaleUnrealizedLossPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableforSaleUnrealizedLossPositionAbstract_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableforSaleUnrealizedLossPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableforSaleUnrealizedLossPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableforSaleUnrealizedLossPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforSaleUnrealizedLossPositionAbstract" xlink:to="lab_us-gaap_DebtSecuritiesAvailableforSaleUnrealizedLossPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_SPY002LicenseAgreementMember_f7bde657-913d-47a5-a9e5-a54fcca0694b_terseLabel_en-US" xlink:label="lab_syre_SPY002LicenseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SPY002 License Agreement</link:label>
    <link:label id="lab_syre_SPY002LicenseAgreementMember_label_en-US" xlink:label="lab_syre_SPY002LicenseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SPY002 License Agreement [Member]</link:label>
    <link:label id="lab_syre_SPY002LicenseAgreementMember_documentation_en-US" xlink:label="lab_syre_SPY002LicenseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">SPY002 License Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SPY002LicenseAgreementMember" xlink:href="syre-20250331.xsd#syre_SPY002LicenseAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_SPY002LicenseAgreementMember" xlink:to="lab_syre_SPY002LicenseAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockTextBlock_223331fe-ca18-4b93-ac37-1341508be9e7_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible Preferred Stock and Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_PreferredStockTextBlock_label_en-US" xlink:label="lab_us-gaap_PreferredStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockTextBlock" xlink:to="lab_us-gaap_PreferredStockTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_7bfc5c13-c884-49a0-a453-22a26cdf3a08_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrDuration_terseLabel_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Arrangement Duration</link:label>
    <link:label id="lab_ecd_TrdArrDuration_label_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrDuration" xlink:to="lab_ecd_TrdArrDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableOtherCurrent_74d05760-91dd-459d-a1ee-f596b9d3631c_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableOtherCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total related party accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableOtherCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableOtherCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Other, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableOtherCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableOtherCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableOtherCurrent" xlink:to="lab_us-gaap_AccountsPayableOtherCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_CashEquivalentsAndMarketableSecuritiesTable_011d0828-b141-4378-8e81-4f73dcc3e667_terseLabel_en-US" xlink:label="lab_syre_CashEquivalentsAndMarketableSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash Equivalents And Marketable Securities [Table]</link:label>
    <link:label id="lab_syre_CashEquivalentsAndMarketableSecuritiesTable_label_en-US" xlink:label="lab_syre_CashEquivalentsAndMarketableSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Equivalents And Marketable Securities [Table]</link:label>
    <link:label id="lab_syre_CashEquivalentsAndMarketableSecuritiesTable_documentation_en-US" xlink:label="lab_syre_CashEquivalentsAndMarketableSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash equivalents and marketable securities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_CashEquivalentsAndMarketableSecuritiesTable" xlink:href="syre-20250331.xsd#syre_CashEquivalentsAndMarketableSecuritiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_CashEquivalentsAndMarketableSecuritiesTable" xlink:to="lab_syre_CashEquivalentsAndMarketableSecuritiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_ba33bfc4-ae6d-4099-964c-bd284b829d40_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_7f217554-5722-42f4-a4ad-69468a58b1cc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Less Than 12 Months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_label_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:to="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_0e680471-0ea5-4757-80f2-68ff3caeeb61_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_terseLabel_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_label_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade_0af09e2d-8457-4c65-a531-41bddeb5f9ec_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable, Trade</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllIndividualsMember_terseLabel_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Individuals</link:label>
    <link:label id="lab_ecd_AllIndividualsMember_label_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Individuals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="lab_ecd_AllIndividualsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_A2016ESPPMember_29843bde-8241-4969-b9a9-4070717ac583_terseLabel_en-US" xlink:label="lab_syre_A2016ESPPMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2016 ESPP</link:label>
    <link:label id="lab_syre_A2016ESPPMember_label_en-US" xlink:label="lab_syre_A2016ESPPMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2016 ESPP [Member]</link:label>
    <link:label id="lab_syre_A2016ESPPMember_documentation_en-US" xlink:label="lab_syre_A2016ESPPMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2016 ESPP</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_A2016ESPPMember" xlink:href="syre-20250331.xsd#syre_A2016ESPPMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_A2016ESPPMember" xlink:to="lab_syre_A2016ESPPMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoMember_terseLabel_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO</link:label>
    <link:label id="lab_ecd_PeoMember_label_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoMember" xlink:to="lab_ecd_PeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndName_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_TrdArrIndName_label_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndName" xlink:to="lab_ecd_TrdArrIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_3d83c6cf-d3ba-4569-b2f6-e1eea12c9856_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_0e2f67d9-e770-4937-84b8-4e5a0caa5319_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_Spyre2023EquityIncentivePlanMember_03d99518-03c3-4530-a474-4e10178126fc_terseLabel_en-US" xlink:label="lab_syre_Spyre2023EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Spyre 2023 Equity Incentive Plan</link:label>
    <link:label id="lab_syre_Spyre2023EquityIncentivePlanMember_label_en-US" xlink:label="lab_syre_Spyre2023EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Spyre 2023 Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_syre_Spyre2023EquityIncentivePlanMember_documentation_en-US" xlink:label="lab_syre_Spyre2023EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Spyre 2023 equity incentive plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_Spyre2023EquityIncentivePlanMember" xlink:href="syre-20250331.xsd#syre_Spyre2023EquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_Spyre2023EquityIncentivePlanMember" xlink:to="lab_syre_Spyre2023EquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_ParagonTherapeuticsIncMember_4f578fb3-830d-4b22-bbf0-4fc2ae1e4fef_terseLabel_en-US" xlink:label="lab_syre_ParagonTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Paragon Therapeutics Inc</link:label>
    <link:label id="lab_syre_ParagonTherapeuticsIncMember_label_en-US" xlink:label="lab_syre_ParagonTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Paragon Therapeutics Inc [Member]</link:label>
    <link:label id="lab_syre_ParagonTherapeuticsIncMember_documentation_en-US" xlink:label="lab_syre_ParagonTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Paragon therapeutics, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ParagonTherapeuticsIncMember" xlink:href="syre-20250331.xsd#syre_ParagonTherapeuticsIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_ParagonTherapeuticsIncMember" xlink:to="lab_syre_ParagonTherapeuticsIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_651e64a1-71c4-47d8-8989-4d303b8ae74a_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Marketable securities, gross unrealized gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_0c90adc6-6c45-4968-b8d4-c1b96db0c11f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from employee stock option exercises and employee stock plan purchases</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_NumberOfDomesticBankingInstitutions_2c6c1924-d9e4-45b7-85bd-ce346f1c30fb_terseLabel_en-US" xlink:label="lab_syre_NumberOfDomesticBankingInstitutions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of domestic banking institutions (in banks)</link:label>
    <link:label id="lab_syre_NumberOfDomesticBankingInstitutions_label_en-US" xlink:label="lab_syre_NumberOfDomesticBankingInstitutions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Domestic Banking Institutions</link:label>
    <link:label id="lab_syre_NumberOfDomesticBankingInstitutions_documentation_en-US" xlink:label="lab_syre_NumberOfDomesticBankingInstitutions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Domestic Banking Institutions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_NumberOfDomesticBankingInstitutions" xlink:href="syre-20250331.xsd#syre_NumberOfDomesticBankingInstitutions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_NumberOfDomesticBankingInstitutions" xlink:to="lab_syre_NumberOfDomesticBankingInstitutions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract_78943943-488c-4671-a7b4-bca977ee23f8_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CASH, CASH EQUIVALENTS, AND RESTRICTED CASH</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_SublicensingFeeOutstandingAndPayable_5b00030a-ee25-49bf-a694-306de62ea729_terseLabel_en-US" xlink:label="lab_syre_SublicensingFeeOutstandingAndPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sublicensing fee, outstanding and payable</link:label>
    <link:label id="lab_syre_SublicensingFeeOutstandingAndPayable_label_en-US" xlink:label="lab_syre_SublicensingFeeOutstandingAndPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sublicensing Fee, Outstanding And Payable</link:label>
    <link:label id="lab_syre_SublicensingFeeOutstandingAndPayable_documentation_en-US" xlink:label="lab_syre_SublicensingFeeOutstandingAndPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sublicensing Fee, Outstanding And Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SublicensingFeeOutstandingAndPayable" xlink:href="syre-20250331.xsd#syre_SublicensingFeeOutstandingAndPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_SublicensingFeeOutstandingAndPayable" xlink:to="lab_syre_SublicensingFeeOutstandingAndPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_SublicensingFee_287c9f47-875d-41f1-beab-c1492acc3423_terseLabel_en-US" xlink:label="lab_syre_SublicensingFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sublicensing fee</link:label>
    <link:label id="lab_syre_SublicensingFee_label_en-US" xlink:label="lab_syre_SublicensingFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sublicensing Fee</link:label>
    <link:label id="lab_syre_SublicensingFee_documentation_en-US" xlink:label="lab_syre_SublicensingFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sublicensing Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SublicensingFee" xlink:href="syre-20250331.xsd#syre_SublicensingFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_SublicensingFee" xlink:to="lab_syre_SublicensingFee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_9483ee04-5105-4843-9ea3-fa6e129deff2_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8ee6ded9-3bce-4a3b-ae54-e28c3111ed5c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_f36991a3-118e-484d-b1a8-fdf2f953b401_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock available for future issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year</link:label>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_label_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:to="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_35f0b60e-597a-450c-88c4-ce3631eb2958_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related and Nonrelated Parties [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related and Nonrelated Parties [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_259e7b71-d005-4728-8c21-8a6ede74f08a_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash equivalents, estimated fair value</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_AggtErrCompAmt_label_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompAmt" xlink:to="lab_ecd_AggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_58a39394-8d07-4dc6-aa3e-20c27c6d52e6_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash Equivalents and Marketable Securities</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, and Marketable Securities [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:to="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_8363cf6a-c810-40e0-bdbf-366a4aa52bc2_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_5bfae70d-5ee4-4ca9-b3be-cce677571964_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_BeneficialHoldersOwnedPercentage_fbea2d3f-e7fa-44f1-b23c-de50eb299570_terseLabel_en-US" xlink:label="lab_syre_BeneficialHoldersOwnedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Beneficial holders owned percentage</link:label>
    <link:label id="lab_syre_BeneficialHoldersOwnedPercentage_label_en-US" xlink:label="lab_syre_BeneficialHoldersOwnedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Beneficial Holders Owned Percentage</link:label>
    <link:label id="lab_syre_BeneficialHoldersOwnedPercentage_documentation_en-US" xlink:label="lab_syre_BeneficialHoldersOwnedPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Beneficial Holders Owned Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_BeneficialHoldersOwnedPercentage" xlink:href="syre-20250331.xsd#syre_BeneficialHoldersOwnedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_BeneficialHoldersOwnedPercentage" xlink:to="lab_syre_BeneficialHoldersOwnedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_label_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_2be0c2be-6792-4dcd-8204-6b4a8e388f6e_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_IssuanceOfConvertiblePreferredStockRelatedToPrivatePlacementUnpaidAmount_ec207e13-5031-4cfc-83e0-a51454b30d89_terseLabel_en-US" xlink:label="lab_syre_IssuanceOfConvertiblePreferredStockRelatedToPrivatePlacementUnpaidAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unpaid amounts related to issuance of Series B non-voting convertible preferred stock in connection with private placement</link:label>
    <link:label id="lab_syre_IssuanceOfConvertiblePreferredStockRelatedToPrivatePlacementUnpaidAmount_label_en-US" xlink:label="lab_syre_IssuanceOfConvertiblePreferredStockRelatedToPrivatePlacementUnpaidAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issuance of Convertible Preferred Stock Related to Private Placement, Unpaid Amount</link:label>
    <link:label id="lab_syre_IssuanceOfConvertiblePreferredStockRelatedToPrivatePlacementUnpaidAmount_documentation_en-US" xlink:label="lab_syre_IssuanceOfConvertiblePreferredStockRelatedToPrivatePlacementUnpaidAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Issuance of Convertible Preferred Stock Related to Private Placement, Unpaid Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_IssuanceOfConvertiblePreferredStockRelatedToPrivatePlacementUnpaidAmount" xlink:href="syre-20250331.xsd#syre_IssuanceOfConvertiblePreferredStockRelatedToPrivatePlacementUnpaidAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_IssuanceOfConvertiblePreferredStockRelatedToPrivatePlacementUnpaidAmount" xlink:to="lab_syre_IssuanceOfConvertiblePreferredStockRelatedToPrivatePlacementUnpaidAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_cec12b40-9389-4dd8-8ddb-b13cd8589ca2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_959b28c6-b3cc-433d-a825-2483264ba357_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_9de42548-5ec4-470a-a74e-5eb7c15e7c6d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt securities, available-for-sale, allowance for credit loss</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoTotalCompAmt_label_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoTotalCompAmt" xlink:to="lab_ecd_PeoTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_247e2b11-5d97-4c7f-9f2f-1e84f8266e61_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_SaleOfStockRemainingAuthorizedAmount_77f03eb9-7b30-4956-8dc8-6c6a3155721a_terseLabel_en-US" xlink:label="lab_syre_SaleOfStockRemainingAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of stock, remaining authorized amount</link:label>
    <link:label id="lab_syre_SaleOfStockRemainingAuthorizedAmount_label_en-US" xlink:label="lab_syre_SaleOfStockRemainingAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Remaining Authorized Amount</link:label>
    <link:label id="lab_syre_SaleOfStockRemainingAuthorizedAmount_documentation_en-US" xlink:label="lab_syre_SaleOfStockRemainingAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sale of Stock, Remaining Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SaleOfStockRemainingAuthorizedAmount" xlink:href="syre-20250331.xsd#syre_SaleOfStockRemainingAuthorizedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_SaleOfStockRemainingAuthorizedAmount" xlink:to="lab_syre_SaleOfStockRemainingAuthorizedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockConvertibleConversionRatio_3d8606ad-bbac-4ed5-9cfb-cfa23a77f66f_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockConvertibleConversionRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion basis</link:label>
    <link:label id="lab_us-gaap_PreferredStockConvertibleConversionRatio_label_en-US" xlink:label="lab_us-gaap_PreferredStockConvertibleConversionRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Convertible, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockConvertibleConversionRatio" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockConvertibleConversionRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockConvertibleConversionRatio" xlink:to="lab_us-gaap_PreferredStockConvertibleConversionRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_38995107-2134-4eab-8a7c-378b2f86ba7c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued and Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_52ad7b01-cf87-4df2-98e8-6864d2564b51_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFDICInsuredAmount_12875685-eff8-4f6c-a1d2-265c4de144f0_terseLabel_en-US" xlink:label="lab_us-gaap_CashFDICInsuredAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash, FDIC insured amount</link:label>
    <link:label id="lab_us-gaap_CashFDICInsuredAmount_label_en-US" xlink:label="lab_us-gaap_CashFDICInsuredAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, FDIC Insured Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFDICInsuredAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFDICInsuredAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFDICInsuredAmount" xlink:to="lab_us-gaap_CashFDICInsuredAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_55fc9f01-6133-4a74-816f-c8957f7ab71c_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Placement agent and other offering costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_faf34fef-fd64-4f7e-a7f1-0bf2d73a2e93_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from maturities and sales of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_685e298f-5cee-4503-8cb6-8b9e26af0f22_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureAxis_terseLabel_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measure:</link:label>
    <link:label id="lab_ecd_MeasureAxis_label_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureAxis" xlink:to="lab_ecd_MeasureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_15b62934-176f-4b54-aad5-48b7ac5d3827_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_MinorityInterestOwnershipPercentageByNoncontrollingOwnersHeldInThirdParty_363248bd-3488-4c12-9bd6-e89798e8af7a_terseLabel_en-US" xlink:label="lab_syre_MinorityInterestOwnershipPercentageByNoncontrollingOwnersHeldInThirdParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of ownership held in third party</link:label>
    <link:label id="lab_syre_MinorityInterestOwnershipPercentageByNoncontrollingOwnersHeldInThirdParty_label_en-US" xlink:label="lab_syre_MinorityInterestOwnershipPercentageByNoncontrollingOwnersHeldInThirdParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minority Interest Ownership Percentage By Noncontrolling Owners Held In Third Party</link:label>
    <link:label id="lab_syre_MinorityInterestOwnershipPercentageByNoncontrollingOwnersHeldInThirdParty_documentation_en-US" xlink:label="lab_syre_MinorityInterestOwnershipPercentageByNoncontrollingOwnersHeldInThirdParty" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Minority interest ownership percentage by noncontrolling owners held in third party.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_MinorityInterestOwnershipPercentageByNoncontrollingOwnersHeldInThirdParty" xlink:href="syre-20250331.xsd#syre_MinorityInterestOwnershipPercentageByNoncontrollingOwnersHeldInThirdParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_MinorityInterestOwnershipPercentageByNoncontrollingOwnersHeldInThirdParty" xlink:to="lab_syre_MinorityInterestOwnershipPercentageByNoncontrollingOwnersHeldInThirdParty" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_USBankingInstitutionMember_89d0858f-af38-42e4-8701-cce598a5c0c7_terseLabel_en-US" xlink:label="lab_syre_USBankingInstitutionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">U.S. Banking Institution</link:label>
    <link:label id="lab_syre_USBankingInstitutionMember_label_en-US" xlink:label="lab_syre_USBankingInstitutionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">U.S. Banking Institution [Member]</link:label>
    <link:label id="lab_syre_USBankingInstitutionMember_documentation_en-US" xlink:label="lab_syre_USBankingInstitutionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">U.S. Banking Institution [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_USBankingInstitutionMember" xlink:href="syre-20250331.xsd#syre_USBankingInstitutionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_USBankingInstitutionMember" xlink:to="lab_syre_USBankingInstitutionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_3d37393e-6937-42a1-a6b4-6d9b82fe33e1_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_11b0b024-3d00-49c7-976b-04d6d75ff3d4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in Derivative Liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_65248f43-ab10-4262-b621-83155ef9ee0a_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_DevelopmentCostReimbursementPercentage_648f1912-f49b-48f3-ad61-a43568a40fd1_terseLabel_en-US" xlink:label="lab_syre_DevelopmentCostReimbursementPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Development cost reimbursement, percent</link:label>
    <link:label id="lab_syre_DevelopmentCostReimbursementPercentage_label_en-US" xlink:label="lab_syre_DevelopmentCostReimbursementPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Development Cost Reimbursement, Percentage</link:label>
    <link:label id="lab_syre_DevelopmentCostReimbursementPercentage_documentation_en-US" xlink:label="lab_syre_DevelopmentCostReimbursementPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Development Cost Reimbursement, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_DevelopmentCostReimbursementPercentage" xlink:href="syre-20250331.xsd#syre_DevelopmentCostReimbursementPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_DevelopmentCostReimbursementPercentage" xlink:to="lab_syre_DevelopmentCostReimbursementPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_ParagonAgreementLicenseMilestonePaymentsMember_28ab8619-3244-4f99-bf1d-030339da2e39_terseLabel_en-US" xlink:label="lab_syre_ParagonAgreementLicenseMilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">License Agreement</link:label>
    <link:label id="lab_syre_ParagonAgreementLicenseMilestonePaymentsMember_label_en-US" xlink:label="lab_syre_ParagonAgreementLicenseMilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Paragon Agreement, License Milestone Payments [Member]</link:label>
    <link:label id="lab_syre_ParagonAgreementLicenseMilestonePaymentsMember_documentation_en-US" xlink:label="lab_syre_ParagonAgreementLicenseMilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Paragon Agreement, License Milestone Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ParagonAgreementLicenseMilestonePaymentsMember" xlink:href="syre-20250331.xsd#syre_ParagonAgreementLicenseMilestonePaymentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_ParagonAgreementLicenseMilestonePaymentsMember" xlink:to="lab_syre_ParagonAgreementLicenseMilestonePaymentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_b5789deb-4270-41f5-a205-134e98c8fce7_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_ParagonAgreementSubsequentToAssetAcquisitionMember_0ecd2efe-5942-4c36-a0d5-5dc26965a6d5_terseLabel_en-US" xlink:label="lab_syre_ParagonAgreementSubsequentToAssetAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent to Asset Acquisition</link:label>
    <link:label id="lab_syre_ParagonAgreementSubsequentToAssetAcquisitionMember_label_en-US" xlink:label="lab_syre_ParagonAgreementSubsequentToAssetAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Paragon Agreement, Subsequent to Asset Acquisition [Member]</link:label>
    <link:label id="lab_syre_ParagonAgreementSubsequentToAssetAcquisitionMember_documentation_en-US" xlink:label="lab_syre_ParagonAgreementSubsequentToAssetAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Paragon Agreement, Subsequent to Asset Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ParagonAgreementSubsequentToAssetAcquisitionMember" xlink:href="syre-20250331.xsd#syre_ParagonAgreementSubsequentToAssetAcquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_ParagonAgreementSubsequentToAssetAcquisitionMember" xlink:to="lab_syre_ParagonAgreementSubsequentToAssetAcquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_45ff3ff3-0c0a-40d3-87b5-15a0e02d8a8b_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingOtherItemAmount_cf9293ad-228b-4b96-ad9d-a70a7f5645f6_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other segment items</link:label>
    <link:label id="lab_us-gaap_SegmentReportingOtherItemAmount_label_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Other Segment Item, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingOtherItemAmount" xlink:to="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_CashEquivalentsUnrealizedGains_a4f71309-b905-4cce-a517-d5aaa755c189_terseLabel_en-US" xlink:label="lab_syre_CashEquivalentsUnrealizedGains" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash equivalents, gross unrealized gains</link:label>
    <link:label id="lab_syre_CashEquivalentsUnrealizedGains_label_en-US" xlink:label="lab_syre_CashEquivalentsUnrealizedGains" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Equivalents Unrealized Gains</link:label>
    <link:label id="lab_syre_CashEquivalentsUnrealizedGains_documentation_en-US" xlink:label="lab_syre_CashEquivalentsUnrealizedGains" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash equivalents unrealized gains.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_CashEquivalentsUnrealizedGains" xlink:href="syre-20250331.xsd#syre_CashEquivalentsUnrealizedGains"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_CashEquivalentsUnrealizedGains" xlink:to="lab_syre_CashEquivalentsUnrealizedGains" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_73ed6514-4248-4b9a-8b4f-8702214a8145_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description</link:label>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_label_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_89f33655-7150-499b-bd46-c9f7ce08b54f_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_559f642a-cd47-47e6-b6f4-3b9c85413de9_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_68eef957-2e15-4053-ae6b-6b14e72798bd_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_c46acd48-b027-4a06-b90f-59ddb027589a_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_063ab15b-490e-4531-9bb1-8c96cead2dd0_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_label_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesOutstanding" xlink:to="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_cf2a5881-0cbd-4297-97c9-8e61a4a3c956_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_Spy001LicenseAgreementMember_1a405c07-2157-47b7-9b01-14b5add6ca85_terseLabel_en-US" xlink:label="lab_syre_Spy001LicenseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SPY001 License Agreement</link:label>
    <link:label id="lab_syre_Spy001LicenseAgreementMember_label_en-US" xlink:label="lab_syre_Spy001LicenseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SPY001 License Agreement [Member]</link:label>
    <link:label id="lab_syre_Spy001LicenseAgreementMember_documentation_en-US" xlink:label="lab_syre_Spy001LicenseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">SPY001 License Agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_Spy001LicenseAgreementMember" xlink:href="syre-20250331.xsd#syre_Spy001LicenseAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_Spy001LicenseAgreementMember" xlink:to="lab_syre_Spy001LicenseAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_b2a33b23-20a0-4e66-85ce-cb0000445639_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of Cash, Cash Equivalents, and Restricted Cash Reported in the Statement of Financial Position:</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_AegleaEmployeesAndDirectorsMember_3abc46dd-85ea-4f21-bf8f-f97269e641bf_terseLabel_en-US" xlink:label="lab_syre_AegleaEmployeesAndDirectorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aeglea Employees and Directors</link:label>
    <link:label id="lab_syre_AegleaEmployeesAndDirectorsMember_label_en-US" xlink:label="lab_syre_AegleaEmployeesAndDirectorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aeglea Employees and Directors [Member]</link:label>
    <link:label id="lab_syre_AegleaEmployeesAndDirectorsMember_documentation_en-US" xlink:label="lab_syre_AegleaEmployeesAndDirectorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Aeglea Employees and Directors</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_AegleaEmployeesAndDirectorsMember" xlink:href="syre-20250331.xsd#syre_AegleaEmployeesAndDirectorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_AegleaEmployeesAndDirectorsMember" xlink:to="lab_syre_AegleaEmployeesAndDirectorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_566fed8a-030b-4dd9-ab84-7d9bdb0e6eff_negatedLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Change in fair value of liability, decrease</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_7e8d6cf6-1e49-4020-abad-d73f2c384a9a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in the fair value of the CVR liability</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_label_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Additional402vDisclosureTextBlock" xlink:to="lab_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_7210d40e-32c3-4a9f-8c8b-e01e65683af7_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_b1ab0b8d-122d-4988-99ed-05c6b89705c7_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_AssetAcquisitionCashPaymentThresholdPeriod_8eeecbc6-aca3-45dc-ae1e-91cbc93bb2f1_terseLabel_en-US" xlink:label="lab_syre_AssetAcquisitionCashPaymentThresholdPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset acquisition, cash payment, threshold period</link:label>
    <link:label id="lab_syre_AssetAcquisitionCashPaymentThresholdPeriod_label_en-US" xlink:label="lab_syre_AssetAcquisitionCashPaymentThresholdPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Cash Payment, Threshold Period</link:label>
    <link:label id="lab_syre_AssetAcquisitionCashPaymentThresholdPeriod_documentation_en-US" xlink:label="lab_syre_AssetAcquisitionCashPaymentThresholdPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Cash Payment, Threshold Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_AssetAcquisitionCashPaymentThresholdPeriod" xlink:href="syre-20250331.xsd#syre_AssetAcquisitionCashPaymentThresholdPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_AssetAcquisitionCashPaymentThresholdPeriod" xlink:to="lab_syre_AssetAcquisitionCashPaymentThresholdPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndTitle_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title</link:label>
    <link:label id="lab_ecd_TrdArrIndTitle_label_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndTitle" xlink:to="lab_ecd_TrdArrIndTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_a1cfc867-cc38-461a-b7a9-b6478c990fe5_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_a150a556-5743-4c10-8a05-adc36e3c9b51_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_53be8a10-dfe0-4b89-a8c8-632721bb5321_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicLineItems_77c901a2-9318-4e17-9786-b9f3dc74d9b9_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicLineItems_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems" xlink:to="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_93a3d7a1-f530-4aae-9d99-2c797ef0662e_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_StockIssuedDuringPeriodSharesExchangeOfConvertibleSecurities_d93720c7-a1ed-4415-bc67-ec7c3d758557_terseLabel_en-US" xlink:label="lab_syre_StockIssuedDuringPeriodSharesExchangeOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exchange of Series A non-voting convertible preferred stock into common stock (in shares)</link:label>
    <link:label id="lab_syre_StockIssuedDuringPeriodSharesExchangeOfConvertibleSecurities_label_en-US" xlink:label="lab_syre_StockIssuedDuringPeriodSharesExchangeOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Exchange of Convertible Securities</link:label>
    <link:label id="lab_syre_StockIssuedDuringPeriodSharesExchangeOfConvertibleSecurities_documentation_en-US" xlink:label="lab_syre_StockIssuedDuringPeriodSharesExchangeOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Exchange of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_StockIssuedDuringPeriodSharesExchangeOfConvertibleSecurities" xlink:href="syre-20250331.xsd#syre_StockIssuedDuringPeriodSharesExchangeOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_StockIssuedDuringPeriodSharesExchangeOfConvertibleSecurities" xlink:to="lab_syre_StockIssuedDuringPeriodSharesExchangeOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_b6715861-8726-4cf8-9f7e-9c38a1f1dabe_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_9699ded2-3bf5-4e06-a119-a295d53f964e_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CURRENT LIABILITIES</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_ImpairmentOfMarketableSecurities_0b40c9f3-60aa-49ac-9dd8-336762900655_terseLabel_en-US" xlink:label="lab_syre_ImpairmentOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment of marketable securities</link:label>
    <link:label id="lab_syre_ImpairmentOfMarketableSecurities_label_en-US" xlink:label="lab_syre_ImpairmentOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment Of Marketable Securities</link:label>
    <link:label id="lab_syre_ImpairmentOfMarketableSecurities_documentation_en-US" xlink:label="lab_syre_ImpairmentOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Impairment of marketable securities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ImpairmentOfMarketableSecurities" xlink:href="syre-20250331.xsd#syre_ImpairmentOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_ImpairmentOfMarketableSecurities" xlink:to="lab_syre_ImpairmentOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_24048f8c-dae2-48bd-a873-3547928eb224_verboseLabel_en-US" xlink:label="lab_syre_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Issuance of Series A/B non-voting convertible preferred stock in connection with private placement, net of financing costs (in shares)</link:label>
    <link:label id="lab_syre_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_8848745a-c355-4732-9827-6c2805aa5e00_terseLabel_en-US" xlink:label="lab_syre_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of non-voting convertible preferred stock (in shares)</link:label>
    <link:label id="lab_syre_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_syre_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Shares, New Issues</link:label>
    <link:label id="lab_syre_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_documentation_en-US" xlink:label="lab_syre_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:href="syre-20250331.xsd#syre_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_syre_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_81f20557-1bc0-493c-acc1-79ad45040b50_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_962d91c3-086e-4e76-a37e-fbb674db6c18_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_44f94dfe-8de3-4076-a939-67340871878c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_PaymentForDeferredOfferingCosts_d6c461d0-030c-41dd-b4b5-8b705b35d64f_negatedTerseLabel_en-US" xlink:label="lab_syre_PaymentForDeferredOfferingCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payment of deferred offering costs in connection with shelf registration</link:label>
    <link:label id="lab_syre_PaymentForDeferredOfferingCosts_label_en-US" xlink:label="lab_syre_PaymentForDeferredOfferingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payment For Deferred Offering Costs</link:label>
    <link:label id="lab_syre_PaymentForDeferredOfferingCosts_documentation_en-US" xlink:label="lab_syre_PaymentForDeferredOfferingCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payment For Deferred Offering Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_PaymentForDeferredOfferingCosts" xlink:href="syre-20250331.xsd#syre_PaymentForDeferredOfferingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_PaymentForDeferredOfferingCosts" xlink:to="lab_syre_PaymentForDeferredOfferingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_8c7709df-0baf-4ecd-a789-d44317d4f724_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental Disclosure of Non-Cash Investing and Financing Information:</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockMember_18a89e69-d517-4a9c-943d-b203751d13ab_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred Stock</link:label>
    <link:label id="lab_us-gaap_PreferredStockMember_label_en-US" xlink:label="lab_us-gaap_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockMember" xlink:to="lab_us-gaap_PreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_ParagonAndLicenseAgreementMember_a9247fe7-7c71-41e7-961a-9ace0b4f42c6_terseLabel_en-US" xlink:label="lab_syre_ParagonAndLicenseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Paragon and License Agreement</link:label>
    <link:label id="lab_syre_ParagonAndLicenseAgreementMember_label_en-US" xlink:label="lab_syre_ParagonAndLicenseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Paragon and License Agreement [Member]</link:label>
    <link:label id="lab_syre_ParagonAndLicenseAgreementMember_documentation_en-US" xlink:label="lab_syre_ParagonAndLicenseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Paragon and License Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ParagonAndLicenseAgreementMember" xlink:href="syre-20250331.xsd#syre_ParagonAndLicenseAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_ParagonAndLicenseAgreementMember" xlink:to="lab_syre_ParagonAndLicenseAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecurities_1e5cc4a3-ffeb-4095-a483-e9323c0856e1_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecurities_label_en-US" xlink:label="lab_us-gaap_MarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecurities" xlink:to="lab_us-gaap_MarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_StockIssuedDuringPeriodValueOptionsExercisedAndEmployeeStockOwnershipPlan_401383d7-efc6-431c-bdcb-abb5676cf938_terseLabel_en-US" xlink:label="lab_syre_StockIssuedDuringPeriodValueOptionsExercisedAndEmployeeStockOwnershipPlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock in connection with exercise of stock options and employee stock purchase plan</link:label>
    <link:label id="lab_syre_StockIssuedDuringPeriodValueOptionsExercisedAndEmployeeStockOwnershipPlan_label_en-US" xlink:label="lab_syre_StockIssuedDuringPeriodValueOptionsExercisedAndEmployeeStockOwnershipPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Options Exercised And Employee Stock Ownership Plan</link:label>
    <link:label id="lab_syre_StockIssuedDuringPeriodValueOptionsExercisedAndEmployeeStockOwnershipPlan_documentation_en-US" xlink:label="lab_syre_StockIssuedDuringPeriodValueOptionsExercisedAndEmployeeStockOwnershipPlan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Options Exercised And Employee Stock Ownership Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_StockIssuedDuringPeriodValueOptionsExercisedAndEmployeeStockOwnershipPlan" xlink:href="syre-20250331.xsd#syre_StockIssuedDuringPeriodValueOptionsExercisedAndEmployeeStockOwnershipPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_StockIssuedDuringPeriodValueOptionsExercisedAndEmployeeStockOwnershipPlan" xlink:to="lab_syre_StockIssuedDuringPeriodValueOptionsExercisedAndEmployeeStockOwnershipPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_09b3c07e-0999-4bd1-b280-dedc3152e4d7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Significant Inputs used to Estimate the Fair Value of Derivative Liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_AssetAcquisitionStockholderPaymentPeriod_ba894fcf-d660-4322-8634-f4d40990b652_terseLabel_en-US" xlink:label="lab_syre_AssetAcquisitionStockholderPaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset acquisition, stockholder payment period</link:label>
    <link:label id="lab_syre_AssetAcquisitionStockholderPaymentPeriod_label_en-US" xlink:label="lab_syre_AssetAcquisitionStockholderPaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Stockholder Payment Period</link:label>
    <link:label id="lab_syre_AssetAcquisitionStockholderPaymentPeriod_documentation_en-US" xlink:label="lab_syre_AssetAcquisitionStockholderPaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Stockholder Payment Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_AssetAcquisitionStockholderPaymentPeriod" xlink:href="syre-20250331.xsd#syre_AssetAcquisitionStockholderPaymentPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_AssetAcquisitionStockholderPaymentPeriod" xlink:to="lab_syre_AssetAcquisitionStockholderPaymentPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_ac636587-81f9-4c5c-8770-4c8a2dd5bec6_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_ProceedsFromRaisingCapital_648d4d9a-e625-4f9c-8fd3-dd009d15b731_terseLabel_en-US" xlink:label="lab_syre_ProceedsFromRaisingCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from raising capital</link:label>
    <link:label id="lab_syre_ProceedsFromRaisingCapital_label_en-US" xlink:label="lab_syre_ProceedsFromRaisingCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds From Raising Capital</link:label>
    <link:label id="lab_syre_ProceedsFromRaisingCapital_documentation_en-US" xlink:label="lab_syre_ProceedsFromRaisingCapital" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Proceeds From Raising Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ProceedsFromRaisingCapital" xlink:href="syre-20250331.xsd#syre_ProceedsFromRaisingCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_ProceedsFromRaisingCapital" xlink:to="lab_syre_ProceedsFromRaisingCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_ea8ad878-2869-4ffd-a831-90c630239315_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_bcc537e0-40e6-4b8c-adae-d7951823b30a_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_1773f276-b39c-42d9-a903-86b01086344f_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_720b7a02-8463-43c9-8661-8cbbd405a761_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_a459e404-6505-4510-bbc5-68cfea078055_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_05342967-4eff-4e7e-a270-6ef7449fd09f_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_terseLabel_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Available</link:label>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_label_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="lab_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_SPY003LicenseAgreementMember_51eea7ec-2cd0-408b-b28b-abd2d3d80030_terseLabel_en-US" xlink:label="lab_syre_SPY003LicenseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SPY003 License Agreement</link:label>
    <link:label id="lab_syre_SPY003LicenseAgreementMember_label_en-US" xlink:label="lab_syre_SPY003LicenseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SPY003 License Agreement [Member]</link:label>
    <link:label id="lab_syre_SPY003LicenseAgreementMember_documentation_en-US" xlink:label="lab_syre_SPY003LicenseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">SPY003 License Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SPY003LicenseAgreementMember" xlink:href="syre-20250331.xsd#syre_SPY003LicenseAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_SPY003LicenseAgreementMember" xlink:to="lab_syre_SPY003LicenseAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_5d0e08a9-b7be-48f5-9a8c-b61ebba98898_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_terseLabel_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Securities</link:label>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_label_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Underlying Securities Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:to="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockNameDomain_9f3d2029-e9c5-49b5-8617-ec1d33c838ad_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of Stock, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockNameDomain_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Conversion of Stock, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockNameDomain" xlink:to="lab_us-gaap_ConversionOfStockNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_e4d9e202-a154-4e3b-8d50-fbfe90f170b3_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_3ebb1919-89bf-49ba-8e6c-6d6e16f8635e_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_ParapyreWarrantsMember_30a60e50-f68b-44ce-bb46-f67daa5e5f18_terseLabel_en-US" xlink:label="lab_syre_ParapyreWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding Parapyre warrants</link:label>
    <link:label id="lab_syre_ParapyreWarrantsMember_label_en-US" xlink:label="lab_syre_ParapyreWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Parapyre Warrants [Member]</link:label>
    <link:label id="lab_syre_ParapyreWarrantsMember_documentation_en-US" xlink:label="lab_syre_ParapyreWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Parapyre Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ParapyreWarrantsMember" xlink:href="syre-20250331.xsd#syre_ParapyreWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_ParapyreWarrantsMember" xlink:to="lab_syre_ParapyreWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_ServiceBasedAwardsMember_4152c5ca-4dca-4174-b34e-4e516c991881_terseLabel_en-US" xlink:label="lab_syre_ServiceBasedAwardsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Service Based Awards</link:label>
    <link:label id="lab_syre_ServiceBasedAwardsMember_label_en-US" xlink:label="lab_syre_ServiceBasedAwardsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Service Based Awards [Member]</link:label>
    <link:label id="lab_syre_ServiceBasedAwardsMember_documentation_en-US" xlink:label="lab_syre_ServiceBasedAwardsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Service-based awards.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ServiceBasedAwardsMember" xlink:href="syre-20250331.xsd#syre_ServiceBasedAwardsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_ServiceBasedAwardsMember" xlink:to="lab_syre_ServiceBasedAwardsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1daff058-e07e-4380-b627-260570937f37_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_7c2ae23c-1623-45e7-a2a4-cfe132c9be99_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average pre-funded warrants (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardGrantDateFairValue_terseLabel_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value as of Grant Date</link:label>
    <link:label id="lab_ecd_AwardGrantDateFairValue_label_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardGrantDateFairValue" xlink:to="lab_ecd_AwardGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_e4f3819f-9f98-4552-8004-21e866cfb751_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_11a44bde-bf35-459b-9567-20282a20ea1d_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares of common stock sold (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_a2d4755a-752e-4a30-aaef-abb95f391a25_verboseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Number of shares sold (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ceda0da3-20ae-48e5-aa65-36f7cea1dab0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_FairmountFundsManagementLlcMember_a122dcb4-0e12-4f46-ac20-4287a09ba0f5_terseLabel_en-US" xlink:label="lab_syre_FairmountFundsManagementLlcMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fairmount Funds Management LLC</link:label>
    <link:label id="lab_syre_FairmountFundsManagementLlcMember_label_en-US" xlink:label="lab_syre_FairmountFundsManagementLlcMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fairmount Funds Management LLC [Member]</link:label>
    <link:label id="lab_syre_FairmountFundsManagementLlcMember_documentation_en-US" xlink:label="lab_syre_FairmountFundsManagementLlcMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fairmount Funds Management LLC.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_FairmountFundsManagementLlcMember" xlink:href="syre-20250331.xsd#syre_FairmountFundsManagementLlcMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_FairmountFundsManagementLlcMember" xlink:to="lab_syre_FairmountFundsManagementLlcMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RecoveryOfErrCompDisclosureLineItems_label_en-US" xlink:label="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recovery of Erroneously Awarded Compensation Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_AmountToBePaidUnderAgreement_77b96e86-c15f-45a4-934b-b17941bca30e_terseLabel_en-US" xlink:label="lab_syre_AmountToBePaidUnderAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent obligation based on milestones</link:label>
    <link:label id="lab_syre_AmountToBePaidUnderAgreement_label_en-US" xlink:label="lab_syre_AmountToBePaidUnderAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amount To Be Paid Under Agreement</link:label>
    <link:label id="lab_syre_AmountToBePaidUnderAgreement_documentation_en-US" xlink:label="lab_syre_AmountToBePaidUnderAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount to be paid under agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_AmountToBePaidUnderAgreement" xlink:href="syre-20250331.xsd#syre_AmountToBePaidUnderAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_AmountToBePaidUnderAgreement" xlink:to="lab_syre_AmountToBePaidUnderAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesNoncurrent_db0f842c-cb05-4f02-b797-e4bec5f5af9c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-current CVR liability</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:to="lab_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_95c2ebff-0f05-4e5b-bc59-5cd2d2365642_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_744d82dc-786f-4c1f-a5cb-7dbaccd904d6_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDateAxis_terseLabel_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date:</link:label>
    <link:label id="lab_ecd_RestatementDateAxis_label_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDateAxis" xlink:to="lab_ecd_RestatementDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_7f31f3da-fc0a-440b-8cba-9eb34ea228db_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_f9259b47-5e29-4be0-9e71-41531873efc0_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, $0.0001 par value; 400,000,000 shares authorized as of March&#160;31, 2025 and December&#160;31, 2024; 60,275,561 shares and 60,257,023 shares issued and outstanding as of March&#160;31, 2025 and December&#160;31, 2024, respectively.</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_19f73d14-d7b8-49e0-b819-e68a5e5a3b45_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_0d0671b9-d7bc-4bb8-998f-98e17e7496b1_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherAccountsPayable_ec9115fa-762f-43e1-bfd6-41412bf8f529_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related party accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_label_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:to="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_TwoThousandAndEighteenEquityInducementPlanMember_ad1dcb60-e1b3-4ef4-ba5f-880c347fd873_terseLabel_en-US" xlink:label="lab_syre_TwoThousandAndEighteenEquityInducementPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2018 Equity Inducement Plan</link:label>
    <link:label id="lab_syre_TwoThousandAndEighteenEquityInducementPlanMember_label_en-US" xlink:label="lab_syre_TwoThousandAndEighteenEquityInducementPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Two Thousand And Eighteen Equity Inducement Plan [Member]</link:label>
    <link:label id="lab_syre_TwoThousandAndEighteenEquityInducementPlanMember_documentation_en-US" xlink:label="lab_syre_TwoThousandAndEighteenEquityInducementPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2018 equity inducement plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_TwoThousandAndEighteenEquityInducementPlanMember" xlink:href="syre-20250331.xsd#syre_TwoThousandAndEighteenEquityInducementPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_TwoThousandAndEighteenEquityInducementPlanMember" xlink:to="lab_syre_TwoThousandAndEighteenEquityInducementPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_17069b41-ee5c-433c-a754-6e5540b69bdb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_51768787-d844-46f1-92a4-76e1d23585ff_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_terseLabel_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_label_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:to="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease_11ffdeb6-9bdc-4e1d-9c9f-026095cb074a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares subject to options outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_c15d8aad-e5b1-4c37-9437-2c94c1ca6513_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Series A non-voting convertible preferred stock &amp; preferred stock shares authorized, issued, and outstanding, value</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_8bafe5af-f794-43d4-83c7-e95b50afb884_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_ba45e720-3dac-40a8-8bce-434c673e688c_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Stock</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_d42811eb-1355-4118-b1c9-e371698ac8ee_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss per share, basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToPeoCompFnTextBlock" xlink:to="lab_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:to="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dee695f6-658d-4959-8a3e-0450700874a0_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based payment award, term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_123743e7-0a4c-4049-8b83-08b94d892f19_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_CompanyAndBasisOfPresentationLineItems_230051f2-7d61-4d3e-97d0-8f9ba4d167c4_terseLabel_en-US" xlink:label="lab_syre_CompanyAndBasisOfPresentationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company and Basis of Presentation [Line Items]</link:label>
    <link:label id="lab_syre_CompanyAndBasisOfPresentationLineItems_label_en-US" xlink:label="lab_syre_CompanyAndBasisOfPresentationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company and Basis of Presentation [Line Items]</link:label>
    <link:label id="lab_syre_CompanyAndBasisOfPresentationLineItems_documentation_en-US" xlink:label="lab_syre_CompanyAndBasisOfPresentationLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Company and basis of presentation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_CompanyAndBasisOfPresentationLineItems" xlink:href="syre-20250331.xsd#syre_CompanyAndBasisOfPresentationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_CompanyAndBasisOfPresentationLineItems" xlink:to="lab_syre_CompanyAndBasisOfPresentationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_TwoThousandAndEighteenEquityInducementPlanAmendedMember_66e84dbb-b3e3-4b46-be9d-372ca1f4d9af_terseLabel_en-US" xlink:label="lab_syre_TwoThousandAndEighteenEquityInducementPlanAmendedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2018 Equity Inducement Plan, Amended</link:label>
    <link:label id="lab_syre_TwoThousandAndEighteenEquityInducementPlanAmendedMember_label_en-US" xlink:label="lab_syre_TwoThousandAndEighteenEquityInducementPlanAmendedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Two Thousand And Eighteen Equity Inducement Plan, Amended [Member]</link:label>
    <link:label id="lab_syre_TwoThousandAndEighteenEquityInducementPlanAmendedMember_documentation_en-US" xlink:label="lab_syre_TwoThousandAndEighteenEquityInducementPlanAmendedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Two Thousand And Eighteen Equity Inducement Plan, Amended</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_TwoThousandAndEighteenEquityInducementPlanAmendedMember" xlink:href="syre-20250331.xsd#syre_TwoThousandAndEighteenEquityInducementPlanAmendedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_TwoThousandAndEighteenEquityInducementPlanAmendedMember" xlink:to="lab_syre_TwoThousandAndEighteenEquityInducementPlanAmendedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_51caa089-2630-4c63-a7de-0d45f1a7422c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Available-for-Sale Securities in an Unrealized Loss Position</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_70dd14bb-9f46-4d5d-b857-d467e409fa20_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock, Class of Stock [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock, Class of Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_4f6e089b-c2a0-4224-82f0-7530cb7c8815_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year</link:label>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:to="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_67bd29f6-8338-418f-816b-d9bedd471819_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_84571bf8-4f0a-44dc-a301-2ad536cd9ca0_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity, Carrying Amount, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_b3c6d1dd-a9b8-4174-bb3e-3288a2a91eba_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">TOTAL ASSETS</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OverAllotmentOptionMember_61d7a82d-c50e-46c1-a93a-f56b27b95280_terseLabel_en-US" xlink:label="lab_us-gaap_OverAllotmentOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Over-Allotment Option</link:label>
    <link:label id="lab_us-gaap_OverAllotmentOptionMember_label_en-US" xlink:label="lab_us-gaap_OverAllotmentOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Over-Allotment Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OverAllotmentOptionMember" xlink:to="lab_us-gaap_OverAllotmentOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashAndCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_7712818d-c6b1-4705-bbcb-abc8f60c5d4a_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of net loss</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_e1365f7f-451c-428b-a87f-36920fe1ea87_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies (Note 6 and 7)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrTerminationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Termination Date</link:label>
    <link:label id="lab_ecd_TrdArrTerminationDate_label_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Termination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrTerminationDate" xlink:to="lab_ecd_TrdArrTerminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_ac2cf24b-c1d4-4de6-930b-0b8e9c88218d_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:to="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_904f6ff1-77b2-4980-a3ea-bcc55fab2ca0_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise price per warrant (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1f164b02-b6f0-4698-a490-a37c8c393c8a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9375fbac-894c-40dd-b742-0f1303a18cee_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_b7c66002-90a3-4df2-b2b4-09cbed1465b6_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_fefa5570-8855-4779-9f2e-8c4ea8eb7517_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_ScheduleOfBalancesDueToAffiliatesTableTextBlock_625db82c-1f67-4d8e-81c3-433dc377bfe1_terseLabel_en-US" xlink:label="lab_syre_ScheduleOfBalancesDueToAffiliatesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Accounts Payable</link:label>
    <link:label id="lab_syre_ScheduleOfBalancesDueToAffiliatesTableTextBlock_label_en-US" xlink:label="lab_syre_ScheduleOfBalancesDueToAffiliatesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule Of Balances Due To Affiliates [Table Text Block]</link:label>
    <link:label id="lab_syre_ScheduleOfBalancesDueToAffiliatesTableTextBlock_documentation_en-US" xlink:label="lab_syre_ScheduleOfBalancesDueToAffiliatesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule of balances due to affiliates.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ScheduleOfBalancesDueToAffiliatesTableTextBlock" xlink:href="syre-20250331.xsd#syre_ScheduleOfBalancesDueToAffiliatesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_ScheduleOfBalancesDueToAffiliatesTableTextBlock" xlink:to="lab_syre_ScheduleOfBalancesDueToAffiliatesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_4560a6be-1936-41d6-93a2-f8627c143329_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_6158176b-e08e-485a-9bf6-95361e1f0bda_verboseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_9adafc02-4ed6-48a9-a9c4-55f3e48fcdbe_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_87992d32-5a6b-4415-8285-f3ffb4c58a86_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_65bd5ff6-1ec0-4e2d-8018-fc170578e6a4_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_95611135-c564-4529-9eb1-897ce95a74d7_negatedLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Adjustments and reconciling items</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_e48e89ba-a2b0-49af-9ae7-5b98749ed64f_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Allocation of losses</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrAxis_terseLabel_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangement:</link:label>
    <link:label id="lab_ecd_TradingArrAxis_label_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrAxis" xlink:to="lab_ecd_TradingArrAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_5172a96e-1c84-4eec-8359-b0f4609b9f70_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Grant Date Fair Value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
    <link:label id="lab_ecd_PvpTableTextBlock_label_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTableTextBlock" xlink:to="lab_ecd_PvpTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year</link:label>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_label_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:to="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_dfd0fd17-120c-4bc2-baa1-38e443814523_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments_037c904c-9b50-4acb-a95b-acf91f8fc479_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Realized gains or losses on marketable securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marketable Security, Realized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments" xlink:to="lab_us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_defaffdb-5b03-4254-b0b9-18fbcf08a1ef_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:to="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_e40d6de0-7139-4b2e-9c8b-2295a0653ede_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_3140a4f2-d802-4038-a8cb-83cc8465522b_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_b5268d63-5ded-4319-9db3-30af0d528504_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_1e4c23cc-b363-44d4-b728-eb217af4baf1_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_PreferredStockSharesNotAutomaticallyConvertedOutstanding_95a145bf-5119-415d-8de0-6ec9e3953487_terseLabel_en-US" xlink:label="lab_syre_PreferredStockSharesNotAutomaticallyConvertedOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, not automatically converted, outstanding (in shares)</link:label>
    <link:label id="lab_syre_PreferredStockSharesNotAutomaticallyConvertedOutstanding_label_en-US" xlink:label="lab_syre_PreferredStockSharesNotAutomaticallyConvertedOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Not Automatically Converted, Outstanding</link:label>
    <link:label id="lab_syre_PreferredStockSharesNotAutomaticallyConvertedOutstanding_documentation_en-US" xlink:label="lab_syre_PreferredStockSharesNotAutomaticallyConvertedOutstanding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Not Automatically Converted, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_PreferredStockSharesNotAutomaticallyConvertedOutstanding" xlink:href="syre-20250331.xsd#syre_PreferredStockSharesNotAutomaticallyConvertedOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_PreferredStockSharesNotAutomaticallyConvertedOutstanding" xlink:to="lab_syre_PreferredStockSharesNotAutomaticallyConvertedOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine3_35c0371d-47c2-4d3d-a7c7-57d93853db45_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Three</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine3_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine3" xlink:to="lab_dei_EntityAddressAddressLine3" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_97a098c2-0448-4910-96e6-3413c2b35eda_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_efbbebe4-061a-47c4-88a0-d7703427cdaa_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of exchange rate on cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_873f63ab-dc89-4bc3-b128-423670a858d8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_07fedd68-61a9-4657-be65-bd35ea6a4075_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total financial assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_704afc20-29ff-48d0-ab08-caa021974d34_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryIndName" xlink:to="lab_ecd_ForgoneRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_bac5554b-5fb9-473c-a517-1bc66f0fbb0d_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_c574e663-66c0-4521-a2b7-b1434448bced_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingArrLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingArrLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="lab_ecd_InsiderTradingArrLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_83af92e1-3d7d-4c43-8df0-bcfaf5dd9079_terseLabel_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments and reconciling items</link:label>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_label_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaterialReconcilingItemsMember" xlink:to="lab_us-gaap_MaterialReconcilingItemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingAggtErrCompAmt" xlink:to="lab_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_label_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoActuallyPaidCompAmt" xlink:to="lab_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAxis_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation:</link:label>
    <link:label id="lab_ecd_AdjToCompAxis_label_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="lab_ecd_AdjToCompAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1a7e91eb-5eba-4d36-85d2-832385d2784a_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_MeasurementInputProabilityOfSuccessMember_4d2659cf-d2a5-408c-978b-e0550d6c3ae1_terseLabel_en-US" xlink:label="lab_syre_MeasurementInputProabilityOfSuccessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated probability of success</link:label>
    <link:label id="lab_syre_MeasurementInputProabilityOfSuccessMember_label_en-US" xlink:label="lab_syre_MeasurementInputProabilityOfSuccessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Proability Of Success [Member]</link:label>
    <link:label id="lab_syre_MeasurementInputProabilityOfSuccessMember_documentation_en-US" xlink:label="lab_syre_MeasurementInputProabilityOfSuccessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Measurement Input, Proability Of Success</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_MeasurementInputProabilityOfSuccessMember" xlink:href="syre-20250331.xsd#syre_MeasurementInputProabilityOfSuccessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_MeasurementInputProabilityOfSuccessMember" xlink:to="lab_syre_MeasurementInputProabilityOfSuccessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_73232719-9dac-46fa-b86c-3156ab60bc3d_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_ec6100b5-7da4-40ae-a68a-6f16f3e4420b_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_TwoThousandAndSixteenEmployeeStockPurchasePlanMember_f3d5e1d3-780f-4169-8597-a57f0bc11005_terseLabel_en-US" xlink:label="lab_syre_TwoThousandAndSixteenEmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2016 Employee Stock Purchase Plan</link:label>
    <link:label id="lab_syre_TwoThousandAndSixteenEmployeeStockPurchasePlanMember_88f030f4-1c03-4cc6-b5ca-118fa03b0756_verboseLabel_en-US" xlink:label="lab_syre_TwoThousandAndSixteenEmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">2016 ESPP</link:label>
    <link:label id="lab_syre_TwoThousandAndSixteenEmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_syre_TwoThousandAndSixteenEmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Two Thousand And Sixteen Employee Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_syre_TwoThousandAndSixteenEmployeeStockPurchasePlanMember_documentation_en-US" xlink:label="lab_syre_TwoThousandAndSixteenEmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Two thousand and sixteen employee stock purchase plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_TwoThousandAndSixteenEmployeeStockPurchasePlanMember" xlink:href="syre-20250331.xsd#syre_TwoThousandAndSixteenEmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_TwoThousandAndSixteenEmployeeStockPurchasePlanMember" xlink:to="lab_syre_TwoThousandAndSixteenEmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syre_ContingentValueRightLiabilityMember_92b7d581-071c-4c9e-817a-aad133938d91_terseLabel_en-US" xlink:label="lab_syre_ContingentValueRightLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CVR liability</link:label>
    <link:label id="lab_syre_ContingentValueRightLiabilityMember_label_en-US" xlink:label="lab_syre_ContingentValueRightLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent Value Right Liability [Member]</link:label>
    <link:label id="lab_syre_ContingentValueRightLiabilityMember_documentation_en-US" xlink:label="lab_syre_ContingentValueRightLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contingent Value Right Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ContingentValueRightLiabilityMember" xlink:href="syre-20250331.xsd#syre_ContingentValueRightLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syre_ContingentValueRightLiabilityMember" xlink:to="lab_syre_ContingentValueRightLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_adae80b1-e74b-4f67-bef9-ca80e11c143d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_05f97ef4-e2b8-4fdb-8939-2873cf107b91_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_8f4cb2a5-1077-4fc9-a907-fa511f51df14_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_b52a0611-5b8d-4fa8-aeb3-ee19214b6235_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_2f461eb5-97c5-42c4-8037-2147a3ec63d0_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of ownership by noncontrolling owner</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsidiary, Ownership Percentage, Noncontrolling Owner</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsSvcCstMember" xlink:to="lab_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_ea5ae978-0963-4821-a0c3-7e39cffbf2a0_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionDomain" xlink:to="lab_us-gaap_AssetAcquisitionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9dc09f61-664a-470d-aa67-d2f52be64822_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average common stock outstanding, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bc35cc34-1d86-4b2b-9b67-af18ee8f59d4_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total basic weighed average shares (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7ad9be25-5aa1-4c6a-81fe-f1f7c9a5f9ee_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related and Nonrelated Parties [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related and Nonrelated Parties [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_label_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_5010dfed-8d1c-4eb1-90aa-6c186fac95a9_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">12 Months or Longer</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_8cba19a5-dc4c-4929-a763-9cdfd036eb60_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Unvested restricted stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_abd946eb-6876-4369-9313-ab8d74c82144_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_6982d930-97c1-4abb-9b90-2ba8eafd1024_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued professional and consulting fees</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_terseLabel_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Executive Category:</link:label>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_label_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Executive Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="lab_ecd_ExecutiveCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:to="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_a825e0c4-3385-462f-9bc2-b0c435f67340_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less Than 12 Months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_277702e7-7d6c-42b8-b46e-e18c9adbac67_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_a75877f0-bf88-419f-be2b-55eda57c6b25_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_b21424b6-b6a1-478a-aac0-af26fd8d3afb_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchases of marketable securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureName_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureName_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureName" xlink:to="lab_ecd_CoSelectedMeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrivatePlacementMember_e9a664ba-b22d-4a11-ab43-5cbbf297173d_terseLabel_en-US" xlink:label="lab_us-gaap_PrivatePlacementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Private Placement</link:label>
    <link:label id="lab_us-gaap_PrivatePlacementMember_label_en-US" xlink:label="lab_us-gaap_PrivatePlacementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Private Placement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrivatePlacementMember" xlink:to="lab_us-gaap_PrivatePlacementMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>syre-20250331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:00f29609-870c-422a-b8be-61cf7b074069,g:31b3bfa9-c84d-47fe-82f5-b77ff3f965cb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://spyre.com/role/CoverPage" xlink:type="simple" xlink:href="syre-20250331.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://spyre.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_df891c3a-5cc3-43a7-921c-3d5dbd75f203" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_e31e593c-e505-43e6-b69f-41270545f2ec" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_df891c3a-5cc3-43a7-921c-3d5dbd75f203" xlink:to="loc_dei_DocumentType_e31e593c-e505-43e6-b69f-41270545f2ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_b265c3fe-0a6b-4fba-aac7-2cdb2dd15d3a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_df891c3a-5cc3-43a7-921c-3d5dbd75f203" xlink:to="loc_dei_DocumentQuarterlyReport_b265c3fe-0a6b-4fba-aac7-2cdb2dd15d3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_61d26b1f-5d48-41ec-99c7-45b5536e26fc" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_df891c3a-5cc3-43a7-921c-3d5dbd75f203" xlink:to="loc_dei_DocumentPeriodEndDate_61d26b1f-5d48-41ec-99c7-45b5536e26fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_44a90f51-d99f-48cf-afb4-b8d867289153" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_df891c3a-5cc3-43a7-921c-3d5dbd75f203" xlink:to="loc_dei_DocumentTransitionReport_44a90f51-d99f-48cf-afb4-b8d867289153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_daf91323-ce36-4646-8d84-9a7c0e2ca863" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_df891c3a-5cc3-43a7-921c-3d5dbd75f203" xlink:to="loc_dei_EntityFileNumber_daf91323-ce36-4646-8d84-9a7c0e2ca863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_3d9ee7fb-7a24-4496-ab62-72f0473013a6" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_df891c3a-5cc3-43a7-921c-3d5dbd75f203" xlink:to="loc_dei_EntityRegistrantName_3d9ee7fb-7a24-4496-ab62-72f0473013a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_5396a691-fe4d-44c5-8a7f-ac8d38bc38ad" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_df891c3a-5cc3-43a7-921c-3d5dbd75f203" xlink:to="loc_dei_EntityIncorporationStateCountryCode_5396a691-fe4d-44c5-8a7f-ac8d38bc38ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_c29eb3b3-7867-487d-842e-436831998f7a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_df891c3a-5cc3-43a7-921c-3d5dbd75f203" xlink:to="loc_dei_EntityTaxIdentificationNumber_c29eb3b3-7867-487d-842e-436831998f7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_dbd9ff60-0613-435f-b4ab-50221fba3865" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_df891c3a-5cc3-43a7-921c-3d5dbd75f203" xlink:to="loc_dei_EntityAddressAddressLine1_dbd9ff60-0613-435f-b4ab-50221fba3865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_a0117357-7c05-4eff-affb-40ab0e7efda0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_df891c3a-5cc3-43a7-921c-3d5dbd75f203" xlink:to="loc_dei_EntityAddressAddressLine2_a0117357-7c05-4eff-affb-40ab0e7efda0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine3_2d7d1425-c148-494b-a2a3-7ee7fde9fadf" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_df891c3a-5cc3-43a7-921c-3d5dbd75f203" xlink:to="loc_dei_EntityAddressAddressLine3_2d7d1425-c148-494b-a2a3-7ee7fde9fadf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_3c427201-5ab0-4fa6-a605-e0db38505ef4" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_df891c3a-5cc3-43a7-921c-3d5dbd75f203" xlink:to="loc_dei_EntityAddressCityOrTown_3c427201-5ab0-4fa6-a605-e0db38505ef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_5a7744c9-6b12-4d45-8809-6b3810f55cf4" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_df891c3a-5cc3-43a7-921c-3d5dbd75f203" xlink:to="loc_dei_EntityAddressStateOrProvince_5a7744c9-6b12-4d45-8809-6b3810f55cf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_7c092ed7-4ec3-46df-9001-215374f2e53a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_df891c3a-5cc3-43a7-921c-3d5dbd75f203" xlink:to="loc_dei_EntityAddressPostalZipCode_7c092ed7-4ec3-46df-9001-215374f2e53a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_2c7ace52-489b-4e2c-af17-fa0150c7f0c3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_df891c3a-5cc3-43a7-921c-3d5dbd75f203" xlink:to="loc_dei_CityAreaCode_2c7ace52-489b-4e2c-af17-fa0150c7f0c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_e0c3f868-52ab-44fb-954f-7dfeca971444" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_df891c3a-5cc3-43a7-921c-3d5dbd75f203" xlink:to="loc_dei_LocalPhoneNumber_e0c3f868-52ab-44fb-954f-7dfeca971444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_4a13393f-4ef9-4865-a127-a806af324fda" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_df891c3a-5cc3-43a7-921c-3d5dbd75f203" xlink:to="loc_dei_Security12bTitle_4a13393f-4ef9-4865-a127-a806af324fda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_17bc816e-56a0-41ca-b683-45f9f90e7e6e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_df891c3a-5cc3-43a7-921c-3d5dbd75f203" xlink:to="loc_dei_TradingSymbol_17bc816e-56a0-41ca-b683-45f9f90e7e6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_4511e2dd-7362-4f41-b60c-40eba39cf32f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_df891c3a-5cc3-43a7-921c-3d5dbd75f203" xlink:to="loc_dei_SecurityExchangeName_4511e2dd-7362-4f41-b60c-40eba39cf32f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_220cc7c4-b58d-46a4-8bd8-9f14d32512c0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_df891c3a-5cc3-43a7-921c-3d5dbd75f203" xlink:to="loc_dei_EntityInteractiveDataCurrent_220cc7c4-b58d-46a4-8bd8-9f14d32512c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_345869dd-c83a-463a-ad57-4457f4647f70" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_df891c3a-5cc3-43a7-921c-3d5dbd75f203" xlink:to="loc_dei_EntityCurrentReportingStatus_345869dd-c83a-463a-ad57-4457f4647f70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_333b8b0e-f351-49a5-badb-2575c84390c6" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_df891c3a-5cc3-43a7-921c-3d5dbd75f203" xlink:to="loc_dei_EntityFilerCategory_333b8b0e-f351-49a5-badb-2575c84390c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_6cd02f4b-d247-4b34-9f2f-14d106978bbf" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_df891c3a-5cc3-43a7-921c-3d5dbd75f203" xlink:to="loc_dei_EntitySmallBusiness_6cd02f4b-d247-4b34-9f2f-14d106978bbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_2c42c630-53c6-40f9-939e-e7d24454f746" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_df891c3a-5cc3-43a7-921c-3d5dbd75f203" xlink:to="loc_dei_EntityEmergingGrowthCompany_2c42c630-53c6-40f9-939e-e7d24454f746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_a94cdbb1-906f-478c-b4f0-8fe0be86de9c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_df891c3a-5cc3-43a7-921c-3d5dbd75f203" xlink:to="loc_dei_EntityShellCompany_a94cdbb1-906f-478c-b4f0-8fe0be86de9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_dba4d1ef-a9ff-4418-9a84-a89d58fbbbc5" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_df891c3a-5cc3-43a7-921c-3d5dbd75f203" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_dba4d1ef-a9ff-4418-9a84-a89d58fbbbc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_177e6dea-3078-4770-a414-97fd66d760b5" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_df891c3a-5cc3-43a7-921c-3d5dbd75f203" xlink:to="loc_dei_EntityCentralIndexKey_177e6dea-3078-4770-a414-97fd66d760b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_e97c7fce-0bc6-4ec6-a8e5-ad1b25a7c596" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_df891c3a-5cc3-43a7-921c-3d5dbd75f203" xlink:to="loc_dei_CurrentFiscalYearEndDate_e97c7fce-0bc6-4ec6-a8e5-ad1b25a7c596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_c0068c82-3da8-44fe-b33f-6b18c3613a27" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_df891c3a-5cc3-43a7-921c-3d5dbd75f203" xlink:to="loc_dei_AmendmentFlag_c0068c82-3da8-44fe-b33f-6b18c3613a27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_18d706e7-ca7c-4027-bcc7-8ac728bd06a9" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_df891c3a-5cc3-43a7-921c-3d5dbd75f203" xlink:to="loc_dei_DocumentFiscalYearFocus_18d706e7-ca7c-4027-bcc7-8ac728bd06a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_375ce6b8-3824-431d-8241-61c11f1d78b8" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_df891c3a-5cc3-43a7-921c-3d5dbd75f203" xlink:to="loc_dei_DocumentFiscalPeriodFocus_375ce6b8-3824-431d-8241-61c11f1d78b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="syre-20250331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://spyre.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_44954c07-6f43-4c35-becc-71e37b1c30c3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ab639c28-81fa-4244-95cb-33d22e3b572f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_44954c07-6f43-4c35-becc-71e37b1c30c3" xlink:to="loc_us-gaap_StatementTable_ab639c28-81fa-4244-95cb-33d22e3b572f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_033fb7f8-fa7a-4990-a106-ddf377539715" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ab639c28-81fa-4244-95cb-33d22e3b572f" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_033fb7f8-fa7a-4990-a106-ddf377539715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_9813fa79-f850-49d3-aadb-39acc7dc9472" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_033fb7f8-fa7a-4990-a106-ddf377539715" xlink:to="loc_us-gaap_RelatedPartyDomain_9813fa79-f850-49d3-aadb-39acc7dc9472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_d39cb380-9518-4b94-839b-8dfa081c6e83" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_9813fa79-f850-49d3-aadb-39acc7dc9472" xlink:to="loc_us-gaap_RelatedPartyMember_d39cb380-9518-4b94-839b-8dfa081c6e83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrelatedPartyMember_e5947c75-3362-4d2d-a595-5572060860a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonrelatedPartyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_9813fa79-f850-49d3-aadb-39acc7dc9472" xlink:to="loc_us-gaap_NonrelatedPartyMember_e5947c75-3362-4d2d-a595-5572060860a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_fe614276-d335-40a0-8bea-0c9b6c1cac90" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ab639c28-81fa-4244-95cb-33d22e3b572f" xlink:to="loc_us-gaap_StatementClassOfStockAxis_fe614276-d335-40a0-8bea-0c9b6c1cac90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_3a3d0dee-e4c0-47e8-a472-06aeb09f6f43" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_fe614276-d335-40a0-8bea-0c9b6c1cac90" xlink:to="loc_us-gaap_ClassOfStockDomain_3a3d0dee-e4c0-47e8-a472-06aeb09f6f43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SeriesANonVotingConvertiblePreferredStockMember_a6a8c7f5-af9e-4c7e-a397-707d692a33e0" xlink:href="syre-20250331.xsd#syre_SeriesANonVotingConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3a3d0dee-e4c0-47e8-a472-06aeb09f6f43" xlink:to="loc_syre_SeriesANonVotingConvertiblePreferredStockMember_a6a8c7f5-af9e-4c7e-a397-707d692a33e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SeriesBNonVotingConvertiblePreferredStockMember_92713604-e9f6-4f52-b52b-685a8a9dd14d" xlink:href="syre-20250331.xsd#syre_SeriesBNonVotingConvertiblePreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3a3d0dee-e4c0-47e8-a472-06aeb09f6f43" xlink:to="loc_syre_SeriesBNonVotingConvertiblePreferredStockMember_92713604-e9f6-4f52-b52b-685a8a9dd14d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_PreferredStockExcludingSeriesAAndBNonVotingConvertiblePreferredStockMember_91f1e491-c0a0-4c56-847f-61a9e029b78e" xlink:href="syre-20250331.xsd#syre_PreferredStockExcludingSeriesAAndBNonVotingConvertiblePreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3a3d0dee-e4c0-47e8-a472-06aeb09f6f43" xlink:to="loc_syre_PreferredStockExcludingSeriesAAndBNonVotingConvertiblePreferredStockMember_91f1e491-c0a0-4c56-847f-61a9e029b78e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_355e7a7c-6823-47f6-9bb0-0cda17d69f09" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ab639c28-81fa-4244-95cb-33d22e3b572f" xlink:to="loc_us-gaap_StatementLineItems_355e7a7c-6823-47f6-9bb0-0cda17d69f09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_f58ecdde-99a4-4e25-938a-b1c19220219c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_355e7a7c-6823-47f6-9bb0-0cda17d69f09" xlink:to="loc_us-gaap_AssetsAbstract_f58ecdde-99a4-4e25-938a-b1c19220219c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_7827970d-8347-4c0c-a29d-1cc763759507" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f58ecdde-99a4-4e25-938a-b1c19220219c" xlink:to="loc_us-gaap_AssetsCurrentAbstract_7827970d-8347-4c0c-a29d-1cc763759507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6ece282e-ded1-49df-a0a1-007588241cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7827970d-8347-4c0c-a29d-1cc763759507" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6ece282e-ded1-49df-a0a1-007588241cf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_79daa0c6-5980-423b-9b05-3cd4cdfc532a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7827970d-8347-4c0c-a29d-1cc763759507" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_79daa0c6-5980-423b-9b05-3cd4cdfc532a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_df03b08f-e730-44ea-a8b2-e1fbbd02511b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7827970d-8347-4c0c-a29d-1cc763759507" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_df03b08f-e730-44ea-a8b2-e1fbbd02511b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3514349d-3b94-4d44-b497-a4799eb235bb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7827970d-8347-4c0c-a29d-1cc763759507" xlink:to="loc_us-gaap_AssetsCurrent_3514349d-3b94-4d44-b497-a4799eb235bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_3d6ae967-28a2-4b2d-9ced-016ea9db1507" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f58ecdde-99a4-4e25-938a-b1c19220219c" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_3d6ae967-28a2-4b2d-9ced-016ea9db1507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_9e5b5bd4-82bf-4717-a97d-19432e366f7e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f58ecdde-99a4-4e25-938a-b1c19220219c" xlink:to="loc_us-gaap_Assets_9e5b5bd4-82bf-4717-a97d-19432e366f7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4477719a-173a-427c-aced-de480e699b84" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_355e7a7c-6823-47f6-9bb0-0cda17d69f09" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4477719a-173a-427c-aced-de480e699b84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_c99e87b8-fa19-4531-bfa6-4a50764f65bc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4477719a-173a-427c-aced-de480e699b84" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_c99e87b8-fa19-4531-bfa6-4a50764f65bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_d4a31228-8f05-4692-9f2e-5f237489df69" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c99e87b8-fa19-4531-bfa6-4a50764f65bc" xlink:to="loc_us-gaap_AccountsPayableCurrent_d4a31228-8f05-4692-9f2e-5f237489df69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_00f706e4-5596-4a52-84ea-1feb76f20211" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c99e87b8-fa19-4531-bfa6-4a50764f65bc" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_00f706e4-5596-4a52-84ea-1feb76f20211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_76ac749d-c275-41c5-8372-21b895676895" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c99e87b8-fa19-4531-bfa6-4a50764f65bc" xlink:to="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_76ac749d-c275-41c5-8372-21b895676895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_8a595a27-7220-44df-92bb-dd616bfaee9b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c99e87b8-fa19-4531-bfa6-4a50764f65bc" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_8a595a27-7220-44df-92bb-dd616bfaee9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_bfedece4-2069-4410-b8cd-9cd91a4016c9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c99e87b8-fa19-4531-bfa6-4a50764f65bc" xlink:to="loc_us-gaap_LiabilitiesCurrent_bfedece4-2069-4410-b8cd-9cd91a4016c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent_e7d8c1e2-9868-40e7-ac14-082aec1bcd65" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4477719a-173a-427c-aced-de480e699b84" xlink:to="loc_us-gaap_DerivativeLiabilitiesNoncurrent_e7d8c1e2-9868-40e7-ac14-082aec1bcd65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_38c1bcb3-d4c9-47fc-befb-ac12810b0e1d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4477719a-173a-427c-aced-de480e699b84" xlink:to="loc_us-gaap_Liabilities_38c1bcb3-d4c9-47fc-befb-ac12810b0e1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_a6d367e0-6b3c-4be4-825d-48290a3d773b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4477719a-173a-427c-aced-de480e699b84" xlink:to="loc_us-gaap_CommitmentsAndContingencies_a6d367e0-6b3c-4be4-825d-48290a3d773b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_1c00983b-79bc-41d4-803b-3b80328e62ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4477719a-173a-427c-aced-de480e699b84" xlink:to="loc_us-gaap_StockholdersEquityAbstract_1c00983b-79bc-41d4-803b-3b80328e62ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_b49680eb-bc8d-43bf-bfbf-a59ad6742f7c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1c00983b-79bc-41d4-803b-3b80328e62ba" xlink:to="loc_us-gaap_PreferredStockValue_b49680eb-bc8d-43bf-bfbf-a59ad6742f7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_17e7be81-8aff-4cb8-8aa1-b81fe8bda99d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1c00983b-79bc-41d4-803b-3b80328e62ba" xlink:to="loc_us-gaap_CommonStockValue_17e7be81-8aff-4cb8-8aa1-b81fe8bda99d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_34289178-7170-4684-ac6b-2b8cb32ecfb0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1c00983b-79bc-41d4-803b-3b80328e62ba" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_34289178-7170-4684-ac6b-2b8cb32ecfb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_31e2ae97-3d63-4887-8852-879ee967225b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1c00983b-79bc-41d4-803b-3b80328e62ba" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_31e2ae97-3d63-4887-8852-879ee967225b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_0a9ef4ef-8bb6-4728-8b99-ab9b0a22a323" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1c00983b-79bc-41d4-803b-3b80328e62ba" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_0a9ef4ef-8bb6-4728-8b99-ab9b0a22a323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e7f2d602-fbce-4a3f-a1bb-7febe353bf9f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1c00983b-79bc-41d4-803b-3b80328e62ba" xlink:to="loc_us-gaap_StockholdersEquity_e7f2d602-fbce-4a3f-a1bb-7febe353bf9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_dd2e5003-ce2e-42bf-b772-4d8a3f2df370" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4477719a-173a-427c-aced-de480e699b84" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_dd2e5003-ce2e-42bf-b772-4d8a3f2df370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="syre-20250331.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://spyre.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_cc93bacc-ed29-46d1-b771-5b8e5bb8a71e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_c4a297d3-f1e7-45ec-8a9f-6ea527a497f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_cc93bacc-ed29-46d1-b771-5b8e5bb8a71e" xlink:to="loc_us-gaap_StatementTable_c4a297d3-f1e7-45ec-8a9f-6ea527a497f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_268e283d-1cd1-4bdf-9cb5-9c03624efc4f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c4a297d3-f1e7-45ec-8a9f-6ea527a497f4" xlink:to="loc_us-gaap_StatementClassOfStockAxis_268e283d-1cd1-4bdf-9cb5-9c03624efc4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_df3b7eca-6243-4ce7-b961-2ac37ed9ccad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_268e283d-1cd1-4bdf-9cb5-9c03624efc4f" xlink:to="loc_us-gaap_ClassOfStockDomain_df3b7eca-6243-4ce7-b961-2ac37ed9ccad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SeriesANonVotingConvertiblePreferredStockMember_a8f2f07b-f5d6-4681-9568-b603dbc2c3f9" xlink:href="syre-20250331.xsd#syre_SeriesANonVotingConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_df3b7eca-6243-4ce7-b961-2ac37ed9ccad" xlink:to="loc_syre_SeriesANonVotingConvertiblePreferredStockMember_a8f2f07b-f5d6-4681-9568-b603dbc2c3f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SeriesBNonVotingConvertiblePreferredStockMember_2841807f-8fb4-49ba-b560-ed1a14dc9b7f" xlink:href="syre-20250331.xsd#syre_SeriesBNonVotingConvertiblePreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_df3b7eca-6243-4ce7-b961-2ac37ed9ccad" xlink:to="loc_syre_SeriesBNonVotingConvertiblePreferredStockMember_2841807f-8fb4-49ba-b560-ed1a14dc9b7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_PreferredStockExcludingSeriesAAndBNonVotingConvertiblePreferredStockMember_590193af-2bfe-4874-b203-ab542ef8828f" xlink:href="syre-20250331.xsd#syre_PreferredStockExcludingSeriesAAndBNonVotingConvertiblePreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_df3b7eca-6243-4ce7-b961-2ac37ed9ccad" xlink:to="loc_syre_PreferredStockExcludingSeriesAAndBNonVotingConvertiblePreferredStockMember_590193af-2bfe-4874-b203-ab542ef8828f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_bde6a39a-7280-4d03-aacd-3b864e9de3f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c4a297d3-f1e7-45ec-8a9f-6ea527a497f4" xlink:to="loc_us-gaap_StatementLineItems_bde6a39a-7280-4d03-aacd-3b864e9de3f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_f141d69e-922c-4998-836a-d7791cb66767" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bde6a39a-7280-4d03-aacd-3b864e9de3f0" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_f141d69e-922c-4998-836a-d7791cb66767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_947ddf35-6dc3-48f0-8996-e587bd373a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bde6a39a-7280-4d03-aacd-3b864e9de3f0" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_947ddf35-6dc3-48f0-8996-e587bd373a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_4ed328d4-ec84-4fde-b197-ff7ea9e2f056" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bde6a39a-7280-4d03-aacd-3b864e9de3f0" xlink:to="loc_us-gaap_PreferredStockSharesIssued_4ed328d4-ec84-4fde-b197-ff7ea9e2f056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_39e7baf2-3f36-4be0-9c13-980d7236bd7a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bde6a39a-7280-4d03-aacd-3b864e9de3f0" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_39e7baf2-3f36-4be0-9c13-980d7236bd7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_92b9e734-b79a-4e55-9e5a-29a0c9421f0e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bde6a39a-7280-4d03-aacd-3b864e9de3f0" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_92b9e734-b79a-4e55-9e5a-29a0c9421f0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_42937dcc-d6cf-4d03-b6d9-06fa97360b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bde6a39a-7280-4d03-aacd-3b864e9de3f0" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_42937dcc-d6cf-4d03-b6d9-06fa97360b2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_15dd4f0c-59d7-4dd3-b8c6-947854822381" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bde6a39a-7280-4d03-aacd-3b864e9de3f0" xlink:to="loc_us-gaap_CommonStockSharesIssued_15dd4f0c-59d7-4dd3-b8c6-947854822381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_612907e9-6cd1-4860-8087-86d75df5a43b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bde6a39a-7280-4d03-aacd-3b864e9de3f0" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_612907e9-6cd1-4860-8087-86d75df5a43b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="syre-20250331.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://spyre.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_01b22eb0-cf02-4622-92e4-1127e0f7eafe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_8091966a-6704-44d3-9d27-c6fc438077aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_01b22eb0-cf02-4622-92e4-1127e0f7eafe" xlink:to="loc_us-gaap_StatementTable_8091966a-6704-44d3-9d27-c6fc438077aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_cac8a679-b60e-4d23-972d-e58c4eb10d20" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8091966a-6704-44d3-9d27-c6fc438077aa" xlink:to="loc_us-gaap_StatementClassOfStockAxis_cac8a679-b60e-4d23-972d-e58c4eb10d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_9024cc06-5a5d-4ef7-84cd-6d2e38e071df" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_cac8a679-b60e-4d23-972d-e58c4eb10d20" xlink:to="loc_us-gaap_ClassOfStockDomain_9024cc06-5a5d-4ef7-84cd-6d2e38e071df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SeriesANonVotingConvertiblePreferredStockMember_69869b63-3407-478e-b7b9-cbbb93bf9177" xlink:href="syre-20250331.xsd#syre_SeriesANonVotingConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_9024cc06-5a5d-4ef7-84cd-6d2e38e071df" xlink:to="loc_syre_SeriesANonVotingConvertiblePreferredStockMember_69869b63-3407-478e-b7b9-cbbb93bf9177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SeriesBNonVotingConvertiblePreferredStockMember_2c5da0df-c34a-4ae9-a45a-508c9cd7e301" xlink:href="syre-20250331.xsd#syre_SeriesBNonVotingConvertiblePreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_9024cc06-5a5d-4ef7-84cd-6d2e38e071df" xlink:to="loc_syre_SeriesBNonVotingConvertiblePreferredStockMember_2c5da0df-c34a-4ae9-a45a-508c9cd7e301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_b8504131-359a-4c28-8d31-5de2c1539013" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_9024cc06-5a5d-4ef7-84cd-6d2e38e071df" xlink:to="loc_us-gaap_CommonStockMember_b8504131-359a-4c28-8d31-5de2c1539013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_130de1ba-0b63-4f16-9eaf-a252bfef2d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8091966a-6704-44d3-9d27-c6fc438077aa" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_130de1ba-0b63-4f16-9eaf-a252bfef2d4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_af005428-ec3a-401e-9d05-a3b22531da7a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_130de1ba-0b63-4f16-9eaf-a252bfef2d4a" xlink:to="loc_us-gaap_RelatedPartyDomain_af005428-ec3a-401e-9d05-a3b22531da7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_cc63819a-d144-4daf-8355-79c2830feafb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_af005428-ec3a-401e-9d05-a3b22531da7a" xlink:to="loc_us-gaap_RelatedPartyMember_cc63819a-d144-4daf-8355-79c2830feafb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b7327ba1-93d3-4357-a08a-38dd75578c3c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8091966a-6704-44d3-9d27-c6fc438077aa" xlink:to="loc_us-gaap_StatementLineItems_b7327ba1-93d3-4357-a08a-38dd75578c3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_7382ba0c-0748-4298-84af-26cf055d99f1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b7327ba1-93d3-4357-a08a-38dd75578c3c" xlink:to="loc_us-gaap_OperatingExpensesAbstract_7382ba0c-0748-4298-84af-26cf055d99f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_6ae8e036-15d6-45b3-8b95-3e4d4f81b844" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7382ba0c-0748-4298-84af-26cf055d99f1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_6ae8e036-15d6-45b3-8b95-3e4d4f81b844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_ac9247d1-4a41-4746-a920-9130a3c4416b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7382ba0c-0748-4298-84af-26cf055d99f1" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_ac9247d1-4a41-4746-a920-9130a3c4416b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_ca437523-ad0a-4c71-9941-8a35a54d54ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7382ba0c-0748-4298-84af-26cf055d99f1" xlink:to="loc_us-gaap_OperatingExpenses_ca437523-ad0a-4c71-9941-8a35a54d54ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_055801cf-4c2b-4275-80a1-f8dbbbbdb141" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b7327ba1-93d3-4357-a08a-38dd75578c3c" xlink:to="loc_us-gaap_OperatingIncomeLoss_055801cf-4c2b-4275-80a1-f8dbbbbdb141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9ecab2a3-c26f-48ec-b22e-72e5628be8e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b7327ba1-93d3-4357-a08a-38dd75578c3c" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9ecab2a3-c26f-48ec-b22e-72e5628be8e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_6f3fc839-9a62-4d68-8187-3a3f29a1faac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9ecab2a3-c26f-48ec-b22e-72e5628be8e7" xlink:to="loc_us-gaap_InvestmentIncomeNet_6f3fc839-9a62-4d68-8187-3a3f29a1faac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_da5354b0-f08b-4439-8a43-2796b84ac059" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9ecab2a3-c26f-48ec-b22e-72e5628be8e7" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_da5354b0-f08b-4439-8a43-2796b84ac059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_5a12cb8b-e2fd-4d2b-9050-59eb1edd3c92" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9ecab2a3-c26f-48ec-b22e-72e5628be8e7" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_5a12cb8b-e2fd-4d2b-9050-59eb1edd3c92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f27edd2f-8f68-4168-b32c-32de11d38693" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b7327ba1-93d3-4357-a08a-38dd75578c3c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f27edd2f-8f68-4168-b32c-32de11d38693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_646af020-a5e9-4c2d-a49c-ac48c3c30a21" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b7327ba1-93d3-4357-a08a-38dd75578c3c" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_646af020-a5e9-4c2d-a49c-ac48c3c30a21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d4d667c0-6c55-4e95-a2e1-7e69de541419" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b7327ba1-93d3-4357-a08a-38dd75578c3c" xlink:to="loc_us-gaap_NetIncomeLoss_d4d667c0-6c55-4e95-a2e1-7e69de541419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_fadfc290-9ab2-48aa-a10c-7046f99b1e2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b7327ba1-93d3-4357-a08a-38dd75578c3c" xlink:to="loc_us-gaap_EarningsPerShareBasic_fadfc290-9ab2-48aa-a10c-7046f99b1e2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_2f410c0f-e9e0-4ead-8cb0-d50d9d61a34f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b7327ba1-93d3-4357-a08a-38dd75578c3c" xlink:to="loc_us-gaap_EarningsPerShareDiluted_2f410c0f-e9e0-4ead-8cb0-d50d9d61a34f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_26aaf676-be77-4893-b1af-d175f0d8a36d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b7327ba1-93d3-4357-a08a-38dd75578c3c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_26aaf676-be77-4893-b1af-d175f0d8a36d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f6dc6b2a-304c-4bc8-bb6f-93b16ac8a4be" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b7327ba1-93d3-4357-a08a-38dd75578c3c" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f6dc6b2a-304c-4bc8-bb6f-93b16ac8a4be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/CondensedConsolidatedStatementsofOperationsParenthetical" xlink:type="simple" xlink:href="syre-20250331.xsd#CondensedConsolidatedStatementsofOperationsParenthetical"/>
  <link:presentationLink xlink:role="http://spyre.com/role/CondensedConsolidatedStatementsofOperationsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_803114e0-420b-438c-a8cf-2341a127f25a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_840fc961-88f4-4a37-b077-54f7f8743cc1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_803114e0-420b-438c-a8cf-2341a127f25a" xlink:to="loc_us-gaap_StatementTable_840fc961-88f4-4a37-b077-54f7f8743cc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5c006855-25cf-4e56-9d02-06f2be3b35b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_840fc961-88f4-4a37-b077-54f7f8743cc1" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5c006855-25cf-4e56-9d02-06f2be3b35b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_0bda7699-1fe1-4e6a-800c-622d5b9fcfc2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5c006855-25cf-4e56-9d02-06f2be3b35b5" xlink:to="loc_us-gaap_RelatedPartyDomain_0bda7699-1fe1-4e6a-800c-622d5b9fcfc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_c5827515-3a5b-4df3-bfa0-451a1915af02" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_0bda7699-1fe1-4e6a-800c-622d5b9fcfc2" xlink:to="loc_us-gaap_RelatedPartyMember_c5827515-3a5b-4df3-bfa0-451a1915af02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_4d283685-377d-4d23-ad65-ca6c260b741f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_840fc961-88f4-4a37-b077-54f7f8743cc1" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_4d283685-377d-4d23-ad65-ca6c260b741f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_43b06e7c-bf79-4968-a183-e6e1b93a00b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_4d283685-377d-4d23-ad65-ca6c260b741f" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_43b06e7c-bf79-4968-a183-e6e1b93a00b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_8d71cde5-8572-4d84-a210-cac3183612c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_43b06e7c-bf79-4968-a183-e6e1b93a00b6" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_8d71cde5-8572-4d84-a210-cac3183612c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_a5aa48a0-c243-42ef-909c-d81903d2cabd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_43b06e7c-bf79-4968-a183-e6e1b93a00b6" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_a5aa48a0-c243-42ef-909c-d81903d2cabd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5694b7c1-b50b-4b24-b49c-62195b7e3ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_840fc961-88f4-4a37-b077-54f7f8743cc1" xlink:to="loc_us-gaap_StatementLineItems_5694b7c1-b50b-4b24-b49c-62195b7e3ce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_e90db06b-3c1b-4211-87d8-8d7d44d04cfd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5694b7c1-b50b-4b24-b49c-62195b7e3ce2" xlink:to="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_e90db06b-3c1b-4211-87d8-8d7d44d04cfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="syre-20250331.xsd#CondensedConsolidatedStatementsofComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://spyre.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_13c8ada4-fb60-4c5b-a4f6-adf73b2c90b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_54e15b2c-a484-4c64-8223-f1bbd4d196cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_13c8ada4-fb60-4c5b-a4f6-adf73b2c90b3" xlink:to="loc_us-gaap_NetIncomeLoss_54e15b2c-a484-4c64-8223-f1bbd4d196cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_c3c67569-768f-4ac5-8a1f-7a91b8bc50c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_13c8ada4-fb60-4c5b-a4f6-adf73b2c90b3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_c3c67569-768f-4ac5-8a1f-7a91b8bc50c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_2e2f7b84-fc8b-4894-8635-82a6d39ad658" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_c3c67569-768f-4ac5-8a1f-7a91b8bc50c0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_2e2f7b84-fc8b-4894-8635-82a6d39ad658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_ecc20765-e3d8-45b3-9566-3a004a076ff8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_c3c67569-768f-4ac5-8a1f-7a91b8bc50c0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_ecc20765-e3d8-45b3-9566-3a004a076ff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_73908221-df44-4e9b-8324-aaf4d5eb5770" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_13c8ada4-fb60-4c5b-a4f6-adf73b2c90b3" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_73908221-df44-4e9b-8324-aaf4d5eb5770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/CondensedConsolidatedStatementsofChangesinConvertiblePreferredStockandStockholdersEquity" xlink:type="simple" xlink:href="syre-20250331.xsd#CondensedConsolidatedStatementsofChangesinConvertiblePreferredStockandStockholdersEquity"/>
  <link:presentationLink xlink:role="http://spyre.com/role/CondensedConsolidatedStatementsofChangesinConvertiblePreferredStockandStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_315038bc-43b4-482e-9e16-415202394f60" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2deb3d74-3c8b-49f1-9cd5-79a3d699a90d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_315038bc-43b4-482e-9e16-415202394f60" xlink:to="loc_us-gaap_StatementTable_2deb3d74-3c8b-49f1-9cd5-79a3d699a90d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d48209f6-bcc7-4cbe-a4fe-f8a292f43f06" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2deb3d74-3c8b-49f1-9cd5-79a3d699a90d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d48209f6-bcc7-4cbe-a4fe-f8a292f43f06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8a297ec5-c92d-44b5-a365-6bdd739cf936" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d48209f6-bcc7-4cbe-a4fe-f8a292f43f06" xlink:to="loc_us-gaap_EquityComponentDomain_8a297ec5-c92d-44b5-a365-6bdd739cf936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_ec21641f-a3e8-4316-ac46-d324eac0fcd3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8a297ec5-c92d-44b5-a365-6bdd739cf936" xlink:to="loc_us-gaap_PreferredStockMember_ec21641f-a3e8-4316-ac46-d324eac0fcd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_60aa7736-dc04-4e73-b243-6476a4caefaa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8a297ec5-c92d-44b5-a365-6bdd739cf936" xlink:to="loc_us-gaap_CommonStockMember_60aa7736-dc04-4e73-b243-6476a4caefaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_22d8519a-9e1d-40ad-8397-3e92ca20f4e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8a297ec5-c92d-44b5-a365-6bdd739cf936" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_22d8519a-9e1d-40ad-8397-3e92ca20f4e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_61bb57b7-42f3-4b11-8217-2821573b3b30" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8a297ec5-c92d-44b5-a365-6bdd739cf936" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_61bb57b7-42f3-4b11-8217-2821573b3b30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_79eb45a4-7d8e-45c1-bc68-25aa25b1e7fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8a297ec5-c92d-44b5-a365-6bdd739cf936" xlink:to="loc_us-gaap_RetainedEarningsMember_79eb45a4-7d8e-45c1-bc68-25aa25b1e7fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_a527197b-a071-4f26-8332-36337cce6d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2deb3d74-3c8b-49f1-9cd5-79a3d699a90d" xlink:to="loc_us-gaap_StatementClassOfStockAxis_a527197b-a071-4f26-8332-36337cce6d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f0753bfe-d6d7-449c-8994-d1c86ab5c68f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a527197b-a071-4f26-8332-36337cce6d2b" xlink:to="loc_us-gaap_ClassOfStockDomain_f0753bfe-d6d7-449c-8994-d1c86ab5c68f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SeriesANonVotingConvertiblePreferredStockMember_cc492604-9ebb-4793-8253-95aded4da0c1" xlink:href="syre-20250331.xsd#syre_SeriesANonVotingConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_f0753bfe-d6d7-449c-8994-d1c86ab5c68f" xlink:to="loc_syre_SeriesANonVotingConvertiblePreferredStockMember_cc492604-9ebb-4793-8253-95aded4da0c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SeriesBNonVotingConvertiblePreferredStockMember_71e29110-1f1c-47f5-92de-c5743467c6c0" xlink:href="syre-20250331.xsd#syre_SeriesBNonVotingConvertiblePreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_f0753bfe-d6d7-449c-8994-d1c86ab5c68f" xlink:to="loc_syre_SeriesBNonVotingConvertiblePreferredStockMember_71e29110-1f1c-47f5-92de-c5743467c6c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_7048e6d0-dcb6-4fbf-9fda-c5e2970e27b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2deb3d74-3c8b-49f1-9cd5-79a3d699a90d" xlink:to="loc_us-gaap_StatementLineItems_7048e6d0-dcb6-4fbf-9fda-c5e2970e27b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_704a39cc-f8c1-4977-bf4f-e051759c2778" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7048e6d0-dcb6-4fbf-9fda-c5e2970e27b6" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_704a39cc-f8c1-4977-bf4f-e051759c2778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_dcabf33e-90ce-41fa-9239-65465236440c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_704a39cc-f8c1-4977-bf4f-e051759c2778" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_dcabf33e-90ce-41fa-9239-65465236440c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_05536040-2d4d-477a-89b9-a3772241305d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_704a39cc-f8c1-4977-bf4f-e051759c2778" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_05536040-2d4d-477a-89b9-a3772241305d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_89cf7ef0-97e7-438a-bddf-396a0cfb2053" xlink:href="syre-20250331.xsd#syre_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_704a39cc-f8c1-4977-bf4f-e051759c2778" xlink:to="loc_syre_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_89cf7ef0-97e7-438a-bddf-396a0cfb2053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_64afc06b-b499-444d-bacc-4afa73415f15" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_704a39cc-f8c1-4977-bf4f-e051759c2778" xlink:to="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_64afc06b-b499-444d-bacc-4afa73415f15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_11106c8a-2d7a-4962-a096-c731d6309641" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_704a39cc-f8c1-4977-bf4f-e051759c2778" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_11106c8a-2d7a-4962-a096-c731d6309641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_47b45851-049e-4e37-9b20-b978936533e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_704a39cc-f8c1-4977-bf4f-e051759c2778" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_47b45851-049e-4e37-9b20-b978936533e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4340884f-2678-4a37-80d4-6f47b49d629a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7048e6d0-dcb6-4fbf-9fda-c5e2970e27b6" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4340884f-2678-4a37-80d4-6f47b49d629a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_1302cceb-73a1-40fe-9b79-0ba16462576f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4340884f-2678-4a37-80d4-6f47b49d629a" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_1302cceb-73a1-40fe-9b79-0ba16462576f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ddd00b90-7206-4c78-b0c1-a8f55b5baf7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4340884f-2678-4a37-80d4-6f47b49d629a" xlink:to="loc_us-gaap_StockholdersEquity_ddd00b90-7206-4c78-b0c1-a8f55b5baf7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_ef811386-0f6c-4de1-99cb-c24429206a84" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4340884f-2678-4a37-80d4-6f47b49d629a" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_ef811386-0f6c-4de1-99cb-c24429206a84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_StockIssuedDuringPeriodSharesOptionsExercisedAndEmployeeStockOwnershipPlan_ae7f569d-cbf5-4166-aa28-35b02869583e" xlink:href="syre-20250331.xsd#syre_StockIssuedDuringPeriodSharesOptionsExercisedAndEmployeeStockOwnershipPlan"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4340884f-2678-4a37-80d4-6f47b49d629a" xlink:to="loc_syre_StockIssuedDuringPeriodSharesOptionsExercisedAndEmployeeStockOwnershipPlan_ae7f569d-cbf5-4166-aa28-35b02869583e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_StockIssuedDuringPeriodValueOptionsExercisedAndEmployeeStockOwnershipPlan_0edddc0f-618d-4d22-a577-68a362ff0e90" xlink:href="syre-20250331.xsd#syre_StockIssuedDuringPeriodValueOptionsExercisedAndEmployeeStockOwnershipPlan"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4340884f-2678-4a37-80d4-6f47b49d629a" xlink:to="loc_syre_StockIssuedDuringPeriodValueOptionsExercisedAndEmployeeStockOwnershipPlan_0edddc0f-618d-4d22-a577-68a362ff0e90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_4cadbe39-1463-41b0-b704-cd78405ef743" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4340884f-2678-4a37-80d4-6f47b49d629a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_4cadbe39-1463-41b0-b704-cd78405ef743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ShareBasedPaymentArrangementSettlementOptionsCash_31fea1a3-db85-40b0-9a6c-e744f1aa992e" xlink:href="syre-20250331.xsd#syre_ShareBasedPaymentArrangementSettlementOptionsCash"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4340884f-2678-4a37-80d4-6f47b49d629a" xlink:to="loc_syre_ShareBasedPaymentArrangementSettlementOptionsCash_31fea1a3-db85-40b0-9a6c-e744f1aa992e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_f20a0f62-2030-49f5-894e-77fb594896da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4340884f-2678-4a37-80d4-6f47b49d629a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_f20a0f62-2030-49f5-894e-77fb594896da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2b7e2351-66cc-4ae7-8b5a-fd30ed9e6221" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4340884f-2678-4a37-80d4-6f47b49d629a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2b7e2351-66cc-4ae7-8b5a-fd30ed9e6221" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3b3aaea1-1819-45d4-9e78-5d5f30ef3643" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4340884f-2678-4a37-80d4-6f47b49d629a" xlink:to="loc_us-gaap_NetIncomeLoss_3b3aaea1-1819-45d4-9e78-5d5f30ef3643" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_dd897e5d-e99c-470e-b276-339b5b56f78c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4340884f-2678-4a37-80d4-6f47b49d629a" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_dd897e5d-e99c-470e-b276-339b5b56f78c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4cc2d205-4cdb-4539-b7cc-bb08504a7479" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4340884f-2678-4a37-80d4-6f47b49d629a" xlink:to="loc_us-gaap_StockholdersEquity_4cc2d205-4cdb-4539-b7cc-bb08504a7479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_4c22a569-1055-4d9e-812a-4d5a2e57f27e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4340884f-2678-4a37-80d4-6f47b49d629a" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_4c22a569-1055-4d9e-812a-4d5a2e57f27e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="syre-20250331.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_9d41ac7f-df8b-4c0e-9b07-72ae133d120a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_28ee79af-4b7e-40bd-a4c0-d12773e11ca3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9d41ac7f-df8b-4c0e-9b07-72ae133d120a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_28ee79af-4b7e-40bd-a4c0-d12773e11ca3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9d1d0c2c-43de-444e-9b5c-89fb594c134b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_28ee79af-4b7e-40bd-a4c0-d12773e11ca3" xlink:to="loc_us-gaap_NetIncomeLoss_9d1d0c2c-43de-444e-9b5c-89fb594c134b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b0f7418a-095f-4ab6-b0bd-e596cd8ce9c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_28ee79af-4b7e-40bd-a4c0-d12773e11ca3" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b0f7418a-095f-4ab6-b0bd-e596cd8ce9c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_3cd2a46d-7c27-4c6f-9d46-4795e3a73282" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b0f7418a-095f-4ab6-b0bd-e596cd8ce9c8" xlink:to="loc_us-gaap_ShareBasedCompensation_3cd2a46d-7c27-4c6f-9d46-4795e3a73282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_26f62c15-317e-4516-a6a0-a3f14611f67d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b0f7418a-095f-4ab6-b0bd-e596cd8ce9c8" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_26f62c15-317e-4516-a6a0-a3f14611f67d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_a52387ad-03df-49ca-ba3b-2d36d38efbba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b0f7418a-095f-4ab6-b0bd-e596cd8ce9c8" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_a52387ad-03df-49ca-ba3b-2d36d38efbba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_InterestProceedsDebtSecurities_3232fa1a-be1e-4c08-aabd-91afe6200856" xlink:href="syre-20250331.xsd#syre_InterestProceedsDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b0f7418a-095f-4ab6-b0bd-e596cd8ce9c8" xlink:to="loc_syre_InterestProceedsDebtSecurities_3232fa1a-be1e-4c08-aabd-91afe6200856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7a5f709d-6928-4ec8-8313-5f33973f08bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_28ee79af-4b7e-40bd-a4c0-d12773e11ca3" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7a5f709d-6928-4ec8-8313-5f33973f08bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_f7fd8260-a842-4210-a1dd-51231592cfb5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7a5f709d-6928-4ec8-8313-5f33973f08bf" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_f7fd8260-a842-4210-a1dd-51231592cfb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3d86e2e5-e15d-48e2-a6de-d4b058b388f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7a5f709d-6928-4ec8-8313-5f33973f08bf" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3d86e2e5-e15d-48e2-a6de-d4b058b388f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherAccountsPayable_0535e984-5abc-4148-b4d2-ebc8c64dfb6b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7a5f709d-6928-4ec8-8313-5f33973f08bf" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherAccountsPayable_0535e984-5abc-4148-b4d2-ebc8c64dfb6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_27be0815-2144-4eba-8732-21c32a373a51" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7a5f709d-6928-4ec8-8313-5f33973f08bf" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_27be0815-2144-4eba-8732-21c32a373a51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5d2745b4-0432-44fd-94c7-11dd65de9d4f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_28ee79af-4b7e-40bd-a4c0-d12773e11ca3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5d2745b4-0432-44fd-94c7-11dd65de9d4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e456741b-4557-4bb1-b870-322d0fe4826e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9d41ac7f-df8b-4c0e-9b07-72ae133d120a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e456741b-4557-4bb1-b870-322d0fe4826e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_26aa6e9c-d99c-42d4-8b9e-5ff72759ddeb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e456741b-4557-4bb1-b870-322d0fe4826e" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_26aa6e9c-d99c-42d4-8b9e-5ff72759ddeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_8d4556a8-1dbd-4644-a37f-be4c218a09cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e456741b-4557-4bb1-b870-322d0fe4826e" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_8d4556a8-1dbd-4644-a37f-be4c218a09cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_27a7df78-4419-4d91-af89-061d8e7ca0ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e456741b-4557-4bb1-b870-322d0fe4826e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_27a7df78-4419-4d91-af89-061d8e7ca0ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_93b7dd06-699f-4e82-bbe1-a4f914efedab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9d41ac7f-df8b-4c0e-9b07-72ae133d120a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_93b7dd06-699f-4e82-bbe1-a4f914efedab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_a84f5362-3974-48de-b594-8830aa270f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_93b7dd06-699f-4e82-bbe1-a4f914efedab" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_a84f5362-3974-48de-b594-8830aa270f6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_66ebfd14-493c-426b-921d-e05683fbcc06" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_93b7dd06-699f-4e82-bbe1-a4f914efedab" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_66ebfd14-493c-426b-921d-e05683fbcc06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_PaymentForDeferredOfferingCosts_ac55bcc2-629e-48c5-88ab-7471da3d643c" xlink:href="syre-20250331.xsd#syre_PaymentForDeferredOfferingCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_93b7dd06-699f-4e82-bbe1-a4f914efedab" xlink:to="loc_syre_PaymentForDeferredOfferingCosts_ac55bcc2-629e-48c5-88ab-7471da3d643c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_48cfb035-d128-4abb-8a02-bbcc34550b77" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_93b7dd06-699f-4e82-bbe1-a4f914efedab" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_48cfb035-d128-4abb-8a02-bbcc34550b77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_PaymentForSettlementOfShareBasedPaymentArrangement_fdca803e-4528-4d36-9137-cd979eb901d5" xlink:href="syre-20250331.xsd#syre_PaymentForSettlementOfShareBasedPaymentArrangement"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_93b7dd06-699f-4e82-bbe1-a4f914efedab" xlink:to="loc_syre_PaymentForSettlementOfShareBasedPaymentArrangement_fdca803e-4528-4d36-9137-cd979eb901d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_50f84fee-5e6a-4ea7-a537-b266ccb65149" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_93b7dd06-699f-4e82-bbe1-a4f914efedab" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_50f84fee-5e6a-4ea7-a537-b266ccb65149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_73975db4-8bcb-4440-b1b0-ce205e307c48" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9d41ac7f-df8b-4c0e-9b07-72ae133d120a" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_73975db4-8bcb-4440-b1b0-ce205e307c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e6f594c1-9b7c-4b11-b608-e919a6c1bb98" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9d41ac7f-df8b-4c0e-9b07-72ae133d120a" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e6f594c1-9b7c-4b11-b608-e919a6c1bb98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract_d6c35355-d7de-4641-be4f-65f0db9d41ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9d41ac7f-df8b-4c0e-9b07-72ae133d120a" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract_d6c35355-d7de-4641-be4f-65f0db9d41ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e0a4f2fb-6cbc-434c-a3e0-89112df90327" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract_d6c35355-d7de-4641-be4f-65f0db9d41ea" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e0a4f2fb-6cbc-434c-a3e0-89112df90327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6917d820-7f01-4eea-ac09-3774deb4836c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract_d6c35355-d7de-4641-be4f-65f0db9d41ea" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6917d820-7f01-4eea-ac09-3774deb4836c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_55191786-0ee6-468b-9b8f-5604f461ab18" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9d41ac7f-df8b-4c0e-9b07-72ae133d120a" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_55191786-0ee6-468b-9b8f-5604f461ab18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_DeferredOfferingCostsUnpaidAmount_1d44f302-9f9b-4965-a31b-e5f8342b196f" xlink:href="syre-20250331.xsd#syre_DeferredOfferingCostsUnpaidAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_55191786-0ee6-468b-9b8f-5604f461ab18" xlink:to="loc_syre_DeferredOfferingCostsUnpaidAmount_1d44f302-9f9b-4965-a31b-e5f8342b196f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_IssuanceOfConvertiblePreferredStockRelatedToPrivatePlacementUnpaidAmount_276155fa-09ba-412b-9697-19e6e97ecfbb" xlink:href="syre-20250331.xsd#syre_IssuanceOfConvertiblePreferredStockRelatedToPrivatePlacementUnpaidAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_55191786-0ee6-468b-9b8f-5604f461ab18" xlink:to="loc_syre_IssuanceOfConvertiblePreferredStockRelatedToPrivatePlacementUnpaidAmount_276155fa-09ba-412b-9697-19e6e97ecfbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_900b1f6f-b924-4869-8201-d1e19cd4b0ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9d41ac7f-df8b-4c0e-9b07-72ae133d120a" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_900b1f6f-b924-4869-8201-d1e19cd4b0ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1e4740d4-8dfd-4b19-b1e3-5a2b8fd953a6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_900b1f6f-b924-4869-8201-d1e19cd4b0ce" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1e4740d4-8dfd-4b19-b1e3-5a2b8fd953a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_274f1134-42b2-4b9d-a2ca-23cc16648829" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_900b1f6f-b924-4869-8201-d1e19cd4b0ce" xlink:to="loc_us-gaap_RestrictedCash_274f1134-42b2-4b9d-a2ca-23cc16648829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_18c813ff-0b06-40e3-ab46-7de4a7986860" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_900b1f6f-b924-4869-8201-d1e19cd4b0ce" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_18c813ff-0b06-40e3-ab46-7de4a7986860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/TheCompanyandBasisofPresentation" xlink:type="simple" xlink:href="syre-20250331.xsd#TheCompanyandBasisofPresentation"/>
  <link:presentationLink xlink:role="http://spyre.com/role/TheCompanyandBasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7015fee6-9dce-4bbf-8e22-0078aa1f825f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_70840144-9239-4634-a180-c968af8161c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7015fee6-9dce-4bbf-8e22-0078aa1f825f" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_70840144-9239-4634-a180-c968af8161c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="syre-20250331.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://spyre.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ed8f4e7a-2aa5-4fe4-ae3f-489604006baf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_adf0fb9f-3765-4096-8a83-e5995186f6b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ed8f4e7a-2aa5-4fe4-ae3f-489604006baf" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_adf0fb9f-3765-4096-8a83-e5995186f6b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="syre-20250331.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://spyre.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_949fcd3f-4a77-4ac5-8b60-9b77188eaada" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_b682ea1a-5477-4c8e-a225-07680c386bd9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_949fcd3f-4a77-4ac5-8b60-9b77188eaada" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_b682ea1a-5477-4c8e-a225-07680c386bd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/CashEquivalentsandMarketableSecurities" xlink:type="simple" xlink:href="syre-20250331.xsd#CashEquivalentsandMarketableSecurities"/>
  <link:presentationLink xlink:role="http://spyre.com/role/CashEquivalentsandMarketableSecurities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_2d81c855-9dcd-48c8-9f12-7362ae4de1aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_8f6d4997-975e-4853-8185-fc53ba48d1be" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_2d81c855-9dcd-48c8-9f12-7362ae4de1aa" xlink:to="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_8f6d4997-975e-4853-8185-fc53ba48d1be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/AccruedandOtherCurrentLiabilities" xlink:type="simple" xlink:href="syre-20250331.xsd#AccruedandOtherCurrentLiabilities"/>
  <link:presentationLink xlink:role="http://spyre.com/role/AccruedandOtherCurrentLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_9c96fba4-fd4d-48b4-b772-b16946a08b3a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_AccruedAndOtherCurrentLiabilitiesTextBlock_53e39842-8600-413f-9909-7a19835527df" xlink:href="syre-20250331.xsd#syre_AccruedAndOtherCurrentLiabilitiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_9c96fba4-fd4d-48b4-b772-b16946a08b3a" xlink:to="loc_syre_AccruedAndOtherCurrentLiabilitiesTextBlock_53e39842-8600-413f-9909-7a19835527df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/LicensingAgreements" xlink:type="simple" xlink:href="syre-20250331.xsd#LicensingAgreements"/>
  <link:presentationLink xlink:role="http://spyre.com/role/LicensingAgreements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_syre_LicensingAgreementsAbstract_26ce8842-6e6f-42d5-9992-19b32e46566a" xlink:href="syre-20250331.xsd#syre_LicensingAgreementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_fb83c1bb-6b1d-42c4-a0b1-773bad46dccd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_LicensingAgreementsAbstract_26ce8842-6e6f-42d5-9992-19b32e46566a" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_fb83c1bb-6b1d-42c4-a0b1-773bad46dccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/RelatedPartyTransactions" xlink:type="simple" xlink:href="syre-20250331.xsd#RelatedPartyTransactions"/>
  <link:presentationLink xlink:role="http://spyre.com/role/RelatedPartyTransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_071362d3-cf34-4946-ae87-fce58fd97deb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_a0782dc1-f8cc-4617-9e5a-8c8e640b59c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_071362d3-cf34-4946-ae87-fce58fd97deb" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_a0782dc1-f8cc-4617-9e5a-8c8e640b59c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquity" xlink:type="simple" xlink:href="syre-20250331.xsd#ConvertiblePreferredStockandStockholdersEquity"/>
  <link:presentationLink xlink:role="http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_0233c314-c60a-497b-ac03-dc9307bdbac8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockTextBlock_990dc457-bdf8-43d2-b25a-e71cc17c9b69" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0233c314-c60a-497b-ac03-dc9307bdbac8" xlink:to="loc_us-gaap_PreferredStockTextBlock_990dc457-bdf8-43d2-b25a-e71cc17c9b69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="syre-20250331.xsd#StockBasedCompensation"/>
  <link:presentationLink xlink:role="http://spyre.com/role/StockBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0fcc0eac-9113-4a6f-ae71-7fb66d3c1fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1179c1e6-6b6d-4714-984f-0459c1ec0149" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0fcc0eac-9113-4a6f-ae71-7fb66d3c1fcd" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1179c1e6-6b6d-4714-984f-0459c1ec0149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/SegmentReporting" xlink:type="simple" xlink:href="syre-20250331.xsd#SegmentReporting"/>
  <link:presentationLink xlink:role="http://spyre.com/role/SegmentReporting" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_c230437e-a3be-41fa-ae34-3af44f19a90f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_c8c9eb6b-bff5-4963-916c-559c781cb06d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c230437e-a3be-41fa-ae34-3af44f19a90f" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_c8c9eb6b-bff5-4963-916c-559c781cb06d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/NetLossPerShare" xlink:type="simple" xlink:href="syre-20250331.xsd#NetLossPerShare"/>
  <link:presentationLink xlink:role="http://spyre.com/role/NetLossPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_d402dfd2-9577-44ef-9160-962732dde054" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_1f92bb38-dd91-490e-bb28-28dc415b5a50" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d402dfd2-9577-44ef-9160-962732dde054" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_1f92bb38-dd91-490e-bb28-28dc415b5a50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="syre-20250331.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://spyre.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_e97e434f-c05b-466e-b164-4d891662d038" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_f83934df-4dee-401e-8dcf-7c8bf009f5a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e97e434f-c05b-466e-b164-4d891662d038" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_f83934df-4dee-401e-8dcf-7c8bf009f5a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_dcedd38d-2894-4d90-8e10-35a5c013aecc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e97e434f-c05b-466e-b164-4d891662d038" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_dcedd38d-2894-4d90-8e10-35a5c013aecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_a3e6d9cc-56bc-4d05-81b5-11bc550323a0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e97e434f-c05b-466e-b164-4d891662d038" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_a3e6d9cc-56bc-4d05-81b5-11bc550323a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/FairValueMeasurementTables" xlink:type="simple" xlink:href="syre-20250331.xsd#FairValueMeasurementTables"/>
  <link:presentationLink xlink:role="http://spyre.com/role/FairValueMeasurementTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_cdb438f2-d9a0-48d1-bffa-a91c27ca6d42" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_fe14919b-a071-44b2-a4a3-fed1e718fe54" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_cdb438f2-d9a0-48d1-bffa-a91c27ca6d42" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_fe14919b-a071-44b2-a4a3-fed1e718fe54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_55705d8c-62f0-4e10-a8cf-8bde0bd4cbf1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_cdb438f2-d9a0-48d1-bffa-a91c27ca6d42" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_55705d8c-62f0-4e10-a8cf-8bde0bd4cbf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_40365c29-f0ce-47c7-a662-3e1111354870" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_cdb438f2-d9a0-48d1-bffa-a91c27ca6d42" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_40365c29-f0ce-47c7-a662-3e1111354870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/CashEquivalentsandMarketableSecuritiesTables" xlink:type="simple" xlink:href="syre-20250331.xsd#CashEquivalentsandMarketableSecuritiesTables"/>
  <link:presentationLink xlink:role="http://spyre.com/role/CashEquivalentsandMarketableSecuritiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_10da530d-e451-4140-b738-6131a84e6e6d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_adfc7ad6-88af-4cf6-9ec0-92a63b8ca9f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_10da530d-e451-4140-b738-6131a84e6e6d" xlink:to="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_adfc7ad6-88af-4cf6-9ec0-92a63b8ca9f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_982ea8f5-b16d-4619-97d9-9000ac2bd37d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_10da530d-e451-4140-b738-6131a84e6e6d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_982ea8f5-b16d-4619-97d9-9000ac2bd37d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_904cd614-915e-4c54-aac5-69419c8f35d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_10da530d-e451-4140-b738-6131a84e6e6d" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_904cd614-915e-4c54-aac5-69419c8f35d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/AccruedandOtherCurrentLiabilitiesTables" xlink:type="simple" xlink:href="syre-20250331.xsd#AccruedandOtherCurrentLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://spyre.com/role/AccruedandOtherCurrentLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_5ecf6184-2f76-4825-93de-545b614a4835" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_5c42b3af-af4f-4c4c-8075-c3fba7bc348b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_5ecf6184-2f76-4825-93de-545b614a4835" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_5c42b3af-af4f-4c4c-8075-c3fba7bc348b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/RelatedPartyTransactionsTables" xlink:type="simple" xlink:href="syre-20250331.xsd#RelatedPartyTransactionsTables"/>
  <link:presentationLink xlink:role="http://spyre.com/role/RelatedPartyTransactionsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_108219fb-c581-4a90-b533-a0080b446abb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_27350a94-e6ed-4041-a35c-7bf5b22f0679" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_108219fb-c581-4a90-b533-a0080b446abb" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_27350a94-e6ed-4041-a35c-7bf5b22f0679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ScheduleOfBalancesDueToAffiliatesTableTextBlock_879bd9a5-4f22-440a-b701-fa8ab7bf3deb" xlink:href="syre-20250331.xsd#syre_ScheduleOfBalancesDueToAffiliatesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_108219fb-c581-4a90-b533-a0080b446abb" xlink:to="loc_syre_ScheduleOfBalancesDueToAffiliatesTableTextBlock_879bd9a5-4f22-440a-b701-fa8ab7bf3deb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="syre-20250331.xsd#StockBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://spyre.com/role/StockBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_29501780-a1a1-485c-9309-42d7ebbceef1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock_909d7ed3-9eba-4972-81e0-edf3f4d74eb5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_29501780-a1a1-485c-9309-42d7ebbceef1" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock_909d7ed3-9eba-4972-81e0-edf3f4d74eb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_4e5c81af-5da9-4c11-bee1-5058b80f5c76" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_29501780-a1a1-485c-9309-42d7ebbceef1" xlink:to="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_4e5c81af-5da9-4c11-bee1-5058b80f5c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_f1f06593-8ef1-4792-8248-66257f3f9c15" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_29501780-a1a1-485c-9309-42d7ebbceef1" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_f1f06593-8ef1-4792-8248-66257f3f9c15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="syre-20250331.xsd#SegmentReportingTables"/>
  <link:presentationLink xlink:role="http://spyre.com/role/SegmentReportingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_aeb840f8-a155-41a2-8670-44e3320ef6dc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_7fa11fc6-e535-447d-b681-08258a6782f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_aeb840f8-a155-41a2-8670-44e3320ef6dc" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_7fa11fc6-e535-447d-b681-08258a6782f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/NetLossPerShareTables" xlink:type="simple" xlink:href="syre-20250331.xsd#NetLossPerShareTables"/>
  <link:presentationLink xlink:role="http://spyre.com/role/NetLossPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_1406872e-9155-49b6-8cec-68033404b86b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_518548d0-0c93-4556-87b2-ec103b85b519" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1406872e-9155-49b6-8cec-68033404b86b" xlink:to="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_518548d0-0c93-4556-87b2-ec103b85b519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_0806da85-66fb-46b6-bce6-e80553f3b218" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1406872e-9155-49b6-8cec-68033404b86b" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_0806da85-66fb-46b6-bce6-e80553f3b218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/TheCompanyandBasisofPresentationDetails" xlink:type="simple" xlink:href="syre-20250331.xsd#TheCompanyandBasisofPresentationDetails"/>
  <link:presentationLink xlink:role="http://spyre.com/role/TheCompanyandBasisofPresentationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5ad9c38f-e483-44d4-a40e-9b6ab0857eb2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_CompanyAndBasisOfPresentationTable_0e7c0225-fe6b-4318-8e58-ecbe46576a86" xlink:href="syre-20250331.xsd#syre_CompanyAndBasisOfPresentationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5ad9c38f-e483-44d4-a40e-9b6ab0857eb2" xlink:to="loc_syre_CompanyAndBasisOfPresentationTable_0e7c0225-fe6b-4318-8e58-ecbe46576a86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_a17d6c56-4a70-4c74-b6e2-7cdfe5b05c15" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_CompanyAndBasisOfPresentationTable_0e7c0225-fe6b-4318-8e58-ecbe46576a86" xlink:to="loc_us-gaap_AssetAcquisitionAxis_a17d6c56-4a70-4c74-b6e2-7cdfe5b05c15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_5e7ffd0c-aaff-4a98-a6fa-74d2289a1bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionAxis_a17d6c56-4a70-4c74-b6e2-7cdfe5b05c15" xlink:to="loc_us-gaap_AssetAcquisitionDomain_5e7ffd0c-aaff-4a98-a6fa-74d2289a1bf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SpyreTherapeuticsIncMember_87dbb632-1064-4a76-af0a-29b695e8260d" xlink:href="syre-20250331.xsd#syre_SpyreTherapeuticsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_5e7ffd0c-aaff-4a98-a6fa-74d2289a1bf9" xlink:to="loc_syre_SpyreTherapeuticsIncMember_87dbb632-1064-4a76-af0a-29b695e8260d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_AssetAcquisitionMember_cf7133ab-52ba-4261-9978-f58ac240dcf9" xlink:href="syre-20250331.xsd#syre_AssetAcquisitionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_5e7ffd0c-aaff-4a98-a6fa-74d2289a1bf9" xlink:to="loc_syre_AssetAcquisitionMember_cf7133ab-52ba-4261-9978-f58ac240dcf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_c51f2db9-b908-40f4-b41e-ab6e7010c396" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_CompanyAndBasisOfPresentationTable_0e7c0225-fe6b-4318-8e58-ecbe46576a86" xlink:to="loc_us-gaap_StatementClassOfStockAxis_c51f2db9-b908-40f4-b41e-ab6e7010c396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_e0bd3be9-98df-4ad8-b469-218770ce8c5a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_c51f2db9-b908-40f4-b41e-ab6e7010c396" xlink:to="loc_us-gaap_ClassOfStockDomain_e0bd3be9-98df-4ad8-b469-218770ce8c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_CommonStockAndSeriesBNonVotingConvertiblePreferredStockMember_d9b6e1de-6a9b-4bf1-a78e-86e6a48e6667" xlink:href="syre-20250331.xsd#syre_CommonStockAndSeriesBNonVotingConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e0bd3be9-98df-4ad8-b469-218770ce8c5a" xlink:to="loc_syre_CommonStockAndSeriesBNonVotingConvertiblePreferredStockMember_d9b6e1de-6a9b-4bf1-a78e-86e6a48e6667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SeriesBNonVotingConvertiblePreferredStockMember_e709b792-4a2f-48d2-9e01-fbef421b2aa2" xlink:href="syre-20250331.xsd#syre_SeriesBNonVotingConvertiblePreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e0bd3be9-98df-4ad8-b469-218770ce8c5a" xlink:to="loc_syre_SeriesBNonVotingConvertiblePreferredStockMember_e709b792-4a2f-48d2-9e01-fbef421b2aa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SeriesANonVotingConvertiblePreferredStockMember_983d6cd5-17a9-4ff3-8760-5f209ef73dc6" xlink:href="syre-20250331.xsd#syre_SeriesANonVotingConvertiblePreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e0bd3be9-98df-4ad8-b469-218770ce8c5a" xlink:to="loc_syre_SeriesANonVotingConvertiblePreferredStockMember_983d6cd5-17a9-4ff3-8760-5f209ef73dc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_7d6da930-69c4-4189-b8a6-c3e9d6014d8f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e0bd3be9-98df-4ad8-b469-218770ce8c5a" xlink:to="loc_us-gaap_CommonStockMember_7d6da930-69c4-4189-b8a6-c3e9d6014d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_56eb9c27-bfdb-4ade-a1d4-98f7abe69544" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_CompanyAndBasisOfPresentationTable_0e7c0225-fe6b-4318-8e58-ecbe46576a86" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_56eb9c27-bfdb-4ade-a1d4-98f7abe69544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_fd68c38d-03a5-4a8e-9070-2adf47fa39be" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_56eb9c27-bfdb-4ade-a1d4-98f7abe69544" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_fd68c38d-03a5-4a8e-9070-2adf47fa39be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_9fc58a91-0c09-434b-b79e-abc2e40a1057" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_fd68c38d-03a5-4a8e-9070-2adf47fa39be" xlink:to="loc_us-gaap_PrivatePlacementMember_9fc58a91-0c09-434b-b79e-abc2e40a1057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_AtTheMarketOfferingMember_2504281e-3240-41e7-8d50-9432df9b16dd" xlink:href="syre-20250331.xsd#syre_AtTheMarketOfferingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_fd68c38d-03a5-4a8e-9070-2adf47fa39be" xlink:to="loc_syre_AtTheMarketOfferingMember_2504281e-3240-41e7-8d50-9432df9b16dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_UnderwrittenOfferingMember_4560d235-89ef-49be-b4c8-6247c328d0dc" xlink:href="syre-20250331.xsd#syre_UnderwrittenOfferingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_fd68c38d-03a5-4a8e-9070-2adf47fa39be" xlink:to="loc_syre_UnderwrittenOfferingMember_4560d235-89ef-49be-b4c8-6247c328d0dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_7b085fb6-6d3b-4357-8078-f4ec8fa9a500" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_fd68c38d-03a5-4a8e-9070-2adf47fa39be" xlink:to="loc_us-gaap_OverAllotmentOptionMember_7b085fb6-6d3b-4357-8078-f4ec8fa9a500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_71a1038c-1c0f-42f6-acff-34c22e44e27c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_CompanyAndBasisOfPresentationTable_0e7c0225-fe6b-4318-8e58-ecbe46576a86" xlink:to="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_71a1038c-1c0f-42f6-acff-34c22e44e27c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_23fe7dd4-aa41-4e65-a852-787a9ffddd13" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_71a1038c-1c0f-42f6-acff-34c22e44e27c" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_23fe7dd4-aa41-4e65-a852-787a9ffddd13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ConversionOfSeriesANonVotingConvertiblePreferredStockMember_4394b3ad-d122-48cd-9855-463391d836e0" xlink:href="syre-20250331.xsd#syre_ConversionOfSeriesANonVotingConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_23fe7dd4-aa41-4e65-a852-787a9ffddd13" xlink:to="loc_syre_ConversionOfSeriesANonVotingConvertiblePreferredStockMember_4394b3ad-d122-48cd-9855-463391d836e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ConversionOfSeriesBNonVotingConvertiblePreferredStockMember_575defac-5146-49d7-9ae3-5fd59be31367" xlink:href="syre-20250331.xsd#syre_ConversionOfSeriesBNonVotingConvertiblePreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_23fe7dd4-aa41-4e65-a852-787a9ffddd13" xlink:to="loc_syre_ConversionOfSeriesBNonVotingConvertiblePreferredStockMember_575defac-5146-49d7-9ae3-5fd59be31367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_21dbe31f-51b5-4d8f-8da6-ed24a6279667" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_CompanyAndBasisOfPresentationTable_0e7c0225-fe6b-4318-8e58-ecbe46576a86" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_21dbe31f-51b5-4d8f-8da6-ed24a6279667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4b37ed10-f7f3-444e-aeb4-20933bb752ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_21dbe31f-51b5-4d8f-8da6-ed24a6279667" xlink:to="loc_us-gaap_EquityComponentDomain_4b37ed10-f7f3-444e-aeb4-20933bb752ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_e17231dd-622e-4332-a65b-a3ccc440b933" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_4b37ed10-f7f3-444e-aeb4-20933bb752ec" xlink:to="loc_us-gaap_PreferredStockMember_e17231dd-622e-4332-a65b-a3ccc440b933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_62658dc1-e196-4b22-8e46-ad0abccb4452" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_4b37ed10-f7f3-444e-aeb4-20933bb752ec" xlink:to="loc_us-gaap_CommonStockMember_62658dc1-e196-4b22-8e46-ad0abccb4452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4fbde19e-fab3-4efd-9202-5f09647c8019" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_CompanyAndBasisOfPresentationTable_0e7c0225-fe6b-4318-8e58-ecbe46576a86" xlink:to="loc_srt_RangeAxis_4fbde19e-fab3-4efd-9202-5f09647c8019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_17521379-4b62-499b-bd82-5766d73839d2" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_4fbde19e-fab3-4efd-9202-5f09647c8019" xlink:to="loc_srt_RangeMember_17521379-4b62-499b-bd82-5766d73839d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_80a9039a-6c30-416c-8a5d-f67286e041de" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_17521379-4b62-499b-bd82-5766d73839d2" xlink:to="loc_srt_MaximumMember_80a9039a-6c30-416c-8a5d-f67286e041de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_CompanyAndBasisOfPresentationLineItems_a567ca30-df4d-465b-b131-53e48ff2f6d5" xlink:href="syre-20250331.xsd#syre_CompanyAndBasisOfPresentationLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_CompanyAndBasisOfPresentationTable_0e7c0225-fe6b-4318-8e58-ecbe46576a86" xlink:to="loc_syre_CompanyAndBasisOfPresentationLineItems_a567ca30-df4d-465b-b131-53e48ff2f6d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_4da8b657-525f-4519-8a12-3c9d8d1e0396" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_CompanyAndBasisOfPresentationLineItems_a567ca30-df4d-465b-b131-53e48ff2f6d5" xlink:to="loc_us-gaap_NumberOfOperatingSegments_4da8b657-525f-4519-8a12-3c9d8d1e0396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_AssetAcquisitionStockholderPaymentPeriod_80d3c411-980d-44b8-94bc-0c2219222ac0" xlink:href="syre-20250331.xsd#syre_AssetAcquisitionStockholderPaymentPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_CompanyAndBasisOfPresentationLineItems_a567ca30-df4d-465b-b131-53e48ff2f6d5" xlink:to="loc_syre_AssetAcquisitionStockholderPaymentPeriod_80d3c411-980d-44b8-94bc-0c2219222ac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_AssetAcquisitionCashPaymentThresholdPeriod_c99262d1-8fc6-41ea-8a21-8497e2a24c49" xlink:href="syre-20250331.xsd#syre_AssetAcquisitionCashPaymentThresholdPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_CompanyAndBasisOfPresentationLineItems_a567ca30-df4d-465b-b131-53e48ff2f6d5" xlink:to="loc_syre_AssetAcquisitionCashPaymentThresholdPeriod_c99262d1-8fc6-41ea-8a21-8497e2a24c49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_647d86db-3f19-407e-a1cf-7b4ddd475c78" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_CompanyAndBasisOfPresentationLineItems_a567ca30-df4d-465b-b131-53e48ff2f6d5" xlink:to="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_647d86db-3f19-407e-a1cf-7b4ddd475c78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockConvertibleConversionRatio_b6fc3759-0a4c-40e4-b264-4d35b048e37a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockConvertibleConversionRatio"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_CompanyAndBasisOfPresentationLineItems_a567ca30-df4d-465b-b131-53e48ff2f6d5" xlink:to="loc_us-gaap_PreferredStockConvertibleConversionRatio_b6fc3759-0a4c-40e4-b264-4d35b048e37a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_ea59864a-dd60-440b-986a-12065d765775" xlink:href="syre-20250331.xsd#syre_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_CompanyAndBasisOfPresentationLineItems_a567ca30-df4d-465b-b131-53e48ff2f6d5" xlink:to="loc_syre_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_ea59864a-dd60-440b-986a-12065d765775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_cf7f56b6-7d65-4d0f-aaa3-eb8752e5f14c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_CompanyAndBasisOfPresentationLineItems_a567ca30-df4d-465b-b131-53e48ff2f6d5" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_cf7f56b6-7d65-4d0f-aaa3-eb8752e5f14c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_898a36cb-05fc-41a8-9596-f9dc410341e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_CompanyAndBasisOfPresentationLineItems_a567ca30-df4d-465b-b131-53e48ff2f6d5" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_898a36cb-05fc-41a8-9596-f9dc410341e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_f0b3be75-c8b1-4bf1-b91d-2f555dec8a20" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_CompanyAndBasisOfPresentationLineItems_a567ca30-df4d-465b-b131-53e48ff2f6d5" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_f0b3be75-c8b1-4bf1-b91d-2f555dec8a20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_d09e3cde-e30e-435d-93fb-76723b931fbc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_CompanyAndBasisOfPresentationLineItems_a567ca30-df4d-465b-b131-53e48ff2f6d5" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_d09e3cde-e30e-435d-93fb-76723b931fbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_StockIssuedDuringPeriodSharesExchangeOfConvertibleSecurities_47acff1f-dcd1-4f06-b2fd-6fe68b977b8c" xlink:href="syre-20250331.xsd#syre_StockIssuedDuringPeriodSharesExchangeOfConvertibleSecurities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_CompanyAndBasisOfPresentationLineItems_a567ca30-df4d-465b-b131-53e48ff2f6d5" xlink:to="loc_syre_StockIssuedDuringPeriodSharesExchangeOfConvertibleSecurities_47acff1f-dcd1-4f06-b2fd-6fe68b977b8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_0d226a8a-9aac-47f3-a495-51ffa3173e3f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_CompanyAndBasisOfPresentationLineItems_a567ca30-df4d-465b-b131-53e48ff2f6d5" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_0d226a8a-9aac-47f3-a495-51ffa3173e3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c328a92e-2b2b-4f96-b4fe-37c197bc142d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_CompanyAndBasisOfPresentationLineItems_a567ca30-df4d-465b-b131-53e48ff2f6d5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c328a92e-2b2b-4f96-b4fe-37c197bc142d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_PreferredStockSharesNotAutomaticallyConvertedOutstanding_be479b84-d83b-4438-affe-94ec7b2eb7be" xlink:href="syre-20250331.xsd#syre_PreferredStockSharesNotAutomaticallyConvertedOutstanding"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_CompanyAndBasisOfPresentationLineItems_a567ca30-df4d-465b-b131-53e48ff2f6d5" xlink:to="loc_syre_PreferredStockSharesNotAutomaticallyConvertedOutstanding_be479b84-d83b-4438-affe-94ec7b2eb7be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SaleOfStockAuthorizedAmount_beb9a49e-d643-49b3-84a8-18e33b9831d3" xlink:href="syre-20250331.xsd#syre_SaleOfStockAuthorizedAmount"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_CompanyAndBasisOfPresentationLineItems_a567ca30-df4d-465b-b131-53e48ff2f6d5" xlink:to="loc_syre_SaleOfStockAuthorizedAmount_beb9a49e-d643-49b3-84a8-18e33b9831d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SaleOfStockAggregateOfferingPrice_9b0ba7c6-aed9-454c-ba54-b59c0ada9907" xlink:href="syre-20250331.xsd#syre_SaleOfStockAggregateOfferingPrice"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_CompanyAndBasisOfPresentationLineItems_a567ca30-df4d-465b-b131-53e48ff2f6d5" xlink:to="loc_syre_SaleOfStockAggregateOfferingPrice_9b0ba7c6-aed9-454c-ba54-b59c0ada9907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_53518521-bb4a-47b7-82f8-2cbd13931d60" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_CompanyAndBasisOfPresentationLineItems_a567ca30-df4d-465b-b131-53e48ff2f6d5" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_53518521-bb4a-47b7-82f8-2cbd13931d60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SaleOfStockRemainingAuthorizedAmount_8086e13a-22d5-4c7a-8380-8cba13a1e4c2" xlink:href="syre-20250331.xsd#syre_SaleOfStockRemainingAuthorizedAmount"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_CompanyAndBasisOfPresentationLineItems_a567ca30-df4d-465b-b131-53e48ff2f6d5" xlink:to="loc_syre_SaleOfStockRemainingAuthorizedAmount_8086e13a-22d5-4c7a-8380-8cba13a1e4c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ProceedsFromRaisingCapital_429af177-ef92-4034-a5ea-7b1c1099d028" xlink:href="syre-20250331.xsd#syre_ProceedsFromRaisingCapital"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_CompanyAndBasisOfPresentationLineItems_a567ca30-df4d-465b-b131-53e48ff2f6d5" xlink:to="loc_syre_ProceedsFromRaisingCapital_429af177-ef92-4034-a5ea-7b1c1099d028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_13bc4dda-272e-4107-8cea-a49a9f50e2db" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_CompanyAndBasisOfPresentationLineItems_a567ca30-df4d-465b-b131-53e48ff2f6d5" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_13bc4dda-272e-4107-8cea-a49a9f50e2db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_c09b2d7b-44dd-458e-9027-1eba987344d0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecurities"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_CompanyAndBasisOfPresentationLineItems_a567ca30-df4d-465b-b131-53e48ff2f6d5" xlink:to="loc_us-gaap_MarketableSecurities_c09b2d7b-44dd-458e-9027-1eba987344d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="syre-20250331.xsd#FairValueMeasurementsFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://spyre.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_f4d14d9a-8317-4603-9b50-7ec41e2e6b73" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0b83aceb-0352-464d-a1b4-6f81a2ab79a4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f4d14d9a-8317-4603-9b50-7ec41e2e6b73" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0b83aceb-0352-464d-a1b4-6f81a2ab79a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_32c7eaaf-c86f-498e-9a35-e1c620bad630" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0b83aceb-0352-464d-a1b4-6f81a2ab79a4" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_32c7eaaf-c86f-498e-9a35-e1c620bad630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_afc1f777-8e02-437d-bfe4-12e35265bbf3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_32c7eaaf-c86f-498e-9a35-e1c620bad630" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_afc1f777-8e02-437d-bfe4-12e35265bbf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_ecd53281-3e1e-40c8-966f-c160b94a3a4d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_afc1f777-8e02-437d-bfe4-12e35265bbf3" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_ecd53281-3e1e-40c8-966f-c160b94a3a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_aa54790c-a655-400c-a17e-c3dfecd1a448" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0b83aceb-0352-464d-a1b4-6f81a2ab79a4" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_aa54790c-a655-400c-a17e-c3dfecd1a448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_ed146ca3-ebf7-46ec-ae21-e780a866b433" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_aa54790c-a655-400c-a17e-c3dfecd1a448" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_ed146ca3-ebf7-46ec-ae21-e780a866b433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_6156dbab-3d59-4fb2-8fcb-2efb47c0c013" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_ed146ca3-ebf7-46ec-ae21-e780a866b433" xlink:to="loc_us-gaap_MoneyMarketFundsMember_6156dbab-3d59-4fb2-8fcb-2efb47c0c013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_de92a715-8f07-4f34-8aa5-168d94bc2f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0b83aceb-0352-464d-a1b4-6f81a2ab79a4" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_de92a715-8f07-4f34-8aa5-168d94bc2f7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c177d214-2eb0-4cb3-93fd-896d2b83f6b8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_de92a715-8f07-4f34-8aa5-168d94bc2f7d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c177d214-2eb0-4cb3-93fd-896d2b83f6b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_5e3af458-e829-4a38-90b4-8ebf770bb77e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c177d214-2eb0-4cb3-93fd-896d2b83f6b8" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_5e3af458-e829-4a38-90b4-8ebf770bb77e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_4c8850fe-f416-4d1a-9e5f-846171e67d37" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c177d214-2eb0-4cb3-93fd-896d2b83f6b8" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_4c8850fe-f416-4d1a-9e5f-846171e67d37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_47a42a3c-72c6-409b-8d93-089ef7206ab3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c177d214-2eb0-4cb3-93fd-896d2b83f6b8" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_47a42a3c-72c6-409b-8d93-089ef7206ab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_adda3617-eb0a-4204-b518-965ffed3750b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0b83aceb-0352-464d-a1b4-6f81a2ab79a4" xlink:to="loc_us-gaap_FinancialInstrumentAxis_adda3617-eb0a-4204-b518-965ffed3750b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9f0e33f6-f3d9-4698-b8ca-aa9e91d8cf53" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_adda3617-eb0a-4204-b518-965ffed3750b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9f0e33f6-f3d9-4698-b8ca-aa9e91d8cf53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_f3e11777-31e1-40bf-b188-275f20e3292d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9f0e33f6-f3d9-4698-b8ca-aa9e91d8cf53" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_f3e11777-31e1-40bf-b188-275f20e3292d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_c295393c-5e2b-4eab-a7ba-c69ea08e037b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9f0e33f6-f3d9-4698-b8ca-aa9e91d8cf53" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_c295393c-5e2b-4eab-a7ba-c69ea08e037b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_c8729c72-18ef-4a22-9faf-d1a56d2cd06a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9f0e33f6-f3d9-4698-b8ca-aa9e91d8cf53" xlink:to="loc_us-gaap_CommercialPaperMember_c8729c72-18ef-4a22-9faf-d1a56d2cd06a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_e3affcd1-3efb-4f11-857c-9d5d08b4f0a8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9f0e33f6-f3d9-4698-b8ca-aa9e91d8cf53" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_e3affcd1-3efb-4f11-857c-9d5d08b4f0a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ContingentValueRightLiabilityMember_19a8f813-79ac-4231-83ec-bbbca66f859d" xlink:href="syre-20250331.xsd#syre_ContingentValueRightLiabilityMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9f0e33f6-f3d9-4698-b8ca-aa9e91d8cf53" xlink:to="loc_syre_ContingentValueRightLiabilityMember_19a8f813-79ac-4231-83ec-bbbca66f859d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d26bfe5c-f5cb-4d21-abf6-b0c98881a4c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0b83aceb-0352-464d-a1b4-6f81a2ab79a4" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d26bfe5c-f5cb-4d21-abf6-b0c98881a4c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_a6d05888-9b8e-48f8-9f8d-8a1ed819555f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d26bfe5c-f5cb-4d21-abf6-b0c98881a4c8" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_a6d05888-9b8e-48f8-9f8d-8a1ed819555f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_b2be4c69-573c-41c8-adb8-346236e688fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_a6d05888-9b8e-48f8-9f8d-8a1ed819555f" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_b2be4c69-573c-41c8-adb8-346236e688fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_2a42534e-3a42-4852-87f7-0ff8c32d8af4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d26bfe5c-f5cb-4d21-abf6-b0c98881a4c8" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_2a42534e-3a42-4852-87f7-0ff8c32d8af4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_2ca93093-23ba-4ac4-8b94-c20afee848b8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_2a42534e-3a42-4852-87f7-0ff8c32d8af4" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_2ca93093-23ba-4ac4-8b94-c20afee848b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="syre-20250331.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://spyre.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_ef5c2c2b-33f1-4662-8d19-198392114e64" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3eb14b17-bc9d-4c34-bcf9-2b85fea41678" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ef5c2c2b-33f1-4662-8d19-198392114e64" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3eb14b17-bc9d-4c34-bcf9-2b85fea41678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_a96e1993-307c-48be-8894-db71021e3bea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3eb14b17-bc9d-4c34-bcf9-2b85fea41678" xlink:to="loc_us-gaap_AssetAcquisitionAxis_a96e1993-307c-48be-8894-db71021e3bea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_5cab2a28-694c-4ac1-bffd-6a0cd01ac0e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionAxis_a96e1993-307c-48be-8894-db71021e3bea" xlink:to="loc_us-gaap_AssetAcquisitionDomain_5cab2a28-694c-4ac1-bffd-6a0cd01ac0e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SpyreTherapeuticsIncMember_00f6db92-25f1-4e5c-906b-33f184c1bcac" xlink:href="syre-20250331.xsd#syre_SpyreTherapeuticsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_5cab2a28-694c-4ac1-bffd-6a0cd01ac0e8" xlink:to="loc_syre_SpyreTherapeuticsIncMember_00f6db92-25f1-4e5c-906b-33f184c1bcac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_b0861d08-2709-4395-b938-ab6806372508" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3eb14b17-bc9d-4c34-bcf9-2b85fea41678" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_b0861d08-2709-4395-b938-ab6806372508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3b23ea28-809a-4138-acbb-9c9f41fb4193" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_b0861d08-2709-4395-b938-ab6806372508" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3b23ea28-809a-4138-acbb-9c9f41fb4193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ContingentValueRightLiabilityMember_cbbc8b1f-8f7f-49c4-b01f-baf5f12d5393" xlink:href="syre-20250331.xsd#syre_ContingentValueRightLiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3b23ea28-809a-4138-acbb-9c9f41fb4193" xlink:to="loc_syre_ContingentValueRightLiabilityMember_cbbc8b1f-8f7f-49c4-b01f-baf5f12d5393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_05cd8ed8-8f37-416b-a446-fa05065ce2c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3eb14b17-bc9d-4c34-bcf9-2b85fea41678" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_05cd8ed8-8f37-416b-a446-fa05065ce2c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_AssetAcquisitionStockholderPaymentPeriod_3bb414d8-3cd0-4aeb-a434-e545a86237a2" xlink:href="syre-20250331.xsd#syre_AssetAcquisitionStockholderPaymentPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_05cd8ed8-8f37-416b-a446-fa05065ce2c5" xlink:to="loc_syre_AssetAcquisitionStockholderPaymentPeriod_3bb414d8-3cd0-4aeb-a434-e545a86237a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_AssetAcquisitionCashPaymentThresholdPeriod_3accfd0a-eed3-40eb-ad49-db82f28e8d27" xlink:href="syre-20250331.xsd#syre_AssetAcquisitionCashPaymentThresholdPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_05cd8ed8-8f37-416b-a446-fa05065ce2c5" xlink:to="loc_syre_AssetAcquisitionCashPaymentThresholdPeriod_3accfd0a-eed3-40eb-ad49-db82f28e8d27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_b528e6fe-e142-4d17-a8e9-fbb3f3531cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_05cd8ed8-8f37-416b-a446-fa05065ce2c5" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_b528e6fe-e142-4d17-a8e9-fbb3f3531cfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/FairValueMeasurementsSignificantInputsusedtoEstimatetheFairValueofDerivativeLiabilityDetails" xlink:type="simple" xlink:href="syre-20250331.xsd#FairValueMeasurementsSignificantInputsusedtoEstimatetheFairValueofDerivativeLiabilityDetails"/>
  <link:presentationLink xlink:role="http://spyre.com/role/FairValueMeasurementsSignificantInputsusedtoEstimatetheFairValueofDerivativeLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_244c0303-201a-491f-8a6a-61e8ac0658db" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_8faadaa3-deef-475d-994e-99ae08fb2347" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_244c0303-201a-491f-8a6a-61e8ac0658db" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_8faadaa3-deef-475d-994e-99ae08fb2347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_66247193-57cf-4add-919c-e27c827474df" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_8faadaa3-deef-475d-994e-99ae08fb2347" xlink:to="loc_srt_RangeAxis_66247193-57cf-4add-919c-e27c827474df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_37ee0014-7815-48dd-8929-117f4da4c5bd" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_66247193-57cf-4add-919c-e27c827474df" xlink:to="loc_srt_RangeMember_37ee0014-7815-48dd-8929-117f4da4c5bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_3d8bd844-8e56-4932-a53e-88c218284c37" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_37ee0014-7815-48dd-8929-117f4da4c5bd" xlink:to="loc_srt_MinimumMember_3d8bd844-8e56-4932-a53e-88c218284c37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b206534a-29f4-4b00-adb7-fc09e14628f8" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_37ee0014-7815-48dd-8929-117f4da4c5bd" xlink:to="loc_srt_MaximumMember_b206534a-29f4-4b00-adb7-fc09e14628f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_feb5418d-737e-4a7f-b273-94ac5ebcdfd4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_8faadaa3-deef-475d-994e-99ae08fb2347" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_feb5418d-737e-4a7f-b273-94ac5ebcdfd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5ed3145c-6e57-4380-8c87-4d25fb4e0b0d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_feb5418d-737e-4a7f-b273-94ac5ebcdfd4" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5ed3145c-6e57-4380-8c87-4d25fb4e0b0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_de4b3855-7d41-4d33-8cc2-50f235c8824a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5ed3145c-6e57-4380-8c87-4d25fb4e0b0d" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_de4b3855-7d41-4d33-8cc2-50f235c8824a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_006209f6-859a-48a7-8977-b1ddd9457dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_8faadaa3-deef-475d-994e-99ae08fb2347" xlink:to="loc_us-gaap_FinancialInstrumentAxis_006209f6-859a-48a7-8977-b1ddd9457dc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0cd48bde-c8c5-4ea0-a5e3-ff0b871cac82" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_006209f6-859a-48a7-8977-b1ddd9457dc4" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0cd48bde-c8c5-4ea0-a5e3-ff0b871cac82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ContingentValueRightLiabilityMember_c7f0068e-e85c-4132-8973-ee051470e8ba" xlink:href="syre-20250331.xsd#syre_ContingentValueRightLiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0cd48bde-c8c5-4ea0-a5e3-ff0b871cac82" xlink:to="loc_syre_ContingentValueRightLiabilityMember_c7f0068e-e85c-4132-8973-ee051470e8ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_50fe9839-06ae-413c-b5fc-a9a8b7998470" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_8faadaa3-deef-475d-994e-99ae08fb2347" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_50fe9839-06ae-413c-b5fc-a9a8b7998470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_ce4100d9-fe98-4eb0-b91d-45519eca7973" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_50fe9839-06ae-413c-b5fc-a9a8b7998470" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_ce4100d9-fe98-4eb0-b91d-45519eca7973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_MeasurementInputProabilityOfSuccessMember_3548bb38-555f-40f8-9613-dad032ad5c47" xlink:href="syre-20250331.xsd#syre_MeasurementInputProabilityOfSuccessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ce4100d9-fe98-4eb0-b91d-45519eca7973" xlink:to="loc_syre_MeasurementInputProabilityOfSuccessMember_3548bb38-555f-40f8-9613-dad032ad5c47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_MeasurementInputReimbursementRateMember_88840654-5d9e-431b-97f6-65eff7b9a518" xlink:href="syre-20250331.xsd#syre_MeasurementInputReimbursementRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ce4100d9-fe98-4eb0-b91d-45519eca7973" xlink:to="loc_syre_MeasurementInputReimbursementRateMember_88840654-5d9e-431b-97f6-65eff7b9a518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_d4973fb8-26dd-4e87-b63c-9fd0aa220607" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ce4100d9-fe98-4eb0-b91d-45519eca7973" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_d4973fb8-26dd-4e87-b63c-9fd0aa220607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_5eed6530-3a6c-409c-948a-dff7715afe9b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_8faadaa3-deef-475d-994e-99ae08fb2347" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_5eed6530-3a6c-409c-948a-dff7715afe9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_0fb33324-0502-4fbb-9a9a-beeb6084d644" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_5eed6530-3a6c-409c-948a-dff7715afe9b" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_0fb33324-0502-4fbb-9a9a-beeb6084d644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ContingentValueRightLiabilityMember_72edce2d-9fee-453c-9b0d-f58bfad3ef2a" xlink:href="syre-20250331.xsd#syre_ContingentValueRightLiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_0fb33324-0502-4fbb-9a9a-beeb6084d644" xlink:to="loc_syre_ContingentValueRightLiabilityMember_72edce2d-9fee-453c-9b0d-f58bfad3ef2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_49dce2fa-bba7-402a-8605-d60721b7dc40" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_8faadaa3-deef-475d-994e-99ae08fb2347" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_49dce2fa-bba7-402a-8605-d60721b7dc40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityMeasurementInput_bc418533-4e0e-4fdd-9f58-e890186cb2ad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilityMeasurementInput"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_49dce2fa-bba7-402a-8605-d60721b7dc40" xlink:to="loc_us-gaap_DerivativeLiabilityMeasurementInput_bc418533-4e0e-4fdd-9f58-e890186cb2ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/FairValueMeasurementsChangesinDerivativeLiabilitiesDetails" xlink:type="simple" xlink:href="syre-20250331.xsd#FairValueMeasurementsChangesinDerivativeLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://spyre.com/role/FairValueMeasurementsChangesinDerivativeLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_19608947-4eec-4ca9-adf1-3e4333182b2d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_bf424118-4e5f-4473-8ef5-e220d5c9ee9f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_19608947-4eec-4ca9-adf1-3e4333182b2d" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_bf424118-4e5f-4473-8ef5-e220d5c9ee9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_7503309c-1282-45ca-9424-ba0edf405176" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_bf424118-4e5f-4473-8ef5-e220d5c9ee9f" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_7503309c-1282-45ca-9424-ba0edf405176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f175ee72-f664-4083-b8e8-404f2cc6b7f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7503309c-1282-45ca-9424-ba0edf405176" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f175ee72-f664-4083-b8e8-404f2cc6b7f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ContingentValueRightLiabilityMember_420cb6e2-a221-49bd-8a7f-5d8d9ee0c12d" xlink:href="syre-20250331.xsd#syre_ContingentValueRightLiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f175ee72-f664-4083-b8e8-404f2cc6b7f9" xlink:to="loc_syre_ContingentValueRightLiabilityMember_420cb6e2-a221-49bd-8a7f-5d8d9ee0c12d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_a0db25e5-1362-4ec5-b222-ee3e81911853" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_bf424118-4e5f-4473-8ef5-e220d5c9ee9f" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_a0db25e5-1362-4ec5-b222-ee3e81911853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_93c745c6-cce5-4cdd-a415-56595099b357" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_a0db25e5-1362-4ec5-b222-ee3e81911853" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_93c745c6-cce5-4cdd-a415-56595099b357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_168ee38d-cea3-4f26-b967-a872738dca66" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_93c745c6-cce5-4cdd-a415-56595099b357" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_168ee38d-cea3-4f26-b967-a872738dca66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_0439a01d-c0e7-4b5c-8fb3-bd8e7345c67a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_93c745c6-cce5-4cdd-a415-56595099b357" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_0439a01d-c0e7-4b5c-8fb3-bd8e7345c67a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_22ef14a4-5491-44ed-be6f-46c758bf173f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_93c745c6-cce5-4cdd-a415-56595099b357" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_22ef14a4-5491-44ed-be6f-46c758bf173f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_15cbb33b-0882-4d32-851a-b548aea5b557" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_93c745c6-cce5-4cdd-a415-56595099b357" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_15cbb33b-0882-4d32-851a-b548aea5b557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/CashEquivalentsandMarketableSecuritiesEstimatedFairValueofCashEquivalentsandMarketableSecuritiesandtheGrossUnrealizedGainsandLossesDetails" xlink:type="simple" xlink:href="syre-20250331.xsd#CashEquivalentsandMarketableSecuritiesEstimatedFairValueofCashEquivalentsandMarketableSecuritiesandtheGrossUnrealizedGainsandLossesDetails"/>
  <link:presentationLink xlink:role="http://spyre.com/role/CashEquivalentsandMarketableSecuritiesEstimatedFairValueofCashEquivalentsandMarketableSecuritiesandtheGrossUnrealizedGainsandLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_53c83802-dfe7-4368-ab10-30dad91d3ea1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_2d29574c-de43-4360-8664-452e6767b134" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_53c83802-dfe7-4368-ab10-30dad91d3ea1" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_2d29574c-de43-4360-8664-452e6767b134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_79b75ac4-405c-4dba-b831-7750c46df391" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_2d29574c-de43-4360-8664-452e6767b134" xlink:to="loc_us-gaap_FinancialInstrumentAxis_79b75ac4-405c-4dba-b831-7750c46df391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cee16247-503a-4583-9d70-a551e745e791" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_79b75ac4-405c-4dba-b831-7750c46df391" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cee16247-503a-4583-9d70-a551e745e791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_75fc2697-90c4-4f79-a367-bc3e5f951583" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cee16247-503a-4583-9d70-a551e745e791" xlink:to="loc_us-gaap_MoneyMarketFundsMember_75fc2697-90c4-4f79-a367-bc3e5f951583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_7b9cbef8-4d6e-4e61-a193-949cdf9dc78f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cee16247-503a-4583-9d70-a551e745e791" xlink:to="loc_us-gaap_CommercialPaperMember_7b9cbef8-4d6e-4e61-a193-949cdf9dc78f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_2adceef2-522b-4cb8-9022-64d5504d8cdd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cee16247-503a-4583-9d70-a551e745e791" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_2adceef2-522b-4cb8-9022-64d5504d8cdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_784a28f4-648d-4528-bc37-6b3d39d581ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cee16247-503a-4583-9d70-a551e745e791" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_784a28f4-648d-4528-bc37-6b3d39d581ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_bbf9375a-3a19-4ab3-a423-110a451182fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cee16247-503a-4583-9d70-a551e745e791" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_bbf9375a-3a19-4ab3-a423-110a451182fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_51b8777a-0f62-4362-ad96-cac9a095055d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_2d29574c-de43-4360-8664-452e6767b134" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_51b8777a-0f62-4362-ad96-cac9a095055d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_b503e5d4-f071-4d1b-83fb-5b5fecb38710" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_51b8777a-0f62-4362-ad96-cac9a095055d" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_b503e5d4-f071-4d1b-83fb-5b5fecb38710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_CashEquivalentsUnrealizedGains_7fcda4ac-c669-46a6-8256-882c4cf3f566" xlink:href="syre-20250331.xsd#syre_CashEquivalentsUnrealizedGains"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_51b8777a-0f62-4362-ad96-cac9a095055d" xlink:to="loc_syre_CashEquivalentsUnrealizedGains_7fcda4ac-c669-46a6-8256-882c4cf3f566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_CashEquivalentsUnrealizedLosses_44f4b7b4-1dbe-439b-bd26-b4599640f6b1" xlink:href="syre-20250331.xsd#syre_CashEquivalentsUnrealizedLosses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_51b8777a-0f62-4362-ad96-cac9a095055d" xlink:to="loc_syre_CashEquivalentsUnrealizedLosses_44f4b7b4-1dbe-439b-bd26-b4599640f6b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_4e7c56be-5846-4599-9944-be8b6cb8d38d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_51b8777a-0f62-4362-ad96-cac9a095055d" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_4e7c56be-5846-4599-9944-be8b6cb8d38d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_5e19230c-5000-47db-a4f7-e1b29f629896" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_51b8777a-0f62-4362-ad96-cac9a095055d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_5e19230c-5000-47db-a4f7-e1b29f629896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_d76f8a4f-eb64-47b7-b3aa-30f29bd8dd9d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_51b8777a-0f62-4362-ad96-cac9a095055d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_d76f8a4f-eb64-47b7-b3aa-30f29bd8dd9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_3e3325ee-aaa6-4cc3-9a9e-f548119c9ca4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_51b8777a-0f62-4362-ad96-cac9a095055d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_3e3325ee-aaa6-4cc3-9a9e-f548119c9ca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_91dceea7-3a29-442e-958b-e442f389fec4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_51b8777a-0f62-4362-ad96-cac9a095055d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_91dceea7-3a29-442e-958b-e442f389fec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/CashEquivalentsandMarketableSecuritiesAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="syre-20250331.xsd#CashEquivalentsandMarketableSecuritiesAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails"/>
  <link:presentationLink xlink:role="http://spyre.com/role/CashEquivalentsandMarketableSecuritiesAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_af45deb0-1f46-476a-a645-64ae3f5f471c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_86a4ec57-e29d-4023-9a8b-db69ecc7a02e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_af45deb0-1f46-476a-a645-64ae3f5f471c" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_86a4ec57-e29d-4023-9a8b-db69ecc7a02e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_23fad563-8e38-4bd8-b18e-7c7228b263fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_86a4ec57-e29d-4023-9a8b-db69ecc7a02e" xlink:to="loc_us-gaap_FinancialInstrumentAxis_23fad563-8e38-4bd8-b18e-7c7228b263fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2eb907d4-78e0-4838-aa1c-47924d1fb6e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_23fad563-8e38-4bd8-b18e-7c7228b263fe" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2eb907d4-78e0-4838-aa1c-47924d1fb6e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_e5e45131-3697-42fc-b301-3e19ec715dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2eb907d4-78e0-4838-aa1c-47924d1fb6e2" xlink:to="loc_us-gaap_CommercialPaperMember_e5e45131-3697-42fc-b301-3e19ec715dfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_ad650488-1b47-4e1d-bcff-0f642d8d5e74" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2eb907d4-78e0-4838-aa1c-47924d1fb6e2" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_ad650488-1b47-4e1d-bcff-0f642d8d5e74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_b29349b0-4ac7-46d8-99f3-4280f2c64b1d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2eb907d4-78e0-4838-aa1c-47924d1fb6e2" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_b29349b0-4ac7-46d8-99f3-4280f2c64b1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_40f63275-c547-450d-b674-7b2b0165d88d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2eb907d4-78e0-4838-aa1c-47924d1fb6e2" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_40f63275-c547-450d-b674-7b2b0165d88d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f6b05e9e-d899-4992-b6d5-f099696585a5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_86a4ec57-e29d-4023-9a8b-db69ecc7a02e" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f6b05e9e-d899-4992-b6d5-f099696585a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_62ad76b8-33ac-427a-a3fb-ec0bca7af70e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f6b05e9e-d899-4992-b6d5-f099696585a5" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_62ad76b8-33ac-427a-a3fb-ec0bca7af70e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_ff3f4276-528f-45a9-b52f-07e4088fb83d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_62ad76b8-33ac-427a-a3fb-ec0bca7af70e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_ff3f4276-528f-45a9-b52f-07e4088fb83d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_f4ce9528-91e3-4a2e-85ac-57590176f085" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_62ad76b8-33ac-427a-a3fb-ec0bca7af70e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_f4ce9528-91e3-4a2e-85ac-57590176f085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_5eb884df-fcda-4c3d-8994-4f5a0dd15fac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_62ad76b8-33ac-427a-a3fb-ec0bca7af70e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_5eb884df-fcda-4c3d-8994-4f5a0dd15fac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableforSaleUnrealizedLossPositionAbstract_e4c9b20f-e703-4d7b-94f7-9b3bfa160d71" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableforSaleUnrealizedLossPositionAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f6b05e9e-d899-4992-b6d5-f099696585a5" xlink:to="loc_us-gaap_DebtSecuritiesAvailableforSaleUnrealizedLossPositionAbstract_e4c9b20f-e703-4d7b-94f7-9b3bfa160d71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_f152b8b6-d8ac-4926-83d1-59446e69b1de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforSaleUnrealizedLossPositionAbstract_e4c9b20f-e703-4d7b-94f7-9b3bfa160d71" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_f152b8b6-d8ac-4926-83d1-59446e69b1de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_c4c179dd-aa4d-40e1-848f-d81c46a5a1b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforSaleUnrealizedLossPositionAbstract_e4c9b20f-e703-4d7b-94f7-9b3bfa160d71" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_c4c179dd-aa4d-40e1-848f-d81c46a5a1b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_82c2a392-1cad-4ef5-8f29-bed6d84990f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforSaleUnrealizedLossPositionAbstract_e4c9b20f-e703-4d7b-94f7-9b3bfa160d71" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_82c2a392-1cad-4ef5-8f29-bed6d84990f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/CashEquivalentsandMarketableSecuritiesNarrativeDetails" xlink:type="simple" xlink:href="syre-20250331.xsd#CashEquivalentsandMarketableSecuritiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://spyre.com/role/CashEquivalentsandMarketableSecuritiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_d38b0009-abcc-4079-900b-32cb46ab0376" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_CashEquivalentsAndMarketableSecuritiesTable_385729d3-59a0-45cf-8d2f-33f484ee4186" xlink:href="syre-20250331.xsd#syre_CashEquivalentsAndMarketableSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_d38b0009-abcc-4079-900b-32cb46ab0376" xlink:to="loc_syre_CashEquivalentsAndMarketableSecuritiesTable_385729d3-59a0-45cf-8d2f-33f484ee4186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_d9a713d2-cd20-4a15-8c33-e36d92993d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_CashEquivalentsAndMarketableSecuritiesTable_385729d3-59a0-45cf-8d2f-33f484ee4186" xlink:to="loc_us-gaap_FinancialInstrumentAxis_d9a713d2-cd20-4a15-8c33-e36d92993d3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2a5af159-30ec-492a-b032-8c4391277993" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_d9a713d2-cd20-4a15-8c33-e36d92993d3e" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2a5af159-30ec-492a-b032-8c4391277993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_e84c46f9-33a0-4a1f-b1fb-b5c280c7faf7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2a5af159-30ec-492a-b032-8c4391277993" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_e84c46f9-33a0-4a1f-b1fb-b5c280c7faf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_USBankingInstitutionMember_2c490142-44fe-4ddd-a55b-93db313b2100" xlink:href="syre-20250331.xsd#syre_USBankingInstitutionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2a5af159-30ec-492a-b032-8c4391277993" xlink:to="loc_syre_USBankingInstitutionMember_2c490142-44fe-4ddd-a55b-93db313b2100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_aca45c8a-65de-4028-97fb-fb7c84b9ee81" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_CashEquivalentsAndMarketableSecuritiesTable_385729d3-59a0-45cf-8d2f-33f484ee4186" xlink:to="loc_srt_RangeAxis_aca45c8a-65de-4028-97fb-fb7c84b9ee81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_819b90f8-b5c9-4b13-b324-7cbb78a6dedd" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_aca45c8a-65de-4028-97fb-fb7c84b9ee81" xlink:to="loc_srt_RangeMember_819b90f8-b5c9-4b13-b324-7cbb78a6dedd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ea2f97f9-8d5e-4ce2-8f08-887023c69b02" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_819b90f8-b5c9-4b13-b324-7cbb78a6dedd" xlink:to="loc_srt_MaximumMember_ea2f97f9-8d5e-4ce2-8f08-887023c69b02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_CashEquivalentsAndMarketableSecuritiesLineItems_96906b74-4e2a-44f6-8154-ba447dba8b77" xlink:href="syre-20250331.xsd#syre_CashEquivalentsAndMarketableSecuritiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_CashEquivalentsAndMarketableSecuritiesTable_385729d3-59a0-45cf-8d2f-33f484ee4186" xlink:to="loc_syre_CashEquivalentsAndMarketableSecuritiesLineItems_96906b74-4e2a-44f6-8154-ba447dba8b77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_c8dedc78-728d-4d08-8565-e63dedd3e3b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_CashEquivalentsAndMarketableSecuritiesLineItems_96906b74-4e2a-44f6-8154-ba447dba8b77" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_c8dedc78-728d-4d08-8565-e63dedd3e3b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ImpairmentOfMarketableSecurities_8242afe3-125b-4fc2-92ad-49cb33e8c9b9" xlink:href="syre-20250331.xsd#syre_ImpairmentOfMarketableSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_CashEquivalentsAndMarketableSecuritiesLineItems_96906b74-4e2a-44f6-8154-ba447dba8b77" xlink:to="loc_syre_ImpairmentOfMarketableSecurities_8242afe3-125b-4fc2-92ad-49cb33e8c9b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_NumberOfDomesticBankingInstitutions_692d7abf-191d-4500-a790-b4951bd48a4b" xlink:href="syre-20250331.xsd#syre_NumberOfDomesticBankingInstitutions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_CashEquivalentsAndMarketableSecuritiesLineItems_96906b74-4e2a-44f6-8154-ba447dba8b77" xlink:to="loc_syre_NumberOfDomesticBankingInstitutions_692d7abf-191d-4500-a790-b4951bd48a4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFDICInsuredAmount_343f1059-125b-42db-a262-8dbc13cd2898" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFDICInsuredAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_CashEquivalentsAndMarketableSecuritiesLineItems_96906b74-4e2a-44f6-8154-ba447dba8b77" xlink:to="loc_us-gaap_CashFDICInsuredAmount_343f1059-125b-42db-a262-8dbc13cd2898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments_7c5f260a-55d7-4b74-881c-7d98f72150c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_CashEquivalentsAndMarketableSecuritiesLineItems_96906b74-4e2a-44f6-8154-ba447dba8b77" xlink:to="loc_us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments_7c5f260a-55d7-4b74-881c-7d98f72150c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivable_36e8ad78-4701-4adf-a3df-7ca87e2c9e13" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestReceivable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_CashEquivalentsAndMarketableSecuritiesLineItems_96906b74-4e2a-44f6-8154-ba447dba8b77" xlink:to="loc_us-gaap_InterestReceivable_36e8ad78-4701-4adf-a3df-7ca87e2c9e13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/CashEquivalentsandMarketableSecuritiesContractualMaturitiesofMarketableSecuritiesatEstimatedFairValueDetails" xlink:type="simple" xlink:href="syre-20250331.xsd#CashEquivalentsandMarketableSecuritiesContractualMaturitiesofMarketableSecuritiesatEstimatedFairValueDetails"/>
  <link:presentationLink xlink:role="http://spyre.com/role/CashEquivalentsandMarketableSecuritiesContractualMaturitiesofMarketableSecuritiesatEstimatedFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_d3060b40-ab1d-419c-9a7a-75b3db0a685a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_a2db5d7c-36e0-46fa-a1bd-fb272ca972ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_d3060b40-ab1d-419c-9a7a-75b3db0a685a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_a2db5d7c-36e0-46fa-a1bd-fb272ca972ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOne_f66cb370-5177-4c4c-94de-96ec9e628ea2" xlink:href="syre-20250331.xsd#syre_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOne"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_d3060b40-ab1d-419c-9a7a-75b3db0a685a" xlink:to="loc_syre_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOne_f66cb370-5177-4c4c-94de-96ec9e628ea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_bf2d4135-b810-4efb-ba72-53b09916c1e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_d3060b40-ab1d-419c-9a7a-75b3db0a685a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_bf2d4135-b810-4efb-ba72-53b09916c1e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/AccruedandOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="syre-20250331.xsd#AccruedandOtherCurrentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://spyre.com/role/AccruedandOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_fba1cb4e-03f2-4dd5-bd2c-4aa56197b946" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent_9c1ae77a-98f5-4ad5-abb1-4153c0058e07" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_fba1cb4e-03f2-4dd5-bd2c-4aa56197b946" xlink:to="loc_us-gaap_AccruedSalariesCurrent_9c1ae77a-98f5-4ad5-abb1-4153c0058e07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_AccruedContractedResearchAndDevelopmentCosts_211842eb-1172-43f2-af8f-b3bd89b6d4ae" xlink:href="syre-20250331.xsd#syre_AccruedContractedResearchAndDevelopmentCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_fba1cb4e-03f2-4dd5-bd2c-4aa56197b946" xlink:to="loc_syre_AccruedContractedResearchAndDevelopmentCosts_211842eb-1172-43f2-af8f-b3bd89b6d4ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_53420622-25a1-42b4-bdc0-c0b22eb5683f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_fba1cb4e-03f2-4dd5-bd2c-4aa56197b946" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_53420622-25a1-42b4-bdc0-c0b22eb5683f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_5727bca0-fa95-4d70-b619-910062fec60b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_fba1cb4e-03f2-4dd5-bd2c-4aa56197b946" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_5727bca0-fa95-4d70-b619-910062fec60b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_583db62d-34e5-4865-a83e-cac3bfafe855" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_fba1cb4e-03f2-4dd5-bd2c-4aa56197b946" xlink:to="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_583db62d-34e5-4865-a83e-cac3bfafe855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/LicensingAgreementsDetails" xlink:type="simple" xlink:href="syre-20250331.xsd#LicensingAgreementsDetails"/>
  <link:presentationLink xlink:role="http://spyre.com/role/LicensingAgreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_syre_LicensingAgreementsAbstract_c8a692e6-9729-4fbb-b83c-d395f6bb6e12" xlink:href="syre-20250331.xsd#syre_LicensingAgreementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_b621ffcf-f318-43be-b892-6e4c9a3de04b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_LicensingAgreementsAbstract_c8a692e6-9729-4fbb-b83c-d395f6bb6e12" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_b621ffcf-f318-43be-b892-6e4c9a3de04b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8cb8fb4f-797f-4e28-bcac-f16201ee0af9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_b621ffcf-f318-43be-b892-6e4c9a3de04b" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8cb8fb4f-797f-4e28-bcac-f16201ee0af9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_f8e4c432-f819-4b57-9435-511347a95063" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8cb8fb4f-797f-4e28-bcac-f16201ee0af9" xlink:to="loc_us-gaap_RelatedPartyDomain_f8e4c432-f819-4b57-9435-511347a95063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_e254df44-be81-45f3-81b6-8d3218ed5bbd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_f8e4c432-f819-4b57-9435-511347a95063" xlink:to="loc_us-gaap_RelatedPartyMember_e254df44-be81-45f3-81b6-8d3218ed5bbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_2c295680-6734-448c-995b-084b890b64a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_b621ffcf-f318-43be-b892-6e4c9a3de04b" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_2c295680-6734-448c-995b-084b890b64a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_3b220e27-2766-43ee-905e-78fae4ba864a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_2c295680-6734-448c-995b-084b890b64a9" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_3b220e27-2766-43ee-905e-78fae4ba864a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ParagonAgreementMember_00c3daf5-d9f3-4e53-961a-895c88287939" xlink:href="syre-20250331.xsd#syre_ParagonAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_3b220e27-2766-43ee-905e-78fae4ba864a" xlink:to="loc_syre_ParagonAgreementMember_00c3daf5-d9f3-4e53-961a-895c88287939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_Spy001LicenseAgreementMember_da5f6f74-0247-445e-864e-0028c75c0afa" xlink:href="syre-20250331.xsd#syre_Spy001LicenseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_ParagonAgreementMember_00c3daf5-d9f3-4e53-961a-895c88287939" xlink:to="loc_syre_Spy001LicenseAgreementMember_da5f6f74-0247-445e-864e-0028c75c0afa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SPY002LicenseAgreementMember_a12b6e98-6b1a-4d21-bdc1-330e9adce975" xlink:href="syre-20250331.xsd#syre_SPY002LicenseAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_ParagonAgreementMember_00c3daf5-d9f3-4e53-961a-895c88287939" xlink:to="loc_syre_SPY002LicenseAgreementMember_a12b6e98-6b1a-4d21-bdc1-330e9adce975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SPY003LicenseAgreementMember_646ab207-c44d-4d09-a335-297c01d4730d" xlink:href="syre-20250331.xsd#syre_SPY003LicenseAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_ParagonAgreementMember_00c3daf5-d9f3-4e53-961a-895c88287939" xlink:to="loc_syre_SPY003LicenseAgreementMember_646ab207-c44d-4d09-a335-297c01d4730d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ParagonAgreementLicenseMilestonePaymentsMember_578c3460-93c3-47cd-b5fd-47b994a972ec" xlink:href="syre-20250331.xsd#syre_ParagonAgreementLicenseMilestonePaymentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_ParagonAgreementMember_00c3daf5-d9f3-4e53-961a-895c88287939" xlink:to="loc_syre_ParagonAgreementLicenseMilestonePaymentsMember_578c3460-93c3-47cd-b5fd-47b994a972ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0dbd4ce2-c1dd-4d14-b791-c967cd2002d2" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_b621ffcf-f318-43be-b892-6e4c9a3de04b" xlink:to="loc_srt_RangeAxis_0dbd4ce2-c1dd-4d14-b791-c967cd2002d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_15e3bceb-f36f-43c4-9ea4-ccb164c9561c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_0dbd4ce2-c1dd-4d14-b791-c967cd2002d2" xlink:to="loc_srt_RangeMember_15e3bceb-f36f-43c4-9ea4-ccb164c9561c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_700f97e4-0e4c-4158-a49a-e019885d1478" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_15e3bceb-f36f-43c4-9ea4-ccb164c9561c" xlink:to="loc_srt_MaximumMember_700f97e4-0e4c-4158-a49a-e019885d1478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_d9060080-65d4-42ea-83a5-9d732701d3c2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_b621ffcf-f318-43be-b892-6e4c9a3de04b" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_d9060080-65d4-42ea-83a5-9d732701d3c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_AmountToBePaidUnderAgreement_1e281a54-085f-4010-ad9f-38ebff1d4ff9" xlink:href="syre-20250331.xsd#syre_AmountToBePaidUnderAgreement"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d9060080-65d4-42ea-83a5-9d732701d3c2" xlink:to="loc_syre_AmountToBePaidUnderAgreement_1e281a54-085f-4010-ad9f-38ebff1d4ff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_PaymentOfMilestone_651bdebe-16b6-4628-be68-2ffedd54c1b4" xlink:href="syre-20250331.xsd#syre_PaymentOfMilestone"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d9060080-65d4-42ea-83a5-9d732701d3c2" xlink:to="loc_syre_PaymentOfMilestone_651bdebe-16b6-4628-be68-2ffedd54c1b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_CampaignTimelineMinimumTerm_6eba0faa-4654-4193-b8cc-f38bebde23bc" xlink:href="syre-20250331.xsd#syre_CampaignTimelineMinimumTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d9060080-65d4-42ea-83a5-9d732701d3c2" xlink:to="loc_syre_CampaignTimelineMinimumTerm_6eba0faa-4654-4193-b8cc-f38bebde23bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_RoyaltyStepDownPercent_b1d9ede5-16da-4884-b8a2-9ccf6fa87a69" xlink:href="syre-20250331.xsd#syre_RoyaltyStepDownPercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d9060080-65d4-42ea-83a5-9d732701d3c2" xlink:to="loc_syre_RoyaltyStepDownPercent_b1d9ede5-16da-4884-b8a2-9ccf6fa87a69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_RoyaltyTermExpirationPeriod_161587ea-ac46-4ecb-9c36-b5cd9948d62e" xlink:href="syre-20250331.xsd#syre_RoyaltyTermExpirationPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d9060080-65d4-42ea-83a5-9d732701d3c2" xlink:to="loc_syre_RoyaltyTermExpirationPeriod_161587ea-ac46-4ecb-9c36-b5cd9948d62e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_TerminationNoticePeriod_6b2527f3-1bfd-4aad-8379-00c8f30a97a9" xlink:href="syre-20250331.xsd#syre_TerminationNoticePeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d9060080-65d4-42ea-83a5-9d732701d3c2" xlink:to="loc_syre_TerminationNoticePeriod_6b2527f3-1bfd-4aad-8379-00c8f30a97a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SublicensingFee_636e1b95-8692-41a5-93d7-1ee21f15396f" xlink:href="syre-20250331.xsd#syre_SublicensingFee"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d9060080-65d4-42ea-83a5-9d732701d3c2" xlink:to="loc_syre_SublicensingFee_636e1b95-8692-41a5-93d7-1ee21f15396f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_LicenseAgreementMilestoneExpenseAmountRecognized_9cfde962-157d-4843-9559-31a37d2d83c8" xlink:href="syre-20250331.xsd#syre_LicenseAgreementMilestoneExpenseAmountRecognized"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d9060080-65d4-42ea-83a5-9d732701d3c2" xlink:to="loc_syre_LicenseAgreementMilestoneExpenseAmountRecognized_9cfde962-157d-4843-9559-31a37d2d83c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_LicenseAgreementMilestonePayments_dd2fa04c-a0d4-4d96-a5cd-a736c3c8b6f6" xlink:href="syre-20250331.xsd#syre_LicenseAgreementMilestonePayments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d9060080-65d4-42ea-83a5-9d732701d3c2" xlink:to="loc_syre_LicenseAgreementMilestonePayments_dd2fa04c-a0d4-4d96-a5cd-a736c3c8b6f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_LicenseAgreementMilestonePaymentsOutstandingAndPayable_0214bd17-bb7d-49ce-a567-f264659128b4" xlink:href="syre-20250331.xsd#syre_LicenseAgreementMilestonePaymentsOutstandingAndPayable"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d9060080-65d4-42ea-83a5-9d732701d3c2" xlink:to="loc_syre_LicenseAgreementMilestonePaymentsOutstandingAndPayable_0214bd17-bb7d-49ce-a567-f264659128b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_PaymentForSublicensingFee_fbcfc7bc-83e4-46fd-b964-78bc9c366faf" xlink:href="syre-20250331.xsd#syre_PaymentForSublicensingFee"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d9060080-65d4-42ea-83a5-9d732701d3c2" xlink:to="loc_syre_PaymentForSublicensingFee_fbcfc7bc-83e4-46fd-b964-78bc9c366faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SublicensingFeeOutstandingAndPayable_e3ea7b41-214c-4994-97be-733774a2bfb7" xlink:href="syre-20250331.xsd#syre_SublicensingFeeOutstandingAndPayable"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d9060080-65d4-42ea-83a5-9d732701d3c2" xlink:to="loc_syre_SublicensingFeeOutstandingAndPayable_e3ea7b41-214c-4994-97be-733774a2bfb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/RelatedPartyTransactionsNarrativeDetails" xlink:type="simple" xlink:href="syre-20250331.xsd#RelatedPartyTransactionsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://spyre.com/role/RelatedPartyTransactionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_793cc3ac-5b7a-4ebd-9437-a4b746bdb3c9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_fab21d49-b362-4ca8-8008-754a688bbd7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_793cc3ac-5b7a-4ebd-9437-a4b746bdb3c9" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_fab21d49-b362-4ca8-8008-754a688bbd7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_31eed31d-96a4-4537-b129-58d30851dc89" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_fab21d49-b362-4ca8-8008-754a688bbd7d" xlink:to="loc_srt_OwnershipAxis_31eed31d-96a4-4537-b129-58d30851dc89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_ba0e348e-c2a8-44bd-b64a-5e1c298cc534" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_31eed31d-96a4-4537-b129-58d30851dc89" xlink:to="loc_srt_OwnershipDomain_ba0e348e-c2a8-44bd-b64a-5e1c298cc534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ParagonTherapeuticsIncMember_de10426b-4077-4caa-908a-413fef74750e" xlink:href="syre-20250331.xsd#syre_ParagonTherapeuticsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_ba0e348e-c2a8-44bd-b64a-5e1c298cc534" xlink:to="loc_syre_ParagonTherapeuticsIncMember_de10426b-4077-4caa-908a-413fef74750e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_FairmountFundsManagementLlcMember_aa41d8f2-07f3-4ca9-a95e-51efca247553" xlink:href="syre-20250331.xsd#syre_FairmountFundsManagementLlcMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_ba0e348e-c2a8-44bd-b64a-5e1c298cc534" xlink:to="loc_syre_FairmountFundsManagementLlcMember_aa41d8f2-07f3-4ca9-a95e-51efca247553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_df2a7799-fb71-4b83-ac52-0960e964d3be" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_fab21d49-b362-4ca8-8008-754a688bbd7d" xlink:to="loc_srt_RangeAxis_df2a7799-fb71-4b83-ac52-0960e964d3be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a42a4031-58d2-4a90-a10d-820fe9df7df7" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_df2a7799-fb71-4b83-ac52-0960e964d3be" xlink:to="loc_srt_RangeMember_a42a4031-58d2-4a90-a10d-820fe9df7df7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3d4a245f-1074-438e-b5d9-eb7ae0da7c9c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a42a4031-58d2-4a90-a10d-820fe9df7df7" xlink:to="loc_srt_MaximumMember_3d4a245f-1074-438e-b5d9-eb7ae0da7c9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_bf45e046-bc8a-4489-9c76-6c7cc97e21f0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a42a4031-58d2-4a90-a10d-820fe9df7df7" xlink:to="loc_srt_MinimumMember_bf45e046-bc8a-4489-9c76-6c7cc97e21f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_8fe14d85-d0c5-4c19-806c-ca342e2ac936" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_fab21d49-b362-4ca8-8008-754a688bbd7d" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_8fe14d85-d0c5-4c19-806c-ca342e2ac936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_0cb7f186-f230-49ff-9dd4-66c251e7392a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_8fe14d85-d0c5-4c19-806c-ca342e2ac936" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_0cb7f186-f230-49ff-9dd4-66c251e7392a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ParagonAgreementMember_1a1f7d21-0c50-4ee1-ab96-a12d6727d118" xlink:href="syre-20250331.xsd#syre_ParagonAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_0cb7f186-f230-49ff-9dd4-66c251e7392a" xlink:to="loc_syre_ParagonAgreementMember_1a1f7d21-0c50-4ee1-ab96-a12d6727d118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_AppointOfBoardMembersMember_c14e5da0-9d68-4872-833d-569ec11b4654" xlink:href="syre-20250331.xsd#syre_AppointOfBoardMembersMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_0cb7f186-f230-49ff-9dd4-66c251e7392a" xlink:to="loc_syre_AppointOfBoardMembersMember_c14e5da0-9d68-4872-833d-569ec11b4654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ParagonAgreementSubsequentToAssetAcquisitionMember_780774e4-7f19-43c1-b8db-4e30bea1df28" xlink:href="syre-20250331.xsd#syre_ParagonAgreementSubsequentToAssetAcquisitionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_0cb7f186-f230-49ff-9dd4-66c251e7392a" xlink:to="loc_syre_ParagonAgreementSubsequentToAssetAcquisitionMember_780774e4-7f19-43c1-b8db-4e30bea1df28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ConsultingAgreementMember_453a23c8-c963-403f-ae65-bd063fa7a5f7" xlink:href="syre-20250331.xsd#syre_ConsultingAgreementMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_0cb7f186-f230-49ff-9dd4-66c251e7392a" xlink:to="loc_syre_ConsultingAgreementMember_453a23c8-c963-403f-ae65-bd063fa7a5f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_12c9c6f1-d2b5-49a0-8e37-4dcd2586e191" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_fab21d49-b362-4ca8-8008-754a688bbd7d" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_12c9c6f1-d2b5-49a0-8e37-4dcd2586e191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_c421efe2-175e-4d71-8eea-2d03b43ee7f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_12c9c6f1-d2b5-49a0-8e37-4dcd2586e191" xlink:to="loc_us-gaap_RelatedPartyDomain_c421efe2-175e-4d71-8eea-2d03b43ee7f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_8495c46c-5369-4238-b0bb-9e8f7618bf80" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_c421efe2-175e-4d71-8eea-2d03b43ee7f6" xlink:to="loc_us-gaap_RelatedPartyMember_8495c46c-5369-4238-b0bb-9e8f7618bf80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_d017568f-82de-43f7-a1cc-01cdaba7578f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_fab21d49-b362-4ca8-8008-754a688bbd7d" xlink:to="loc_us-gaap_PlanNameAxis_d017568f-82de-43f7-a1cc-01cdaba7578f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_1470e276-f484-4deb-a140-0eab52afbb20" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_d017568f-82de-43f7-a1cc-01cdaba7578f" xlink:to="loc_us-gaap_PlanNameDomain_1470e276-f484-4deb-a140-0eab52afbb20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ParapyreOptionObligationMember_a6755b5d-81a6-4c6f-aac3-0baf8a4c132c" xlink:href="syre-20250331.xsd#syre_ParapyreOptionObligationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_1470e276-f484-4deb-a140-0eab52afbb20" xlink:to="loc_syre_ParapyreOptionObligationMember_a6755b5d-81a6-4c6f-aac3-0baf8a4c132c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_79e95d17-2d12-4507-87b5-0f07f972fe4f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_fab21d49-b362-4ca8-8008-754a688bbd7d" xlink:to="loc_us-gaap_VestingAxis_79e95d17-2d12-4507-87b5-0f07f972fe4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_368b862d-05b9-4f21-92f9-0d6394863433" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_79e95d17-2d12-4507-87b5-0f07f972fe4f" xlink:to="loc_us-gaap_VestingDomain_368b862d-05b9-4f21-92f9-0d6394863433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_00d978c8-7ee1-40d0-a38e-9315df8850fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_368b862d-05b9-4f21-92f9-0d6394863433" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_00d978c8-7ee1-40d0-a38e-9315df8850fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_f8927fe6-a392-47e8-b63e-19e596a38a84" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_fab21d49-b362-4ca8-8008-754a688bbd7d" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_f8927fe6-a392-47e8-b63e-19e596a38a84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_48ac1301-87af-4013-9623-c177250a5bed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_f8927fe6-a392-47e8-b63e-19e596a38a84" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_48ac1301-87af-4013-9623-c177250a5bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_RelatedPartyTransactionNumberOfBoardSeats_01af8638-7d07-411e-ab38-aab43fe72f8d" xlink:href="syre-20250331.xsd#syre_RelatedPartyTransactionNumberOfBoardSeats"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_f8927fe6-a392-47e8-b63e-19e596a38a84" xlink:to="loc_syre_RelatedPartyTransactionNumberOfBoardSeats_01af8638-7d07-411e-ab38-aab43fe72f8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_MinorityInterestOwnershipPercentageByNoncontrollingOwnersHeldInThirdParty_688e7eca-2556-4f54-989e-26a02604e794" xlink:href="syre-20250331.xsd#syre_MinorityInterestOwnershipPercentageByNoncontrollingOwnersHeldInThirdParty"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_f8927fe6-a392-47e8-b63e-19e596a38a84" xlink:to="loc_syre_MinorityInterestOwnershipPercentageByNoncontrollingOwnersHeldInThirdParty_688e7eca-2556-4f54-989e-26a02604e794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_DevelopmentCostReductionPercentage_ee1c42d8-8852-43f5-a9a8-3101a57791bf" xlink:href="syre-20250331.xsd#syre_DevelopmentCostReductionPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_f8927fe6-a392-47e8-b63e-19e596a38a84" xlink:to="loc_syre_DevelopmentCostReductionPercentage_ee1c42d8-8852-43f5-a9a8-3101a57791bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_DevelopmentCostReimbursementPercentage_f884d062-fcd1-4449-b63a-0758608ec16f" xlink:href="syre-20250331.xsd#syre_DevelopmentCostReimbursementPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_f8927fe6-a392-47e8-b63e-19e596a38a84" xlink:to="loc_syre_DevelopmentCostReimbursementPercentage_f884d062-fcd1-4449-b63a-0758608ec16f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_80db7726-3eba-4704-88ab-2a3520c41722" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_f8927fe6-a392-47e8-b63e-19e596a38a84" xlink:to="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_80db7726-3eba-4704-88ab-2a3520c41722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_470533e6-4a29-4df5-b662-dbd943859151" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_f8927fe6-a392-47e8-b63e-19e596a38a84" xlink:to="loc_us-gaap_ShareBasedCompensation_470533e6-4a29-4df5-b662-dbd943859151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_CommonStockSharesOutstandingPercentageAvailableToPurchaseOnADilutedBasis_b6dec537-e507-4b1f-8d6a-f1ad2ff7a5d9" xlink:href="syre-20250331.xsd#syre_CommonStockSharesOutstandingPercentageAvailableToPurchaseOnADilutedBasis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_f8927fe6-a392-47e8-b63e-19e596a38a84" xlink:to="loc_syre_CommonStockSharesOutstandingPercentageAvailableToPurchaseOnADilutedBasis_b6dec537-e507-4b1f-8d6a-f1ad2ff7a5d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_4108edcd-b5a7-46e9-8ec1-12b9f6f1e595" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_f8927fe6-a392-47e8-b63e-19e596a38a84" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_4108edcd-b5a7-46e9-8ec1-12b9f6f1e595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_09575457-df9a-45b7-8a38-12f4f32b3826" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_f8927fe6-a392-47e8-b63e-19e596a38a84" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_09575457-df9a-45b7-8a38-12f4f32b3826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_c46fc1dc-0185-482b-9335-58e3d6e0d852" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_f8927fe6-a392-47e8-b63e-19e596a38a84" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_c46fc1dc-0185-482b-9335-58e3d6e0d852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_3beaa0ae-ece9-44c8-8c80-6cc5f340d663" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_f8927fe6-a392-47e8-b63e-19e596a38a84" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_3beaa0ae-ece9-44c8-8c80-6cc5f340d663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_98df3fb5-3c2e-43f3-97be-b7178eb1f0ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_f8927fe6-a392-47e8-b63e-19e596a38a84" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_98df3fb5-3c2e-43f3-97be-b7178eb1f0ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/RelatedPartyTransactionsExpensesrelatedtoRelatedPartywhichwereSettledinCashDetails" xlink:type="simple" xlink:href="syre-20250331.xsd#RelatedPartyTransactionsExpensesrelatedtoRelatedPartywhichwereSettledinCashDetails"/>
  <link:presentationLink xlink:role="http://spyre.com/role/RelatedPartyTransactionsExpensesrelatedtoRelatedPartywhichwereSettledinCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_71f18ba9-93b5-495f-84e1-15eba2531eac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d8400dff-7493-4190-b561-ce05d786e767" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_71f18ba9-93b5-495f-84e1-15eba2531eac" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d8400dff-7493-4190-b561-ce05d786e767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_801240b7-63d0-42a6-b459-a45103af08ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d8400dff-7493-4190-b561-ce05d786e767" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_801240b7-63d0-42a6-b459-a45103af08ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_05ab35a3-eb21-4674-b921-b80ace7a278e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_801240b7-63d0-42a6-b459-a45103af08ba" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_05ab35a3-eb21-4674-b921-b80ace7a278e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ParagonAndLicenseAgreementMember_847bbb31-d82a-4f84-af58-ea0801d750dc" xlink:href="syre-20250331.xsd#syre_ParagonAndLicenseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_05ab35a3-eb21-4674-b921-b80ace7a278e" xlink:to="loc_syre_ParagonAndLicenseAgreementMember_847bbb31-d82a-4f84-af58-ea0801d750dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ParagonAgreementMember_b8ad9b22-98d9-42d0-b430-799549ce2cbf" xlink:href="syre-20250331.xsd#syre_ParagonAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_ParagonAndLicenseAgreementMember_847bbb31-d82a-4f84-af58-ea0801d750dc" xlink:to="loc_syre_ParagonAgreementMember_b8ad9b22-98d9-42d0-b430-799549ce2cbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ParagonAgreementLicenseMilestonePaymentsMember_85abaa3c-e402-493f-bb49-07efb91aab74" xlink:href="syre-20250331.xsd#syre_ParagonAgreementLicenseMilestonePaymentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_ParagonAndLicenseAgreementMember_847bbb31-d82a-4f84-af58-ea0801d750dc" xlink:to="loc_syre_ParagonAgreementLicenseMilestonePaymentsMember_85abaa3c-e402-493f-bb49-07efb91aab74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dbcfdc4d-2ccc-41da-98d0-b364a7829504" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d8400dff-7493-4190-b561-ce05d786e767" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dbcfdc4d-2ccc-41da-98d0-b364a7829504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_f55c314c-7d6e-4ef7-ba99-d0059e25bd6a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dbcfdc4d-2ccc-41da-98d0-b364a7829504" xlink:to="loc_us-gaap_RelatedPartyDomain_f55c314c-7d6e-4ef7-ba99-d0059e25bd6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_4aa10e21-6802-402b-84c9-a09614206874" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_f55c314c-7d6e-4ef7-ba99-d0059e25bd6a" xlink:to="loc_us-gaap_RelatedPartyMember_4aa10e21-6802-402b-84c9-a09614206874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_6bdd169f-7f6e-4b83-aac1-edd9a7fe211a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d8400dff-7493-4190-b561-ce05d786e767" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_6bdd169f-7f6e-4b83-aac1-edd9a7fe211a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_e967f517-e7c9-429d-a51e-458dd7d8be5b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_6bdd169f-7f6e-4b83-aac1-edd9a7fe211a" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_e967f517-e7c9-429d-a51e-458dd7d8be5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/RelatedPartyTransactionsRelatedPartyAccountsPayableDetails" xlink:type="simple" xlink:href="syre-20250331.xsd#RelatedPartyTransactionsRelatedPartyAccountsPayableDetails"/>
  <link:presentationLink xlink:role="http://spyre.com/role/RelatedPartyTransactionsRelatedPartyAccountsPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_d42bb9d9-e4fd-431c-9692-9d14c285b535" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9bcaf180-0f59-4b22-883e-49a8efd2f644" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_d42bb9d9-e4fd-431c-9692-9d14c285b535" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9bcaf180-0f59-4b22-883e-49a8efd2f644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_40f9e319-2666-41e3-ab7e-00fcef848e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9bcaf180-0f59-4b22-883e-49a8efd2f644" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_40f9e319-2666-41e3-ab7e-00fcef848e5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_6d8bf421-fcd7-4676-9cd5-3692c644d15f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_40f9e319-2666-41e3-ab7e-00fcef848e5b" xlink:to="loc_us-gaap_RelatedPartyDomain_6d8bf421-fcd7-4676-9cd5-3692c644d15f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_293e5c59-b43b-4f39-a4c5-471fd809b6e9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_6d8bf421-fcd7-4676-9cd5-3692c644d15f" xlink:to="loc_us-gaap_RelatedPartyMember_293e5c59-b43b-4f39-a4c5-471fd809b6e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_3bd3bf03-74d5-401d-818a-8f666f977234" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9bcaf180-0f59-4b22-883e-49a8efd2f644" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_3bd3bf03-74d5-401d-818a-8f666f977234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_628b3d82-0181-49cc-931a-e5a4c6440349" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_3bd3bf03-74d5-401d-818a-8f666f977234" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_628b3d82-0181-49cc-931a-e5a4c6440349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ParagonAgreementMember_02bc3aa6-88ac-4c20-bf8e-c9fc60e80e5a" xlink:href="syre-20250331.xsd#syre_ParagonAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_628b3d82-0181-49cc-931a-e5a4c6440349" xlink:to="loc_syre_ParagonAgreementMember_02bc3aa6-88ac-4c20-bf8e-c9fc60e80e5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ParapyreLiabilityLicenseAgreementsMember_43f31f18-8e54-4e2a-a789-787c1def6a61" xlink:href="syre-20250331.xsd#syre_ParapyreLiabilityLicenseAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_628b3d82-0181-49cc-931a-e5a4c6440349" xlink:to="loc_syre_ParapyreLiabilityLicenseAgreementsMember_43f31f18-8e54-4e2a-a789-787c1def6a61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_9c85934b-ea83-403a-92ec-95e1bad747a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9bcaf180-0f59-4b22-883e-49a8efd2f644" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_9c85934b-ea83-403a-92ec-95e1bad747a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableOtherCurrent_08c69c9e-bb39-4cea-b584-8d0463a0981b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableOtherCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9c85934b-ea83-403a-92ec-95e1bad747a7" xlink:to="loc_us-gaap_AccountsPayableOtherCurrent_08c69c9e-bb39-4cea-b584-8d0463a0981b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="syre-20250331.xsd#ConvertiblePreferredStockandStockholdersEquityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_8bf595dd-d562-4f61-8024-65084bb9f52f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_00983c02-afe3-442e-9518-643d98bc6455" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_8bf595dd-d562-4f61-8024-65084bb9f52f" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_00983c02-afe3-442e-9518-643d98bc6455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_5d5d7107-0c72-4bc3-9df5-fc13a8eb2427" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_00983c02-afe3-442e-9518-643d98bc6455" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_5d5d7107-0c72-4bc3-9df5-fc13a8eb2427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_481890d7-5922-40cb-9466-26a6394b0a48" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_5d5d7107-0c72-4bc3-9df5-fc13a8eb2427" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_481890d7-5922-40cb-9466-26a6394b0a48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ParapyreWarrantsMember_5bb784da-f857-45ba-8499-b7d28c56fb04" xlink:href="syre-20250331.xsd#syre_ParapyreWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_481890d7-5922-40cb-9466-26a6394b0a48" xlink:to="loc_syre_ParapyreWarrantsMember_5bb784da-f857-45ba-8499-b7d28c56fb04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_df491008-b9a1-4f32-a838-d22e0b71b6b4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_00983c02-afe3-442e-9518-643d98bc6455" xlink:to="loc_us-gaap_PlanNameAxis_df491008-b9a1-4f32-a838-d22e0b71b6b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_1beb7b5b-c632-44a5-87aa-9c471acd34ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_df491008-b9a1-4f32-a838-d22e0b71b6b4" xlink:to="loc_us-gaap_PlanNameDomain_1beb7b5b-c632-44a5-87aa-9c471acd34ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_A2024ParapyreOptionObligationMember_4c7acfae-3ee0-4e2e-8fef-f62d223220cd" xlink:href="syre-20250331.xsd#syre_A2024ParapyreOptionObligationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_1beb7b5b-c632-44a5-87aa-9c471acd34ae" xlink:to="loc_syre_A2024ParapyreOptionObligationMember_4c7acfae-3ee0-4e2e-8fef-f62d223220cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_024550c6-2a2d-405a-8619-ebce65fa4237" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_00983c02-afe3-442e-9518-643d98bc6455" xlink:to="loc_us-gaap_StatementClassOfStockAxis_024550c6-2a2d-405a-8619-ebce65fa4237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_2fe42cb9-64bb-4e09-8ee4-04248cf42694" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_024550c6-2a2d-405a-8619-ebce65fa4237" xlink:to="loc_us-gaap_ClassOfStockDomain_2fe42cb9-64bb-4e09-8ee4-04248cf42694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SeriesANonVotingConvertiblePreferredStockMember_eb9cccd0-bb4d-4f12-b20d-5e56506661d0" xlink:href="syre-20250331.xsd#syre_SeriesANonVotingConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_2fe42cb9-64bb-4e09-8ee4-04248cf42694" xlink:to="loc_syre_SeriesANonVotingConvertiblePreferredStockMember_eb9cccd0-bb4d-4f12-b20d-5e56506661d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_5c65d2b2-35f7-4b32-88aa-62b1484e3fee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_2fe42cb9-64bb-4e09-8ee4-04248cf42694" xlink:to="loc_us-gaap_CommonStockMember_5c65d2b2-35f7-4b32-88aa-62b1484e3fee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SeriesBNonVotingConvertiblePreferredStockMember_28f16fe2-6766-4634-a57c-d21c02e47da0" xlink:href="syre-20250331.xsd#syre_SeriesBNonVotingConvertiblePreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_2fe42cb9-64bb-4e09-8ee4-04248cf42694" xlink:to="loc_syre_SeriesBNonVotingConvertiblePreferredStockMember_28f16fe2-6766-4634-a57c-d21c02e47da0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_CommonStockAndSeriesBNonVotingConvertiblePreferredStockMember_05ee4d78-1ac2-4d99-ab21-54ea8ff20329" xlink:href="syre-20250331.xsd#syre_CommonStockAndSeriesBNonVotingConvertiblePreferredStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_2fe42cb9-64bb-4e09-8ee4-04248cf42694" xlink:to="loc_syre_CommonStockAndSeriesBNonVotingConvertiblePreferredStockMember_05ee4d78-1ac2-4d99-ab21-54ea8ff20329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_96ce7cbd-0b8d-4e00-b586-cf7b0f184e8e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_00983c02-afe3-442e-9518-643d98bc6455" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_96ce7cbd-0b8d-4e00-b586-cf7b0f184e8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1b7abb6c-0e1c-4a1a-88ba-d36d347bb3a6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_96ce7cbd-0b8d-4e00-b586-cf7b0f184e8e" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1b7abb6c-0e1c-4a1a-88ba-d36d347bb3a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_1f7cc62c-e0ba-4d15-8cfb-e77bb58b07a5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1b7abb6c-0e1c-4a1a-88ba-d36d347bb3a6" xlink:to="loc_us-gaap_PrivatePlacementMember_1f7cc62c-e0ba-4d15-8cfb-e77bb58b07a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_AtTheMarketOfferingMember_ec719759-db9b-47fc-a6a5-486b13c97a2b" xlink:href="syre-20250331.xsd#syre_AtTheMarketOfferingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1b7abb6c-0e1c-4a1a-88ba-d36d347bb3a6" xlink:to="loc_syre_AtTheMarketOfferingMember_ec719759-db9b-47fc-a6a5-486b13c97a2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_UnderwrittenOfferingMember_7b87a98f-f8da-4aa7-8eb5-d36fa5ebccd2" xlink:href="syre-20250331.xsd#syre_UnderwrittenOfferingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1b7abb6c-0e1c-4a1a-88ba-d36d347bb3a6" xlink:to="loc_syre_UnderwrittenOfferingMember_7b87a98f-f8da-4aa7-8eb5-d36fa5ebccd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a4310037-4c07-4755-b969-ec52ff3d7b5e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_00983c02-afe3-442e-9518-643d98bc6455" xlink:to="loc_srt_RangeAxis_a4310037-4c07-4755-b969-ec52ff3d7b5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_72bcfa3a-762d-4b78-9f95-33da27a874b4" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_a4310037-4c07-4755-b969-ec52ff3d7b5e" xlink:to="loc_srt_RangeMember_72bcfa3a-762d-4b78-9f95-33da27a874b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c09df570-2cee-41cc-bc52-3971947ab709" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_72bcfa3a-762d-4b78-9f95-33da27a874b4" xlink:to="loc_srt_MinimumMember_c09df570-2cee-41cc-bc52-3971947ab709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2eb7b31c-4c72-41c0-9a44-632767d64c63" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_72bcfa3a-762d-4b78-9f95-33da27a874b4" xlink:to="loc_srt_MaximumMember_2eb7b31c-4c72-41c0-9a44-632767d64c63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_0e609c01-1395-4827-83c2-8004cc0a3f76" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_00983c02-afe3-442e-9518-643d98bc6455" xlink:to="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_0e609c01-1395-4827-83c2-8004cc0a3f76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_8d3ade70-ccb1-4153-b967-c159a8f6331f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_0e609c01-1395-4827-83c2-8004cc0a3f76" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_8d3ade70-ccb1-4153-b967-c159a8f6331f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ConversionOfSeriesBNonVotingConvertiblePreferredStockMember_f1a226b6-97c4-463c-882d-8dcacde9f715" xlink:href="syre-20250331.xsd#syre_ConversionOfSeriesBNonVotingConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_8d3ade70-ccb1-4153-b967-c159a8f6331f" xlink:to="loc_syre_ConversionOfSeriesBNonVotingConvertiblePreferredStockMember_f1a226b6-97c4-463c-882d-8dcacde9f715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_7d511b79-4e7f-4b61-b456-b84e2655c880" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_00983c02-afe3-442e-9518-643d98bc6455" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_7d511b79-4e7f-4b61-b456-b84e2655c880" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_95ef33b6-3418-4d92-8c15-f1df2dd7e0ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7d511b79-4e7f-4b61-b456-b84e2655c880" xlink:to="loc_us-gaap_EquityComponentDomain_95ef33b6-3418-4d92-8c15-f1df2dd7e0ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_83f31fdf-127c-4c90-90b4-1e710ca728fc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_95ef33b6-3418-4d92-8c15-f1df2dd7e0ec" xlink:to="loc_us-gaap_PreferredStockMember_83f31fdf-127c-4c90-90b4-1e710ca728fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_1106da3b-2fcf-4a74-b550-939f14d4735a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_00983c02-afe3-442e-9518-643d98bc6455" xlink:to="loc_us-gaap_ClassOfStockLineItems_1106da3b-2fcf-4a74-b550-939f14d4735a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_89fc4d06-901b-4721-9119-624396e9fa95" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1106da3b-2fcf-4a74-b550-939f14d4735a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_89fc4d06-901b-4721-9119-624396e9fa95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_59a0473b-6e71-4e8a-98f4-d6edc5eccc5f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1106da3b-2fcf-4a74-b550-939f14d4735a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_59a0473b-6e71-4e8a-98f4-d6edc5eccc5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ClassOfWarrantOrRightNumberOfSecuritiesExercised_1923467f-1707-4ba2-8cc0-9bcb43359e50" xlink:href="syre-20250331.xsd#syre_ClassOfWarrantOrRightNumberOfSecuritiesExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1106da3b-2fcf-4a74-b550-939f14d4735a" xlink:to="loc_syre_ClassOfWarrantOrRightNumberOfSecuritiesExercised_1923467f-1707-4ba2-8cc0-9bcb43359e50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_PreferredStockRemainsIssuedAndOutstandingPercentage_a0963e41-7887-415b-aa0d-8f88615559b5" xlink:href="syre-20250331.xsd#syre_PreferredStockRemainsIssuedAndOutstandingPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1106da3b-2fcf-4a74-b550-939f14d4735a" xlink:to="loc_syre_PreferredStockRemainsIssuedAndOutstandingPercentage_a0963e41-7887-415b-aa0d-8f88615559b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_StockIssuedDuringPeriodSharesExchangeOfConvertibleSecurities_c6990dc8-3629-482d-be50-2d4507102b0d" xlink:href="syre-20250331.xsd#syre_StockIssuedDuringPeriodSharesExchangeOfConvertibleSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1106da3b-2fcf-4a74-b550-939f14d4735a" xlink:to="loc_syre_StockIssuedDuringPeriodSharesExchangeOfConvertibleSecurities_c6990dc8-3629-482d-be50-2d4507102b0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_c65adb30-4274-4912-80b1-44ea334a7bee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1106da3b-2fcf-4a74-b550-939f14d4735a" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_c65adb30-4274-4912-80b1-44ea334a7bee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockConvertibleSharesIssuable_8acca36b-3281-4e9a-a8c3-965c5845d324" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockConvertibleSharesIssuable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1106da3b-2fcf-4a74-b550-939f14d4735a" xlink:to="loc_us-gaap_PreferredStockConvertibleSharesIssuable_8acca36b-3281-4e9a-a8c3-965c5845d324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_dd1e63a3-1507-4392-853e-95f1e880b621" xlink:href="syre-20250331.xsd#syre_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1106da3b-2fcf-4a74-b550-939f14d4735a" xlink:to="loc_syre_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_dd1e63a3-1507-4392-853e-95f1e880b621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_cfde6cac-078d-4244-af8b-23d6c82654fb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1106da3b-2fcf-4a74-b550-939f14d4735a" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_cfde6cac-078d-4244-af8b-23d6c82654fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_4d6493a7-7e67-42a5-9a9d-2fbd1a8bd516" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1106da3b-2fcf-4a74-b550-939f14d4735a" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_4d6493a7-7e67-42a5-9a9d-2fbd1a8bd516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_329b8d61-a49d-46d8-8f0a-7ba25ebdf8dc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1106da3b-2fcf-4a74-b550-939f14d4735a" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_329b8d61-a49d-46d8-8f0a-7ba25ebdf8dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockConvertibleConversionRatio_35dd6743-50e9-4c53-baef-cf366b68e3a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockConvertibleConversionRatio"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1106da3b-2fcf-4a74-b550-939f14d4735a" xlink:to="loc_us-gaap_PreferredStockConvertibleConversionRatio_35dd6743-50e9-4c53-baef-cf366b68e3a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_BeneficialHoldersOwnedPercentage_2fbea9f3-9b97-4d00-b494-d0099a7d4e98" xlink:href="syre-20250331.xsd#syre_BeneficialHoldersOwnedPercentage"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1106da3b-2fcf-4a74-b550-939f14d4735a" xlink:to="loc_syre_BeneficialHoldersOwnedPercentage_2fbea9f3-9b97-4d00-b494-d0099a7d4e98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_29035007-b4c5-46ed-a2ce-87e2444f41fc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1106da3b-2fcf-4a74-b550-939f14d4735a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_29035007-b4c5-46ed-a2ce-87e2444f41fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_PreferredStockSharesNotAutomaticallyConvertedOutstanding_c6d562d5-dab9-47b9-8ed3-a0b91b2f5ac2" xlink:href="syre-20250331.xsd#syre_PreferredStockSharesNotAutomaticallyConvertedOutstanding"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1106da3b-2fcf-4a74-b550-939f14d4735a" xlink:to="loc_syre_PreferredStockSharesNotAutomaticallyConvertedOutstanding_c6d562d5-dab9-47b9-8ed3-a0b91b2f5ac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SaleOfStockAuthorizedAmount_1c9ad9f3-43b5-4e07-ac09-723300061aaa" xlink:href="syre-20250331.xsd#syre_SaleOfStockAuthorizedAmount"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1106da3b-2fcf-4a74-b550-939f14d4735a" xlink:to="loc_syre_SaleOfStockAuthorizedAmount_1c9ad9f3-43b5-4e07-ac09-723300061aaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SaleOfStockAggregateOfferingPrice_e2d1bb32-1cc3-4d3e-a2dd-0fe5276a9f17" xlink:href="syre-20250331.xsd#syre_SaleOfStockAggregateOfferingPrice"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1106da3b-2fcf-4a74-b550-939f14d4735a" xlink:to="loc_syre_SaleOfStockAggregateOfferingPrice_e2d1bb32-1cc3-4d3e-a2dd-0fe5276a9f17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_e4069eaa-0b8c-4ae6-bc58-5dc38b3c090f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1106da3b-2fcf-4a74-b550-939f14d4735a" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_e4069eaa-0b8c-4ae6-bc58-5dc38b3c090f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SaleOfStockRemainingAuthorizedAmount_c59dd9c0-7757-4b98-8deb-9d6acda06e31" xlink:href="syre-20250331.xsd#syre_SaleOfStockRemainingAuthorizedAmount"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1106da3b-2fcf-4a74-b550-939f14d4735a" xlink:to="loc_syre_SaleOfStockRemainingAuthorizedAmount_c59dd9c0-7757-4b98-8deb-9d6acda06e31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/StockBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="syre-20250331.xsd#StockBasedCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://spyre.com/role/StockBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_72ccd188-6817-4d0e-81c3-815c9c4c55d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_86033456-cae2-48dc-929c-a21d1b71427d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_72ccd188-6817-4d0e-81c3-815c9c4c55d2" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_86033456-cae2-48dc-929c-a21d1b71427d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_3e3cfe83-355a-4312-8b5c-28a893ccb464" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_86033456-cae2-48dc-929c-a21d1b71427d" xlink:to="loc_us-gaap_PlanNameAxis_3e3cfe83-355a-4312-8b5c-28a893ccb464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_a6632908-1fac-485b-9236-34d2612b467b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_3e3cfe83-355a-4312-8b5c-28a893ccb464" xlink:to="loc_us-gaap_PlanNameDomain_a6632908-1fac-485b-9236-34d2612b467b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_TwoThousandAndFifteenAndTwoThousandAndSixteenEquityIncentivePlanAndTwoThousandAndEighteenEquityInducementPlanMember_adfcfa8e-19d3-4883-b0b2-d24950404bf3" xlink:href="syre-20250331.xsd#syre_TwoThousandAndFifteenAndTwoThousandAndSixteenEquityIncentivePlanAndTwoThousandAndEighteenEquityInducementPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_a6632908-1fac-485b-9236-34d2612b467b" xlink:to="loc_syre_TwoThousandAndFifteenAndTwoThousandAndSixteenEquityIncentivePlanAndTwoThousandAndEighteenEquityInducementPlanMember_adfcfa8e-19d3-4883-b0b2-d24950404bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_TwoThousandAndFifteenEquityIncentivePlanMember_6bd6cdc5-14a0-44f0-842a-4758d0e02baa" xlink:href="syre-20250331.xsd#syre_TwoThousandAndFifteenEquityIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_TwoThousandAndFifteenAndTwoThousandAndSixteenEquityIncentivePlanAndTwoThousandAndEighteenEquityInducementPlanMember_adfcfa8e-19d3-4883-b0b2-d24950404bf3" xlink:to="loc_syre_TwoThousandAndFifteenEquityIncentivePlanMember_6bd6cdc5-14a0-44f0-842a-4758d0e02baa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_TwoThousandAndSixteenEquityIncentivePlanMember_f7767a49-e420-4afd-907d-c4f13a2af10a" xlink:href="syre-20250331.xsd#syre_TwoThousandAndSixteenEquityIncentivePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_TwoThousandAndFifteenAndTwoThousandAndSixteenEquityIncentivePlanAndTwoThousandAndEighteenEquityInducementPlanMember_adfcfa8e-19d3-4883-b0b2-d24950404bf3" xlink:to="loc_syre_TwoThousandAndSixteenEquityIncentivePlanMember_f7767a49-e420-4afd-907d-c4f13a2af10a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_TwoThousandAndEighteenEquityInducementPlanMember_db62913d-db71-45da-8ac8-213a28a065e7" xlink:href="syre-20250331.xsd#syre_TwoThousandAndEighteenEquityInducementPlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_TwoThousandAndFifteenAndTwoThousandAndSixteenEquityIncentivePlanAndTwoThousandAndEighteenEquityInducementPlanMember_adfcfa8e-19d3-4883-b0b2-d24950404bf3" xlink:to="loc_syre_TwoThousandAndEighteenEquityInducementPlanMember_db62913d-db71-45da-8ac8-213a28a065e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_TwoThousandAndEighteenEquityInducementPlanAmendedMember_e69b84e7-1c1f-4eff-b97b-2e6368c47579" xlink:href="syre-20250331.xsd#syre_TwoThousandAndEighteenEquityInducementPlanAmendedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_TwoThousandAndEighteenEquityInducementPlanMember_db62913d-db71-45da-8ac8-213a28a065e7" xlink:to="loc_syre_TwoThousandAndEighteenEquityInducementPlanAmendedMember_e69b84e7-1c1f-4eff-b97b-2e6368c47579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_Spyre2023EquityIncentivePlanMember_9da4b39e-9cb0-4f1f-8f77-0dfdf873a5cc" xlink:href="syre-20250331.xsd#syre_Spyre2023EquityIncentivePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_a6632908-1fac-485b-9236-34d2612b467b" xlink:to="loc_syre_Spyre2023EquityIncentivePlanMember_9da4b39e-9cb0-4f1f-8f77-0dfdf873a5cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ParapyreOptionObligationMember_6c85c6c2-8b22-45f0-8ec2-473606786e0d" xlink:href="syre-20250331.xsd#syre_ParapyreOptionObligationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_a6632908-1fac-485b-9236-34d2612b467b" xlink:to="loc_syre_ParapyreOptionObligationMember_6c85c6c2-8b22-45f0-8ec2-473606786e0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_A2024ParapyreOptionObligationMember_1b0095c2-f2ff-4528-b3a4-d0971a6a5524" xlink:href="syre-20250331.xsd#syre_A2024ParapyreOptionObligationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syre_ParapyreOptionObligationMember_6c85c6c2-8b22-45f0-8ec2-473606786e0d" xlink:to="loc_syre_A2024ParapyreOptionObligationMember_1b0095c2-f2ff-4528-b3a4-d0971a6a5524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_TwoThousandAndSixteenEmployeeStockPurchasePlanMember_a8e61cba-e6e8-48c9-bc55-6b52a9904f76" xlink:href="syre-20250331.xsd#syre_TwoThousandAndSixteenEmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_a6632908-1fac-485b-9236-34d2612b467b" xlink:to="loc_syre_TwoThousandAndSixteenEmployeeStockPurchasePlanMember_a8e61cba-e6e8-48c9-bc55-6b52a9904f76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_fdb0c319-47b3-483f-925e-773f9adf852a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_86033456-cae2-48dc-929c-a21d1b71427d" xlink:to="loc_us-gaap_AwardTypeAxis_fdb0c319-47b3-483f-925e-773f9adf852a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_06ab76d4-cdec-4e4e-8e6b-574dbeba4256" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_fdb0c319-47b3-483f-925e-773f9adf852a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_06ab76d4-cdec-4e4e-8e6b-574dbeba4256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ServiceBasedAwardsMember_dfa8daee-9ca6-430d-98ac-0459c6b0cfc3" xlink:href="syre-20250331.xsd#syre_ServiceBasedAwardsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_06ab76d4-cdec-4e4e-8e6b-574dbeba4256" xlink:to="loc_syre_ServiceBasedAwardsMember_dfa8daee-9ca6-430d-98ac-0459c6b0cfc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_0f89bc98-bd0a-460f-9fd8-f0fd1233f4f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_86033456-cae2-48dc-929c-a21d1b71427d" xlink:to="loc_us-gaap_AssetAcquisitionAxis_0f89bc98-bd0a-460f-9fd8-f0fd1233f4f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_f86d1235-2aa8-45f6-be46-b80d7a15a4c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionAxis_0f89bc98-bd0a-460f-9fd8-f0fd1233f4f5" xlink:to="loc_us-gaap_AssetAcquisitionDomain_f86d1235-2aa8-45f6-be46-b80d7a15a4c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_AssetAcquisitionMember_a7a43d3e-b244-48d5-bf2e-aaa19cd1213b" xlink:href="syre-20250331.xsd#syre_AssetAcquisitionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_f86d1235-2aa8-45f6-be46-b80d7a15a4c6" xlink:to="loc_syre_AssetAcquisitionMember_a7a43d3e-b244-48d5-bf2e-aaa19cd1213b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_164de455-fbe9-457d-8435-a9725e1c2ae6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_86033456-cae2-48dc-929c-a21d1b71427d" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_164de455-fbe9-457d-8435-a9725e1c2ae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_dc49f355-b05f-47b4-aaba-9b259db99308" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_164de455-fbe9-457d-8435-a9725e1c2ae6" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_dc49f355-b05f-47b4-aaba-9b259db99308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_A2016ESPPMember_85002e28-89f7-42fa-bd13-456a8d645b7d" xlink:href="syre-20250331.xsd#syre_A2016ESPPMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_dc49f355-b05f-47b4-aaba-9b259db99308" xlink:to="loc_syre_A2016ESPPMember_85002e28-89f7-42fa-bd13-456a8d645b7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_3a9208bd-9c5b-40c1-ad6b-50774c2cc456" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_86033456-cae2-48dc-929c-a21d1b71427d" xlink:to="loc_us-gaap_StatementClassOfStockAxis_3a9208bd-9c5b-40c1-ad6b-50774c2cc456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f042e8e2-f323-4a66-903c-3cbacd904474" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_3a9208bd-9c5b-40c1-ad6b-50774c2cc456" xlink:to="loc_us-gaap_ClassOfStockDomain_f042e8e2-f323-4a66-903c-3cbacd904474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_35c382de-ab1b-4a69-9923-d11050f2ab3a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_f042e8e2-f323-4a66-903c-3cbacd904474" xlink:to="loc_us-gaap_EmployeeStockMember_35c382de-ab1b-4a69-9923-d11050f2ab3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_45506d47-0378-4020-822a-ebe8f1d772b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_86033456-cae2-48dc-929c-a21d1b71427d" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_45506d47-0378-4020-822a-ebe8f1d772b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_04a1caa5-c05b-489e-9003-3daf1ca57432" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_45506d47-0378-4020-822a-ebe8f1d772b1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_04a1caa5-c05b-489e-9003-3daf1ca57432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ParapyreWarrantsMember_e01367f3-8e65-4747-b1e6-44889ee798ba" xlink:href="syre-20250331.xsd#syre_ParapyreWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_04a1caa5-c05b-489e-9003-3daf1ca57432" xlink:to="loc_syre_ParapyreWarrantsMember_e01367f3-8e65-4747-b1e6-44889ee798ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d580a91-c3eb-4d47-a767-b1d81416d376" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_86033456-cae2-48dc-929c-a21d1b71427d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d580a91-c3eb-4d47-a767-b1d81416d376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease_901e0733-6980-4138-85bf-6dbe0f40e60e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d580a91-c3eb-4d47-a767-b1d81416d376" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease_901e0733-6980-4138-85bf-6dbe0f40e60e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_AnnualPercentageOfAdditionalSharesWhichEqualsToIssuedAndOutstandingShares_85c2ad52-5645-48ec-bc3a-cbd09cf2e2d5" xlink:href="syre-20250331.xsd#syre_AnnualPercentageOfAdditionalSharesWhichEqualsToIssuedAndOutstandingShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d580a91-c3eb-4d47-a767-b1d81416d376" xlink:to="loc_syre_AnnualPercentageOfAdditionalSharesWhichEqualsToIssuedAndOutstandingShares_85c2ad52-5645-48ec-bc3a-cbd09cf2e2d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalNumberOfSharesAvailableForGrant_5473dbad-4aab-4fc9-8fc6-7977016b5785" xlink:href="syre-20250331.xsd#syre_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d580a91-c3eb-4d47-a767-b1d81416d376" xlink:to="loc_syre_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalNumberOfSharesAvailableForGrant_5473dbad-4aab-4fc9-8fc6-7977016b5785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_fd07ae4f-7615-4e0b-bb9b-36e6d0930a55" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d580a91-c3eb-4d47-a767-b1d81416d376" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_fd07ae4f-7615-4e0b-bb9b-36e6d0930a55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d987eef0-dca5-4bdc-9ca9-e4292392eab2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d580a91-c3eb-4d47-a767-b1d81416d376" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d987eef0-dca5-4bdc-9ca9-e4292392eab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_CommonStockCapitalSharesReservedForFutureIssuanceIncreasedAmount_cf70e14a-8ba9-443e-9474-546c519d24a5" xlink:href="syre-20250331.xsd#syre_CommonStockCapitalSharesReservedForFutureIssuanceIncreasedAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d580a91-c3eb-4d47-a767-b1d81416d376" xlink:to="loc_syre_CommonStockCapitalSharesReservedForFutureIssuanceIncreasedAmount_cf70e14a-8ba9-443e-9474-546c519d24a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_14bbabb6-82cc-44b6-8075-f523586dbf82" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d580a91-c3eb-4d47-a767-b1d81416d376" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_14bbabb6-82cc-44b6-8075-f523586dbf82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_570598cf-aa4e-4292-b756-d0fae08822aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d580a91-c3eb-4d47-a767-b1d81416d376" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_570598cf-aa4e-4292-b756-d0fae08822aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_OutstandingAndUnexercisedStockOptions_0494f5e8-482b-4cef-b582-6686f7288dee" xlink:href="syre-20250331.xsd#syre_OutstandingAndUnexercisedStockOptions"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d580a91-c3eb-4d47-a767-b1d81416d376" xlink:to="loc_syre_OutstandingAndUnexercisedStockOptions_0494f5e8-482b-4cef-b582-6686f7288dee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_9ebfa596-2972-4705-88ea-2734a62c07f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d580a91-c3eb-4d47-a767-b1d81416d376" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_9ebfa596-2972-4705-88ea-2734a62c07f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_51d2deba-1c60-4d10-864b-de5580814e42" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d580a91-c3eb-4d47-a767-b1d81416d376" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_51d2deba-1c60-4d10-864b-de5580814e42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_089df1c1-99d6-42b5-8036-26e368232573" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d580a91-c3eb-4d47-a767-b1d81416d376" xlink:to="loc_us-gaap_ShareBasedCompensation_089df1c1-99d6-42b5-8036-26e368232573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_ea4c3047-2049-4a67-bb5c-286c177d8261" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d580a91-c3eb-4d47-a767-b1d81416d376" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_ea4c3047-2049-4a67-bb5c-286c177d8261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_e22bbe9c-23b0-4f67-8603-7dd3295f9b9f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d580a91-c3eb-4d47-a767-b1d81416d376" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_e22bbe9c-23b0-4f67-8603-7dd3295f9b9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_bd7cffa6-4d0e-47dc-9d30-94ac460829c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d580a91-c3eb-4d47-a767-b1d81416d376" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_bd7cffa6-4d0e-47dc-9d30-94ac460829c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/StockBasedCompensationStockAwardsGrantedDetails" xlink:type="simple" xlink:href="syre-20250331.xsd#StockBasedCompensationStockAwardsGrantedDetails"/>
  <link:presentationLink xlink:role="http://spyre.com/role/StockBasedCompensationStockAwardsGrantedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_401acb0c-3ad6-4c7b-929c-42789e2a200c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c0ced0c8-1e3a-4d67-a20b-858fdeab074f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_401acb0c-3ad6-4c7b-929c-42789e2a200c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c0ced0c8-1e3a-4d67-a20b-858fdeab074f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_96d9898e-eef7-41ac-b991-b386a570f168" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_401acb0c-3ad6-4c7b-929c-42789e2a200c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_96d9898e-eef7-41ac-b991-b386a570f168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="syre-20250331.xsd#StockBasedCompensationStockBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://spyre.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_72457bcf-8500-4e18-ad17-b273681770e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_54b7952d-0674-41dc-a51c-8c5bb3c53010" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_72457bcf-8500-4e18-ad17-b273681770e4" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_54b7952d-0674-41dc-a51c-8c5bb3c53010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_298b08dc-daba-47c1-8ea2-eae7536c84a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_54b7952d-0674-41dc-a51c-8c5bb3c53010" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_298b08dc-daba-47c1-8ea2-eae7536c84a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_509cb56a-878f-4dd4-96b6-94332a896cf1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_298b08dc-daba-47c1-8ea2-eae7536c84a7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_509cb56a-878f-4dd4-96b6-94332a896cf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_a0593770-dbe7-4b83-9da8-3c375565facd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_509cb56a-878f-4dd4-96b6-94332a896cf1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_a0593770-dbe7-4b83-9da8-3c375565facd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_33e1c84b-115c-4d63-a50a-f5cd4039a444" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_509cb56a-878f-4dd4-96b6-94332a896cf1" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_33e1c84b-115c-4d63-a50a-f5cd4039a444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_31718cd1-a8a1-437d-932c-54e82241387d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_54b7952d-0674-41dc-a51c-8c5bb3c53010" xlink:to="loc_us-gaap_PlanNameAxis_31718cd1-a8a1-437d-932c-54e82241387d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_cbe917ba-4854-4b79-a812-e18d44c6b718" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_31718cd1-a8a1-437d-932c-54e82241387d" xlink:to="loc_us-gaap_PlanNameDomain_cbe917ba-4854-4b79-a812-e18d44c6b718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ParapyreOptionObligationMember_e40a8fe2-99e9-4d6f-bbcd-31d354a24c96" xlink:href="syre-20250331.xsd#syre_ParapyreOptionObligationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_cbe917ba-4854-4b79-a812-e18d44c6b718" xlink:to="loc_syre_ParapyreOptionObligationMember_e40a8fe2-99e9-4d6f-bbcd-31d354a24c96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_656205a4-939e-4902-9074-20e8533adcd3" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_54b7952d-0674-41dc-a51c-8c5bb3c53010" xlink:to="loc_srt_TitleOfIndividualAxis_656205a4-939e-4902-9074-20e8533adcd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_eeedb6d6-8574-4b96-a3d4-e59ce1347a5a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_656205a4-939e-4902-9074-20e8533adcd3" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_eeedb6d6-8574-4b96-a3d4-e59ce1347a5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_AegleaEmployeesAndDirectorsMember_7583122b-96d4-4afa-a775-b2af0fb495a6" xlink:href="syre-20250331.xsd#syre_AegleaEmployeesAndDirectorsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_eeedb6d6-8574-4b96-a3d4-e59ce1347a5a" xlink:to="loc_syre_AegleaEmployeesAndDirectorsMember_7583122b-96d4-4afa-a775-b2af0fb495a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0850ef9d-8323-49fc-88c9-14e29d5a64d0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_54b7952d-0674-41dc-a51c-8c5bb3c53010" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0850ef9d-8323-49fc-88c9-14e29d5a64d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_a5a13077-531e-4d79-aac5-dea3d9ce6a93" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0850ef9d-8323-49fc-88c9-14e29d5a64d0" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_a5a13077-531e-4d79-aac5-dea3d9ce6a93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_79c281e9-31f1-47c5-8b93-42026be337bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0850ef9d-8323-49fc-88c9-14e29d5a64d0" xlink:to="loc_us-gaap_ShareBasedCompensation_79c281e9-31f1-47c5-8b93-42026be337bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/StockBasedCompensationAssumptionsusedtoEstimatetheFairValueofStockOptionsGrantedDetails" xlink:type="simple" xlink:href="syre-20250331.xsd#StockBasedCompensationAssumptionsusedtoEstimatetheFairValueofStockOptionsGrantedDetails"/>
  <link:presentationLink xlink:role="http://spyre.com/role/StockBasedCompensationAssumptionsusedtoEstimatetheFairValueofStockOptionsGrantedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_40c12d31-45dd-4946-8114-1a4474bceac8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_4508c9c4-c423-44f2-965d-7c1757507f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_40c12d31-45dd-4946-8114-1a4474bceac8" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_4508c9c4-c423-44f2-965d-7c1757507f7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_d3314663-351c-414d-8756-619c232b4c00" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_4508c9c4-c423-44f2-965d-7c1757507f7d" xlink:to="loc_us-gaap_PlanNameAxis_d3314663-351c-414d-8756-619c232b4c00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_19ac9f6a-ba68-4b5b-b5f6-4431a0c5b90b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_d3314663-351c-414d-8756-619c232b4c00" xlink:to="loc_us-gaap_PlanNameDomain_19ac9f6a-ba68-4b5b-b5f6-4431a0c5b90b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_TwoThousandAndSixteenEquityIncentivePlanMember_f08ad179-7941-4509-9871-4a550f4f2011" xlink:href="syre-20250331.xsd#syre_TwoThousandAndSixteenEquityIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_19ac9f6a-ba68-4b5b-b5f6-4431a0c5b90b" xlink:to="loc_syre_TwoThousandAndSixteenEquityIncentivePlanMember_f08ad179-7941-4509-9871-4a550f4f2011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_TwoThousandAndSixteenEmployeeStockPurchasePlanMember_2254006f-2dbf-4869-b7cd-84d45155aa0d" xlink:href="syre-20250331.xsd#syre_TwoThousandAndSixteenEmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_19ac9f6a-ba68-4b5b-b5f6-4431a0c5b90b" xlink:to="loc_syre_TwoThousandAndSixteenEmployeeStockPurchasePlanMember_2254006f-2dbf-4869-b7cd-84d45155aa0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_b3d82768-1da7-4b28-a8a0-fb5a5a6d7d2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_4508c9c4-c423-44f2-965d-7c1757507f7d" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_b3d82768-1da7-4b28-a8a0-fb5a5a6d7d2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_be58f49d-f008-4769-8744-f228367e4e85" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_b3d82768-1da7-4b28-a8a0-fb5a5a6d7d2f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_be58f49d-f008-4769-8744-f228367e4e85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_6659ee56-dc0d-4650-a8ba-4c9b41644625" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_b3d82768-1da7-4b28-a8a0-fb5a5a6d7d2f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_6659ee56-dc0d-4650-a8ba-4c9b41644625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_7fc32531-0074-404f-82d8-e473f2b6e486" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_b3d82768-1da7-4b28-a8a0-fb5a5a6d7d2f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_7fc32531-0074-404f-82d8-e473f2b6e486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_aa260dc4-3c59-4313-9b01-138581123eb2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_b3d82768-1da7-4b28-a8a0-fb5a5a6d7d2f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_aa260dc4-3c59-4313-9b01-138581123eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/SegmentReportingSummaryofSignificantSegmentExpensesDetails" xlink:type="simple" xlink:href="syre-20250331.xsd#SegmentReportingSummaryofSignificantSegmentExpensesDetails"/>
  <link:presentationLink xlink:role="http://spyre.com/role/SegmentReportingSummaryofSignificantSegmentExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_55f7821a-7d9b-4b50-9c6b-add337bff746" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_5ae70802-b1ea-46b3-9274-7ba786a7bcb7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_55f7821a-7d9b-4b50-9c6b-add337bff746" xlink:to="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_5ae70802-b1ea-46b3-9274-7ba786a7bcb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e9ca5493-eb37-4ebb-ab2b-71a3613c9c56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_5ae70802-b1ea-46b3-9274-7ba786a7bcb7" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e9ca5493-eb37-4ebb-ab2b-71a3613c9c56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b1338c13-431c-4cbb-a932-7fcd7e0acddd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e9ca5493-eb37-4ebb-ab2b-71a3613c9c56" xlink:to="loc_us-gaap_SegmentDomain_b1338c13-431c-4cbb-a932-7fcd7e0acddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ReportableSegmentMember_2f21e6e3-a26c-4c31-a466-bf12fa2cb1f2" xlink:href="syre-20250331.xsd#syre_ReportableSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b1338c13-431c-4cbb-a932-7fcd7e0acddd" xlink:to="loc_syre_ReportableSegmentMember_2f21e6e3-a26c-4c31-a466-bf12fa2cb1f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_45c88ead-3b41-4f56-b105-144df9b5c464" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_5ae70802-b1ea-46b3-9274-7ba786a7bcb7" xlink:to="loc_srt_ConsolidationItemsAxis_45c88ead-3b41-4f56-b105-144df9b5c464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_7e3d69e1-6ae9-4767-b866-048a9132de10" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_45c88ead-3b41-4f56-b105-144df9b5c464" xlink:to="loc_srt_ConsolidationItemsDomain_7e3d69e1-6ae9-4767-b866-048a9132de10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_f7e7cb3c-e4ef-4ab3-8261-bf56565c4061" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_7e3d69e1-6ae9-4767-b866-048a9132de10" xlink:to="loc_us-gaap_OperatingSegmentsMember_f7e7cb3c-e4ef-4ab3-8261-bf56565c4061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_088166fc-91f1-414d-a70c-617a4183ac6d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_7e3d69e1-6ae9-4767-b866-048a9132de10" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_088166fc-91f1-414d-a70c-617a4183ac6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1f30dbb4-6979-45f0-a087-b15430d9e244" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_5ae70802-b1ea-46b3-9274-7ba786a7bcb7" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1f30dbb4-6979-45f0-a087-b15430d9e244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_ce466c12-e53d-4b5f-8267-7e6819016abf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1f30dbb4-6979-45f0-a087-b15430d9e244" xlink:to="loc_us-gaap_RelatedPartyDomain_ce466c12-e53d-4b5f-8267-7e6819016abf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_e5b675b9-cc80-4ab4-bdfd-d0b2b836f6b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_ce466c12-e53d-4b5f-8267-7e6819016abf" xlink:to="loc_us-gaap_RelatedPartyMember_e5b675b9-cc80-4ab4-bdfd-d0b2b836f6b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_65201786-daca-41a6-9491-690f9d57a4bc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_5ae70802-b1ea-46b3-9274-7ba786a7bcb7" xlink:to="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_65201786-daca-41a6-9491-690f9d57a4bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold_2baac8d3-fa6e-4008-93dd-86143cb869d1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_65201786-daca-41a6-9491-690f9d57a4bc" xlink:to="loc_us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold_2baac8d3-fa6e-4008-93dd-86143cb869d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_00321fcc-9ceb-4f26-85f9-70045cff7363" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_65201786-daca-41a6-9491-690f9d57a4bc" xlink:to="loc_us-gaap_ShareBasedCompensation_00321fcc-9ceb-4f26-85f9-70045cff7363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_62829913-61bb-4808-8d37-ac1e015e8d9f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_65201786-daca-41a6-9491-690f9d57a4bc" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_62829913-61bb-4808-8d37-ac1e015e8d9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_1d678260-b754-4d1b-8231-d74f97fd3ae9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_65201786-daca-41a6-9491-690f9d57a4bc" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_1d678260-b754-4d1b-8231-d74f97fd3ae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d540ea64-35a4-4cf3-8b1a-5d397aa23bca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_65201786-daca-41a6-9491-690f9d57a4bc" xlink:to="loc_us-gaap_NetIncomeLoss_d540ea64-35a4-4cf3-8b1a-5d397aa23bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_22331d47-3aaa-4e9c-b557-5835705ddd68" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_65201786-daca-41a6-9491-690f9d57a4bc" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_22331d47-3aaa-4e9c-b557-5835705ddd68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4039399d-34cc-402b-b220-6afccf978153" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_22331d47-3aaa-4e9c-b557-5835705ddd68" xlink:to="loc_us-gaap_NetIncomeLoss_4039399d-34cc-402b-b220-6afccf978153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a6f03f60-98fe-4ce2-887f-e57cb1a5def5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_22331d47-3aaa-4e9c-b557-5835705ddd68" xlink:to="loc_us-gaap_NetIncomeLoss_a6f03f60-98fe-4ce2-887f-e57cb1a5def5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails" xlink:type="simple" xlink:href="syre-20250331.xsd#NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://spyre.com/role/NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_dae89188-fa20-4c03-81f6-6bfad9b87521" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_b32d06c5-5f28-45b4-987c-ee3deec11c09" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_dae89188-fa20-4c03-81f6-6bfad9b87521" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_b32d06c5-5f28-45b4-987c-ee3deec11c09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_9e901c07-d23c-48ce-83dc-3c8ce6914024" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_b32d06c5-5f28-45b4-987c-ee3deec11c09" xlink:to="loc_us-gaap_StatementClassOfStockAxis_9e901c07-d23c-48ce-83dc-3c8ce6914024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_aba02781-42e3-4d1c-9b7e-a099d437861b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_9e901c07-d23c-48ce-83dc-3c8ce6914024" xlink:to="loc_us-gaap_ClassOfStockDomain_aba02781-42e3-4d1c-9b7e-a099d437861b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SeriesANonVotingConvertiblePreferredStockMember_d0474122-9129-40ff-83fb-482256964e54" xlink:href="syre-20250331.xsd#syre_SeriesANonVotingConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_aba02781-42e3-4d1c-9b7e-a099d437861b" xlink:to="loc_syre_SeriesANonVotingConvertiblePreferredStockMember_d0474122-9129-40ff-83fb-482256964e54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SeriesBNonVotingConvertiblePreferredStockMember_4266818c-7a00-4fcd-9475-94ac3f81c235" xlink:href="syre-20250331.xsd#syre_SeriesBNonVotingConvertiblePreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_aba02781-42e3-4d1c-9b7e-a099d437861b" xlink:to="loc_syre_SeriesBNonVotingConvertiblePreferredStockMember_4266818c-7a00-4fcd-9475-94ac3f81c235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_0c6051f3-bcff-4a25-85fd-9f809b8522f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_aba02781-42e3-4d1c-9b7e-a099d437861b" xlink:to="loc_us-gaap_CommonStockMember_0c6051f3-bcff-4a25-85fd-9f809b8522f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_48402543-90da-4ac4-a002-22a6e3ab2dd9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_b32d06c5-5f28-45b4-987c-ee3deec11c09" xlink:to="loc_us-gaap_EarningsPerShareBasicLineItems_48402543-90da-4ac4-a002-22a6e3ab2dd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e4ff8497-f6e2-46c0-9fce-840e9bb19f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_48402543-90da-4ac4-a002-22a6e3ab2dd9" xlink:to="loc_us-gaap_NetIncomeLoss_e4ff8497-f6e2-46c0-9fce-840e9bb19f4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_0f6396d7-aad7-417e-b007-db55438cfcb4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_48402543-90da-4ac4-a002-22a6e3ab2dd9" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_0f6396d7-aad7-417e-b007-db55438cfcb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_bb0c2818-3935-48c8-8ef9-cb60741fa2d4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_48402543-90da-4ac4-a002-22a6e3ab2dd9" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_bb0c2818-3935-48c8-8ef9-cb60741fa2d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0a92ddc1-88fb-4ca9-8da2-d2b4428481fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_48402543-90da-4ac4-a002-22a6e3ab2dd9" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0a92ddc1-88fb-4ca9-8da2-d2b4428481fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d3a02d72-a722-4d0d-b012-c1845accef7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_48402543-90da-4ac4-a002-22a6e3ab2dd9" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d3a02d72-a722-4d0d-b012-c1845accef7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_995864d1-5447-4ac4-976d-2cc5aabdcb06" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_48402543-90da-4ac4-a002-22a6e3ab2dd9" xlink:to="loc_us-gaap_EarningsPerShareBasic_995864d1-5447-4ac4-976d-2cc5aabdcb06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_82de753a-735b-4c0e-a9d0-09bf069ef625" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_48402543-90da-4ac4-a002-22a6e3ab2dd9" xlink:to="loc_us-gaap_EarningsPerShareDiluted_82de753a-735b-4c0e-a9d0-09bf069ef625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://spyre.com/role/NetLossPerShareWeightedAverageEquityInstrumentsExcludedfromCalculationofDilutedNetLossPerShareDetails" xlink:type="simple" xlink:href="syre-20250331.xsd#NetLossPerShareWeightedAverageEquityInstrumentsExcludedfromCalculationofDilutedNetLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://spyre.com/role/NetLossPerShareWeightedAverageEquityInstrumentsExcludedfromCalculationofDilutedNetLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_df060d5e-e643-46ee-9317-49ec5129528c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_203bcb7f-0c33-47c0-a521-630b35295bfb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_df060d5e-e643-46ee-9317-49ec5129528c" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_203bcb7f-0c33-47c0-a521-630b35295bfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_374aac3b-fc11-4094-ae2c-feb39a835fa8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_203bcb7f-0c33-47c0-a521-630b35295bfb" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_374aac3b-fc11-4094-ae2c-feb39a835fa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d9d94a4d-587c-45a9-ab17-427d0824f632" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_374aac3b-fc11-4094-ae2c-feb39a835fa8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d9d94a4d-587c-45a9-ab17-427d0824f632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_3ac9f8aa-9a7a-4608-bf8c-94be9b8a2e4d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d9d94a4d-587c-45a9-ab17-427d0824f632" xlink:to="loc_us-gaap_EmployeeStockOptionMember_3ac9f8aa-9a7a-4608-bf8c-94be9b8a2e4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_aeb0a5d2-f628-4ef5-b947-b1fe82e18952" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d9d94a4d-587c-45a9-ab17-427d0824f632" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_aeb0a5d2-f628-4ef5-b947-b1fe82e18952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_ParapyreWarrantsMember_e98e585d-3316-45e2-bb55-b049a0d72404" xlink:href="syre-20250331.xsd#syre_ParapyreWarrantsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d9d94a4d-587c-45a9-ab17-427d0824f632" xlink:to="loc_syre_ParapyreWarrantsMember_e98e585d-3316-45e2-bb55-b049a0d72404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SeriesANonVotingConvertiblePreferredStockMember_ce42ac20-fc20-4805-af6d-1b1d42d4f5ad" xlink:href="syre-20250331.xsd#syre_SeriesANonVotingConvertiblePreferredStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d9d94a4d-587c-45a9-ab17-427d0824f632" xlink:to="loc_syre_SeriesANonVotingConvertiblePreferredStockMember_ce42ac20-fc20-4805-af6d-1b1d42d4f5ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syre_SeriesBNonVotingConvertiblePreferredStockMember_f70b341e-fb97-4f1e-8086-038e7ef3a187" xlink:href="syre-20250331.xsd#syre_SeriesBNonVotingConvertiblePreferredStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d9d94a4d-587c-45a9-ab17-427d0824f632" xlink:to="loc_syre_SeriesBNonVotingConvertiblePreferredStockMember_f70b341e-fb97-4f1e-8086-038e7ef3a187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6daf562a-8337-488d-8155-4e6e753cd37d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_203bcb7f-0c33-47c0-a521-630b35295bfb" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6daf562a-8337-488d-8155-4e6e753cd37d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_40f6d1a6-9679-4168-a81a-ef7ec03ac0c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6daf562a-8337-488d-8155-4e6e753cd37d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_40f6d1a6-9679-4168-a81a-ef7ec03ac0c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTimingDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaap_AwardTypeAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardExrcPrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ErrCompDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompRecoveryTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_RestatementDateAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonNeosMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ecd_NonNeosMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDeterminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_ExecutiveCategoryAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="loc_ecd_AllExecutiveCategoriesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_PeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_NonPeoNeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_AdjToCompAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="loc_ecd_AllAdjToCompMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_MeasureAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TabularListTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_us-gaap_NetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_OtherPerfMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_MeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TradingArrByIndTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_TradingArrAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllTradingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrAxis" xlink:to="loc_ecd_AllTradingArrangementsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndTitle" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrAdoptionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrTerminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrExpirationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrDuration" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingPoliciesProc"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>syre-20250331_g1.jpg
<TEXT>
begin 644 syre-20250331_g1.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 23"KT# 2(  A$! Q$!_\0
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MGT?V?A?^?:#V,.Q]>?\ #SCXH_\ 0!\(_P#@'=?_ "33A_P4V^*/_0!\(_\
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M_P#Q^G#_ (*"?$3_ * WAC_P%N/_ (_7S#3EH^I8?^1![.'8^G1_P4"^(?\
MT!O#/_@+<?\ Q^G#_@H#\0S_ ,P;PS_X"W'_ ,?KYC6G+2^I8?\ D0>SAV/I
ML?\ !0#XA_\ 0&\,_P#@+<?_ !^G#]O[XA?] ;PS_P" MQ_\?KYE6G+2^IX?
M^1![.'8^F?\ AOWXA?\ 0&\,_P#@+<?_ !^C_AOWXA?] ;PS_P" MQ_\?KYH
MHI?4\/\ R(/9P['TO_PW[\0O^@-X9_\  6X_^/T?\-^_$+_H#>&?_ 6X_P#C
M]?-%%'U/#_R(/9P['TO_ ,-^_$+_ * WAG_P%N/_ (_1_P -^_$+_H#>&?\
MP%N/_C]?-%%'U/#_ ,B#V<.Q]+_\-^_$+_H#>&?_  %N/_C]'_#?OQ"_Z WA
MG_P%N/\ X_7S111]3P_\B#V<.Q]+_P##?OQ"_P"@-X9_\!;C_P"/T?\ #?OQ
M"_Z WAG_ ,!;C_X_7S111]3P_P#(@]G#L?2__#?OQ"_Z WAG_P !;C_X_1_P
MW[\0O^@-X9_\!;C_ ./U\T44?4\/_(@]G#L?2_\ PW[\0O\ H#>&?_ 6X_\
MC]'_  W[\0O^@-X9_P# 6X_^/U\T44?4\/\ R(/9P['TO_PW[\0O^@-X9_\
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M%'U/#_R(/9P['TO_ ,-^_$+_ * WAG_P%N/_ (_3D_;^^( 8;]%\-LO<+;7
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M?^A?\'_^ 5W_ /)-?'=*M']GX7_GVA>QI]C[#_X>B_%7_H7_  ?_ . 5W_\
M)-'_  ]%^*O_ $+_ (/_ / *[_\ DFOCVBC^S\+_ ,^T#HT^Q]AC_@J)\5/^
M@!X/_P# *[_^2:7_ (>A_%3_ * '@_\ \ KK_P"2:^/%IU']GX7_ )]H/8T[
M;'V#_P /0_BI_P! #P?_ . 5U_\ )-*/^"H7Q4_Z '@__P  KK_Y)KX]I5I?
MV?A?^?:%[&'8^PO^'H7Q4_Z '@__ , KK_Y)H_X>A?%3_H >#_\ P"NO_DFO
MC^BG_9^%_P"?:#V,.Q]@#_@J#\5/^@!X/_\  .Z_^2:7_AZ!\4_^@!X/_P#
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M (!W7_R31_P\R^*'_0!\(_\ @'=?_)-?)%%'U#"_\^T'L8=CZW_X>9?%#_H
M^$?_  #NO_DFE_X>8_$__H ^$?\ P#NO_DFOD>G4?4,+_P ^T'L8=CZV_P"'
MF'Q/_P"@#X1_\ [K_P"2:4?\%,/B?_T O"/_ (!W7_R37R12K1]0PO\ S[0>
MQAV/K?\ X>7_ !/_ .@%X2_\ [K_ .2:/^'E_P 3_P#H!>$O_ .Z_P#DFODJ
MBE]0PO\ (@]C#L?6P_X*7?$__H!>$O\ P#NO_DFE_P"'EWQ._P"@%X2_\ [K
M_P"2:^2EZ4M#P&%_D0O90['UI_P\N^)W_0"\)?\ @'=?_)-+_P /+/B=_P!
M+PE_X!W7_P DU\E4ZE]0PW\B!TH=CZS_ .'EGQ._Z 7A+_P#NO\ Y)I1_P %
M*_B<?^8%X3_\ [K_ .2:^2Z<M'U##?R(/90ML?6?_#RKXG?] +PG_P" =U_\
MD4?\/*OB=_T O"?_ (!W7_R17R;11]0PW\B$J4.Q]9_\/*/B;_T O"?_ (!W
M7_R12_\ #RCXF_\ 0"\)_P#@'=?_ "17R;2T?4,-_(@]E#L?6/\ P\H^)O\
MT O"?_@'=?\ R12_\/)OB;_T O"?_@)=?_)%?)M.H^H8;^1![*'8^L/^'DWQ
M-_Z 7A/_ ,!+K_Y(I1_P4F^)O_0#\)_^ EU_\D5\G4JT?4,-_(@]E#L?6/\
MP\E^)G_0#\)_^ EU_P#)%'_#R7XF?] /PG_X"77_ ,D5\H44?4,-_(@]E#L?
M5_\ P\D^)G_0#\)_^ EU_P#)%._X>2?$S_H!^$__  $N?_DBODZGT?4,-_(@
M]E#L?5W_  \D^)G_ $ _"?\ X"7/_P D4?\ #R3XF?\ 0#\)_P#@)<__ "17
MRC12>!PW\B#V4.Q]7#_@I%\3/^@'X3_\!+G_ .2*7_AY%\2_^@'X4_\  2Y_
M^2*^45I:7U'#?R(/90['U;_P\B^)?_0#\*?^ ES_ /)%+_P\B^)?_0#\*?\
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M2*^7Z*/J6&_D0>SAV/J ?\%#/B-_T!?"_P#X"W/_ ,D4[_AX5\1?^@+X7_\
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M^OFBBCZGA_Y$'LX=CZ7_ .&_?B%_T!O#/_@+<?\ Q^C_ (;]^(7_ $!O#/\
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MC_AOWXA?] ;PS_X"W'_Q^OFBBCZGA_Y$'LX=CZ7_ .&_?B%_T!O#/_@+<?\
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M^OFBBCZGA_Y$'LX=CZ7_ .&_?B%_T!O#/_@+<?\ Q^C_ (;]^(7_ $!O#/\
MX"W'_P ?KYHHH^IX?^1![.'8^E_^&_?B%_T!O#/_ ("W'_Q^C_AOWXA?] ;P
MS_X"W'_Q^OFBBCZGA_Y$'LX=CZ7_ .&_?B%_T!O#/_@+<?\ Q^C_ (;]^(7_
M $!O#/\ X"W'_P ?KYHHH^IX?^1![.'8^E_^&_?B%_T!O#/_ ("W'_Q^C_AO
MWXA?] ;PS_X"W'_Q^OFBBCZGA_Y$'LX=CZ7_ .&_?B%_T!O#/_@+<?\ Q^KE
MK_P4"\9)C[3X=T*;U\H31_SD:OERBCZEA_Y$+V4.Q]K^'?\ @H3ITTBIKOA"
MZM4_BFT^[68_]\.J?^A5[AX!_:.^'_Q':&#2]?A@OY3M6QO_ -Q,3Z -PQ_W
M2:_+BE!*D$'!%<M3+*$OAT(E0B]M#]DJ*_-OX/\ [6GC#X7O%9WD[^(]"4\V
M=[*3)&._ER')7Z'(]J^]/AE\5_#GQ:T(:GX?O1.%P)[:3"S6['^%U[=.#T/8
MUX.(P=3#ZO5=SDG3E#<["BBBN$R"BBB@ HHHH **** "BBOGK]M;]HP?L_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MRTVG+38"T445(#Z*** %6EI%I: "G+3:<M "T444 /HHHI( IU-IU)@%%%%
MF/HHHH&%.6FTY: %HHHH *=3:=2 *5:2E6A@.HHHI(!R]*6D7I2T, IU-IU(
M3"G+3:<M =!:*** 0ZEI*6@04ZFTZ@ I5I*5: '4444 %/IE/H ****E@*M+
M2+2T= "EI*6D ZBBB@!5IU-6G4 %.IM.H$%*O6DI5ZT#'4444D JTZFK3J3
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MT-1U"YU;4+J^O)FN+NZE:::9^KNQ)9C[DDFOO']@GQ+=:K\+]5TJXF:5-+U
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MY++YV>S_ ,CBBW[%GF'[?G@W0/!OC;PO!H&AZ;H<$VGN\D>FVD=NKMYI&6"
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MRL "< D')/!X^.].\):YK&K-I=AHVH7NIJ<-96]K)),/J@&[]*_3[X;?MO\
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M=X]\&^)[C_CX\.RSNJ8!$@DCPN?]UPK#WKQ#]O;Q]_9'@?2?"D#XGUBX^T7
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MO,IO]6G6[NHQ@E+:(Y7//&Z3;C_KFU97_!-F^A?0/'-D&_TB.ZM9F7'\+)(
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MXO6>M^([[^SM,CM9XVG\F27#,N%&U%9NOM7="$_J');6ST-$G[*Q]D_MM?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)R\]S(TDC?5B2356GA,*L+%J]VQTZ?LT%%%%=QJ%%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M(!ZTY::M.6D ]:<M-6G+2 =1112 **** "BBB@ HHHH **** "BBB@ HHHH
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MGT= "BBBD ZBBB@!RTM(M+0 4Y>E-IR]* %HHHH =1114@.6EI%I:& 4444
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M*[.BCVD_YF',^YQG_"E_A[_T(GAG_P $]O\ _$4?\*7^'O\ T(GAG_P3V_\
M\179T4>TG_,PYGW.,_X4O\/?^A$\,_\ @GM__B*/^%+_  ]_Z$3PS_X)[?\
M^(KLZ*/:3_F8<S[G&?\ "E_A[_T(GAG_ ,$]O_\ $4?\*7^'O_0B>&?_  3V
M_P#\179T4>TG_,PYGW.,_P"%+_#W_H1/#/\ X)[?_P"(H_X4O\/?^A$\,_\
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M_"E_A[_T(GAG_P $]O\ _$5V=%'M)_S,.9]SC/\ A2_P]_Z$3PS_ .">W_\
MB*/^%+_#W_H1/#/_ ()[?_XBNSHH]I/^9AS/N<9_PI?X>_\ 0B>&?_!/;_\
MQ%'_  I?X>_]")X9_P#!/;__ !%=G11[2?\ ,PYGW.?TWX?>%M%D$FG^&M'L
M9!T:VL(HS^:J*Z"BBH<G+<D****0!1110 4444 %%%% !1110 4444 %%%%
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M,]_"S_HFG@__ ,$-K_\ &Z] HH]M4_F?WAS/N<!_PSY\+?\ HFOA#_P0VO\
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M_&Z[VBCVU3^9_>',^YP7_"@/A?\ ]$W\(_\ @BM?_C='_"@/A?\ ]$W\(_\
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M+_P1VO\ \;H_X4'\,?\ HG/A+_P1VO\ \;KO**/:U/YG]X<S[G!_\*#^&/\
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M//"O_@DMO_B*[FBCVM3^9_>',^YPW_"B?AK_ -$\\*_^"2V_^(H_X43\-?\
MHGGA7_P26W_Q%=S11[6I_,_O#F?<X;_A17PU_P"B>^%?_!);?_$4?\**^&O_
M $3WPK_X)+;_ .(KN:*/:U/YG]X<S[G#_P#"BOAM_P!$]\*_^"2V_P#B*/\
MA1?PV_Z)[X5_\$MM_P#$5W%%'M:G\S^\.9]SA_\ A1?PV_Z)[X5_\$MM_P#$
M4?\ "B_AM_T3WPK_ ."6V_\ B*[BBCVM3^9_>',^YP__  HOX;?]$]\*_P#@
MEMO_ (BC_A1?PV_Z)[X5_P#!+;?_ !%=Q11[6I_,_O#F?<X?_A1?PV_Z)[X5
M_P#!+;?_ !%'_"B_AO\ ]$^\*_\ @EMO_B*[BBCVM3^9_>',^YP__"C/AO\
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MCVM3^9AS/N<3_P *1^'/_0@>%_\ P36W_P 12_\ "D?AU_T(/A?_ ,$UM_\
M$5VM%'M:G\S#F?<XK_A2/PZ_Z$'PO_X)K;_XBC_A2/PZ_P"A!\+_ /@FMO\
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M  I7X>_]"'X9_P#!/;__ !%=G11[2?\ ,PYGW.,_X4M\/?\ H1/#/_@GM_\
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M%'M)_P S#F?<XS_A2_P]_P"A$\,_^">W_P#B*/\ A2_P]_Z$3PS_ .">W_\
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M -")X9_\$]O_ /$4?\*7^'O_ $(GAG_P3V__ ,179T4>TG_,PYGW.,_X4O\
M#W_H1/#/_@GM_P#XBC_A2_P]_P"A$\,_^">W_P#B*[.BCVD_YF',^YQG_"E_
MA[_T(GAG_P $]O\ _$4?\*7^'O\ T(GAG_P3V_\ \179T4>TG_,PYGW.,_X4
MO\/?^A$\,_\ @GM__B*/^%+_  ]_Z$3PS_X)[?\ ^(KLZ*/:3_F8<S[G&?\
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M]Z5_\AT?\,S^-?\ HXGXC_\ ?O2O_D.@#W^BO /^&9_&O_1Q/Q'_ ._>E?\
MR'1_PS/XU_Z.)^(__?O2O_D.@#W^BO /^&9_&O\ T<3\1_\ OWI7_P AT?\
M#,_C7_HXGXC_ /?O2O\ Y#H ]_HKP#_AF?QK_P!'$_$?_OWI7_R'1_PS/XU_
MZ.)^(_\ W[TK_P"0Z /?Z*\ _P"&9_&O_1Q/Q'_[]Z5_\AT?\,S^-?\ HXGX
MC_\ ?O2O_D.@#W^BO /^&9_&O_1Q/Q'_ ._>E?\ R'1_PS/XU_Z.)^(__?O2
MO_D.@#W^BO /^&9_&O\ T<3\1_\ OWI7_P AT?\ #,_C7_HXGXC_ /?O2O\
MY#H ]_HKP#_AF?QK_P!'$_$?_OWI7_R'1_PS/XU_Z.)^(_\ W[TK_P"0Z /?
MZ*\ _P"&9_&O_1Q/Q'_[]Z5_\AT?\,S^-?\ HXGXC_\ ?O2O_D.@#W^BO /^
M&9_&O_1Q/Q'_ ._>E?\ R'1_PS/XU_Z.)^(__?O2O_D.@#W^BO /^&9_&O\
MT<3\1_\ OWI7_P AT?\ #,_C7_HXGXC_ /?O2O\ Y#H ]_HKP#_AF?QK_P!'
M$_$?_OWI7_R'1_PS/XU_Z.)^(_\ W[TK_P"0Z /?Z*\ _P"&9_&O_1Q/Q'_[
M]Z5_\AT?\,S^-?\ HXGXC_\ ?O2O_D.@#W^BO /^&9_&O_1Q/Q'_ ._>E?\
MR'1_PS/XU_Z.)^(__?O2O_D.@#W^BO /^&9_&O\ T<3\1_\ OWI7_P AT?\
M#,_C7_HXGXC_ /?O2O\ Y#H ]_HKP#_AF?QK_P!'$_$?_OWI7_R'1_PS/XU_
MZ.)^(_\ W[TK_P"0Z /?Z*\ _P"&9_&O_1Q/Q'_[]Z5_\AT?\,S^-?\ HXGX
MC_\ ?O2O_D.@#W^BO /^&9_&O_1Q/Q'_ ._>E?\ R'1_PS/XU_Z.)^(__?O2
MO_D.@#W^BO /^&9_&O\ T<3\1_\ OWI7_P AT?\ #,_C7_HXGXC_ /?O2O\
MY#H ]_HKP#_AF?QK_P!'$_$?_OWI7_R'1_PS/XU_Z.)^(_\ W[TK_P"0Z /?
MZ*\ _P"&9_&O_1Q/Q'_[]Z5_\AT?\,S^-?\ HXGXC_\ ?O2O_D.@#W^BO /^
M&9_&O_1Q/Q'_ ._>E?\ R'1_PS/XU_Z.)^(__?O2O_D.@#W^BO /^&9_&O\
MT<3\1_\ OWI7_P AT?\ #,_C7_HXGXC_ /?O2O\ Y#H ]_HKP#_AF?QK_P!'
M$_$?_OWI7_R'1_PS/XU_Z.)^(_\ W[TK_P"0Z /?Z*\ _P"&9_&O_1Q/Q'_[
M]Z5_\AT?\,S^-?\ HXGXC_\ ?O2O_D.@#W^BO /^&9_&O_1Q/Q'_ ._>E?\
MR'1_PS/XU_Z.)^(__?O2O_D.@#W^BO /^&9_&O\ T<3\1_\ OWI7_P AT?\
M#,_C7_HXGXC_ /?O2O\ Y#H ]_HKP#_AF?QK_P!'$_$?_OWI7_R'1_PS/XU_
MZ.)^(_\ W[TK_P"0Z /?Z*\ _P"&9_&O_1Q/Q'_[]Z5_\AT?\,S^-?\ HXGX
MC_\ ?O2O_D.@#W^BO /^&9_&O_1Q/Q'_ ._>E?\ R'1_PS/XU_Z.)^(__?O2
MO_D.@#W^BO /^&9_&O\ T<3\1_\ OWI7_P AT?\ #,_C7_HXGXC_ /?O2O\
MY#H ]_HKP#_AF?QK_P!'$_$?_OWI7_R'1_PS/XU_Z.)^(_\ W[TK_P"0Z /?
MZ*\ _P"&9_&O_1Q/Q'_[]Z5_\AT?\,S^-?\ HXGXC_\ ?O2O_D.@#W^BO /^
M&9_&O_1Q/Q'_ ._>E?\ R'1_PS/XU_Z.)^(__?O2O_D.@#W^BO /^&9_&O\
MT<3\1_\ OWI7_P AT?\ #,_C7_HXGXC_ /?O2O\ Y#H ]_HKP#_AF?QK_P!'
M$_$?_OWI7_R'1_PS/XU_Z.)^(_\ W[TK_P"0Z /?Z*\ _P"&9_&O_1Q/Q'_[
M]Z5_\AT?\,S^-?\ HXGXC_\ ?O2O_D.@#W^BO /^&9_&O_1Q/Q'_ ._>E?\
MR'1_PS/XU_Z.)^(__?O2O_D.@#W^BO /^&9_&O\ T<3\1_\ OWI7_P AT?\
M#,_C7_HXGXC_ /?O2O\ Y#H ]_HKP#_AF?QK_P!'$_$?_OWI7_R'1_PS/XU_
MZ.)^(_\ W[TK_P"0Z /?Z*\ _P"&9_&O_1Q/Q'_[]Z5_\AT?\,S^-?\ HXGX
MC_\ ?O2O_D.@#W^BO /^&9_&O_1Q/Q'_ ._>E?\ R'1_PS/XU_Z.)^(__?O2
MO_D.@#W^BO /^&9_&O\ T<3\1_\ OWI7_P AT?\ #,_C7_HXGXC_ /?O2O\
MY#H ]_HKP#_AF?QK_P!'$_$?_OWI7_R'1_PS/XU_Z.)^(_\ W[TK_P"0Z /?
MZ*\ _P"&9_&O_1Q/Q'_[]Z5_\AT?\,S^-?\ HXGXC_\ ?O2O_D.@#W^BO /^
M&9_&O_1Q/Q'_ ._>E?\ R'1_PS/XU_Z.)^(__?O2O_D.@#W^BO /^&9_&O\
MT<3\1_\ OWI7_P AT?\ #,_C7_HXGXC_ /?O2O\ Y#H ]_HKS#X7_"#Q#\/]
M?N-1U;XK>+/'5M+;-;KIVO+9""-BZ,)5\BWC;> I49)&';C."/3Z "BBB@ H
MK@/BM\,]:^(O]E_V/\1?$G@'['YOF_\ "/K:G[7OV;?,\^&3[FTXVX^^V<\8
M\_\ ^&9_&O\ T<3\1_\ OWI7_P AT >_T5X!_P ,S^-?^CB?B/\ ]^]*_P#D
M.C_AF?QK_P!'$_$?_OWI7_R'0![_ $5X!_PS/XU_Z.)^(_\ W[TK_P"0Z/\
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M_(= 'O\ 17@'_#,_C7_HXGXC_P#?O2O_ )#H_P"&9_&O_1Q/Q'_[]Z5_\AT
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MO_D.C_AF?QK_ -'$_$?_ +]Z5_\ (= 'O]%> ?\ #,_C7_HXGXC_ /?O2O\
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MWI7_ ,AT?\,S^-?^CB?B/_W[TK_Y#H ]_HKP#_AF?QK_ -'$_$?_ +]Z5_\
M(='_  S/XU_Z.)^(_P#W[TK_ .0Z /?Z*\ _X9G\:_\ 1Q/Q'_[]Z5_\AT?\
M,S^-?^CB?B/_ -^]*_\ D.@#W^BO /\ AF?QK_T<3\1_^_>E?_(='_#,_C7_
M *.)^(__ '[TK_Y#H ]_HKP#_AF?QK_T<3\1_P#OWI7_ ,AT?\,S^-?^CB?B
M/_W[TK_Y#H ]_HKP#_AF?QK_ -'$_$?_ +]Z5_\ (='_  S/XU_Z.)^(_P#W
M[TK_ .0Z /?Z*\ _X9G\:_\ 1Q/Q'_[]Z5_\AT?\,S^-?^CB?B/_ -^]*_\
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MWI7_ ,AT?\,S^-?^CB?B/_W[TK_Y#H ]_HKP#_AF?QK_ -'$_$?_ +]Z5_\
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M&9_&O_1Q/Q'_ ._>E?\ R'0![_17@'_#,_C7_HXGXC_]^]*_^0Z/^&9_&O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MFOS0\=?\%@O%?C+QE+X>^!?PKD\2L&86\VIV]Q=W-T <;UM+8AE7D8RY/(R
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MLD3+\\)42'*'MD$&OI7P'\:/ OQ0UK7])\(^*M,\27V@O&FI1Z;.)EMFDW[
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M[76CZ_I?BFTTO1O'6CN)S::6LD<%U9M@++&LCNP*M\KC<0-R'^+ YS_@L?\
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M6J75C:W*7A6U\WRR7:X9,GRQN^3G)QBOT(K\6?V(_P#E*QXA_P"PSXD_]N*
M/U3_ &C/VD/!O[+_ ,/)O%OC&[D6$OY%GI]J US?3D$B.)20,X!)8D  <GIG
M\](_^"K7Q_\ BMJEY)\(_@=!J^E6[E75=,U#69D'&-[VS1JIP1QCOUKRS_@J
M]XNU/XI_MG:9\/H[O;::+;6.F6L+'Y(KB["2O(1ZL)80?:-:_8?X6_#/P_\
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MOT3H **** "BBB@ HHHH **** "BBB@ KXJ_;6_:<_:+^"_Q4TK1/A%\)_\
MA._#=QHT5[<:C_PCFHZCY=TT\Z-%YEM(J#"1Q-M(W#?G."*^U:* /QV\6?\
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MJ#(_OF-BWM/7[0>'=?L?%?A_2];TR87.FZE:Q7EK,O22*1 Z,/JK T ?C/\
M\/J_C?\ ]"M\/_\ P77W_P F5^Q/P]\967Q&\!^'/%6G,&L-;TZWU&#!SA)8
MU<#Z@-C\*_G'^!7PND^*R_$*S@@$USI'A*]UV)L99#:O#*Q4=R4#I]'-?J7^
MP[^TVN@_\$U?$>OW-QOU/X=VVH6";\;F8+YMFO/&,SQQC_<]: /&_CE_P6$^
M)G@GXQ>,_#OA'P_X,O?#>D:K<:?976HV5W)/,D3F/>S)=(IW%21A1P17Z1_L
MR_$[5/C/\ _ _C?6[>SM=6US3DN[F'3T=($<D@A [,P''=C7\^^M?#U]+_9P
M\/\ CFZC/VKQ!XGOK*.:3EI(;:W@;<#Z&2XD'N4YZ"OW9_8)_P"3.?A-_P!@
M2+_T)J /?:*** "BBB@ HHHH **** "BBB@ JEK5X^FZ/?W<05I+>"250PX)
M521GVXJ[67XJ_P"18UC_ *\YO_0#0!^17@G_ (*T?M,_$K59=,\(_##POXJU
M*&$W,EGHGA_4[R9(@RJ9"D=TQ"AG0;L8RP'<5N:U_P %5_VDOA7>6<OQ)^"N
MFZ'8W#8CCO=&U+27FQ]X(\\K@G'HIQ7D?_!(GXA>%?AK^TEXDU/Q=XET?PKI
MLWA*YMH[S6[^*SA>4WEFPC#R,H+%4<[<YPI/8U]B_P#!2K]J[X+^)OV7?$WA
M#2?&&@^-?$>KO;+I]KH=Y%?>1(DZ2&9I(RRQA45AUR2VW&"< 'T_^S]^TYX=
M_:4^"3?$#PLC6[1)-%=Z;=,&DLKJ--S1/M/(P58$8RK \9P/S;\$_P#!6C]I
MGXE:K+IGA'X8>%_%6I0PFYDL]$\/ZG>3)$&53(4CNF(4,Z#=C&6 [BO6O^".
M_AG5M-_9O^*6LW:2Q:3J=\R6(D3"NT5L1*ZGN,NJYZ9C(ZYQ\B_\$O\ X]>!
M/V=_C[K_ (D^(6N_\(_HMUX9N-/AN?L<]SNG:ZM)%3;#&[#*Q2')&/EZY(R
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MX#4;^[L_MI*)J%G=,Y6:&;:=L@5P"0&VL'4]Z /H*3_@JS^T%\*]1L;CXM?
M^WTG1;IPL8;2M0T:60=6\M[EI%8XYQM[?E^C_P "?C?X8_:(^&6D^./"5P\V
MEWZE6AF7;-;3+Q)#(O9U/'&01@@D$$_#7BG_ (*(?LU_MA?#34?AS\2T\2>
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M%$N7O5T+2;32Q<R9W3"&%(]Y]SMS^-=)0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110!\@_P#!5[_DR/QC_P!?FG?^
MED5?#W_!/3_@GI\.OVLO@OK7B[Q=K7BC3M2LO$$VE1Q:)=6T4)B2VMI0Q$EO
M(=VZ9^<XP!QU)_2C]MOX$:_^TE^SMKW@+PS>:;8ZQ?W%I+%/JTLD=N!%.DC;
MFC1VSA3C"GGTKEO^">G[+_BK]DWX+ZUX1\77^CZCJ5[X@FU6.71)I981$]M;
M1!29(HSNW0OQC&".>H !@_"/_@E?\!_A)XALM;73-5\6ZC9.);=O$MXD\22
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MQ$MO&/A/0_%EO:Z5;R6\.N:;#>I"QF8%D$JL%)'&17ZF?\,G?!#_ *(W\/\
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M!OB#]D6[\9:SXSU'0]6U_6$@M+2319994@MD+/("TL49R[E,@ C]VO/I]M4
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MFJ2:O9VLC!7N;:2*-'*#^(H\1+8Z"1:]HN?^"H7PL\,_%WQIX#\:6.M>#I=
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M-#DL(9X\C<H9F*L""NYNHXH D^(W_!-W]G;XLV[W8\$6N@W-TN^/4?"UPUD
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MO_*(&7_LGMU_Z+DKD/V\/^"8.M_M$?%F+QY\.-3\/Z'?:C!LURVUJ::%)9D
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M>E?H_P#!?X+^$_@#\/\ 3_!O@S31IVC6>6^9M\L\K8WRRO\ QNV!D^P
M!^,7P U>V_8?_P""C,^F^+BNE:%9ZG>:/<74HVI':7"M]FN,X&(_F@<GC"Y]
M*_7+]IC]F?PC^U]\.=+\+^*-4U6TT>WU&+6(+G0;B%))'6&6-?FDCD4H5G8\
M#.0O..O%?MA?L%^!OVNK6VO]0GF\-^,K&'R+7Q!91J[-'DD13QG'FH"21RK
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MMSJF@Z/;:?<S63LT#R1QA6*%E5BN1QE0?:O0J "BBB@ HHHH **** "BBB@
MHHHH **** "OP5\=?"W2OC9_P4Y\3^!M<N+RUTG7/&EY:W,VGNB3HNYSE&=6
M4'('537[U5^=>C_\$Z_B1I_[>DGQMDUOPLWA5O$T^LBS6[N?MWDOOPNS[/LW
M_,.-^/>@#>TW_@B_\"[&[2:;7/'.H1KUM[G4K4(WU,=JK?D17U]\'_@GX*^
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M7Q*\/^,? VJ>']*O8=-.GZFNN7$\(EV2%H73RH9,G$DBMG'"IC/8 ]._;/\
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M5X)U75+SP[93W-]>^';.:>>1HE+.[M&69B>22<FO;O#?[.OPH\&ZY:ZSX?\
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M'XQ\"ZA>Z3<ZEJ8T\^';VZ-RDB>4[F6%F!D&PJH;<S#YUY!P&]RD\;:YX_\
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M%% !1110 4444 %%%% !7R#_ ,%7O^3(_&/_ %^:=_Z615]?5X1^VW\"-?\
MVDOV=M>\!>&;S3;'6+^XM)8I]6EDCMP(ITD;<T:.V<*<84\^E 'YK_\ !/3_
M ()Z?#K]K+X+ZUXN\7:UXHT[4K+Q!-I4<6B75M%"8DMK:4,1);R'=NF?G.,
M<=2?N'X1_P#!*_X#_"3Q#9:VNF:KXMU&R<2V[>);Q)XDD!RK&*...-B.P92.
M!QGFM[_@GI^R_P"*OV3?@OK7A'Q=?Z/J.I7OB";58Y=$FEEA$3VUM$%)DBC.
M[="_&,8(YZ@?4% 'Q;_P5U_Y,SU;_L,6'_HPUYC_ ,$HO@7\-OB+^R[/JOBO
MX>^%?$^J#Q!=PB^UG1;:[G$:QPE4WR(S;02<#..37T[^W3^SWXB_:<_9_OO
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MU\/O^@/XE_\  6W_ /C]? U%']FX?L_O#_5++.TOO/OG_AOKX??] ?Q+_P"
MMO\ _'Z/^&^OA]_T!_$O_@+;_P#Q^O@:BC^S</V?WA_JEEG:7WGWS_PWU\/O
M^@/XE_\  6W_ /C]'_#?7P^_Z _B7_P%M_\ X_7P-11_9N'[/[P_U2RSM+[S
M[Y_X;Z^'W_0'\2_^ MO_ /'Z/^&^OA]_T!_$O_@+;_\ Q^O@:BC^S</V?WA_
MJEEG:7WGWS_PWU\/O^@/XE_\!;?_ ./T?\-]?#[_ * _B7_P%M__ (_7P-11
M_9N'[/[P_P!4LL[2^\^^?^&^OA]_T!_$O_@+;_\ Q^C_ (;Z^'W_ $!_$O\
MX"V__P ?KX&HH_LW#]G]X?ZI99VE]Y]\_P##?7P^_P"@/XE_\!;?_P"/T?\
M#?7P^_Z _B7_ ,!;?_X_7P-11_9N'[/[P_U2RSM+[S[Y_P"&^OA]_P! ?Q+_
M . MO_\ 'Z/^&^OA]_T!_$O_ ("V_P#\?KX&HH_LW#]G]X?ZI99VE]Y]\_\
M#?7P^_Z _B7_ ,!;?_X_1_PWU\/O^@/XE_\  6W_ /C]? U%']FX?L_O#_5+
M+.TOO/OG_AOKX??] ?Q+_P" MO\ _'Z/^&^OA]_T!_$O_@+;_P#Q^O@:BC^S
M</V?WA_JEEG:7WGWS_PWU\/O^@/XE_\  6W_ /C]'_#?7P^_Z _B7_P%M_\
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MHH_LW#]G]X?ZI99VE]Y]\_\ #?7P^_Z _B7_ ,!;?_X_1_PWU\/O^@/XE_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %??/[ O_)'=8_[#TW_I/;U\#5]\_L"_\D=UC_L/
M3?\ I/;UY>9?[N_5'QG%O_(L?JCZ5HHHKY,_#PHHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ML88GO MUYOE@HTJID>8-WS\8.,U^V7_#)WP0_P"B-_#_ /\ "7L?_C5?GO\
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MKYE44J[:M;=*_P#E?7SL?!MWX3N_'7QEO_#]A)##>:CK,]O%)<,5C5C*V"Q
M)Q] :]?C_8%\?EP'UKPVJ]RMQ<$_EY KB_AI_P G6:;_ -C))_Z-:OTKK3&8
MJIAW&,.J.C/LZQ>62HT\.TDXIZJY\V_ G]CFQ^&FO6_B'Q#J,>MZQ:MOM8((
MRMO V/O_ #<NP[<  \X)P1])445X-6M.M+FF[L_,\;CL1F%7VV)E=_EZ'Q__
M ,% /"NG1Z?X9\1QP"/59)WL99EX\V+:74-ZE2#@_P"T?;'3_L'^%=.L?AG?
MZ]'#G4[^]>"69N3Y<8&U1Z#+$GU/T%9__!0+_D1/"_\ V$G_ /11KI_V'?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** /BK_@I#^Q3XX_;"_P"%=_\ "&ZKX?TS_A'?[1^U
M_P!NW$\6_P"T?9=GE^5#)G'D/G..JXSSCZ@^"/@F^^&OP7\ ^$=3EMY]2\/^
M']/TJZEM&9H7E@MHXG9"RJ2I9#@D XQD#I7:T4 %%%% !1110 4444 %%%%
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M%_C[4_B?_P $[;SQ)K+K+JEU8K%<2J,>8T5^(=Y'JWE[CCC)-?/7[./[%?\
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M/A-H'P7\%VOAOP];F.VC/F33R<RW,I #2R'NQP/8  #@5V=?)G[(/[)GB_\
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MWKOW#&??;L_#%>]^,?".F>//"^I^'M9M_M.F:C UO/'G!VGN#V(."#V(!KY
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MSP>U=I\)?V6/B9I/A/4/ GCSQCIFH?#R?3KBS@TO2RSR0R2.KK*'>%3E7!8
ML0"3Q@FN6\$_L=?&_P"%_P#:NB^$?BAIFC^&M1DS/+")!<'MO5#&?+? '*2
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M_P!!CQ+_ .!5O_\ &*/^&!?A]_T&/$O_ (%6_P#\8KZ5HH^N8C^=A_;V9_\
M/^1\U?\ # OP^_Z#'B7_ ,"K?_XQ1_PP+\/O^@QXE_\  JW_ /C%?2M%'US$
M?SL/[>S/_G_(^:O^&!?A]_T&/$O_ (%6_P#\8H_X8%^'W_08\2_^!5O_ /&*
M^E:*/KF(_G8?V]F?_/\ D?-7_# OP^_Z#'B7_P "K?\ ^,4?\,"_#[_H,>)?
M_ JW_P#C%?2M%'US$?SL/[>S/_G_ "/FK_A@7X??]!CQ+_X%6_\ \8H_X8%^
M'W_08\2_^!5O_P#&*^E:*/KF(_G8?V]F?_/^1\U?\,"_#[_H,>)?_ JW_P#C
M%'_# OP^_P"@QXE_\"K?_P",5]*T4?7,1_.P_M[,_P#G_(^:O^&!?A]_T&/$
MO_@5;_\ QBC_ (8%^'W_ $&/$O\ X%6__P 8KZ5HH^N8C^=A_;V9_P#/^1\U
M?\,"_#[_ *#'B7_P*M__ (Q1_P ,"_#[_H,>)?\ P*M__C%?2M%'US$?SL/[
M>S/_ )_R/FK_ (8%^'W_ $&/$O\ X%6__P 8H_X8%^'W_08\2_\ @5;_ /QB
MOI6BCZYB/YV']O9G_P _Y'S5_P ,"_#[_H,>)?\ P*M__C%'_# OP^_Z#'B7
M_P "K?\ ^,5]*T4?7,1_.P_M[,_^?\CYJ_X8%^'W_08\2_\ @5;_ /QBC_A@
M7X??]!CQ+_X%6_\ \8KZ5HH^N8C^=A_;V9_\_P"1\U?\,"_#[_H,>)?_  *M
M_P#XQ1_PP+\/O^@QXE_\"K?_ .,5]*T4?7,1_.P_M[,_^?\ (^:O^&!?A]_T
M&/$O_@5;_P#QBC_A@7X??]!CQ+_X%6__ ,8KZ5HH^N8C^=A_;V9_\_Y'S5_P
MP+\/O^@QXE_\"K?_ .,4?\,"_#[_ *#'B7_P*M__ (Q7TK11]<Q'\[#^WLS_
M .?\CYJ_X8%^'W_08\2_^!5O_P#&*/\ A@7X??\ 08\2_P#@5;__ !BOI6BC
MZYB/YV']O9G_ ,_Y'S5_PP+\/O\ H,>)?_ JW_\ C%'_  P+\/O^@QXE_P#
MJW_^,5]*T4?7,1_.P_M[,_\ G_(^:O\ A@7X??\ 08\2_P#@5;__ !BC_A@7
MX??]!CQ+_P"!5O\ _&*^E:*/KF(_G8?V]F?_ #_D?-7_  P+\/O^@QXE_P#
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MR0%3@CJ"17N]:3I5*:3G%J^UT*Z"BBBLAA1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MR^A]6EB:4VTMO^"+F=[,_3'7-<T[PSI-UJFKW]MI>FVJ>9/>7DJQ11+ZLS$
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MX*_"GQE^W%\<;]M7UR0RR*;_ %G6KA=YAAW!0D:<#))"H@P  >RU]'_M ?\
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M:8UQ*26D2)R(R23R0A1<GKMKZ*KY^M3=&I*F^CL:IW5PHHHK$84444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %>5?LT_\ ).M7_P"QS\6?^I#J->JU
MY5^S3_R3K5_^QS\6?^I#J- 'JM%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7N%Y2DTGL?%__!..9+CXX>,Y8VW1OI,C*WJ#<Q$&O;?''[=]CIWCJ[\*>!O
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MC&22=2DKQ^U$^MI5*<:<\7@8WI/^)2?3S7EV>Z]-O5?A?\4M"^+7AF+6-$N
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M]5Q'_/N7W,[*BN-_X71\/O\ H>O#7_@WM_\ XNC_ (71\/O^AZ\-?^#>W_\
MBZ/9S_E8?5<1_P ^Y?<SLJ*XW_A='P^_Z'KPU_X-[?\ ^+H_X71\/O\ H>O#
M7_@WM_\ XNCV<_Y6'U7$?\^Y?<SLJ*XW_A='P^_Z'KPU_P"#>W_^+H_X71\/
MO^AZ\-?^#>W_ /BZ/9S_ )6'U7$?\^Y?<SLJ*XW_ (71\/O^AZ\-?^#>W_\
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M7_@WM_\ XNNRJ7&4=T95*52E;VD6K]U8****DR"BBB@ HHHH **** "BBB@
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M"BBBH*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "J46BZ?#JT^J1V-NFI3Q+#+>+$!*Z*254MC) )/%7:*8U)J]F>
M"_ML?\D,NO\ K_M__0C7HWP5_P"2.^!_^P)9?^B$KSG]MC_DAEU_U_V__H1K
MT;X*_P#)'? __8$LO_1"5V2_W:/J_P CZ.K_ ,B6E_U\E^2/!O\ @G__ ,BK
MXM_Z_8?_ $6:^G;[P_IFJ:C87]YI]M<WU@S-:7$L09X"PPQ0D9&1Z5\Q?\$_
M_P#D5?%O_7[#_P"BS7U;3QC:Q$K?UH/B&3CFM9Q=MO\ TE!1117"?-!1110
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MJ &25R<*B+D98GM]2< $U\?>(O\ @H!XDFO'_L+PUI5G:9^0:BTMQ(1ZDHR
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MBR(KHP=&&0RG((]:5:A4H.U1$8_+<5ELU#$QM?;JF.HHHKG/+"BBB@ HHHH
M**** "OR \4_\E$^(G_8Y^(?_3M=5^O]?D!XI_Y*)\1/^QS\0_\ IVNJ]C*_
MXS]/U1][P9_R,)_X'_Z5$H4445]0?LP4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7['5^.-?L=
M7S^;?8^?Z'Y;QO\ \PW_ &__ .VA1117SY^7!1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M2^%7 [ZBJ.C:YIOB*PCOM)U"UU.RD^Y<V<RS1M]&4D&KU3MHP"BBBD 4444
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MZ-^[P2R]NF*\/U#]D/X9?%;2(?$?@W4KS1[2_!D@>V!DMB 2IQ%( X^8'C<
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M-O7[3JL94CRPH1=^7=FO$&*HJE0RZE/G]DM9>>UEZ?\  Z!1117E'Q(4444
M%%%% !1110 5^0'BG_DHGQ$_['/Q#_Z=KJOU_K\@/%/_ "43XB?]CGXA_P#3
MM=5[&5_QGZ?JC[W@S_D83_P/_P!*B4****^H/V8**** "BBB@ HHHH ****
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MUN[G2?$&EZI;6:[KF:RO8YD@&"<N58A1@$\^AH\/^.?#?BZ6:/0O$&EZU)"
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M-%Y=Q-(5#-,YE4[ERP''4AN1BF_LKW6K_#G]H[5O D.H->:5YMY:W*KGRV:
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M5%]\.AJ/VK3;FYO]-O(XR?(DEMDE99E!Z',) /7#D5I[.+3<7L1SR32DMS]
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MOVG&T+@?ZO\ "O6?C1^U1X"^!5]%I_B"[NKK5Y(_.&FZ9")9E0YPS9957..
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M>_[D>G'[(44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M?/G[8GP7U#XH>$+#5-#MC=ZUHK2,+6-<R7$+@;E7U8%00O?YL<GGYI^"O[4W
MB+X'Z;+X>N=*CUC28I6=;.XD:":W8DEE5MIP">2"IYSTR:_1FL+7/ ?AGQ1-
MYVL^'=)U:7&/,OK&*9L?5E->E1Q<8T_8U8\T3ZW 9W2I83ZAC:/M*=[K6S7]
M?(^ ?C5^U%XA^.6FP>'X-(BTG2VG63[);NT\T[C[BEL#(!/0*,G\*^G_ -CW
MX0ZG\+_ =[=ZW$UIJNM2I.]FX(>") 0BN.S'<Q([ @'D$5Z]H?@+PSX8F\[1
M_#NDZ3-T\RQL8H6YZ\JHK>HK8J,J?L:4>6(9AG5*MA/J&"H^SIWN];M_U\S\
MU/AI_P G6:;_ -C))_Z-:OTKKF;7X8^#K+5EU2W\)Z'!J:R^<M[%IL*S"0G)
M<.%SNSWSFNFK/%8A8AQ:5K(Y,ZS2&:3ISA%QY8VU"BBBN$^=/E;_ (*!?\B)
MX7_["3_^BC73_L._\D.3_L)7'\DKVWQ!X3T3Q9;Q0:YHVGZS#$V^./4+5)U1
ML8R X.#CO4FA^'=*\+V/V+1M,L])L]Q?[/8VZ0Q[CU.U0!D^M=SQ">&5"VMS
MZ*6:0EE,<NY7=2O?IU_S+L\,=U#)#*@DBD4HZMT((P0:_-K6-+\2?LG_ !L6
M]@M3+#:S2-92SJ?)O;5@5QD=]IP1G*L/IG]*:HZQH>F^(K(V>JZ?:ZG:$[C;
MWD"RQD^NU@1W/YTL-B/8-IJ\7NB<HS7^S93A4ASTYJTE_7JS\Y_C+\;=?_:8
M\0Z'IECH1M(X69+/3+:0W$DDKX#,S;5S]T8X  S[FOM?P+\&;?0O@-#\/[YE
MW7&GRP7DR*#B:8,SL.>=K-P<]%'2NTT'P/X<\*R.^B>']+T=W&&:PLHX"?J4
M45MU=?%*<8TZ4>6*.G,<YCB*5+#8.G[.G3=TKW=^_P"?<_-+P1XN\4_LG_%*
M^6_TGS9E1K6ZLIF*)<P[@0\;X/=00V#U(QU%'C?Q=XH_:P^*E@ECI0AF9%M;
M6RA8NEM"&+,\CX&<;B2V!T QTK]&=>\*Z+XJ@2'6M'L-8AC)*1W]LDZJ3UP'
M!QT'Y4F@^$]$\*Q/%HNC:?I$3_>2PM4@!^H4"NK^T(7]IR>_;<]G_6BAS?6O
MJW^T6MS7T];?T^ESS#XO>+(_V=?@'#%I)!N[6WATC3G9 !YNS'F$>H5'?ODC
MGK7Y\^%/'%SX7\81>));&QU^_CD:?9K"/-$\IR?,8!E+,"<\GKS7ZK>(/"NB
M^++:.WUS1[#6;>-_,2'4+5)T5L$;@'! ."1GWK!_X4Q\/O\ H1?#7_@HM_\
MXBLL-BZ=&#4HW;W./*,]PV7T*D*U)RG-OF=]UV_/[SXX_P"&^OB#_P! ?PU_
MX"W'_P ?K[:^'_B"X\5^ O#6MW:11W>I:9;7DR0@A%>2)78*"20,L<9)^M9G
M_"F/A]_T(OAK_P %%O\ _$5U=E96^FV<%I:016MI;QK%#!"@1(T48554<
M  =,5AB*M&HDJ4.4\O-,;@,5"*P=#V;3U\R>BBBN$^="BBB@ HHHH **** "
MOR \4_\ )1/B)_V.?B'_ -.UU7Z_U^0'BG_DHGQ$_P"QS\0_^G:ZKV,K_C/T
M_5'WO!G_ ",)_P"!_P#I42A1117U!^S!1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 58T_3[G5;Z"SLX)
M+FZG<1Q0QKEG8] !1I^GW.JWT%G9P27-U.XCBAC7+.QZ "OT!_9E_9EMOA=8
MQ:_KT4=SXIG3*J1N6S4_PK_M>IKDQ.)CAXW>_1'A9MFU'*:///63V7?_ ( ?
MLR_LRVWPNL8M?UZ*.Y\4SIE5(W+9J?X5_P!KU-?0M%%?'U:LJTG.;U/P?&8R
MMCZSKUW=O\/)>04445D<(4444 %%%% !1110 4444 %%%% !1110 4444 %?
M)?\ P4&_Y%GP?_U^3_\ H"U]:5\Q?MS>$==\7>'O"L>A:+J.M20W4S2II]I)
M.4!1<%@@. ?>NW!-+$1;_K0^BX>E&&:492=E=_DSPWQ$Q^&NK? _QS'&4@ET
MRV:=NSF&3$@_[]2**TO">SXJ>._CEXUF7SK2UT'4WMBW(4O$\<.<^D2-CW ]
M*]+^/GPOUGQ-^S)\.$LM&U"[U_1K2QCDL(+5WG16M5253&!N!#*F>.,'-+^S
MI\*]7\._L[_$5-3T:_L]8UJWNX$L+BU>.=XUMF5 $(W$LSOCCGM7K.M#V7/?
MWKV^5_\ (^XECZ#P+Q'-^\YO9[_9Y[_D<I^QI_R3'XM_]>:?^B+BJO["-X^F
MZAX^NXU5G@TR.55;H2I<@'\JZ;]DWP-XD\.?#OXH6VK>']4TNYO+15MH;VRE
MA><^3.,(&4%CD@<>HI/V'O 7B'POKWBP^(/#NIZ3;W-G#&G]I6,D*R_.V5&]
M0&X/(]Z5:4;5]>WZ&685J3AF7O)W=.VN^BV.5_89T&S\4_$KQ%KFJPK?ZC96
MZSPR3 -MEDD.Z0?[7!Y[;C4/[>7A?3M%^(&B:G96T=M<:G:.UUY:[1*Z/C>?
M]HAL$]\"M+3/A_\ $3]ECXK7VI>&?#%WXP\-WBM$([*)Y3) 6#*K;%9HY%(
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MX+^VQ_R0RZ_Z_P"W_P#0C7HWP5_Y([X'_P"P)9?^B$KSG]MC_DAEU_U_V_\
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MA#++<G&R*)D*J2 =S?*0!@<%@:]?L_V!?@'8WXO(_AY;-*&W;9M0O)8^N?\
M5M,5Q[8KW/0]#T[PSI-KI>D6%MI>FVJ>7!9V<2Q11+Z*J@ #Z5%;$8-4G3P]
M+5]7T]-P2E>[9^;W_!0;QS\=?A'\3);G3_&FN6/@'5PK:;+IK"W2W?8!);M)
M& VX$%AN.2K<9(:NK^''_!5KPM#X#LK/QQX7URX\1P6RP3S:8L$UO=N%P7;S
M)$*;L9(PV,GK7WGX@\.Z5XKTBYTK6M-M-7TRY7;-9WT"S0R#T9&!!KP[4OV
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M]'S517TK_P ,"_$'_H,>&O\ P*N/_C%'_# OQ!_Z#'AK_P "KC_XQ1]<P_\
M.@_M[+/^?Z/FJBOI7_A@7X@_]!CPU_X%7'_QBC_A@7X@_P#08\-?^!5Q_P#&
M*/KF'_G0?V]EG_/]'S517TK_ ,,"_$'_ *#'AK_P*N/_ (Q1_P ,"_$'_H,>
M&O\ P*N/_C%'US#_ ,Z#^WLL_P"?Z/FJBOI7_A@7X@_]!CPU_P"!5Q_\8H_X
M8%^(/_08\-?^!5Q_\8H^N8?^=!_;V6?\_P!'S517TK_PP+\0?^@QX:_\"KC_
M .,4?\,"_$'_ *#'AK_P*N/_ (Q1]<P_\Z#^WLL_Y_H^:J*^E?\ A@7X@_\
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M7_@5<?\ QBCZYA_YT']O99_S_1\U45]*_P## OQ!_P"@QX:_\"KC_P",4?\
M# OQ!_Z#'AK_ ,"KC_XQ1]<P_P#.@_M[+/\ G^CYJHKZ5_X8%^(/_08\-?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %>5?LT_\DZU?_L<_%G_ *D.
MHUZK7E7[-/\ R3K5_P#L<_%G_J0ZC0!ZK1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7E7[-/_ "3K5_\
ML<_%G_J0ZC7JM>5?LT_\DZU?_L<_%G_J0ZC0!ZK1110 4444 %%%% !1110
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M=DVU@<!NBQ*<$N>I QQ][K?BO\+[;X0_L:Z[X=@E%Q/']EFN[E00)IVO(-S
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M7W?9Z=S-7]IKV/3]2_;2^"^EWSVDWCFW>53M+6UG<SQ]<<21Q,I'N#7?:/\
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MPW=?$*ZO-.N-/MDMM,T?1'(S;1MD(MN 42/^'=\O P#\HPYQBY)"A*5FSO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KRK]FG_DG6K_ /8Y^+/_
M %(=1KU6O*OV:?\ DG6K_P#8Y^+/_4AU&@#U6BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OE3]N3XO7OA
MK2=/\%Z7,]M+JT+7%_*G#&WR46,'/1B'W>R@=":^JZ*WHU%2J*<E>QZ67XJG
M@L3'$5*?.H]+VUZ='MN?FE\*_P!IS7O@]H)TO0/#WAW]XQ>>]N;:9KBX.>-[
MB89 '    ],DD_4GPY\4:Q^U=^S[XNM]:BL+"_N+F;3X#8QND0*10RQLP9V/
MWVYP>@Z5]$T5UUL5"I[T86E>][GMX_.Z&+?M:6&4*MT^;FN]/DC\]_AU\;_&
M7[,.GZWX,U'PMYEU)<-+;K>%H_)F*JNX8!\U"%4@ C/4'FO5?V+_ (8ZKX5C
M\0^/_$T$NG?;+<Q0?:4VNT.[S)967&0"53'K@GTKZSHHJ8Q3C)1A9RW?<,9G
MRQ%&I"G04)5;<\DV[V[+I^)^7/Q(^-%]\0_BD_BK4+2#4K.WG_T'2=0#-;I
MI.R-E5E)[%L$9.<\<5ZMX?\ VYO'5QJ6FZ>-$\,P6KRQP!8;2==B$A<*//P,
M#IQ7WA16LL;2E%1=+;;7_@';5XAP5:G&E/!)J*LO>V_\E/D3]LOX0:Y-XDTO
MXA^&K.6\DM8XTO8[="\D;1MNCFV]2,':<#C8#W->9_$SX^>+/VEM'TGP;8>$
MA%>)=+-.+)GE,LH#*, @>4@W-G<3TZ\5^@]%94\9R1BI0NX[,X\)GZH4J4:U
M!3G2^"5VK>JZGB4RZG^S7^R^GV(6MYJ^AVB.RW"LT)EEG!D&%8$@&5L'(S@'
MVK6_9J^+&K_&3X>SZ[K5M96MW'?R6H2P1TCVJB,#AG8YRQ[^E>KT5RRJJ46I
M1]YN]SQ:F,A6HSC4IWJ2ES<]^^ZM;OKN%?G=\'?^4C6O_P#84U?_ -%RU^B-
M%9QERIKN>1*/-;R"N#^/G_)"OB-_V+>I?^DLE=Y14+1W*>J/AW_@F!_R!?B%
M_P!?%E_Z#-7!_%+_ )22V7_8<T?_ -)K:OT>HK;VOO.5MS+V?NJ-]C\V?^"@
MGQRO_%/Q"D\ 6%P\6@:'L-U&AP+F[*AB6]0@8*!_>W'TQSO@?]O/QG\.?#-E
MH'A[PGX.T[3+1 J1QV5SECCEV/VCYF/4L>37ZD452JQY5%Q$Z<KWYCA/@9X[
MO_B;\)?#/BC5(;:#4-3M?.FCLU98E;<PPH9F(''<FN?_ &I/@]<?&[X/ZGX?
ML)%CU:*1+ZQ\PX5YH\X0GMN5F7)X!8'M7K=%8<UI71K:ZLS\_P#X'_M87O[,
M_@MOA_\ $CP;KL%UI;RC3VAA568.Q?RW$A4%=S,1(I;(88& ";/P'^&OB_\
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M/]2L1_S^7W,_5RBORC_X71\0?^AZ\2_^#>X_^+H_X71\0?\ H>O$O_@WN/\
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MZM^1]>>!_P!L?X=^.-8@TP37^B7-PXCA.K0)'&['H-Z.P&?]HBO<J^!OVO\
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MHKXK_;)_:.\:Z7\2--^%WP[GEL=4N5@6YN+4#[3+-,?W<,;'[@P5)88/S8R
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0L8IW5 2=H9U) R2<>YK?HIIN.J+A.5-\T'9^1QO_"F/A]_T(OAK_P %%O\
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MH^OR6ZE87U2PBN3&#R0I=3@' Z>E;D%K!:VL=M##'%;1H(TAC4*BJ!@* .
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M(****0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M***YSQM\2/"7PST^"_\ %_BC1?"EC<2^1#<ZWJ$-G%))@ML5I64%L G YP#0
M!T=%9GAOQ-H_C+1+76= U6QUS1[M2UOJ&FW*7%O,H)4E)$)5AD$<'J#65XX^
M*7@OX8PVDOC'Q=H/A.*\9EMI-<U.&R6=E +!#*R[B,C..F10!U%%84GCSPU#
MX/'BR3Q%I*>%3;B\&N->Q"Q\@@$2^?NV;""/FSCFJ_@?XF>#_B;:7-UX/\5Z
M'XKM;5Q%/-H>HPWB1.1D*S1,P4XYP: .EHHHH **** "BBB@ HHHH ***K7V
MI6FEI$]Y=0VB32I!&T\@0/([!409/+,2 !U).!0!9HK"\9>//#/PZT@:KXK\
M1:3X8TLRK"+[6;Z*T@,C E4WR,%W$ X&<\&I?"?C+0/'FAPZSX9US3?$6CS,
MRQ:AI-W'=6\A5BK!9(R5)!!!P>"* -BBBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ K\I=1^&/C'Q#XT\?ZAI7A/7-3L)O&?B+R[JSTV:6)\:O=J=K*I!P01QW
M!K]6J\J_9I_Y)UJ__8Y^+/\ U(=1KKPV(>&FYI7/;RG-)Y37=>$5)M6U]4_T
M/SX_X4Q\0?\ H1?$O_@HN/\ XBC_ (4Q\0?^A%\2_P#@HN/_ (BOU<HKT?[5
MG_*CZS_77$?\^5][/RC_ .%,?$'_ *$7Q+_X*+C_ .(H_P"%,?$'_H1?$O\
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M^(K]7**/[5G_ "H/]=<1_P ^5][/RC_X4Q\0?^A%\2_^"BX_^(H_X4Q\0?\
MH1?$O_@HN/\ XBOU<HH_M6?\J#_77$?\^5][/RC_ .%,?$'_ *$7Q+_X*+C_
M .(H_P"%,?$'_H1?$O\ X*+C_P"(K]7**/[5G_*@_P!=<1_SY7WL_*/_ (4Q
M\0?^A%\2_P#@HN/_ (BC_A3'Q!_Z$7Q+_P""BX_^(K]7**/[5G_*@_UUQ'_/
ME?>S\H_^%,?$'_H1?$O_ (*+C_XBC_A3'Q!_Z$7Q+_X*+C_XBOU<HH_M6?\
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MUUQ'_/E?>S\H_P#A3'Q!_P"A%\2_^"BX_P#B*/\ A3'Q!_Z$7Q+_ ."BX_\
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M  =A3J**\@^%"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5'_"RO"/_0TZ+_X,8?\ XJ@#I**YO_A97A'_ *&G1?\ P8P__%4?\+*\(_\
M0TZ+_P"#&'_XJ@#I**YO_A97A'_H:=%_\&,/_P 51_PLKPC_ -#3HO\ X,8?
M_BJ .DHKF_\ A97A'_H:=%_\&,/_ ,51_P +*\(_]#3HO_@QA_\ BJ .DHKF
M_P#A97A'_H:=%_\ !C#_ /%4?\+*\(_]#3HO_@QA_P#BJ .DHKF_^%E>$?\
MH:=%_P#!C#_\51_PLKPC_P!#3HO_ (,8?_BJ .DHKF_^%E>$?^AIT7_P8P__
M !5'_"RO"/\ T-.B_P#@QA_^*H Z2BN;_P"%E>$?^AIT7_P8P_\ Q5'_  LK
MPC_T-.B_^#&'_P"*H Z2BN;_ .%E>$?^AIT7_P &,/\ \51_PLKPC_T-.B_^
M#&'_ .*H Z2BN;_X65X1_P"AIT7_ ,&,/_Q5'_"RO"/_ $-.B_\ @QA_^*H
MZ2BN;_X65X1_Z&G1?_!C#_\ %4?\+*\(_P#0TZ+_ .#&'_XJ@#I**YO_ (65
MX1_Z&G1?_!C#_P#%4?\ "RO"/_0TZ+_X,8?_ (J@#I**YO\ X65X1_Z&G1?_
M  8P_P#Q5'_"RO"/_0TZ+_X,8?\ XJ@#I**YO_A97A'_ *&G1?\ P8P__%4?
M\+*\(_\ 0TZ+_P"#&'_XJ@#I**YO_A97A'_H:=%_\&,/_P 51_PLKPC_ -#3
MHO\ X,8?_BJ .DHKF_\ A97A'_H:=%_\&,/_ ,51_P +*\(_]#3HO_@QA_\
MBJ .DHKF_P#A97A'_H:=%_\ !C#_ /%4?\+*\(_]#3HO_@QA_P#BJ .DHKF_
M^%E>$?\ H:=%_P#!C#_\51_PLKPC_P!#3HO_ (,8?_BJ .DHKF_^%E>$?^AI
MT7_P8P__ !5'_"RO"/\ T-.B_P#@QA_^*H Z2BN;_P"%E>$?^AIT7_P8P_\
MQ5'_  LKPC_T-.B_^#&'_P"*H Z2BN;_ .%E>$?^AIT7_P &,/\ \51_PLKP
MC_T-.B_^#&'_ .*H Z2BN;_X65X1_P"AIT7_ ,&,/_Q5'_"RO"/_ $-.B_\
M@QA_^*H Z2BN;_X65X1_Z&G1?_!C#_\ %4?\+*\(_P#0TZ+_ .#&'_XJ@#I*
M*YO_ (65X1_Z&G1?_!C#_P#%4?\ "RO"/_0TZ+_X,8?_ (J@#I**YO\ X65X
M1_Z&G1?_  8P_P#Q5'_"RO"/_0TZ+_X,8?\ XJ@#I**YO_A97A'_ *&G1?\
MP8P__%4?\+*\(_\ 0TZ+_P"#&'_XJ@#I**YO_A97A'_H:=%_\&,/_P 51_PL
MKPC_ -#3HO\ X,8?_BJ .DHKF_\ A97A'_H:=%_\&,/_ ,51_P +*\(_]#3H
MO_@QA_\ BJ .DHKF_P#A97A'_H:=%_\ !C#_ /%4?\+*\(_]#3HO_@QA_P#B
MJ .DHKF_^%E>$?\ H:=%_P#!C#_\51_PLKPC_P!#3HO_ (,8?_BJ .DHKF_^
M%E>$?^AIT7_P8P__ !5'_"RO"/\ T-.B_P#@QA_^*H Z2BN;_P"%E>$?^AIT
M7_P8P_\ Q5'_  LKPC_T-.B_^#&'_P"*H Z2BFHZR(KHP9&&0RG((]:=0 44
M44 %%%% !7YV?\%L_P#DW_P-_P!C.O\ Z23U^B=?G;_P6S4_\,^^!VP=H\4*
M"<<?\>EQ_@: /?\ _@G%_P F3_"S_KQG_P#2J:OE7_@N)_R*/PE_Z_M1_P#1
M<%?57_!.+_DR?X6?]>,__I5-7RK_ ,%Q/^11^$O_ %_:C_Z+@H ]7\1?\H@8
MO^R>VO\ Z+CKS[_@B)_R27XD?]AN#_T0*]!\1?\ *(&+_LGMK_Z+CKRS_@C7
MK(\.? 'XO:LR&1;#4%NB@ZMLM2V/TH ^K/VCOV_/A#^S#K T3Q1JMYJ?B,1B
M5]%T*W%Q<Q*1E3(6940D8(5G!((.,'-<_P# ?_@IE\$_C]XJL_#6FZAJGAK7
MKY_*L[/Q):I!]I?LB21R21[CV4L"20!D\5^?7_!,OX4:+^U9^TQXV\6_%"TA
M\7/96KZM+::BOF0W-[/.!YDB'Y751YGR-QDKQ\M?:WQL_P""4OPT^*GQ,T[Q
M7X?OY?AE;6\")/IGA2QBMTDF1RRSQG.V%@"!\J?P@]<Y /K/XF?%#PK\'/!U
M[XI\9:W;:!H5F!YMU<D\L>B(H!9W/95!)["OD*Q_X+'? *Z\1#398/%ME9[]
MO]L3Z5&;7''S;4F:;'_;//'2OF#_ (+4^/=67XE?#SX>M>3S:-IVA+K!\QAF
MXN)9IH/,D  !8+;\'''F/@#)KF/'7[1G[%NL? +4/ >@_"#Q+I^NIIK1:=XD
MDT:P2^%ZL?[N::Y6[,C*9 "ZY(() 7H* /V#TOXG>&_$7P[;QQH6IPZ_X;^Q
M27T5YIKK(LT:*Q8+R!N^4C!(P1@XKY+T'_@KY\"]:\,Z]K4UOXHTA=*,"I8W
MUE;_ &F_>7?A;=([AP=HC)8N4497G) KYV_X)+_$+4]0^!OQY\%74\DVF:9I
MW]I64;-E86F@N$F49Z ^5&<#C.X]37S?_P $U?V9O#'[3GQXO=*\9V\E[X9T
M;29-2N+**X> W+^9'''&70APO[PL2I!^0#/- 'ZZ?"']N;X6_&#X/^(?B9!>
MW_ACPGX?G^S:E<^(K80&&0JI"CRV=7)WH J%B2RC&2,^(ZI_P68^ ^GZH;6#
M2_&FIP!@/MUKIENL)YZXDN$?'?[M>G?%[]EO]G;P#^S3<>#_ !3 /!'PMTZ_
M_M5S'J]S'BZ8%0Q=G9YF.["HV_D+A>!CXH;XQ?L@Z+\.[_X<_#/X&:W\7=3:
MUFB76GT*-KYV?=B7[4R_:$()XV1J %X H _1+X8_M=?#7XQ_"GQ%X^\(:O+J
M^F>'[66ZU.Q6'R[VV$<;2;&B<C!94;:<[6(.&X./R"^)G[="?$;]MKPW\4;V
M\\2W7PV\/ZU9W^G:#<+$)[6"-4\T) )?*$C,'.=^3D9;L/4O^"*ZKJ7Q;^)>
MBWD<=WI%_P"&@+NQN(UDBG N$3#J00PVR2 @\$,<UQ?Q ^'GA6S_ ."L5KX0
MM_#.CP>$V\5Z9;G08[");$Q/# 7C\@+LVDL25Q@Y/K0!]E?M0?M"?!']IS]B
M>P\<^+K+Q_8> )_$D=K'#HL5C'JHNHUE )621XO+QN_BW=/>M_X"_M ?";]F
M7]@[0O'7A;2/'FK_  UMM2GM@NH0V4NJPM)=2*TDH26.+R_-^4;23\Z9'4CF
MO^"L'@GP[\/_ -BNTT?PMH&E^&M)3Q1:2+8:19QVL"LT<Y9A'&H7)/4XYK1_
M8'^&EC\9/^"9L7@C4=HM==AU>R\QAGRG:YF\N0>Z/M8>ZB@#ZA_9Q_:*\*_M
M0?#.'QOX02^M]->ZFLY+74XTCN8)8R,JZH[J"59&&&/RNO0\#S'X[_\ !0CX
M>? 'XQ6'PRU71/%'B#Q1>QVS1Q:!:VTL8DG<K%"3+<1GS#\IQC&'7GD@?%G_
M  2!^*=U\+?BQ\2/@YXHD_LYI%EOUAN' 6WO+-C'=)UZF/DGTMZY_P#8PTN7
M]L7_ (*/>*/BO?1&?0=%NYM=C,B<#:?(TZ(YY#*H1Q_U[GI0!^HWQX_:,\ ?
MLV^%4U[Q[KL>DV\S,EI:HIENKQP!E88E^9L97)^ZNX;B,U\Y>!?^"O/P#\:>
M(TTF[E\1>%$D<1QZCKNGQK:L2<#+0RR,@_VG50,\D<U\&?\ !1;XE6/BS]O^
MYL?'W]H7?@+PM<:?82Z?II!G-EY<4]PL0+*HDD:23YLC^'GY12?M8?M#?LH_
M%KX/G1_AI\)]7\$^-;&6%]-U*/1[*SB= ZB5+EX;AFD!CW$%E8[@O(!)H _<
M6RO;?4K."[M)XKJTN(UEAGA<.DB,,JRL.""""".N:GKXK_X)%_$/4O'?[(=M
M9ZE/+<MX:UFZT2WDF;<WD*D,Z+GKA1<; .P4 < 5]J4 %%%% !1110 45DZM
MXNT+0+A;?4]:T_3KAD\Q8KNZCB8J20& 8@XR#S[&J/\ PLKPC_T-.B_^#&'_
M .*H Z2BN;_X65X1_P"AIT7_ ,&,/_Q5'_"RO"/_ $-.B_\ @QA_^*H Z2BN
M;_X65X1_Z&G1?_!C#_\ %4?\+*\(_P#0TZ+_ .#&'_XJ@#I**YO_ (65X1_Z
M&G1?_!C#_P#%4?\ "RO"/_0TZ+_X,8?_ (J@#I**YO\ X65X1_Z&G1?_  8P
M_P#Q5'_"RO"/_0TZ+_X,8?\ XJ@#I**YO_A97A'_ *&G1?\ P8P__%4?\+*\
M(_\ 0TZ+_P"#&'_XJ@#I**YO_A97A'_H:=%_\&,/_P 51_PLKPC_ -#3HO\
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M@#I**YO_ (65X1_Z&G1?_!C#_P#%4?\ "RO"/_0TZ+_X,8?_ (J@#I**YO\
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M7_P8P_\ Q5'_  LKPC_T-.B_^#&'_P"*H Z2BN;_ .%E>$?^AIT7_P &,/\
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MZ+_X,8?_ (J@#I**YO\ X65X1_Z&G1?_  8P_P#Q5'_"RO"/_0TZ+_X,8?\
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M#_\ %4?\+*\(_P#0TZ+_ .#&'_XJ@#I**YO_ (65X1_Z&G1?_!C#_P#%4?\
M"RO"/_0TZ+_X,8?_ (J@#I**YO\ X65X1_Z&G1?_  8P_P#Q5'_"RO"/_0TZ
M+_X,8?\ XJ@#I**YO_A97A'_ *&G1?\ P8P__%4?\+*\(_\ 0TZ+_P"#&'_X
MJ@#I**YO_A97A'_H:=%_\&,/_P 51_PLKPC_ -#3HO\ X,8?_BJ .DHKF_\
MA97A'_H:=%_\&,/_ ,51_P +*\(_]#3HO_@QA_\ BJ .DHKF_P#A97A'_H:=
M%_\ !C#_ /%4?\+*\(_]#3HO_@QA_P#BJ .DHKF_^%E>$?\ H:=%_P#!C#_\
M51_PLKPC_P!#3HO_ (,8?_BJ .DHKF_^%E>$?^AIT7_P8P__ !5'_"RO"/\
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M_P"#&'_XJ@#I**YO_A97A'_H:=%_\&,/_P 51_PLKPC_ -#3HO\ X,8?_BJ
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M *([X$_\)RT_^-T?\,A_ W_HCO@3_P )RT_^-UZY10!Y'_PR'\#?^B.^!/\
MPG+3_P"-T?\ #(?P-_Z([X$_\)RT_P#C=>N44 >1_P##(?P-_P"B.^!/_"<M
M/_C='_#(?P-_Z([X$_\ "<M/_C=>N44 >1_\,A_ W_HCO@3_ ,)RT_\ C='_
M  R'\#?^B.^!/_"<M/\ XW7KE% 'D?\ PR'\#?\ HCO@3_PG+3_XW1_PR'\#
M?^B.^!/_  G+3_XW7KE% 'D?_#(?P-_Z([X$_P#"<M/_ (W1_P ,A_ W_HCO
M@3_PG+3_ .-UZY10!Y'_ ,,A_ W_ *([X$_\)RT_^-T?\,A_ W_HCO@3_P )
MRT_^-UZY10!Y'_PR'\#?^B.^!/\ PG+3_P"-T?\ #(?P-_Z([X$_\)RT_P#C
M=>N44 >1_P##(?P-_P"B.^!/_"<M/_C='_#(?P-_Z([X$_\ "<M/_C=>N44
M>1_\,A_ W_HCO@3_ ,)RT_\ C='_  R'\#?^B.^!/_"<M/\ XW7KE% 'D?\
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M_P##(?P-_P"B.^!/_"<M/_C='_#(?P-_Z([X$_\ "<M/_C=>N44 >1_\,A_
MW_HCO@3_ ,)RT_\ C='_  R'\#?^B.^!/_"<M/\ XW7KE% 'D?\ PR'\#?\
MHCO@3_PG+3_XW1_PR'\#?^B.^!/_  G+3_XW7KE% 'D?_#(?P-_Z([X$_P#"
M<M/_ (W1_P ,A_ W_HCO@3_PG+3_ .-UZY10!Y'_ ,,A_ W_ *([X$_\)RT_
M^-T?\,A_ W_HCO@3_P )RT_^-UZY10!Y'_PR'\#?^B.^!/\ PG+3_P"-T?\
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M)RWEA!UV[_XJ_41T61&1U#*PP589!'I7GR_LZ_"A-<_MI?ACX-76-_F_V@-
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M@#R/_AD/X&_]$=\"?^$Y:?\ QNC_ (9#^!O_ $1WP)_X3EI_\;KURB@#R/\
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MX&_]$=\"?^$Y:?\ QNC_ (9#^!O_ $1WP)_X3EI_\;KURB@#R/\ X9#^!O\
MT1WP)_X3EI_\;H_X9#^!O_1'? G_ (3EI_\ &Z]<HH \C_X9#^!O_1'? G_A
M.6G_ ,;H_P"&0_@;_P!$=\"?^$Y:?_&Z]<HH \C_ .&0_@;_ -$=\"?^$Y:?
M_&Z/^&0_@;_T1WP)_P"$Y:?_ !NO7** /(_^&0_@;_T1WP)_X3EI_P#&Z/\
MAD/X&_\ 1'? G_A.6G_QNO7** /(_P#AD/X&_P#1'? G_A.6G_QNC_AD/X&_
M]$=\"?\ A.6G_P ;KURB@#R/_AD/X&_]$=\"?^$Y:?\ QNC_ (9#^!O_ $1W
MP)_X3EI_\;KURB@#R/\ X9#^!O\ T1WP)_X3EI_\;H_X9#^!O_1'? G_ (3E
MI_\ &Z]<HH \C_X9#^!O_1'? G_A.6G_ ,;H_P"&0_@;_P!$=\"?^$Y:?_&Z
M]<HH \C_ .&0_@;_ -$=\"?^$Y:?_&Z/^&0_@;_T1WP)_P"$Y:?_ !NO7**
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M3EI_\;KURB@#R/\ X9#^!O\ T1WP)_X3EI_\;H_X9#^!O_1'? G_ (3EI_\
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M@;_T1WP)_P"$Y:?_ !NO7** /(_^&0_@;_T1WP)_X3EI_P#&Z/\ AD/X&_\
M1'? G_A.6G_QNO7** /(_P#AD/X&_P#1'? G_A.6G_QNC_AD/X&_]$=\"?\
MA.6G_P ;KURB@"*UM8;*VBM[>*."WA01QQ1*%1% P% '  '&!4M%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%?)_[
M?O[<%M^R'X,L+72+2#5O'NNK)_9MI<Y,%M$N UQ, 02H) 5<C<<\X4T ?6%%
M?D+X%^#_ .W3^U3X9A\??\+2O?!FG:BIN;"VN-<N='^T1$95XX+.,A4(^Z9
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MM9>$OB)JG[6FC7V@?M*^&/AWH"_V=YG@S4O'ESIEU/B3Y\6:#:WFC@?W^AH
M_0:BHKFZAL[>2>XE2""-2SR2,%50.I)/05YW'^TO\()M4_LV/XJ^"7U'=L^R
M+XBLS-N')&SS,Y_"@#TFBH[>XBNH(YX)$FAD4.DD;!E92,@@CJ".]24 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %>5?LT_\DZU?_L<_%G_J0ZC7JM>5?LT_\DZU
M?_L<_%G_ *D.HT >JT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %?AW_P4EO/^%@?\%%&\-ZH)&TZS?1=&"AB#Y$L<4SA
M3V^:YD_'-?N)7Y ?\%A?@CXA\(_&+0/C-HT,QT>_@M[2YO85S]BOX"?*+^@=
M FTGO&P],@'Z]V]O%:P1P01I##&H1(XU"JJ@8  '0 =JQ]5\"^&]=UJVUC4O
M#VE:CJUM'Y,%_=644L\29SM61E+*,DG .,FOGWX%_P#!1#X,?%SX>6&MZIXY
MT'P9K8@7^T=&UZ_CLY()P!O6/S6'FIGE60G((SAL@?*WQH_X*M^)[K]I+1O#
M7P*T^Q\<>&F\K3?LEY:.#JU[)(03 ^5= ,HBL?E)#-@K@T >N?\ !6/]J+7/
M@7\)=$\*>$[^;2O$7C"6:-]1MF*RVUE"%\[8PY1W:6-0PY"[\8."/"OV;_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO?J* ,[Q%X=TOQ=H=]HNMZ?;:KI%]"UO=65Y$)(IHV&"K*>"#7Q=XF_X([_
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M+18&,GE1%G>60XW22.Q+.YP/F8DX '0 5VE%% !1110 4444 %%%% !1110
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MC&/(BVX\OWSGM0!^[?@_Q-:^-O"6B>(K&.:*RU>Q@OX([A0)%CEC610P!(#
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M':&/%?#?_!*/]H+XD?&7]JKQFOC+QOK_ (@L)O#5[J*Z7?:E/+903&^L\-%
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M]9[;DO'[D?>7_@0_BKY-^&/@/Q'^T5\6#>W4<DT-Q>_:]6U 1XBB4MN8>@)
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MLL"=2Q/&XXQV&<$?7U>;^!_V?/!7@/Q!>:[9::;S6KF=YS?7["62-G8L?+&
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OQ"_9G\6:=^Q)_P44\
M3:9\093IFE^??Z-+J4P^2**9UEM[EL?P.%B.>PDR>AK]O:\!_:6_8?\ A7^U
M5-:WOC'3+JTUZUB^SPZYH\XM[P19)$;%E9'4$DC>K8R<8R<@'PU_P5X_:H\
M?$[P'X/\ >"O$^F^++B/5!K=[=:/<I<V\"I#+%&AE0E2[>>Y*@Y&WG&17HUM
MH'C?]I'_ ()+^"O#GPQM)-2\036]OI=S96]Y%:%X;6Y:.5&>5T7!$2D@GY@>
MX->S_#G_ ()>_ WX;>&?$FE6VFZIK%YKNFSZ7+K6L74<UY;12H59K?$:QQN
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *_(#Q3_R43XB?]CGXA_\ 3M=5^O\
M7Y >*?\ DHGQ$_['/Q#_ .G:ZKV,K_C/T_5'WO!G_(PG_@?_ *5$H4445]0?
MLP4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 444Y$:1U1%+NQP%49)/I0 (C2.J(I9F. JC))]*^V_V6?V6%T%+7Q?
MXPM0VI,!)8Z;*,B =I''][T':E_99_9870%M?%_B^U#ZDP$ECITHR(!V=Q_>
M]!VKZPKYW'8[FO2I/U9^4\1<1\_-@\%+3:4EU\E^K"BBBO!/S(**** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ KP3X _#'P=XA\%Z[J&J^$]#
MU._F\9^*_,NKS38997QX@U!1N9E).  .>P%>]UY5^S3_ ,DZU?\ ['/Q9_ZD
M.HU2DXZIFD*DZ;O!M/R.C_X4Q\/O^A%\-?\ @HM__B*/^%,?#[_H1?#7_@HM
M_P#XBNRHJO:3_F9M]:Q'_/R7WLXW_A3'P^_Z$7PU_P""BW_^(H_X4Q\/O^A%
M\-?^"BW_ /B*[*BCVD_YF'UK$?\ /R7WLXW_ (4Q\/O^A%\-?^"BW_\ B*/^
M%,?#[_H1?#7_ (*+?_XBNRHH]I/^9A]:Q'_/R7WLXW_A3'P^_P"A%\-?^"BW
M_P#B*/\ A3'P^_Z$7PU_X*+?_P"(KLJ*/:3_ )F'UK$?\_)?>SC?^%,?#[_H
M1?#7_@HM_P#XBC_A3'P^_P"A%\-?^"BW_P#B*[*BCVD_YF'UK$?\_)?>SC?^
M%,?#[_H1?#7_ (*+?_XBC_A3'P^_Z$7PU_X*+?\ ^(KLJ*/:3_F8?6L1_P _
M)?>SC?\ A3'P^_Z$7PU_X*+?_P"(H_X4Q\/O^A%\-?\ @HM__B*[*BCVD_YF
M'UK$?\_)?>SC?^%,?#[_ *$7PU_X*+?_ .(H_P"%,?#[_H1?#7_@HM__ (BN
MRHH]I/\ F8?6L1_S\E][.-_X4Q\/O^A%\-?^"BW_ /B*/^%,?#[_ *$7PU_X
M*+?_ .(KLJ*/:3_F8?6L1_S\E][.-_X4Q\/O^A%\-?\ @HM__B*/^%,?#[_H
M1?#7_@HM_P#XBNRHH]I/^9A]:Q'_ #\E][.-_P"%,?#[_H1?#7_@HM__ (BC
M_A3'P^_Z$7PU_P""BW_^(KLJ*/:3_F8?6L1_S\E][.-_X4Q\/O\ H1?#7_@H
MM_\ XBC_ (4Q\/O^A%\-?^"BW_\ B*[*BCVD_P"9A]:Q'_/R7WLXW_A3'P^_
MZ$7PU_X*+?\ ^(H_X4Q\/O\ H1?#7_@HM_\ XBNRHH]I/^9A]:Q'_/R7WLXW
M_A3'P^_Z$7PU_P""BW_^(J:S^$O@;3;J*ZM/!GA^UN8FWQS0Z5 CHPZ$$)D&
MNLHH]I/NP>*KM6=1_>PHHHK,Y0HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ KRK]FG_DG6K_\ 8Y^+/_4AU&O5:\J_9I_Y)UJ__8Y^
M+/\ U(=1H ]5HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ KRK]FG_DG6K_ /8Y^+/_ %(=1KU6O*OV:?\
MDG6K_P#8Y^+/_4AU&@#U6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MUH>1C,*\)5]E*2<NMNC[7[KK8****R. **** "BBB@ HKYR_X*'?\F>>/_\
MN'_^G"VK\COA/\&?&/QQ\17.A>"='_MK5;>T:^EM_M,-OMA5T0MNE=5/S2(,
M YYZ<&O:P>71Q5%UI5.5)VV]/-=S.4N5VL?O]17XCZ]^P]\>O!.GR:M<^ ;]
M(K=6D:33KRVNI5 ')"02L_3T%='^R3^V?XM^"OCK2M-U[6[S5O EW.MO?65_
M,TOV1&.WSH2Q)39G<5'# $8S@CHEE'-!SH55.W;_ (=B]IW1^RM%%%?.FH44
M44 %%%% !1110 4444 %%%?%G_!6+_DW7P[_ -C5;?\ I)>5TX>C]8JQI7M<
M3=E<^TZ*_/;_ ()#_P#(O_$S_KZL/_0)Z\[_ &KOV*?C/\2OVA?&GB;PWX-_
MM'1-1NDDM;K^U+*+S%$,:D[7F5ARIZ@=*[_J$%B9X>I545'J^NWGYD\SM=(_
M4VBL+P)IMSHW@?P]I]Y'Y-W::=;P31[@VUUB56&02#@@\CBMVO(>CL6%%%%(
M HHHH **** "BBB@ HHHH **** "BBOPC^.'_)U7C_\ ['34/_2Z2O3P."^N
MRE'FM;RN1*7*?NY1117F%A1110 4444 %%%% !1110 4444 %%%?F?\ MM?L
M>?%[XN_M$:]XG\)>$?[6T.Z@M$ANO[2LX=S) B,-LDRL,,".179A:$,1/DJ3
M4%;=_P##HF3LM#],**XKX(^'=0\(?!?P#H6KV_V35=+\/Z?8W=OO5_*FCMHT
M==RDJ<,I&02#C@FNUKEDE&32=R@HHHJ0"BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\OXK_,/]6,W_ .?/_DT?_DC['HKXX_X>'?\ 4@?^5G_[GH_X>'?]2!_Y6?\
M[GH_L_$_R_BO\P_U8S?_ )\_^31_^2/L>BOCC_AX=_U('_E9_P#N>C_AX=_U
M('_E9_\ N>C^S\3_ "_BO\P_U8S?_GS_ .31_P#DC['HKXX_X>'?]2!_Y6?_
M +GH_P"'AW_4@?\ E9_^YZ/[/Q/\OXK_ ##_ %8S?_GS_P"31_\ DC['HKXX
M_P"'AW_4@?\ E9_^YZ/^'AW_ %('_E9_^YZ/[/Q/\OXK_,/]6,W_ .?/_DT?
M_DC['HKXX_X>'?\ 4@?^5G_[GH_X>'?]2!_Y6?\ [GH_L_$_R_BO\P_U8S?_
M )\_^31_^2/L>BOCC_AX=_U('_E9_P#N>C_AX=_U('_E9_\ N>C^S\3_ "_B
MO\P_U8S?_GS_ .31_P#DC['HKXX_X>'?]2!_Y6?_ +GH_P"'AW_4@?\ E9_^
MYZ/[/Q/\OXK_ ##_ %8S?_GS_P"31_\ DC['HKXX_P"'AW_4@?\ E9_^YZ/^
M'AW_ %('_E9_^YZ/[/Q/\OXK_,/]6,W_ .?/_DT?_DC['HKXX_X>'?\ 4@?^
M5G_[GH_X>'?]2!_Y6?\ [GH_L_$_R_BO\P_U8S?_ )\_^31_^2/L>BOCC_AX
M=_U('_E9_P#N>O2?@)^U7_PN_P 976@_\(O_ &+Y%B][]H_M#S\[7C3;M\I?
M^>F<Y[=*B>#KTXN4HZ+S1SXCA_,L+2E6JTK1CN[Q_1GOU%%%<1\\%%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1137D6-&=V"(HR68X 'K0 ZBN7
M@^*?@NZOA90^+]!EO"VT6\>IP-)GTVALYKJ*IQ<=T:3ISI_'%KU"BN?UKXA>
M%O#=\+'5O$NCZ7>G!%M>W\4,AST^5F!YR/SK;MKJ&\MXY[>5)X)%#))&P96!
MZ$$=12<6E=H)4YQ2E)-)DM%9>O>*M%\*P)-K6KV&CPR$A)+^Y2!6(ZX+D9ZC
M\Z30?%FA^*HGET76=/UB-.&>PNDG"_4H3BGRNU[:![.?+S\KMWZ&K17-ZU\2
M_"'AS4)+#5O%6B:7?1@%[6]U&&&501D95F!&00?QJC_PNCX??]#UX:_\&]O_
M /%T_9S>J1K'#5Y*Z@VO1G9455TO5;+6["&^TZ\M[^RF&Z*YM95DCD&<95E)
M!'TJU4'.TXNS"BBN,U+XU?#W1=0N+#4/'?AFQOK:0Q3VUSK%O'+$X."K*S@J
M0>QIV;V)N=G17&:?\:OA[JUTEM8^//#-[<OPL-OK%O([<XX ?/>NKU#4+72;
M&YOKZYAL[*VC::>XN'"1Q1J"6=F/"J "23P *+,+EBBL+POX[\->.$N'\.>(
M=*U]+<J)FTN]BN1$6SM#;&.,X.,^AK=I#"BJVI:E9Z/8RWE_=06-G"-TEQ<R
M".-!G&2Q( _&L#P_\4O!GBR^^QZ)XNT'6;SK]GT_4H9Y/^^48FG9B.HHHHI#
M"BBB@ HKG;SXC^$].\21^'KOQ1HMKK\CI&FE3:A"ETS. 441%MQ+ C QSD5T
M5, HHHI %%%% !1110 4444 %%%% !1110 45!]NMOMPLOM$7VPQ^<+?>/,V
M9QNV]=N>,],U/0 4444 %%%<UKGQ,\'^&=7CTK6/%>AZ3JD@4I8WVHPPSL&.
M%(1F#')Z<<TP.EHKGO%'Q$\*^"98(O$7B;1] DN%+0IJE_%;&0#@E0[#(&1T
M]:W+:YBO+>*XMY4G@E021RQL&5U(R&!'!!'>@"6BBBD 445SMY\1_">G>)(_
M#UWXHT6UU^1TC32IM0A2Z9G **(BVXE@1@8YR*8'14444@"BH;R\M].LY[N[
MGCM;6!&EEGF<(D:*,LS,>   22>F*R/"_COPUXX2X?PYXATK7TMRHF;2[V*Y
M$1;.T-L8XS@XSZ&F!NT444@"BH+V^MM-MVN+NXBM8%(#2S.$4$D  D\<D@?4
MBIZ "BBB@ HHHH **** "BBB@ HHHH **** *VI:;:ZQI]Q8WUO'=V=PACF@
MF4,CJ1@@@]17RSX@\)>(OV2?$4_B?PFDVL_#J\D#:EH[,6:TSQN!]N@?Z*W8
MU]7U'-#'=0R0S1K+%(I1XW4%64C!!!Z@BMZ55T]'JGNCT\%CI81N$ES4Y?%%
M[/\ R:Z/H>+^-O 7@_\ :F\"6>NZ+>K#J*+NL=6A&);>0<^5*!SP<9'4<$=L
M\[\(/CIJ_A7Q"OP[^*"_8-<A(BL]4E/[N[7HN6Z$GLW?OS6)XX^'/B/]FGQ)
M<^.?AU$U[X4F._5_#I)*QKU+*.?E'.&'*>ZY [_4=+\#_M=?#>.[MI-ES&,1
MS8 NM/FQG8X]/;H1R*[?=4+/6F]GUB_Z^\^CDJ,<.HS;GA9/27VJ;[/]5L]T
M>U45\Q?#/XP:]\'/$L/PZ^*+-Y0^32O$#Y,<L><*&8]1VR>1T/8U]*76HVMC
M8R7MQ<1PV<:>8\[L @7&=V?2N&I2E3=MT]GW/FL9@:N#FHOWHR^%K:2\O\NA
M-)*D,;R2.L<: LS,<  =23Z5\P?$3XL>(/CMXEF^'_PQ=HM.!V:IX@&1&D><
M,%8=%ZCCEN@]:I^+O'GB/]J/Q)/X/\#/)IO@FV?;JFN$$?:!_=!_N^B]3U/%
M>A>(/$G@C]DGX>06-G;B2]E'^C6,9'VB^EQ@NY[*#U8\#H,G /73I^Q:NKS>
MR[>;/=PV#^H2CS0Y\1+X8?R^<O/JETW8^*W\#?LA_#4R.=T\@QNX^U:C.!T'
MH/T4?KPO@'X3^(/C]XDM_B!\3XVAT=?GTCPT<B,1YRK.I_A/!YY?J<+@&_\
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MF3=N7(^\!74_L]?!WXO>-/CQX+U>[T_QGI,6JZC'<W/BBX@NX1) O[V5OM)
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M8CK7XU_M&2?&&^US2=2^,(U9=4O+=FL4U94B98@WS;85QY8W'IM7/X5^IO\
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MHHKY,V"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ML5W2?O?+7)!(&_..<#(SZ/\ !7]I7P1\>H[E/#=Y/#J-LN^;3-0C$5RJ=-X
M+*RYX)5CCC.,C/B__!.7P+HMO\(M0\2&R@GUG4-0FMI;J2,,Z0HJ 1 ]E)+,
M1WW<]!7C7B:Q@^$O_!0S2[?PS!_9UG=:O8HUK;+M14NTC690HX"_O';'0=N@
MK?D@VXK=&7-))2?4D^/6L67A[_@H)INJ:E<QV6GV=]I=Q<7$IPD<:Q1%F)]
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MBOD;]NO2+3X0_'SPMXK\*0IHVIW%NFH2?95$:FXCE(\S XRP #>N#G.35?\
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MQ5/%U8SI;)#A%Q6I^#/Q8M;SP+^T=XH'B:Q_M"YL?$LUS>6MQP+M?M!D.?\
M9D4YSZ/7Z+_$3_@IE\*M.^&$\WA&>_U'Q-<6;16FDBRDM_L<I7"F61@$VJ3G
M]V6SMP,=:]D^//['_P -_P!HFYBO_$VG7%KK448A75]*F$%SL&<*V597 SQN
M4X[5QOPO_P""=?P=^&&N0:N+#4?%%];OYD!\0W*31QN""&\N-$1B,<;@?SQ7
M=5QN#Q4(2KI\T>BV?_ )491>A^;/[$MY'IW[5GPXDFRJG4C#V'S/$Z+U]V%?
M<'_!5#X/:AXQ^&_A_P ;:7;M<OX9EFCODC!+"UF"?O"/1'C7/H)">@X[C4/^
M"<?PWN_B=<>.[77_ !;I.MR:LVLQK8WELD4%P9O-'EAK<L%#= 6/UKZGN+>*
M[MY()XTFAD4H\<BAE=2,$$'J".U98K,82Q-/$T>BU7]>HXQT:9^7'[ ?[;'A
M?X)^%M0\#>/99M/T<W37UAJT,#SK$7"B2*1$!;&5#*54\LV>U8'[??[86B_M
M"KH_A;P6MS<>%])G-_<7]Q"T7VFXVF-"J-\RHJNPRP!)DZ# S]<>-?\ @F3\
M&/%^NRZG;1:YX9$K;WLM%O(TM\GKA98I"H]E( SP!70K_P $_P#X26OPQU;P
M5I]CJ&F0:L\+WNL6]RKZA+Y3AU7S)$=57(&550#C.,\UO]<P"KK$I/F?W+S%
MRRM8\'_X)#_\B_\ $S_KZL/_ $">ODS]NC_D['XB_P#7['_Z3Q5^K'[.7[+/
MA3]F*SUVV\+:AK-_'K$D,DYUB:*0J8PX79Y<28^^<YSVKSSXK_\ !.GX;_&'
MXA:UXQUG6_%5MJ>K2K-/#8W=LD*D(J#:&MV8#"CJQJ:.84(8ZI7=^5K_ "_R
M!Q?*D=I\2?AC-\9/V/YO"%J1]MU#PY:-:AC@-/$D4T2D]@7C4?C7Y=_LC?'I
M_P!EGXV2:EKFGW3:9-#+I.L6:)B>%=ZG<%;'SH\8RIQQN%?L+XJ\2:5\#_A3
M=:O=PWU[HWAK3E,BVRI)<-#$H7(!*J2 ,GD#@U\0>*=>_9'_ &PO'=G]LNM8
M\(^+]4D$7VV"'[$UU)CY1*Q62'<<8#, 3P,G@5GE];]W4IU(.5-]N@Y+5=S9
M_:H_X*'>!?$'PGU7PO\ #:]N]>UWQ#:-8/<?8I8$LXY1LD!\Q59I"I95V @$
MYSQ7RC_P3Q_Y/#\ ?]Q#_P!-]S7VSKO[+OP0_9'^&'B[Q6DGVG75TBZ33M0\
M1W:3S"9X75%@151=[,P&57=SU S7QO\ \$W=#N=6_:U\+W4",T6EVM]=SE5R
M%0VLD()]!NF09]2!WKT<.Z"P==4$^6SU?5V(=^97/5O^"M__ "4KP'_V")O_
M $=7TY_P37_Y-.\/?]?M]_Z4/75_M%?L;^"_VFM<TG5?%&IZ]87&F6[6T*Z1
M<01HRLVXEA)"Y)SZ$5W?P0^#.B? /X>V?@[P_=7]YIEK++,DVI2(\Q,CEVR4
M1%QD\?+7C5L72G@(8=?$G_F:*+YKGY;?\%-?^3J-2_[!=G_Z :_2G]D;_DV/
MX9?]@*V_] %<5\=/V"_A_P#M!>/Y_%_B+6/$EEJ4T$5NT6F7-O'#MC& 0'@<
MY]>:]O\ ASX%L/ACX%T+PII<US<:=H]I'9V\MXRM,R(, N5503] /I1BL72K
M82E1CO'?[@C%J39^(W[6'_)S'Q._[&"\_P#1K5^V?Q*^&/AGXO\ A.X\,^+M
M-_M;1+ATDEM?/EAW,C!E.Z-E88('0U\Z_$+_ ()J_#'XE>.==\5:GKOBR#4-
M8O)+VXCM+RU6)7=BQ"!K9B!D\9)/O7UG3QV,A6A1]DW>*].W^01C:]SYR_X=
MX_L^_P#0@?\ E9U#_P"2*ROVB/V1]#N/V4==\ ?#G1FT]K&?^VM.T]9Y;@RW
M"'+H&E=F+.F]0,XR17U%17GQQE=2C)S;L[ZMLKE1^-G["_[3UA^S%\0M<M_%
M-M=CP[K4207K01EI;6>)F\MRAY(&^16 Y^;(SC!]W_;-_P""A6B^(O"=AX>^
M#WB34UOY+I+B\UZSCFLO+B4'$2;PCDLQ&>,87'.>/IOXS?L,?"?XW:U<:UJV
MD7.CZY<$FXU+1)Q;R3,?XG4JT;-_M%<GN37&>#_^"8OP7\*ZE%=W<>N^)?+?
M>+?6+Y#$<= 5ACCR/8]>^17N2QF K55B:D7S=NAGRR2LBK_P3G\3?%/X@> M
M;\4_$#Q%?:QH]U,EOHL=\D>Y@F[SI0X7>REBJC)Q\C5^</QP_P"3JO'_ /V.
MFH?^ETE?NII^G6FD6%O8V%K#965O&L4-M;QB..)%&%55 P !P *^5/%7_!-7
MX8^+OB!K'C"\UWQ9%J>J:I-JTT4%Y:B%99)3*RJ#;$A=S$ $DX[GK6.#S"E3
MKU*LURJ6R2'*+LD?6=?A'\</^3JO'_\ V.FH?^ETE?NY7R9XJ_X)J_#'Q=\0
M-8\87FN^+(M3U35)M6FB@O+40K+)*9650;8D+N8@ DG'<]:Y\KQ=+"RFZG5#
MG%RV/-/^"N6BZI=>#/AYJL"R-H]G?7<%UM7*B65(C"2>W$4P_&O._P#@GS^U
MI\,O@7X"\0^'O&<DF@ZC<7QODU2.TDN!=IY:JL1\M692A5B,C;\YY!SG]*?&
M'@_1?'_AN_\ #_B+38-6T:^C\JXM+A<JZ]?J"#@@C!! (((KY5G_ ."6/P:F
MU<WB7GBB"WW;O[/CU"(P8_NY,)DQ_P #S[UMA\9AY83ZKB+JW;UN)Q?-='PK
M^VW^TA8?M)_%2VU71+2XM?#^EV8L+-KH;9)_G9WE*@D+DL !UPH)Y.!^E'[
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MR/X4@\=:M%XS^*SV?]GV@DO);D:A=KR]Q)+(%E:) REF(!)*KQN!'PQ^R?\
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MKUK%:VLNJ6<MKN8Q3KN&]064%EW8[''>ONVBM?:Z62L1[/6[9^=7P!O/C/\
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M2QEMA,DD,:?)O4;L&$YQG&X9QD9^JJ*3J7CRI H6?-<****Q-0HHHH ****
M"BBB@ HHHH **** "BBB@#R#]K;_ )-[\6_[MM_Z50UQ/Q0_Y,7LO^P)H_\
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M0QE*^B^\WOACI4_[/?PUU/6_B-XMENKF\F^VWAN)#)'#*V<QQ<;F9CUQU(X
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M!)]HL=1M@/-M9L$;@#PRD'!4]1Z$ CX&U[_@DK\0K>Z9=%\9>&=0ML_+)?\
MVBU<CL2JQR@'_@5?J917HX?,,1A8\M.6A+BI;GYF> ?^"2OB*75('\;>--+M
M=.4YFAT%))Y9!G[JO*B!>W)5OI7Z)^ / FB_#'P;I/A;P]:"QT;2X1!;PYR<
M9)+,>[,Q+$]R2:Z"BHQ.-KXJWM7H@45'8****X2@HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%?,JJK5WJE;3335_J?'GQ._8-EU'7+B^\$ZO9V-G.Y?^SM2WJL&>R2*K$KZ
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MVNJ]C*_XS]/U1][P9_R,)_X'_P"E1*%%%%?4'[,%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !117TO\ LN_L
MN2?$":W\5>*K=HO#4;;K:S<$-?L#U/I%_P"A=!Q6-:M"C#GF>?CL=0R^BZ]=
MV2^]OLO,/V7?V79?B!/;^*?%-NT7AF-MUM:."&OV!ZGTCSW_ (N@XK[SM[>*
MU@CAAC6*&-0B1H %50,  #H*((([6&.&&-8H8U")&@ 55 P  .@J2OC\1B)X
MB?-+;L?@V:YK7S6M[6KI%;+HE_GW84445RGBA1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_7]44_C/4_\ @JE:Q3?LVZ=*\:M+#XAMC&Y'*YAG!Q]17EG_  2!_P":M?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "O*OV:?^2=:O\ ]CGXL_\ 4AU&O5:\J_9I_P"2
M=:O_ -CGXL_]2'4: /5:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** /F/]DW_DKWQY_P"PZO\ Z47M'@__ )/T\<_]@*/_ -%6='[)O_)7OCS_
M -AU?_2B]H\'_P#)^GCG_L!1_P#HJSK[>M_O>+_Z]+\J9S+X8^O^9].4445\
M0=(4444 %%%% !1110 4444 %%%% !1110 5XM^T5^R;X&_:4L;<^(;>:PUN
MT0I:ZUIY"7$:]=C9!5TSSM8<<X(R<^TT5I3J3I24X.S0M]S\\%_X)"V/]H;V
M^*-P;'=_J1H:B7'IO^T8S[[:^K_V>?V6? _[->DW$'AFVFNM5O%5;S6+]@]S
M.!SM!  1,\[5 [9R1FO8**ZZV.Q.(CR5)W7]=A**6QSWCWX?^'OB?X7O/#OB
MC2K?6-'NQB2VN!QD=&4CE6!Y# @CL:^)_&7_  22\,:EJ4DWACQ[J6@VC-N%
MKJ%@E]L'<!EDB.,],Y..I/6OOFBLZ&+KX;^%*P.*>Y\@_!'_ ()I?#SX6:Y:
MZWK]_=>.=4M7$D$=] L-DCCHQ@!;<0>S,1[=Z^L]7L/[5TF]LM_E?:8'A\S&
M=NY2,X[]:MT5%;$5:\N>K*[&DEL?#/P9_P""8_\ PJ/XI>&O&7_"R?[6_L:[
M6Z^Q?V%Y/G8!&W?]I;;UZ[37UQ\7/ /_  M3X8^)O"'V_P#LO^VK&6R^V>3Y
MWD[QC=LW+NQZ9'UKKJ*NKBZU>:J5)7:VV$HI:(^//V9?^">__#.?Q4MO&?\
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M?_8_[!\KSO+8-LW_ &EMN<=<'Z5]W45A1Q-7#J4:;LI;[%-)[GCW[4_[/?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 5Y5^S3_R3K5_^QS\6?\ J0ZC7JM>5?LT_P#).M7_ .QS\6?^I#J-
M 'JM%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7_PC_P"AM_\ *;=__&J_-6BC^RZ/=_A_D'^IF7_SS^^/_P B?I5_PU_\(_\
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M_P#"/_H;?_*;=_\ QJC_ (:_^$?_ $-O_E-N_P#XU7YJT4?V71[O\/\ (/\
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M3G)N*OJU;_TD^_****^>/RP**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "OS5^+'[;?[87A/XJ>,M$\,? /\ MCPWINM7EEI>H_\ "&ZQ/]JM
M8YW2&7S(Y@C[D56W* ISD#!K]*J* /QVT/\ X*T?M,^)O%<GA?1_AAX7U;Q+
M&\D;Z-8^']3FO%://F*85NBX*[3N&.,'/2OJ']D']JO]ICXO?&2#P_\ %/X/
M?\(5X4:QGG?5/^$8U.PQ,H&Q/-N)63G)XQDXXKY!_8C_ .4K'B'_ +#/B3_V
MXK]IJ /SY_9-_P""@_Q$^/'[6FL_"_7]%\,6>@67]H^7<Z;:W*71^SR;4RSW
M#KR.OR?3%?H-7XN?\$X?^4D'BG_N.?\ HXU^T= !7Q7_ ,% _P#@H,G[*<&D
M>'O!:Z+K_P 0+N42W5CJ0DF@L+0*?FE6*1&$CL5VKNZ!B1]W/OW[4VE?$?7/
M@/XHT_X2W9L/B!="VBTZZ$L<1B4W40G;?)\JX@\[G[P_A^;%?CC^V=^P[JO[
M+_PO\,^+?&'BZ3Q5X\\3:O*FH-$S/;Q_NB['S9!YDTA;DNVW_=[T ?LM^S+\
M3M4^,_P#\#^-];M[.UU;7-.2[N8=/1T@1R2"$#LS <=V-=CX[\9:=\._!.O^
M*=6?R]+T6PGU&Y8=?+BC9VQ[X4X]Z\?_ &"?^3.?A-_V!(O_ $)J\)_X+"_&
MK_A /V<[/P39SB/5/&E\()%!PPLK<K+,P^K^0GN';WH ^4E_X+3?&Q)(KF3P
M;X&_L]IBHQ8WH+!<%D#_ &K&X!EYQQN!QSBOV(\'^*M/\=>$]%\1Z1,MSI>K
M6<-]:S*00\4B!U/'LPK\C?'O['O]C_\ !*'PQXF2QQXHL[\>,KHJF9#:W>V$
MKZA1!]ED/IY1KZH_X)$_&8_$;]F'_A%[N?S=4\%WK:>0S98VDN9;=CZ 9EC
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MO_M)?L[:#X]\36>FV.L7]Q=Q2P:3%)';@13O&NU9'=LX49RQY]*\._X+'_\
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M[S5M[R'56+W%H6QB57/S$ $$@D@KT[&OO>O@7]O32X+/XNZ9=1($DO-(B:;
M^\RRRJ&/_ 0H_P" U]H_"J^DU3X7^#[R4DRW&CV<SDG)RT"$\_C48R,94X5X
MJW-N<^?T:-;#8;,:4%!U%[R6U_ZO^!U-%%%>2?$!1110 4444 %%%% !7Y >
M*?\ DHGQ$_['/Q#_ .G:ZK]?Z_(#Q3_R43XB?]CGXA_].UU7L97_ !GZ?JC[
MW@S_ )&$_P# _P#TJ)0HHHKZ@_9@HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OI+]@G_DLFJ?]@.;_
M -'P5\VU])?L$_\ )9-4_P"P'-_Z/@KCQG^[S]#P<^_Y%E?_  GWY1117Q9_
M/04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]0K].GI^GOA;PQI?@GPWI?A_1+*/3M'TRVCL[2TA&$BB10JJ/H * -2BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5]3?L#^&=3;X@:QK_V.0:0FF26ANF&$,K2Q,$'J<(Q]L5YO^S[^S[J
M?QHUP22"2R\.6KC[7?8^]_TS3U8_I7Z-^%_"^F>#-"M-'T>T2RT^U39'%&/U
M/J3W->+F&*C&+HQU;_ _/N*,ZI4:,L!3]Z<M_)?YFK1117S)^.A1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/_R)\<?\.\?^I_\ _*-_]T4?\.\?^I__ /*-_P#=%?8]%'U_$_S?@O\ (/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !17+?$C4O&&E>&VG\#Z%I7B'7/-119ZQJ;V
M$/EG.YO,2&4EAQA< ').>,'RG_A-_P!I3_HE7@/_ ,+.X_\ D&@#W^BO /\
MA-_VE/\ HE7@/_PL[C_Y!H_X3?\ :4_Z)5X#_P#"SN/_ )!H ]_HKP#_ (3?
M]I3_ *)5X#_\+.X_^0:/^$W_ &E/^B5> _\ PL[C_P"0: /?Z*\ _P"$W_:4
M_P"B5> __"SN/_D&C_A-_P!I3_HE7@/_ ,+.X_\ D&@#W^BO /\ A-_VE/\
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M_P"0: /?Z*\ _P"$W_:4_P"B5> __"SN/_D&C_A-_P!I3_HE7@/_ ,+.X_\
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M_P!I3_HE7@/_ ,+.X_\ D&@#W^BO /\ A-_VE/\ HE7@/_PL[C_Y!H_X3?\
M:4_Z)5X#_P#"SN/_ )!H ]_HKP#_ (3?]I3_ *)5X#_\+.X_^0:/^$W_ &E/
M^B5> _\ PL[C_P"0: /?Z*\ _P"$W_:4_P"B5> __"SN/_D&C_A-_P!I3_HE
M7@/_ ,+.X_\ D&@#W^BO /\ A-_VE/\ HE7@/_PL[C_Y!H_X3?\ :4_Z)5X#
M_P#"SN/_ )!H ]_HKP#_ (3?]I3_ *)5X#_\+.X_^0:/^$W_ &E/^B5> _\
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MKP#_ (3?]I3_ *)5X#_\+.X_^0:/^$W_ &E/^B5> _\ PL[C_P"0: /?Z*\
M_P"$W_:4_P"B5> __"SN/_D&C_A-_P!I3_HE7@/_ ,+.X_\ D&@#W^BO /\
MA-_VE/\ HE7@/_PL[C_Y!H_X3?\ :4_Z)5X#_P#"SN/_ )!H ]_HKP#_ (3?
M]I3_ *)5X#_\+.X_^0:/^$W_ &E/^B5> _\ PL[C_P"0: /?Z*\ _P"$W_:4
M_P"B5> __"SN/_D&C_A-_P!I3_HE7@/_ ,+.X_\ D&@#W^BO /\ A-_VE/\
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M_P"0: /?Z*\ _P"$W_:4_P"B5> __"SN/_D&C_A-_P!I3_HE7@/_ ,+.X_\
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M_P!I3_HE7@/_ ,+.X_\ D&@#W^BO /\ A-_VE/\ HE7@/_PL[C_Y!H_X3?\
M:4_Z)5X#_P#"SN/_ )!H ]_HKP#_ (3?]I3_ *)5X#_\+.X_^0:/^$W_ &E/
M^B5> _\ PL[C_P"0: /?Z*\ _P"$W_:4_P"B5> __"SN/_D&C_A-_P!I3_HE
M7@/_ ,+.X_\ D&@#W^BO /\ A-_VE/\ HE7@/_PL[C_Y!H_X3?\ :4_Z)5X#
M_P#"SN/_ )!H ]_HKP#_ (3?]I3_ *)5X#_\+.X_^0:/^$W_ &E/^B5> _\
MPL[C_P"0: /?Z*\ _P"$W_:4_P"B5> __"SN/_D&C_A-_P!I3_HE7@/_ ,+.
MX_\ D&@#W^BO /\ A-_VE/\ HE7@/_PL[C_Y!H_X3?\ :4_Z)5X#_P#"SN/_
M )!H ]_HKP#_ (3?]I3_ *)5X#_\+.X_^0:/^$W_ &E/^B5> _\ PL[C_P"0
M: /?Z*\ _P"$W_:4_P"B5> __"SN/_D&C_A-_P!I3_HE7@/_ ,+.X_\ D&@#
MW^BO /\ A-_VE/\ HE7@/_PL[C_Y!H_X3?\ :4_Z)5X#_P#"SN/_ )!H ]_H
MKP#_ (3?]I3_ *)5X#_\+.X_^0:/^$W_ &E/^B5> _\ PL[C_P"0: /?Z*\
M_P"$W_:4_P"B5> __"SN/_D&C_A-_P!I3_HE7@/_ ,+.X_\ D&@#W^BO /\
MA-_VE/\ HE7@/_PL[C_Y!H_X3?\ :4_Z)5X#_P#"SN/_ )!H ]_HKP#_ (3?
M]I3_ *)5X#_\+.X_^0:/^$W_ &E/^B5> _\ PL[C_P"0: /?Z*\ _P"$W_:4
M_P"B5> __"SN/_D&C_A-_P!I3_HE7@/_ ,+.X_\ D&@#W^BO /\ A-_VE/\
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M_HE7@/\ \+.X_P#D&@#W^BO /^$W_:4_Z)5X#_\ "SN/_D&C_A-_VE/^B5>
M_P#PL[C_ .0: /?Z*\ _X3?]I3_HE7@/_P +.X_^0:/^$W_:4_Z)5X#_ /"S
MN/\ Y!H ]_HKP#_A-_VE/^B5> __  L[C_Y!H_X3?]I3_HE7@/\ \+.X_P#D
M&@#W^BO /^$W_:4_Z)5X#_\ "SN/_D&C_A-_VE/^B5> _P#PL[C_ .0: /?Z
M*\ _X3?]I3_HE7@/_P +.X_^0:/^$W_:4_Z)5X#_ /"SN/\ Y!H ]_HKP#_A
M-_VE/^B5> __  L[C_Y!H_X3?]I3_HE7@/\ \+.X_P#D&@#W^BO /^$W_:4_
MZ)5X#_\ "SN/_D&C_A-_VE/^B5> _P#PL[C_ .0: /?Z*\ _X3?]I3_HE7@/
M_P +.X_^0:/^$W_:4_Z)5X#_ /"SN/\ Y!H ]_HKP#_A-_VE/^B5> __  L[
MC_Y!H_X3?]I3_HE7@/\ \+.X_P#D&@#W^BO /^$W_:4_Z)5X#_\ "SN/_D&C
M_A-_VE/^B5> _P#PL[C_ .0: /?Z*\ _X3?]I3_HE7@/_P +.X_^0:/^$W_:
M4_Z)5X#_ /"SN/\ Y!H ]_HKP#_A-_VE/^B5> __  L[C_Y!H_X3?]I3_HE7
M@/\ \+.X_P#D&@#W^BO /^$W_:4_Z)5X#_\ "SN/_D&C_A-_VE/^B5> _P#P
ML[C_ .0: /?Z*\ _X3?]I3_HE7@/_P +.X_^0:/^$W_:4_Z)5X#_ /"SN/\
MY!H ]_HKP#_A-_VE/^B5> __  L[C_Y!H_X3?]I3_HE7@/\ \+.X_P#D&@#W
M^BO /^$W_:4_Z)5X#_\ "SN/_D&C_A-_VE/^B5> _P#PL[C_ .0: /?Z*\ _
MX3?]I3_HE7@/_P +.X_^0:/^$W_:4_Z)5X#_ /"SN/\ Y!H ]_HKP#_A-_VE
M/^B5> __  L[C_Y!H_X3?]I3_HE7@/\ \+.X_P#D&@#W^BO /^$W_:4_Z)5X
M#_\ "SN/_D&C_A-_VE/^B5> _P#PL[C_ .0: /?Z*\ _X3?]I3_HE7@/_P +
M.X_^0:/^$W_:4_Z)5X#_ /"SN/\ Y!H ]_HKP#_A-_VE/^B5> __  L[C_Y!
MH_X3?]I3_HE7@/\ \+.X_P#D&@#W^BO /^$W_:4_Z)5X#_\ "SN/_D&C_A-_
MVE/^B5> _P#PL[C_ .0: /?Z*\ _X3?]I3_HE7@/_P +.X_^0:/^$W_:4_Z)
M5X#_ /"SN/\ Y!H ]_HKP#_A-_VE/^B5> __  L[C_Y!H_X3?]I3_HE7@/\
M\+.X_P#D&@#W^BO /^$W_:4_Z)5X#_\ "SN/_D&C_A-_VE/^B5> _P#PL[C_
M .0: /?Z*\ _X3?]I3_HE7@/_P +.X_^0:/^$W_:4_Z)5X#_ /"SN/\ Y!H
M]_HKP#_A-_VE/^B5> __  L[C_Y!H_X3?]I3_HE7@/\ \+.X_P#D&@#W^BO
M/^$W_:4_Z)5X#_\ "SN/_D&C_A-_VE/^B5> _P#PL[C_ .0: /?Z*\ _X3?]
MI3_HE7@/_P +.X_^0:/^$W_:4_Z)5X#_ /"SN/\ Y!H ]_HKP#_A-_VE/^B5
M> __  L[C_Y!H_X3?]I3_HE7@/\ \+.X_P#D&@#W^BO /^$W_:4_Z)5X#_\
M"SN/_D&C_A-_VE/^B5> _P#PL[C_ .0: /?Z*\ _X3?]I3_HE7@/_P +.X_^
M0:/^$W_:4_Z)5X#_ /"SN/\ Y!H ]_HKP#_A-_VE/^B5> __  L[C_Y!H_X3
M?]I3_HE7@/\ \+.X_P#D&@#W^BO /^$W_:4_Z)5X#_\ "SN/_D&C_A-_VE/^
MB5> _P#PL[C_ .0: /?Z*\ _X3?]I3_HE7@/_P +.X_^0:/^$W_:4_Z)5X#_
M /"SN/\ Y!H ]_HKP#_A-_VE/^B5> __  L[C_Y!H_X3?]I3_HE7@/\ \+.X
M_P#D&@#W^BO /^$W_:4_Z)5X#_\ "SN/_D&C_A-_VE/^B5> _P#PL[C_ .0:
M /?Z*\ _X3?]I3_HE7@/_P +.X_^0:/^$W_:4_Z)5X#_ /"SN/\ Y!H ]_HK
MP#_A-_VE/^B5> __  L[C_Y!H_X3?]I3_HE7@/\ \+.X_P#D&@#W^BO /^$W
M_:4_Z)5X#_\ "SN/_D&C_A-_VE/^B5> _P#PL[C_ .0: /?Z*\ _X3?]I3_H
ME7@/_P +.X_^0:/^$W_:4_Z)5X#_ /"SN/\ Y!H ]_HKP#_A-_VE/^B5> __
M  L[C_Y!H_X3?]I3_HE7@/\ \+.X_P#D&@#W^BO /^$W_:4_Z)5X#_\ "SN/
M_D&C_A-_VE/^B5> _P#PL[C_ .0: /?Z*\ _X3?]I3_HE7@/_P +.X_^0:/^
M$W_:4_Z)5X#_ /"SN/\ Y!H ]_HKP#_A-_VE/^B5> __  L[C_Y!H_X3?]I3
M_HE7@/\ \+.X_P#D&@#W^BO /^$W_:4_Z)5X#_\ "SN/_D&C_A-_VE/^B5>
M_P#PL[C_ .0: /?Z*\ _X3?]I3_HE7@/_P +.X_^0:/^$W_:4_Z)5X#_ /"S
MN/\ Y!H ]_HKP#_A-_VE/^B5> __  L[C_Y!H_X3?]I3_HE7@/\ \+.X_P#D
M&@#W^BO /^$W_:4_Z)5X#_\ "SN/_D&C_A-_VE/^B5> _P#PL[C_ .0: /?Z
M*\ _X3?]I3_HE7@/_P +.X_^0:/^$W_:4_Z)5X#_ /"SN/\ Y!H ]_HKP#_A
M-_VE/^B5> __  L[C_Y!H_X3?]I3_HE7@/\ \+.X_P#D&@#W^BO /^$W_:4_
MZ)5X#_\ "SN/_D&C_A-_VE/^B5> _P#PL[C_ .0: /?Z*\ _X3?]I3_HE7@/
M_P +.X_^0:/^$W_:4_Z)5X#_ /"SN/\ Y!H ]_HKP#_A-_VE/^B5> __  L[
MC_Y!H_X3?]I3_HE7@/\ \+.X_P#D&@#W^BO /^$W_:4_Z)5X#_\ "SN/_D&C
M_A-_VE/^B5> _P#PL[C_ .0: /?Z*\ _X3?]I3_HE7@/_P +.X_^0:/^$W_:
M4_Z)5X#_ /"SN/\ Y!H ]_HKP#_A-_VE/^B5> __  L[C_Y!H_X3?]I3_HE7
M@/\ \+.X_P#D&@#W^BO /^$W_:4_Z)5X#_\ "SN/_D&C_A-_VE/^B5> _P#P
ML[C_ .0: /?Z*\ _X3?]I3_HE7@/_P +.X_^0:/^$W_:4_Z)5X#_ /"SN/\
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MJ***S.4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ KRK]FG_DG6K_\ 8Y^+/_4AU&O5
M:\J_9I_Y)UJ__8Y^+/\ U(=1H ]5HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M2@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#X7_P""Q_\ R:+;?]C+9?\ HJ>OA;]FOQ)^V;X1
M_9]_M?X.K=M\-+6XN91]ALM*O)?-!S,1%*CW#<CH%(]*^Z?^"Q__ ":+;?\
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M.N^+K'46L9593!#*4>W0;@"5$)BVL1RN#WH _?JBBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M8&FLH(O,_P" AR<]1CCFMCX#_P#*1#Q%_P!AS7OYW%'Q2_Y22V7_ &'-'_\
M2:VKL^W\CE^S\R/]JS]F<_L[>']!\<Z#XRUR^U:;4%LKJZO)\3F9HY)%EC=
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M_M :M\?/@O)/XCF%UXCT.[.GW5U@ W*;%>.5@/XB"5/')0GO7E?_  5K4?\
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M.W.TD*B8&.<<9_6CXP?%OPY\!_AY?^*_$4C0:99*L<<%N@,D\AX2*->!N/X
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MM6$5Y$K>H616 / YJQX5\&>'_ FE+IGAK0M-\/::IRMGI5G':P@X R$C '0
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MK8X_NB%D0'N8FH ^PJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M8KU"BI52<;VD]=_/U *X/XH_ WP1\:/[,_X3+1/[8_LWS?LG^ESP>7YFS?\
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M!0QS(S'D*.,XXKBXOV1_A'!XFC\00^"[6#5(YQ<H\5S.D:2!MP81"3RQ@C.
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M,?A;]F71]8TWPO?ZO?P:I.EQ,VKS12,K*I4!?+C0 8/<&CZW2_L_ZO\ :O\
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M_!.A7-[=Z5I?G>3-J+H\[>9,\S;BB*I^:1@,*. .O6LJ^+I5,#3H1^)/_/\
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M6+)[*SOCG@$  !: /JWP_P#M ?"[Q9'J,FB?$GPCK,>G6YN[UM/UVUG%K""
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MRU5B65"Q.3EF(4LS,3UQR/V:HKM_M=_'[->TM;F_X'_!)]GYZ'S-^V1\2O\
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M@HHHKE&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\?V@O^A _P#*SI__ ,D4?7,-_P _(_>@Y7V/G*BOHW_AWC^T%_T('_E9T_\
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MX_M!?]"!_P"5G3__ )(H^N8;_GY'[T'*^Q\Y45]&_P##O']H+_H0/_*SI_\
M\D4?\.\?V@O^A _\K.G_ /R11]<PW_/R/WH.5]CYRHKZ-_X=X_M!?]"!_P"5
MG3__ )(H_P"'>/[07_0@?^5G3_\ Y(H^N8;_ )^1^]!ROL?.5%?1O_#O']H+
M_H0/_*SI_P#\D4?\.\?V@O\ H0/_ "LZ?_\ )%'US#?\_(_>@Y7V/G*BOHW_
M (=X_M!?]"!_Y6=/_P#DBC_AWC^T%_T('_E9T_\ ^2*/KF&_Y^1^]!ROL?.5
M.CC>:1(XT:21R%55&22>@ ]:^B_^'>/[07_0@?\ E9T__P"2*^N/V*?^"?\
M+\-[Z/QG\3;&%_$<+YL-',B3QVA'_+1V0LK/Z $@5A7S'#T8.:FI/LFF-1;9
M4_83_833PG'8_$/XAV*R:TX$VF:/.N1: \B60'^/T';ZU]\T45\#B<34Q51U
M*C_X!U)**L@HHHKE&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %>5?LT_\DZU?_L<_%G_ *D.HUZK7E7[-/\ R3K5_P#L
M<_%G_J0ZC0!ZK1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M-XA\?7%Q]HBTJYTJ]FAM&4X1Y"D!1V&!M1?D08ZGA?K[X_\ CCPS^U3^QO\
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M*NIW'CJ.QKYF_9Q\36?C+]O:^US3F+V&H7VJW%NYZM&T<I5OQ&#^-?1.H?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *XCX/^"[_ , ^$[_3-1D@DN)_$.N:JK6[%E\J\U6[NX@2
M0/F$<Z!AT# @$CD]O10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7-<^@/B9\2]!^$?@Z]\2^(KEK?3K4 ;8UW22N?NQHN1EB>G('<D $U\UP_\
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M'IN'SL>I+<YP*44K<TBI-WY4<Y9_M\3:#JUE!\0OA7XA\"6%V<)?7!DDX/\
M%L>&(E?7;DXS@'I7U3HVL6/B'2;34]-NH[W3[N)9H+B%MR2(PR&!^E8GQ.\'
M:/X^\!:YH>O0Q2:9=6L@D:9<B$A21*/1E/S CD$5\7?"OXLZGX'_ ."?7B&^
M2YD6]AOY]'TV3)S&)C'DJ>Q42RL/0BJY5-7BK$\SB]6>M^/OVX+32_&5_P"'
M/ /@C5/B5=:=D7EQI;LL,9'WMI2*0L 006P%X."1S7J?P&^.VC?'KPI/JNFV
ML^F7MG.;6_TVZP9+:3&0,]U(Z' Z$8!!KX^^"/CSXK?"?X/V=_\ #_X46]]X
M66/[9J>L:BK&ZU"3!+R1HLBMY:@;%(1QA<\$D5],_#WXN>$M<^ _B/XJ^'M%
ML?#UW+:75YJBPV\:2->0H[$2N%'FL6.0QR3O'<D54X)*R1,9-O5E#X._M<6G
MQ<^,WB'P+#X>.GV^FK=-;:L;TRB\\F9(^(_*&S<K;_O'&,<YKZ DD6-&=V"(
MHR68X 'J:_.K]EGP_-X%^(_P.UR[!0>+K?60\A!RS+O"Y]2=L9X[.,U]-?M7
M>-=2FTO1_A?X5D/_  EWC:4V89,DVEC_ ,O$[8.0-N1]!(>JTIP7,E$<9/EN
MQ/@O^UA!\;OBQKWA31_#ABT738);F+7GO=PND258E*Q>4,!BQ(^?HI[\5[]7
MR1^PEHNGW6K?$OQ+I<!CT87\.A:5G^&VMD/IQN</&['NQ)[G/T_XO\5:=X'\
M+ZIX@U:;R--TVW>YG<#)VJ,X [D] .Y(%1424K1*@VXW9L5Y%XT^/Q\+_'KP
MA\,;70?[4NM=MC=2WPO/+^R1CS<GR_+;?Q"Y^\M>(>'_ !Y^TK\>+>;QCX)?
M1?"'A-I&.G:=J4:-)>QJ<?>:)R<D$;LQJ3G'K7,_!'Q]<^-OVH/&WQ%\<6:Z
M"W@WP\T%]#G*VUQ&%BE"\GJ1<D#)/('-4J=KW)<[VL?>5%?&6B_$/]I#]HB.
MX\1^ 'TGP'X/:1UT]M3BC>2Z521G+Q2DG/&0JKD8!.":],_9E^.'BGQEKOBC
MP#\0[&&S\<^&V5YI;<!4N86/#87@$90Y'!#J<#FI=-I7*4TV?0-%?%6E?%;X
M\_M!>+O%C?#GQ!X=\)Z1H=[):)IU^(GNI0AP&8-%*W/]["KDD G!KU#X8_&+
MX@V?PP^(5S\3?#\FBZ]X0MYI5U)K5HK7456.1E:(D;)"&CP2AP=Z<#-#IM I
MIGH_PO\ B-K?C[4?%46J>#-0\*6>DZ@UG8W&H;U;4HP6'GJC1IM4@*>"P^;K
MQSWU?+>@_&KQCHO[$=Y\1=?UE;SQ5<6TSVEV]M#'Y3/.8(,1J@1B/E?E3GOD
M<5Q_AKQ9^U'\4_AWIWB'0[W1_#6GQ6*S+=:E% +K52%RT@4Q,B*QSM^6,;0#
MD]2_9WOT%SGVI17RUX+_ &P);/\ 97C^(WBJUAN-<6YDTR&VM_W8OKD'Y"!_
M"",LV.FUL#H*Y=O$7[5]CH#?$"Z;0_[)A4WDOA%H(UG^S@;C_P L]X^7MYN_
MVSQ2]F^H^==#[-HKP3]D/XI>*/C/X9\5^*]>NBVFW&MS0:19-#&AM;955@FY
M%!?'F!=S$G*&O1OC5XTD^'?PE\6^(X)/*NM/TV:6V?:&Q.5*Q9!X(WE>OY&I
M<6I<I2DFKG:T5\5>"?&?[3GQB^&.C:UX6O=-TF."!VDU#5(8$N=9DWL<QQ^2
M8T0#" X3.TG=SQZ;\$_VD-1\<? +Q;XG\1VT5AXD\*)=PZA'&A1'DAAWJ^T\
M GH5S]Y3@ $"J=-HE33/HBBOBKX2>/OVB/CM\/=%NM US3=#MH))/[1\3ZM:
MPJUZWFD>7!$L++MC3 +%5RX8;N*TI_C7\9/V@O%6JZ?\&3I^B>$]'F-H_B?5
M(T;[7(,9/S(XP?O!4C) ()(W 4_9N]KB]HNQ]AUX?^T!^TXGP5U[0O#NF>%+
M_P :>)]71IH-+L7*-Y8)&?E1V8DAL *?NG.*X[X*_&;XE>'_ (P/\*OBU%9W
MVMWEF][I.K6:K''<A0Q(.Q5!4A'YV@@H00<\>#:%X3^/'CW]IK7S:>-="?QU
MX4L5MIM9>$?9(H9.?)B7[,1D>:XYC'(?YCU-1IZ^\*4]-#ZR\'_'+Q?XF\0>
M"=.N?A5K.BV^O6T]S?WEZ\JQZ3Y;2A4E)@ +OY0(4E3B1/6M;P=\<4\9?'#Q
ME\/[71]MMX:MXI)=8^U;A+*X0^5Y6P;<%G&=QY0\<UR7PG^)WB?QM^TM\2M!
M?56N?!WABUM[..V-M$O^EL$#R,ZH&R6CG^7=MYZ<#'F'[-_Q&L/!?@'XT_&K
M7/FL]6U^5XHHCAYPA)BC3/JUQL'I@D\"ER[Z?TPYMM3[.HKXYTS5/VKOBEI:
M^+-%N] \&Z5<(+BRT2ZBC,L\1Y7EXI""1CEF3.<X';U;]GW]H"[^)7POU_5?
M$&GI:^)?"\T]IJUG:'AWB3=N09.-V",9/S*>V*ATVE<M339[A17P]X%^(/[2
MOQ\T6[\9>#?$OA?2=)6=TBT'$+S !B K;H7*GCJ[IGJ  17TM^SWX\\5?$+X
M=QWWC7PW=>&/$=K<R6=U;W-K);B8J%(FC5QG8P8#()&Y6P:)0<>H1FI'I=%8
M7CCQ-+X.\(ZKK4&DWVNW%G TD6FZ;"TL]R_1415!/)(R<' R>U?*_G?M9^)M
M'D\61ZOX<\(6+)]IC\/WT44<J1]0KF2%MAQUWR*1SG'2E&/-U'*5NA]BT5\X
M^"?VE-2\5?LD:[\1[V"+3]=TZSNH=UNH,;72+MBD"MG +LF5.<<]:XGX8>-O
MC]\8O"/A;7+37M-\+>&+55?5M>U*VA%SJ2AR9WBB\ED547*+P@8H3NYXKV;U
MN3SKH?8E%?'MO\6?CI^TAJNH7WPE_LSP=X(M9VM[;6-8B1GO&7JV&CDZ^BI@
M9P6)!QVW[//QD\=7'Q(UWX7?%&*Q/BO3;1=0MM0LBJI=PDJ#D+A<_.I& #C=
MD#%#IM(%--GT9117R)>?&7XR_M">)M6M_@RNF^'O!^EW+6?_  DFJ(K"[D&,
M[=R2<=P%0D!@6(R )C%R*E+E/KNBOFCX(?&#XC:+\7)?A3\6EL+O7)[ ZEIF
MKZ>%5;F,$@@A0HP0DA!VJ1L8$<BIY/C5KWPI_:5UKPMX_P!<CD\$ZQ8/JFA7
MUQ##"MF(PSR0LR*"V LB_,68[8^[\OV;O87.MSZ0HKYX^ ?Q!\?_ !S\;:MX
MU:]DT+X6Q.UMI&D-:P^;J#+E3,\C(7"YY^5@,_*/NMGRGX=?&WXZ_'6\\:V/
M@6ZL8;:/6)/LNN:K!$EMIUKEO+@CVQ,99&!!)97P%&?O9I^S>NNPN='V[17S
M1^S;\9O']U\1/%/PS^*BVK^(]%LQJ4>I0(D:RP;D#%M@"$?O8R" O\0(R..7
M_P"%P?&S]HS7M3?X/?V9X5\%V%PUK%K^K1JQO'7J0&CDX/& J'&X9;/ /9N]
M@YU8^OZ*^;?@'\9/']O\4M3^%?Q66QF\2PV7]HV.J6.U4NH\@%2$ 7."6!VK
MPK CI7*7'QG^,?[1/BK6;3X,-I?ASPCH]RUJWB/5$5_M<@Y.W<DG!'("H2 P
M+$;@ >S=PYU8^O:\_P#"7QDTSQM\3O%/@[2K2YE?PU'&-0U!P%B6=V(6%1U)
MPKDGC[I SV\B^&WBWX^3+XW\#^+;&U@\26VEM<Z-XT>U*::93M7#NL?ELPWA
MP-F1L?<I%>3?L9V?Q%.H>(_BKJ?BO3[;P-=7]Y=^)-\2_:+]X8G?S4_<X2,/
M*3\K)PK#;TI^ST;;%SZJR/O:BOCG2_B-^T1^T5Y^O_#DZ3X#\&>8Z6%QJL:/
M+>*K$%CNCE).>,A54$$9)!->@_L[_''Q3K.O^+_ GQ.@L['Q?X5B2YGO+8JL
M4]LRAO,.#M& R'(P"'' (-)TVD-339]"UY%\<_C\?@YX@\#:+;Z#_P )!J'B
MJ_\ L,,0O/LYB^:--_\ JWW<RKQQ]:\5L_B]\<OVDM<U6_\ A')IOA'P3I\Y
MM[?4M8A1FOF7J?FCDY/!PJ@+D MG-<?X9UOQA\6_VQ_ .B>/M-BL=<\%VLSZ
M@ML08I9%#RQSH < -NMC_AP!4:=G[Q+G?8^]Z**^,M0^/?Q@\9_M _$/P?\
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M)SP,"M/XN?'3Q_XF^)UU\,_@WI]K-K&FQK)K&NWP5H+,L 0@W97(R,DAB22
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M5$KGT%HO[3&N>(_V?K;XDZ5\-]0U:^NKMK>V\/Z=</<RR(LAC:7>D!( *O\
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M#>D6NC:<AW""UC"AF[LQZLWN232O!:I#M/9GDGQG_9Y\:?$WQE_;.@_&+7O
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M-+ [*.@<QNN\#_:SQQ5W2?@9X$T'Q1HOB'3?#=KI^JZ-:-8V$EJSQQP1-OW
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M%]:EYR$""3;(R+)M' WJJO@<?-Q7/6W[&OP9M-6&HQ^!K0W ?>%DN;AX<_\
M7)I"F/;;BO9((([6".&&-888U")'&H554#   Z "IG)-60XQ:=V?-?[=GC_7
M?!G@'P[8Z1JL_AVSUO55LM1UFV#;[:#:20"O(SR>""0A'<U\W?%3X5_ +P/X
M!O-23XFZEXZ\4/:L=/L[34H9HVG<?*SJD;&, \L&<$@8ZXK]#O&'@O0_B!H-
MQHGB+3+?5]+GP7MKA<C(.0P/4$=B""*\WT?]D#X/Z#:WT%GX*MD6]A>WF>6Z
MN)9-C##!'>0LF1QE"#R:J%115A2@Y.Y\R^)+23PO_P $_/ _ANR(34/&&I00
ME0<M+YMP\X./3$<2\>P[\_5WQ0\'SZ/^SAXE\,>&8]LEKX;FL;2*-<%U6W*[
M5 'WF4$#W/4=:TIO@7X(N--\(Z?+HGF6?A.9+C1H6NYR+612"I^_^\P5'#[A
MQ7>U,IWV[W*C&Q^9?P<^"_[//C/X9V>M>*?B-J&@:_&A&HZ?)J-K;E'#$?NH
MWA9W4C!^4MU[=*]X_8U^%?PNC\5ZSXP^'S>,[J#3P^F)J'B 6ZV=WO(+- $1
M7) 1<[@N XXST]=\0?LC_"'Q1KLNL:AX)LWOY7\R1H)YX(W8G))CC=4)/?CF
MO4=%T33_  WI5MIFE65OIVG6J>7!:VL8CCC7T51P*J=7F3LV1&G9ZF=\0;.]
MU#P%XEM=-!.HSZ9<Q6P7KYK1,$Q_P(BOSA^!/P9^ WCCX>I?>-O'VH^%_%5K
M)+'J&GS:A;6BC#ML,22PEG^3;G!)W;N!Q7Z>UY-XP_93^%'CO7Y=:UGP;:3Z
ME,_F2S03S6PE;NSK$ZJQ..20<\YZU-.?*FBIQYG<\+_9'^$_PDE^)VH>(_AY
M<>--3_X1[?;C5=7^SKIUPTJ%"L>V-9&8*2>0N.">HSQ_[4VN:I^U5JNKV7@;
M2XM1\-?#Z">[N]9(S]KF(&^&%AU&U"<#[VW/]W/VS'\.O#EMX+F\)6FE1:=X
M>E@:V>RT]FM1Y;## -&58$CJ0<G)R>:/ 7PY\-_#'PU'X?\ #&E1:5I".TGV
M=&:3<S?>9F<EF)X&6)X '0"G[3WN;J+DTY3R[1_C!HEQ^R)/XTT""'2[2T\/
MRK'8VH 6TN4C,?D@9X DP!GD@@]Z\T_8O^-'PW\ _L_V.FZQXDTWP_K-K-<7
M&H6VH2B&61GD+1NBGF0&+RL;0>E3?M:>"?#GP7_9RU+PSX+TXZ2GBS7+:!K-
M+F656E9O,8JKNVP$0J#MP.@KUK4OV3OA?XDM]&;7O"EKJ5_IMG!9BZ666!I5
MBC5%WB-U#\*!\P/'%/W>779L/>OIT/!?A^VL_';Q?\=OBIHEK/;Z7>>&[OPY
MH'F(5>Y?REPP&.N8D)]#+CG!QY#\$?@O\ /''PWM]5\7_$+4/#GB2 NFH:?+
MJ-K;!6#MM,220LS@KM/REN<YQTK]*]&T6P\.Z7:Z9I=G!I^GVJ"."UMHQ''&
MHZ!5' %>8>*/V2_A)XQUZ76=5\%VDNHROYDDD$\UNLC$Y+,D;JI)/4D<]Z:J
MK5;"=/YGSM\ OA#\-KQ/'GB3X5/XWU*]TO2[W3K34=7%NME=S2PN ( B+(S#
M@\A<;AD<BNE_8U^.7PV\!_L[V.GZSXETW0=7TV>Y?4;6\D\N>1VG<HR1_>D_
M=^6/D!QMP>E?5_A_P[IGA31[;2M&T^WTO3;9=D-K:QB.-![ ?Y->:^(_V3OA
M+XL\12:YJ?@JSFU*5_,D>*::%)&ZEFC1U1B>^5Y[U+J*5U(?(XV<3@[S]IBX
M^('[.OQ0\:6GAR;1-%LH;BPT>]N+G=)?%@8UF\O8/+ 9X^ S9.X9^7-<GI6F
MV5Q_P3ROM'\):C9ZM?P:(+B_CTZ997BDDD%Q/'(%R0X1G4@\_+7U-J/@7P]J
MOA"3PK<Z/9OX<D@%L=,6()"(QC"A1C;C (QC! (K*^&OP>\'_"'2[S3O"6C+
MI-G>2^=/'Y\LWF-C&29&8].V<4N>*6BZCY6WJ?!7PZ^"/[-OB3X9Z5X@U[XE
MZIH^K?98SJ6GR:C:QRQ7 4>:(X3 TC)NSM(W9&.<UW_PI^%/@J+X)?%CQ9\+
M4\9.]UH=[I$,_B,6X2\0)N=K=8E#'.W;EL<G &0<?0NH_L?_  =U77'U>X\#
M67VQG\QEBFGBA+9)_P!2KB/'/3;BO6M.TVTT>Q@LK"UALK.!0D5O;QB..-1T
M55 P!["KE5[7)C3[GRU^RW^T1\,?!_[.6@6NI>*--T>\TB&1+RPG<)<&0R.Q
M9(A\TF[.<J#U]>*Q?V0?$+?&G]HCXJ_% V[6UJT$&G6D4O++&V H] =ELA;W
M>O;+C]DOX177B9]?D\#:>VHO)YS#?*("V<Y\@/Y77MMQ78> OA7X7^&(U8>&
M=+&F?VK=&]O#Y\LIEF/5LR,V.IX&![5+G'6V[&HRTOLC?UK5K?0='O\ 4[MB
MMK9027,S*,D(BEF/Y U\X?L!Z+(_PIUKQA>18U'Q5K5S>R3'JZ*VP#/<"3SO
MS-?1GB'0;'Q5H.HZ-J<+7&FZA;R6MS"LC1F2)U*NNY2&&02."#S53PCX,T;P
M)X7LO#F@V?\ 9VC6<9B@MTE=BBDDGYV)8G+$Y)SS6:E:+1I;WDSYW_9-QX\^
M+WQI^([JTD=YJXT>QG;_ )XPCI_WP+?CM@4OP_;_ (6+^W)X]UTAY;'PAI$.
MC6['HDKG+#\_M(_6O>_AW\,_#?PI\/G1/"NF_P!EZ8T[7+0^?),3(V S%I&9
MB3@=^U-\&_#'PU\/]2U^_P!!TW[%>:]=&]U*9KB69KB8ECN/F,V.7;A<#GI5
MN:NVB5%V1\#> ['PG^T-<>(O$_QB^+MYX;U2&_FB7P_]NCM#!" ,",2A@1DE
M=J+GY.<DUL_LF^$O!-S^UY?2?#^>\OO"^@:1-+!?:@V9+B5MD+.!M7 /G,!\
MHX7/>OJ[Q1^R?\)O&?B.?7=7\&VMQJD[^;-+'<3PK(Y.2S)&ZJQ)ZDCGO72>
M$_@KX*\"^*)_$7A_08=)U6:R33GDMI)%C\A=FU!%N\L?<7D*#UYY.='55FD9
MJF[JY\_?LY:[;S^.OVA?BO= S6,%]+;P29P#!:K([#/NBP_2NF_8'\-R:?\
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MR@J?F)78JEOD)/+ U8_9E\'^ [C]LBUC^'<]]JGAK0-+GN?MVH.&:>;;Y+2
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MX$^ OB\T$GBWPW:ZM/ NR.XWO#,JYSM\R-E;;GMG')]351J)?<2X-GQAX?\
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MW2.Q&><C/"FO*_CQ\,_@5\//!-S)H7C_ %'QSXRD"QVD,.HPW-LF6^9W:*/
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MT+'S,]!BOT"KS'X@?LS_  S^*6N?VSXF\*6^H:H0 ]U'/-;O)@8&_P IUWX
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M16)4D!58DBM5?"]OKW[:'@GPTJ_:]-^'GA..0[QQYV-B,1V/[R%@/5<U[O\
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MJSJN2@7.<, 3C Y-?,OQ>^$<GP[^"?P$TKQH;[3]!&H7<GB%K4 RVAN7BD4
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M@LK"UALK.!0D5O;QB..-1T55 P!["B=3F5DV$:=G=EFBBBN<V"BBB@ HHHH
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M/3"NP-%NB'?N=+14%G>V^HVL5U:3Q75M*N^.:%PZ.IZ$$<$5A'XE^$%TZ]U
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M"X='4]""."*GJ"@HKFI/B=X.AT>YU9_%FAII5K<FRGOFU&$017  )B=]VU7
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MC$KTQS19L5SM**^%? GQ(\6^'OV%?&7C76/$NLWFNZM>R0Z;?75]*\L2M)'
M/)8L2FUA,WRD8(/I7TO\(?&FCZ!X#\&>'?$/C.QN?&,FEVTEQ;:EJB/?2S21
MAVRKOO8Y8@>PJY0<25*YZG117)P?%OP-=:L-+A\9^'I=3+;!91ZK TV[.,;
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M!\3?%X_:&\)Z_?2ZOJ<LMAXK@GF:R,;$E2/*93G'./F(&%*+@Y]/F6T_9/\
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MV''I=''?";XF7GPY_9K^+?Q;C8?V[XF\0S"Q,BY^=V 1^>NUI96QT^3WKO\
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MG5YUX7^)VN^(OBWXE\*S>!]2TKP_I,(>W\37GF)#?2?NP4C0Q!2,M)\PD;A
M<?-QZ+7,U;<W3N%%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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G HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>syre-20250331_g10.jpg
<TEXT>
begin 644 syre-20250331_g10.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &Y!=X# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MSN^M=T,-0HUIN2;48WZ?UZ'T%#*LOP&-Q$JJE*%*FIV=M&UL]+-ZZ=.YZ_\
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M&O@'3!^V;<:9I"*-'T>^GNDC4Y6/RU)"CV60@#Z5TT*-##U9M-N4$V^VQZN
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ME%VNU*S^YQT:\[(****XCP0HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MKC(VECN]P,=*\A\$FX\7?M@:,T7A:'P7-9/ON=-M2N(]D+,2VT 98$ @#O\
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MS(]E%%(Q4J,L"P7:,#KS[=:R/&7[0GP_\!ZH^FZOXBACOXSB2WMXWF:,^C;
M=I]CS7@WPO\ !^H?!_X!^+?B9>ASXOUBS:6":49D@CD8!6Y_B9F$A^B^]<'\
M -1L-%\+WM_J?PIU;QW>:G,^=3-K]HBV#@JA93SNW9/7/TK18&D^:2;:CINE
M=]=^AT0X?P<G5J0E*<*;4-'%.4]Y6;T45TW;[GW#X1\9:)X[T>/5= U&'4[%
MR5\V$_=8=58'E3TX(SS7%^*?VD_ASX/U273M0\1Q&\A;9+';123^6PZABBD
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MC%*$N9)1LK_(\PU#X<ZK8_L^'P3HS6XU<:0NGAY)"D>]E"R-N ]W/2L;X(?
MJ;P3\&=4\'^(3"]SJSW'VMK1RZ[9$$8P2!R% /3K7M%%<_UBIR.'=W^9Y_\
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MI7UU13IXRK35M'K?57U[E8;/<7AH.#Y9KFYES)2M)]5YGA4W[/<_A']G[5_
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M!R0 .B@=.U=C7I8C,)2J2=-*VR=M;'U69<2UJV(JRPJBHOW8RY5SJ/9/I?\
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M+IKF=7AE)B\UD"1Y;;GC:N>*]HHIO$U)1E%]7=^H3S7$5*=2E*UISYWIN_\
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M7:T\I !;'8   #L!]37@S?L<W^K?':^U_4Y+$^#IM0DO_L\<C&64$[Q&5VX
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M( "J#_" .IZ\GCH/3***Y*E256;G-ZL\;$XBKBZTJ]9WE)W84445F<P4444
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M:7%A+,N%$DVT*CX[$^8A..^:XK]F^1OAY^RWXU\6@F.YN3<20/T.401QX/\
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M=0=C&\DKLFQTW$%> ?8'VS4GQ]TGQE\'?%_A2^B\?ZMK7B'4BTLJEV2-75E
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M$[RD^6,#A045>.@KO_[0_:2\_P [_A'/#/G8QYFZ+=CTSYM/75OVEE)(\/\
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M+?4FEB2$>NY)"% Y)8_@#FOM71M+MM#TFRTZS@CM;2UA2&*&+.U%4 !1GG
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MK?\ V*[.[NO$OC_QMK",)_+P\C#&6D=I9,?]\+^=?8,=K##([I#&CO\ >95
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M-L:L<L<LHP/45N4[-:L HJIJVK66@Z9=:CJ5W!8:?:QM+/=7,@CCB0#)9F/
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M>TC4KGP9XUU.SU&\>TMW>U@E,I28RE1M4J6D?GM(:[;]JW4M:L/VU/".OO\
M#[Q!XM\*>$+"%1;Z9ITDL<TA620!6VE3AGCS_N8KIINGSPE3V?-.WG9)+[[B
M=[:GD?QX\0?LW_$+PG8^&O@]X2GM?'5]>P0VE])NLH8QNPPD::7:=PX&1U.<
MC'/T[^V1\+_B)=?L8^%O#U@]UX@U;1DL?^$@CLBTDMY'% 5D8 ?,X$FUCWXS
MCBO)_CQJGBK]L/2]%\'^$/@'JGA2X74$FF\0:Q9"V%M&%(*[]BA5.[)Y.=HP
M"<5[C\>/$'QF^ ?B?X?:WX6MM1\<?#K2],BL=<T6PMT>>26-64SL=C2#<"K
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M'/S "C^R;HWBGPG\)_V@/B9JGAW5;+Q/KES=36=E/9R+=2%8Y)$VH1N8&2?
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M*/Y5JU\Y6J>UJ2J=VV;+16"BBBL1A1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %?(7[:_C#5OB3XC\,_L^>#9RNL^*)%N-<
MN8^19:>IR=^.F[:6([A /XQ7U%XU\41^"_"6KZ[+:75^NGVSW M+*)I9IRHX
MC15!)9C@#ZU\"_"#]D/XA?'VZUOXN^*_''B#X:>*/$%[-LL]/BDAG6U! 56.
M]&5?E"JI_A13WKU,#&$6Z]25E';UZ:>6Y$K[([;_ ()WZ>GPW^(GQQ^&:R2/
M#HFLI):^:?F:(-+'N/N52+-=)J/[87C[7/VB/&GPP\!> ++Q1)HJ&."\ENS
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M&VB_L:_&C6&T+48O&WBJ2^,=A-;/'<R+Y6W*HP#$DR3$#OQCK7(:+JVMQ_\
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MH?$-[HT'S2^3&2/*P.LGSM(5'L.HK:>&P]^2248WBD[ZM=6]?^&%S,Z[QO\
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MN[RSTVXG@M[="\DLBQL415'))8 #'K7F8V4IJG3J.\]6_*[T1<>K6Q\C:/\
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M-VB M*=PQ'VV*N-V,?;GQL_:"UWX$K)>W?PUU?7/!UH;.&?Q-;:G9)&CSS)
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MDS7FI:5=:JET"/+1()(8V0CKDF8$?0T ==1110 4444 %%%% !1110 4444
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M3YD;6\ENJJHZ8/GMG/H* .]HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-?3VLOD6VSRS!Y*C(>,@;_FW$-YA)RO&!7$_MZ?\FN>)_P#K_P!&_P#3K:4
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M)H \,_8+_P"30?AE_P!@UO\ T=)7OM>!?L%_\F@_#+_L&M_Z.DKWV@ HHHH
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M;7Q^\'_"/XJ_M2?$G2/%_P 1;SX#>(-+.E32WEIXE@@MO$:B)9(+B2%P%2:
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M\"_V]O#/QJ^(&D^%9O"'B;P9)XAM9;_PS?:];+'!K5O'DLT1!.#M!;'(QWZ
M]MXP_P"3N/AM_P!BQKG_ *.L:^+O!?CCP_\ %CXJ?L,:7X,U&UU;4?#VB7$^
MKPV,@=]/1+.*-UF ^X2\;C!_J,_4L/@_6O"_[8W@Z?5?&VK^+(;WP[KDEO;:
MG;VD26"_:+,[(C!#&S## ?O"YPHYZY /I:BBB@ HHHH **** "BBB@ HHHH
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M/OAK\6!\0[Z[MAIGV'[/&)-WG^9NYQC&T8KT&@ J&\N5L[2>X<%EB1I"%ZD
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MBG\9-+^$^I^!;+4K*\NY/%VOP^'K1K4(1#-(DCJ\FYA\@$9SC)Y'%=_7P/\
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M:AJWA7P9H7AW5-0S]KO-,T^*WEGRVXAF502,\X]:XCQA_P G<?#;_L6-<_\
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M,TS6=+F^PNUT=+1K1O/2?;Q EM'<1M\V!AT(RV#WG_#>6E?]$6^-?_A#S_\
MQ='_  WEI7_1%OC7_P"$//\ _%T =7\+?".F>(OC=XY\9C2+.S@\/S_\(QHJ
M0VB1;,1QRWMQP!EI)'6/=_=@X^\:]SKYB'[>6EL0!\%OC7G_ +$:?_XJK/[
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MG82=HE=@W!(Z@$A0: /LJO//@_\  /P3\"=)UO3?!VE/I]EK-_)J5['-<R7
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MG/.5W"*-GV],X&<5XEHOQB-EX@BEU2U:UL9S&23J;S^2KH3NV G=U&1CCVH
M]SHK@V^+EC=;?[+TC5M7W$JK6]J0N1ZD]/RJ-O%WC+4%;['X8M]/&W*R:C>*
M>?=1@B@#T"BO-[A/%EQSJ/C#1]%&[)6SC5N/3,F#5;_A%=!NLMJ_CJXU,%2&
MC?4D2,_\!R?YT 2:I\3I;/4KJ91=#2K662*8^5!NW(X4A090Q'#<XSTKO%\2
M:4R@_P!IV8R,_P"O3_&OFS5O#.DVOBO^R;75=).FSEI%O&N7;RT)SM8@$;P
M0!SGN1FO7%C^&2J 9-() Z^8/\:93BT=O_PD6E?]!.S_ / A/\:/^$BTK_H)
MV?\ X$)_C7$^7\,O[^D?]_/_ *]'E_#+^_I'_?S_ .O2).V_X2+2O^@G9_\
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MSX9^'[[Q9'XEFM9&UN.6.6.[$[ADV(R!%YX0AVW(/E8G)!-=3117.<@4444
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M +!K?^CI*]]KP']@A=O['_PP7);&F,-S=3^^DY/O7OU !1110 4444 %%%%
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M]L2?&W0OA'XRU[PCKOB+Q-&UX!:Q:+)IMW;LEMYDWF)> 8(\MO),9=LQ[=P
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MJQH ]JHHHH **** "N!^.7_)-M1_WXO_ $8M=]7 _'+_ ))MJ/\ OQ?^C%H
M^5:*** "OJCX$_\ )-[#_KI+_P"AFOE>OJCX$_\ )-[#_KI+_P"AF@#T"OB+
M5_\ D*77_71OYU]NU\1:O_R%+K_KHW\Z *E%%% 'LO[-/_(<U?\ Z]A_Z$*^
M@Z^?/V:?^0YJ_P#U[#_T(5]!T %<;KWA7Q5J&J7%SIWCB;2;-\&.S73+>41X
M !^=ADY.3SZUV5(WW3]*J,G'5&M.I*D[QM\TG^:9X]\.;/QUXU\'Z5KD_P 0
M);=[M6=H(](M2HP[+@';GH*]A&<#)R?6N ^ G_)(_#G_ %RD_P#1KUZ!6E9^
M^UV9V8^=\1.%DE&32LDNODD%%%>$?MC?M":M^S;\,++Q/H^F6>JW,^I1V30W
MQ<(%9)&+#:0<_(/SI4J<JTU3ANSS6[:GJ?C3X;^%/B-;VL'BKPYI?B*&U9G@
MCU2T2X6)B,$J'!P2!VKP?PK^SS\,+K]H+X@:9-\/?#4NG6FCZ/+;VK:5"8HG
M=KL.RKMP"VQ,D==H]*^5/^'MGCO_ *$KP[_WW/\ _%US6E_\%,O&.E>/]?\
M%<?A+0GN]8L[.SE@9YMD:VYF*E?FSD^<V<^@KWZ>6XZ$916FG?S1GSQ/U4\*
M^#]"\"Z.FD^'='LM#TR-F=;/3X%AB5F.6(50!DFMBORX_P"'MGCO_H2O#O\
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M_A'^V)\9_#GCW7-<G\-6MKI!T33['2[B^CMG: M.0((V*;BRGYNN..E>@_\
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MC_\ 9;^''B+Q%J,VK:WJ&EK-=7MP09)GWL-QP.N * /::*** "BBB@ HHHH
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MM%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445R_Q/\ B-I/PC\
MZWXPUU;EM(TB#[1<BSA,LNW('RH.IR10!\0_'3P]XT_:^^.GC+1? ?@'X87&
MG_#^:+2;O7O'M@UQ<WETZ"1HX]BL1&F<888SDYYP/>OV.?%UE\4/!L]WK?@7
M0?"OC[P+J%WX-U"+2+:,06SPLK.MJP&4A?<IV XR#UP#7P]\7OVA/@EXV^)>
MK>.? OQ+^+7PFUK7$C76T\.Z.X@U!XUVQRL@D7#A>"<D'T!R3]N_L"O\.6^
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M\1:O_P A2Z_ZZ-_.OMVOB+5_^0I=?]=&_G0!4HHHH ]E_9I_Y#FK_P#7L/\
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M^JLI((^E<5:A.B]5IT?1_,SE%Q+E%%%<Y 4444 %%%% !1110 4444 %%%%
M'Q[_ ,%,MEM\+O &J:S::G>^ M+\9V%[XIATD,9OL"+)\QP0=H?9SD8)7D5\
M.Z#X?F^(UO9?%R?0=4?XJ_$SXI0S^#+M(Y0]K86TJ/-(2#M$>Q]O.>(B1\JD
MU^Q%_P"*_#:M/9WNL:6",QRV]Q=1_0JRD_H:BM_%'A5I+6*#5M',D?[NW2.Y
MBRN>-J 'C/ P* .AHHHH _,+XF_M0>/_ (P?&+XFVNA?'G0?@;X:\'ZC_8.B
M6FH1PEM;O@7#-*[\HFZ,YDP50,H*Y))^]OA_XDUN'X-:#=?$74M"A\4W&G?Z
M9<Z9=J;*YDVG]Y"QQE77:^ ,#=@<8K\PO%'ACX?_ +./QE_:-T3XR_#B^\0W
MWC)KBY\%:HFF&[6Y\YI76.!_^6<N]X\LIR#&P)' ;Z^_9C_9@T[Q5^Q;\./#
MOQI\)0:WJFD6MS=6ECK",9+%)'=HT(R"K",H-IZ<#C&* /2?V"N?V0?AB1R/
M[-;_ -'25[[7@/[!"B/]C_X8(HPJZ8R@>@$TE>_4 %%%% !1110 4444 %?/
M?[1'_)P/[-7_ &,NI?\ IHNJ^A*^>_VB/^3@?V:O^QEU+_TT75 &[\6_%OQ
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MI<:CXCM]/DOKV]@*&VM64!O(8YR9-K*2 ,#(!YR _P 8?\G<?#;_ +%C7/\
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MKUCQA\4O"7P_U30=-\1^(;#1M0UZZ%GI=K=2A9+R8D#9&O4G+*/^!#UKR?\
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M<#^S5_V,NI?^FBZKZ$KPS]HSP+XTU[QG\)_%?@O1;'Q!<^$-8NKZYTZ^U+[
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MU/9PFS$HHHKZL[S]$_\ @DK_ ,>OQ/\ ]_3?Y75?H17Y[_\ !)7_ (]?B?\
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MCV?Q"O/'EO<3:[X7ATNWA.A!(]WFQRPC)13N&YL!MC<$\CWC5O%FA^)/VO\
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M$$$$$=: /$_V"_\ DT'X9?\ 8-;_ -'25[[7@7[!?_)H/PR_[!K?^CI*]]H
M**** "BBB@ HHHH *K:EJ5MI%C->7DRP6T*[GD;H!4EU=165O)//(L,,:EWD
M<X"@=237G%K;S_%K5EO+I'@\(V<F;>W8$&^D'\;#^Z/3\/7 !Y=,MUXA6[>>
MU=K(RSSZ>IFBAVM))N,D@9@2 #_+\<3]H;XE7MSI<+Z;YG]L:](VD>'K5/\
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M2US597@TS3K=[JZECA>5DB12S-L0%FP 3@ GBM.FR1K+&R.H=&&&5AD$>AH
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M?H,NJ^%-7GOGL81&;F3[79G<^.IRS?F:^E:\5\1_\G@^!_\ L3M7_P#2JQH
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M*&MPI=AYB_:VV A> #Z+KA?C9_R3?5/K%_Z,6NZKA?C9_P DWU3ZQ?\ HQ:
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M;<\167PL\$OH'@C]G/PAJJ2ZMJR/!9C5[B,EOLUC"-NV++DF0#!+;O0-[/\
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M4U.I+GDV&)K>WJN:5ET79+1+Y(****S.8**** "BBB@ HHHH **** "BBB@
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M?_B:^MPV(HQHQ4I*]C]SR?-,#1R^C3J5HIJ*NFT4*['X-_\ )6O!O_88M/\
MT<E<;H.G^)_%.DP:IH_P]\;:GITY8175KX>N)(WVL4;# 8.&5@?<&NQ^'>E^
M+_#/CWP[J]]\,/B"MG8ZA;W,QC\,73,$216; V\G /%;5,31<&E-?>=^(S?+
MY49Q5>-VGU78_5ZOC+_@JK_R;OI/_8?@_P#1,U>M?\-::3_T3CXI?^$3>_\
MQ%?.G[=/Q!U/]H#X0V'AWPC\,OB1/J<.JQ7CK=^$KN!/+6.12=S+URXXKYK
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MI$S;L8SOD7CKS0!NU]1_ /\ Y)Q:?]=YO_0S7R__ ,*[^-7_ $2=/_"GL_\
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MD[X[_P#1.[7_ ,**UKZC#8NA"C&,I:H_9\HSS+L/@*-&K52DEJK/_(\RK?\
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M5>H?\>-S_P!<V_D:_GVU3_D)W?\ UV?^9K]H+CXJ?&*:WEC_ .%$2#>I7/\
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MX.2?-:)=L7I& ?4FN[_X9/TC_H>_'W_@]/\ \10![C17AW_#)^D?]#WX^_\
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M5ULPG)>SHKDCY;_?_D8XC'SK1]E32A37V5^;ZM^;U(8K.""-$C@CC1 %550
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M8& !PP'F?</A[Q%IGBS0[#6=&O[?5-)OH5N+6\M7#Q31L,JRL.H(H T:***
M"BF32&*%W"-(54G8GWFQV'O7YO\ Q+^)'QHNO'W@?]H#QE'J'P[^%VA^+[;2
M+;P?.6BN?L$[/!-?WH!QDL5 5L@ \<8+@'Z$^#O!NC^ /#MKH.@62Z?I-J9&
MAMU=G"EY&D?EB3RSL>O>MJD5@ZAE(96&01R#2T %%%% !6-;^#](M/%M]XFB
MLU37+VTAL;B[WMEX8F=HTQG PTCG(&?FKY@_:F_;&\>? ;X[^"? _AKX8_\
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MT;PO' ^L:O8:2MPXBA:^N4@$CGHJEB,GV%?G3^T-\._B_;21_M+?$NX:SN?
MGB:SNM'\$:1.+BVL-(2Z"3S.P_UDLBE6+#!VCG PB 'Z0Z?IMGI%JMK8VL%E
M;*S,L-O&(T!9BS$*!C)8DGU))JS5+1-:L?$>CV.K:9<QWNG7T"7-M<1'*2QN
MH96!]""#5V@ HHHH *K+IMHFH/?K:PK?21K"]T(QYK1@DA"V,E022!TR37QY
M^W%\=?C9\'_BS\)M,^'#^'X-"\2SRV#?VY%F*ZU#CR[>67.8@X*A"I7+%LG
MJEX'_P""GOA;2?%]WX%^-GAR\^%'C33Y%M[PNXO=.$C*"/WT>2@8'(R",?Q4
M ?;-%5["_M]4L;:]LYDN;2YC6:&:-MRR(P!5@>X((-6* "BBB@"M?:;::FL*
MWEK#=K#*D\:SQAPDB'*.N1PRGD$<@U9KX1UC]L?XZ^+O#_B'XK?#/P!X;UGX
M.>'[RY@>WOKN4:SJ4%NQ6:YB"_)&HPQ"D,V%Z&OL/X5?$;2_B]\-_#?C31?,
M&EZY8Q7T"3##H'7)1L?Q*<J?<&@#JZ*** "BBB@ HHHH **** "N.^,GABZ\
M;?"'QQX>L1F]U;0[ZQ@'K)+ Z+^K"NQHH _%'4OBCI?Q(_83^&_[-^E0WK_%
MV/Q7_9]SX?:TE$EN%N+A_,8E<8Q*H(SD8?( 7-?<G[:'PC_X1GPW=?$2QN1"
ML%G8Z1J:/))(]P'N(K>+8I.U,&1-Q&,C=P3U^M(?">AV^O2ZY%HVGQZU,GER
M:DEK&+EU_NF3&XCV)K2GMXKJ,QS1I+&<$I(H8'!R.#[TT[.Z*C)PDI+='QQX
M;^ OQG^%:Q6?A+P;\)-=B4"1M4\175Z+MI"26 "P,%4$X7!SCK7:QZE^UO#&
MJ1^&/@VB*,!5U;4P!^'D5ZC\/_V@/ WQ2\>>,?!_AC65U76_";QQ:LL43>5$
M[[@%63&UR"C [2<$$&O1:+L'*35FSYK_ +6_:Z_Z%OX._P#@WU/_ .,4?VM^
MUU_T+?P=_P#!OJ?_ ,8KZ4HI$GRSXF\:_M9>%?#>JZW>>&?A"]IIMI->3+#J
MVIERD:%V"@P@$X4XR157P'\1_P!JWXA^!_#WBK3/#'PDBT[7-.M]3MH[G5=2
M658IHUD0.!"0&VL,@$C/<U[E\:/CAX%^ ?A$^(/'^NV^AZ3))]GC\U&E>XD(
M)\M(T!9S@'H.!R<"H?@C\>/ 'Q_\)MK?P]UVWUG3+:06TT<<;0R6S@ A'B<!
MDXZ<8/;- 'E_]K?M=?\ 0M_!W_P;ZG_\8H_M;]KK_H6_@[_X-]3_ /C%?2E%
M 'S7_:W[77_0M_!W_P &^I__ !BE_M;]KK_H6_@[_P"#?4__ (Q7TG10!\B_
M#_XK_M4?$C2;_4-+\+_":*&SU.[TJ1;K5-25C+;3-#(1B$_*60X/7'4#I73?
MVM^UU_T+?P=_\&^I_P#QBO3?A9\>/ ?Q<\0^,=#\&ZK'JEWX5O!::J;>%EA2
M9R_W'QMDY1\E21D5Z/0!\U_VM^UU_P!"W\'?_!OJ?_QBC^UOVNO^A;^#O_@W
MU/\ ^,5]*44 ?-?]K?M=?]"W\'?_  ;ZG_\ &*Y#P[\:/VH_%'Q&\8^"[3PM
M\*%U;PLED]])+JFHB%Q=1M)'Y;"(DX"G.0,'IFOKC5M6LM!TN[U+4;J&QT^T
MB:>XNKAPD<4:@EG9CP  "237@?P[_;R^ GQ-^(2^%/#?C>TG\07D@@M_-LYK
M=+UQP%CE=%5SV SSVS0!2_M;]KK_ *%OX._^#?4__C%']K?M=?\ 0M_!W_P;
MZG_\8KZ4HH ^:FU3]KEE*MX:^#A!X(.KZG_\8KE?$'P]_:&\5;O[6^&/P&OG
M88,LMWJ'F?\ ?8M]P_.OK^B@#\S]4^!/Q'B\='X=2^&/!-GXPUZTN?$=I+8Z
M]J T^"UAGAC>$YBSG=*NWY&XS\PP*[;_ (99^-__ $)OPS_\*_6__C5>YWW[
M>7P!L?BE_P (7<>/-/7Q''.;!IOL\IMHYMVTPFYV>6#N&#\VW(Y.:^ALYY'(
MH ^!?^&6?C?_ -";\,__  K];_\ C5'_  RS\;_^A-^&?_A7ZW_\:K[[HH ^
M!/\ AEGXW_\ 0F_#/_PK];_^-5S'B3X!?$[P1JFGMX@\-^#$;Q/>0^'].BTO
MQ+J<B0W3I(ZRRL\0;9A&R/F[87K7Z15RWQ,^(GA7X4>#[SQ7XSU2VT70--*O
M+>W2EA&Q(5=JJ"Q8DX 4$G- 'Q+IW[)WQQL;"WMG\)_#6Y:&-4,S>+=90O@?
M>*K"%&?0 "K'_#+/QO\ ^A-^&?\ X5^M_P#QJON;PIXITOQQX9TKQ#H=VM_H
MVJ6T=Y9W2HRB6&10R. P!&00<$ UJT ? G_#+/QO_P"A-^&?_A7ZW_\ &J/^
M&6?C?_T)OPS_ /"OUO\ ^-5]]T4 ?FQ\2O@C\3_A/X9O_'WBOPKX)7P[X=M9
M+J\M=%\3:K-<SJ=J@+YL:X()SPZY[YK?TC]D_P"-=O;.\'ACX=7L%Q(UQ')<
M^*M7CD"N=P4B.$#(!QGDGN37UQ\</VC?AC\ ;?2U^)/B2VT&'6/-6TCN+6:X
M$_E[=_$:/@#>O7'6KGP9_:!^'_[06D:AJ7P]\11^(K#3YQ;7,L5M-"(Y"H8+
MB5%)X(Z9% 'R1_PRS\;_ /H3?AG_ .%?K?\ \:H_X99^-_\ T)OPS_\ "OUO
M_P"-5]]T4 ? G_#+/QO_ .A-^&?_ (5^M_\ QJJU_P#LC_&[5$@A?PQ\.;&-
M9XY'F@\5:O(^U6R0!)"5YZ9ZCL17Z"5RWQ*^*'A7X.^$;OQ1XSUNU\/Z%:X$
MMY=$XW$X554 LS'LJ@D^E 'FO[*\=QXP\&Z=\2[TPV\GB+2+."TTZW#;;2TA
M#"-6=F+22$LQ+$^@KW.O(_@'^U#\+?VBK6_3X=>(H-4?3-OVFQ-O);30J20K
M>6ZJ=IQ]X9';K7KE !1110 4444 %%%% 'Y?? ^:WM_ /[?8UED6^74-3-P+
MC[VPQW83.>V<UV_P?TWQC>?\$Z_@\-.$L]B@E?4;*VB<WD]M]HF,8B8'Y0%S
MGU!&"._LOQE_X)T_##XT?$34?%UY?^(_#]SK.S^W;#0=1%O:ZN$((\]"IS]T
M9VD9(SUYKZ.T#PKI7A7PK8>'-'LX]-T:PM$LK6U@&%AA50BJ/H .M S\VO /
MQD\8?"?29M6TF\?1= U9PEH(]#N]2B;;DGRUACEVCGEC@$].AK8N/VR/&URY
M9O&-\,]H_!>KH/\ QVU%?>7PA^&>F?!?X;Z!X)TBZNKO3M'@,$$U\RM,Z[F;
M+%54$Y8] *[*G?R'*2DV[6/S%N/VH/$]T6,OC#5F#=5/A77,?E]GJM'^T)=;
M2+G4)+TGO/X0UW^D K]0Z*!'YH6_[0]_K$7]CV*68N;P&WA9O!VL1D.W"GS)
M(=J')^\QP.IKB=*N-=M9-1:YEO-+M-/'E:K<06-U<R;CM(62.+<[.=Z_= (5
M]W YK]9:Y7P?\/=/\&^(O&>LV=Q<37/BC4X]4O$F92D4J6D%J%CP 0NRW0\D
MG);G& &G;5%1ERZK?\CX7\)_M:OX%TE--\/W5KI-DO/E6WP\UE=Q_O,?*RS'
M^\22:VO^&Z/$'_0?_P#,?ZS_ /&J^^**3;D[LF4G)WD[L^!_^&Z/$'_0?_\
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M/]9_^-4?\-T>(/\ H/\ _F/]9_\ C5??%% 'P/\ \-T>(/\ H/\ _F/]9_\
MC597BK]MGQ1JGAO4;*TU^Y-S<0M$GV/P/J]O-EN/DD:+:AP?O'I7Z&T4 ?FE
MX4_:,O?AGX@$N@ZZJZ=<69ANOL/AW5+^V^TQL PD10["<<AFX'4'-=K_ ,-T
M>(/^@_\ ^8_UG_XU7V)\+?A7IGPFTO6['2[J[NHM6UN_UZ9KQE9DFNYFFD1=
MJCY S$ ')QU)KM* /@?_ (;H\0?]!_\ \Q_K/_QJC_ANCQ!_T'__ #'^L_\
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MJS<4S:)\)/!/B;X'?M4?VMXCM-:?^W?"GQ#TR6XU,WLICCC1;0G<8Y5PN%
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M9- ^/OAN;4-)U>^TL_:%T]S;6^L0S1J8GNHBH+,JD$9P<A=V2HQ[?0 @XX'
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MK:+(\VCWVGV]S9R2 AVA>-60MGOM(S7QC>?\$MX&^V^%;#XN^)M,^#5]J/\
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M,'C;5='_ &QO$G@_XJ?#/PIX6^*]_P"'TO;;Q%X0:3[/>6*LH\ET9R 05'S
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MHHH *\"^/?[7VA_LW_$3PWH_C30=2L?">M6DS)XP4!K.*[3)6U<#)#,H)W'
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M?M%^,_%$GPQ@^!'ANW\9V/BZ5;R?Q7>%O[)L+&-E,R2LIW+,02-I ((( 9N
M >>_LWZE\)?VKOV=[[X'Z_X*@\'ZOX;A&GZSX)D7RKC3YT)'VJW+?,3O);S.
M6#,0V<Y; ^&O["WQ)UC7+'P3\8O')\7_  2\%W0F\.Z0K8EUGH8EO<<F.$?*
M$8G)X'RU](>-/V6?!OC+XX>$OBR/MNB>,=!8B2ZTF;R!J46PJL-S@?O%&?8D
M?*<C 'L= $=O;Q6=O%;V\2001*$CBC4*J*!@* .  .U245X!^U+^T-K_ ,*K
MSP?X(^'^A6_B3XG^-;B6WT:SOI#':6\<2AIKF=@0=B CY003SZ8(![IJVK66
M@Z7>:GJ5U#8Z?9PM/<75PX2.*-02SLQX  !)-?GU^TM^TIX0_;,\)W/PP^$O
MQ%O-$\632-)9:?J=B]IIWBR,*0UFLTBC(;^$$J&.!@\$>S^._ OQ6^)G[(/C
M[PA\8/$'@_0?&6MA[+3[S199+>QP6C,$;O*<EI)%*' '#@8)KPJ\T/XK?M,>
M'_A/\,=>^".H?#_7? VL6%UJ'C2YV1V%K!:C#&R8<R-*%7Y4)4$#)P,@ U?A
M'X+L/VDO%&B?%;X4E?@?\8O"5[#HOCGPY)8,MI-".)(GA 4/E4.P\'Y0&P55
MA][Z-X;TGPZU\=*TRTTTWUR]Y=&T@6/SYVQNE?:!N<X&6/)Q5JWL+:SEN)8+
M:&"2X?S)GC0*97P%W,1U. !D]@*L4 %%%% !1110 4444 %%%% !1110 444
M4 %%1O/'')&CR*KR$A%9@"Q R0!WX&:^1]4_:V\3_"7]HS6?AG\7K?3?#6B>
M)W=_ OBVS)^R;<!%AN2QXD#%26. &;'W64T >N?'?Q]J%_X'\6^$?A=XF\/O
M\7WL_+TW2IM3@6YA=F4-*8V;(*1LS@D8R!UK\Z_#,_B+X+_$C5?$'PNOY/B'
MX?OO$"^!=>\#Z[JAO+SQ=?);L^H7BH_$85MRJ2OW5)/RMM/ ^'X;;P+X@C\,
M^.?!XTCXU>"+FYOM&AM=.NKK5/&^N33.UO/-=Q@'[(F8SL#_ #]<@94_J-\'
MOV9_!GA+7++XDZAX,TFP^+.IV$;ZWJEJIQ]L>,?:6C3)1"SELL@&<GGDT 3?
MLS_LYZ+^SOH>NVWAZ;5[+2==O!JD?AO4+M9X-%9D&^"#&1C<3DY.<#DXR?9J
M*CGGCM89)II%AAC4N\DC!550,DDGH * )*\I_:2\7?"W1?AKJ.@_%GQ)8>'_
M  YXC@DTYUN[PV\DX9?F$>T[B0"#D=.,]:\\_;-\6^+K_P#9N?Q_\&?%$=U-
MX>O;?7I?[)F2>+5+*!]TT.],Y7'SL%/S!"O?%?-O[4VL>*O&NJ^ /VB? NBM
MXI\">(_""Z%>/'I8U6Z\-"6??/=PVQ(5I0I>/)X#(0W!% ' Z'X.\'?#SXF:
M1X:^/-];_%7X*^(M&_L+X??$6659K;3HC*S^4\JG$4PW!?,SE1&N,)N"_5_P
M5_8[U.QT6Y\"?%>XTKXE_#KPUJ5OJ/@/4;PN=2MD7YO*E88&Q<*H )# $8V[
M57$_8X^#]EXR\!^+="U?P-+9_ EI;%/"/AOQ9IL<=[,T(9[F_N$/S%I9F4@L
M>B8 "X%?:44201I'&BQQH JHHP% Z #L* 'T452UK6;'P[H]]JNIW45CIMC
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MB33;W]F7XU^%M,\.^.-'L?[-&D- J:=KU@%PLMNH 4Y09*KUP67&&"L^%O\
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MG@8X ->1?\,_?M(?%KX<^&O@7\0])\*VO@#1+RS\_P =6=[YMS>V5JP,200
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MH'3I?&UKIB/8!PX0N!OW;,D=MW(&W)Q7U_87T&J6-O>6L@FMKB-9HI " R,
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M^EJ** "O/OCA\=/"?[/?@D^)_%]W-#9O.EI;6MG T]S=SL"5BBC'+,0K'L
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M)?ACX3F^(4'CJ3P_8/XP@LVT^/63"/M"V[')0-Z>_7!(S@D4 <?^S=\(=?\
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M:&U7XD^#=;O/#>DZ[:NNM^$;6-?L%]=D_)<@'_5L,L2%')/4 L#[Q0 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^)NH_%#X.:;/X@^3Q?HL\V@>((F^\FH6KF*8G_?PL@]I!7KU !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !3719%964,K#!5AD$>E.HH
M^+M6_8_\5?![XZ#7O@W]D_X5KXWF:R\;>"KRZ:VM8(I%(>ZMF3YD;!; 3D$@
M#Y3A?I/X._ ?P%\ ?#\VC> ?#5IX=L9Y/-G\C<\D[@8#22.2SX' R3CM7?44
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M)!XK+^)GP&\?ZAX!_:#33_#CWU]K?CO3/$>C6:7,(?4+6V.GO)L)?"L?L\H
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M!T %2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
H0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>syre-20250331_g11.jpg
<TEXT>
begin 644 syre-20250331_g11.jpg
M_]C_X  02D9)1@ ! 0$"6 )8  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" IT%5@# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHILDBQ1L[L$11EF8X 'J: '45^:GBK_ (+9>%=%\3:MI^F?#>^UK3;2
M[E@MM275TB6[C5RJRA/).T, & R<9K+_ .'XVA_]$DU#_P 'D?\ \8H _3^B
MO%OV2?VE+;]JWX2CQS::#+X<B-_-8_8IKD7#9C"G=N"KUW=,=J]IH **** "
MBBB@ HHKYP^,7_!0OX$?!22XM=5\;VVM:O#E6TOPZOV^?<.J,R?NT8'L[J:
M/H^BOSGUC_@MM\,87(TOP%XMO$SP;PVMN<8ZX663G/\ GM5G0O\ @MA\)KK8
MNK^"_&.G,W!:UBM;A5YZDF9#C'/ S[&@#]#Z*\.^#G[;'P5^.UQ;6?A/QYIL
MNKW!"1Z1J!:RO'<_P)%*%,A_W-U>XT %%%% !1110 4457U#4+72;&XO;ZYA
MLK*WC:6:XN)!''$@&2S,3@ #DDT 6**^2?BM_P %2/V?OA;,UO%XFN/&MZK8
M:W\*6XNU'.,B9V2%A_NR'^5>*ZA_P6X^'<<V+'X>>)[F'^]<36T+=?0,_;WH
M _2"BO@'PO\ \%HO@OJUQ!!J_A[QAH)D;#7#VEO/!&,=6*3;^N>B&OK+X1?M
M+?"_X\0[O ?C?2?$,XC\U[*&;R[N-/[SV\@651[E10!Z91110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MH!?2CH?L\>2(1Z.V7Y& A%?*W_!0.ZGNOVR?BIYTTDWEZNT:>8Q;:H1<*,]
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M<>K (#T4D!JN_P#!9[C]D_1 .!_PEEG_ .DMW7WK7P5_P6>_Y-0T3_L;;/\
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M]=L;4@#.0]PB_P!:_IWK^;']D:U2\_:I^#T4@RA\7:4Q&,@XNXC@^W%?TG4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ KX*_X+/?\ )J&B?]C;9_\ I+=U]ZU\%?\ !9[_
M )-0T3_L;;/_ -);N@#\3**** /W)_X(]?\ )GZ?]C!??RBK[?KX@_X(]?\
M)GZ?]C!??RBK[?H **** /QO_P""VTS-\=O 41QL7PV7'KDW4P/_ *"*_.>O
MT@_X+<6Q7XS?#NXV8$F@21[_ %VW#G'X;OUK\WZ "OZ'/^"=ZK'^Q;\*@JA1
M_9KG &.3<2DG\Z_GCK^A;_@G',TW[$_PL9SDBPF7\!=3 ?H* /I*BBB@#X@_
MX+"_\F?O_P!C!8_REK\-J_<#_@L?,T?[(MLJM@2>);)6'J/*G./S _*OP_H
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M. >E?G!^UC_R=-\9/^QSUG_TNFKRJ@ HHHH _JHHHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBLCQ3
MXOT+P/H\VK>(]:T_0-*A_P!9?:G=);PI]7<@#\Z ->BOD;Q__P %4?V=_ LC
MPP^*KOQ5<H<-%X?T^28?A))LC;\'->.ZM_P6V^&L,V-,\ >*[N+)^:[>V@;'
M8X61_?O^= 'Z-T5^;^G_ /!;CX=R3$7WP\\3V\6.&MY[>5NOH67^=>H>"?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^3J?X74X96'((!'2OYQOVC/@KJ7[/'QH\4> -4<SR:3<[8+K;@7-NZAX9?\
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M=9\6/BAKWQG^(NO>-?$UU]JUK6+EKB9AD(@Z+&@[(BA54=@HK0^!?P7\0_M
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MVONG_@C;_P G<7G_ &+-[_Z-MZ^%J^Z?^"-O_)W%Y_V+-[_Z-MZ /V_HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *\J_:Q_Y-9^,G_8F:S_Z0S5^2O[0G_!1[]HGP/\ 'WXE^&]$^(?V+1='
M\3:GI]C;?V)ITGDP174D<:;GMRS850,L23CDDUY5XL_X*/?M$^./"NL^&];^
M(?VW1=8LIM/OK;^Q-.C\Z"6-HY$W);AERK$94@C/!!H ^:Z*** /ZJ**** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "HYYX[6&2::18H8U+O)(P554#)))Z "I*^%OVQ_V@+GQ!KUUX&T.Z:'1]
M/DV:A+"^/M4XZH<?P(>,=V!/.%-=.'H2Q$^2)[&5995S7$*A3T6[?9?UL>D?
M%/\ ;FT+PS=S:?X1L/\ A(KF,LC7TSF.U5A_=&-T@SGGY1Z$UXM>?MR?$JYF
MWQ'2;1?^><5F2.O^TQ/ZU\]T5]13P-"FK<M_4_9<-PYEN&@H^R4GWEK_ ,#[
MD?5W@_\ ;[UZUO%3Q-H%EJ%FS &73V:"5!GDX8LK<=OE^M?6/PU^*WAKXL:*
M=2\.WXN5CP)[>0;)K=B,A73MWY&0<'!.*_*"NF^'7Q#UGX7^*K37M$N##<PM
MAXSGRYX\_-&X[J?TX(P0#7/B,NIU%>GH_P #R\SX5PF)IN6$7)/IV?JNGR/U
MHHKF?AOX\L/B9X*TOQ'IWRV][%N:)CEHI <.A]PP(SWX/0UTU?,2BXMQ>Z/Q
MJI3E2FZ<U9K1^H4445)F%%%% !1110 4444 %%%% !1110 5^%?_  5G^#-U
M\-?VJ+_Q)';NNB^,K:/4[>;;\GVA%6*XC![L&59#[3+7[J5X9^V'^RWHW[6/
MPAO/"UZ\=CK=LQN]%U5E)^R70! W8Y,;CY7'H<@95: /YRJ_5K]@#_@J!X>T
M3P;I'PV^,%_)I<NFQK::5XHE5I()(%&(X;DC)1E&%$F-I4#<5VEF_-/XK?"?
MQ5\$_'&H^$O&.D3Z-K=BY5XI1\LBY.V2-NCQMC(8<&N1H _J7\/^(])\6:1;
MZKH>IV>LZ7<+NAO=/N$GAE'JKJ2"/H:T:_F&^'/QA\<?"+43?>"_%NL>&+AF
M#.=,O'A27'9T!VN/9@17UQ\-?^"PWQQ\'K%!XBBT+QS;+@-)J%G]FN2!Z/ 4
M7/N4:@#]P:*_.+X<_P#!;#X>ZSY4/C7P-KWAF9L*9],FBU&!3W9L^4X'T5C_
M #KZJ^&/[<'P+^+K1Q^'?B3HOVR3 6QU.4Z?<,W]U8[@(7/^[F@#W.BFHZR*
MK*P96&0RG((]:=0 4444 %%%% 'X _\ !4?_ )/L^)O_ '#/_37:5\JU]5?\
M%1_^3[/B;_W#/_37:5\JT ?TN_LR_P#)MOPH_P"Q2TG_ -(XJ]+KS3]F7_DV
MWX4?]BEI/_I'%7I= !1110 444C,$4LQ"J!DD]!0!S7Q-\;6GPU^'/BCQ9?M
MML]#TRYU&7U(BC9\#W.W ]S7\OS,78LQ+,3DD]37Z??\%3/V]-&\:Z/-\'?A
MUJD>J:>TRR>(-;L9MT$NPY6TB8<.NX*SL#C*JH)^:OS H ];_9&\-S>+/VI/
MA/ID,33>9XGT^615Z^5'<))*?P1&/X5_2;7XQ?\ !&SX&W?BWXW:K\3+J#&C
M>%+22VMIF7[]]<(4PO\ NPF4MZ>8GK7[.T %%%% 'C?[67[-^C_M2_!?5_!F
MH^7;:B1]JTC477)LKQ0?+D]=IR48#JK-WP1_.MXV\&:S\._%VK^&/$-C)IVM
MZ3<O:7=K)U21#@\]QW!'!!!'!K^HVOS5_P""N7['O_"8>'/^%U>%;'=K6CPK
M%XAMX$^:YLUX2YP.K1=&/_//!X$= 'Y2?#GX@:W\*?'6A^+_  Y=M8ZWHUTE
MW:S#IN4\JP[JPRK+T*L0>M?T=_LZ_'31/VCOA!X?\=Z$P2'4(<75INW/9W*\
M2P-[JV<'NI5NA%?S0U]Q_P#!*G]JH_!'XS#P-KUYY7@WQE*EONE;Y+34/NP2
M^@#_ .J8^\9)PE '[BU^%_\ P5$_:X_X7]\73X/\/7OF^!?",SP1-$^8[Z^'
MRS7''!5>8T// 9@</7Z ?\%0/VKS^S[\%F\,Z#>^1XW\7QR6ELT38DL[/&)[
MCCE3@^6AX.YBP^X:_">@!54NP5068G  ZFOW8_X)G_L<K^S?\+?^$G\1V0C^
M(7BB%);M95^?3[7AH[4=PW1Y/]K:I^X#7Q=_P2B_8V_X6MXV7XL>++'S/"/A
MRYQI=M.GR7^H+@A\=XX>&]"^T<[6%?M!0 4444 %?'/_  5F\5OX;_8O\1VD
M9*MK6HV.G;AU \X3G\Q 1^-?8U?GE_P6PU<V_P"SKX,TT9'VKQ3',3[1VEP,
M?G(/RH _&2OUL_X(>^%UM_!_Q4\1%<O=W]CIZL1T$4<LC ?7SU_(5^2=?M=_
MP1=TU;3]E?Q!=;</=^++IMWJJVMHH'YAOSH ^^J*** "BBB@#YA_X*6^&U\3
M_L3_ !*B(_>VEO;7\;?W3#=0NWYJ&'XU_/K7])/[86FC5?V4?C! 5WX\)ZG*
M%QGYDMI''XY45_-M0!^HO_!#OQ0T>N?%CPX\A*3VVGZA%&3PI1IHW(^OF1Y_
MW17ZQU^+/_!%;5?LO[37BJQ9L)=>$YV ]62[M2/T9J_::@#\OO\ @N'XJ>W\
M,_"CPTC9CN[R_P!1E7/0Q)#&AQ_VWD_(U^3%?I'_ ,%NM5>;XP?#G33GR[?0
MIKA?3,EPRG_T4*_-R@#]ZO\ @E'X53PW^Q3X2N@NR;6;R_U&48YS]I>%3^*0
MH?QKZ^KP7]@W31I7['?PEA5=H;0H9\?]="9"?QWU[U0 4444 %?G-_P6T\,)
M>? WP%XAVYET_P 1-9 XZ+/;2.?PS;+^E?HS7Q)_P6 L!>?L=W$I7)M=>L9@
M<9QGS$S[??\ UH _#*OW _X(X^*&US]DFXTYY"QT7Q%>6:(3]U'2&<8]BTS_
M (YK\/Z_7S_@B#JAF^%_Q,TW=Q;ZQ;7&WT\R KG_ ,A?I0!^EE%%% 'YW_\
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MBBB@ HHHH **** "BBB@ HHHH **** "BBB@#^:S]K'_ ).F^,G_ &.>L_\
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M%4;!1110!T&@?$+Q3X5LWM-$\2ZQH]H\AE:#3[^6",N0 6*HP&< #/L*TO\
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M ))7XR_[ M[_ .B'H _F"K[I_P""-O\ R=Q>?]BS>_\ HVWKX6K[I_X(V_\
M)W%Y_P!BS>_^C;>@#]OZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "O*OVL?^36?C)_V)FL_^D,U>JUY5^UC_
M ,FL_&3_ +$S6?\ TAFH _FLHHHH _JHHHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** /+/$7[,/PS\6:Y>ZQJOAK[5J-[*9IY
MOM]TF]SU.U90!^ K._X9 ^$?_0I?^5*[_P#CM>R45NL162LIO[V>G',\?%*,
M:\TE_>?^9XW_ ,,@?"/_ *%+_P J5W_\=H_X9 ^$?_0I?^5*[_\ CM>R44_K
M%;^=_>Q_VKF'_01/_P "E_F>-_\ #('PC_Z%+_RI7?\ \=KX=^/GPCNO@_\
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M-HW7>Q_CD';'"D9&3@C"OBJ>'C>3U['F9EG&%RRFY5)7ETBMW_DO,?\ !O\
M8Y\(1_#_ $V;QOH;7_B*Y'VB<-=SP_9PV-L6V-U&0,9R,[BPS@"NU_X9 ^$?
M_0I?^5*[_P#CM>R45\I+%5I-OG?WL_$ZV<YA6J2J>WDKN]E)I+T5SQO_ (9
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MS^,0H _<JBBB@#\ ?^"H_P#R?9\3?^X9_P"FNTKY5KZJ_P""H_\ R?9\3?\
MN&?^FNTKY5H _HE_9S^!/PUU3]GOX87M[\//"MW>7'A?2YIKB?1+9Y)7:TB+
M.S%,EB222>237H?_  SW\+/^B:>#_P#P0VO_ ,;JI^S+_P FV_"C_L4M)_\
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MBX6OP]^&/A<.-U]JEUJ3)WQ!"L8/_DRWZT ?D37['_\ !$G1?(^!?C[5MO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !7E7[6/_ ":S\9/^Q,UG_P!(9J_ ']K'_DZ;XR?]
MCGK/_I=-7E5 !1110!_511110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MVO?&5M#:6\VB^ M'D8Z5I4C R2N>#<SXX,A' 4$A 2 22S, ?+E?H!_P1?\
M!,^N?M)>(?$>TBST+0)%+@9'G3RQHBD]LHLQ_P" U^?]?O/_ ,$O_P!FVY^
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M'8  #\*LT ?.'_!0[X7O\6/V0?B%IMO&9+_3K,:U:A1EM]JPF8 =RT:R*/\
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M;;T ?M_1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110!_-9^UC_R=-\9/^QSUG_TNFKRJOZ7=6_9E^#VO:K>:GJ?
MPG\#ZCJ5[,]S=7EWX<LY9IY78L\CNT9+,S$DL3DDDFO*OVFOV9?@]H/[-OQ7
MU/3/A/X'T[4K+PEJUS:WEIX<LXIH)4LY621'6,%65@"&!R" 10!_/O1110!_
M511110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M*U]<4 %%%% !7R1_P42_8P'[5OPT@O?#\<$7Q#\/!Y=+DD8(+R(\R6CMT&[
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7E7[6/_
M ":S\9/^Q,UG_P!(9J]5KRK]K'_DUGXR?]B9K/\ Z0S4 ?S64444 ?U44444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %>5?M8_\FL_&3_L3-9_](9J]5KRK]K'_DUGXR?]B9K/_I#-0!_-
M91110!_511110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!^:OQ8_X+*?\*O^*GC+P;_PJ#^T_P#A'=:O-(^V
M_P#"3>5]H^SSO%YFS[&VW=LSMW'&<9/6O*OBQ_P64_X6A\*_&7@W_A4']F?\
M)%HUYI'VW_A)O-^S_:('B\S9]C7=MWYV[AG&,CK7Q7^UC_R=-\9/^QSUG_TN
MFKRJ@ HHHH _JHHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ KRK]K'_DUGXR?]B9K/_I#-7JM>
M5?M8_P#)K/QD_P"Q,UG_ -(9J /YK**** /ZJ**** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O*OVL?^36
M?C)_V)FL_P#I#-7JM>5?M8_\FL_&3_L3-9_](9J /YK**** /ZJ**** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "O*OVL?^36?C)_V)FL_^D,U>JUY5^UC_ ,FL_&3_ +$S6?\ TAFH _FL
MHHHH _JHHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MR""" 016W0 4444 %%4M:UK3_#>D7FJZM>V^FZ99Q-/<WEU((XH8U&6=V/
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\=_\
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MQD*+C;G\*\-^*7_!%;X>:U8S3> O%^M^&-2Y*0ZKLO[0^BX"I(O^\6;Z'O\
MHU10!_-W^TC^R7\1OV6?$2:=XUT@+87#LMCK=BQEL;W']Q\ AL<['"L!SC&#
M7C=?T[_%SX2>&/CC\/\ 5?!OB_38]3T74(]KJP >)_X98V_@D4\AA_+(K^<?
MX^?!O5OV?_B]XF\ ZTPEO-&NO*6X5<+<0LH>*4#L'C9&QVSCM0!^A'_!(_\
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M:21NLD;@,KJ<A@>A!]*?0 4444 )G')X%?A5_P %.?VOS^T1\6#X5\.WOF^
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MHLDBQ1L[L$11EF8X 'J:_+O_ (*#?\%/K6TL=1^&WP9U87-[*&M]6\763_)
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]0N--OX3E+BVD*,/;(Z@]QT->KBL"L19IV:5C[/..'89IRSC4Y915EU6G?\
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M5Y^/P<::]K36G5'R_$V04\+'Z[A%:/VET7FO+R/H"BBBO#/S<**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?:IFBY1F&/+9.]>_T4 %%%% 'X _\%1_^3[/B;_W#/\ TUVE?*M?57_!4?\
MY/L^)O\ W#/_ $UVE?*M ']+O[,O_)MOPH_[%+2?_2.*O2Z\T_9E_P"3;?A1
M_P!BEI/_ *1Q5Z70 4444 %%%% &1XN\-VOC+PGK7A^^4/9:K936,ZD9!CEC
M9&&/HQK^7&:%K>:2)QAT8JP]P<5_4'\1/&5I\._ 'B7Q3?MLLM%TVXU&8_[$
M43.?Q^6OY>G=I&9F8LS')9CDD^M 'HG[-^L2^'_VA?ACJ4#%9;7Q-ILHP,YQ
M=1DC\1Q^-?TQU_-=^R9X=E\5?M0?"?3(HC,)?%&G/(H_YY)<(\A_!%8_A7]*
M- !575-,M-:TV[T^_MHKRPNX7M[BVG0/'+&ZE61E/!!!((/8U:HH _GF_;P_
M91N_V4?C5=:5:QRR>#=8WWV@7;Y;,.[YH&8]7B)"GN5*,<;L5\X5_1Q^V)^S
M+I?[57P5U3PG=>5;:W#F\T747'_'K>*IVY/78X)1Q_=;(&0,?SN>*O"^J^!_
M$VJ>']<LI=-UC2[F2TN[288>*5&*LI_$=1P: /V(_P""2_[7O_"T/ 1^$WB>
M]W^*?#-N&TJ:9OFO-.7"A/=X20ONA3^ZQK]"Z_F"^%?Q,UWX-_$30/&OAJY^
MR:UHUTMS YSM;'#1N!U1U+(P[JQ%?T?? ?XT:%^T%\)_#WCOP\_^@ZK;AWMR
MP9[68?++ _\ M(X*^^ 1P10!W]<'\<_C-H'[/_PLU_QUXEEV:=I4!=858"2Y
MF/$<$>>KNQ"CL,Y/ )KO*_$#_@JE^UQ_PO#XJCP!X<O?-\%>$9VCD>)LQWVH
MC*RRY'58P3&OOYA!(84 ?)7QF^+>O_'3XFZ_XX\37'GZMJ]P9G52=D*#B.%,
M]$1 JCV7GGFCX-_"3Q!\=/B9H/@?PQ;?:-7U:X$*,P.R%!S),Y'1$4,Q/H.,
MG KBZ_<C_@E_^QM_PS_\-?\ A-_%%CY7C_Q1;JYBF3$FFV)PR08/*N_RNXX(
M.U2,H<@'T]\ _@CX?_9W^%.A>!?#<6++38OWMRR@27<[<RSR8ZL[9/L,*. !
M7H5%% !1110!YO\ M)>+M5\ _L^?$GQ+H5U]BUK2/#M_?65SY:OY4T<#LC;6
M!4X8 X((XYK^;OQIXY\0_$?Q'=Z_XIUJ^U_6KHYFOM0G:65O09)X Z #@#@
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M$+D^Y:,U[/0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M(7,+ZIN9O1A$X'Z,U=F#5\1#U/>R&+EF=!)V]X^$Z***^T/Z%"BBB@ K[$^
MG[57@7X7?"O1O#FI#5I[ZU\UI6@M$*9>5GP"9.<;L9[XKX[HKGK4(8B/+/8\
MO,,NH9G25'$7LG?337^F?H7;_MR?#2;=O.L6^.GF60.?^^7-6%_;;^&#, ;S
M4E!.-QL6P/?K7YV45P_V90\SYM\'Y;WE]Z_R/T>_X;.^%7_0<N?_  7S_P#Q
M-68?VP_A++&&;Q0T)/\  ^G761^41'ZU^;%%+^RZ/=_U\C-\&Y?_ #S^]?\
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M=T/\IO\ XNC_ (;^\8_]"[H?Y3?_ !==']G8CM^)ZG^J>:?R+[T?=E%?"?\
MPW]XQ_Z%W0_RF_\ BZ/^&_O&/_0NZ'^4W_Q=']G8CM^(?ZIYI_(OO1]V45X3
M^R_^T!K'QS_X2;^UM.L;#^R_LWE?8@_S^;YN=VYCT\L8QZFO=JX:E.5&;A/=
M'S>,PE7 UY8>LK2C:_S5_P!0HHHK(XPHHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MV[=V^8_]<F<GT% 'R]\+/V@OB3\$[KSO WC76/#:[M[6UI<M]FD;U>%LQO\
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M\8_M#>,+?Q-XUU+^TM4@L+?3HV VJL<28R%[%VWR-C@M(Q  X%W]F[X!:_\
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MB68:#1M$CD+1V4).22?XI&P"[XYP ,!5 \/M[>6ZGC@@C>::1@B1QJ69F)P
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MAV]ZZG3?V^? UQM%[HNNV;'J4BAE0<>OF _I6$L#B(_8/.J<.YK3WHOY-/\
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MQIJA"]-\@<_B2#G\:\VHJ?94WO%?<8RP.%EO2B_^W5_D>OV/[6GQ5L;I)O\
MA*I+@+UCGM8&1O8C9_*OKS]F7]HY?C7I]WIVJ6\-EXET^-9)4A)\NYB)QYJ
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M E%JG*47ZI_H?L;17G'[.WBR_P#&WP7\+:OJ;M+?RV[12RN,-(8Y'C#GU)"
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MMUE$45NK#(WO@G<1@[0.A&2,BM:=.=:7+!79V87!U\=55'#QYI'NM%?$</\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MW\(DN]:MD_X6!XC1+K5Y" 6M$QF.T4^B Y;'5RW)"KC\$])_Y"ME_P!=D_\
M0A7]3U !1110 4444 %%%% !1110 4444 ?A#_P5L_Y/2\0?]@S3_P#T0*^-
M:^RO^"MG_)Z7B#_L&:?_ .B!7QK0!_4[I/\ R"K+_KBG_H(JW532?^059?\
M7%/_ $$5;H **** "BBB@ HHKYS_ &P_VW/!G[(_A?.H,NM^,KV(MIGARWD
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:^8K49T)<M3=GXWF&7XG+JJIXI>\U?>X4445SGEB$9&",BL34O OAK6 1?\
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MJM-_;J^&]]@3Q:UI_J;BS1A_XX[?Y%?GS16,LMP[V5OF>=4X3RN?PQ<?1O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7E7[6/\ R:S\9/\ L3-9_P#2&:O5:\J_:Q_Y-9^,G_8F:S_Z0S4 ?S64444
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MDBD .=KJ>H/0U^HGQZL]*O/@_P"*_P"V=/\ [3L8+"2X:W63RF+(-RE7P=K
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M[)_Z$*_J>H **** "BBB@ HHHH **** "BBB@#\(?^"MG_)Z7B#_ +!FG_\
MH@5\:U]E?\%;/^3TO$'_ &#-/_\ 1 KXUH _J=TG_D%67_7%/_015NJFD_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %<QXX^*'@WX8V]K/XQ\6Z%X3@NV9+>37-2ALEF90"
MP0RLNX@$9 ]:Z>OS+_X+@_\ (@_"S_L)WO\ Z*CH ^W_ /AK'X(?]%D^'_\
MX5%C_P#':LZ7^T]\'-;U*TT[3OBSX&O]0NYDM[:TM?$EG)+-([!41$64EF8D
M  #)) K^:.O2OV9?^3DOA1_V-ND_^ED5 ']+U%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%>,_M??'RU_9M_9_P#%
M/C-YHDU6. VFCPR$?OKZ4%85"G[P4YD8?W8V]*_"?_AM?X]G_FKWC#_P;2_X
MT ?T?45_.#_PVM\>_P#HKWC#_P &TO\ C7[I?L5^*-7\:_LJ_#77->U*YU?6
M+[2EENKZ\D,DLS[V&YF/)/% 'ME%%% !1110 445\\_M1?MS?#+]E>QD@U_4
MO[8\5M'OM_#.ELKW;9&5:7G$*'CYGY(SM#8Q0!]#45^)'Q:_X+%?&;QK)+#X
M/L]'^'M@WW&MX1?W@'HTLRE#QW$2GW]/#-6_;Z_:%UJ0/<?%GQ#&=P;_ $29
M;89 QTC51CVZ&@#^BJBOY]/#7_!2W]I#PS<1/%\2;K4(D.6@U*QM;E7&<X)>
M(M^3 ^AKZZ^ _P#P6H-UJEGIGQ<\(V]G:28237_#A<B(]-SVKEB1W)1\CLAZ
M4 ?JC17/> _B!X;^*'A>S\1^$];LO$&B78S#>V,HD0^JG'W6'0J<$'@@5T-
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MOA'Q$LGF#0=0W9S@V+D?EMQ4_P#PCOB;_H7[O_P5_P#V%?K711_:K_D_$?\
MKK-[X=?^!?\  /R4_P"$=\3?]"_=_P#@K_\ L*_0K]DFUNK/X#>'HKRW>UN%
MDNMT4D7E$?Z1)CY<#''M7L-%<F)QKQ$.3EL>'F_$,LVH*@Z2C9WO>_1KMYA1
M117FGR 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MY:WUM? FWN(K@#&3$X;&>G2LW%K=')*G.'Q1:)Z***DS"BBB@ HHHH ****
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M'AW_ %('_E9_^YZ/^'AW_4@?^5G_ .YZK^S\3_+^*_S-?]6,W_Y\_P#DT?\
MY(^QZ*^./^'AW_4@?^5G_P"YZV?!?[=G_"7^,-"T+_A"/LG]J7\%E]H_M;?Y
M7F2*F[;Y SC=G&1G'44G@<0E=Q_%?YD2X:S6$7.5'1?WH_YGU=1117 ?,A11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M<>H8<$5G.G.GI-6.;$8/$81VKTW'U5B>BBBLSD"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@#AOC!\$?!'QZ\*/X=\=^'K7Q!I9.^-9@5E@?&-\4BD/&W
MNI'H>*_,WXZ?\$5]9L[FZU'X3>+K?4K,DNFB>(\PSH/[J7"*4<^FY4]R>M?K
M710!_.-X^_8C^._PS,AUWX7>(1#']ZXTZU^WPK[F2W+J!]37C>J:/?Z'=&VU
M*QN=/N5ZPW4+1..<=& /4&OZG:KWVGVNI1"*\MH;N(-N"3QAP#TS@CKR?SH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OS+
M_P""X/\ R(/PL_["=[_Z*CK]-*_,O_@N#_R(/PL_["=[_P"BHZ /R+KTK]F7
M_DY+X4?]C;I/_I9%7FM>E?LR_P#)R7PH_P"QMTG_ -+(J /Z7J*** "BBB@
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M?"GQ/\;/'VE>#O"&FOJFNZE)LBB4[510,M([=%10"2QZ 5^HGPY_X(D^%X]
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M05U;9_YA1117E'Q(4444 >2_M4Z7H^I? OQ-+K$#3)9PBXMF0X:.XR$B8?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MTK$O/^"?OB5"?LOBG2IANX\Z*6/CUX#<^U?<=%:+,,0OM?@CLCQ3FL=ZM_\
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M]IS%>?\ 9+8KC:*APB]T<\L/1G\<$_DCTVS_ &E_B?8X\OQGJ+8&W]\4E_\
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M2%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >=^)?V>
M_A[XPUR[UC6/#,%]J5TP::X>:52Y "C@.!T [=JS/^&5OA5_T)]M_P"!$_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K\R_\ @N#_ ,B#
M\+/^PG>_^BHZ_32OS+_X+@_\B#\+/^PG>_\ HJ.@#\BZ]*_9E_Y.2^%'_8VZ
M3_Z615YK7I7[,O\ R<E\*/\ L;=)_P#2R*@#^EZBBB@ HHHH **** "BBB@
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MU4GU4].E?TCU^,/_  6J\*KIG[1'A+78XPBZKX<2*1A_')#<2@GZ[)(Q^ H
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MHH ^??VX_P#DAS?]A*W_ )/7+?\ !/W_ )$CQ3_V$8__ $4*ZG]N/_DAS?\
M82M_Y/7+?\$_?^1(\4_]A&/_ -%"O8C_ +A+U_R/OJ7_ "3%3_'^J/JNBBBO
M'/@0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_A73A6U7A;NCV,GE*&8X=Q=GS1_%V?X'YNUTD?Q*\70QJB>*M:1% 55749@
M!T &ZN;HK[9Q4MT?T/*G"I\:3.F_X6=XQ_Z&S7/_  93?_%4?\+.\8_]#9KG
M_@RF_P#BJYFBIY(]C/ZO1_D7W(Z;_A9WC'_H;-<_\&4W_P 57ZT5^.-?L=7@
MYK%1Y++O^A^9<:TX4_J_)%+XO_;0HHHKP#\Q"BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HK@9/V@/A=#(T<GQ(\(HZDJRMKMJ""
M.H(\RF_\-"?"S_HI?@__ ,'UK_\ '* /0**\_P#^&A/A9_T4OP?_ .#ZU_\
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M^P'_ ,F;?"?_ + R?^AO7\Z]?T4?L!_\F;?"?_L#)_Z&] 'T!1110 5^(/\
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MQ]W[9+MZ>V*_I5K^<3]MR%H?VNOBZKC!/B2\;\#(2/T- 'B5>F?LPZX_AO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\_$9DY)QI*WF?,9IQ<ZL'1P47&_VGO\ )?J,AACMX4BBC6**-0J1H %50,
M#H*?117A'YH96I>$]$UHDZAHVGWY/)^TVJ29[_Q UR6I?L^_#;5@1/X)T9,\
M'[-:K!VQ_P L]M>A45I&I./PMHZ:>)KTOX<VO1M'B6I?L;?"K4"3'H,]@Q.2
M;:_F]?1F8#\!7):E^P-X&N,FRUK7;-CT#RPRJ./3RP?UKZ:HK>.*KQVFSTJ>
M=YE3^&O+YN_YW/CK4_\ @GJA+-I_C=E':.ZTW/\ X\LG]*Y/4OV!?&UODV.N
MZ'>*.TKS1,?H/+8?K7WC16\<PQ"^U?Y'I4^*<UAO43]4OT2/SBU+]C'XJ6&?
M)T:UU #O;7\(_P#0V7_)KD]3_9V^)>DY\_P5J[X_Y]8#/_Z+W>M?J316\<TK
M+=(]*GQGCH_'"+^]?J?D5J?@OQ#HN?[0T+4[#'7[59R1XZ_WE'H?RK&K]CJS
M-3\,:/K6?[1TFQO\]?M5LDGI_>!]!^5;QS7^:'XGI4^-O^?E#[I?\#]3\A**
M_4_4_@#\-]7S]H\$Z*I/4V]HL![]T ]:Y/4OV.?A5J&2GA^:Q<]6MKZ<?HSD
M#\JWCFE+K%GI4^,\%+XZ<E]S_5'YN45][ZG^P3X$N@39ZOKMD_8&:*1!^!C!
M].]<IJ7_  3UA;+:?XWD3TCN=-#?^/+(/Y5O',,.]W;Y'I4^*LJGO-Q]8O\
M2Y\9T5]/ZE^P'XSA4FQU_0[O SMF::(GCH,(P_6N4U+]BWXIV)(@TFSU''>V
MOXAG_OX5K>.+H2VFCTJ>>9;4^&O'YNWYV/"Z*]'U+]G/XF:2"9_!6K/CG_1H
M?/\ _19:N4U+P+XDT4D:AX>U6P*\'[392QXYQ_$HK>-2$MI)GI4\5AZO\.HG
MZ-,PZM6.JWNEOOL[RXM'_O02LA_0U5HK0Z6DU9G:Z;\;/B!HY'V7QIKJ*.0C
M:A*Z?]\LQ'Z5U>F_M;_%;3%"KXJ:X0#&VYM().WJ4S^M>/T5C*C2EO%?<<%3
M+\'5_B48OUBO\CZ-TW]N[XB69 N;30]07OYMK(K?@4D _2NKTS_@H1J<07^T
M?!EI<GN;6^:']&1Z^1Z*PE@L/+>!YU3A_*ZGQ4%\KK\FC[ETS_@H%X8EQ_:'
MA?5K7U^RR13?^A%/:NKTS]M[X97X'GW&J:;G_GZL2V/^_9;_ "*_.^BL)9;A
MWM=?,\VIPEED_A4H^C_SN?IYIG[3_P +=6QY'C*QCS_S]));^O\ ST5?2NLT
MOXG>#]:Q_9_BK1;TG^&WU"%SV[!O<?G7Y+T5A+*J?V9,\VIP5A7_  ZLEZV?
M^1^Q<,R7$8DB=9$;HR'(/XT^OQZL=2O-,D\RSNI[1_[T$A0_F#[G\ZZK3/C/
MX]T?'V3QGKL2CI'_ &A*R=OX2Q';TK"652^S/\#S:G!-5?PZZ?JK?JS]6Z*_
M-#3/VM/BMI> GBN2X0?PW5I!+G\2F?UKK--_;L^(UD1]HM]$U!>_G6CJ?PV2
M+_+O6$LLKK9IGFU.#LQA\,HOYO\ 5'Z!T5\3Z;_P4'U:+']H>#;*Z]?LUZ\/
M_H2/76Z;_P % O#<I']H>%M5M1W^S313=_\ :*5A+ 8B/V?R/-J<,YK3_P"7
M-_1I_J?5=%?/^F_MP?#.^QY\NK:=D?\ +S99QQ_TS9JZW3?VHOA9JQ @\8V:
M9X_TF.6#_P!&(M<\L/6CO!_<>;4RG,*7QT)?^ L]3HKE],^*7@W6@OV#Q9HE
MX3_##J,+'\0&R#72PS1W$8DBD66-NC(00?QK%Q<=T>;.G.GI.+7J/HHHJ3,*
M*** /._B-\ ? WQ3N/M>O:*CZC@+]NMG:&8@# #,I^;CCY@<5X[KO[ 'A:Z#
M'2/$FK:<QZ"Z2.Y4'Z (<?C7U-1733Q-:FK1D>QALXQ^$BHT:S273=?<[H^%
MM=_8!\5VNXZ1XCTG45!X%TLENQ'T <9_&O.M=_9*^*>@[F;PRU]$HSYEC<13
M9^BAMWZ5^EU%=L<RKQWLSWZ/%^8T_CY9>J_RL?D=KO@/Q+X7W?VQX?U32PO5
MKRSDB'YL!6O\+_A'XD^+6O0:=H=C*\!D"W&H.A^SVR]V=^G3^'J>PK]6J*W>
M:RY;*.IZ4N-:SIN,:*4N]]/NM^IF^&]!MO"WAW3-&LP1::?;1VL6[KM10HS[
MX%:5%%>&W=W9^<2DY-RENPHHHI$GR)^VK\=-8\-ZE:^"?#][)IQDMUN=0NK=
MBDI#$A(E8<@8&3CKD#.,@_&5O>3VMP)X9I(9P<B2-RK ^N17U]^W%\'-8U+6
MK3QQI-I+?62VJVM^D*[F@*L2LA YVD-@GMM&>M?'=?7X%4_8+D^?J?O/#<<-
M_9M/V%KOXN]^M_T\CN]#^.WQ"\-A5L/&6L)&O"QS733(/HKY _*O1-"_;>^)
MFDE?M<^F:T,\_;+((3_WZ*5X!175+#TI_%%'KULLP.(_BT8OY*_W[GV%H7_!
M0>9=J:SX-C<_Q36-Z5_)&0_^A5Z1X;_;B^'.M310WO\ :FALQVF2\M@T8_&-
MF./?%?GK17)++L/+96/#K<*Y75^&#CZ-_K<_8+2=7LM>TVVU'3;J&^L;E!)#
M<0.'1U/<$5<KXV_X)_\ BR_DG\3^'))6DTZ...^A1B2(G+;7QV&X;?\ OGZU
M]DU\UB*/L*CIW/R'-, \MQ<\->]MGY/4****YCR0HHK@_%GQV\ ^!]3;3M:\
M46-I?+]^W4M*\?LX0':?8X-5&,INT5<VI4:M>7)2BY/LE?\ ([RBN&T'XY?#
M[Q)M&G^,='D=L;8I;M8I#GT1R&_2NUM[B*ZA66&1)HF&5>-@RGZ$42C*.DE8
M*E&K1=JL7%^:L24445)B%%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10!\^_MQ_P#)#F_["5O_ ">N6_X)^_\ (D>*?^PC'_Z*%=3^W'_R0YO^PE;_
M ,GKEO\ @G[_ ,B1XI_[",?_ **%>Q'_ '"7K_D??4O^28J?X_U1]5T445XY
M\"%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %?G/\ M,?\G7:O_P!?>G?^D]O7Z,5^<_[3'_)UVK_]?>G?
M^D]O7KY9_%EZ/\T?<\(?[[5_Z]O\XGZ,4445Y!\,%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 ?RV>+/\ D:M9_P"OV;_T
M8U95:OBS_D:M9_Z_9O\ T8U95 !1110 4444 %%%% !1110 4444 %>E?LR_
M\G)?"C_L;=)_]+(J\UKTK]F7_DY+X4?]C;I/_I9%0!_2]1110 4444 %%%%
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MD'/(;!'YU_1K7\W?[9ETEY^UG\8)$^ZOBK48^O=;AU/Z@T >-UK>$5+>*]%
M&2;V$ #_ *Z+6376?"+3FUCXL>"K!<[KK6[* 8ZY:=%_K0!_3Y1110!^*W_!
M:O\ Y.F\+?\ 8F6O_I=?5\ 5_5110!_*O17[D_$+_@KM\'OAKX^\2^$=3\-^
M.)]2T#4[G2KJ6TL+-H7E@E:)V0M=J2I9#@D XQD#I7E7QN_X*[?![XE?!?Q]
MX1TSPWXX@U+7_#^H:5:RW=A9K"DL]M)$C.5NV(4,XR0"<9P#TH _(NBBB@#^
MBO\ ;<_Y(3=?]?\ ;?\ H1K _8#_ .25:[_V&G_]$0UO_MN?\D)NO^O^V_\
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M;]F'X2I\*?AC91W-NL6NZF%O-08KAPQ'R1$_["G&.FXL>]?'W[77_)R&N_\
M;G_Z3Q5^CU?G#^UU_P G(:[_ -N?_I/%7S^7S=3$RG+=I_FC\MX7Q%3%YM6K
MU7[THM_C$_1ZBBBO$/SH**** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HK'\7^)[7P7X7U77KZ.:6STZW>YE2W4&1
ME49(4$@$_4BO O\ AOKX??\ 0'\2_P#@+;__ !^MZ="I55X1N>EA<MQ>-BY8
M>FY)=CZ5K\]/VY/^2X-_V#+?^;U[M_PWU\/O^@/XE_\  6W_ /C]?+'[1WQ2
MTKXO_$8Z_HUO>6UG]CBM_+OD1)-RELG"LPQSZUZ^ P]6E6YIQLK'W/#.5XW!
MX_VE>DXQY7J_D?I?HO\ R![#_KA'_P"@BKM?,6G_ +>7@"UL+:!](\2%XXE0
ME;:WQD #_GO5C_AOKX??] ?Q+_X"V_\ \?KSG@Z]_@9\I+(<SYG^X9]*T5YI
M\&?CYX?^./\ ;']A6>IVG]E^3YW]HQ1IN\S?MV[)&S_JVSG'4=:]+KEG"5.7
M+)69X]?#U<+4=&M'EDMU^(4445!SA1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 9VI>'-)UK/]H:797^>OVFW23/;^(&N3U+X"_#G5B3<>"=$#-U
M:&R2$GOG* <UWM%7&<H_"['13Q%:E_#FUZ-H\6U/]CSX4ZCDIX=DLG/\5K?3
MC]"Y'Z5R>I_L%^ KK+6FJ:[8MV7SXI$'7L8\_KVKZ5HK>.*KQVFSTJ>=9E3^
M&O+YN_YW/C_4O^">UNV3I_C:6+T2YTX/G_@2R#'?M7)ZI^P#XPAR=/\ $.BW
M8'_/QYT)/7T1O;OWK[LHK>.88A?:O\D>E3XIS6&]2_JE^B1^<^I_L5_%*PSY
M&EV.I8_Y];^,9Z?\]"O^17)ZG^S;\3M)SY_@O4Y,?\^J"X]?^>9;TK]1**WC
MFE9;I'I4^,L='XX1?R:_4_(_4_ /B?1<_P!H>'-6L,=?M5C+'C_OI1ZBL(@@
MX(P:_8VJ&I:#IFL*5O\ 3K2^!X(N8%D[8[@]JWCFK^U#\3TJ?&S_ .7E#[I?
M\ _("BOU4U+X%_#O5\FY\%:&6;DM%8QQ,?J4 -<EJ7['_P *=2!*^&VLW/\
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M^'-Q&DVHR>(]*& UCJDC2';_ +$ARR'TZCV-?=?PA^-'AWXS:#]OT:?R[N(
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M)[>O7RS^++T?YH^YX0_WVK_U[?YQ/T8HHHKR#X8**** "BBB@ HHHH ****
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MYG6.-%ZLQ. /S-?U'^%M#B\+^&=(T:'!ATZSAM$P,#;&@0?H*_G1_8S\ /\
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MG_>8<CNJM7Z3UQYG7VHKU9X'&.9?#@*;\Y?HOU^X*_.']KK_ ).0UW_MS_\
M2>*OT>K\X?VNO^3D-=_[<_\ TGBKFRO^,_3]4>3P;_O\_P# _P XGZ/4445Y
M!\(%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M(KY3$471JN!^'YI@7E^,J8?HGIZ;K\!:***YCR0HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_P"Q2TO_ -)8Z]@H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@#\(O^"MSLW[:&O DD+I>G@9/0>0#C\R:^-*^RO^"MG_)Z
M7B#_ +!FG_\ H@5\:T ?U.Z3_P @JR_ZXI_Z"*MU4TG_ )!5E_UQ3_T$5;H
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MTT N?,C2:=(V9<RD;@&)&1C- 'ZT4444 %%%% !1110 4444 %%%% !1110
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MU4L.] '\U-%=!\0/ 6N_"_QIK'A3Q+82:9KFDW+6MU;2#[K*>H/\2D896'#
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MXU/MNE:?ZA5/I7Y7?LS_  !US]I;XQ:'X&T1&074GFW]Z!E;*S4CS9F[< X
M/5F5>]?T>>"_!^E?#[PCHWAG0K5;+1](M(K&TMU_@BC4*H)[G Y/<Y- &U11
M10 4444 ?$'Q"_X*[?![X:^/O$OA'4_#?CB?4M U.YTJZEM+"S:%Y8)6B=D+
M7:DJ60X) .,9 Z5Y5\;O^"NWP>^)7P7\?>$=,\-^.(-2U_P_J&E6LMW86:PI
M+/;21(SE;MB%#.,D G&< ]*_.#]K'_DZ;XR?]CGK/_I=-7E5 !1110!_17^V
MY_R0FZ_Z_P"V_P#0C6!^P'_R2K7?^PT__HB&M_\ ;<_Y(3=?]?\ ;?\ H1K
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?_P3#_:V_P"&>?C&OAGQ!>^3X%\6R1VMTTK8CLKO[L-SSP%R=CGCY6#'[@H
M_=FBBO!_VT/VG=/_ &5?@CJGBAS%/XANLV.AV,G/GW; [6([I&,NWLN,Y84
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MH *\N^-W[3?PS_9UTK[9X\\5V6CRNF^#3@QEO;@?],X$R[#/&[&T=R*^6?\
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M$Q9/ACJEG\1OB_8VT_B6 K-I'APNLT>GMU$\Y&5:8'[J@E4QNR6QL_2:BB@
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M7.[Z=^'_ ,+O!_PIT<Z7X-\,:3X8T]B"\&E6B0"1AT9]H!=O=LFNHH ****
M"BBB@#Y,_;G_ &!= _:VT5-7TV:#P_\ $;3X?+L]6=3Y-U&,D07(4$E<DX<
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M_P"D\5897_&?I^J/-X-_W^?^!_G$_1ZBBBO(/A HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@""\L;;4(C%=6\5S'_<F0./R-<QJ7PA\#:P2;WP=H5P
MYY,CZ=#O_P"^MN:ZZBJ4I1V9K"M4I_!)KT9Y)J7[*'PJU0'S/"4,+=FMKF>+
M'X*X'YBN4U+]A?X;7Q8P/K6G9Z"VO%8#G_IHC5]#45O'$UH[3?WGI4\XS"G\
M->7WM_F?)FI?\$^=$ES_ &?XOO[7T^TVB3?^@LE<IJ?_  3[UZ$G^SO%NFW0
M[?:K:2'_ -!+^U?;U%;QQ^(C]K\CTJ?$^:T_^7M_5+_(_/74OV&_B58Y\C^Q
M]1Q_S[7I&?\ OXB_Y%<GJ?[*OQ4TG/F^$+F51WM9X9L]>R.3VK]-J*WCF=9;
MI,]*GQCF$?BC%_)_HS\G=3^$OC?1<F^\(:Y:J/XY-.F"]NC;<'J*YFZM)[&4
MQ7$,EO(.J2H5/Y&OV(J&ZLX+Z(Q7$,=Q&>J2H&'Y&MXYJ_M0_$]*GQM-?Q*"
M?I*WZ,_'>BOJK]N'X0IX?UG3O&&D6,5OI=X@M+R.VB"+'.N2K$#^^O'3JAR>
M17RK7MT:RKTU./4_1,OQU/,<-'$T]GT[/J@HHHK<](***]2^"7[/NO?'"35#
MIMQ;Z=:6"+ONKM6V-(V=L8P.N 2?3CU%1.<:<>:;LCFQ&(I86FZU>7+%=3RV
MBOI:\_8'\>P[C;ZOX?N% X!GF1C^'E8_6L6\_8D^)]KN\NTTV[QT\F^49^FX
M+7.L70?VT>9'/,MGM7C]]OS/ Z*]AO/V1?BQ9Y)\*-*N[:&AOK9\^^!)G'U%
M8EU^SI\3+,XD\%:LW)'[J#S/_02:T5>D]IK[SKCF6"G\->+_ .WE_F><T5U=
MU\)_'%B ;GP;X@MP<D&72YUZ=>J5B7?A[5=/R;K3+RV 7<?.@=>/7D=*U4HO
M9G7&M2G\,D_F9]%%%4;!1110 4444 >N_#K]J7QU\,?#MKH6E7%G/IELSM%#
M>6_F;=Q+$ @@XR2<9[UW5G^WQX]AP+C1_#]PH'403(Q/KGS<?I7S117++"T9
MN\HH\:MDV7UY.=2C%M[NQ]96?_!077$Q]J\(Z?,=O/DW4D?/KR&X]JV[7_@H
M7 V?M/@62/I@Q:H'SZ]81BOC*BLG@,,_L_BSAEPSE,O^7/XR_P S[HM?^"@'
MA1_^/GPUK,(S_P LFBDX]>66N2U3_@H-?_VE)_9OA"V&GAL(+JZ8RLOJ=HP"
M?3G'J:^1**E9?AU]DSI\+Y5!M^SOZM_YGVOHO_!0;2I=HU;P?>6O]YK*\2;M
MU 94_G7=:-^VY\,=4Q]INM3TC/\ S^6+-C_OT7K\[J*B66X>6R:^9A5X3RRI
M\,7'T?\ G<_4?1OVC/AGKO\ Q[>-=)CXS_IDWV7_ -&A?RKI+'XD>$M2!-GX
MHT6Z Y/D:A"^,_1J_)2BN=Y5#I)GE3X*P[^"M)>J3_R/V(M[R"\#&">.8+U\
MMPV/RJ:OQS5FC8,I*LIR"#@@UJ6?B[7=/Q]EUK4+;#;AY-U(F#Z\'K63RE])
M_A_P3CEP0_LXC_R7_P"V/UXHK\HK/XR^/M/V_9_&OB"-5Y"?VG,5_P"^2V*V
M[/\ :5^)]CM\OQGJ3;1@><RR_P#H0.:S>55.DD<DN"L4OAJQ?WK_ #/U"HK\
MV+/]L'XL6F ?$ZW"@8"S:?;'\<B,$GZFMJU_;B^)EN"))-)NN ,RV6/Q^5A6
M;RRNNJ_KY')+@[,8[2B_F_U1^AM%?!UK^WYXW0_Z3H/A^49'^JCG3COUE:MN
MS_X*$:I'C[5X,LYANY\F^>/CTY1N?>LGEV(73\3DEPKFL=H)_P#;R_6Q]K45
M\AV?_!0JPDV_:_!-Q#SSY.HK)@?C&M;=G^W]X-DV_:_#VN0_WO)$,F/3&9%S
M6;P.(7V/R.27#F:PWH/[T_R9]0T5\\V?[='PVNL>9'K5I\N?WUFIQ[?*[<UM
M6O[9'PHN!F3Q%-:\ XETZX/X?*AK-X6NOL/[CDEDV8PWP\ON;_(]LHKR^U_:
M=^%UYD1^,K%>@_>K)'U_WE%;=G\;/A]?$"'QOX?+%MH5M2A5B?8%@363HU%O
M%_<<DL#BX?%2DO\ MU_Y':T5B6?C?PYJ.W[)K^EW.XX'DWD;Y/IPU;$,T=Q&
M)(I%EC;HR$$'\:S::W.24)0^)6'T444B HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_
M.?\ :8_Y.NU?_K[T[_TGMZ_1BOSG_:8_Y.NU?_K[T[_TGMZ]?+/XLO1_FC[G
MA#_?:O\ U[?YQ/T8HHHKR#X8**** "BBB@ HHHH **** "BBB@#\X?@3_P G
M8:9_V%KS_P! FK]'J_.'X$_\G8:9_P!A:\_] FK]'J]?,OXD?0^[XN_WJC_@
M7YL****\@^$"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH *_ G_@J/\ $5_B#^V5XOB68S67A^*WT2VY^Z(HP\J_]_I)
MJ_?7..3P*_E_^*7BR3Q[\3/%WB:5_-EUG5[O46?U,LSR9_\ 'J (/A[X3F\?
M>/O#7ABVR+C6M3MM-CV]=TTJQC]6K^H&QLH--LK>TMHUAMK>-8HHUZ*J@  ?
M0"OYZ/\ @GCX8_X2[]M#X5V13>(=3;4#Z#[-#)< _G$*_H>H **** "BBB@#
M\U?^"G'_  3YO_B7=7/Q;^&>FF[\2+$/[=T*U3,FH*HP+F%1]Z4* &0<N "/
MF!#_ )!S0R6\KQ2HT<J,59'&"I'!!'8U_5-7RO\ M1_\$Y_A9^TW-<:Q-;2>
M$/&<F6;7]&C4&X;UN83\LW^]\K\#Y\<4 ?S_ -=]\,_C]\2/@W,LG@GQMK?A
MM VXV]E>.MNY]7A),;?\"4U])_&3_@DU\<OAE)/<:#867Q"TA22L^AS!;D+V
M+V\FUMWM&9/K7R+XH\'Z]X'U1]-\1Z)J6@:BGWK/5+22VF7ZHX!'Y4 ?;?PY
M_P""R'QK\*K##XFL/#_C:W7&^:YM#9W3?1X2L8_[]FOI_P"'?_!:SX;:YY4/
MC+P7K_A:9N&FL)(M1MU]R?W;X^B&OQNHH _I"^%_[9'P5^,C0Q>%?B-H=W>S
M8":?=S_8[MB>RPS!';\ :]FK^5>O<?@G^VO\9?@#-"GA;QM?MI49&=&U1S>6
M)7^Z(I,[,^L94\=: /Z-Z*^$_P!DW_@JUX'^.-]9^&O'=M#\/_%TVV.&:2?.
MFWLAXVI(W,3$]$DR.@#L2!7W90 4444 ?'__  5@_P"3)?%__7[IW_I7%7X+
MU^]'_!6#_DR7Q?\ ]?NG?^E<5?@O0!^C_P#P1'_Y+1\0_P#L7X__ $I2OV)K
M^;G]F?\ :J\:?LH^)-7UOP5%I<M[JEH+*<:I;-,GEAP_RA77!R!WKZ'_ .'R
M7Q[_ .?/P?\ ^"N7_P"/T ?M_17X@?\ #Y+X]_\ /GX/_P#!7+_\?H_X?)?'
MO_GS\'_^"N7_ ./T ?M_17X=7G_!8KX_74)2-/"EHV<^9#I3EOI\TK#]*\M^
M('_!1;]H;XC0W%M?_$C4-,LYAM-OH<46G[5] \*K)CZL: /V._:Y_;:\"_LH
M^%;MM0OK?5O&LL!;3?#-O)F>5R/D>;'^JBSR6;&0"%#'BOP!^(7CS6?BAXXU
MWQ;XAN?MFM:S=R7MU-C +NV<*.RC@!>P ':L.[NY[^ZEN;F:2XN)6+R33,6=
MV/4DGDFHJ -KP5X/U7XA>+]%\,Z';->:QJ]Y%8VD"_QRR,%4$]AD\GL,FOZ6
M_@Q\-;3X-_";PCX(LI//@T'3(+#S]NWSG1 'D([%VW-_P*O@'_@E/^PU<^"8
M8?C-X]TQ[77+F(CPYIMTFU[6!UPUVZGD.ZL50'HA)_C&/TQH **** "J^H:?
M:ZMI]S8WMO'=V5U$T$]O,H9)8V!5E8'@@@D$'UJQ10!_/9^WM^R==?LI_&BY
ML+*&5_!6M%[W0;I\G$6?GMV;N\1(7U*E&_BKYJK^C[]KK]FG2/VJ/@OJOA"_
M$5MJRC[5HVI.N39WB@[&SUV-DHX[JQQR 1_.QXO\):OX"\4ZMX<UZQDTW6M+
MN9+2[M)A\T4J,58>_(X(X(P1Q0!^X'_!,7]K"/X[? G^PO$6H*?%_@N)+2^F
MN' -Q9@$07))ZX52CD]TW'[XK\Q/^"@W[5$O[47QVO;O3KEG\%Z"7T[0H\_+
M)&&_>7./65EW>NQ8P>17@7A#Q]XA\ R:L_A[5KG26U;3IM)OC;-M^T6DH DA
M;_9; _(5@4 :WA'PGJWCOQ1I7AW0;&74M9U2Y2TM+2$9:61R H'XGJ> .37]
M$/['?[,6D_LI_!C3?"EIY5UK<^+S6]21>;N[8#=@GGRT&$0<<+G&6;/R+_P2
M2_8V_P"$/T!/C7XML=NM:M 8_#EM.G-M:,,-=8/1I1PI[1Y/(DX_2N@ HHHH
M **** /YA?C!JCZY\6O&VHR9\R\UR^N&SUR]P['^=>E_L':>-3_;$^$L)7=M
MUV&?&,_ZL&3/_CM>.^,)&F\7:V[G<[7T[$GN3(U>\_\ !.6%;C]M?X6*Q( O
MYGX]5M9F'ZB@#^ABBBB@ HHHH *_#C_@L19BU_:_\T  W/AZQE..^&E3_P!D
MK]QZ_$O_ (+/?\G7Z)_V*5G_ .E5W0!\%U_3/^SSJO\ ;OP!^&>I9W?;/#&F
M7&?7?:1M_6OYF*_I3_9._P"36?@W_P!B9HW_ *0PT 6OVG-3;1?V;?BO?H<2
M6OA/59DYQ\RV<I'Z@5_-%7](?[9MQ]G_ &2_C ^W=GPMJ*8SC[UNZY_6OYO*
M /O/_@C%IXO/VL-9F*@_9/"=Y,">Q-S:)_)S7[:U^,'_  1/_P"3DO&7_8I3
M?^EEK7[/T %%%% !1110!_-]^VA8C3_VM?B_$%V[O%&H38X_CG9\\?[U<C\!
M]3.B_''X=Z@O#6GB/3K@8_V+F-OZ5Z%^WI"MO^V-\654D@ZY*_/JP4G]37D_
MPUF:W^(OA:5/OIJMJPSZB930!_4+1110 4444 %%%% 'XU_\%M/^2^^!?^Q9
M'_I5/7YUU^BG_!;3_DOO@7_L61_Z53U^== ']*?[)W_)K/P;_P"Q,T;_ -(8
M:]5KRK]D[_DUGX-_]B9HW_I##7JM !1110 4444 %%%% !11575-3MM%TN\U
M&]E6"SM(7N)Y6Z)&BEF8_0 T ?D9_P %COVF;C7_ !QIWP:T6\9-)T58]0UQ
M8S@3WDBAH8F]1'&P?'0M+R,H,?FI75_%CXA7WQ8^)WBGQEJ)8WFN:E/?NK'.
MP2.65![*I"CV KT#]C'X+I\??VE_ W@^ZA\_29KT7>I*?NFT@!EE4GMO5-@]
MW% 'W?\ \$W?^";^C:CX9TOXL?%?2XM6.H1K=:%X;O$)A2$G*7-PAXD+C!2,
MY4*0QR6 7]2X88[>&.**-8HHU"I&@ 55 P  .@HAACMX8XHHUBBC4*D: !54
M#   Z"GT %>!_M6?L9> ?VK?"MQ;:[I\.G>*8H2NF^)K6("ZM6_A#D8\V+/6
M-CC!.W:?F'OE% '\QWQJ^#OB/X"?$O6_ _BJV6WU?2Y=C/&28IXR R2QL0-R
M,I!!QGG! ((KB*_8G_@LY\"8/$7PKT#XIZ?9K_:OAVZ73M1G1?F>QG.(RQ[A
M)BH'_7=J_':@#]2?^"&O_(5^,G_7'2?_ $*\K]7Z_*#_ ((:_P#(5^,G_7'2
M?_0KROU?H *_+3_@L-^U=?:4UI\$?#=YY$=U;QW_ (CFA;YV1CF&T/H" )&'
M<&,="P/ZAZAJ%OI.GW-[=RK!:VT3332-T1%!+$_0 U_,C\9/B;J7QF^*GBKQ
MOJTC/?:YJ$MX58Y\I"W[N(?[*(%0>RB@#C:_2C_@G%_P3<L_B=I=A\4_BK8R
M2>&I&$NB^'9@5&HJ.EQ/W\DG[J<;\9/R8#_&?[)?P7'[07[1'@GP-,LAT_4+
MWS-0:,X*VD2F6?![$HC*#ZL*_I$T_3[;2;"VL;*WCM;.VB6&&"%0J1QJ %50
M.    ![4 1Z/HVG^'M+MM-TJQMM,TZU01P6=G"L4,2#HJ(H 4>P%7*** ,GQ
M5X3T7QQX?O=#\0Z59ZWH]ZGEW%C?PK-#*OHRL"#Z^QYK\9/^"C7_  3P3]GD
MR?$/X?0RR_#NXF6.\TYF:231Y7.%^8Y+0,V &8Y5B%).0:_;&L#Q]X)TOXE>
M"->\*:W!]HTC6K*:PNH^YCD0J2/0C.0>Q - '\NU?NE_P2S_ &J+[]H'X+W7
MAWQ+>F\\8>#VCM)KB1B9+NS=3]GF<G[SC8\;'J=BL3EZ_$KQ]X0N_A]XY\1>
M%]0_X_M%U&XTV?C'[R&1HVX^JFOHC_@F?\5[GX5_M?\ @M1<^3IOB*5M O8R
M<"59QB$?43B$_ACO0!_0'1110!^0'_!;S_DJGPT_[ MQ_P"CQ7YK5^E/_!;S
M_DJGPT_[ MQ_Z/%?FM0!_21^QW_R:A\'O^Q2TO\ ])8Z]@KQ_P#8[_Y-0^#W
M_8I:7_Z2QU[!0 5\H?\ !2#]JBZ_9B^!)?0+E(/&GB69M-TI\_/;*%S/<J.Y
MC4J!Z/*AY (KZOK\(/\ @J]\7+KXD?M::SH@N/,T?PC;PZ3:1J3M$A19;AL?
MWO,<H3W$2^E 'QQ--)<2O+*[22NQ9G<Y+$\DD]S7U9^P7^POJG[7'BVXO]4E
MN-&^'FD2*NHZE"H\RYEX(M8">-Y4Y9L$(",@EE!^6+&QN-4OK>SM(7N+JXD6
M&&&,99W8@*H'J20*_I5_9M^"NF?L]_!/PKX%TR)5_LVT7[7,O)N+M_FGE)[[
MI"Q'H, < 4 ;_P ,?A-X/^#/A:W\.^"O#UCX=TF%0/)LX@ID(&-\C_>D<]W<
MECW-=;110 V2-98V1U#HPPRL,@CT-?FK_P %!_\ @F7H_B+P_J7Q&^$&C0Z3
MK]DDEUJGANR3;!J$8!9I+>,<),!D^6H <= &^]^EE% '\J]?IQ_P1Y_:JO=-
M\47'P2\07OFZ3?QRWWAYIGY@N%^>:W7/\+KOD [,C?WZ^7_^"C7P9MO@G^UE
MXOTW3H/LVCZPR:[8Q*NU42XRTBJ!P%683* .@4"O!? /C;5/AMXWT'Q7HDYM
MM6T:]AOK60=I(W# 'U!Q@CN"10!_45169X7\0VGB[PUI.NZ>_F6&IVD-[;O_
M 'HY$#J?R85IT ?E]_P62_:<GT?3='^"^@WDD$VH1KJFOO"V,V^2(+8D=0S*
MTC+Z)%V8U^3%>K?M5_%67XU_M%>/_&+S_:+?4-6F6S;.0+2,^5;C\(DC_6L3
MX#_"N\^-WQC\'^!;(LDNN:C%:R2KUBASNFD_X!&';_@- 'VO_P $W?\ @G39
M_&RQMOBA\2[=W\%K*RZ5H9+(=49&P99&&"( P90H.793G"CY_P!A]!T#3/"V
MCVFDZ-IUKI.E6<8BMK*QA6&&%!T5$4 */8"F^'/#VG>$?#^FZ'H]I%I^E:;;
M1VEI:PKM2&)%"H@'H  *T: "N;^(7PX\,?%CPG>^&?%^B6>OZ'>+B6SO(]RY
M[,IZJP[,I# \@BNDHH _GK_;N_9!O/V1_BP-.M))[_P9K*-=:'J$X&\H"!)!
M(1P9(RR@D=59&XR0/G/3=1NM'U"UO[&XEL[VUE6>"XA<I)%(I#*ZL.000""/
M2OWY_P""CW[..I?M(?LYW>F^&]*&J^,=(O8-0TF!72-Y#N$<T8=B  8G=L$X
M)1?05^:WA+_@D'^T)XBV'4;+P[X6#=1JNKK(5X_Z=EEH _6S]D/XZ1_M&?L]
M^$?&[%?[3NK;[/J<:KM"7D1\N; [!F7>!_==:]DKYA_8%_97\4_LD?#/7/"O
MB/Q)I_B".^U/^TK=-.BD5+=FB1)!N?!8'RT/08P?6OIZ@#\(?^"MG_)Z7B#_
M +!FG_\ H@5\:U]E?\%;/^3TO$'_ &#-/_\ 1 KXUH _J=TG_D%67_7%/_01
M5NJFD_\ (*LO^N*?^@BK= !7XU_\%M/^2^^!?^Q9'_I5/7[*5^-?_!;3_DOO
M@7_L61_Z53T ?G77]*?[)W_)K/P;_P"Q,T;_ -(8:_FLK^E/]D[_ )-9^#?_
M &)FC?\ I##0!ZK7@W[;/[1\7[+W[/\ KOBV(QOK]QC3=$ADP0][*K;&(/54
M57D([B/'>O>:_&W_ (+2?%B7Q#\:/"O@"WE;[#X<TS[;<(#@&ZN6S@COMBCB
M(/;S&]>0#\]-8UB^\0:M>ZIJ=W-?ZE>S/<7-U<.7DFE=BS.S'DL2223ZUZM^
MRQ^S%XG_ &K/BA;^$?#I6SMHT^TZGJTZ%H;&W! +D#[S$G"ID;B>H +#QZOW
MU_X)E_L_V_P/_9AT&]N;)8/$WBR-=:U*9EQ)L<9MHB>N$B*G:>C._J: /5?V
M=OV5_AW^S#X8CTOP7HD4-Z\2I>ZU<J)+Z^88R9)<9QD9"+A!V45Z]110 5\4
M_ML_\$U_"/[0VCZAXD\%6-EX4^)2YF%Q"OE6NJ-U*7"J,!SVE W9^]N'3[6H
MH _EF\0:#J/A77-0T;5[.;3M5T^X>UNK2==LD,J,5=&'8@@BO8OV.OVFM8_9
M9^-&D^)K.>1M!N)$M-=T\9*75F6&_P"7^^G+H>S#'0D'Z]_X+.?L\P>&_&'A
MSXN:/9+!;:]_Q*M9:)< WB*6AE;_ &GB5E/_ %P'<DU^:- ']3VEZG::UIMI
MJ%A<1W=C=PI/!<0MN26-E#*RGN"""#[U:KXW_P""4/Q8G^)G[(^DV%]<FYO_
M  K>S:&S.?F\E LD _W5CE6,>T?M7V10!^:O_!;S_DEGPT_[#-Q_Z(%?D#7Z
M_?\ !;S_ ))9\-/^PS<?^B!7Y T =3\+_AGXB^,7C[1?!OA6P;4M>U:<06\"
M\ <$L[G^%%4,S,>@4GM7[N_LF_\ !/KX;_LPZ19WC:?;^*_'0"O<>(]1MU=H
MI/2U0Y$*@]"/G/=CP!\>_P#!$SX16M]K'C[XEWD)>XL4BT/3W(^53(/-N"/]
MK:L ^CMZU^LE !3)8DFC>.1%DC<%61AD,#U!'I3Z* /S"_X*;?\ !/CP['X*
MU?XO?#72(]'U/3!]HUW1=/B"6UQ;C_67,<8&$=.&<+A64,V P);\E*_J;UO1
M[3Q%HM_I5_$)[&^MY+6XB;H\;J593]037\N6NZ5)H6N:AILIW2V=Q);N<8R4
M8J?Y4 ???_!&'XK2>&?CWXB\#3RL+'Q1I1GBCZC[5:DNO';]T\^3_LK^'[/U
M_/E_P32U!]-_;?\ A?*C!2]S=PG/0A[*X0C_ ,>K^@V@ HHHH *\ _;X\"?\
M+%_8]^*6E+'YDT&D/J<0 ^;=:LMR /<^21^.*]_K,\3:'%XF\-ZMH]QCR-0M
M);23(R-LB%#^AH _EJK]1_\ @B%\1'CUCXF> YIMT<UO;:W:PY^Z48PSL![^
M9;C_ ("*_+Z]LY=/O)[6==D\$C12+Z,IP1^8KZV_X)3>+9/#'[:OA&V$GEP:
MU:7VFS>X-L\RC\9(8Z /WLHHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "OS7_P""WE]+'\*/AM9C=Y,N
MMW$K8^[N2# S[X=L?C7Z45\'?\%D?A[-XI_9<T_Q#;1;W\,ZY!<W#<_+;S*\
M#?\ D22"@#\2*[_X#_!;7OVA/BMH'@/PXJ+J.JS%6N)L^7;0J"TLSX_A1 QQ
MU. !R17 5]^?\$6WL%_:B\1+<@&];PI<BU+#(!^U6N_'H=N?PW4 ??'P@_X)
M@? ;X7:+:PZAX5C\;ZRJ 7&J>(&:82MCDK!GRD7.<#:2!P6;K7MEC^S5\(M,
M@\FT^%G@JUASG9#X>M%&?7B/K7I%% 'G_P#PSW\+/^B:>#__  0VO_QNC_AG
MOX6?]$T\'_\ @AM?_C=>@44 >?\ _#/?PL_Z)IX/_P#!#:__ !NC_AGOX6?]
M$T\'_P#@AM?_ (W7H%% 'G__  SW\+/^B:>#_P#P0VO_ ,;J>Q^!/PUTN^M[
MVR^'GA6TO+>19H;B#1+9)(G4@JZL$R&! ((Y!%=S10 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110!^('[0G_!1[]HGP/\ 'WXE
M^&]$^(?V+1='\3:GI]C;?V)ITGDP174D<:;GMRS850,L23CDDUY5XL_X*/?M
M$^./"NL^&];^(?VW1=8LIM/OK;^Q-.C\Z"6-HY$W);AERK$94@C/!!K@/VL?
M^3IOC)_V.>L_^ETU>54 %%%% ']%?[;G_)";K_K_ +;_ -"-8'[ ?_)*M=_[
M#3_^B(:W_P!MS_DA-U_U_P!M_P"A&L#]@/\ Y)5KO_8:?_T1#7KQ_P!P?J?<
MT_\ DFI_]?/\CZ<KDOBM\0+7X7^ -8\1W6UC:0GR(6/^MF;Y8T_%B,^@R>U=
M;7PM^W1\5?[>\56?@JQFW66D8GO-IX>Y9?E4_P"XA_-V':N/"T?;U5'IU/#R
M7+WF6-A1?PK67HO\]OF?,NK:I=:YJEYJ-],UQ>W<SSSS-U=V)9B?J2:J45ZW
M^S#\*_\ A:GQ3L+:YA\S1M.Q?7^X?*R*1MC/^^V!CTW'M7V,YQI0<GLC][Q%
M>G@Z$JT](Q5SCO'7AD^#4T72IUVZDUBE_>(1\T3S_.D9^D7E-@]"[5RM>H_M
M/6]W;_'CQ@+U&21KL.F[O&44QD>VW;7EU*E)R@I/J3@JCJX:G5D]9)/[]3ZN
M_8 \*_;/%OB7Q%(F4L;1+.)B.-\K;B1[@18_X%7W!7S!^S_,_P #OV5;WQ?/
MIIN[FX=]5-JTGE-(A98HQNVM@%5##@_>]ZY?_AX=_P!2!_Y6?_N>OF\11JXJ
MM*=-72TZ=#\ES3 XW.L?6K82'-&+Y=TMEYM>I]CU^</[77_)R&N_]N?_ *3Q
M5ZO_ ,/#O^I _P#*S_\ <]?.'Q=^)G_"U/B1?^+/[-_LO[5Y/^A^?YVWRXT3
M[^U<YVYZ<9KKP&%K4:KE4C96\O(]GAK)L=E^,E5Q-/EBXM;IZW79OL?JM17Q
MQ_P\._ZD#_RL_P#W/1_P\._ZD#_RL_\ W/7F_P!GXG^7\5_F?)_ZL9O_ ,^?
M_)H__)'V/17DO[/GQZ_X7OINL7?]A?V'_9\T<6S[7]H\S<I.<^6F,8]Z]:KC
MJ4Y4Y.$UJCY_$X:K@ZLJ%=6DMUO^04445F<P4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!F>)O#>F^,-!OM&U>U2\TZ\C,4T,@
MX(/<>A!P01R" 17YZ_'']E;Q)\*[RZO]-@FUWPN,R+>PINDMUY.)E'3&/O\
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M->7*,QP 4@=@2?PK^8&OZ8?VE)'B_9T^*;Q<2+X4U4K@9Y%G+BOYGJ /L_\
MX)&:4NH?MFZ/<-C-AI-_<+GU,7E<?A*:_=FOQ _X(V_\G<7?_8LWO_HVWK]O
MZ "BBB@ HHHH **** "LCQ-X0T+QKIK:?XAT33M>L&^]:ZG:1W,1^J."/TK7
MHH ^3_B1_P $O?V>?B-YLJ>#Y/"E[)G-UX;NWM=OTB.Z$?\ ?NOE/XF?\$0[
MJ-99_A[\28ICSY=AXFLS'],W$.?_ $57ZN44 ?SP_%S_ ()]_'CX,Q376L>
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M5X=.U^'A?M4;$)!./5U)6,^JE.FSG]0J^/\ _@K!_P F2^+_ /K]T[_TKBH
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M,[A]%A8?\"K\[*_43_@AND9U[XP.3^]%MI849_A+W6>/P% 'ZR4444 %%%%
M'CG[8W@M?B!^RO\ %/1"H>27P_=W$*MT,L,9FC_\?C6OYNJ_J"^)]JE]\-?%
MMO)]R;2+N-LC/!A<&OY?: /U)_X(:_\ (5^,G_7'2?\ T*\K]7Z_*#_@AK_R
M%?C)_P!<=)_]"O*_5^@#PW]N/Q9/X)_9%^*VJ6K^7<?V%/:(X."IGQ!D'U'F
MY'O7\Y-?OW_P5(O)+/\ 8:^(WE YE.G1,P_A4ZA;9_/I^-?@)0!]0?\ !/']
MH3P/^S+\<-0\9^.H]3FLO[%GL;--+MEFD$\DL)W$,ZX78D@Z]6%?H]_P^2^
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M2?\ D%67_7%/_015N@ K\:_^"VG_ "7WP+_V+(_]*IZ_92OQK_X+:?\ )??
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M-6/^'YW_ %1/_P NO_[BH _52BORK_X?G?\ 5$__ "Z__N*C_A^=_P!43_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M444 %?'_ /P5@_Y,E\7_ /7[IW_I7%7V!7Q__P %8/\ DR7Q?_U^Z=_Z5Q4
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M  3G\7)X+_;2^%]Y+((XKJ_DTQLG 8W,$D"#_ON1/QQ7]#%?RU^%?$=YX/\
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M]7**** "BBB@ HHHH _&O_@MI_R7WP+_ -BR/_2J>OSKK]%/^"VG_)?? O\
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MW^]_9NJ17GKTWQQ?[/YGTY /THTG1M/T&Q2RTRQMM.LT)*V]I"L4:DG)(50
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M*/VV/ &]-\&G?;-0DXZ>7:R[#_W\,= '[_4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !3)94AC>21UC
MC0%F=C@*!U)/I3Z^4/\ @IY\8KGX/_LC^)&TZX>UU7Q)-%X?M9HSAE$P9IL>
MF8(YAGL6!H _.?\ X*(?\% -6_:"\4ZCX'\%ZC+8_##3YC"S6[[3K<B-S-(1
M_P L<CY$Z' =N2 GP]110 4444 %%%% !1110 5Z5^S+_P G)?"C_L;=)_\
M2R*O-:]*_9E_Y.2^%'_8VZ3_ .ED5 ']+U%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 ?B!^T)_P4>_:)\#_'WXE^&]$^(?V+1=
M'\3:GI]C;?V)ITGDP174D<:;GMRS850,L23CDDUY5XL_X*/?M$^./"NL^&];
M^(?VW1=8LIM/OK;^Q-.C\Z"6-HY$W);AERK$94@C/!!K@/VL?^3IOC)_V.>L
M_P#I=-7E5 !1110!^[G[?G[1G@WPSH%Q\.[V:\7Q(S6M^(TMBT7E$MSOSUX/
M%>2_LT_MT?#KX,_##Q!I^HMJ,^M2WDMW:6\5H3'(?)C5 SY^7+(<^@KK?V^/
M@W\,O'6HW'C(^++B;QLBV^GG2;&_MVB6)2V6:/RRX89/5L=.*^,6^#'A[[+&
M%N-3^T;VWL9H]A7"[0!Y>0<[LG/.1TP<_882AAJN%4)7\_7_ "/M<#@<XQF7
M_5Z,(^R<KZZ.^GX&EK7QTTKQ#K%[JE_=7-Q?7DSW$\K0G+.Q)8_F:I_\+<\/
M?\]+C_OR:P?$WPKTG1=!O;Z"XO&E@CWJLCH5)]\**Z;]CO\ 9RM/VE/B1+H>
MHW%]::79Q"YO+BQ=%=(OF'!=&&XML4<=R><5[,E0ITW4>R/5Q>=9YEU6.&K1
MIIN+:[62?GY:(^I?V8/VRO@M\&/!-Q%J=[JC>(-1F\V\>'36955<B.,-GD $
MM]7/I7LT/_!3/X)33)&M]K6YV"C_ (EC=3^-<U_PZ=^$?_0Q>-?_  .M/_D6
MGP?\$H_A+;S1RKXB\:%D8,,WUIC@Y_Y]:^9J2RRK)SE*5V?G>*Q5?&5I8BL[
MRDS[0HHHKYPQ"BO-_P!HSXD:G\(?@GXL\8:/!:7.IZ3:B>"*^1GA9C(JX8*R
MDC#'HPK\Y_\ A[%\7/\ H7?!7_@#=_\ R57HX; 5L7%SI;(ER4=S]8**_)__
M (>Q?%S_ *%WP5_X W?_ ,E4?\/8OBY_T+O@K_P!N_\ Y*KK_L;%]E]Y/M(G
MZP45^3__  ]B^+G_ $+O@K_P!N__ )*H_P"'L7Q<_P"A=\%?^ -W_P#)5']C
M8OLOO#VD3]8**^7_ -A?]J#Q5^TYX?\ %=]XHT_1[";2;J""!=(AEC5E=&8E
MO,E?)RHZ8KZ@KR:U&6'J.G/=%IW5PHHHK$84444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MS\<T ?U445^"G[.W_!4#XP_ /2;30;BYM?''AFU0106&NAC-;H.BQ7"D. .
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MU\+_ +)OPUNM:U2>"\\374;IHF@[_P![>S= 2!RL2D@N_0#@?,5!_-?XC?\
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MUU%% 'YJ_P#!;S_DEGPT_P"PS<?^B!7Y U^OW_!;S_DEGPT_[#-Q_P"B!7Y
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M'RM1\6W<NNN&&&$+!8X!]#'$L@_ZZT ?9%%%% !1110 4444 %%%% !1110
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M?_[]/_\ %4?\,!_L\_\ 1)_#_P#WZ?\ ^*KZ HH ^?\ _A@/]GG_ *)/X?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M,_A3X0^#?A>#P[X*\/6/AS1H>1;64>W>V,;W8Y:1S@99B6..375T44 %%%%
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M^"+/B35IK>_^*WBRUT&S#!GT?0/])NG7NK3L!'&?=5DK]=J* .%^#WP/\$?
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M_P #KAAZ9P>0178_L9_'[_AFO]HCPMXTN-S:,DC66K1HI8M9S#9*0!R2G$@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_0*K!U#*0RD9!'0T +1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MEZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_9(_:AO/V7O'&H:M_9TNMZ/J5H;:\TR.Y\D.P.Z.4':PW*=PY'1V]:^S=/\
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M1]HL/%>MV(4$+]FU&:/ /4##"NHT_P#:<^+NEJ%M_B=XM5 H0))K5Q(J@=
MSD#\*Q>0U.E1?</VGD?O/17X@:?^W)\==-.8?B-J3\AO](B@FZ?[\9X]JZC3
M?^"D'QZL2OG>*K/4,')^TZ1:C/M^[C7BL)9'B%M)?C_D/VB/V7HK\C]-_P""
MIWQEL0OGV?A;4< @_:=/E&?<^7,M=/I__!6OQ]&O^F^"O#EP=H&;=[B+YNYY
M=N/;]:Q>38M;)/YC]I$_4FBOS?T__@KU<*V+[X6QR*6'S6^NE"H[\&W.3^(K
MJ--_X*X>%)=OV_P!K-L,_-]FO(IL#L1D)FL7E6,C]C\5_F/GB??%%?%VF_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BF331V\322NL<:C+.YP /4FJ'_"2Z1_T%;+_P(3_&G9O8#2HK-_X272/^
M@K9?^!"?XT?\)+I'_05LO_ A/\:?*^P&E16;_P )+I'_ $%;+_P(3_&C_A)=
M(_Z"ME_X$)_C1ROL!I456L]2M-0W_9;J&YV8W>3('VYZ9P>.A_*K-2 4444
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M]X-U?4O$,-W)=6M_]GC-O<&,;/+1N0!URQKW;]M7_D@NI_\ 7W;?^C!7)_L
M_P#)-O$7_86/_HF.O4C6J?4W/F=[_P"1]G3S'%O()XAU7SJ=KWUMH=+_ ,,1
M_#'_ )]=3_\  YO\*T/#_P"Q]\._#.O:;K%C;:@M[I]S%=P%[PLHDC<.N1CD
M9 XKVVBO+>*K/1S9\;+.,QDG%UY6?FPHHHKF/'"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_.?]IC_DZ[5_\
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M_P#CE'_#I_\ 9M_Z%#4/_!W=_P#QROL"B@#X_P#^'3_[-O\ T*&H?^#N[_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% '"_'3P7J'Q&^#?C/POI1A74M7TJXL[<W#E(
MQ(Z%5W$ X&3Z&OS'_P"'6?QE_P"?KPO_ .#&7_XS7ZY45Z.%Q];"1<:=M291
M4MS\C?\ AUG\9?\ GZ\+_P#@QE_^,U\^_&[X)>(?@!XV/A7Q.]E)J8MH[K=8
M2M+'L?..2JG/RGM7[Z5^0O\ P5"_Y.?;_L"VG\Y*^ARW,:^*K^SJ6M8RE%15
MT.L_^"7OQBOK."YCN?#/ES1K(N[4) <$9&?W7O4W_#K/XR_\_7A?_P &,O\
M\9K]8/#7_(NZ5_UZ1?\ H K2KS'G6*OT^XKV<3Y&_8$_99\9_LT_\)W_ ,)=
M+I<G]M?8/LO]FW#2X\G[1OW;D7'^M7'7O7US117CUZT\14=6>[-$K*R"BBBL
M!A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MP:IIUIJ4*G<([N!95!]<,#7LT<RG37+45_S/OLOXNQ.&@J>)C[1+K>S^??\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^*O^"O/_ "9MJ/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M.<=!(,]17@YG@\/'#RJ1BHM=M#6$G<_3>BBBOACH"F22)#&\DCK'&@+,S'
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M+<MH5:"JU5=O\#"4VG9'WO?_ /!5)=8<G4O@[HNH*Q&\7&H;RV/=H#61J/\
MP4(^&FL,3?\ [,7A2]);>3<7-M)\WKS8]:^'Z*]A9;A5M&WS?^9GSL^N-0_:
M\^"FI?Z[]EKP^G7_ (]]9$/7_<M!_P#6KGI?CK^SUJUR@O?V;FL(B-K3V'C.
M[WH/4)L56/UKYHHK58.E':Z_[>E_F',S])/@3^S3^RW^U'HMW=^$X?$.BZE:
M;3>:/+J)%Q:@D@,-X<.C8/S GK@[3Q7;ZA_P2=^%<[%K/Q+XNM"6SM>YMI%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#PG]M7_D@NI_\ 7W;?
M^C!7)_L _P#)-O$7_86/_HF.NL_;5_Y(+J?_ %]VW_HP5R?[ /\ R3;Q%_V%
MC_Z)CKUH_P"X2]?\C[FE_P DU4_Z^?\ R)]14445Y)\,%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?G/
M^TQ_R==J_P#U]Z=_Z3V]?HQ7YS_M,?\ )UVK_P#7WIW_ *3V]>OEG\67H_S1
M]SPA_OM7_KV_SB?HQ1117D'PP4444 %%%% !1110 4444 %%%% 'YP_ G_D[
M#3/^PM>?^@35^CU?G#\"?^3L-,_["UY_Z!-7Z/5Z^9?Q(^A]WQ=_O5'_  +\
MV%%%%>0?"!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3G_OU7RY\1?^"8?[0_P[\R3_ (0K_A)[-,_Z5X=NX[O=](LK*?\ OBOW^HH
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M!^F/PY_X+<>++#RH?'7P[TG64Z-=:%=R63@?WO+D\T,?8,H^E?4GPY_X*X?
M'QOY46K:CK'@FZ?Y=FM:>SQ[O:2 R #W;;^%?A510!_4SH.NZ?XHT/3M9TF[
MBU#2M1MH[RTNX&W1SPR*'1U/<,I!'L:OUY5^R=_R:S\&_P#L3-&_](8:]5H
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MJC#X8_GU-H1L@KYK_P""@WPIUGXL_LXZA::!:R7^IZ3>PZLEE"A>6=8U='5
M.K!)68#G.W Y(KZ4HKR:-5T:D:D=TRVKJQ_.:RE6*L""#@@TE?NA\0OV/_@[
M\4M1FU'Q!X$T^349BSRWEBTEG+(YY+N863>V>[9KR+Q!_P $M?@UJV\V4_B3
M1&/W19Z@CJ#SCB6-R1R._;K7V<,\P\E[Z:9A[-GY&45^E/B+_@D7I4JR-H/Q
M'O+5@"4BU'2TGW=< LDB8[<[3WX[5^<&J:9<Z+JEYI][$T%Y:3/;SQ-U21&*
MLI]P017JX?&4<5?V3O8S<7'<JUZ;^S-XPU7P+\?O 6J:/+)'=?VQ;6S+&"?-
MBED6.2,CN&1V&/>L[X2_ _QG\=-5O=,\$:5'K6HV<(N9K4WL%NXBW!=X\YT#
M $J#C.-P]:^\OV-_^"=^M_#_ ,<:=XZ^)3VL-WIC^?IVAVLPF9+@'Y99G7Y?
MEZJJDY.TDC&#EC,50HTY1J25[;=?N'&+;T/T%HHHK\V.L_.?_@KEX-M53X?>
M*XXPMZQN=+G?'+QC;)&/^ DR_P#?=? OP[UQ_#/Q \,ZQ&[1R:?JEK=JZG!4
MQRJV0?PK[>_X*S?$JTU/Q5X-\#6DJR3Z5#+J-\JG.QYMJQ*?0[49L>CJ:^,O
M@SX7G\:_%SP9H5M%YLNH:O:P;>VTRKN)]@N2?8&OT++KQP,>?L_NU.67Q:'H
M?[<.L:KK/[5'Q ;5GE,MM??9;=)#D);HBB(*.P*X;_@1/4FO"J_7[]L+]@VP
M_:*U5?%7AW4K?P]XR6)89VNHV-M?JH 3S"H+(ZCC> V0 ". 1\G0_P#!*7XO
MRS2HVL^#X50X61[^Y*O[C%N3^8'6L\)F.&]A%2ERM*UARB[GQE17W=9?\$D_
M',F[[7XX\/P=-ODQ3R9]<Y5<5TEC_P $A;ELF\^*446",+!H1?([\FX&/R-=
M#S3!K_EY^#_R%R2['YVT5^F]A_P2-\,1X^V_$+5KCYLG[/811?+W'+-S[_I7
M:>%/^"6/PCT.^2YU34/$7B)5;/V6ZNXXH6''!$4:OZ]''6L)9QA([-OY#]G(
MYW_@DWX4U72OA7XOUR[CFBTO5M2C2Q$G"R>2C+)(H]-SA<^L9':ONJJ&AZ%I
MWAC1[32M(L;?3-,M(Q%;VEK&(XHD'154< 5?KXK%5_K-:56UKG1%65@HHHKE
M&<!\>OA/;_'#X1>)?!-Q<"S_ +4MPL-RR[A#,CK)$Y'<!T7..V:_$WXE?L__
M !!^$NO7&E>)?"NHV<L386XC@:6WF7/#1RJ"K ^QR.A /%?OC17KX',9X).*
M5TR)1YC^?'3_ (9>,-7V?8/">N7N\;E^SZ=-)D>HPM=+IW[-'Q;U7:;;X9>+
MG1EW+(VB7*(1[,R '\Z_>FBO2>?3Z4U]Y'L_,_#K3_V)_CCJ6/)^&^KIE=_^
MD>7#Q_P-QSSTZUTEA_P3K^/M[R_@J.T4J&#7&KV7/MA9B0?J!7[0T5B\\Q'2
M*_'_ #'[-'YU?LQ_\$RM6\-^,],\4?$^]T][?3I4NK?0=/D,WFRJ=R^>Y4+M
M! .U=V[H2!D']%:**\?$XJKBI<]5EJ*CL?)G_!2KX1W'Q'_9_;6=.MC<:GX5
MNAJ6$&7-J5*3@>P!20^T1K\?Z_HON+>*\MY8)XDF@E4I)'(H974C!!!Z@BOQ
MM_;6_9 U']GGQA-J^B6EQ=_#[49-]I= %Q8NQ_X]I6[8_@8_>&.20U?1Y+C(
MI/#3>O3_ ",JD>I]V_L,_M=:9\=/ ]AX:UR_C@^(&E0"&>"9\/J,:* +B//W
MF('S@<@@G !%?0WC_P"'7AKXI>&;GP_XKT:VUS2+C[]O<J>#V96!#(P[,I!'
M8U_/QINI7>CW]O?6%U-8WMNXDAN;:0QR1L.C*P(((]17T[X'_P""E'QL\&V,
M5I<ZGIGBB*(!4;7++?)@#H7B:-F^K$GWIXK)Y^T]IAG;RVMZ!&II9GW!>?\
M!,OX'74LKQZ9K%HKYVQPZI(0GTW;C^9-?&_[:GP1^"'[/=K#X=\)WFLZOX\G
M97EAN-0CDAT^'@[I56,'>P/RID<'<>-H;GOB#_P4:^-?CVQDLXM:LO"UM*"L
M@\/VODR$'L)79Y%QZJP/O7S/=7<]_=2W-S-)<7$S%Y)I6+.[$Y+$GDDGN:[L
M'A,7"2GB*K:[7_,F4H]$15^C_P  _P#@F-X2\;?"+PWX@\<ZEXFTKQ'J=O\
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MH? W_!53XFZ-JL1\3:3HGB+2VD!FCB@:UN O<1NK%0?]Y#7Z7_";XI:%\9_
M&D^+_#DS2Z9J,>Y4E $L+@D/'( 3AU8$'DCN"00:\[%8&OA$G46CZEQDI;'7
MT445YY0445!?W]MI=C<7MY<1VEG;1M--<3.$2-%!+,S'@  $DGTH GHKXO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^<3]&****\@^&"BBB@ HHHH **** "BBB@ HHHH _.'X$_\ )V&F?]A:\_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ KRK]K'_DUGXR?]B9K/\ Z0S5ZK7E7[6/_)K/QD_[$S6?_2&:@#^:RNR^
M#:E_BEX: _Y_$/Y9-<;7;?!-3)\5?#8'_/UG\E)K:C_%CZH[\OUQE%?WH_FC
MZ6^+WAJ'R3K9G<392 0X&WOSFO**]C^-%T(_#]E;_P 4ESN_!5/_ ,4*\<K]
M-H7<-3U>+*=*GFDU25M$WZO4MZ18'5-5L[,';]HF6+<.V2!FO:/"/[.-OXN\
M5:/HEOJ=PLVHW<5HK>6IVEW"Y_#.?PKS;X8V?VSQI8Y&5BWRG\%./U(K[S_8
MM\)_\))\;[*\==T&CVTM\V1P6P(T'UW2!O\ @-<F,KRHQ<D]D>GD678.IE6(
MQV+I\SC>V_1+L^K9O_\ #H_PC_T/VM?^ D-26_\ P25\)6]Q'*/'NM$HP;'V
M2'L<U]YT5\7_ &GC/^?GY?Y'PO)'L%%%%>66%?D1_P %18]27]IH/>J1:-HE
MK]A/.#$&DW?^1/,K]=Z\@_:/_9A\)?M,>&8-.\0B:RU*RWMI^K6F/.MF8#(P
M>'0X7*GKC@@\UZ>78F.%KJI/;8B2YE8_"NGQPO))&BKEI#A1ZY./YU^DGAG_
M ()&V%KX@CEU_P"(LVHZ+&X+6MCI8MYIE[CS&E<)^"M^%?+W[:WA'2/ /[4N
MK>'= L8].T?38-,M[6UCR0B"S@[GDD\DDDDDDG)-?;4<?0Q%3V=)WTN<[BTK
ML[KP'_P2\^+WB:X7_A(&TCP?:C&]KJ[6ZFQ_LI 64GZNM?=G[.G[#_P^_9YE
M@U6VAD\1^+43!US4E&8B1AO(B'RQ \\_,V"1N(.*^AZ*^*Q&98G$KED[+LCH
M4$@HHHKRRPHHHH **** "OR#_P""C_P#G^%_QHN/%EC Q\.^+G>]$BK\L-YU
MGC)'=B?,&>N]A_"37Z^5QOQ<^$_A_P"-G@'4_"7B6U^T:=>I\LBX$EO*/N2Q
MGLZGD'OR#D$@^C@,6\'64WL]&1*/,C\+?A/\5-?^"_CW2_%OAJY^SZG829VN
M"8YXSP\4@[HPX(Z]P00"/U\^ /[<GPU^..EVL4FKV_A7Q.5 GT75IUB)?OY,
MC8649SC'S8ZJ*_,/]I+]DGQK^S?KDPU*UDU7PP[XM/$-K$?(D4G"K)U\J3_9
M8\_PEAS7B%?98C"8?,H*HGKT:,%)PT/Z+Y;B*"!YI)$CA5=[2,P"A1SDGTKY
M;_:1_P""@7@+X-Z3<V7AK4+/QIXP92L-G83"6UMV[-/*IVX!_@4ECC!VYW#\
M=S/(81"9&,2L6$>X[03U./7@?E3*X*.1TX2O4GS+M:WZLIU'T-KQIXRUCXA>
M*M4\2:_>OJ&L:E.UQ<W$G5F/8#H !@ #@  #@5]J?\$N?@'/XB\=7?Q1U.%D
MTK0@]IIFY>)[N1"KL,]1'&Q'^](O]TUY)^RO^Q%XM_:(U*WU.^BN/#G@9&#3
M:O/$5>Z7/*6RM]\G&-_W5]R-I_87P5X,T;X>>%=,\-^'[&/3M'TV%8+:WC'"
MJ.Y/=B<DL>222>31FF.A2IO#4GJ]'Y((1N[LVZ***^+.@**** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ K\G?V@/V9/VA_&'Q>\?76DZ#KU]X:U'6
M;R6T5=5C$$MN\S%,(9AA2I'!'X5^L5%=V$Q<\')R@D[]R91YC\1_^&$/CQ_T
M3N]_\"[;_P".U'-^PM\=K>,NWPZU J/[EQ;N?R$A-?MY17K?V[B/Y5^/^9'L
MT?B)%^PK\=YHU=?AU?@-TW7%NI_(R9%/_P"&$/CQ_P!$[O?_  +MO_CM?MQ1
M1_;N(_E7X_YA[-'Y?_LE_LZ_'WP+\>_!6I>*=&URR\+6,TGVG[1JB201IY$B
MJ#&)3D;BHP!Z5^H%%%>1BL5+%S4Y)*VFA<8\JL%%%%<104444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M7(_%7X5^&_C1X)O_  KXJL?MVE78!^4[9(9!]V2-OX74]#]0<@D'KJ*J,G%J
M479H#\8/VE/V%?'GP#O+W4K*TF\4>"D8O'K%E'N>"/L+B,<QD=VY0\<@G ^:
MZ_HSKROQO^RS\)?B+=&ZU_P!HMU=L<O<PP?9I7/JSQ%6;\2:^IP^>.*Y:\;^
M:_R,73['X05I>'?#>J^+M8MM)T33;K5]4NFV0V=E"TLLA] J@DU^SEC_ ,$_
MO@#I\WFQ?#Z%FQC$^IWLJ]<_=>8CMZ5[!X)^&GA/X;V)M/"OAO2_#T! #+IU
MHD)?']XJ,L?<DFNFIGM)+]W!M^>G^9/LWU/B+]CS_@G*_A74K'QI\5H(I=3M
MW6>P\-JZR1PN.5DN&&59@>1&"5&!N)^Z/T"HHKY7$XJIBI\]1_\  -E%1V"B
MBBN4H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L
M;6O!?A_Q)N_M;0M-U3=][[;9QS9XQSN4]@/RK9HIIM:H#RO6OV5O@]K[,UY\
M,_"^]CEGM],B@9CG.28PI)S7!:U_P3O^ NL*VWP6^GRD8\RRU.Z4CC'"F0K[
M]*^D:*Z(XJO#X9M?-BY5V/C/6O\ @E3\(M0W-9:MXITI_P"%8KV&1!SW#PDG
M_OJN"UG_ ()$Z3-DZ3\2KVT]%O-)2?UXRLJ>W;UK]":*ZHYEBX[5'^#)Y(]C
M\NM:_P""2?CF#=_9/CCP_>^GVV*>VSTZ[5DQWKA-:_X)A_&W2RPMK70M8P>#
M9:F%SS_TU5/\FOV HKJCG.+CNT_D+V<3\0M:_89^.V@JQN?ASJ,H49/V*>"Z
M[9X\J1LUPFM? 7XE^'=W]J?#[Q18*IY>?1[A4ZXX8I@C)'(/>OWXHKICGM;[
M4%^/_!)]FC^=*[LKC3YC#=02VTHY,<R%&_(U#7]%=]I]KJD!AO+:&[ASGRYX
MPZ]".A'H3^=<3K7P!^&7B/<=3^'GA>^<_P#+2;1[=G'3HVS(Z#H>U=4<^C]J
MG^/_  !>S\S\"J*_;K6OV$_@1KQ)N/AW80D_\^5Q<6OJ>D4B^M<%K7_!,'X)
MZH&%M#K^CYZ&RU/=CCMYJ/\ 6NJ.>89[IK[O\Q>S9^05%?J%K7_!)'P5.6_L
MGQUKUD,_+]M@@N,<]]HCSQ_GM7!:U_P2)UJ'=_9/Q)L+P]A>Z4]OV/=99.^*
MZ8YM@Y?;M\F3R2/SZHK[*UK_ ()5_%[3MS66I^%]63^%8;V:-^W4/" /S/2N
M#UK_ ()Y_'K1<D>"1?Q#_EI9:E:R>O\ #YH;MZ=Q75''866U1?>+E?8^<:*]
M2UK]EKXP>']QO/AGXH"+RTD&ES3H!C.2T:L /QK@]9\(Z[X=9AJVBZCI94X8
M7EK)#@YQ@[@._%=,:D)_#),DR:***U **** "M#P]-I=MKEC+K5I<WVDI*IN
MK:SG$$LD>>0KE6"GWVG^M9]%)ZJP'Z<^!_\ @J=\,_#^BZ=HY^'^O:'IEC E
MM;VNF-!<)#&BX55W/'P, ?K7I6C?\%./@AJF/M-_K6D9_P"?S2W;'3_GD7]?
MTK\?**\.>3863OJOG_F:>T9^X&B_MQ? O7MOV;XC:9%NZ?;8YK7UZ^:BXZ5W
M>B_'3X<>(E4Z7X_\,:AN_AMM8MW8<9P0'R#R.#7X"45RRR&E]F;7W?\  '[1
MG[4_MF?LWI^U'\*[>WT.\ME\2:1,UUI<[R?N921MEA9AG 8 <]F1>@S7Y0>)
M/V:OBMX3U)['4OAWXDCG4D;H=-EGC;'7;)&K*P^A->?Z?JM[I$PFL;RXLIN#
MYEO*T;<<CD&NVT7]H3XH>'=HTWXB^*;-%X$<>L7 CZ8^[OP?RKT,+A:^#A[.
M$U)>:M^I,I*6IB3?#'QC;R/'+X3UR.1"0ROILP*D=01MXK)FT'4[>)I9=.NX
MHU&6=X&  ]22*]NT;]O+X\:&1Y'Q"O)U[K>6EM<YY'>2-CV^M=YHO_!4+XU:
M7M^TMX>UC&,_;=-*YZ_\\G3U_05T.>+CM"+_ .WG_D+0^1J*^[M/_P""L?BF
M>$1:_P##SP_JL?4K;SRPJ3CKA_,]_P ZZW2?^"I'@2\G@EUGX/&TDB.4DM+F
M"Y:/)Y*EHH^<?2L98G%Q_P"7'W20[1[GG7_!./\ 9E\1>*/BGI'Q(U;3IM/\
M)Z)ON;2>ZB*B_N"K(@BSU5"2Y<<90#N<?J[7QQHO_!5'X/ZD%%YI_BC2GQ\Q
MN+&)U!QV,<S$CMT%=[HW_!0;X"ZT0J^.ELY3_!>:==Q8YQ]XQ;>_K7RN.AC,
M55]I.DU\KFT>6*M<^BJ*\PT7]J#X1>(-OV+XE^%F=ONQS:K#"YZ]%=@3T]*[
MO1_%.B^(EW:5J]AJ:]<V=RDH['^$GU'YBO'E3G#XHM%W-2OPE_:L^'>J_#']
MH'QOI6J0R)YVISW]I,^2)[::1I(I W?*M@^C!AU!K]VJX?XI?!'P-\:],AL/
M&OANTUV& DPR2[HYH<]=DJ%77/&0&&<#TKT<NQJP51RDKIDRCS(_ 2BOV(NO
M^"9OP-N)BZ:3JULO_/.+5)"O_CV3^M94W_!+7X,22.RS^)H@Q)")J,>%]AF(
MG\Z^G6=87S^[_@F/LV?D917ZNS?\$G?A.T3"+Q+XR23'RL]Y:, ?<"V&?SK*
MNO\ @DIX">+%MXU\1Q29^]*ENXQ] B_SJUG&$[O[@]G(_+>OUO\ ^"6>AZGI
M'[-]Y<WR-'::EKMQ=6*NI&Z(10Q%@3U!>-QQW4UE>#O^"4WPVT/6(+S7/$&N
M>([:%@WV!C';12_[+E!O(_W64^]?9NC:/8^'=)L]+TRTAL-.LX5M[>UMT"1Q
M1J %50.@  %>1F>94L12]E2U\RX1:=V7****^7-@KY7_ ."E>O:KHG[+>J)I
MCO%'?:A:V=[)&Q4BW9F8CCLS*BD=PQ%?5%<W\1OA_HOQ4\#ZQX4\0VYN=(U2
M P3*I =>ZNA(.'5@&4XX*@UT8>HJ5:%22NDT)ZJQ_/A17VU\0/\ @E3\1]'U
M><^$]9T;Q#I#2'R#=3-:W2KV\Q2I3/;*L<]<#I7&7G_!-'XZ6NSR]$TN[W9S
MY.JPC;]=Q7]/2OT..8862NJB.7E?8^6**^D[K_@G3\?[>79'X(CNEQG?%K%B
M!]/FF!_2LN?]@GX]6\S1O\/+HLIP3'?6CK^!$I!_"M5C,.]JD?O0N5]CP"N]
M^ _Q&U?X4_%SPOXDT6>2*ZM;V-9(T!83PNP62)E'W@RDC'N".0#76M^Q;\;U
M8@_#;6L@XX1#_P"S5]&_L@?\$\_&"_$+2O%WQ*TY= T;1[A+N#2I9E>YO)D(
M:/<$)"1A@"=QR<8Q@DC'$8O#1I2<I)JVU]QJ+N?IY1117YJ=9^('[</B*?Q+
M^U5\0IYI6E%O?BRC!.0BPQI&%'H,J?Q)KTW_ ()>^ +7Q9^T/<:S>QK*GAW2
MY;R!67</M#LL2'GT5Y"#V(%>7?MM:%-X>_:H^(MO-$T7G:C]L3</O+,BRAA[
M'?7K'_!+7QU:^&?V@K[1+N01#Q!I,EM;[F #3QLLJC\467\<5^A5K_V=^[_E
M7W6_R.5?%J=9_P %*OVG?$D_Q&N_A;H.I3Z5H.F01_VI]CF*-?32QK)L<C_E
MFJ,HV="2V<X&/@NON[_@IC^S;XBL?B1=?%/2+";4O#VJ00C4I+>/<;&>*-8@
M7 Y",B(=_3<&!Q\N?A&M<M]E]5A[+MKZ]0G>^I/9ZA=:>S-:W,ULS#!:%RA(
M].*M:EXBU;6+>&WO]4O+Z"#_ %45S</(L?&/E!) _"LZBO3LMR KVCPC^V5\
M:/!(M4TWX@ZJT%LJQQV]\R7<010 %VRJPQ@ 5XO16<Z<*BM.*?J%['[8?L9_
MM2Q?M.?#^[NKVVAT_P 5:/(D&J6EN3Y;;P3',@/(5]KC:22"C=L$_0=?GW_P
M27^'>K:5X?\ &WC*\@FMM*U9K>RL&<86X\DRF5QZA2ZJ#TSO'4&OT$K\YQ].
MG1Q,X4MD=<6VM0HHHKSR@KXX^+W_  4Z^'?P[\27>B:#I=]XTGM&,<UY9R+!
M:>8#@JDC E\8/S!=IXP2.:]O_:PU34M%_9L^)%YI!9+Z/1+@*Z$AD1EVR.".
MA5"Q![8K\)*^BRK 4L4I5*NJ6EC*<G'1'Z>V/_!7#PA(8_MO@+6[<'[_ )%W
M#+M^F=N?TK=LO^"L7PKD4?:O#/B^W?=C]W;6LB@>I/V@']*_*6BO>>3X1_9?
MWF?M)'Z]6?\ P5"^"MSO\QO$-IMQCSM-!W?3;(?UK>L?^"C_ ,!;MD$OBRZL
M@RY)GTB[.T^AV1MS].*_&>BLGDF%?5_?_P  /:,_?#X7_M"?#GXT-(G@SQ;I
M^MW,:>:]HA:*Y5,XW&&0*X&2.=N.1ZUZ'7\\?A'Q9JW@7Q-IGB#0[V33]6TZ
M=;BVN(C@HZG(^H/0@\$$@\&OW\^'OB@^-_ /AKQ&8A"=7TRVU#RU! 3S8EDQ
MSSQNKY[,LO6"<7!WBS6,N8Z"BBBO%- HHKY!_;\_:^U7]GS3-*\,^$#'%XNU
MB)KDWTT:R+96P)0.JMP79@0,@@!&R#Q710H3Q%14J>[$W979]?45^#%U^TY\
M7[RX>:3XH^,5=NHBUVYC7\%5P!^ K2L_VO/C38L6C^)GB-B1M_?7K2C_ ,>S
MS[U[_P#8-7I-?B9>T1^ZM%?B38?MY_'K33&8OB)>/L&T?:+.UF_/?$<GW-;]
MC_P4@^/5F(_-\56=]M.29](M1N]CLC7CZ8K)Y'B>DE^/^0_:(_9>BOR-T?\
MX*E?&33KA&N[?PWJL0;+1W&GNF1Z QR+CZ^OKTK[S_9*_:YT7]J'P_>[+(Z)
MXGTL(;_3&D#H5;(66)NK(2,'(RIP#G()X<1EN(PL.>:T\BE-,]_HHHKRRPHH
MHH **\I^+W[4?PQ^!EU'9^,/%5O8:E(NY=.MXY+FYP1D%HXU8H".A? /8FO-
M[#_@I%\!KPQ^;XHO+'<,DW&D71V>QV1M^F>M=4<+7J1YH0;7HQ<R[GT]17@%
MC^WK\!=1"&+XAVB;FVCS[*[AY]]\0P/<\5OV?[7_ ,%;Y6:/XF>'5"G!\Z\6
M(_@&QFD\-7CO3?W,.9=SV"BN L_V@OA;J#,MK\2O"%RRC+"'7;5R/KB2NNT3
MQ)I/B:U-SH^J66JVXQF:QN$F3D9'*DCD5C*$X_$K#-&BBBH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *XSX
MH?&/P;\&=#_M;QCK]IHMJV?*29MTTY&,B.-<LYY'0'&><5\Y_'K_ (*.>&?@
MOXT\3^#5\+:MJ7B+20(HYBT2VDDK1*Z9._?M^<9PN>#7Y<_%+XJ^)OC)XPN_
M$OBO4Y=3U.?Y06.$AC!)$<:]$09. /4GJ37OX/*:F(?-5]V/YF4II;'VK^TY
M_P %'/"?Q.\'W7A;PQX8U6>WEECE.H:A+';\HX.!&N\D''4D'VKGOV6/^"@O
MA_X,:3?Z+XA\*:C+9WEV;HWFG7"2O'\B*%\MP@/W2<[A]*^':*^H66X94O8V
MT]3J68XJ.&>#4OW;=[66_K:_3N?O9\'?VAO 'QXTTW7@[Q!;ZA,B[I]/D_=7
M<'3.^)OFQD@;AE2>A->CU_/-X-\::W\/?$UAX@\.ZE/I.L6,GF075NV&4]P>
MQ!&05.002""#7Z;? _\ X*=:'X\U#P9X5U[PMJ<7BS6+RVTN:ZL3$;/SI95B
M$@W.&"DL&(P<<@9QFOFL9E%2B^:C[T?Q1RQG?<^XZ***^=-0HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OSG_:
M8_Y.NU?_ *^]._\ 2>WK]&*_.?\ :8_Y.NU?_K[T[_TGMZ]?+/XLO1_FC[GA
M#_?:O_7M_G$_1BBBBO(/A@HHHH **** "BBB@ HHHH **** /SA^!/\ R=AI
MG_86O/\ T":OT>K\X?@3_P G8:9_V%KS_P! FK]'J]?,OXD?0^[XN_WJC_@7
MYL****\@^$"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBN8\??$[PC\+-';5?&'B;2O#.GC.)]4NT@#'T7<0
M6/L,GF@#IZ*^)OB!_P %>O@#X.F>#2;K7O&DJDKNT;33'%N'JUPT61GNH;VR
M*\=U3_@N)X>ADF&G?"?4[I /W376LQP%C_M!87V_@30!^G=%?E_I_P#P7&T6
M01?;OA'?VY)_>?9]=27:,]LP+GCUQ7J'@G_@LG\#O$4\<&MZ?XH\)L<;KB\L
M$N+=?QAD=S_WQ0!]X45YY\*?VAOAK\<+7S_ OC32/$9"[WMK6X N8U]7@;$B
M#_>45Z'0 4444 %%%% !17S_ /%+]O7X$_!?QWJ?@WQEXY_L;Q)IOE?:[+^R
M+^?R_,B25/GB@9#E)$/#'&<'D$5RO_#T;]F+_HIG_E U3_Y&H ^JJ*^5?^'H
MW[,7_13/_*!JG_R-1_P]&_9B_P"BF?\ E U3_P"1J /JJBOE7_AZ-^S%_P!%
M,_\ *!JG_P C4?\ #T;]F+_HIG_E U3_ .1J /JJBOF/3_\ @I=^S5J4>^'X
MH6B#=L_TC3+Z$YX[/ #CGKTKT+P;^UI\%_B!=):Z#\4/"M]>.=J6IU2**9SS
M]V-RK-T["@#UJBD5@ZAE(92,@CH:6@ HHK"\<>-=(^'/A'5O$^OW$MIHFE0-
M=7EQ#:RW+11+]Y_+B5G( Y.%. "3P": -VBOE7_AZ-^S%_T4S_R@:I_\C4?\
M/1OV8O\ HIG_ )0-4_\ D:@#ZJHJCH6N6'B;1;#6-*NXK_3+^WCNK6Z@;<DT
M3J&1U/<$$'\:O4 %%%% !1110 4444 %%>%_&#]M[X)? 7Q@WA7QSXYBT;7T
M@2Y>RCT^[NVC1\E-Y@A=5) SM)!P0<8()XG_ (>C?LQ?]%,_\H&J?_(U 'U5
M17E_P/\ VF/AQ^TA:ZK=?#K7YO$-KI;I%=W!TR[M8T=P2JAIXD#-@9(4D@$9
MQD9]0H **** "BN:\=?$KPE\+]*74_&'B;2/"^GL2J7&KWL=LCL!G:I<C<WL
M,FOG;Q)_P5&_9N\.W,EN/'KZI-'G=_9NE7<J9'8/Y00Y]02/4B@#ZNHKX^T7
M_@K!^SAJTJ)<>+-1TG<VW=>Z+=$#C(),:/P3Q_/ YKW[X7_M#?#3XT1*W@CQ
MQHGB.4KO-K9W:_:4'JT!Q(OXJ* /0Z*** "BBB@ HHHH ***X+XF?'KX<_!N
M-#XW\;:'X9DD3?';ZA>HD\B^J19WL/\ =!H [VBOD+6_^"KG[-VD22)!XPOM
M69#C_0=%N\-S@X,D: X]?RS5GPW_ ,%3OV;O$,T<+^.)](ED' U+2;M%!]"Z
MQLH_$XH ^M**Y;P!\5/!OQ5TLZCX-\4Z1XGLUQOETJ]CN!&3T#A22I]FP:ZF
M@ HHHH **** "BBD9@JDDX Y)- "T5XM\1/VT/@=\*VD3Q'\3O#]O<1\/:V5
MS]NN$]C%;AW'XBO(M3_X*S_LXV#$0>)]4U+#E<VNBW*Y'][]XJ\?KSTH ^QJ
M*^3]$_X*E?LUZU,D3>/Y-.D<A5%]H]ZBY/JPA*@#U) KZ \ _&'P+\5+;S_!
MWC#0_$Z;=S#2[^*=D'^TJL2I]B!0!V%%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !7S=_P47U_5/"_P"QC\2-4T;4;O2-3MX;,PWEC.T,T>;ZW4[7
M4@C()'!Z$U](U\O_ /!33_DQSXG_ /7&Q_\ 2^VH _#;_AH3XI_]%+\8?^#Z
MZ_\ CE'_  T)\4_^BE^,/_!]=?\ QRN HH [_P#X:$^*?_12_&'_ (/KK_XY
M1_PT)\4_^BE^,/\ P?77_P <K@** .__ .&A/BG_ -%+\8?^#ZZ_^.4?\-"?
M%/\ Z*7XP_\ !]=?_'*X"B@#O_\ AH3XI_\ 12_&'_@^NO\ XY1_PT)\4_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3^E;%G_P5!^"ERK&1_$%H0>!-IH.?IM<UF\OQ2_Y=L?-'N?7%%?,-K_P4C^
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MS1]SPA_OM7_KV_SB?HQ1117D'PP4444 %%%% !1110 5\M?\%!/AW\1/B/\
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M85@5[)^S/^R?X^_:L\6R:/X-L(TL[7:VH:U?$QV=DIZ;V )+'LB@L<$XP"0
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M/?(/<$5^87[</_!,'5_V>]+OO''@"[NO$W@&W'F7EO=8:_TQ<X+MM $L0/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&J+O'HS17MJ%%%%8#"BBB@ KYN_;S^.OBK]GWX0:/XB\(S6L.I76NPZ?(UW
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MVSA.[^X?LY'Y.T5^N/\ PZS^#7_/UXH_\&,7_P 9K0C_ ."8OP12-5-GKDA
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M82D$'H0=M7;3X/\ CS4(S):^"?$5S&#M+0Z3<, ?3(3KR*_H%HKY_P#MZ?\
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MV2Z)<J?R*5Z]I7_!1SX^:??1SW'C"WU2)>MK=:19K&_U,<2-^3"OT+_8U_;
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M_P %<O#+QDW/P\U:&3/"Q:A%(,>N2J_RK-Y7C%_R[_%?YCYX]S[]HKX=M?\
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M9.-\;!@#CJIQ@CN"17ZZ?\%J?AO'KGP.\(>-(HMUYX?UDV<C@<BWN8SN)/\
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M:2.QF=<O:Z?'(4VKGH9)$9CCJHCK\P->_8Y^.?AG>;_X2>,0B?>DM]&GN$7
M!R6C5@!SUS7] O[._A4>!_@'\.= ^S-9OIWAZPMY874JRR+;H'W \AMVXG/<
MF@#T*BBB@ JOJ&GVNK6%S8WMM%>65S$T,]O.@>.6-@0R,IX*D$@@\$&K%% '
M\Z'[<'P!B_9M_:1\4>$;%6&A.RZCI)?K]DF&Y4]]C;X\]_+SWKQ;P]KU[X6U
M_3-:TV8V^HZ;=17EM,O5)8W#HWX, :_0+_@MG]F_X:"\#[#_ *9_PBZ^8/\
MIG]KN-GZ^97YVT ?U"_#?QI;_$?X=^%_%EFACM->TNUU2%&ZJDT2R*#] PKH
MZ\/_ &'Y+F7]D/X1-=KME_X1RT51G/[L( A_[X"U[A0 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !7R[_P4H^,T_P5_9*\57=A,UOJ^O,GA^RE7JK7 ;S2#V(@
M2<@]B :^HJ_-C_@MW=W"?"7X;VR[OLLFMSR28^[O6 A<^^'?'XT ?C]7VO\
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MV%KQL\K*56-)?9_4NFM+A1117S)L%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M&%%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M88>4Q2O$)&]2PC#9[YSWKV"L7P5X/TOX?^$='\-:+ ;;2M*M8[2VC)W$(B@
MD]R>I/<DFMJOS:K*,JDI15DVSK6P4445D,^1/^"D'[0>M?!CX7Z3HWAF]DTS
M7/$\TL/V^!RLUO;Q!#*8R/NL3)&N[J 6QS@C\BIYY+J:2::1I9I&+O)(Q9F8
MG)))ZDFOV%_X*%?LXZS\>OA?IE[X8MS?>)/#<\EQ!8*0&NH9 HF1,X^<;$8#
M/.T@9)%?D%JFDWVAWTMEJ5E<:?>1';);W4312(?0JP!%?=Y*Z7U>T?BZ_I^!
MS5+W*E%%%?0&9>@U[4K6%8H=1NH8EX5(YV51] #6S;_%+QG9SI-!XNUZ":,[
MDDCU*964^H(;BN8HJ7&+W0'Z)?\ !/W]M;Q7XB\?6?PV\>:I-K\.I))_9>J7
MA,EU%.JE_*DD/+HRJV"V6#8&<'C](:_'C_@G'\'-8\?_ +0&D>)TM9%\.^%V
M:[N[SE4,QC988E/=BS!B/[JMGJ,_L/7P.;TZ5/$VI:::^ITT[VU"BBBO$-"K
M>:79:@RM=6=O<LHPIFB5R/ID5\#_ +8G[97A'X4^+K_P7X,\!>%O$>OVQVZI
MJ.K:>DMK#(>6A"+M,CC(W$L IX(8Y _0*OP3_:0\/ZIX7^/GQ!T_64E%^NN7
MDK/,,-*LDK2)+]'1E8>S"O?RC#PQ%67M.BV,JCLM#N9/VR-8NU(O?AI\+=0&
M\LGVKPC WE@_PKR..._/O4+?M80S*?.^"?PCE=AAI!X<DB)_".=5'X 5X+17
MV7U6CTB8<S/=9?VC?"-W'&ES\!_ 14$%OLYO86/K@K<9'Z_C2-\;OA3=7:RW
M?[/NAO'C#);>(]3@SQQC$N!S[5X711]7I]+_ 'O_ #"Y]$>$_B-^SMJNI):^
M)_A!J^A64LBAM0T?Q-/<O I(R?*D4;@/8YQT&:^V_#__  3E^ 'Q!\/:9X@\
M/7NO3Z/J$"SVUQ::D"DJ-T/SQD@]B#@@@@C-?DY7ZW?\$L;C5)OV;+Q+XNUE
M%KURNG[V)Q$8X2P4=E\PR'ZEJ\;-(SP])5:-1K7:[?YFD+-V:*%U_P $G_A-
M-YI@\1>,8'8DH#>6K(GMC[-D@?7/O6+>?\$D_ LFS[+XW\0P]=WG1029],85
M<?K7W=17S*S+%K_EXS7ECV/SYNO^"1.BN\AMOB5?Q(?N"724<CCN1*N>?I6)
M=_\ !(.Y2,&U^*D4SYY6;0#&,>N1<M_*OTAKYG_X*'_$C6/AO^S3JLNAS36M
MYJ]W#I+W4'#0Q2!VD(/;<J%,CD;^/6NJAF&-K5(TXU-W;9?Y"<8I7L?G/\1/
MV<?AU\.==N-)N_CQH-[>V[>7+'9:/=W&QNX+1!TR#P1OSGC'!KCF^%'@J2W1
MK?XT>%?/;'[JYTS6(P,^K"R8#^7O7EM%?;1IS2UJ-OY?Y'/?R/4G^".EFZ2&
M#XL^ KDL,[UN+^-![$R6BXZ5$OP+EF\\6_COP+.8^@.O1Q;^?X?,"_KBO,J*
MKDG_ #?@!Z3_ ,*#UZ2-7MM>\$W0)*D#QII,17&.HEN5/.>V>AKJ+/\ 8F^-
M.IV9N]/\%-JEGC*W.GZE9W,3\9^5XYF#?@37AU>U_LF_M Z]\!/BQHUY97LO
M]@7UW';ZMIK2$03PL=I<CH'0-N5NH(QT)!RJ_6(P;IM-KNG_ )@K=2M=_L=_
M&NR0/)\-/$# G'[FU,A_)2:R;K]F/XOVDQC?X7>,68<YBT*YD7\U0BOWGHKY
M99]6ZP7XFWLT?S]W7P=\?6,7FW/@?Q);Q9QOETFX4?F4K(N_!OB"PD"76A:E
M;.1N"S6<BDCUP17]#=%:+/I=:?X_\ /9^9_.=(C1NR.I1U."K#!!]#3:_3G_
M (*"?MJZY\-_$3_#3P/)%9ZDMNDNKZI)"LKQ>8H>.&(-E0=A#%B"?F7;@@FO
MS[O/C7X^U"]%U=>,=:N91G:)KUW1<]<(3M'X"OHL+7JXBFJCARI[:_\  ,FD
MG8XJBNM_X6KXG9IS+?PW9G&)?M=E!/N'3G>A]?QJ-?B1JRP"$6F@; =V3X=T
M\M_WUY&<>V:Z[S[?C_P"3EJ*Z>3XB:I-(KO9Z$< #:N@6" @<?PPC\^M3Z;X
M\L[:Z5[_ ,&^'M7MP03;3QW$"G_@4$T;_P#CU%Y+H!R-%?IS^S3^SQ^S3^U%
MX#_M_2_ ]SH6IV3BVU/1TUR[D-O+C(8,TI+(PSM;C.TC&5->CW7_  3$^"5P
MDBQVFN6I8Y#1:F25YZ#<I^G.:\>><4*<W"<9)KR7^9I[-O5'X_T5^M%Y_P $
MI_@_<E3'J_BZTQU$-_;G=]=UNWZ5C7?_  27^'3^;]E\8>*(<Y\OSFMI-OIG
M$2Y_2A9SA'U?W![.1^6%%?IK>?\ !(SPVZK]E^(FJ0MGDS:='(#],.N*^)/C
M1\._AI\._$][HWAKXAZEXPEM&,<EQ;Z$D=J)!PRK,;G+X(ZJFWT)KLH8^AB7
MRTFV_1DN+6YY+16FMOH_D@M?WPFS]T62%<?7SOZ4R6'2E*^5>WCC'.ZT1<'T
M_P!:>*[KDF?13U56E"[PB$XWN#P/4@9_2K2Z? SA3J5JH_O%9<?^@4P*5%>A
M?#/X&^(_C)JTND^#IM+UC5T1I%T][^.UFF Y/EB<IOP.>.@Y->AWG_!/_P"/
MUBJF3X>S,&.!Y.IV4OY[9CBL)8BC3?+.:3\W8=F?/5%>VW7[%/QQLY'23X;Z
MPQ09/E".0=,\%6(/X5YYKGPJ\9>&M9DTC5/"^K66J1LJO9RVCB4%E#*-N,\A
M@1]151K4I_#)/YFD*52H[0BWZ(Y6BN[NO@+\3;&7R[GX=>++>3&=DNAW2G'K
M@QUAW7P_\4V,;27'AO5[>->&>6PE4#G')*U2J0>S1D8%%375G<64FRX@D@?^
M[*A4_D:AJP"GPS26\JR1.T<BG*NA((/J#3**8&U9^-O$6GEC:Z]J=L6^]Y-Y
M(F?KAJV+7XT?$&QC1+;QUXEMTC.46+5[A0O.> 'XYKC:*APB]T!Z;:_M/?%^
MSD,D?Q1\8,V,?O=<N9!^3.14^K?M3_%S7O#][HFH_$+7K[2[V)H;FWGNB_FQ
ML,,A8\[2.",]"17E=%9^PI7OR+[D.["BBBMQ!1110 Z.1HY%=3M93D'T-?NU
M^RO\3)_B[^S[X*\3WDCS:A<6(@O)9/O23PLT,CG_ 'FC+?\  J_".OT^_P""
M5OQLM=8\$ZO\,KV0)JFDROJ5@"?];:R,!(![I(<GVE'H:^?SJC[3#J:6L7^'
M]6-*;U/O6BBBOA#I"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "JVI:E::-I]S?ZA=0V-C;1M-/<W$@CCB11EF9CP
M!R2:LU^47_!1;]JV]^(GC6]^&WAZ[:'PGH=QY5^T)(_M"[0_,&/>.-LJ%Z%@
M6Y^7'=@\)+&5?9QT75DRERJYZ_\ '3_@JEI>@7\^E_##1(M?>(E6UK5@Z6K'
M_IG$I5W'^TS)R.A'-?,NI?\ !2#X]7UX9H/%=KI\6_<+>WTBT9,?W<O&S8_'
M//6OF2BONJ66X6E&W(GZZG,Y-GVQ\-_^"J7Q'\/74,?B_2=*\6V&?WDD4?V*
MZQ_LLF8^/0Q\^HK]"_@/^TAX(_:*\/R:EX3U!FN+? N]+NU$=W:D]-Z9.5/9
ME)4\C.00/P<KK/A=\3_$'P>\;:;XI\-7K6>IV,@8<G9*O\4<@_B1AP1[UR8O
M*:-:+=)<LOP*C-K<_H'HK@/@3\8-+^.WPMT3QCI86);Z+%S:A]YM;A>)8B<#
M.&Z$@9!4XYKOZ^%E&4).,E9HZ0HHHJ "BBB@ HHHH **** "BBB@ HHHH *_
M#7_@KE\%;GX<_M/3^+(;=ET3QI:I?12@?(+J)5BN(Q[\1R'_ *[5^Y5>-_M7
M_LSZ#^U5\(=0\':PXLKU6^U:5J@3<]C=J"%?'=2"59>ZL>A ( /YNZ_3S]@;
M_@J/I/@#PCI7PW^+\MQ#INFHMKI/B>*)IA# !A(;E%!;:@^59%!XP".-U?G]
M\:O@CXP_9_\ 'E]X1\::5)IFIVS$QR8)@NHLD+-"^,/&V."/<$ @@<)0!_43
MX)\?^&OB3H<6L^%-?TWQ'I4OW;S3+I)X\XSM)4G##N#R.];]?RZ>#_'GB7X>
MZLNJ>%O$&J>'-248%WI-Y);2XZXW(0<>U?57PS_X*Q?M _#]8H-0UK3?&UG'
MA1%XAL%9PO\ UUA,;D^[LWX]* /WAHK\POAS_P %N]!NO*A\=_#;4-./ >\\
M/WJ70/OY4HC*CVWM7U3\,?\ @HM^S]\5#%%9?$&QT2^DP/L?B)6T]@3T&^4"
M-C_NN: /I2BJ^GZA:ZM90WEC<PWEI,N^*XMY!)&Z^JL#@CZ58H **** "BBB
M@#\ ?^"H_P#R?9\3?^X9_P"FNTKY5KZJ_P""H_\ R?9\3?\ N&?^FNTKY5H
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M:M=7^H2@C')NI(E/XI$A_&OKJO!_V$=/&F?L>_"6$# ;08)O^_F9/_9J]XH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !7SM^W)X1EU[X01:I "SZ+>QW$@'/[IP8V_)F0_0&OHFO,/VH[
MR33OV9_BU>0$+<6OA+5KB)B =LB6<K*WU# '\*VHU/95(S['?E^*>"Q5/$+[
M+O\ +K^!^8!&1@C(KY6T;P3-\/\ XOZ_8/%MM&TV]FLY,8#1,AVX/J,[3[@U
M]"?#SQW8_$+PS;ZI9,!(1LN(,_-#*!\RG^8/<$4[Q]9V\GAN_NI(4:XAMY%B
ME*_,@888 ^AX_(>E?8NG'$2IU(O9IH_:\VPU',L+'%TY?!>2?=6U7]=4?/M6
MM*M?MNJ6=N0")IDC^;IRP%5:T_"]R+/Q+I-PR>:L5W#(4'\6'!Q7T;V/YYBG
M)I+J?OS\2?'VG?#+P7J?B+4W40VD9,<6X!IY#]R-?=CQ[<GH*_*/5M4N-;U6
M]U&[?S+J\F>XF?\ O.[%F/YDUW?QD^.WB3XU:M'/JTB6NG6Y)M=,MB1#%G^(
MYY9\=6/X #BN:\ ^!=6^)'BNP\/Z-!YU[=/C<<[(D'WI'/95')_+J17R6#P_
MU6#E-ZO<_?LARE9+AIU<0US2U?9)=+_F?7O[ 'A.6R\+^)O$4H(2_N8[.$$=
M5B4LS#V)E _X":^E_&7BO3_ OA+6?$>JR>5INDV<M[<,.NR-"Q ]20, =R14
M'@'P78?#SP?I7AW3%VVEA"(@V,&1NKN?=F)8^YKY'_X*E?& ^$?A#IG@>RFV
M7_BBYWW(4\K9P%68'TW2&(>X5Q7B1B\=B[+[3_#_ (8_(<VQOU[&5<2MF]/1
M:+\#\Q/B!XTU#XC>.->\4:HV[4-7O9;V;G(4NQ;:/900![ 5S]%>@_ 'X6S_
M !H^,7A7P="&\K4KQ1=.G6.V7+S/]1&KX]\5^BMQI0N]$E^1\]N?J;_P3F^#
MY^&/[/%AJEW!Y6K^*I/[6FW##" C;;K]-@W_ /;4U]2U!96<&FV<%I:Q);VU
MO&L4448PJ(HPJ@=@  *GK\OKU77JRJ2ZL[$K*P4445@,**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M /"/C9^Q3\+/CM=2ZCK.BOI6NR??U?17%O/(?5QM*2'_ &F4G'&:_*O]K;X#
MV'[.?Q>E\):;JEQJ]G]BAO$GNHU20;]PVG;P<;>O'6OW+K\A?^"H7_)S[?\
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MY)-)1344MD 44450!1110!K:3XMUS0;=H-,UG4-.@9M[16EU)$I; &2%(&<
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M4O\ @E%\?OARLT^GZ)I_C>PCRQF\.W@>3;V_<RB.0GV16_&@#YQ^&GQO\?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !7Y"_\%0O^3GV_[ MI_.2OUZK\A?\ @J%_R<^W_8%M/YR5[^2_
M[U\G^AG4^$_6CPU_R+NE?]>D7_H K2K-\-?\B[I7_7I%_P"@"M*O!ENS0***
M*0!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 ? _[0W_  4@\2?!?XS>
M)O!=EX/TK4;729HXDNKBYE5Y-T2/D@<#E\?A7G7_  ]P\7?]"#HO_@7-7Z#:
M]\#?AOXJU:YU76OA]X6U?5+DAI[V_P!%MIYI2  "SLA9C@ <GH!6?_PS;\(_
M^B6>"O\ PGK3_P"-U[E/$X&,$I4;OU,^67<_,#]H3_@H%XA_:$^&=YX-U#PI
MIFDVMS/#.;JUN)'<&-PP&&XYQ6)^S#^VUK?[,7A+5=!TOPUI^M0ZA??;FFNY
MG1D;RU3: O;" _C7ZM?\,V_"/_HEG@K_ ,)ZT_\ C='_  S;\(_^B6>"O_">
MM/\ XW74LQP:I.BJ+Y=[7)Y97O<^"?\ A[AXN_Z$'1?_  +FKJ/A;_P5"\4?
M$#XG>$/"]QX)TBTM];UBSTV2XCNI2T:S3)&6 /!(#9_"OL[_ (9M^$?_ $2S
MP5_X3UI_\;JSIO[/_P +]%U&UU#3_AOX1L;^TE2>WNK;0K6.6&12&5T98P58
M$ @@Y!%<TL5@'%I4-?4KEEW.^HHHKPC0**** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K\Y_VF/\ DZ[5_P#K[T[_
M -)[>OT8K\Y_VF/^3KM7_P"OO3O_ $GMZ]?+/XLO1_FC[GA#_?:O_7M_G$_1
MBBBBO(/AC&U3P;X?UNZ-UJ.A:;?W) 4S75I'(^!T&6!.*QIO@S\/KF5I9O O
MAJ61CEG?2+<D_4E*[*BK4Y+9@>:S_LS_  AN(6C?X6^#0K<$QZ#:HWX$1@C\
M*RKO]D'X+7L823X9^'5 .?W-DL9_-<&O7Z*T5>JMIO[V*R/$X_V*_@?#>1W2
M_#;1C*@P%97:/KGE"VT_B*]ATG2;'0=-MM.TVSM]/T^V0106MK$L<42#HJJH
M  'H*MT5,ZM2I\<F_5A9$=Q;QW4$D,R++#(I1T89#*1@@CTQ7X&_'?X9W/P=
M^+_BOPA<1/&FFWTB6QDZR6['= __  *-D/XU^^U?&O\ P4-_9,N/C-X:B\<>
M%K9I_%^AVYCFLH4R^H6@);:H')D0EBH_B!8<G;7L93BHX>LXS>DOSZ$3C='R
M7_P3Q_:;L?@;\1+WP_XDN5M/"GB4QI)=R'"6=TN1'*Q[(P8JQ[?*3PIK]1?'
MWP5^'_Q>M0?%7A72/$'F1A4NYH%,X3J-DRX=1_NL*_ >1&C=D=2CJ<%6&"#Z
M&OH;X#_MV?$[X#:9!HUE>6WB'PY#Q%I>M*TBP+_=BD5@Z#T7)4=EZU[F89;.
MM/V^'=I?=<SC*RLSTSX1_ 'P#XB_:*L?#VH^'TN=&DU&Z@>T:YF"E%60J,AP
M>-H[]J_2W1/"'@3X(^&KZYTK2-%\':-;1>=>7%O!';)L0??E< %L#NQ)K\??
M!_[7%_X-^)4/C*U\.6T][#<S7*6\URWE[I%<8.%!P-_XX[5C_';]KKXD_M#?
MZ-XEU9+71%<.FB:6A@M P.067)9R.Q=FQVQ66(R_$XJI%2E:-M=?T/I\]Q6
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M3^&7P>U1H-)4M;:OXKLY,/=]FAM7'2/LTHY?D+\O+@'K/[>G_!4"P^%?]H^
M/A+=V^K>,EW07^OIMEM=+;D,D742SCOU1#P=S95?QXUC6+_Q%JMWJ>J7MQJ6
MI7DK3W%Y=RM++-(QRSN[$EB3U)JG7OW[(_[&?C7]K;Q?]CT6(Z5X7LY%&J^(
M[F,F"V'78@X\R4CH@/<%BHYH X;X#_ 'QI^T=X]M?"?@G2VO[Z3#W%S)E;:R
MAS@S328^1!^))P%!) /[R_LB_L;^#?V1_!?V#1D75/$][&O]K>(IXPLUTPYV
M(.?+B!Z(#[DL>:[/]G_]GCP5^S3X!M_"O@K3!:6RX>ZO9L-=7TV,&69\#<Q]
M.%4<* .*]+H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MM7_Z^]._])[>O7RS^++T?YH^YX0_WVK_ ->W^<3]&****\@^&"BBB@ HHHH
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M?ESZ[?(!( 1\RPH,B)#W )8]V(Q7OE%%?&U*LZTG.H[LU2ML%%%%9#"BBB@
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M"W;(!!1.6!Z/(X[4 ?6-%%% 'X _\%1_^3[/B;_W#/\ TUVE?*M?57_!4?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MAQH^J?$_7+W3-0\2:;:75K+(A2:&2ZC1T/R]"I(_&OD2O2OV9?\ DY+X4?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7Y"_\ !4+_ ).?;_L"
MVG\Y*_7JOR%_X*A?\G/M_P!@6T_G)7OY+_O7R?Z&=3X3]:/#7_(NZ5_UZ1?^
M@"M*LWPU_P B[I7_ %Z1?^@"M*O!ENS0****0!1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@_\ !I/_ /%T?\+8\;_]#EX@_P#!I/\ _%U]*_\ #I_]I+_H4-/_ /!W:?\
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M+P?XGM4L]>TFQ:"[@CE6548RNV ZD@\,.AKV2@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\<OV_P#X7:;\)?%$G@KQG#JOBN2R>#3;>WMYU<32?() 60*-FXOR?X,=37Y
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Y5^UC_R:S\9/
M^Q,UG_TAFKU6O*OVL?\ DUGXR?\ 8F:S_P"D,U '\UE=Y\+Q\NI'U,?_ +-7
M!UZ!\,5_T6^;U=1^A_QKV,I5\9#Y_DR)_"=K7U]_P3+UZQ\(_&+QIXBU.40:
M;I'@^\O;J4_PQ)/;LQ]^!7R#72^%?&U[X2T/Q58V+^6=?L$TRX8'#"#SXIV
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M9\,O^XG_ .FN[H _?ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !7Y"_\ !4+_ ).?;_L"VG\Y*_7JOR%_X*A?\G/M_P!@6T_G)7OY
M+_O7R?Z&=3X3]:/#7_(NZ5_UZ1?^@"M*LWPU_P B[I7_ %Z1?^@"M*O!ENS0
M****0!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 45S?Q$\<6GPW\%ZIXDOH)KJUT]%>2&WQO8%U7C) ZL.]> _\ #?W@
M[_H7=<_*'_XNNBGAZM97A&Z/4PN5XS'0=3#TW))V^9]15^<_[3'_ "==J_\
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ME%%%8G"%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?+__  4T_P"3
M'/B?_P!<;'_TOMJ^H*\^^/OP9TS]H3X1^(/A]K-]=Z;IFM)"DUU8[?.3RYHY
MAMW CDQ@<CH30!_,Q17[)_\ #DOX6?\ 0]>,/^^K7_XS1_PY+^%G_0]>,/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH *_(7_@J%_P G/M_V!;3^<E?K
MU7Y"_P#!4+_DY]O^P+:?SDKW\E_WKY/]#.I\)^M'AK_D7=*_Z](O_0!6E6;X
M:_Y%W2O^O2+_ - %:5>#+=F@4444@"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@##\:^#].\?>%[_ $#5ED?3KU5298GV
M,0&##![<J*\>_P"&(_AC_P ^NI_^!S?X5[[16T*U2FK0DT>AA\PQ>$BX4*KB
MGKH['@7_  Q'\,?^?74__ YO\*/^&(_AC_SZZG_X'-_A7OM%:?6J_P#._O.K
M^VLR_P"?\OO9X%_PQ'\,?^?74_\ P.;_  H_X8C^&/\ SZZG_P"!S?X5[[11
M]:K_ ,[^\/[:S+_G_+[V<5\+_A%X>^$&F7EAX=CN([>[F$\HN)C(=P4+P3TX
M%=K117/*3F^:3NSRJM:I7FZE65Y/=L****DR"BBB@ KSWXT?!?2_C9H-CI6J
MWUW8PVES]J5[/;N+;&7!W \88UZ%15QE*$E*+U-Z-:IAZBJTG:2V9\N_\, ^
M#O\ H8M<_.'_ .(H_P"& ?!W_0Q:Y^</_P 17U%175]=Q'\Y[7^L&:?\_P!_
MA_D?+O\ PP#X._Z&+7/SA_\ B*/^& ?!W_0Q:Y^</_Q%?45%'UW$?SA_K!FG
M_/\ ?X?Y'R[_ ,, ^#O^ABUS\X?_ (BO>?AC\/[/X6^!]-\,:?<3W=I8^9LF
MN=OF-OE>0YP .KD=.@KJ:*RJ8BK57+.5T<>*S3&XZ"IXBHY)._S_ *84445S
MGE!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;17>L[K+:$?Q_P R?9H_&E?V5_VI44*NA^)U51@ :W& /_(]+_PRS^U-_P!
M3Q1_X.X__C]?LK12_MJM_)'[G_F'LT?&G_!.SX6?%/X9_P#"P/\ A9=CJEG]
MM_L_^S_[2OEN=VS[3YNW#MMQOCSTSD>E?9=%%>-B*SQ%5U9*S?8T2LK!1117
M.,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **Q?&'C30?A_X?NM=\3:S8Z#HU
MJNZ:^U&X6&)/0%F(&3T ZD\"ORV_;#_X*\3:I#?>$_@=YMG;MNAN/&-U%ME8
M=#]DB893(_Y:.-W)PJD!J /I7]O;_@H3H7[,NB7GA3PM<0:Q\4;J#$=NN)(M
M(##B:X[;\'<D74\%L*1N_#+6];U#Q)K%]JVJWDVHZG?3/<W-W<N7DFD<EF=F
M/)))))J+4-0NM6O[B^OKF:]O;F1II[FXD,DDKL<LS,3EB2223R:KT %%%% '
M]1'P]_Y$'PS_ -@RV_\ 12UT%<_\/?\ D0?#/_8,MO\ T4M=!0 4444 5=4U
M.TT73;O4+^XCM+&TA>>>XF;:D4:J69F/8  DGVK^>7]MO]J[5?VKOC%>ZUYT
M\'A+3F:TT'37)"PVX/\ K67H)9,!F/4?*N2%%?IY_P %=OCM)\+_ -G.#P?I
MURUOK'C>Y:R8HV&%C$%>Y.?]HM%&1W65J_#^@ HHK]-/^"7W[ /AOXH>&/\
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M1'WU3ARG3A*?UNF[*^__  3[KHHHKRCXL**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[5:PS;=OF(K[<YQD9Q4U5-)_Y!5E_P!<4_\ 015N@ HHHH ***\"_;"_:_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%AK7Q-XLAQ-:Z%&!)I^GOU#.2/W\J_38IS@.0K#Y:_X+/?\ )U^B?]BE9_\
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MOVL?^36?C)_V)FL_^D,U>MA\RJX:FJ<8IKS7_!(<$W<_G\_X2GPU_P ]8?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&GE(]B(EC/M(:_"^@#H/A_X!U[XH^--'\*>&=.EU77=6N%MK6UB'+,>Y/15
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M,G\?H5M_CM\1XD^Y'XDU)1GT%U(* .#KV_\ 8?U7^Q_VO/A%<9V[_$=I;_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MMCAB10J(H[   ?A5^BB@ HHHH \?_;$_Y-0^,/\ V*6J?^DLE?S;U_37\??
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M[=H1QT/W_:O@/7O^",OQSTO>UAJW@[64YVK;ZC/&YY'420* ?^!'IUK]MJ*
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MR?QH ^**_H'_ .":/P_3X?\ [&7@",QA+O6(9=9N& QO,\K-&?\ OSY0_P"
MU_/Q7]//P?\ #J^#_A)X)T%(_*32]$LK(1C^'RX$3'_CM '7T444 %%%% 'X
M)_\ !5?P&G@C]LSQ1<0Q"&VU^TM-8C51@9>,12-^,L,C'W)KY0T36+OP[K5A
MJMA*;>_L;B.ZMYEZI(C!E8?0@&OT<_X+>>'UMOBI\-=="$/>Z+<61?L1#/O
M_#[0?SK\UJ /ZC? _BBW\<>"] \1VF/LNL:?;ZA#M.1LEC61>?HPK;KY_P#V
M O$C>*OV-?A/>L<F+1DL?PMW>W'Z15] 4 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %?/7Q(_P""?_P$^+GC;5?%_BWP'_:WB+5'
M62[O/[8OX?-945 =D<ZH/E51P!TKZ%HH ^5?^'7'[,7_ $3/_P K^J?_ "36
MEX9_X)N?LY^#?$FDZ_H_P[^QZMI5W#?6=Q_;>HOY4T3AXWVM<%6PR@X((..0
M:^F** "N$^.?PATCX]?"7Q-X"UMFBL-:M#!]H1 S6\@(:*50>"4=58#OMKNZ
M* /GC]GG]@SX/_LVK;W?A_PXNK>(X@#_ ,)#KFVYO WK'D!(>_\ JU4XZDU]
M#T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %?B7_P6>_Y.OT3_ +%*S_\ 2J[K]M*_$O\
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MZS,Z21G((\F$=?PK;._X"]3WL"TLLQ2OJY4__;CZ4HHHKX8\@**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MK3I]HF2+KC[S ?UK^IU5"J !@#@ 5_+KX!C6;QUX<C<;D?4K96'J#*M?U%T
M%%%% !1110!^67_!<JSW6/P:NP/]7)J\1./[PLR/_03^M?E)7ZT_\%QO^15^
M$G_7[J7_ *+MZ_):@#]\?^"5-\UY^P]X$B;I;7&I0CZ?;IW_ /9Z^MZ^-?\
M@DG_ ,F6^'_^PGJ'_H\U]E4 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P""SW_)U^B?]BE9_P#I5=U^VE?B7_P6>_Y.OT3_ +%*S_\ 2J[H ^"Z***
M/ZB/A[_R(/AG_L&6W_HI:Z"N?^'O_(@^&?\ L&6W_HI:Z"@ HHHH _G-_;L\
M*/X-_;!^+6GR)Y9EUZ?4 O\ LW.+E3^4PKPFOOW_ (+,_#=_#/[2.B^+(X\6
MGB?1H]TGK<6S&)Q^$9M_SKX"H [CX$^(D\(_&[X>Z[*XCBTOQ%IUZS-T CN8
MW)_\=K^G"OY5\XY'!K^E/]EGXN0?'3]GSP+XTCG6>YU#3(A?;3G9=QCR[A3]
M)4?\,'O0!ZK117)?%SXB6/PC^%_BKQGJ146>AZ;/?LK''F%$)5![LV%'NPH
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M[MID:Y^64#Z0"9O^ U_/M0 5]F_\$C_"+^)/VS=$OUCWIH.E7^I.<<*&B^S
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:%X \.V6@>&](L]#T6R3R[>QL(5BBC'4X51U)R2>I))/-;-% !1110 4444
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M8AR>"VT$;OQ!\;>-]>^)'BK4O$OB?5;G6M=U*4SW5]=/N>1C^@ & %&
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /@;_@LY
MI-W=?LP:%J5FTBBQ\2P+<F-B!Y$EO<(=V.H+^6,'UK\4*_I!_;(^#\OQW_9G
M\>^#;1/,U.[L#<6"XY:Z@99X5'IN>,(3Z,:_F_92C%6!5@<$'J* /UW_ .")
M'Q(AOOAW\0O <LH%UIVIQ:S!&QY:.>(1/M]E:W3/O(/6OTPK^<']CO\ :%N/
MV9/C]X<\:!I6T=7^Q:Q;P\F:QE($H [LN%D4=VC6OZ*O"_BC2?&WAW3=>T+4
M(-5T;4H$N;2]MFW1S1L,JP/T_*@#4HHHH **** "O,/VH/#MEXL_9O\ B?I6
MH(CVL_AO4"2_1&6W=T?V*LJL#ZBO3Z^3/^"FG[0%C\$_V8?$.FK<JOB/Q?!)
MH>G6P;#E)%VW,OJ%2)FY_O.@[T ?@57VM_P2$EGC_;(L%B&8Y-%OUE]EVJ?_
M $(+7Q37Z2_\$3_AE/JGQ4\<^/9H&-EI&E+I4$K#Y3/<2*[;3W*I 0?02#U%
M '[!T444 ?@#_P %1_\ D^SXF_\ <,_]-=I7RK7U5_P5'_Y/L^)O_<,_]-=I
M7RK0!_2[^S+_ ,FV_"C_ +%+2?\ TCBKTNO-/V9?^3;?A1_V*6D_^D<5>ET
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M3*Q/_7=: /T@HHHH ***HZYK5CX;T6_U;4[F.STVPMY+JYN)3A8HD4L[D^@
M)_"@#\1/^"PGC1?$W[7DFE))N7P[H=GI[H#P'??<G\=MPGY"OB*.-YI%CC5G
M=B%55&22>@ KNOCQ\4+CXU?&;QEXXN0ZG7-3FNXHY#DQ0EL11_\  8PB_P#
M:] _81^$LWQF_:L^'^A_9_M&GVNH)JVH;A\@MK8B9PWLQ58_K(* /W^^#_@T
M?#OX3^"_"H4)_8FBV>G$#UB@1#^.5-==110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M9/=$PO'+,"17Z=44 0VEI!I]K#:VL,=M;0HL<4,*!4C0# 50.     *FHHH
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M9=T<\#AT<>H8<$?2OY7ZVO#GC;Q%X/E\W0=>U31),[M^FWDEN<\<Y1AZ#\J
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M^NR?^A"OZGJ_EATG_D*V7_79/_0A7]3U !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M /T#_8@_X*C>)/A/J6E^#/BI?3^(_ C%;>'5YLRWVE+T4EOO30CNIRZC[I(
M0_LUI6JV6NZ7::EIUW#?Z?>1+/;W5O('CFC8!E=6'!4@@@CKFOY8J_5O_@CG
M^U3<WPO?@?X@N#*MO%+J7AV:1N50'=<6ON/F,J^G[WMM% 'ZFT444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_-9^UC_ ,G3?&3_
M +'/6?\ TNFKRJOI_P#::_9E^,.O?M)?%?4],^$_CC4=-O?%NK7-K>6GAR\E
MAGB>\E9)$=8R&5E((8'!!!%>5:M^S+\8=!TJ\U/4_A/XXT[3;*%[FZO+OPY>
M10P1(I9Y'=HP%55!)8G  )- &)\-%_XFUTWI!C_QX5Z-7GWPR7_3;UO2-1^M
M>@U^@9.O]DC\_P SEJ?$=A\)X]_C2V.,[8Y#_P".D?UK]IOV2P1^SWX1R,?N
M[C_TIEK\8/A N[Q=G^[;N?U _K7[3?LKJ5^ '@_(P?L\AY_Z[25Y^>?!'U_S
M/L;6X>AYU7_Z2>K4445\>?,!1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%9OB/Q+I/@_1;K5]<U*UTC2[5=\UY>S+%%&/
M=F.*:3;L@-*BOA;XM?\ !5;P=X;N[FP\"^'KKQ;-&2@U*[D^QVA/]Y%*F1Q]
M0G]:\*O?^"L'Q7FG5K;P[X0MX58'8UI=.6XY!/V@<9YX / YKUJ>4XNHK\MO
M4SYXGZO45^9W@?\ X*W:]#>(OC'P+IUY:, &ET.XDMY$]2$E,@;Z;E^M?:WP
M-_:F^'?[0EF#X6UI5U54WS:+?@0WL0[GR\D.!Q\R%E&1S6%? 8C#+FJ1T[[E
M*2>QZW1117GE!1110 4444 %%%% !1110 4444 %%%% !1110 G7@\BOE7XZ
M?\$S_@=\<;FZU)] D\'Z_<$L^I^&G%MO<_Q/ 08F)/)(0,<GYN]?5=% 'Y"^
M/O\ @B+XPL6DD\%_$?1=93JL.N6DMBP'INC\X$^^!^%>*>(O^"3?[2&BR[+/
MPKIFOKG'F:=K=J@[\_OWC../3N/?'[RT4 ?@#_PZX_:=_P"B9_\ E?TO_P"2
M:Z7PG_P2-_:)\1.JZAHVA^%P3@MJVLQ.!SC/^C>=]:_=FB@#\O?A/_P1)TJS
MFM[OXD?$&XU)5P9-+\.6H@0D=OM$NXD'IQ&I]QV^_/@O^SO\._V>]#;2O /A
M:RT"*0#S[B,&2YN".\LSDN_L"<#/ %>C44 %%%% !1110!^>'[5W_!*O5?VD
M?C[XI^(UM\1;/0H=:^R[=/ETIYFB\FUA@.7$JYR8MW08SBO)/^''.N?]%;T_
M_P $<G_Q^OUJHH Y?X6^#7^'?PQ\(^%)+I;Z30M'L]+:Z5-@F,$*1%PN3@';
MG&3C-=1110 4444 %%%% !1110 4444 %%%% !1110 5^8?Q>_X(YZQ\3OBQ
MXU\8Q?%"QT^+Q#K=[JZVCZ,\A@$\[RA"WG#<5WXS@9QTK]/** /R;L_^"(.M
MVMW!,?BUI["-U?;_ &&_.#G_ )[U^LE%% !1110 4444 %%%% !1110 4444
M ? /[87_  3!U3]J+XX:CX^M?B!:>'H;NUM[86,VEM.R^5&$SO$JYSC/2O$_
M^''.N?\ 16]/_P#!')_\?K]:J* (;.#[+:00D[C&BIN]<#%3444 %%%% 'YJ
M?'S_ ()%ZW\:_C-XP\=+\3K'3$U[49+U+-]'>5H58_*A;SAG  &<"N _X<<Z
MY_T5O3__  1R?_'Z_6JB@#\E?^''.N?]%;T__P $<G_Q^C_AQSKG_16]/_\
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MK!U#*0RD9!'0TM<-\"=6?7O@A\/-3D<RR7GAW3KEG;JQ>VC8D_G7<T %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 5Y%^T1^RK\.?VH?#\6F^.=%^T7%L#]CU:S80WUIGKY<N#P>Z
M,&4G!*Y KUVB@#\9?CA_P1I^)'A.\EN?AIK%CXZTILE+.]D2POT]%.\^4_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M9E![5_.7^TA\!==_9K^+^N>!=>4R26<GF6=Z%*I>VK$F*=?9@,$<[65EZJ:
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M,9<#N:]RK^5VRO;C3;R"[M)Y;6Z@=98IX7*/&ZG*LK#D$$9!%?K;_P $Z_\
M@I=>^/M8T[X7?%N_B?6IPL&B^)ICL:]DZ"WN3T\T]%DXWD;3EB"P!^FM%%%
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M)/- '],$,JSQ)(AW(ZAE..H/(I]5-)_Y!5E_UQ3_ -!%6Z "O@__ (*!?\%
MO&/[(OQ*\.>&_#?AS0]9M=3T@:A)+J@FWJ_G21[1L=1C" \CN:^\*_&O_@MI
M_P E]\"_]BR/_2J>@ _X?:?%/_H1?!__ 'S=?_'J_6'X+>-KKXF?!SP)XOOH
M(;6^\0:#8:M/!;Y\N.2>WCE94R2=H+D#))P*_F*K^E/]D[_DUGX-_P#8F:-_
MZ0PT >JT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/_!;S_DJGPT_[ MQ_P"CQ7YK4 ?TD?L=_P#)J'P>_P"Q2TO_ -)8Z]@KQ_\
M8[_Y-0^#W_8I:7_Z2QU[!0 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% 'X0_P#!6S_D]+Q!_P!@S3__ $0*^-:^RO\ @K9_
MR>EX@_[!FG_^B!7QK0!_4[I/_(*LO^N*?^@BK=5-)_Y!5E_UQ3_T$5;H *^6
M_P!K'_@G[X._:Z\9:/XD\2>(]<T:ZTS3_P"SXXM+,.QD\QY-QWHQSER.#V%?
M4E% 'YU?\.2_A9_T/7C#_OJU_P#C-?>7PW\$VOPS^'?A;PA8SS75CX?TJUTF
M">XQYDD<$*Q*SX &XA 3@ 9-='10 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110!^:'_!97]F[_ (2#P?HWQCT:UW7V
MB;=,UORUY>T=_P!Q*?\ <E8H3UQ,O9:_+'X5?$S7/@W\1- \:>&[G[+K6BW2
MW4#'.U\<-&P[HZEE8=U8BOZ6OB/X%TWXH> /$7A'6$\S3-<L)M/N.,E5D0KN
M'^T,Y![$ U_,SX_\$ZE\-_'&O^%-8B\G5-%OYM/N5QQYD3E"1Z@XR#W!!H _
MI1^"7Q:T?XZ_"GPSX[T)O^)=K5HMP(BP9H).5EA8C^)'5T/NIKN*_)+_ ((R
M_M'-I?B/7?@SJ]R?LNI!]7T/>?NW"*/M$(_WHU$@'0>5(>K5^MM !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %8WC/Q=I?@#PCK/B;7+D6>CZ19RWUW.>=D4:%V('<X!P.YXK9KXF_
MX*[_ !)N? O[)%QI-FVR;Q3J]MI$C*<,L(#W#D>Q\A4/LYH _(#]I3X^:[^T
MI\7]=\;:Y-+LNIF2PL7<LEC:*3Y4"#.!@<G'5BS=37E]%% !171>"?ASXK^)
M6I-I_A+PUJ_B>^4 M;Z/8RW3H#T+!%.![GCBO9-(_P"">_[16MP^9;_"G6XU
MP#B\,-LW.>TKJ>WX4 ?/-%?57_#KC]IW_HF?_E?TO_Y)H_X=<?M._P#1,_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ KP']NKXZ?\,^?LQ^,/$MM<?9];N8/[*T@
M@X;[7."BLONB[Y?^V1KWZOR1_P""VGQ8^W>+O /PWM9LQZ?:R:Y?1J<@R2L8
MH0?0JL<I^DHH _,7.>3R:_8K_@BO\)(]!^$?B[XAW,&+[Q!J(TZUD8<_9;=<
MDJ?1I9'!_P"N0]*_'6OZ3_V3_A@OP;_9O^'GA#R_*N+#2(6NU'_/S*/.G_\
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M 'Z/_P#!$?\ Y+1\0_\ L7X__2E*_8FOQV_X(C_\EH^(?_8OQ_\ I2E?L30
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M)Z,D*MY<?T8R9]NE?&7C;]LKXX_$2:1]<^*?B>5)"2UO9Z@]G <_],H-B?\
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M:Z7IM_H@O9XY]/@N"TOGRIG=(I(^5%X'I7Z15^-?_!;3_DOO@7_L61_Z53T
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M;G\'^-;FWB^)&CQ;_-4",:M;# \Y5' D4X#J..0P&"0H!]NT444 ?%/_  5
M_::^('[,O@/P3J?@#58-+O-4U*:VNGGLXK@.BQ!@ )%('/I7YV?\/8/VDO\
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M]H;X(SZ'XCOI+[QIX0>.TO+B=BTEW:N&-O.S'[S81T8\G,88\O7V=0 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M9S[MN_&ODOQ?X!\3_#_4#8>*/#NK>'+[D?9M6LI;63C_ &74&L&@#]@_A?\
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MR]0QLY0#^9%?S6U_2%^V?YG_  R7\7_*SN_X1;4,X_N^0^[],U_-[0!]^_\
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M%\CXPK^C_P#8W^#=O\"/V:_ OA2.()>QV"7FH-C!>[G'FS9]<,Y49_A11VH
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M9X- 'W'1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MO=Q*!ZY<"OZ(:_GL^'EN;KQ_X9@4 M)J=J@!Z<RJ*_H3KYS/OBIKU_0Z:?\
M#3\W^@4445\H4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7Q[_ .?/P?\ ^"N7_P"/UY5_P[=_:2_Z);J'_@;:?_'J/^';O[27_1+=0_\
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M ./4 >J_\/DOCW_SY^#_ /P5R_\ Q^C_ (?)?'O_ )\_!_\ X*Y?_C]>5?\
M#MW]I+_HENH?^!MI_P#'J/\ AV[^TE_T2W4/_ VT_P#CU 'JO_#Y+X]_\^?@
M_P#\%<O_ ,?H_P"'R7Q[_P"?/P?_ ."N7_X_7E7_  [=_:2_Z);J'_@;:?\
MQZC_ (=N_M)?]$MU#_P-M/\ X]0!RG[37[6?C7]K#6-#U/QK;:1#=Z/!);6[
M:3;/#N1V#$/N=LX(XQCJ:\6KZ4_X=N_M)?\ 1+=0_P# VT_^/4?\.W?VDO\
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MV!0 4444 %?S&?&[_DM'C[_L8-0_]*9*_ISK^8SXW?\ ):/'W_8P:A_Z4R4
M>J_\$\?^3TOA5_V$V_\ 1$M?T/5_/#_P3Q_Y/2^%7_83;_T1+7]#U !1110
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MA_Q2]E[[_P#T-JWJ_3\'_NU/_"OR..6[.P^#<)N?B[X(B&,OK=D.>G^O2OZ
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M?S8_M:^.$^)'[37Q.\0Q2>;;7>OW:V\F<[H8Y#'$?^^$6OWD_;'^.EM^SO\
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MRL#Z$$4 :5%%% !1165XJ\4:7X)\,ZKX@UN[CT_1]+M9+V\NI/NQ11J6=C]
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M_P#T0*^-:^T/^"ND(A_;-UA@<^;I%@Y]OW6W^E?%] ']3ND_\@JR_P"N*?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^)-.1I;"<'[N7Q^[8_W'P<@XR.2 >[_LK_\ !6#Q_P#!.QL_#GCFU?XA^%8
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M5 ]  * -.BBB@#\GO^"XVD-'K/PAU0(=DMOJ=LS=@5:V8#_Q\_E7Y<5^\O\
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MA/C&]L?=4<A4'"CU)9B >JZ/I-GH&DV6EZ=;QV>GV4"6UM;Q#"11(H5$ ]
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MXR^-/@?XJ@\1>"/$-[X?U.-E+-:R$1SJ#G9+&?ED3_98$4 ?TZ45\@_L/_\
M!0SPS^U79P^'=8CA\-?$J"$O-I88_9[]5'S2VK'GW,9.Y1D@L 6KZ^H ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _FL_:Q_Y
M.F^,G_8YZS_Z735Y57Z7?%_]D:;5/C!\0-1U3X=ZA?76H>)=4OUNH8)Y4FBF
MO)987#1DKS&Z''49P0""*XO4/V2M)TC3[F^OOAU?V5C:Q-//<W%M<QQQ1J"S
M.[$X50 22> !7J1P$Y14N9:GV5'ABO7I1JJM!*23U;OK\CY?\%?\BQ8_1O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MVEOA/J?@'7=0OM+TV_E@E>YT_9YRF*59% WJPY*@'BOCC_AR7\+/^AZ\8?\
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M?/'[17[!GP@_::NFU+Q-H<FF>(BNPZ]H<@MKMQV\SY624CL9%8@< @5]#T4
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M?5?P#_X)%_";X4W]MJWBZZNOB5K$!#I'J42P:<K#O]F4MO\ I([K_LU]T44
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MWP7FM[^XT2;QQKD+"1+_ ,2N)T1AS\ENH6+K@C<K$8ZU];T4 (JA%"J J@8
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ML4W'^]TKXZ\9?\$/]6COI7\*?%&RN+-@3'#K.F/%(GHI>-V#?[VT?2OUEHH
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M^\OAOX)M?AG\._"WA"QGFNK'P_I5KI,$]QCS)(X(5B5GP -Q" G  R:Z.B@
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M/\=)O@O^U1X>M)YQ'H7BQAH-^CG"[I6'V=_0%9@@SV5W]: /WVHHHH ****
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MEAY2JN2E!-+^779:_P"04445\<>6%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MV    ]JM444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %175K#?6TMO<0QW%O,ACDAE4,CJ1@J0>"".,&I:*
M/S+^(/\ P1+T/Q)XVUG5/#7Q.D\+Z%>7+3VNC2:!]K^QJW/E"7[4FY0<[<J"
M!@')&3]??L=_LX:Y^RS\+Y/ VI>._P#A.=+@NGN--=M*-D]DC_-)#_KY=R%\
MN.F"[=<C'NU% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MK]B:_(+_ ()GQEOVBM-< D*)?_22Y_\ K5^OM?&9U_O7R1[F(5L/AO\  _\
MTY,****\ \\**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MUL9EV'QM!W<:<4X^25[K[]C[EHHHKY8_.@HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1/(OXUYC10!_5117(?!_7)/$_P )/!&L32&674-#L;MY&.2S26Z.3^)-=?0
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MDHTX+9W,Z?4_"*-=L:CT&*=5?3YFN-/MI7.7>)68^Y )JQ7U,6G%-&)^@G[
MOPUT;XM?#WQEX2UVW6;3]3T7R68J"T3&=BDJ9Z,C!6!]5%?!_BKP[=^#_$^L
M:#?KLO\ 2[R:QN%':2)RC#\U-?I#_P $LA_Q+]=./^7&'_T=)7PI^TMJEKK7
M[0WQ)OK)E>TF\0WS1R(<JX\]QN'L<9_&O&PM27URM#IHSZ#.OXU/_KW3_P#2
M(GW1_P $D?'4][X3\>>$)F)AT^[M]3M\G./.5HY!] 8$/U8U^@-?F3_P2-LY
MI/''Q#NU9OL\6G6L3KV+-*Y4_DC?F:_3:OELVBHXR=O+\CR8?"%%%%>06%%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M &U'PK(LT3GU,$SJR#Z2.?:OI/PK_P %1OV;_$]N'D\=R:)/WMM5TNZC8?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQ5K/AO6[7[%K6CWLVGWUMYGB63R9XI&CD3<A*MAE(RI(.."17G_Q8_X=V?\
M"J_&7_"$_P#(Y_V->?V'_P C%_Q_^0_V?_6_N_\ 6[/O_+_>XS7Q7^UC_P G
M3?&3_L<]9_\ 2Z:O*J /<XQMC0#I@4ZFQ_ZM?I3J_6EL<1^Q?_!-M0O[-\)
MP6U!B?\ P&MQ_2OJBOE__@G-&L?[->GX'WKMB?KY$-?4%?F6-_WF?J>]F'^\
MS^7Y(****XCS@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH _GK_X*0_\ )[7Q2_Z_;?\ ])(*^:Z^E/\ @I#_
M ,GM?%+_ *_;?_TD@KYKH ]*_9E_Y.2^%'_8VZ3_ .ED5?TO5_-#^S+_ ,G)
M?"C_ +&W2?\ TLBK^EZ@ HHHH *_F:_:)\#M\-?CU\0O"_EF./2M>O;:$$8S
M")F\MOH4VG\:_IEK\/O^"P/PIE\#_M2+XJB@V:=XPTV&[611A3<0*()5^H5(
M6/\ UTH ^&*]Q_8=\:1> ?VN/A7K$\@A@&MPV<DC' 1+C-NQ/L!*2:\.I]O<
M2VL\<\,C131L'21#AE8'((/8@T ?U2T5X[^R5\?+#]I+X#>&/&EM-&^HS6ZV
MVK6Z$9M[Z,!9D([ M\Z^JNI[U[%0!S7Q,\81?#WX<>*O%,YQ!HFE76I/GTAA
M:0_^@U_+Z[M(S,S%F8Y+,<DGUK]P/^"MW[05E\,_V=YO EI=K_PDWC1UMA C
M?O(K%&#3RD>C%5BYZ^8V/NFOP^H *^XO^"/?@4^*/VN%UIHR8O#>B7E\),<"
M20+;*/J5GD_[Y-?#M?L;_P $6?A%+X;^$'BWX@WEOY<OB;4$LK)W'+6UJ&#.
MI]#+)(I]X?84 ?HW1110 4444 ?S[?M-?LR_&'7OVDOBOJ>F?"?QQJ.FWOBW
M5KFUO+3PY>2PSQ/>2LDB.L9#*RD$,#@@@BO*M6_9E^,.@Z5>:GJ?PG\<:=IM
ME"]S=7EWX<O(H8(D4L\CNT8"JJ@DL3@ $FO<_P!H/XT:KHWQ[^)6G_\ "8:K
M:_9?$VI0>0E[.%CVW4B[0 < #&./2O.[OXX7VH6LUK=>,=4N;:9&CEAFO)V2
M1",%6!."""00:]^.64I)/V\?P_S,N=]B)1M4#TI:**^[.<_9O_@G@ /V9]&P
M,9G;/_?N.OIBOQ"^&_P"^/GC+PI;:IX,TK7KC0921#)9ZHD,9(QG"F5<=NU?
M1O['OP#^/O@G]HSPCK7C72]>MO#-M]K^URWNJ)-$-UG,B;D$K9^=DQP><&OB
M<9@*?-4J^V5]7;KZ;GIXFM*K7E*46K]#],****^;,0HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MSV\=_O-3U84445R'"%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% 'Q/\=O^"5?P^^/GQ8\0^/M8\6^)=.U+6I4
MEFMK$V_DH5B2,!=T1/1 >3WK@O\ AR7\+/\ H>O&'_?5K_\ &:_16B@#X)\
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M4445S'&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MSA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %>5?M8_\FL_&3_L3-9_](9J]5KRK]K'_ )-9^,G_ &)FL_\ I#-0!^$-
M%%%?K9Q'[\_ >,0_ _X>J!C_ (I[3_S^S1YKNJXSX*J%^#?@, 8 T"P '_;O
M'79U^45/CEZGJ5_XL_5_F%%%%9F 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% '\UG[6/_)TWQD_['/6?_2Z:O*J]5_:
MQ_Y.F^,G_8YZS_Z735Y50![K1117ZV<1_0-\(4\OX3^"DQC;HED,>G[A*ZVN
M;^&O'PY\*CI_Q*K7_P!$I725^3S^)GIUOXDO5A1114&(4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 ?SX?$JW:T^(WBF!BQ:/5;I"6Z\3,.?>N;KV+
M]JCP+/X/^,/B@FW>&W;5+F/#(5VLLC 'IT90&![YR.*\=K]5HR4Z<9+L&,PT
ML)7E2ETV\T]4_F@HHHK8X@KW;]AN W'[5WP[4,RXOG<E?]F&0X_2O":^MO\
M@G+X!N-6^/6A:R\#-#;^=(K8X55C8ES[;MJCW)KBQDE'#S;[/\CNP>&EBJC2
MVBG)^B5_^!ZL_7VBBBOS$04444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% 'Q!^WM\!_P"T9V\:6UDUSIMY&MOJP4$^5(N%
MCE]@1M7., J.[5^;?BSX:ZCX?EDEMXVO;#.1)&,LH_VA_7I_*OW\OK&VU2SG
ML[R".ZM9T,<L,R!DD4C!5@>"".U?#W[2/[(D7@+0_$'C;PQ>1IX<TNTFU*^T
MZY8^9:P1(9)&C8YWJJJQVGYL# W&OILNS)4XJE49]GA*V S7#PP>8RY)PTC/
MR[/T\_O77\M.G7BE1&D8*JEF/ "C)KU'X@>(O#/B/PPUSI5]IM]=LZ-N@=&E
MVYYSCYAU[U2^'GC+PYX/\/7EQK.HV=A.9SM$A!F9-J_=4?,1G/05]3]9A[+V
MO3U/.ED-.&8K!2Q"Y7'FY^EM?/\ 4A\'?"N\U*:.YU:-K2R'/DMQ))[8_A'U
MY_G7ZJ_L1?!%_ 7A>;Q5J-I]EO\ 58%ALH""##9\,#CMO(4_15/>L[X%_L4P
M>'KNVUOQX]OJ-W'B2+1XOGAC;J#*W1R/[H^7CJPXKZPKY',LP]NO9P>AV8_$
MX' X=Y?EGO<WQS[VZ+R_#UU"BBBOGCY$**** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ KRK]K'_DUGXR?]B9K/_I#-7JM
M>5?M8_\ )K/QD_[$S6?_ $AFH _G0^'W_(Q)_P!<V_E5KXE?\AFV_P"O<?\
MH355^'W_ ",2?]<V_E5KXE?\AFV_Z]Q_Z$U?01_Y%4O\7^1E]L_IZHHHKY\U
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "O*OVL?^36?C)_V)FL_^D,U?B7^TU^TW\8=!_:2^*^F:9\5_'&G:
M;9>+=6MK6SM/$=Y%#!$EY*J1HBR *JJ  H&   *\JU;]IOXPZ]I5YIFI_%?Q
MQJ.FWL+VUU9W?B.\EAGB=2KQNC2$,K*2"I&""0: .9^'W_(Q)_US;^56OB5_
MR&;;_KW'_H355^'W_(Q)_P!<V_E5KXE?\AFV_P"O<?\ H35]!'_D52_Q?Y&7
MVS^GJBBBOGS4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "O*OVL?^36?C)_V)FL_^D,U>JUY5^UC_P FL_&3_L3-9_\
M2&:@#^=#X??\C$G_ %S;^56OB5_R&;;_ *]Q_P"A-57X??\ (Q)_US;^56OB
M5_R&;;_KW'_H35]!'_D52_Q?Y&7VS^GJBBBOGS4**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5_R&;;_KW'_H35]!'_D52_Q?Y&7VS^GJBBBOGS4**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ KRK]K'_DUGXR?]B9K/_I#-7JM>5?M8_\ )K/QD_[$S6?_ $AF
MH _G0^'W_(Q)_P!<V_E5KXE?\AFV_P"O<?\ H355^'W_ ",2?]<V_E5KXE?\
MAFV_Z]Q_Z$U?01_Y%4O\7^1E]L_IZHHHKY\U"BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O*OVL?^36?C)_V)
MFL_^D,U>JUY5^UC_ ,FL_&3_ +$S6?\ TAFH _G0^'W_ ",2?]<V_E5KXE?\
MAFV_Z]Q_Z$U5?A]_R,2?]<V_E5KXE?\ (9MO^O<?^A-7T$?^15+_ !?Y&7VS
M^GJBBBOGS4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH *\J_:Q_P"36?C)_P!B9K/_ *0S5ZK7E7[6/_)K/QD_
M[$S6?_2&:@#^=#X??\C$G_7-OY5:^)7_ "&;;_KW'_H355^'W_(Q)_US;^56
MOB5_R&;;_KW'_H35]!'_ )%4O\7^1E]L_IZHHHKY\U"BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^"O_  4X
M_:?MOVBOC\UCH-W]J\'^$8Y-,T^5&S'<SELW-POLS*B C@K"K=Z^K_\ @I1_
MP49M-'TW5/A-\*]6%QJ\VZUU[Q!9/\EHG1[6!QUD/(=QP@RH.XG9^25 !7U5
M_P $N/\ D^SX9?\ <3_]-=W7RK7U5_P2X_Y/L^&7_<3_ /37=T ?O]1110 4
M444 %%%% 'S1\4O^"??PP^+WC[5_%^NW&OIJVJ2+).MI>QI$"J*@VJ8R1PH[
MUX[\=/\ @G+\*?AS\$?B%XLTJX\1-JF@^'M0U2T6XOHVC,T%M)*F\"($KN09
M&1QWK[YKRK]K'_DUGXR?]B9K/_I#-7=''8F*48U'9$\J['\ZG_"QM5_NV_\
MWP?\:/\ A8VJ_P!VW_[X/^-<O15?VABO^?C#ECV/WF_X=9_!K_GZ\4?^#&+_
M .,UN>!_^"</PH^'_C+0_$VF7'B)M1T>]AO[87%]&T9DC<.NX"(9&0,C(KZF
MHJ7CL5)6=1ARKL%%%%<)04444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%?)O_!2;]ICQ
MC^R[\#])U[P0;"+6-5UE-*-S?6_G_9XV@FD+QJ2%WYB4?,&&">/0 ^B/B5\4
MO"7P>\*W/B/QGK]EX=T:W'S7-[)MW-C(1%^\[GLJ@L>PK\BOVT?^"K&O?%R"
M]\'_  H^V>%/",@:&ZUB0^7J&H+T*K@_N(CZ [V'4J"5KXG^*7QB\:_&SQ(V
MO>.?$NH>)=4(*K+>RY6)2<[8XQA(USSM0 >U<=0 45/8V-SJE];V=E;RW=Y<
M2+%#;P(7DD=CA551R220 !US2ZEIUUH^HW5A>P26M[:RM!/!*,/'(I*LI'8@
M@C\* *]?57_!+C_D^SX9?]Q/_P!-=W7RK7U5_P $N/\ D^SX9?\ <3_]-=W0
M!^_U%%% !1110 4444 %>5?M8_\ )K/QD_[$S6?_ $AFKU6O*OVL?^36?C)_
MV)FL_P#I#-0!_-91110!_511110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\
MY,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?
M5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H
M5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X
M+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^
M3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^
MBO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A
M]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^
MA6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_
M (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\
MY,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?
M5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H
M5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X
M+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^
M3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^
MBO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A
M]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^
MA6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_
M (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\
MY,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?
M5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H
M5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X
M+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^
M3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^
MBO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A
M]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^
MA6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_
M (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\
MY,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?
M5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H
M5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X
M+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^
M3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^
MBO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A
M]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^
MA6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_
M (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\
MY,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?
M5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H
M5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X
M+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^
M3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^
MBO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A
M]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^
MA6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_
M (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\
MY,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?
M5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H
M5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X
M+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^
M3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^
MBO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A
M]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^
MA6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_
M (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\
MY,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?
M5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H
M5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X
M+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^
M3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^
MBO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A
M]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^
MA6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_
M (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\
MY,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?
M5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H
M5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X
M+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^
M3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^
MBO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A
M]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^
MA6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_
M (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\
MY,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?
M5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H
M5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X
M+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^
M3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^
MBO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A
M]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^
MA6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_
M (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\
MY,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?
M5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H
M5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X
M+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^
M3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^
MBO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A
M]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^
MA6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_
M (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\
MY,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?
M5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H
M5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X
M+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^
M3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^
MBO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A
M]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^
MA6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_
M (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\
MY,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?
M5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H
M5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X
M+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^
M3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^
MBO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A
M]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^
MA6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_
M (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\
MY,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?
M5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H
M5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X
M+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^
M3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^
MBO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A
M]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^
MA6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_
M (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\
MY,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?
M5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H
M5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X
M+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^
M3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^
MBO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A
M]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^
MA6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_
M (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\
MY,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?
M5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H
M5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X
M+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^
M3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^
MBO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A
M]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^
MA6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_
M (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\
MY,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?
M5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H
M5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X
M+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^
M3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^
MBO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A
M]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^
MA6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_
M (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\
MY,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?
M5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H
M5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X
M+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^
M3* /O^BO@#_A]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^
MBO@#_A]7\$/^A6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A
M]7\$/^A6^('_ (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^
MA6^('_@NL?\ Y,H_X?5_!#_H5OB!_P""ZQ_^3* /O^BO@#_A]7\$/^A6^('_
M (+K'_Y,H_X?5_!#_H5OB!_X+K'_ .3* /O^BO@#_A]7\$/^A6^('_@NL?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_F,^-W_ "6CQ]_V,&H?
M^E,E?TYU_,9\;O\ DM'C[_L8-0_]*9* .*KZJ_X)<?\ )]GPR_[B?_IKNZ^5
M:^JO^"7'_)]GPR_[B?\ Z:[N@#]_J*** "BBB@#\5O\ @M7_ ,G3>%O^Q,M?
M_2Z^KX K]:?^"H'[&?QB_:)^/N@>)/A[X/\ ^$@T6U\,V^GS7/\ :=G;;9UN
MKN1DVS3(QPLL9R!CYNN0<?('_#KC]IW_ *)G_P"5_2__ ))H ^5:*^JO^'7'
M[3O_ $3/_P K^E__ "363XL_X)P_M$^!_"NL^)-;^'GV+1='LIM0OKG^V].D
M\F"*-I)'VI<%FPJDX4$G' )H ^:Z*** "BOJK_AUQ^T[_P!$S_\ *_I?_P D
MT?\ #KC]IW_HF?\ Y7]+_P#DF@#Y5HKZJ_X=<?M._P#1,_\ ROZ7_P#)-'_#
MKC]IW_HF?_E?TO\ ^2: /E6BOJK_ (=<?M._]$S_ /*_I?\ \DT?\.N/VG?^
MB9_^5_2__DF@#Y5HKZJ_X=<?M._]$S_\K^E__)-'_#KC]IW_ *)G_P"5_2__
M ))H ^5:*^JO^'7'[3O_ $3/_P K^E__ "31_P .N/VG?^B9_P#E?TO_ .2:
M /E6BO:OC5^QG\8OV=O"MKXD^(7@_P#X1_1;J]33X;G^T[.YW3M')(J;89G8
M96*0Y(Q\O7)&?%: "BNJ^%OPM\3_ !I\=Z9X-\&Z9_;'B34O-^R67VB*#S/+
MB>5_GE94&$C<\L,XP.2!7T!_PZX_:=_Z)G_Y7]+_ /DF@#Y5HKZJ_P"'7'[3
MO_1,_P#ROZ7_ /)-'_#KC]IW_HF?_E?TO_Y)H ^5:*^JO^'7'[3O_1,__*_I
M?_R31_PZX_:=_P"B9_\ E?TO_P"2: /E6BOJK_AUQ^T[_P!$S_\ *_I?_P D
MT?\ #KC]IW_HF?\ Y7]+_P#DF@#Y5HKZJ_X=<?M._P#1,_\ ROZ7_P#)-'_#
MKC]IW_HF?_E?TO\ ^2: /E6BOJK_ (=<?M._]$S_ /*_I?\ \DUXI\:O@+X[
M_9V\56OAOXA:%_PC^M75DFH0VWVN"YW0-))&K[H9'49:*08)S\O3!&0#@***
M]5^!?[+?Q/\ VE/[;_X5QX9_X2/^Q?(^W_Z?:VOD^=YGE?Z^5-V?*D^[G&WG
M&1D \JHKZJ_X=<?M._\ 1,__ "OZ7_\ )-'_  ZX_:=_Z)G_ .5_2_\ Y)H
M^5:*^JO^'7'[3O\ T3/_ ,K^E_\ R31_PZX_:=_Z)G_Y7]+_ /DF@#Y5HKZJ
M_P"'7'[3O_1,_P#ROZ7_ /)-'_#KC]IW_HF?_E?TO_Y)H ^5:*^JO^'7'[3O
M_1,__*_I?_R31_PZX_:=_P"B9_\ E?TO_P"2: /E6BOJK_AUQ^T[_P!$S_\
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M8X66,Y Q\W7(. #Q6BOJK_AUQ^T[_P!$S_\ *_I?_P DT?\ #KC]IW_HF?\
MY7]+_P#DF@#Y5HKZJ_X=<?M._P#1,_\ ROZ7_P#)-'_#KC]IW_HF?_E?TO\
M^2: /E6BOJK_ (=<?M._]$S_ /*_I?\ \DT?\.N/VG?^B9_^5_2__DF@#Y5H
MKZJ_X=<?M._]$S_\K^E__)-'_#KC]IW_ *)G_P"5_2__ ))H ^5:*^JO^'7'
M[3O_ $3/_P K^E__ "31_P .N/VG?^B9_P#E?TO_ .2: /E6BBB@ HKZ4\)_
M\$X?VB?''A71O$FB?#S[;HNL64.H6-S_ &WIT?G02QK)&^U[@,N58'# $9Y
M-:W_  ZX_:=_Z)G_ .5_2_\ Y)H ^5:*^JO^'7'[3O\ T3/_ ,K^E_\ R31_
MPZX_:=_Z)G_Y7]+_ /DF@#Y5HKZJ_P"'7'[3O_1,_P#ROZ7_ /)-'_#KC]IW
M_HF?_E?TO_Y)H ^5:*^JO^'7'[3O_1,__*_I?_R31_PZX_:=_P"B9_\ E?TO
M_P"2: /E6BOJK_AUQ^T[_P!$S_\ *_I?_P DT?\ #KC]IW_HF?\ Y7]+_P#D
MF@#Y5HKW_P"*7[!7QV^"W@34_&7C+P-_8_AO3?*^UWO]KV$_E^9*D2?)%.SG
M+R(.%.,Y/ )KP"@ HK5\)^%M4\<>*M&\-Z):_;=:UB]AT^QMO,6/SIY9%CC3
M<Y"KEF RQ &>2!7TK_PZX_:=_P"B9_\ E?TO_P"2: /E6BOJK_AUQ^T[_P!$
MS_\ *_I?_P DT?\ #KC]IW_HF?\ Y7]+_P#DF@#Y5HKZJ_X=<?M._P#1,_\
MROZ7_P#)-'_#KC]IW_HF?_E?TO\ ^2: /E6BOJK_ (=<?M._]$S_ /*_I?\
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M9_\ E?TO_P"2: /E6BOJK_AUQ^T[_P!$S_\ *_I?_P DT?\ #KC]IW_HF?\
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MUQ^T[_T3/_ROZ7_\DT?\.N/VG?\ HF?_ )7]+_\ DF@#Y5HKZJ_X=<?M._\
M1,__ "OZ7_\ )-'_  ZX_:=_Z)G_ .5_2_\ Y)H ^5:*^JO^'7'[3O\ T3/_
M ,K^E_\ R31_PZX_:=_Z)G_Y7]+_ /DF@#Y5HKZJ_P"'7'[3O_1,_P#ROZ7_
M /)-'_#KC]IW_HF?_E?TO_Y)H ^5:*]_^*7[!7QV^"W@34_&7C+P-_8_AO3?
M*^UWO]KV$_E^9*D2?)%.SG+R(.%.,Y/ )KP"@ HK5\)^%M4\<>*M&\-Z):_;
M=:UB]AT^QMO,6/SIY9%CC3<Y"KEF RQ &>2!7TK_ ,.N/VG?^B9_^5_2_P#Y
M)H ^5:*^JO\ AUQ^T[_T3/\ \K^E_P#R31_PZX_:=_Z)G_Y7]+_^2: /E6BO
MJK_AUQ^T[_T3/_ROZ7_\DT?\.N/VG?\ HF?_ )7]+_\ DF@#Y5HKZJ_X=<?M
M._\ 1,__ "OZ7_\ )-'_  ZX_:=_Z)G_ .5_2_\ Y)H ^5:*^JO^'7'[3O\
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M^B9_^5_2_P#Y)H ^5:*^JO\ AUQ^T[_T3/\ \K^E_P#R37RK0 445]*>$_\
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MC]IW_HF?_E?TO_Y)H ^5:*^JO^'7'[3O_1,__*_I?_R31_PZX_:=_P"B9_\
ME?TO_P"2: /E6BOJK_AUQ^T[_P!$S_\ *_I?_P DT?\ #KC]IW_HF?\ Y7]+
M_P#DF@#Y5HKZJ_X=<?M._P#1,_\ ROZ7_P#)-'_#KC]IW_HF?_E?TO\ ^2:
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M'']M_P#".?VU]E_XF?V3[5Y/DW44_P#JMZ;L^5M^\,;L\XP0#^:RO5?V3O\
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M]VT ??\ ^R=_R:S\&_\ L3-&_P#2&&O5:Y3X3^!?^%7_  K\&^#?MO\ :?\
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M27[#_P PG[#]F^S_ &C_ *;R[]WVCVQM[YX /JJBBB@ HHHH **** "BBB@
MHHHH _FL_:Q_Y.F^,G_8YZS_ .ETU>55^OWQ8_X(U_\ "T/BIXR\9?\ "W_[
M,_X2+6KS5_L7_",^;]G^T3O+Y>_[8N[;OQNVC.,X'2N5_P"'&/\ U6S_ ,M3
M_P"[: /JK_@EQ_R8G\,O^XG_ .G2[KZJKRK]EOX%_P##-?P)\,_#C^V_^$C_
M +%^U?\ $S^R?9?.\ZZEG_U6]]N/-V_>.=N>,X'JM !1110 4444 %%%% !1
M110 5_*O7]5%?E7_ ,.,?^JV?^6I_P#=M 'Y5U_517Y5_P##C'_JMG_EJ?\
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MOX%_\,U_ GPS\./[;_X2/^Q?M7_$S^R?9?.\ZZEG_P!5O?;CS=OWCG;GC.
M>JT444 %%%% !1110 4444 %%%% '\J]%%% ']*?[)W_ ":S\&_^Q,T;_P!(
M8:]5KRK]D[_DUGX-_P#8F:-_Z0PUZK0 4444 %%%% !1110 4444 ?*O_!4?
M_DQ/XF_]PS_TZ6E?@#7]*?[4GP+_ .&E/@3XF^'']M_\(Y_;7V7_ (F?V3[5
MY/DW44_^JWINSY6W[PQNSSC!^ /^'&/_ %6S_P M3_[MH ^ /V3O^3IO@W_V
M.>C?^ET-?TIU^:OPG_X(U_\ "K_BIX-\9?\ "W_[3_X1W6K/5_L7_",^5]H^
MSSI+Y>_[8VW=LQNVG&<X/2OTJH **** "BBB@ HHHH **** "ORK_P""YW_-
M$_\ N-_^V%?JI7RK^W/^PQ_PVE_PA/\ Q6W_  AW_"-?;O\ F$_;OM/VC[/_
M --XMFW[/[YW=L<@'X U]_\ _!%3_DZ;Q3_V)EU_Z76->J_\.,?^JV?^6I_]
MVU[_ /L4_P#!-[_ACWXJ:KXR_P"%B?\ "6_;M&ETC[%_8GV+9OG@E\S?]HDS
MCR,;=H^]G/&" ?:M%%% !1110 4444 %%%% !1110!^*W_!:O_DZ;PM_V)EK
M_P"EU]7P!7[I_MK?\$WO^&POBII7C+_A8G_")?8=&BTC[%_8GVW?LGGE\S?]
MHCQGS\;=I^[G/.!X!_PXQ_ZK9_Y:G_W;0!ZK_P $5/\ DUGQ3_V.=U_Z0V-?
M?]?/_P"Q3^RE_P ,>_"O5?!O_"4_\);]NUJ75_MO]G_8MF^""+R]GFR9QY&=
MVX?>QCC)^@* "BBB@ HHHH **** "BBB@ K^5>OZJ*_*O_AQC_U6S_RU/_NV
M@#\JZ_I3_9._Y-9^#?\ V)FC?^D,-? '_#C'_JMG_EJ?_=M?I3\)_ O_  J_
MX5^#?!OVW^T_^$=T:STC[;Y7E?:/L\"1>9LW-MW;,[=QQG&3UH ZNBBB@ HH
MHH **** "BBB@ KRK]K'_DUGXR?]B9K/_I#-7JM<I\6/ O\ PM#X5^,O!OVW
M^S/^$BT:\TC[;Y7F_9_M$#Q>9LW+NV[\[=PSC&1UH _F"HK]5/\ AQC_ -5L
M_P#+4_\ NVC_ (<8_P#5;/\ RU/_ +MH _52BBB@ HHHH **** "BBB@ HHH
MH _*O_@N=_S1/_N-_P#MA7Y5U^_W[<_[#'_#:7_"$_\ %;?\(=_PC7V[_F$_
M;OM/VC[/_P!-XMFW[/[YW=L<_*O_  XQ_P"JV?\ EJ?_ ';0!Y5_P14_Y.F\
M4_\ 8F77_I=8U^U-?%7[%/\ P3>_X8]^*FJ^,O\ A8G_  EOV[1I=(^Q?V)]
MBV;YX)?,W_:),X\C&W:/O9SQ@_:M !1110 4444 %%%% !1110 5^*W_  6K
M_P"3IO"W_8F6O_I=?5^U-?BM_P %J_\ DZ;PM_V)EK_Z77U 'P!7ZJ?\$,?^
M:V?]P3_V_K\JZ_53_@AC_P UL_[@G_M_0!^JE%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !7X _P#!4?\ Y/L^)O\
MW#/_ $UVE?O]7S_\4OV"O@3\:?'>I^,O&7@;^V/$FI>5]KO?[7OX/,\N)(D^
M2*=4&$C0<*,XR>230!_.O7[4_P#!%3_DUGQ3_P!CG=?^D-C7JO\ PZX_9B_Z
M)G_Y7]4_^2:]J^"OP%\"?L[>%;KPW\/="_X1_1;J]?4)K;[7/<[IVCCC9]TT
MCL,K%&, X^7IDG(!Z!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M)]W&=W.<# !ZK1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !7\QGQN_Y+1X^_[&#4/_ $IDK^G.OYQOC)\!?B;??%[QQ<VWPZ\67%O-
MKM])%-%H=TR.IN'(92(\$$'((H \0KZJ_P""7'_)]GPR_P"XG_Z:[NO%/^&>
M_BG_ -$T\8?^"&Z_^-U]-?\ !-?X-^/O"O[:WPZU36_ _B31],M_[1\Z]O\
M2+B"&/=IMTJ[G= HRS #)Y) [T ?N?1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MI6^F07%R+;RHWFD5%9MLI.T%AG )K[NH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **_)7]J+_@K5\0? _QV\6^&OAS!X=N/"VC71T^&ZU"SDGDGEC 69PRRJ"OF
M!PN!RH![UY5_P^2^/?\ SY^#_P#P5R__ !^@#]OZ*^(/^"9_[9/CW]K;_A8_
M_"<0Z/%_PC_]F_8_[)M7@SY_VKS-^YVS_J$QC&.:^WZ "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %9GB+POHWC#2WTW7M)L=;TYV5FL]
M1MDN(68'()1P02#TXK3HH \__P"&>_A9_P!$T\'_ /@AM?\ XW1_PSW\+/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH _$O_@L]_P G7Z)_V*5G_P"E5W7SK^SW^QW\
M5/VFM05/!GAN4Z2'VS:]J&;?3X><',I'SD=UC#-[5^\_C7]EGX6_$KXH6WQ
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M0QV]M"BQQ0Q*%1% P%4#@  8 %2T4 ?RPZM_R%;W_KL__H1JK5K5O^0K>_\
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M-$2D<9'548N<D9C(K]?-'T>P\.Z39Z7I=G!I^FV<*V]M:6L8CBAC4 *BJ.
M   * +E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?A
MM_P6%_Y/ ?\ [%^Q_G+7Q!7W5_P62T][/]KBSF;.V[\,V<R\=A-<1_S0U\*T
M %?TI_LG?\FL_!O_ +$S1O\ TAAK^:ROZ2OV/[G[5^RC\'7RK8\(Z5'\O3Y;
M2-?SXH ]>HHHH _.K_@MI_R0+P+_ -C,/_26>OQLK]A_^"W,P7X-_#N+=AFU
M^1@OKBW<9_4?G7X\4 %?M%_P11\S_AF7Q?G/E?\ "7S[?3=]BL\_IMK\7:_;
M/_@C!8/9_LH:W*V<77BV\F7Z"UM$_FAH ^]:*** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_78T ?:%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\@/^"U?Q@_MKXC>#/A
MM9S[K?0[-M6OE4\&XG.V-6]UCC+#VG_+\UJ]F_;+^(Q^*W[4OQ,\2"3SK>;6
MIK:VDSG=;P$6\)_&.)#^->,T =%\.?!-[\2OB!X;\)Z<,W^N:E;Z; <9P\LB
MH"?8;LGV%?TZ>&?#]EX2\.:5H>FQ>1IVF6D5E;1#^"*- B+^"J*_#7_@DO\
M#D>.OVP-(U*:#SK3PQIUUJ[[A\N_:((\^X><,/=,]J_=R@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?XR?!3PG'X9\$^.;O0="CF>=;.&VMW4.YRS9>-CSCUKKO^'D/[27_14M0_\
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MP(M=/A)P9)6 XZ'"CEB, =<?OA^R_P#LL^#/V4_A_%X=\+V_GWTP635-:N$
MN=0F QN8\[4'.V,'"@GJ2S':_9__ &??!O[-?P]M/"/@S3Q:VD>'NKR7#7-]
M-C#33/CYF/IT48"@  5Z50 4444 %%%% !1110 4444 ?RPZM_R%;W_KL_\
MZ$:JU:U;_D*WO_79_P#T(U5H ^U/^"0__)Y.F_\ 8&O_ /T!:_=2OPK_ ."0
M_P#R>3IO_8&O_P#T!:_=2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MCT  Z*H& %& H    J?XG?$SQ)\8?'.K>+_%FIRZMKNIRF6>XDZ#LJ(.BHH
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M4CDE578?12Q_"N(KV#]CS7H/#/[57PFU&Z=8K:/Q+8I)(W1%>94+'V&[/X4
M?T@:?I]MI.GVUC9PI;6=M$L,,,8PL:* %4#L  !5BBB@ K\_/^"SGPUL_$7[
M.^A>,1%&-4\.:S'$)BOS&VN%*2)G_KHL!_X"?6OT#KXK_P""O&L0Z7^QKJ=M
M*ZH^HZS86L0;&68.9<#WVQ,?H#0!^%=%%% '[U_\$J/'$_C/]C'PO!<NTL^A
M7=YI)D8Y)5)3)&/HJ2HH]E%?7M?"W_!&[3Y+/]D>[F<_+=^)KV9/H(K>/^:&
MONF@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /GW]OCX22
M_&C]D_Q_H-G!]HU6WLQJM@H&6,ULPFVK_M.J/&/]^OYV:_JGZ\'D5_/C_P %
M!/V8+G]F7X_:K:VEFT/@W7I)-2T&91^[$3-F2W![&)VVXZ[3&3]Z@#YFK]#/
M^".W[1%G\/?BOK7PVUN[2UT[Q>D<FG23-A5U"+($?H#+&S#W:-%'+5^>=/AF
MDMYHY8G:*6-@R2(2&5@<@@CH: /ZI:HZYKEAX9T:^U;5;R'3],L8'N;FZN&"
MQPQHI9G8GH  37X<?"G_ (*V?'7X:Z!;:/?S:-XXM[=2D=UXCMI9+O;CY0TT
M<J%\'^)PS')R>F/-OVC/V^/B_P#M.:=_9/B?6;?2_#A(9]"T&)K:TF8-N!DR
MS/)@@8#N0"H(&>: .-_:L^-;_M#?M ^,_'8#I9:E>;;".3ADM(E$4 (['RT4
MD?WB:\GHHH ]7_93^$DOQR_:(\!^#%A\^UO]3C>^&.!:1'S;@_\ ?I'Q[X'>
MOZ4.G X%?F9_P1O_ &99_#?AW6/C)KUDT-WK$9TW05F7!%H&!FG ]'=513P<
M1OV<5^FE !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M'_Y/)TW_ + U_P#^@+7[J4 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110!D^+/%.F>!_"^K>(M;NDL='TJTEO;RY
MDZ1Q1J6=OP /%?SJ_M<?M+ZS^U1\9M4\8:AYEMI2G[+H^FLV19V:D[%/;>V2
M[GNS''  'Z/?\%FOC]+X5^'7AWX5:5=^5>>)'_M'55C;#"RA;$:'_9DF&?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-%CC0!511@*!T 'I0!5T71['P[H]CI6F6D5AIMC EM:VL"A8X8D4*B*!T
M ]JNT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M4\>E '\S]%?M3_PY4^"'_0T_$#_P8V/_ ,AT?\.5/@A_T-/Q _\ !C8__(=
M'5?\$AO^3-M._P"PU?\ _H:U]JUY?^SC^SSX<_9A^&</@?PM>ZI?Z3#=37:S
M:Q+')/OD(+ F.-%QQQ\M>H4 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MM<\67^K0VLUHL.L7=K)!LD #$B.W1L\<?-7UA0 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M** "BBB@#S3]IGQ1JO@?]G;XF>(=#O&T_6=+\.7][9W2*K-#-';NR. P()#
M'D$5^&W_  \A_:2_Z*EJ'_@%:?\ QFOVT_;$_P"34/C#_P!BEJG_ *2R5_-O
M0!]*?\/(?VDO^BI:A_X!6G_QFOOG_@D[^TU\3?V@/$'Q'M_B#XLN/$L.EVMC
M)9K/!#'Y3.\P<CRT7.0J]<]*_'*OT^_X(<_\C5\6_P#KRTW_ -&7% 'ZU444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !7R%_P4-_8S\3_MA:-X)L_#6MZ3HKZ%<74L[:J9<2
M"58@H7RT;IY9SG'45]>T4 ?C7_PY+^*?_0]>#_\ OJZ_^,T?\.2_BG_T/7@_
M_OJZ_P#C-?LI10!^-?\ PY+^*?\ T/7@_P#[ZNO_ (S7DG[3W_!-KQQ^RS\,
M3XW\0>)_#^K:>+V&Q^SZ:9_-W2!L'YXU&!M/>OWOKX@_X+"_\F?O_P!C!8_R
MEH _#:BBB@#Z._9%_8?\5_MB6_BF;PUKVCZ*OA][9)QJQES)YPE*[/+1NGE-
MG..HKZ&_X<E_%/\ Z'KP?_WU=?\ QFO2O^"&O_(*^,G_ %VTG_T&\K]2J /Q
MK_X<E_%/_H>O!_\ WU=?_&:/^')?Q3_Z'KP?_P!]77_QFOV4HH ^ OV ?^"=
M_C3]DGXQZSXO\1^)-!UBQO=!FTE(-+,_F+(]Q;RACOC4;<0,.N<D5]^T44 ?
MFU_P4F_83^*G[3WQRT/Q3X'M-+GTFS\.0:9*U[?K _G)=74A 4CD;9DY^OI7
MRA_PZ'_:&_Z!OA__ ,'"?X5^ZE% 'X5_\.A_VAO^@;X?_P#!PG^%?MMX"T>X
M\/>!?#NE7@5;NQTVVMI@AR Z1*K8/<9!K>HH **** "BBB@ HHHH **\^\8?
MM#?"WX?W$EMXE^(WA70KN/(:UO\ 6;>*;(."/+9]Q(^E9>@_M7?!?Q1<+;Z7
M\5_!MW<NVQ+===MED<_[*%P3^ H ]5HJ.WN(KJ".:"1)H9%#))&P964\@@CJ
M*DH **** "BO//%_[17PK\ 7$EMXD^)'A31+N,D-:WVLV\4V00"/++[C@GGC
MBL_0OVJO@QXFECATSXK^"[NXD;:ENFO6HE8].$+[OTH ]3HJ&TNX+^UBN;::
M.XMY5#QS0L&1U/0@C@BIJ "BBB@ HHHH ***R_$'BC1O"5@;[7-7L=%L@<&Y
MU"Y2"/.,XW.0* -2BO)M2_:V^".DW26]U\7?!$<[/LV#Q!:L5/'WL2';UZMB
MNA\._'3X;>+IHHM"^(7A76I9N(X].UJVN&?G' 1SGGCCO0!W%%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%1W%Q%:P233R)##&I9Y)&"J
MJCDDD]!7FNN_M0_!WPSO75/BIX,LI$)!AEUZU$G!P1L\S<<'K@<4 >G45P7A
M;X^_#'QQ<0V_AWXB^%-=N)FVQP:=K5M/(S<?*%5R<\CC&>:[V@#Q_P#;$_Y-
M0^,/_8I:I_Z2R5_-O7])'[8G_)J'QA_[%+5/_262OYMZ "OT^_X(<_\ (U?%
MO_KRTW_T9<5^8-?I]_P0Y_Y&KXM_]>6F_P#HRXH _6JBBB@ HHHH **HZQKN
MF^';,W>JZA:Z9:KP9[R=8D'_  )B!7FVH?M9?!+2Q-]I^+_@6-XCAXQXCM&D
M!SC&P2%L_A0!ZO17CEE^V3\"=0F,<7Q@\$JP&[,VNV\2_F[@9]J[GPO\5O!/
MCAD7PYXQT#Q T@R@TO5(+DL, Y&QCG@@_B* .JHHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KX@_X+"_\
M)G[_ /8P6/\ *6OM^OB#_@L+_P F?O\ ]C!8_P I: /PVHHHH _5[_@AK_R"
MOC)_UVTG_P!!O*_4JORU_P""&O\ R"OC)_UVTG_T&\K]2J "BBB@ HHHH _'
M#_@LAXW\1^&OVG/#%KI&OZII5L_@^UD:&RO)(4+F]O06(5@,X &?85\(?\+8
M\;_]#EX@_P#!I/\ _%U]J_\ !:O_ ).F\+?]B9:_^EU]7P!0!U7_  MCQO\
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M[XN?%_PG\#/ NH>+_&FK1:/HEF,&1^7FD.=L42#EY&P<*.>">@)'X[?M(?\
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M4N+6XC:*6&10RNC##*0>H()% '\Q'_"V/&__ $.7B#_P:3__ !='_"V/&_\
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M@VW.M7(T?3G9>1;0X>9E/]UY65?K;T ?I?1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M"4 =77Y*_P#!<;_D:OA)_P!>6I?^C+>OUJK\E?\ @N-_R-7PD_Z\M2_]&6]
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MG:<J<#*FO5:* /YN?VK?V:-?_94^+E_X,UJ47]J4%WIFJ1H42]M6)"R '[K
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M/E,ZD+;+GU\UED'M$U?O)0 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M 5_3[\)O^25^#?\ L"V7_HA*_F"K^GWX3?\ )*_!O_8%LO\ T0E '5U^2O\
MP7&_Y&KX2?\ 7EJ7_HRWK]:J_)7_ (+C?\C5\)/^O+4O_1EO0!^8-%%% ']%
M?[!-BNG?L<_":)1@-HD<W3'+LSG]6KWVO%/V*?\ DT?X0_\ 8LV/_HI:]KH
M*_.K_@MI_P D"\"_]C,/_26>OT5K\ZO^"VG_ "0+P+_V,P_])9Z /QLHHHH
M_=K_ ()'Z:MC^QCHDXQF]U74)S]1-Y?_ +3%?9U?(_\ P2GA6/\ 8?\  S+U
MDN-29OK]NG'\@*^N* "OBG_@KT ?V-]0R,XUJP(_[[:OM:OBK_@KS_R9MJ/_
M &&K#_T-J /PLHHHH _;/_@C#_R:AK?_ &-MY_Z2VE?>M?!7_!&'_DU#6_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?$J#2?B1\0O UQ*J/K6G6^IVH=L9>V=D=5]25N V/2,^E?K[7\Q7P;^+&N_
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M1?\ @-<?H>O:CX:OS>Z5>36%V89K?SH&VMY<L312KGT:-W4^S&J% !7Z#_\
M!&KX*_\ "9?'36_B%>P;]/\ "-CY5JS#C[;<AD4CUVQ"?/H70U^?%?T ?\$T
M?@K_ ,*7_9-\+K<P>3K/B3/B"^W+ALSA?)4]QB%8LCL=U 'U11110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !7Q!_P %A?\ DS]_^Q@L?Y2U]OU\0?\
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M/\(?^Q9L?_12U[70 5^=7_!;3_D@7@7_ +&8?^DL]?HK7YU?\%M/^2!>!?\
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MT1K\0_\ @C_\:(?AW^TC=^$;^?R=/\:6/V./)POVR$F2#/U4SH/]J117[>4
M%%%% 'R[_P %)/@C_P +N_91\4P6MOY^M^'@-?T_:N6+0!C*H[DM"TP '5BO
MI7\_-?U321I-&T<BJZ,"K*PR"#U!%?S=_M>?!5_V?_VB_&W@Q86BTZUO6N--
M)'#6<O[R#![X1@I/JK4 >.T444 >J_LL_!R7X^?M ^"? XC=[34M00WS)U2T
MCS)<-GL?+1\>Y%?TGV]O':P1P0QK%#&H1(T&%50,  =@!7Y3?\$4/@KYU]XW
M^*U]!\L*KX?TQV'&YMLMRP]P/(4$?WG%?J[0 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 5ROQ)^%OA/XP>&SX?\ &>A6OB+1O.2X^QW@)3S%SM;@
MCD9/YUU5% 'S_P#\,!_L\_\ 1)_#_P#WZ?\ ^*H_X8#_ &>?^B3^'_\ OT__
M ,57T!10!P/PI^ OP^^!T>IIX#\*6'A=-2,;7@L5(\XQ[MF[)/3>_P#WT:[Z
MBB@ HHHH **** /+_BA^S#\*_C5X@M];\<>"-+\2ZM;VJV45W>HQ=(5=W"#!
M' :1S_P(UQ__  P'^SS_ -$G\/\ _?I__BJ^@** /G__ (8#_9Y_Z)/X?_[]
M/_\ %5[QI^GV^DZ?;6-G"MO:6T2PPPIT1% "J/8  58HH *\[^*O[//PX^.%
MQIT_CSPAIWB>;3E=+1[Y6)A5RI<+@CJ57\J]$HH ^?\ _A@/]GG_ *)/X?\
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M_P#%5] 44 >':#^Q!\"?"^N:?K.D_#/1=/U73[B.[M+NW5UDAF1@R.IW<$,
M1]*]QHHH **** "OP;_X*M?%:P^)W[7.L6FFQPFV\*V<6@/<Q@9FFC9Y)MQ]
M4DE>/';RSZU^GG[=W[;'A[]EWX;ZG9:;JEK=_$O4(##I6DQNLDELSCBZG7^!
M$!W -]\@ <;B/P&OKZYU2^N+R\GDNKNXD:::>9BSR.Q)9F)Y)))))]: (*55
M+L%4%F)P .II*^E?^"=OP1;XY_M5^$=/GM_/T71)?[>U/*Y7R;=E9%;U#RF)
M"/1S0!^UO['?P7'P!_9O\#^#I(1#J=O8K<ZEQR;R8^;,">^UW* ^B"O9J**
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'G'Q9_9S^&
MGQT:U?QYX-TSQ+-:QF*">[0B6)"<E5D4AE!//!ZUX???\$J?V:KRX,L?@:ZL
MP1_JX-<OMN?7YIB?UQ7UO10!\FZ3_P $LOV:]*N1,W@&:_88*K=ZS>L@_P"
MB8 _CFO>/AO\"_AY\'XW7P5X*T/PRT@VR3:=8QQS2#T>0#<WXDUW5% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
3 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>syre-20250331_g12.jpg
<TEXT>
begin 644 syre-20250331_g12.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 1R#V8# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHJ-KB-9!&TBAST4GDT 24444 %%%% !14<L\< !D=4!_O'%/!!&1R* %
MHHJ.2XBA^_(J?[QQ0!)15?[?;?\ />/_ +ZIT=W#(P5)58^@- $U%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?KS_ ,$^?^3-_A?_ -@L?^AM0!]#T444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7G?A?]J;X>>,/B%+X*TS7K>Y\0Q/L>S4_,#0!ZY1110 4444 %%%% !1110
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M:^<?%'_!'^^\4?$2ZU6Y\1R2:=?W[W%R[3 RHCL20O';/%?6W[(_AG5O@O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\4_\ @LU_
MR<IHG_8#C_\ 0VK])?\ @GS_ ,F;_"__ +!8_P#0VK\VO^"S7_)RFB?]@./_
M -#:OTE_X)\_\F;_  O_ .P6/_0VH ^AZ*** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$GQ(GNO$NA7;'[-#>3@PO@C/*CC\: /V3HKS;]GWXX:+^T%\-=-\6:+(I2=
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MHH **** "BBB@#Y)_;J_8;TW]J+PVE_I;0Z=XMLE8V]RP(63/9\=:_,?4?\
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M?]M__19K]_Z_ #_@F)_R>9X(_P"V_P#Z+-?O_0 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _%/\ X+-?
M\G*:)_V X_\ T-J_27_@GS_R9O\ "_\ [!8_]#:OS:_X+-?\G*:)_P!@./\
M]#:OTE_X)\_\F;_"_P#[!8_]#:@#Z'HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MP1K7_BW'B7_:=#^9->)_\%$-!O/@U^VSX6^)=S!(WAQ9;.59L9/F)EG7W_\
MK4 ?KIX7\-V/A'0+'1]-A6"RLXA%&B* , 5Y9^UY\.=,^)OP#\6:3J%I%.S6
MA,4C("\;9'*GJ/PKLOA5\6/#_P 6?!>E^(=&U*UN8KR!96CBF5FC)'W6 .0?
MK7BW[?7[0&B?"'X ^)(UU*#_ (2&_MFBL+82 DOD=1G@8S0!\P?\$??%TVGS
M>*_ S&1XK*YFE#$_+PV*_3VOS9_X(\^ ;QO".O>.;R%HWOKJ6+>ZE2^2#D>U
M?I-0!7U"\73[&>Y8%EB0N0.^*_'7]C32XOB__P %$O&$^O@7JVCWEQ"LXW!-
MDGR@9K]C;JW2[MY(9!E)%*GZ&OQ>^#/BH_LC?\%!M>G\6PFTMM8N;B""1ON^
M7-+\K'T'O0!^TJJ%4 # '  K\G?^"S?@#1M+N/#7B>VM$AU6^F\B>1 !N54X
M_&OU5L]<T[4;-+NUOK:XM77<LT4JLA'KD&OR-_X+"_&GP_XN\1Z+X,TN\AOK
MS2I!<SR6[AT&Y2,9'>@#]'/V:_\ DU3P-_V+D7_HJOS?_97_ .4CFL_]??\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !7%?&S_DCWC;_L#7?_HEJ[6N*^-G
M_)'O&W_8&N__ $2U 'X:_P#!,3_D\SP1_P!M_P#T6:_?^OP _P""8G_)YG@C
M_MO_ .BS7[_T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110!^/'_  6V_P"2O?#[_L#3?^CJ^V_^"8/_
M "9GX*^L_P#Z,-?$G_!;;_DKWP^_[ TW_HZOMO\ X)@_\F9^"OK/_P"C#0!]
M64444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110!^*?_!9K_DY31/\ L!Q_^AM7Z2_\$^?^3-_A
M?_V"Q_Z&U?FU_P %FO\ DY31/^P''_Z&U?I+_P $^?\ DS?X7_\ 8+'_ *&U
M 'T/1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !4=Q;QW4+Q2H'C<;64]"*DHH \\UCX'^&=2W-
M%9);2,<LRY.:U?#OPM\.^&ITN+6PC%TO_+4\FNNHIW8!1112 **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^*?_!9
MK_DY31/^P''_ .AM7Z2_\$^?^3-_A?\ ]@L?^AM7YM?\%FO^3E-$_P"P''_Z
M&U?I+_P3Y_Y,W^%__8+'_H;4 ?0]%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M2U">XCDT/3II+;2TBZ>3NX)YY-??'_!&-0OA#Q20 "1'G_OHU\E_'+]DFS^
M_P"RYH7B#5+<2>)=:$-SYD@P]N&(R@KZV_X(R?\ (G^*/I'_ .A4 ?I7169X
MF\16/A'P]J.MZI+Y&G:? ]S<2XSMC4$L<?05\O+_ ,%2OV=V7/\ PE\X^MA(
M/Z4 ?6E<5\;/^2/>-O\ L#7?_HEJ\!_X>D?L[_\ 0WS?^ ,G^%<W\3/^"EW[
M/_B3X<^*=+M/%LTEW>:9<V\$?V*0;I'C95&<>I% 'YK_ /!,3_D\SP1_VW_]
M%FOW_K\ /^"8G_)YG@C_ +;_ /HLU^_] !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MO_!,7_D\SP1_VW_]%FOW_K\ /^"8G_)YG@C_ +;_ /HLU^_] !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MO][%6!]76=W%?6L<\+B2*095EZ&IJX[X6Z5J^B>%K:QU4)OA&$*G)Q[UV-9
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% 'XI_P#!9K_DY31/^P''_P"AM7Z2_P#!/G_DS?X7_P#8+'_H;5^;
M7_!9K_DY31/^P''_ .AM7Z2_\$^?^3-_A?\ ]@L?^AM0!]#T444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P#1AKXD_P""VW_)7OA]_P!@:;_T=7VW_P $P?\ DS/P5]9__1AH ^K****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I*6B@!
M**6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "DSCK5>ZU&VLV59YTB9AD!CC->!?ML?%[4?A?^SYXF\0
M^%]2@@UFTMR\#MA@#]* /H4,#T.:6O@/_@F;^TYXR^.&EZK)XWUB"[EA=EC.
MP1G QUK[N_MS3_\ G\A_[[% %ZBO"OVN_C3>_"+X%^)/$GAK4K.'7+6V:2T\
MX"12PZ<=Z^9?^":_[9_C[]HCQ/JFC>-[N&_FC1YHIH81&  !Q@4 ?H?1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'XI_\ !9K_ ).4T3_L
M!Q_^AM7Z2_\ !/G_ ),W^%__ &"Q_P"AM7YM?\%FO^3E-$_[ <?_ *&U?I+_
M ,$^?^3-_A?_ -@L?^AM0!]#T444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M-3N[66E_O(=Q) +/SBOT2H **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "N*^-G_)'O&W_8&N_P#T2U=K7%?&S_DCWC;_ + UW_Z)
M:@#\-?\ @F)_R>9X(_[;_P#HLU^_]?@!_P $Q/\ D\SP1_VW_P#19K]_Z "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L
M_7M8A\/Z3=:C<9\BW0R28&3M R:T*S/$VBCQ%H-_IK/Y8NH6BWXSMR",T >.
M?"7]M?X4?&:22+0O$ @ECF:!DU$"W.Y3@_>/3WKV^TOK;4(O,M;B*YC_ +\+
MAA^8K\7OCI_P2E^*'@*[N=3\&WLGC!IIWG\NR0PN@))[GK7F'AO]JC]H3]E?
M5K?1]4O-0T^U@($FGWD88$#MNY_G0!^^]%?FE\&?^"QN@Z[=0Z=XTT$Z*% #
M:B9]RGU) %?;?PL_:;^&OQGC5O"/BFSU5CP8T)5@?3F@#U*BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _'C_@MM_P E>^'W
M_8&F_P#1U?;?_!,'_DS/P5]9_P#T8:^)/^"VW_)7OA]_V!IO_1U?;?\ P3!_
MY,S\%?6?_P!&&@#ZLHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@#Q#]KKX-ZQ\9?A'J.F>'=:O-
M"UN(>=!<V<AC<[<G;D>M?B'\4O"?QTT/0-17Q=>Z]-HL.Y)OM4LC1,H.,G/&
M*_HKKSKX\?!RR^.7PUU;PA>S+:VVH1^6\OEAB!0!_/=\'-)^)^J^>O@"?5H5
M&?,_L]W4>^=M>G?\(;^TQ_S_ /BC_O\ 2U^NG[+O[*/AS]D72KN&#7(KJ.<D
MM). AR<=R<U[G_PFWAO_ *"=E_W\6@#\#=2^$?[0_C.-=+U-O$%_;S':8KJ2
M1H^?7(K](/\ @F7^QUXC^ >CZCXA\911VNLWC%;>"%]X$+ <MQUK[2_X3;PY
M_P!!2R_[^+5[3?$FEZO(8[*]AN7 SMB<'^5 &G1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% 'XI_P#!9K_DY31/^P''_P"AM7Z2_P#!/G_D
MS?X7_P#8+'_H;5^;7_!9K_DY31/^P''_ .AM7Z2_\$^?^3-_A?\ ]@L?^AM0
M!]#T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M;/Y&ORY_8A_X*/:%\.?#(\ ?%=Y-#N-*)A6^G#';M^785 [8KUW]HK_@J?\
M#/P]X#O8_A]JL?BK7KE##'#&C(%W#&<D=LT ?+OP':*W_P""BE\F@-NL&NE\
MXQ]/O<YQ7??\%=@#\4/  /(,D&?^_E6_^"47[/\ K][XH\0?%?Q-8R0VFI@M
M9-*.3)O))YY[_I53_@KI_P E1\ ?]=(/_1E 'Z+_  '58_A-X<55VJ+9< 5X
ME_P4F /[->MY&?W<G_H->W? G_DD_AS_ *]EKQ'_ (*2_P#)M6M_]<Y/_0:
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MQ3)-"DR,&C90P8="",YK\\?VY_\ @I9-\&?%$W@GP/:6^IZFL8,]X7(\HG/
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MFC4X+J#]10 ^BH_/C_YZ+^8H\^/_ )Z+_P!]"@=F244BL&Y4@CVI:!!1110
M4444 %%%% !1110 4444 %%%% ''^*/&-_HU[Y%KI%U=J.LD:9%85S\4-6M;
M>6>3P_>+'&NYF,?0"O3:Q_&!(\*ZMC_GUD_]!-,#A=.^+.I:K9QW5MH-Y)#(
M,JRQY!K:T'QUJ6I:E%;7&B7=O&YQYCI@+[FK'PE8GP#I6?\ GG784 %%%%(
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M$NL:Y8,6BLFN%N8Y"1_$WM7Z.1QK#&J(H5% 4*.@ [4 9/C'_D4=<_Z\9_\
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M2QQ(L<:C"H@P /0"O O''[$'PS^('Q<@^)&K6VH/XDAD\Q'CNBL>[&/NXKZ
MHH BMK=+2WB@C^Y&@1<^@&!4M%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %>>_&/X"^"_CUH<>D>--*&J6,;;E3>4(/J"*]"HH ^$_'7_!(
MWX3:Q;R+X;BFT64_=::9Y,5\Y>,O^".?CCP^L]QX>\>17D YCM8XY%<>V<BO
MUD\1>*]%\(V7VS6]5L])M<X\Z]G6),^F6(KF_P#A>GPZ_P"AY\/?^#*'_P"*
MH _'2W^&/[7W[/\ >M!HFEZY=64/"7BQB1"!_O-6]X?_ ."DW[07PCU#ROB)
M9S7ULI $<ELD3#V)%?K7)\</AO,A1_&_AUE/53J4.#_X]7*ZYKGP&\3*RZKJ
M/@G4 W7[1/;.3^9H XC]BO\ ;,@_:TTC4Y4T&;1I].53(TCAA)DXXQ7TY7C/
MPQ/P;\":A?-X/UWP[:O=@"2WL;R''!XP%->QQ2I-&LD;!T895E.01ZT /HHH
MH **** "HYIA;PR2M]U%+'Z 9J2JFK?\@J]_ZXO_ .@F@#\"?V\O$%Y\5OVO
MO$5K%=,]LUQ'!;(Q)6,8 .!7Z[_"O]DGX>:?\ ;#PL-#@:+4],C-U,R@N9'C
M&Y@>HY-?C;\:N/VP=0Q_T$$K]_/A_P#\B+X>_P"P?!_Z+6@#^?;5FE_9?_;
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MTNSL9",%K>!4/Z"@#3HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@#\4_P#@LU_R<IHG_8#C_P#0VK])?^"?/_)F_P +_P#L%C_T-J_-K_@L
MU_R<IHG_ & X_P#T-J_27_@GS_R9O\+_ /L%C_T-J /H>BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M\$_?V>U&!\+=%Q_N/_\ %5]"T4 ?/?\ P[^_9[_Z)=HG_?#_ /Q5<O\ %/\
M84^ FA_#'Q;J%G\,M&@N[72KF:&9%8-&ZQ,58<]00*^K*XKXV?\ )'O&W_8&
MN_\ T2U 'X:_\$Q/^3S/!'_;?_T6:_?^OP _X)B?\GF>"/\ MO\ ^BS7[_T
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "OGK]N[Q=XF\$_LX>*M6\)7UYI^MP6Y:"XL5)E4Y
MZC%?0M>5_M/_ !67X*_ _P 5>,!;QWD^FVIEAMY5#"1LXQ@]: /PD;]MC]H.
M&80/\3/$J2]HVE^;\MN:NK^U]^THZY7Q[XN8>H5O_B*^I?\ @GW\);#]K#XO
M:Y\2_'\-M?+"[_9]/A01K&X;() X(&:_62S\&Z#86R6\&C6$<2+M"BV3I^5
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MOB3_ (+;?\E>^'W_ &!IO_1U?;?_  3!_P"3,_!7UG_]&&@#ZLHHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MM/\ ^?ZV_P"_R_XT ?C!_P %FO\ DY31/^P''_Z&U?I+_P $^?\ DS?X7_\
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M9_%S]HH:7X;\17^J^%M*NB)=8;Y595Y&0?6OW9L;<VMC;P,VYHXU0MZX &:
M)Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /#
M/VROVB8_V9?@GJ7BT0&ZO3(EI;0KC/F/D!N>P.*_%7P7X3^+W[<OQ.U&YMKR
M\N[FXD#7,^Y_LUL#T& < 5^IW_!5GX>ZGXV_9BNY-'M9KV]L[V"5H85+$Q@D
ML<#T KS'_@CWXH\*#X?ZSH]OY-GXE@*B]67"22?,<=>3B@#P-?\ @BQ\4'@\
MP^+O#ZR8SY963/TS7@WQ8^"/Q?\ V)_%FFWEQ?7B11D21WEF\@MN#]T\XYK^
MA*OA+_@K=XV\,P_LVW>@37-M+XANKJ![6)65I%57^;W% 'K?["?[2TW[2'P:
ML-3U9X_^$CMP4O%C4 <' .*^DJ_/O_@D+\,=:\+?">^\2ZC!);66K?);QS J
MQVOR<'M[U^@E !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 5Q7QL_P"2/>-O^P-=_P#HEJ[6N*^-G_)'O&W_ &!KO_T2U 'X:_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MYM72,*U>GATG5E9/N?,GQ@^+VCZC^U0_@SPC<QMI-GI<S7\2\E;I#Z]J]/\
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MXI2:XITG4YE\]%'DNW5^>E?--=E\))&7X@:)M/)N%!'^SSG^E-Z@?9E%%%9
M%%%% !1110 4444 %%%% !1110 4444 %%%% !17G7Q"^+T7@75%L3IMY>.4
M#[H("Z\^XKE/^&E8_P#H :G_ . K5O&A4DKI'IT\MQ56"G"%TSW"OGW]IO\
M:*;X6VJ:5H[*=:F ;<V&"J?ZUII^TI$6YT#4\?\ 7JU?!WQ4\77?C+QMJ=_=
MM)DS,J++PRKG@8[5Z.#P;G4O46B/JL@R&5?%<V+C[L=;=RKXA^(6O^)M3FOK
MW4K@S2G)"2LJCZ &N@^&_P <O$_PWU07-E?R31,0)(IV+@CVR>*\[HKZ1TX2
MCRM:'ZY/"T*E/V,H)Q[6/U3^#OQ2L?BMX3AU2U.)E 2=,]'QS7=U^=_[*OQ8
MN? ?B&XM3;W-Y92HSM#;H7^;'7 KZ@_X:5C_ .@!J?\ X"M7RN(PDJ=1J"T/
MQ3-<AK8;%SAAXWANCW"BO#O^&EH_^@!J?_@*U>F> _&D?CC26O([6XM-K;2E
MQ&4.?H:XY49P5Y(\"M@<1AX<]2-D=+1116)P!1110!YO\>/CQX8_9[\"W7B;
MQ-=)#!&"(H=P#S/C(1?<U^?>J?\ !3;XM_$AS>_#7X::H^EY.UGMUE!'U%?6
M7[6/[&MC^U)J6EMK>OWFG:/8E9&MH7 1B,Y)!]C7>_#_ $GX5_ _P;8>'K'5
M] LK>PB$1:2ZA61\=V&<YH ^ =%_X*K?$7X:ZY%%\4O ][;VTAP(Q"L+>_-?
MI/\ "'XL:)\9O VG>)]"F62UNXE=HMP+0L1G:WO7P=_P4K^)WP<\6?"V:PM)
M],U'Q''N:":UV.P;''(-;O\ P1?O+BZ^ 'BA9IGE6+6=D8=L[%\L<#VH T_V
MS?VZO$G[.OQ8TC0K,0#2KASYSR1 X48[UQ7B_P#X*=^,?'4R6_PC\!:GKBQP
MKYUY%$)8_,Q\W;UKQ;_@K!H\_B+X]>'M+ME#7%U(8U#' YQUK]//V>?@GX4^
M$OPST&QT31[6TEDLH99Y8XP&>1D!8D_4T ?"?PU_X*M>)?#?C:U\/_%7PI=:
M=+<2+%GRUB,>XXR?;-?H)X^\>W47PCU/Q/X00:M=BT\ZS2$;_,8XX [U\-?\
M%?/A1H5O\-+'QE::=;VNJVUQ'%]HB0*[9;J37T9_P3IUZZ\5?LB>"[W4&\Z>
M2.5&)YR Y% 'X]_'+XO?$7Q9^TQI?BKQ#HL]GXML[J%K2Q>+:[E'RF!WR:_6
MK]BOX]?%?XPVOB27XD>&)_#KV;?Z,)K<1;QMSGIS7PQ^VA;Q1_\ !1KP0B1J
MJ&\L,J!P?WM?L==6\4-G<F.-4)C;.T8[4 ?"?@G]N+Q;X@_:]?X8SQP_V2LZ
MQ[A$ V#[U][U^.OPI_Y28S?]?4=?KUJ'B'2M*F$5[J5G9RL,A+B=$8CUP30!
MH5P7QXNI;+X-^+YX6V2QZ=(RMZ'%=)_PFGA__H.Z;_X%Q_XUR/QXO(+[X&^,
MIK:>.XB.FRXDB<,IX]10!^>G_!)3RY_'OCK4[A4-Q]JG9YV'(&.>?2OO/Q[^
MUE\*?AW83S:MXUTF*X13Y=K]H'F2-_= ]<U\#_\ !)BU&H:]\0;-F*+<S7$)
M9>HW+C(KK?BG_P $AK7Q;?W^K67BR_N;^8L\<-U(NQ2><#VH Y?]G?X'^+_C
MY^UM=_%BY\.7?A3PO;L);66]CPMUM?(*D=<CFOU2K\<_@?\ M%?%S]B7XTZ=
M\+/B%+)J6A7%S' LEW*SK%$QP&0GT'Y5^P.DZI;:WIMM?V<@FM;A!)'(.C*>
M] %NOS@_X*I_M%:A:?V1\(/"URT6N:Q+'YS1MU23Y0AQ[FOT$\:>*K3P3X7U
M+7+]Q':64)ED8G  %?D1^R+X7O?VM/VU->\8>(D-]I>DS236DTHW(NR3Y #]
M/YT ??\ ^PC^S7:?LZ_!C3K62 )K^I1K/J,A')DYX]J^DZ3ITXI: "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBH)+ZWAG2%YXT
MF<X5"PR?H* /D3_@IM\9?%OP9^ TFH^$M1&G7=U<1VLLAB$F8W.&'(('%?B1
MX1^+'BKP+XM/B70]4EL-79_,,T7 +>I'2OZ9M=\,Z1XHM/LNL:79ZK;9SY-Y
M LJ9]<,"*P/^%,> ?^A*\/\ _@MA_P#B: /PM/\ P4P_:':#RO\ A.9-NW;_
M ,>L><?7%>$^.OBIXI^)7B)=<\1ZI-J6HJV]9).@.<].E?TD?\*9\ _]"5X?
M_P#!;#_\31_PIGP#_P!"5X?_ /!;#_\ $T ?A'H?_!1SX^>'-)MM-T_QE]FL
MK= D42VD>% [=*]?_9G_ ."@GQT\>_&;P[HFM>+VO--NKE(YH3:IRI8#J!Q7
MZ^_\*9\ _P#0E>'_ /P6P_\ Q-+%\-_ ?ANXANXO#.@Z=/O"QS)8Q1MN[ $+
MUH [&BBB@ HHHH **** *FJZK::'I\]]?3I;6D"[Y)9#@*/6O#;K]O#X#V>L
M?V7-\1M*2_\ ,\KR<OG=G&/NU\ _\%8/VL-6NO'7_"LM O[C3H=+.;Y[=RGF
M[E! )!KQ3PE_P3)^+7C+X9MX]AGL;>V,!NX[>X=A<2J!NR!CG- '[H>&_%6D
M^,--2_T>^AO[1QE986R*UJ_#?_@GW^TUXG^!'QV3P=XEU*8^'KR9H;RWO'9F
MBE PNW<>.3TK]Q+>9;B".5.4D4,/H1F@"2D9@H))P!R2:6OA?_@J9^T_>?!7
MX;VOA;1IY+76O$,;&.YA)#1*K<\CI0![YXU_;1^"_P .]6DTSQ#X^TW3;Z,X
M:&0L2/R!KO/A[\7O"'Q4L%O?"NNVNLVS+N#V[=1ZX-?A1^SY^PS\3_VN-)N_
M$VE7]NMJ'8->ZK*W[QP<$ \Y.:S?"/B;XD_L0_'RRL9[^2VFL[E;>>!W8V\L
M)<!BJDXZ9P: /Z&:YGQU\2O#7PSTO^T?$VKV^D6><>9.V/TK/\-?%/2O$WPP
MMO&EK)YFG36OVA67G.!T_.OP5^.7Q8^)/[5'[05WI]]>7'VVZO3IUIIUNSI
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MPYKMAKL,.D2I+)83K*L;&7(!*GKCFOO;_@F#_P F9^"OK/\ ^C#0!]64444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 5RGQ4^(NF_"7X>ZYXNU=MFFZ3;FXF.<<# _F:ZNOF;_@H
MU'<-^R'X_,6?*6R)EQ_=R.M 'Y6_$CXN?%S_ (*"?%ZY\/\ AE;N]TT.SV^G
M0MM6.$-]]CQV/2L;Q!^S7X@_9G^.G@/2_$,K&ZU&02A>A7##CKS7U/\ \$9=
M1T'[=KEF9+7_ (2 J[A,#SO*X_'%3_\ !2Y7_P"&MOA.&!Z-C/\ O"@#H/\
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MK44U)2L<%/B#&8;&*5-2W2TM:WI?;Y'C/P/_ &1]*\11IJ^JZDMY;HV#:"/
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ML3 #Y(,=_:M#QUX=.K6MOK6FG%[:XG5H^LJ@9"^])6V/+Q,94_W]):K?S7_
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MWG[;'C_;\V[Q)QCO\R5^_P!\,;6:R^'^@Q3QF.5;.+*GJ/D% '45^+?_  6
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MO0U]D?"_Q9'XL\*VLPE$MS$@2<_[55(#KZ***@ HHHH **** "BBB@ HHHH
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MBIIWP7^&>N^+]2P\.FV[3"'=@R$=A7\]?Q:^.>H_'KXR_P#"3>,KF:]TJ2]
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KG_'_ ('TSXD>#=6\,ZS"
M)]+U*$P3QD9!4UY7^US^TPG[+/PW/BZ719-=C$\<!M8Y A^9L9S[5XY\,_\
M@JU\(O&-O"^OWT?A5W'S)=2;MOUP* /SY_:!_9E^*/[$?Q3;Q'X+EU"'2IIC
M]DO-+RS",MGRV"@_+@8KR3XK?'SXB_%GQ;H/B#7[&\;5-'&(9&BD+'G/.17[
MW^#_ (Z?#7XKVZ?V'XBTS6XI1@+P0<_[PJ>^^ ?@+5;@W,_AZSDD8YW! * /
MPW\0>,_CU^V1X@L/#WE:I<P!$AAL9 Z6RX&,EB,5^MW[!O[)W_#+7PK-AJ,P
MN_$&I2"ZO'(!\EBH!C4CL*^A-!\(:-X8M5M],TVWM(UZ>7&H/YXK8H ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _%/\ X+-?\G*:)_V
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MZGO%8/CS_D2]<_Z\Y?\ T$UKV5[!J-K'<6TJS0R#<KJ<@BO.?VA/BAHOPO\
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M,3_D\SP1_P!M_P#T6:_?^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** .2^)OBY/"'A:XN>&ED_=(G?+<9KXUNYY+JX>5RS
M,QR2W)K[#^(7PWB\?)$DUX]LD8QM49S7#?\ #,>G?]!.3_OV*I- ?-^#Z5ZQ
M\ _&K:!X@&GSR+%8W62Q8X^8#BNX_P"&8]._Z"<G_?L5+:?LU:?:W4,PU.0F
M-PP&ST/UIW0'LZL&4$<@\TM,BC\J)$SG: ,T^H **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBJ]_=+8V-S<M]V&-I#] "?Z4 9'C'QWH'@
M#2VU#7]5M=*ML':UU*$W$=AGJ:^5_&G_  52^"W@G5A833ZEJ$N_9OL8!(OU
MSGI7YS?M ?%7Q[^W=^T4WA70[BZDT5;O[-9Z8&_=0LI*L_XXJY^U-_P3U?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M3?\ HZOMO_@F#_R9GX*^L_\ Z,-?$G_!;;_DKWP^_P"P--_Z.K[;_P""8/\
MR9GX*^L__HPT ?5E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_G78:.,:9;_[M>9ZU\-?$.MVJ03Z@&19 XS(>HJY#X'\2P1+&NHX51@?O#5
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M2O?#[_L#3?\ HZOMO_@F#_R9GX*^L_\ Z,- 'U91110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'G
M_P :?CEX2^ 7A&3Q'XPOS8::K",.J%R6)P!@>IKXB^)7_!9#PIX>C)\*Z$OB
M)\X DD:(?6O=?^"AGP1\0?'KX+GPUX<BWWSW,4@++D *V:^+_AO_ ,$8?$UQ
M/!=^*O%.G+:, 6M($=9/Q- '"?$;_@KM\3/%T=PF@V:^&'D4A&MIB^PGH1D5
M\[^(_P!I[XW?%"%M.U?Q5K&MI<':T3Q!MV?HM?K%X!_X)-_!CPR\-UJEG>ZG
M?1G<#]K8)GZ&OIWP;\#/ W@2T6WTGPY8(JC :6!';\R* /P3\'?L)_&SXAP?
M:M'\'SW*.-^YY%3KWYK])_\ @G+^Q1XP_9TUR?7O%8^S75S;LC6JL&"$CID5
M]]V]G!9KM@@C@7^[&@4?I4U !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% 'XI_\%FO^3E-$_[ <?\ Z&U?I+_P3Y_Y,W^%_P#V"Q_Z&U?F
MU_P6:_Y.4T3_ + <?_H;5^DO_!/G_DS?X7_]@L?^AM0!]#T444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MY:^-M3U0Z:QCGVX'/85[9]D@_P">,?\ WP*/L<'_ #PC_P"^!3 X#_A:D_\
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M%S_UR;^1H X7X(_\B=_VWD_]"KT*O/?@C_R)W_;>3_T*O0J; ****0!1110
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MUCQIX2^V-<Z:MYE4=BP7:N!MST'TK]3Z "BBB@ HHHH **** "BBB@ HHHH
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M5_*TUU/"&=V.237\\GQ2^#]Y\$?BM;^&=0NUN[RWNT64JN,,''%?T%_LX_\
M)&_#?_7NO\J /2Z*** "N*^-G_)'O&W_ &!KO_T2U=K7%?&S_DCWC;_L#7?_
M *):@#\-?^"8G_)YG@C_ +;_ /HLU^_]?@!_P3$_Y/,\$?\ ;?\ ]%FOW_H
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MA0_Q.<#\Z +-%,BFCF4-'(LBD9!4@@T^@ HHHH **** "BBB@ HHHH ****
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M_8__ .3?/"7_ %[?U->T5KB?X\_5CG\3"BBBN8@**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BN,\8>%?$NMZ@LVD>*'T:W"@&%80^3ZUS__  KOQY_T
M/\O_ (#BK45W/-J8JM";C&A*2[IQ_61ZG7P5XT_Y&C4_^OF7_P!#:OJ-?AWX
M[[^/Y?\ P&%?*GB:":VUR^BN)_M,RSR*TN,;B&()_$UUX=)-V9^?\5UZE:G1
MYZ3A9O>W;R;,RBBBNT_.3U[]F'_DHC_]>KU]95\9? _1]4UKQ@T&DZLVC70@
M9OM"IO./3%>]_P#"N_'G_0_R_P#@,*\^M%.>K/U?AK$5:6 Y84925WJG'R[M
M'J5%>6?\*[\>?]#_ "_^ PKM_">D:IH^GM#JNJMJ]P6R)F0+@>F*YW%+J?94
M<15JRY9T917=N/Z-FY1114'>%%%% 'Q?_P %&OVD_%GPG\'6_AGP)IMY=>(]
M7(B^T6\+.(48$;@1T.:^=_A+_P $S_&GQD\%Z?XC^(WC_7+?4+Z/SA;_ &DL
MR9/0YYK[W_:$^-?PX^!>CIK_ (XN+6*8?);1RIO=V[ "OB36O^"S49U633_#
M'PVFU9,[891.5#>X4+0!XS^T_P#L4_$+]D718_%W@OQIJDVFQL?.D-T5D3 S
MGBOOO_@G7^T3??M$? M;[4PS:AH\JZ?/,_+2L%SN)[DU^?/[47[8'Q@^._PX
MN%O/!%QX?\+2!A)(SY&._45]0?\ !%C_ )('XM_[#?\ [3% '@7_  5:\5:I
MX6^.6AWFG74D4D3,RH&PI/'6NW^%/["7Q2_:9\.V?B?XI>.-6TB"X@46EG97
M)(\O'RG!]JY'_@IUIUOK'[3GA"RO(_-M9KC$D><;AD<5^LW@>%+?P7H$4:[(
MTT^W55'8"-<4 ?B[^T'\#?B9^P/XRT?7=#\6:C=>&VF1O,-R<D;ONL/>OU,\
M!Z[%^U;^S+;W37!LDUZS,336YY4@@$@_45\^_P#!8"VB;]G(3% 95O80&]!N
MKTK_ ()B_P#)F?@?Z3_^C#0!^4/[07[,EO\ #7]JW1?AW'K%Y=Q:K=6ZF\E;
M]ZGFR8X/M7ZW_LI_L<V?[*=AXB6T\17^O#4?WA:]8'9A<8%? /[:7_*1WP/_
M -?EA_Z-K]C[[_CQN/\ KFW\C0!^0_PKU:^D_P""E$MNUW*;?[5'^[W?+7Z_
MU^.OPI_Y28S?]?4=?:G[6'_!0+0_V6/B!8>%]2T2;49KNS%V)8RP !)&.![4
M ?6U4M:_Y!-W_P!<F_E7YVC_ (+,>$RRC_A%;CYB!]Y__B:^T?A+\7+;XW?"
M-/%=I:M9P722*(FSD8'_ ->@#\P_V"_^4EWB_P#W=2_F*_4OX\_\DE\1_P#7
MLU?EI^P7_P I+O%_^[J7\Q7ZE_'G_DDOB/\ Z]FH _.O_@D)_P E'\?_ ._-
M_P"C*_5.ORL_X)"?\E'\?_[\W_HROU3H ***^7/VKOVYM'_9:URUTW4M'EU%
MIXED#1D\9^@H ^HZ9)"DR[9%#KZ$5^<3?\%FO":J3_PBMQQ_M/\ _$U]F_LT
M_'2S_:-^$^G>.+&S:PM[R22,0.22"AP>M 'I\-O%;+MBC6->N%&*P/B#XZTC
MX;^$M0U_7+I+/3[2,L\CD#G' %9WQ:^+OAGX*^$+GQ'XIU"/3["+A2YY=L<*
M*_*/XA?%KXG?\%*/BC-X+\&BYTSX>0S;;J5.8]N>"WKTZ?Y(!G_LY:3K7[:/
M[<LOC\Q-:Z?H%TEVLT2D1R)&Y"C=TR1S@5^SD]O%=1[)HUD3KM89%>0_LP?L
MVZ%^S1\.;3PWI2I-<+E[B\VX:1CUY^M>PLP498@#WH Y?XB>*A\// VJ:W#:
M-<_8HO,%O"A8M[ "OR4_:._X*1?%KQQH^M>'H?!5UX>\,3!X)[XV<T<ICZ$[
MB-H&/>OV0DCBNHBCJLL;=0>0:P/&GP\\/?$'PY>:'KNEP7NFW49BEB9 /E(P
M0#VH ^.O^"6OPR^'GA3X6S:YX:UUM;UO6"L]X+ID\V!\8*@#G%?=%?C+\&(+
MG]EG_@H1?^%?#LL@\,S7$R)8;R5V'@#GTK]EH)/-AC?IN4'\Q0!)1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %?F-_P6J_Y$OP;_P!?S?\ H!K].:_,;_@M4?\
MBB_!O_7\W_H!H \Y_P""<G[*?@G]J#]FOQUI?BBVDCNH]:C^SZA:D+-%B,$
M-C[N>HKS/X]?\$[OBU^SG?7NM^#[FZU#1V;,!T>60W04=F"U]9?\$3S_ ,64
M\<_]AJ/_ -$U^C% 'X4^ ?\ @HE\>?@#:VVEZG:^=;*0C+KELYE8#K@L>M?4
M/@K_ (+.^'%L4_X2?P_>O=\;OL48"^_>ON;XC_LR_#'XL1O_ ,)1X/TW592=
MPEEC^96]1S7S3XZ_X)*_"SQ5,SZ=-)H"E2-EK""!GOR: /;_ -F']L#PA^U9
M::C/X6L]0M!8@&5;Z,+U..,&O=Z^</V0?V,=,_9'L]6M].\1WFOC4  QNHE3
M9@YXP:^CZ "BBB@ HHHH *J:M_R"KW_KB_\ Z":MU%=0_:+6:+IYB,GYC% '
M\]'QJ_Y/ U#'_002OW\^'_\ R(OA[_L'P?\ HM:_ W]M&SG^%O[8?B;]R)9+
M*ZCF57^ZX*@U^X?PK^*OAS5/@KH?B)-4M?LD&E123_OE!C98AN4\^H- 'X4_
MM@?\GL?$#_L9/_9DK]^/A.V[X=>'SG/^AQ_^@BOP#^+C3_&W]LGQ)=^&X/MW
M]JZ_Y\*IT*;ER?IQ7]"/AJUAT7POI=NVRWCAM8D.3@ A!F@#8K\3?^"M_P#R
M7BPQZ/\ S%?M5!J%K=/LAN89GQG;'(&/Z5^/'_!9;PI)H/Q2\)ZKC='J,$L@
M;'&0PX^M 'WY_P $\_\ DUWPU_OR?TK\]_\ @M1_R7SPC_V!/_:IK[2_X)?_
M !4TKQ9^S'I5G+=6MKJEE<3)+:F0 A00%;D]\5\#_P#!6?Q_IOQ*_:,TFTT2
M5+MM-LO[/<QL&!D\SH#]30!^A/\ P2_.[]D[PL"<CRVX_P"!&OI_1?!NA^';
MB6XTW2K2RN)26DFAA578GKD@9KPW_@G[X.N_ _[*/@?3M1M?LFHBV9IT[Y+G
M&?PQ7T70!^ ?[>A)_:ZU8GD_VE_[4%?MC^SC_P D;\-_]>Z_RK\3?V]/^3NM
M5_["7_M05^V7[./_ "1OPW_U[K_*@#TNBBB@#\O/VVO^"D?Q1_9\_:'USP5X
M:M]%DT>QAA>,W=L9),N@8Y.:^>?$7_!73XS^)O#VJ:/=6?A];;4+62TE:.S(
M8(ZE6Q\W7!-?KAX\_91^$7Q.\33^(O%7@'2-<UN=%26^NHR9&51@ G/:L#_A
MA/X _P#1*] _[\M_\50!^!GP-^,VN? 'XDZ7XV\.);R:MI^_RENTWQG<I4Y&
M?0U]9'_@LA\;O^?+PZ/^W(__ !5?J#_PPG\ ?^B5Z!_WY;_XJC_AA/X _P#1
M*] _[\M_\50!P7_!.?\ :B\7?M4?#/Q%KOC".PCOM/U,6D7]GQ>6NPH&Y&3S
MS7UK7&_#'X.^"_@SI-QI?@GP[9>&]/N)?/EM[)2JN^,;CDGFNRH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M,WGZI\0-<O-W)M68&-?8<UTFG_L^^#H0#J.F0ZQ(.CW:9(/K7/RT8[ROZ?\
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M5BLB\J=K<'M7ZD?L;?#'Q=\'_@9HOA;QC?PZCJ-GO EC))VEL@$GK7N5%<Q
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MTBQL@V\6T"0ACWVJ!G]* /AW_@K]_P FUG_K^@_]"KT7_@F+_P F9^!_I/\
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MY;,,-[5^B'AW2O[#T'3M.\QIOLL"0^8W5MJ@9/Y4 </_ ,,Y_#C_ *%#2?\
MP$3_  K7U*Y\,_ WX=W]\MO!I'A_2HFN'CA41HH[\=*[*O+?VCO@TWQX^&6I
M^#VU2?2[;4(S%-)!U*GM0!^2_BOXB:W_ ,%%/VD'T#5?%5GX9\#V+.R2S2&*
M%X4;@>A<CH:_3[X'6WP5_9_\#V'AGPQXAT6&"U38URUPAFF/<NW4FOD"S_X(
MRVFFC_1/B'J]L3U,05<_E5K_ (<]O_T4[7?^^A0!]_V?QD\#7]U%;6WBO2I[
MB5ML<:7*EF/H!7E_[<GAOQ;XL_9ZUB#P/<RP:U$Z7*26[$,44$L!BOF_X?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'_Z&U?I+_P $^?\ DS?X7_\ 8+'_ *&U?FU_P6:_Y.4T3_L!Q_\ H;5^DO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *0TM(WW30
M!^=W[1W_  5&OO@=\2K_ ,+0^'[:]^SKD2-NR>2!W]J^V/@;\16^+GPC\*^,
MFA6W;6K%+LQ+T7=G@?E7X6?\%$?^3E-:_P!P?S-?L[^Q%_R:7\+?^P+%_,T
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MTWPC^S1HVDZ-8PZ9IL%U(([6V0*B_*.WXUX__P $8?\ 6^(?^NC?^@BO</\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MPU\2?\%MO^2O?#[_ + TW_HZOMO_ ()@_P#)F?@KZS_^C#0!]64444 %%%%
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MB@ HHHH BN85N+>2-UW*RD$&O*O"5FUQX3\0^&9"3=9ED3U 8\5ZU7F]T/\
MA'?BH;U_EMK^%+=5[;JI$3@JD7"6ST/(O#.H_P!B_&KPY\VVRL=/>SN/7S#P
M,U]2*VY01T-?)WQXMV\!>)HKFW3_ $G4-0CE&W^Z6Y-?55A.MQ902HP9612"
M/I757UC"9TTI.ME^'E+>%Z;_ .W7I^#18HHHKC,0HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MO.?.CA ;-=J..!P* %HHHH *XKXV?\D>\;?]@:[_ /1+5VM<5\;/^2/>-O\
ML#7?_HEJ /PU_P""8G_)YG@C_MO_ .BS7[_U^ '_  3$_P"3S/!'_;?_ -%F
MOW_H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0E<U2E.C+EFK'D8S!5\#4]EB(V84445D<(4444 %%%% !1110 4444 %%%%
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MKT^[8\QN/V@/#'AN-E\+^ -9\8*.!):[91CUY[5Y??:Y+XDNIM2:Q>P\]O\
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M^-AJ6FR:-<2M)=Q$LF[^X!TJI >ST445F 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+4 ?AK_P3$_Y/,\$?]M__19K]_Z_ #_@F)_R>9X(_P"V_P#Z+-?O_0 4444
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MC_:>\%-9:PT,7B[3US<PP\!HQ@!L>M 'UM1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 ?CQ_P6V_Y*]\/O\ L#3?^CJ^V_\
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ML_(YYS<WS,****Y#,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M(OY&)>[W'OZ8KH/V]OBS\*9_V:=4BN;_ $W55NMAL[:U*[V/.&7CH.*^+?\
M@C[H-[J7QBUS4+6WD:RM5C:60#A02<9H _9ZBBB@ KBOC9_R1[QM_P!@:[_]
M$M7:UQGQH0R?"#QLJC)_L6\_]$M0!^&?_!,3_D\SP1_VW_\ 19K]_P"OP _X
M)B?\GF>"/^V__HLU^_\ 0 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!YO^T9K\WAOX(^,[VW'[]=+N C9QM)C(S^%?AA^
MP;X+L/C'^UAX7TOQ,#J%O=/+<3>=\Q=D7<"?Q%?NU\>/#_\ PE'P=\8:<L9D
MFFTNX$2KU+^6<?K7X4_L0^++'X#_ +77AV^\72C2H+"66VN&FXV,R[0#^)H
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MRRNF_=VH;]\%!PPIO8#Z&HHHK, HHHH *3KP>12T4 94GA729KT7;V$+7/\
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MZU\:?\$9]:O5\?:QI@FQ8M!)*T7JP YH _7RBBB@ HHHH _,?_@H+^WA\0O
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH YWQ[HHUSPW<0D9\LB89_V<FO&OC$
MJ>+_ -GF?6F4O<V"%D..1A@*^@[B(3P21GHZE3^(Q7D-EH_]HV?C'P<1B*.,
M>6#T.>36U*7+-2\SKPDXT\1"<MKJ_IU_ Z;X)^*5\6?#O2;I3DQPI$WU"BN\
MKYQ_93\3(LNK^&XS\EI-(<>X.*^CJ*T>2HT<*4H3G2F_>@VGZH****Q+"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK6(;52) /S]: +]K:QV5M%!"NR*-0JJ.P%2T44 %%%% !1110 4444 %%%%
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M (]?B=_OVO\ )J^BO^"IWPWN?B%^S'=KI\'FWUC>Q76Y1DA%R6%?#G_!)O\
M:*\,?!CQAXCT'Q+>K8+KQC$,L@. R ]: /LS_@K,"?V=[; S_I;?^@U\Y?\
M!&-#_:_B)MIVAS\W;[@K2_X*T?M1>$O&G@O0_!'A37A>:I#>?:;U(0=ODE"
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M9+QDSM$1#8S^.* /W'^.TVH6_P &?&TFE-.FI+I%R;9K7/FB3RSMVX[YZ5^
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MZU2&)_%^H+FZN(\'$9P0F:]Q^&7P)\!_!RS^R^#_  W9Z)#C&V!23^9S7?4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ KC_$WPE\*^*S(][H]JUQ(<M.(AO/XUV%%5&3B[Q=C6G5J49<U.33\C
MA_"_P8\)>$]C6NCVKS(<K-)$"R_0UVX 4  8 I:*)2E)WD[CJUJE:7-4DV_,
M****DQ"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-\I4\K@]*XGX">-/^$?\2K82']Q?$1Y8\*>N:JV@'U112 A@"#D4M2 4444
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M#V<K"T445PF04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 <_XR\":)X_TLZ=KMDE]9D@F-^F17#?\,L_#3_H6K;_OD?X5ZS10
M!Y-_PRS\-/\ H6K;_OD?X4?\,L_#3_H6K;_OD?X5ZS10!Y-_PRS\-/\ H6K;
M_OD?X5TG@KX.^$_A[>-=:#I,5A.RE2T8 X-=K10 4444 %%%% !6!KW@/0/$
MUPDVJ:5:WTJ#"M-$K$#\16_10!2T?1;+P_81V6G6T=I:Q_=BB4*HS["KM%%
M&7K'A?2/$$+Q:EIMK>JW!\Z%6/YD5'HW@_0_#Z*NG:39VFWD-% JM^8%;%%
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M"'1FF64M+O7H<BC0#H5\3Z+"N%O;=!Z*<5I6MW#>1B2"194/1EKD3\*M*/\
MRTF_,5T^DZ3%H]FMO"6*+P-W6D!=HHHI %%%% !1110 4444 %%%% !1110
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M 4444 %%%% !1110 4444 %%-=MJ,?09KY\UKX_:]I^K7=O';0O#'*R(VSJ
M2/Z4TK@?0M%?-O\ PT9X@_Y](?\ OBC_ (:,\0?\^D/_ 'Q3Y6!])5\[_M%^
M-A<7D>B6TA4PD^>H/7(XJC/^T=K_ );#[/"A(P#LZ5Y-K6L7.NZA->73[YI3
MEC32 F\-ZR^A:U:WR$YAD#E0>HSTK[5\,ZVGB+0[/4$P!/&'*@]/:OA8'!S7
MH/@7XQ:QX+T][*#9/"Q! D&2OL*;5P/KRBOFW_AHSQ!_SZ0_]\4?\-&>(/\
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M1110 4444 %%%% !1110 4444 %%%% 'G_QX\87W@/X4^(]=TYBMY8V<DT9
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MYDI<SN>)AZ*P]-0W?5]WU9V]G9Q:?:QV\"".*,851VJ>BBH.D**** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#:+,UM<^((FDEN86P\:JW3\1_.OB3_@F_J4GAW]K*!;0^6K!X,#^Z7 Q7?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1167XD\3:7X1TF?4]8OH=/L(1ND
MGF;"@4 ?-'[6G[ '@;]I#3I]1M[2/0O%BJ674;6,![@@<*Y/:ORKU*]^,O[
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MP8[X1!1$?7'M6E3#*$FN9>7H>_7R^G1G*#K1T>F^J>J>Q]1-:_$#GY++_O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH KWFGVNHQ^7=6\=PG]
MV10P_6J/_")Z+_T"K/\ [\K_ (5\Z?M_?M!>(?V=?A$OB+PY 9[TW,<.W)
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M?_HEJ /PU_X)B_\ )YG@C_MO_P"BS7[_ -?@!_P3$_Y/,\$?]M__ $6:_?\
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BD9@JDD@#U-8U]XR
MT;3;A8)]0@21NB[P::3>Q<82F[15S:HJ"VO;>\4-!/',N,YC8'^53TB=5N%%
M%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** *6M:M;Z#H][J5VVRUM(6GE;T5023^0K\'OVT/VLO&O[37QEN=%T"]N
M6\/6<[6FF66ELX^T(2/FD"GYCG/TK]G/VG]0ET_X"^-GA;:S:7<(3[%"#7XU
M_P#!+/P;#XC_ &J-!O;E5EM[%)6,+KD,Q0X/X4 >Y_!'_@CUJ6O:#9ZCX]U0
M64ER@E$%E+\RJPR <CK7J]U_P1C\ ^2WD:]JGF?P[I1C^5?HV %  & .@I:
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P#!/G_DS?X7_P#8+'_H;5^;7_!9K_DY31/^P''_ .AM7Z2_\$^?^3-_A?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M)(9)&8G))R:^@_V<?&HFBET&XD9YLF6-F/ 4=A5M: >[T445 !1110 4444
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M1110 4444 ?BG_P6:_Y.4T3_ + <?_H;5^DO_!/G_DS?X7_]@L?^AM7YM?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'P;_
M ,%A+B5?V:5A#$1-J-N2O;.ZJ7_!*2XL]!_9UOM4E$<2QQEY9#@=">IKW/\
M;W^!]Y\?/V=M8\/::,ZA#*E[%@9),>3@>YXK\:?!?[57Q)^ OP]\5_"]$&G0
MWJ_9YH;B'$T!!R>>W7]: ,9;R\^)?[6D*7UPUZ][XF,",W/R&X(4?3%?J_\
M\%,-!A\*_L(7VD+L'V2XLHD P.C\XKXC_P""6/P$U#XG_&J3Q?JVG2-HFG#[
M2E])'E'G#YPI]:WO^"E7Q4^)'Q4^.1^%5G:R3Z:LQ2ST^UB):;#<,<=<<\^U
M 'MG_!&66Z;PGXF20L;947RP>F=_-?I=7S3^P/\ L[WG[/?P-TW3-:$9U^XW
M2W+1C "L=RK]17TM0 4444 %%4]7U2VT/2[O4+R18;6UB::61C@*JC)-?E7^
MTQ_P5ZUG3O$USI7PJ@MH[>TD,;W]["LT<I'=10!^L%%?CW\#_P#@L-XTA\1V
ML'Q)M[._TR20(\VGVRP[ 3U-?K)X#\;Z5\1?"FF^(=&N%N+"^A6:-E8' (Z&
M@#H**** "BOS]_;4_P""G%G\$]:N_"'@B&/4/$UL2L]RX62&!A_"P]:^3_!7
M_!87XP66N1R>)ETO4=*W9>&TL5BDQZ YH _;*BO)/V;/VCO#G[2G@&#Q%H,F
MQAB.XMG8%XWP,C%;7QR^->@? /X>ZCXL\02?Z):+D0HP#R$] ,T >@T5^*_Q
M(_X+#?%6_P#$5P_@R/3=,T?=^Z2^LEEDQGN<U]!?LC?\%6HOB-XFT_PO\1HH
M=/U"[ 1-1C58H#)T"X]2: /TFHIJ.)$5E.589!]:=0 45^<W_!0/_@HQKWP)
M\96?A7X:WFG7&HI&3?33PK.L+AL;2#WKV[_@G[^T1XQ_:*^&+:YXRDLY;\'
M:SA$2GYL=!0!]5T444 %<5\;/^2/>-O^P-=_^B6KM:XKXV?\D>\;?]@:[_\
M1+4 ?AK_ ,$Q/^3S/!'_ &W_ /19K]_Z_ #_ ()B?\GF>"/^V_\ Z+-?O_0
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445GZ]JT6AZ3
M<WDKJ@C1F&[N<<"@#S3XL_%B7PCK-C::?(KN,_:$SC'M7INB:I#K.EV]W"X=
M9$!)'KCD5\4>+/$$WB;7KO49OOS/N^E>Y?LY^-/M%K+H4S8\H&6-F/7)Z"K:
MT ]FUC5K?1-/FO+IQ'%&I))JCX1\5V?B_28[ZT<%6R"O<<UY-^T9XT^SVT6@
MPMN$H$LA4],'H:Y7]GOQF-%U]M+E+&.^("DGY4(I6T ^GJ*2EJ0"O)?B_P#%
M:;P?JEAI]FVV3>LDS+S\F>17I>N:Q#H.DW-_<?ZF!-[5\6>+O$$OB+7KJ]DD
M+AY"4SV7/ JHH#[1\/ZU#X@T>UU&#_57";Q6C7@_[.GC82Q2Z)=2[I./LZ^@
M YKWBDP"BBBD 4444 %%%% !45S;QWEO)#*N^-QM93W%2T4!L?F1^T1\+;_X
M=^/KU94:2VNW:XCD5> I/3->45^M_B_P/H_CG2Y;#5[1+B*1=I; W@>Q[5X!
MK7[#?AN:]1M-N)H+8?>264EC^-?28?,H<BC4W1^N99Q9A_8QIXRZDEOT9\-:
M7IESK%]%:6D333RMM5%')-?I-^S+\+9?A?\ #U+>YD+W5\PN9%(P4)'W:F^&
M7[-OA#X9W1OK.U:XOV4*TEPV]1] >E>K !0 !@5Q8S&JNN2&Q\]Q!Q#',H+#
M8=6AN[]1:***\@^$"BBB@ HHHH **** "BBB@ KA/CA_R3#6_P#KD/YBN[KC
M/C!IMSJWP[U>TLX6GN)(P$C09)Y%7#XD<&8)RPE5+?E?Y'Q$:*ZG_A6?B3_H
M#WW_ 'X:C_A6?B3_ * ]]_X#M7K<R[G\_P#U7$?\^Y?<_P#(]=_93_X_-:_Z
MX1_^A-7T57A'[-?AO4]!O-7-_8SVBM#&JM-&5W$,20,U[O7FUOC9^T\-PE3R
MRG&:L]=_5A1116!],%%%% !1110 4444 %%%% !7D'[4OQ@3X,_"35M9B*27
MY3RX8"<,V[@D?2O7F8*I). .I-?D]_P4.^-__"P?B:?#EFSI::"S6[%6^28D
MYS[UZ>7X;ZU747LM6;T8<\['RCJNH2:IJ=U>2$[YY6E.3GJ2?ZU^D/\ P35^
M.8UK1[KP)J5RUQJ41:YMRYZ1 8VU^:==Y\$_B-??"_XB:3K5E<?9U6=%G;UB
MW#</RK[G&X98F@Z?7H>G5ASQL?N_16'X)\76/COPMIVO::_F65]$)8VSGBMR
MOS1IQ=F>*%%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\]^,?QW
M\%_ ?PZVL>,=7BTNUQ\@8;F<]@ .>M=AXDUR'PUX?U+5KC_46-O)<R?[J*6/
MZ"OY^?VE?B_XJ_:Y^/\ >VNFW$VI6$UX8=,LX22JQDCG'?% '[;?LX_M+>'/
MVD?#T^K: 1Y44C+M[X!QGFO7;JXCL[:6>4[8HD+LWH ,DU\N?L&_LCW'[+_@
M,QZEJ"7VJZA&'F\G(1,X;&#W%?2_B+2SKF@ZCIP?R_M=O) 6] RE2?UH ^;M
M'_X*'?"B\^*&H^"K[6(["]@F$$$K E9F],]!7TY9W<%_:Q7%O(LT$BATD0Y!
M!Z&OPG_;2_8%\9?LXWUUXQM;O^U_#4\[2BZM]YDM,G@2,>^3P:^H?^"2O[5F
MI^*!>_#/Q%>-/]CA-S:75R^YGRV-F3S0!^GM%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110!^/'_!;;_DKWP^_[ TW_HZOMO\
MX)@_\F9^"OK/_P"C#7Q)_P %MO\ DKWP^_[ TW_HZOMO_@F#_P F9^"OK/\
M^C#0!]64444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%5M2_P"0;=_]<G_]!-6:K:E_R#;O_KD__H)H \N_9U_Y%.;_ *[R?^A5ZU7D
MO[.O_(IS?]=Y/_0J]:JI;FE3X@HHHJ3,**** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-*1@?,?UK\^O^"4O_)Y?AK_KSN__ $77[,_M0?\ )O\ XX_[!S_S% 'Y4_\
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M/?F@#]HZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!<?M!ZK+;S(8K##(R_>]1]:]K\0>!]$\42+)JFGQW;J,!GSQ^58__"FO!O\
MT [?\S_C71&I!*SC<]*EBJ-."C*BF^]V>"?#KXM:CX/TE[2%+5D:1G_>'!Y.
M:[K0OCYJ.H:M:VLT5GLED"'RVR>37H/_  IKP;_T [?]?\:FL_A+X3L;B.>#
M1H(Y8SN5AG@_G3]I"WPE?6Z/+RNBF^]V=<#D TM)TI:YCRPHHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M,$#)'H<5^?O_  6 \6:?XP_:(T.VTJX2\DL=-^R2K&<D2>83M^O->#$_'?\
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MBO5?^"6_[/O@;Q)\-8M?\2>![:X\0VSEH;Z^MV$B_,1E<XH _0;6-!MOB/\
M#VZTC5=WV36=/,%SY)VG;(F&P>W6OCI?^".GP, YG\1'_M__ /L:^YX84MX4
MBC4)&@"JHZ #M3Z /A7_ (<Z_ O_ )[>(O\ P/\ _L:P/B%_P23^"/A;P!XE
MUBVE\0?:[#3KBZA+WV5#I&67(QR,BOT)KBOC9_R1[QM_V!KO_P!$M0!^&O\
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MHHKY4_$PHHHH **** "BBB@ KE/BE<2VO@'69(9&BD$#8=#@CZ5U=<A\6O\
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MMM_R5[X??]@:;_T=7VW_ ,$P?^3,_!7UG_\ 1AKXD_X+;?\ )7OA]_V!IO\
MT=7VW_P3!_Y,S\%?6?\ ]&&@#ZLHHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH _/[]M[7+NX^*[6!F?['!;1,L.?EW$')Q7SE7UG^W'\-[Z/Q#%XNB
M1GLYT2W8(,X*CJ?2ODVOL\'*+H1Y3^@\@J4ZF6T?9]%9^O42O:/V4_&%QX5^
M)UHL6\I>8@95Z<GK7B]?2_[&7PSNM=\7-K=U;E=.MTS'*1U<'M5XJ48T9<QO
MG%2E3P%5UMK'WO1117Q)_.H4444 %%%% !1110 4444 %(3CDTM177_'M+_N
M'^5 GL9=SXRT*SF:&?5K.*5>J/* 147_  GGAW_H-6/_ '^6OB_QK=2_\)+J
M&7R3*2<UA?:I?[WZ"NY8=-7N?F%7C"M3J2@J*T?=GWG:>,-$O[A8+;5;2>9O
MNQQR@D_A6Q7Q!\+;F4^-]-^?!#DC K[;@YAC)Z[1_*N>I3]F['UN29K/-:4J
MDX<K3MH24445B?1A1110 4444 %%%% !1110 5\J_M_?'$?#7X8OHNG78@U[
M4BNQ<_\ +')#?6OJJOSD_:L_9=^-GQR^*%WJD6DVMQI5L6AL7:\53Y6<C(/2
MO4RZ%*5=.M))+74VHI.7O,^ 9)#+(SMU8Y-6-+U*XTC4+>]M7,5S XDC<=F'
M0U]'_P##NWXT_P#0"M/_  .2C_AW;\:?^@%:?^!R5]U]<PW_ #\7WGJ^TAW/
MT2_9!^,5M\7OA#IDXF:;4M/B2WO68YS)C.:]PKX3_8C_ &?_ (P? OQU+!K]
MA;V?A2[1GN/+NE<^8%PO K[LKX#'4Z=.O+V4DXO70\FJDI/E>@4445P&0444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?B
MG_P6:_Y.4T3_ + <?_H;5^DO_!/G_DS?X7_]@L?^AM7YM?\ !9K_ ).4T3_L
M!Q_^AM7Z2_\ !/G_ ),W^%__ &"Q_P"AM0!]#T44R:9;>%Y7.$12S'V% 'G7
MQQ\9KX9\*R6T;E+R[7;$P/3'6ODR21I)6<DEB22?QKN_B_XP?Q;XIN&AD,ME
M"Q2'O@=ZX+:?0_E6B ]S_9Q\:"UO)="F)(G)D5V/ P.E?15?"6AZC/H^IV]U
M"TD;1N"2O7&1D5]I>#_$D'BKP_:ZC!]V1<$=P1P:F0&W1114@%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "9GX*^L_P#Z,- 'U91110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQZXJ2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH _%/_ (+-?\G*:)_V X__ $-J_27_ ()\_P#)F_PO_P"P6/\ T-J_
M-K_@LU_R<IHG_8#C_P#0VK])?^"?/_)F_P +_P#L%C_T-J /H>JNI6@OK">W
M9MB2(58^Q'-6JAO+5;VVD@<LJN-I*G!H \=_X49X9!.=07.?4_XUROB+X6Z'
MIOB"QM(;M6BE=59L],UZO_PIW1>?W]]R<_Z\U#-\$?#\\BR/)>,ZG()G-5<#
MF6^!OA@,?^)@H_'_ .O7H7@?PM:>%=+%M93^=!V-9)^#NBG_ );WW_?\UTOA
M[PW;>&K7R+5YG3_IL^XT7 UJ***D HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^;_VQ/VPK
M3]D_1M*O[K2AJ8OY_)5=Q&.,YXKZ0K\QO^"U7_(E^#?^OYO_ $ T ?:?[+?[
M15M^TIX#F\26MBMC''*(O+5BW49KV:OSO_X):_&#P1X4^ ][9ZMXGT_3[I;M
M2T,\H5A\M?9?_#17PT_Z'72/^_XH ]%HKSK_ (:*^&G_ $.ND?\ ?\4?\-%?
M#3_H==(_[_B@#T6BN?\ "OQ \.>.$D?0-9M=66,9<VS[MOUKH* "BBB@ JAJ
MFO:=HL+27U];VB+R?.D5?YFN9^,7Q*LOA/\ #S6/$E\X1;2W=HP?XI-I*C\Z
M_!?Q]\6OBY^V=\4&.F#4M0N9)&%M8:>S*$4^H4]<4 ?T%:3XFTG7(P]AJ-M=
M \8CE5C^6:TZ_G9N&^-O['?CBPU;4TU?1KN-E:/[<SF*0]=N">O%?MS^R+^T
M);?M&_"'3?$*NKZG$B1:@$P )B,G@=* /;:**K:EJ$.DZ?<7ER_EV\"&21O1
M0,DT .NKZWL8S)<SQ6Z?WI7"C\S67IOC;0=6F>*TU>SFD4X*K.N?YU^)G[<7
M[7GC?X^?%C4_!7ANXN4T*SNS;VMO8L5>?!&#E3R*\@\5?!7XZ_!/3+'Q9JVG
M>(-)MEQ,+B223:@'(+<]* /Z+ 0P!!R*6OA[_@FK^V-??'_PC+X;\47,<WB?
M31\A0 %H%  )'<^]=C_P4*_:Q;]FGX7F'2+F.W\7:LA&G^8 PV@X<XH ^EM4
M\9Z'HK!;W5;2W?IM:90?RS6C8ZE::E$LEI<PW,;#(:)PPQ^%?SL>$?AW\;OV
MEM0U'7M%MM<UMF+223V\DGEEL\JN#7<?LU_M+?$K]D?XN0:/KAOEM)[I;>]T
M_4&+LFY@I(W'C% '[\57O-1M=/C+W5S#;(!DM*X4?K7-W/Q*T>V^'S>+S.IT
ML6WVCS >.G3\Z_"K]IO]JKXC?M7?%"32M)DO?L45TT&GZ;IQ*/(02H)VGG-
M'[QV/CSP]J5T;:WUBSDFQG8)UR?UK<219%#(P93T*G(K^=KQI^S;\>/AAX;M
MO$VKZ3XBL+, .\S22 P-U ;GK7W%_P $T/V\]8\6>(;7X9>.+L7=S.5ATJ;&
M'+=PQ[T ?J+1110 5Q7QL_Y(]XV_[ UW_P"B6KM:XKXV?\D>\;?]@:[_ /1+
M4 ?AK_P3$_Y/,\$?]M__ $6:_?\ K\ /^"8G_)YG@C_MO_Z+-?O_ $ %%%%
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M\Z^!J:FG@\C54ECN?-/$O7&*]%KFDN5V/M,+6^L48UK6YE>P4445)U!1110
M4444 ,FF2WA>65@D:#<S-T ]:_(/]O3XU2?%#XMW.EQ%6T[0W:WMI%;(D!YS
M7ZS>,M$F\2>$]6TJWG^S37MM) LQ_@+ C/ZU\ S?\$L=8NIY)9?&%H\DC%F9
MHW).37NY54P]";JUI6:V.K#RA%\TF?GW74_#/QK=_#_QII6LVEQ);?9[A'E,
M?\2!@2OXBO5_BM^SGIOPI^+&E^!K_P 0VL]Q=2(LUXI(2W5AD,PKWJS_ ."6
M]_J-G#=6WC&QE@F021R)&Q!4C((-?6U,;AHP3J2TD>A*I"VKW/O?X7>/K/XG
M^ ](\36!'V;4(1(H!SCL1755X[^S1\$+_P"!/@W^P;S54U1%P(S&"%4#V->Q
M5^=UE"-22INZZ'CRM=V"BBBL20HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@#\>/^"VW_)7OA]_V!IO_1U?;?\ P3!_Y,S\%?6?_P!&
M&OB3_@MM_P E>^'W_8&F_P#1U?;?_!,'_DS/P5]9_P#T8: /JRBBB@ HHHH
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M "BBB@ HHHH **** /Q3_P""S7_)RFB?]@./_P!#:OTE_P""?/\ R9O\+_\
ML%C_ -#:OS:_X+-?\G*:)_V X_\ T-J_27_@GS_R9O\ "_\ [!8_]#:@#Z'H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7WA'5M-MQ+8:/J/VJZD_N(0P!_6M[]JO]J?QI^V_\3H_"'A*&X;PX)_+M;"
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M='$,"@Y8_E7E.A52NX/[CGY9=CTNBBBL"0HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y[
MQ;\/_#_CJ&*+7=*MM3CC;<BW,0< ^HR*Z&B@#'\,^$M)\'V36FCV,-A;,=QC
M@0*,_05L444 %%%% !1110 4444 ?)7_  4X^%]]\4?V8]1M-.@::ZL;J.^.
MU<D(@)8_2OSJ_P""8?[5V@_L\>.]6T7Q$IATWQ$T:M?,P$<!0'!;-?N%J&GV
M^K6%Q97<*SVMQ&T4L3C(=2,$'\*_-#]HC_@D'8>(O$VI:]\/M1-BM[(9!I#!
M(X(#W"GTH \__P""IW[87A'XM>%=&\%^#K\:@;:[^U7%Y X:-E*XVC'?->X_
M\$??A3?>#?@[KGB#5(0AU>Z2>S;'_+'9US^%>4?!O_@CI=P^(;"^\=:KML[>
M99)+.!DD2< _=;V-?J)X7\):9X*\,V>A:-:QV6G6<(AAAC& J@8% 'FWB[]K
M;X6>!O$%SHFM>+M.L-3MR!+;S3JK*3TR*Z3XLZ2GQ'^"OB2QL,7::OI$JVY3
MG?OCRI'YBOSI_:<_X)A^/OC!\;O$7BW2I[5+'494=5>=0>  >OL*_37P#H4O
MA?P-X?T>;!FT_3X+5\'(W)&JG^5 '\^_[//Q&?\ 8_\ VHK?5=:LY;AM%GEL
MKF%<!ANPI)SZ"OTE_;0_;\^'6H?L[:WHWAS58]4UGQ!8F")+:4,;=C@_/BNA
M_:__ ."9OAC]H#Q!)XMT"Y/A_P 0NK&XBMT4)>.?XW)[U\M>$_\ @C7XMO-6
M\O7]82PL-W^NMI$=\9]* ,C_ ((^_"W4=>^--]XSN(?,T>SM)(#(1G,QP17<
M_P#!:+X=7RZ]X/\ %5C8R26 @D2\N47Y8W+ +N/OBOT8^ /P#\,_L\^ [3PU
MX<M8XD109YP@#3R8P7;W-;?Q6^%>@?&3P7?^&?$=G'>:?=IM(=0VT]B* /SZ
M_P"";_[<G@?PK\%H/!?C+4X])U+3))95N;APJ2HQ^51GO@5\<?MW?'[3_P!J
MK]H2SFT.&2*SM2NDP2N01+F3 =<=N:^AOB)_P1KU^UU:8^$M9%]9/(67[4Z1
ME%)X ^E>U_LI_P#!*70?A9XLL?%GC:Y_MV^M!F+2ID5X%DZB3([@CB@#Z>_9
M<\%)\ _V9_"^B:S,EHNE61>>64[0,DMD_G7Y$_MJ?MB:W^U1\3_^$9L+W^PO
M!]M=FVA2=]BLP)5I'(/W>^*_8;]JKX;:_P#%CX%^(_"/A>X%EJNHPK%%/YFS
M8 0>OX5^7?\ PYY^)LGS27EHTC<LQN5Y/<T ?1_[')_9M_9F\&6<LGB[1M0\
M7W,:O?WDUPD@63&#Y>?NBOK+PC^UI\+?'7B:PT#1?%VG7^K7S[+>VAG5G<^@
M%?E]_P .=_B5_P _5G_X$)7J/[+O_!,/QY\&_P!H#P7XTU6>UDT[1[O[3*J3
MJ6^Z0, ?4T ?JC1110 5Q?QJ8K\'_&Q!(/\ 8MYT_P"N+5VE<5\;/^2/>-O^
MP-=_^B6H _#7_@F)_P GF>"/^V__ *+-?O\ U^ '_!,3_D\SP1_VW_\ 19K]
M_P"@ HHHH **** "BBB@!DT?FPNG]Y2/S%?&GQ.\)S>%/%%W;.I,;-O1\<'.
M3Q7V=7,>-OA_IOCFQ,%XFR3^&91\PIIV ^**55+' &:]?UC]G+Q!%=N+#RKF
M#/RL\BH<>O2NG\#_ +.QM;A+G7906C((ACP5;ZU=T!>_9S\(S:7IUSJ\JE/M
M.8U5A@X!R#7M-0V=G#8VZ001K'$@P%4<5-4, HHHI %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !161XL\5:?X+\/WFL:G+Y5G:I
MO=AR?P%?#/Q6_;&\0>)KJ:VT!CI5FK$1SPL0[#L:ZZ&&J8A^[L>YEF3XK-9/
MV*M%;M['W[6)XTL9M2\*ZG;6^?.DA*KCUK\XO#'[2WCOP]J2W,NN76I1@Y,-
MU*2IK[5^ 7[0^G_&33W@F1+'6H5W2V_12#P"N>M;UL%5PZY]T>CF'#V,RI+$
M.THKJNGJ?G7XNMI+/Q-J<$O,D=PZM]<FLBOL#]IS]F"_N-5N?$GAJU1[9D,M
MS&IPQ;J2!WKY.DT+48F"O8W"L>@:%@?Y5]+0K0K04HL_7\MS"AF&'C4IRUMJ
MNS*%?<?[#-KY'@/6;VY=4LEG*OYGW2-O)/M7S)\*_@7XD^)VM"UM;*2WMX\-
M--,I0!?;(Y-?1_[1&J0_!/X2Z?X+T%Q8W=PJ-/-#PTG9L_6N3&256V'B]7^!
MX6?5H8U0RNC*\YM7\DNK/-/VD-<^%NH>)KW^Q;.>34MW[VXM7 @8_P"R!7C/
MA"Y\,V^J(WB"UNKBRW_,MN^&V_XUS3,6Y)S25VTZ*IPY+L^BPV!CAL.L.IR>
MEKMZ_P# /U%^!NL>"]1\'V:^$!%%;K& T)(,R\='([UZ37YA_L]_%"\^&_CZ
MQFC=GM+A_)E@)^4EL $U^G,,GFPH_P#>4&OEL9AW0J;W3/Q;B#*Y9;BOB<HS
MU3>_G<?1117GGRX5A>./^12U;_KW?^5;M07UG'J%G-;3+NBE4HP]B*:W,JL7
M.G**ZH_/IXV+9VGFF^6_]TU]@']G[PSDD1$?\!%'_#/OAG_GF?\ OD5Z'UB)
M^1?ZI8[NCQK]F52OQ&Y&,VLF/R%?2OCCQ*/"/A>^U9D,@MUW;1WYK,\(_"W1
M?!M\;RQA N"I7?M .#VJK\</^28:W_UR'\Q7-.2J5$?;8#"5\HRNI";7,N9Z
M>AY4W[4%YN/^AJ!]%_QI/^&H;S_GT7\E_P :\ -%=GL8=C\V_P!8<R_Y^GV-
M\(_BI+\1)+Z.:W\E[=%<'C!!)';Z5N?$SQP/ /A_^T#$927V #UKR/\ 93_X
M_-:_ZX1_^A-78?M*_P#(A)_UW'\JY)12J\O0_0\+C\14R-XN4O?L]?1G$?\
M#4%X.MFN?HO^-'_#4%Y_SYK^2_XUX!177[&'8_//]8<R_P"?I]I?";XD/\0M
M-GFEA\J2.3;VQ^E=]7A/[+?_ " ;S_KJ:]VKSZB49-(_7,GQ%3$X&G5JN\F@
MHHHK,]D*^0OVU?V9?%7QSU*PGT"ZAACAV[UESS@8[5]>T5T8>O/#U%4ANBXR
M<'='Y0_\.X_B9_T$+3_OIZ/^'<?Q,_Z"%I_WT]?J]4<\\=K"\LKK'&@W,S'
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M,J<K:Z;'ERQ$VFF%%%%>&<H4444 %%%% !1110 4444 %%%% !1110 4444
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M?]]FO?:*V]K/N?/2R#+IR<G25V>,>%?V=[;P_KEM?O=-*L)SMW&O954(H4=
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "N*^-G_)'O&W_8&N__ $2U
M=K7%?&S_ )(]XV_[ UW_ .B6H _#7_@F)_R>9X(_[;_^BS7[_P!?@!_P3$_Y
M/,\$?]M__19K]_Z "BBB@ HHHH **** "N9\;>/=-\#Z<UQ>2 RX_=PYY<^E
M='-)Y4+O_=4G]*^-/B=XLF\5>*;JY:0F-6V(H)VC&0<4TK@=IKG[1FKWDVZP
M06D>[.UB#QZ5T_@O]HJ"[O(K36(?)60X^T[AA:^=:%8KT-79 ??%K=17D"30
MN)(W&59>]2UXO^SGXNEU339](E<R&U!D5F.3@G&/I7M%0 4444@"BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Y)_;P\57=EI>BZ7
M:7#103E_M"+_ !<< U\3U]T_MR>!;[7/#NF:U91!X-/WFY/H".#7PM7UV7\O
MU=6/W7A:5-Y9!0W5[^M^H5WGP1\32^%?B5H=\DK1HDZ[P#P1[UP=>F?L^>"[
MKQE\3='@BMVEMHIE>=@,A%YY-=M:RIRYMK'T.-=..%J.K\-G?[C].-/NEU'3
M[>XP"LT8?\QFLO4O VAZO=+<76G0R2KT;:!6Q9VRV=K# GW(U"#Z"IJ^&NT]
M#^;E4E"3=-V(+2QM[&)8[>%(448 10*^0?V\/"-Q<2:9X@5&-O"BV[-V!)K[
M%KG/'W@?3_B#X;N='U&/?#*,J?[K8X-=&'K>QJJ;/4RG'?V?C88F6J6_H]S\
ME**]J^*W[+_BGP#J(^RV<FJV<K$HUHC2%1[X%<-I/PC\6ZQ>Q6\.A7RF1]F]
MH&VK[DU]A&M3E'F4M#][I8_"UJ:K0J+E]2G\.M O/$?C#2[2RB,LOVB-R%[*
M&!)K]8[1/+M84Z;44?I7SU^S7^S&OPQF_MW6G6XUAEQ$J'Y44CN/6OHNOF<P
MQ$:TTH;(_'^*,TI9AB(PH.\8=>[>X4445Y9\6%0WEW%86LUS,VR*)2[,>P%3
M5A^./^12U;_KW?\ E36YE5DX4Y271'*_\+Y\)GIJ,9'K1_POCPG_ -!"/\Z^
M-Y"=YYIM=_U>)^2_ZW8W^6)]Q^%OB=H/BZ^-EI]XDMT%+^6.N!WJA\<>/A?K
M?_7(?S%>$?LR<_$;Z6LG\J^J=2TVWU:REM+J,202##*1P:YIQ5*:L?;9;BJN
M<Y;.52RE+FC^!^?;(?4?F*38?;\Q7VJ?@SX9))^QC\A2?\*8\,_\^8_(5T_6
M(]CXS_5#%_SH\P_95&V\UD?],(__ $)JZ_\ :6_Y$)/^NX_E7?>&O!NE^$_-
M_LZ 0F7[Y '-7=:T.S\069M;V)983SM85S2J)U.<^UP^55*64O .2YFGKTU=
MSX!,9]1^8I-A]OS%?:G_  I?PS_SY_RH_P"%,>&?^?,?D*Z?K$3XK_5#%_SH
MX3]EOC0[P=Q*:]VK'\-^%=/\*VK6^GPB*-FW'BMBN*<N:3:/TC+,++!82%";
MNT%%%%0>H%%%% ''?%KXD:=\*/ >I^(]3E$5O;(0I)ZN0=H_.OAGQA^WY!XP
M_9ZU73W)@\4WJ21*P;!0;OE./I47_!2OXZ->WUIX%TF[CELE4MJ$8.2LJMP/
M;BO@)06(6OL,MRV$J*JU5K>Z/1HT4XJ4AUQ/)=3232L7D=BS,>I)[UUGPE^(
M&H?#/QYI6O:9,8+B"4 N/[I(#?I447PI\830QRQ^'-0>*10R.L!PP/0BJVJ?
M#OQ-H=D][J&B7ME:H?FFFB*J/QKZ:3A-.#:U.VZ>A^BGQ8_;,\&Z]XU\&>')
MH(]3T>62,ZA<EAM0,HS^M>Z^+/A[\+O#G@&\\3G2;1;,6C7%O)TWG:2H'UXK
M\6&GD:0.SDN.C=Z^C/B#^UQJ?CKX!Z=X!N"T4UH\>)XL@M&@QM)KY^ME;C[.
M-%M+K_F<<J%K<IJ_LV_%+0-:_:#GC\1V$,6@:S.<I)C;#@?*#^E?H'\3/A_\
M./AUX U7Q.VAVK"TMFN(5S@R'&0!]:_%ZRO)+&\AN(W9)(W#AE.#D'-?3OQ^
M_:^G^,'P?\/>&5\VUO;)P+AX\J)4";0#Z]*UQF!G4K4Y4VU'9EU*3E)6/O;]
MC_\ :&M?CMX-O)%M5TR6PF\B*T+ GRP.HKZ!K\7OV-_C4?@W\7;"ZN'E?3[S
M_17@4_+ER &(K]G+>X2ZMXYHF#QNH964Y!!KYO,\+]5K>[\+V.*O3]G+38EH
MHHKR#G"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MI_\ XJC_ (9]_:3_ .A6\<_]]3__ !5 ']#_ /:EG_S]P?\ ?Q?\:/[4L_\
MG[@_[^+_ (U_/!_PS[^TG_T*WCG_ +ZG_P#BJ/\ AGW]I/\ Z%;QS_WU/_\
M%4 ?T/\ ]J6?_/W!_P!_%_QH_M2S_P"?N#_OXO\ C7\\'_#/O[2?_0K>.?\
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M[ZG_ /BJ /Z'_P"U+/\ Y^X/^_B_XT?VI9_\_<'_ '\7_&OYX/\ AGW]I/\
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M_/W!_P!_%_QK^>#_ (9]_:3_ .A6\<_]]3__ !5'_#/O[2?_ $*WCG_OJ?\
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M^&??VD_^A6\<_P#?4_\ \51_PS[^TG_T*WCG_OJ?_P"*H _H?_M2S_Y^X/\
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M_P#?4_\ \51_PS[^TG_T*WCG_OJ?_P"*H _H?_M2S_Y^X/\ OXO^-']J6?\
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M_P!"MXY_[ZG_ /BJ/^&??VD_^A6\<_\ ?4__ ,50!_0__:EG_P _<'_?Q?\
M&C^U+/\ Y^X/^_B_XU_/!_PS[^TG_P!"MXY_[ZG_ /BJ/^&??VD_^A6\<_\
M?4__ ,50!_0__:EG_P _<'_?Q?\ &C^U+/\ Y^X/^_B_XU_/!_PS[^TG_P!"
MMXY_[ZG_ /BJ/^&??VD_^A6\<_\ ?4__ ,50!_0__:EG_P _<'_?Q?\ &C^U
M+/\ Y^X/^_B_XU_/!_PS[^TG_P!"MXY_[ZG_ /BJ/^&??VD_^A6\<_\ ?4__
M ,50!_0__:EG_P _<'_?Q?\ &C^U+/\ Y^X/^_B_XU_/!_PS[^TG_P!"MXY_
M[ZG_ /BJ/^&??VD_^A6\<_\ ?4__ ,50!_0__:EG_P _<'_?Q?\ &C^U+/\
MY^X/^_B_XU_/!_PS[^TG_P!"MXY_[ZG_ /BJ/^&??VD_^A6\<_\ ?4__ ,50
M!_0__:EG_P _<'_?Q?\ &C^U+/\ Y^X/^_B_XU_/!_PS[^TG_P!"MXY_[ZG_
M /BJ@U#X&?M%Z3I]U?WGASQO;6=K&9III'F"QH.2Q.[H* /Z*8[^VF<)'<12
M.?X5<$U/7X._\$R?%FNZM^V)X0@O=;U&[@:.XW13W4CJW[L]037[Q4 %%%%
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M>.2,Y# ]P:_$W_@HI^PKH_[,NG:1XG\*2L-%O;C[-]G9BSQN%SN)/X5]K_\
M!)WXV7OQ0^!MYI&I2,T_AZ>.RA,C;B\>S.<_E0!]QT45S/Q-\5-X'^'OB+Q
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M^3S/!'_;?_T6:_?^OP _X)B?\GF>"/\ MO\ ^BS7[_T %%%% !1110 4444
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MO>']-U*-@R7=O'."O3YE!_K6C0 4444 ?CQ_P6V_Y*]\/O\ L#3?^CJ^V_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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ME)8C;@$^E?2G[.?_  2;TSXZ?!/PIX[E\?W6F3:U;?:&LX[-76+YB,;B>>E
M'T[_ ,/CO@?_ ,^GB+_P"'_Q5'_#X[X'_P#/IXB_\ A_\57E/_#D'2O^BFWG
M_@ G^-'_  Y!TK_HIMY_X )_C0!ZM_P^.^!__/IXB_\  (?_ !5'_#X[X'_\
M^GB+_P  A_\ %5Y3_P .0=*_Z*;>?^ "?XT?\.0=*_Z*;>?^ "?XT >K?\/C
MO@?_ ,^GB+_P"'_Q5'_#X[X'_P#/IXB_\ A_\57E/_#D'2O^BFWG_@ G^-'_
M  Y!TK_HIMY_X )_C0!ZM_P^.^!__/IXB_\  (?_ !5'_#X[X'_\^GB+_P
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M^ "?XT?\.0=*_P"BFWG_ ( )_C0!ZM_P^.^!_P#SZ>(O_ (?_%4?\/CO@?\
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M;_A\=\#_ /GT\1?^ 0_^*H_X?'? _P#Y]/$7_@$/_BJ\I_X<@Z5_T4V\_P#
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M'S">59@>E?FC_P .Q/VB/^A(_P#)N/\ QH_X=B?M$?\ 0D?^3<?^- '[E?\
M"Z_A]_T.WA__ ,&4/_Q5'_"Z_A]_T.WA_P#\&4/_ ,57X:_\.Q/VB/\ H2/_
M ";C_P :/^'8G[1'_0D?^3<?^- '[E?\+K^'W_0[>'__  90_P#Q51W'QD^'
MEU;R0OXV\/E)%*-_Q,H>A&/[U?AS_P .Q/VB/^A(_P#)N/\ QH_X=B?M$?\
M0D?^3<?^- 'Z1?$B?PIIOB5H](\4Z-J4-RQ:"&TO$D<>Q -8&PCJ"/PKX+T/
M_@G#^TOX;U*'4-,\(R6EY"<I+'>1@C]:];TW]GS]LRSLWBFT.>Z<KM61[R+*
M_K5J0'TQ'?:7:W]O!J>L6.D>:P :]F$8QGKS7U5X)\??#OP7X?M=-7QOX>=X
MURT@U*'YL\_WJ_'WQQ^PG^U?\1KA)?$/AZ?43'P@DO(L*/0<URO_  [$_:(_
MZ$C_ ,FX_P#&DW<#]Q+SXP?#J_M9;>;QKX?:*52K#^TH>A_X%7@?CKP[X'6X
M:]T;Q]X;%JQ):.74H]P/M@U^.WQJ_8]^*?[/GAVTUSQQX=_LG3;J?[-%+YZ2
M9DP3C /' J'X(_LD_$[]HC1]2U/P)X?_ +7LM/F6"XD\](]KD9 ^8\\4KV _
M5:Q/AN^O3;+XU\.1L.-SZBFW\Z]J^'=M\,?"*_:=4\;>&[^\D3:5.HPF,#V!
M/6OR&_X=B?M$?]"1_P"3<?\ C1_P[$_:(_Z$C_R;C_QIW _9&^G^#E]>BX/B
MWP_&1_ FHP!?_0JZ71/B)\+/#\>VR\6>&X6Q@NNH0AC]3NK\2?\ AV)^T1_T
M)'_DW'_C1_P[$_:(_P"A(_\ )N/_ !I7 _<K_A=?P^_Z';P__P"#*'_XJC_A
M=?P^_P"AV\/_ /@RA_\ BJ_#7_AV)^T1_P!"1_Y-Q_XT?\.Q/VB/^A(_\FX_
M\:0'[E?\+K^'W_0[>'__  90_P#Q5'_"Z_A]_P!#MX?_ /!E#_\ %5^&O_#L
M3]HC_H2/_)N/_&C_ (=B?M$?]"1_Y-Q_XT ?N5_PNOX??]#MX?\ _!E#_P#%
M4?\ "Z_A]_T.WA__ ,&4/_Q5?AK_ ,.Q/VB/^A(_\FX_\:/^'8G[1'_0D?\
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M]HC_ *$C_P FX_\ &C_AV)^T1_T)'_DW'_C0!^Y7_"Z_A]_T.WA__P &4/\
M\51_PNOX??\ 0[>'_P#P90__ !5?AK_P[$_:(_Z$C_R;C_QH_P"'8G[1'_0D
M?^3<?^- '[E?\+K^'W_0[>'_ /P90_\ Q5'_  NOX??]#MX?_P#!E#_\57X:
M_P##L3]HC_H2/_)N/_&C_AV)^T1_T)'_ )-Q_P"- '[E?\+K^'W_ $.WA_\
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M )DCWXO(_P#&D_X=B?M$?]"1_P"3<?\ C0!^Y7_"Z_A]_P!#MX?_ /!E#_\
M%4?\+K^'W_0[>'__  90_P#Q5?AK_P .Q/VB/^A(_P#)N/\ QH_X=B?M$?\
M0D?^3<?^- '[E?\ "Z_A]_T.WA__ ,&4/_Q5'_"Z_A]_T.WA_P#\&4/_ ,57
MX:_\.Q/VB/\ H2/_ ";C_P :/^'8G[1'_0D?^3<?^- '[E?\+K^'W_0[>'__
M  90_P#Q5'_"Z_A]_P!#MX?_ /!E#_\ %5^&O_#L3]HC_H2/_)N/_&C_ (=B
M?M$?]"1_Y-Q_XT ?N5_PNOX??]#MX?\ _!E#_P#%4?\ "Z_A]_T.WA__ ,&4
M/_Q5?AK_ ,.Q/VB/^A(_\FX_\:/^'8G[1'_0D?\ DW'_ (T ?N5_PNOX??\
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M_9=^(_[.^I>/)?'FA'1H]2BMTM29E?S"I8MPIXZB@#]":*** "BBB@ HHHH
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M?@KX^\#?M66.J>(/!VLZ-IHTF[1KN]M'BC#,HVC)'4X-?L]10 4444 %%%%
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MCC3*$#+$8ZU^W]%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^']EXIT"VEO]=\.Q,L5E;J2\R,V6P.^,5]QVMK%96\5O!&L4,2A$C08"J!@
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MZ%Z_GH_;E_Y/@^(7_8=7^24 ?O[X)_Y$S0/^P?;_ /HM:VJQ?!/_ ")F@?\
M8/M__1:UM4 %%%% !1110 4444 %%%% !1110 4444 ?G?\ \%JO^2#^#_\
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MR38\ZXCC"O)CU(H [CP_I::'H.G:=& $M+>. 8_V5 _I6A110 4444 %%%%
M!1110 4444 %%%% !1110!^>?_!:8G_A0'A0=O[<_P#:9K&_X(D$_P#"I_B&
M.W]L0_\ HFMG_@M-_P D!\*?]AO_ -IFL7_@B1_R2?XA_P#88A_]$T ?I-11
M10 4444 %%%% !1110 4444 %%%% !5#7B1H>HD<'[-)_P"@FK]4-?\ ^0#J
M7_7M)_Z": /YZ_V5V(_;@\%$'!_X2D\_]M'K^B.OYW/V6?\ D^#P5_V-)_\
M1CU_1'0 4444 %%%% !1110 4444 %%%% !1110 5^.G_!;-B?C+X!!/ T67
M'_?ZOV+K\<_^"V7_ "6;P%_V!9?_ $=0!]R_\$R23^QGX%S_ '9O_1C5]3U\
ML?\ !,C_ ),S\#?[LW_HPU]3T %%%% !1110 4444 %%%% !1110 4444 %?
MSH>)&/\ PVU=G//_  FHY_[>Q7]%]?SG^)/^3V;K_L=1_P"E8H _HOI:2EH
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M.K"10RD,IY!!R#7\\6A_ OXZ^(/A]/X[@;7Q80!I TDLPF91SN&>>?6OJ/\
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M648&5! K\A/V\OB-IO[4G[4AMOAY;C61.L-G;W,:X>>0+@C'H".M?L5^TI\
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MA_M>>&/VJ? \=]I\L=GXAM4']H:2S[I(#T!SW!QF@#Z HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2 AAD<BODC_
M (*)?M&^,OV?_A2;OPGI,YGNW\G^UE 9("0>V*\N_P"">O\ P4.MOBQ8VO@?
MQ[>I!XKB&RWO)6 ^V=R<=L4 ?H312*P8 @Y!Y!%+0 4444 %%%% !1110 44
M44 %%%% !117+_$GXD^'_A-X/U#Q-XFU&+3-)LDWR3RGCV'XF@#IZ6OQNF_X
M*E>._&'[3^G7&@NUCX'GNH[/^R#AC*@;!DW=MW!Q7[ >'=87Q!H=CJ2QF%;J
M)91&QR5R.E &C1110 4444 %%%% !1110 4444 %%%% !137=8U+,0JJ,DGH
M*^7?C%_P46^$?PGUBXT<Z];ZKJUJYCN;6!\&)AV)QUH ^I**^?\ X#_MM?#+
MX^7:Z=HNN6\>M-C%@S9<Y]*^@* "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@"*YA%Q;RQ'I(A4_B,5^ G[;V@ZA\#?VO=6O+&S-N+::.
MZM9&C(BD)&3@]^M?T 5\_?M:?L>^&/VJ?"8L=1V:=K, )M-45-SQ,1U]Z /(
M?!?_  4F^&%Q^S[!JESJ$T.LVVG"VEM-@#&Y$>#CG[N>]?FE\"]'G_:F_;'M
M+A[>1H]5OFNI6"G"!1D%CVZ5]$7'_!&?Q/%JHMX_$_F6F['VCR0/QQFONK]C
M[]AWPS^RMI$KQRKK7B"?!DU*2/:PXY H ^D-+LQI^FVEJ.D$*1#_ ("H']*M
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?BK_P %
M>/\ DMFF_P# _P"8K]JJ_/S]N+]@?Q)^TE\0[77-+U VL,6X%=H/!Q^O% 'M
M'_!.?_DUOP__ -=9/_9:J?\ !23X6W7Q8_9AUC3;" RWMK<17BE5RP6/)/\
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M/8>&O#UI';V]O&J/(JX,K#^(UWE !1110 4444 %%%% !1110 4444 %%%%
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M[,T?78([T_<AN)55G^G-?G[^S[_P2%OO'7A?4=4^)>MWF@:U)<2Q1VMNBR<
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MY!Z&OPF_;6_8I\2_LG^.(_%?A5[F7PU)<>=9W\ Q);R?>Q@=,9K[/_X)Y_\
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M5U&)(Y(SD8(SBM.O/_@3\);;X(_#/2?"5K>W.H1V:Y:>Z?<Y8@9&?3/2O0*
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M2GFM($QD8X)H \(\7?MT?";P'\3+CP=K?B2ST^6"$2/>/*/+#$\I]17YG_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M V>L8)/I0!\1?L8VOAC]J+XU#QW\<?&UG?:GIZK]@T>>0QDR(P*L5Z$>W?\
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M_P $:+'58_!NO7,V[^RI%VP>F\/S7Z64 9'A+19?#OARPTZ:?[3+;Q+&TO\
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MTI$O<8XQB@#]3?\ @K9\+=1^(G[/ME?6$;NGA^ZDU"<J,[4V8)-?(G_!*O\
M:_\ #_P7U:_\ >*)H],TK6[G[4FISOA$F"A50_6NP_9)_P""EQ\6S0_#3XPV
MD=[HNJ(NGQWP3<2S<'SB3TKD?VN/^"8_B+POKUSXQ^& BU3PI='[2L,3YDB9
MCN C51RM '[%S:]IT.BG57O(5T[R_-^TEODVXZYK\&?BE>6'Q<_;@L1X3C6X
MMY-6BB+VJ_+D2'<W%8O@OP/^TG\0+U_#%M=>+;>W3$9CO99XX,=,<\8K]'?V
M"_\ @G6OP%O#XT\<2IJ'BZ92J6ZL)(8@3D/GKOH ^W/">D/H/AG3=.D;>]M
ML;-ZD"M>BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHJ*ZNHK*WDGGD6*&-2SNQP !WH
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ML5^G/[%G[+=G^S#\*[/29#%<Z_<+OO;N,8W9.0OX4 ?0M%%% !1110 4444
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M>*-#O](U&%;BPO86@GB;HR,,$?E6A45U=0V-K+<7$BPP1(7DD<X"J!DDGZ4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%)7SQ^UM^V1X5_9?\,R27L@OM>F4BWL(6&\-C(+ ]J_+BX_X*Q?'1O%J:O\
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M7XQ?#.'PAX*U:5;^WU1TOA&"H>)05QGTS7U)X9_;R^&7[0WQ6UCX.R),UEJ
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M+PU8-,K;M\=NB%C[X'-=1X=\%Z%X3MUAT?2;/3E48S;P*C'ZD#F@#SW]EWX
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M$5]');ZGKS)J-W;3??A<IC:1V(H ^J=H]*6BB@ HHHH **** "BBB@ HHHH
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M#[H_X>[?!C_GO?\ _@*]26O_  5T^";7,:SW6H1P$_.ZV;L0/7'>OE3]EO\
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M<_9/M_V6_%-CIUMJB:E'=9P54C;QF@#]*/\ A[M\&/\ GO?_ /@*]='\._\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1+<V6JV<^(G@W>7=+V (Z\'M7[N_LY_$36?BE\)M&\0Z]IW]EZE<)B2$J1G
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH X_P",7_))?&?_ &!KS_T2]?SU?LD_\G">%/\ KY/\J_H5^,7_ "27QG_V
M!KS_ -$O7\]7[)/_ "<)X4_Z^3_*@#^CK2/^039?]<$_]!%<]\5_#]IXH^&_
MB33KR!+B*33YR$D&1N$;;3^==#I'_()LO^N"?^@BLWQW<_8_ _B&XP#Y6G7#
MX/0XB8T ?S8^$]<N?A#\7+349E(GTN]+-Y?7@D9'X5^^OQ@\;>([3]FJ#4/"
MMG->:WJFD1^1Y2EF1GA!#<?6OY_KQYOB5\3)/W?V:74+PC;&-VW+=J_HBN_B
M5H'P.^!&B:WXCO5M+*QTBW7<_5V6%>![\4 ?E9^S7_P3_P#&W[07Q0FU/XPC
M5;;2!O:XD9V69WZ@*6'"UVW_  4"_P""?/@+X*_#&/Q;X.^U6T\&X7$4S@HR
M@#!  ZUH>./^"O7BWQCKTVA?#WP6DZ/)LM[I7?S9!V.,<5XI^U&W[4OC7P#)
MXB^(*W5EX+92XM3<*4"]^.M 'I__  1Q^,'B>[^*&I^ [F_>Y\/+ITEY'#*Q
M8QN"  ,GISTIG_!8SX+Q:#XWT#QGI5@%CU"*0ZA.B8_>;@ 2:X[_ ((U?\G.
M:K_V YO_ $):_2+]OOX/?\+C_9TU_3+=,:C"%FAE"Y("G)'Z4 >+_P#!(CXM
M0>)_@6W@Z2[%SJ.C2R3N&?<ZQN_R@^W3%7?^"N'Q./A/]GM=%L+LP:I?WL09
M5.#Y/(;^=?$__!*7XH6_PL_:/O= NV E\0*NF+GC+*Y-6/\ @JU\3)?B5^T3
M9^'=+N3+;:?$+$VR/E3/OQD^^30!VW_!''X-6OB?QQKWC:^L\2Z&8Q9SR1]2
MX.=IJ;_@KY^T)XDA^*=O\-;"_GT_2[*VAOI/LTK1F4R*?E;!Y'M7WC^P-\)!
M\)OV;_"UG=6BVVLSV_F7IQRS9.,_A7S1_P %/OV'_$_QB\06GQ \$6']K:J(
MUM[^WWA"D**<,,]>: ,/]CG_ ()W?!_XJ?!W3?$.LW\VKZUJ5N)+B.*=28"P
MY&,<&O)OCQ_P2R\6>"_B5:P_"Z:YETF9_P!Q<W4I$D1]2RCUKY5\,_%+XR_L
MYZM-I^BZSK7AF:WDQ)#"I"$CJ.1R*^L/A7_P6&\;^%Y;>S\3Z'!KEN2%EN9I
MF$B^IP!0!^C_ .QS\/\ XE?#/X16^A?$_4K75=;@E/DS6LIDQ#@;58GO7NM>
M5_L\?M%^%/VDO \?B+PO=&6-6\JXA=2K1R <C!YQ[UZI0 5^&/\ P5L_Y.:3
M_L')_P"A&OW.K\,?^"MG_)S2?]@Y/_0C0!]Q?\$__P!H;X>^"_V9?">E:SXG
MT[3]0@M@LD,UPJLIST()KMOVD/V\OA?X+^&NM)9ZY#K&H7-L\=O%92+)\Y'&
M<'I7Y?\ P7_X)R_$7XV> =.\6:/$G]G7T?F1,TBC(_&O2M"_X)!_$F\O1'J4
MR65OWD1T8_E0!\F>!;34OBE\=M*DTRSDN+N^UB*Y,4:Y*KYJEC@=@*_H.^*W
MQ*LOV>/@??\ BC5 9(-'LUW*HR2V  !^->(?L<?\$\/"_P"S%<R:Y>7(\0^)
M91\EW-$%-NI RBUA_P#!6#5KJS_9SOK2%V6WN!B51T.&&,T ?E7\0/B?\1OV
MSOC,L/VBYNY]4N1;VMC$S_9X4+84LO0<=37T?JO_  1S^)5CX+>]BU32YM8B
M3S7M_-." ,E1QUJ'_@C1H=EK'Q]\22W<*3/9Z2)H=XZ-YF,BOVGH _GF^ ?[
M0GCG]C7XN1VM_)>+8V<_EW^DRLVW;ZJI/%?LS\<OCN=,_9<O/'.B,%EU'2S+
M;LIYB=X\_@17Y0?\%4O#=GI/[46N7ULRB6\$9DC7'!"CG%??G[*O@V;X]?L*
MW/AO4'9KB>*6"VD?^!M@"T ?FY^R3\,]/_:]^/D=E\3/$UR;>X5Y'D>ZVS.V
M,A5+= 3Q7W9^T5_P2=\!-\-=2U#P$EY!XCL[?=;0[@4F(Z @#FOSP^*G[,GQ
M:_95\4-J$]C=V/V>4BUU.S^8E<\-QG%=S\+?^"DWQJ^&5P/[8UJ]\1VR@!+?
M46*A<?A0!]1?L&?L=_'SX.^/[+Q+<:I;V?A\1&"XTNYN7*D''(C/ (&>?>O9
M/^"G7[)VJ?'_ $/0_$VFWD%L/#=O,)5E;!=6(/'X@5!^R/\ \%1M"^.VMKX>
M\7Z=;^%M;D.RW$,C.DYX .3T)STKZE_:._Y(UXD_Z]S_ "H _G8^&/PWN/B-
M\6-#\$P2K%<ZGJ L%D8X4,21G/X5^U_[#?[$NI_LJWFJ27^H6]]]K9B&A8D\
MC [5^1_[*O\ R>)X#_[&1?\ T-J_HTH **** "OQQ_X+'_\ )1-$^K?^@U^Q
MU?CC_P %C_\ DHFB?5O_ $&@#WS_ ((S_P#)$M9_["4G\A7Z)5^=O_!&?_DB
M6L_]A*3^0K]$J "H;R[BL+.:YF;;#"AD=O0 9-35R/Q>FDM_A3XQEB8I(FD7
M;*PZ@B%L&@#\2O\ @H'^U5XN^-GQOU+P[8ZC);^&=)N6M=/M[%V3SU;',F#\
MQR2*['P!_P $A_B9XO\ !J:S<ZEI=C/>0":T@DD8$9&1NXKYJ_9E@C\4?M!^
M'!K*_;A/=%Y?//WFZY/XU_1UHL:Q:/8(@VHMO&% [ ** /YV](\"_%O]G'XQ
M26.E:?JQU;2KP+,-*CD>.X"-R!@<@U^Y7A#X\&']G&V^)'BZQGT)HK(S75M=
M1^6\9' R#TR<?G7ID?@O0X=8.JII=N-1/6XV?-S7SC_P4RU"6U_9#\:P(A*S
MP*KL.PW T ?C_P#%3XG?$']LKXY/9K=3WS7][]DL;.%G^SQQ[R$9@,@<8)->
M_>,O^"0GQ(\,^ WU>#4=.N]1M83-<VT<A/ &3MX]*^8?V8?B5XC^%7Q&CUSP
MQHG]NZC$@Q;>P.<U]W77_!2?X[W=O<0R?"9=DT;1L"[=",'M0!\]_P#!/C]J
M+Q3\$?CMI_AK4K^XN/#VK7"V5Y:W<C.(-I/,8)^4\5^S?QRNH[[X"^-KF%MT
M4NA73HWJ#"Q%?@9KGA7X@7OQ&;QE:^"Y]/G^TB=;.)&*@Y]<>]?N?XHFN+G]
MD/4I;N,PW3^$G:6,_P +&V.1^= 'X6_L8_\ )Q/A;_KJ:_</]LK_ ),]^)'_
M & '_DM?AY^QC_R<3X6_ZZFOW#_;*_Y,]^)'_8 ?^2T ?C/_ ,$\?^3E-%_W
M#_,5_0<OW1]*_GQ_X)X_\G*:+_N'^8K^@Y?NCZ4 +7XT_P#!3_\ 9+U+P5JV
MJ_%-KJ!K&^O0GE*WS_.W&17[+5\$_P#!87_DW&/_ +"$'_H5 'YI_LA?LCZK
M^U;K6KV&F7L-F=.1'=IGVY!]/RK]*_B]\$YO@#^P=J?@Z[EBN983+(6CY7E*
M^>/^"+/_ "/7C/\ ZXP_S-?<W_!0C_DW'7O^N3_^@F@#\&?A^WB/4M6AT+PU
M)/%?:C(L6;9BKG/&"1SCGFOT9^!__!('Q!INN:!K'C35+&6".59[BVM9"WR]
M0.1R:^6/^"<-E;ZA^U=X7BN8EFB\N4[6'&0!BOZ"8@%C0 8   H _/C_ (*3
M:?\ $G5/".A?#CX=:=J*Z5:PQRR76G[U9U4%1&67MCM7#_LC_P#!++P]XB\#
M_P#"0_%**^;6;SYH[;?C8#G)8$=:^L_VM?VV/"G[+.E^5>[;_P 1RQ^9;Z:<
MC>.<9(Z5\+VW_!1?X^?M%7DEE\//!JZ;+]T-:3L50GI\Q'6@#YI_;H_9SLOV
M5?CC+I/A2]NDTCRHI[2268_:(V9<GD8X]#7ZT?\ !.?XFZO\3/V>=.GUF9KF
MXL-MHLSDEG4+U)/4U^-O[5WAOXQ:'X\,GQDN+BY\0S(K![B99#M(RH&.V*_6
M/_@E'_R;D_\ U]C_ -!H ^+/^"P"C_A<>FM@;MK\X^E>.?LU_LR_%']KW?IV
MD:FUGX:L<-(+J9UMP 0"$7H6KV3_ (+ ?\E@TWZ/_2OL3_@D!801_LFPW:QJ
M)Y=6NE9\<X## _6@#\M_VJOV.?&'[*>N6D&NR6]Y8WH,MM=6;%E"YP QQP:_
M1'_@CW\<=;^('@OQ#X/U6XDNH?#T<;P33,68J['@D^F*B_X+(*O_  K/2VP-
MWF1\_P# Z\\_X(@_\AKXF_\ 7O:_^A-0!QW_  5O^/OB>;XP)X%T[4I['P[;
MV<<SQ0NR&60Y#!L'IQTKU_\ 8]_X)S_![XD_ GP]XFU:YGU;6-:LEGNHTF1O
MLS'C:!CY:C_X*;?L*^+OBMXR7XB^"+<ZE(+9(+O3@0NQ4!)D!/?)Z5^>'A7X
MT?&;X"7<NE:%X@UOPV;23;);PJ0N1VY'2@#ZB^,7_!+CQYX5^,\UE\,99E\/
M-L-E?7,[++&2,D%E'8]Z_2O]G/X=_$OPO\")_"WQ%U2TO?$2P/;6]U92%L1E
M-JEF/\6:_.GX3_\ !8KQEX;N+.Q\5:#!K-H2J3WDLS"5!W8 #FOU)^!?QV\+
M_M!>"8?$?A>\%U;'"3+C!CDQDK0!^*7_  4(_9S\4_ ?QAHL_B/Q'-KZ:TDL
MUL)9VD\@*P!49Z=:T/V//V-O'O[0OA.\U+PSXON/#]I&64QPW;19(;'05[Y_
MP6^_Y&3X9_\ 7I<_^ABO3O\ @CE_R2W4?^NDG_H= &O^W%^T-JG[*/[-OAKP
M!IFKB;QQ+8PVTES(Q9FB VO(#G).>]?GA^S'^R!\0/VR-<U'48;QA96C!KK4
M-3D;=+NSPC'[U>Q?\%C]0EOOVA=#61"@ATKRUSZ;ZQ_V3?VP/BE\#_A^FE>%
M? 8U[3W'%UDC//L* . _:@_8I\??L@-9:Y/?JVG7,GE07VG2L'1L9P2,$5^B
M_P#P2R_:DU/XQ_#.?PQXGN?M.KZ(RV]M.Q+/-$%R6<GJ:^2OV@OVLOB]^T7X
M$;POKGPL$%ON+QS@LQ1B,9Z5?_X)4>'?&?@7]HR/3-2T.>TTJZLIY9+B12 K
M!< ?C0!QW_!6A%'[1EVVT;MJC..?NBN _9U_9:^(O[:-P#::A';Z/I<8B$ET
M["-=O&%]^:] _P""M/\ R<5=?[J_^@BOM'_@C?:PK^S#?3B-1,VM3JTF.2 %
MP* .X_8;_89A_99CU>\U&Z6_U>\D4I)&V0B@8(Z5]>444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !112,P526( '4F@!:_+__ (*G_M9:WIWB*U^$'@V6XMM5D"O>
M36Q(9UD7A%(YSFOTZCNH;D$131R>NQ@<5^(/_!2W3=:^&/[91\7"U\VVV6\U
MK++]R1E!)4_G0!W'A3_@D[K.O?"!_%WB/Q/;VFL7-K]O5KF5@(UV[L2$]Z^>
M_P!EO_A;_AOX[6WAWX4ZN=2O[>Y\MYHV>6P"@\LX'&.#7OWCS]L+X@?MH:?X
M/^$/PVMSI<US9Q_VK/"YC;C D4>JX/\ GK7U?'^SSIO["_[(_B?5/##1CQI%
M:"2;5I"$DDD)'&?;)_*@#T+]K#]G&V_:U^#MCX3O]6M8O&FEQ+>(87 "W.S:
MV1UVY)XK\P-)_P""</QPL_%,_AJU>2Q@D?9+=0O(ML_;)QC-?0G_  23^(GC
M?XC_ !J\:ZGXEU.[U>U>P)%Q<ON D\P?*/;%?JY0!\V_L4?L>Z9^RGX&:W:1
M+OQ-?*!J%W&?D?!R .*^DJ** "BBB@ HHHH **** "BBFLZK]X@?4T >)_M-
M?M<>!_V6O#T.H>)K@W5]/(B0Z5:N/M$BDX+A3_".]?FWIW@'2/\ @H)^W1K^
MI37\LO@RW6"1X5F.=A0#:G8'CFOMK]O?]BBR_:A\+IJ^GMY/BW2X"MH_ #IG
M<5)K\D_@5\3_ !3^Q?\ 'B";5+::T%K<!+^U8$"5 ?U% 'Z#?M._\$F?"6J^
M$;C5/AN;BQUVSA)^S7$I=)E49P !]XU\2?LL_M4>-/V*?B=-HFNP70T/SO+U
M'2IP=\>.,H"?E^E?M]\&_C)X=^-_@JR\1^';V.YMYD!DC!^:-L D$5\P?M\?
ML!Z;^T%HMQXF\*VL5EXV@4MMC 5;PD\ESZXH ^A+6Z\ ?M:?"-AFVUO0-4@V
M/L*L\)(YP>=K#UKY]\"?\$H?A%X)\<1:^HU"]CMY/-@M9Y]R @Y&017)_P#!
M+O\ 9E^(OP;TO5M4\6ZG<66F7.Z*WT02;HU<-\SX]Z_02@""SLX-.M8K:UAC
MM[>)=J11J%51Z "IZ** "BBB@ HHHH **** "N*^,OPWTSXN?#/7_"6L320:
M=J=LT$TD;[<*?>NGUG6K'P]ITU_J5W#96D*EGEF<*H ]S7S'=_\ !2?X"2>+
M!X4F\07,E[-+]F)^QDP;CQ@OG&* /PX^)6B-\+/BAXDT71-4E\K3[N6TCNK:
M8JS1@XP6&,^]?H#_ ,$>;[X?CQ%K27>I3V/C9R@AMYKD*MV.<[5_BQ7UQKW_
M  3W^#7Q,OM4\465A;.=9@D97A1602..),YZC-?DM^T%^SWX\_8J^+$4]K<7
M=I%!,9=*UNW.&('<D< \].] '[E?M%?LZ^&?VB_ MWH.NVD9G*-]FNPH#Q/C
M@YQG%?B'\0_AY\1_V"OC4MQ;/<6T<$Y:VNTW"*XC#=">AR*^^_@#_P %9O".
MI?!ZX;QXQL?&VFV[!;>*-FCNPHPK%O4]_K7I/@KQI\,/^"F7PPO;*_TUH;NP
MF5'E: [HCUVJ3V.: /2OV,_VJ+7]J#X=1ZI]DDM-5M4"W890$9LXRM?0M>>?
M!'X&>%_@+X/M_#_AJRC@BC&))P@5Y><Y:O0Z "BBB@ HHHH **** "N>^(7B
MB;P5X'UO7;?3Y]5GT^U>X2RM5W23%1]U1W)KH:* /Q$T?_@IY\0]'_:(F\1:
MY%);Z$L[V[Z+-&5>",G!#@G[PK]8O#OB3P#^UM\)3)%]GU?1=2AVRP$JTD)/
M\C7QW_P42_X)TV_Q$M;WXA_#BQCMO$D2F2_TR%0B78^\\I/]\ =.]? W[(_[
M7'BK]E'QXD<C7#Z$THCOM,GW * >?E]: .J_;@_8>U[]FGQ9+K.C137?A2XE
M\V"ZA#$VY)) )[8_2OI'_@G'_P %&/LRZ?\ #+XEWX$2@0Z7K-PP544#[DK$
MY))Z&OT"\.^(? ?[6WPC\R,6^L:-J,&V6%P"T+E>>.Q&:_&O]N+]A[7/V:?%
MDNKZ/%+=^$KB0R6]Q&.8.> <=* /W@OM:L-,TF34[N[AM].CC\Y[F1@$5,9W
M$^E?CW_P4&_X*#7_ ,4]6F^'OP\N)H-$CF\F>ZMR1+<2@[<(R]5.>!7SMK7[
M='Q3\6?!73_AE-JEQ/;QLT<EXLC-<749^[$P[@=!7VG_ ,$Z?^"<J6*V'Q,^
M)U@LURX$VF:/<*'0*0&69NX8'M0![K_P3!^'?Q0\"_!]YO']VQT_4 LNF6%R
M6^TVR<Y$F>F:^TJ15"*%484#  I: "BBB@ HHHH **** "BBL[7?$&G>&=/E
MOM4O8;&UC4LTDSA1QZ9H T:_*C]OS_@H3\1/AO\ %FX\'^%-.ET&SL%D@EN=
M0MR5O PQNC.1D<]:^TK[]O3X-:?J36,OB;]^K[#MBRN?KFN9_:0_9X^'G[<7
MPU-WI-Y9RZW'$7LM2MRK31GKM(SQGWH ^</^"/\ ;^#M?T;Q)<W,-G>^,)I)
M)[I9D5V56?((!Z5Z3^W[_P $\=+^-FAW'B[P1:PZ9XQLH]S01@)#<QKEF&U1
MRY[&OR]L[WXE_L+_ !P)7S]*U:PF4RPAB(;V$-D*Q'53Z=J_;?\ 9'_:X\,?
MM4> H=3TZ>.UUZW58]1TUCM:.7&3L!Y9?>@#\>/V2OVM_&7[%_Q*ETS6+:\/
MA]IA%J^B7*GS8@,\QAC\IY_&OW-^'GQ$\*?'?P!;ZUH=W:ZUHFH0[9$5A(H)
M W1O[C."*^:?VP_^"<7A7]I37K7Q)ILP\-Z^&)O)K6)<WN<??)[@5]$? ?X)
M^'_@#\.M/\*>'+1+6UA&^4J,>9*0-SGW)H V_ _PS\-?#E+Q/#NDVNEI=R>;
M*MO$J G\!74T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !7C_ .U5\=8/V??@YKOBG<C:A;P$VD+<
M[W^G>O7]PSC//I7PK_P5M\+ZIK7P'CO[)6:TT\O)=;>@4@8S0!\-?"_X&_&C
M_@HAXBU7Q7_PD7]FZ4L[(\ES-((5YY15'&>:\Z_:,^!?C_\ 8F^(&EV)\5-+
M/=C[3;/IURXX5APXSR:]R_8B_;\\,_LR_L\Z[X7O+:6?Q"UU-=V2I&2KNR@*
MI/U%>Q?LG_LI^*?VI?&R_'+XWK)<Z;*QN=%T"X^:%T.2"0>5 (&/\X /IG]D
M'Q;XV^-W[.4 ^+UJFG3ZJC6<,4D)@DFC'"M@]<@ U^8W[1W[!OQ=^#GQ$U'4
M?#>G7VK6=Y>226DV@AS)'&S$J&*]".!7L?[0G[2WQ$N_VW?"W@VTO3I>C:1?
MPQV^FV,N874C@''L*_6_09YKG1;&6X&V=X59QZ''- 'Y<_L1_P#!/;QAJ'C;
M2_B'\5KJXN4LSOM[#4)7DFR1_%OS7ZI0PI;PI%&-J(H55] !@4^B@ HHHH *
M*** "BBB@ HHHH K:AJ%MI-C/>7DR6]K ADEED.%50,DDU^;G_!1O]K;P_X[
M^&)\&_#[Q#'JU[J$BQR#39LN?G P-IZ5]Y_&CX=2_%7X=ZQX;AU.?27O8'C$
M]OU.5(VGV-?SY?';X#^+OV6?B8VG:G%-;FVGWVE]']V0 @@Y'% 'WEX1_P""
M.]GK?P:CO+W66A\;WEJ)X)/-;[/&S*&4.OX\U\:QI\4OV /C8C2B6QO+64JV
M WV:\CR 2H. >!P:_8;]B']K30_VC_AGI\8EBM/$>GPK!<V6[DA %#C/7.*Z
M;]JO]E/PQ^T]X%N-,U6W2WUF)";/4D0>;&1DA,^A- $'[+G[4GA+]JKX?Q7E
MF\/]H^7MOM*G*LZ'H<KZ&O#?C7_P2G\ ?$WQS+X@T^6?25NFW7%O#)M7.<D@
M 5\1_LZ_L\_&_P"!W[5L/A[0+>XMI;2Y47CK(5MYXL$@,W0\'-?M]IOV@:?;
M"[P+KRU\W:<C?@9_6@#S']GK]F[PC^S?X/30_#%IMW8,US+AI)& ZYQ7J]%%
M !1110 4444 %%%% !2-RI%+7E_Q._:4^'OPAF6+Q)K\-M,>#%&0[#Z@'B@#
M\7/V_/@W>_L__M!W6HP>)(;N^O9O[0ACCF)GAW,6'N!6/^QS)=_&+]IG0CXN
M\;7>G1[FE-Y<7S(VX8(123P">,5^FGQS_8^^&7[=6MZ-XZTOQ)Y-Q&8TN'M-
MK/)"O\+#/%?G7^VE^Q3XC_95\9#7-",]UX9>7S;6]C'S0D$8!QTH _<CQ9X$
MT7Q]X0F\/:W:QZCIEQ (G$@#$C &X$]#[U^)?[:7[%?B7]E7QQ_PE?A3[1)X
M<:?S[>ZM]V;=MQ(!(KZN_P"">O\ P49MO%NGVO@/XCWXAU:%1'9ZG.Q)N/\
M9<G@8%?1T'[4GP8_:+\9:Q\()+@:I?M'(LD<T.83CY25;ID9H \2_P"">/\
MP4$MOBM8V/@+QI<I!XFA01VMS(0HG4#G))Y-?H."& (.17QA^SY_P33\&?!+
MXNZIXR,[ZF%F+:;;3(-L*D<U]GJH50 , < 4 +1110 4444 %%%% !1110!\
M!_\ !07_ (*&ZE^SGXBT[P=X.LO^*D#1W=S=748>'[.2<H!G[QQ7N?[*'[5_
MA7]J[P A+VXUI8@E_ILVWYB0<X7TK#_;:_8A\._M1>$9[JW@CTWQI:(7M-2C
M0;Y< XA8G^$FOQ?\/>(OB)^QK\9)8V%QHVO:5/Y=S;AB(Y<=<'HPYZB@#[4_
MX*)?\$[9/#LUY\0OA[9M+8/F2]T^($M'QDL !ZUXI^P=^WCK7[,OB9/#7B9[
MB_\  ]W-MFMWYEM).%#*6/RH.<BOU2_91_:M\*?M8?#\<P+JXB\N_P!,E[]B
M<'KFOAC_ (*)?\$[9/#L][\0OA[9[]/D8R7NGQ*!Y9))) 'M0!^K/A+Q=I'C
MKP_9ZWH5_#J6EW:!X;FW<,C#V(KY8_;J_;JT7]FWPO<:1H\\=_XSNT*0V\;!
MC;D@X=QGI7Y9_LV_M\?$/]F7PSJWAO3U&K:;<)Y=O;7\C 6+<Y,8QQG-=-^S
M'^S'XW_;A^*TWBCQ//<R:*9O-O+^Y.=R;O\ 5KGJ!G% 'MO_  3)U;XV_$+X
MT:IXMDOII?#%\\DVH27V\PM(1_RS!X K]=USM&>O>N4^&/PQT#X2>$;+P[X=
MLH[.QMHU3]VH!D(&-S>]=90 4444 %%%% !1110 444E "U\G_M\?MA:A^RU
MX/M&T72)KK6+TJT-[)$&M8ANP5?W/:OHS6OB1X7\//LU#7M/MY.GEM<IN'X9
MKDOB=\/_  %^TIX&N_#^IR:=K5K<QDQM'(DC1MCAL ]C0!^1/[-OCK3_ -K'
M]N73/%OQ#DMVN+BXC,&GN (9"JXV[3U'M7Z:_M3?L0^!_P!HKP3-8KIEOHVM
MVT;-875E&L($@!"A]HY7VK\>OVGOV8/&G[&GQ.BNK.>ZCTY)_-TK6H#AP1ZD
M=",_C7Z7_P#!/G_@H%IOQZT6V\&^+IXM.\;6405&8D)=QJ -^YOXR>HH _+V
MUO/BA^P/\=CCS=.U73IF7#JWV6^C'!8 X#C'?L:_;7]E/]K3PG^U%X&MM3TF
MY2UUJ-=M[I,SKY\3#@L5'\).<56_:Z_9#\+?M5>"7L-3B2RU^W7-CK$<8,T.
M#G:,]CWKS?\ 8%_873]EFTU/6M6NFN?$VHJ;>5 042)6RI!'<T >\Q_LX^ 8
M?BC_ ,)]'H%JFO\ DF$L(EV')SO*X^][UZ92T4 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M''_&+_DDOC/_ + UY_Z)>OYU?V</$^G^#OC1X>U?59UMK&VGW22N<!17]'WC
MC0Y/$_@O7M'B8++J%C/:JQ. "\94?SK\D5_X(T^.>=VK6)Y./WXZ9X_2@#[R
MTW_@H%\#X=.M$;QQIH984##S>A Z5\Q_MJ?\%//#$G@>^\)_#R8ZEJ&H)L?4
MX9 T21D$,N/4YKRK_AS3XX_Z"UC_ -_Q7<?#O_@C)$U]&WC#7I(K=6!9;&16
M)]NE 'S)_P $WOV?-5^,GQZTO73!NT#1+@3WS,A(8$' 'XU]K_\ !9J"]M/@
M/X4AMF,>EQZHJ-''D=(R!GVK[7^#?P1\*_ SPI;Z%X8T^*UAC4+).$ DFQW8
MCK5CXP?"+P]\;O NH^%O$=JMQ97<;(LA4%X6(QO3/1A0!^4?_!'_ %CP'9>.
MM7M=?-J/$\S$Z?\ :<']WL^; /OWKWG_ (*R?'GPMIOPOM_!=C?P7NKWK/')
M;6[C,"X&"P]*\YUK_@C]XH\,^*A=^!O%DEI!&Q\J\>X$<X4_0>E>D:7_ ,$C
M])U3PMK,_BSQ5JFM>*[R$+%<7$PD6-AWR: /F#_@C?<Q6_[3FHB618R^BS*N
MXXR=R\5^UNI6::AI]U:R*&2:)HV4]P017YO?LQ_\$X?'W[.GQ<M_%5GJ-A=V
MJGR76289\HD$G [\5^D[RI']]U7_ 'CB@#^>;]HCPS>?LE_M9W@T)FM[W2;I
M=1MF<[MK/N8?AS3OV6_ >J?M3_M46;WL_F7UQ>'6;IFYW;) [#Z5](?\%C+'
MPFWC[1]2TVXMY_$DI$=[Y3 L(PGR@XKT+_@C/\'8O[+UWXB3VPCNHYGT^*1U
MPS*5!./:@#]0[6WCL[:*&)0D<:A54#   KY/_:>_X**>"?V:?$%UX=U+3+C5
M]=BB$GV*"15.&Z9R.]?6M?._[4/[$'P__:BMHY]:MCINMQ<KJEDBB9\#A68]
M5H K?"SXC?!S]L;X<6NJ+::7)+,@^UV+*@GMI".48XZU^=G_  4X_9]^#OP?
M_L>Y\"2QVGB"[ED^W6:W)DX &#M[=Z]+F_X)._$/P;J,R^!/'-SI5C(<OLO/
M*9R.A.*U_"__  2%U/Q;J@NOB7XUU"^?/S30W E?'IEJ (/^",>AZXNGZ_JK
M)+_8#%X5;G9YN1G\<5^I-<?\*?A3X=^#/@NQ\,^&;"*QT^U0+^[0*9& P7;'
M5C784 %?AC_P5L_Y.:3_ +!R?^A&OW.K\\/VUO\ @G3XJ_:2^+2^*=)U&UMK
M<6@@VRRA3D$D''XT >T_\$UV/_#)G@L9X^RC^=?4U>/?LI?!N^^ _P &="\(
M:A+'-<Z?#Y;/&VX'\:]AH *\ _;D^#UY\:OV=?$^A:5#YNL-"'MN,\@Y(_(5
M[_2,H92",@\&@#^=']E'X]WG[*_QL75I8GDMTF^QZA%&<%D5R&'YBOUVU7_@
MIM\';/P,VN6^M0W&H&+>NE"4><&QP#^-97[2G_!,CX>?&[4)];TI&\-:P_S-
M'8*L<4K'JS#'4FOE.W_X(S^*#JQ$VLVPT_=PRS#?M_*@#XZ^+'C;6/VOOVC+
MK5+"TD74_$-RL5O:GYB,#  Q[#-?M_X5O-%_9"_9UT9]6C98;6UC:Y5?EQ)L
M!:N7_99_X)]^ /V;VCU5(#K?B+ 87EZJN8&]8SVKZ/\ %WA#2?'&@W>CZU90
MW]C<QM&\<R!AR,9&>] 'QO\ "'_@I?\ "_X__$IO!]YH2Z5;-N6.^U8QR1SX
MZ;>.,^]=3^T+^RO^SWXF\&ZIK_B:"TTV"WA:87T,_EJAQP<#M7AWQ6_X(^Z/
M-J\^K_#_ %^\TZ[ED,J0R2+&D)/92.U<:W_!+CXQZXJ:=KWQ$N[S1)"%GMWU
M L&3TP: /@?X>>&GU']HK2=/\'+-J-M#KD9M9+8DDPK,,/GTVU_0)\:=,O+S
MX(:Q:-^]N_L6&P.I"\UY'^RO_P $^? W[--T=6@>76=<D7YI[Q5;R_9:^I;R
MUCOK6:WF4/%*A1E(Z@C!H _FV^"'BZQ^'?[3'AKQ#JC;+#2]=^T3L3C"J[9K
M]\?@]^U)X!^.>H&S\)ZQ#J,RH798W!*XZ@U\/?'3_@C[%KWBBZU3P/JQCCO)
MFFEAO) H4L<G'XFO:?V'?V";K]EWQ%<Z[J&H_:KV:)HS''(&3D8H ^UJ***
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M;AGN,U^;/Q:_X(VV-UJ<USX'UJ58I6+^3?2*H7/.!Q0!ZE\9O^"H7P?^&[6
MT#2K7QB)I LWV 1CRU[GD5[A^R[^U)X*_:6L9]0\*Z2+%[8[)@R+NC8C.TD
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK^>KQTFF:U^VYK@\0S[;.3Q'EW9L MYB[1],T >T?L[_ /!*?Q=\7_"L>O\
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M_2[5=TDAY;\!WKJZ^6OV^/V4[O\ ::^&WE:3?R6>MZ<C-;IO;RY.<D,HZYH
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M'<<]Z_5S]A[]N+0OVF?"L.GWT\=AXPM$"W%G(XW2XP/, ]": /E3X2_\$SO
MOP<U32_$?QD\4Q87D:#,JE)6/?<.>#70?M__ +47PQ\&_!.\^$?P^L+*[GU:
M+[-)':I@6J\$%?4FMW]N3]AWXO?M#?$J'7K7Q7;2:5;JT-E9QQNI@C+9YP1D
M^]6?V5_^"4EE\._%%OXJ^)&K1>)]0MRLMI:Q[PL;#^^&R&H ZK_@E)\!M=^&
M'P=FUKQ':R:?>ZI.TMO;/CF!@"K'T)]*^[*BM;6*RMXX((UBAC4*D:# 4#H
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MH?[,NFZ1J6O(IL;V4QL^3N7&.@'7K7;Z)\5O"7BWP#:^)H]5M'T2]@#[Y)%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MWIA<XS7[2U^;O_!)']F?4?!/AO4?B!X@M2CZPB&P21<-& 3D_C7Z14 %%%%
M!1110 4444 %%%% !1110 5\U_M#?L0^%/VCOBQX6\7^(;BXCCT6!HC:PXVS
M'=N&[/X5]*44 ?DE_P %1/C?;QZOH?P(\+2_V/86+(NH1QGRXF1P"H;^=?6T
M'P[^&'PM_8@N-)N4TL:1-H37+ERA\RY:'[Z_[6:^9_\ @J'^Q+XI\;>-1\1_
M!>CRZS)=+C5%B8 PJB@*V">?PKY4\#_!7]HS]H+3M.\%I#J=SX:M[A(9%F8+
M';(" 6(X) ';O0!!^S3^P?\ $/\ :$_XJ3PE-#8>'[>Y4"\N)_*GVYZJ,<G
M-?N1\%_AHWPE^'NF^&WUB^UR2V0;[O4)-\A8@9&?0=JQ_P!FWX'V?[/?PCT'
MP;;3B]GL(!'/>[-IG?\ O$5ZC0 4444 %%%% !1110 4444 %>=?$3]H#P+\
M+YHX=>\065M<L<>0)U+K]1GBL;]J3XQ1?!CX.Z_KJ3*EZMO)';D,-RR%3@X]
MJ_&;PG^R9\<OVNK"_P#B)-:7&HK>?O8;F>0#S^OW030!^GOQ>_9B^$W[<FHZ
M#XH@UJ.:6QE#W+:?*C22(!@*XZXZ5^='[=/[ 6K_ +-NK_\ "3>$Q=:CX1D?
M=YRY,UO(3D<*. /7M7F_P1^-?Q#_ &&?C T%Y#<6:QR*FHZ5(WRS1@]![?2O
MV[^$_P 5/ W[6GPI%]:?9]4TZ\B$5]8OSY3E?F0_GUH ^ _^"=O_  4>%K#9
M?#?XF7S,JCR],UB8Y)ZDB9V/8#@U]5I^UU\'/VA/B%JWP@N/^)DDUOM$\L:F
M)V/&$;UY[5\3?M=?\$I?%6D^.)=6^$&F?VMHE_(7&E1L$^PC'W0S'D5[5_P3
M[_X)Q:A\(]<7QS\18U&LJFVVTEN?L[@Y$FX'DT >@? +_@F3X5^#OQKOO',E
M[+=PPS2?V=I[;3$J-W88ZBOMU0%4 < <4M% !1110 4444 %%%% !1110 C*
M&4@C(/4&OP9_X*/? ?4O@;^T/=^((4EDL==N&U2&8(3'$V\87(Z'(Z5^\]>9
M_'[X!>&/VA/ MYX<\1V4=PLBY@F8?-$X^ZP/L: /EW_@GG^WEI'QB\)VG@_Q
M7?1V7BRPC""2X8(EPN<*%)/)P*^[58,H(.0>017\]GQ^_9"^)O[)OC*34X[2
MZ;2;6;?8:Y;C[P]<#D$5O>%?^"D7QW\-Z#_9LGB6]OF08AFE0;D7' Z<T ?<
MO_!8'X@:!9?"BU\,R30R:Y=LLD4:L"Z*K\Y]*Y;_ ((O_#R_TC1?%/BV669K
M#5(5MHD;_5ADDY(]Z^2/A5^S_P#&']O#XD0:YXBDO9],EDS=ZS<KA8USG 7W
MK]M?@C\'M#^!/PYTSPAX?@$&GV8)X_B<\LWXF@#O**** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MO[VUO/"VKJX9?F!5\=LCCI7[+?L5_MJ>'_VHO"$-K/)'9^+;6(+=6#-DR
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&P=%93E2,@^M?DK_ ,%C/@OX:\-WFA^.--M!9ZMJ,PM;A85"QL I.[ [D]Z
M/U)^'?CG3OB5X(T;Q/I3A]/U2W6XA.<_*:Z.OC/_ ()7Z]JVL?LZ1Q:D'$-G
M)'#:[NGE[3TK[,H **** "BBB@ HHHH **** "BBO,OBK^T=X ^#D>/$?B*Q
MM+S/RV;3J)2/7% 'IM?@;X[\2/\ M.?MR16OBB=8+./6QIOERDGS(HYBNSVS
MBOU]\"_MI_"CQ[JG]GVGBFPMKDX"+<7"KO/H.:_*3_@HE^SSJWP#^.0\9^'K
M:<:'J+KJ$6J0@^6L[,6^\* /L_\ ;R\:?!7X _"#_A $\,VFIZQ=(J66DPG$
MBCH&+#)X)%?/'[(O[*?AWX(Z#%\</C3)_85O"3<Z/I<VY6# D@D@\\&O.OV#
M=8^'OQ&^-5QXG^-.O-<:K!)OLI-5N ;8<=]WOTKZ3_X*>?M3?#O6OA?9^!_#
M%]:^(+J8LJMITBR10C: .E 'V'^R7^U+I7[4WA/6=:TK3VTVVTZ_:RCC9]QD
M0#A_QKW>OB+_ ()1_!G5_A=\!KF\UV P76L7?VN!.<"$J,?C7V[0 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5YA
M^TA\4G^$'P?\1>(H.+ZWM)#;'KB3:=IKT^O.?C_\)T^,_P +=;\,&189[NW=
M()&^ZKD8!/M0!^/W[%/[.LW[<7QF\0>-/'=[]LL$NS-J,)SF=V&<9SP*R/\
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MM.0JMQ*3G'-?H/110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MIKGAUX&X9ZD]<5^:'_!0#]C7Q/\  ?XDW_C;1TGO/#FI7AO([J$?-:RL^X*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7_9)\)?LM^$QIVBI]MU68?Z3JLT8$T@.#MX[ U[I110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% &7XF\3:;X/T.[U?5[N.RT^U3?+-(<!17P]\2/\ @KC\.?"NM36>
M@P?\)!!&Q4SJQ09!P>U?-G_!4[]I[7/&'Q/?X4^'IYX;739/*N5M2?\ 2&;&
M!QUKV7X%_P#!(;X?7WPUT^]\>W%_>Z_?6Z7 :QNFB2(.H8 C')&: /7/@O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MTRW3)BZ#,:J.: /K_P#:P_953]N#PKI5YH7C&"QTMHUGMW*LZ%L<$@?6O/\
M]GO_ ()+^#/AGJ%KJ7C*]C\6:A;MO1H0\<>X=#M-:?\ P2V^''Q-\#_#!I?&
M,TJ:-=$O9V=V[&:($# P>@Q7W30!!8V-OIMI%;6L*06\2A4CC4  #VJ>BB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
9110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>syre-20250331_g13.jpg
<TEXT>
begin 644 syre-20250331_g13.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" ,E U4# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@?\ @NL?_DR@#[_HKX _X?5_!#_H5OB!_P""ZQ_^3*^_ASS0 M%%% !1110
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MH?\ 8YK_ .EVJT ??]%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MU"[^.'A+1_!WBM-3DBM;'1)5DADLQ%$4D)6XG&XR&88WCA1\HZGV&@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MT>KGPMK>KW5K8))+>10111W]SNVR1VXW<[6W<D ?*: /<**^??A)^TA=>/\
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MKXCO+CQ'J5UKLD:?:+/4#J4IB$LXS<QFV)VY\S<WF'[V_.,]/?:** "BBB@
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MZTNHEFBDP1N5AD'!Y'!Z&K50>C&2DDUL%%%% SRS]JS_ )-=^,7_ &)NL?\
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MH **** "BBB@ HHHH **** /@#_@M5_R:QX6_P"QSM?_ $AOJ^_E^Z*^ ?\
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M!PZ,/4,.#4]8':%%%% 'EG[5G_)KOQB_[$W6/_2&:O)O^"6W_)BOPU^NI_\
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MQX6_['.U_P#2&^K[^7[HKX!_X+5?\FL>%O\ L<[7_P!(;ZO5!_P5&_9BP/\
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M;U2TEF$KQ11%08]1C&W;"O!&<D\] /U?HH ^ /\ A<G_  4,_P"B$_#_ /\
M Z'_ .6M??P]Z6B@ HHHH **** "BBB@ HHHH ^ /@__ ,IDOCC_ -B9;_\
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M!BA/H3].WI6B2_S-(PIU$JB;:MJUMKMULUYOY'WU17QCI/QH\3:+.T=IXO\
MM!5RK6]XZ3[>?NY8EAZ=J] T7]IK7(%3^TM'L=13IOM)6A8^_.X']*'"W4\Q
M8BK&7+6H3AYV37X-O\#Z.HKQ&X_:FTR&W4IX6UN>?^)$>V"#Z,903^5<GJG[
M96H6G_'K\-=1N.G^LOT7_P!!1ZJ-&4]K?>O\SWJ&!K8C^'R_.45^;1]-45\G
MV_[5GQ+\1$#1?AQ:1DX ^UW9/.?<IV_*M.'QE^TMXB7=;>%O#FEQ-C$@FC;'
M/4@W#GI[?05M]5DOBDE\T>E_8E:/\2K3CZSC^C9].T5\S?\ "*?M-ZU_K?%W
MA_1HVZHL<9(YZ B!C^OXT'X!?&C5\_VG\8I[3=G/]GB4=3VVF/M^5'U>*^*H
MOQ?Z"_LNA'^)BZ:].:7Y1/IFN$^-'Q7L?@WX&N=?NXOM4V]8+2T#;3/,V2%S
MC@ !F)]%]<5Y$W['>LZEG^V_BUXBU3<#NR'&<_[\S]JY_P >?LL>$_A7X=N/
M$*:M?ZG?[O*$6K%)(YL@G:H6/(<[>&8[>H..M.-.@FO?YO*V_P P]CE.%_>U
ML3SQCJURN*?DY2:LO,\QT[]N+XB6_B!;V[.G7>G&3+Z:+8(@7/(5Q\X..A)/
MN#7VWX%^)F@^/O"VG:Y87\"0W<0D,,DJB2%NC(PSP001[XXKX9E;38]*M;S_
M (1P,;B3R_(^S)OCZ_,W8#CK[BO=?#/['GP_\9Z!9:U<W=_+/>)YC/ILHA@/
M)'R(\>X 8QR!G&<5T5G0J)7CR>FIZ.-Q>38Z4:?)["2O\/+*Z6FL4UIVEU\S
MZ:CD65%=&#HPR&4Y!'K3J^:7_8*\#Q[7M=>\203*<AVN(#C\H1_.FR?L4Z=8
M;I+3X@>(K&(@;RTJ\GW(VUS>SH?\_/P_X)YWU/+'MBW\Z;_23/IBBODN]_9Z
M_L6/;%\?=2L'C.8U-PQ*<Y^ZMP#^6*PK[PIK>CN?LO[0^NWS8PRFWNV_+,Q7
M]:/8T>E7\&'U# /X<8OG":_1GVC17PG)K7Q%L6:.U^*FK7*(?D>6VY;GON<F
MM/3?B%\4;:8-)\0[J8GC:--MC^C(W/X5$J4%M47X_P"1A4P.&@KQQ4'\I_\
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M_P $X?\ DZ;]M#_L<U_]+M5K[_KX _X)P_\ )TW[:'_8YK_Z7:K0!]_T444
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M&VGT.!Q7K4,GG0I)M*[E#;3U&: 'T444 %%%% !1110 4444 %%%% !1110
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MP)!((!QSBO5HQIO#2FZ-VK=];WU,XI<C?*?;M%%%>*<H4444 %%%% !1110
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M!U964'MT =?Y4T^#_B7X=YTSQ/#J\*_\L[W[[?\ ?8;_ -"%'_"R_'/AX?\
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MG3=X.QUX;%U\'/VF'FXOR_7N?EC\9+SQ-9^+[SPSXB\07VOC09I+.WFO';E
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ME?-WB+_@H1!XFU231/@_X"UKX@:KT%RT#Q6Z_P"WL4%RO^]Y?UK7\ _\$[O
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M01E5#71 )!QGYL9'!Z5^@?[-?[,/@?\ 97\#'PWX,LY,W#B:_P!4O"KW=](
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MINN9&7]V6W8(8$<=Z]+-L/5C2C-S<DK*UO+<WQ$)<J=[GU71117R9YX4444
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M10 5S?Q"\5+X-\)WVI943JOEVZM_%*W"_7'7Z UTE>->,KB/XA?$RWT9Y -
MT%6NM0D)^0LO+ _HOM\] '!>+M27X:_"58KB0KJFNJ=0OY"?G6!>54]\L?U+
MBO+OAC\+=:\?7ERMHJ+J<D?VR^:X)5(68X2+.W((7:,$=5?TJS\6/%C?$+QS
M/)(N[3X2MQ)$PROEJ2+>$\$?,0793C(1_6OJOX)^!6\$>"X1=*?[4OS]JNV;
M[P8CY4/^Z/U+>M=T7[&ES=7^7]?H>7FE-8N,,KZ2M.I;I%?!'_MYWD_)19C_
M  :^"(^',TVI:C<Q7FKR(8E\C/EPJ3S@D DG YP,=*]7HHKCE)R=V=&$PE'
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M #<U5_X5C^UM\,&SX?\ B!H_Q T]/NVNK@"=\>IE4$?]_J/J]&?\.JOFFO\
M-!R1?PR^\^S**^,F_;$^,WPX7'Q(^!5\8$_UNHZ"TGD)[YQ*A_[^"NO\&_\
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M"^@^/"UUL.EZQ]Y=0M0 Q;L77HWUX/'6M>:,OC^\\'ZEB<![V ES0_DD]/\
MMV73T=T8'Q"^)'CSP?>:I<6_AJSFT"U8;+Z5CDJ<#) ?/4XZ5:^'/C[QUXLU
M+39=2\-VMIH%W&TOVZ%CG;L)0@%R>3@=.]?/OC_Q?XKAFNO"FJZ]-J%KITS0
M-M.!+M/\1P&?I_%G%=E^SO\ $S5;/Q-9^&[NX>[TJZ#)$DC9-NP4D;?8XQMZ
M<Y^O1*G:%[(^3P^=>US.-*52:BW:SY?BOL[+X>G<^I:***X3]."BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJM 'W_1110 4444 %%%% !1110 4444 %%%% !1110 4444 %87C;Q/%X/\
M#-]JDF"T*8B0_P <AX4?G^F:W:\<^(4__"P?B%IWA2.3&EZ=_I>HR X48&2"
M?92!GL7/I0!PNN:H?A_\++F[O9MNM>)MUU<RM]Y+49))_P![/XACZ5A_LU^
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MZMMXVC@C1W\QU4 MZG'6IG#DTN;Y;F2S*#J0@XQ7FG^3=OF24445F>R%%%%
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M5I2\Y?97R^)_]NFS1116![(4444 %%%% !1110 4444 %%%% !1110 4444
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M5\ ?\$X?^3IOVT/^QS7_ -+M5K[_ *^ /^"</_)TW[:'_8YK_P"EVJT ??\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1167XF\4:/X+T&]UO7]4L]%T>S3S;F^OYUAAB7U9V( _P#KT :E%?..A_\
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M:^VDE:&B\OZN=?\ :&(C%PH6IQ?\NC?K+XGZ-V/+O#/[//AO1(XS?>;JTJC
M5_W4(QTPBG]"2*['6O FB:YHL>DSV*0Z?'()5M[4F%0P!'1,>IKH**YSS+=3
MSW_A0_@W_H'S?^!,G^-;7A7X;:#X,OI;O2K:2":2/RF+3NX*Y!Z$XZ@5U%%
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MM-MXXTF+/3[9,;7_ -&A:[K2?%&C:^H.F:M8ZD#SFTN4E_\ 02?2@#3HHHH
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M;?0UM8FM[*(D'_5X*JW"@ 9( .22QQ[G_P *M\%_]"AH/_@L@_\ B: /+_\
MAMSX2?\ 0=NO_!=/_P#$T?\ #;GPD_Z#MU_X+I__ (FO4/\ A5O@O_H4-!_\
M%D'_ ,31_P *M\%_]"AH/_@L@_\ B: /+_\ AMSX2?\ 0=NO_!=/_P#$T?\
M#;GPD_Z#MU_X+I__ (FO4/\ A5O@O_H4-!_\%D'_ ,31_P *M\%_]"AH/_@L
M@_\ B: /+_\ AMSX2?\ 0=NO_!=/_P#$T?\ #;GPD_Z#MU_X+I__ (FO4/\
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M!VZ_\%T__P 37J'_  JWP7_T*&@_^"R#_P")H_X5;X+_ .A0T'_P60?_ !-
M'E__  VY\)/^@[=?^"Z?_P")H_X;<^$G_0=NO_!=/_\ $UZA_P *M\%_]"AH
M/_@L@_\ B:/^%6^"_P#H4-!_\%D'_P 30!Y?_P -N?"3_H.W7_@NG_\ B:\/
M_:&_:ITSXF:IHWA;PQXFN-"\(W W:QK"6LHE.2?W80 .0 ,X'#%P"0 :^P/^
M%6^"_P#H4-!_\%D'_P 37A/[0W[.=ZVO:'XY^'6@Z3+J>DKLNM!>UB%O>1@D
M@^7@*S89@02"1MP05&0#S&]^!^D>$?A4GQ:^#GC/7!-IZM/(]]M07$:2%),*
M$7&"&^5@P(&/>OKSX0^/!\3?AKX?\3>4L$FH6P>6-#E5E4E9 /;<K8KY@UK6
MOB]\:?#(^'VC_"]/AWHUPWEW]W/"]O $W;FV HH"D\D*&)]>37U=\/\ P9:?
M#SP5HWANQ9I+;3;98!(PP7(^\Y]R23^- '0T444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !7Y7_\ !8[]G/Q%?Z]X;^,_ARUN
MKRSL;%=+UC[&K%[+RI'EAN3M&0O[QU9\@*4C]<U^J%-DC2:-HY$5XV!5E89!
M!Z@B@#\@/VD/^"LFD_&;]F&\\#:/X6U33O&FO6<=CK-W<^4+&!#@SF J[/)O
MP5 94VAR<DK@_6G_  2M_9UUGX$?L[S7_B>QFTSQ'XLO?[3EL;B/9-:VRH$M
MXY%SD,0'DP<$"4*0&4U])Z3\!_AIX?\ $7_"0:7\._"FFZ]G=_:EIHEM%=9X
MY\U4#9X'?M7=4 ><_%#X#^&OB],LGB!KQU6)85C@D154 L0PRA(;YCSFOA']
MD#X0^'_C9\<OC_X7\0K<KIGP\\0C2]+%I*$>>+[3>Q9G+!@S;;6/[H49+<8(
M _32O'_@I^R_X5^ _C[XG>+M O\ 6+S4OB#J8U75(M2FB>&&42W$NV )$A5=
MUU)PQ<X"\\$D \9^,'_!+'X2_&KQ5#KVL:WXNT^[BM([,1Z7=VD<11"Q4D-;
M,<_-CKC '%<-_P .5/@A_P!#3\0/_!C8_P#R'7W_ $4 ? '_  Y4^"'_ $-/
MQ _\&-C_ /(='_#E3X(?]#3\0/\ P8V/_P AU]_T4 ? '_#E3X(?]#3\0/\
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M/Q _\&-C_P#(=??]% 'P!_PY4^"'_0T_$#_P8V/_ ,AT?\.5/@A_T-/Q _\
M!C8__(=??]% 'P!_PY4^"'_0T_$#_P &-C_\AT?\.5/@A_T-/Q _\&-C_P#(
M=??]% 'P!_PY4^"'_0T_$#_P8V/_ ,AT?\.5/@A_T-/Q _\ !C8__(=??]%
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M4T3PPRB6XEVP!(D*KNN9.&9S@+SP2?8* "BBB@ HHHH **** "BBB@ HHHH
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M(B_\DA^(O_8=B_\ 2=:_22@ HHHH **** "BBB@ HHILDB0QM)(RI&H+,S'
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M\2_%K7]/ET\:Y:IIFB+.A1YK3>)9IP#SL=TB"GOY;'D$&@#]-:*** "BBB@
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M+,3DECDL2222<T ?K!X9\-Z;X-\-Z7H.CVD=CI.EVL5E:6L0PL4,:A$4>P4
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M\">,?#^L>*=%TG7]5UZ$:?I=]J$,-U>$PJH\J)F#2<\?*#S7ZCU^*'_!+/\
M9#_X7)XNM/BK_P )9_9'_"$>(+=_[)_LWS_MNU1)_K?-7R^N/N-ZU^U] !11
M10 4444 %%%% !6!\0-#U#Q-X#\2:/I-Y%I^J:AIMS:6EY.A>.":2)D21E!!
M(5B"0#SBM^N4^*^@:]XI^&OB;2O"VL2>'_$MU82IIFIQG!M[G:3$QX/R[@,\
M=": /S9^$O\ P1+C75-3?XG^/&FTY2%L8O".(YI!CEY7N(F"8/ 55;(YW#I7
MSM\<O ?B?_@E[^U9H=[X%\27FH:5-;Q:G;?:&"&]M#(R2V=TJC:X)1AN"C&Y
M67:P&/1?V;_^"B'Q#_96^)7C#PQ^T-#XP\3B0QQM;W4PEO=,GCW#]TDKJC1R
M*P)(< [$9<@DGDOB9KWB3_@JU^UMI$7A#0+W1O"NG6L-C)<7.&-A8B5WEN9R
MN461B[A4!.=JJ"<$T ?MMHVJP:YH]CJ5J6-M>0)<1%A@[74,,CMP:N56TW3X
M-)TVUL;9/+MK6)88D'\*J  /R%6: "BBB@ HHHH **** "OYV_&W@_Q#X]_;
MP\7>$])U271]>USQYJ.DG4(Y2IA\^]EBF8E2"5V.^Y0?F7(YSBOZ)*_&C_@H
M9\'?&'[,?[7=C\>_#^FF^\,WNK6FM0W*H3#;WT90RV\Y'*B1D+ \9$A R5-
M#OVWO^":>B?LL_!^Q^(_@3Q9KE]<:5>6\>I)J;Q!E+MM2>W:)$*%9-@VG<?F
MSN^7G[R_X)O_ +06L?M%?LRZ;K'B.Z:_\1Z/>S:)J%XR[3</$J.DA]6,4L6X
M]VW'VKX1_;1_X*5Z+^U7\%['X:^!_!VNVFJ:U>6S:@+](WRR.&2"V6)F:4M+
MLPQ"'Y<;26X^\?\ @G'^S[JO[.G[,FE:-XAMC8^)-8NY=;U*S+%C;R2JB)&<
M]&6**(,!P&W#GJ0#Z@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^:O\ P5(_
M:_\ BY^SG\5/"&C_  \\6_\ "/:=?Z*;NYA_LVTN=\OGR)NW31.1\J@8! XK
M]*J_''_@MM_R7#P!_P!BZW_I3+0!UUCJW_!3#4M)M]3M7:>RN(5N(G2/PUET
M90RD+C=R".,9I/A#_P %4/BE\*/BM'X'_:,\-+;VHG%O>WRZ>;+4-/W?=F:(
M?)+%T/R*"5)92_"M^GGPS_Y)QX5_[!5K_P"B5K\W_P#@M[X%TUM!^&?C%(4C
MU=;JYTF655&Z:$HLJ!CU(1EDQ_UU:@#]0+6ZAOK6&YMI4GMYD62.6-@RNI&0
MP(Z@@U+7Q7^R-\==9\._\$T?#WC=-$OO%FN>']*N;"TTG3K:2:6Z:"ZDMK6,
M+&&;:%$(=@/E57;&!7R%\,O#O[:O[;?_  D'BO3OB;?^"+/3;U[,VDVJW>AQ
M>;M60PQ0VT9)V*Z#=)SR/F)S0!^R-%?D7^PK^V)\:/"/[55K\$OBEKMYXDM+
MB]N=&N5UB3[1=6%Y"DF&2?EY SQA3N9@0VX>[/\ @HQ\2/BW^R_^UWHOB71/
M'OBT^#-6-KKEIH?]NW*Z>SP.JW%H8MY7RV**S+MVXGQ@]* /UWHKS#XD?'31
M?!O[.NL_%BSGCO-&@T ZU8.6 6YWQ![=0?\ ;9HU'NU?!O\ P20\1?$[XJ>)
M?'OQ \=?$#Q;XA\-Z1;+I]M9ZKK-S<VCW4A\V5Q"SE=T<:*.G G&/8 _4&BO
MQ<TG]I#]I#_@H+\;-9\-_#SXA0_#?2XTEN[#3H]4?2A':K*H0-+"&GFFPR[M
MN5X; 53BN]T/PQ^WK^S+\4]%LX[[5OB_I<^)YHVU&34].N(PV'A>XN@LEN_(
M(/R]B-P#"@#]9J*KZ=<2WFGVT\]K)93RQ*\EM*RL\3$ E"5)4D'C@D<<&K%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?"6GZIY6FWLUFVO:U-.1&(YIE\U_,).!Y<>R,GIB*OQN_9=^ .F_&+]LK1O
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^UY)\7OV>_B5KWA+P5K<?CKPJTNEZGX.N[B.TOK.XX5W$I.W:BF20'@GR6
M.*^=_P!D[XT2^'_^";NK7_Q!^&$WB7P3H=M<W0NM2O89H?$9FU6<RKY;!F0Q
MR,,F0'<1D5Z'^SZUUJ'[17[<&FQDR*9=/,,7 'F/:7:GGWVJ.?2O+/!I'_#D
M*[&>EA?9_P#!Y+0!^BGPSU6RUWX<>%=2TS3TTG3KS2K6XMM/CQMMHGA5DB&
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M  3CN]!LO@?J/ABT_M:+QEH.M74/C"WUQ$6Z75G;=,_R,RF,GA&!.0O.3DT
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M3^*^CZI-\/O@CXK\9:CI%S-!J<-G<PQ6UKL<JJ_:)-OF2LHW^7&K$!EYR<4
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M\B(O3Y3O.< 98 _I!6+X:\%^'O!D,L/A_0=,T*&4[I(]-LX[=7([D(HR:VJ
M/A?X??$/2?V$_CM\2_!WQ#$V@?#OQUX@E\5>&O%<L+O8BYN%47%G-(H/ELI1
M=N[C:A+$9!/4?'_]N[0KK1(/!OP$UFU^(OQ;U^6.UTFWT*,7UO9 N/,N;B0
MQK&B[LY)QD%@%#,/K75-)L=<L9++4;*WU"SD&'M[J)9(V^JL"#6=X9\"^&_!
M:S+X>\/:5H2S',JZ9916X<_[6Q1G\: /B_Q_KK?LO_MR>$OB=\3+UAX6\5>!
M4\)WGBB&V<65KJR3QRMY@4'R8Y/+!7/]]C]U&(F^*GQ8\._M5?M2? [PK\+M
M0A\7VG@W66\4>(=<T[,MC8PI'B*,S#Y6>0Y7 )P2O^UM^V]4TJRURPFL=1L[
M>_LIEVRVUU$LD;CT96!!'UJMX=\*Z+X1L39:%H]AHMEN+_9].MDMX]QZG:@
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M3J/_ ,?KUGXH?L[_  \^-'@BR\)^-O#-OX@T:Q55M5N'=9K<JH4-',K"13@
M$AAGOF@#Y7^/W@OPE\"?VHO@!_PIW3;'PCXVU_Q EEK7A[PW$MK;7^B[3]IF
MN;:/:A\I-[(Q7.0S#)08^[Z\?^#?[)/PJ^ NL7FL^#O"R6NNW:>5-J]]=37M
MX4X&P2S.[(N N0I .T9SBO8* "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
2**** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>syre-20250331_g14.jpg
<TEXT>
begin 644 syre-20250331_g14.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" (. \L# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110!^:?[>G[76H_$3XK-^S=X#\5Z/
MX'LIF%OXK\8ZUJ,=E!"I7=);+*[* H4X?:=SL?+&!NW5?VJO@[X%T'_@FC-X
M9^"^NZ;XZT3PGJ]MJ&KZEHM[%?/++R)YI3"S ,/.1BO\$8'\*YK[KU;]F7X/
M:]JMYJ>I_"?P/J.I7LSW-U>7?ARSEFGE=BSR.[1DLS,22Q.222:Z?P;\-/"'
MPZTJYTSPIX4T3PQIMU(99[/1M.AM(97*A2SI&JAB5 &2.@ H ^!OCQ\0_"O[
M7'[6_P"R3;?#[6K7Q,-$NIO$^J-I,PF&GPA[2=5G(!\ILVI4J^&!900"RYQ?
M@G\6_#G[-FK_ +8WA/XAZI9^&=;DUC4-:TRSU"X6*3589TG,0MP?]86!B(5<
MM^]''!Q^A_@_X6^#/AW/>S>%?".@^&9KYM]W)H^F0VC7#9SF0QJ-QR3US3?%
MGPI\$^/M1LM0\3^#M \1W]B0;6ZU;2X+J6W(.08VD0E<'GC'- 'RK^PK\!]2
MU3_@GOX<\(ZMK'B;P'>Z^\VI_P!H>'KW[#J=K&UYYL312[3L$D<:9X.4E8<9
MX\)_X*%_"7Q5^R;\%]%\7>$?C]\:-1U*]\00Z5)%K?C*66$1/;7,I8"-(SNW
M0ISG&">.A'ZD@!0 !@5\ _\ !:O_ )-9\+?]CG:_^D-]0!]_T444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/B;J%I!<>++.<Z*UN@Q#+?X&R1@,84HRR,H/9@,<5RRP,G%2I24KNVG1_/\
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MBBB@ HHHH *^ /\ @M7_ ,FL^%O^QSM?_2&^K[_KX _X+5_\FL^%O^QSM?\
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M(\11PG,2:M8170C/JHD4X_"M#0_#^E^%]+ATW1M-M-)TZ$8BM+&!(84'HJ*
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M[5RQ&&W'@;0<XX71?V6_%.I_\$\YK*/2[@>)9M8_X2J'2RK"=X@@A"[.N\Q
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M%%%8'TH4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MHI %%%% !1110 4444 %%%% !1110 4444 %%%% !7RK_P $N/\ DQ/X9?\
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M\.OVLO@OHOA'PCHOBC3M2LO$$.JR2ZW:VT4)B2VN8BH,=Q(=VZ9.,8P#ST!
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MUE59O%5_,B2I/&Z. TQ =6"LK=5(!&" :U_^%^?$7[5]F_X6WX\\_P#YY_\
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MBC^P_P#\GA?"C_L(7O\ Z;+ROVNKX_.?]Z?HCEQ/\0****\(Y0HHHH ****
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M_@M7_P FL^%O^QSM?_2&^K[_ *^ /^"U?_)K/A;_ +'.U_\ 2&^H ^_Z***
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M[JW=(Y[.7<T:J[<,4(8?[I0#@5]5>)/^1=U3_KUE_P#0#7._!?\ Y([X$_[
M-C_Z3I6RK1^J.CR:WW_KRT*YE[/EL=G1117G&(4444 %%%% !1110 4444 %
M%%% !1110 5SNM_\C?X:_P"WG_T6*Z*OAOQ;XNUP>+-3(UB^S#=S",_:7^0%
MB,#GCCTK>E3]HV?-YWFD<MIP<H\W,_R:9]R45S7PUNIKSP!X?GN)7GFDLHB\
MDC%F8[1R2>IKI:Q:L['OTJGM:<:BZI/[PHHHI&H4444 %%%% !1110 4444
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M$VD%%%%?6'>>V_L/_P#)X7PH_P"PA>_^FR\K]KJ_%']A_P#Y/"^%'_80O?\
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M/3?A-HWPTTKPMX0UC^P7E\=-J!O;JX2&.5Y%%L<",B5"N0,@@Y/./HCX4_\
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M(;Z@#[_HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MR!@$^M>O1QTJV,JX5TI)02?,_AE?MZ&\:KE5E3Y6K=>C/=/V'_\ D\+X4?\
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MQRIS$ GW-GW17PMHO[5'[<7QRN39>#?@UI_@>TD.TZIK6FS6_D\D;P]W(J.
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M\+1R&74+K4M6F;[QGG"@_P#?(!_6GRP6\B?KF.J?P<-9=Y22_!<S/F^]\?\
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M7PC_ ,%J_P#DUGPM_P!CG:_^D-]7W_7P!_P6K_Y-9\+?]CG:_P#I#?4 ??\
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M;;[MO5GV>5UI8C!4JL]VNA^3G_!4O_DZ;3/^Q,T__P!+M1KY'KZX_P""I?\
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M^K^S=K7YNGH:_5X_5OK'M%?FMR]=KW].@[7O^0'J/_7M)_Z":_I"K^;W7O\
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M):VL8^\W5CV51U)/H*\ZM2E2JRIO=&<I1HQYINR74T9IH[>%Y976**-2SNY
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MGD_A3Z[,%E."R^K5K86'+*I+FEJ]7W>IO7QE?$PIPK2NH*T?)'V)_P $I/\
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MO\A5FL3VH?"@HHHH+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P F)_#+_N)_^G2[H ^JJ_F]T'_D!Z=_U[1_^@BOZ0J_F]T'_D!Z=_U[1_\
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M3W)KMZ**PE)R=V?34,/2PT%3HQ48KL%8OC;_ )$W7O\ KPN/_1;5M5B^-O\
MD3=>_P"O"X_]%M2CNAU_X4_1_D:.F_\ (.M?^N2_R%6:K:;_ ,@ZU_ZY+_(5
M9I&D/A04444%A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MH_7^#_\ <)_XW_Z3$\9_;/\ ^32_B_\ ]BMJ'_HAZ_$JOVU_;/\ ^32_B_\
M]BMJ'_HAZ_$JOI<AVJ?+]3]*PFT@HHHKZP[SVW]A_P#Y/"^%'_80O?\ TV7E
M?M=7XH_L/_\ )X7PH_["%[_Z;+ROVNKX'.?]Z?HCR<3_ ! HHHKPCE"BBB@
MHHHH ^'?^"N7_) ?!'_8YP?^F[4*_*ZOU1_X*Y?\D!\$?]CG!_Z;M0K\KJ^Y
MR/\ W:7^)_DCGJ;A1117T1D?8G_!*3_DZ;5_^Q,O_P#TNTZOUOK\D/\ @E)_
MR=-J_P#V)E__ .EVG5^M]?G>;?[[/Y?DCJA\*/D3]L[_ )+)\+/^P!XA_P#2
MC1Z\JKU7]L[_ )+)\+/^P!XA_P#2C1Z\JK+#_ ?C/%7_ ",GZ(****Z3Y ]5
M_8Q_Y+)\4_\ L >'O_2C6*^NZ^1/V,?^2R?%/_L >'O_ $HUBOKNO)J_&S]\
MR/\ Y%M#T/R<_P""I?\ R=-IG_8F:?\ ^EVHU\CU]<?\%2_^3IM,_P"Q,T__
M -+M1KY'K[_*?]RA\_S9]IA_X:"BBBO7.@_3_P#X),?\D)\<_P#8YS?^FW3Z
M^W*^(_\ @DQ_R0GQS_V.<W_IMT^OMROR_&?[S4_Q/\SPZGQR]0HHHKD,PHHH
MH **** "BBB@ HHHH **** "O@#_ (+5_P#)K/A;_L<[7_TAOJ^_Z^ /^"U?
M_)K/A;_L<[7_ -(;Z@#[C\;W.F6?A#6)=9L8]4TD6L@NK*6)94GC(PR,C?*P
M(."#QS7S#\-9_A18_%*]O;7X;Z-:OJ&H61T=X='M5?3W5$0LA"CRSY@WY3GO
MUKZ<\>:)<>)/!VKZ7:&,7-U;M'&9"0NX^IP:^+]+:Q\&_%BZT?4-4M?[2\,W
MEG+?00B1\APLHV$+@G;ZD<C%>AA[N$DF_P"K'R.<X[,,%5A+#Z4M.9VT6MMS
M[NHKQNZ_:B\-*A-IIFK7>T9+"%%4>Q._^E>?>(OV]O"NCF6-8M/BF3@K=:J@
M=3[QJI)[]ZYXX>K/2,3U/[9P,M(3YO\ "I/\DSZEHKXRL_VX-;\=7#6O@W1)
M=<GSC;HND75XRGW?&P?4\5W6BZ5\<OB(D;ZI/+X1L6(W"YN8H+C;ZJMMN.>^
M'=3]*TEA:E/^)IZ@\QG+^%AZC]5RK_R9HO?MH^+[[PK\'_%'E>+?#6BVMUHU
MS#_9.JV#S7M^[(PVV[K=1[3@X_U4F.IXXKR#6OVU?B5/;W>F^%?#MCKUTTF(
M?$>HZ1-HMI$F.HM9+J:67GD,63']P]:UOVAO@OX,^'WP=\=SZWXM@F\4W&CW
M5Q;03316LEU)L;!$;,SR$L.QY-?1G@'PK\-;J![CPK%H>L+;ML>YM9TO3&V,
MX+[FVG!]177&=.E1BW'FU?33I\_Q+]IF-2*<*<8?XFY?A&R_$^(-!^"7C#XU
M>(H?$7Q*EUGXEZ@K,T&FH[VVDVQ)SM!7;\I Z+Y73DM7U3H'P<\97VBVVE7F
MK6/@WP_"H6+1?#\"QI&O=<)@?^/-7NZJ%4 # '  I:YJV,J5;)Z);+HO1;$R
MR^IB/]\KRFNR]R/W1U^]G!^$?@GX3\'LDL&GB^O%Y%U?$2N#Z@8V@^X -=Y1
M45S,;>WEE6)YVC0L(H\;GP,[1D@9/N17&Y.3U/1H8>CAH<E&"BO)$M%>6:?\
M=GU#Q1<>'U^'OC"+4;:"WNKA9(+,+##.\J1R,1<G@M;S=,GY#QTKU.G*$H?$
M= 4445 !7.^.);Z30;ZPL='N]3EO+6:$/;R0*L;,I4;O,D4]^P/2NBKC?B1\
M21\-=+EU*?PWKFMV%O;2W=S<:3' ZV\<:[F+^9*AZ9(V@]#5P3E));F56'M(
M.%[7[?\ !N;GAV^NKJS6.ZTF[TMX45,73PMOXY*^7(_3'?'6M:N:\#^-)?&E
MG+<OX<UCP_&H1H_[72%3,K G*>7*_ XSG'45TM*2:=F5"/+%1O?^OD%%%%26
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !145U=P
M6-M+<7,T=O;Q*6DEE8*B*.I)/ %?./Q2_P""@7PC^'4DECIVKR>-]=SY<6G>
M&T^T!W. H\[_ %?4_P +,?8]*VI4:E9VIQ;$VEN?2=?GA\=/VN/ ?@GX_+H,
M&K_$"[TK3KVYAU^;3O$=S'")CQLMX_-'RQ/D$?*."!D $]L_BC]JK]I3]WHF
MBVOP/\(SD@WNI;CJ;)T. R^8#W!$<7^_7S/X]_8Q\*:7\4M*TNX^..F:C%?3
MW UK4;Z BXM9X^9"P\Q@Q=L@;F!SG)/4^Y@L-2IS?MYZVV5W;UMH9RDWL?JS
MX/OM.U3PGHMYH][)J6DW%E#-:7LTK2O/"R I(SM\S%E(.3R<\UL5SOP[T71O
M#O@'PYI?AV87&@V>G6]O83!]_F0+&H1]W\1*@'/?-=%7S\K<SL:A1114@%%%
M% !1110 4444 %%%% !1110 4444 %%%% !7RK_P2X_Y,3^&7_<3_P#3I=U]
M55\J_P#!+C_DQ/X9?]Q/_P!.EW0!]55_-[H/_(#T[_KVC_\ 017](5?S>Z#_
M ,@/3O\ KVC_ /017U&0_P 2?H8U-D7Z***^S,"AKW_(#U'_ *]I/_037](5
M?S>Z]_R ]1_Z]I/_ $$U_2%7QF??Q(>AO3V/*OVL?^36?C)_V)FL_P#I#-7R
M)7UW^UC_ ,FL_&3_ +$S6?\ TAFKY$KQ,-U/SGC3_F'_ .WO_;0HHHKN/S,S
MM3_Y#/@G_L<_#?\ Z>K.OTAK\WM3_P"0SX)_['/PW_Z>K.OTAKSL1\:/U_@_
M_<)_XW_Z3$\9_;/_ .32_B__ -BMJ'_HAZ_$JOVU_;/_ .32_B__ -BMJ'_H
MAZ_$JOI<AVJ?+]3]*PFT@HHHKZP[SVW]A_\ Y/"^%'_80O?_ $V7E?M=7XH_
ML/\ _)X7PH_["%[_ .FR\K]KJ^!SG_>GZ(\G$_Q HHHKPCE"BBB@ HHHH ^'
M?^"N7_) ?!'_ &.<'_INU"ORNK]4?^"N7_) ?!'_ &.<'_INU"ORNK[G(_\
M=I?XG^2.>IN%%%%?1&1]B?\ !*3_ ).FU?\ [$R__P#2[3J_6^OR0_X)2?\
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MH"HV@_+N)P1R!GK7N9?]65.JZ[Z;?UYV(DY+1'O?_#<OQ%_Z-A^(7_@+<_\
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M;_HVJ]_\&9_^-U\$7_[4'QKD^/3^)3K&KV_C&.]:S70U$GE1_O #8_9<_<W
M QD9+#)^;FOVYKQVZ\#^'&_:FL=:;0-+.L?\(U-/_:!LX_/\P7$48?S-N[<$
M)4-G.TD=*[<+C:-/FO16WG^MR91?<\<D_: _:J:%A'^S_8)(1\K/J:$ ^X\T
M?SJG#\=/VOYI5C7X%Z&&8X!>\51^)-U@?C7VC17%]:I_\^8_C_F5R^9\>?\
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M HHHH **** "BBB@ HHHH *^5?\ @EQ_R8G\,O\ N)_^G2[KZJKY5_X)<?\
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M$_\ &_\ TF)XS^V?_P FE_%__L5M0_\ 1#U^)5?MK^V?_P FE_%__L5M0_\
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M+X4?]A"]_P#39>5^UU?BC^P__P GA?"C_L(7O_ILO*_:ZOC,Y_WI^B/-Q/\
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M?'/_ &.<W_IMT^OMROS?&?[S4_Q/\SQJGQR]0HHHKD,PHHHH **** "BBB@
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M3PWX3^$WP_U76O!M[_9^NVV]H?L<_F2Q[-TFI*LGS02C,98?+UP1G]/Z\_\
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MJ]33X;G>USNG:.214VPZD[#*Q2')&/EZY(SZ!_PN3_@H9_T0GX?_ /@=#_\
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MMH>50'Y.O)SZ!0!^:O\ PUM^W+_PM/\ X5Q_PISX?_\ "9_V-_PD/]F></\
MCP\_R/.\W^T_+_UOR[=V[OC'-'Q2_:V_;E^"_@34_&7C+X.?#_1_#>F^5]KO
M?.$_E^9*D2?)%J;.<O(@X4XSD\ FOO\ _P"%6^&/^%I_\+'_ +,_XK/^QO\
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M^";NGZAI?[$OPMAU,YN6LKB=/^N,EW/)#V'_ "R9/_K]:^E: "BBB@ HHHH
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M?]G&VD\;Z7\6?%VL>,M9\4O!-=Z=H'B[4H;J'PQ)=C-Q%;I$@16 /E;LGY%
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MUC]J?X3>'?%WB;PQJWCO2=*UOPU:B\U>WOI&@%I$6B569W 0Y:XA  )),B@
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M0<#GO!OC[6M'_P"",WB6'3IIH?\ B?R:-)*C$E;6:YB>51_=5O,9".AWGN:
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJGQ$^(FL0-;7.MZBK1JD;,KOA6=V9V*)F1W)(7@+E@?JRB@#YG_8E_9'UO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&^O^K<OV@/\ PAO_ +?0!]545\J_\-]?]6Y?M ?^$-_]OH_X;Z_ZMR_: _\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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##__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>syre-20250331_g15.jpg
<TEXT>
begin 644 syre-20250331_g15.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" ,# W\# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZ!\,/A/X2TKP-\/[K1;+3;8$065G>QRRS.>6=CN+2.<9+')X]!7I= 'Q_P#
M7_@J!\+/VB?BQH7P]\-Z!XPLM:UCS_(GU2SM8[=?*@DG;>R7+L,K$P&%/)'0
M<C[ KX ^,G_*9+X$_P#8F7/_ *)UFOO^@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MEAL&Q&/<\=*7Q9\1M$\(^%K_ %Z:Y6_MK2T>^,-@Z232Q)]YHU+ ,!ZYQ[T
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M\4/!_BG5/$2SZ#=:A)#"!J>V>6(P+-& B16X*DHY&XY/R\]\G'R__P $Y/\
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M(=[QR3(-K;68CY>/2NXK&249-)W&%%%%2 4444 %%%% !1110 4444 %%%%
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MGU.VBU>^M+R)IK:S:51/(@&IN2RQEV V-R!\IZ5]P44 %%%% !1110 4444
M%%%% !7Y0?LP> _VXOV3? 6H>$?"'P9\+ZCIM[J<FJR2ZWJEI+,)7BBB*@QZ
MC&-NV%>",Y)YZ ?J_10!\ ?\+D_X*&?]$)^'_P#X'0__ "UK[^I:* "BBB@
MHHHH **** "BBB@#\H/AK\3/C#^R;^TI^T;JFF?LY>./B%IOC+Q9<7%K>6EE
M>6T(BBO+QDD1UM)1*LBW (8$#"@C.>/8/^'CWQO_ .C+_B!_WW??_*VOO^B@
M#S_X"?$C7/BY\)]#\6>)/!>H?#S6M0\_S_#>J&0W%IY<\D2[]\43?.J+(,H.
M''4<GT"BB@ HHHH **** "BBB@ K\UOVN?BCX8^"_P#P53^#?C+QEJ?]C^&]
M-\'2?:[W[/+/Y?F#58D^2)6<Y>1!PIQG)XR:_2FN*\;?!'X=?$K5(M3\7^ ?
M"_BK4H81;1WFMZ-;7DR1!F81AY$8A0SL=H.,L3W- 'A7_#T;]F+_ **9_P"4
M#5/_ )&KU3X%_M2?##]I0ZV/AQXF_P"$C.B^1]O_ - NK7R?.\SR_P#7Q)NS
MY4GW<XV\XR,K_P ,G?!#_HC?P_\ _"7L?_C5=5X%^$W@?X7_ &W_ (0WP;X?
M\)?;MGVK^PM+@LOM&S=L\SRD7=MWOC.<;CCJ: .KHHHH **** "BBB@ HHHH
M _*O_@AM_P ?'QM_[@O\[^OT\U+PCHVL37LM[IT-S)>0+;3M(,EXP<A?8 \\
M=P/05^8?_!#;_CX^-O\ W!?YW]?I7\0/B/I'PWT&;5=3,TT4,UO \-FJR2AI
MYEAC)4D8!=P,FJBI2=H[D2IQJ+EDKFU=Z#I]\U@UQ:QS&QD$MMN&?*8 J"/<
M U!'X3TB'1+C1X["*/3+C?YELN0K;R2W?C))Z5+?>(+"QM;B=KF.3R1(6BB<
M-(61=S(%SRP':LOP;\0M&\;>$M+\164_V:PU"S2^B6\*QR+"_P!UF7)QGZT^
M65K]!>Q@VY.*UTV_KL:ECX>TW3+Z6\M+**WN98HX'DC7&4081<>P./ICTJM!
MX-T2UDMI(M-@22VN)+N)P#N65\[VSZG/Z#T%4/#?Q(T?Q1K/B#3+8S07&B7Z
MZ;<&Z58UDF,2R@1\_,-CJ>@ZTR\^)FB6?C73?#+22/>7]C<:A'<QA3;+%"Z)
M)NDW<$%UXQWJN6=[6%]7I[<BT\OG_P $ZRBFQR++&KHP=&&593D$>HIU9&H4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 45\]?MC?MG>%O
MV/O!ME?ZK:2:[XCU0NFEZ%;RB)I]@&^21R#Y<:[E!;!)+  'G'R5^R3_ ,%.
M/B?^T7^U/X.\#:OX?\-Z+X5UL7K%+.VG-SMBL[B9")7E*GYX0"0@& 1@'F@#
M].J*^*_V'_\ @HUIO[4GB_6/!.N:;;Z'XIMS-<Z9+:LWV?4K5'/0/\R2JA4E
M?XAN8;<%1]J4 %%%% !1110 4444 ? 'QD_Y3)? G_L3+G_T3K-??]? 'QD_
MY3)? G_L3+G_ -$ZS7W_ $ %%%% !1110 4444 %%%% !1110 4444 %%%%
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MMWA:XGP) <CRVFRKYXV[L\<UZI\2(8K?_@LQ\'(H$2.%/"DRHD8 55%EJ@
M'08KT;]OO]GOX8_M3:AH/@R]\>:+X.^,5G;FYT&.^N462[@D<@PO$2&D1FB;
M:5RRE6(!&X'X7N/^"8'[5>G^*K&XM]2M)[JQ@-E:ZU;^)67[/;D.ACC9MLJQ
M[7<;0N,.1CDB@#U3Q1<:'??\%HO#/_"#FW,\<ZIJS:>/D-TMA-]JSC@L(^'Q
M_$&S\VZOUBKXG_8%_P""=-O^RE?7?C#Q5JMKX@\>W5N;2(V(;[)I\+8+K&7
M9W8J 7*K@?*!RQ;[8H **** "BN1^*WQ6\+_  4\!ZIXP\8:I'I.A:<@:6=@
M69F)PJ(HY9V) "CKFO@74O\ @MYX%BU7R]/^&WB*ZTW/_'Q<WD$,V,\_NUWC
MI_MT ?I117CG[,_[5_@#]J[PK=:QX*O9Q<6+)'J&DW\8BN[)F!*[U!(*MAL.
MI*G:PSE2!['0!\ ?&3_E,E\"?^Q,N?\ T3K-??\ 7P!\9/\ E,E\"?\ L3+G
M_P!$ZS7W_0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^
M5?\ P0Q^]\;/^X)_[?U^JE?E7_P0Q^]\;/\ N"?^W]?5?[0^K^/K/XA:>FFI
M9Z[I^@SIXFRVDR_\2R!0T&'82 3GYWDVKA_W>1@<4 ?5-%?-OQPA^(EY\,M)
MT>WU:P\2WOB6!M,DL8](D@-Q)*6<3!_,'D".+&=_!*'(YP-3POXK\>7'P/N_
M$]QKNFZ5>68$ILQH$V+-(%*S6IC,F]VWKC>#V..N0 >_45\R?LUCXB(=8T/5
M38^%3;B?45TUM,DD=VO-TL4QF,FTA'9E,8^8>7AN>:Y[PCK/Q+NOC3<7;W&G
MV=KK##0U\2-HDQ6\>S9F=5B\S]UO#R#>WRMY/&#0!]>4444 %%%% !116?KV
MO6/AG2YM0U&X6WM8ADLW4GL .Y/H*!-I*['ZQK-EX?TVXU#4;E+2S@7=)+(>
M!_B3V Y-?)OQ(\?'XB^(VU!+4VEI$@@MU?[[1@D[F]"2QX[#'7J=7Q9XEU_X
MT>(4M;&SF>RB;-O81_=3_II*>F[W/ Z#N3YW^T?]E_9V\/Z-=^*GN+BVUDR6
M^[2L[HI ,E=VY2/E.0P/4'TR=H4W4DH05VSCC[6I4]I)\L%LNK\WV\E]_9-A
MCNQ?3M+-"UGM ABCA82!@3EF<M@@C' 48]36W966A75JIU*YOK>?) ,-FDR8
M_&137RK;_M!?"^UN(YDD\9L\;!P)-5O'4D'/*M=$$>Q!!KZ,\(_&C]H&7PY:
M)\+/@];:KX;OXTO+?4_$*B$W'F '=C[1&"FT#!STP>F*[98&LFKKE\W:/ZF\
ME":M)77WG21>'] 659+;7_LTB\AY;.2,C\4+5U6E^*/$>B1_\2[QY;72J.(Y
MYI7_   N(^*\ZNM-_;)\89^T>$O 'AWS.OF0VLVS<>>KS=/QX]35 ?LL_M2^
M(9/-U/XA>"-)C8D^58Z;"&3)Z82R4=.GS'^=#PO\U:/WW_),PCAZ$'>%-)^2
M2/<!\=/&&DQJMS#I.H^K0LLKGWQ%)Q^530_M07<#;;S1;<L,959VB/OU!KS'
M0/V*_BZC!M5^-5@HQDI#X9BF&<],[XSR/R_6O3O#_P"RK>6*XU7QLVJG!&Z/
M2TM^_!XD-<LZ<(;33]+_ *HT:K?9:7JK_JC2M?VJ-)=PEQI31/QE8KM'/Z@=
MJV[7]I#PQ<*I>VU&'/.?*1E_ A_Z5SFK?L@^%=4SYDL<V>OVNQBF]_0=^:Y&
M^_85\/0LTNGVVAB<G.Y=-%KD^I,9)S6:5/JW]W_!-ES)>]K_ %\SV:W^/'@V
M9<OJ,L'&<26LA/\ XZIKC_$/[7GA#0<[-%\4ZKT_Y!^D,_7M\S+]?_KUP\/P
M)\4^ QG3=$T_4(5ZBW6*88 P/EE 8]>PK%U76KO17VZUX1M;4]/]*L);<'Z%
M&7]*<4K[71S5,90H_P 6?+ZZ?BRI\0?VXY?'7A7Q!X=\$_#/QC%X@NK"2.UN
M?$-C;V=O$[?*'.^4@X!W 'J1TQFO#/ /A_XAI\)M;MO$.IS)XNNC.UF[S([6
M_P @$:[E)7EE)XZ!J]HO-=TS5;<K::3:V,P()>WFE/'<;9';CI7.7MOK4FJ6
M\EI?V,&FKCSK>:Q>29^>=L@F4+QZHV/>NGVR2Y(P4>NMV]/T^1I3J4ZT?:4Y
M<R[IW1;_ &5?VA_$WP<\"R>'?BAX5\1ZE?3:@\MKJ>D06UXHB9$!6;RY=P((
M.&*G@@9X KZET[]H?P;J.FK="XO;9V_Y=KBRD24< \C&.^.M>#^!O"NH^+M0
MFM=-M+6ZF2/S&-U(5"+G&0,C/4=C7HB?LW:GK$:IK&I:;#'U*6UH'_/A,UA5
MJQJRYN5)OMM]QNE8Z6^_:2\/6_%O8W]PW8LJ(I_\>)_2L&]_:9G;(L]!CCQ_
M%/<EOT"C^=:MC^S!X>MK0Q-J.H(Q_BM!%$ ?4*4:O/?'/[#+^)]_]F?%KQ=H
MP;.%V6Q5?8>3'"V/J2?>HIQA)VE*R^?Z :%Q^T%XMU*01VD-G;LW"K;V[.W_
M (\3G\J?'JGQ8\3?ZL:HBMT985M5_ X7^=>8VW[&G[0'@-2/!O[0UU=H.5CU
MB&95[<89YQZ]NWO4YL?VX?!8.+_P?X["=!B"/=P?5+?VZ^WO79]4A+X*T7ZW
M7YHGF[H]1C^#7C[7\'5-5$2G[PO+UY6_(;@?SK:TW]F:%<-?ZY(_JEM %Q_P
M(D_RKQ7_ (:D_:?\'G_BJ/V>O[7V'#_\(^\K9Y[>6UQ[^M"_\%-['PZ5'C?X
M2>,/"S=& 19,'C@>:(<]?;J/6C^SZ[^!*7HT_P!0YD?2>F_ /PC88\VVN+\C
MO<W#?R3:*V[[X=Z+#H>H6NE:/IUK>36\D<,S0C*NRD EL%L9->!^'_\ @I;\
M#-:VBZUK5-"+?]!#2Y6QUZ^2)/3]1[X],\/_ +6WP9\3;18_$KPZK-PJWE\M
MJQ/IB7:<^U82PN(I_%3?W,?,NY\L_M8? _0/A_X'MO%_Q%L%U[3K.Y6SAATN
M[G$B-+DYV[HUQ\G))SP*];^#'[,S>&='\-3Z7'IT?AIO*O!87%Q-,WE28=EP
MZMSACQNQDU\T_P#!1#]L/P_\1[&Z^%WA:!-4LK&^BGN]>28-#)*@/[N$+G<H
M+8+D\D' QAC]+_L/_M=:/\?/#:^%IK#^Q?%&@V,0>V\S?'=0(%C\Z,]1@[0R
MGIN7!.3CT:N%Q$<%&<KVOM?1+II]Y*DN8]=UKX ^%=4RUM%<:9)US;2DKGW5
ML_IBN1F^"'BOPRQ?PWXD8H#GR_,>W8^V 2I_'%>[45XAH?/TGC?XH^"_^0I8
M->P)UDGMA(@'^_%C]36EI/[3$+;5U/19(_62TE#?^.L!_.O;ZPM;\"^'_$6X
MZCI%K<.W679MD_[[7#?K0!@Z3\;/"&K;5_M/['(?X+N-DQ_P+[OZUV-AJEEJ
MD7FV5W!>1_W[>57'Y@UY;K?[.&B7FY]-OKK3G/1'Q-&/P.#^M<'JGP%\6:%+
MY^FO#?[>5:UF\N0?@V/T)H ^F**^5U\<>/\ P3(L5Y=ZA;#.-NHQ&12/8N#^
MAKI]&_:,UB/:M]I-IJ SM'V60Q.??!W9_(4 ?0->0_%KXH>(/!GB2*RTRW@D
MM6M5F9I86<[BS \@CC %7]-_:#\-W$GEW\5[I4HX;SH=ZC_OG)_2N(U3QYXF
M\8:SXBM-&\0V<>CQI(4CN$B3S(2""$)3<3C/OS0 OAOXY>*]8US3;9[:T:VG
MNHX9&CMVX5F .#NX.#7T+7RWX9U7QEX7\ RZOI&IP6NBK<E&B\N-Y/,. 3\R
M'V[U]+:%<R7FB:?<3-OFEMXW=L 98J"3Q[T 7J*** "BBB@ HHHH ^ &_P""
M*OP09B?^$I^('//_ "$;'_Y#H_X<J?!#_H:?B!_X,;'_ .0Z^_Z* .>^'?@F
MQ^&?@#PUX0TN6XGTW0-,MM*M9;ME:9XH(EB1G*JH+%5&2 !G. .E=#110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'XZ_
M\%5[FT^'?[8G@OXAZ=K6GZKJVF0Z;<3^'96D6>%[>9Y8V/R[3%( !E6)#;L@
M9&?H[PS_ ,%G_@MJFGH^L:#XNT2^"*9819P7$6XYR$D68%@,=65>O2O?/C5^
MPK\&OV@O&K^+?'/ARXU/6VMX[4W$>IW-NOEIG:-L;A>,GG%?.5[^R;^P+INN
M'1KKQ#X9M]463RFMI/',@9'SC8W^D<-GC!YH ]6^$_\ P4^^#7QF^(NA>"O#
MR>(QK6LS_9[7[7IR1Q;MI;YF$AP,*>U?6]?,GPN_X)X_ /X9>,=#\;>$?#4\
M&KZ;(+JPO1K%U/&"5(# -(58$,>H(YKZ;H **** /B3_ (*W?"7Q7\5/V9[!
M_"VGW&KOH&MQ:K>V-JK/*UN()HC(B $L4,H) Y"ECV->&?LD?M8?LK_#_P#8
MX@\*^+[2QM];CM9UU[0KC1Y+F?5YV9L.)!&5DWJ% W./+ 4':%!KU_\ X*V?
MM*>)/@?\(_#?ASPEJ4^B:SXONKB.74K5F2>*T@6,RK&XY1F::(;@<[=P'7(\
MV_96_P""77PN^*7[,>A>)_&<VJWWC#Q78_VDNJVM\R"P$N3$(T^ZY"[2WF!L
ML6Z#& #C/^"*7PK\5VWC7QG\0I[:YL_!TVD_V3!)+&5BOKDW$;[HR?O>4(G4
MD< RXSG(K]:Z_(?_ ()6_&[QGX&_:.UGX&:IK,^N>%MM]#;0SNS+97%J2=\.
MXDI&ZHX*#C)4\$'/VQ^U!_P3T^'7[67C[3_%WB[6O%&G:E9:9'I4<6B75M%"
M8DEEE#$26\AW;IGYSC ''4D \@^,G_*9+X$_]B9<_P#HG6:^_P"OR@\!_LO^
M%?V3?^"JGP9\(^$;_6-1TV]\/WNJR2ZW-%+,)7M-4B*@QQ1C;MA3C&<D\] /
MU?H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _*O_ ((8
M_>^-G_<$_P#;^OU4K\J_@9_P3W_:]_9K_MO_ (5Q\4/A_P"'/[:\C[?S)=>=
MY/F>5_K].?;CS9/NXSNYS@8]5_X4W_P4,_Z+M\/_ /P!A_\ E50!]_T5S_P]
ML_$6F^ ?#5IXOO[?5?%D&F6T6L7UHH6&YO%B43R( B *T@9@-B\$?*.E=!0
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M8ZAX3OY[:WN&@,LRKY4A5B 1N&.<9%=)\//BVOC[5I+%-!O],5+<W GN1\C
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MX/UUFEMK:;1KDG(DL9,+G_<.5 ^F*]/HJHRE'9G'B,'A\6K5Z:EZK]3Q'_A
M_BAX&Y\/^)8_$-FO2TU#[Y'8#>2 /HXI\/[0&J>&I4M_&OA*\TMB<?:K528V
M^@;@CZ,:]KIDT,=Q$T4L:RQL,,C@$$>A!J^=/XD>;_9E2A_N=>4/)^]'[GJO
MDSEO#7Q5\*>+-BZ?K5NT[<"WF;RI<^@5L$_AFNLKSWQ+\!O!OB3>YTP:;.W_
M "VT]O*Q_P !Y3_QVN3_ .%2^//!/S>$?%[7=JGW;#4?N@?W0#N7\?EHY82V
M=O47UK,,/_'HJ:[P>O\ X#+]&S4_:<_Y)D?^OV'^35Z1X9_Y%S2O^O6+_P!
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M\5IBZ5*C5=.FV[;W%%MJ["BBBN(H3KP:Y_5OA]X;US<;W1;.1VZR+&$<_P#
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MX'Y<M] :\!\9:@?AO\*8K%Q++K6ND7MW%&-TS1YQ%"!U+.Q  ZDEAWII-NR
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M.S%\=:]%HHK"4G)W9Z.'H0PU*-&FM(JP4445)T!1110 4444 %%%% !1110
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M_BC'\**S9  Z>4XR?X.U7[+#U_X4N5]I;?)_YE<L)?"[>I]MT5\M_##_ (*
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M=-W3ZH****1H%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M'8#'&.: /Z#/@[HNG>'OA5X1L=*L+73+*/2K79;6<*Q1KF)<X50 *[&O@_\
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M)^S3\8+6;PW>?$'PAK5E>XADT[7=L<$^[@*5N556SZ<U\*?LV_\ !'N7XD^
M]*\7_$WQC?Z+<:U E[%H^E0(;B*.0;E:::3(WLI!*A/ESR2<@>C>,/\ @B+X
M,N-'E'A7XC:[8:H!F-M8MH;J!CZ$1B-@#TR"<9S@]* /H;2/^"=/P;\/_&/P
MK\4O!%I=>%=3TFZ^W+9Z7<>9IUWN4C_5ONV##<>4RJ/[IKZHK\D?^"</QB\?
M_L^?M0:E^S9X]O);G3));FTM;621I4L;V)#*KP.V"()HU8[< $O&P"DMN_6Z
M@ HHHH *_'__ (*T?M?/\0/$$_P;\'737'A_P_,)_$MY:L62:[1PJV[$<;(7
M*[L\>:0.#&,_:'_!13]KQ/V6_@Z\&B7*KX_\1K)::.J[6:T7'[R\93QB,$!<
M@Y=EX(#8^+]4_9!;X#_\$R_B?XZ\66A?XD^+HM+GN9+I29[&S?5;-TMR6Y#L
M0)).AW;5.?+S0!Z[_P $1?\ DC_Q%_[#T7_I.M?I'7YN?\$1?^2/_$7_ +#T
M7_I.M?0?[4'C[]JCPKX^T^T^!_PU\+^,?";Z9'+=7VMW,<<T=Z990\8#7L!V
MB-86SL/+'YCT !Y!\9/^4R7P)_[$RY_]$ZS7W_7Y0> _$WQE\5?\%5/@S=_'
M#PGH_@[Q8GA^]BM;'1)5DADLA::H4D)6XG&XR-,N-XX4?*.I_5^@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH *^3/VUOC9%X+T2XA@*W#Z> L-MU^TW
MT@Q%'C(W!0<D#G&_TKZ:\7^(X?"?AN^U2;&+>,E%/\;GA5_$D5^:&JZA/\9?
MCY))/*9] \'R&YN9&.4N-2?)&>>?+Y/^R5(Z-75AJ:G/FG\,=7_E\WH3)V1T
M_P +_!EWX1\(V&CL7O?$VKS?:+Z0-F2>ZF8;\MD9)8A >A .:^_OA[X-@\!>
M$;#1H2LCPINGF QYLK<NWTSP,]  .U>$?LT^"VU[Q%=>*KR/-I8$P6BMWF(Y
M/7^%#Z8)?(Y6OIJG7J.3UW>K]3PLNC]9J3S"6TO=A_@77_MYZ^E@HHHKD/?"
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KY^
M^,?[$?P^^.'CBX\5^(+G7(=3N(HX76PNXXXL(NU3AHV.< =Z^@:*UI5JE&7-
M3=F5&3B[H^3M/_X)H_"73[^VNEN_$DK02K*(Y;Z(HVT@X.(1P<>M=!\4_P!@
M?X7_ !#F;4-+LIO!.N;MZ7N@D11[QR"8?N=>?DV'WKZ1HKI^O8GF4O:.Z+]K
M.][GQ1_9?[4O[-I)LKRW^-'A.'_EC-N:^5![$^;NXZ!I0/2NY^&?_!0/X<^,
M+S^R?%"7?P\U]&\N6UUQ<0*_=?.P N/614KZ>KA?B9\#_ OQ@LS!XN\,V.KO
MMV)=/'LN8Q_L3+AU^@.*T^L4:W\>&O>.C^[9_@5SQE\:^X[+3]0M=6LX;RQN
M8;RTF7='/;R!XW7U5AP1]*L5\7W_ .Q+X[^#MY/JWP*^)5]I(+>8V@ZTX>"4
M^F[:48]AOCS_ +7>ET[]MKQU\'[R+2OCK\-;[1P6\M=>T6/?;R'Z%BC'N=DG
M_ :/J?M-</-2\MG]S_07L^;X'<^SZ*X;X9_&[P+\8++[3X1\2V.L$+N>V1]E
MQ&/5X6PZCW(Q7<UY\HR@^62LS)IK1A7(^.OA=H'Q"MR-2M-EV!B.]@PLR?C_
M !#V.17744DW%W1A6HT\1!TZL5*+Z,^<?$%UXR^!MFD%^]GXL\,NWE6IOAN,
M4FTE1@G<. >,D8& 1FO*M&^)%]I/C&?Q ]G8W4EQ\LUK);+Y)3CA5 ^7&T<C
MGUSS7U1\9O $WQ$\&O8VCJE_;RBYMPQPKL 04)[9#'\0*^7K'X-^,K_5AIXT
M"\@?=M::>(I"OJ?,/RD?0GVKOI2C*+<MS\KSK"8["XF%/"\SIJSCUL^U_+HG
MT/L3PAKEEXD\,Z=J>GQB&SN(@Z1  ;.Q7 ]""/PK8K#\$>%X_!?A33=&CD\T
M6L6UI,8W,268X]V)K<K@=KZ'ZG0]I[&'M5[UE?UMJ%%%%(W"BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH *_(?\ X+@?\E&^%_\ V"KO_P!')7Z\
M5\<_MU_L!WO[9'B7PKJMKXT@\*KHEI-:F*;3FNC-O=6W B1,8Q[T >^>'OCM
M\-8] TQ6^(?A566VB!4ZW; @[!_MUH?\+Y^&?_11/"?_ (.[;_XNOS4_X<<:
MM_T5^R_\$#__ "11_P ..-6_Z*_9?^"!_P#Y(H YOQ!K6D^(O^"TFGZCH=_9
MZGIEQJ^GM%=Z?,DL,A&D0ARKH2I^8,#@]0>]?L37YP?LZ_\ !)+4O@3\;/"7
MCV;XF6NLQZ%=_:FL4T9H3-\C+M#F9MOWO0]*_1^@ HHHH ^!O^"B7[ OQ!_:
MX^(_ACQ!X/UCPUIMGI>DFPFCURZN(I&D\YWRHB@D!7##J0<]J^#_ (]?\$O_
M (I_L[?"?7?B%XDU_P 'WNBZ/Y'GP:7>74EPWFSQP+L5[9%.&E4G+#@'J>#^
M]-<I\4OA;X8^-/@34_!OC+3/[8\-ZEY7VNR^T2P>9Y<J2I\\3*XP\:'AAG&#
MP2* /Q:_X)F_LH^+?BW\4O#_ ,4-'U'1;;0/!GB&V;4+:^GF2ZEV@2'R56)E
M;@_Q.O-?NA7FWP1_9S^'G[..CZCI7P[\/?\ "/6&HSBYNH?MMQ=>9(%VALS2
M.1P,8! KTF@#X ^,G_*9+X$_]B9<_P#HG6:^_P"O@#XR?\IDO@3_ -B9<_\
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MLPC&G%0BK):!1112+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MK_QU\0Q31Z7!'<V]E=RQB,:C?3L?/D0# *1KO!P,;I !RC ?:?[4'[67Q%^
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MH%L860[A%;1_ZR7)SR<<$]?E'>OI^QL8-,L;>SM8E@M;>-8HHD&%1% "J/8
M"O)/V<_!/]EZ%-XDNH\7FJ#;;[AS'; \$9&1O8;NI!41FO8J4M/=./#KG<L0
M_M;?X5M]^_SMT"BBBH.T**** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM(B#GH##'^5?H'^VY\>/#WA6PM_ 5MJ8'CV6&+6HM/-O+\MDS30>?YFSR^)
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M79^T'X;XUWX16VI!>ITB1F)X_P!B27U';U_!?^&WI=#_ .1K^%WB;P_M^_\
M*7V]?^>B1^A_*OJ*B@#Y[T?]NKX5ZIM^TWNIZ1GK]LL&;'U\HO\ Y%=UH_[2
M7POUW'V;QQH\9/3[9/\ 9O\ T;M]*ZO6/ 'ACQ#N_M7PWI&I[NOVRQBES_WT
MIKA=8_93^%&N!O/\&64)/>S>6WQ_W[9: /1])\2:3KR[M,U2RU%<9S:7"2C_
M ,=)KE?C%\9- ^"GA?\ MC7'DD:5S%:V=N 9;B3&<#/0#NQX'U(!\JU;]@GX
M;7S^98W&N:/(IW(;6\5@I[?ZQ&/Z]J^??V@O@/<_![Q9X+\WQAJD_A^ZGV1Z
MM?QF8:9(&7D -CIM;C!(0\'% 'M</[9^OZ*]KJ7BWX4ZUH'A6[=1'JF9&V*>
MA(>)5;/4<C(Z9KZ9T+7+'Q-HMEJVF7*7FGWD*SP3Q]'1AD'_ .MVKXA^+6E_
M$SP[\,[^ZU;XT>']?\.W4!5+5V622_5AG;'^Z8LWH<\8!RN,B_\  OPC^T19
M_#'0Y/"FNZ18>'+B)YK.QU*-/-B1I&;=S"3AB2X^8C#CITH ^WJ*^6O^,JK.
M$<>&[]D/_3$,_/\ P$?RI_\ PEW[5-C+_P B3X9U!2/^>\0 _P#)I3F@#ZBH
MKY:_X6[^TE9Q,;KX5:5,R'YC;N3GGL!<-G\,T\_M#?&VSD7[5\%+B9&!P+=Y
M2?Q(5L4 ?45%?+9_:Q^)-C')]L^ GB$F,G=)&UPJ ?7[*1^.:<W[:FJVKI]N
M^$7B:T1LX8A\GZ Q#/YT ?45%?+G_#>FBVRR"_\  WB6TDC^\OEH<#&<G)7%
M36__  4&^',SJLFD^)8,]6:U@*CCVG)_2@#Z=J-KB*.5(FD19),[$+ %L=<#
MO7RE\0/V]?"LG@C51X1345\2/'Y=G]NM55$9C@R$AF!VC) /4@#I7@NBV7P?
M\3:"=5\<_$CQ)/XXO%\Z6YAM9)([>0\A3NC)DVGJ0P!QQCK0!^E=%?$/P#_;
M,L/ ^AZIH/CG5+[7HK&;;I6J00-)+<0\C:V\@C& 06YPQ!^Z*]%N?^"@7PV@
MV[-.\1W&>OEVD(Q]=TPH ^F:*^6S^W]X6N(Y'L/"/B2[0$A&\J( GT.';'ZT
MX_MM7EPR)8_"GQ-=R-SMPP./;$;9H ^HJ*^7/^&N_'EVLAL/@/XEN(QPLF;@
MX..X%J?RS1_PT?\ &:\\M;7X(7T+MSFX,V,8]T7'XT ?4=%?+O\ PN?]HB\,
MC6OPDLH4' %Q(00<>\JY_ 4G_"<?M47RQA/A_P"&[(,0WF>='D#'0@W9(_+-
M 'U'17RZ+S]JF]D=OL'AFP  PNZ(@_3YV/YU#<>&?VJ=0LVC;Q1X=L_,7#;(
MXMX!'(SY!_2@#9\:?M>7'_"7WWAKX=^"K_QY>:>S)=W5J7\F-@2"%"(Q9<@C
M<2HR.,]:ZOX*?M*:;\6-6O/#VH:/=^$_%UFI>;1[_.2HQDJQ53D9&5*@C/<9
M-?(W[-NE_$*XCUO1/"WQ T?P1>6]R?M6E:DJI=2.!M+8:(D@8*XW94@Y R"7
MMX?^(GBK]I+3-/TSQWINO^,[2W8OX@T^,&"T54<,LC+& Q ;;T/+A<YX !^C
M5%?,'_"H_P!H_P#Z*QI?_?@?_&*/^%1_M'_]%8TO_OP/_C% 'T_17S!_PJ/]
MH_\ Z*QI?_?@?_&*/^%1_M'_ /16-+_[\#_XQ0!]/T5\P?\ "H_VC_\ HK&E
M_P#?@?\ QBC_ (5'^T?_ -%8TO\ [\#_ .,4 ?3]%?,'_"H_VC_^BL:7_P!^
M!_\ &*/^%1_M'_\ 16-+_P"_ _\ C% 'T_7C?QL_:5TOX2:I9Z!8Z3=>*O%M
MX T.CV)(8*<[2Q"L03@X4*2?88-<)_PJ/]H__HK&E_\ ?@?_ !BO SX?^(GA
M3]I+4-/U7QUIV@^,KNW79XAU",""[5D4*J,T9"DA=H.!RA7.>" ?1W@O]KJ8
M^+;'PW\1/!>H> KW4&"6=S=;S#*Q. #O12HR0-PW#/7%?1M?G1^TAI/Q M;/
M1M%\5?$/2?&M_<W:_9-'TV-7N48@J'XC4J"2% S\Q(P#CCW.U^$7[1RVL(_X
M6IIL6$ V-%N*\="?(YH ^I**^8/^%1_M'_\ 16-+_P"_ _\ C%'_  J/]H__
M **QI?\ WX'_ ,8H ^GZ*^8/^%1_M'_]%8TO_OP/_C%'_"H_VC_^BL:7_P!^
M!_\ &* /I^BOF#_A4?[1_P#T5C2_^_ _^,4?\*C_ &C_ /HK&E_]^!_\8H ^
MGZ*^8/\ A4?[1_\ T5C2_P#OP/\ XQ1_PJ/]H_\ Z*QI?_?@?_&* /;OBM\5
MM"^#WA.;7M>E<0*PBAMX0#+<2$$A$!(YX)R>  :\$7]M+Q'IL<.M:Y\)=:TW
MP?.5V:H'<E5/1\M$J-G(P-RY[$UX_P#M,> _BKX6C\*:GX\\6VOB'3DO&C@N
MX;?=%92'8<R+Y0#;@N0"#G8PQZ_0WAKQ0?"/P3\1WOQ.\>:+XTLKZ*0VTEG(
MC+-"T040JH5=S%L\8.,\XQP >W^$_%6F>-_#MAKNC72WFFWT0EAF7C([@CL0
M<@@\@@BM>OGO]A?2]1TWX$0/?(Z0W5_/<6:NN#Y)VJ#]"RN1]:^A* "BBB@
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M@?\ ?=]_\K:^_P"B@#X _P"'CWQO_P"C+_B!_P!]WW_RMH_X>/?&_P#Z,O\
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M!\ ?\/'OC?\ ]&7_ ! _[[OO_E;1_P /'OC?_P!&7_$#_ON^_P#E;7W_ $4
M? '_  \>^-__ $9?\0/^^[[_ .5M'_#Q[XW_ /1E_P 0/^^[[_Y6U]_T4 ?
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M]_T4 ? '_#Q[XW_]&7_$#_ON^_\ E;1_P\>^-_\ T9?\0/\ ON^_^5M??]%
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M)/',+XQNC%XI_,:97Z$44 ? '_#Q[XW_ /1E_P 0/^^[[_Y6T?\ #Q[XW_\
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M_MA)^U]\+;S4K_3X=)\6Z'.EIJ]I:D^0S,I:.>($EE1P&^5B2"C#)&"?IJ@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:  47Y<885\]?\$2O^2Y>/O^Q='_ *4Q5^M7Q*_Y)SXJ_P"P5=?^B7K\E?\
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MEK]H/QU^S;\0M0\3_#[3+/5=:NM,DTZ:&]LY+I! TL4C,%C92#NB09SCD^M
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M/?:\&?PK]0* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "OS\^-G_  3C\8_%#]MA?C58^*=#
MM-$&L:1J7]G7"S?:=EI%;(Z\(5RQ@;'/<9K] Z* "BBB@ HHHH **** "BBB
M@#/\0:!IWBK0M1T76+*'4=)U&WDM+NSN%W1S0NI5T8=P5)!^M?F=XL_X(_\
MBWPGXNU2^^#OQ=G\,:)J'[MK*\DN(+B.$]8FF@/[Y<YQN5>" <D9/Z@T4 ?(
MO[$'_!//P_\ LAW.H^(;S6F\6>-M0M_LC7_V<06]G 6#-'"F2V6(7<['D*H
M7YMWUU110 4444 %%%% !1110 4444 97BS2)/$'A76=+A=8YKZRFMD>3.U6
M="H)QVR:^*_^"?\ _P $_P#Q;^R'\1/$OB'Q#XET76[;5-+%A'%I@F#HWG(^
MX[U QA37W310 4444 %%%% !1110 4444 %?EE^T%_P2B^*WQT^-?C+QY=>/
MO#*_VYJ,EQ!%.MR7AMP=L$1Q'C*1+&G_  &OU-HH _''_AR3\3/^A_\ "?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M50BA5 50,  8 I:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MAD'._;4^'^B_%[XL?LH^)KZ\U2*3QE>V]I=?8;^6!$A*12AH5!S$^96^<8;
M4'H* /O#4]3\:Q?$S1[*QT73)_ TMI(^H:K+>,MY!<#=L2.'&&4X7+9&,FNO
MKXM\5--\/_\ @H!\#/"5EJ^I+X;T_P "7D+6]S>R2B584F59)LG]XX5 2[9)
M/->T:#^VE\#?%&O:=HND_$_P_?ZKJ-S'9VEI#<Y>::1@B(HQR68@#ZT >/\
MQ:_:/_:6^"WP[UOQKXC^%'@<:'H\2S7)M?$DTDNTNJ#:OE#/+#O7=?#/XE?M
M'>*]3\.7>N?#7P9IGA;4##-=7EIXAEEN(;=P&++&8P&8 ],T[_@HI_R97\5/
M^P=%_P"E,5>T_#+_ ))OX4_[!5K_ .B5H \R_9N_:(OOCGXJ^+VDWFCV^E1^
M!_%=UX<@D@E9S=)"[*)6R/E)V]!Q7N5?&/\ P3Y_Y*5^U3_V4_4__1TE?9U
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M$;Q'X#B^!S^&->O-'36/B%IFG7K6,Q075K)OWQ/C[R-@<4 ?5M%%% !1110
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M(/ ^^:^7?VI/V'=/_:4^*7@OQ9)KW]BVNGQ)I_B'3Q:F4:YIZ745U':LV\;
M)(W.2&Y8' V\@'#?!;PGXB^ '_!/'QWXWE:>+XD^(]%U7QOJ5XRE9DO;BW>6
M-B",J8T$9*\88/P,FO-/V6=4\2^&?V:/#FA:=^R/-XRT?6]-2[U#6)M:TQAK
MC3+O>>42Y<AMW"ORH 7C%?HYJ&EVFJ:9<Z==V\=Q8W,+6\UO(N4>-E*LA'H0
M2,5\FZ+^QW\6?A3I]UX8^$W[0%SX3\ /([6.CZQX<@U:?25=BS1P7$D@8IEC
MA6'&.I)+$ ^3OC-X+\>_#G_@F7XU\,>./#-YX3MK#QK&WA[2[Z^CNY+?2Y)4
MDBB,B.V[8[2KDD$^E?2?_!1[X0>"O!?[ _B>VT3PQI>FKX:_LQM(>WMD22S;
M[=;PET<#(8QR.I;.3N.<UU?Q*_8,L_%7[*,_P:T;Q??0W5UJ4>K7WB;75:^N
MKRY$@>227YUR6P%'/ 4=>I]5_:K^!LW[2/P#\4?#F#6$T&76OLN-0DMS.L7D
MW4,_*!ESGRMO48W9[8H ^<_C5J4NL?MF_L97\W^NNK#5IWYS\S6,;'GZFM#]
MB3P]I7Q(^,G[1WQ \3Z5:ZEXP@\=7OAV&YO8UF>SL+8!(H(]P^08X8KC=L&>
M@KU?Q9^R_<>)?C!\#/&Z^(8K>/X;6EU;261M"QO_ #K=8<J^\>7C;GD-G.*Q
MO'/[)WBK3_BKKGQ!^#?Q.E^&>K>(]C>(-+NM*CU/3M1E12JS^4[+Y4N#RRGG
M';+9 /!_VVO@KX(^"_[+/[2B^#]<$;^(KO1M6OO",4\'D:5,=0M098H44/$)
M003NX.U<8 K!^+VN:WK7[87P=T<?#:?XLZ=X:^'%OKFG>%?ML%M$+J60Q/>D
M3_))M"1J%Y(958?=./;=?_X)]MKWP'^*/A74/B!=Z[\1/B-<V%UKOC?5+%?G
M:UN(I8XX[:-E$<2K&RJ@8XW]<*JCOOB]^R;_ ,+$L_ NL>'O&-]X"^)7@RT6
MTTOQ9IMNLP,>P+)%-;N=LL38SL8\$GD@L" ?/GC;3?BW\0_CW\(_'>A_LVWW
MP[UO0-<ACU?7EUJPD^TZ1(?+N8)5B92X",64G=M^; ^8U^@U?,_A']EKQ]K7
MQ)\/^,/B_P#%^Y\?)X;F^U:/X?TO28])T^*XQ@3SJCL9V4X*[L;2."02*^F*
M /CW_@FJ?[#\#_%;PC?2-_PD6@?$#5(M0BF7;(V\QE)L9)VN%;!/7:<9 S7T
MI\5OBMX8^"?@/4O&/C'4AI/A_3O+^T77EM(1O=8U 1068EF P 37D7Q:_9(O
M/$/Q*G^)?PO\?ZA\)_B!>0I;ZE>6=G'>V.JHF GVJUD(5W51M#YR!V)%<NO[
M%WC'XG^+M'U7X[_%VX^)>A:-=)>V7A&PT:+2M+>=/NO<JC,9P#SM;'<9*L5H
M Y73[71OC9_P4LNV\1VJZOI'AGP#;:EX:L-2C)B#3S1L]VL$@&V0>;L)*Y!5
M<X*KB]^T)X7T?X:_MN_LY^*O"]M;Z%X@\3W>I:+K(LE6(:G9K;HP\U!C?L9A
M\Q'!V9^ZN/4_C]^RY<_%#QOH/Q$\$>-+OX;?$_0[9K&WUZVM$O(;JT9BQMKF
MW<A9$RS$9/RELX; QE_"G]D[6]*^+L'Q4^*WQ$N/B?XWT^VDL]&VZ;'IUAI,
M4@VN88$9@9&!8&3(R&P02 : /'OV!?ASX:U3X[_M3^*;[1+*^UZ/XAZGIT5]
M=0K(\5O]IF<HA8':&9LMC&[:N<[15W]DG3]-T'XY?MB^#]-TZ"QT&QU:SO8+
M&(8@C>XM[@R;8_NJ,Q \<=!@!17O'[.O[.L_P)\3?%G59M=CUA?''BJZ\2)$
MEL839K,[-Y))9MY&[[W&<=*/@O\ LZS_  G^-OQF\?2Z['J4?Q!N[&YCL5MC
M&;+[.DRD%]QW[O-]%QM[YH ^'/AQ:PQ_\$5O$DZPQK.\-X&D"@,P&J\ GO7N
M7Q:TVV^"/_!+V:_\#:1!I>IQ>#+"!;FPC6*X5;LVRW4OF*-VXB1Y&/4L,]>:
MG\,_L!^,/"_[/_CSX+)\6(=1\ ZO"\>B6]UH"+<:8SW23LTDJ2 S?=88^7)?
M(VC"CZ>L?A3I=U\%K/X<>(436M(_L*+0[T%3&MS&L B<C!RN0"1@Y''/% 'G
M/P]_9G^%M[^RUH7@2Y\+Z3/X6O=!MS<NT$8>5WA5FNC* #YNX[_,!!!P01@5
M\%Z7XFU/Q5^Q/^QS/JMR]Y-:_$^ST^&23J((;JXCA3Z(BJ@]E%?4\/[$?Q8T
MSP;_ ,*VTO\ :/U:S^%*Q_8X]/;0+=]6BL=NTVBWH8$+MX#!1@8 7;\I[CXF
M?L7:1XC^'_P=\&>$M1C\+:%\.O$5EK<$4MN;AKI8"Q9"0RX>1G9B_/S$G'-
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MR$9(#/;6S8S^?Y5]7_&[X*V_QJ^!NN_#:XU632[?5;.*S;4(H1(\81T;<$)
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M!^%G[7@\4_%&V^&_C[X?ZY\*O&VH6SW>EV>L2Q7%MJ4: EQ!<1':SJH+%<<
M'GB@#Z'HKP#XN?M8CP3\2O\ A7/@CP)K7Q2\>0VBW]_IFCRQ6\.FP-C8;BXE
M.U&<$%5Y)&"<9&>@_9^_:4T?X]?\)'IHT75?"/C#PS<):ZWX9UR-4NK-W!*.
M"I(>-P&VN.H&<8(R >OT444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MOT*\5>)].\$^%=6\0ZO.MKI6E6<M]=S,0 D4:%W;GT"FOF#_ (*8>%M:\7?
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M;XP^,/A5K<6LQZ6O@GQ$FNO"]N93=A5*^4#N&P\_>Y^E>O44 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
? %%%% !1110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>syre-20250331_g2.jpg
<TEXT>
begin 644 syre-20250331_g2.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &N PT# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z*** "B
MBO)=0_:M^%FEWUS9W/BGRKFWD:&5/[/NCM9201D18/(/2KC3G/X%<Z:&%KXE
MM4*;E;LF_P CUJBN5\!_%+PK\3+>>;PSK4&J+ 0)40,DD>>A9' 8 ^N,<&NJ
MI2BXNTE9F52G.C)PJ1::Z/1A114-G>6^H0">UGCN826420N'4D$@C(]""#[@
MU)&NY-1110(***@^VV_VS[)Y\7VOR_-\C>-^S.-VWKC/&:!ZLGHHHH$%%%%
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M.5^]G)50" 3R<=*P? 'PS\2W7['?C#PY-H.H6NM7%^9X;"ZMWAFD"-;OE58
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M)L&6;'11[DX ]S7@_P +_"FMZ?\ M>?$#6;K1]0MM(NK"1(-0FM72WE8R6Q
M60C:QPK< _PGTKV+XN>"9/B-\-M?\.0S+!<7UOMADDSM$BL'3..Q90#['O7-
M5C3]K'HG:_ZGC8^EA5C:25HPDH.5ME=+FMN>*P_'CXLZGX%N?B%8^$M 3P?$
M6E%G--,;Y[=20T@8$+@8/.W/&0I%<]^T]\0+[XF? '1/$>B?8H_"M].GVR&X
M+_;8[E68!!CY-H*MG/)^4BETOQ)X^T#X(W7PND^&FOR^(#;3:5'?0P;K PR[
MP9#-G:" Q'7!ZY'2I_B/\&-=\)?LFZ5X3M+"ZUK7([^.ZN8--A>=@S,[, %!
M)"@A<].,]Z[HQIPJ1=DO>T].Y]-2IX7#XJE/EA%JK:-G>\.[U?E9]SVWX 0:
M_!\+=#&OQZ3&_P!E@^PC2%D"_9/)C,?F[_\ EKDONV_+R,=ZP/C#\;-7\*^-
M-!\#>#]*MM7\6ZLAF7[<S"""/YL%@I!/".QY& N><UZ%\.+6:Q^'GA>VN89+
M>XATNUCDAE4JZ,(5!5@>001C!KQ+XV>"_$GA?XX>%_BEX?T2Z\26MG#]EOK"
MQ7?.HVR(65!R<I(<8S@KSUKBI\LZTN;SMVOT/F\(J.(S"HZR7VG%/2+EKRIZ
M[-^9UW@?XH>-K/Q5K&A?$/PQ'I\%C;-=)XBT>WG;3755WL"[@X.W/?.5(QG%
M<):?M#_$KQ9X5UWQQX:\,Z$/!NE22 PW\LIOIHXUW2.I5@HVKR<CCH-V*ZW0
M_%WCSXQ:UKVES>$Y/"?@2>PFM?M&N6DD.HR/)&R#:N_ Y.3\I  QG)%?.>D_
M"&7P?H.JZ%KGP<U?Q/XO2Y9;#5K=KIM/D0X ,C12( !R>,$Y&<8KJITZ;;YT
MKZ:?GU7_  #V\)A<)*4W7A%5/<]U--6?Q/644GM?5\O8],_:>\?67Q._9AT#
MQ)IZ-#!>ZI"6A<@M$ZI,KH2.N&!Y[C![UE?%W_DI7[.G_</_ /1UO6M\9OA1
MK.E?LOZ#X>TSPSG5UU..ZNM+T&.XNTB9EE+8W-(Y W*"=Q&>G!%/^*7@WQ!J
M'Q!^ MS:Z%J5S;Z;]A^W30V<CI:[98"WFD#"8 ).[&,&M*;@DE%Z7E^1U8.>
M'IQIQI2]U2K6NUMRZ?UU/0])^-&MWW[36L_#J2UT\:)96BSQW"QO]I+&"*3!
M;?MQF1OX>@%'@;XT:WXF_:&\7> [JUT^/2-(M'G@FAC<7#,'@4!F+E2,2MT4
M=!7!^+=*\1_#;]JN\\=Q^$]9\2:#J5HD.[1;8W$B'R8XSE1T(,6?F(&#UI/@
M1HOBJ?\ :<\9>)]=\*ZCX?M-2TR1HFN86\H;I+9D3S<;2^T<@'((8=C6#IT^
M1R5OA7WGFSP>%^KRK14;>QC;5?'I?2][]S&_9!U^7POX'^)FJPZ;=ZQ/:W:/
M'86,;233OAPJ*%!/)(YP<#)[5=\0?M1?$/P#;Z)JOB?1O#"6.H2D2:+;2S)J
MEJ@P?WJLQ"'&<97KP0*YCX:_#SX@V?P4^*-AINDZIH^LWEY"\,5Q!);2W, +
M>:L18#)*Y''7..]<1XP^&FI:I\-_#]GX?^$OB/3=9LMIUC4KFSD:6ZF*E?W:
MG+E"<MP %X'/4]G)2J59.=G=_IZGT+PV"Q6.JU*_+).26ZT7(O[RMKU2;OH?
M2OQX^.OBGX;_ !&\+>&O#NE:=JAUJ,!8[M9/,,S2&- &5P ,XSD'O7J_@3_A
M+3HI;QE_8PU8RDJNAB7R5CP, F0Y+9SGMTKPKXT>'=:\2?M!?"?6]/T/5+C3
M(3;RW%PME(5MAY^XB4@80@'D-C%?3%>75Y8TX)+5K4^'QRHTL)AXTXKFDFY/
MK>[^X\F^+'Q(\9Z#XGTW0O".@6T@FB,]YK^NQS)I=HO.%:5<#=QZ_P 2C!)K
M"^!?[0NH>/M;\5Z+XFMM+M[O05:5]0T>1GM)8U8J[#+,<< @@\@]!CGA/CMX
M0UJ\^/MCJWB#PCKGCCP&MLJP6&D(\HC?RR#E4(P=_P QR0"".3C%5_V=_A]K
M%G\4/B#!JGA'4?"6DZUILBVL;6S>1#'(RE8EE V%E1QQG.58$ @BNKV=+V%W
MO:_X^OZ'M1P>"_LURE;FY%*ZWOS:KXKMI;KE21U/@WX^?$?XF)K7B/PQX5T:
M3P?I<S)Y-[/*E[=A0&98G'R!]I!^9<#(&37A'P]_Y,_^*?\ V$K'_P!'6]>J
M?!V^\>? ?0=?\#/X!UG6M1:\DFTO4["#=9.[JJ R2G"J@VAL]><$#K7'>"OA
MOXKT_P#9;^)>C3^&M7CU6YU&T:WLVL)1-.JS0%F1"NY@ I.0.@-=,>2#:C9*
M\;>:N>U1C0P\IQI*,8>TH\K3U<5+=ZO[_7L=)X?^,'Q(^&7P)\+>(K?0-!?P
MC;116@CN9I3?2C)7S?E(159@0/O'ID8YKU3XE?M$2>']!\%+X:TI-3\1^,(H
M)M.L[IRL<22!"&DQ@GEP, CN<\8/$_$'P?KU[^QKH&B6^B:C/K,<5F'TZ*TD
M:X4J^6S&!N&._%8GQ:^"VM:[X#^$FO1^'KK7?[$TBRL]7\/@/%<M&(XRR@##
MALAU('S D<<&L.6C4DG)):O_ (!YRI8#%5HU*\8K]Y46CWLKQOKU?6ZOM<]*
M\+_&KQ9H?Q6L? ?Q%TO2+2^U2W\_3[_1'D,$A^;Y6#DD9*,.W('&"#7'7G[4
M7BSQ%XN\3Z=X6A\)Z?;:+(\<=OXBN9$N[\HQ4B$*RJ6)4_*>F1R:H_"7X8V>
MJ?%O3]5T;X43>#?#6F*)S>^(7O4OFG .!&C3[",E>JL, D\D"L;XA>!WU3QE
MXC/COX3ZI?W,DA>PUSP#;2XNNN#,K.Z D8);&X'.0>M.,*//:W3R_*_ZCIX?
M+OK#BX)OD5U[NCOK[O.UM:ZYKK=(]<U;XJZGKG[..N>*=9\()8ZE;1;9M&UZ
MR=K:8ADPVQ]I>,A@1[@C)Q7/0?M$IX%^ /@[6;?P[IZZWKCRV]AHNE1&VM%8
M2LI(4$D*/ER <EG[9R.7\%_#7QOH?[*?C72M6LK^6ZOCOTW1MC37,4>Y,C8
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MUH_L+XN?]#OX+_\ ".N__EK1R1_G7X_Y >C45YS_ &%\7/\ H=_!?_A'7?\
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MW\%_^$==_P#RUH_L+XN?]#OX+_\ ".N__EK1R1_G7X_Y >C45YS_ &%\7/\
MH=_!?_A'7?\ \M:/["^+G_0[^"__  CKO_Y:T<D?YU^/^0'HU%><_P!A?%S_
M *'?P7_X1UW_ /+6C^POBY_T._@O_P (Z[_^6M')'^=?C_D!Z-17G/\ 87Q<
M_P"AW\%_^$==_P#RUH_L+XN?]#OX+_\ ".N__EK1R1_G7X_Y >C45YS_ &%\
M7/\ H=_!?_A'7?\ \M:/["^+G_0[^"__  CKO_Y:T<D?YU^/^0'HU%><_P!A
M?%S_ *'?P7_X1UW_ /+6C^POBY_T._@O_P (Z[_^6M')'^=?C_D!Z-17G/\
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MZ[_^6M')'^=?C_D!Z-17G/\ 87Q<_P"AW\%_^$==_P#RUH_L+XN?]#OX+_\
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M[6'H/@;PWX5U36-3T7P_I>D:EK,HN-3O+"RC@FOI!NP\[JH,C#<W+$GYCZT
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MI\/O"VI:UJ41@OM1O-%MI;BZC*A"DLC(6==JJN&)&% Z"@#!_9._Y-9^#?\
MV)FC?^D,-?F=\>M8U[X"?$?X_P#[/'AZ!Q)\7=:TR[\,JG$<?VZ?%RN0/E5B
M?(QS@1\ ]:_7O2=)L=!TJSTS3+*WT[3;*%+:UL[2)8H8(D4*D:(H 554 !0,
M   5BZQ\,_!_B+Q5IOB?5?"FAZGXETU56QUF\TZ&6\M0&+ 13,I= "S$;2.6
M)[T ?$'[;'@VT_9NC_97\9Q:/<:I\.?A3J7]GZHMI#ODAC>.V2&Y*G(R&MV.
MYB,R.@W!G!KO;?\ X*)?![XG?''X:>$? &BW?Q0U?4;R=!JUIIKP2:$#"RM,
M@NHT8@J6\PH5VQ"0Y8@1M]@7ME;ZE9SVEW!%=6EQ&T4T$R!TD1AAE93P002"
M#US7+>!_@[X!^&-U=7/@[P/X;\)W%T@CN)M#TFWLGF4'(5S$BE@#S@T ?FC\
M:]1^,O[2/[77Q+\0?"3X>Z3\1O#7A73+CX>NNM7445K'YJ,+MT#7,&Z4L\R;
ME+ (5R/NX=X!\>:U%_P39^._P>\9VTFG>-_AFK:;<V4TBR,MK+<*\1W*2&"N
M)D!4E=JQD$AA7Z@>$_ WAOP#9W5IX8\/Z7X<M+NY>\N(-)LHK5)IV"AI76-0
M&<A5!8\G:.>*S=0^$'@/5K[7;Z^\$^';V]UZ%;?5[BXTF"2348UV[4N&*9E4
M;$P'R!M'H* /R&U;POKEKXP\&_ ^QBN%\+?&[3? ^LW6P[4B@@M56\*_[1>$
M2$C_ )YC/:O<OV4-<^+'A'X1?'2?X(^%-'\5>+%^*MY#_9FK2+%;K:^6-[#,
M\ R"$ &_N>#V_1!?AGX/75-!U(>%-#&H^'[?[)H]X-.A\[38=FSRK=]N84V_
M+M0@8XZ59\+^!O#?@=;]?#GA_2] 74+EKV\&EV4=L+F=OO2R;%&]S@98Y)QU
MH ^5/BMX5\1>./V,_&GQ ^,_@70]$^,6F^#=?M%%CMF33H9(YE'D-YTRHTD0
M3<RN6PS+D E:;\,/$7Q;\,?\$^_A!>?!;POI/B[QB=+L(VT_695C@%L8W\Q\
MM/"-P(3'S]SP>WU[K&C:?XBTF\TO5;&VU/3+R%K>YLKR%9H9XV&&1T8%64@D
M$$8(-,T/0=,\+Z/::3HVG6FDZ59QB&VL;&!88($'1$10%51Z 8H XK]G_6_B
M1XB^%6D7_P 6= T[PQX[D><7VEZ5(KV\2B9Q$5(FF',81C^\/)/3H/1*** "
MBBB@ HHHH *^2/\ @J-XV\1?#_\ 9-U/6/"VOZIX:U9-5LHUO](O)+6=5:0A
ME$D;!L$=1GFOK>OF+_@HQ\&_&'QX_9GU#PGX&T?^W-?EU*TN$L_M,-OE$<ES
MOE=%X';.: /EO7_VC?'T/[#-MX"B\8:K_P +F7QZ_P .9M92\E34?.BNC(93
M+N\S_5>7&7SGYCDYS7I'[*W[2>L>!/\ @FCJOQ3\7:_?^(]<TT:D8+S6[R2Z
MFGN//:*UB:20LQ!D:->^ >G%1WW[%?C1O^"@FK_$".Q,OPO>*ZU^U_TJ$)_:
M\UB+9D,6_P S<9/WH<J%& ,]<^<^&_V*_C+XF_9H^#'P,\1>'+CPYX;_ .$G
MO-6\::A;:K9-):VJR%H(X]LK^8T@>0C:KA66,L#@@ 'H/_!/'XD?$KP;\3M=
M^$7Q@\1ZIXAUO6?#^G^--#N]9O)KB98IH4^T6VZ5B1L9@NP8 :&8C(->M^,/
MVUM<C^-7B?P-\//A#K'Q,T_P:L+^*]9T_4X+0V&[+/';PRC%U*J!L1AT9V5E
M' W5X/JW_!->\_9<^('PZ^)'P D\1^+]=TG7$&KZ3K6IV*>9ISHRSF-BD"Y*
M%D(+$_O 0/E->AV_PQ^._P"SO^T5\5M9^&O@C2/B#X6^)EU#J"7]]K<6G_V#
M>?.K23HP+S1!I68I$K%E5=I5LJ0#P'X6_M2_%JR_8B^&NE>'/$EWJWQ2^(?C
M.?PY8>(O$=V]X]FAD4%R\V_D%D49#!59B!D"O:? O[+?[4'P#^*G@C5]%^.6
MH?%[PW>WOV;Q/IGBRXFCBM;/ 8R1B::X)8X90T05PWEY#1M)MXKX>?L$_$Z[
M_8N\'>'9)(? /QB\%^*)O$FAR7-S#<0A]X*J[PF5 & 5APWS1J",$UU_@VP_
M;@^,_P 4_!'_  GUOHOP:\'>'[W^T=1N/#MU#+)JZ#:IMGC%Q<[R5+X#!(UW
M,Y#LD:T ;W_!0OQQX^\3^(_A_P#!+X2Z_J/A[QSX@6]UZXOM)NY;::.TM;:5
MHXFDC(9$FE!7/]Z,#G.#:T']HS5?B]_P3,\1^/[35+K3O&-AX6OK6^O+.9H;
MFWU"VC9&D#J=R.VU900<@2#H:XCQC_P3XU#]KK]HGXF^-_C0=>\)Z%%<6^F^
M$;71=1LFDFLH596F?Y9MBN0) AVL#*^0, 5G^#?V-_B7\#/"_P"TC\(_".DW
MOB3X9>*O#S3^%=2O]2LEG.I-;K')!(NZ,JSEL;R@3%NAR"QH \^_9T_:R\9_
M#O\ 9"^.<'C7QCJNM>,='T>QUK0M5U>\DN+G9JMI&MN(Y)&+,(I74XSP6/OC
MV+_@E+XJ\>ZUIWQ@T?X@^*]<\5:OX?\ $$>F>9K>I37C0-&)$D5#*S%067H/
M2O-_$'[ /Q(U[Q=^S9=#1S;:/9Z!I&C_ ! M!?6VR!;&=)L,/,_?%AE 8@X'
ME ]#SZ;\._V&-2^($/[2OAGXHV6I^'/#/C?Q[)KVDWFDW]JUQ<VRW,TL<@XE
M" [DRKH&YZ T >M_MO?$/XP>$_!*:5\(M @>ZO=+U34-6\67DI2'0K6UBC)*
MC&&GE\T^6,DCRF.Q@&:/5_8%\3:QXR_9!^&VLZ_JM]KFL7=G,UQJ&I7+W%Q,
MPN95!>1R68X ')Z 4_PG^R]I?P+_ &6?%WPL\!S:IK,=UIFIK9_VO<0M/+<7
M$+@(75(T +$ $@8SR:X/X8_L=GQY^P;X.^"WQ3CU/PW=6T8>_ATF[MVN(9$N
MY)D EVRQD$%<XSUZ@T =/^TI^U[J/P%^*WP^\!:/\.KOQ[J_C**Y^Q1V.II:
MR+/'@1QD2(5V,S#=(SJ(U#-AMN#Y%'_P4L\77GA[QZUE^SYJ]QXF^'L\P\8:
M<_B.V2STFWCWCS!=>63.Q,4GR1Q$;49@S"H]*_82U#X*_M"?L\M\/K/5-;^'
MWA"75[C5=6U>_M#/;/<QG:"JB)G!; &R,X[FIO#_ .S/\2;&U_;92;PWL;XC
M?:/^$7'VZV/]H;HKQ5Z2?NLF:/\ UNS[WL< 'IWC+]N&T@\+_"Q_ /@;4_'O
MC7XD6/\ :.B>%OM<5@RP+&))GN+A]R1;!N[$$H>0.:@T_P#;Z\.Z?\$OB#XT
M\9^&-2\(>)/ 5_\ V3KOA&29+F9+QF"P)#,H"2QR$\28 PKG!4!F^<OB!^P=
MXTUOX3?L^:GJ'P[M/'^J^"]%DT?Q#\/KG7UTU[I'+,C17L4@16C=BQP^#Q][
MD5KZ3_P3TUOQ1^RC\3O#T'@7PU\(O%OBC4K>^TW0K'5[W4O*@LY7:VBO;J6X
MFC:5EEF7= JK\RL1D[(P!WQ(_:>^+7B[XW?LRV/B'P%XF^"T>M^)%F>RBU];
MFUUBQ?[/A)_*\LAU+'=!-'E0XSR2!Z'\$_VB)]#D_:AUFTT3XA^.KWPKXQN;
M&WT!M5?7))Y?M$R)%8P);H;2WR!E/WNQ!]YMO/*>*/!G[2_Q\^+G[/GB+QI\
M)M.\'Z9X'UQ+G5WM_$=I=RS,1 9;L(K )$=AVQ*TC@[LY&TGE?%7[&_QJUKX
M:?M3Z3I6F)I=[XR\>/KND6\FIP*-:TX7,\ABW)(?+WAXSME*=,-CG ![7\,?
MV\/$OC7XG>)_AEK7PBCT'XCZ?H5QJ^F:'8^,++4TO)X@W^A7$\2A;.5F"C$F
M2H;<P4;=WD'[('[<GC'P[^S?\0?B1\8=,U36]&L=9E^R:\FH0S37UY(T48TV
M"T4+Y*ID-N&(\.V!P<['[./[,_Q"\'_M9>"?B!+\$M"^$W@FW\+SZ#+I.B:U
M;7TMI(F\I/>2 AKB64D#S%\QMOE^8V037&>'OV)_B]K/[,?Q+^!6J^#[+1(;
M?Q!-XC\.^*)=;AFM=6D6956W,$9,L*O$K$/)@@N RJ0: /J7X2_M>:YKWQ.3
MX?\ Q6^%]Y\(?$M]I#Z[I*W&KPZG;7UK&3YP,L2KY4J!2QC8$A02=ORAOG+X
M_P#[>GCCXG?LS_$7Q/X'^&?BCPW\/B_]GZ-\3+#6HX+CSDN85\PVPV311-\Z
M>:C. Q"'DL%U_P!EW]BNYL_BN_B/6/V?= ^">DZ?HL]G%-_PEMYKNIW5Y<12
MV\KPE;MH(X?)E<%98V8'&TMN+1\?>? ']I_PQ^R3XG_9JTWX;:+KVBVTLO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M>'/_ &XH ^JJ^*/VP?V??BE\2OBUIFL^&D?5-'6"*.U5+E(?[/D!&XD,PZL
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M+XLR^)?$GB'1_"?B'Q2E]'X=TZ6P%GJMJNG6$1DE?R'N4W2021LJS1Y6(?*
MQ+=CJWPSO;K]I70O%$=@6\,KHEU-?/YZB(ZO')!%92F+=DR"VFOT\P+C:%#'
M*18 .GL?C'X0U#QQ?>$8-7SKEF)/-22UF2 M&J/+&EPR"&21%D1GC1RR!@6
M%1>!OC;X)^(VCZEJNA:XDNGZ=&EQ<W%Y;S6:K Z%X[@>>B;H'569)ES&X4E6
M(!KQB;X*^+];\>'29](&F:'IVO:_K\7B-;B$PWRZC9W$$4'E*YFWHUXY?>BK
MBWCVLQ.!O? 'X;^)%U[4M;\:>%H?#B?\(KH7A8:/)-;W,5Q)8-=R2W*")W7R
M2UTJQ;]LFV,ED0D"@#VCP7XST7XA>%M-\1^';]-4T34HO/M+R-659DR0& 8
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M]"HH \]_X5/=?]#MXF_\#C7;Z78MINFVUHUQ-=M#&$,]PVZ23 ^\Q[DU;HH
M**** "BBB@ HHHH **** "BBB@ K-\2QV$OAS54U2=K73&M)1=3K,T)CA*'>
MPD4@IA<G<"",9!KD_B+\;/#OPRU33]+U&VU[5-5OH9+F*Q\.Z#>ZM,L*,JM*
MZVT4AC3<ZJ"V,DG&<'%BU\4Z+\3/AKJU]/H^NIHEU:W-O<Z=JFBW=G>RQ;&6
M11;2QK,2RDA<+EL_+F@#YMF\ GX-^#?#WQ*\ ZO_ &9X:TY[JZ.G^+/"X0Q0
M3(RO<7,UJL4\<>%\QIITGD ?=)_%C[#MF>2WB:389&0%O+.5SCG![BOA75/C
M!+J'A/6O#.N_$+QW<?#VTMFTO5G'PCU2WU>.V\L"2*XOPOE1NT;89Q;HP#@K
MM;#5]T60B%G ($,</EKL0J5*KC@8/3B@">O*/$G[/NG^(O'4^N_VU?6>FWVJ
M:;K>IZ+!%#Y5Y?6#1M:S&79YBX,%MN4-AA;QCY07W^KT4 >4_#O]G^P^'_C%
M==&N:CJ\=C!J%IHUC>"/R],@O;M;JY12JAGR\<2JSDE4B5>268_('[2'[&?P
M=_9V\5?L^>)/A[X/_P"$?UJZ^+/A[3YKG^T[RYW0-)+(R;9IG49:*,Y S\O7
M!.?T5KY5_;Z_YMR_[+-X<_\ ;B@#ZJHHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HJGJL=W)9M]BN([69?FWR1>8,#MC</YU1\(75_J&@V
M5[J%Q#/)=P1S@0PF,)N0';]XYZ]>* -JBBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH ^8_P!I;]I;PGH-UXF^$_BSP3XSN-/U
MS2VTV;6+7^S[&QN8[N%HV2WNKR[A5Y0'*X )#<8->]> /%[^//"MGK;Z)J/A
M[[3N(L-5:W:=0&(#$V\LL9# 9&USP1G!XKYH_:FO/%FD^+]5N+[XS:+X>\$O
MIX>/P;Y$POI$5/W\I-F/M<@)Z>6P"@\Y)&/8OV7O"@\$_!G1](7P]'X82"6X
M*V$<-Q%PTSMYA6XEEFW/G<3(VXEB2!TH ]7HHHH \5_:B\$3>.?#_A2">#4;
MOPY9ZVMWK-MI.GPW]P\(MIUB86\L<BR!9WA; C=E(#J 4#+Y1HGPJO=)M_"-
MAJ/@'4;_ %NVTW0+7P_JS6L6=(CMKV1I@[QG99NL)C>18]J2 ^6@8($'V#10
M!\?_ +:W_#1?_"O?B]_PCW_"K_\ A4__  C-]YO]I_VC_;OV7[ WVO;L_<>;
MGSO+S\N-F[O7M?[)W_)K/P;_ .Q,T;_TAAH_:Q_Y-9^,G_8F:S_Z0S4?LG?\
MFL_!O_L3-&_](8: /5&4.I5@&4C!!'!K#T#P/H7A>[N;K2]-BM)[C_62*23C
M.<#).T9[# X%;M0QWD$ES+;I-&\\05I(E8%D#9VDCMG!Q]* )JY;7?ACX8\3
M>.?#/C'4M*6Y\2>&UN4TN^\V13;B= DOR*P5\J,#>&VY.W&3GJ:X>;XQ^'+?
MXR1_#*:6XA\32Z0FM1;X2+>6%Y)HQ&LO3S?]'F;R^I5&89"M@ CD^!O@F7Q\
M_C-]&9M=><73DWD_V5KD0^2+DVGF>09Q%^[\XQ^9M^7=CBL;1?V6_A?H,.IP
M6WA=9+;4=+ET2>VO+VYNH1I[N'-I''+(RQ0AAE8XPJID[ N36YX5^-7A#Q5X
M)\)^*5UFUTC3O%%K%=Z7'J\\=M-.LBAE4(S<MAAE03UI='^-G@G6I/%ZQ>(]
M/@C\)ZG_ &1J\UU<)#';7'E1R;2S$#'[P+G^\CKU4T 9NF_LY_#_ $NULX8]
M%GN'M;VXU!;J]U2[NKJ6XFM'LI))KB65I9C]FE:(>8S;5VA<;%Q#X4_9L\">
M"=06ZT:#7K2,9#:>WBC5)=/D!B$.'LWN3 X\L*N&C/W0>H!K4U/XT>'-/UT:
M5'*]_,UC9ZBD]K)#]GDAN;L6L;+*TBJ3OYP#DC[NYB%.GIWQ4\%:Q)=)8>+]
M!O7M0#<+;ZG!(8<N$&\!OER[*O/<@=30!R.A_LM?#+PZ(?L/AZ8&$Z;Y;7&J
MWD[*-/NFNK%09)F.V&5B57IM"H0455&Y#\#? \+9&@QN/.U6<I+<3.C/J4AD
MOLJSD$2LQ.TC"YPH4<5O:GX\\,Z*MP^H^(M)L%MY6@F:ZOHHQ%(J+(R-N888
M(Z,0>0&!Z$5)#XS\/W$.I2Q:[ILL6F@&^=+N,K:@KN!E.?DRO/S8XYH \XM_
MV2?A;:Z?<68T"]E6X-@TMQ<:YJ$URS64DLEFWGO.9 T+3R;&#9 V+G:B!?0_
M!/@C1?AWX<M]"\/V9LM-A>20(\TD\CR2.TDDDDLC,\DCNS,SNQ9F8DDDUD:A
M\9/!VFC19I=?T]]-U;SOL^JQW<1LQY0!;=-NVCJ .>O%=#J_B33M#LK:[O+G
M;!<SPVT!B1I3+)*P5 JH"3DD'(&  6.%!( -.BBO,+C]I;X<Q^#])\4P:_)J
MFA:M)=)976D:;=W_ )RVSLEQ,$@B=A!&R'=.0(@"AW8=20#T^BN;D^)'AB/Q
M;I_A?^W+.7Q#?Z>^JVVFPR>9-):(0IG"KG"$L &/#'(7.#C5T'7;'Q-HUGJN
MFS?:+&[B$L,A1D)4]F5@&5AT*L 0000""* +%]>0Z=9SW=PXC@@C:61SV51D
MG\A7B5OX'7XB:EIGB'7);J"36;J3R887"^3;I$QBQD'D[0<^A]Z[CXKSR:C:
MZ5X8MW*3ZW=+%(R]5@3#2-^6/PS6EK5UI^EZUX:M1/;VR6\LBB,R*OEK]G<+
MQG@=* .HC7RXU7<6VC&YNI]S3J0$, 1R*6@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH ^;OVD(3>?%+PO;:#=^(X/&9T>\DC32?
M$5KHUL;(30"0RM-'(96WM'M"HVWG)3<-_??L^^*K36?AC+>2:IJUTUA?7EG?
MS^(+^WNY89H)6CE7[1!B)XU*$AAT'#!6#*. _:7T;3->N8]+\5^(]#?3[.TN
MM;-GK7@)=>B@MT=$#<DA9,N$10-\I)"J2I%=O\*;S2+/X%W.Z6+Q/HUA;W44
MVGV7AAM)81(&WVATUP&1\97RV4%MPXYH \@\<7_PTU[6KVP\):AX^\;)XHDN
M;B?PQX*OG&BZK(R_Z0/M<I2W0-UD2*X3.YB5)9L_6EHNVUA'DBVPBCR1C$?'
MW>...G%?!VE_%+X<_$#6K.X^%L7Q0\*^)-(+BWT[26L[E+(N@0QMI=Y<2+ I
M4 ;$CB..A'6OO&S9VLX#(6,A1=Q=0ISCG('0^U $U%%<MK'Q5\%>'_%UAX5U
M3QAH.F^*+\(;31+S4X(KVX#L50QP,P=]Q5@, Y(([4 =37RK^WU_S;E_V6;P
MY_[<5]'Z/XW\.^(M:U;2-*U_2]3U;2'6/4;"SO(YI[)FR56:-6+1DX. P&<5
M\X?M]?\ -N7_ &6;PY_[<4 ?55%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 45Y'>?M4?#JQ^*(\!2ZNXUKSOLK2B$FV2X)V^2TG9\\'C /!((-=
MYXX\?^'_ (;:!-K7B758-)TZ+CS)CR[?W44?,['^ZH)K5TJD6DXO78[)X/$T
MY0C.FTYZK1Z^G<M>*O$FE^$?#][JVM7\&FZ;;)F6YN'VHN> /<DD  <DD 5D
M?"OQ/I7BCP/IDNDW\%^EI"EE<&%LF*>-%5XV'4,#V/J#T(KYR^*WB_5_VCO"
MBA/ FIZ;\.[.ZCOEUC4I/)FO64,J;80=PB._.[)!XZ&H/A!^S8/%2ZUJ4'B[
MQ9X3TN\N1)-9Z%?FVCNY<$LQ)!SUZ8QSQBMO94XKEJ2M+[_Z9Z'U/#45[/%5
M'"IOLI);:.SO??TT3/KZ25(8VDD=8T499F. !ZDUC7GCGPWIY<77B#2[8QC+
M^=>QIM'J<MQ7C,G[&?PB@=7UV&_UF4?\M-7UJ?<<@#JKKZ5?M_V;_@-IK%1X
M>T(-@ B>^:0_^/R&IY:"^T_N7^9E[/+8[U9OT@E^<_T/1I/B[X%BC9W\:^'4
M11EF;58  !W/SU3_ .%[?#7_ **'X4_\'=M_\77'V_PC^ MK'Y:Z'X-(!_Y:
M- Y_-F)ITGPP^ L2Y;0?!9'3Y4@8_I3_ ''G^ [9;U=3[H_YC_B1^TEX:\.^
M';G4O#7BSP3K<]K#)-)9S^((DEEVKE4B6/>78G(QQVK9\/\ QZ\%R::K:WX\
M\#V]_N.Z/3_$,,L6WMAG*G/X5X7^TUKWP2^&OPUN;72O!WAB_P!<U:&6SL3I
MVFVPD@;9@S-*$RNW<I'<G&.Y';?"_5/@)\3O!=EKT7@SP?I+S;DFL;W2;020
M2*<,I^3D=P1U!'0Y Z'3IJBJG*[7WT/4G@\)' 0Q3ISY')KFT_S]>G0]0_X7
MM\-?^BA^%/\ P=VW_P 71_PO;X:_]%#\*?\ @[MO_BZYK_A$?@7_ -"YX$_\
M%EI_\11_PB/P+_Z%SP)_X++3_P"(KF_<>?X'D_\ "=_?_P#)3I?^%[?#7_HH
M?A3_ ,'=M_\ %T?\+V^&O_10_"G_ (.[;_XNN:_X1'X%_P#0N>!/_!9:?_$4
M?\(C\"_^A<\"?^"RT_\ B*/W'G^ ?\)W]_\ \E.PTGXO>!/$&I0:?I?C7P[J
M5_<-MAM;358)99#C.%17))P#T%==7FGAKPW\(K/7+.;0-#\(6VL(^;:;3["V
MCG5L'E&500<9Z5Z764^2_N7^9Q5_8<R]A>WG;] HHHK,Y@HHHH **** "BBB
M@#(\7>*M,\"^%M7\1:U<-:Z3I5K)>W<RQM(R11J68A%!9C@'"J"2> ":Y[P#
M\5H/B!?3VL/ACQ5H9AA\[SM?T6:QC?D#:K..6YSCK@&H_CU>:/I_P2\>7/B&
M"[NM!AT.\DOX+"58IY(!"QD5'8A4)7(W,0!G)('->2_LR:Q<0^.-3T35;^_N
MM3_LM;V!%\>R>*+7[-YJIN=GBB,,I;&,A@PWX8[6P =E\2OA/\//B+KGB>QG
MU#4-(\3W>E*VKR^'[Z6*XDM2"B-/"NZ*4X5@GFQN<*=O>N[^&>H+JW@NPO(_
M%*^,X)M[1:TL449G4.0 RQ )N7!5L*O*GY5/%>'_ !7\4ZK\+_BGK=_H_BRS
M\ 66M)#+J&H^,O"UQJ&B2RQPI&)X[Z"YA2V8(J(R7# ,4RHZEO9?A#X4MO!_
M@>"VM]='B9KVZNM4GU=0BI=3W-Q)<2.BIE53=(0J@G"@9+'+$ [2BBB@ HKG
M/'GC[2?AOH0U;6#=&V:>.VCCLK62YFDD<X55CC!9NY.!P 2>!6%??'3PGI>K
M:/IE[+J5I>:E%;3;)=*N0MFMQ(8K?[6XCVVQED5D42E<LI Z4 97[6/_ ":S
M\9/^Q,UG_P!(9J/V3O\ DUGX-_\ 8F:-_P"D,-'[6/\ R:S\9/\ L3-9_P#2
M&:C]D[_DUGX-_P#8F:-_Z0PT >JUY7X3\%^+]+^(MWK]_-9M;7Q9;F*.9FPF
M/D"_+_#A0,]L^M>J44 %>*>-O@CJWBKXN>)O%EM=VM@\OAS2;70[UBS2VFIV
M=WJ$XD=!C,16[C1E#?.C3(<!N?:Z* /B7QO^RC\6=9_9_P#!OPZTO4M%A73/
M PT.Y*WYMPFIHJ;)=XM7DEB^7"A7AVMEF#\ >B^)O@G\0K6^^()\+_V1!:^(
M?&=IXB\QKQ8+F>S.F06L\ =K69;>59[=7#A7W1NX!1CFOI6B@#XVT7]DGQSI
M_@W1=)GN])EN;"ST:T9UN9-A%GXE&I-MRF<?9E 7/.["G ^:NLU+X0_$+QIX
M,\8PZOX6\-:3XLUB&WGCU&VUAY8"UM=1SP6*J+56CA^5\R_,VYBQ4Y"K].T4
M ?+>D_LX^+-8\?W7B7Q/8>'REUXKU+Q!]CBN&N5@CGT*VL(@"\2YD62%\G X
M.1UVC)\)?LO>//A[X%-EX:D\/Z;K7_"O/#'AMV5AY<E_8W-S)?N"\#J"\<Y$
M<S1OAR&9,+@_75% 'Q[H/[-/Q"\,CPY?OI/AKQ-<Z3XLU?7SI6K:I(8GAO+'
MR543_9C^]65W);R@I^8A5W#;Z?X;^%^K?#+X=_ [2;B4ZJ_@R]@CU'^S()'3
M:^GW5D#%&/F\J.6ZCZ_=B5F(^7(]SHH ^1/"7[&^L+KMW%J\&@^&+&X\.76@
MW_B3PG=EM9UN:6ZMI6O[I)[/R1+.D$BRJYF/[U@'8'C.U[]G?Q]H5UX5\-6$
MC>,Y'A\833:AJ.I/I-O!'>:G9W%NCSV5EMWL 7:!X3'(1<1X,0"C[,HH \[L
M_AYJ%EXH\$:U<W-E=3Z-I5S::I=06WD27D\D=LHD2)%( _<-\N?E!4#/:7X'
MZ3>:7X%EGO()K,ZKJ^IZS#:7,312P0W=]-<Q))&P#))LE5G1AE79E/2N_J&[
MNH[&UFN)FVQ0HTCMZ*!DG\J .&TC_BHOBUJ]\<O;:+;)8PGMYK_,Y'N!\M=I
M<:38W<OFSV5O-)_?DB5C^9%<C\';60^$6U2X7%UJ]U-?RY_VF('X8 /XUW-
M" !0 !@4M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M24"=$5V^8;"DN]U:,@MG(H ]0HHHH X#XS> )_B#H.E6]OI'AW7Y-/U%+_\
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MDC&=Y[DU[;2*H10J@*JC  & *6L6W)W9P3G*I)SF[MZL****1 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 >+_M:?$J7X<_"'4UM
M-2L=%U+6HIM+L]3OM?M-'^R3/"Y25);F1 64C.$.X8R.F:X#]D?Q9X&\0>+-
M7A\+1LM]'IX>?/Q1_P"$K&WS%'^H^VS^7SC]YM7TSSBO:?CE!X5U+X9ZYI'B
M_7K7PUIFK6LNG+J,\L4;QO*C(/*\P$-)SPN#NZ8.<5Y7^S7%<^(/B!K7B.74
M;C7K:VL7T2WU2Q\)KX=TX"*X^>%H99GN)IE<-ARBQ*-X0 N<@'<?%+X0ZEXN
M\5:;XEM_B?K7@J;3 Z6?]GVNGLL(D15E0M<6\FY7VJQ#9Y52,8KI?A!X%A^'
M?@F/2(O$%UXJ9KNZO9M7O5@$US-/.\TC/Y"(A.^1NBC@"O)?VQ=*TFX_X0?4
MM:M_!FKV-G=72?V'XVMI[VWO'DB #0VT44K/+&%8[]AV(7Z;LCTC]GE-+7X3
M:.^C:=X4TO39&F:*U\%1&+34_>N&"(8T*ON#!U*@APP/(- 'H]%%% !17-_$
M#QQ9_#WPQ<ZO=0S7LJ_N[73[4 SWDY!V0Q@G&YL'DD!0&9B%4D><0?M!:OJ$
M?AS4+'P:EQH5UINDZCK%V^J[)K'^T&VQ)!%Y)%SY9^:0L\6$(*!VR@ -;]K'
M_DUGXR?]B9K/_I#-1^R=_P FL_!O_L3-&_\ 2&&N*_;$^-WPZT7X%_&'PCJ'
MC[PO8>+'\):I;+H-SK-M'?-++82&*,0,X<LX=-JXRVY<9R*[7]D[_DUGX-_]
MB9HW_I##0!ZK1110 4444 %%%% !1110 4444 %%%% !1110 5P,?_$V^-,K
M#F+2=*"'VED?/_H'\J[ZN"^&V=0\0>-=7/S>=J?V16]5A7:,>WS4 =[1110
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M62:']V7:0OE%"A#\FU=NT<5^U];^'YD\'_VN=?EG>XDAFL]!CM6^T::TEO\
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M).,.JX''R5[I52WLC2M93<8NZ6@4445!@%%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBN=\:?;8;"*YLM4N=/83P0E84A96$DR(2=Z,<@,<8(]\T
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M&50=A  _02U9GMH69M[,@);84R<==IY'TH EHHHH *^5?V^O^;<O^RS>'/\
MVXKZJKY5_;Z_YMR_[+-X<_\ ;B@#ZJHHHH **** "BBB@ HHHH **** "BBB
M@ KPWXD2?\)'\2-7@61Q#H/AVZE>-AE3(\+#CWQ-&?\ @%>Y5X-X775_%UO\
M0-9TFSBU4ZS<2:9']HN! T$7EL0XRIW#;)$,9'W*N.YO1^*YZWX"_P"1%\._
M]@VV_P#12UO5SG@&#5;'PO8V.K6$5A/90QVRB*X\[S%1%7>?E&W)!XY^M='4
MO<SG\3"BBBD0%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/=R7_P#9JZNLKPK?QZGX;TVYB@>V1X$Q#(I#1X&"O([$8K5H **** "BBB@
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MJ***DR"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"W,BVCM:DYA9H!$Q0X()Y5"=B@'HE%%% !1110!Y5^UC_P FL_&3_L3-9_\
M2&:C]D[_ )-9^#?_ &)FC?\ I##1^UC_ ,FL_&3_ +$S6?\ TAFH_9._Y-9^
M#?\ V)FC?^D,- 'JM%%% !1110 4444 %%%% !1110 4444 %>6?%R]:?Q9X
M,TV/YECO4O)E] )$1"?Q9A7J=>/:K/+K7Q"U^[ALKJ]%@;*QB-O'O "3QS2Y
MYX(VGZT >PT5#9W/VRVCF\J6#>,^7,NUQ]14U !1110 4444 %%%% !1110
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M=Z'8SH8KKR/M%Q&W5)96,CK_ ,!9ROT KKJ**AN[N82ES2<NX4444B0HHHH
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M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >%?M5:?X[U/2=
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MY_UTO_Q7Z5Q/QI\(^#?AK\*_$?B1?#LEP^GV_F1QVL\@<NS!5.22 H+ G@@
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M&TZ3R8(HVDD?:D19L*I.%!)QP":^JO\ A$]#_P"$J_X2?^QM/_X23[%_9O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
&*** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>syre-20250331_g3.jpg
<TEXT>
begin 644 syre-20250331_g3.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" '%!$L# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MHH **** +.F_\?T/^]73US&F_P#']#_O5T]92W..ON@HHHJ#F"BBB@ HHHH
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M&M6E6E=[=%V"BBBH.<*FM?\ 6'Z5#4UK_K#]*3)EL-N/]<W^>U1U)<?ZYO\
M/:HZ!K8****8PKFOB)KS^'?"-_<P3F"]D7R+4QQF60ROPOEQ@$NXY8* <[?3
M-=&[K&C.[!449+,< #UKSB2RU7XA>((==TF]CTG2+:WEM+2ZFM_.EG$A7?<P
M L%CX3:CL&#!B=N,;M*:5[O9'7AH1<^>II%;_HNN_H^Y7NM/T?P/I5AK?A5X
MKE+X+$^GK*9!K>_G<#SNN.6;S#U&X.0H#)N> ? /_"/JM_J&)-2VM';VRR&2
M'38&;=]G@)_A' +=\ #"JJC5\.^ ?#WA5UETS2+6VN@FQKORP9WR<L6D/S,6
M.223DDY-=!52J:61M6Q3E%P@V[[M[OLOZUZ;:!1116)YP4444 6+3^/\*AF_
MUC?6IK3^/\*AF_UC?6EU(7Q,;1113+"BBJ^H:A;:38SWEY/';6L"&26:5MJH
MHY))H&DV[(Y3XHZ]!I.BVUI-?O8+J%RD,TL.[S4MP09W7:,J @(:3@(&W9&!
M6%KFCV7@WR=,\.Z?9ZC8:TAA;PNS;87^7'VB/ (1!QYF1M.0P^?B2:W\+ZQX
MTUB^UN>Y;1-+U*".T%HT)%]]E0LQQ)N'D^:6^90I8 +\RM]WLM \'Z%X55QH
MVCV.E[U56-I;K&6 & "0.0/2NGFC35KGK>TIX:"@G=]5TOYOR\K^310\#^"Q
MX5L_-N[N35=:FC1+G4)V+.RJ/EC4L20B]@223EF)8DGIZ**YY2<G=GF5*DJL
MG.;U84444C,*LVO^K/UJM5FU_P!6?K29,MBNWWC]:2E;[Q^M)04%%%%, KS[
MQEJ>EZSX\T/PSJ<JRZ:T4EQ<6[ F*2YW1_9H9CC&&'GNJ,?F,8X. #U7B;Q-
M:^&+%9YUDGGF<0VUG -TUS*>B(.YXSD\  DD $UQN@_"^[O+5T\3W-K=V5Q>
M3:E/I5O =LD\DA=5GE+'SEB!55&U!\BY!VBMJ=H^](]##1A33K5';HN]^Z]/
MEKU1EZUI=V=1?P/H;17\"JMW;7<DC>9X<(.%)8<L,%O*3(;AE.8\[?2/#?AN
MT\+Z>;6U\R5Y',UQ=3MNFN93]Z21N[' ]@     !/H^A:=X>L_LNEV%OI]MG
M=Y5M$L:D^I ')]ZO4I3YE9$5\2ZD5".WYON_Z^]W84445D<04444 6K?_4U5
MJU;_ .IJK2)6["BBBF4%<E\5U=OA[K2H_EN8E"MC.#O7!QWKK:Q?&FC3>(/"
MFJZ?;%!=3P,(/,)">8!E-Q'.W<!G';-5!VDF;X>2C6A)[)K\S-'@?4&#/)XR
MUXW!.?,C-LJJ?9/)VX'H0??-)'/XOT.0)/;6?B:R_P">UJXM+L#T,;DQN?\
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M!.?,C-LJJ?9/)VX'H0??-)'/XOT.0)/;6?B:R_Y[6KBTNP/0QN3&Y_V@\?\
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M$\8A+(P&,;0K#/KW/%:6O> ]7^$_ACX)^);^PN&M?#LK'5X88S(]JLL_G$D
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M=&U%WN]4]%]K\T>[_%C7O$GB+XL> _AG8>)+O2(+ZP_M#4M6TD^1-.%63[C
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MY# ]"#W%?#FL>)_^%F_!GP+\*M)L;U_&-M?I%>V<EJZ?98XA(N]B1@##@]>
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MLJE%XRQ"\]OE8\=N7^!'P!\!>+/A;X>UO5M 6\U.X21I9FNIU#$2NH^4.%Z
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M3(LD;=589!JG_8&F_P#/A;_]^Q0!H45G_P!@:;_SX6__ '[%']@:;_SX6_\
MW[% &A16?_8&F_\ /A;_ /?L4?V!IO\ SX6__?L4 :%%9_\ 8&F_\^%O_P!^
MQ1_8&F_\^%O_ -^Q0!H45G_V!IO_ #X6_P#W[%']@:;_ ,^%O_W[% #]1T33
MM8FL)K^PM;V;3[C[79R7$*R-;3;'C\V,D?(^R21=PP=KL.A-1_\ ".:2?$(U
M\Z79_P!NBU-B-4^SI]I%N7#F'S<;O+W@-MSC(SC-+_8&F_\ /A;_ /?L4?V!
MIO\ SX6__?L4 86H> 1-\3-)\9V-VEE=PV,NEZC"UOO^WVI/F1+NW H\4N65
MOF&V692N7#)>U;X?^%]>T'4]$U/PWI&HZ+J<QN+_ $Z[L(I;>[E+!R\L;*5=
MBRJV6!.5!ZBK_P#8&F_\^%O_ -^Q1_8&F_\ /A;_ /?L4 <K=?"FRN/%G@N]
MB:VL?#GA"WD&D>'K.S6*&"Y:(VZ3 @[0L5NTL21J@"B9SD_*%[JL_P#L#3?^
M?"W_ ._8H_L#3?\ GPM_^_8H DN/]<:CJK/H>G"0@6-N/^V8J/\ L/3_ /GR
M@_[]BJ-EL7J*H_V'I_\ SY0?]^Q1_8>G_P#/E!_W[%,>I>HJC_8>G_\ /E!_
MW[%']AZ?_P ^4'_?L4!J7J*H_P!AZ?\ \^4'_?L4?V'I_P#SY0?]^Q0&I>I&
M7<I!S@\<'%4O[#T__GR@_P"_8H_L/3_^?*#_ +]B@-3Q6^_9V\8W%CJVDQ?%
M_6I- U,&.>SU&T%Y,8SD%!.\FY00<': #SD<UZUX%\&V/P_\(Z7X>TXR-9V$
M7EH\IR[$DLS'W+$G\:T/[#T__GR@_P"_8H_L/3_^?*#_ +]BM9UIU%RR>AZ%
M?'8C$P5.HU:]]$EKM=V2N[=R]4UK_K#]*R_[#T__ )\H/^_8J:VT+3F<YL;<
M\?\ /,5B>=+8N7'^N;_/:HZJSZ'IPE8"RM_^_8J/^P]/_P"?*#_OV*!K8O45
M1_L/3_\ GR@_[]BC^P]/_P"?*#_OV*8R]15'^P]/_P"?*#_OV*/[#T__ )\H
M/^_8H O451_L/3_^?*#_ +]BC^P]/_Y\H/\ OV* +U>>?$_X8ZUXWO\ 3+_0
MO'.K>$+RRZI:$R6TW.09(=ZJQ!]<@C@BNU_L/3_^?*#_ +]BC^P]/_Y\H/\
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M_P#/E!_W[%']AZ?_ ,^4'_?L4 7J*H_V'I__ #Y0?]^Q1_8>G_\ /E!_W[%
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MUA_[X% :EJBJO]EV?_/K#_WP*/[+L_\ GUA_[X% :EJBJO\ 9=G_ ,^L/_?
MH_LNS_Y]8?\ O@4!J=A'_P @^+_KFO\ (5#5>/0M.-C&QL;?.Q3GRQZ"H?[#
MT_\ Y\H/^_8K$X5U+U%4?[#T_P#Y\H/^_8H_L/3_ /GR@_[]BF/4O451_L/3
M_P#GR@_[]BC^P]/_ .?*#_OV* U+U%4?[#T__GR@_P"_8H_L/3_^?*#_ +]B
M@-2]4=Q"+B"2(LZ"12I:-BK#(QD$<@^XJK_8>G_\^4'_ '[%']AZ?_SY0?\
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M&K!LA@H!%=?[]ZREN<=;="T445!SA1110 4444 %%%% !1110 4444 %%%%
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MCO;RJB7$#QS1F65<[RC*^"A(# $Q/V4;R:]_9W\#-=>)5\77<5C]FGU=?/\
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MW..ON@HHHJ#F"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:Z:%Q_I-R<;NLI[C^G:D_LP;<?:;K[NW/FGUSGZU=HH R;C3QYK?Z1<=5/\
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MX7'^D7!QGK(>XJW10!4_L\;<?:+C[NW_ %A]<Y^M!T\'/^D7 Y!_UA[5;HH
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MCIC]R?3G^+O0!;HJIY-WD?Z5'C<3_J>W8?>_6D\F]P/]*BSMP?W!ZYZ_>^E
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M:HJKY-WM_P"/F/.W&?)[YZ_>]*/)N^<7,?;'[K\_XJ +5%5O)NN/](CQD_\
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M!#=\9N8SUS^Y_+^*@"U157R;O;_Q\QYVXSY/?/7[WI1Y-WSBYCZC_EC^?\5
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M>5V[C[U230W8T]\W,9&QL_N>O''\5(E[HQ**@\NXQ_KTSC_GGWSUZT>7<?\
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M #S[_G5FQ8HJN8[CM.@X'_+/\^]+Y<^[/G)C.<>7V].M $]%5Q'<<9G3H?\
MEG^7>CR[CG]^G3C]WW_.@"Q14'ES[L^<F,YQY?;TZT@CN.\Z'K_RS_+O0!8H
MJOY=Q@_OTSC_ )Y]_7K2^7<?\]DZC_EGV[]Z -#3?^/Z'_>KIZY+2XYUU"WW
M2JPW\C9C(_.NL_E64MSCK[H6BBBH.8**** "BBH+V]@TVSGN[J58+:WC:666
M0X5$499B>P !- $]%?,7P+^-/Q \0>+[R#Q+]EN;?QMH4_B[P+87B"R$%O'.
MR?89I4B9MWD3:=,S%7=3/-@,$ KN?V8?'OB[X@?LV^%_%/C VC>(+[3?M+7-
MI*)!.-I*RLHAB6-SW15*C'#&@#V2BOC'PK^W8-)^&_@2+5M0\(ZAXJ;P;IOB
M#7[GQ5XKMO#S7$MQ!O$5G%Y+B:9MCL5(AB7?"-_SD)V_Q2_;&D\"_#JR^(>G
M^'] D\#7NB0ZU8WGB;Q9%I%[JOF0&<V]C;"&8S3+'M!1VB)=MJ[A\U 'TO17
M@&E_M277BCXMW'@[P_X;TN]6SGM([JUOO$<5EKCP300SM>6^GO%MFMHUN$W2
M>>I)CE"JQ50^U^S'X\\;^/M#\97'C6#38I]/\5:KIEFVGWAGVPP74D8B/^C0
M_+'M"JYRS@;FVGB@#V6BO!+7]IK4IKG3M>E\&QP_#'4O$@\,6GB(:MNOC,UP
MUI'<R67D;4MGNE\I6\\OMDC=HU!8)G>#_P!JW6-8;PAJNO>"+3P[X-\4:S?:
M#9:I_;IGNH[FV6[??+;_ &=%6%Q8S882E@2N4P<T ?1E%?,/PO\ VY_#?Q(\
M9>$],CD\+C3O%TLD.CQZ5XLAU#6(&\IYXO[0T]8U-J'CB?.V279(41PI;(^G
MJ "BBB@ HHHH IW'^N-1U)<?ZXU'5&ZV"BBBF,**** "BBB@ HHHH **** "
MIK7_ %A^E0U-:_ZP_2DR9;#;C_7-_GM4=27'^N;_ #VJ.@:V"BBBF,**** "
MBBB@ HHHH **** +%I_'^%0S?ZQOK4UI_'^%0S?ZQOK2ZD+XF-HHHIEA1110
M 4444 %%%% !1110 59M?]6?K5:K-K_JS]:3)EL5V^\?K24K?>/UI*"@HHHI
M@%%%% !1110 4444 %%%% %JW_U-5:M6_P#J:JTB5NPHHHIE!1110 4444 %
M%%% !1110 5+<?\ (-E_W#452W'_ "#9?]PTB7NCFJ***V.\**** "BBB@ H
MHHH **** "BBB@#IH_\ D'Q?]<U_D*AJ:/\ Y!\7_7-?Y"H:Q.!=0HHHIE!1
M110 4444 %%%% !1110 5:N/]5^-5:M7'^J_&D1+=%6BBBF6%%%% !1110 4
M444 %%%% !2I]Y?K24J?>7ZT 0^(/]3%_O'^58E;?B#_ %,7^\?Y5B5<=C>C
M\ 44451L%%%% !1110 4444 %%%% %G3?^/Z'_>KIZYC3?\ C^A_WJZ>LI;G
M'7W04445!S!1110 5QGQB^'\_P 5OAOK7A&'6&T.'6(UM+RZCA,CM:,Z_:8E
MPZ[6DB\R,/GY=^[!QBNSK,\3?VQ_PC>K?\(]]A_M_P"R2_V=_:>_[+]IV'RO
M.V?-Y>_;NV\XSCF@#R/6/V2? EEXB\(>(_ /AWPW\./$7AW5X]0&H:'H$$+7
M=L8Y(KBTD\KRR4DCE89).U@K8.,'K?@U\+KSX5?"C3O ]SK,&LP:9"]G9WD-
MBULPM^1&LBF5]\@!^9P5#=D7I7R;H/[17[5][\1/BCX9O++X-C_A6<-C>^()
M((M6_?P7-LUT!:$R?,XBC8?O @W$<D<TO[.O[7/QE^,FK>!;B_\ '/[.<.GZ
MY-!)=>'+/5[U?$*0,09(DMS*P%P$#84Y&1SQ0![3X(_9@\4_"/2=$@\ ?$.R
MTF\C\-6'A[6)-7\/-?P7KV<?EV][!$MU$;>8(SJP9Y48"/*Y0EJOCS]D35?%
MFJ^.;BT\=6D!\:>'D\/:OK&J>&X;O6Q"+802+;W:2110PS;(Y)(1 5WF1D,9
M93'YIXH_;4^)4W[3'B7P)X4TSX?G3?#>LV.DS>&?$>JOI_B365F +3V!E>.W
M=<$D)\S853@^8@KI_P!KS]L;Q-\!?B)H>A^$M T_Q!I^EZ<OB3QJ]U%+)-9:
M0;R&V!@V.H$IWRM\X8 )NVD T =KXP_9CU[Q\NBZ5K_C/2-5\,Z7=V%]:I<^
M%HSJNGRVWDEA8WHG MTD:'DO#+*%ED42?=*^C?"GX:WGPTD\60/J\&IZ9K&N
MWFMVL*V30S6K74K32QR2>:PE =SM(2/"X!#'FO!?VMOVJ/&GPI^(7PS\.>!-
M8^&VD6/BRPOKZ37?B+<3V^GQK"L31XFBD7;O#D#(.25Z5ZI^R_\ $#QE\2/!
M.HZIXR\2?#7Q1<I?M;VU[\+[Z:\L%C$:$I*\K,1*"Q) .-K)ZT 9-I^S+J$-
MQ8:#-XQCF^&6F^(QXGLO#JZ5MOA.MR;N.VEO?.*R6R73>8J"!9,)&C2, V^>
M']F&'_A"OASX<N=?%S;^$?$MSX@D<V6T7RS)?H;?'F?N\"_^_EO]7]T;OE]R
MHH \@^%OP?\ &OPVA\/Z ?B-'?\ @3P]$;;3]-70DCU&:W4%+>"[O'F=9$B0
M@9B@A=C'&2_WP_K]%% !1110 4444 4[C_7&HZDN/]<:CJC=;!1113&%%%%
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M_$FM?##XA_#_ $FW\3>)O 6L/=CP]<WB6?\ :-K.JQSHDS_(D@"J07XQN/)
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MNMK<'G.+ACVX_@]?R]ZC\R^VG_1K?.WC_2&ZYZ?<Z8[_ *5?N/\ 7-_GM4=
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MVJW10!5\R\WX\B#9OQGSFSM]<;.OM^M()+[C-M;C@Y_TANO8?<^G_P!>K=%
M%0R7W.+:W/ Q_I#=>X^YTZTOF7F_'D0;=^,^>V=OKC9U]OUJU10!462^P,V]
MN#@YQ<-U[?P?_J]Z/,OMI_T>WSMR/](;[V>GW.F,\_I5NB@"KYE[N/\ H\&-
MP _?M]WN?N=?;]:DFDOO[/DS;6X&Q\XN&/;C^#_]7O4U2W'_ "#9?]PTB7NC
MDO,NMO\ J8<X_P">QZYZ?=]*-]US^YAZC_EJ>G?^&K%%;'>5]]UQ^YAZG_EJ
M>G;^&CS+O'^IASC_ )['KGI]WTJQ10(KF2Z[0P]O^6I_'^&EWW.1^YBQD_\
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M6Z* *GF7VT_Z-;YV\?Z0W7/3[G3'?]*7S+WG_1[?&1C]^W3N?N=>G_UJM44
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MM"(FD4*KG>A:GX-_:NT#QEJGA^-?"_B?2-%U_4;O1]-\0:G!:I97%[;"=I8
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M&>XKI*\J_:LT;4/$7[,OQ5TO2K&YU/4[SPQJ-O;65G"TTT\C6[A41%!9F)(
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MBBF,**** "I;C_D&R_[AJ*I;C_D&R_[AI$O='-4445L=X5\T?M/>$]<\0?M
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M"<8'3[W>@"Y15/\ M"3:3]AN?N[L?)ZXQ][K_A2_;GW$?8KC&X+G"]^_WNE
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M.=/<?8[@91QDA>,#_>[TB7NC$HJO]J;&?LTW3/\ #Z].M'VIO^?:;J/[O?\
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M_P#"_2_$<-WXZT&W6ZU#25@E4PQD1G(D*"-\>='D(Q*EL$ @X\W^('_!0CX
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MK!&42#YPA0&?8T,GG0I)M9-RAMKC##/8CUI]-3<%7<0S8Y*C )^E.IC+5O\
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MF5B$(EEG98T3YOF+'IG 8X4]-10!^?OB[PC:?%']G_XP>%_AA\1/!=[KFJ:
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MCBKFBZ+IWAO2;/2M(L+72],LXE@MK*RA6&&"-1A41% 55 X  P*NT4 %%%%
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M %%%% !1110 4444 %%%% !1110!4G1FD)"DCZ4SRW_NM^57J*=R^8H^6_\
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MKU%%PYB*!2L>",&JWEO_ '6_*KU%!*D4?+?^ZWY4>6_]UORJ]11<KF*/EO\
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MFAO+6_C_ .$4\11:]:36\3>'F@@:\83J6BDW+,850A)"6>5=OE,&P< Y%Y\
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M>BGQ9-JT]VMIKNBQ7]FMJT$5ND4ELEP55@(5=2L[[2QRSDFG: O>.POOVDM
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MXKM?'FM:)I3Z!;7=BT)TWPYJ\,D5[XAC,:R2M:W+3)$I_P!9& $EV-'F3:'
M%V+QKX^\86FJZ_X0M-#;0K&YEM[+3K^.1KK6?(E:.8I.)42U#LC)&720<!VP
MK8#_ !!\'=<\20R:+?>+X[OPDVIIJ26]UIIFU.+;,)Q"EXTVT*L@PK&$NL>%
MW9&^I;/X1:YI<,^AZ?XR?3_!<M]+>"RM;)HM2B61S*]O'>K* L9E9N?*\P(Q
M4.#AQ7NV)U-OX@?$FV\"QZ7+>>9;)-%=7URIMUF*6UM;O-,"1*H1N% ;YQDX
MQSN&!#\>+#4E%O\ 8-2\-7S2V+(NN6D?-O<&9A*R+.#&/+M;DGS"KIM#,A&
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M.(8D8%6+JOWB,#D]9T^/UA=?Z)9>%O$6I>((Y;F.YT"SCM7N[00;?,>1O/\
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M_<:/XR76)]:@N;*'5KW5X+..P,;K)/"(55I/-8'RX]R@A5R"!VY?N"]XKO\
MM#:0^G^?9^']>U.X@M;J]U"SLX[=I=.AM[B2WD>4F8(W[R"956)I&?RF*A@,
MUL/\9=#:TU&YM8+Z_AL[W3]/1K>- +J:\6!X5BW.N<+<Q,V[;M!)Z"N.T_\
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M0@CC! 48Z?PKX1TOP7I9T_28)(H&F>XD>XN)+B::1SEGDEE9GD8^K,3@ =
M)E)/8<4UN;-%%%9EA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?RBX227:BEG.Y3S4\JZ#YGU/9ZH:+KMCXBLY+K3K@75ND\UL9%4A?,BD:.0
MD<X=67(XX.*^;9+&\^V:KX=A\'^) +_Q#8++#<6<\D$.E6%M#)&CW3;DE,AM
MW4[9'):7!.2,\KX?^'-II_@^WT_4O &I:I+>>%H4T.SAT&6.*WUB9Y1>22AH
MU6UF5_LP%Q)LQ%&"C<'+Y%W%S'TSXD^+WA?PGJMUINHW=X+RU2!Y4M=+NKH*
M9I!'"FZ*)E,CL<+&#O/4#'-=;;7"W5O%.@=4D0.HDC9& (SRK %3[$ CO7RW
MH/P7M[[Q%I5YXI\'V^I7DOB.[O=4U.;1_,>:&SLOL\9),98K-.OG#O(23SFO
MJ.SNDOK."YC618YD615FB:)P",@,C ,IYY5@".A J9)+8J+;W)J***@H****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
EHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>syre-20250331_g4.jpg
<TEXT>
begin 644 syre-20250331_g4.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 1B"F@# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MO;FT>Y2U"6*(\FYE8@X9E&,*>_I7.:A^U-\+--OFM)O%]NTJMM+06\\T>?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]II-L3A6N9 I<\<*O5CST -9I.3LCFA"522A!7;Z(W**\?\ ^&N?A+YWE_\
M"7+NSC/V"ZV_GY6*[[P;\1/#7Q!M'N?#NM6FK1QG#BWD^=/]Y#\R_B*TE1J0
M5Y1:^1U5L#B\/'GK4I17=Q:_-%CQIXLM/ OA75/$%_'--9Z? UQ+';*&D91U
M"@D#/U(KR+P+^V1X+^(7B[3/#NG:9KT-[J$GE1275O"L8."?F*S$XX[ UV/[
M17_)#?&O_8-DKX'_ &8_^2]>#?\ K\/_ *+>O1PN&IU:,YRW7^1]5D^4X;&Y
M=B,363YH7MKVC<_3R21(8VDD941069F.  .I)KP;Q5^VO\-_#.I2V<,NI:ZT
M;;6FTNW1HL]\-(Z;A[C(]*V?VE/B-HFB_"WQAI,?B/3;;Q"]B8ET\WL:W1$F
M 0(]V[E&)Z=#FOS\^%_AG2O&7CS2='US68?#^DW#O]HU&XD2-(E6-G^\Y"@L
M5"C/=A3P>$A5A*I5O9&F0Y'0QF'J8O&<W+'9+JK7OM=^5C]#/A1^TUX/^,.M
MOI&C)J5MJ*PM/Y-];!<HI )W(S+_ !#J:]9KPG]G[X*^ / 7B+4]=\$>*_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MPM]5"B*)?$FGQ2 9/W4F(90,GN5Z]*]S\.^$]!\*PRIH.C:=H\4Y#R+IUK'
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M=_UZ'_T8]:XG$3AAX36[M^1VYQFF)H930Q$&N:HE?3O&[/EK]O3_ )+!H_\
MV H?_2BXKW3]B'_DB*_]A*X_DE>%_MZ?\E@T?_L!0_\ I1<5[I^Q#_R1%?\
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M@]'0Y(/L1T)K]+Z_+C7?AK\3?$NM7VK:EX,\27&H7LS7%Q-_8LR;Y&.6.%C
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M5PT?]_?J_P!3YS _\E++_KY/_P!N,W_@GC_S/_\ W#__ &YKSK]N+_DN3_\
M8-M__9Z]%_X)X_\ ,_\ _</_ /;FO.OVXO\ DN3_ /8-M_\ V>O0A_R,)^GZ
M(^GP_P#R5%?_  K_ -)@9GP;^"GBW]HJS@ADU@:;X:T%?LD,\Z&18RS%V2*,
M$;FRVYB2.J\]!7+_ !R^"FH? _Q1!I5Y>Q:G;W4/VBVO(D,>]=Q4AD).U@1T
MR1R.:^ROV([5+?X%6KJ/FFO[F1N.^X+_ "45Y#_P4&_Y&;P?_P!><_\ Z&M.
MGB9RQ;I?9U*PF<8BIGDL"K*DG)6LMU=WOO=L\P^&_A/QW^TO<:9X8_MAO[%\
M/6VT37;$Q6J,S;?E'+N>5'^RF,@"JOQ]_9YU+X$WFF^=J46L:;J <0W<<)B8
M.F-RLFYL<,".3GGTKZ%_X)]VJ)X1\6W(^_)?11GCLL9(_P#0S47_  4&_P"1
M9\'_ /7Y/_Z M"Q$UB_8QTC_ ,"X1S:O#/5E].RI:JR2WY>9OUN7OV!_&E_K
M7@_Q#H%W,\]OH\\,EJ7))C28290?[(:,G'^T:\Z_;=\8>)->\;#P_'9:A!X:
MTI%8/]G=8KF=E#-)NQA@H(4=0"&QUK3_ ."?$TB^(?&40=A$UK;LR9X)#N ?
MPR?S->P_';]K#1/@_J3Z':6+:[XA6,-) L@CAM]PROF-@G.,':!T/49%<TKT
M\=)TX<S_ *U/(JJ>%XCJ2PU#VDK)I7M:Z5W?9=?O/!/AS^PWK/C3P?9ZYJ7B
M*'0I;Z%;BWLOL9G;8PROF-O7:2,' #8!]>*\0^(7@G5OA!X^O-"N[E1J6FR)
M)'=6CD Y4.CJ>"#@@^H->K^(/VV/B9XDE,.F&PT8."JII]IYDA]\R%^?H!TK
MQ;QAJFOZUK\]]XFEO9]7F"M))?AA*R[1MX/;;C';&*]2@L1S-UFK/H?9Y='-
M?;3ECYQY&M(K=?.VWS9^G?P1\67/CCX3^%];O7$E[=6:^?(#]^1249OJ2I/X
MU^8>MW<FG^,K^ZBQYL-_)(FX9&1(2/Y5^CO[*T30_L_^#U88)@E;\#/(1^AK
M\W/%'_(S:O\ ]?DW_H9KAP"2K54MK_JSYSABG&&.QU.*T3M\KR/HOP7^R/XP
M^-.F/XS\3^)%TNZU9?M</VBW-Q-,&&59QN4(I&,8S@8X%>"_$#P/JGPO\::A
MX?U)E74-/D'[V!CM<$!D=3P<$$'U%?J]I&GKI&DV5C&=R6L"0*<8R%4*..W2
MOSS_ &UO^2]:E_UYVW_HL48+%U*U9PEM;0.'\[Q.88Z="I;V=FTDK6LU;\.Y
M]I_L]^,+SQY\&?"^M:A(9KZ:W:*:5NLC12/$6/N=F3[FO1*\,_8MN))O@%I"
M.Q98;FZ1!_=7S6;'YL3^->YUX6(BHU9Q7=GYOF=.-''5Z<59*4K>EPK\?;^1
MH=8N9$.UTG9E/H0QK]@J_(*:%;CQ!)$_W7NBIQZ%\5[&5;S^7ZGW?!.^(O\
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MO_L]Z]K_ (F\3ZGI$NEC2I$=K":5V0*ZR,Q#1KP%1N]?*_Q"\>>)/VA?B8C
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M5G8_$)QY)./8****1 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/[+_ .T1X+\!_#"Q\.ZO>7$6L"_=5MX[9WWB1\JP8#: ,X.2#[5/_P %!/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?(7_!0K_D&>!_
M^NUY_P"@PU5_X)X_\S__ -P__P!N:]H_:%_9_P#^%\6NAP_V]_8?]F/,^[['
M]H\SS @Q_K$QC9[]:B_9X_9X_P"%"_\ "0?\5!_;O]K?9_\ ER^S^5Y7F_\
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M&R=GVBMK7Z/H7_V*?^2"Z=_U^7/_ *,->-_\%!O^1F\'_P#7G/\ ^AK7T_\
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MG' K:AB,)0<HQ;UZL]#+<SR/+9U*=&I*TMY23=_+17ZOH>S_ +17_)#?&O\
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M$_AG3?&6@WNBZQ;?;-,O$\N>#S&3>N0<;E((Y Z&O+_^&0/A'_T*7_E2N_\
MX[7LE%>;&K4IJT)-?,^1HXW%8:+C0JRBGV;7Y'GG@?\ 9^\ _#?7!K'AS0?[
M.U$1M#YWVRXE^1L9&UY&'8=J_/#X\?\ ):?''_88NO\ T8U?JE7RMX\_89_X
M3;QIKGB#_A-OL7]IWDMW]G_LGS/+WL6V[O/&<9ZX%>E@L3&%24JTNGFSZ_AW
M.*>&Q52MF%5ZQLF^:3W^;/H'X6?\DQ\(?]@>S_\ 1"5^5O\ S,W_ &^?^SU^
MLWA71/\ A&?#&CZ/YWVG^S[.&T\[9L\SRT"[MN3C.,XR:^5O^'?W_$S^U_\
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MHW$$XY(&*6BBO%/SP**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%'+AOYY?^ K_ .2#4^C:*^<O^'>/[/O_ $('_E9U#_Y(H_X=X_L^_P#0@?\
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M*/\ AWC^S[_T('_E9U#_ .2*.7#?SR_\!7_R0:GT;17SE_P[Q_9]_P"A _\
M*SJ'_P D4?\ #O']GW_H0/\ RLZA_P#)%'+AOYY?^ K_ .2#4^C:*^<O^'>/
M[/O_ $('_E9U#_Y(H_X=X_L^_P#0@?\ E9U#_P"2*.7#?SR_\!7_ ,D&I]&T
M5\Y?\.\?V??^A _\K.H?_)%'_#O']GW_ *$#_P K.H?_ "11RX;^>7_@*_\
MD@U/HVBOG+_AWC^S[_T('_E9U#_Y(H_X=X_L^_\ 0@?^5G4/_DBCEPW\\O\
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M-3Z-HKYR_P"'>/[/O_0@?^5G4/\ Y(H_X=X_L^_]"!_Y6=0_^2*.7#?SR_\
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M[Q_9]_Z$#_RLZA_\D4<N&_GE_P" K_Y(-3Z-HKYR_P"'>/[/O_0@?^5G4/\
MY(H_X=X_L^_]"!_Y6=0_^2*.7#?SR_\  5_\D&I]&T5\Y?\ #O']GW_H0/\
MRLZA_P#)%'_#O']GW_H0/_*SJ'_R11RX;^>7_@*_^2#4^C:*^<O^'>/[/O\
MT('_ )6=0_\ DBC_ (=X_L^_]"!_Y6=0_P#DBCEPW\\O_ 5_\D&I]&T5\Y?\
M.\?V??\ H0/_ "LZA_\ )%'_  [Q_9]_Z$#_ ,K.H?\ R11RX;^>7_@*_P#D
M@U/HVBOG+_AWC^S[_P!"!_Y6=0_^2*/^'>/[/O\ T('_ )6=0_\ DBCEPW\\
MO_ 5_P#)!J?1M%>!>'?V$/@9X3\0:9K>E>!_LNJ:;=17MI/_ &M?/Y<T;AT;
M:TY4X90<$$''(KWVL:BII_NVWZJWZL>O4****R&%%%% !1110 4444 %%%%
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M9]_Z$#_RLZA_\D4?\.\?V??^A _\K.H?_)%'+AOYY?\ @*_^2#4^C:*^<O\
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M7_@*_P#D@U/HVBOG+_AWC^S[_P!"!_Y6=0_^2*/^'>/[/O\ T('_ )6=0_\
MDBCEPW\\O_ 5_P#)!J?1M%?.7_#O']GW_H0/_*SJ'_R11_P[Q_9]_P"A _\
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M_L^_]"!_Y6=0_P#DBCEPW\\O_ 5_\D&I]&T5\Y?\.\?V??\ H0/_ "LZA_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 456U'4[/1[-[N_NX+&U0J&GN)%C0%B%4%B<<D@#W(JS0 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110!QOQ@_Y)SJ_P#VQ_\ 1R5\TU]+?&#_ ))SJ_\
MVQ_]')7S37J87X'ZGVF2_P"[R_Q?H@HHHKL/?"BBB@#ZO\%_\B=H7_7A!_Z+
M6MFL;P7_ ,B=H7_7A!_Z+6MFO!E\3/S&K_$EZL***^"/VN_^"HUM\$OB3/\
M#?X=^%!XW\7VLJV]Y-.[BVAN&QBWCCC&^:3D X*A3Q\QR!)D?>]%?D[<?\%5
M/VBOA==65]\4O@=:Z7H5RZJADTG4='>7N1'+</(I..GRFOT:_9\^/GA;]I3X
M8:=XW\)3R/87),,]K< +-9W"@>9!(!P&7<#QP0RD9!% 'I%%?DIXL_X*K?M
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MAU)M+UG3F2/5-"O&#36C,#M8,.'C;:VUP!G:00I&* /=Z*** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M[_H/?^2=O_\ &Z/^&@O'W_0>_P#).W_^-U]4?\*Y\)_]"OHW_@OA_P#B:/\
MA7/A/_H5]&_\%\/_ ,37?SQ['TWUBC_)^1\K_P##07C[_H/?^2=O_P#&Z/\
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M-N,KA2I#'C<.<?4?[2'[4'@O]E?PMIWB#QL-2^P:A=?8H/[-M//9I=A?:?F
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M<9ZT ?4]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH XWXP?\DYU?_MC_P"CDKYIKZU\2>'[
M?Q1HMQIET\L=O/MW-"0&&U@PP2".H':N'_X4#X>_Y_-3_P"_L?\ \;KNH5HT
MXVD?29;CJ.%HN%3>]_P1X%17OO\ PH'P]_S^:G_W]C_^-T?\*!\/?\_FI_\
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M ((^W#^.Y_%OP1\<1^"YWF:Y@TJ^,T*64AR?]'N8<NB9. I0E1_$>E<E<?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR361^Q#X1^(NB_M(:U=^)_VE?"_Q4T9K"\6/PMI/CRYUBX@8S1E9#:R *H0
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M=_P3G^."_P##'.F>*OBCX_'F/J][ VM^+M9Y(#_*AGN'[#.!FOKKPIXT\/\
MCS24U3PSKNF^(M,<[5O=)O([J%CZ!XR5_6OQ]_8/_P""=ME^U;\(?^$M\?\
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M&37!?\%3/CI\:?!UC>^!O /A6^N/ VI^&S/X@\2V>BW%Q]E266:*2$W*DQ1
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?
M/7[?'_)K?B;_ *_]'_\ 3I:5]"U\]?M\?\FM^)O^O_1__3I:5]"T %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M]@/P=^R)\1?ACJ%E\:(-)TOQUIUY(YO-<\176FQ7=JP!C,96>.,LIWJ5'S<
M\YX^A/V:;?\ 89\5_'_2=)^&?@_5H?'.F:A)/I-ZTVJRV\CV^Y_/0FX=/+PF
MX&55!R,CG%>I?$K_ ()(_ 3XA^(+C5K:WU_P=)<2&66U\.7T4=N6/7;'-%*$
M&>=J8 [ #BO9?V<OV.?A?^RW;W9\$:+(NJ7B>7<ZQJ,WVB\E0$'9OP JY .U
M H) )!(% 'Y>?M47D_[+O_!4:W\?:Y9S/H$VKV6OQR*NYIK.1%CG9.F61A,
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M_P $:O#NIZM^TMXT\3:;:RVOAFUT.>WG.3Y:O-<1-##Z$XC<_P# #7UAK/\
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M-XL\):-X\\-:CX?\0Z;;ZQHNHPM;W=C=H'CE0]01^H/4$ C!%?&,_P#P1S^
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% 'SU^WQ_P FM^)O^O\ T?\ ].EI7T+7SU^WQ_R:
MWXF_Z_\ 1_\ TZ6E?0M !1110 4444 %%%% !115:#4K2ZD:.&ZAED7JL<@8
MCZ@&@=F]BS1110(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110!\]?M\?\FM^)O\ K_T?_P!.EI7T+7SU^WQ_
MR:WXF_Z_]'_].EI7T+0 4444 %%%% !114=Q,EM!)-(=L<:EV/H ,F@#P/\
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M_/%=_INL6&L0B6PO;>\C_O02!Q^AKDE3E#XD>)6PU:A_%@T7****@Y@HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\0_:=_::C_9QLO#\O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M"R7) C"NF&/EQJ,,,97V!T?&W[./C#X<>&[K7O$G[4OB?2=)ML>9<3)=GDG
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MB.JYX'[OYW/J3^G2K7@']I[XB_"WQ0D/B"^U+6+..0)>Z7K3.TP7/.UG^='
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M!!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH ^>OV^/\ DUOQ-_U_Z/\ ^G2TKZ%KYZ_;X_Y-;\3?]?\ H_\
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M5I='OH[F([EZ.N>'7TKC/%&F;'^UQCY6XD'H>QJUX9U+[1 ;:0YDC'R^Z_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-CZT*U52INZL>5Q-CL/F&,C5PTN:*BELUK=]TNX4445YQ\F<O\4_^28^+_\
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M5]G\C.]LXV[FZ?6N\K"O)3JRE'9L\[,JT,1C:U:D[QE)M>EPHHHK \T****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** /GOPK^P9\%_#?Q$\1^.;OPG#XF\4ZYJUUK$U[K^+M899YFF*Q1$>6JJS
MG:=I;@98U] PPQVT,<,,:Q11J$2-  JJ!@  = !3Z* "O!?%_P"VM\(/"?QL
MC^#VM:Y<)XUN;VSTL:=_9L\D337:Q&%#($*883QY).!DYZ&O>J_%;]I;_E,E
MI'_8Y^$__1.G4 ?I9XN_87^#7BKX@>'/'$'A&V\.>*M"U:UU>WU#0 +/S98)
MDE"S1*/+D#% &)7=@G# \U[[110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M5*-2B[5(M>I)1114F(4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#33RN$C0$Q  EF Y('- 'T!1110 4444 %%%% !1110 4444 %%%% !1110
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M4 >Q45E>'_$$.N6VY<)<*/WD6>GN/:M6@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MP)=:W8V>IWDCV^L(+-YT2:5IOFN(PJ%CN8C&,GB@#]2:*** "BBB@ HHK/\
M$'B#3?">AW^LZS?0:9I5A"UQ=7ERX2.&-1EF8GH !0!H45\#_LW_ /!4-OVC
M/VFK3X;:=X)AL?#]]+>_9-:>^8SO##%))&[0^6 "XC&1NXW=\5]\4 %%?"_[
M4W_!5SP1\ ?&5[X/\-Z#-X]\0:>YAOY(KQ;:SM91UB\S:Y=U/# +@'C.00,G
M]F__ (*\>"OC!XSL/"WC+PW+X O]0D$%GJ!OA=63RL<*DCE$:,L> 2"N>I%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%0W=W#86LMS<RI!;Q*7DED8*JJ.I)/05\.
M_M$_M@7OB6XO/#O@FX>RT89BFU2,E9KKLP3^ZG;/4^U=6'P\\1+EB>QEF58C
M-:OLZ*T6[Z+^NQ[1\;_VO/#_ ,,Y9M)T5$\0>(%&&6-O]'MV]'8=3_LK^)%?
M#OQ"^*7B7XHZL;_Q%J4EXX/[N ';#"/1$Z#^=<HS%F+,26)R2>II*^IP^$IX
M=>ZKON?M>5Y)A,KBG35Y]9/?Y=OD%%%%=I] %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>X_
M!G]K#Q3\+6@L+YV\0>'U./LES(?-B7/_ "S<]._RG(^E>'45E4IPJQY9JZ./
M%82AC:;I8B"DOZV['ZM?"_XN>&_BYHBZAH%Z)'4#S[.7Y9[=O1U_J,@^M=I7
MY%^$?&6L^!-<M]7T._FT^^A.1)$V P[JPZ,#Z&OT _9U_:<T[XP68TO5!%IG
MBJ%?FMP<1W2@??CSW]5[?2OFL7@94??AK'\C\?SOAJIE]Z^']ZG^*]>Z\_O/
M=****\D^("BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OP
ME_:J_:*_:+^'W[3GQ \,V_COQIH\$GB&^;1]*AO95S9O=2?9?*C!SL:/;L '
M((QP17[M5^2'_!*;Q[X=\=?M0_%7Q%\0)[=OBAK16YTAM1(,@W2RF\CA+='
M,"A5Y"*P V@B@#YYO/B1^VQIVEMJ5W=_&.UTY5W->366H)"!ZERF,<>M8'@7
M]I#]J[XC:A<6_@[QC\2?%=Y9J)I[?1C=7S1+G 9TC5L+GCYA@]*_H4K\D/BW
MX^\-^!_^"N'@6\^%,L#2:E>6&D^*$TL_N)KJZG>*ZW;/E8B)X7;TD0D_,"0
M=+^P+_P4$^)NJ?&^U^#WQK>:ZN]1WV]C>ZE8BTO[2Z";TAF4*NY74$ LN_<R
M\D'C]2J_)S]M*XL+G_@K-\$X]">-M2@N?#J:J+9AO6;^T'9A)CH?LS0G!_@*
M^M?K'0 4444 %?C1\7-:_:3_ ."AWQD\1?#S1X'L/A[HFN7-C(]M$]MI4*PS
M,@EN9229I,*#L!//*H.M?LO44%M#9P^7!$D,>2=D:A1DG).!ZDDT ?@S_P $
MNK4V/[=W@ZV+;S"FIQ[@,9Q9SC/Z5^U7[0GCZ7X5_ OQ]XNMSMNM&T2[O+<_
M]-EB8Q_^/[:_%[_@F7_R?]X8_P![5O\ TDN*_67]O>-YOV./BRL:EF&B2,<>
M@92?T!H _+7_ ()/?!_1/C3^TMK&J>+]/M_$-IH>E2ZD+?48Q/'+=O*B(\BM
MD-@-(W.?F /:ND_X+$? _P -?"_XK>#/$?A?1[30H?$=A.MW:Z? L,+7%NZ?
MO0B@ ,RRH#CKLSU)KH/^"(C#_A;GQ(7(W'0X"!W_ ./@5U?_  7(=?/^#RY&
M[;JIV]\9M* /O#]C+XC7?Q8_9;^&WB>_E-QJ%UI,<-U,QR9)H2T$CGW9HR?Q
MKVBOE?\ X)?PR0_L/_#GS%*[A?,N?0WUQ@U]44 ?A)_P4T\97_Q<_;BU3PVL
M[&UTAK+P_8H3E4+*CR$#U,LS_D/2OT$_;-_8]^&FE?L3^*-.T'PCI6F7WA'2
M/[0T_4K6SC2Z#6X#2%Y0-SF1%<-N)R6R>0#7YK?M.*UO_P %'/$WF_)_Q6ML
M_P W]TRQ$'\B*_:']L!UC_94^+K,0H_X174N3_U[/0!^?O\ P1%^)%VNM?$?
MP%+,SV+VT&MVT1/$<BOY,I'^\'AS_N"OUAK\7O\ @BG#(W[2?BV15)C3PK,&
M/89N[;'\C7UC^U'^Q7\6?C!\;-<\5^%_$VG:=HEY';K#;W&IW,+J4A1&RB(5
M&64G@T >U_M\?\FM^)O^O_1__3I:5]"U^17Q6_8K^+/P?\&OXM\4>)M.U'0]
M/OK$7%M;ZG<S._F7<,:81T"G#.IY/;-?KK0 4444 %%%% 'RU^WU,1X)\)0C
MH^K[C^$3?XU?_8+AV_"O7)?^>FMR_I%%6-^W\X_X1[P2F>3J,I_*,?XUT?["
M2X^#-ZV/O:S<'_QR*O9?^X+U_4^_G[O#,/.7_MS_ ,CZ,HHHKQCX **** "B
MBB@ HHHH **** .1\;>'?M$;:A;+^\4?O5'\0_O?45PM>S]>#7GOB[PW_9DQ
MN[9?]$D/*C_EFW^!H Y>6))XVCD4.C#!4UQ^K:3)I<P="3"3\C]U/H?>NSID
MT*3QM'(H=&&"IH R=#UP7JB"<XN!T/\ ?_\ KULUQNL:/)I<WF1[C 3\K]U/
MH:UM$UX76V"X($W17[/_ /7H W*UM!\1W.AS#:3+;$_/"3Q]1Z&LFB@#UW3=
M3M]6MA/;/O7N.ZGT(JW7D6F:I<:3=">W?:W\2G[K#T(KTC0_$-MKD.4/ESJ/
MGA8\CW'J* -6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH *RM<\+Z1XEA\K5-.M[U<8!E0%A]&ZC\*U:
M*:;6J*C*4'S1=F>->)?V:]*O \FBWTVG2]1#/^]B^F?O#\S7E_B+X)^+/#V]
MSI_]H0+_ ,M;%O,_\=X;]*^M:*ZH8JI'?4]NAG.*HZ2?,O/_ #/A&2-X9&CD
M1HY%X9'!!'U!IM?;&O>#]%\3Q[=4TRWO.P>1!O'T8<C\#7FFO?LU:->;WTK4
M+C3G/(CE FC^G.&_4UV1Q<'\6A]#0SW#U-*J<7]Z_KY'SE17H/B+X%^*] W/
M'9KJL _Y:6+;C_WP<-^0-<%<6TUG,T-Q#)!,O6.52K#\#79&<9?"[GNTJ]*N
MKTI)E*^TVTU./9=VT-RGI*@;^=<KJGPGT.^RT FL'/\ SQ;*_P#?)_QKLZ*U
MC*4=F=U.M4I?!)H\=U7X/ZI:AFLIX;]?[O\ JW_(\?K6!YGB+PC)C-]IP!Z'
M<$/_ +*:^@:1E#*58!E/4'D5NJ[VDKGHPS*I:U6*DCQS3/B]J]KM%W%!?)W)
M&QOS''Z5U^E_%G1;["W/G6$G_31=R_F/\*U]4\"Z%JV3-I\4;G_EI!^[;]*Y
M#5/@RIRVG:@5]([I<_\ CP_PIWHSW5B^? U_B7*_Z_K8]#L=5LM43=9W<-T/
M^F3AC^56J\'U#P#XAT-_-%I)(%Y$UFV_'Y<C\J?IOQ&\0:.WEM=&X5>#'=KN
M(_'[WZT>POK!W$\O4U>A-,]UHKS72_C- V%U'3WC/>2V;</^^3_C77Z5XST7
M6<"VU"+S#_RSE/EM^1_I6,J<X[HX*F%K4OBB;=%%%9'**K&-@RDJPZ,IP174
MZ+\4_%>@[5M=;N6C7I'<$3+^39_2N5HI.*EHT95*4*JM4BFO,]FT7]IG5;?:
MNJ:5;7B=WMV,3?D=P_E7?:'^T'X4U7:MU+<:5*>US%E?^^ES^N*^6Z*YI8:G
M+I8\BKDV$J[1Y7Y?U8^X=+U[3=<B\S3K^VO4ZY@E5\?7!XJ_7PE#-);2B6&1
MX95Z/&Q5A^(KK='^+WB[0RHAUJ>>,?\ +.[Q,/\ Q[G\C7++!O[+/&J\/S6M
M*=_4^P**^?-%_:<O8MJZKHT-P.\EI(4/UVMG^8KO-%^/WA'5L+-=3:9(?X;N
M(@?]]+D?F:YI8>I'H>-5RO%T=X7]-?R/1Z*HZ7KFGZU#YNGWUO>Q_P!ZWE5_
MY&KU8;;GEM.+LT%%%%(04444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %-DD2&-I)&5(U!9F8X  ZDF
MG5\M_ML?&I_"^AP^"M(N#'J6IQ^9>R1GYHK?. N>Q<Y_ 'UK>C2E6FH1ZGHY
M?@:F8XF.&I[O\%U9Y)^U-^TM/\0M4N?#/ARZ:+PQ;N4EFC)!OG!Y/_7//0=^
MM?.%%%?9TJ4:,%"!_0>"P5'+Z$:%!62_'S?F%%%%;'>%%%% !1110 4444 %
M%/AADN)4BB1I)78*J(,EB>  .YKU+1_V6OBGKME'=VOA"Z2&1=R_:IX;=\>Z
M2.K#\16<JD*?QM(YJV)H89)UYJ-^[2_,\JHKN/''P1\<_#FT^U^(?#=W86>=
MINE*S1*<@ ,\991DD8R>>U</51E&:O%W1=*M3KQYZ4E)=T[K\ HJWI.DWVO:
MA!8:;9SW]].=L5M;1F21SC. H&3P"?PKU.']DKXLS6XF7PC($(SA[VV5O^^3
M)G]*F52%/XY)&5;%X?#-*O4C&_=I?F>0T5L>*?"&M^"=5?3=>TNZTJ^4;O)N
MHRI9?[RGHPX/(R*QZM--71T1E&<5*#NF%%%%,L**** "BO8+?]D?XL75O'-%
MX4W12*'5O[1M!D$9!_UM>/UG&I"I\$DSEHXK#XF_L*BE;>S3MZV"BBBM#J"B
MBB@ HHHH **** "BBB@ HHHH **** "K.FZE=:/?V][8W$EK=V[B2*:)MK(P
MZ$&JU% FDU9GZ+?LO_M%1?%S1CI&KR)%XJL4S(O0748X\Q1ZCN/QKWBOR)\(
M^*]1\$>([#6])G:WOK.42(PZ''53Z@C@CWK]3?AC\0+'XG>!]+\16! CNX_W
MD6>8I1PZ'Z'/Z5\IC\*J,N>'PO\  _%.)LE67U5B*"_=SZ=GV]'T.IHHHKRC
MX@**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K\J/VUO^"4OB?7?
MB!JWC[X,&WO4U2X>^N_#<]RMM-!<LVYWMI'(0HS$MM9EVG(4D$!?U7K\5?C]
M_P %-OC]X!^._P 1_#&C>)M/M]'T7Q)J6FV43Z1;.R00W4D<:EBF6(50,GDT
M >>R?LG?MEZQ#_8$^A>.KBR),?V6ZUW_ $7G(/+3^7@Y/?')K[4_X)__ /!,
M?4?@;XPLOB3\3KJTF\46:,=*T.QD\V*R=E*M+-)C:\@#$*J95<[MS'&WXP_X
M>Q?M(?\ 0V:;_P""2U_^(KT3]G?_ (*4?M#_ !*^.WP]\-:CKUK?Z-JGB'3K
M+48[?1+<'[-+=1QRY94R@VL?FXQ0!]8_#7]AKQ;JG[?'B[X[^.C9V>A6NJ3S
MZ#I\4PEGNR(_(@FD"Y"(L8#@$[MP7( !S]Y444 %%%% !2-]TTM% 'X._P#!
M,O\ Y/\ O#'^]JW_ *27%?MO\6/ D/Q0^%_BWPA<,J1:[I5SIQD8<)YL3(&_
M D'\*\W^&W[$?P5^$/CRV\:>$O!4>D>);8RF*^6_NI2OFHR2?*\K+RK,.G&>
M*]SH _!#]B;XX']A3]J+6K?XBZ=?6%D;>?0=:ABA+S6KB1'24)P64-&.G57)
M&> =/_@H5^TUIO[:7QL\):;\.++4-3TO3;?^SM.$EN4FOKJ>0%RD?4 XB49P
M<J3@5^M_QX_8S^$?[2%Y%?\ C?PI%=ZQ$@C35K.9[6ZV#HK/&1O [!\X[8JA
M\"_V&?@S^SOK7]M^$/":KKP4JFJZC<27=Q$",$1ER1'D9!*@$@D9Q0!8\(Z>
MG['O[&]FEQ9_VK)X&\+M=7=K#*(_M$T41EF57P<;I-^#@]:\Z_8N_P""@EE^
MV+XN\0Z%:^";CPLVD6*7IGFU);D2[I FW B3'7.<FOJ+Q?X3TKQYX5U;PYKM
MH+_1=6M9+*\M2[()89%*NNY2&&02,@@UYS\%OV3?A3^SSK&HZI\/O"D?AZ^U
M" 6US*EY<3>9&&W!<2R,!SSD#- 'Y2?\%:/A!K'PP_:B3XB6=M(FC>*([>\@
MO50F..]@18Y(R>@;$:28[ASZ&O9OVHO^"I7@#XL?LF:IX8\.P:DGCKQ+81V-
M]936Q2&Q#%?M!\S.'! =5VY)W D+TK]+?B)\-?"_Q:\*W?AKQAH=GXAT.ZP9
M;.]CW+N'1E/56'9E(([&OFO1_P#@E7^SEH^O)J8\'W=ZL;^8EC>:K<26X/8%
M=^6'LQ(]<T >#?\ !%GX(ZCX>\(^,OB9JEI);0ZZT6F:49%P98(F9II%]5+E
M%!]8FK],JJZ7I=EH>FVNG:=:06%A:Q+#;VMM&(XHHU&%15 PH    JU0!\]?
MM\?\FM^)O^O_ $?_ -.EI7T+7SU^WQ_R:WXF_P"O_1__ $Z6E?0M !1110 4
M444 ?)?_  4 ;_B5^!$QUO;AL_1$_P :Z[]A=2OP1<_WM6N3^B#^E<7_ ,%
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MBL<BA@N>ORDE>><*.O6ONKX1_#_1_P!F3X7W46M:["8_/>]O;^;]U%O*JH5
M3GHB@#DL<^H ^#/CI\1D^*OQ0UKQ# CQ64SK%:QR##"%%"J3[G&XCL6QVK7
M*U>?L_@.SAF'+F.(>$N\/TOM>ZM\]_EN?:'['GPALO _PXLO$=Q;H^OZ["+E
MKAAEH[=N8HU/8%=KGU)YSM%;7B3]K3X>^%O'#^%[R]NFN(93!<WT, :UMY <
M%7;=G(/!VJ0#G)X->L6-K'H>BV]M&@$5G;K&J+TPB@ #\J_(?4+^?5=0N;VZ
MD,MS<RM-+(>K.Q)8_B2:Y\/16.J3G49YF4X&'$>*Q&(Q<G9;6?>]ON2/U!^.
M'PGT[XQ^ +W398XVU%(FFTV\ &Z*8#*X;^ZW ([@^H%?EQ)&\,C1R(R2*2K*
MPP01U!%?JI\#M0FU3X.^"[FX=I9GTFV#R.VYF(C R3W)Q7YO_&S2O[%^,'C.
MS&W:FK7+(%Z!6D9E'U 85U9;-QE.BWL>OPC6G3J5\#-W47=??9_?H<3117;?
M!OX;3_%CXB:3X<B=H8)W,EU.G6*!1EV&>^.!GN17MRDH1<I;(_1:U6%"G*K4
M=HQ5W\CG=!\+:UXIF>'1=(O]7FC +QV%L\[+GID*#CI4GB#P;K_A,QC6]#U+
M1C)PG]H6DD&['IO S7ZCQP^$O@?X"9E6V\/^'-,B!=L?09./F=V./5F)[DUY
MGI/[3'PJ^-%]+X-OHY_*U!_LT4>L6H6"[8GY0C!CM;.-N[:<XQSBO&CF%2;<
MH4[Q1\!2XHQ.(E*K1PKE2CNUO;[K>=OQZGMF@?\ (!TW_KVC_P#017Y 5^Q-
MK;I9VL,$>?+B0(N>N ,"ORF^$?P^F^*7Q$T7PU$[11WDW[^91S'"H+2,.#SM
M4XSQDBL<LDHJI)[*WZGG\'UH4HXNM-VBN5OT]XPM#\,:SXGFDBT?2;[5I8P"
MZ6-L\S+GID*#CH?RK:N/A#X[LXS)/X*\10QCJTFE3J/S*5^DNK:MX+_9Y^'\
M<LL<.B:%:%88H;>/<\LAZ  <NYP22?0DGJ:YGX6_M4^"/BQX@31--.H:=JDH
M8P6^I0*AFVJ6;:4=AD $X)!X-:_VA5DG.%/W4=KXHQM:$\1AL+>E'KK^GX[V
M/S5=&C=D=2KJ<%6&"#Z4VON3]N3X5Z3<>#$\;6EK%:ZQ:7,<-U-&-OVB)R5&
M['5@Q7!ZXR/2N^_9!\?_ /"<?!G38)I-]]HK'39O]U #$?\ OV5&?536[QW[
MA5HQOK9Z['IU.)$LNCF%.CS*_*U>UGZV=U]VY^;M%>V?M?\ @8>"_C9JDT,8
MCL]81=2BVJ0-SY$HSZ^8KM_P(5U_[!_@G^VOB-J?B.:,-!HMILB9ATGFRH(^
MB+)_WT*ZY8B,:'M^ECVJF:4Z>7?VC:ZY4[>;Z7]=#YDJ:TLY[^YCM[:&2YN)
M#M2*%"SL?0 <DU]Q_MZ>//[)\$Z3X5@?$VKS_:+@#_GC$00#]7*G_@!KT#]F
MKX1Z/\+?AKIFHM:Q?VYJ%HEY?WS@&1=ZA_+#<X500,#@D$]ZXWC^6BJKCJ]D
M>'/B94\OCC:E*SFVHQO>]NM[+\CX%7X.^/9(_,7P1XC:/&=PTFX(_/97.:KH
M]_H-XUIJ5C<Z==J,M!=0M$X'NK &OORY_;G^&T&J"T1-:N(,X^W1V:B'ZX9P
M^/\ @%=_XYT?P-\;/ARAU.ZLIM(O[?S[+4G98W@)!VR(S<JP/4'T((ZBL_KU
M6FU[6G9,X_\ 63&X6</KV%<82ZZ_U\M#\N**N:QIQT?5KZP,\-T;6=X#/;.'
MBDVL5W(PZJ<9![@U3KVC]"34E=!1110,**** "OK7]@CXA26NOZUX-N)";>[
MB^WVJMT61,!U'U4@_P# #7R57I?[-NM2:'\=/!L\;,OFWZ6K;3U$H,9!_P"^
MZY<5352C*/D>+G.&CB\OK4WV;7JM4?J'17*?$CXJ^$/@_P"&Y=>\:>(]/\-Z
M3'Q]HOY@F]L9VHOWG;_94$GTK\UOVD?^"S7_ !]:-\%M"]4_X2;7HO\ QZ"V
M_4-*?K'7Q)_.Q^JE%?ES_P $N?VLK34;CXLZW\9OBOIMOK.H7&G&VF\6:W#:
MF156YW+ DKJ BEE^5 %&X<#-?>/_  UC\$/^BR?#_P#\*BQ_^.T >JT5Y5_P
MUC\$/^BR?#__ ,*BQ_\ CM'_  UC\$/^BR?#_P#\*BQ_^.T >JT5YUX?_:0^
M$OBS6;32-$^*/@O6=6O'\NVL-/\ $-I//,_]U(TD+,?8"O1: "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M,"",@\$&N7UOP^;?=/;+F+JT8ZK[CVKJ:* .6T3Q ;?;!<MF+HLAZK['VKJ
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M?,I(]B/K7R-XU_8E\9S?$:\AT*&Q/AJZN7E@OFG6-;6)F)"-'G>2H.T;00<
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M@MSQWKPO]G'X??%O7/B9I?BCQE<:Y;Z-8M+*T>N7$H>5VC= JPN<C!;.2H
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M1KT":/3?C5\)V4,R:=XBTOA@ 6B\Q.O/\2D_FM9OQ>\56_P>^#.K7]BJV_\
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MZ=:2LY).W:ZN%%%%:'4%%%% !7=? NS>^^,_@>) 21K-K(<>B2JQ_137"U]
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MX0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3_K7L%%%%:G8%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%7M%T34/$6I0:?I=E/?WT[!8[>
MW0N[$^PI;:LER45=O0HU]&?LT_LLW?Q(N(/$/B6&2S\,1MF*%@5DO2/3N$_V
MN_:O3O@#^QC#H_V77_'L27-[@20Z,&W1Q'L92.&;_9''UKZQCC2&-(XT6.-
M%55&  .@ ]*\+%Y@E>%'[_\ (_-,\XIC%/#8!W?67_R/^?W$.G:?:Z186]C9
M01VMG;QK%##$NU40# 4#L *LT45\Z?E3;;NPHHHH$%%%% !1110!^57Q]_Y3
M)?#G_N&_^B9*_56ORJ^/O_*9+X<_]PW_ -$R5^JM !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?"O]C'Q?XX\F]UT_\(OI38;_ $A-URZ\?=C_ (>.[$?2OM+X9?!GPK\)=/\
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MO@W_ *]Y/_1TE>S7_P!RI^O^9^@YE_R3F%_Q?_)GK%%%%>,?GP4444 %%%%
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M:/\ OGD?I7(:I\&[R'+:?>QW*]HYQL;\QD?RKUFBM8U9QZG;3QM>GM*_KJ>
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MK[SBJ9I@:7QUXK_MY'A5%?4FD_L ^+;C:=2\1Z/9 ]?LXEG(_-4'ZUWNB?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MU+XHFW11V!'(]:*R.4^K?@+_ ,DST[_KI+_Z&:]#KSSX"_\ ),]._P"NDO\
MZ&:]#KY^M_$EZGY5CO\ >JO^)_F%%%%9'"%%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 ?E5\??^4R7PY_[AO\ Z)DK]5:_*KX^_P#*9+X<_P#<
M-_\ 1,E?JK0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[^\AX9?J*NT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MK'?[U5_Q/\PHHHK(X0HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHKYH_(0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** /QL_P""G_P"\6_ ?]HBV^._@W[1;:1JMW!?
M'4K1?^09JD>T8?T638'!/!8NIZ#/HWPO_P""V]G'H=K;_$+X>74FJQJ%FO\
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M'L])TBPMM+TNSB6&VLK.)8H88P,!410 H'H!0!>HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** /GK]OC_ )-;\3?]?^C_ /ITM*^A:^>OV^/^36_$
MW_7_ */_ .G2TKZ%H **** "BBB@#X$_;S_Y+%IG_8%B_P#1LU?6_P"SQ_R0
M[P/_ -@J#_T&ODC]O/\ Y+%IG_8%B_\ 1TU?7'[//_)#O __ &"H/_0:]G$_
M[G2/T'-_^1#@_P"NC/0Z***\8_/@HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH Y_Q%X!\/^*E/]IZ7;SR'_EL%V2#_ (&,&O*?$G[,J-OD
MT+52G<6]\N1] Z_U!KW:BMH5IT_A9WX?'XG#?PYZ=MT<=\)_#M]X5\$VNFZC
M$L5W#))N57##!8D$$>U=C116<I.3<F<M6HZU2526[=PHHHJ3(**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH _*KX^_\IDOAS_W#?_1,E?JK7Y5?
M'W_E,E\.?^X;_P"B9*_56@ HHHH **** "BBB@ HHHH _'S4F*ZI=,I((F<@
MCM\QKUOX;?M8^/\ X=^5;MJ/_"0:8@"BSU8F7:H& $DSO7'89(XZ5]0_$O\
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M"TM/&?A^ZN[B18H8(=4@=Y'8X554/DDD@ #KFNLK\H_@O_R6+P+_ -AZP_\
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M.5B4<&9QW / '<^P-?G9XF\4ZMXRUB?5=;U"?4]0F.7GN'+'V ] .P' I87
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M110 4444 %%%% 'SU^WQ_P FM^)O^O\ T?\ ].EI7T+7SU^WQ_R:WXF_Z_\
M1_\ TZ6E?0M !1110 4444 ? G[>?_)8M,_[ L7_ *.FKZX_9Y_Y(=X'_P"P
M5!_Z#7R/^WG_ ,EBTS_L"Q?^CIJ^N/V>?^2'>!_^P5!_Z#7LXG_<Z1^@YO\
M\B'!_P!=&>AT445XQ^?!1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% ',>+/"HU)6N[5<7:CYE'_
M "T'^->?LI5BK @@X(/45[/7+>+/"HU!6O+1,70&7C'_ "T'^/\ .@#@**.G
M!&#10 4444 ,EB2>-HY%#HPP5-<CK&BR:;)YL6YH,Y#=U]C_ (UV-(RAU*L
MRD8(/>@#"T/Q!Y^VWNFQ)T60_P 7L?>MZN1US0S8L9H1FW)Z=T_^M5[0M>$F
MVVN6P_1)#W]C[T =!1110 4444 %/AFDMYEEB=HY%.593@BF44 >@^&_&,>H
M[;>\*PW/17Z*_P#@:Z>O%ZZ?P_XTFL=L%Z6GM^@DZNG^(H ]!HJ.WN(KJ%98
M762-AD,IR#4E !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^
M57Q]_P"4R7PY_P"X;_Z)DK]5:_*KX^_\IDOAS_W#?_1,E?JK0 4444 %%%%
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M6MU XDBFA8JZ,#D,".A!KW9J..H_NY67];GZ57C1XCP'^S57%/MW[26_RO\
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M -@J#_T&O:Q/^YTC]!S?_D0X/^NC/0Z***\4_/@HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MXU>"WDV#6UW9QS;S ?F4Q75:3K5AKUJ+G3KR&]@/\<+A@#Z''0^QH NT444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?E5\??\ E,E\
M.?\ N&_^B9*_56ORJ^/O_*9+X<_]PW_T3)7ZJT %%%% !1110 4444 %%%%
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M *$*^UI0]G2C#LC^A,'AWA,'3H/>,4OP/V$HHHKX4_FT**** "BBB@ HHHH
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MR(L%_71G?4445XQ^>A1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M <1GG!K-^.'_ "5#6O\ MC_Z(CKZ1\!_\B-X=_[!UO\ ^BEH ^7O%7PZ\0^
M_*N;ZWV0EL)=6\FY0W4#(Y!^N*]D^!_Q-N/%$,NC:K,9M1MT\R&=R-TL8P"#
MZL..>I!]J[WQUIL.K>#=9M9UW1O:R'Z,JEE/X$ _A7S!\)]0DTWXB:')&Q!D
MN!"WNK@J1^M 'T9\4/'2^ _#;7,85[^<^5;1MR-V.6/L!_0=Z^;="\/Z[\3_
M !#*L3M=W;_O)[JX8[4&<98^GH!^ KN?VE;Z23Q1I5F6/E16?FJO;+NP)_\
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MOYCM2"W3<3[GT'J3P*_1QOV2?A,UP9CX1CWYS@7UT%_[Y\W'Z5Z%X4\"^'O
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M9_L[_L_>%OV9_AAI_@GPI#)]D@)FN;RX(,]Y<,!OFD([G   X   X%>F444
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MZUR/Q\_Y*1=_]<(O_016OX1^/W_"*^&[#2?["^U?94V>=]LV;N2<X\LXZ^M
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MF2OU5H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M8FNB\,_M]? 'QEXDTG0-&^).GWVL:K=Q6-E:I:W(::>5PD: F( $LP') YH
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M=A8WT6H0"6(Y'=3U4^AJ#5=)CU.'!^691\C_ -#[5RT$]SHEZ>-KKPR'HPH
M[BBJUC?1:A )8C_O*>JGT-6: "BBB@ HHHH * 2"".#110!U_AWQLT.VWU%M
MT?1;CN/][U^M=NCK(H9&#*PR&4Y!KQFMKP_XHN-%81MF:T)YC)Y7W7TH ].H
MJKIVI6^J6XFMI Z=QW4^A':K5 !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %<SXB^&WAOQ9?B]U735N;H((_,$TD9*@DC.UAGKUKIJ* ,CPWX3
MTKPA9R6ND6@M()'\QUWLY+8 SEB3T K7HHH Y;7_ (8^&?%&I/?ZGIOVF[90
MK2>?*F0!@<*P%9W_  H_P3_T!?\ R:G_ /BZ[JB@#A?^%'^"?^@+_P"34_\
M\76OX:^'GA_P?>2W6D:?]DGD3RW;SI'RN0<89B.H%='10!R>N?"OPOXDU2?4
M=1TO[1>3;?,D^T2KG"A1PK = .U4?^%'^"?^@+_Y-3__ !==U10!RND_"WPI
MH=PLUIHMN)5^ZTQ:4CW&\GFNJHHH *Y3Q5\,?#OC"0S7]B%NCUN;<^7(?J1P
M?Q!KJZ* /*E_9Q\,+)N-UJC#/W#-'C_T7FNV\+^!-#\&QD:78I!(PVO.Q+R-
M]6//X#BM^B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH _*KX^_\IDOAS_W#?_1,E?JK7Y5?'W_E,E\.?^X;_P"B9*_56@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZ,[ZBBBO&/ST**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "JFJ:9!
MJUHUO.N5/1NZGU%6Z* /(]6TF?1[QK>8>ZN.C#U%4Z]7US18=<LS#)\KCF.3
M'*G_  KR^^L9M-NGMYTV2*?P(]1[4 04444 %%%% !5'5-*BU.'#?+*OW9/3
MV^E7J* .'22ZT.^/&R1>JG[K#_"NMT[4HM2AWQG##[R'JM&I:;%J4.R088?=
M<=5KDI([K0[T<[''1AT84 =Q15#2M6BU2+CY)E^]'_4>U7Z "BBB@ HHHH *
M*** +6G:E<:7<":VD*-W'9AZ$5Z'X?\ %%OK:B,CR;H#)C/?W!KS*M[P3_R,
M,/\ NM_(T >E4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% 'Y5?'W_E,E\.?^X;_Z)DK]5:_*KX^_
M\IDOAS_W#?\ T3)7ZJT %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MUKY0HH ^CKS]I#P]#D6]CJ%P?4HB#_T+/Z5BWG[37:TT#_@4UU_0+_6O"Z*
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MS_W#?_1,E?JK7Y5?'W_E,E\.?^X;_P"B9*_56@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^"8?[:WCG3_C!;_!?XC:IJ&KZ?J1FMM.DUEF>\TV]C#,8&=_GV,$=-C9VN%
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M_18KV<5_NE(_0LX_Y$6"_KH=]1117C'YZ%%%% !1110 4444 %%%% !1110
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MJU^57Q]_Y3)?#G_N&_\ HF2OU5H **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\D_\
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M!_\ )$_ _P#V"+;_ -%BO9Q7^Z4C]"SC_D18+^NAWU%%%>,?GH4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 ?/7[?'_)K?B;_ *_]'_\ 3I:5
M]"U\]?M\?\FM^)O^O_1__3I:5]"T %%%% !1110!^?O[>'_):+/_ + \/_HR
M6OL3X!_\D3\#_P#8(MO_ $6*^._V\/\ DM%G_P!@>'_T9+7V)\ _^2)^!_\
ML$6W_HL5[.*_W2D?H6<?\B+!?UT.^HHHKQC\]"BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 3KP>17!>+/"OV$O>VB_Z
M.3F2,?P>X]OY5WU(RAE((R#P0: /&**Z/Q9X9.E2&ZMES9N>5'_+,^GTKG*
M"BBB@ HHHH *3KP>12T4 <OKF@?9]UQ;+F+JT8_A]Q[4NAZ]Y.VWN6S'T20_
MP^Q]JZ>N:USP_MW7%JOR]7C';W% '2?3D5O^"?\ D88?]UOY&O-=%UXV>V"X
M):#H&ZE/_K5Z3X&82:] RD,I1B".A^6@#TNBBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M7KC2?$EI$+>2[21C'Y*?>7/!(^G>MFMCP-9PIXICG6-1*R,"WX&@#U"BBB@
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MV4U[-W6%"V!ZD]A[FO;_ -I+Q+Y-AIVAQ/\ /,WVF90>=J\*"/0G)_X#7?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH ^>OV^/^36_$W_ %_Z/_Z=+2OH6OGK
M]OC_ )-;\3?]?^C_ /ITM*^A: "BBB@ HHHH _/G]NMBWQLA!.0ND6^/^^Y:
M^S?@6H3X,^" HP/['M?_ $4M?&/[=7_);HO^P1;_ /H<M?9_P-_Y(WX(_P"P
M-:_^BEKV<5_NE(_0LZ_Y$F"_KH=Q1117C'YZ%%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $-W:17UN\$Z
M!XW&"IKS'Q!H,NAW6TY>!_\ 5R>OL?>O5*K:AI\.IVKV\Z;HV_,'U'O0!Y!1
M6AK>BSZ'=F*7YHVYCD X8?XUGT %%%% !1110 5O>"?^1AA_W6_D:P:WO!/_
M ",,/^ZW\C0!Z51110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?(_"?ANQTF+P\)5MDVF07FS>Q));'EG&22>M;'_#3W_4M?\ D_\ _:J\+HH
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M7.>+?CYKGB*SDM+.&/2+>1=KM$Q>4@]1O.,#Z#/O7F-% !1110 4444 %%%
M!)P!DT 26MM+>7,5O!&TLTKA$C49+,3@ ?C7UY\-_!R>"/"UM8$*;IOWMPX_
MBD/7\!P/PK@O@C\*VTE8_$&K0[;QUS:V\@YB4_QD=F(Z>F:]EH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1AA_W6_D: /2J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@"EK&CV>OZ=-8W\"W%M*,,C#]1Z&OF+XE?"?4/
M]T]Q C7>CL<I<*,F/_9?T^O2OJJF30QW$3Q2HLD;##(XR"/0B@#X:HKW?XA?
ML_B9Y+_PT5C/+-I[G S_ +#=OH?SKQ#4-/NM*NY+6\MY+:XC.&CE4JPH KT4
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%='X/\  &L^-KH1Z?;'R </=2?+&GX]S["@
M#GX()+J9(H8VEE<X5$&23Z 5] ?"?X*C26BUCQ!"K7GWH;-N1%Z%O4^W:NL^
M'OPGTOP+"LQ OM4(P]W(OW?9!V'ZUW- !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^M 'GE;W@G_D88?]UOY&L$@J2",$<$&M[P3_ ,C##_NM_(T >E4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MOBI\8/!WP3\)W/B3QMK]GH&DP GS+E_GE;'W(T'S2.>RJ":_#3]K+]O?QO\
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MOVZ?AE\:O@UJ?@[PX=9.L:C?Z88/M=AY4?[N_MY6RVXX^5&_'%?H50 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MS=,K:EJ%K8Q]UBS*_P"7 _6N^T/]G_PQI>U[L7&J2CG]^^U/^^5Q^I->F44
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M ?IK_P $V=#F\/\ [$_PR@G5EDGM;B[ ;^[+=32(?Q5E/XU],UY'\8/#>H^
MOV6?%>@_#N&^MM3T?PM/9:#%I88W2216Q2 1;1N+Y5<8YS7R)_P3$U#]H6\^
M(WC)?C*?'9TE=)C-C_PED=RL/G><,^7YH W;<].<4 ?HO7X2?\%:/^3UM<_[
M!NG_ /HD5^[=?C'_ ,%./V?_ (F_$+]KK6-9\,?#_P 3>(=(DT^Q1+[3-*GN
M(&98@& =%()!Z\\4 ?L?HO\ R![#_KA'_P"@BO(?B1^QO\)_BUXPO?%'BCPY
M+J&MWBQK-<+J%Q$&"($7Y4<*,*H' KV#28VCTJR1U*NL* J1@@[1Q5N@#X/_
M &L/V-_A/\)?@;JWBKPOX<ET_7+&_P!+%O<-J%Q*$WZA;QO\KN5.5=AR.]?>
M%?/7[?'_ ":WXF_Z_P#1_P#TZ6E?0M !1110 4444 ?GQ^W5_P ENB_[!%O_
M .ARU]G_  -_Y(WX(_[ UK_Z*6OC#]NK_DMT7_8(M_\ T.6OL_X&_P#)&_!'
M_8&M?_12U[.*_P!TI'Z%G7_(DP7]=#N****\8_/0HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M3!?UT/3**R/^$NT+_H-:=_X%1_XT?\)=H7_0:T[_ ,"H_P#&O&/SXUZ*R/\
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MHK(_X2[0O^@UIW_@5'_C1_PEVA?]!K3O_ J/_&@#7HK(_P"$NT+_ *#6G?\
M@5'_ (T?\)=H7_0:T[_P*C_QH UZ*R/^$NT+_H-:=_X%1_XT?\)=H7_0:T[_
M ,"H_P#&@#7HK(_X2[0O^@UIW_@5'_C1_P )=H7_ $&M._\  J/_ !H UZ*R
M/^$NT+_H-:=_X%1_XT?\)=H7_0:T[_P*C_QH UZ*R/\ A+M"_P"@UIW_ (%1
M_P"-'_"7:%_T&M._\"H_\: ->BLC_A+M"_Z#6G?^!4?^-'_"7:%_T&M._P#
MJ/\ QH UZ*R/^$NT+_H-:=_X%1_XT?\ "7:%_P!!K3O_  *C_P : ->BLC_A
M+M"_Z#6G?^!4?^-'_"8:#_T&]._\"X_\: ->BLC_ (2[0O\ H-:=_P"!4?\
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M:%_T&M._\"H_\: ->BLC_A+]"_Z#6G?^!<?^-'_"7Z#_ -!O3O\ P+C_ ,:
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,OQ-X7TCQIH%]H>
MO:;:ZQH]]&8;JQO(A)#,A_A93P17D_\ PQ+\ _\ HD/A'_P51?X5[910!XG_
M ,,2_ /_ *)#X1_\%47^%'_#$OP#_P"B0^$?_!5%_A7ME% 'B?\ PQ+\ _\
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MB7X!_P#1(?"/_@JB_P */^&)?@'_ -$A\(_^"J+_  KVRB@#Q/\ X8E^ ?\
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MB7X!_P#1(?"/_@JB_P *]LHH \3_ .&)?@'_ -$A\(_^"J+_  H_X8E^ ?\
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MB@#Q/_AB7X!_]$A\(_\ @JB_PH_X8E^ ?_1(?"/_ (*HO\*]LHH \3_X8E^
M?_1(?"/_ (*HO\*/^&)?@'_T2'PC_P""J+_"O;** /$_^&)?@'_T2'PC_P""
MJ+_"C_AB7X!_]$A\(_\ @JB_PKVRB@#Q/_AB7X!_]$A\(_\ @JB_PH_X8E^
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M\,2_ /\ Z)#X1_\ !5%_A7ME% 'B?_#$OP#_ .B0^$?_  51?X54U?\ 8K^
MT&DWLD?PC\(I(D#LK#2HL@A3@]*]WJMJ5N]YIMW!'C?+$Z+NZ9*D"@#\FO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M ?IK^QS^T)>?M/\ P/T[QY?Z/!H5Q=75Q;FSMYFE11&^T'<0#S]*]NK-\/\
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M2WA,?% ?$+_A",77V[^W(Y1:?\>TOE[]PQ]_9CWQ0!^JM%%% !1110 4444
M%%%% !1110 4444 %<1\</&EY\-_@UXX\5:=''+?Z+HMYJ%NDP)1I(H6=0V.
MV0*[>J^H:?:ZM8W%E>VT-Y9W$;136]Q&'CD0C!5E/!!'!!H _G/^ W[3T_PC
M^.=U\5O$/AR'XA>)Y'EN8I-4NVB6.ZD;+7!PIW, 6"C@+G(Z#%K]L+]K+4/V
MO/'ND>)]1\/6WAR73]/&GK;VMRTRN!([[B648/SXQ[5^^?\ PH7X9?\ 1.O"
M?_@CM?\ XW7YD_\ !4+]DSQ9XH^,WAJX^%?PKN[K18]$5+EO#.CA8!-YTA(;
MRE W;2O7G&* /6OV(?VO-8_:H^&'BSX53>%[71T\.>"ELK>]M[II9+DK$MN"
M5*@+GKP37R#_ ,$D-2BTK]LK2K6X/E2W>F7UNBOP=XB+D?7"&OV"_9U^%^B^
M /A/X-6+PKIWA_7V\/V%OJ;06$=O<M*L$?F+*RJ&)#@YW=\U^7W[5W[#WQ;_
M &<?C]-\5_@OIFH:QHSZ@VK6;:+;_:+G2YF8L\3P $O'DM@A2NT[6 [@'O'_
M  6VU6"+X(^ =-+@7,_B$W"IGDHEM*K'\Y%_.N]_X(^:#/H_[(2W,R,J:EK]
MY=PD_P 2!8HLC_@43?E7PAKWPZ_:I_X*%?$;08O&/AS4].LM/'V=+[4M*?3-
M.T^-B#))AE!=CM!(7<QV@ 8%?LU\&?A9I7P3^%OAKP-HI9].T2S6U25P TK<
MEY"!T+N68CU:@#M**** "BBB@ HHHH **** "BBB@ HHHH *_,+_ (+6?%KQ
M!H>@^!OA_87/V;0=<$]_J*ID-<-"T8B1C_<!<MCN0I[5^GM<_P")_AYX5\;3
M6\OB+PSH^ORVX987U2PBN6C!QD*74X!P,X]!0!^)G[.O_!29OV:_@_'X#\._
M"W2YA()'OM5FU*19[R=P097 CP,+M4+T 4>YKPW]E7]I"]_9:^+4/CJQT2#7
M[B.UFM19W$[0H?,7&[< 3Q]*_?[6O@'\-WT>^6#X<^%3,T$@39HEMNW;3C'R
M=<U^5W_!.3]D7QYX;_:6M;SXD_"G4K;PP-.NU:3Q#I&ZU\PIA 1(I7.>E 'H
M/_!33]I;Q#XT_9.^#C6T9T2U\?PG5-4M[64E2L:1LL!;@E=T@;WV"O4_^"<?
M['7PD\0?LIZ!XG\2^#='\6ZWXF%Q-=7>K6J7#0JLSQ+%%NSY8 CSE<$ECSP,
M>P?MT?L:6O[37P1L_#OAI;'0]?\ #TGVG0U\L16W"E6MR%'R(PQR!P54XP*_
M./X6_$;]L7]C'1;_ , Z3X"UI]-:9Y(8;O0)=1BMY&X9[>:+*D$X.-S+GG&2
M<@'):XK_ +&W_!12YT[X?W4\&FZ3X@MX(K;S2PDM9UB=[9SG++ME*<Y/R@]>
M:_>VOR _8J_8-^*7Q4^/%M\7_C/I]]H]A;:A_;#QZTGEWNJ78;>@\DX,<8;!
M.X 8 51CD?K_ $ %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>X((->.?$G]B_P""OQ>\7WGBGQAX!L=;U^\5$GOI9YT:0(H5<A) .% '3L*
M/$?^"1GPQ_X07]E"VUR>'9>^*M1GU$L1AO)0^3&#[?NW8?[]?+?_  6P^&9T
MKXD>!/'MO%MCU6PDTNYD4<"2!]\9/N5E;\(Z_6;PCX3TCP'X9TSP]H%C'IFB
MZ; MM:6<.=L4:C 49))^I.:YOXN_ WP+\>-#M-'\>^'+;Q)IMI<"[@@N'D3R
MY0K+N!1E/1F&,XYH _(G_@C?\/3XJ_:;U/Q/.A>'PWH\TRR-S^_G(A4?4HTI
M_"ON[_@K)_R93XJ_Z_M/_P#2J.O>O@[^SC\-_@"-4_X5_P"%+7PU_:GE_;#;
MR2N9O+W;,EV;&-[=/6M_XF?"WPM\9/"-SX7\9:/%KN@W+QR2V4SNBNR,'0Y1
M@>& /7M0!^7_ /P2,_9]\"_%;X:_%34?$^A0:M?71&@B>X&XP6LL),@BS]QR
M2/G'(P,$<Y\-^$OBGQ!_P35_;;N]%UZ2:3PZMQ_9^I,JG;>Z9*P,5RHZ%E&U
M^.C*RYZU^SOPA^ O@'X":7?Z=X!\-V_ANROYA/<PV\LCB20+M#'>S$<>E9'Q
M>_97^%/QYUBRU7Q[X+L?$6I6<!MH+F:26-UC+;MF8W7(R21G.,G'4T >B3:Y
M8MX=?6([J*733:F[2ZC8-&T6S<'!Z$%><U^)W_!+?19OB1^W4WB<1%H=/@U+
M693CA?-#1+_X]<"OT>_;2\6:'^RW^Q-XGT[P_$-*MO[._P"$>T6T$SN8VG!C
M"HSL6.Q"[#)X">U>*_\ !&_X"S^"/A'KGQ(U2V,5]XLF6"PWKAA90EAO'H'D
M+?A&I[T ?H?1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M(QM),3XPS=*U?#?QKNF^"U_\0?&?A6^\$BRCGFETBZ9GN0D9*KP\<9#.1P"
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M'C+X?VNC[;;PU;Q22ZQ]JW"65PA\KRM@VX+.,[CRAXYII-["O8]2HK@?A?\
M$;6_'VH^*HM4\&:AX4L])U!K.QN-0WJVI1@L//5&C3:I 4\%A\W7CGOJ&K:,
M$[A145U<"UMI9BDD@C0N4B4L[8&< #J?:N*^#?C[6_B5X-&M:_X/O/!%ZUQ)
M$NEZ@[M-L7&)#OCC(R<\;>@SGFBVEPOT.ZHHHI#"BBO-_P!H'XS6_P !_AM=
M>*IM..KR1SPVT%CY_D>:[M@C?M;&%#M]TYVXXSD-)MV0F[*[/2**J:5=3WVE
MV=Q<VQLKF:%));8MN,3%02F<#.#D9P.G2N*^+GQDTSX1P:%'=6ESJ6J:[?QZ
M;IMC:@;IIG95Y8_=4;AS@GD8!H2;=D%[:GH%%%8GC;Q!<^%/"&LZQ9Z5<ZY>
M6-K)/!IEFK-+=2*I*Q*%5CEC@9 .,YP:0S;HKF_ASXFU+QEX)TC6M7T&?PQJ
M-[#YLVDW+LTMM\Q 5BR(<X )!48SBNDH **\W_:!^,UO\!_AM=>*IM..KR1S
MPVT%CY_D>:[M@C?M;&%#M]TYVXXSD=[I5U/?:79W%S;&RN9H4DEMBVXQ,5!*
M9P,X.1G Z=*=G:XKJ]BW1112&%%>6>./C@?"/QH\$?#NUT3^U+OQ''+/)=?:
MO+^QQ(&._9L;?D))W7[M>ITVFMQ7N%%%%(84444 %%%% !117EGCCXX'PC\:
M/!'P[M=$_M2[\1QRSR77VKR_L<2!COV;&WY"2=U^[32<MA-VW/4Z***0PHHH
MH **** "BBB@ HHHH **** "BBB@ HHKE_BAX[@^&/P\\0>*KBW-W'I5G)<B
MV#[/.8#Y$W8.W<Q S@XSG!Z4]] .HHKBO@S\1)?BQ\,M"\6S:5_8CZI&\HL?
MM'G^6HD95._:N<JH;[HQNQSC-=K0U9V8M]0HHHI#"BN ^*?QBTSX6WOA?3;B
MTN-1UCQ+J,>FZ=9V^ &=G16=V/W54."3S_4=_3L]Q7"BBBD,**Y?XH>.X/AC
M\//$'BJXMS=QZ59R7(M@^SSF ^1-V#MW,0,X.,YP>E4O@S\1)?BQ\,M"\6S:
M5_8CZI&\HL?M'G^6HD95._:N<JH;[HQNQSC-.SM<5U>QVM%%%(84444 %%%%
M !1110 4444 %%%% !1110 4444 ?)7Q\TZ#XI?MA?"WP1=@7&EZ=IUSJ5Y#
MVPX?*GZ^1&/HU=#^Q[K=WX1F\8_!W6I6?4_!M\S6+R<&>PE;=&P&.Q8-])4'
M:L;X)[O'7[:GQ?\ $[*)+;0[:/1(3VC?*H<>^;>7_OHU9_:3)^"OQJ\#?&.V
MC_XETI;0=>"Y :)U)B=L>G/./^6:=>E=._[OR_$P_O\ F9?P*U"W\2_M3_'/
MXA7T\::9H:#25NG/R1QQG:[ ^@6TR2/[WO6;I?Q8^/G[2>I7^I_"TZ9X)\%6
M\S06FHZM$C/=[>K'='*2?]U !G&2036#\$_">JW7[#'Q*UFTAEEUKQ,U_>,R
M [IHEPCJH[CY)O<[B*])_9G_ &B/AAX;_9[\,VM_XMTK1KK2;(0WEC<S".<2
M!B6*Q?>DW$[LH#][US525KM*]M!+HF[=23X$_&KXB:OXI\7?"WQ[!8V_Q"TN
MP:\T_4%"K!<J0H4L$&T@&1&RHY4L"H*FO&OV8_#OQ<\5?'#Q9XU;QCI306&K
M1Z;XGU"2-?\ B90PD!D@S!A5V1J,CRR 5Z=NL^#WC";X@_%GXL_'Y=.DMO#&
MCZ)-9Z5]J0J9O*C5RQP>2%B)89X\X#M6M^S%!:W_ .QKXIT_0M7M-3\7ZG8:
MK>W5K;3H]Q#=2I)'%YB EE+".,C(Y[9H?NWT["7O6U[B?\+@^-G[1FO:F_P>
M_LSPKX+L+AK6+7]6C5C>.O4@-')P>,!4.-PRV>!UOP#^,GC^W^*6I_"OXK+8
MS>)8;+^T;'5+':J74>0"I" +G!+ [5X5@1TKY9^"/P7^ 'CCX;V^J^+_ (A:
MAX<\20%TU#3Y=1M;8*P=MIB22%F<%=I^4MSG..E>Y_L?_"GX4MX\U7Q5\/9O
M&E_%HV^Q75-;^SK871D&#Y(5%D8@#/S!<!AD<BG*,4FK?A^H1<FT_P!3W^'0
M_B4WQLGU.;Q#IJ_#,6>R'1HXU-TUQL4%V8PY W;CQ(>B\<FO1JR/#/B[0O&E
MC)?>'M:T[7;*.0PO<:9=QW$:R  E"R$@, RG'7##UK5DD2&-I)&5(U!9F8X
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M1QY4ACPR!@0.QYW_ -@_PF?#_P"S]IVISH/M^OW=QJ<\A'SOES&F3_NQ@_\
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MPSM[7Q-J<VE>-]/$J_:?#NDV:2W"*6 QB.%7/7JC/C&3P#6[\:+N;XC?M3?
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MHJ[=OPN2V[)'TC\'_P!HO6/&W[-?C'QEX@AMK/6_#?VZTFDM2/+FEA@6174
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M_ *:+X^UO3]6EM?*M],ATU%$=I:QQ*JQLPBC+-D').[H#N.37C7[2#Z-X?\
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MP,&O0/V]-/U'4/V;-=^P*SQP7-K/=JG4PK*,G'<!BC'T SVKYMTWX&_LO2^
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M^T;\/8?"7[/OP"TW6?MD'A6SN(EUV6R4&6$SJDDC)D$;@#<;<C&<<&L?Q?\
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MBG\5?M >&?ASX@\9W'@#P)/IOVN:^CD\I+J9FD&'<D*%^15&\E5.2>HKY_\
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M9I(L, ?UKYX;X ?LZWWQ T?P=X=\3>-_&6L:E+Y9;P]<65Q;VR@\R2RF%5V
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M!^?? /PA^&/C7XD?$73?BWXPOO"/BFTUNX9 U];VD%PA=BS>9-&REMW/49#
M@'FO0/@S\$_@5JOQSTNQ\#ZOXW\3:AH,T6K-JD;VK:5$\3AT623RD<Y95'R
M@YX/!(IQC%6_3]2>:3=_U/>OCMX\^+$WB^P\%?"OP\\5S+!]IO/%.IVK?8;<
M9XC1V4HS]"?O'G 7.2/.]"^)WQN^#/Q@\%^%_B=J^A>+=,\57/V.&33A''+
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M_9[L=+UGQ)IV@:OIDUR^H6][((I96:9V5T4_-+^[*+\H)RI&.*SOV<_%]O\
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M9^\K#;LK)FQXJ^)/[0W[.E]H.N?$#7O#OBSP[J%]':2V%FL<<J[LDA2(8FR
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MO'VF?%?PO\,/A[=:3H6KZQ9_;GUK5RFQ07D18UWAES^Z8D;&8Y4 =<U;X_\
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M[=^-=7D\,B0#5]3^SC2YGEC:(HA$:R,VV1R.%'RYZ$9TE&,4U^GZF<7)M/\
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MB_>!QCW-=/12NPL@KQ[6?V0O@_K^MR:M>>![,WLCF1_(GGAB9B<DF)'"=?\
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M+;W$4=Q;S(8Y(I5#(ZD8*D'@@CC!KQ^']COX-V^M#54\"V/VH/O"--.T&?\
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MTK6N3RK>QRWA/X8^&O VN>(M8T33?L6I^(;@76IW!GED-Q("Y!P[$* 9'X4
M<]*2Z^%_AF\^(EIXZGTTR^*;2U-E;W[7$I\N$[LJ(]VP???G;GYCS7544KL=
MD<)\3/@7X$^,7V5O%_AVWU>6U&V&?S)(9D7.=OF1LK;<\[<XR>E9NB_LU_#3
MP[JF@:AIGA2WL;S07>73Y(9IE\MWQN=AOQ(QP/F<,>!Z"O3:*?-*UKARK>P5
M\B_ ;PCH?QM^+GQ]UWQ!80ZWI%WJ<>C0QW*[D>.$L,CN#B. J001C\OKJBG&
M7*G83C=H\]^&_P"S_P##[X1W<]WX3\,6NE7DRE'NC))/-M/50\K,R@X' ('
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M2IO0!$0L,K_> QD X)KH/%?BK2O _AS4->UN[%CI-A$9KFX9&?8H[[5!8_0
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M N8KC:=@X0$I&=H 'RJ<<UI?LQZM;7WC;X__ !2N8V>S_M22V@G;C]Q;*[L
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M%?/'[,8>W^$?[1UF=,DT&*"?4-NCO)O^PG[/,##D  E=H0D 9V5ZG^P]\.M
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M7.B^&X(;3=GY=ZVS%A_W]D'_  (U],ZOJ]EH&EW6I:E=16-A:QM-/<3N%2-
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MLC!510,EB3P !WKYI\8?LD^!OBSK$OCKP!XPN?#&J7DKN^J>&KI9K667<0[
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M &>?"/QZ^.OQZ_X2I+U_[)\22_9OL=QY7^MNKO?G@Y_U:_K74_'#]D?P_P#
M_P"&^J>._AYK^N^&]>T,)=!OMI9)EWA2AP 0?FXY(/((.<CEO@_X7^)OB7XZ
M_'K_ (5SXSLO"'D^))?M_P!LL8[G[1FZN_+QOC?;MQ)TQG<.N*]3UG]ECXI_
M%;R=/^)WQ=.I^'$=9)=.TC3X[?S]IR VU47KSDJV,#CTVE)J6LM#-)..VIP_
M[2?C:Z^(WP+^!'B6^B$-]J.KVLUPJC"F380[*.RD@D#T(KW#]H[]H[_A6'V3
MPIX4M/\ A(/B1K&(M/TN%?,\C=P)90/S"GKC)PH)KRS]OK15\,_#7X9:5X>M
MTMUL-9AMM/MQC:FR$K&O/&.!UKCO%WP=\<?LLW'A[XU'5YO%NOK.W_"712'<
MK1S$ A&QG:/N;CT;80 .!*49)7\QMM-GT#^SG^S6GPSDG\7>+;G_ (2+XE:K
MNEOM4F;S/L^_[T<1/MP6'7H,+Q7O%8?@CQII/Q$\*:9XBT.Y%WI>H0B:&3H1
MGJK#LP.01V(-:>IVLE]IMW;0W#VDLT3QI<1_>B8J0''N"<_A7-)N3U-XI):'
ME7BC]K;X1^#M=FT?5/&EI'J$+^7+';V\]PL; X*L\4;*"#P03QSFNKU7Q)X5
M\??"O6M1CUJ.Z\*7FFW*W&I:>_F;(/+82LN WS*N[C:3D=.U?'OP]U3Q'^RE
MH-_X6\<_!=O$^C?:9))/$NEP+<BX1CUD)0AACH'9"!P1UKTCX.S_  TF_9S^
M*A^&>I:I-ITUG?75WIFJD![&5[9\*JA0 I50 06SLZD@UM*"6J,U-O1G?_"_
MQE\,/@O^SGHFJZ5XDNY_A[:O-';:O?6TKS.SW4FX,B0JW$I=1^[' 'U.GX@_
M:P^$OA;Q))H6I>-;*+4HY/*D2.*::.-\X*M*B%%(/!RPQWKY6UC_ )1BZ%_U
M^M_Z<YJ]\\9?!OPGH?[(.N:;'H5B&M/"TU[YXA4RM=1VQE\XN1N+&1<Y]\<#
MBAQC?7N)2=M.QW'CC]ISX7_#G4+>QU[QC96UW/&LJ16Z271V,,JS>2K[0001
MNQD$'I753?$KPS#X"D\:C5X)_"T=L;QM2MPTR>4.K ("Q(((( R"",9%>+_L
MB?"7PK+^SAH$E]H=CJ5QKEM)+?SW<"R/,&9E5"Q&=JHJJ .!CCK7D7P94P_L
M#_%&VWLT5M<:E#$&.=JA(CC\R3^-+DCLNC*YGU/M?POXGTSQIX=T_7=&N?MF
ME:A"L]M<>6R>8AZ':P##Z$ UY?\ $/XG>&OB3\"OB[_PCFI?VC_9.CZI87O[
MB6+RIUM9-R?.J[OJN1[UI_LO?\F\_#__ +!$'_H-?./P599/@/\ M0,I#*UU
MK9# Y!'V62E&*N_(;EHO,]Y_97U*TT?]F'P3>W]U#96<&FEY;BXD$<<:B1\L
MS$X ]S4$O[:7P7AU#[&WCFW,V[;N6RNFCS_UT$6W'OG%>=:#I_@[5/V$/"]O
MX\UV]T#PR;*-IYM/E"33,)7*1*"K;R6 .W!^Z#T!K&U3XP>#_%'P[N?#G@KX
M"^(==T0V+01W,^C1VUJB^60LGG8?!'WMYP<C.>]5RJ3;?<GF:2/6_P!I;X]:
M7\._@K<ZSH_B**VU76;8C0+RWB-PD\GRG*L%9!\I)RV!7(Z/\4_AU\;?V4[N
MR\3^+;YK/3M'TV#Q1J$%O-]IM[@B/)RT+>8QE0@LJN.I[YKS+P&JWW_!-W6W
MN56=[6.\6!I!N,0^U9PI/3J>GK7>_$K3[6S_ ."><$D%M#!)-X5T=Y6CC"EV
MQ;<L1U/)Z^M5RI:>8N9O7R/?/!.H>&?"7PB\.75EJP'A&QT:U-KJFH,(MUHL
M*"*20LJX)3:3E5Y/0=*XS2_VQ/@YK&L)IEOXYLQ=.X16G@GAA))Q_K7C"8]]
MV*\!^+BR>*/AG^RKX!GFDBT/Q)#IXU!8B09%C@M%"_E,_P"(![5]*?$CX(>!
M]=^%>K^'W\,Z9;6,5A+]E^SVB(]JZH=DD9 RK @'/?D'()!SY8KXNI7,WL=7
MXX^(WAWX;Z5::EXBU$:?97=U'903"&24/-)G8N(U8C.#R>/>N#U3]KKX0:/X
M@?1;KQQ8K?)(8G\N*:2%6'!!F5#&/^^J^/?$?B/4_&/[ /A..]N6EN;/Q1'I
MT,\C$MY:B7R\G_9#!1[**^O/B=\%/!.C_L^>*- M?#FGQ6-CHEQ) RVZ"598
MX69)=X&3)N4,6ZD]>M-PC'XA<SEL>PVMU!?6L-S;31W%M,BR131,&1U(R&4C
M@@@Y!%?._P"W]_R;7K/_ %^VG_HX5T'[%NHR:I^S'X&FE9F98+B %CD[8[F:
M-1],*,>U<_\ M_?\FUZS_P!?MI_Z.%3%<M1+S*D[P;\C>L_VK_A-X733/#^I
M>-+.#5(;>*&6-8II(XW"#*M*B%%(/!RW!&#S7LD6KV,^EKJ<=[;R::T7V@7B
MRJ83'C=OWYQMQSG.,5YGX)^ ?@2'X/Z9X6D\-V%SIUQI\:W,DD"F::1D!:5I
M,;MY8DA@>.,8 %?/'[/MYHFK_LG^/O"_CSQ!?:5X2T/6)]/;4[>4))]GS'((
MD)5LDN3\H!)$@7'-/EC)70N9K<]SOOVS_@QIVH-92^.;5YE;:6@M+F:+.<?Z
MQ(RA'OG%>J:=XOT/5O#,?B.TU:SFT&2 W*ZD)E$'E@'+ER< #!SGI@YZ5\H:
M#\8/ ESX'MO"W@+X%>)?&FC);BV$LVBQQV]P",!Y)\-R^"2Y YY^G-_ /X>Z
MU\5?V'?&?A/1;C['J<VLS+;132X4^6UO*82V. VUAG@9;GC-4Z:M?82F_4^@
MK?\ ;*^#5UJXTU/'5H+DOLW/;7"0Y_ZZF,1X]]V*]>EU2S@TUM0DNX([!8O.
M-TTBB(1XSOW9QMQSG.*^%;SXJ:1X;^&Z_#[XP_!'4?"VF"T6Q;6M'LXV0.%"
MK/&S*%#AOFR'?GL<X-W]IOQ-I.G_ +*WPY\/> M4U+6/"6L7T=FMRN7N9[>/
M<1;D;5^8/M 4@?ZH#M0Z>J2%[31W/H&']L;X-W&M#2T\=67VHOY8=H)U@SG'
M^N,?EX]]V*]<N-4LK737U&:[@AT](O/:[DE58ECQG>7)P%QSG.,5\>7?CSP]
M=?#]_!W_  S-XYCT8VWV=57P\?,3Y<"0/MW>9GG?G.><UY?KVL^-=,_8W\,^
M"?$ECK&@2WGBM=%/]IVKVTIL0@F48< E=[8!Z?NBO04>S3V'[1K<^L+G]JSX
M3^+%U/P_I?C2SN-5FMI8HHVBFC25RA 5)'0(Q)X #')Z5S_[ /\ R;7HW_7[
M=_\ HXUVWC;X!^!+CX/ZGX6C\.6%OIUOITBVSQP*)H'5"5E5\;MX8!BV>3G.
M037$_L _\FUZ-_U^W?\ Z.-+W>1\H]>97/HN21(8VDD94C4%F9C@ #J2:\;O
M?VQO@WI^L-IDWCFS-TK;"T5O/)#G_KLL9CQ[[L5S'[?7BJ_\,_L[W\=A*T)U
M2]@T^=TX/E-N=AGW\L*?9B*]+\,_ 3P-X;\ VWA(>&M+N]-2V6"X,UHA:Y;;
MAI')!)8GG.<@]#P*A1BHWD4V[V1T&M?$+P[H'@F;Q?>:K#_PC4, NFU&W#3Q
MF(XPZ^6&+ Y'W0:X/Q!^UO\ "/PO-:0ZCXTM8IKF&.=(X;>>9E1U#+O"1MY9
M((.U\$9Y KY9\*R3^'_V>_VEO J7,MQHWA?5);;3Q,V61#.Z$>P/DAL>K,>Y
MKZ0_9L^#?A.Q_9]\*PW7A_3;V36M)AO;^:>W61[EIXQ(=[,,G <+[8XJW",5
M=DJ3EL>P^&_$VE>,-%M=7T34+?5-,NEWPW5K('1Q]1W!X(/(((/-4/B-_P D
M]\4?]@NZ_P#1+5\]?\$^;@6WP^\:Z)&'^S:9XFN4@WONVQF.,!1]"A/N6KZ%
M^(W_ "3WQ1_V"[K_ -$M42CRRL4GS1N?$'[)/[)/@'XS?"&+Q%XBBU%M2:^G
MMR;6[\M-J;<<8//-:?QP^%D?[%UUX4\=_#K7=5@LYM4CL+_0;JY,L=VI5I.@
MQE2(V4@YP64@@UF?LD^"/C3KWPABNO OQ&T[PQH)OIU%A=:9#.XD&W<VYHF.
M#QQGM7L>C_LF^*O&'C31_$7Q=^(<GC1=)F%Q::1:VJP6OF @Y8#"XRJY 0$X
MP3BNF4K2?-+3L81C>*LM2OXW_P"4B'P^_P"Q3E_G?4SXV?&SQ#\5?&,OP@^$
M$OF:H^4USQ)&Q\G3HLX=5<=&'0L.<_*N6/'"_M4>'?%/B[]LCP?HG@[41H^L
MZAX7%O\ V@6VFW@:6\$S@]<^7NQCGGC!Y"^&]/G_ &#OC-9:=>7DVH?#'Q='
M'$^I7"C?:W2#!=\# P221_<?/)0U*2LGUL.[NUTN?3OP1^!?AKX$^%4TG0H/
M,NI0K7VIS#]_>2 ?>8]E&3A1P >Y))]$9@JEF("@9)/04D<B31K)&RO&P#*R
MG((/0@UXE^VEXJO?"/[./BRYT]Y(KFY2&Q\Z,X*)+*J2'/NA9?\ @5<^LY:]
M3?2*-*;]K;X0V_B3^PG\<Z?]O\SRBRI*;<-G&//">5U[[L5YS^PW(OE_%M]P
MV?\ "6W1W9XQZUZ%\(_@7X'L?@AH.@2^'-.OK.^TR&2]>XMU9[F22(%Y&?&[
M<23@@Y7C&,"O"_V1M T72OA'\:M$U?5Y](\/VVLW5G<ZDDPBEBMUC",V\@X)
M4=<=^.:UM'E:1G[UU<]PU[]L3X.>&]4ET^]\<6AN8W*/]DMKBY0$'!&^*-E_
M6NMNOC;X'M?AQ-X]/B&WF\)0E1)J5LDDRH6D6, HBE\[W4$;<C/.!7S5\/\
MXO?#/PYX,@\+_#GX1^*?B#8PAHVOCH4;I> L=SRS%<L22!\R  $#C&*TOV#;
M-)H/BUIMSHW]DV<?B-O^)%<$2K9'+ PG@ E-JKG SL%#II*_8%-MV-C]BO\
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MT%U^R]^T9X<\!6.L7VI> /&-M(;2RU&;SGT^[0'A&/.TX4=L[^<E<F1?A?\
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MH/3WKZ%HHI.3:2[#M9ME;4;"#5=/NK*Y3S+:YB:&5/[RL""/R)KXT\,_#?\
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M-<.@PM>Q7,\ZVOV@R(F[]WMWIC)*G.3C;TKTBUMHK.VBMX$$<,2"-$7HJ@8
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MDXWXZ\#P'XC_  W^-?B']HJ^\;7'PUM/&.C:7+);Z#8ZCJUJMK'$K8CG\LS
M[FQOPP!!89'R@#[@HIJHTVQ.":2/GGPO\1_VA[[Q-I%MK?PETG3=&FO(8[Z\
MCUB!V@@+@22!1.2Q523@ YQTJ+XN?"7QUX;^,4'Q8^%T-GJFKW%F-/UG0;Z4
M0K>Q+C:RNQ #81!R1@HIYRPKZ+HI<^MTA\NFK/F+P[\+_B5\9?B_X<\:_%/2
M['PKHWA5C/I7AZSNDN7>Y)!$KNC$<%4;K_ HQ]XUP_QR^&_QD\<?M IXD_X5
MU:^,/"&AGR]'TN_U2UCM9/E&9I(S*&8E\MA@,[4!R!@_:M%-5&G>PG!-6/FS
M3?B5^TC)?6D-U\'=&MK-I$261-:MSY<>0"0!/S@9X]JF^-7P8\;:?\7M-^+7
MPO\ L-WXACMOL.I:+J#^7'?18P"&) !QM&"5^XI!Z@_1M%+GUND/ETLV?)_B
M3X:?%W]IK6M$T[XCZ'I_@+P'IURMY=:=9WZ75S?NN0%W1L0!@D<XQN)^8XQ]
M71QI#&L<:*D:@*JJ,  = !3J*F4N;0:C8\#^/WP:\5ZKX\\-?$[X<S68\9Z%
M$UK)8:@VV"_MB6_=DY&"-[]2,ANH*C/$^+/ _P :OVDKK1=!\;>'=.^'G@ZS
MO8[V^:UU%+JYO-F0$0QLVW@MUQ@G/. *^LJ*I5&A."9\R?$SX6_$GP-\?'^*
M/PTTS3_$L>I:<FFZCH=U<);-M0( 49F50/W<9!SD$$8(-<WXB^&'QH^)_P 6
M/AIXW\4Z-I^G6NB:Q&?[#T^\CD&GVP='DGDD9_WCL548CSQ&.*^OZ*?M'V%R
M(^;_ (]_#_XB6_QS\%_$SP%H-IXI?2=/FT^XTN>\CMFP_F#=N=E&,2GH<Y7I
M@U5^('PE^(VC_$O3OC!\/+2Q/BG4--BM/$'A?4)U$<Q"("%E#!25V(N=PYC4
M@D$BOIJBESO0?(CY.\2?#/XN_M-:UHFG?$?1-/\  7@33;E;VYTZSODN[F^D
M4$!2R,R@8+#G&-Q.&.,=;\;/A3XG\6?M"?"+Q+H^E"YT+099&U"Y$\48@4LI
M'R,P9N ?N@U]"44>T?0.1'SY\;OA7XH\7_M#?"/Q-I&E_:]#T&:1M1NOM$2>
M0"RD?*S!FX!^Z#7>^-=<^)5K\3/"NG^&/#^FW?@R?YM;U:\D7S;<;C\L2^<K
M9VCKL<98>AKT:BES;#Y0HHHJ"@HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
F*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>syre-20250331_g5.jpg
<TEXT>
begin 644 syre-20250331_g5.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" )8!<L# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBJ&N:[IWAK2Y
M]2U6]@TZP@7=+<7,@1%'U/\ +O3WT0XQ<FHQ5VR_17DL?[5OPIFN_LR^+H1)
MG&YK2X5/^^S'M_6O5+.\M]1M(;JTGCNK69!)%-"X='4C(96'!!'<5<J<X?$F
MCIK87$8:WMZ;C?NFOS)J*Y7X@?%+PO\ "VRM;OQ/JJZ7!=2&*$^3)*78#)PL
M:L< =\8Y'K5WP7XWT3XA:#%K7A^^74=-E9D681O&=RG# JX# Y]1Z'H:7)+E
MYK:$/#UE259P?(]+V=K^NQNT5Q/Q ^,_@[X6W5G;^*-8_LR:[1I(5^RS2[U4
M@$YC1L<D=:YBW_:T^$]U,L2>+4#,< R6-TB_BS1 #\:N-&I)7C%M>AT4\OQE
M:"J4Z,G%]5%M??8]=HJKI>J6>M:?!?:?=0WME.N^*XMW#HZ^H8<&K58G"TXN
MS"BN(\=_&SP3\-+R.T\2:_!IUW(N];<1R32;3T)6-6('U%:G@?XB^&_B1ITE
M]X;U>#5;>-@DGEY5XR>0&1@&7/;(YQ5^SFH\S6AT2PM>-)5G3:@^MG;[]CHZ
M**X[XA?%[PE\*_L'_"4ZM_9?V_S/LW^C33;]FW?_ *M&QC>O7'6E&+D[15V9
MTJ52O-4Z47*3Z)7?W'8T5@>"?'FA?$;0UUCP[?C4=.:1HA,(GC^9>H*NH8=1
MU'>N-\1?M-_#3PIKE[H^J>)1;:C9R&&>$6-S)L<=1N6,@_@:I4YR;BHNZ-H8
M/$U*DJ4*<G);I)W7JNAZC117G%C^T1\/-2\7+X8M?$<<VMM=-9K;K;3[6E!(
M*B39L/(/.[![&E&$I7Y5>QG2P]:LFZ4'*VKLF[+S/1Z**\@E_:V^$\,CQOXK
MVNA*L/[.N^"/^V5.-.=3X$V70PN(Q-_84W*V]DW;[CU^BN"\$_';P'\1-0%A
MH'B2VO;T@E;:1)()'QUVK(JEOPS7>U,HR@[25C.M1JX>7)6BXOLU9_B%%%%2
M8A1110 4444 %%%% !1110 45D^*O%6E^"?#]YK>M77V+2[0*TT_EO)L!8*/
ME0%CRPZ#O7F?_#7?PE_Z&S_RFW?_ ,:K6-*I-7C%OY'91P6*Q,>:A2E)>2;_
M "/8J*YGP/\ $KPQ\2+.:Z\-:S;ZK'"P658\J\>>FY& 8 ]B1S@^E<AK7[4G
MPP\/ZQ?:7J'B;[/?V,\EM<0_8+IMDB,59<B(@X((R"10J523<5%W7D.&"Q52
M;IPI2<ENDG=>JL>JT5YSX1_:'^'?CC5(M-T;Q1;3WTS;8H)HI;=I&_NKYBKN
M/L.37HU3*$H.TE8QK4*V'ER5H.+[--?F%%%%08!1110 4444 %%<AX^^+?A'
MX7K;'Q/K<.EM< F*,QO+(X! )"(K-CGKC%8-W^TI\-['P_8ZW-XD"Z7?2R06
M\XLKEM[QA2Z[1'N& Z]0.M:JE4DDU%_<=M/!8JK%3ITI-/9I-W]-#TVBN)\<
M?&?P=\-[72KCQ'K']G0ZHC26;?99I?-50A8X1&Q@2)UQU^M=M4.,DDVM&82H
MU*<8SG%I2O9VT=M[=[=0HHHJ3$**** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HKSSQQ^T#X!^&^N
M'1_$>O?V=J(C6;R?L=Q+\C9P=R1L.Q[UC6/[67PGU&Z2WB\7PH[D &>SN(4Z
MXY9XPH_$ULJ%62YE!V]#T(Y=C:D%4A1DXOKRNWWV/7**YOQE\1?#OP_\.IKV
MNZDMGI#NB)=)&\RL7&5P(U8D$#KC%:'ACQ-IOC+0;+6M'N?MFF7B>9!/Y;)O
M7)&=K $<@]16?+*W-;0Y71J*G[5Q?+>U[:7[7[FI17G&G_M$?#[5_%B^&M/\
M0?VAK33&W6WL[*XF4N.N'6,H5&#EL[0!G.*]'IRA*'Q*PZV'K8=I5H.-]5=-
M:?,**X/X@?'+P1\+M4M].\3ZW_9EY<0_:(X_LD\NZ/<5SF-& Y4\$YXKG+;]
MK;X37<RQ)XNC5F. 9+&ZC7\6:( ?B:M4:LES*+MZ'33R_&58*I3HR<7U46U]
M]CU^BL+7_'&A>&?"<WB;4-1B308HTF:^A#3H48@*R^6&+ EAT!ZUYQ_PU_\
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M10 4444 %%%% !1110 4444 %%%% !1110 4444 ?"'[4W]B?\-3:-_PDO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M5JJ5E)_>=4<QQL(\L:TDO\3_ ,RKI>EV>BZ?!8Z?:PV5E NR*WMXPB(OH%'
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MT_9.3Y;WM?2_>W<\\U3]G_P%K'C/_A++C0=OB'STN?MMO>7$)\U<8?:D@7/
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M?\*L\3?]%B\:_P#@'H?_ ,K:]'HH]K+LON7^06/./^%6>)O^BQ>-?_ /0_\
MY6T?\*L\3?\ 18O&O_@'H?\ \K:]'HH]K+LON7^06/./^%6>)O\ HL7C7_P#
MT/\ ^5M'_"K/$W_18O&O_@'H?_RMKT>BCVLNR^Y?Y!8\X_X59XF_Z+%XU_\
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MHH]K+LON7^06/./^%6>)O^BQ>-?_  #T/_Y6T?\ "K/$W_18O&O_ (!Z'_\
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M_P#Y6T?\*L\3?]%B\:_^ >A__*VO1Z*/:R[+[E_D%CSC_A5GB;_HL7C7_P
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MQZ=XKU?PH\;EGFTB*SD:48QM;[3;S# Z_* ?>N7_ .%6>)O^BQ>-?_ /0_\
MY6UZ/16D:CBK*WW(1YQ_PJSQ-_T6+QK_ . >A_\ RMH_X59XF_Z+%XU_\ ]#
M_P#E;7H]%5[679?<O\@L><?\*L\3?]%B\:_^ >A__*VC_A5GB;_HL7C7_P
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M "MH_P"%6>)O^BQ>-?\ P#T/_P"5M>CT4>UEV7W+_(+'G'_"K/$W_18O&O\
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M_*VC_A5GB;_HL7C7_P  ]#_^5M>CT4>UEV7W+_(+'G'_  JSQ-_T6+QK_P"
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M%B1PQ-O9Q29'48<#U!KLJ*3J2:MI]R_R ****R&%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MP2VW!!*JQSP >:_:X^ OQ4^-&L^(]-M?AM\*_&6@WMK]FT77M;DFM]7TG=$
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MU&/*@HHHK(X@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BN0D^+W@N._\ %5DWB?31<^%;=+K7$\\?\2Z-E9E:8]%^5&.#
MR /<5POP6_;(^$'[0?B&\T+P-XQM]5UBU5I#92P2VTDD:GEXQ*J[U'?;G'>@
M#VFBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M FC,X&3%N&X#UQUH FHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M]:]/%8>$/<@]4CU^(Z.$P&(CA:3DY0BD[VMW_)_(^JJ;)(L,;.[*B*-S,QP
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M;K4/[6N;#3;:UEU DG[2Z1*IEY)/S$%NIZ]:WJ /S)_X:%_X* _]$>TG_P
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M#V<.QJ_V[_TP_P#'_P#ZU']N_P#3#_Q__P"M6511RH/9P[&K_;O_ $P_\?\
M_K4?V[_TP_\ '_\ ZU>+>%?VHOAAXX^*VI_#;0?%4>I^,]-,PN]/@L[@K$8B
M!*/.,?E$J3@X<\\=17JE'*A>S@]C5_MW_IA_X_\ _6H_MW_IA_X__P#6K*HH
MY4/V<.QJ_P!N_P#3#_Q__P"M1_;O_3#_ ,?_ /K5E44<J#V<.QJ_V[_TP_\
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M^^V[_DV;<=\]<U;K)T+_ );_ / ?ZUK5R2T9X<THR:04445)F%%%% !1110
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M-7\">#+;1=4NHA#)>R7-Q=S",$G:CSR.8P<\A,;L+G.T8=BW%MW/FG_@F/\
M#G^P?$7QJU;_ (2CQ)J/V'Q;J&A_8=0U#S;6XVO&WVR5-HW71VX,N1D$C'-8
MW[77C[XL^.?VIKWX:^#O^$H_L?0_#L>K+9>$?&-MX7N)6=AYES+<SQMYT: [
M/+7 &-V1SG[<^'/PA\)?"7^W_P#A%-)_LK^WM2EU?4?])FF\^[DQOD_>.VW.
M!\JX4=A7-_&C]EGX6?M"7FGW?C_PA;Z]>Z>ABM[L7$]K,L9.=ADA=&9022%8
MD LQ !)R6TL+E?+9'R3XV^)/Q$B_8-\)_$[7_B$NA?$;PMJ8-K=Z-K<=Y8>(
MRMSY:VLXLI7AN2Z+R#G#1/NV*TAKFY/B9XOU+_@G%\5/BT?B9KEYX_UC5;<W
M8L-3N($\..FIP1_8K:/<#;?NI<L%P66502RA6/W-J?[./PWUA?!$5SX5MC:>
M"I?.T&QCEECM+.3C#^0KB.1@5!#2*Q!R1R23Y;^T-^QCH_C;X._%70?AO8V/
MASQ7X]N+.[O[B]OKI;&::*\BG>1HE\Q(W(1_FCC!);GJ32LQ.,CQG3;KQ?\
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M#_J_.C20).0 %)E5BRJJDE0 -[XP_LQ_##X^66DVOCKPC:ZU%I619,DTUK)
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M0O\ EO\ \!_K6M63H7_+?_@/]:UJ\R6Y\=4^-A1114F04444 %%%% !1110
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M&MZ3\3[7Q?H>C6^@Z:MC=Z7XBNSI]M<1K+))D7><1L?,*X9<< [J ,#]G?\
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MW@FUU3]G'QYJBK(U[%;0R_?)7:DR?P].F:ZK]C?5#K'[+OPVN"=Q728X,_\
M7,M'_P"R5V2E>C'[CU:GOX"F_P"64E]^OZGLU%%%<9Y1B1Z/=KXMFU0SPFT>
MV$ AVG>,'.<].N:VZ**=[B"BBBD,S=%T&UT"*>.U,I6:0ROYLA?YCU/-:5%%
M, HHHI %%%% !1139(UEC9&&588(]C0!S_@#_D5K7_?E_P#1C5T54M)T>ST.
MT^RV, MX-Q;8"3R>O4U=JI.[N):*P4445(PHHHH **** .<MX[D>/+J4V<JV
MC6:Q+<<;"P;=CK[_ *5T=%%-NXEH%%%%(84444 %%%% !1110 4444 %%%%
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M,/@AX US7T*:WJ6@V-W>AA@F9X$9R1[DD_C7>4R&)+>)(HD6.-%"JBC 4#@
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M_MH]*BL+>/XA72WNN:^ZA&\M+!+82KL8"-9&E="LF>,/Y?(_L1_"?QM^S?\
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M='V-J/[2/PYTGX>>&/'-UXB\KPMXFNH++2;_ .PW)^TS3;O*7RQ'O3.QN74
M8Y(KG_%7[9WP;\%?$"Z\#ZQXR%KXLM[VWTY]*73;R64SSJ&B1=D)#Y!'S*2
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M+M)$]%%%9F 4444 %%%-DD2&-GD9411EF8X 'J30 ZBD5@ZAE(92,@CH:6@
MHHHH ***I7>M:?8Y^TWMO!C_ )Z2JO\ 6GN-)RT2+M%<O>?$KP[9YSJ"S-Z0
MHS?KC%9[?%."Y.W3M'U"_/;;'@?IFK5.;Z'3'"UY:\C_ "_,[BBN&_X27Q?J
M'_'IX<CM5/1KJ7^F11_9?CG4!^^U6RT]3_#"FXC]/ZT_9]VBOJS7QSBOG?\
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M8!_FB0X8$<4 ?"W_  Q+^VA_T<D?_!U?_P#QNO0OV?\ ]E7]J/P#\8/#>O\
MCOXY?\)3X3LII'O](_M2\E^TJ8G51M= IPQ4\GM7W910 5@>/?'.@_#7P?JO
MBCQ/J,.E:%I<)N+J[N#\J*/;J220 !R20!R:WZ^>/VTOV5-1_:Y\":/X3@\;
MR>#M,M;TWMVD=A]J^V,%*QJP\Q,!26/?)(]* /ECP_X?\9?\%//C9X>\<:YI
M$_A7]G[PC>--I-K>#$^M2*PRWON**&8?*J@HI9BQJY;@VG_!:RX-[P+C0/\
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MO[W_ )G#3?\ !2SPZOW;"%/]XN:HS?\ !3+15^Y;6O\ WZD/_LPKV&T_8#^
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M+_K+[5'_ -T0K_[)6;GA?+\3CE+)WJYW^4OU1D-_P4.T;MK/AP?\ N#43?\
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M6<&O3_\ 7/3Q_5Q7NT6@:9#_ *O3;2/_ '8%']*LI9P1_<@C3_=0"N/GP_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3;2UNKBYAMHHKBX(,TJ( TF!@;CWP*LT44#;;W"BBB@04444 %%%% !1110
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M7CWQYJ=_I:PM%:ZEJR&!]\R1G<$C5N Y(PPY H _3FBOSW^'_P#P2Q\#>,?
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M_P .COA__P!%-^)7_@WA_P#C-'_#H[X?_P#13?B5_P"#>'_XS0!]U45\*_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]NO%OB7PAJ'A>YFN["]\,W4<$PDE0(6+/&^"%! (P1N;UH \Y_X)Y_&+Q/\
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MAOJO@70?#FGZ9+>7]]XKBN)96F0L=B^6RJD81<EVR1GIQ7DOP1^(GQ)_:6^
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7F45].?L4^$?V--0^,?A?5_AUXA\36OQ!M9I)-/TCQ#(Z.[F)PPPJ>6V$+G
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M8Y7+\Y]:[^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MX8^(/Q?\9^!(G\*Z=>V>E:#X0OHYI;LW"!97D"NWR *K<L>47"CDUQ?[>S_
M%?CT?^%D?%CXA^#?$?\ 95M_Q+?#(;[)Y.7V/Q$WS'YL\]A5?]B/6/V1;S]H
M#18_A)X2\7Z/XX:TNC;7&L/,8$C\EO-#;IW7.W('!YKZY_:X\>:;\&O@WKOC
MD>$]+\3>((3;V.GP:A!&5DN)YDAB$CD9"!I-QY' (R,YH ^%_P!E>3]FEOVA
M/!'_  AWQI^*'B/Q-]M/V'2]:5_L=P_EO\LN85XQD]1R!7ZKU^?'P1^.WC[2
M?$/@JU\;Z)X+_MBX^)FI>!M672-)2)X#'91RQ/;2*1@+(7#,P.58=.M?H/0
M4444 >0_M@?\FJ_%W_L5=2_])GKD/^"=O_)E?PJ_[!LG_I1+77_M@?\ )JOQ
M=_[%74O_ $F>N0_X)V_\F5_"K_L&R?\ I1+0!]&T444 %%%% !1110 4444
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M8Y+-&I)_2@#\;_AM^T?8_M3_ /!4;X8>.-/T2YT"W9/L7V.ZF65\QVESEMP
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M8*IB*2J4/>T;:6Z2ZL]THHHKSSSPHHHH **** "BBB@ HHHH **** "BBB@
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M T?V6?VK/'7[1&JV<U]\.]!T+PQ<Z<+XZEI_C*UU*YA+JK11RVJ*)(RP8YW
M%2,$5Q7[-_PV\<^!?@G\0O#6K? 00ZSJ%DUS>7'B#Q9;7\_C&\E#+.ES,B_N
M@5) W94!_7<3S'P9_9U\8:E^V!X2^).G?!>P_9_\(^']*N+/4;&TU"UE;6))
M$=57R[;Y< LAW,!GRP<DX  /HG]KSQ9HDG[,OQ<L$UC3WOCX9U*$6JW2&7?]
MG<;=N<[L\8ZUB_\ !.W_ ),K^%7_ &#9/_2B6O._VKOV+_A7I?PM^*_Q(M]'
MNU\5PZ9J.N)<F_E*"Z$;R[O+W;<;^=N,5Z+_ ,$[>?V+?A6>_P#9TA_\F):
M/HRBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHK(\4ZU/X?TE[V&T%X(V =#)LP"<9Z>
MN/SIK70#7HJ&TDEEM8GGC$,S*"\8;<%/<9[U-2 **** "BBB@ HHHH ****
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MK\JX?"7CZ;XG?\("-0U(>(/MALS&;V78".3)G/W-OSYQ]WFOTM^&6BZQX;\
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M3^\1Y,O'^\4KO?AG\%?V)O'=PMO??%KQYX3OS\IL_$L5O;;&[YE2!HQCW84
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M9<DRVK[F#C +<X) )'0T =/^V!_R:K\7?^Q5U+_TF>N0_P""=O\ R97\*O\
ML&R?^E$M=?\ M@?\FJ_%W_L5=2_])GKD/^"=O_)E?PJ_[!LG_I1+0!]&T444
M %%%% !1110 4444 13W,5JH::5(E)P#(P4?K3T=9%5T8,K#(93D$5S?Q&M8
M;KPI=>=$LFQHV7<,X.\#(_ G\ZZ*WACMX(XHD6.-%"JJC  '0"G;2XNMB2BH
M8;N"X9A%-'*5ZA&!Q^534AA1110 4444 %%%% !1110 4444 %%%% !1110
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MAUZ*SC-VL/\  A<C+(I (0G&0.*_)6Z\-^)(?V0)-8@36/#VD^-/C;'J6CB
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M+,!T[T ?J]17Y7>"_P!J#]O+XB>%=,\2^'/A[I&J:'J<(N+2\CL[=5EC)(#
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M&FG9W*C)QDI+H>4_!2W\ _&"QMK^#4(/$_A35TEM(YT1XQYBL5)PZJP(8<'
MYYH\6?!?5OAZS?8=%DGT?[2]N)[./<4C"EEDD"C(4C(W=C^%?$/['WQ&_:Z\
M._ W2K+X1^ M.U[P3'=7+6U]<6\#NTAE)E&7F4\-D=*]N/QK_P""AC @_"W2
MR/\ KUMO_DBN^.,G&5WJNQ]$L]Q*DI+RNNFG;M=:&_JG[(OQ!UJ^BEL-$6&R
MO)YPL-U,B>2J@$,_/ <DA0,GCG%<A^TA^RS=?";3?"\.DR"^U_5K9HY;:.SD
M,/V@8 $<F[EB3C;CMG !Q6A_PNS_ (*&?]$NTO\ \!;;_P"2:AN/B_\ \%!+
MQH6G^$^CS-"_F1&2RM6V. 0&7-QP<$\CUKO_ +8JN46XJRZ6W^^_X$0SFO)\
MN);E&[>CY7M9+F6MEV/IS]G;]CVW\'_!J\TKQVT&L>*=<M=MW<")3]@4K\D<
M38SN0D$MQEAZ 5\ZW'['?Q#U#Q%J.D0Z<QL[;45L!J4J[(WC8$BY4$_,@4 G
M!)!8#UJG_P +L_X*&?\ 1+M+_P# 6V_^2:Z3PW\5OVVM0TZZN/$?P]FL]2LF
M,UI!IL%FL5UE=NR0&<YP3GD@<9ZBG@LUKT9S?NOF[]/3Y:''1KXK%S=.6(<4
M]7S2=GRJZOO?;0Z#P?\ \$Z_$MG;+'J_BW3X=UT0ZV<+R!8=O#*6V_.3V/ '
M<UXO\7_V6?B1'^T1J/A[PCX?U\>"YKVWBMM3\II+:*%UC$CE\\A69L]^#72?
M\+L_X*&?]$NTO_P%MO\ Y(KSWQ-^W;^V7X-^)VB_#S6?"FAV'C/6EC?3])DL
M8B\ZNS(A#"8J,LC#DCI7+'-,3%<JE9>6GW]RZF:XC$5/:8A\]E9)[+T7<[:\
M_P""=/Q%\)ZY8:;;KI_B'2;J2..YU2W81A%9OF\R)SNPHYX)_.M_PW_P3+\<
M6^L0VU]XHTF'19/,=[B.)VFA(<!4$><-N4[L[AC&.]9G_"[/^"AG_1+M+_\
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M7?E$%XS)LPOKG'TJ]8S2W%G#+/$()G4,T8;<%/IGO2MI<=];%BBBBD,****
M"BBB@ HHHH *JZEJ=MH]F]U=R^3;IC<Y!.,G':K59GBC_D6]4_Z]I/\ T$TU
MN)[%K3]1M]6LX[JUD\VWD^Z^",\X[U9JAH'_ " M._Z]H_\ T$5?H>X!1112
M&%%%% !1110 5SWC[_D4K_Z)_P"AK70USWC[_D4K_P"B?^AK51^)"ELSH%^Z
M/I2TB_='TI:D84444 %%%% !1110 4444 %%%% !1110 4SR4\P2;%\S&-^.
M<>F:?10 QX4D92Z*Q4Y4L,X/J*)(TF0I(BNAZJPR#3Z* $VC &.*,#GBEHH
M\S^+_P #(/B]/IL[>-?&G@V:QCEAW^$=::P\])"I(E&U@V-HP<9&3@\TSX$_
M#OP-\$_#(\ ^![2>TM+*22XG^T%Y)9IF(WRRRM]]V..?0 #  %>GUSNC?\C=
MXB^EO_Z :I=1,Z':.>*3:O\ ='Y4ZBI&)TZ<48]J6B@!, =J6BB@ HHHH **
M** "BJ5SK5A9WD=I/>0Q7,F-D3N S9.!@?6KM !1110 4444 %%%% !1110
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MQ+XQ?LC>"/CA\5?!/Q \0RZHFN^$98I=/6SN5CA+1SB9?,4H2WS#L1Q7MM%
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M\9:SJMOX \!Z?(EKIFG7'E RH8HV;D$!FDD=BV,D(HZ"N@_X)H?\G>?M5?\
M89D_]+[NL;X;>.M!_9?_ ."HWQF;XA:G#X9TGQ18275AJ>H-Y=NXE>&=?GZ
M';*N?[R$=: .V_X)?^,M>\)_$/XS_ K6-7NM:TWP3J3_ -D37;EWCB6>2&10
M3T4[8VVC@%FQUK]":_-__@F4K_$;]I;]H[XK:>CGPQJNJ/;6-RRD+/YES)-Q
MGN$$9([>8*_2"@ HHHH **** "OSO_X*/?%3XVZ_I/Q%\"^"_##:%\.=!TA+
MSQ!XPN&9/MT3QJ[6L#$ <[PK!-Q.#DJ"0?T0KP/]O7_DSGXL_P#8#E_FM 'E
MG["'C+_A7O\ P34T/Q4ZB7^Q=)UG4=C=&,5S=. ?J5Q7Q'X%_9ON/CS^Q_\
M$G]I3Q)XMUZ?XG6EY=ZE8W<=T5C1+;8[C&,\_O -I 7:F.A!^R_V,?"ESX[_
M ."6MIX<LE+WNK:#KEE H[R27%VJ#\217RI\!_VEO!7@/_@F;\3_ (=ZYK,&
MG>.(WU'38-!N05NIC<A55E3&2%+2;O[NPYQQD [OXX_MD^+]5_X)A_#_ %JW
MU:YM_%_BJ\_X1W4-4A<I,Z0&59G##D-(L*!B/^>C>M<G\8/@F/\ @G'XM^ W
MQ$\#^(M8DN-6N$L_$MK>7&Z*].(FE&T ?*RO(-IS@JA'(S6%\:_@EXA\/_\
M!*7X0:G+9S"33-:?6[N$H=T-M=M/Y3L.P^>'_OX*[;]NKXT^$_VMF_9Q\%?#
MG6(?$>NZCJ$=Q<V]GEFLC(L*!)1_"P_>$@]!&2>,4 ?K$K!E!!R#R*6FHHC1
M5'11BG4 %?/O[;'P?^)GQU^$D?A'X:^)['PK/=W:MJES=S2PM-:A6S"C1JQ
M9BI/3(7'0FOH*O!_VS/VIM,_9,^#USXIGMEU+6[N7[%H^FLV%GN2I.7(Y$:
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M3RPJ(H"@>8O  KHU^Z*B<N;WBXQY=#S?P-\.]$L]9U*Y^SM/+97C1V_G/N"
M $''<\]37I-<YX3_ ./WQ!_V$&_]!6NCJ9MMZCBDEH>2?%3X8K=27>OV5PL+
M8#W$$@.&/ W*1T/M6]\.?AC#X122[NY4O;Z= N0OR1KUP,]2>.?:M[QY_P B
MCJ?_ %S_ *BMJV_X]XO]T?RJW.7)87*N:XGV.#_GA'_WP*/LD'_/&/\ [X%3
M45B:$7V6'_GC'_WR*/LL/_/&/_OD5+10!%]EA_YXQ_\ ?(H^S0_\\D_[Y%2T
M4 1_9XO^>2?]\BC[/%_SR3_OD5)10!']GB_YYI_WR*\W^*'PQAUL3ZU:3K:W
M,,)::-ERLH4<'CH<<?E7IE9GB?\ Y%O5/^O:3_T$U<).+NB9)-:G%_"_X:1>
M&_+UBYN!<WDT(,2JN%B5@"?J<<5Z/5#0?^0'IW_7M'_Z"*OT2DY.["*459!1
M114%!1110 4444 %<]X^_P"13O\ Z)_Z&M=#7/>/O^12O_HG_H:U4?B0I;,Z
M!?NCZ4M(OW1]*6I&%%%% !1110 4444 %%%% !1110!%):PR_?AC?_>4&JLF
M@Z9-_K-.M'_WH%/]*OT4[L#&E\%Z!-]_1; _]NZ#^E4Y/AOX8F^]HEJ/]U=O
M\JZ6BGS2[BY5V.0D^$OA.7KI"+_NRR#_ -FJG)\%?"LGW;2:/_=N'_J:[NBG
MSR[D\D>QYZWP/\/_ /+.;4(3_L7 _JM,_P"%+VD?_'OKNKP?2<?X"O1:*?M)
M=PY(]CQKQU\,-2T_P[-/;:UJ.KI"P=[2=BPVCJP&>2/IZUY+;6TM[<1V]O&T
M\\C;4C099CZ 5]?UR^A6=O%XR\0ND$:.!!AE0 \H<_G6T*S2=S*5)-Z'.V/P
MR\0)8VZ/XRO[<K&H,,8)6/@?*#OZ#I4W_"L=:;KXWU0_]]?_ !=>B45C[21K
MR1/._P#A5FJ'[WC35C_P(_\ Q5'_  JB^;[WC#5S_P #/_Q5>B44>TD')$\Z
M_P"%1W#?>\6:P?\ MJ?\:/\ A3[-][Q1K!_[;5Z+11[27<.2)YU_PIN(_>\1
MZPW_ &WH_P"%+VG\6NZNW_;<?X5Z+11[27<.2/8\[_X4KIQ^]K&K'_MN/_B:
MCN/@?IDEO*L>IZD92I">9,"N['&1MY%>D44>TEW#V<>Q\HZCX5U?2]2^P7&G
MW NBQ5%2,MYGNI'WA]*]]^%7AFZ\+^%5@O1LN9Y6G>+.?+R  I]\ ?G5_6?^
M1N\._2X_] %=%6E2HY)(B%-1;84445SFP4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 >/2_L?_!>;QY_PF;_#
M;P^WB/SOM/VS[(N#-G=YAC^X7SSNVYSSFO8:** "BBB@ HHHH **** "BBB@
M HHHH **** /*OBA^RS\)OC-K46K^-/ >CZ]JL:JHOIX-LS*.BLZD%@/1B17
M?^%?">B^!?#]GH?A[2K/1-'LT\NWL;&%8H8E]%50 *UJ* "BBB@ HHHH ***
M* "BBB@ HHHH **** .0\'_"'P5\/M>UO6O#7A;2]#U;6Y#+J5[8VJ12W;EF
M<M(P&6.YV//=C69\6/V??AS\<X;1/'?A#3/$K6F?L\UY%^]B!.2%D&& /< X
M->A44 8'@?P%X<^&GANU\/\ A71;+0-%ML^58Z?"L4:DG).!U)/))Y-;]%%
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MND_]*):Z[]L#_DU7XN_]BKJ7_I,]<A_P3M_Y,K^%7_8-D_\ 2B6@#Z-HHHH
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M?\BE?_1/_0UKH:Y[Q]_R*5_]$_\ 0UJH_$A2V9T"_='TI:1?NCZ4M2,****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YW1O^1O\1?2W_P#0
M#715RF@:A'-XTU^-4F&\1;6:)@IV JV"1CJ:I;,E]#JZ***DH**** "BBB@
MHHHH **** ,'5=#OK[Q!IVH0WL<,-IG]RT6XMNX;G/<5O444[B"BBBD,****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^MZ_.']O]6\/_M\?LIZ[IY:/5+O5+;3I6C(#/!_:$*[,^A%S,.>/F/O7Z/4
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !7YV_\ !0[X6^)O VJ#XDVWQY\9^#]/\2:_
MINB1:79W<T.F:2)$"27#E)1A%2*20@*,L<9Y)K]$J^9/VO\ ]ISX!?#_ $._
M\"?%>2+Q/<7T2,_A&ULVN[F4'YHS@86-L@%69U/0@T ?.W[/^GR?"_\ ;7\
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M(U2UDL[RUE'RS0R*5=#]02*^"%_X)"Z6]]!H=Q\7?%4_PLAOC?Q^#S@!6)/
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M7_AJ[]JZ3[MAI(^FA2FC_5_&]E]X>UB?IQ17YD?\-1?M:2?=L].'^[X?D/\
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M3_AO;XQ=OV<?$7_?B[_^,4G_  WI\9>W[./B'_P'N_\ XS3_ ++Q'E_X$O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M&Z(FCJ2?_(M 'VY17Q"__!7_ .!$;LCVWB]64X*G2%R#Z?ZVF_\ #X+X#?\
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MX#?\^_B[_P %"_\ QVC_ (?!? ;_ )]_%W_@H7_X[0!]P45\/_\ #X+X#?\
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M^_B[_P %"_\ QV@#[@HKXE@_X*\? VZW^39>,9?+7<^S1E.T>I_>U#_P^"^
MW_/OXN_\%"__ !V@#[@HKX?_ .'P7P&_Y]_%W_@H7_X[1_P^"^ W_/OXN_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "JO
M]EV1Y-G;D_\ 7)?\*M44 5/[)LO^?.W_ ._2_P"%5M2T:TETV[1+.WWM"ZC]
MVHY*GO6I7Q]_P50\3:OX=_9:\C3+RXT^TU?7K'3-4N;=RC+9R%S("PZ*Q1%/
MJ&([T ==^PA\*=7^&?P(&B^*M-M(-5&JW4^R.>&Z&QBNT[XV9>QXSD5]$?V3
M9?\ /G;_ /?I?\*^%?@CX3TGX$_\%'M;^'?PXMSI?@34/ L.J:AI%O,\EO%=
M+*J)-@DX<KMY[^83WK[UH J?V39?\^=O_P!^E_PH_LFR_P"?.W_[]+_A5NB@
M"I_9-E_SYV__ 'Z7_"OFSX6_"G5M,_;0^*WB^ZL+(^&-5TRUM[*:.Y@D+2(L
M(8&)6+IRC<LHZ5]*:I8PZGIMW9W!86]Q"\4A5MIVLI!P>W!ZU^</@7X+^ /%
MG[7G@.X_9PT4^'_"WP\N9$\6^,K6[E:TU1R%Q81L[DW+D!P[CC$F<G"Y /T=
M_LFR_P"?.W_[]+_A1_9-E_SYV_\ WZ7_  JW10!4_LFR_P"?.W_[]+_A1_9-
ME_SYV_\ WZ7_  JW10!\S?M+_"+6_%OQJ^!GB'1M+M7T/P[K$EQJ]P\\,"PQ
MEH2#M=@7X1^%!/%?1W]E6/\ SYV__?I?\*_(3_@I1\>O#_QDUCQSH=]XE;39
M? 6JP:1H7A=4D#W]V)!]NOY2%V;44>5&I;./,; S@_K%\./&>C?$/P'H7B/P
M]?+J6BZC:)-:W:(R"5,8SA@&'(/4"@#9_LFR_P"?.W_[]+_A1_9-E_SYV_\
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MKYZ_9%^#NO\ PKN/BO/XPT>WTVWUCQ//J-@\LL4BO;,6VO\ *3M'/0X-?/\
M^W)\'_A=XW\9:CX'^'WA;_A(?VC/%5[!J4FK6][+G084:/=<W,N_;!'Y:[5C
M R=P.,E<U_V^/C)IFGZ%8_ ?Q9XVDTFVT_P?_:^LZHR2F;Q%>I R65G&45MJ
MR7$?G2,V!A57/)H _1.&PTZXB62*VM98V&5=$4@_0BG_ -DV7_/G;_\ ?I?\
M*^:O^":WC31?%W['?@2VTB_6]GT6W;3-0149?(N58N8SN R=LB'(R/FZU]04
M 5/[)LO^?.W_ ._2_P"%']DV/_/G;_\ ?I?\*MT4 (JB-0J@*H&  , 4M%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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ME?$3X'^!_BL^@/XHT"#4FT'4H]7T_#O%Y-U']R3Y&7=C^ZV0>XKXDN?VQ/\
MA0/[4W[3]WXP\0ZKK6E:7'I<'AKPE)J$CK/>20 B"UB)98]S<NRKP,D@\ ^U
M?$S]M#Q/\,=!^%VFW_PG:X^*_P 0)7%CX)7Q%%#';*N#B:^EA1!*=\8\O9]X
MLN[@;@#ZJ4!0 !@#@ 4M?,UK\1/'W[1GP)^*N@:EX&\6?!#X@Z;:SVUL[74N
MPS[':":SU")8UG7?'A_+. "!DAP3U'[%'QLG_:!_9E\$>,+^7SM:EM39:FY
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MSO@GXAZ'\1+.:\T">ZO+*)M@NY+"X@AEY89BDD15E7*D;HRP]^12&=)1112
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M[*@D]A0!9HK+T[Q/I>K:M?:7:7:S:A8Q0S75L%(>!9@QC#@CY6(1CM/S 8)
M##.I0 4444 %%%9'AWQ9I7BQ=1;2KK[4NGWTVG7)\IT"7$1 D0;@-V"<9&1U
MYXH UZ**R+'Q9I6I>)-3T"VNO-U;3(H9[N 1/B)9=WEY?&TD[&X!R,<@9% &
MO116/%XMTF?Q9<^&H[K?K=O9QW\UL(WPD+NR(Q?&W)9&^7.[C.,<T ;%%%%
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MD(QP"2.,XR,R,UJ*S?$?B+3?".AWNLZQ>1Z?IEE&99[B4_*BCZ<DDX  R22
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M:ZO\P.U0/ISQ/\'?"7C'5;C4=5TR66XNDBCO$@O;BWAO4C),:W,4<BQW &2
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M<E\*JJ#C%:7QDTG1/&FBV7@K4M7FT;5-=GWZ1<6\1=ENK8?:5?H4.WRMQ5R
MP! .:]!K%\6>#='\<:;'8:U9_:X(ITN8661XI8)D.4EBE0J\;CG#HP(R>>32
MOK<+:6/&]0\8:EX0\96,/Q.T[2]5U+0],U/7M#\1:+-+ DD4$(CN%GMF)\J0
MQR9SN>,[OEP5J7P3;Q?#O]D$W6N;!/=:)<:E>C;EI;B[#RF/'\3EYA&!SDX
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M^.[Y;W5[*X:[^RM92365_<6;3V[')AF,$B>;'G)"2;E&YL ;FR*6EAN)\_\
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M( RF=IP..*O>%_ ^E?#OPO+HWA'3;;2[96FGM[4L_DK-(Q<YY)"[CT' '
M I.2:T&HM,^<];U;5-0^&?Q3^)$?B[7%OK'Q!<IX<@M]3FCM(?(FCMXH_(5M
MDPFD0 I(&4A^%4LY:Q<>*+VZ\4^/[BSEU2UUGQ-XCM/#%O!H<<;WSQ6-F)+L
M0/++''$<O< 2E_DR6 +**]-^%?[/>B^#/"_A:/68?[3U_2XX[BX=+RX:R>^
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M[#X:UG4M8CM?!<\UU#J][)/;PW"3006ERL;DK"-\C@QQ;4*H1M^4$>W/\"?
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MZC2REH/WCLA6-51SCH4&/;O$GAO3/&&A7NC:S9QW^F7D9BGMY,X8=<@CE2"
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M6.C6HTMM-31HVAT^31[N?3YK:-AAHTEMW1PC8&5S@D D$@&JMY\"_!%Y;:)
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MG,^[YI)Y[F.^N)V[MM57)/8 >@%4VD:\_8UUF[($_B/X@7\^4'WI[V]O/)1
M/]B,(,=EB]!7T#X9^#_A'PAK2ZKI6E&"\C65+?S;J::*S21MTB6T4CLENK'J
ML2H, #& !2:3\'?"&A^)%URSTDI?QR33PI)=326]M+*<RR06[.8H7<YR\:*Q
MW-S\S9KG7ZD\K.;_ &A+[5K'X9V6A:-JEQI^OZ_J5CHEIJ4,CQR1/)*IDERK
M!N(DE8[6!P#S7F&M6UQIOBCXPBX\9>*?^$:\)Z);7,T;ZW<))/J+6\LQD61&
M5HQM:/\ <Q%(RS+\F JCZ-USP?I'B74M%O\ 4K3[5=:-<F\L6,CJ(IBC)OV@
M@,=K,!N!QG(YK(OOA'X2U/2?$NF76DB:R\277VS5HS<2@W4F$ )8/N5<1H-J
MD+@'CDY49)*PW%MGBW@*XU[Q[I.N1^,O%&L:4/"/A_3H_M&FWTEHWVR6P2ZG
MO)BC+YQ3>BA)"8_D<LI+<>G_ +-\VL7WP1\*:CK][<ZAJ^I6QU&XGNY&=SY[
MM*H&[HH5U 4<   5QGQ8^!>O_$C5/$L(L-!M(=:6*T.NP:I?6\PM5 Q]HL$4
MP7DL9:;8TDB@;DX7;S[AHNDV_A_1K#2[-2EI96\=M"IZA$4*H_("B35M BG<
MNT445D:!1110 4444 %%%% !7RMI.I76J0ZAHOB#Q;X@\&_&Z>>XETS^UM2N
MK;2;F5)5$"VT0)M)X&#1H4"/*09#@L-U?2GBK19?$GAC5M)@U"YTF>^M);>/
M4+-RDULSH565"""&4D,.>HKRWQ!\/_'OQ%\)V/A#Q3#X;ATQ9K=KW7;*]GGN
MYDA<.&BMW@5897*+\YFDV;F(#\5I%I$2':6VK_&#QYXBL=1U:\TWPQX8D@T^
M2UT*[FLS?:B8%EG9KB,I,(XQ*BJBLH8Y+9P!79_#_P +Z]X1NM=L+[5WUCP\
M;A9M%>]N)+B^@C9<RPS2N,R*KYV,S,^UL,QVBL&/P;XN\"^-?$>J>$H-%UC1
MO$,ZW]UINK7TUB]K=B..)I(Y$AF#K(L:DJ57!7@D' ZCP#X8U3P[I]W+KFM3
M:WK.H7#7=U)N<6T!( $-M$S-Y<2@  9R3ECR>"6V@(X>Z\7:CXJ\7^+]3L?M
M\V@^ XY(8;#3&DWZOJ8@\R1'5.9%B5D18N0SR,2"53',?!&:/3;SP=IWC"T\
M>Z;XVO\ 3VO$N/$&N7$EG?S*@:=%@2[DC4J')$<L:$  [00<:_P[TO6YM ^+
M&B:%JJ:#XJB\67UQ#<W$"S"/SC%<0ET;.8WC<+GK@MMY7C7;X:^(_'_C+3]=
M\<26>DVVDVDUO8:9X:U.Y+F68!99VN@D$B':NU40#&22QSBJT6A.NY'^T9\0
M-1\)Z/X=T'16OH]:\4:HFF12Z9&CW4<6TO,T.\A%D*@*K.0J%][$!21YSKWB
M2Z\/_#7XH:MHFN>*-*N/#D]G=_\ "/>(+F6XO=-N8F21@;DW$OG07$83]WO:
M/!;'WB*]2\2?".>PN?#&L>$YWN]8\/7TUU#;^)-6N[J.YCGA\F:,W$AFDB.W
M#*0&4%2-OSDCSO7/ NIZ]JVJ^$=3N[6]\4>-]1M=3\2+II8VVDZ1;% D*N0&
M+2"(1*S*-Y>5MH"&G&U@E<^E:\B^/E]JVGWGA.5QKX\#BYF/B"3PR9EO(P$!
M@9C ?/$(;>7,7S8"YXR#WWACQ-)XCOO$$8MX$L]-OS8P74%P91<E8T:0XV *
M4D9HR 6PT; D$$#GO$&@^--+\=R>(?#5U9ZOI]W9):7.@ZUJ$]K!#(C,RW$#
MI%,%9@^UU\OYMJG=Q@YQT9;U1Y5K7C=O!?P=^(OC'PKXT7Q+X(N-+C.AS7&J
MRW=YI^H2CRBC32Y=5W20-MD<NC;AA1BJDU]H5O%X*L/A]\0=0\7^._[0L1="
MS\67FK6TD"N@O);J$SR1I"4+_,57#,H7!Q71:E\ =?\ $&H+J-]-I%I-J_BN
MQU[6["SDD^SQVUHA$<,1\L&:1F5&>1A'GG"C KWZK<DMB%%L^9]9^+.O_!/7
MO$O@#9?>)_$>K7B7'@G[;*\YFCNBP,4TC$D1VTBODLV?+V9(R"-/X?>%]7US
MQ5?^!]8\5Z[J&G>$K2VDU:\AU>Y@N=3U6ZC\UCYR.LD=O%'C9"C*O[P%MQ7C
MTB^\ WVJ?&[2_%UU+;R:/I.B365C;EV,T=W-,IEEV[=H'E1HN=V3EN. :YW6
MOAKXPTWQ%XXD\*7>DV]CXQ:"2>^OI91<:7*(5@EDBA5"L^8T5E#21[7SG<.*
M.9!9GGOP?\:ZW\<&\.>&KS7M072]*TJ2_P!8O;&YDM;O4'-W-;V:-/$4=08X
M3*S1D%R5'0D'9T?XF^+M'^"_BFZT2*/7Y] U/6;*#7-;O,PPV=H\A2:X?F2=
MMJA 44ERH+L.6._I_P '=?\ A;J%T?AL=(^Q7^CV>E2+KDTB-926JND-P@CB
M83EEE8O&WEY9 =_S$"]X@^"4\?[/4_PV\/WZB6:W6UDOKUC'YHDG#W4C;%.&
M<-,0 ,98 D#FFW&_D"3.C^!\6K1_"'PE)KM]/J6LW&GQ7=W<W,A=VEE'F,"3
MV!?  X   X K@_B!XH\<:A\<OA_X9MXH_#WA>XU"XN99%N\WNHQVL(D)VIE4
MMR\B+M+;V/WE5?O>XPPI;Q)%$BQQHH5408"@<  =A7%3>!KZZ^-=MXOGEMWT
MNRT%],M8-Q,JW$MPLDLF-N -D42@ALG+# '7--7;9;6B1YAK6J:A\1=#^*/B
M^;Q#JFC:5X6:_L=#BTG4);1$DM(\S74VP@3DRH0$D#1A4.%.YB4\"ZY?_'H:
MSJ.N:WJFB^'-#TZUM"-%OI].=M0>TBN+J=Y(F5CY7F*BH<I]XE6^4C3D^!_B
M23PYK'@!;O3(_ FJ:M/?7&HB:0ZB;6:8SRVBP^7Y8)<LGG&0_(3^[W<BQJ7P
MA\6V</C+PUX=O-(L/"GBN]>[GU&6207VGI-$L=S%# (_+?(3Y'+ILWG*MM&=
M+HBS.6^#/C/7OVBETJVUS4KVPTW1="L;K5!I-U+I\^H:A<HS(S20E'6-8E#[
M$90S3#.0H ])^ /BZZU[X+Z5K.LW[W;PF\B>_N#EI88+F:))7( R3'&K%L<D
MD]ZQ?^%3^*O!>J>)8? =QI%EI?B"VL;<75_+*L^D&"W6U\R&)$*S_NDC*JTD
M6'4Y)!XZ'Q%\+Y]-^!%]X \%2PV,HTAM)LI[]R%5638TCLBD[B"S9"\L>U*5
MGHAQNMSA]!_:6\1ZY:>"+K_A7,D$7C%9ETJ%M6'GETC,BR2(81MMRN"902P&
M2(V&TOLZ3^T#=:LO]D1>'(7\:OKEWH<6DQZD3:,ULB23W!N3"&$*)(N3Y1;<
MP4*<YK9@^%-S!\3O!NL+/ /#OA;0)M-LK9782_:9#$A<KMV[!%%C[V<GI@<^
M2+X='P.U+P+J.K^(?"]KXUC&LW>HKKVHS6%AJ0O)UDE:*]:%E\V-Q"-A3<R%
MB0, T_=>R%[RW/8OA=\5+[Q_XA\7:-J'A[^PKOPW/#9W#"\^T)+,P=F\L^6A
M,>P1,K$ L)1E4((KBOBAX@CT3XH7<OQ!O/$>C?#]-/MQI6IZ)=7EK81W+R[)
M_MLUHRNDA+PB,RD1;0^,-G.Q^R_9ZM/X*UOQ+KD0CU'Q1K=UJX/D-#N@.V*
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M_P##7X4R:GXUU6XO]6AMY]9UNZFG:58I"&EECB!8JD48^157"X0' )-<G??
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MM5S;NKN0,EI#FM'5/V==<U[5/$%C=76EVOA/Q%K5J^IVMI+*DIT>SMT2VLT
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M[1X+8^\17=:7X;NO&G@+X2^,/"DEC/JN@V4,]M:ZC(T5O<0S6HAGB:1%=HG
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M>>(]&^'Z:?;C2M3T2ZO+6PCN7EV3_;9K1E=)"7A$9E(BVA\8;.>U^"O@#6_
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M=-;PR%NJB)0J[<Y+$C:_<ZB][H=1H/QJU2[OO",^M^$_[!\/^+9&ATF[:_\
M.NTD,;30)=6XC"PF2)'(V22;2 K8R2,&U_:6U"ZTN'Q /!OE>$I?$ T*+4I-
M2_?W.ZZ-ND\$ B.]<C+!G7'(4O@U6T#X"ZM8W<6I1>%_A[X4U'3--EBLCH6G
MQR/>7[1E4N)+A[9)+=$;!"1AV.XY<@8;8L/@7?V/A;X0^&TN[0:5X2NH=0U3
MYF+W-Q%"VPQ_+R#.Y<[B. .IH]P/>.R^*_Q*C^&.@V%Z;6&[N=0U*WTNV6ZN
MA:VZRRL0'FF*MY: !B2%8] !S7GGQ ^('B76M,T7PW=Z7?>#==O/%]AI$\EC
M=R-'<6H/VJ26TN@D9=&AB*-\JE261AZ][\4/#/B'Q)_92Z5%HFLZ,K2QZMX:
M\0(%M=2C908V,ODS,C12*& V$-N.<$*1YKX3^ 'BGPK=^&YK6^TV"WT1]9OK
M#3C>3SPZ=/=1+%;6\3/'EX8E\TEF"DF0X0#BE'EM<<KW-7P7\;IO$BVUKX9\
M.M>Z[KEUJ%]':ZEK4WV>&SMYS;_:7E:.1H5D>,!(8XR,DG@;FKD?%'QZUWQU
M8>'[/2M U31M5/C:/27TZSOP+FZ6TA$]W&S *$BWCRBV2"@9C@<52VVO[.FJ
M^'8HO$GAB#7-+\&0Z7J%EXANY[)9BLCRBXM)/*;[23*9@85 ;E!N4D5T?P)^
M$OB:-O 'BCQ$4MI;>TU;5+ZUG5H[MM2U"X$FYXB"$VPDJ1NW*QQCJ:NT5J3=
MO0B^(7QH\6:[X-UC0M'TVST/Q=_PD]KX3DGMM6>2*)IUCD,L,WV8,3L=E;Y%
M:/EADJ ;N@_%#6;'XI>(;V^MY+O2K[Q'IWA&.W34G:WT^=;(S3R1HR .#-(L
M>[:A8;3Q@BGV?P/\56-YHFHO-I%[<Q^-;[Q3J-FUW+'%(LL<D4&R3R6)>)#'
M\K( =N-PZUS/C_POJ/A+X80^&+?5+&X^+NL^*QXBTZTLYO-S<-J!E\WRV"MY
M$<"D.Q7:-C=L4>[L@][=GNO@[Q\?&GB/Q3:6=BHT?0[P::NJ>?G[3=*H,\:Q
M[>%B+*A;<<L'&/E-<5K7Q]O[73_$GB+2_"J:GX(\.W#V]]JTFI>5<3>4^VY>
MU@$3+*L6#RTD>XJP'3)]#^'_ (,L_AYX,TCP[8LTEOI\ B,TF=\SG+22MR?F
M=RSGW8UY0/@KXL_X0F[^&BWNE1^!;F^G>765GE_M-[&:=IY+;R/+$:R$NT7G
M>81L^;R]QP,URW+?-8X#XM?$?QA/XL\?>(M,CSH7@_2[6VM+>U\1WEH'N[D>
M;#<F&. +.^R6 &"4[!_>.XX[/PMXW\2?#EF\!VNA_P#"5>+=*T-=<U?^T/%=
MU<RW?)C_ -#,\+O(S>4"4Q%&CR*N?FW5<N_@'K-[H>N::\^F1Q:UXWAUV\6-
MV .F0R1&* ?N_OA;>/Y/N@EOF]4^*7P9\6_$2^U:TN5\.ZE;RW4=QH?B:XDD
MM-6\-C*$B 0PYEV,GF+F:,L3M8XQ6EXO0BTMS;NOCEJ>KS:NGA'PC)JPT.Q2
M\U;^U[TZ<T$CPK,EI&HBE+W 0G>K;%0[06R3C)L?B7KWQ"^-'@B/PYY"^#V\
M.CQ%<+)>O%+/'<D1P^9&L3#='B7$>_:Q))8% *R]>_9KN6UCQ.+#1/!FMKK]
MPMVOB7Q/8)=ZEIDC1I'-MA:!H[@?)YB O$H:0AE8#YNZ\!_#&_\ !/Q/\0:I
M'#IK>';S2=/T^Q,+>5<6HM@X\KR$B$81S*[Y1E (4;.XGW4M!^\]SE/C]XAU
MZX^('@OPII\ZV.BR1W.N:O<P:U<Z=,UK;+MD1I((BZ)F6-@5?+%2I"C#'3T/
MXW:FEEX2U*]\(R:;X.\0WL.F:;?SZFTVH#S01;2SV[1_*LF%Y\YV&]2PZXT_
M%?PCO/&?Q \2:G>W4%OH^H^$9/#5N86+7$;32.T\A4J% QY6!N.2ASBL2/X8
M^/->L/"6F:]/H-II_A01W-M_9]Q-*VIWD$92VDE#PJ+>-6Q(44RDG S@<GNV
M2'K<Z7X7?%+6/BA->WUMX9BT[PO;WUW8Q:G<:CF6[\F5XQ)%"L1!0E>2SJ0<
M@!L9,>M?&ZT\-I\2)-5T\V\7@_R"ICFWM?B:!9(@J[1M9I&\H#GD9SS6]\)?
M!<GPZ^&?AKPW/+'/=Z=8QQ7,L1)22?&964D [2Y8C(!P>:XK7O@;=^(/CLGB
MFXN[5O",D%G=W>FN6,UQJ-I]H6W)&W;Y2K<!_O$EXDXQTGW;OL/WK(QM5_:
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
C **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>syre-20250331_g6.jpg
<TEXT>
begin 644 syre-20250331_g6.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" '& S0# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/,RPM.E[5R@VX*#LM[RCKT?4VT;276<HW\EL?:-M\>_ =U\)3\2T\16P\&"
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M\_F8QCG->8_$C2=5T7]EG]EO4?%]O<7'@ZSU.:;5870NGV>2Y$D 9<<@VXD
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MC/Q=XQM=!U&2:6TUVW"+8HC7+-%:9NY@RX0CD1?=7CTBNO\ @J)\&K;0M.U
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M;BF0I'"\= *G_9-_;,O?C!X*\?\ AWQ;J6L'QI]@U+6QJMC;1+;V=HD4:*D
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MO%9)67]7.&\=_!'P5\3/%'ACQ%XDT7^TM8\-3_:M)N?M4\7V:3>C[MJ.JO\
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M@_SO\^_J?+_[27P)TWP3^QGXS\#?#3PQ>-#(89;;2-/^T7T\CF[A=RH8O(W
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M3E1T5I(71F [!B0*Z;X;_"GPC\(=!_L;P=H-IH&G,_F/':J=TKXQN=V)9VP
M,L2<"NKHK#VL^3V?,^7MT^X;U=V%%%%9@%%%% !1110 4444 %%%% !1110
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M\F,@#.&;:)]K*SE=Z)OY)V_/_/8IQLTGU:7S:NM?3_+<]L_X5GI'_/YX@_\
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M22;3V\_.WSU$[*U^OZJ_Y':_\*STC_G\\0?^%)J/_P ?H_X5GI'_ #^>(/\
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M(/\ PI-1_P#C]6?!/Q&\*?$K39M0\(>)]&\56$,OD2W6B:A%>1)( &*,\;,
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MN>/O#/AAM'76?$>DZ2VL3K:Z8M]?10F^F;&V.'<P\QSD85<DY%0>"_B9X/\
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M#J37+:U\"O GB#Q=X)\3WGAZ'^V?!:2Q>'Y;>:6".P21 CJL,;+&5VJH 92
M!QBN]KIG/GBX[7E)_>]/F<T8<LN;R2^[]/T/RX^ ?PY^&_Q0_9A_:/\ &7Q8
MTO2=2^(\6KZT=<U/5(DEOM(ECB_<+ [Y:(!P0H1OF(VY(7:.<M="NOC5J_[
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MF 8Y_17PW\#/ WA'Q-XV\0:9H$4>J>-61O$$D\TL\=_L5U4-%([(HVR."JJ
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MEOHUY_P3[^"$'B-UC\/2_%B1-2=W**MJ3.)26'(&S=R.17Z^3_!?P;<_%?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MV:?BGX:D^&K_  X\7Z;J>BR>(/"UM*)-.D>6YA6.6T7=Y"I*L1R$ &1\S/\
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MIU'.4HN-K'!B,+&A3C4C-2NY+3^[;\[A1116YYX4444 %%%% !1110 4444
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M:35F-2<7=;E73M,L]'M$M;"T@LK5/NPV\:QHOT4# JU110DDK(&W)W>YF?\
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M[-- ML_VDH047H,*H[<?_7YJG;_#?2K7P_\ V3$]RL0G%RL^]?-$@(P<[<'
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MU!5&H;!111748!1110 4444 %><?&?XH7'PWT^P6QMHY[^^9]C3@F-%3;N)
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MMP8X8T,1:23)!"\8. ,L<5U>H?#73;^>^Q=7MK9Z@8S>V%O(HAN-G SE2RY
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M-KIZP*JV\S.49E+<$H-^>Y.W&T8!R33[+X5Z996]M%]LOYC!J@U<22R(6>?
M!W'9]TXS@>O6MFQ\+6^G>)-0UFWN;A);]4%Q;_(8G*#"M]W<" 3T;'/2FK?U
M\OUN:0ABKQ<Y;/7;7XO_ +7_ (<VJ***D],**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\DA\#?\ 8"L?_2=*[&N.^#?_ "2'P-_V K'_ -)TKL: "BBB@ HHHH ****
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M.:^I+7]G?X2PL2_@K4K@8QB6XNP/K\L@K;-L3EV3U(TZO.W))^[&+\OYD=.
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M&*-FCCM;%A&2 <$MV''ITKL/!O[&?P"\!2J\?AC2]4O5^]<:[=&]=CZE9&*
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M@TVTAM;6)8+>%0D<:#"JHZ 5/13&Y2ENPHHHH)"BBB@ HHHH **** "BBB@
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M5&\&>']'_8J\;75AH6FV5TEQIP6:WLXXW7-["#A@,CB@#Z@^#?\ R2'P-_V
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M\>7WB7X=GQHF@V^D^ 8IVM)M*NY9Y=4NF@:UCE>-XD$"+"\A*[I"7<8("98
MX;]M;QIX>UN3X&Z=IVNZ9?ZA#\7/#ADM+6\CDE3;.X;**Q(P2 <CBOK2OB3]
MKCX ?#CX?>(/@MXI\->"M&T3Q'??%OP^MSJ=E:+'/*)+EWD#,.3N8 GW%?;=
M !1110 4444 %%%% !1110 4444 %%%% !114=Q<16L$DTTBQ0QJ6>1SA5 Y
M))["@!E]?6^FV<UW=S1VUM"ADEFE8*J*!DDD]!7Y ?%3P1X!_: _:BO4\#W<
M^@>%KR>2;4M<NHFDMGE5AYS6ZJN3G=D GDG/ KZB\>>-/$G[='Q(N?AYX&O+
MC1_A%I$H'B#Q'$I4Z@P/^IC/<$C@>Q9N !7K?B!? O[,NJ>%5LX[71] T#0-
M4G>!&422;1 >>[.Y&!GJ37O85O OO4DMNWKY^1#U/'OB];:5\&/"/AOX ? ^
MT\CQ5XN1#>:DAS<K;,,/<3/UW,-WH%&0 !@5]3_ GX*:%\!?AWI_A?0X5_=C
MS+R\8?O+N<CYY7/<D]/0  <"O!/V&/ ^J>-KKQ%\>O&49;Q'XOGD&G1OR+6Q
M5L*$!Z [=H_V4!_BKZ^KEQE1Q_<)WM\3[R_X&PUW"OFW]L7PRU[8Z+K:W<*"
MT#P-;R.%=MQ!W*.^,5Z5\4OC/9> VCTO3X&UKQ/=82VTV %B&/ +XZ#V')]N
MM8'@OX+W^M:LGBCXAW7]JZRQWPZ=G-O:CL,="1Z#CZU\CCI+&1E@Z2NWN^D?
M7S\CZS*8/+)PS/$/EBOA76?31=%_>>G:YX[\$_@[XQ\2Z9?*M[/X=\-:F8S=
MOC;+=*F[:$'7'SMGH#[XKZD\$?#S0?A[IHL]%L4M\C]Y.PW2RGU9NI_E71HB
MQJJHH55& H& !3JVP>7TL)%6]Z2ZO].R.7,\ZQ&93E?W8-WY5U\WW?K\@HHJ
M&[;;:RGSOL^%)\WCY/?GBO4/GB2218HV=V"HHR68X 'K7D?B+QYJ_P 0=3E\
M/>"B8H%.R[U@Y"QCN$/]1SZ5AR7WB+XM^(KW0=-UF23PO;NHNM0\E8RXQRJ[
M0,Y.<#TY->R^&_#.G>$]+BL--MU@@C';[S'U)[FM+*.^YXJJU,QO&G>--;OJ
M_)>7G]QC^ _AKI/@*TQ;)]IU"0?O[Z89DD/?'H/;^==;114-WU9ZU*E"C!0I
MJR04444C4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_.
MOXK_ !.OOBU^TE;> _$?]D7,\'B:/2;3PI#H5W%K=I8M*J-JD.I* J*J$R\'
M:0,<U^BE>8?&W]HSP;\ 8M%'BB:_EO=9EDAT_3=)LI+R[N"B[I"L48+$*""3
MVS0 _P"%?@OQUX#U*]TO6O%<?B[PLL8.G75]%MU*$Y_U<KK\LB@8PV >.<UZ
M97EWP9_:(\.?'.74H]!TSQ'IQL K2_V]HT]@&W9QL\P#=T[5ZC0 44A.!D\"
MH;:^MKR$RV]Q%/$"09(W#*".O(H GKY&_P""K'_)C_CG_KYTW_TN@KZSM;RW
MOX1+;3QW$1./,B<,N1UY%?)G_!5C_DQ_QS_U\Z;_ .ET% 'T1\&_^20^!O\
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M*M>[J>-B'+&SEAJ;M!?$_P#VU?K]Q\U?!>_UW3_B!IUEIYG$<DX6[M^=GEY
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M'G[QSU]?<^PKT^J?NZ'#23Q4U7FO=7PK]?\ (****@],**** "BBB@ HHHH
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M%^K\PHHHJ#V0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@HHHI&@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJQ_R8_XY_P"OG3?_ $N@KZ8\&_$+PU\0K.XNO#6N6.MP6[^7,UG,)/+8C(#
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MU!=)ENX[S3I%BO=/U*RFLKJV9AN3?#,BN PY5L8(S@G!KYP_X*L?\F/^.?\
MKYTW_P!+H* /HCX-_P#)(? W_8"L?_2=*[&N.^#?_)(? W_8"L?_ $G2NQH
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MNU[GHOPW\"ZW8^'(M*TB+^P]-?YKF_F7_2+ICU;UQZ < <9/6O4/#/@/2_#
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MEHHJ#UPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@$9.*CU?X?\ A?Q ^I/JGAK2-2?4XHX+YKRPBE-W'&VZ-)=RG>JMRH;(!Y%
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M%?!_Q#K-P;32-)^*&@7][<"-Y#%!$\KR-L0%FPJDX4$G& ":O_\ #S']F_\
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M:GIH-X/-\Z<SF3>VWYAFYEP,#''I5SESM/T_ #C1_P %0/V9VQCXD.<D ?\
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M=*^P;5+'/<U=_8YTVZT?P+XOL+W5[[7KJU\7ZK"^I:DX>XN"LH&YRH S[
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M6OZQXGO]-L)-*TIM8DB8:=:.T;/''Y:+N+&&++ON<A%&ZO3* "BBB@ HHHH
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M=:YC]E[7M6\4? 'P7JFNZC+J^L7-F7NKZ< /._F."Q X'3H.!7IEY;FZLYX
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MSWK,.J>$E\6>*+7Q!HG@^VN(-%M;?33;S,\L+6_G7,AE<.R0.\8"*@R[,1T
M7P/^SWK7A[4?!MKK'BFVU?POX*:5]"LHM.,-SDQM%$;B4RLK^7$[(-J+G.30
M![C7'_%B;Q7#X%U(^"WT^#72A$=UJ>XQ6RX.Z78O+LHY"Y )ZD5V%5M3M#J&
MFW=J&V&>)XMV,XW*1G]: /E_0?'WBGQ!\(?@%H<_B*]CU7QM?_9M7UR$A+J2
M"&VN;F4(V/W;2&!4W+RJLVW!P15UOXB^)O"^J^(?AG:^)=0GD7Q3I6F6>LW+
MB2^MK&\B:1XS*R_.ZF&15D8%@'&22,UZ3#^SY>:?\+_ &AZ?K\-KXF\%727N
MFZM)9F2!Y DL<B20[P3&\4TB$!P1D$'BJUU^SGJ&L:'K5YJ/B6#_ (3K4=9M
M]<36+73REM;36ZA((E@:0LT03<#F3<V]CE>  #SKQI\1/%'PS\2>-OAO8>)-
M2NUDN?#K:/JVH2BXO+"'4KF:WGC\UER^PVS.C/N8>;C.%&$^)GQ&\4?!J_\
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M+:Q\+:/%\3]>\67GA)HIKA_[.AEMLF2?(^8KC V^O>@#[<HKX\^-'[7'Q'^
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MGQ1XZ^)=O\0/VP6U^ZT_7/"6B01*=+FO+H&&-H$>V2WVN/*!1@TFTC+EB.M
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
D0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>syre-20250331_g7.jpg
<TEXT>
begin 644 syre-20250331_g7.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" '%!*(# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#]!^)W@3XSZK=7_BGP5YUY976HW+S3ZBA8*(5E<EGR[QE"?X)>P2OH3]F/\
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M8M]0_LW>'_AUX-^&-EX;^&FNZ9X@T72V,<]YIU_%=F2X;YG>5XR1O;(..,#
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MU<6WV.?4M/M[R2W.?W321JY3GG@G'X5^?.A^,/#G[9GQ'MO&WQ:^('AGP?\
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MU6#P9HO]C1:I.+F\7[5//YL@! ;]Z[8ZG@8%4_\ A:7B;_HCWC3_ ,#-$_\
MEE1_PM+Q-_T1[QI_X&:)_P#+*F_:RO>6^_O+7UU#0]&KA/B-\#_!/Q:UCPUJ
MGBO1?[5O_#D[7.ER_:IX?L\C-&Q;$;J'YAC.&!'R^YS4_P"%I>)O^B/>-/\
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M*ZM!J5A\/;1KJ!@\?VV\NKN,$'()CFE9#^(KM/\ A:7B;_HCWC3_ ,#-$_\
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M/<6<-SI;V_V5[2X7S(WBV[2C!L[@1QSUKB/^%I>)O^B/>-/_  ,T3_Y94?\
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MC)5BI*Y'0X)''!-%6565G4E?YW_4%;H34445SC"BBB@ HHHH **** "BBB@
MHHHH *\G^)W[*?PG^,FL?VMXN\&6>I:HP"O>Q2S6LT@ P-[PNA? X^;/  [5
MZQ7GMS\3O$<%Q+&GPD\8W"(Y59H[O10K@' 8;M1!P>O(!]0*VI.I%\U.5GZV
M$[=2[\+_ (+^"/@OI<UAX*\-V>@6\Y#3- &:68@8&^1R7?&3C<3C)]347PR^
M!_@GX.W&NS^$-%_LB77)Q<Z@WVJ>?SI 6(;]Z[;?OMPN!S]*I_\ "TO$W_1'
MO&G_ (&:)_\ +*C_ (6EXF_Z(]XT_P# S1/_ )95H_:RO>6^_O+7UU#0]&KA
M?B;\#_!/QBN-"G\7Z+_:\NASFYT]OM4\'DR$J2W[IUW?<7ALCCZU3_X6EXF_
MZ(]XT_\  S1/_EE1_P +2\3?]$>\:?\ @9HG_P LJF,*D'S1=GZK_,-#T:O&
M9OV-_@Q<>-CXMD\ :<VMF?[29-\H@,N[=N-OO\HG//W.:Z#_ (6EXF_Z(]XT
M_P# S1/_ )94?\+2\3?]$>\:?^!FB?\ RRJH*K3OR2M?M)?YAHSIO'7@#P[\
M3?#=SX?\4Z1;:WH]Q@R6MTN1D'(8$8*L.S @CUKF/A+^SM\.O@8UZ_@?PO;Z
M)->*$GN/-EGF=0<A?,E=F"YYV@XX'H*7_A:7B;_HCWC3_P #-$_^65'_  M+
MQ-_T1[QI_P"!FB?_ "RH2JJ+@I:/IS*WYAH<!J/[ /P%U;4+J^N_ K3W=U*T
MTTK:SJ&7=B2S']_W)->C_"/X#^!O@3I^H6/@;0_[#M;^59KF/[7/<>8ZC .9
M7<CCTQ5?_A:7B;_HCWC3_P #-$_^65'_  M+Q-_T1[QI_P"!FB?_ "RK24\1
M4CRSJ77^+_@BT[%OXM? _P $_'31[+2_'&B_VW86<_VF"+[5/;[)-I7=F)T)
MX)&"<<UY[H7[!OP&\.ZI#J%G\/;5[B$[D%Y?7=U'G.>8Y960_B#7;_\ "TO$
MW_1'O&G_ (&:)_\ +*C_ (6EXF_Z(]XT_P# S1/_ )94HRQ$(\D9V7;F_P""
M&G8] >SMY+-K1X(WM6C\HP,@*%,8V[>F,<8KPR__ &$_@1J6N/JTWP[L5NG?
M>4ANKF*#/_7%)1&!STVXKL_^%I>)O^B/>-/_  ,T3_Y94?\ "TO$W_1'O&G_
M (&:)_\ +*II^VI7]G.U^TDOU#1[DWC;X!^ /B%X!L?!.M>&X)/"EC*DUMI5
ME++90Q,@8+CR&0X&]N,XR<XS@UYE_P .\?V??^A _P#*SJ'_ ,D5Z/\ \+2\
M3?\ 1'O&G_@9HG_RRH_X6EXF_P"B/>-/_ S1/_EE5PJ8BFK0J6])?\$-.Q-X
MN^ O@3QUXB\):[KFA?;M5\)R1RZ-<?:YX_LK(Z.IVI(%?#1H?G#=/<UZ!7G/
M_"TO$W_1'O&G_@9HG_RRH_X6EXF_Z(]XT_\  S1/_EE6,HU)))RO;S7^8]#T
M:N;^(GP[\/\ Q6\(WWA?Q38MJ6A7VS[1:+<2P>9L=74%HF5L!E4X!YQS7._\
M+2\3?]$>\:?^!FB?_+*C_A:7B;_HCWC3_P #-$_^65*-.<6I1:37FO\ ,#SC
M_AWC^S[_ -"!_P"5G4/_ )(KWOPWX=T_PAX=TK0M(M_LFE:7:16-I;[V?RH8
MT"(NYB6.%4#)))QR37%_\+2\3?\ 1'O&G_@9HG_RRH_X6EXF_P"B/>-/_ S1
M/_EE6M25>JK5)W]9)_J+1;&G\4/@YX+^-&BQ:5XT\/6NO6<+%X1/N22%B,$Q
MR(0Z$C&=I&<#TK.^''[/?P]^$6BZEI7@[PW#H-MJ49CNY;:>;[1*N",&=G,H
MQDXPPP3D8/--_P"%I>)O^B/>-/\ P,T3_P"65'_"TO$W_1'O&G_@9HG_ ,LJ
MG]\H\BEIVYE;\PTW(?"7[-?PT\#> M<\%Z+X4M;7PWK>_P#M&SDEEF-SN4*=
MTDCM)P!QAOE/*X/-;GPM^$OA7X+^&3X>\':=)I6C><UP+5[R>Y5';&XJ9G<J
M#C. 0,DG&2363_PM+Q-_T1[QI_X&:)_\LJ/^%I>)O^B/>-/_  ,T3_Y94Y>V
MDFI2O?\ O+_,-"WXX^!_@GXD>+?#'B?Q'HO]HZYX:G6YTJZ^U3Q?9I%D20-M
M1U5_G13AP1QZ9I8_@?X)A^+$WQ+31<>-I8/LSZI]JGYCV"/;Y6_R_NJ!G;GB
MJ?\ PM+Q-_T1[QI_X&:)_P#+*C_A:7B;_HCWC3_P,T3_ .65+]\E92TV^);=
MMQZ%NQ^!_@G3?BQJ/Q+MM%\OQMJ$ MKG5/M4Y\R,)'&%\HOY8^6*,9"@_+ZD
MYYCXA?L@_!_XJ>))-?\ $W@BSOM8E(:6ZAGGM6F88YD$,B!SP.6!-;G_  M+
MQ-_T1[QI_P"!FB?_ "RH_P"%I>)O^B/>-/\ P,T3_P"655&5>+YHSL]OB6W;
M<6@GBC]G7X<^,?AS8> M3\+V[>$;"59[;2[666UCCD4, V8G5B?G;.3R22<F
MNT'AO2_^$<70'L89]&%J+(V5P/-C:$)LV,&SN&WCG.>]<9_PM+Q-_P!$>\:?
M^!FB?_+*C_A:7B;_ *(]XT_\#-$_^650U5DK.7_DR_S'H<[X1_8U^#'@7Q9#
MXET7P'8VNL02>=#-)//,D3@Y#)%)(R*0>A"C':MWXK_LV_#7XX7EE>>-O"MM
MK5Y9KLAN?.E@E"YSL+Q.I9<Y.UB1R>.34O\ PM+Q-_T1[QI_X&:)_P#+*C_A
M:7B;_HCWC3_P,T3_ .65:<U=R4W/5=>9?YBT*_@']FGX:?"WQA)XH\)^%H=
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MZ*(V&T>7D'+&OL;1]0/P[\':);^.O&=CJ&J,Z63ZW?)#IJW]RY.Q5B#;0[=
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M[ 2"WEV#IM<[L9(].]0^%?B-\1?'/A>76-.L_#UK;1>9')).)MQ95+;E4,>
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ML15N6)4@$Y!&>1]#6O\ "GP%K^B>,/%-WXBTJWM[/5XL_P"CRHT.6;)B"YW
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M:_G:]NUSDCD-.7+0>(2KRCS*'*[;<R7->U[>5O,^GJ*^>OV@O ?@7PGX?O\
M61H N?$FL7++;DW<_P T\A+/)L$F.,DX QDJ,8-=/X)_9Y\/6WP]TS1O$=DV
MI7*R-?3 SR1A)Y$56 V,. $5>?0GO6RQ->5:5%05TK_$_E?W=W\SCEE^#AA(
M8N5:24G:W(KNRU:_>:I.RUL>O45\P?!GX>Z)XL^*VI>(]%L3IWA?0YQ%91K+
M(_VB8='+,Q./XL9[J/6N7T^PM/&?PW\:>-M>U.X3QE97W^CRFY9'@P$*HJ \
M!BS*..-@QC!KD_M2?(I>S6O-;WM&H[N]ONT/5_U<I>U=-5W[O(G[FJE4>B:4
MGM]IWTVLV?8]%?+FM>,M1^)7A_X4:#>W<R6^N2,-3DA?8UPL<WE8)]3M8^F2
M#VKJ/AVL?PY^/FL^"]-DF7P]=68N;>SDE9Q#+M5C@MD]-_?TSG%;1S)3G%1C
M[K:5[]9*ZT_X)QU>'YT:,W.I^\BI2Y;:<L)<K]Z^][M*VRW/>Z*^2]<U3QAK
MOQB^'VI>++1=*6XOXS9:6N08(Q*@)8'G<QZYYXZ 8%>U_$#X2V_CKQ+;:KK^
MN3?\(W90GS-'YBA. 29&D#C'J3CH ,BKI8Z==3=*G\+2U=M];OM^+,L3D]/!
M2I+$5U:<6[Q7-JFURJSLW?K=*_7J>DT5\U?!/Q)J&D-\1(_"\-SKOAW3SOTF
MVD9VW2;F"*G&<%1D\= .F:H_#MO$DG[2T$WBLHNL36,DKP1GY8$:,E8QCT&.
MYZ]2>:RCF:DJ;4'[[MY+6V_7;0Z9\.RIRQ"=56I1YO[S]U2MRWNK7U>MGW/J
M.BL_7KR_T_1[JXTS3O[6OXUS%9>>L/FG(XWMPO&>OI7D?[-OQ#\4^/+35I]:
MM#=6374CKJOGHJQR!80+980,@!26W=.3W.:]"IB84ZT*+3O*_333^O\ ,\*C
ME]6OA:N,BURT[)W:OKV7]7Z7L[>L>(/#6F^*;2&VU2V^U013+<(N]DQ(N=IR
MI'3/3I5.^\!Z%J5AJME<6.^WU2<7%XHFD4S.-N"6# @?*OR@@<=.37045V7:
MV/%E0HU&W."=]]%Z?DV<QX3^&OAOP-<SW&B:=]BFG01R-Y\DFY0<X^=CCFNG
MKD(/&FJ2_$>X\.-X9O(]*C@$JZZ2_D.VU3L'R;<Y)'WNU=?6<:JJW:=[.WW'
M3]36!C&G&"BFDTE:UGZ;>F_<***XWQ3\8/!_@K5AIFLZU'97Q4-Y/DR.0#T)
M*J0/QI5*D*2YJDDEYZ&U##UL3/DH0<GV2;?X'945Q$WB[P/\2K?_ (1T:M9Z
MRFI1,39V\S;F1?F.XH04Z=R#7A7CCX2>%]8^+&D^!_"NE'3C"GVK5KU9Y93'
M&0#M =R =I'..KK7!B,9*E%3HI33:7Q:W?39KSW/;P&4PQ$Y4L5*5*23D[PN
ME%=7>47OIHGJ?5E%06-G%IUE;VD"[8((UBC4G.%4  9^@KQ[5/CK<:]-XDL_
M#_A.\UK2--22&\U2*X1-G!!9(R/G'!. <D#.*Z:V(IX=+VCU?35_E^9YN$P%
M?'2DJ"NH[MM)*[LMVE=]%>[Z'M%%?./[/_BR?P=\$;J^MM%O]>N6U:2..ST^
M(NQ)CC.YB =J@#EB/2NO\,_'RYUKQA_PB]]X973]9FMY)K6.'5(KJ.1U1G$;
MN@PA(1NN2.,CFN6EF-&<(.>CE;35[]+VL>IB<AQ5&K6A2]^--N[O%.RW?*W>
MRZ[I'K]<WXJ^'7AWQM<VMQK6G+?2VP*Q%I9$ !()!"L >G>N4\,_'*RU[X:Z
MUXKN-/-A)I+21SZ>9][;U V+NVC[Q8#.WKGKBLJ^_:&:P\.>&+MO#;-J_B#<
M]KIOVU558PVU6>9D &[((XZ=36W]H8>*4^?=7Z[7M^>EMSAGP_C,0Y4*E%2M
M+E:?+:Z7-U=M$KWV\]CV"WMXK2WB@AC6*&-0B1H,!5 P !Z 5)7%>!?'FK^)
MM2OM.UKPCJ/AJ[M5W!YCYUM*,@$),%"L>1P,]_0UVM=5.I&K'FCM\U^9P5\/
M/"S]E42NNS37R:;3^04445H<X4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !17.ZM\1/#.@^,M!\)ZAK=G:>)=>69],TN20"
M>Z6%"\I1>X5023['TK!\9_M!?#7X=^+=/\+^)_'.A:%XAOPIM]-OKY(YF#':
MA*D_*&/ +8S@XZ4 >@45P_Q,^./P_P#@RE@WCGQAH_A8Z@S+:)J=VL3S[<;B
MJDY(7<N3C W#)&14GC3XT> _AWX1LO%/B7Q?H^B^';[RQ::E=7B+#=%UWH(F
MS^\RH+#;G@$]!F@#M**R/"?B[1/'GAVRU[PYJUGKFBWJ>9;7]A,LL,JY()5E
M.#@@@^A!%:] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*[=I()Z9&"?U!HH ^5?VI/@%_P C-\3?^%C_ +0'_+K_ ,4=\+=<_P"N5O\
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M/_A,?#3>$=5UK^T)7>POK&+= ^Y2H,C]%&,'USD8[U]*448C#>WE&:E9QO\
MCN+ Y@\'"I2E!3A.UT[K6+NG='Q[;>!?&2_ VTLHM%U1537))K[3!!)'/-"8
MT"D)@,RY##CN1Z<=%X1\.SVWQR\*ZSI?@/5O#/AN.&2W FM7+;C%*OF2]=F6
MD498]%!KZ@HKSHY3"$HR4W[O+T7V?R7<^@J<4UJL*D'27O\ /LW]M:Z;-KHV
MM%H?)'Q,\(:G9_%R]\%:;(8M*\7W=MJ$B+V 9RYP.@#>8WT4>E>K?&SPU93Z
M;HME+X$N_$FDVZ>2MQI-PPN[%0 ,)&%.\8 ZG''..#71^$_@SHWA3Q1+XB^W
M:IK&KM&8DN-5N1,T2GC"X4=N.<X'%=]3HY>^2JJFG.]M'97O;56W;)QF>KVN
M'='WE2CJ]8N4K6;T=]DEYVU5M#P#X%:+XFTOQM?K:6VOZ;X%6$^7:^)1MF\P
MXQL3''(/3C'4DXKW^BBO2PN'6%I^S3O_ %T\CY[,<=+,:_MY1479+3K;JWU;
MZL****ZSRPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** /SR\2?!VR^%O_!3KX"WZZYK?B36?$%MK]Y?ZEKEX9Y.+*Z\N&)>%
MCAC#%511P.I/6N2\4^&_#GBWPW^WYK'B:PL]0\1V5XT<$]_"K2VT,-LWV(QE
MAE?F08(/.Q?05]]^)/@?X6\6?%WPA\2M0M[A_%/A6"YM],F2=EB1)XWCEW(.
M&RKMC/2N'^*7[$?PB^,7CR7Q=XE\.S3ZM=^0-12UOY[>WU,0D&(742,%EV[5
M )&<* 20!@ ^5OV?=(TKXI_M0>&(?B5;1:^Z_ +1W6WURW66-EE$/VN4AU(W
MYDD!/!Q(XYYQY1^Q^L7C3Q'^Q=I/BW=JFCPV7BV33[34(O-@EF26<*I# @[%
M0%?[I1 .P/Z(_&W]D/X8_M 7>EWGBO19UU#3;1].@O-*O9;&7[(_W[9S$P#Q
M')^5@0-S8QN;+O'7[(OPM^('@/PIX1OO#K6.E>%,'0I-)NY;.YTXA=I,4T;!
M_F &[<3N(#'+ $ 'AG[!]U>^$_ _[2MIX0T9=9M= ^(OB"/PYX>@N$M;>7RU
M1H;2*1ALA1B$7.-J[]V.M.^*7[;/QV^"_@34_&7C+]EG^QO#>F^5]KO?^%A6
M$_E^9*D2?)%"SG+R(.%.,Y/ )KZC^$?PA\)_ OP+8>#_  7I2:1H5F69(5=G
M=W8Y9W=B6=B>I)]!T %?F[_P5'^#_P#R4WQW_P ,^?\ 0,_XNU_PFG_7I#_R
M"=__ &[?=_Z:>] 'ZJ4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MW*KF%/,?9^]%WM=M:;)=DO(RO"<,EOX6T:*6-HI8[*%7C<$,K! ""#T->/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M9DN(UDB=9(V&5=#D$>H-/K\NO"W_  4,^,OPAT706\=>&M*\1Z1J-JMQ8S2
M6-U-"0-I!CRNW'?RN_4U] _#W_@J)\)O%0BB\0P:MX-NFP&:ZM_M5N">P>++
M$9[E!7@2R^O;F@N9=XZ[:/ST/1?-3M&HK/3\=?N?0^Q**Y'P+\7?!/Q-MQ+X
M4\5Z1KXQN,=C=I)(G^\@.Y3[$"NNKSY1<7:2LQA1114@%%%% !1110 4444
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MIU:51<LFHI[ZOY_UY'SM%IW[9?P3MT-I>^'_ (O:/$!MBN,"Z6/W+>3(S?\
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M:#X?U+]F/7+_ %6QM[C6+"6 Z3<R)^]@D::,2;&'(#1ALCH<#/(%?4M?$?\
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MRG*VY^KNA6^HV>DVT.K7T.I:BBXFNK>V-NDAR<$1EWV\8_B/3\*OU\1^!/\
M@J;X-U"WM#XW\(:YX0-TNZ&[MP+VUE4-M9@V$<@$'[J-T(SD<_2'P_\ VE_A
M;\4MJ^&O'.CW]PP#"TDG\BXP?^F4NU_TXK@K83$4;NI!K\OPT*4D]CTRBO$_
MC-\/[%O$'A6^BU?Q593:QXA@L[R.Q\5ZI;0O"T,I*+%'<*D8)13\BKT]SGUG
MP[X?M?"^CP:;9RWTUO#NVOJ-_/?3G+%CNFG=Y&Y/&YC@8 P !6$HQ45)/?\
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MHRZ[9MS+*K;00ON-P/T'I1RV@[NS,_K\<1F%+V$.>FT[R2OKI^5E?M<]RI"
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M)%=*Z;95:/\ =OQS\I)X]B36_M-$I:GS$<K<:LZ^%O1FWY.+5EO%/O?LS/\
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M:CX<N7=X[G-W;L1D"0#YQ^(P?^ GUKZ1I5(N,FF=&2XFEBL%"I25NC7FM/\
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MQ\ ]4\(^3J'@?Q#-8ZG&BB>"<XAN& Y..0,G)VL&&3U%6M#^/%QH=\FD>/\
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MK-<F+Q"Q-3VG+9O?4J*LK!1117$4%%%% !1110 4444 %%%% !1110 4444
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M#PG\,_VE_AWKG[0NE^$?B9H^H>0UN!X6N9M-U3Q+8PX6-Q C$2QL&.UB Y5
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MAKNP_P#"K>B_]*0U_7W,^[:***X1!1110 4444 %%%% !1110 4444 %%%%
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M"*[[X.?&[P5\?O"!\4> M:_M[0A<O:&Z^RSV_P"]0*679,B-P&7G&.:^4/\
MB]D?[87QS3X+67P]TF-AH[ZM!X^ENVEOI?L@V7ENMLH=8BO[HAF*;H6(PQ<#
MZO\ @Y_PLO\ X1 _\+6_X13_ (2G[2^/^$-^T_8O(PNS_CX^??G=GMTQ0!W-
M%%8/CKPI_P )UX/U;P^=6U/0EU&!K=M1T:X^SWD"MU:*3!V/C.&QQF@"GX7^
M*?A3QIXL\4^&=#URVU/7?"\D,6LV<&XFS>56:-6.-I)"/P"<%2#@\5S'@_\
M:@^%'C[X@7?@?P[X\T;5_%5J7#Z;;3[F8I]\(V-LA7!R$)Q@YZ&OC/\ 95\%
M6GPC^(7[<7AWP9%<VD.CVEBNG S//.)!9Z@ZMO<EF<N<Y)ZFN(\,Z7X?T_\
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MD9ZJBBIE9O0 HHHJ0"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?\()J?\ PKC_ (1__A,_W7V#_A*?/_L[_6IYOF^1^\_U7F;=O\6W/&:^-?\
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MR=Q?CY>2!R![=^U9X\\5_#']GKQMXH\$6']H>)M.LUDM8_)\[RE,J++/Y?\
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MB*FT?Q?1'N/PG^$OA?X)^#+7POX2TY=/TR F1LMOEGE(&Z61SRSG Y[
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M=B22<D =O3-5+D:NM&<F$>/IUW1JM3IK3FVDM$]5L][:>IV5%%%9'NA1110
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ME&+U6NNC_2Z7J?1-%%%9'OA1110 4444 %%%% !1110 4444 %%%% !1110
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M"RVMBJE6O]8IN*YKQ\U:WZ7^99HHHK(]T**** "BBB@ HHHH **** "BBB@
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M7_JXW]H#_P +G_[17BG_  S?KG_#:'_"HO\ AH/XX?\ "-_\*_\ ^$K^U?\
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MU:B<:T;27W/S7]:"S##X>C*-3"5.:G/5?S1\I+NN^SW1]545\J_\-$?M._\
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MNMNWR^#^\\LG'[64 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQ)XL^Q_VS>_:)7^U?98C%;_(S%$VHQ'R*N<Y.3S75T4 %%%?+G[47[07QA^
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MWQ%\-?'W@7X=> O!\/C'QYXN6ZN+:&^O?L=G:V]O'ODDEDVL<GHHXY!YSM#
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M/AR/XG>*E^$MEK0UV#P%B'R%F$AD$?VC;O,.XGY",]]V_P">OLNBB@ HHHH
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M9)X1^Q?V;O\ [/W0"+[1O\X>;C&=FU/3=WH ^?\ 1?VZ?V@X[/X-:QJOP_\
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MLNY]2D\)QZ/;SK;W4L@<A;@LLGV<%0#"NS<!AG/)-JX_X)U75KXI\):YX?\
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<H **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>syre-20250331_g8.jpg
<TEXT>
begin 644 syre-20250331_g8.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" '8 S0# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"<'.<9'5@N!35VWU=_P_J^HL7B)4WRQFX14$X:?$]='=-]E;?4[#XB?&*_\
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M7*?\+,TC_GS\0?\ A-ZC_P#&*/\ A9FD?\^?B#_PF]1_^,57LY]@.KHKE/\
MA9FD?\^?B#_PF]1_^,4?\+,TC_GS\0?^$WJ/_P 8H]G/L!U=%<I_PLS2/^?/
MQ!_X3>H__&*/^%F:1_SY^(/_  F]1_\ C%'LY]@.KKSSP9\/-1\._$3Q)K]S
M-:O9ZEN\E(G8R+EPWS J .!V)K8_X69I'_/GX@_\)O4?_C%'_"S-(_Y\_$'_
M (3>H_\ QBFH33NEY&%2C"JXN7V7=>NJ_4ZNBN4_X69I'_/GX@_\)O4?_C%'
M_"S-(_Y\_$'_ (3>H_\ QBE[.?8W.KHKE/\ A9FD?\^?B#_PF]1_^,4?\+,T
MC_GS\0?^$WJ/_P 8H]G/L!U=%<I_PLS2/^?/Q!_X3>H__&*/^%F:1_SY^(/_
M  F]1_\ C%'LY]@.KHKE/^%F:1_SY^(/_";U'_XQ1_PLS2/^?/Q!_P"$WJ/_
M ,8H]G/L!U=%<I_PLS2/^?/Q!_X3>H__ !BC_A9FD?\ /GX@_P#";U'_ .,4
M>SGV J?%SP3?>/O"@TS3Y;>&?[0DNZY9E7 !SRJDYY]*ZG0[)]-T6PM)2K26
M]O'$Q3D$JH!Q[<5@_P#"S-(_Y\_$'_A-ZC_\8H_X69I'_/GX@_\ ";U'_P",
M4U":35M]3#V,/:NM]JUOE>_ZG5T5RG_"S-(_Y\_$'_A-ZC_\8H_X69I'_/GX
M@_\ ";U'_P",4O9S[&YU=%<I_P +,TC_ )\_$'_A-ZC_ /&*/^%F:1_SY^(/
M_";U'_XQ1[.?8#JZ*Y3_ (69I'_/GX@_\)O4?_C%'_"S-(_Y\_$'_A-ZC_\
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MS2/^?/Q!_P"$WJ/_ ,8H_P"%F:1_SY^(/_";U'_XQ1[.?8#JZ*Y3_A9FD?\
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M'LY]@.KHKE/^%F:1_P ^?B#_ ,)O4?\ XQ1_PLS2/^?/Q!_X3>H__&*/9S[
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M<:!X?\6>7!!NV%8K[_1?]+7:1NB'E@$L-YZUD_M(_M[?$O\ 9FOY9?$G[/\
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MT^?,=?11169L%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M-1^.FO>-?!GB>3PG?>+?"9MY)=8\"ZB;W1=3@G#,DEN[$LI3 1U8GYO3[H\
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MQ_\ C5'_  R=\$/^B-_#_P#\)>Q_^-5ZK10!Y5_PR=\$/^B-_#__ ,)>Q_\
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M6Z!N[O<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZ=9S,&EM[:.)V4Y!95 )_,5?IO1V1*U5PHHHI#"BBB@ HHHH **** "BBB@
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M FHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!_QV\$>/?%=WX<T/6A>:K;B5MAMY8XYQ$_ERF&1E"2A'(5MA.TD9ZT ?,O\
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M^'_^0#IO_7M%_P"@"OC;_@K]_P F<W?_ &'+'^;U]D^'_P#D Z;_ ->T7_H
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M'5__ $BEKRG_ ()B_P#)C/PQ_P"N>H?^G&ZH ^HZ*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ KYU^(MU+X^^+46D6[%HH2MA&0>%)^:9_P&0?:O
M>O$&K1Z%H=]J$I"I;0M)STX''ZUXI^SUHSZKKFJ>(;H;GC!1"1_RTD.YS]0,
M#Z-5+9L\^O\ O:].ET7O/Y;?CK\CW6SM(K"TAMH5V0PH(T7T &!4U%%2>@%%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110!\3?\%?O^3.;O_L.6/\ -Z^R?#__ " =-_Z]HO\ T 5\;?\
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MX/>MVJ]A8Q:;:K;P>88USCS96D;DY^\Q)/YU8K,]:G%0@HI6L%%%%!84444
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M:#_8/@/3XV7;-< W$F>N6YQ^ P/PKS/XQ3/XK^*VCZ#$25MD2-QU^:0AB/\
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M_7M%_P"@"@#0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@#D?BQX+A^)?PU\3^$9;T6']LZ=/9BXZF(NA4/C(R 2"1WK\_YOAO\
MM;7WPEC^ 4W@_P"'<?A!;-=%/C!95)^PA0@D\OSO]9@=?+S_ +.?FKZ!_;&G
M^&/@&^G\;>._&VJZ#?S>'KS2K/1[*]\D7JOC<8@1@S#C:2>,U\:7'@_]E2U^
M'9\3M^T#XREO!8"].@0>(-U]O*!O("X ,F?EQGK0!^JOPY\)1^ O /A[PY%<
M&[32K"&S%P?^6FQ I;\2*Z.N*^"L]A=?"3PA-I<EY+ILFEP-;OJ#;K@QE 09
M#W;'6NUH **** /*_P!JFPMKS]FOXJO<6\4[0^$]6>-I$#%&^QR\C/0_2O,/
M^"8O_)C/PQ_ZYZA_Z<;JO5OVH/\ DVCXM_\ 8HZO_P"D4M>4_P#!,7_DQGX8
M_P#7/4/_ $XW5 'U'1110 4444 %%%% !1110 4444 %%%% !1110 4C,%4D
MG ')-+7+_$[6O^$?\!ZS>*VV06[1IZ[F^48_/]*:UT,JM14H2J/9*YY'\)U/
MC+XN:OKS#=$DDTZ,W]TMLC'X#^5?0E>1?LWZ+]C\+WVH,OS74_EJV/O*@QD?
MB6_*O7:'JS+"TW2H0C+>VOJ]7^(4444CJ"BBB@ HHHH **** "BBB@ HHHH
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M@L3Q6M112-(Q45:*T"BBB@H**** "BBB@ HHHH **** "BBB@ HHHH ****
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MVH/^3:/BW_V*.K_^D4M>4_\ !,7_ ),9^&/_ %SU#_TXW59O[7'[9/P:\/\
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MT_X>:I-I#2)=@*"\/WU0L Y'X9KM:\X^./CH^$?"IM+1LZIJ68(5'55_B?\
M+@>Y'I3CN<^(:5&;<N71Z]O,\$^'6AZK\2M:L-#N+NXET>T<SRJSDK&I^\!Z
M%NGXU]>VMK#8VL5O;QK#!$@2.-!@*H& !^%>=_ ;PI;^'_ ]M=!?],O\RS,P
MY&"0%_#%>DU<Y7>AYV5X>=&@IU7>32U\NB"BBBLSV0HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@#YW_:L_9I^#/Q*TF]\?_%+0+C5AX;TV
M63S+>^N("(4!<J%C=022._K7YUZ3X,^#OB33X-3T/]CWQ]J.CW2^;:W:ZU=
M31G[KC][W%?K!\;]/F\1?"OQ7H-@=,EU74M,GMK:UU64)!(SJ5 ?G.WGJ*^)
MOA[IW[;GPX\%Z/X8L=6^&%Y8:3;):6TEY>*THB0;44LH&<* ,D9..23S0!]T
M?"2WM[/X8^%X+32)] M8]/A6+2[IR\MJH48C9CR2.F376UA^!Y-:F\'Z._B,
MVK:\UK&;XV1S"9L?-L/]W/2MR@#Y]^*_[(Z_%;QKJ6I7/Q&\6:?X7UHVS:SX
M2ANA)8W9A "A-X)@5@HWK'@-U-8]U^PIX>F^(7]K0>+=?M/!TFO0^)[CP5#(
MGV&;48@ DA8C?LRH)CSC(!X(&/IJB@#R_P#:AAC/[-7Q;8HN[_A$=6.<<_\
M'E+7EG_!,7_DQGX8_P#7/4/_ $XW5>K?M0?\FT?%O_L4=7_](I:\I_X)B_\
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M-_LC6M1L8[BZLMK+Y4A'(PW(!ZX/(S7:4 %%%% 'F7[4'_)M'Q;_ .Q1U?\
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M!QFOM74]&T_6HEBU"QMK^)3N5+J%9 #Z@,#S5F*)(8UCC18XU&U548  [ 4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MU3^WI+ZQU$3#3Y39^5ND&#<8V;^/NYS7W]X?_P"0#IO_ %[1?^@"@#0HHHH
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M% !1110 4444 %%%% !1110 4444 >9?M0?\FT?%O_L4=7_](I:\I_X)B_\
M)C/PQ_ZYZA_Z<;JO5OVH/^3:/BW_ -BCJ_\ Z12UY3_P3%_Y,9^&/_7/4/\
MTXW5 'U'1110 4444 %%%% !1110 4444 %%%8WBWQ39^#M"N=3O6^2(?)&O
MWI'[*ON301.<:<7.3LD>5?$/P/H6N>/+#1M-T^--2O7^U:A<(3\D0//'0%JZ
M3PI"GB'XG:OJ4:K]@T6!=,M=HXW=7(^G(^A%4-#6Y\'^$]<\9ZTN/$&J*9!&
M?^60/$48!]../:NO^&?AYO#?@^S@F'^F3YN;DGJ9'Y.?H,#\*N3Z'G8&BH\U
M?EY7/6VVG3Y]7ZG54445!Z@4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?$W_  5^_P"3
M.;O_ +#EC_-Z^R?#_P#R =-_Z]HO_0!7QM_P5^_Y,YN_^PY8_P WK[)\/_\
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M %%%% !1110 4444 %%%% !1110 4444 ?$W_!7[_DSF[_[#EC_-Z^R?#_\
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M[,OAV/Q%J6O)=W2ZWJ4'V6]U !?/N(L*NQWQEEPBC!_NCTKO9H-8/B5+Q;.
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MZ "BBB@ HHHH **** "BBB@ HHHH **** $90RE6&5(P0>]>)^#_ -C3X2>
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MP?\ &#PSX\\<^,/">B74M[JGA.6&WU9EA8012RIO6-9.C,!G<!G:00<&NUH
M\:^)G[(7PI^+WC>#Q9XI\,_VAK$:QI*RWDT4-VL9S&L\2.$E"GH'!].G%>R
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M*GB+Q+\4OA1^S!X7_:;_ .%Q>(_$'B6_GM[O4?#.H7:MH4]O+(P-O%;!<1L
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M0D\4>#/^$!FL]'T>]\JXM-:T!8-/O)&.\RP!EV3+GDN!UK\^OBIX)O\ XO\
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M2.&R1S_=&*^D;S]D'2O^%Z>(?B9I?B[7]&N/$5F;36-&MWB:SOAY+Q(7W(6
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M>8W,A)[\5]J5\K?LR_#W6-4_:<^//Q=US3+C3(]7OK?P_HR7,91Y;2UC56G
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.1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>syre-20250331_g9.jpg
<TEXT>
begin 644 syre-20250331_g9.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" '[!.\# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_M10+=>+/"L+_<DC9#CT,BBNY^,_AO2O#7P9\00:5IUKIT3?9MPMXE3?B>,
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M?B):0EDMHX'58\G'RM(%_(?SJI4XJ]NAQX7.,96E2=6,>6HYK2]URWUW.O\
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M[76&A7IJ-W#F:M)O>W2RBO-M]K=3TK]H;X@:[X(L]!ET'4!9_:FF\QA%'('
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M:/??8X[Z:5;@>3&^\*T0'WE./O-TQUKUVOG[]JF)I[_P7$DAB=Y;E1(O523
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MM&MT,2$*A!"8P,?2LGPZM_KWQ<\6W,WA&'Q==QS3*;*[NXXE@ DV _O 0V
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M:4<B?8_L^WR]SHV=^XYQLQT'6JW_  TE\(_^BI^"O_"AM/\ XY1_PTE\(_\
MHJ?@K_PH;3_XY35.JMHO[CGJX>E7E"517<7=>3,[QY\ ;3QCXPBU^VU/^RY2
M4:>$6WF"5U/WL[UP2  >#TS6UXT^%?\ PF'C;P]XA_M3[)_9,D;_ &;[/O\
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MW]F>7MW9_>;\[O,S_>W<^G;IQ6+_ ,-)?"/_ **GX*_\*&T_^.4?\-)?"/\
MZ*GX*_\ "AM/_CE4XUWNG]QQ4<KP5!S=.FES*S]'NK/9>2.:TG]F>WAU"R.K
M>([O6-*LVW0Z<\91 ,YVYWG )ZX S79_$[X3Z=\2H+9Y;B33]1M<^1>0J&(!
M.=K#(R,\CD8/XU1_X:2^$?\ T5/P5_X4-I_\<H_X:2^$?_14_!7_ (4-I_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M9*2O%W04444%!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MKT<O_P!X7I+_ -)9,MC[3HHHKSB@HHHH **** "BBB@ HHHH **** "BBB@
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M&D^$O%?A#3+*YLAH4K26=UI[KLC9"9),[0(QN#D'<1A2I% 'UG1110 4444
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M96:W/<A4A47-!IKR"BBBD:!1110 4444 %%%% !1110 4444 %%%% !1110
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MCG-<9KW[7'QN^*7C3XO/\$]!\(/X/^&#O;7<OB47+W.MW,6\S1V_ELJH (G
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M]AU[3YV;I'YZJ_\ WR2#^E=%4--;GHTZM.JN:G)->3N%%%%(U"BBB@ HHHH
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M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\6?MV?\
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M>3_EVE/^EP*/[I_B '89^@ZUV'A/QYHWC.$MI]S_ *0H_>6DPV31_5?ZC(H
MZ&BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBBBD;!1110 45#'>6\LFQ)XW?^ZK@G\JFH$FGL%%%% PHHHH **** "BBB@
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MYLDRV>68=TZDKN3OY+^NX4445B?0A1110 4444 %%%% !1110 4444 %%%%
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MD\N3S$!.) [ YW$-N)&,<_7->;BJ7L:K@E9>M_Q*B[H****Y"@HHHH ****
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MPGJE[KGA71M1U+3WTG4;RRAN+G3Y"2UM*Z*SQ$D#E6)7H.E &K1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*;<G)ZDFO;?A7\*?#'P7\'6OACPEIB:9I4!,A4,7>:0@;I)'/+.<#D]@ ,
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M#X?ZYJ'DP7*QL%$0;.PY9MH6-8W;+!>]?H[#"EO$D42+'$BA51!@*!P !V%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M6A?"_0Y]"T<NFN:S*LOV<OYA(\B+[0) JQM&&;,@#9)VC KO/V@_C-!\?O\
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M)'Z$5XK^T9^Q]\,?VI+6S'CG1'EU*R0QVNL:?,;>\A0DDH' (9,DG:X8 DD
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M=V[?Q1GH?0CJ#[&@#0HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3A5 R22<<UE?L&6-OKO@S]K[4=0@CO+W5?$6J0WTTR!C<)Y=PVU_49ED./\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 <)\:-0UC3? MQ-HWF+)YBK<21??CA(.YAZ<[1GL":YS]
MG74-8N]"O8KPR2:7"R+:/)V/.Y5/<#CCM7JVH?\ 'C<_]<V_D:Y[X7_\D]T#
M_KT3^5 %OQ5X(T?QG:^3J=HLCJ/W=PGRRQ_[K?TZ>U<9N\7_  Q^\)/%OAU.
MX_X_+=?_ &8#\>G\(KU&B@##\+>--'\96GGZ7=K,RC+PM\LL?^\O4?7I6Y7%
M^*OA=INO77]HV,LFAZVIW+?V7RDG_;48W?H?>L:'Q]KO@69+7QK9>=9DA8];
ML$+1G_KHHZ'Z >P/6@#TVBN8NOB9X9L_(\S5X2)T$D31JT@8'/=0>>#QUXKI
M482*K*<JPR* '4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%9^K:_IN@PF;4;ZWL
MH\9S-(%S]!W_  KS[6OVAO#6GAELDNM3D!P#&GEH?Q;G]* /4:*^=]4_:4UB
MXR+#3+.S!Z-*S2L/_01^E<S??&WQC?9_XFOV=?[L$*+^N,_K0!]745\9WGCK
MQ%J!_P!(US4)!_=^TN!^0.*RYM2N[CF6ZFE/^W(3_6@#[@HKX89F<Y8EC[FG
MK=31L"LTBD=PQ% 'W)17Q5;^*-9LV!@U:^A(Z>7<NO\ (UMV?Q:\7V./+UVY
M?'_/;;+_ .A T ?75%?,^G?M$>*+1A]I2ROD[^9$4/YJ1_*NQT7]I6PF94U7
M29[7UDMG$H_(X(_6@#V>BN8\/_$OPUXFPMEJL/G'_EC,?*?\ V,_AFNGH **
M** "BBB@ HHHH **** "OBS]NS_DXK]E/_L:F_\ 2O3:^TZ^+/V[/^3BOV4_
M^QJ;_P!*]-KT<O\ ]X7I+_TEDRV/M.BBBO.*"BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OGG]OSQ:_@7]E7QCKL>
MD>&=>EL3:2KIWBZT2ZL)\7,65:)_E=\9V#(.[&.<"OH:O'?VNO%'@#P5^SYX
MKUWXFZ''XE\(V,<4DVD2)O\ M<QF18(P/4RE.>B\L> : / _A7\=OV*?[#\.
M^)8(OA7X<\1K;Q3N\7AVWL+BUN=@WA 8@Z8;< 03[$]:^T])U6TUW2[/4M/N
M$N["\A2XM[B,Y62-U#*P]B"#^-?DOI6N>#M'\-_$;7O&W['OAO24\'76A3WF
MB689[VWTR_6Y9[B1B<%D$,1"[4QO(;;@D?JUX+FTFX\':%+H")%H3V$#:>D8
MPJVYC4Q #L-FV@#9HHHH **** "BBB@ KYE_97U#0]8\8:Y?>&_ >H?#+1GL
ME%OX5U31TTFXLOG4-OM4.V/>RM(,?>$@;JU?35?/WP U[Q5XK^)'B?6/&?@\
M^!/$5Q:1"ZT'^THM1%KMVJG^D1 (^]%5^!QOVGD&M([2]#R<<FZN&M_/_P"V
M3/H&BBBLSU@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@#/UZQO-2TJ>VL;X:=<R !;AH1*%&>?
ME)&<C(Z]ZSO _AJ\\)Z+'IMUJ@U..$!(&%L(?+0#[O#'/U-=#10 4444 %1S
M01W,+Q31K+$XVM&Z@JP]"#UJ2B@#Q'X@>#;/P;XBT2[\-WL.E7]S>;EL;B8"
MWW!&P^T] ?N^GS\8KKM"^*T:7R:3XILV\.ZOT!F_X]Y?='Z?F<>YKS[XT?#W
M6=4\>6UW;,MQ!JCI;P!I OE.J<J<GIA6;(]^_7V!?!MGJ'A.QT76HH]3$%O'
M$\C@Y+*H!93U!XZ]: .@SGD<BEKR]O#OBOX;?O/#\[>(]#3DZ5=M^_B7TC;O
M]/\ QT]:ZCPA\1M'\8[H;>5K74(^);"Z&R9".O'<#V_'% '44444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%>9?%CXN1^#8VTW3MLVL.O+'E8 >A/J?:@#K/%WCS1O!-KYNI7065ES';
M1_-+)]%_J>*\,\7?M :UK#-#I"C2+7^^N&F8>Y/ _#\Z\TU+4KK5[R2[O;B2
MYN9#EI)#DFJU $UY?7&HW#W%U/)<SN<M)*Q9C]2:AHHH **** "BBB@ HHHH
M **** "BBB@ KKO"WQ4\1^$VC2VOVN+1/^76Y_>1X]!GE?P(KD:* /IWP3\=
M-&\3,EK?XTB^;  E;]TY]%;M]#BO2J^&*]1^%_QFN_#$T6G:O*]WI+$*KMR\
M'T/=?;\J /I>BHK>XBO+>.>&1989%#(ZG((/0U+0 4444 %%%% !7Q9^W9_R
M<5^RG_V-3?\ I7IM?:=?%G[=G_)Q7[*?_8U-_P"E>FUZ.7_[PO27_I+)EL?:
M=%%%><4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%)H)$FAD&Y)(V#*P]01U% $E%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ JEK6G'6-&O[ 2F W4$D'FKU3<I&?
MPS5VB@#Y\^%_PAN4\8W[:L;6>STQWMYH?OB=FCXX(Z8<-D\Y X].WN/A[K7@
MF:2\\$WN;8G=)HM\Y:)_]QB>#]2/KVKH/!W_ ",7B_\ ["*_^B(JZR@#BO#/
MQ2T_6+S^S-3ADT'6U(5K*]^7<?\ 8;HWMT)[9KM:Q?%'@[2?&%G]GU2T6<#[
MDHXDC/JK=1_*N(^S>+_AD<V[2>+?#J_\L7/^F0+['^(#\?HM 'J-%<_X3\=:
M/XTMC)IMR&E4?O+63Y9H_P#>7^HR/>D\=:YJ/AOP_<:GI\%K<?95,DR7+LOR
M ?PX!R<XZXH Z&BJ&AS7USI<$NHQV\=VXW,MJS-& 3Q@L >F.W6K] !1110
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MQ" 0I&B_(!@*6"AB,<<GF@"/7/%*ZUXVNM<N;9;R&2Z\W[--D!HP<*AP?[H
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MWK.G^(-%NO\ A$_(U'2[I+FWFVZ=,C;)$)5L,K*<'@J1U% 'V!1110 4444
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MZ.HKG?A_XVL?B)X1T_7]/22*"Z5MT,PQ)$ZL5=&'J&4C]:Z*@ HHHH ****
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MO _P*T?PRZ76HD:O?+@CS5_=(?4+W/N:],I:* "BBB@ HHHH **** "BBB@
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MPR![XS7<444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M5J^&CR.5Y=/1K_VZ_P F?=]%>5?\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\
MHLGP_P#_  J+'_X[6)] >JT5Y5_PUC\$/^BR?#__ ,*BQ_\ CM'_  UC\$/^
MBR?#_P#\*BQ_^.T >JT5Y5_PUC\$/^BR?#__ ,*BQ_\ CM'_  UC\$/^BR?#
M_P#\*BQ_^.T >JT5Y5_PUC\$/^BR?#__ ,*BQ_\ CM'_  UC\$/^BR?#_P#\
M*BQ_^.T >JT5Y5_PUC\$/^BR?#__ ,*BQ_\ CM'_  UC\$/^BR?#_P#\*BQ_
M^.T >JT5Y5_PUC\$/^BR?#__ ,*BQ_\ CM'_  UC\$/^BR?#_P#\*BQ_^.T
M>JT5Y5_PUC\$/^BR?#__ ,*BQ_\ CM'_  UC\$/^BR?#_P#\*BQ_^.T >JT5
MY5_PUC\$/^BR?#__ ,*BQ_\ CM'_  UC\$/^BR?#_P#\*BQ_^.T >JT5Y5_P
MUC\$/^BR?#__ ,*BQ_\ CM'_  UC\$/^BR?#_P#\*BQ_^.T >JT5Y5_PUC\$
M/^BR?#__ ,*BQ_\ CM'_  UC\$/^BR?#_P#\*BQ_^.T >JT5Y5_PUC\$/^BR
M?#__ ,*BQ_\ CM'_  UC\$/^BR?#_P#\*BQ_^.T >JT5Y5_PUC\$/^BR?#__
M ,*BQ_\ CM'_  UC\$/^BR?#_P#\*BQ_^.T >JT5Y5_PUC\$/^BR?#__ ,*B
MQ_\ CM'_  UC\$/^BR?#_P#\*BQ_^.T >JT5Y5_PUC\$/^BR?#__ ,*BQ_\
MCM'_  UC\$/^BR?#_P#\*BQ_^.T >JT5Y5_PUC\$/^BR?#__ ,*BQ_\ CM'_
M  UC\$/^BR?#_P#\*BQ_^.T >JT5Y5_PUC\$/^BR?#__ ,*BQ_\ CM'_  UC
M\$/^BR?#_P#\*BQ_^.T >JT5Y5_PUC\$/^BR?#__ ,*BQ_\ CM'_  UC\$/^
MBR?#_P#\*BQ_^.T >JT5Y5_PUC\$/^BR?#__ ,*BQ_\ CM'_  UC\$/^BR?#
M_P#\*BQ_^.T >JT5Y5_PUC\$/^BR?#__ ,*BQ_\ CM'_  UC\$/^BR?#_P#\
M*BQ_^.T >JT5Y5_PUC\$/^BR?#__ ,*BQ_\ CM'_  UC\$/^BR?#_P#\*BQ_
M^.T >JT5Y5_PUC\$/^BR?#__ ,*BQ_\ CM'_  UC\$/^BR?#_P#\*BQ_^.T
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MC_\ ': /5:*\J_X:Q^"'_19/A_\ ^%18_P#QVC_AK'X(?]%D^'__ (5%C_\
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MTD+-A59C@<!2>@H ] HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P#_  E['_XU7JM% 'E7_#)WP0_Z(W\/_P#PE['_ .-4?\,G?!#_ *(W\/\
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M9C^#MK8W-E#\)_ \-G=;3/;Q^'+-8Y=IRN]1'AL'D9Z55_X9.^"'_1&_A_\
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MRAOHW]G+X[Z+^TE\(-"\?:%!-96VHJZ2V5PP:2UFC<I)&Q'7#*<'C((.!G%
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M=YO$HW2C;R1YO'^Z* /?H9DN(8Y8F#QR*&5AT((R#3Z15"*%4!5 P !P*6@
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MB=H_[,<7[4ES\0K*XU#XI^'+]]9\3:U;3+)!K.^23R5MU5$$.Z65L@CK/DD
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MX7R_KG_@F;XD\(^(/V1/"J>#])NM&M=/DGLKZWO)O/D:]#[YI/,PNX.7##
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BOBC]O;X]?%_X<?%GX.>!OA+J^F:5J7C26ZM&.J6D<L1E
M5X%C)9D8J!YC9P#7GGBC]I#]JO\ 8_UCP[K_ ,<K3PQXP^&NHW\=AJ&H^'X]
MLMAO_B&U$.0 S %&5MNW<I8&@#]&J*\W^*O[1WPS^"-O83>.?&>E^'1J">9:
M1W,I:6=.,ND:@L5Y'S 8YK,_X:R^$3?#&7XAQ>.],N?!D-RMG/JUKOF2WG8
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MAL#[$K&\)>#- \ Z)#HWAG0].\/:3"28['2[5+:!2>I"( ,GN<<ULT %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
40 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>May 02, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37722<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SPYRE THERAPEUTICS, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">46-4312787<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">221 Crescent Street<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Building 23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine3', window );">Entity Address, Address Line Three</a></td>
<td class="text">Suite 105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Waltham<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02453<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">651-5940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.0001 Par Value Per Share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SYRE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,353,561<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001636282<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 3 such as an Office Park</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>CURRENT ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 48,493<span></span>
</td>
<td class="nump">$ 89,423<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">516,327<span></span>
</td>
<td class="nump">513,665<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">4,948<span></span>
</td>
<td class="nump">5,386<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">569,768<span></span>
</td>
<td class="nump">608,474<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">569,778<span></span>
</td>
<td class="nump">608,484<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">CVR liability</a></td>
<td class="nump">42,810<span></span>
</td>
<td class="nump">25,080<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities', window );">Accrued and other current liabilities</a></td>
<td class="nump">21,631<span></span>
</td>
<td class="nump">27,711<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">70,678<span></span>
</td>
<td class="nump">54,060<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Non-current CVR liability</a></td>
<td class="nump">16,490<span></span>
</td>
<td class="nump">36,620<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">TOTAL LIABILITIES</a></td>
<td class="nump">87,168<span></span>
</td>
<td class="nump">90,680<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies (Note 6 and 7)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>STOCKHOLDERS&#8217; EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.0001 par value; 400,000,000 shares authorized as of March&#160;31, 2025 and December&#160;31, 2024; 60,275,561 shares and 60,257,023 shares issued and outstanding as of March&#160;31, 2025 and December&#160;31, 2024, respectively.</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">1,343,300<span></span>
</td>
<td class="nump">1,334,223<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">682<span></span>
</td>
<td class="nump">180<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(1,017,205)<span></span>
</td>
<td class="num">(972,432)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">TOTAL STOCKHOLDERS&#8217; EQUITY</a></td>
<td class="nump">482,610<span></span>
</td>
<td class="nump">517,804<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#8217; EQUITY</a></td>
<td class="nump">569,778<span></span>
</td>
<td class="nump">608,484<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=syre_SeriesANonVotingConvertiblePreferredStockMember', window );">Series A Non Voting Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>STOCKHOLDERS&#8217; EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Series A non-voting convertible preferred stock &amp; preferred stock shares authorized, issued, and outstanding, value</a></td>
<td class="nump">146,425<span></span>
</td>
<td class="nump">146,425<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=syre_SeriesBNonVotingConvertiblePreferredStockMember', window );">Series B Non Voting Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>STOCKHOLDERS&#8217; EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Series A non-voting convertible preferred stock &amp; preferred stock shares authorized, issued, and outstanding, value</a></td>
<td class="nump">9,395<span></span>
</td>
<td class="nump">9,395<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=syre_PreferredStockExcludingSeriesAAndBNonVotingConvertiblePreferredStockMember', window );">Preferred Stock, Excluding Series A Non Voting Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>STOCKHOLDERS&#8217; EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Series A non-voting convertible preferred stock &amp; preferred stock shares authorized, issued, and outstanding, value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Related party accounts payable</a></td>
<td class="nump">2,548<span></span>
</td>
<td class="nump">603<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember', window );">Nonrelated Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">$ 3,689<span></span>
</td>
<td class="nump">$ 666<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483466/210-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483466/210-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=syre_SeriesANonVotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=syre_SeriesANonVotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=syre_SeriesBNonVotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=syre_SeriesBNonVotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=syre_PreferredStockExcludingSeriesAAndBNonVotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=syre_PreferredStockExcludingSeriesAAndBNonVotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (in shares)</a></td>
<td class="nump">400,000,000<span></span>
</td>
<td class="nump">400,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued (in shares)</a></td>
<td class="nump">60,275,561<span></span>
</td>
<td class="nump">60,257,023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding (in shares)</a></td>
<td class="nump">60,275,561<span></span>
</td>
<td class="nump">60,257,023<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=syre_SeriesANonVotingConvertiblePreferredStockMember', window );">Series A Non Voting Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized (in shares)</a></td>
<td class="nump">1,086,341<span></span>
</td>
<td class="nump">1,086,341<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, issued (in shares)</a></td>
<td class="nump">346,045<span></span>
</td>
<td class="nump">346,045<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding (in shares)</a></td>
<td class="nump">346,045<span></span>
</td>
<td class="nump">346,045<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=syre_SeriesBNonVotingConvertiblePreferredStockMember', window );">Series B Non Voting Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized (in shares)</a></td>
<td class="nump">271,625<span></span>
</td>
<td class="nump">271,625<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, issued (in shares)</a></td>
<td class="nump">16,667<span></span>
</td>
<td class="nump">16,667<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding (in shares)</a></td>
<td class="nump">16,667<span></span>
</td>
<td class="nump">16,667<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=syre_PreferredStockExcludingSeriesAAndBNonVotingConvertiblePreferredStockMember', window );">Preferred Stock, Excluding Series A Non Voting Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized (in shares)</a></td>
<td class="nump">8,642,034<span></span>
</td>
<td class="nump">8,642,034<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=syre_SeriesANonVotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=syre_SeriesANonVotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=syre_SeriesBNonVotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=syre_SeriesBNonVotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=syre_PreferredStockExcludingSeriesAAndBNonVotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=syre_PreferredStockExcludingSeriesAAndBNonVotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Research and development</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 41,623<span></span>
</td>
<td class="nump">$ 34,928<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">11,944<span></span>
</td>
<td class="nump">12,846<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">53,567<span></span>
</td>
<td class="nump">47,774<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(53,567)<span></span>
</td>
<td class="num">(47,774)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Interest income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,493<span></span>
</td>
<td class="nump">4,432<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,286<span></span>
</td>
<td class="num">(483)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,779<span></span>
</td>
<td class="nump">3,949<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income tax expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(44,788)<span></span>
</td>
<td class="num">(43,825)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (expense)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">15<span></span>
</td>
<td class="num">(32)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(44,773)<span></span>
</td>
<td class="num">(43,857)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=syre_SeriesANonVotingConvertiblePreferredStockMember', window );">Series A Non Voting Convertible Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (8,288)<span></span>
</td>
<td class="num">$ (12,642)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share, basic (in dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (23.95)<span></span>
</td>
<td class="num">$ (28.93)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share, diluted (in dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (23.95)<span></span>
</td>
<td class="num">$ (28.93)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average common stock outstanding, basic (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">346,045<span></span>
</td>
<td class="nump">437,037<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average common stock outstanding, diluted (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">346,045<span></span>
</td>
<td class="nump">437,037<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=syre_SeriesBNonVotingConvertiblePreferredStockMember', window );">Series B Non Voting Convertible Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (399)<span></span>
</td>
<td class="num">$ (4,810)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share, basic (in dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (23.95)<span></span>
</td>
<td class="num">$ (28.93)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share, diluted (in dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (23.95)<span></span>
</td>
<td class="num">$ (28.93)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average common stock outstanding, basic (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">16,667<span></span>
</td>
<td class="nump">166,261<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average common stock outstanding, diluted (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">16,667<span></span>
</td>
<td class="nump">166,261<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (36,086)<span></span>
</td>
<td class="num">$ (26,405)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share, basic (in dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (0.60)<span></span>
</td>
<td class="num">$ (0.72)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share, diluted (in dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (0.60)<span></span>
</td>
<td class="num">$ (0.72)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average common stock outstanding, basic (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">60,265,932<span></span>
</td>
<td class="nump">36,512,662<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average common stock outstanding, diluted (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">60,265,932<span></span>
</td>
<td class="nump">36,512,662<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Includes $2.5 million and $17.1 million in related party expenses for the three months ended March&#160;31, 2025 and 2024, respectively.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Includes $0.3 million in related party expenses for the three months ended March&#160;31, 2025 and 2024.</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Excludes cost for computer software product to be sold, leased, or otherwise marketed, writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both, and write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=syre_SeriesANonVotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=syre_SeriesANonVotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=syre_SeriesBNonVotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=syre_SeriesBNonVotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations (Parenthetical) - Related Party - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Research and Development Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Amount of related party transaction</a></td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="nump">$ 17,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Amount of related party transaction</a></td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transactions with related party during the financial reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAmountsOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (44,773)<span></span>
</td>
<td class="num">$ (43,857)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized gain (loss) on marketable securities</a></td>
<td class="nump">488<span></span>
</td>
<td class="num">(681)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive loss</a></td>
<td class="num">$ (44,271)<span></span>
</td>
<td class="num">$ (44,522)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481839/830-10-45-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482014/830-20-35-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Changes in Convertible Preferred Stock and Stockholders' Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Series A Non Voting Convertible Preferred Stock</div></th>
<th class="th"><div>Series B Non Voting Convertible Preferred Stock</div></th>
<th class="th">
<div>Preferred Stock </div>
<div>Series A Non Voting Convertible Preferred Stock</div>
</th>
<th class="th">
<div>Preferred Stock </div>
<div>Series B Non Voting Convertible Preferred Stock</div>
</th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Beginning balance at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 84,555<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Series A/B non-voting convertible preferred stock in connection with private placement, net of financing costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Issuance of Series A/B non-voting convertible preferred stock in connection with private placement, net of financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 168,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">272,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance at Mar. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 253,405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Beginning balance, preferred stock (in shares) at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">437,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2023</a></td>
<td class="nump">$ 184,016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 184,927<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 763,191<span></span>
</td>
<td class="nump">$ 302<span></span>
</td>
<td class="num">$ (764,414)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance, common stock (in shares) at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,057,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_StockIssuedDuringPeriodSharesOptionsExercisedAndEmployeeStockOwnershipPlan', window );">Issuance of common stock in connection with exercise of stock options and employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">572,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_StockIssuedDuringPeriodValueOptionsExercisedAndEmployeeStockOwnershipPlan', window );">Issuance of common stock in connection with exercise of stock options and employee stock purchase plan</a></td>
<td class="nump">4,390<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,390<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">8,385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized gain (loss) on marketable securities</a></td>
<td class="num">(681)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(681)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(43,857)<span></span>
</td>
<td class="num">$ (12,642)<span></span>
</td>
<td class="num">$ (4,810)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(43,857)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Ending balance, preferred stock (in shares) at Mar. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">437,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2024</a></td>
<td class="nump">152,269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 184,927<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">775,966<span></span>
</td>
<td class="num">(363)<span></span>
</td>
<td class="num">(808,271)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance, common stock (in shares) at Mar. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,629,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Beginning balance, preferred stock (in shares) at Dec. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">346,045<span></span>
</td>
<td class="nump">16,667<span></span>
</td>
<td class="nump">346,000<span></span>
</td>
<td class="nump">17,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2024</a></td>
<td class="nump">$ 517,804<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 146,425<span></span>
</td>
<td class="nump">$ 9,395<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">1,334,223<span></span>
</td>
<td class="nump">180<span></span>
</td>
<td class="num">(972,432)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance, common stock (in shares) at Dec. 31, 2024</a></td>
<td class="nump">60,257,023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,257,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_StockIssuedDuringPeriodSharesOptionsExercisedAndEmployeeStockOwnershipPlan', window );">Issuance of common stock in connection with exercise of stock options and employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_StockIssuedDuringPeriodValueOptionsExercisedAndEmployeeStockOwnershipPlan', window );">Issuance of common stock in connection with exercise of stock options and employee stock purchase plan</a></td>
<td class="nump">$ 335<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">335<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">8,859<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,859<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_ShareBasedPaymentArrangementSettlementOptionsCash', window );">Cash settlement of stock option award</a></td>
<td class="num">(117)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(117)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized gain (loss) on marketable securities</a></td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(44,773)<span></span>
</td>
<td class="num">$ (8,288)<span></span>
</td>
<td class="num">$ (399)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(44,773)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Ending balance, preferred stock (in shares) at Mar. 31, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">346,045<span></span>
</td>
<td class="nump">16,667<span></span>
</td>
<td class="nump">346,000<span></span>
</td>
<td class="nump">17,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2025</a></td>
<td class="nump">$ 482,610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 146,425<span></span>
</td>
<td class="nump">$ 9,395<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">$ 1,343,300<span></span>
</td>
<td class="nump">$ 682<span></span>
</td>
<td class="num">$ (1,017,205)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance, common stock (in shares) at Mar. 31, 2025</a></td>
<td class="nump">60,275,561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,276,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_ShareBasedPaymentArrangementSettlementOptionsCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Payment Arrangement, Settlement, Options, Cash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_ShareBasedPaymentArrangementSettlementOptionsCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_StockIssuedDuringPeriodSharesOptionsExercisedAndEmployeeStockOwnershipPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Options Exercised And Employee Stock Ownership Plan</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_StockIssuedDuringPeriodSharesOptionsExercisedAndEmployeeStockOwnershipPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_StockIssuedDuringPeriodValueOptionsExercisedAndEmployeeStockOwnershipPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, Options Exercised And Employee Stock Ownership Plan</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_StockIssuedDuringPeriodValueOptionsExercisedAndEmployeeStockOwnershipPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Stock Issued During Period, Shares, New Issues</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481839/830-10-45-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482014/830-20-35-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.E.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of new stock classified as temporary equity issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (44,773)<span></span>
</td>
<td class="num">$ (43,857)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">8,859<span></span>
</td>
<td class="nump">13,835<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Change in fair value of CVR liability</a></td>
<td class="num">(2,400)<span></span>
</td>
<td class="nump">430<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Net accretion of discount on marketable securities</a></td>
<td class="num">(2,642)<span></span>
</td>
<td class="num">(2,423)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_InterestProceedsDebtSecurities', window );">Interest proceeds from maturities of zero coupon US Treasury Bills</a></td>
<td class="nump">530<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade', window );">Accounts payable</a></td>
<td class="nump">3,023<span></span>
</td>
<td class="nump">2,210<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities', window );">Accrued and other liabilities</a></td>
<td class="num">(5,998)<span></span>
</td>
<td class="nump">8,151<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccountsPayable', window );">Related party accounts payable</a></td>
<td class="nump">1,945<span></span>
</td>
<td class="num">(6,507)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="nump">462<span></span>
</td>
<td class="num">(381)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(40,994)<span></span>
</td>
<td class="num">(28,542)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities', window );">Proceeds from maturities and sales of marketable securities</a></td>
<td class="nump">71,383<span></span>
</td>
<td class="nump">47,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Purchases of marketable securities</a></td>
<td class="num">(71,444)<span></span>
</td>
<td class="num">(152,713)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(61)<span></span>
</td>
<td class="num">(104,963)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds from issuance of Series B non-voting convertible preferred stock in connection with private placement, net of placement and other offering costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">169,205<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Payments related to CVR</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,430)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_PaymentForDeferredOfferingCosts', window );">Payment of deferred offering costs in connection with shelf registration</a></td>
<td class="num">(93)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds from employee stock option exercises and employee stock plan purchases</a></td>
<td class="nump">335<span></span>
</td>
<td class="nump">4,390<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_PaymentForSettlementOfShareBasedPaymentArrangement', window );">Cash settlement of employee stock option award</a></td>
<td class="num">(117)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">125<span></span>
</td>
<td class="nump">172,165<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate on cash, cash equivalents, and restricted cash</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">NET (DECREASE) INCREASE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH</a></td>
<td class="num">(40,930)<span></span>
</td>
<td class="nump">38,656<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract', window );"><strong>CASH, CASH EQUIVALENTS, AND RESTRICTED CASH</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Beginning of period</a></td>
<td class="nump">89,423<span></span>
</td>
<td class="nump">189,215<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">End of period</a></td>
<td class="nump">48,493<span></span>
</td>
<td class="nump">227,871<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental Disclosure of Non-Cash Investing and Financing Information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_DeferredOfferingCostsUnpaidAmount', window );">Unpaid deferred offering costs in connection with shelf registration</a></td>
<td class="nump">69<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_IssuanceOfConvertiblePreferredStockRelatedToPrivatePlacementUnpaidAmount', window );">Unpaid amounts related to issuance of Series B non-voting convertible preferred stock in connection with private placement</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">355<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Reconciliation of Cash, Cash Equivalents, and Restricted Cash Reported in the Statement of Financial Position:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">48,493<span></span>
</td>
<td class="nump">227,552<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">319<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents, and restricted cash shown in the statement of cash flows</a></td>
<td class="nump">$ 48,493<span></span>
</td>
<td class="nump">$ 227,871<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_DeferredOfferingCostsUnpaidAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Offering Costs, Unpaid Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_DeferredOfferingCostsUnpaidAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_InterestProceedsDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Proceeds, Debt Securities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_InterestProceedsDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_IssuanceOfConvertiblePreferredStockRelatedToPrivatePlacementUnpaidAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Convertible Preferred Stock Related to Private Placement, Unpaid Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_IssuanceOfConvertiblePreferredStockRelatedToPrivatePlacementUnpaidAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_PaymentForDeferredOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment For Deferred Offering Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_PaymentForDeferredOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_PaymentForSettlementOfShareBasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment For Settlement Of Share-Based Payment Arrangement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_PaymentForSettlementOfShareBasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDerivativeInstrumentsNetPretax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableTrade</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in accrued expenses, and obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligations classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (f)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-11<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The Company and Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">The Company and Basis of Presentation</a></td>
<td class="text">The Company and Basis of Presentation<div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Spyre Therapeutics, Inc., formerly Aeglea BioTherapeutics, Inc. (&#8220;Spyre&#8221; or the &#8220;Company&#8221;), is a clinical stage biotechnology company focused on developing next generation therapeutics for patients living with inflammatory bowel disease and other immune-mediated diseases. The Company was formed as a Limited Liability Company in Delaware on December 16, 2013 under the name Aeglea BioTherapeutics Holdings, LLC and was converted from a Delaware LLC to a Delaware corporation on March 10, 2015. On November 27, 2023, the Company completed its corporate rebranding, changing the name of the Company to Spyre Therapeutics, Inc. The Company operates in one segment and has its principal offices in Waltham, Massachusetts.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 22, 2023, the Company acquired, in accordance with the terms of the Agreement and Plan of Merger (the "Acquisition Agreement"), the assets of Spyre Therapeutics, Inc. (&#8220;Pre-Merger Spyre&#8221;), a privately held biotechnology company advancing a pipeline of antibody therapeutics with the potential to transform the treatment of inflammatory bowel disease through a research and development option agreement (as amended, the "Paragon Agreement") with Paragon Therapeutics, Inc. ("Paragon") and Parapyre Holding LLC (&#8220;Parapyre&#8221;) (the "Asset Acquisition"). The Asset Acquisition was accomplished through a two-step reverse triangular merger whereby Aspen Merger Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of the Company ("First Merger Sub"), merged with and into Pre-Merger Spyre, which existed at the time the Acquisition Agreement was entered into, and became a wholly owned subsidiary of the Company in accordance with the terms of the Acquisition Agreement. Immediately following this merger, Pre-Merger Spyre merged with and into Sequoia Merger Sub II, LLC, a Delaware limited liability company and a wholly subsidiary of the Company (&#8220;Second Merger Sub&#8221;), in accordance with the terms of the Acquisition Agreement and Pre-Merger Spyre ceased to exist. Subsequently, Aeglea BioTherapeutics, Inc. was renamed Spyre Therapeutics, Inc. and is a different entity than Pre-Merger Spyre, which ceased to exist upon merging with Second Merger Sub.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Asset Acquisition, a non-transferable contingent value right ("CVR") was distributed to stockholders of record of the Company as of the close of business on July 3, 2023 (the "Legacy Stockholders"). Holders of the CVRs will be entitled to receive cash payments from proceeds received by the Company for a three-year period related to the disposition or monetization of its legacy assets for a period of one-year following the closing of the Asset Acquisition.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 20, 2024, the Company completed a private placement of Series B non-voting convertible preferred stock, par value of $0.0001 per share ("Series B Preferred Stock") (convertible on a 40 to 1 basis) (the &#8220;March 2024 PIPE&#8221;) to a group of investors. The Company sold 121,625 shares of Series B Preferred Stock at $1,480 per share. The net proceeds from this offering were approximately $168.9 million after deducting placement and offering costs of $11.2 million.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 23, 2024, the Company entered into an exchange agreement with Fairmount Healthcare Fund II L.P. (the &#8220;Stockholder&#8221;), pursuant to which the Stockholder agreed to exchange an aggregate of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90,992</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shares of Series A non-voting convertible preferred stock, par val</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ue of $0.0001 per share ("Se</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ries A Preferred Stock"), par value of  for an aggregate of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,639,680</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shares of the Company's common stock (the &#8220;April 2024 Exchange&#8221;). The common stock issued in connection with the April 2024 Exchange was issued without registration under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;) in reliance on the exemption from registration contained in Section 3(a)(9) of the Securities Act. The April 2024 Exchange closed on April 25, 2024, with </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">346,045</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shares of Series A Preferred Stock remaining outstanding following the April 2024 Exchange.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 14, 2024, the Company's stockholders approved the issuance of its common stock upon conversion of the Company's Series B Preferred Stock to common stock. A total of 254,958 shares of Series B </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preferred Stock automatically converted to 10,198,320 shares of common stock; 16,667 shares of Series B Preferred Stock did not automatically convert and remained outstanding as of March&#160;31, 2025.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 6, 2024, the Company filed a new shelf registration statement on Form S-3 that was declared effective by the SEC for the potential offering, issuance and sale by the Company of up to $500.0&#160;million of its common stock, preferred stock, debt securities, warrants and/or units consisting of all or some of these securities. Concurrent with the filing of the shelf-registration statement, the Company entered into a sales agreement, dated September 6, 2024, with TD Securities (USA) LLC (&#8220;TD Cowen&#8221;) ("Sales Agreement"), as its sales agent, pursuant to which the Company may issue and sell shares of its common stock for an aggregate offering price of up to $200.0&#160;million under an at-the-market (&#8220;ATM&#8221;) offering program included in the shelf registration. During the year ended December 31, 2024, the Company sold an aggregate of 777,432 shares of common stock under the ATM at an average price per share of $26.935, resulting in aggregate net proceeds of approximately $20.5 million after deducting $0.4 million in commissions paid to TD Cowen as sales agent and other offering costs. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 18, 2024, the Company entered into an underwriting agreement (the "Underwriting Agreement") with Jefferies LLC, Goldman Sachs &amp; Co. LLC, Evercore Group L.L.C. and Guggenheim Securities, LLC as representatives of the several underwriters (collectively, the "Underwriters"), pursuant to which the Company sold an aggregate of 8,366,250 shares of its common stock, inclusive of 1,091,250 shares pursuant to the full exercise of the Underwriters' over-allotment option, at a public offering price per share of $27.50, resulting in net proceeds of approximately $215.9&#160;million after deducting approximately $14.2&#160;million of underwriting discounts and other offering costs (the "November 2024 Offering"). The November 2024 Offering closed on November 20, 2024 and the over-allotment option was exercised in full on November 26, 2024 and closed on November 29, 2024. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2025, the Company filed a new shelf registration statement on Form S-3 (the "February 2025 Shelf Registration Statement") that was declared effective by the SEC for the potential offering, issuance and sale of up to $500.0&#160;million of shares of common stock, preferred stock, debt securities, warrants and/or units consisting of all or some of these securities. Concurrent with the effectiveness of the February 2025 Shelf Registration Statement, the offering of unsold securities under a previous shelf registration statement on Form S-3 (File No. 333-281975), which was initially filed with the SEC on September 6, 2024 and became effective on September 18, 2024, was deemed terminated pursuant to Rule 415(a)(6) under the Securities Act. The February 2025 Shelf Registration Statement contains a sales agreement prospectus supplement covering the offering, issuance and sale by the Company of up to $179.1&#160;million of shares of common stock that may be issued and sold under the Sales Agreement in connection with the ATM offering program. No shares were sold under the ATM offering program during the three months ended March 31, 2025.  As of March 31, 2025, $179.1&#160;million remained available for sale under the Sales Agreement. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a clinical stage biotechnology company with a limited operating history, and due to its significant research and development expenditures, the Company has generated operating losses since its inception and has not generated any revenue from the commercial sale of any products. There can be no assurance that profitable operations will ever be achieved, and, if achieved, whether profitability can be sustained on a continuing basis.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since its inception and through March&#160;31, 2025, the Company has funded its operations by raising an aggregate of approximately $1.3&#160;billion of gross proceeds from the sale and issuance of convertible preferred stock and common stock, pre-funded warrants, the collection of grant proceeds, and the licensing of its product rights for commercialization of pegzilarginase in Europe and certain countries in the Middle East. As of March&#160;31, 2025, Spyre had an accumulated deficit of $1.0&#160;billion, and cash, cash equivalents, and marketable securities of $564.8&#160;million.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on its current operating plans, the Company has sufficient resources to fund operations for at least one year from the issuance date of these financial statements with existing cash, cash equivalents, and marketable securities. The Company will need to secure additional financing in the future to fund additional research and development, and before a commercial drug can be produced, marketed and sold. If the Company </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is unable to obtain additional financing or generate license or product revenue, the lack of liquidity could have a material adverse effect on the Company.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States (&#8220;U.S. GAAP&#8221;) as defined by the Financial Accounting Standards Board and include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unaudited Interim Financial Information</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interim condensed consolidated financial statements included in this Quarterly Report on Form 10-Q are unaudited. The unaudited interim financial statements have been prepared on the same basis as the annual financial statements and reflect, in the opinion of management, all adjustments of a normal and recurring nature that are necessary for a fair statement of the Company&#8217;s financial position as of March&#160;31, 2025, and its results of operations for the three months ended March&#160;31, 2025 and 2024, changes in convertible preferred stock and stockholders&#8217; equity for the three months ended March&#160;31, 2025 and 2024, and cash flows for the three months ended March&#160;31, 2025 and 2024. The results of operations for the three months ended March&#160;31, 2025, are not necessarily indicative of the results to be expected for the year ending December&#160;31, 2025 or for any other future annual or interim period. The December&#160;31, 2024 balance sheet was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP for complete financial statements. These financial statements should be read in conjunction with the audited financial statements included in the Company&#8217;s Form 10-K for the year ended December&#160;31, 2024 (the "Annual Report") as filed with the SEC on February 27, 2025.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/810/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-top:18pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These interim condensed consolidated financial statements have been prepared in accordance with U.S. GAAP and SEC instructions for interim financial information, and should be read in conjunction with the Company's Annual Report. Significant accounting policies and other disclosures normally provided have been omitted since such items are disclosed in the Company's Annual Report. The Company uses the same accounting policies in preparing quarterly and annual financial statements.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no significant changes from the significant accounting policies and estimates disclosed in the Notes titled &#8220;1. The Company and Basis of Presentation&#8221; and "2. Summary of Significant Accounting Policies&#8221; of the Company's Annual Report.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no recent accounting pronouncements or changes in accounting pronouncements during the three months ended March&#160;31, 2025 that are of significance or potential significance to the Company.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Not Yet Adopted Accounting Pronouncements</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the Financial Accounting Standards Board&#8217;s ("FASB") issued Accounting Standards Update 2023-09 ("ASU 2023-09"), Income Taxes (Topic 740): Improvements to Income Tax Disclosures. ASU 2023-09 expands disclosures in an entity&#8217;s income tax rate reconciliation table and disclosures regarding taxes paid both in the U.S. and foreign jurisdictions. This update is effective for fiscal years beginning after December 15, 2024. ASU 2023-09 will have no impact on the Company&#8217;s consolidated financial condition or results of operations. The Company is currently evaluating the impact to its income tax disclosures.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, the Financial Accounting Standards Board issued Accounting Standards Update 2024-03 ("ASU 2024-03") Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses to require more detailed information about specified categories of expenses (purchases of inventory, employee compensation, depreciation, amortization, and depletion) included in certain expense captions presented on the face of the </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">income statement. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and for interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. The amendments may be applied either (1) prospectively to financial statements issued for reporting periods after the effective date of this ASU or (2) retrospectively to all prior periods presented in the financial statements. The Company is currently evaluating the impact ASU 2024-03 will have on its disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div style="margin-top:18pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures and reports certain financial instruments as assets and liabilities at fair value on a recurring basis. The following tables set forth the fair value of the Company&#8217;s financial assets and liabilities at fair value on a recurring basis based on the three-tier fair value hierarchy (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31, 2025</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 3</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46,800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46,800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 15.4pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government treasury securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">223,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">223,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 15.4pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72,730&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72,730&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 15.4pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">147,450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">147,450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 15.4pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72,647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72,647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total financial assets</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">270,300&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">292,827&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">563,127&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVR liability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59,300&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59,300&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 3</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65,902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65,902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government treasury securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">227,244&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">227,244&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86,681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86,681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 15.4pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">165,130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">165,130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 15.4pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56,448&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56,448&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total financial assets</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">293,146&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">308,259&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">601,405&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVR liability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61,700&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61,700&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures the fair value of money market funds and U.S. government treasury securities on quoted prices in active markets for identical assets or liabilities. The Level 2 assets include U.S. government agency securities, commercial paper and corporate bonds, and are valued based on quoted prices for similar assets in active markets and inputs other than quoted prices that are derived from observable market data. The Company evaluates transfers between levels at the end of each reporting period. There were no transfers between Level 1, Level 2, or Level 3 during the periods presented.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CVR Liability </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Asset Acquisition, a non-transferable CVR was distributed to the Legacy Stockholders. Holders of the CVR will be entitled to receive certain cash payments from proceeds received by </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company for a three-year period, if any, related to the disposition or monetization of the Company&#8217;s legacy assets for a period of one year following the closing of the Asset Acquisition.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the CVR liability was determined using the probability weighted discounted cash flow method to estimate future cash flows associated with the sale of the legacy assets. Analogous to a dividend being declared/approved in one period and paid out in another, the liability was recorded at the date of approval, June 22, 2023, as a common stock dividend, returning capital to the Legacy Stockholders. Changes in fair value of the liability will be recognized as a component of Other income (expense), net in the consolidated statement of operations and comprehensive loss in each reporting period. The liability value is based on significant inputs not observable in the market such as estimated cash flows, estimated probabilities of regulatory success, and discount rates, which represent a Level 3 measurement within the fair value hierarchy. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The significant inputs used to estimate the fair value of the CVR liability were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.748%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.052%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated cash flow dates</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">08/28/25 - 06/22/26</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated probability of success</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72% - 100%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated reimbursement rate compared to reimbursement target</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49% - 100%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk-adjusted discount rates</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.78% - 7.90%</span></div></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in fair value between December&#160;31, 2024 and March&#160;31, 2025 was a $2.4&#160;million decrease, primarily driven by changes in the likelihood of achievement of certain milestones and an increase in risk-adjusted discount rates, partially offset by  time value of money adjustments.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents changes in the CVR liability for the periods presented (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">CVR Liability</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning balance as of December 31, 2024</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61,700&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of the CVR liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,400)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ending Balance as of March 31, 2025</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59,300&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 107<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 940<br> -SubTopic 820<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478119/940-820-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash Equivalents and Marketable Securities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock', window );">Cash Equivalents and Marketable Securities</a></td>
<td class="text">Cash Equivalents and Marketable Securities<div style="margin-top:18pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the estimated fair value of the Company&#8217;s cash equivalents and marketable securities and the gross unrealized gains and losses (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31, 2025</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cost</span></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gains</span></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Losses</span></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Estimated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46,800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46,800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total cash equivalents</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46,800&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46,800&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">147,448&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">147,450&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72,618&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72,647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government treasury securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">222,942&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">638&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(80)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">223,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.68pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72,673&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72,730&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">515,681&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">807&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(161)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">516,327&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cost</span></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gains</span></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Losses </span></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Estimated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65,902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65,902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total cash equivalents</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87,734&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87,740&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">143,265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(77)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">143,292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56,471&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(48)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56,448&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government treasury securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">227,155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">385&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(296)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">227,244&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.68pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86,616&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(72)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86,681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">513,507&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">651&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(493)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">513,665&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the available-for-sale securities in an unrealized loss position for which an allowance for credit losses has not been recorded as of March&#160;31, 2025 and December&#160;31, 2024, aggregated by major security type and length of time in a continuous unrealized loss position:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.964%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31, 2025</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Less Than 12 Months</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">12 Months or Longer</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Losses </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Losses</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Losses </span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36,057&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(24)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36,057&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(24)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government treasury securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32,810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(80)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32,810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(80)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23,154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23,154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105,150&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(161)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105,150&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(161)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Less Than 12 Months</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">12 Months or Longer</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Losses </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Losses</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Losses </span></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67,200&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(77)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67,200&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(77)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42,916&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(48)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42,916&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(48)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government treasury securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">126,588&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(296)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">126,588&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(296)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(72)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(72)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">249,264&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(493)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">249,264&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(493)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluated its securities for credit losses and considered the decline in market value to be primarily attributable to current economic and market conditions and not to a credit loss or other factors. Additionally, the Company does not intend to sell the securities in an unrealized loss position and does not expect it will be required to sell the securities before recovery of the unamortized cost basis. As of March&#160;31, 2025 and December&#160;31, 2024, an allowance for credit losses had not been recognized. Given the Company's intent and ability to hold such securities until recovery, and the lack of significant change in credit risk of these </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">investments, the Company does not consider these marketable securities to be impaired as of March&#160;31, 2025 and December&#160;31, 2024. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial instruments that potentially subject the Company to a concentration of credit risk consist principally of cash deposits. Accounts at each of our two U.S. banking institutions are insured by the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) up to $250,000 per depositor. As of March&#160;31, 2025 and December&#160;31, 2024, cash deposits at the Company's U.S. banking institutions exceeded the FDIC limits.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no realized gains or losses on marketable securities for the three months ended March&#160;31, 2025 and 2024. Interest on marketable securities is included in interest income. Accrued interest receivable on available-for-sale debt securities as of March&#160;31, 2025 and December&#160;31, 2024, was $3.4 million and is reflected in Prepaid expenses and other current assets.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the contractual maturities of the Company&#8217;s marketable securities at estimated fair value (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due in one year or less</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">367,106&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">338,442&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due in 1 - 2 years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">149,221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">175,223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">516,327&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">513,665&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may sell investments at any time for use in current operations even if they have not yet reached maturity. As a result, the Company classifies marketable securities, including securities with maturities beyond twelve months as current assets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/320/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued and Other Current Liabilities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_AccruedAndOtherCurrentLiabilitiesTextBlock', window );">Accrued and Other Current Liabilities</a></td>
<td class="text">Accrued and Other Current Liabilities <div style="margin-top:18pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued and other current liabilities consist of the following (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued compensation</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,561&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,688&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued contracted research and development costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19,078&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,861&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued professional and consulting fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">621&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">661&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total accrued and other current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21,631&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27,711&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_AccruedAndOtherCurrentLiabilitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_AccruedAndOtherCurrentLiabilitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Licensing Agreements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_LicensingAgreementsAbstract', window );"><strong>Licensing Agreements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Licensing Agreements</a></td>
<td class="text">Licensing Agreements<div style="margin-top:18pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 12, 2023, December 14, 2023, and June 5, 2024, the Company exercised the Option available under the Paragon Agreement with respect to the SPY001, SPY002, and SPY003 research programs, respectively. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 14, 2024, the Company and Paragon entered into (i) a license agreement (the &#8220;SPY001 License Agreement&#8221;), pursuant to which Paragon granted the Company a royalty-bearing, world-wide, exclusive license to develop, manufacture, commercialize or otherwise exploit certain antibodies and products targeting &#945;4&#223;7 integrin and (ii) a license agreement (the &#8220;SPY002 License Agreement&#8221;), pursuant to which Paragon granted the Company a royalty-bearing, world-wide, exclusive license to develop, manufacture, commercialize or otherwise exploit certain antibodies and products targeting TL1A, respectively.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 11, 2024, the Company and Paragon entered into a license agreement (as amended, the "SPY003 License Agreement", and together with the SPY001 License Agreement and the SPY002 License Agreement, the "License Agreements"), pursuant to which Paragon granted the Company a royalty-bearing, </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">world-wide, exclusive license to develop, manufacture, commercialize or otherwise exploit certain antibodies and products targeting IL-23 in the field of IBD.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 24, 2025, the SPY003 License Agreement was amended and restated to, among other things, clarify each party's rights and obligations with respect to license exclusivity and patent prosecution.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of each License Agreement, the Company is obligated to pay Paragon up to $22.0 million based on specific development, regulatory and clinical milestones for the first product under each agreement, respectively, that achieves such specified milestones, including a milestone payment of $3.0 million upon the first dosing of a human patient in a Phase 2 trial. In addition, the following summarizes other key terms of each License Agreement:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Paragon will provide the Company with an exclusive license (such license, with respect to the SPY003 License Agreement only, being limited to the field of IBD) to its patents covering the related antibody, the method of use and its method of manufacture.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Paragon will not conduct any new campaigns that generate anti-&#945;4&#223;7 or anti-TL1A monospecific antibodies in any field or anti-IL-23 monospecific antibodies in the field of IBD, in each case for at least 5 years.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">The Company will pay Paragon a low single-digit percentage royalty for single antibody products and a mid single-digit percentage royalty for products containing more than one antibody from Paragon.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">There is a royalty step-down of 1/3rd if there is no Paragon patent in effect during the royalty term.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">The royalty term ends on the later of (i) the last-to-expire licensed patent or Company patent directed to the manufacture, use or sale of a licensed antibody in the country at issue or (ii) 12 years from the date of first sale of a Company product. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Agreement may be terminated on 60 days&#8217; notice by the Company; on material breach without cure; and to the extent permitted by law, on a party&#8217;s insolvency or bankruptcy.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">With respect to the SPY002 License Agreement only, on a product by product basis, the Company will pay sublicensing fees of up to approximately $20 million upon the achievement of mostly commercial milestones.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes the expense associated with each milestone when the achievement of the milestone is deemed probable. During the three months ended March&#160;31, 2025, the Company recognized expense of $2.5 million related to Paragon license milestone payments recorded within Research and development expenses in the accompanying condensed statement of operations. There was no such expense for the three months ended March&#160;31, 2024. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2025 and 2024, there were no cash milestone payments to Paragon. As of March&#160;31, 2025 and December 31, 2024, there were $2.5 million and nil, respectively, of Paragon license milestone payments outstanding and payable to Paragon. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Additionally, there were no expenses recognized related to sublicensing fees for the three months ended March&#160;31, 2025 and 2024. For the three months ended March&#160;31, 2025 and 2024, the Company made sublicensing fees payments to Paragon totaling $0.5 million and nil, respectively.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2025 and December 31, 2024, nil and $0.5 million in sublicensing fees were outstanding and payable to Paragon, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_LicensingAgreementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Licensing Agreements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_LicensingAgreementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org/808/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text">Related Party Transactions<div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Paragon and Parapyre each beneficially own less than 5% of a class of the Company's voting securities through their respective holdings of the Company's common stock. Fairmount Funds Management LLC ("Fairmount") beneficially owns more than 5% of a class of the Company's voting securities, has two seats on the Board (held by Peter Harwin and Tomas Kiselak) and beneficially owns more than 5% of Paragon. Fairmount appointed Paragon's board of directors and has the contractual right to approve the appointment of </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any executive officers of Paragon. Parapyre is an entity formed by Paragon as a vehicle to hold equity in Spyre in order to share profits with certain employees of Paragon and will not perform any substantive role under the Paragon Agreement other than to receive warrants granted to Parapyre under the Paragon Agreement. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is the summary of expenses related to the Paragon Agreement and License Agreements, which are ultimately settled in cash (in millions) and recorded within Research and development in the consolidated statement of operations for the periods presented:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.629%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:27pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reimbursable costs under the Paragon Agreement</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">License Agreements milestone and sublicensing fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total related party expense (excludes stock-based compensation)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is the summary of Related party accounts payable and other current liabilities (in millions):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reimbursable costs under the Paragon Agreement</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">License Agreements development milestone liability (see Note 6)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total related party accounts payable</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Paragon Agreement</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Asset Acquisition, the Company assumed the rights and obligations of Pre-Merger Spyre under the Paragon Agreement. Spyre is obligated to compensate Paragon for its services performed under each research program based on the actual costs incurred with mark-up costs pursuant to the terms of the Paragon Agreement. Spyre was also obligated under the Paragon Agreement to issue Parapyre annual equity grants of warrants in accordance with the Parapyre Option Obligation (as defined below). </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 12, 2023, December 14, 2023, and June 5, 2024, the Company exercised the Option available under the Paragon Agreement with respect to the SPY001, SPY002 and SPY003 research programs, respectively. Please refer to Note 6 for additional information on the License Agreements.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 14, 2024, the Company, Paragon and Parapyre entered into a second amended and restated antibody discovery and option agreement that amends and restates that certain amended and restated antibody discovery and option agreement, dated September 29, 2023, by and between Paragon, Parapyre and Spyre Therapeutics, LLC, in order to, among other things, (i) replace the Company&#8217;s subsidiary with the Company as a party to the agreement and (ii) amend certain terms related to the SPY003 research program, including without limitation, (a) establishing an SPY003 antibody selection process pursuant to which the Company and Paragon shall alternate in turn to select a project antibody to be included and excluded, respectively, from the Company&#8217;s rights under its option to license certain intellectual property rights related to SPY003 from Paragon until all project antibodies under the SPY003 research program have been selected; (b) reducing the development costs invoiced to the Company for the SPY003 research program incurred from and after April 1, 2024 through completion of the SPY003 antibody selection process by 50%; (c) requiring Paragon to reimburse the Company for 50% of the development costs for the SPY003 research program incurred prior to April 1, 2024; provided, that Paragon receives rights to at least one SPY003 project antibody following completion of the SPY003 antibody selection process; (d) obligating the Company to exercise its option to license the intellectual property rights to SPY003 project antibodies and technology following the completion of the SPY003 antibody selection process; and (e) establishing a license agreement term sheet for the SPY003 research program with substantially similar milestone payment terms and royalty payment terms as the SPY001 License Agreement. Please refer to Note 6 for additional disclosures. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2025 and 2024, the Company recognized de minimis and $17.1 million, respectively, expenses related to services provided by Paragon, of which nil and $5.4 million, </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">respectively, of related stock-based compensation expense were recorded as Research and development expenses in the consolidated statements of operations. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2025 and 2024, the Company made payments totaling $0.1 million and $18.2 million respectively, in connection with the Paragon Agreement. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Parapyre Option Obligation</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Paragon Agreement, the Company agreed to issue Parapyre an annual equity grant of warrants, on the last business day of each of the years ended December 31, 2023 and December 31, 2024, to purchase 1% of the then outstanding shares of the Company's common stock, on a fully diluted basis, during the term of the Paragon Agreement (the "Parapyre Option Obligation"). See Note 9 for disclosures related to the Parapyre Option Obligation.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Paragon License Agreements</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 6 for disclosures related to the License Agreements entered into with Paragon.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mark McKenna Option Grant</span></div>On February 1, 2024, the Board appointed Mark McKenna as a Class I director. Mr. McKenna and the Company are parties to a consulting agreement, pursuant to which Mr. McKenna agreed to continue to provide consulting services as an independent contractor to the Company, with an effective date of August 1, 2023 (the &#8220;Vesting Commencement Date&#8221;). As compensation for Mr. McKenna&#8217;s consulting services, on November 22, 2023, he was granted non-qualified stock options to purchase 477,000 shares of the Company&#8217;s common stock under the 2016 Plan (as defined in Note 8) with an exercise price of $10.39 per share, which vest as to 25% on the one year anniversary of the Vesting Commencement Date and thereafter vest and become exercisable in 36 equal monthly installments, subject to Mr. McKenna&#8217;s continued service to the Company through each applicable vesting date. For the three months ended March&#160;31, 2025 and 2024, the Company recognized $0.3&#160;million in stock-based compensation expense related to Mr. McKenna's consulting agreement.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Preferred Stock and Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockTextBlock', window );">Convertible Preferred Stock and Stockholders' Equity</a></td>
<td class="text">Convertible Preferred Stock and Stockholders&#8217; Equity<div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Parapyre Warrants</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, the Company settled its obligations under the Parapyre Option Obligation by issuing Parapyre 848,184 warrants to purchase the Company's common stock at an exercise price of $23.28.  As of March&#160;31, 2025, a total of 1,532,591 warrants with a weighted-average exercise price of $22.49 had been issued to Parapyre under the Parapyre Option Obligation.  As of March 31, 2025, none of the warrants issued under the Parapyre Option Obligation have been exercised and all remain outstanding. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Series A Non-Voting Convertible Preferred Stock</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Company's Certificate of Designation of Preferences, Rights and Limitations of the Series A Non-Voting Convertible Preferred Stock (the "Series A Certificate of Designation"), holders of Series A Preferred Stock are entitled to receive dividends on shares of Series A Preferred Stock equal to, on an as-if-converted-to-common stock basis, and in the same form as, dividends actually paid on shares of common stock. Except as provided in the Series A Certificate of Designation or as otherwise required by law, the Series A Preferred Stock does not have voting rights. However, as long as any shares of Series A Preferred Stock are outstanding, the Company will not, without the affirmative vote of the holders of a majority of the then outstanding shares of the Series A Preferred Stock: (a) alter or change adversely the powers, preferences or rights given to the Series A Preferred Stock, or alter or amend the Series A Certificate of Designation, amend or repeal any provision of, or add any provision to, the Company&#8217;s Certificate of Incorporation or its Bylaws, or file any articles of amendment, certificate of designations, preferences, limitations and relative rights of any series of preferred stock, if such action would adversely alter or change the preferences, rights, privileges or powers of, or restrictions provided for the benefit of the Series A Preferred Stock, regardless of whether any of the foregoing actions will be by means of amendment to the Certificate of Incorporation or by merger, consolidation, </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recapitalization, reclassification, conversion or otherwise, (b) issue further shares of Series A Preferred Stock or increase or decrease (other than by conversion) the number of authorized shares of Series A Preferred Stock, (c) prior to the stockholder approval of the conversion of the Series A Preferred Stock into shares of common stock in accordance with Nasdaq Stock Market Rules (the &#8220;Series A Conversion Proposal&#8221;) or at any time while at least 30% of the originally issued Series A Preferred Stock remains issued and outstanding, consummate (x) any Fundamental Transaction (as defined in the Series A Certificate of Designation) or (y) any merger or consolidation of the Company with or into another entity or any stock sale to, or other business combination in which our stockholders immediately before such transaction do not hold at least a majority of our capital stock immediately after such transaction or (d) enter into any agreement with respect to any of the foregoing. The Series A Preferred Stock does not have a preference upon any liquidation, dissolution or winding-up of the Company. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 23, 2024, in connection with the April 2024 Exchange, the Stockholder agreed to exchange an aggregate of 90,992 shares of Series A Preferred Stock for an aggregate of 3,639,680 shares of the Company's common stock. This exchange was recorded as a reclassification between Series A Preferred Stock and common stock based on the historical per-share contributed capital amount, inclusive of any forward-contract valuation adjustments, of the Series A Preferred Stock. Following the April 2024 Exchange, 346,045 shares of Series A Preferred Stock remained outstanding and are convertible into 13,841,800 common shares.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Series B Non-Voting Convertible Preferred Stock</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Company's Certificate of Designation of Preferences, Rights and Limitations of Series B Non-Voting Convertible Preferred Stock (as amended, the "Series B Certificate of Designation"), holders of Series B Preferred Stock are entitled to receive dividends on shares of Series B Preferred Stock equal to, on an as-if-converted-to-common stock basis, and in the same form as, dividends actually paid on shares of common stock. Except as provided in the Series B Certificate of Designation or as otherwise required by law, the Series B Preferred Stock does not have voting rights. However, as long as any shares of Series B Preferred Stock are outstanding, the Company will not, without the affirmative vote of the holders of a majority of the then outstanding shares of the Series B Preferred Stock, alter or change adversely the powers, preferences or rights given to the Series B Preferred Stock, or alter or amend the Series B Certificate of Designation, amend or repeal any provision of, or add any provision to, the Company&#8217;s Certificate of Incorporation or its Bylaws, or file any articles of amendment, certificate of designations, preferences, limitations and relative rights of any series of preferred stock, if such action would adversely alter or change the preferences, rights, privileges or powers of, or restrictions provided for the benefit of the Series B Preferred Stock, regardless of whether any of the foregoing actions will be by means of amendment to the Certificate of Incorporation or by merger, consolidation, recapitalization, reclassification, conversion or otherwise. The Series B Preferred Stock does not have a preference upon any liquidation, dissolution or winding-up of the Company.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 18, 2024, in connection with the March 2024 PIPE, the Company filed a certificate of amendment to its Series B Certificate of Designation to increase the number of authorized shares of Series B Preferred Stock from 150,000 to 271,625.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 20, 2024, as part of the March 2024 PIPE, the Company completed a private placement of 121,625 shares of Series B Preferred Stock at $1,480.00 per share in exchange for net proceeds of approximately $168.9&#160;million, after deducting placement agent fees and offering costs of $11.2&#160;million.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 14, 2024, the Company's stockholders approved the issuance of common stock upon the conversion of all issued and outstanding Series B Preferred Stock into shares of common stock in accordance with the Nasdaq Stock Market Rules (the "Series B Conversion Proposal"), among other matters, at its 2024 annual meeting of stockholders. As a result of the approval of the Series B Conversion Proposal, all conditions that could have required cash redemption of the Series B Preferred Stock were satisfied. Since the Series B Preferred Stock is no longer redeemable, the associated balances of the Series B Preferred Stock were reclassified from mezzanine equity to permanent equity during the second quarter of 2024. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following stockholder approval of the Series B Conversion Proposal, each share of Series B Preferred Stock automatically converted into 40 shares of common stock, subject to certain limitations, including that a holder of Series B Preferred Stock is prohibited from converting shares of Series B Preferred Stock into shares of common stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">own more than a specified percentage (established by the holder between 0% and 19.9%) of the total number of shares of common stock issued and outstanding immediately after giving effect to such conversion. 254,958 shares of Series B Preferred Stock automatically converted to 10,198,320 shares of common stock; 16,667 shares of Series B Preferred Stock did not automatically convert and remain outstanding as of March&#160;31, 2025 due to beneficial ownership limitations. This conversion was recorded as a reclassification between Series B Preferred Stock and common stock based on the historical per-share contributed capital amount of the Series B Preferred Stock. The remaining outstanding Series B Preferred Stock is convertible into 666,680 common shares as of March&#160;31, 2025.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">September 2024 ATM Facility</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 6, 2024, the Company filed a new shelf registration statement on Form S-3 that was declared effective by the SEC for the potential offering, issuance and sale of up to $500.0&#160;million of the Company's common stock, preferred stock, debt securities, warrants and/or units consisting of all or some of these securities. Concurrent with the filing of the shelf-registration statement, the Company entered into the Sales Agreement, pursuant to which the Company may issue and sell up to $200.0&#160;million of shares of common stock under an ATM offering program included in the registration statement. During the twelve months ended December 31, 2024, the Company sold an aggregate of 777,432 shares of common stock under the ATM offering program at an average price per share of $26.935 resulting in net proceeds of $20.5 million, after deducting sales agent commissions and other offering costs of $0.4 million. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2025, the Company filed a new shelf registration statement on Form S-3 that was declared effective by the SEC for the potential offering, issuance and sale of up to $500.0&#160;million of the Company's common stock, preferred stock, debt securities, warrants and/or units consisting of all or some of these securities. Concurrent with the effectiveness of the February 2025 Shelf Registration Statement, the offering of unsold securities under the previous shelf registration statement on Form S-3 (described above), was deemed terminated pursuant to Rule 415(a)(6) under the Securities Act. The February 2025 Shelf Registration Statement contains a prospectus supplement covering the offering, issuance and sale by the Company of up to $179.1&#160;million of shares of common stock that may be issued and sold under the Sales Agreement in connection with the ATM program. No shares were sold under the ATM program during the three months ended March 31, 2025. As of March 31, 2025, $179.1&#160;million remained available for sale under the Sales Agreement. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">November 2024 Underwritten Offering</span></div>On November 18, 2024, the Company entered into the Underwriting Agreement with the Underwriters, pursuant to which the Company sold an aggregate of 8,366,250 shares of common stock, at a public offering price per share of $27.50, resulting in net proceeds of approximately $215.9&#160;million after deducting approximately $14.2&#160;million of underwriting discounts and other offering costs. The November 2024 Offering closed on November 20, 2024 and the over-allotment option was exercised in full on November 26, 2024 and closed on November 29, 2024.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text">Stock-Based Compensation<div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2015 Equity Incentive Plan</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2015, the Company adopted the 2015 Equity Incentive Plan (&#8220;2015 Plan&#8221;), administered by the board of directors, and provides for the Company to sell or issue shares of common stock or restricted common stock, or to grant incentive stock options or nonqualified stock options for the purchase of common stock, to employees, members of the board of directors and consultants of the Company. The Company granted options under the 2015 Plan until April 2016 when it was terminated as to future awards, although it continues to govern the terms of options that remain outstanding under the 2015 Plan.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2025, a total of 952 shares of common stock are subject to options outstanding under the 2015 Plan and will become available under the 2016 Equity Incentive Plan (&#8220;2016 Plan&#8221;) to the extent the options are forfeited or lapse unexercised.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2016 Equity Incentive Plan</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2016 Plan became effective in April 2016 and serves as the successor to the 2015 Plan. Under the 2016 Plan, the Company may grant stock options, stock appreciation rights, restricted stock awards, restricted stock units, performance awards, and stock bonuses. The 2016 Plan, as amended, provides for an automatic increase in the number of shares reserved for issuance thereunder on January 1 of each year for the remaining term of the plan equal to (a) 5.0% of the number of issued and outstanding shares of common stock </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(including such shares issuable pursuant to the exercise or conversion, as applicable, of any outstanding pre-funded warrants and nonvoting convertible preferred stock) on December 31 of the immediately preceding year, or (b) a lesser amount as approved by the board each year (the &#8220;Evergreen Provision&#8221;). As a result of the Evergreen Provision, on January 1, 2025 and 2024, an additional 3,814,905 and 3,023,650 shares, respectively, became available for issuance under the 2016 Plan.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2025, the 2016 Plan had 11,007,869 shares available for future issuance, of which 4,817,317 shares were subject to outstanding option awards.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2018 Equity Inducement Plan</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2018 Equity Inducement Plan (&#8220;2018 Plan&#8221;) became effective in February 2018.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2024, the Company amended the 2018 Plan to increase the number of shares of common stock reserved for issuance by 1,000,000. After this amendment and as of March&#160;31, 2025, the 2018 Plan had 6,856,811 shares available for future issuance, of which 6,300,368 shares were subject to outstanding option awards and restricted unit awards.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service-based awards granted under the 2018 Plan, 2016 Plan, and 2015 Plan generally vest over four years and expire after ten years, although awards have been granted with vesting terms less than four years. Under the 2016 Plan and 2018 Plan, the Company may grant stock-based awards with service conditions (&#8220;service-based&#8221; awards), performance conditions (&#8220;performance-based&#8221; awards), and market conditions (&#8220;market-based&#8221; awards). </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Spyre 2023 Equity Incentive Plan</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;22, 2023, in connection with the Asset Acquisition, the Company assumed the Amended and Restated Spyre 2023 Equity Incentive Plan (the "2023 Plan") and its outstanding and unexercised stock options, which were converted to options to purchase 2,734 shares of common stock. The acquisition-date fair value of these grants will be recognized as an expense on a pro-rata basis over the vesting period. As of March 31, 2025 none of the stock options under the 2023 Plan remained outstanding.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s stock awards granted under all equity incentive and inducement plans for each of the periods indicated:</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.515%"><tr><td style="width:1.0%"></td><td style="width:42.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.353%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.769%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.353%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.774%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Grants</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted Average Grant Date Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Grants</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted Average Grant Date Fair Value</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,897,917</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21.45&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,044,658</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.50&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Parapyre Option Obligation</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, the Company settled its obligations under the Parapyre Option Obligation by issuing Parapyre 848,184 warrants to purchase the Company's common stock at an exercise price of $23.28.  As of March&#160;31, 2025, a total of 1,532,591 warrants with a weighted-average exercise price of $22.49 had been </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">issued to Parapyre under the Parapyre Option Obligation.  As of March 31, 2025 none of the warrants issued under the Parapyre Option Obligation have been exercised and all remain outstanding. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2024, $5.4 million was recognized as stock compensation expense related to the Parapyre Option Obligation. There are no ongoing obligations under the Parapyre Option Obligation as of January 1, 2025.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2016 Employee Stock Purchase Plan</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Company&#8217;s 2016 Employee Stock Purchase Plan (&#8220;2016 ESPP&#8221;), the Company issued and sold 16,877 and 2,330 shares during the three months ended March&#160;31, 2025 and 2024, respectively. The aggregate cash proceeds were $0.3 million and de minimis for the three months ended March&#160;31, 2025 and 2024, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-based Compensation Expense</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation expense recognized from the Company&#8217;s equity incentive plans, 2018 Plan, 2016 ESPP and Parapyre Option Obligation during the periods presented was as follows (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.748%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.408%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,512&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,857&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,978&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation expense </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,859&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,835&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:9pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2024, $5.4 million was recognized as stock compensation expense related to the Parapyre Option Obligation.</span></div><div style="margin-top:9pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Of the total $13.8 million of stock-based compensation expense for the three months ended March&#160;31, 2024, $2.9 million is related to legacy Aeglea employees and directors who had been terminated as of the end of the period.</span></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify"><span><br/></span></div></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the weighted-average Black-Scholes option pricing model assumptions used to estimate the fair value of stock options granted under the Company's equity incentive plans, and the shares purchasable under the 2016 ESPP during the periods presented: </span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.484%"><tr><td style="width:1.0%"></td><td style="width:64.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.696%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock Options Granted</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.03</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.03</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk-free interest</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.46%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.88%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2016 ESPP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.50</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.50</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk-free interest</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.23%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.31%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting</a></td>
<td class="text">Segment Reporting<div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates under a single operating and reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated diseases. The Company's Chief Operating Decision Maker ("CODM") is the Company's Chief Executive Officer. The Company's CODM uses consolidated Net loss as the measure of segment profit or loss and uses consolidated Total Assets as reported on the balance sheet as the measure of segment assets. The Company's CODM compares Net loss against budgeted and/or forecasted amounts to track the Company's financial performance against expectations and to inform, along with development timelines and scientific and commercial considerations, their decisions regarding resource allocations to fund the Company's development of its pipeline. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table sets forth the significant expenses provided to the CODM on a regular basis (in thousands):</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.545%"><tr><td style="width:1.0%"></td><td style="width:71.807%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.142%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.143%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,991&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,174&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,859&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,835&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development, excluding compensation and stock-based compensation </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2) (3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33,551&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26,103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other segment items </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4,628)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(255)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44,773&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43,857&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reconciliation of net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjustments and reconciling items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated net loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44,773&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43,857&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes $0.3 million and $5.7 million in related party expenses for the three months ended March 31, 2025 and 2024, respectively. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes non-clinical study, clinical trial, and manufacturing expenses. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes $2.5 million and $11.7 million in related party expenses for the three months ended March 31, 2025 and 2024, respectively. </span></div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span> Includes general and administrative expenses such as audit, legal, and other professional fees, interest income, and other expense, net.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share</a></td>
<td class="text">Net Loss Per Share<div style="margin-top:18pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company computes net loss per share of common stock, Series A Preferred Stock, and Series B Preferred Stock using the two-class method required for multiple classes of common stock and other participating securities.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The two-class method is an earnings (loss) allocation method under which earnings (loss) per share is calculated for each class of common stock. The Company has determined that the Series A Preferred Stock and Series B Preferred Stock do not have preferential rights when compared to the Company's common stock and therefore it must allocate losses to these other classes of common stock, as illustrated in the table below.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted net loss per share is computed by dividing the net loss by the weighted-average number of shares and pre-funded warrants outstanding during the period, without consideration of potential dilutive securities. The pre-funded warrants are included in the computation of basic net loss per share as the exercise price is negligible and they are fully vested and exercisable. For periods in which the Company generated a net loss, the Company does not include potential shares of common stock in diluted net loss per share when the impact of these items is anti-dilutive. The Company has generated a net loss for all periods </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">presented, therefore diluted net loss per share is the same as basic net loss per share since the inclusion of potential shares of common stock would be anti-dilutive.  </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net loss per share of common stock, Series A Preferred Stock, and Series B Preferred Stock (in thousands, except share and per share amounts):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.445%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.445%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.445%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.445%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.445%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.449%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="15" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Series A Preferred Stock</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Series B Preferred Stock</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Common<br/>Stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Series A Preferred Stock</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Series B Preferred Stock</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Common<br/>Stock</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net loss per share, basic and diluted:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Numerator</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Allocation of losses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(8,288)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(399)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(36,086)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(12,642)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4,810)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(26,405)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Denominator</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Weighted-average shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">346,045</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">16,667</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">60,265,932</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">437,037&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">166,261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">36,262,662</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Weighted-average pre-funded warrants outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">250,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Number of shares used in per share computation</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">346,045</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">16,667</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">60,265,932</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">437,037&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">166,261&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">36,512,662</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net loss per share, basic and diluted</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(23.95)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(23.95)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(0.60)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(28.93)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(28.93)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(0.72)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following weighted-average equity instruments were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive for the periods presented:</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.121%"><tr><td style="width:1.0%"></td><td style="width:65.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.951%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.951%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options to purchase common stock</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,866,235</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,200,918</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unvested restricted stock units</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22,622</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61,253</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding Parapyre warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,532,591</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">684,407</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (44,773)<span></span>
</td>
<td class="num">$ (43,857)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States (&#8220;U.S. GAAP&#8221;) as defined by the Financial Accounting Standards Board and include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted and Not Yet Adopted Accounting Pronouncements</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no recent accounting pronouncements or changes in accounting pronouncements during the three months ended March&#160;31, 2025 that are of significance or potential significance to the Company.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Not Yet Adopted Accounting Pronouncements</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the Financial Accounting Standards Board&#8217;s ("FASB") issued Accounting Standards Update 2023-09 ("ASU 2023-09"), Income Taxes (Topic 740): Improvements to Income Tax Disclosures. ASU 2023-09 expands disclosures in an entity&#8217;s income tax rate reconciliation table and disclosures regarding taxes paid both in the U.S. and foreign jurisdictions. This update is effective for fiscal years beginning after December 15, 2024. ASU 2023-09 will have no impact on the Company&#8217;s consolidated financial condition or results of operations. The Company is currently evaluating the impact to its income tax disclosures.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, the Financial Accounting Standards Board issued Accounting Standards Update 2024-03 ("ASU 2024-03") Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses to require more detailed information about specified categories of expenses (purchases of inventory, employee compensation, depreciation, amortization, and depletion) included in certain expense captions presented on the face of the </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">income statement. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and for interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. The amendments may be applied either (1) prospectively to financial statements issued for reporting periods after the effective date of this ASU or (2) retrospectively to all prior periods presented in the financial statements. The Company is currently evaluating the impact ASU 2024-03 will have on its disclosures.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss Per Share</a></td>
<td class="text"><div style="margin-top:18pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company computes net loss per share of common stock, Series A Preferred Stock, and Series B Preferred Stock using the two-class method required for multiple classes of common stock and other participating securities.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The two-class method is an earnings (loss) allocation method under which earnings (loss) per share is calculated for each class of common stock. The Company has determined that the Series A Preferred Stock and Series B Preferred Stock do not have preferential rights when compared to the Company's common stock and therefore it must allocate losses to these other classes of common stock, as illustrated in the table below.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted net loss per share is computed by dividing the net loss by the weighted-average number of shares and pre-funded warrants outstanding during the period, without consideration of potential dilutive securities. The pre-funded warrants are included in the computation of basic net loss per share as the exercise price is negligible and they are fully vested and exercisable. For periods in which the Company generated a net loss, the Company does not include potential shares of common stock in diluted net loss per share when the impact of these items is anti-dilutive. The Company has generated a net loss for all periods </span></div>presented, therefore diluted net loss per share is the same as basic net loss per share since the inclusion of potential shares of common stock would be anti-dilutive.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurement (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Financial Assets and Liabilities Measured at Fair Value on Recurring Basis</a></td>
<td class="text">The following tables set forth the fair value of the Company&#8217;s financial assets and liabilities at fair value on a recurring basis based on the three-tier fair value hierarchy (in thousands):<div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31, 2025</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 3</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46,800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46,800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 15.4pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government treasury securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">223,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">223,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 15.4pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72,730&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72,730&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 15.4pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">147,450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">147,450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 15.4pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72,647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72,647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total financial assets</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">270,300&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">292,827&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">563,127&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVR liability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59,300&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59,300&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 3</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65,902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65,902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government treasury securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">227,244&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">227,244&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86,681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86,681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 15.4pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">165,130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">165,130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 15.4pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56,448&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56,448&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total financial assets</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">293,146&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">308,259&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">601,405&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVR liability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61,700&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61,700&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Significant Inputs used to Estimate the Fair Value of Derivative Liabilities</a></td>
<td class="text">The significant inputs used to estimate the fair value of the CVR liability were as follows:<div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.748%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.052%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated cash flow dates</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">08/28/25 - 06/22/26</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated probability of success</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72% - 100%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated reimbursement rate compared to reimbursement target</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49% - 100%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk-adjusted discount rates</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.78% - 7.90%</span></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Changes in Derivative Liabilities</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents changes in the CVR liability for the periods presented (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">CVR Liability</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning balance as of December 31, 2024</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61,700&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of the CVR liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,400)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ending Balance as of March 31, 2025</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59,300&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash Equivalents and Marketable Securities (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock', window );">Estimated Fair Value of Cash Equivalents and Marketable Securities and the Gross Unrealized Gains and Losses</a></td>
<td class="text"><div style="margin-top:18pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the estimated fair value of the Company&#8217;s cash equivalents and marketable securities and the gross unrealized gains and losses (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31, 2025</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cost</span></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gains</span></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Losses</span></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Estimated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46,800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46,800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total cash equivalents</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46,800&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46,800&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">147,448&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">147,450&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72,618&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72,647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government treasury securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">222,942&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">638&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(80)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">223,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.68pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72,673&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72,730&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">515,681&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">807&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(161)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">516,327&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cost</span></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gains</span></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Losses </span></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Estimated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65,902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65,902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total cash equivalents</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87,734&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87,740&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">143,265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(77)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">143,292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56,471&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(48)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56,448&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government treasury securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">227,155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">385&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(296)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">227,244&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.68pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86,616&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(72)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86,681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">513,507&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">651&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(493)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">513,665&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock', window );">Available-for-Sale Securities in an Unrealized Loss Position</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the available-for-sale securities in an unrealized loss position for which an allowance for credit losses has not been recorded as of March&#160;31, 2025 and December&#160;31, 2024, aggregated by major security type and length of time in a continuous unrealized loss position:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.964%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31, 2025</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Less Than 12 Months</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">12 Months or Longer</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Losses </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Losses</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Losses </span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36,057&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(24)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36,057&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(24)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government treasury securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32,810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(80)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32,810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(80)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23,154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23,154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105,150&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(161)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105,150&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(161)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Less Than 12 Months</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">12 Months or Longer</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Losses </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Losses</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Losses </span></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67,200&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(77)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67,200&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(77)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42,916&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(48)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42,916&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(48)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government treasury securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">126,588&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(296)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">126,588&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(296)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(72)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(72)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">249,264&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(493)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">249,264&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(493)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Contractual Maturities of Marketable Securities at Estimated Fair Value</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the contractual maturities of the Company&#8217;s marketable securities at estimated fair value (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due in one year or less</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">367,106&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">338,442&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due in 1 - 2 years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">149,221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">175,223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">516,327&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">513,665&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479081/326-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-6<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash, cash equivalents, and investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued and Other Current Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Accrued and Other Current Liabilities</a></td>
<td class="text"><div style="margin-top:18pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued and other current liabilities consist of the following (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued compensation</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,561&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,688&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued contracted research and development costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19,078&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,861&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued professional and consulting fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">621&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">661&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total accrued and other current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21,631&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27,711&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock', window );">Expenses related to Related Party which were Settled in Cash</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is the summary of expenses related to the Paragon Agreement and License Agreements, which are ultimately settled in cash (in millions) and recorded within Research and development in the consolidated statement of operations for the periods presented:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.629%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:27pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reimbursable costs under the Paragon Agreement</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">License Agreements milestone and sublicensing fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total related party expense (excludes stock-based compensation)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_ScheduleOfBalancesDueToAffiliatesTableTextBlock', window );">Related Party Accounts Payable</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is the summary of Related party accounts payable and other current liabilities (in millions):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reimbursable costs under the Paragon Agreement</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">License Agreements development milestone liability (see Note 6)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total related party accounts payable</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_ScheduleOfBalancesDueToAffiliatesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of balances due to affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_ScheduleOfBalancesDueToAffiliatesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock', window );">Stock Awards Granted</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s stock awards granted under all equity incentive and inducement plans for each of the periods indicated:</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.515%"><tr><td style="width:1.0%"></td><td style="width:42.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.353%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.769%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.353%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.774%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Grants</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted Average Grant Date Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Grants</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted Average Grant Date Fair Value</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,897,917</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21.45&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,044,658</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.50&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Stock-Based Compensation Expense</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation expense recognized from the Company&#8217;s equity incentive plans, 2018 Plan, 2016 ESPP and Parapyre Option Obligation during the periods presented was as follows (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.748%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.408%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,512&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,857&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,978&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation expense </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,859&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,835&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:9pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2024, $5.4 million was recognized as stock compensation expense related to the Parapyre Option Obligation.</span></div><div style="margin-top:9pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Of the total $13.8 million of stock-based compensation expense for the three months ended March&#160;31, 2024, $2.9 million is related to legacy Aeglea employees and directors who had been terminated as of the end of the period.</span></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify"><span><br/></span></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Assumptions used to Estimate the Fair Value of Stock Options Granted</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the weighted-average Black-Scholes option pricing model assumptions used to estimate the fair value of stock options granted under the Company's equity incentive plans, and the shares purchasable under the 2016 ESPP during the periods presented: </span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.484%"><tr><td style="width:1.0%"></td><td style="width:64.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.696%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock Options Granted</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.03</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.03</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk-free interest</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.46%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.88%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2016 ESPP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.50</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.50</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk-free interest</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.23%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.31%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the total intrinsic value of options exercised (or share units converted), share-based liabilities paid, and the total fair value of shares vested during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (d)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Summary of Significant Segment Expenses</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table sets forth the significant expenses provided to the CODM on a regular basis (in thousands):</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.545%"><tr><td style="width:1.0%"></td><td style="width:71.807%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.142%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.143%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,991&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,174&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,859&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,835&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development, excluding compensation and stock-based compensation </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2) (3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33,551&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26,103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other segment items </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4,628)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(255)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44,773&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43,857&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reconciliation of net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjustments and reconciling items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated net loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44,773&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43,857&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes $0.3 million and $5.7 million in related party expenses for the three months ended March 31, 2025 and 2024, respectively. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes non-clinical study, clinical trial, and manufacturing expenses. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes $2.5 million and $11.7 million in related party expenses for the three months ended March 31, 2025 and 2024, respectively. </span></div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span> Includes general and administrative expenses such as audit, legal, and other professional fees, interest income, and other expense, net.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock', window );">Reconciliation of Basic and Diluted Net Loss Per Share</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net loss per share of common stock, Series A Preferred Stock, and Series B Preferred Stock (in thousands, except share and per share amounts):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.445%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.445%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.445%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.445%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.445%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.449%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="15" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Series A Preferred Stock</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Series B Preferred Stock</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Common<br/>Stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Series A Preferred Stock</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Series B Preferred Stock</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Common<br/>Stock</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net loss per share, basic and diluted:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Numerator</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Allocation of losses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(8,288)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(399)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(36,086)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(12,642)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4,810)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(26,405)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Denominator</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Weighted-average shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">346,045</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">16,667</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">60,265,932</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">437,037&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">166,261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">36,262,662</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Weighted-average pre-funded warrants outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">250,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Number of shares used in per share computation</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">346,045</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">16,667</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">60,265,932</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">437,037&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">166,261&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">36,512,662</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net loss per share, basic and diluted</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(23.95)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(23.95)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(0.60)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(28.93)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(28.93)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(0.72)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Weighted-Average Equity Instruments Excluded from Calculation of Diluted Net Loss Per Share</a></td>
<td class="text"><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.121%"><tr><td style="width:1.0%"></td><td style="width:65.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.951%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.951%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options to purchase common stock</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,866,235</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,200,918</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unvested restricted stock units</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22,622</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61,253</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding Parapyre warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,532,591</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">684,407</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The Company and Basis of Presentation (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1">121 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 29, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 20, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>May 14, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 23, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 20, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 18, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 11, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 22, 2023 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($) </div>
<div>segment </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 06, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 25, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 24, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_CompanyAndBasisOfPresentationLineItems', window );"><strong>Company and Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_ProceedsFromRaisingCapital', window );">Proceeds from raising capital | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,017,205)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (972,432)<span></span>
</td>
<td class="num">(1,017,205)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Marketable securities | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 564,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 564,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockByUniqueDescriptionAxis=syre_ConversionOfSeriesBNonVotingConvertiblePreferredStockMember', window );">Conversion Of Series B Non-Voting Convertible Preferred Stock | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_CompanyAndBasisOfPresentationLineItems', window );"><strong>Company and Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Shares converted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,198,320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,198,320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=syre_AtTheMarketOfferingMember', window );">At-The-Market Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_CompanyAndBasisOfPresentationLineItems', window );"><strong>Company and Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_SaleOfStockAuthorizedAmount', window );">Sale of stock, authorized amount | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=syre_CommonStockAndSeriesBNonVotingConvertiblePreferredStockMember', window );">Common Stock and Series B Non Voting Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_CompanyAndBasisOfPresentationLineItems', window );"><strong>Company and Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Series B non-voting convertible preferred stock, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleConversionRatio', window );">Conversion basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=syre_SeriesBNonVotingConvertiblePreferredStockMember', window );">Series B Non Voting Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_CompanyAndBasisOfPresentationLineItems', window );"><strong>Company and Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleConversionRatio', window );">Conversion basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of non-voting convertible preferred stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">121,625<span></span>
</td>
<td class="nump">271,625<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,667<span></span>
</td>
<td class="nump">16,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_PreferredStockSharesNotAutomaticallyConvertedOutstanding', window );">Preferred stock, not automatically converted, outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=syre_SeriesBNonVotingConvertiblePreferredStockMember', window );">Series B Non Voting Convertible Preferred Stock | Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_CompanyAndBasisOfPresentationLineItems', window );"><strong>Company and Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of non-voting convertible preferred stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,000<span></span>
</td>
<td class="nump">17,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=syre_SeriesBNonVotingConvertiblePreferredStockMember', window );">Series B Non Voting Convertible Preferred Stock | Conversion Of Series B Non-Voting Convertible Preferred Stock | Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_CompanyAndBasisOfPresentationLineItems', window );"><strong>Company and Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Shares converted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">254,958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">254,958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=syre_SeriesBNonVotingConvertiblePreferredStockMember', window );">Series B Non Voting Convertible Preferred Stock | Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_CompanyAndBasisOfPresentationLineItems', window );"><strong>Company and Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of stock, proceeds received | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 168,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Placement agent and other offering costs | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=syre_SeriesANonVotingConvertiblePreferredStockMember', window );">Series A Non Voting Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_CompanyAndBasisOfPresentationLineItems', window );"><strong>Company and Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_StockIssuedDuringPeriodSharesExchangeOfConvertibleSecurities', window );">Exchange of Series A non-voting convertible preferred stock into common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,992<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">346,045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">346,045<span></span>
</td>
<td class="nump">346,045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">346,045<span></span>
</td>
<td class="nump">346,045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=syre_SeriesANonVotingConvertiblePreferredStockMember', window );">Series A Non Voting Convertible Preferred Stock | Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_CompanyAndBasisOfPresentationLineItems', window );"><strong>Company and Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">346,000<span></span>
</td>
<td class="nump">437,000<span></span>
</td>
<td class="nump">346,000<span></span>
</td>
<td class="nump">346,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">437,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=syre_SeriesANonVotingConvertiblePreferredStockMember', window );">Series A Non Voting Convertible Preferred Stock | Conversion Of Series A Non-Voting Convertible Preferred Stock | Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_CompanyAndBasisOfPresentationLineItems', window );"><strong>Company and Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Shares converted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,992<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_CompanyAndBasisOfPresentationLineItems', window );"><strong>Company and Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_StockIssuedDuringPeriodSharesExchangeOfConvertibleSecurities', window );">Exchange of Series A non-voting convertible preferred stock into common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,639,680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock | At-The-Market Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_CompanyAndBasisOfPresentationLineItems', window );"><strong>Company and Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26.935<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of stock, proceeds received | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Placement agent and other offering costs | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_SaleOfStockAggregateOfferingPrice', window );">Sale of stock, aggregate offering price | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares of common stock sold (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">777,432<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_SaleOfStockRemainingAuthorizedAmount', window );">Sale of stock, remaining authorized amount | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 179,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 179,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock | At-The-Market Offering | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_CompanyAndBasisOfPresentationLineItems', window );"><strong>Company and Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_SaleOfStockAggregateOfferingPrice', window );">Sale of stock, aggregate offering price | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 179,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock | Underwritten Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_CompanyAndBasisOfPresentationLineItems', window );"><strong>Company and Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of stock, proceeds received | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 215,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Placement agent and other offering costs | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares of common stock sold (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,366,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock | Over-Allotment Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_CompanyAndBasisOfPresentationLineItems', window );"><strong>Company and Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares of common stock sold (in shares)</a></td>
<td class="nump">1,091,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=syre_SpyreTherapeuticsIncMember', window );">Spyre Therapeutics, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_CompanyAndBasisOfPresentationLineItems', window );"><strong>Company and Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_AssetAcquisitionStockholderPaymentPeriod', window );">Asset acquisition, stockholder payment period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_AssetAcquisitionCashPaymentThresholdPeriod', window );">Asset acquisition, cash payment, threshold period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=syre_AssetAcquisitionMember', window );">Asset Acquisition | Series A Non Voting Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_CompanyAndBasisOfPresentationLineItems', window );"><strong>Company and Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_AssetAcquisitionCashPaymentThresholdPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Cash Payment, Threshold Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_AssetAcquisitionCashPaymentThresholdPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_AssetAcquisitionStockholderPaymentPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Stockholder Payment Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_AssetAcquisitionStockholderPaymentPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_CompanyAndBasisOfPresentationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Company and basis of presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_CompanyAndBasisOfPresentationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_PreferredStockSharesNotAutomaticallyConvertedOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Preferred Stock, Shares Not Automatically Converted, Outstanding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_PreferredStockSharesNotAutomaticallyConvertedOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_ProceedsFromRaisingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Raising Capital</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_ProceedsFromRaisingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_SaleOfStockAggregateOfferingPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale of Stock, Aggregate Offering Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_SaleOfStockAggregateOfferingPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_SaleOfStockAuthorizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale of Stock, Authorized Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_SaleOfStockAuthorizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_SaleOfStockRemainingAuthorizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale of Stock, Remaining Authorized Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_SaleOfStockRemainingAuthorizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_StockIssuedDuringPeriodSharesExchangeOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Exchange of Convertible Securities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_StockIssuedDuringPeriodSharesExchangeOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Stock Issued During Period, Shares, New Issues</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockConvertibleConversionRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common shares issuable upon conversion for each share of preferred stock to be converted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockConvertibleConversionRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockByUniqueDescriptionAxis=syre_ConversionOfSeriesBNonVotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockByUniqueDescriptionAxis=syre_ConversionOfSeriesBNonVotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=syre_AtTheMarketOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=syre_AtTheMarketOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=syre_CommonStockAndSeriesBNonVotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=syre_CommonStockAndSeriesBNonVotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=syre_SeriesBNonVotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=syre_SeriesBNonVotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=syre_SeriesANonVotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=syre_SeriesANonVotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockByUniqueDescriptionAxis=syre_ConversionOfSeriesANonVotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockByUniqueDescriptionAxis=syre_ConversionOfSeriesANonVotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=syre_UnderwrittenOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=syre_UnderwrittenOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=syre_SpyreTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=syre_SpyreTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=syre_AssetAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=syre_AssetAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) - Fair Value, Measurements, Recurring - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">$ 563,127<span></span>
</td>
<td class="nump">$ 601,405<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">59,300<span></span>
</td>
<td class="nump">61,700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">U.S. government treasury securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">223,500<span></span>
</td>
<td class="nump">227,244<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">U.S. government agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">72,730<span></span>
</td>
<td class="nump">86,681<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">147,450<span></span>
</td>
<td class="nump">165,130<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">72,647<span></span>
</td>
<td class="nump">56,448<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">CVR liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">59,300<span></span>
</td>
<td class="nump">61,700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">270,300<span></span>
</td>
<td class="nump">293,146<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1 | U.S. government treasury securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">223,500<span></span>
</td>
<td class="nump">227,244<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1 | U.S. government agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1 | Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1 | CVR liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">292,827<span></span>
</td>
<td class="nump">308,259<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2 | U.S. government treasury securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2 | U.S. government agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">72,730<span></span>
</td>
<td class="nump">86,681<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">147,450<span></span>
</td>
<td class="nump">165,130<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2 | Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">72,647<span></span>
</td>
<td class="nump">56,448<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2 | CVR liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">59,300<span></span>
</td>
<td class="nump">61,700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 3 | U.S. government treasury securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 3 | U.S. government agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 3 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 3 | Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 3 | CVR liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">59,300<span></span>
</td>
<td class="nump">61,700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">46,800<span></span>
</td>
<td class="nump">65,902<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Money market funds | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">46,800<span></span>
</td>
<td class="nump">65,902<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Money market funds | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Money market funds | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=syre_ContingentValueRightLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=syre_ContingentValueRightLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 22, 2023</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=syre_ContingentValueRightLiabilityMember', window );">CVR liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value of liability, decrease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=syre_SpyreTherapeuticsIncMember', window );">Spyre Therapeutics, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_AssetAcquisitionStockholderPaymentPeriod', window );">Asset acquisition, stockholder payment period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_AssetAcquisitionCashPaymentThresholdPeriod', window );">Asset acquisition, cash payment, threshold period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_AssetAcquisitionCashPaymentThresholdPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Cash Payment, Threshold Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_AssetAcquisitionCashPaymentThresholdPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_AssetAcquisitionStockholderPaymentPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Stockholder Payment Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_AssetAcquisitionStockholderPaymentPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=syre_ContingentValueRightLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=syre_ContingentValueRightLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=syre_SpyreTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=syre_SpyreTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Significant Inputs used to Estimate the Fair Value of Derivative Liability (Details) - Level 3<br></strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Estimated reimbursement rate compared to reimbursement target | CVR liability</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">0.49<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Risk-adjusted discount rates | CVR liability</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">0.0778<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | CVR liability | Estimated probability of success</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">0.72<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Estimated reimbursement rate compared to reimbursement target | CVR liability</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Risk-adjusted discount rates | CVR liability</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">0.0790<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | CVR liability | Estimated probability of success</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure derivative liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=syre_MeasurementInputReimbursementRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=syre_MeasurementInputReimbursementRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=syre_ContingentValueRightLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=syre_ContingentValueRightLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=syre_ContingentValueRightLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=syre_ContingentValueRightLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=syre_MeasurementInputProabilityOfSuccessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=syre_MeasurementInputProabilityOfSuccessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Changes in Derivative Liabilities (Details) - CVR liability<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning balance</a></td>
<td class="nump">$ 61,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Changes in the fair value of the CVR liability</a></td>
<td class="num">(2,400)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Payments</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending balance</a></td>
<td class="nump">$ 59,300<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=syre_ContingentValueRightLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=syre_ContingentValueRightLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cash Equivalents and Marketable Securities - Estimated Fair Value of Cash Equivalents and Marketable Securities and the Gross Unrealized Gains and Losses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-Sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents, amortized cost</a></td>
<td class="nump">$ 46,800<span></span>
</td>
<td class="nump">$ 87,734<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_CashEquivalentsUnrealizedGains', window );">Cash equivalents, gross unrealized gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_CashEquivalentsUnrealizedLosses', window );">Cash equivalents, gross unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents, estimated fair value</a></td>
<td class="nump">46,800<span></span>
</td>
<td class="nump">87,740<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Marketable securities, amortized cost</a></td>
<td class="nump">515,681<span></span>
</td>
<td class="nump">513,507<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Marketable securities, gross unrealized gains</a></td>
<td class="nump">807<span></span>
</td>
<td class="nump">651<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Marketable securities, gross unrealized losses</a></td>
<td class="num">(161)<span></span>
</td>
<td class="num">(493)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Marketable securities, estimated fair value</a></td>
<td class="nump">516,327<span></span>
</td>
<td class="nump">513,665<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-Sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents, amortized cost</a></td>
<td class="nump">46,800<span></span>
</td>
<td class="nump">65,902<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_CashEquivalentsUnrealizedGains', window );">Cash equivalents, gross unrealized gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_CashEquivalentsUnrealizedLosses', window );">Cash equivalents, gross unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents, estimated fair value</a></td>
<td class="nump">46,800<span></span>
</td>
<td class="nump">65,902<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-Sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents, amortized cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,832<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_CashEquivalentsUnrealizedGains', window );">Cash equivalents, gross unrealized gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_CashEquivalentsUnrealizedLosses', window );">Cash equivalents, gross unrealized losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents, estimated fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,838<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Marketable securities, amortized cost</a></td>
<td class="nump">147,448<span></span>
</td>
<td class="nump">143,265<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Marketable securities, gross unrealized gains</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">104<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Marketable securities, gross unrealized losses</a></td>
<td class="num">(24)<span></span>
</td>
<td class="num">(77)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Marketable securities, estimated fair value</a></td>
<td class="nump">147,450<span></span>
</td>
<td class="nump">143,292<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember', window );">Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-Sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Marketable securities, amortized cost</a></td>
<td class="nump">72,618<span></span>
</td>
<td class="nump">56,471<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Marketable securities, gross unrealized gains</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Marketable securities, gross unrealized losses</a></td>
<td class="num">(20)<span></span>
</td>
<td class="num">(48)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Marketable securities, estimated fair value</a></td>
<td class="nump">72,647<span></span>
</td>
<td class="nump">56,448<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. government treasury securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-Sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Marketable securities, amortized cost</a></td>
<td class="nump">222,942<span></span>
</td>
<td class="nump">227,155<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Marketable securities, gross unrealized gains</a></td>
<td class="nump">638<span></span>
</td>
<td class="nump">385<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Marketable securities, gross unrealized losses</a></td>
<td class="num">(80)<span></span>
</td>
<td class="num">(296)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Marketable securities, estimated fair value</a></td>
<td class="nump">223,500<span></span>
</td>
<td class="nump">227,244<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember', window );">U.S. government agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-Sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Marketable securities, amortized cost</a></td>
<td class="nump">72,673<span></span>
</td>
<td class="nump">86,616<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Marketable securities, gross unrealized gains</a></td>
<td class="nump">94<span></span>
</td>
<td class="nump">137<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Marketable securities, gross unrealized losses</a></td>
<td class="num">(37)<span></span>
</td>
<td class="num">(72)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Marketable securities, estimated fair value</a></td>
<td class="nump">$ 72,730<span></span>
</td>
<td class="nump">$ 86,681<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_CashEquivalentsUnrealizedGains">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash equivalents unrealized gains.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_CashEquivalentsUnrealizedGains</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_CashEquivalentsUnrealizedLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash equivalents unrealized losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_CashEquivalentsUnrealizedLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cash Equivalents and Marketable Securities - Available-for-Sale Securities in an Unrealized Loss Position (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less Than 12 Months</a></td>
<td class="nump">$ 105,150<span></span>
</td>
<td class="nump">$ 249,264<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 Months or Longer</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total, fair value</a></td>
<td class="nump">105,150<span></span>
</td>
<td class="nump">249,264<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableforSaleUnrealizedLossPositionAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less Than 12 Months</a></td>
<td class="num">(161)<span></span>
</td>
<td class="num">(493)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 Months or Longer</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total, unrealized losses</a></td>
<td class="num">(161)<span></span>
</td>
<td class="num">(493)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less Than 12 Months</a></td>
<td class="nump">36,057<span></span>
</td>
<td class="nump">67,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 Months or Longer</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total, fair value</a></td>
<td class="nump">36,057<span></span>
</td>
<td class="nump">67,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableforSaleUnrealizedLossPositionAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less Than 12 Months</a></td>
<td class="num">(24)<span></span>
</td>
<td class="num">(77)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 Months or Longer</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total, unrealized losses</a></td>
<td class="num">(24)<span></span>
</td>
<td class="num">(77)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember', window );">Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less Than 12 Months</a></td>
<td class="nump">13,129<span></span>
</td>
<td class="nump">42,916<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 Months or Longer</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total, fair value</a></td>
<td class="nump">13,129<span></span>
</td>
<td class="nump">42,916<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableforSaleUnrealizedLossPositionAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less Than 12 Months</a></td>
<td class="num">(20)<span></span>
</td>
<td class="num">(48)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 Months or Longer</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total, unrealized losses</a></td>
<td class="num">(20)<span></span>
</td>
<td class="num">(48)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. government treasury securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less Than 12 Months</a></td>
<td class="nump">32,810<span></span>
</td>
<td class="nump">126,588<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 Months or Longer</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total, fair value</a></td>
<td class="nump">32,810<span></span>
</td>
<td class="nump">126,588<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableforSaleUnrealizedLossPositionAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less Than 12 Months</a></td>
<td class="num">(80)<span></span>
</td>
<td class="num">(296)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 Months or Longer</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total, unrealized losses</a></td>
<td class="num">(80)<span></span>
</td>
<td class="num">(296)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember', window );">U.S. government agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less Than 12 Months</a></td>
<td class="nump">23,154<span></span>
</td>
<td class="nump">12,560<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 Months or Longer</a></td>
<td class="nump">0<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total, fair value</a></td>
<td class="nump">23,154<span></span>
</td>
<td class="nump">12,560<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableforSaleUnrealizedLossPositionAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less Than 12 Months</a></td>
<td class="num">(37)<span></span>
</td>
<td class="num">(72)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 Months or Longer</a></td>
<td class="nump">0<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total, unrealized losses</a></td>
<td class="num">$ (37)<span></span>
</td>
<td class="num">$ (72)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479081/326-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479081/326-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479081/326-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableforSaleUnrealizedLossPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableforSaleUnrealizedLossPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash Equivalents and Marketable Securities - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($) </div>
<div>bank</div>
</th>
<th class="th">
<div>Mar. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_CashEquivalentsAndMarketableSecuritiesLineItems', window );"><strong>Cash Equivalents And Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_NumberOfDomesticBankingInstitutions', window );">Number of domestic banking institutions (in banks) | bank</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">US Government Agencies Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_CashEquivalentsAndMarketableSecuritiesLineItems', window );"><strong>Cash Equivalents And Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Debt securities, available-for-sale, allowance for credit loss</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_ImpairmentOfMarketableSecurities', window );">Impairment of marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments', window );">Realized gains or losses on marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestReceivable', window );">Accrued interest receivable on available-for-sale debt securities</a></td>
<td class="nump">3,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=syre_USBankingInstitutionMember', window );">U.S. Banking Institution | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_CashEquivalentsAndMarketableSecuritiesLineItems', window );"><strong>Cash Equivalents And Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFDICInsuredAmount', window );">Cash, FDIC insured amount</a></td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_CashEquivalentsAndMarketableSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash equivalents and marketable securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_CashEquivalentsAndMarketableSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_ImpairmentOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Impairment of marketable securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_ImpairmentOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_NumberOfDomesticBankingInstitutions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Domestic Banking Institutions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_NumberOfDomesticBankingInstitutions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFDICInsuredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFDICInsuredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477802/946-310-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=syre_USBankingInstitutionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=syre_USBankingInstitutionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cash Equivalents and Marketable Securities - Contractual Maturities of Marketable Securities at Estimated Fair Value (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Due in one year or less</a></td>
<td class="nump">$ 367,106<span></span>
</td>
<td class="nump">$ 338,442<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOne', window );">Due in 1 - 2 years</a></td>
<td class="nump">149,221<span></span>
</td>
<td class="nump">175,223<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Total marketable securities</a></td>
<td class="nump">$ 516,327<span></span>
</td>
<td class="nump">$ 513,665<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Fair Value, Maturity, Allocated And Single Maturity Date, After Year One</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477268/942-320-50-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued and Other Current Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Accrued compensation</a></td>
<td class="nump">$ 1,561<span></span>
</td>
<td class="nump">$ 5,688<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_AccruedContractedResearchAndDevelopmentCosts', window );">Accrued contracted research and development costs</a></td>
<td class="nump">19,078<span></span>
</td>
<td class="nump">20,861<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional and consulting fees</a></td>
<td class="nump">621<span></span>
</td>
<td class="nump">661<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Accrued other</a></td>
<td class="nump">371<span></span>
</td>
<td class="nump">501<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities', window );">Total accrued and other current liabilities</a></td>
<td class="nump">$ 21,631<span></span>
</td>
<td class="nump">$ 27,711<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_AccruedContractedResearchAndDevelopmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued contracted research and development costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_AccruedContractedResearchAndDevelopmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalariesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalariesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Licensing Agreements (Details) - Related Party - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 11, 2024</div></th>
<th class="th"><div>May 14, 2024</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Paragon Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_CampaignTimelineMinimumTerm', window );">Campaign timeline, minimum term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_RoyaltyStepDownPercent', window );">Royalty step-down percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_RoyaltyTermExpirationPeriod', window );">Royalty term expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_TerminationNoticePeriod', window );">Termination notice period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">60 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_SublicensingFee', window );">Sublicensing fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_LicenseAgreementMilestoneExpenseAmountRecognized', window );">Milestone expense recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_LicenseAgreementMilestonePayments', window );">Milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_LicenseAgreementMilestonePaymentsOutstandingAndPayable', window );">Milestone payments, outstanding and payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_PaymentForSublicensingFee', window );">Payment for sublicensing fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">SPY001 License Agreement | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_AmountToBePaidUnderAgreement', window );">Contingent obligation based on milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">SPY002 License Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_PaymentOfMilestone', window );">First milestone payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">SPY002 License Agreement | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_AmountToBePaidUnderAgreement', window );">Contingent obligation based on milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_SublicensingFee', window );">Sublicensing fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">SPY003 License Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_PaymentOfMilestone', window );">First milestone payment</a></td>
<td class="nump">$ 3,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">SPY003 License Agreement | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_AmountToBePaidUnderAgreement', window );">Contingent obligation based on milestones</a></td>
<td class="nump">$ 22,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">License Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_SublicensingFeeOutstandingAndPayable', window );">Sublicensing fee, outstanding and payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_AmountToBePaidUnderAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount to be paid under agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_AmountToBePaidUnderAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_CampaignTimelineMinimumTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Campaign Timeline, Minimum Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_CampaignTimelineMinimumTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_LicenseAgreementMilestoneExpenseAmountRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>License Agreement, Milestone Expense, Amount Recognized</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_LicenseAgreementMilestoneExpenseAmountRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_LicenseAgreementMilestonePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>License Agreement, Milestone Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_LicenseAgreementMilestonePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_LicenseAgreementMilestonePaymentsOutstandingAndPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>License Agreement, Milestone Payments Outstanding and Payable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_LicenseAgreementMilestonePaymentsOutstandingAndPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_PaymentForSublicensingFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment For Sublicensing Fee</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_PaymentForSublicensingFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_PaymentOfMilestone">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment of milestone.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_PaymentOfMilestone</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_RoyaltyStepDownPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalty Step-Down, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_RoyaltyStepDownPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_RoyaltyTermExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalty Term, Expiration Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_RoyaltyTermExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_SublicensingFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sublicensing Fee</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_SublicensingFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_SublicensingFeeOutstandingAndPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sublicensing Fee, Outstanding And Payable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_SublicensingFeeOutstandingAndPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_TerminationNoticePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Termination Notice Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_TerminationNoticePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=syre_ParagonAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=syre_ParagonAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=syre_Spy001LicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=syre_Spy001LicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=syre_SPY002LicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=syre_SPY002LicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=syre_SPY003LicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=syre_SPY003LicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=syre_ParagonAgreementLicenseMilestonePaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=syre_ParagonAgreementLicenseMilestonePaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions - Narrative (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 22, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($) </div>
<div>seat </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th"><div>Apr. 01, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,859<span></span>
</td>
<td class="nump">$ 13,835<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,897,917<span></span>
</td>
<td class="nump">1,044,658<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,859<span></span>
</td>
<td class="nump">$ 13,835<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=syre_ParapyreOptionObligationMember', window );">Parapyre Option Obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 5,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_DevelopmentCostReductionPercentage', window );">Development cost reduction, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_DevelopmentCostReimbursementPercentage', window );">Development cost reimbursement, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="nump">$ 5,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=syre_ParagonAgreementMember', window );">Paragon Agreement | Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Amount of related party transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">18,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_CommonStockSharesOutstandingPercentageAvailableToPurchaseOnADilutedBasis', window );">Common stock, shares outstanding, percentage available to purchase on a diluted basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=syre_AppointOfBoardMembersMember', window );">Appoint Of Board Members</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_RelatedPartyTransactionNumberOfBoardSeats', window );">Number of board seats held by related party | seat</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=syre_ParagonAgreementSubsequentToAssetAcquisitionMember', window );">Subsequent to Asset Acquisition | Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Amount of related party transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">17,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=syre_ConsultingAgreementMember', window );">Consulting Agreement | Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares) | shares</a></td>
<td class="nump">477,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 10.39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vest period grant date</a></td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=syre_ConsultingAgreementMember', window );">Consulting Agreement | Related Party | Share-Based Payment Arrangement, Tranche One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vest period grant date</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=syre_ParagonTherapeuticsIncMember', window );">Paragon Therapeutics Inc | Maximum | Paragon Agreement | Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Percentage of ownership by noncontrolling owner</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=syre_FairmountFundsManagementLlcMember', window );">Fairmount Funds Management LLC | Minimum | Paragon Agreement | Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Percentage of ownership by noncontrolling owner</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_MinorityInterestOwnershipPercentageByNoncontrollingOwnersHeldInThirdParty', window );">Percentage of ownership held in third party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_CommonStockSharesOutstandingPercentageAvailableToPurchaseOnADilutedBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Shares, Outstanding, Percentage Available to Purchase on a Diluted Basis</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_CommonStockSharesOutstandingPercentageAvailableToPurchaseOnADilutedBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_DevelopmentCostReductionPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Development Cost Reduction, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_DevelopmentCostReductionPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_DevelopmentCostReimbursementPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Development Cost Reimbursement, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_DevelopmentCostReimbursementPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_MinorityInterestOwnershipPercentageByNoncontrollingOwnersHeldInThirdParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minority interest ownership percentage by noncontrolling owners held in third party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_MinorityInterestOwnershipPercentageByNoncontrollingOwnersHeldInThirdParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_RelatedPartyTransactionNumberOfBoardSeats">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Related Party Transaction, Number Of Board Seats</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_RelatedPartyTransactionNumberOfBoardSeats</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transactions with related party during the financial reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAmountsOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=syre_ParapyreOptionObligationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=syre_ParapyreOptionObligationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=syre_ParagonAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=syre_ParagonAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=syre_AppointOfBoardMembersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=syre_AppointOfBoardMembersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=syre_ParagonAgreementSubsequentToAssetAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=syre_ParagonAgreementSubsequentToAssetAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=syre_ConsultingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=syre_ConsultingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=syre_ParagonTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=syre_ParagonTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=syre_FairmountFundsManagementLlcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=syre_FairmountFundsManagementLlcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions - Expenses related to Related Party which were Settled in Cash (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Research and development</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 41,623<span></span>
</td>
<td class="nump">$ 34,928<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=syre_ParagonAndLicenseAgreementMember', window );">Paragon and License Agreement | Related Party</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Research and development</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,500<span></span>
</td>
<td class="nump">11,700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=syre_ParagonAgreementMember', window );">Paragon Agreement | Related Party</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Research and development</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">11,700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=syre_ParagonAgreementLicenseMilestonePaymentsMember', window );">License Agreement | Related Party</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Research and development</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Includes $2.5 million and $17.1 million in related party expenses for the three months ended March&#160;31, 2025 and 2024, respectively.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Excludes cost for computer software product to be sold, leased, or otherwise marketed, writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both, and write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=syre_ParagonAndLicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=syre_ParagonAndLicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=syre_ParagonAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=syre_ParagonAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=syre_ParagonAgreementLicenseMilestonePaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=syre_ParagonAgreementLicenseMilestonePaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Related Party Transactions - Related Party Accounts Payable (Details) - Related Party - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableOtherCurrent', window );">Total related party accounts payable</a></td>
<td class="nump">$ 2.5<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Paragon Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableOtherCurrent', window );">Total related party accounts payable</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">License Agreements development milestone liability (see Note 6)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableOtherCurrent', window );">Total related party accounts payable</a></td>
<td class="nump">$ 2.5<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableOtherCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligations incurred classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableOtherCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=syre_ParagonAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=syre_ParagonAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=syre_ParapyreLiabilityLicenseAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=syre_ParapyreLiabilityLicenseAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Preferred Stock and Stockholders' Equity - Narrative (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 20, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>May 14, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 23, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 20, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 18, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 11, 2023 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 06, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 25, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 24, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>shares</div>
</th>
<th class="th"><div>Jun. 22, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=syre_AtTheMarketOfferingMember', window );">At-The-Market Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_SaleOfStockAuthorizedAmount', window );">Sale of stock, authorized amount | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=syre_SeriesANonVotingConvertiblePreferredStockMember', window );">Series A Non Voting Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_PreferredStockRemainsIssuedAndOutstandingPercentage', window );">Preferred stock issued and outstanding percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_StockIssuedDuringPeriodSharesExchangeOfConvertibleSecurities', window );">Exchange of Series A non-voting convertible preferred stock into common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,992<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">346,045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">346,045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">346,045<span></span>
</td>
<td class="nump">346,045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleSharesIssuable', window );">Number of common shares issuable upon conversion (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,841,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=syre_SeriesANonVotingConvertiblePreferredStockMember', window );">Series A Non Voting Convertible Preferred Stock | Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">346,000<span></span>
</td>
<td class="nump">437,000<span></span>
</td>
<td class="nump">346,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">437,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_StockIssuedDuringPeriodSharesExchangeOfConvertibleSecurities', window );">Exchange of Series A non-voting convertible preferred stock into common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,639,680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock | At-The-Market Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26.935<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of stock, proceeds received | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Placement agent and other offering costs | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_SaleOfStockAggregateOfferingPrice', window );">Sale of stock, aggregate offering price | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares of common stock sold (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">777,432<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_SaleOfStockRemainingAuthorizedAmount', window );">Sale of stock, remaining authorized amount | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 179.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock | At-The-Market Offering | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_SaleOfStockAggregateOfferingPrice', window );">Sale of stock, aggregate offering price | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 179.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock | Underwritten Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 27.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of stock, proceeds received | $</a></td>
<td class="nump">$ 215.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Placement agent and other offering costs | $</a></td>
<td class="nump">$ 14.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares of common stock sold (in shares)</a></td>
<td class="nump">8,366,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=syre_SeriesBNonVotingConvertiblePreferredStockMember', window );">Series B Non Voting Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleSharesIssuable', window );">Number of common shares issuable upon conversion (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">666,680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of non-voting convertible preferred stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">121,625<span></span>
</td>
<td class="nump">271,625<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleConversionRatio', window );">Conversion basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_PreferredStockSharesNotAutomaticallyConvertedOutstanding', window );">Preferred stock, not automatically converted, outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=syre_SeriesBNonVotingConvertiblePreferredStockMember', window );">Series B Non Voting Convertible Preferred Stock | Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of non-voting convertible preferred stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=syre_SeriesBNonVotingConvertiblePreferredStockMember', window );">Series B Non Voting Convertible Preferred Stock | Conversion Of Series B Non-Voting Convertible Preferred Stock | Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Shares converted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">254,958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">254,958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=syre_SeriesBNonVotingConvertiblePreferredStockMember', window );">Series B Non Voting Convertible Preferred Stock | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_BeneficialHoldersOwnedPercentage', window );">Beneficial holders owned percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=syre_SeriesBNonVotingConvertiblePreferredStockMember', window );">Series B Non Voting Convertible Preferred Stock | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_BeneficialHoldersOwnedPercentage', window );">Beneficial holders owned percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=syre_SeriesBNonVotingConvertiblePreferredStockMember', window );">Series B Non Voting Convertible Preferred Stock | Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of stock, proceeds received | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 168.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Placement agent and other offering costs | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=syre_CommonStockAndSeriesBNonVotingConvertiblePreferredStockMember', window );">Common Stock and Series B Non Voting Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleConversionRatio', window );">Conversion basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=syre_ParapyreWarrantsMember', window );">Outstanding Parapyre warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_ClassOfWarrantOrRightNumberOfSecuritiesExercised', window );">Number of warrants exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=syre_ParapyreWarrantsMember', window );">Outstanding Parapyre warrants | 2024 Parapyre Option Obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,532,591<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">848,184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per warrant (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22.49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_BeneficialHoldersOwnedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Beneficial Holders Owned Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_BeneficialHoldersOwnedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_ClassOfWarrantOrRightNumberOfSecuritiesExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of Warrant or Right, Number of Securities Exercised</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_ClassOfWarrantOrRightNumberOfSecuritiesExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_PreferredStockRemainsIssuedAndOutstandingPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Preferred stock remains issued and outstanding percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_PreferredStockRemainsIssuedAndOutstandingPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_PreferredStockSharesNotAutomaticallyConvertedOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Preferred Stock, Shares Not Automatically Converted, Outstanding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_PreferredStockSharesNotAutomaticallyConvertedOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_SaleOfStockAggregateOfferingPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale of Stock, Aggregate Offering Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_SaleOfStockAggregateOfferingPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_SaleOfStockAuthorizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale of Stock, Authorized Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_SaleOfStockAuthorizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_SaleOfStockRemainingAuthorizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale of Stock, Remaining Authorized Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_SaleOfStockRemainingAuthorizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_StockIssuedDuringPeriodSharesExchangeOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Exchange of Convertible Securities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_StockIssuedDuringPeriodSharesExchangeOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Stock Issued During Period, Shares, New Issues</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockConvertibleConversionRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common shares issuable upon conversion for each share of preferred stock to be converted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockConvertibleConversionRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockConvertibleSharesIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common shares issuable upon conversion of preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockConvertibleSharesIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=syre_AtTheMarketOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=syre_AtTheMarketOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=syre_SeriesANonVotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=syre_SeriesANonVotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=syre_UnderwrittenOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=syre_UnderwrittenOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=syre_SeriesBNonVotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=syre_SeriesBNonVotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockByUniqueDescriptionAxis=syre_ConversionOfSeriesBNonVotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockByUniqueDescriptionAxis=syre_ConversionOfSeriesBNonVotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=syre_CommonStockAndSeriesBNonVotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=syre_CommonStockAndSeriesBNonVotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=syre_ParapyreWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=syre_ParapyreWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=syre_A2024ParapyreOptionObligationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=syre_A2024ParapyreOptionObligationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Narrative (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 22, 2023</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jan. 01, 2024</div></th>
<th class="th"><div>Jan. 01, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,859<span></span>
</td>
<td class="nump">$ 13,835<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=syre_TwoThousandAndFifteenAndTwoThousandAndSixteenEquityIncentivePlanAndTwoThousandAndEighteenEquityInducementPlanMember', window );">2015 and 2016 and 2018 Equity Inducement Plan | Service Based Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vest period grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=syre_TwoThousandAndFifteenEquityIncentivePlanMember', window );">2015 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease', window );">Shares subject to options outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">952<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=syre_TwoThousandAndSixteenEquityIncentivePlanMember', window );">2016 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_AnnualPercentageOfAdditionalSharesWhichEqualsToIssuedAndOutstandingShares', window );">Annual percentage of additional shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalNumberOfSharesAvailableForGrant', window );">Additional number of shares available for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,814,905<span></span>
</td>
<td class="nump">3,023,650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock available for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,007,869<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding option awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,817,317<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=syre_TwoThousandAndEighteenEquityInducementPlanMember', window );">2018 Equity Inducement Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock available for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,856,811<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding option awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,300,368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=syre_TwoThousandAndEighteenEquityInducementPlanAmendedMember', window );">2018 Equity Inducement Plan, Amended</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_CommonStockCapitalSharesReservedForFutureIssuanceIncreasedAmount', window );">Common stock available for future issuance, additional amount authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=syre_Spyre2023EquityIncentivePlanMember', window );">Spyre 2023 Equity Incentive Plan | Asset Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syre_OutstandingAndUnexercisedStockOptions', window );">Number of outstanding and unexercised stock options to purchase (in shares)</a></td>
<td class="nump">2,734<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=syre_ParapyreOptionObligationMember', window );">Parapyre Option Obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 5,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=syre_A2024ParapyreOptionObligationMember', window );">2024 Parapyre Option Obligation | Outstanding Parapyre warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,532,591<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">848,184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per warrant (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22.49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=syre_TwoThousandAndSixteenEmployeeStockPurchasePlanMember', window );">2016 Employee Stock Purchase Plan | Employee Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Number of shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,877<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=syre_TwoThousandAndSixteenEmployeeStockPurchasePlanMember', window );">2016 Employee Stock Purchase Plan | 2016 ESPP | Employee Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares sold (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,877<span></span>
</td>
<td class="nump">2,330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of stock, proceeds received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_AnnualPercentageOfAdditionalSharesWhichEqualsToIssuedAndOutstandingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Annual percentage of additional shares which equals to the issued and outstanding shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_AnnualPercentageOfAdditionalSharesWhichEqualsToIssuedAndOutstandingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_CommonStockCapitalSharesReservedForFutureIssuanceIncreasedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Capital Shares Reserved for Future Issuance, Additional Amount Reserved</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_CommonStockCapitalSharesReservedForFutureIssuanceIncreasedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_OutstandingAndUnexercisedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Outstanding and unexercised stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_OutstandingAndUnexercisedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syre_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based compensation arrangement by share-based payment award, additional number of shares available for grant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syre_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase or decrease in number of shares reserved for issuance under stock option agreements awarded under the plan that validly exist and are outstanding, including vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=syre_TwoThousandAndFifteenAndTwoThousandAndSixteenEquityIncentivePlanAndTwoThousandAndEighteenEquityInducementPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=syre_TwoThousandAndFifteenAndTwoThousandAndSixteenEquityIncentivePlanAndTwoThousandAndEighteenEquityInducementPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=syre_ServiceBasedAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=syre_ServiceBasedAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=syre_TwoThousandAndFifteenEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=syre_TwoThousandAndFifteenEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=syre_TwoThousandAndSixteenEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=syre_TwoThousandAndSixteenEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=syre_TwoThousandAndEighteenEquityInducementPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=syre_TwoThousandAndEighteenEquityInducementPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=syre_TwoThousandAndEighteenEquityInducementPlanAmendedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=syre_TwoThousandAndEighteenEquityInducementPlanAmendedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=syre_Spyre2023EquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=syre_Spyre2023EquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=syre_AssetAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=syre_AssetAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=syre_ParapyreOptionObligationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=syre_ParapyreOptionObligationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=syre_A2024ParapyreOptionObligationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=syre_A2024ParapyreOptionObligationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=syre_ParapyreWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=syre_ParapyreWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=syre_TwoThousandAndSixteenEmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=syre_TwoThousandAndSixteenEmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=syre_A2016ESPPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=syre_A2016ESPPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Stock Awards Granted (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Grants (in shares)</a></td>
<td class="nump">1,897,917<span></span>
</td>
<td class="nump">1,044,658<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Grant Date Fair Value (in dollars per share)</a></td>
<td class="nump">$ 21.45<span></span>
</td>
<td class="nump">$ 26.50<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Stock-Based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 8,859<span></span>
</td>
<td class="nump">$ 13,835<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">8,859<span></span>
</td>
<td class="nump">13,835<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=syre_AegleaEmployeesAndDirectorsMember', window );">Aeglea Employees and Directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,900<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=syre_ParapyreOptionObligationMember', window );">Parapyre Option Obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">3,512<span></span>
</td>
<td class="nump">6,857<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 5,347<span></span>
</td>
<td class="nump">$ 6,978<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=syre_AegleaEmployeesAndDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=syre_AegleaEmployeesAndDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=syre_ParapyreOptionObligationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=syre_ParapyreOptionObligationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Assumptions used to Estimate the Fair Value of Stock Options Granted (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=syre_TwoThousandAndSixteenEquityIncentivePlanMember', window );">Stock Options Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">6 years 10 days<span></span>
</td>
<td class="text">6 years 10 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">76.00%<span></span>
</td>
<td class="nump">105.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest</a></td>
<td class="nump">4.46%<span></span>
</td>
<td class="nump">3.88%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=syre_TwoThousandAndSixteenEmployeeStockPurchasePlanMember', window );">2016 ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">69.00%<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest</a></td>
<td class="nump">4.23%<span></span>
</td>
<td class="nump">5.31%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=syre_TwoThousandAndSixteenEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=syre_TwoThousandAndSixteenEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=syre_TwoThousandAndSixteenEmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=syre_TwoThousandAndSixteenEmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting -Summary of Significant Segment Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems', window );"><strong>Segment, Reconciliation of Other Items from Segments to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">$ 8,859<span></span>
</td>
<td class="nump">$ 13,835<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="nump">44,773<span></span>
</td>
<td class="nump">43,857<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of net loss</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Adjustments and reconciling items</a></td>
<td class="nump">44,773<span></span>
</td>
<td class="nump">43,857<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="nump">44,773<span></span>
</td>
<td class="nump">43,857<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems', window );"><strong>Segment, Reconciliation of Other Items from Segments to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">300<span></span>
</td>
<td class="nump">5,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development, excluding compensation and share-based compensation</a></td>
<td class="nump">2,500<span></span>
</td>
<td class="nump">11,700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syre_ReportableSegmentMember', window );">Reportable Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems', window );"><strong>Segment, Reconciliation of Other Items from Segments to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="nump">44,773<span></span>
</td>
<td class="nump">43,857<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of net loss</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Adjustments and reconciling items</a></td>
<td class="nump">44,773<span></span>
</td>
<td class="nump">43,857<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="nump">44,773<span></span>
</td>
<td class="nump">43,857<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syre_ReportableSegmentMember', window );">Reportable Segment | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems', window );"><strong>Segment, Reconciliation of Other Items from Segments to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold', window );">Compensation</a></td>
<td class="nump">6,991<span></span>
</td>
<td class="nump">4,174<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">8,859<span></span>
</td>
<td class="nump">13,835<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development, excluding compensation and share-based compensation</a></td>
<td class="nump">33,551<span></span>
</td>
<td class="nump">26,103<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherItemAmount', window );">Other segment items</a></td>
<td class="num">(4,628)<span></span>
</td>
<td class="num">(255)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="nump">44,773<span></span>
</td>
<td class="nump">43,857<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of net loss</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Adjustments and reconciling items</a></td>
<td class="nump">44,773<span></span>
</td>
<td class="nump">43,857<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="nump">44,773<span></span>
</td>
<td class="nump">43,857<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syre_ReportableSegmentMember', window );">Reportable Segment | Adjustments and reconciling items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems', window );"><strong>Segment, Reconciliation of Other Items from Segments to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of net loss</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Adjustments and reconciling items</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Other employee benefit expense includes, but is not limited to, service component of net periodic benefit cost for defined benefit plan. Excludes compensation cost in cost of good and service sold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingOtherItemAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingOtherItemAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=syre_ReportableSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=syre_ReportableSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Reconciliation of Basic and Diluted Net Loss Per Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Allocation of losses</a></td>
<td class="num">$ (44,773)<span></span>
</td>
<td class="num">$ (43,857)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=syre_SeriesANonVotingConvertiblePreferredStockMember', window );">Series A Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Allocation of losses</a></td>
<td class="num">$ (8,288)<span></span>
</td>
<td class="num">$ (12,642)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesIssuedBasic', window );">Weighted-average shares outstanding (in shares)</a></td>
<td class="nump">346,045<span></span>
</td>
<td class="nump">437,037<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants', window );">Weighted average pre-funded warrants (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Total basic weighed average shares (in shares)</a></td>
<td class="nump">346,045<span></span>
</td>
<td class="nump">437,037<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Total diluted weighed average shares (in shares)</a></td>
<td class="nump">346,045<span></span>
</td>
<td class="nump">437,037<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share, basic (in dollars per share)</a></td>
<td class="num">$ (23.95)<span></span>
</td>
<td class="num">$ (28.93)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share, diluted (in dollars per share)</a></td>
<td class="num">$ (23.95)<span></span>
</td>
<td class="num">$ (28.93)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=syre_SeriesBNonVotingConvertiblePreferredStockMember', window );">Series B Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Allocation of losses</a></td>
<td class="num">$ (399)<span></span>
</td>
<td class="num">$ (4,810)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesIssuedBasic', window );">Weighted-average shares outstanding (in shares)</a></td>
<td class="nump">16,667<span></span>
</td>
<td class="nump">166,261<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants', window );">Weighted average pre-funded warrants (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Total basic weighed average shares (in shares)</a></td>
<td class="nump">16,667<span></span>
</td>
<td class="nump">166,261<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Total diluted weighed average shares (in shares)</a></td>
<td class="nump">16,667<span></span>
</td>
<td class="nump">166,261<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share, basic (in dollars per share)</a></td>
<td class="num">$ (23.95)<span></span>
</td>
<td class="num">$ (28.93)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share, diluted (in dollars per share)</a></td>
<td class="num">$ (23.95)<span></span>
</td>
<td class="num">$ (28.93)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Allocation of losses</a></td>
<td class="num">$ (36,086)<span></span>
</td>
<td class="num">$ (26,405)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesIssuedBasic', window );">Weighted-average shares outstanding (in shares)</a></td>
<td class="nump">60,265,932<span></span>
</td>
<td class="nump">36,262,662<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants', window );">Weighted average pre-funded warrants (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Total basic weighed average shares (in shares)</a></td>
<td class="nump">60,265,932<span></span>
</td>
<td class="nump">36,512,662<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Total diluted weighed average shares (in shares)</a></td>
<td class="nump">60,265,932<span></span>
</td>
<td class="nump">36,512,662<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share, basic (in dollars per share)</a></td>
<td class="num">$ (0.60)<span></span>
</td>
<td class="num">$ (0.72)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share, diluted (in dollars per share)</a></td>
<td class="num">$ (0.60)<span></span>
</td>
<td class="num">$ (0.72)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-26<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesIssuedBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the weighted average total number of shares issued throughout the period including the first (beginning balance outstanding) and last (ending balance outstanding) day of the period before considering any reductions (for instance, shares held in treasury) to arrive at the weighted average number of shares outstanding. Weighted average relates to the portion of time within a reporting period that common shares have been issued and outstanding to the total time in that period. Such concept is used in determining the weighted average number of shares outstanding for purposes of calculating earnings per share (basic).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesIssuedBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=syre_SeriesANonVotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=syre_SeriesANonVotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=syre_SeriesBNonVotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=syre_SeriesBNonVotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Weighted-Average Equity Instruments Excluded from Calculation of Diluted Net Loss Per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Options to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">1,866,235<span></span>
</td>
<td class="nump">3,200,918<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Unvested restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">22,622<span></span>
</td>
<td class="nump">61,253<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=syre_ParapyreWarrantsMember', window );">Outstanding Parapyre warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">1,532,591<span></span>
</td>
<td class="nump">684,407<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=syre_ParapyreWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=syre_ParapyreWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>77
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( "2 J%I&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( "2 J%IN+L/]\@   "L"   1
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MNIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X8-DOV]:[MR_>X%<R)!%!,!FGK_#
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M"CS<_N\-L,+$CN'MB[\!4$L#!!0    ( "2 J%IRVB/X"08  +(@   8
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M@PE/;3?(MR=:KO(]YD>IM8SSPZ7@@5#F ;@_EU+O3\P?*/Z;PN!_4$L#!!0
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M&AQKY3+'#P]0U@#O9U*:S<;^0?,ID_P%4$L#!!0    ( "2 J%KI?#Y!80H
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MO5RR#[ED2W/)S5:2,_B_Q<7A;,80B5\*'RM^)&R!A+E(F&</)A)B"R829,P
M"0N1L @$ZXG?.8C?&2/^<P0O!8X5/!*V0,)<),QS!J,],75#Y<_?D3$#)"Q$
MPB(0K"?X^4'P\W&7K-X-ED=CK^%* XY-""1L@82Y\\&@;>CV8-#VD#%])"Q
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M?-O\KLO7O*KR3?-P3>,5+>H"[/V[/*^>GM0_%7/XS:6K_P)02P,$%     @
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M9=\B[52!JZJ@+/$L)DZWCSLUVP1<2 ?<+!VF]"/;\XF<E&&7!YL$*\RJ&JC
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MQ6C(A#: SY><J_V-_H+##SX&_P502P,$%     @ )("H6L^NKE:;$   >3
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MS.L+_T.(AELUG3 7%V/U4ZK^FNV$M]DE1^X\8+9J2<@DL:'#;.D:<@;)?E6
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M*6-V/!OMG[#W!75D[2X"[239VZY_!ZP'R,0C\I#8K0:G BE&V7.;UG<9P!S
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M@$Y"U*W$RT_7TZ90D!522'R#LM'JVOD#@]P"!9062=A"'J:_T^+W_6SPJ;
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M*@R;GW9+O,PA50JV]"M8=UO!WNJBXF7#Q*TPF;0B]ZN?JU!>-UPJGBK!:G#
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MS7$O%I;FBS=5^$E@9KPW9?A8".2:I0UX/C= (WVA"]K?B"[^ %!+ P04
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MM.Z*-AC<?Q=G\ZAN5VM,,X%81W<4?@B" AMF$2HUQR3%#3'1E) "_0+A"!P
MZ"'CF54N,CHWX0,^*>BX(H #&(CI% DY\@2< MC3;AFH^)K)-FUS[WO.+/W+
M[N7WIPVAY1>#ZP*S3\O=F>GA&0RX*CU0R*O!BUO&Z(K!>!1=CJ='U88](*(N
MMA?U+Z?1<+ /2B]$?Q)-)A?'[).@82)RL7._BDANOSWD+FC['2:"D$S:\A]Y
M#YHO=='&<77XT:H WW[\L<-<3WG\\5BN"H0MV(43_5$%RST\CYA,)GQHM'$8
ML=.Z=$)1^/">GFO-U:\_B_<R1O @_WW,6X\GN][BUQ0M5RMLH](Y46A-5RG8
MOA#?5PPF%W291MR<#4.:6?'!+/Q!J@1L4U=1Q=G-N[<->R_02>:>'5]1BVA-
M!<A!?* *U<!$H?RS<0_$IZ8;AT_,HH?=2J)FGK(]4K_7G#[JU^;8ZAPBE3DE
M&*+IT+.JQU1 \<B9K.YYG6HMTJ6\CR^V.2'E7@)&#M.YP)#USG9;;]/F?/9:
MYWTVEB2R<56?P49T[:$Y10IGR.WYF:Q.X(/Q%&2O+#?8MMR>U!5N#B!S$EH:
MOH>"L+ RJ^K)^@ADMTY=\>.ZNB(*4S@_"W>%^+SIT?LC?+*]=5YZ<7$1C8:#
MPW+S^> NP<--D/JN1KBBL:;/?%ECTKT<CJNZQ-DZ?T"C8<7N>#]O=NRLP)E)
M.'BBZ:T#!]Q!H'O=T9H_?T HJ9D%$[FO;GG\'9%/$Y&-TGEU D _;MA:W+!)
M/[5->K,9IHW[2/^<8;K>MP5!Z'FK3>F.]]))HER,TD+^G:$K.HTJGV$H*CC8
M*[T[(A+3BG_J1,2H/SZ1IR>3T];^-VNAKF(?:L_QNG*9XY=TU*\:?M]#NI0%
MVMAJP*UJ OP03BJ U0!>PZ9_<=GM'Y&.&+V4U6:JS:K8]"U]-[/DWA<_R Q5
M0NB*7QJ.&EJ9S15;0]NM@E]BB\U<MEUT=U_6VE*X>0<A;Z5.J0OB &2;[56+
M9+YMU?/?:. *?D;$BH^5%W9=2SQO727ELRBZ,$M1!>(2;I4VOS9W<J_"5=3U
M\'"A%WHM"!FIFF-JKWLQ[H1#O/J+-P5?3)T9#W;('Y=*0E :@.=S@P13?:$-
MFIO*K_\#4$L#!!0    ( "2 J%K26J_"6PH  /L=   9    >&PO=V]R:W-H
M965T<R]S:&5E=#$W+GAM;,U967/;.!+^*RA-/&M7T9)(ZDQL5]F38V:KIN**
M,S,/6_L D9"$#4DH &A9^^NWNP%>LB0[\[0/MG@ C3Z__@!>;97^9M9"6/:4
M9X6Y[JVMW;P=#$RR%CDW?;41!;Q9*IUS"[=Z-3 ;+7A*D_)L$ V'DT'.9=&[
MN:)G]_KF2I4VDX6XU\R4><[U[DYD:GO="WO5@R]RM;;X8'!SM>$K\2#L'YM[
M#7>#6DHJ<U$8J0JFQ?*Z=QN^O1OA>!KPIQ1;T[IF:,E"J6]X\UMZW1NB0B(3
MB44)''X>Q2\BRU 0J/'=R^S52^+$]G4E_2/9#K8LN!&_J.POF=KU=6_68ZE8
M\C*S7]3V5^'M&:.\1&6&_K.M&SN*>RPIC56YGPP:Y+)PO_S)^Z$U838\,B'R
M$R+2VRU$6K[GEM]<:;5E&D>#-+P@4VDV*"<+#,J#U?!6PCQ[\V!5\NWR#NQ*
MV2\JAU@;CNZZ&EB0CF,&B9=TYR1%1R3%['=5V+5A'XI4I-WY ]"J5BVJ5+N+
M3@K\G>L^B\. 1<-H?$)>7)L:D[SXF*EKKH4W]9[O(+,LN]6:%RM!U_^Z71BK
M(4W^?<AX)WMT6#:6SENSX8FX[D%M&*$?1>_FYY_"R?#="<U'M>:C4])_*$A_
M3Q+X.!RS#]]+:7?LMR(!?T"QL/N,%W#+(!3)FL8$S*X%3>7%CO%4;2R(PF<G
M))S__-,LBH;O: @^H?OPW44 $B"II;%"@YC%CB0M%-<I4TN62@W%J[2!<47*
M-EH]RE08!EC44<,J!G6>,7@LC2D%,QAJ@R(2E>=@GD&[\3T\MEHFJ'3[58#O
M0,P*TL$R6:OOYVW01P;'%*KX7O),+B5(Z+ZMM-J4X"SP\/[R 2X@\DVF=D*
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MR_<5_-.IJB-VG XS7&\RN 5FR 4-R#07!YM#TQ* 9 ARG7,U>$EMJ/><AQ>
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M5%'B<:_]2EJ^.%W[F]%4.]RS_#+'Q98,"V!_IC'"NQ=VL+HJ7_\+4$L#!!0
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MES%6NK9AP%E79^'J!&?JA.B.,U5(](GED+_$8ZVY%QX<A2^"BX1W1(Q0./Z
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M\S!M0>\:T/@5T!%[4*7-#?M<9I2=^X<@V+&,CRSOXHN #UP/V&CXCL51/+Z
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M#>C]7$JSO;$.VO\EX_\ 4$L#!!0    ( "2 J%K4@*H:A@,    (   9
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M1J\JE&8#K6^%T(\#8Z!_IRW^!5!+ P04    "  D@*A:I;D?G#H6  # D0$
M&0   'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6S-W6MSFUB"QO&O0GF[MF:J
MDEB@F]V;N,H)]SN3[MX76_N"R-A611(:0$YGJC_\H(N-CR0?0?+WUO:+M&R+
MWSD2\1,0//#^6UY\+>^SK%+^G,\6Y8>S^ZI:_GI^7D[NLWE:OLN7V:+^R6U>
MS-.J_K*X.R^719;>;!::S\ZU7F]T/D^GB[.K]YOOQ<75^WQ5S::++"Z4<C6?
MI\7WC]DL__;A3#U[_,8_IG?WU?H;YU?OE^E=]CFK?E_&1?W5^9-R,YUGBW*:
M+Y0BN_UP=JW^FHS'ZP4VS_ACFGTKGSU6UB_E2YY_77_AW'PXZZUGE,VR2;4F
MTOI_#]FG;#9;2_4\_KE#SY[&7"_X_/&C;FY>?/UBOJ1E]BF?_??TIKK_<'9Q
MIMQDM^EJ5OTC_V9GNQ<T7'N3?%9N_E2^[9[;.U,FJ[+*Y[N%ZQG,IXOM_],_
M=V_$LP4T]84%M-T"VMX"@Y=&Z.\6Z.^/\-("@]T"@[93&NX6&+:=TFBWP*CM
M"./= N.]!?K:"PM<[!:XV!]A^,("E[L%+O=?P\5+*Z[WN.9Z;5^%^K2R]]?V
MB^^4^KBZU=;K6WU<X>K!&G_IW5(?5[G:>IVKCRM=W5_K+R_RN-K5UNM=?5SQ
MZF;-GV]_KS:_E'I:I5?OB_R;4JR?7WOK!YO?[,WR]>_B=+$.H<]54?]T6B]7
M7?UVGRF?\ODR77Q7TL6-\C$MIZ62WRIQD979HDHW4?$W/:O2Z:S\N_*+<JZ4
M]VG]0V6Z4'Y?3*OR3?W-^O%O]_FJK(GR_7E53VS-GT]VDW"WD]!>F$1?"?)%
M=5\JQN(FNSFRO"]?7M5. <$I0)4(Y_5[^O3&:H]O[$=-2H;YPSM%NWRC:#UM
ML'O+CDSL4QNEMU-^_ZPK?_M%6 DOPKH<#M+OBCHX-3M#CEPOBWIV_5.*>6HJ
MQ0^^1JL%K%Z<FIXM5_1L4BOJ1NFWFI8C!]W5HGZ]V@%X[/>FQ0OL;Z<V?'KG
MRNRNWDJH6DW5:S^ Y!WT6[R#3TJ7%1S\R.MO X=R^'.V?*?T1N*,CS!1F]^/
MX:FW+VZCG/Q=3=JOA/Y118BY_M._'_T-VW^!/?UOQ__X]2**4V7S\G^/3/OC
MUA\<]]?;X+^6RW22?3A;KM7B(3N[^L__4$>]_SJ6IB2FDYA!8B:)621FDYA#
M8BZ)>23FDUA 8B&)1206DU@"84* #IX"="#3K\+5_$M6K%,S7V9%'9F+N\=_
MP4OEK\>'QX)3ZG8-3A+32<P@,9/$+!*S2<PA,7>+#3?8^C.MAROU_?G#\S0D
MA_-)+""QD,0B$HM)+($P(0V'3VDXE*9A7.23++LIE=LBGRM%.BW7>3A)E],J
MG=5Q^,NQ()2278.0Q'02,TC,)#&+Q&P2<TC,)3&/Q'P2"[;8Z'G>]WOK_\34
M#\E!(Q*+22R!,"$.1T]Q.)+&X?5DLIJO9FF5W:R/K$PGT^JE$)1"74.0Q'02
M,TC,)#&+Q&P2<TC,'1VDPUNUIXZUWG!OHY <U3\RZN58&_0U<=!@=+"M>GQV
M(3F[B,1B$DL@3 BO\5-XC:7A%:3%UZQ*O\RR>B]VLBJFU30K7XHO*=4UODA,
M)S&#Q$P2LTC,)C&'Q-SQ09 ,1X.+_6T;CQS3)[&@W0L(R3$C$HM)+($P(=\N
MGO+M0IIOG_+%0U9LSL:);I7/6;&.MX]*F"_>_I%O/L?;/J.:KB,P+K+;K"CJ
M#;G/53[Y6N?@IWP^KY?=?'DL$J6C=XU$$M-)S" QD\0L$K-)S"$QE\0\$O-)
M+""QD,0B$HM)+($P(5XOG^+U\I6/+%^2 4IB.HD9)&:2F$5B-HDY).:2F$=B
M/HD%)!:26$1B,8DE$"8$J-I[2M#U*;>2+=3/V[.@)MO-T'K3\V_3Q>[4GV-G
M,WV4<UT3$]7TG28<ANRIEQ=];6_7QT#'-5'-0C4;U1Q4<UNO+P\=UT>U -5"
M5(M0+4:UA-+$X'MV4KLJ/VY2O?WM/GN[_02RWCNO][SK_?&CD2>%.D<>J>FH
M9J":B6H6JMFHYJ":BVH>JOFH%J!:B&H1JL6HEE":&)U:$YW:*^]V[P:@(I74
M=%0S4,U$-0O5;%1S4,U%-0_5?%0+4"U$M0C58E1+*$V,U*8BHTI/(+_ZG,ZR
M=8J6ZR,];Y1T5=WGQ?1?]?YX.L]7BQ=/Z9&SG8,4[<:@FH%J)JI9J&:CFH-J
M+JIYJ.:C6H!JX4X3CLD?.6$R0D>-42VA-#$BFQ+,NE O/9;>' O?;'H^/YRN
MG#Z<?C0^I4-VCD]2TU'-0#43U2Q4LU'-0347U3Q4\U$M0+40U2)4BU$MH30Q
M9)MNC3I\[5U[M&J#:CJJ&:AFHIJ%:C:J.:CFHIJ':CZJ!:@6HEJ$:C&J)90F
M1FK3SU'E!9VGS=1%OGC[L-U,G3S;3%T^;:;N=OZ7::$\I+-5MCD6?Y//9FE1
M*LNLV!Z7__OZLP#9%6$^RB?4.8+1I@^J&:AFHIJ%:O9.&S_;@>R]J_<?]WK6
M#CJJBVH>JOFH%J!:B&H1JL6HEE":&*Y-?TB5%XB>G6#_9;VY>C0.T>(0JNFH
M9J":N=.>GYXSV/N\RD)'M%'-0347U3Q4\U$M0+40U2)4BU$MH30Q"INJD2KO
M&A$?AZ)](E334<U -1/5+%2S4<U!-1?5/%3S42U M1#5(E2+42VA-#%3FWZ1
M^MH%(Q5M&*&:CFH&JIFH9J&:C6H.JKFHYJ&:CVH!JH6H%J%:C&H)I8F7/&\*
M1YJ\<-1FCUU.= U-5--1S4 U4SLLU!SLL:,CVJCFH)J+:AZJ^:@6H%J(:A&J
MQ:B64)H8A4T%29-7D)RR7*6+R>;$SW8'ATZU,^4#=@Y.M*J$:@:JF3M-:")J
MZD@;[H?GX?.T\>'S[&/>\/!T/P=]%2ZJ>:CFHUJ :B&J1:@6HUI":6+@:4W@
M2<^BOXKQ0]WR 3L''EHD0C4#U4Q4LU#-1C4'U=R==NHPO(>.ZK<<-6CYO!"=
M781J,:HEE"8&7E/KT>2UGH/ RU=56:6+F_5VWJEM.;3:@VHZJAFH9J*:A6HV
MJCFHYNXT89MU-!J-]Y,-[>RT&S1H][00G5N$:C&J)90FYEK3Q:D?=LJU15ZM
M2XOY/*VFDW0V^]Y<4:A;Z$G'[1QZI*:CFH%J)JI9J&:CFH-J[DX[&7KDH#ZJ
M!>U>0H@.&J%:C&H)I8G9V%1H-/G]:3J>AU/OXK8X,T<^9N=<1%LUJ&:@FHEJ
M%JK9J.:@FHMJ'JKYJ!:@6HAJ$:K%J)90FIBR3:M&&[WRF3D:VI)!-1W5#%0S
M4<U"-1O5'%1S4<U#-1_5 E0+42U"M1C5$DH3([7ITFCR+LTK'(Y&FS>HIJ.:
M@6HFJEFH9J.:@VHNJGG:8?])U;2#@_@^.FJ :B&J1:@6HUI":6)X-NT;3=Z^
M^:DC/6CM!M5T5#-0S40U"]5L5'-0S=UI0K"-#W+-0P?UVPT:M'M:B,XM0K48
MU1)*$W.M:<!HTM/!?^#3S)^]YUF;3T/14@VJZ:AFH)J):A:JV:CFH)J+:AZJ
M^:@6H%J(:A&JQ:B64)J0TOVF5-/OO?*GH7VT<H-J.JH9J&:BFH5J-JHYJ.:B
MFH=J/JH%J!:B6H1J,:HEE"9&:E/.Z<O+.5UOC";G.@<H6KWI'ZFM# >7PXN]
MVZ*AHYJH9J&:C6H.JKDMUY:'CNJC6H!J(:I%J!:C6D)I8NAI3>C)"SH_<N[2
M]"&MZI_,ZEG-Z\W-H]F(MG1034<U ]5,5+-0S48U!]5<5/-0S4>U -5"5(M0
M+4:UA-+$G&UZ0?W^:^^OH^T@5--1S4 U$]4L5+-1S4$U%]4\5/-1+4"U$-4B
M5(M1+:$T,5*;2E+]4+KI*MY!;5E,)UG3)/_1?KE\T,XQ2VHZJAFH9NZTY_>[
M4@<7^]<B0L>T4<U!-1?5/%3S42U M1#5(E2+42VA-#$^F]92_T1K:3\^\TF6
MW91*D4VRZ4.]P__"#2CE;.> 1(M)J&:@FKG3A( <75SNG^ABH:/:J.:@FHMJ
M'JKYJ!:@6HAJ$:K%J)90FAB13>6H+[^1S]-'G$IZM_FSWGG/J_MZ8S*_O<V*
M[;GR956^&)5HX0C5=%0S4,W<:4)4JMIA4J)-(E1S4,U%-0_5?%0+4"U$M0C5
M8E1+*$U,RJ9)U)<WB7:'D:Y_XE84\A$ZAR5:'4(U ]5,5+-0S48U!]5<5/-0
MS4>U -5"5(M0+4:UA-+$3&T*1OV+USYDA-:,4$U'-0/53%2S4,U&-0?57%3S
M4,U'M0#50E2+4"U&M832Q$AMNDU]>;<IQB]'+!^P<\2BQ214,U#-1#4+U6Q4
M<U#-W6DG+T>,CNJW'#5H^;P0G5V$:C&J)90F!-Z@J0D-Y/?>,?Z<W*>+N\V!
MGJ=]]):7^I@NJKQ^PGQ>;VFVNOB'?"Y=LQ#5=%0S!H>WW;GL75YJXE]S$QW4
M0C4;U1Q4<U'-0S4?U0)4"U$M0K48U1)*$V.UJ0H-Y%6A@^W(#M?^D-.=4Q*M
M#:&:@6HFJEFH9J.:@VKNX+!<U!^,>H.].QAYZ*A^RU&#EL\+T=E%+4>-6SXO
MH68GQI'6Q%&K$D_;HR_M+KDA'[-S3J$5'E0S4,U$-0O5;%1S4,U%-0_5?%0+
M4"U$M0C58E1+*$U,V:;",WCM"L\ K?"@FHYJ!JJ9J&:AFHUJ#JJYJ.:AFH]J
M :J%J!:A6HQJ":6)D=I4>.J'K[8?+:4[ARFIZ:AFH)J):A:JV:CFH)J[T_;W
M!0\NHGGD>8/^X04M_99>T/)Y(?IJ(U2+42TY_0Z+<=148@:M;N3383_ZZ*4O
MK]%+7\KGW#GGT+X-JAFH9J*:A6HVJCFHYJ*:AVH^J@6H%J):A&HQJB64)J9T
MT\H9O/:-@ 9H+P?5=%0S4,U$-0O5;%1S4,U%-0_5?%0+4"U$M0C58E1+*$V,
MU*:^,SA1W^EXZ4LYUSE T:X.JAF#PUO"'#W3!RWAH)J-:@ZJN:CFH9J/:@&J
MA:@6H5J,:@FEB<G8E' &\KO\?-J>__CRWCE:L4$U'=4,5#-1S4(U&]4<5'-1
MS4,U']4"5 M1+4*U&-422A,#LZG8#"Y?>^\<K=2@FHYJ!JJ9J&:AFHUJ#JJY
MJ.:AFH]J :J%J!:A6HQJ":4)D3IL2CS#_T<E'OE<NJ8OJNFH9@P/2SS]4?]R
MM'_12A,=UD(U&]4<5'-1S4,U']4"5 M1+4*U&-422A.#M:GQ#.4UGN<[]\I?
MRG7U]K?[[&V0%E^S2HEVEW@[&I)HAP?5=%0S4,U$-0O5;%1S4,U%-0_5?%0+
M4"U$M0C58E1+*$U,4JU)4NV5]_J':-T(U714,U#-1#4+U6Q4<U#-134/U7Q4
M"U M1+4(U6)42RA-C-2F;C24GGO_2K>WD _:.6;1"A*J&:AFHIJ%:C:J.:CF
MHIJ':OY.NWSV 9 V>G?9W^^HHZ.&J!:A6HQJ":6) =J4B^J'G0*TY0TNY&SG
MB"0U'=4,5#-1S4(U&]4<5'-1S4,U?Z<]OQ*_UAL>=)3004-4BU M1K6$TL2$
M;/I.0WG?Z6?O;R'G.R<E6DU"-0/53%2S4,U&-0?57%3S4,T?'M[>:7"8DVCC
M"-4B5(M1+:$T,2>;QM%0?A^@O2W)].ZNR.[6]T!_BLGMWOE+,8G6C5!-1S4#
MU4Q4LU#-1C4'U5Q4\U#-1[4 U<*=]OR$$*W7.VC:1^BH,:HEE"8F95,D&LJ+
M1.%J_F6S^;C["'+]2#C[J,QG)]M%\C$ZYR7:+D(U ]5,5+-0S48U!]7<X6''
M:_^B'NB _I$!Q^/QH*_M;RZBG2%4BU M1K6$TL00;#I#0WEG:&]SL<CFZ72Q
MWDI,5]5]7DS_E=THZ3Q?U7O<+VTQHJTB5--1S4 U$]4L5+-1S4$U=Z<)-]P<
M7ZH'US9"1_51+6CY&D)TU C58E1+*$V,P:8)-)3?;*?5V97U#X+TS^E\-3^:
M@V@5"-5T5#-0S40U"]5L5'-0S44U#]5\5 M0+42U"-5B5$LH3<C445,%&FW/
MB'^]\RQ':+\'U714,U#-1#4+U6Q4<U#-134/U7Q4"U M1+4(U6)42RA-C-2F
M!#22EX!^\N".7.^<IV@5"-4,5#-1S4(U&]4<5'-1S4,U']4"5 MWVJF/!R)T
MU!C5$DH3DU)KDE)^FZ&]'?K?%S=9\:V85E6VD+8EY6SGB$2K/:AFH)J):A:J
MV:CFH)J+:AZJ^:@6H%J(:A&JQ:B64)H8I$VU9_3:=Q(:H34>5--1S4 U$]4L
M5+-1S4$U%]4\5/-1+4"U$-4B5(M1+:$T,5*;LD_]L,->/-26E _:.6:WVL7S
M\\O&[_;:9CHZIH%J)JI9J&:CFH-J+JIYJ.:C6H!J(:I%J!:C6D)I8GPV3:#1
MB3L?_6!74LYV#LC##H6F#B_W/Z/1T5$-5#-1S4(U&]4<5'-1S4,U']4"5 M1
M+4*U&-422A,CLBD!C>0EH)\M2\KYSE$Y.OPX>Z =)B5:[T$U$]4L5+-1S4$U
M%]4\5/-1+4"U$-4B5(M1+:$T,2F;$M#H_Z $)!^C<UP>-BXN^J.1-CP(3+3?
M@VHFJEFH9J.:@VHNJGFHYJ-:@&HAJD6H%J-:0FEB8#:%H5'[FPS5FX_10U:\
MO9[-\FJSN1DMUX>$CF8D6A-"-1W5#%0S4<U"-1O5'%1S4<U#-1_5 E0+42U"
MM1C5$DH3@[2I'(U>^^9#([1QA&HZJAFH9J*:A6HVJCFHYJ*:AVH^J@6H%J):
MA&HQJB64)D3JN&D<C>4W'T)VYL>'M]I1>Y?JP>[W)_EDN@8FJAFH9J*:A6HV
MJCFHYJ*:AVH^J@6H%J):A&HQJB64)@9FTR<:G^@3+;\7F?+;?5:DRVQ532?E
M&\593-X=S46T/(1J.JH9J&:BFH5J-JHYJ.:BFH=J/JH%J!:B6H1J,:HEE":&
MI]:$YVO?1VB,EHU034<U ]5,5+-0S48U!]5<5/-0S4>U -5"5(M0+4:UA-+$
M2&W*1F/Y?82NRS*KE'3RS]6TG*XC],UVQ_V^WF^O=^R7Z??-4:9E5DSSFZ.)
MBG:-4$U'-0/53%2S4,U&->?$W\"^\CU+BV,%"Q>=AX=J/JH%J!:B6H1J,:HE
ME":F9],KJA]V3,])6MX_QN8;I;JOAUUGJ2Q!I6-T3E!2TU'-0#43U2Q4LU'-
M.?&W4-TDZ-$ ):?AH9J/:@&JA:@6H5J,:@FEB0':-(O&\F;1-D"OFP!5_E(^
MUTF9E<JU$M9?_I%7ZW/G/^6+AZRHIE]FV7J'_S8KBNQF>TK4T4A%BT>HIJ.:
M@6HFJEFH9J.:@VHNJGFHYJ-:@&HAJD6H%J-:0FEBSC;UI/'HM3\Y10M*J*:C
MFH%J)JI9J&:CFH-J+JIYJ.:C6H!J(:I%J!:C6D)I8J0V/::QO,?4;(8^UN+3
M0GE(9ZL?OIZ(?,#.$8O>V0C5#%0S4<U"-1O5G)TV?G:F7.]=K]=3Q1/E7'14
M#]5\5 M0+42U"-5B5$LH;1N>Y^5]EE5Z6J57[^=9<9=]RF:S4IFL[V+TX6Q]
M?/_INTH=F_7?4/573ST[/_C^M?KKM;;^_GG#7+U?IG=9D!9WTT6IS++;FNR]
M6V]0%].[^Z<OJGSYX4P]4[[D597/-P_OL_0F*]9/J']^F^?5XQ?K ;[EQ=?-
MM*_^#5!+ P04    "  D@*A:$3[! F,(  #M4   &0   'AL+W=O<FMS:&5E
M=',O<VAE970S,2YX;6RUG&UOFT@0Q[_*RE>=>E(;FWT"]Q)+;:KJ3FJEJD_W
MFCB;!!6##W#22/?A#VR78<-ZO-3#F\1V9O^9\4S(C[\7SA_RXGMY9TS%?JS2
MK+R8W%75^M5T6B[OS"HNS_*UR>J?W.3%*J[JI\7MM%P7)K[>+EJE4SZ;Z>DJ
M3K+)XGS[VL=B<9YOJC3)S,>"E9O5*BX>WY@T?[B8!).?+WQ*;N^JYH7IXGP=
MWYK/IOJZ_EC4SZ:MRG6R,EF9Y!DKS,W%Y'7PZG+.FP7;B&^)>2@[CUE3RE6>
M?V^>_'U],9DU&9G4+*M&(JZ_W9M+DZ:-4IW'OWO12?L[FX7=QS_5WVV+KXNY
MBDMSF:?_)-?5W<4DFK!K<Q-OTNI3_O"7V1>D&KUEGI;;K^QA'SN;L.6FK/+5
M?G&=P2K)=M_C'_LWHK,@D <6\/T"[KM [!>(;:&[S+9EO8VK>'%>Y ^L:*)K
MM>;!]KW9KJZK2;*FC9^KHOYI4J^K%N_BI&#?XG1CV <3EYO"U#VJ2O:2O4NR
M.%LF<<I>EZ6I7XJS:_8^B:^2-*D24_Z,OV9QQ3HR=6\^F>6F*)+LEKV)RZ1D
MS]^:*D[2\H]&MHU\8?W&%YU5+]G7SV_9\V=_L&<LR=B7NWQ3UK^]/)]6=<E-
MXM/EOKPWN_+X@?(^Q,49$\$+QF=<.99?XLO?FF6[7-K+I_4;W;[;O'VW^59/
M''JWG[RGKUP5[22D6Z+YLWY5KN.EN9C4?[>E*>[-9/'[;X&>_>FJCTC,JE:T
MU0I,??$EK^I*;]J:XVW-KI)W.GJKTQQX[A=*BX"'Y]/[;C'],#T+Y$RU85::
MLDU3HDWIS+2S'Y*R'T1B5J&J+51Y]".%<EW5[B14MQ5S,9L]Z40_2@=A)\K*
M3[?Y:32_KV>?S]AM?F^*K#DDL*K8'A\>6=D<&0YFC(H.[0^1F%5_V-8?GGYT
M""FK)1*SJHW::B.BHT/4&S;.A>K-I"LLY%*ZAW+>ICD?-)0UVV3+8R.)2@YM
M$I&857TP SZ8G3Z4>PVB@JG4[(H[1!00#>9>J#MR(0_%T\%TA$5:1X%[, .
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MSE9<E@;Z\R<AU,^#\LF1YDFA^?]02P,$%     @ )("H6I7_W1$1!   -Q(
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MQHWK*@8HC=2TX4YGXZ&G__9$L9RXKPI4S4Q9=KP#_T195FQ;6@=6,9R0SF)
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M7'(6\5R?H+Z?"R%?=G0!S<+<R?]02P,$%     @ )("H6I8@)C+X!P  WD
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M:&5E=#0R+GAM;+5776^;2A#]*RL:5:W4:U@^["2U+25VJQNID:*D'P_5?=C
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M"YJ2&P69_*=-MY+7;^?5A\>E+%@($PM/!PEB#=;T[1LZ=#ZV!=T364,"OY;
M[V)'"20P@46%%8(O\!I/I@+/&=7BYW4WTT_:JE0)&AJ0/A774Y\.76]LK_<E
M>&GE^1?N>6W5B"VH8PLZ/<*TLJ4^[#"T+TFHWRURM10 .D#R;_/=:O.]D_[4
M+/=$UE!B6"LQ?*5"'_8I04]D#0E&M02CO@I]5C(%>]7H!HYS4+(OC2@=[5DU
MO#ROO3S_HY(]J4P[*4_-44]DC>@OZN@O7JE,+_J4H">RA@34V74(3F^%6E'M
M%^%AF;:8=-0IW6MD:*>;_^M [>8\-4]]L345<'<*N*]4K15Q7S+TQ-:48==#
MT<[^Y+1Z]5[\S[><K"U6Q\I5MSG-E5US0+N[ ^Q7R$T>IJL(.^XS=Q!@OY^F
M2=4OG-'1@-8K25[WY(7)-FQ;=1P%B8H!/_@:D*QLET&WR^36J++M=@VK[EL_
M()4LP Q@Z?.@+0?VWH"1@5B:04V2D*]R5;9V]6H]#%Z;$>A@?::'Q);U*^I?
MSJC?NA/@CAG;[-VCRZD4 UHF.*FDL$ WG,$(!1;EH%?>*%Z8T>>1*QRDS&6,
MPS$(;8#["\[5]D8_H!ZWI_\!4$L#!!0    ( "2 J%HL^ !0W@(  +T*   9
M    >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;+56:V_:,!3]*U963:VTD@>/
M0@>16M"T2NV$^M@^3/M@P@6L.G%F&VC__:Z=U$NV%+42?($XON?DW.-K^PZW
M0CZJ%8 F3RG/U,A;:9V?^[Y*5I!2U1(Y9#BS$#*E&H=RZ:M< IU;4,K]* AZ
M?DI9YL5#^VXJXZ%8:\XRF$JBUFE*Y?,E<+$=>:'W\N*6+5?:O/#C84Z7< ?Z
M(9]*'/F.9<Y2R!03&9&P&'D7X?EX8.)MP'<&6U5Y)B:3F1"/9G U'WF!$00<
M$FT8*/YM8 R<&R*4\;OD]-PG#;#Z_,+^Q>:.N<RH@K'@/]A<KT9>WR-S6- U
MU[=B^Q7*?+J&+Q%<V5^R+6,#CR1KI45:@E%!RK+BGSZ5/E0 8><50%0"HK<"
MVB6@;1,ME-FT)E33>"C%ED@3C6SFP7ICT9@-R\PJWFF)LPQQ.KX%3C7,R91*
M_4SN)<T4M08K<DKJDQ=)(M:95CA\IC,.Y'@"FC*N3OX+/24/=Q-R?'1"C@C+
MR WCW% .?8V2S8?]I)1W6<B+7I%W0V6+M,-/) JB;@-\O!L^@<3!.W6XCT8Y
MMR+G5F3YVN]UB_R\QE!RI2%5OYK2+'@[S;QFJYZKG"8P\G O*I ;\.*/'\)>
M\+DIZ3V1U2QH.PO:N]CC>Z$IQ_U;&)%;(^A+9>1%93094+"&A;/F;-G$40N7
M=%--K"$H:/5<4$UPQPGN[!2,:T67N$(72PF YX]N4K>3XKW+LR>R6K9=EVWW
M0!7:W:<%>R*K6=!S%O0.4J$%:[=:>_^49Q$1=FKE&3:7YYE3>[93[35+\$Z$
MO^6I\!;:X.V:FP$>^1SP$L"5XXS.&&>8S+$"(-^$!M([:4IDYP??NY)[(JMY
MTW?>] ]4S/U]6K GLIH% V?!X"#%/'C+<=L0%%2""L%^I;DPC1U>R4N&[0&'
M!:*"UAGN&%DT2\5 B]SV&S.AL7NQCROL+T&: )Q?""S=<F!:&->QQG\ 4$L#
M!!0    ( "2 J%I#0--OC!(  /4] 0 9    >&PO=V]R:W-H965T<R]S:&5E
M=#0T+GAM;+W=77.;2*+&\:]"^4SMF:V:V *]V,XZKDK".S2D-CN[%UM[061L
MJR*!%K"=G,J'/R!AH9;EEIC\=R]FHLCBU\BRG]#H47/UE!=?R_LTK;1OBWE6
MOCNYKZKEV[.S<GJ?+I+R-%^F6?V5V[Q8)%7]U^+NK%P6:7*SVF@Q/S,&@\G9
M(IEE)]=7J_L^%==7^4,UGV7IIT(K'Q:+I/C^(9WG3^].])/G._XZN[NOFCO.
MKJ^6R5WZ.:U^7WXJZK^=;92;V2+-REF>:45Z^^[DO?XVGEPV&ZP>\?=9^E1N
MW=::I_(ES[\V?_%NWIT,FCU*Y^FT:HBD_N,Q_9C.YXU4[\>_6_1D,V:SX?;M
M9]U>/?GZR7Q)RO1C/O_'[*:Z?W=R<:+=I+?)P[SZ:_[DINT3&C?>-)^7J_]K
M3^UC!R?:]*&L\D6[<;T'BUFV_C/YUGXCMC88O;:!T6Y@[&Q@O+;!L-U@N+N!
M_LH&HW:#T;&[-&XW&!\[PJ3=8'+L!N?M!N?'[M)%N\'%L2-<MAM<'CN"/GA^
MY0:[8QBO;;)YL7=?[5=W2W]^N?47K_>KFSR_X/K1K[C^_)+KNZ]Y\Y7]FSR_
MZ.L?^+/U3_SJU\5,JN3ZJLB?M*)Y?.TU-U:_<ZOMZ]^26=;$P^>JJ+\ZJ[>K
MKC_FV6-:5+,O\U3[5/]FID61WFB?JWSZ54NR]M9]/K])B_)_->O?#[/JN_9&
MBY*B2)I?;.U7,ZV2V;S\L_:+=J:5]TF1EMHLTW[/9E7Y6WUG?5O,YO,Z"\JK
MLZK>Y6;@LVF[>^YZ]XQ7=F^HB3RK[DO-RF[2FSW;^^KM=4,!G-7?J\TWS'C^
MAGTPE&*4/YYJQN"W^C]CI/W^V=1^_45Z[NL_]NSJ1S4LDN^:/FK=5Q%3C;Q?
M%O7>#0\IUJ%=*?[@<[2/@/6+0[OGJ!4SG=:*OE*&KRON$?LR7"OC7D_2.QY6
M/$G_B">Y4?KL7J"&/Z?+4VTPD>$]3'C,3]KXT+,4QR@'?^JCX[]7BA^(6*WX
M#UF]+\9:423%<!.MPY4W>NVY56_^=I^^J7\<OM:'>?%MG:VS[&[/?GU0.LT!
MXMMRF4S3=R?U$6"9%H_IR?6?_D>?#/ZR+V5(S"0QB\1L$G-(S"4QC\1\$@M(
M+"0Q06(1B<40)L71:!-'HY4^?.U(;YZ4I9;?M@=W_PSKKVM>E2[*?^W+I!&9
M221FDIA%8C:).23FDIA'8CZ)!206DI@@L8C$8@B3,FF\R:2Q\A#I<U)/.^M(
M*IM(^DU+'JK[O)C]7ST#31;Y0U9I/[1?]H634NT;3B1FDIA%8C:).23FDIA'
M8CZ)!6MLLL*:L[:/U^/!X.KL<3MSR $%B44D%D.8E#F33>9,U)E33\/JZ?-[
M+<HS[>]Y5<_)-,59L'WQHQR@;_R0F$EB%HG9).:0F$MB'HGY)!:06$AB@L0B
M$HLA3,JI\TU.G9/SM7,RDTC,)#&+Q&P2<TC,)3&/Q'P2"T@L)#%!8A&)Q1 F
M9=+%)I,NE,=.W;'1:L:FS<KRH9FL93=:_E"557VC.9Q:IL4TS:KD+MV75,HA
M^B85B9DD9I&836(.B;DDYI&83V(!B84D)D@L(K%XC>G&UHQW<#K<S'BE!+K<
M)-"E,H&L;]/[)+M;G37:S.2R/'OSN)[)3;=F<LO=M,JJO'[ 8E%/_-;W_#K+
MVK<+][T#^D&Y*WV3BL3,-3;>^LY>#BXO#?EL@D4.:9.80V(NB7DDYI-80&(A
MB0D2BT@LAC IJO3!)JN:,MKQATN_20=)![)'3?<-'U0S4<U"-1O5'%1S6VT[
MMH>CR6 TEG/;0T?UCQPU0$<-CQQ5'/FX"-V[F-+D8-@J7>K*8(@>%E_2HCF&
M>3X<:7N3]7PJ:0Y='I;UG>MCF541^U!8*(?K'1:D9J*:A6HVJCFHYJ*:AVH^
MJ@6H%J*::+7M>-*'%R/]8O>MNP@=-Z8T.:",+J ,\DTR[<<Q;YNIQ^R=4J1F
MHIJ%:C:J.:CFHIJ':CZJ!:@6HII M0C58DJ3DZPK8>M#\FTT'>UBHYJ):A:J
MV:CFH)J+:AZJ^:@6H%J(:@+5(E2+*4W.J*Z9K2M+EC]WGDA)]PXL4C-1S4(U
M&]4<5'-;;?><R.Z4P]OSN-'P_,7C_".] 'T6(:H)5(N._,[%U*AR,'3U:%W=
MC_ZX/COT^HP*+4*CFHEJ%JK9J.:@FHMJ'JKYJ!:@6HAJ M4B5(LI30ZEKC^M
M3] 9%=J61C43U2Q4LU'-0347U3Q4\U$M0+40U02J1:@64YJ<45UW6E?6(/^[
M-2'UOO1..+1\W6K2H?]D>#FYV#G2M=!A;51S4,U%-0_5?%0+4"U$-8%J$:K%
ME":'5U>RUM4MZ^U9G_9#.WX=$;7;.XC0;C6J6:AFHYJ#:BZJ>:CFHUJ :B&J
M"52+4"VF-#FMND*V?HE.!]%2-:J9J&:AFHUJ#JJYJ.:AFH]J :J%J"90+4*U
MF-+D)1N[(K:A+F+OK#.R+&;3M/F4VGI6MYK?W>3S>5*4W;U_;A8?V2RWMR_*
MU(/VC3)4,U'-0C4;U1Q4<U'-0S6_U2ZWYO+&Y/1RN%OD1D<-44V@6H1J,:7)
M(=65P@UU*?Q%2.73-+TIM2*=IK/'].:UQ9#4;.\80LO?J&:AFHUJ#JJYJ.:A
MFM]J^G [AP:G+U((;76CFD"U"-5B2I-3R.A22-W\_C2O[46:55IRM_I_\]G^
MZG[U:97UF2=MFI=5^6H:H25O5#-1S4(U&]4<5'-1S4,UO]6D-!J<CG;#""UO
MHYI M0C58DJ3PZ@K;QOJ);1WUX>\NRO2NZ1*NRQ:3^5>RR*TS(UJ)JI9J&:C
MFH-J+JIYJ.:C6M!J8^DP:W?!2'1(@6H1JL64)D=1U]&N;ZJBJ/O(;OM9W:T/
M[ZY.?)?Y_.904T ]1N] (C43U2Q4LU'-036WU;9_37=[VNB _IX!S\_/1T-C
M]YB''#5$-8%J$:K%E"8'3=?Y-GJMB5VDS47>FD.=HU?'5@_0.V705CBJ6:AF
MHYJ#:FZK2=,<_?SR5-^-&K3OC6H!JH6H)E M0K68TN1 ZOK>AGK![*/J2/47
M1/)MMGA8[$TDM ..:B:J6:AFHYJ#:BZJ>:CFHUJ :B&J"52+4"VF-#FWN@ZX
M@2Z@;: M;E0S4<U"-1O5'%1S4<U#-1_5 E0+44V@6H1J,:7)&=55O0UUU?MG
M3W"CA6]4,U'-0C4;U1Q4<U'-0S4?U8)6.S2G#=%1!:I%J!93FIQ&797;4"^N
MO3/3^SV[28NG8E95::;\W(F:[1U#:*<;U2Q4LU'-0347U3Q4\U$M0+40U02J
M1:@64YI\<>VNTST<D-.[(5K61C43U2Q4LU'-0347U3Q4\U$M0+40U02J1:@6
M4YJ<45VE>]BSTHU\[J0=]&*[&'*^V[_]J-ZUWA&%%KE1S48U!]5<5/-0S4>U
M -5"5!.H%J%:3&ER1!E=1!U8Z?L/?NIDN*=W:^CCT\O=&$(;W*AFH9J-:@ZJ
MN:CFH9J/:@&JA:@F4"U"M9C2Y!CJFMY#==/[9S]VTO+RN<31J;&;1FB'&]4L
M5+-1S4$U%]4\5/-1+4"U$-4$JD6H%E.:G$9=V;N^J4HCI.S=CK'=T[T83B;&
M>+ ;2LJ=Z1U*I&:AFHUJ#JJYJ.:AFH]J :J%J"90+4*UF-+D4.J*X<,#Q?#U
M.I8?CKPFT]Y(0IOAJ&:BFH5J-JHYJ.:BFH=J/JH%J!:BFD"U"-5B2I-SJ^N/
M#]'UPH=H5QS53%2S4,U&-0?57%3S4,U'M0#50E03J!:A6DQI<D9U7?&A>KWP
M3S]Q!28UW3NPT.(XJEFH9J.:@VKN\.6RZ?ID,CG?^;0=.JA_W* !.FB(:@+5
M(E2+*4V.F*[J/517O>EK?JN'ZQT[:/<;U2Q4LU'-036WU;83H Z %Q=K\-!1
M?50+4"U$-8%J$:K%E";'4]?]'JJ[WUX30]ETU04X\D(IAP(*;86CFHEJ5JM)
M_W ;^L38J639>QYGG+]\G+//&P]>7)W019^%AVH^J@6H%J*:0+4(U6)*DT)E
MU'6T1^IUMS]V1S-?DG*VM\VH)OK&!*J9J&:UFG31T9U?:1L=T4$U%]4\5/-1
M+4"U$-4$JD6H%E.:'#==W7JDKEN_.(N3Y56S;%*^2*K9-)G/OS\?SZ0WO4[Q
MJ,?MG5%H,QO5+%2S4<U!-;?5#IWB00?U42U M1#5!*I%J!93FAQ31A=3!RK7
M_=[(UWX<\]:^>LS>$86VME'-0C4;U1Q4<U'-0S4?U0)4"U%-H%J$:C&ER4G6
MM;9'0_*M_1&Z'C>JF:AFH9J-:@ZJN:CFH9J/:@&JA:@F4"U"M9C2Y(SJNMPC
M92WSI][:5].] XO43%2S4,U&-0?5W%:3YGWG+\ZM>^B@_G&#!NB@(:H)5(M0
M+:8T.6*Z9O9(W<SFWSM3#]@[>-"B-JI9J&:CFH-J+JIYK2:_YVB\B!0?'35
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MC-8,,)TV5W2JU&M:.S$9><.19]L[B0FTV@!*"Z&T"$JC4!I#T705-P:@8S8
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MLH#Z_BG+BLV'LH+M.TS'_P-02P,$%     @ )("H6H :H1&I @  C@8  !D
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M$W;ZV8WBM1D@*ZYP')EECC\,$-H []><J_U&.^A^0<D?4$L#!!0    ( "2
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MH+W1V5(-R=1G7 DFGQ*9)X*5H.'SQ[DT(D(+FLKJX%C[^Q%=??3XHL: WC^
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M9=&RXL"CN! TUV<&:RH$3?4P!AP!4P'R^892<;Q0+ZB.G8)_ %!+ P04
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M>(?^<QF\#.8><S*CZ9])+%839^2 F"SP)A5W=/L+J0,*"[R(IKS\!-O:UG-
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M_H%:T-C@Q2)3]I?LZK6>0^)2:9'7P<@@9[SZIX^U$:T Q.D/".J X#!@]$I
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M*1Z90)H%>'\MA-X/S .:0]CB?U!+ P04    "  D@*A:VK]?ZEX#  "R%@
M#0   'AL+W-T>6QE<RYX;6S=6%%OVC 0_BM1NDZM-#6$K(&L@+0A59JT397:
MA[U5ACA@R7$RQW2P7S^?'4*@/D3[L,*"2NS[<M]]=[X$IX-*K3B]GU.JO&7.
M137TYTJ5GX*@FLYI3JJKHJ1"(UDA<Z+T5,Z"JI24I!4XY3SH=CIQD!,F_-%
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M',$4@ 8,B2+S.[CS>Q2L?Z>"S7^I1W\!4$L#!!0    ( "2 J%J7BKL<P
M !,"   +    7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$^0%6
MH@_8$@6*19V_K]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8ECVG.
MD4*NU"P>-8?20$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^ KSI,
M<4)I2$LS#O#-TG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE?QW'
M]I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ )("H
M6D.+TYQ.!   ;"(   \   !X;"]W;W)K8F]O:RYX;6S%FEMOVS84@/\*H:?N
M(;-UL=L&=8$L:;8 :6K$0?8XT!(M$:%(CZ2<NK]^A_*,48A]L)=3/=FB;I](
M\WR'Q_KT:NS+VI@7]KU5VBV2QOOMY63BRD:TW/UJMD+#GHVQ+?>P:>N)VUK!
M*]<(X5LUR:;3^:3E4B>?/QVOM;23>,-X47II-#2&AF<I7MU_^\,FVTDGUU))
MOU\D_7<E$M9*+5OY0U2+9)HPUYC7/XR5/XSV7*U*:Y1:).EAQ[.P7I9OFE<!
M\HFO7=_B^?J1 \@BF4_A@AMIG>^/Z*_/@7$GX.##5N?-K51>V!ONQ>_6=%NI
MZW 9>(I)]!A]/QP_#YUX:?]/-YK-1I;BQI1=*[0_]*,5*@!JU\BM2YCFK5@D
MUV8G+%OR6H2'@KO<58<']$ 6=9>]E+##WE4](R6/KH1VHF+PS1DE*^"HV&]<
M<5T*%D%F"&0V(N1?6029(Y#Y*)"K@ .G1I % EF,"#GHR1D".1L3,H\@YPCD
M?$S((H)\CT"^'Q-R%D%^0" _T$(^-0+PVBW7>\9UF-9..F8V;&F%&TR<CPCD
M1UK(5=>VW.X#UDK66L)I7'MV59:FTU[&P7R*1?,I+>8MEY8]<]4)]E5PU]D0
M>KR+\5#94-N&NX9]^;N3.ZX"5S_>7[E]$:!S-5 BIIN4V#<PJK:#>1+HOOD&
MA'W=60OGL'O)UX/!QH23$AOG'@[3#C(9=E5;\7:D,<^DQ*)Y#(W0A4MN_9X]
M6:X=[_/& 2$FF93>,KN0:,)=0Z39"!CA$!I-^1(&/L;$-),2>Z8'NH"8V ?Q
M%J[D^H-B/LPP*;%B5J(.1[!'L370F[J.P3"KI,1:>8#KWAOGV!+F[ZKA=A!>
M,)6DQ"Y9\CW;]5S]Z2'/OI&N5";$ZSCCQDR2$9OD#B)+!3T'4[?J0XR%.5R_
M"3(9II.,6">HE ?9;(:N7HAU<EK*[-U3<)[[)<;$=))1+V P.0][$S-+1FP6
M5,Y#3$PO&;%>S@NP'_@8$]-+-I)>_OUUQIB89;*?;9F3LP?33?;3=7,2$?-.
M1NP==*$U+*-@YLG'6<.P"W8K-8\3GQR33TXLG_.8#QQ<&6-B\LE'D4_ [)49
M8Z+%,V+YG,>\;O@@J<PQ^>34]3/4D7%I*L?DDU.O;5#,N#B58_+)J6MH*&9<
MGLHQ^>345304<QYC8@;*B0V$)T:#WR9FH9S80J>J%NS=#?2E5 -7%IB$"F()
M(>E;"/ Q)B:A@EA"*.:7[S$F)J&"6$(HYF.<91:8A KZOW#.EX0&"5*!_H=#
M+*&S.?LA]8@Q,0D5Q!)",,.N&!.34#'6"BA@#@<=DU!!O0(ZCWGE7!=C8A(J
MB"7T=J%V$5=I8DQ,0@6QA$ZLUD(@*HTNI9)Q>)]A%IH16^@DYI]"U@U$TXNK
M&!.ST.SPHL/Q[89*;*06U0/<PD%[R56YM"Q\'/YY*6:A/+KIE+J&MF_ZWO#J
M^++$\46/S_\ 4$L#!!0    ( "2 J%JAE^J4R0$  * >   :    >&PO7W)E
M;',O=V]R:V)O;VLN>&UL+G)E;'/-V;ENPD 4A>%707X AKN8+()4:=)&O(!%
MAD4LMCP3!=X^" IRK!1IHCF5-;9\_<O%)VL\>X_[)F_;8]ILNS0Z'?;'-*\V
M.7?/(:3E)AZ:-&Z[>+Q<6;7]H<F79;\.7;/<->L8=#*9AO[GC.IE]G/F:''N
MXE\FMJO5=AE?V^7G(1[S+X/#5]OOTB;&7(T63;^.>5Z%T_Y^.H7K0<:7R=7H
M[6->]6\?4H7200I!6C[((,C*!SD$>?F@&H+J\D%3")J6#WJ H(?R08\0]%@^
MZ F"GLH'R01EG! D#; FT%J0:R'P6A!L(1!;D&PA,%L0;2%06Y!M(7!;$&XA
MD%N0;B&P6Q!O(=!;46\ET%M1;R706P<?VP1Z*^JM!'HKZJT$>BOJK01Z*^JM
M!'HKZJT$>BOJK01Z*^JM!'H;ZFT$>AOJ;01Z&^IM!'K;8+.$0&]#O8U ;T.]
MC4!O0[V-0&]#O8U ;T.]C4!O0[V-0&]'O9U ;T>]G4!O1[V=0&]'O9U ;Q]L
M=A/H[:BW$^CMJ+<3Z.VHMQ/H[:BW$^CMJ+<3Z%VCWC6!WC7J7?^GWBF?]S'=
M>VYK?/Y_4ITO]\;[XZ_+V\G!2[CB'."'],LW4$L#!!0    ( "2 J%HHM&@3
MPP$  (D>   3    6T-O;G1E;G1?5'EP97-=+GAM;,W9R6[",!0%T%]!V5;$
M>( . C9MMRV+_H";/" BB2W;4/C[.F&06M&HB$J]FT2)[7=?;.EL,G[;6?*]
M;576?I(L0[ /C/EL297VJ;%4QY&Y<94.\=$MF-792B^(B<%@Q#)3!ZI#/S0U
MDNGXB>9Z78;>\S:^]H6I)XFCTB>]Q_W$)FN2:&O+(M,ACK--G7]+Z1\2TKBR
MG>.7A?4W<4+"SB8T(S\''-:];LBY(J?>3+OPHJLXBVU+YL.N))]VESC3HYG/
MBXQRDZVKN"3UUI'._9(H5&6Z+WK3G1SB#M/^RJ_.;\MT!<:9,V>LCR?FZ/*X
MXY$TJ_LV%B(7BNY//"7&TE=_'S6GG5/^R^RXO1_&K=KS\*R]7;_'7\_X5/_"
M/@1('Q*D#P72QQ"DCQ%('[<@?=R!]'$/T@<?H#2"(BI'(96CF,I14.4HJG(4
M5CF*JQP%5HXBJT"15:#(*E!D%2BR"A19!8JL D56@2*K0)%5H,@J4625*+)*
M%%DEBJP215:)(JM$D56BR"I19)4HLBH4616*K I%5H4BJT*15:'(JE!D52BR
M*A19%8JL0Q19A_\IZ[LQJ[_^.=K<TTH7]3&?M7^@IY]02P$"% ,4    "  D
M@*A:1L=-2)4   #-    $               @ $     9&]C4')O<',O87!P
M+GAM;%!+ 0(4 Q0    ( "2 J%IN+L/]\@   "L"   1              "
M <,   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( "2 J%J97)PC$ 8
M )PG   3              "  >0!  !X;"]T:&5M92]T:&5M93$N>&UL4$L!
M A0#%     @ )("H6G+:(_@)!@  LB   !@              ("!)0@  'AL
M+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( "2 J%K>+!12R 8
M !,B   8              " @60.  !X;"]W;W)K<VAE971S+W-H965T,BYX
M;6Q02P$"% ,4    "  D@*A:\[(7R<4#  !E$@  &               @(%B
M%0  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @ )("H6G;-
MG'-4!@  P!\  !@              ("!71D  'AL+W=O<FMS:&5E=',O<VAE
M970T+GAM;%!+ 0(4 Q0    ( "2 J%I\Z3\*L0(  (P'   8
M  " @><?  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4    "  D
M@*A:K>(5K@P#  #6"   &               @('.(@  >&PO=V]R:W-H965T
M<R]S:&5E=#8N>&UL4$L! A0#%     @ )("H6NE\/D%A"@  ?VD  !@
M         ("!$"8  'AL+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0
M   ( "2 J%KWV+3[_@<  /PA   8              " @:<P  !X;"]W;W)K
M<VAE971S+W-H965T."YX;6Q02P$"% ,4    "  D@*A:SZZN5IL0  !Y,
M&               @(';.   >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L!
M A0#%     @ )("H6F</&P<)!@  ? \  !D              ("!K$D  'AL
M+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4    "  D@*A:#T)+;< '
M  #\%   &0              @('L3P  >&PO=V]R:W-H965T<R]S:&5E=#$Q
M+GAM;%!+ 0(4 Q0    ( "2 J%K1I586^@<  $P7   9              "
M@>-7  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%     @ )("H
M6M_T#Y.R @  0P8  !D              ("!%&   'AL+W=O<FMS:&5E=',O
M<VAE970Q,RYX;6Q02P$"% ,4    "  D@*A:<+Y8U\P'  !Z%@  &0
M        @(']8@  >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0
M   ( "2 J%I\^#HS3 D  "\:   9              " @0!K  !X;"]W;W)K
M<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ )("H6N0MK^C9#   M2P
M !D              ("!@W0  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q0
M2P$"% ,4    "  D@*A:TEJOPEL*  #['0  &0              @(&3@0
M>&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( "2 J%K+8[B)
MTP0  "H+   9              " @26,  !X;"]W;W)K<VAE971S+W-H965T
M,3@N>&UL4$L! A0#%     @ )("H6F).*6W !0  -@\  !D
M ("!+Y$  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4    "  D
M@*A:7HS]8T,"  ":!0  &0              @($FEP  >&PO=V]R:W-H965T
M<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( "2 J%H3K8?K1 (  (H&   9
M          " @:"9  !X;"]W;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#
M%     @ )("H6K8[O0F]!P  -!0  !D              ("!&YP  'AL+W=O
M<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    "  D@*A:&+6@KM<$  ";
M#0  &0              @($/I   >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM
M;%!+ 0(4 Q0    ( "2 J%J0QD.ZI04  -81   9              " @1VI
M  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @ )("H6IU;
M U6X @  )@8  !D              ("!^:X  'AL+W=O<FMS:&5E=',O<VAE
M970R-2YX;6Q02P$"% ,4    "  D@*A:^;D' ((#  "\"   &0
M    @('HL0  >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    (
M "2 J%IVB]\KY00  *,,   9              " @:&U  !X;"]W;W)K<VAE
M971S+W-H965T,C<N>&UL4$L! A0#%     @ )("H6M2 JAJ& P    @  !D
M             ("!O;H  'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"
M% ,4    "  D@*A:*Q\N</D#  "S"0  &0              @(%ZO@  >&PO
M=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( "2 J%JEN1^<.A8
M ,"1 0 9              " @:K"  !X;"]W;W)K<VAE971S+W-H965T,S N
M>&UL4$L! A0#%     @ )("H6A$^P0)C"   [5   !D              ("!
M&]D  'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4    "  D@*A:
M)2K*[2T#   ?"P  &0              @(&UX0  >&PO=V]R:W-H965T<R]S
M:&5E=#,R+GAM;%!+ 0(4 Q0    ( "2 J%I\T R:C ,  %P1   9
M      " @1GE  !X;"]W;W)K<VAE971S+W-H965T,S,N>&UL4$L! A0#%
M  @ )("H6JT]Q.;& @  K 8  !D              ("!W.@  'AL+W=O<FMS
M:&5E=',O<VAE970S-"YX;6Q02P$"% ,4    "  D@*A:S6> I"4&  #=)@
M&0              @('9ZP  >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+
M 0(4 Q0    ( "2 J%HQZ[WOKP4  #4D   9              " @37R  !X
M;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @ )("H6I7_W1$1
M!   -Q(  !D              ("!&_@  'AL+W=O<FMS:&5E=',O<VAE970S
M-RYX;6Q02P$"% ,4    "  D@*A:FUJ3Z)\"  "\!@  &0
M@(%C_   >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    ( "2
MJ%I^$IFST0(  -@'   9              " @3G_  !X;"]W;W)K<VAE971S
M+W-H965T,SDN>&UL4$L! A0#%     @ )("H6AB%PCZ#!@  I#L  !D
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M=#0T+GAM;%!+ 0(4 Q0    ( "2 J%J2B4<?&PH  ,]T   9
M  " @?(J 0!X;"]W;W)K<VAE971S+W-H965T-#4N>&UL4$L! A0#%     @
M)("H6H :H1&I @  C@8  !D              ("!1#4! 'AL+W=O<FMS:&5E
M=',O<VAE970T-BYX;6Q02P$"% ,4    "  D@*A:_9$CG]@#  ""$@  &0
M            @($D. $ >&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4
M Q0    ( "2 J%I'\,RHG0,   \.   9              " @3,\ 0!X;"]W
M;W)K<VAE971S+W-H965T-#@N>&UL4$L! A0#%     @ )("H6OQ-I;T8!0
MAAX  !D              ("!!T ! 'AL+W=O<FMS:&5E=',O<VAE970T.2YX
M;6Q02P$"% ,4    "  D@*A:;96C8%$%  !)'   &0              @(%6
M10$ >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    ( "2 J%I_
M<RL(@0,  ) -   9              " @=Y* 0!X;"]W;W)K<VAE971S+W-H
M965T-3$N>&UL4$L! A0#%     @ )("H6MJ_7^I> P  LA8   T
M     ( !EDX! 'AL+W-T>6QE<RYX;6Q02P$"% ,4    "  D@*A:EXJ[',
M   3 @  "P              @ $?4@$ 7W)E;',O+G)E;'-02P$"% ,4
M"  D@*A:0XO3G$X$  !L(@  #P              @ $(4P$ >&PO=V]R:V)O
M;VLN>&UL4$L! A0#%     @ )("H6J&7ZI3) 0  H!X  !H
M ( !@U<! 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @
M)("H6BBT:!/# 0  B1X  !,              ( !A%D! %M#;VYT96YT7U1Y
><&5S72YX;6Q02P4&     #L .P 4$   >%L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>243</ContextCount>
  <ElementCount>241</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>77</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>9952151 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>9952152 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>9952153 - Statement - Condensed Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/CondensedConsolidatedStatementsofOperations</Role>
      <ShortName>Condensed Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>9952154 - Statement - Condensed Consolidated Statements of Operations (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/CondensedConsolidatedStatementsofOperationsParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Operations (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>9952155 - Statement - Condensed Consolidated Statements of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/CondensedConsolidatedStatementsofComprehensiveLoss</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>9952156 - Statement - Condensed Consolidated Statements of Changes in Convertible Preferred Stock and Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/CondensedConsolidatedStatementsofChangesinConvertiblePreferredStockandStockholdersEquity</Role>
      <ShortName>Condensed Consolidated Statements of Changes in Convertible Preferred Stock and Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>9952157 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>9952158 - Disclosure - The Company and Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/TheCompanyandBasisofPresentation</Role>
      <ShortName>The Company and Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>9952159 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>9952160 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>9952161 - Disclosure - Cash Equivalents and Marketable Securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/CashEquivalentsandMarketableSecurities</Role>
      <ShortName>Cash Equivalents and Marketable Securities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>9952162 - Disclosure - Accrued and Other Current Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/AccruedandOtherCurrentLiabilities</Role>
      <ShortName>Accrued and Other Current Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>9952163 - Disclosure - Licensing Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/LicensingAgreements</Role>
      <ShortName>Licensing Agreements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>9952164 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>9952165 - Disclosure - Convertible Preferred Stock and Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquity</Role>
      <ShortName>Convertible Preferred Stock and Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>9952166 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/StockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>9952167 - Disclosure - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/SegmentReporting</Role>
      <ShortName>Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>9952168 - Disclosure - Net Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/NetLossPerShare</Role>
      <ShortName>Net Loss Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>9955511 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://spyre.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>9955512 - Disclosure - Fair Value Measurement (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/FairValueMeasurementTables</Role>
      <ShortName>Fair Value Measurement (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://spyre.com/role/FairValueMeasurements</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>9955513 - Disclosure - Cash Equivalents and Marketable Securities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/CashEquivalentsandMarketableSecuritiesTables</Role>
      <ShortName>Cash Equivalents and Marketable Securities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://spyre.com/role/CashEquivalentsandMarketableSecurities</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>9955514 - Disclosure - Accrued and Other Current Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/AccruedandOtherCurrentLiabilitiesTables</Role>
      <ShortName>Accrued and Other Current Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://spyre.com/role/AccruedandOtherCurrentLiabilities</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>9955515 - Disclosure - Related Party Transactions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/RelatedPartyTransactionsTables</Role>
      <ShortName>Related Party Transactions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://spyre.com/role/RelatedPartyTransactions</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>9955516 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/StockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://spyre.com/role/StockBasedCompensation</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>9955517 - Disclosure - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/SegmentReportingTables</Role>
      <ShortName>Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://spyre.com/role/SegmentReporting</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9955518 - Disclosure - Net Loss Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/NetLossPerShareTables</Role>
      <ShortName>Net Loss Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://spyre.com/role/NetLossPerShare</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9955519 - Disclosure - The Company and Basis of Presentation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/TheCompanyandBasisofPresentationDetails</Role>
      <ShortName>The Company and Basis of Presentation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://spyre.com/role/TheCompanyandBasisofPresentation</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9955520 - Disclosure - Fair Value Measurements - Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements - Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9955521 - Disclosure - Fair Value Measurements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9955522 - Disclosure - Fair Value Measurements - Significant Inputs used to Estimate the Fair Value of Derivative Liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/FairValueMeasurementsSignificantInputsusedtoEstimatetheFairValueofDerivativeLiabilityDetails</Role>
      <ShortName>Fair Value Measurements - Significant Inputs used to Estimate the Fair Value of Derivative Liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9955523 - Disclosure - Fair Value Measurements - Changes in Derivative Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/FairValueMeasurementsChangesinDerivativeLiabilitiesDetails</Role>
      <ShortName>Fair Value Measurements - Changes in Derivative Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9955524 - Disclosure - Cash Equivalents and Marketable Securities - Estimated Fair Value of Cash Equivalents and Marketable Securities and the Gross Unrealized Gains and Losses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/CashEquivalentsandMarketableSecuritiesEstimatedFairValueofCashEquivalentsandMarketableSecuritiesandtheGrossUnrealizedGainsandLossesDetails</Role>
      <ShortName>Cash Equivalents and Marketable Securities - Estimated Fair Value of Cash Equivalents and Marketable Securities and the Gross Unrealized Gains and Losses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9955525 - Disclosure - Cash Equivalents and Marketable Securities - Available-for-Sale Securities in an Unrealized Loss Position (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/CashEquivalentsandMarketableSecuritiesAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails</Role>
      <ShortName>Cash Equivalents and Marketable Securities - Available-for-Sale Securities in an Unrealized Loss Position (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9955526 - Disclosure - Cash Equivalents and Marketable Securities - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/CashEquivalentsandMarketableSecuritiesNarrativeDetails</Role>
      <ShortName>Cash Equivalents and Marketable Securities - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9955527 - Disclosure - Cash Equivalents and Marketable Securities - Contractual Maturities of Marketable Securities at Estimated Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/CashEquivalentsandMarketableSecuritiesContractualMaturitiesofMarketableSecuritiesatEstimatedFairValueDetails</Role>
      <ShortName>Cash Equivalents and Marketable Securities - Contractual Maturities of Marketable Securities at Estimated Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9955528 - Disclosure - Accrued and Other Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/AccruedandOtherCurrentLiabilitiesDetails</Role>
      <ShortName>Accrued and Other Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://spyre.com/role/AccruedandOtherCurrentLiabilitiesTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9955529 - Disclosure - Licensing Agreements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/LicensingAgreementsDetails</Role>
      <ShortName>Licensing Agreements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://spyre.com/role/LicensingAgreements</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9955530 - Disclosure - Related Party Transactions - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/RelatedPartyTransactionsNarrativeDetails</Role>
      <ShortName>Related Party Transactions - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9955531 - Disclosure - Related Party Transactions - Expenses related to Related Party which were Settled in Cash (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/RelatedPartyTransactionsExpensesrelatedtoRelatedPartywhichwereSettledinCashDetails</Role>
      <ShortName>Related Party Transactions - Expenses related to Related Party which were Settled in Cash (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9955532 - Disclosure - Related Party Transactions - Related Party Accounts Payable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/RelatedPartyTransactionsRelatedPartyAccountsPayableDetails</Role>
      <ShortName>Related Party Transactions - Related Party Accounts Payable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9955533 - Disclosure - Convertible Preferred Stock and Stockholders' Equity - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails</Role>
      <ShortName>Convertible Preferred Stock and Stockholders' Equity - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquity</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9955534 - Disclosure - Stock-Based Compensation - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/StockBasedCompensationNarrativeDetails</Role>
      <ShortName>Stock-Based Compensation - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9955535 - Disclosure - Stock-Based Compensation - Stock Awards Granted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/StockBasedCompensationStockAwardsGrantedDetails</Role>
      <ShortName>Stock-Based Compensation - Stock Awards Granted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9955536 - Disclosure - Stock-Based Compensation - Stock-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails</Role>
      <ShortName>Stock-Based Compensation - Stock-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9955537 - Disclosure - Stock-Based Compensation - Assumptions used to Estimate the Fair Value of Stock Options Granted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/StockBasedCompensationAssumptionsusedtoEstimatetheFairValueofStockOptionsGrantedDetails</Role>
      <ShortName>Stock-Based Compensation - Assumptions used to Estimate the Fair Value of Stock Options Granted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9955538 - Disclosure - Segment Reporting -Summary of Significant Segment Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/SegmentReportingSummaryofSignificantSegmentExpensesDetails</Role>
      <ShortName>Segment Reporting -Summary of Significant Segment Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9955539 - Disclosure - Net Loss Per Share - Reconciliation of Basic and Diluted Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails</Role>
      <ShortName>Net Loss Per Share - Reconciliation of Basic and Diluted Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="syre-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9955540 - Disclosure - Net Loss Per Share - Weighted-Average Equity Instruments Excluded from Calculation of Diluted Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spyre.com/role/NetLossPerShareWeightedAverageEquityInstrumentsExcludedfromCalculationofDilutedNetLossPerShareDetails</Role>
      <ShortName>Net Loss Per Share - Weighted-Average Equity Instruments Excluded from Calculation of Diluted Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" isDefinitelyFs="true" isUsgaap="true" original="syre-20250331.htm">syre-20250331.htm</File>
    <File>syre-20250331.xsd</File>
    <File>syre-20250331_cal.xml</File>
    <File>syre-20250331_def.xml</File>
    <File>syre-20250331_lab.xml</File>
    <File>syre-20250331_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>syre-20250331_g1.jpg</File>
    <File>syre-20250331_g10.jpg</File>
    <File>syre-20250331_g11.jpg</File>
    <File>syre-20250331_g12.jpg</File>
    <File>syre-20250331_g13.jpg</File>
    <File>syre-20250331_g14.jpg</File>
    <File>syre-20250331_g15.jpg</File>
    <File>syre-20250331_g2.jpg</File>
    <File>syre-20250331_g3.jpg</File>
    <File>syre-20250331_g4.jpg</File>
    <File>syre-20250331_g5.jpg</File>
    <File>syre-20250331_g6.jpg</File>
    <File>syre-20250331_g7.jpg</File>
    <File>syre-20250331_g8.jpg</File>
    <File>syre-20250331_g9.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="652">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="31">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>84
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "syre-20250331.htm": {
   "nsprefix": "syre",
   "nsuri": "http://spyre.com/20250331",
   "dts": {
    "inline": {
     "local": [
      "syre-20250331.htm"
     ]
    },
    "schema": {
     "local": [
      "syre-20250331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "syre-20250331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "syre-20250331_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "syre-20250331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "syre-20250331_pre.xml"
     ]
    }
   },
   "keyStandard": 192,
   "keyCustom": 49,
   "axisStandard": 25,
   "axisCustom": 0,
   "memberStandard": 30,
   "memberCustom": 40,
   "hidden": {
    "total": 8,
    "http://xbrl.sec.gov/dei/2024": 5,
    "http://fasb.org/us-gaap/2024": 2,
    "http://spyre.com/20250331": 1
   },
   "contextCount": 243,
   "entityCount": 1,
   "segmentCount": 77,
   "elementCount": 529,
   "unitCount": 7,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2024": 652,
    "http://xbrl.sec.gov/dei/2024": 31,
    "http://xbrl.sec.gov/ecd/2024": 4
   },
   "report": {
    "R1": {
     "role": "http://spyre.com/role/CoverPage",
     "longName": "0000001 - Document - Cover Page",
     "shortName": "Cover Page",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://spyre.com/role/CondensedConsolidatedBalanceSheets",
     "longName": "9952151 - Statement - Condensed Consolidated Balance Sheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PrepaidExpenseAndOtherAssetsCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://spyre.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "longName": "9952152 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://spyre.com/role/CondensedConsolidatedStatementsofOperations",
     "longName": "9952153 - Statement - Condensed Consolidated Statements of Operations",
     "shortName": "Condensed Consolidated Statements of Operations",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GeneralAndAdministrativeExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://spyre.com/role/CondensedConsolidatedStatementsofOperationsParenthetical",
     "longName": "9952154 - Statement - Condensed Consolidated Statements of Operations (Parenthetical)",
     "shortName": "Condensed Consolidated Statements of Operations (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-22",
      "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "link:footnote",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-22",
      "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "link:footnote",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://spyre.com/role/CondensedConsolidatedStatementsofComprehensiveLoss",
     "longName": "9952155 - Statement - Condensed Consolidated Statements of Comprehensive Loss",
     "shortName": "Condensed Consolidated Statements of Comprehensive Loss",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ComprehensiveIncomeNetOfTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://spyre.com/role/CondensedConsolidatedStatementsofChangesinConvertiblePreferredStockandStockholdersEquity",
     "longName": "9952156 - Statement - Condensed Consolidated Statements of Changes in Convertible Preferred Stock and Stockholders' Equity",
     "shortName": "Condensed Consolidated Statements of Changes in Convertible Preferred Stock and Stockholders' Equity",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-42",
      "name": "us-gaap:TemporaryEquitySharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-42",
      "name": "us-gaap:TemporaryEquitySharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows",
     "longName": "9952157 - Statement - Condensed Consolidated Statements of Cash Flows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GainLossOnDerivativeInstrumentsNetPretax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "unique": true
     }
    },
    "R9": {
     "role": "http://spyre.com/role/TheCompanyandBasisofPresentation",
     "longName": "9952158 - Disclosure - The Company and Basis of Presentation",
     "shortName": "The Company and Basis of Presentation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://spyre.com/role/SummaryofSignificantAccountingPolicies",
     "longName": "9952159 - Disclosure - Summary of Significant Accounting Policies",
     "shortName": "Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://spyre.com/role/FairValueMeasurements",
     "longName": "9952160 - Disclosure - Fair Value Measurements",
     "shortName": "Fair Value Measurements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://spyre.com/role/CashEquivalentsandMarketableSecurities",
     "longName": "9952161 - Disclosure - Cash Equivalents and Marketable Securities",
     "shortName": "Cash Equivalents and Marketable Securities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://spyre.com/role/AccruedandOtherCurrentLiabilities",
     "longName": "9952162 - Disclosure - Accrued and Other Current Liabilities",
     "shortName": "Accrued and Other Current Liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "syre:AccruedAndOtherCurrentLiabilitiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "syre:AccruedAndOtherCurrentLiabilitiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://spyre.com/role/LicensingAgreements",
     "longName": "9952163 - Disclosure - Licensing Agreements",
     "shortName": "Licensing Agreements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://spyre.com/role/RelatedPartyTransactions",
     "longName": "9952164 - Disclosure - Related Party Transactions",
     "shortName": "Related Party Transactions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquity",
     "longName": "9952165 - Disclosure - Convertible Preferred Stock and Stockholders' Equity",
     "shortName": "Convertible Preferred Stock and Stockholders' Equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PreferredStockTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PreferredStockTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://spyre.com/role/StockBasedCompensation",
     "longName": "9952166 - Disclosure - Stock-Based Compensation",
     "shortName": "Stock-Based Compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://spyre.com/role/SegmentReporting",
     "longName": "9952167 - Disclosure - Segment Reporting",
     "shortName": "Segment Reporting",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://spyre.com/role/NetLossPerShare",
     "longName": "9952168 - Disclosure - Net Loss Per Share",
     "shortName": "Net Loss Per Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R21": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:NonRule10b51ArrAdoptedFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:NonRule10b51ArrAdoptedFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://spyre.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "longName": "9955511 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://spyre.com/role/FairValueMeasurementTables",
     "longName": "9955512 - Disclosure - Fair Value Measurement (Tables)",
     "shortName": "Fair Value Measurement (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesTables",
     "longName": "9955513 - Disclosure - Cash Equivalents and Marketable Securities (Tables)",
     "shortName": "Cash Equivalents and Marketable Securities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://spyre.com/role/AccruedandOtherCurrentLiabilitiesTables",
     "longName": "9955514 - Disclosure - Accrued and Other Current Liabilities (Tables)",
     "shortName": "Accrued and Other Current Liabilities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://spyre.com/role/RelatedPartyTransactionsTables",
     "longName": "9955515 - Disclosure - Related Party Transactions (Tables)",
     "shortName": "Related Party Transactions (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://spyre.com/role/StockBasedCompensationTables",
     "longName": "9955516 - Disclosure - Stock-Based Compensation (Tables)",
     "shortName": "Stock-Based Compensation (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://spyre.com/role/SegmentReportingTables",
     "longName": "9955517 - Disclosure - Segment Reporting (Tables)",
     "shortName": "Segment Reporting (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://spyre.com/role/NetLossPerShareTables",
     "longName": "9955518 - Disclosure - Net Loss Per Share (Tables)",
     "shortName": "Net Loss Per Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://spyre.com/role/TheCompanyandBasisofPresentationDetails",
     "longName": "9955519 - Disclosure - The Company and Basis of Presentation (Details)",
     "shortName": "The Company and Basis of Presentation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfOperatingSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfOperatingSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://spyre.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
     "longName": "9955520 - Disclosure - Fair Value Measurements - Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)",
     "shortName": "Fair Value Measurements - Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-106",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-106",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://spyre.com/role/FairValueMeasurementsNarrativeDetails",
     "longName": "9955521 - Disclosure - Fair Value Measurements - Narrative (Details)",
     "shortName": "Fair Value Measurements - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-145",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R33": {
     "role": "http://spyre.com/role/FairValueMeasurementsSignificantInputsusedtoEstimatetheFairValueofDerivativeLiabilityDetails",
     "longName": "9955522 - Disclosure - Fair Value Measurements - Significant Inputs used to Estimate the Fair Value of Derivative Liability (Details)",
     "shortName": "Fair Value Measurements - Significant Inputs used to Estimate the Fair Value of Derivative Liability (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-141",
      "name": "us-gaap:DerivativeLiabilityMeasurementInput",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-141",
      "name": "us-gaap:DerivativeLiabilityMeasurementInput",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://spyre.com/role/FairValueMeasurementsChangesinDerivativeLiabilitiesDetails",
     "longName": "9955523 - Disclosure - Fair Value Measurements - Changes in Derivative Liabilities (Details)",
     "shortName": "Fair Value Measurements - Changes in Derivative Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-146",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-146",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesEstimatedFairValueofCashEquivalentsandMarketableSecuritiesandtheGrossUnrealizedGainsandLossesDetails",
     "longName": "9955524 - Disclosure - Cash Equivalents and Marketable Securities - Estimated Fair Value of Cash Equivalents and Marketable Securities and the Gross Unrealized Gains and Losses (Details)",
     "shortName": "Cash Equivalents and Marketable Securities - Estimated Fair Value of Cash Equivalents and Marketable Securities and the Gross Unrealized Gains and Losses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails",
     "longName": "9955525 - Disclosure - Cash Equivalents and Marketable Securities - Available-for-Sale Securities in an Unrealized Loss Position (Details)",
     "shortName": "Cash Equivalents and Marketable Securities - Available-for-Sale Securities in an Unrealized Loss Position (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesNarrativeDetails",
     "longName": "9955526 - Disclosure - Cash Equivalents and Marketable Securities - Narrative (Details)",
     "shortName": "Cash Equivalents and Marketable Securities - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "syre:NumberOfDomesticBankingInstitutions",
      "unitRef": "bank",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "syre:NumberOfDomesticBankingInstitutions",
      "unitRef": "bank",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesContractualMaturitiesofMarketableSecuritiesatEstimatedFairValueDetails",
     "longName": "9955527 - Disclosure - Cash Equivalents and Marketable Securities - Contractual Maturities of Marketable Securities at Estimated Fair Value (Details)",
     "shortName": "Cash Equivalents and Marketable Securities - Contractual Maturities of Marketable Securities at Estimated Fair Value (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://spyre.com/role/AccruedandOtherCurrentLiabilitiesDetails",
     "longName": "9955528 - Disclosure - Accrued and Other Current Liabilities (Details)",
     "shortName": "Accrued and Other Current Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AccruedSalariesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AccruedSalariesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://spyre.com/role/LicensingAgreementsDetails",
     "longName": "9955529 - Disclosure - Licensing Agreements (Details)",
     "shortName": "Licensing Agreements (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-169",
      "name": "syre:CampaignTimelineMinimumTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-169",
      "name": "syre:CampaignTimelineMinimumTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://spyre.com/role/RelatedPartyTransactionsNarrativeDetails",
     "longName": "9955530 - Disclosure - Related Party Transactions - Narrative (Details)",
     "shortName": "Related Party Transactions - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-184",
      "name": "syre:DevelopmentCostReductionPercentage",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "unique": true
     }
    },
    "R42": {
     "role": "http://spyre.com/role/RelatedPartyTransactionsExpensesrelatedtoRelatedPartywhichwereSettledinCashDetails",
     "longName": "9955531 - Disclosure - Related Party Transactions - Expenses related to Related Party which were Settled in Cash (Details)",
     "shortName": "Related Party Transactions - Expenses related to Related Party which were Settled in Cash (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-180",
      "name": "us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "unique": true
     }
    },
    "R43": {
     "role": "http://spyre.com/role/RelatedPartyTransactionsRelatedPartyAccountsPayableDetails",
     "longName": "9955532 - Disclosure - Related Party Transactions - Related Party Accounts Payable (Details)",
     "shortName": "Related Party Transactions - Related Party Accounts Payable (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-7",
      "name": "us-gaap:AccountsPayableOtherCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "syre:ScheduleOfBalancesDueToAffiliatesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-7",
      "name": "us-gaap:AccountsPayableOtherCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "syre:ScheduleOfBalancesDueToAffiliatesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails",
     "longName": "9955533 - Disclosure - Convertible Preferred Stock and Stockholders' Equity - Narrative (Details)",
     "shortName": "Convertible Preferred Stock and Stockholders' Equity - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c-73",
      "name": "syre:SaleOfStockAuthorizedAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-197",
      "name": "syre:PreferredStockRemainsIssuedAndOutstandingPercentage",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "unique": true
     }
    },
    "R45": {
     "role": "http://spyre.com/role/StockBasedCompensationNarrativeDetails",
     "longName": "9955534 - Disclosure - Stock-Based Compensation - Narrative (Details)",
     "shortName": "Stock-Based Compensation - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-215",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "unique": true
     }
    },
    "R46": {
     "role": "http://spyre.com/role/StockBasedCompensationStockAwardsGrantedDetails",
     "longName": "9955535 - Disclosure - Stock-Based Compensation - Stock Awards Granted (Details)",
     "shortName": "Stock-Based Compensation - Stock Awards Granted (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "unique": true
     }
    },
    "R47": {
     "role": "http://spyre.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails",
     "longName": "9955536 - Disclosure - Stock-Based Compensation - Stock-Based Compensation Expense (Details)",
     "shortName": "Stock-Based Compensation - Stock-Based Compensation Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-224",
      "name": "us-gaap:ShareBasedCompensation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "unique": true
     }
    },
    "R48": {
     "role": "http://spyre.com/role/StockBasedCompensationAssumptionsusedtoEstimatetheFairValueofStockOptionsGrantedDetails",
     "longName": "9955537 - Disclosure - Stock-Based Compensation - Assumptions used to Estimate the Fair Value of Stock Options Granted (Details)",
     "shortName": "Stock-Based Compensation - Assumptions used to Estimate the Fair Value of Stock Options Granted (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c-225",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-225",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://spyre.com/role/SegmentReportingSummaryofSignificantSegmentExpensesDetails",
     "longName": "9955538 - Disclosure - Segment Reporting -Summary of Significant Segment Expenses (Details)",
     "shortName": "Segment Reporting -Summary of Significant Segment Expenses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-235",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "unique": true
     }
    },
    "R50": {
     "role": "http://spyre.com/role/NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails",
     "longName": "9955539 - Disclosure - Net Loss Per Share - Reconciliation of Basic and Diluted Net Loss Per Share (Details)",
     "shortName": "Net Loss Per Share - Reconciliation of Basic and Diluted Net Loss Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-16",
      "name": "us-gaap:WeightedAverageNumberOfSharesIssuedBasic",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "unique": true
     }
    },
    "R51": {
     "role": "http://spyre.com/role/NetLossPerShareWeightedAverageEquityInstrumentsExcludedfromCalculationofDilutedNetLossPerShareDetails",
     "longName": "9955540 - Disclosure - Net Loss Per Share - Weighted-Average Equity Instruments Excluded from Calculation of Diluted Net Loss Per Share (Details)",
     "shortName": "Net Loss Per Share - Weighted-Average Equity Instruments Excluded from Calculation of Diluted Net Loss Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c-237",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-237",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syre-20250331.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "syre_A2016ESPPMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "A2016ESPPMember",
     "presentation": [
      "http://spyre.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2016 ESPP",
        "label": "2016 ESPP [Member]",
        "documentation": "2016 ESPP"
       }
      }
     },
     "auth_ref": []
    },
    "syre_A2024ParapyreOptionObligationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "A2024ParapyreOptionObligationMember",
     "presentation": [
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails",
      "http://spyre.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024 Parapyre Option Obligation",
        "label": "2024 Parapyre Option Obligation [Member]",
        "documentation": "2024 Parapyre Option Obligation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting Policies [Abstract]",
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related party accounts payable",
        "label": "Accounts Payable and Other Accrued Liabilities, Current",
        "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Accounts Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r648"
     ]
    },
    "us-gaap_AccountsPayableOtherCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableOtherCurrent",
     "crdr": "credit",
     "presentation": [
      "http://spyre.com/role/RelatedPartyTransactionsRelatedPartyAccountsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total related party accounts payable",
        "label": "Accounts Payable, Other, Current",
        "documentation": "Amount of obligations incurred classified as other, payable within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "crdr": "credit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Net accretion of discount on marketable securities",
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "syre_AccruedAndOtherCurrentLiabilitiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "AccruedAndOtherCurrentLiabilitiesTextBlock",
     "presentation": [
      "http://spyre.com/role/AccruedandOtherCurrentLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued and Other Current Liabilities",
        "label": "Accrued And Other Current Liabilities [Text Block]",
        "documentation": "The entire disclosure for accrued expenses, and other liabilities that are classified as current at the end of the reporting period."
       }
      }
     },
     "auth_ref": []
    },
    "syre_AccruedContractedResearchAndDevelopmentCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "AccruedContractedResearchAndDevelopmentCosts",
     "crdr": "credit",
     "calculation": {
      "http://spyre.com/role/AccruedandOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://spyre.com/role/AccruedandOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued contracted research and development costs",
        "label": "Accrued Contracted Research And Development Costs",
        "documentation": "Accrued contracted research and development costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedLiabilitiesAndOtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedLiabilitiesAndOtherLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      },
      "http://spyre.com/role/AccruedandOtherCurrentLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://spyre.com/role/AccruedandOtherCurrentLiabilitiesDetails",
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued and other current liabilities",
        "totalLabel": "Total accrued and other current liabilities",
        "label": "Accrued Liabilities and Other Liabilities",
        "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedProfessionalFeesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://spyre.com/role/AccruedandOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://spyre.com/role/AccruedandOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued professional and consulting fees",
        "label": "Accrued Professional Fees, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "us-gaap_AccruedSalariesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedSalariesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://spyre.com/role/AccruedandOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://spyre.com/role/AccruedandOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued compensation",
        "label": "Accrued Salaries, Current",
        "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r610"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated other comprehensive income",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r12",
      "r65",
      "r120",
      "r475",
      "r506",
      "r507"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofChangesinConvertiblePreferredStockandStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Income",
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r6",
      "r12",
      "r376",
      "r379",
      "r421",
      "r502",
      "r503",
      "r760",
      "r761",
      "r762",
      "r770",
      "r771",
      "r772",
      "r773"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional 402(v) Disclosure",
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r698"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital, Common Stock",
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital."
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofChangesinConvertiblePreferredStockandStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid-In Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r520",
      "r770",
      "r771",
      "r772",
      "r773",
      "r823",
      "r886"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation, Amount",
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r711"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation:",
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r711"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote",
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r711"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment To PEO Compensation, Footnote",
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r711"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "syre_AegleaEmployeesAndDirectorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "AegleaEmployeesAndDirectorsMember",
     "presentation": [
      "http://spyre.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aeglea Employees and Directors",
        "label": "Aeglea Employees and Directors [Member]",
        "documentation": "Aeglea Employees and Directors"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table",
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r744"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Amount",
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r670",
      "r680",
      "r690",
      "r722"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined",
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r673",
      "r683",
      "r693",
      "r725"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Pension Adjustments Service Cost",
        "label": "Aggregate Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r745"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Adjustments to Compensation",
        "label": "All Adjustments to Compensation [Member]"
       }
      }
     },
     "auth_ref": [
      "r711"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Executive Categories",
        "label": "All Executive Categories [Member]"
       }
      }
     },
     "auth_ref": [
      "r718"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Individuals",
        "label": "All Individuals [Member]"
       }
      }
     },
     "auth_ref": [
      "r674",
      "r684",
      "r694",
      "r718",
      "r726",
      "r730",
      "r738"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Trading Arrangements",
        "label": "All Trading Arrangements [Member]"
       }
      }
     },
     "auth_ref": [
      "r736"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://spyre.com/role/RelatedPartyTransactionsNarrativeDetails",
      "http://spyre.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation expense",
        "verboseLabel": "Total stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r351",
      "r356"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://spyre.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "syre_AmountToBePaidUnderAgreement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "AmountToBePaidUnderAgreement",
     "crdr": "credit",
     "presentation": [
      "http://spyre.com/role/LicensingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent obligation based on milestones",
        "label": "Amount To Be Paid Under Agreement",
        "documentation": "Amount to be paid under agreement."
       }
      }
     },
     "auth_ref": []
    },
    "syre_AnnualPercentageOfAdditionalSharesWhichEqualsToIssuedAndOutstandingShares": {
     "xbrltype": "percentItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "AnnualPercentageOfAdditionalSharesWhichEqualsToIssuedAndOutstandingShares",
     "presentation": [
      "http://spyre.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Annual percentage of additional shares",
        "label": "Annual Percentage Of Additional Shares Which Equals To Issued And Outstanding Shares",
        "documentation": "Annual percentage of additional shares which equals to the issued and outstanding shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://spyre.com/role/NetLossPerShareWeightedAverageEquityInstrumentsExcludedfromCalculationofDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive securities excluded from computation of earnings per share (in shares)",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r169"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://spyre.com/role/NetLossPerShareWeightedAverageEquityInstrumentsExcludedfromCalculationofDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities [Axis]",
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://spyre.com/role/NetLossPerShareWeightedAverageEquityInstrumentsExcludedfromCalculationofDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://spyre.com/role/NetLossPerShareWeightedAverageEquityInstrumentsExcludedfromCalculationofDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities, Name [Domain]",
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "syre_AppointOfBoardMembersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "AppointOfBoardMembersMember",
     "presentation": [
      "http://spyre.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Appoint Of Board Members",
        "label": "Appoint Of Board Members [Member]",
        "documentation": "Appoint Of Board Members"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetAcquisitionAxis",
     "presentation": [
      "http://spyre.com/role/FairValueMeasurementsNarrativeDetails",
      "http://spyre.com/role/StockBasedCompensationNarrativeDetails",
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Acquisition [Axis]",
        "label": "Asset Acquisition [Axis]",
        "documentation": "Information by asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r822"
     ]
    },
    "syre_AssetAcquisitionCashPaymentThresholdPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "AssetAcquisitionCashPaymentThresholdPeriod",
     "presentation": [
      "http://spyre.com/role/FairValueMeasurementsNarrativeDetails",
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset acquisition, cash payment, threshold period",
        "label": "Asset Acquisition, Cash Payment, Threshold Period",
        "documentation": "Asset Acquisition, Cash Payment, Threshold Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetAcquisitionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetAcquisitionDomain",
     "presentation": [
      "http://spyre.com/role/FairValueMeasurementsNarrativeDetails",
      "http://spyre.com/role/StockBasedCompensationNarrativeDetails",
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Acquisition [Domain]",
        "label": "Asset Acquisition [Domain]",
        "documentation": "Asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r822"
     ]
    },
    "syre_AssetAcquisitionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "AssetAcquisitionMember",
     "presentation": [
      "http://spyre.com/role/StockBasedCompensationNarrativeDetails",
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Acquisition",
        "label": "Asset Acquisition [Member]",
        "documentation": "Asset acquisition."
       }
      }
     },
     "auth_ref": []
    },
    "syre_AssetAcquisitionStockholderPaymentPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "AssetAcquisitionStockholderPaymentPeriod",
     "presentation": [
      "http://spyre.com/role/FairValueMeasurementsNarrativeDetails",
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset acquisition, stockholder payment period",
        "label": "Asset Acquisition, Stockholder Payment Period",
        "documentation": "Asset Acquisition, Stockholder Payment Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL ASSETS",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r89",
      "r98",
      "r116",
      "r139",
      "r174",
      "r182",
      "r200",
      "r204",
      "r244",
      "r288",
      "r289",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r297",
      "r298",
      "r371",
      "r373",
      "r408",
      "r469",
      "r555",
      "r620",
      "r621",
      "r648",
      "r661",
      "r791",
      "r792",
      "r843"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ASSETS",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r121",
      "r139",
      "r244",
      "r288",
      "r289",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r297",
      "r298",
      "r371",
      "r373",
      "r408",
      "r648",
      "r791",
      "r792",
      "r843"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CURRENT ASSETS",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://spyre.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total financial assets",
        "label": "Assets, Fair Value Disclosure",
        "documentation": "Fair value portion of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r386",
      "r387",
      "r638"
     ]
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsFairValueDisclosureAbstract",
     "presentation": [
      "http://spyre.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Assets:",
        "label": "Assets, Fair Value Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "syre_AtTheMarketOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "AtTheMarketOfferingMember",
     "presentation": [
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails",
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "At-The-Market Offering",
        "label": "At-The-Market Offering [Member]",
        "documentation": "At-The-Market Offering"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesEstimatedFairValueofCashEquivalentsandMarketableSecuritiesandtheGrossUnrealizedGainsandLossesDetails": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesEstimatedFairValueofCashEquivalentsandMarketableSecuritiesandtheGrossUnrealizedGainsandLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Marketable securities, gross unrealized gains",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r217"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "crdr": "debit",
     "calculation": {
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesEstimatedFairValueofCashEquivalentsandMarketableSecuritiesandtheGrossUnrealizedGainsandLossesDetails": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesEstimatedFairValueofCashEquivalentsandMarketableSecuritiesandtheGrossUnrealizedGainsandLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Marketable securities, gross unrealized losses",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r218"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "crdr": "debit",
     "calculation": {
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesEstimatedFairValueofCashEquivalentsandMarketableSecuritiesandtheGrossUnrealizedGainsandLossesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesEstimatedFairValueofCashEquivalentsandMarketableSecuritiesandtheGrossUnrealizedGainsandLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Marketable securities, amortized cost",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r214",
      "r252",
      "r468"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract",
     "presentation": [
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "crdr": "debit",
     "calculation": {
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesContractualMaturitiesofMarketableSecuritiesatEstimatedFairValueDetails": {
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesContractualMaturitiesofMarketableSecuritiesatEstimatedFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due in one year or less",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r221",
      "r467"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
     "crdr": "debit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesEstimatedFairValueofCashEquivalentsandMarketableSecuritiesandtheGrossUnrealizedGainsandLossesDetails": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0,
       "order": 3.0
      },
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesContractualMaturitiesofMarketableSecuritiesatEstimatedFairValueDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesContractualMaturitiesofMarketableSecuritiesatEstimatedFairValueDetails",
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesEstimatedFairValueofCashEquivalentsandMarketableSecuritiesandtheGrossUnrealizedGainsandLossesDetails",
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Marketable securities",
        "verboseLabel": "Marketable securities, estimated fair value",
        "totalLabel": "Total marketable securities",
        "label": "Debt Securities, Available-for-Sale, Current",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current."
       }
      }
     },
     "auth_ref": [
      "r212",
      "r252"
     ]
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price",
        "label": "Award Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r733"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value as of Grant Date",
        "label": "Award Grant Date Fair Value"
       }
      }
     },
     "auth_ref": [
      "r734"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r729"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing, How MNPI Considered",
        "label": "Award Timing, How MNPI Considered [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r729"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Method",
        "label": "Award Timing Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r729"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Considered",
        "label": "Award Timing MNPI Considered [Flag]"
       }
      }
     },
     "auth_ref": [
      "r729"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Disclosure",
        "label": "Award Timing MNPI Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r729"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Predetermined",
        "label": "Award Timing Predetermined [Flag]"
       }
      }
     },
     "auth_ref": [
      "r729"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://spyre.com/role/StockBasedCompensationNarrativeDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Axis]",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Securities",
        "label": "Award Underlying Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r732"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r731"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures",
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r730"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table",
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r730"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://spyre.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "syre_BeneficialHoldersOwnedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "BeneficialHoldersOwnedPercentage",
     "presentation": [
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Beneficial holders owned percentage",
        "label": "Beneficial Holders Owned Percentage",
        "documentation": "Beneficial Holders Owned Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "syre_CampaignTimelineMinimumTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "CampaignTimelineMinimumTerm",
     "presentation": [
      "http://spyre.com/role/LicensingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Campaign timeline, minimum term",
        "label": "Campaign Timeline, Minimum Term",
        "documentation": "Campaign Timeline, Minimum Term"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets",
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r114",
      "r609"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAxis",
     "presentation": [
      "http://spyre.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents [Axis]",
        "label": "Cash and Cash Equivalents [Axis]",
        "documentation": "Information by type of cash and cash equivalent balance."
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesEstimatedFairValueofCashEquivalentsandMarketableSecuritiesandtheGrossUnrealizedGainsandLossesDetails": {
       "parentTag": "us-gaap_CashEquivalentsAtCarryingValue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesEstimatedFairValueofCashEquivalentsandMarketableSecuritiesandtheGrossUnrealizedGainsandLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash equivalents, estimated fair value",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r825",
      "r826"
     ]
    },
    "us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsAndMarketableSecuritiesTextBlock",
     "presentation": [
      "http://spyre.com/role/CashEquivalentsandMarketableSecurities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash Equivalents and Marketable Securities",
        "label": "Cash, Cash Equivalents, and Marketable Securities [Text Block]",
        "documentation": "The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r782"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning of period",
        "periodEndLabel": "End of period",
        "totalLabel": "Total cash, cash equivalents, and restricted cash shown in the statement of cash flows",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r74",
      "r137"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation of Cash, Cash Equivalents, and Restricted Cash Reported in the Statement of Financial Position:",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CASH, CASH EQUIVALENTS, AND RESTRICTED CASH",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET (DECREASE) INCREASE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r74"
     ]
    },
    "syre_CashEquivalentsAndMarketableSecuritiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "CashEquivalentsAndMarketableSecuritiesLineItems",
     "presentation": [
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash Equivalents And Marketable Securities [Line Items]",
        "label": "Cash Equivalents And Marketable Securities [Line Items]",
        "documentation": "Cash equivalents and marketable securities."
       }
      }
     },
     "auth_ref": []
    },
    "syre_CashEquivalentsAndMarketableSecuritiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "CashEquivalentsAndMarketableSecuritiesTable",
     "presentation": [
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash Equivalents And Marketable Securities [Table]",
        "label": "Cash Equivalents And Marketable Securities [Table]",
        "documentation": "Cash equivalents and marketable securities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesEstimatedFairValueofCashEquivalentsandMarketableSecuritiesandtheGrossUnrealizedGainsandLossesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesEstimatedFairValueofCashEquivalentsandMarketableSecuritiesandtheGrossUnrealizedGainsandLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Cash equivalents, amortized cost",
        "label": "Cash Equivalents, at Carrying Value",
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r756",
      "r854"
     ]
    },
    "syre_CashEquivalentsUnrealizedGains": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "CashEquivalentsUnrealizedGains",
     "crdr": "credit",
     "calculation": {
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesEstimatedFairValueofCashEquivalentsandMarketableSecuritiesandtheGrossUnrealizedGainsandLossesDetails": {
       "parentTag": "us-gaap_CashEquivalentsAtCarryingValue",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesEstimatedFairValueofCashEquivalentsandMarketableSecuritiesandtheGrossUnrealizedGainsandLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash equivalents, gross unrealized gains",
        "label": "Cash Equivalents Unrealized Gains",
        "documentation": "Cash equivalents unrealized gains."
       }
      }
     },
     "auth_ref": []
    },
    "syre_CashEquivalentsUnrealizedLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "CashEquivalentsUnrealizedLosses",
     "crdr": "debit",
     "calculation": {
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesEstimatedFairValueofCashEquivalentsandMarketableSecuritiesandtheGrossUnrealizedGainsandLossesDetails": {
       "parentTag": "us-gaap_CashEquivalentsAtCarryingValue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesEstimatedFairValueofCashEquivalentsandMarketableSecuritiesandtheGrossUnrealizedGainsandLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cash equivalents, gross unrealized losses",
        "label": "Cash Equivalents Unrealized Losses",
        "documentation": "Cash equivalents unrealized losses."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashFDICInsuredAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashFDICInsuredAmount",
     "crdr": "debit",
     "presentation": [
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash, FDIC insured amount",
        "label": "Cash, FDIC Insured Amount",
        "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changed Peer Group, Footnote",
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r709"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year",
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r706"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested",
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r704"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://spyre.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets",
      "http://spyre.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://spyre.com/role/CondensedConsolidatedStatementsofChangesinConvertiblePreferredStockandStockholdersEquity",
      "http://spyre.com/role/CondensedConsolidatedStatementsofOperations",
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails",
      "http://spyre.com/role/NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails",
      "http://spyre.com/role/StockBasedCompensationNarrativeDetails",
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Domain]",
        "label": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r117",
      "r118",
      "r119",
      "r139",
      "r160",
      "r164",
      "r166",
      "r168",
      "r176",
      "r177",
      "r244",
      "r288",
      "r291",
      "r292",
      "r293",
      "r297",
      "r298",
      "r302",
      "r303",
      "r306",
      "r307",
      "r309",
      "r408",
      "r512",
      "r513",
      "r514",
      "r515",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r543",
      "r564",
      "r586",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r748",
      "r766",
      "r774"
     ]
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Line Items]",
        "label": "Class of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r118",
      "r119",
      "r176",
      "r302",
      "r303",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r512",
      "r513",
      "r514",
      "r515",
      "r630",
      "r748",
      "r766"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightAxis",
     "presentation": [
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails",
      "http://spyre.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Warrant or Right [Axis]",
        "label": "Class of Warrant or Right [Axis]",
        "documentation": "Information by type of warrant or right issued."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightDomain",
     "presentation": [
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails",
      "http://spyre.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Warrant or Right [Domain]",
        "label": "Class of Warrant or Right [Domain]",
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails",
      "http://spyre.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price per warrant (in dollars per share)",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r310"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "presentation": [
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails",
      "http://spyre.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants to purchase shares (in shares)",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares."
       }
      }
     },
     "auth_ref": [
      "r310"
     ]
    },
    "syre_ClassOfWarrantOrRightNumberOfSecuritiesExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesExercised",
     "presentation": [
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of warrants exercised (in shares)",
        "label": "Class of Warrant or Right, Number of Securities Exercised",
        "documentation": "Class of Warrant or Right, Number of Securities Exercised"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Amount",
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r710"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Name",
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r710"
     ]
    },
    "us-gaap_CollaborativeArrangementDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CollaborativeArrangementDisclosureTextBlock",
     "presentation": [
      "http://spyre.com/role/LicensingAgreements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Licensing Agreements",
        "label": "Collaborative Arrangement Disclosure [Text Block]",
        "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r105",
      "r107"
     ]
    },
    "us-gaap_CommercialPaperMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommercialPaperMember",
     "presentation": [
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails",
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesEstimatedFairValueofCashEquivalentsandMarketableSecuritiesandtheGrossUnrealizedGainsandLossesDetails",
      "http://spyre.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commercial paper",
        "label": "Commercial Paper [Member]",
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r287",
      "r656",
      "r657",
      "r658",
      "r659"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies (Note 6 and 7)",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r90",
      "r471",
      "r542"
     ]
    },
    "syre_CommonStockAndSeriesBNonVotingConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "CommonStockAndSeriesBNonVotingConvertiblePreferredStockMember",
     "presentation": [
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails",
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock and Series B Non Voting Convertible Preferred Stock",
        "label": "Common Stock and Series B Non Voting Convertible Preferred Stock [Member]",
        "documentation": "Common Stock and Series B Non Voting Convertible Preferred Stock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "presentation": [
      "http://spyre.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock available for future issuance (in shares)",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "documentation": "Aggregate number of common shares reserved for future issuance."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "syre_CommonStockCapitalSharesReservedForFutureIssuanceIncreasedAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "CommonStockCapitalSharesReservedForFutureIssuanceIncreasedAmount",
     "presentation": [
      "http://spyre.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock available for future issuance, additional amount authorized (in shares)",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance, Increased Amount",
        "documentation": "Common Stock, Capital Shares Reserved for Future Issuance, Additional Amount Reserved"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofChangesinConvertiblePreferredStockandStockholdersEquity",
      "http://spyre.com/role/CondensedConsolidatedStatementsofOperations",
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails",
      "http://spyre.com/role/NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails",
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r652",
      "r653",
      "r654",
      "r656",
      "r657",
      "r658",
      "r659",
      "r770",
      "r771",
      "r773",
      "r823",
      "r885",
      "r886"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value (in dollars per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, authorized (in shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r543"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, issued (in shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://spyre.com/role/CondensedConsolidatedStatementsofChangesinConvertiblePreferredStockandStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, outstanding (in shares)",
        "periodStartLabel": "Beginning balance, common stock (in shares)",
        "periodEndLabel": "Ending balance, common stock (in shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r57",
      "r543",
      "r561",
      "r886",
      "r887"
     ]
    },
    "syre_CommonStockSharesOutstandingPercentageAvailableToPurchaseOnADilutedBasis": {
     "xbrltype": "percentItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "CommonStockSharesOutstandingPercentageAvailableToPurchaseOnADilutedBasis",
     "presentation": [
      "http://spyre.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares outstanding, percentage available to purchase on a diluted basis",
        "label": "Common Stock, Shares, Outstanding, Percentage Available to Purchase on a Diluted Basis",
        "documentation": "Common Stock, Shares, Outstanding, Percentage Available to Purchase on a Diluted Basis"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, $0.0001 par value; 400,000,000 shares authorized as of March\u00a031, 2025 and December\u00a031, 2024; 60,275,561 shares and 60,257,023 shares issued and outstanding as of March\u00a031, 2025 and December\u00a031, 2024, respectively.",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r473",
      "r648"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure",
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r715"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Net Income",
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r714"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Other Measure",
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r716"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return",
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r713"
     ]
    },
    "syre_CompanyAndBasisOfPresentationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "CompanyAndBasisOfPresentationLineItems",
     "presentation": [
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company and Basis of Presentation [Line Items]",
        "label": "Company and Basis of Presentation [Line Items]",
        "documentation": "Company and basis of presentation."
       }
      }
     },
     "auth_ref": []
    },
    "syre_CompanyAndBasisOfPresentationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "CompanyAndBasisOfPresentationTable",
     "presentation": [
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company and Basis of Presentation [Table]",
        "label": "Company and Basis of Presentation [Table]",
        "documentation": "Company and basis of presentation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CompensationExpenseExcludingCostOfGoodAndServiceSold",
     "crdr": "debit",
     "calculation": {
      "http://spyre.com/role/SegmentReportingSummaryofSignificantSegmentExpensesDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://spyre.com/role/SegmentReportingSummaryofSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation",
        "label": "Compensation Expense, Excluding Cost of Good and Service Sold",
        "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Other employee benefit expense includes, but is not limited to, service component of net periodic benefit cost for defined benefit plan. Excludes compensation cost in cost of good and service sold."
       }
      }
     },
     "auth_ref": [
      "r620",
      "r763"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total comprehensive loss",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r126",
      "r128",
      "r132",
      "r464",
      "r483",
      "r484"
     ]
    },
    "srt_ConsolidationItemsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ConsolidationItemsAxis",
     "presentation": [
      "http://spyre.com/role/SegmentReportingSummaryofSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidation Items [Axis]",
        "label": "Consolidation Items [Axis]"
       }
      }
     },
     "auth_ref": [
      "r96",
      "r142",
      "r174",
      "r184",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r204",
      "r205",
      "r206",
      "r288",
      "r289",
      "r290",
      "r291",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r620",
      "r621",
      "r791",
      "r792"
     ]
    },
    "srt_ConsolidationItemsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ConsolidationItemsDomain",
     "presentation": [
      "http://spyre.com/role/SegmentReportingSummaryofSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidation Items [Domain]",
        "label": "Consolidation Items [Domain]"
       }
      }
     },
     "auth_ref": [
      "r96",
      "r142",
      "r174",
      "r184",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r204",
      "r205",
      "r206",
      "r288",
      "r289",
      "r290",
      "r291",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r620",
      "r621",
      "r791",
      "r792"
     ]
    },
    "syre_ConsultingAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "ConsultingAgreementMember",
     "presentation": [
      "http://spyre.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consulting Agreement",
        "label": "Consulting Agreement [Member]",
        "documentation": "Consulting Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "syre_ContingentValueRightLiabilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "ContingentValueRightLiabilityMember",
     "presentation": [
      "http://spyre.com/role/FairValueMeasurementsChangesinDerivativeLiabilitiesDetails",
      "http://spyre.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://spyre.com/role/FairValueMeasurementsNarrativeDetails",
      "http://spyre.com/role/FairValueMeasurementsSignificantInputsusedtoEstimatetheFairValueofDerivativeLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CVR liability",
        "label": "Contingent Value Right Liability [Member]",
        "documentation": "Contingent Value Right Liability"
       }
      }
     },
     "auth_ref": []
    },
    "syre_ConversionOfSeriesANonVotingConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "ConversionOfSeriesANonVotingConvertiblePreferredStockMember",
     "presentation": [
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion Of Series A Non-Voting Convertible Preferred Stock",
        "label": "Conversion Of Series A Non-Voting Convertible Preferred Stock [Member]",
        "documentation": "Conversion Of Series A Non-Voting Convertible Preferred Stock"
       }
      }
     },
     "auth_ref": []
    },
    "syre_ConversionOfSeriesBNonVotingConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "ConversionOfSeriesBNonVotingConvertiblePreferredStockMember",
     "presentation": [
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails",
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion Of Series B Non-Voting Convertible Preferred Stock",
        "label": "Conversion Of Series B Non-Voting Convertible Preferred Stock [Member]",
        "documentation": "Conversion Of Series B Non-Voting Convertible Preferred Stock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConversionOfStockByUniqueDescriptionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConversionOfStockByUniqueDescriptionAxis",
     "presentation": [
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails",
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Conversion Description [Axis]",
        "label": "Stock Conversion Description [Axis]",
        "documentation": "Information by description of stock conversions."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r18",
      "r19"
     ]
    },
    "us-gaap_ConversionOfStockNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConversionOfStockNameDomain",
     "presentation": [
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails",
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of Stock, Name [Domain]",
        "label": "Conversion of Stock, Name [Domain]",
        "documentation": "The unique name of a noncash or part noncash stock conversion."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r18",
      "r19"
     ]
    },
    "us-gaap_CorporateBondSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CorporateBondSecuritiesMember",
     "presentation": [
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails",
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesEstimatedFairValueofCashEquivalentsandMarketableSecuritiesandtheGrossUnrealizedGainsandLossesDetails",
      "http://spyre.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Corporate bonds",
        "label": "Corporate Bond Securities [Member]",
        "documentation": "This category includes information about long-term debt securities that are issued by either a domestic or foreign corporate business entity with a date certain promise of repayment and a return to the holder for the time value of money (for example, variable or fixed interest, original issue discount)."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://spyre.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesAvailableForSaleAllowanceForCreditLoss",
     "crdr": "credit",
     "presentation": [
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt securities, available-for-sale, allowance for credit loss",
        "label": "Debt Securities, Available-for-Sale, Allowance for Credit Loss",
        "documentation": "Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r216",
      "r252",
      "r259",
      "r260"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger",
     "crdr": "debit",
     "calculation": {
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails": {
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "12 Months or Longer",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r256",
      "r626"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss",
     "crdr": "debit",
     "calculation": {
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails": {
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "12 Months or Longer",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss",
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r256"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
     "crdr": "debit",
     "calculation": {
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails": {
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Less Than 12 Months",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r256",
      "r626"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
     "crdr": "debit",
     "calculation": {
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails": {
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less Than 12 Months",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss",
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r256"
     ]
    },
    "syre_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOne": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOne",
     "crdr": "debit",
     "calculation": {
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesContractualMaturitiesofMarketableSecuritiesatEstimatedFairValueDetails": {
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesContractualMaturitiesofMarketableSecuritiesatEstimatedFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due in 1 - 2 years",
        "label": "Debt Securities, Available-For-Sale, Fair Value, Maturity, Allocated And Single Maturity Date, After Year One",
        "documentation": "Debt Securities, Available-For-Sale, Fair Value, Maturity, Allocated And Single Maturity Date, After Year One"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "presentation": [
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails",
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesEstimatedFairValueofCashEquivalentsandMarketableSecuritiesandtheGrossUnrealizedGainsandLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Securities, Available-for-Sale [Table]",
        "label": "Debt Securities, Available-for-Sale [Table]",
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
     "crdr": "debit",
     "calculation": {
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total, fair value",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r254",
      "r626"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
     "crdr": "debit",
     "calculation": {
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Total, unrealized losses",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss",
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r255"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
     "presentation": [
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Available-for-Sale Securities in an Unrealized Loss Position",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block]",
        "documentation": "Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r626",
      "r789"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableforSaleUnrealizedLossPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesAvailableforSaleUnrealizedLossPositionAbstract",
     "presentation": [
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized Losses",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "syre_DeferredOfferingCostsUnpaidAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "DeferredOfferingCostsUnpaidAmount",
     "crdr": "credit",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unpaid deferred offering costs in connection with shelf registration",
        "label": "Deferred Offering Costs, Unpaid Amount",
        "documentation": "Deferred Offering Costs, Unpaid Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeContractTypeDomain",
     "presentation": [
      "http://spyre.com/role/FairValueMeasurementsChangesinDerivativeLiabilitiesDetails",
      "http://spyre.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Contract [Domain]",
        "label": "Derivative Contract [Domain]",
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset."
       }
      }
     },
     "auth_ref": [
      "r532",
      "r534",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r556",
      "r557",
      "r558",
      "r559",
      "r574",
      "r575",
      "r576",
      "r577",
      "r580",
      "r581",
      "r582",
      "r583",
      "r596",
      "r597",
      "r598",
      "r599",
      "r652",
      "r654",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835",
      "r837",
      "r838"
     ]
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeInstrumentRiskAxis",
     "presentation": [
      "http://spyre.com/role/FairValueMeasurementsChangesinDerivativeLiabilitiesDetails",
      "http://spyre.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instrument [Axis]",
        "label": "Derivative Instrument [Axis]",
        "documentation": "Information by type of derivative contract."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r42",
      "r43",
      "r88",
      "r532",
      "r534",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r556",
      "r557",
      "r558",
      "r559",
      "r574",
      "r575",
      "r576",
      "r577",
      "r580",
      "r581",
      "r582",
      "r583",
      "r596",
      "r597",
      "r598",
      "r599",
      "r611",
      "r652",
      "r654",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835",
      "r837",
      "r838"
     ]
    },
    "us-gaap_DerivativeLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CVR liability",
        "label": "Derivative Liability, Current",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "us-gaap_DerivativeLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-current CVR liability",
        "label": "Derivative Liability, Noncurrent",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "us-gaap_DerivativeLiabilityMeasurementInput": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeLiabilityMeasurementInput",
     "presentation": [
      "http://spyre.com/role/FairValueMeasurementsSignificantInputsusedtoEstimatetheFairValueofDerivativeLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative liability, measurement input",
        "label": "Derivative Liability, Measurement Input",
        "documentation": "Value of input used to measure derivative liability."
       }
      }
     },
     "auth_ref": [
      "r388",
      "r389",
      "r390"
     ]
    },
    "syre_DevelopmentCostReductionPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "DevelopmentCostReductionPercentage",
     "presentation": [
      "http://spyre.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Development cost reduction, percent",
        "label": "Development Cost Reduction, Percentage",
        "documentation": "Development Cost Reduction, Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "syre_DevelopmentCostReimbursementPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "DevelopmentCostReimbursementPercentage",
     "presentation": [
      "http://spyre.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Development cost reimbursement, percent",
        "label": "Development Cost Reimbursement, Percentage",
        "documentation": "Development Cost Reimbursement, Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://spyre.com/role/StockBasedCompensation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-Based Compensation",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r321",
      "r324",
      "r352",
      "r353",
      "r354",
      "r635"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-Based Payment Arrangement [Abstract]",
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://spyre.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://spyre.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://spyre.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://spyre.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Quarterly Report",
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r665"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://spyre.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r697"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://spyre.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year",
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r708"
     ]
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earnings Per Share [Abstract]",
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofOperations",
      "http://spyre.com/role/NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss per share, basic (in dollars per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r158",
      "r160",
      "r166",
      "r167",
      "r168",
      "r173",
      "r367",
      "r370",
      "r383",
      "r384",
      "r465",
      "r485",
      "r613"
     ]
    },
    "us-gaap_EarningsPerShareBasicLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasicLineItems",
     "presentation": [
      "http://spyre.com/role/NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]",
        "label": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r160",
      "r164",
      "r166"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofOperations",
      "http://spyre.com/role/NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss per share, diluted (in dollars per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r160",
      "r166",
      "r167",
      "r168",
      "r173",
      "r367",
      "r370",
      "r383",
      "r384",
      "r465",
      "r485",
      "r613"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://spyre.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Loss Per Share",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r25",
      "r170"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://spyre.com/role/NetLossPerShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Loss Per Share",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r157",
      "r169",
      "r171",
      "r172"
     ]
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of exchange rate on cash, cash equivalents, and restricted cash",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r411"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "presentation": [
      "http://spyre.com/role/StockBasedCompensationAssumptionsusedtoEstimatetheFairValueofStockOptionsGrantedDetails",
      "http://spyre.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Service Share Based Compensation Allocation of Recognized Period Costs [Line Items]",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockMember",
     "presentation": [
      "http://spyre.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Stock",
        "label": "Employee Stock [Member]",
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://spyre.com/role/NetLossPerShareWeightedAverageEquityInstrumentsExcludedfromCalculationofDilutedNetLossPerShareDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Options to purchase common stock",
        "terseLabel": "Stock Options",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://spyre.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://spyre.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Two",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://spyre.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Three",
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://spyre.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://spyre.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://spyre.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://spyre.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r663"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://spyre.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://spyre.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://spyre.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r663"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://spyre.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://spyre.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r663"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://spyre.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://spyre.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r747"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://spyre.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r663"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://spyre.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r663"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://spyre.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r663"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://spyre.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r663"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Footnote",
        "label": "Equity Awards Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r702"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table",
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r743"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments",
        "label": "Equity Awards Adjustments [Member]"
       }
      }
     },
     "auth_ref": [
      "r743"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table",
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r743"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity [Abstract]",
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofChangesinConvertiblePreferredStockandStockholdersEquity",
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails",
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component [Domain]",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r109",
      "r129",
      "r130",
      "r131",
      "r143",
      "r144",
      "r145",
      "r147",
      "r152",
      "r154",
      "r156",
      "r175",
      "r245",
      "r246",
      "r276",
      "r311",
      "r361",
      "r362",
      "r364",
      "r365",
      "r366",
      "r368",
      "r369",
      "r370",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r382",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r481",
      "r502",
      "r503",
      "r504",
      "r520",
      "r586"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Valuation Assumption Difference, Footnote",
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r712"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneous Compensation Analysis",
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r670",
      "r680",
      "r690",
      "r722"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneously Awarded Compensation Recovery",
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r667",
      "r677",
      "r687",
      "r719"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive Category:",
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r718"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://spyre.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://spyre.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r386",
      "r387",
      "r400",
      "r638"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "presentation": [
      "http://spyre.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://spyre.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r386",
      "r387",
      "r400",
      "r638"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "presentation": [
      "http://spyre.com/role/FairValueMeasurementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Significant Inputs used to Estimate the Fair Value of Derivative Liabilities",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r388",
      "r389",
      "r641"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://spyre.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://spyre.com/role/FairValueMeasurementsSignificantInputsusedtoEstimatetheFairValueofDerivativeLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r299",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r385",
      "r387",
      "r388",
      "r389",
      "r390",
      "r399",
      "r400",
      "r402",
      "r433",
      "r434",
      "r435",
      "r628",
      "r629",
      "r631",
      "r632",
      "r633",
      "r638",
      "r641"
     ]
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByLiabilityClassAxis",
     "presentation": [
      "http://spyre.com/role/FairValueMeasurementsSignificantInputsusedtoEstimatetheFairValueofDerivativeLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liability Class [Axis]",
        "label": "Liability Class [Axis]",
        "documentation": "Information by class of liability."
       }
      }
     },
     "auth_ref": [
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r401"
     ]
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByMeasurementFrequencyAxis",
     "presentation": [
      "http://spyre.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Frequency [Axis]",
        "label": "Measurement Frequency [Axis]",
        "documentation": "Information by measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r386",
      "r387",
      "r388",
      "r390",
      "r638",
      "r828",
      "r839"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Disclosures [Abstract]",
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://spyre.com/role/FairValueMeasurements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements",
        "label": "Fair Value Disclosures [Text Block]",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r395",
      "r397",
      "r398",
      "r399",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r463",
      "r638",
      "r642"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://spyre.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 1",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r299",
      "r313",
      "r318",
      "r387",
      "r400",
      "r433",
      "r631",
      "r632",
      "r633",
      "r638"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://spyre.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 2",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r299",
      "r313",
      "r318",
      "r387",
      "r388",
      "r400",
      "r434",
      "r628",
      "r629",
      "r631",
      "r632",
      "r633",
      "r638"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://spyre.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://spyre.com/role/FairValueMeasurementsSignificantInputsusedtoEstimatetheFairValueofDerivativeLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 3",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r299",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r387",
      "r388",
      "r389",
      "r390",
      "r400",
      "r435",
      "r628",
      "r629",
      "r631",
      "r632",
      "r633",
      "r638",
      "r641"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "presentation": [
      "http://spyre.com/role/FairValueMeasurementsSignificantInputsusedtoEstimatetheFairValueofDerivativeLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value by Liability Class [Domain]",
        "label": "Fair Value by Liability Class [Domain]",
        "documentation": "Represents classes of liabilities measured and disclosed at fair value."
       }
      }
     },
     "auth_ref": [
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r401"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "presentation": [
      "http://spyre.com/role/FairValueMeasurementsChangesinDerivativeLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "presentation": [
      "http://spyre.com/role/FairValueMeasurementsChangesinDerivativeLiabilitiesDetails",
      "http://spyre.com/role/FairValueMeasurementsSignificantInputsusedtoEstimatetheFairValueofDerivativeLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "presentation": [
      "http://spyre.com/role/FairValueMeasurementsChangesinDerivativeLiabilitiesDetails",
      "http://spyre.com/role/FairValueMeasurementsSignificantInputsusedtoEstimatetheFairValueofDerivativeLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "documentation": "Disclosure of information about financial instrument liability measured at fair value on recurring basis using unobservable input."
       }
      }
     },
     "auth_ref": [
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r401"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "presentation": [
      "http://spyre.com/role/FairValueMeasurementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in Derivative Liabilities",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability."
       }
      }
     },
     "auth_ref": [
      "r391",
      "r396",
      "r401"
     ]
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementFrequencyDomain",
     "presentation": [
      "http://spyre.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Frequency [Domain]",
        "label": "Measurement Frequency [Domain]",
        "documentation": "Measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r386",
      "r387",
      "r388",
      "r390",
      "r638",
      "r828",
      "r839"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "crdr": "credit",
     "presentation": [
      "http://spyre.com/role/FairValueMeasurementsChangesinDerivativeLiabilitiesDetails",
      "http://spyre.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Change in fair value of liability, decrease",
        "terseLabel": "Changes in the fair value of the CVR liability",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3)."
       }
      }
     },
     "auth_ref": [
      "r392",
      "r401"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements",
     "crdr": "debit",
     "presentation": [
      "http://spyre.com/role/FairValueMeasurementsChangesinDerivativeLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payments",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements",
        "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r394",
      "r401"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "crdr": "credit",
     "presentation": [
      "http://spyre.com/role/FairValueMeasurementsChangesinDerivativeLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r391",
      "r401"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://spyre.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://spyre.com/role/FairValueMeasurementsSignificantInputsusedtoEstimatetheFairValueofDerivativeLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r299",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r385",
      "r387",
      "r388",
      "r389",
      "r390",
      "r399",
      "r400",
      "r402",
      "r433",
      "r434",
      "r435",
      "r628",
      "r629",
      "r631",
      "r632",
      "r633",
      "r638",
      "r641"
     ]
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsRecurringMember",
     "presentation": [
      "http://spyre.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Measurements, Recurring",
        "label": "Fair Value, Recurring [Member]",
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r638",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r839"
     ]
    },
    "syre_FairmountFundsManagementLlcMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "FairmountFundsManagementLlcMember",
     "presentation": [
      "http://spyre.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fairmount Funds Management LLC",
        "label": "Fairmount Funds Management LLC [Member]",
        "documentation": "Fairmount Funds Management LLC."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails",
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesEstimatedFairValueofCashEquivalentsandMarketableSecuritiesandtheGrossUnrealizedGainsandLossesDetails",
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesNarrativeDetails",
      "http://spyre.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://spyre.com/role/FairValueMeasurementsSignificantInputsusedtoEstimatetheFairValueofDerivativeLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instrument [Axis]",
        "label": "Financial Instrument [Axis]",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r253",
      "r257",
      "r258",
      "r301",
      "r308",
      "r381",
      "r407",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r482",
      "r626",
      "r638",
      "r639",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r649",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r784",
      "r785",
      "r786",
      "r787",
      "r824",
      "r827",
      "r828",
      "r829",
      "r836",
      "r839"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r674",
      "r684",
      "r694",
      "r726"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount",
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r674",
      "r684",
      "r694",
      "r726"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r674",
      "r684",
      "r694",
      "r726"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery, Explanation of Impracticability",
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r674",
      "r684",
      "r694",
      "r726"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r674",
      "r684",
      "r694",
      "r726"
     ]
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year",
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r707"
     ]
    },
    "us-gaap_GainLossOnDerivativeInstrumentsNetPretax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainLossOnDerivativeInstrumentsNetPretax",
     "crdr": "credit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Change in fair value of CVR liability",
        "label": "Gain (Loss) on Derivative Instruments, Net, Pretax",
        "documentation": "Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative",
        "label": "General and Administrative Expense",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r566"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofOperationsParenthetical",
      "http://spyre.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative",
        "label": "General and Administrative Expense [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "syre_ImpairmentOfMarketableSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "ImpairmentOfMarketableSecurities",
     "crdr": "credit",
     "presentation": [
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of marketable securities",
        "label": "Impairment Of Marketable Securities",
        "documentation": "Impairment of marketable securities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss before income tax expense",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r93",
      "r97",
      "r466",
      "r479",
      "r615",
      "r620",
      "r775",
      "r777",
      "r778",
      "r779",
      "r780"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement [Abstract]",
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://spyre.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Income Location, Balance [Axis]",
        "label": "Statement of Income Location, Balance [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r277",
      "r279",
      "r280",
      "r392",
      "r396",
      "r401",
      "r499",
      "r501",
      "r571",
      "r608",
      "r640",
      "r856"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://spyre.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Income Location, Balance [Domain]",
        "label": "Statement of Income Location, Balance [Domain]",
        "documentation": "Location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r279",
      "r280",
      "r392",
      "r396",
      "r401",
      "r499",
      "r501",
      "r571",
      "r608",
      "r640",
      "r856"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Income tax benefit (expense)",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r106",
      "r155",
      "r156",
      "r174",
      "r190",
      "r204",
      "r359",
      "r360",
      "r363",
      "r486",
      "r637"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableTrade": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsPayableTrade",
     "crdr": "debit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Increase (Decrease) in Accounts Payable, Trade",
        "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued and other liabilities",
        "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities",
        "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other."
       }
      }
     },
     "auth_ref": [
      "r764"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in operating assets and liabilities:",
        "label": "Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOtherAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOtherAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related party accounts payable",
        "label": "Increase (Decrease) in Other Accounts Payable",
        "documentation": "Amount of increase (decrease) in obligations classified as other, payable within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses and other assets",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofChangesinConvertiblePreferredStockandStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofChangesinConvertiblePreferredStockandStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncrementalCommonSharesAttributableToCallOptionsAndWarrants",
     "calculation": {
      "http://spyre.com/role/NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://spyre.com/role/NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average pre-funded warrants (in shares)",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method."
       }
      }
     },
     "auth_ref": [
      "r161",
      "r162",
      "r163",
      "r168"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Individual:",
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r674",
      "r684",
      "r694",
      "r718",
      "r726",
      "r730",
      "r738"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r736"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r666",
      "r742"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Adopted",
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r666",
      "r742"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted",
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r666",
      "r742"
     ]
    },
    "syre_InterestProceedsDebtSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "InterestProceedsDebtSecurities",
     "crdr": "debit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest proceeds from maturities of zero coupon US Treasury Bills",
        "label": "Interest Proceeds, Debt Securities",
        "documentation": "Interest Proceeds, Debt Securities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestReceivable",
     "crdr": "debit",
     "presentation": [
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued interest receivable on available-for-sale debt securities",
        "label": "Interest Receivable",
        "documentation": "Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable."
       }
      }
     },
     "auth_ref": [
      "r758",
      "r888"
     ]
    },
    "us-gaap_InvestmentIncomeNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentIncomeNet",
     "crdr": "credit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income",
        "label": "Investment Income, Net",
        "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r70",
      "r72"
     ]
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "presentation": [
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contractual Maturities of Marketable Securities at Estimated Fair Value",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments."
       }
      }
     },
     "auth_ref": []
    },
    "syre_IssuanceOfConvertiblePreferredStockRelatedToPrivatePlacementUnpaidAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "IssuanceOfConvertiblePreferredStockRelatedToPrivatePlacementUnpaidAmount",
     "crdr": "credit",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unpaid amounts related to issuance of Series B non-voting convertible preferred stock in connection with private placement",
        "label": "Issuance of Convertible Preferred Stock Related to Private Placement, Unpaid Amount",
        "documentation": "Issuance of Convertible Preferred Stock Related to Private Placement, Unpaid Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL LIABILITIES",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r53",
      "r54",
      "r139",
      "r244",
      "r288",
      "r289",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r297",
      "r298",
      "r372",
      "r373",
      "r374",
      "r408",
      "r541",
      "r614",
      "r661",
      "r791",
      "r843",
      "r844"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS\u2019 EQUITY",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r91",
      "r477",
      "r648",
      "r767",
      "r788",
      "r840"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r113",
      "r139",
      "r244",
      "r288",
      "r289",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r297",
      "r298",
      "r372",
      "r373",
      "r374",
      "r408",
      "r648",
      "r791",
      "r843",
      "r844"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CURRENT LIABILITIES",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://spyre.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total liabilities",
        "label": "Liabilities, Fair Value Disclosure",
        "documentation": "Fair value of financial and nonfinancial obligations."
       }
      }
     },
     "auth_ref": [
      "r387",
      "r825"
     ]
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "presentation": [
      "http://spyre.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities:",
        "label": "Liabilities, Fair Value Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "syre_LicenseAgreementMilestoneExpenseAmountRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "LicenseAgreementMilestoneExpenseAmountRecognized",
     "crdr": "debit",
     "presentation": [
      "http://spyre.com/role/LicensingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Milestone expense recognized",
        "label": "License Agreement, Milestone Expense, Amount Recognized",
        "documentation": "License Agreement, Milestone Expense, Amount Recognized"
       }
      }
     },
     "auth_ref": []
    },
    "syre_LicenseAgreementMilestonePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "LicenseAgreementMilestonePayments",
     "crdr": "credit",
     "presentation": [
      "http://spyre.com/role/LicensingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Milestone payments",
        "label": "License Agreement, Milestone Payments",
        "documentation": "License Agreement, Milestone Payments"
       }
      }
     },
     "auth_ref": []
    },
    "syre_LicenseAgreementMilestonePaymentsOutstandingAndPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "LicenseAgreementMilestonePaymentsOutstandingAndPayable",
     "crdr": "credit",
     "presentation": [
      "http://spyre.com/role/LicensingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Milestone payments, outstanding and payable",
        "label": "License Agreement, Milestone Payments Outstanding and Payable",
        "documentation": "License Agreement, Milestone Payments Outstanding and Payable"
       }
      }
     },
     "auth_ref": []
    },
    "syre_LicensingAgreementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "LicensingAgreementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Licensing Agreements [Abstract]",
        "documentation": "Licensing Agreements"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://spyre.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketableSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MarketableSecurities",
     "crdr": "debit",
     "presentation": [
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Marketable securities",
        "label": "Marketable Securities",
        "documentation": "Amount of investment in marketable security."
       }
      }
     },
     "auth_ref": [
      "r92",
      "r757"
     ]
    },
    "us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments",
     "crdr": "credit",
     "presentation": [
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Realized gains or losses on marketable securities",
        "label": "Marketable Security, Realized Gain (Loss)",
        "documentation": "Amount of realized gain (loss) on investment in marketable security."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MaterialReconcilingItemsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MaterialReconcilingItemsMember",
     "presentation": [
      "http://spyre.com/role/SegmentReportingSummaryofSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments and reconciling items",
        "label": "Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment [Member]",
        "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity."
       }
      }
     },
     "auth_ref": [
      "r199",
      "r202",
      "r205",
      "r620",
      "r621"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MaximumMember",
     "presentation": [
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesNarrativeDetails",
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails",
      "http://spyre.com/role/FairValueMeasurementsSignificantInputsusedtoEstimatetheFairValueofDerivativeLiabilityDetails",
      "http://spyre.com/role/LicensingAgreementsDetails",
      "http://spyre.com/role/RelatedPartyTransactionsNarrativeDetails",
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "verboseLabel": "Maximum",
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r283",
      "r284",
      "r285",
      "r286",
      "r320",
      "r357",
      "r390",
      "r461",
      "r498",
      "r500",
      "r508",
      "r533",
      "r534",
      "r592",
      "r593",
      "r594",
      "r595",
      "r600",
      "r606",
      "r607",
      "r625",
      "r630",
      "r634",
      "r641",
      "r642",
      "r646",
      "r647",
      "r650",
      "r793",
      "r845",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measure:",
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r710"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Measure Name"
       }
      }
     },
     "auth_ref": [
      "r710"
     ]
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputDiscountRateMember",
     "presentation": [
      "http://spyre.com/role/FairValueMeasurementsSignificantInputsusedtoEstimatetheFairValueofDerivativeLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk-adjusted discount rates",
        "label": "Measurement Input, Discount Rate [Member]",
        "documentation": "Measurement input using interest rate to determine present value of future cash flows."
       }
      }
     },
     "auth_ref": [
      "r827",
      "r828",
      "r829"
     ]
    },
    "syre_MeasurementInputProabilityOfSuccessMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "MeasurementInputProabilityOfSuccessMember",
     "presentation": [
      "http://spyre.com/role/FairValueMeasurementsSignificantInputsusedtoEstimatetheFairValueofDerivativeLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated probability of success",
        "label": "Measurement Input, Proability Of Success [Member]",
        "documentation": "Measurement Input, Proability Of Success"
       }
      }
     },
     "auth_ref": []
    },
    "syre_MeasurementInputReimbursementRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "MeasurementInputReimbursementRateMember",
     "presentation": [
      "http://spyre.com/role/FairValueMeasurementsSignificantInputsusedtoEstimatetheFairValueofDerivativeLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated reimbursement rate compared to reimbursement target",
        "label": "Measurement Input, Reimbursement Rate [Member]",
        "documentation": "Measurement Input, Reimbursement Rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputTypeAxis",
     "presentation": [
      "http://spyre.com/role/FairValueMeasurementsSignificantInputsusedtoEstimatetheFairValueofDerivativeLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Input Type [Axis]",
        "label": "Measurement Input Type [Axis]",
        "documentation": "Information by type of measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r388",
      "r389",
      "r390",
      "r641"
     ]
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputTypeDomain",
     "presentation": [
      "http://spyre.com/role/FairValueMeasurementsSignificantInputsusedtoEstimatetheFairValueofDerivativeLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Input Type [Domain]",
        "label": "Measurement Input Type [Domain]",
        "documentation": "Measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r388",
      "r389",
      "r390",
      "r641"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MinimumMember",
     "presentation": [
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails",
      "http://spyre.com/role/FairValueMeasurementsSignificantInputsusedtoEstimatetheFairValueofDerivativeLiabilityDetails",
      "http://spyre.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r283",
      "r284",
      "r285",
      "r286",
      "r320",
      "r357",
      "r390",
      "r461",
      "r498",
      "r500",
      "r508",
      "r533",
      "r534",
      "r592",
      "r593",
      "r594",
      "r595",
      "r600",
      "r606",
      "r607",
      "r625",
      "r630",
      "r634",
      "r641",
      "r642",
      "r646",
      "r650",
      "r793",
      "r845",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850"
     ]
    },
    "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners",
     "presentation": [
      "http://spyre.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of ownership by noncontrolling owner",
        "label": "Subsidiary, Ownership Percentage, Noncontrolling Owner",
        "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity."
       }
      }
     },
     "auth_ref": []
    },
    "syre_MinorityInterestOwnershipPercentageByNoncontrollingOwnersHeldInThirdParty": {
     "xbrltype": "percentItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwnersHeldInThirdParty",
     "presentation": [
      "http://spyre.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of ownership held in third party",
        "label": "Minority Interest Ownership Percentage By Noncontrolling Owners Held In Third Party",
        "documentation": "Minority interest ownership percentage by noncontrolling owners held in third party."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MNPI Disclosure Timed for Compensation Value",
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]"
       }
      }
     },
     "auth_ref": [
      "r729"
     ]
    },
    "us-gaap_MoneyMarketFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MoneyMarketFundsMember",
     "presentation": [
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesEstimatedFairValueofCashEquivalentsandMarketableSecuritiesandtheGrossUnrealizedGainsandLossesDetails",
      "http://spyre.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Money market funds",
        "label": "Money Market Funds [Member]",
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities."
       }
      }
     },
     "auth_ref": [
      "r794"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Material Terms of Trading Arrangement",
        "label": "Material Terms of Trading Arrangement [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r737"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Named Executive Officers, Footnote",
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r711"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES",
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES",
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r75",
      "r76"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES",
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      },
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      },
      "http://spyre.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://spyre.com/role/SegmentReportingSummaryofSignificantSegmentExpensesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://spyre.com/role/CondensedConsolidatedStatementsofChangesinConvertiblePreferredStockandStockholdersEquity",
      "http://spyre.com/role/CondensedConsolidatedStatementsofComprehensiveLoss",
      "http://spyre.com/role/CondensedConsolidatedStatementsofOperations",
      "http://spyre.com/role/NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails",
      "http://spyre.com/role/SegmentReportingSummaryofSignificantSegmentExpensesDetails",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss",
        "terseLabel": "Net loss",
        "negatedTotalLabel": "Net loss",
        "negatedLabel": "Adjustments and reconciling items",
        "verboseLabel": "Allocation of losses",
        "label": "Net Income (Loss) Attributable to Parent",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r76",
      "r94",
      "r111",
      "r125",
      "r127",
      "r131",
      "r139",
      "r146",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r155",
      "r156",
      "r165",
      "r244",
      "r288",
      "r289",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r297",
      "r298",
      "r367",
      "r370",
      "r384",
      "r408",
      "r480",
      "r563",
      "r584",
      "r585",
      "r660",
      "r791"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://spyre.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recently Adopted and Not Yet Adopted Accounting Pronouncements",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-GAAP Measure Description",
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r710"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-NEOs",
        "label": "Non-NEOs [Member]"
       }
      }
     },
     "auth_ref": [
      "r674",
      "r684",
      "r694",
      "r718",
      "r726"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r701"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount",
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r700"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO",
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r718"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted",
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r737"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated",
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r737"
     ]
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental Disclosure of Non-Cash Investing and Financing Information:",
        "label": "Noncash Investing and Financing Items [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total other income",
        "label": "Nonoperating Income (Expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income:",
        "label": "Nonoperating Income (Expense) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NonrelatedPartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonrelatedPartyMember",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nonrelated Party",
        "label": "Nonrelated Party [Member]",
        "documentation": "Party not related to reporting entity."
       }
      }
     },
     "auth_ref": [
      "r768",
      "r769"
     ]
    },
    "syre_NumberOfDomesticBankingInstitutions": {
     "xbrltype": "integerItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "NumberOfDomesticBankingInstitutions",
     "presentation": [
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of domestic banking institutions (in banks)",
        "label": "Number Of Domestic Banking Institutions",
        "documentation": "Number Of Domestic Banking Institutions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfOperatingSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NumberOfOperatingSegments",
     "presentation": [
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of operating segments",
        "label": "Number of Operating Segments",
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues."
       }
      }
     },
     "auth_ref": [
      "r621",
      "r776"
     ]
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating expenses",
        "label": "Operating Expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating expenses:",
        "label": "Operating Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss from operations",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r615",
      "r775",
      "r777",
      "r778",
      "r779",
      "r780"
     ]
    },
    "us-gaap_OperatingSegmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingSegmentsMember",
     "presentation": [
      "http://spyre.com/role/SegmentReportingSummaryofSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Segments",
        "label": "Operating Segments [Member]",
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r205",
      "r620",
      "r621"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "presentation": [
      "http://spyre.com/role/TheCompanyandBasisofPresentation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "The Company and Basis of Presentation",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r87",
      "r509",
      "r510"
     ]
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://spyre.com/role/AccruedandOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://spyre.com/role/AccruedandOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued other",
        "label": "Other Accrued Liabilities, Current",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other non-current assets",
        "label": "Other Assets, Noncurrent",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r115"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofChangesinConvertiblePreferredStockandStockholdersEquity",
      "http://spyre.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency translation adjustment",
        "verboseLabel": "Foreign currency translation adjustment",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax",
        "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r63",
      "r64",
      "r65",
      "r409",
      "r410",
      "r412"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive income (loss):",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofChangesinConvertiblePreferredStockandStockholdersEquity",
      "http://spyre.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized gain (loss) on marketable securities",
        "verboseLabel": "Unrealized gain (loss) on marketable securities",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r124",
      "r243"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income (expense), net",
        "label": "Other Nonoperating Income (Expense)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Performance Measure, Amount",
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r710"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount",
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r672",
      "r682",
      "r692",
      "r724"
     ]
    },
    "syre_OutstandingAndUnexercisedStockOptions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "OutstandingAndUnexercisedStockOptions",
     "presentation": [
      "http://spyre.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of outstanding and unexercised stock options to purchase (in shares)",
        "label": "Outstanding and Unexercised Stock Options",
        "documentation": "Outstanding and unexercised stock options."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Amount",
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r675",
      "r685",
      "r695",
      "r727"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r675",
      "r685",
      "r695",
      "r727"
     ]
    },
    "us-gaap_OverAllotmentOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OverAllotmentOptionMember",
     "presentation": [
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Over-Allotment Option",
        "label": "Over-Allotment Option [Member]",
        "documentation": "Right given to the underwriter to sell additional shares over the initial allotment."
       }
      }
     },
     "auth_ref": []
    },
    "srt_OwnershipAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "OwnershipAxis",
     "presentation": [
      "http://spyre.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ownership [Axis]",
        "label": "Ownership [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_OwnershipDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "OwnershipDomain",
     "presentation": [
      "http://spyre.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ownership [Domain]",
        "label": "Ownership [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "syre_ParagonAgreementLicenseMilestonePaymentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "ParagonAgreementLicenseMilestonePaymentsMember",
     "presentation": [
      "http://spyre.com/role/LicensingAgreementsDetails",
      "http://spyre.com/role/RelatedPartyTransactionsExpensesrelatedtoRelatedPartywhichwereSettledinCashDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License Agreement",
        "label": "Paragon Agreement, License Milestone Payments [Member]",
        "documentation": "Paragon Agreement, License Milestone Payments"
       }
      }
     },
     "auth_ref": []
    },
    "syre_ParagonAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "ParagonAgreementMember",
     "presentation": [
      "http://spyre.com/role/LicensingAgreementsDetails",
      "http://spyre.com/role/RelatedPartyTransactionsExpensesrelatedtoRelatedPartywhichwereSettledinCashDetails",
      "http://spyre.com/role/RelatedPartyTransactionsNarrativeDetails",
      "http://spyre.com/role/RelatedPartyTransactionsRelatedPartyAccountsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Paragon Agreement",
        "label": "Paragon Agreement [Member]",
        "documentation": "Paragon agreement."
       }
      }
     },
     "auth_ref": []
    },
    "syre_ParagonAgreementSubsequentToAssetAcquisitionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "ParagonAgreementSubsequentToAssetAcquisitionMember",
     "presentation": [
      "http://spyre.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent to Asset Acquisition",
        "label": "Paragon Agreement, Subsequent to Asset Acquisition [Member]",
        "documentation": "Paragon Agreement, Subsequent to Asset Acquisition"
       }
      }
     },
     "auth_ref": []
    },
    "syre_ParagonAndLicenseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "ParagonAndLicenseAgreementMember",
     "presentation": [
      "http://spyre.com/role/RelatedPartyTransactionsExpensesrelatedtoRelatedPartywhichwereSettledinCashDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Paragon and License Agreement",
        "label": "Paragon and License Agreement [Member]",
        "documentation": "Paragon and License Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "syre_ParagonTherapeuticsIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "ParagonTherapeuticsIncMember",
     "presentation": [
      "http://spyre.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Paragon Therapeutics Inc",
        "label": "Paragon Therapeutics Inc [Member]",
        "documentation": "Paragon therapeutics, Inc."
       }
      }
     },
     "auth_ref": []
    },
    "syre_ParapyreLiabilityLicenseAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "ParapyreLiabilityLicenseAgreementsMember",
     "presentation": [
      "http://spyre.com/role/RelatedPartyTransactionsRelatedPartyAccountsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License Agreements development milestone liability (see Note 6)",
        "label": "Parapyre Liability, License Agreements [Member]",
        "documentation": "Parapyre Liability, License Agreements"
       }
      }
     },
     "auth_ref": []
    },
    "syre_ParapyreOptionObligationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "ParapyreOptionObligationMember",
     "presentation": [
      "http://spyre.com/role/RelatedPartyTransactionsNarrativeDetails",
      "http://spyre.com/role/StockBasedCompensationNarrativeDetails",
      "http://spyre.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Parapyre Option Obligation",
        "label": "Parapyre Option Obligation [Member]",
        "documentation": "Parapyre Option Obligation"
       }
      }
     },
     "auth_ref": []
    },
    "syre_ParapyreWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "ParapyreWarrantsMember",
     "presentation": [
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails",
      "http://spyre.com/role/NetLossPerShareWeightedAverageEquityInstrumentsExcludedfromCalculationofDilutedNetLossPerShareDetails",
      "http://spyre.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding Parapyre warrants",
        "label": "Parapyre Warrants [Member]",
        "documentation": "Parapyre Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r699"
     ]
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PayablesAndAccrualsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities",
     "crdr": "credit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payments related to CVR",
        "label": "Payment for Contingent Consideration Liability, Financing Activities",
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "syre_PaymentForDeferredOfferingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "PaymentForDeferredOfferingCosts",
     "crdr": "credit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payment of deferred offering costs in connection with shelf registration",
        "label": "Payment For Deferred Offering Costs",
        "documentation": "Payment For Deferred Offering Costs"
       }
      }
     },
     "auth_ref": []
    },
    "syre_PaymentForSettlementOfShareBasedPaymentArrangement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "PaymentForSettlementOfShareBasedPaymentArrangement",
     "crdr": "credit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Cash settlement of employee stock option award",
        "label": "Payment For Settlement Of Share-Based Payment Arrangement",
        "documentation": "Payment For Settlement Of Share-Based Payment Arrangement"
       }
      }
     },
     "auth_ref": []
    },
    "syre_PaymentForSublicensingFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "PaymentForSublicensingFee",
     "crdr": "credit",
     "presentation": [
      "http://spyre.com/role/LicensingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payment for sublicensing fee",
        "label": "Payment For Sublicensing Fee",
        "documentation": "Payment For Sublicensing Fee"
       }
      }
     },
     "auth_ref": []
    },
    "syre_PaymentOfMilestone": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "PaymentOfMilestone",
     "crdr": "credit",
     "presentation": [
      "http://spyre.com/role/LicensingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "First milestone payment",
        "label": "Payment Of Milestone",
        "documentation": "Payment of milestone."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsOfStockIssuanceCosts",
     "crdr": "credit",
     "presentation": [
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails",
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Placement agent and other offering costs",
        "label": "Payments of Stock Issuance Costs",
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
     "crdr": "credit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchases of marketable securities",
        "label": "Payments to Acquire Debt Securities, Available-for-Sale",
        "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r134",
      "r211"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Issuers, Footnote",
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r709"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Total Shareholder Return Amount",
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r709"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Actually Paid Compensation Amount",
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r701"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO",
        "label": "PEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r718"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Name",
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r711"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Total Compensation Amount",
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r700"
     ]
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails",
      "http://spyre.com/role/RelatedPartyTransactionsNarrativeDetails",
      "http://spyre.com/role/StockBasedCompensationAssumptionsusedtoEstimatetheFairValueofStockOptionsGrantedDetails",
      "http://spyre.com/role/StockBasedCompensationNarrativeDetails",
      "http://spyre.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Axis]",
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r820"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails",
      "http://spyre.com/role/RelatedPartyTransactionsNarrativeDetails",
      "http://spyre.com/role/StockBasedCompensationAssumptionsusedtoEstimatetheFairValueofStockOptionsGrantedDetails",
      "http://spyre.com/role/StockBasedCompensationNarrativeDetails",
      "http://spyre.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Domain]",
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r820"
     ]
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Prior Service Cost",
        "label": "Pension Adjustments Prior Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r702"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Service Cost",
        "label": "Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r746"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Benefits Adjustments, Footnote",
        "label": "Pension Benefits Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r701"
     ]
    },
    "us-gaap_PreferredStockConvertibleConversionRatio": {
     "xbrltype": "pureItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockConvertibleConversionRatio",
     "presentation": [
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails",
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion basis",
        "label": "Preferred Stock, Convertible, Conversion Ratio",
        "documentation": "Number of common shares issuable upon conversion for each share of preferred stock to be converted."
       }
      }
     },
     "auth_ref": [
      "r304"
     ]
    },
    "us-gaap_PreferredStockConvertibleSharesIssuable": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockConvertibleSharesIssuable",
     "presentation": [
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of common shares issuable upon conversion (in shares)",
        "label": "Preferred Stock, Convertible, Shares Issuable",
        "documentation": "Number of common shares issuable upon conversion of preferred stock."
       }
      }
     },
     "auth_ref": [
      "r304"
     ]
    },
    "syre_PreferredStockExcludingSeriesAAndBNonVotingConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "PreferredStockExcludingSeriesAAndBNonVotingConvertiblePreferredStockMember",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets",
      "http://spyre.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred Stock, Excluding Series A Non Voting Convertible Preferred Stock",
        "label": "Preferred Stock, Excluding Series A and B Non Voting Convertible Preferred Stock [Member]",
        "documentation": "Preferred Stock, Excluding Series A and B Non Voting Convertible Preferred Stock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockMember",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofChangesinConvertiblePreferredStockandStockholdersEquity",
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails",
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred Stock",
        "label": "Preferred Stock [Member]",
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company."
       }
      }
     },
     "auth_ref": [
      "r652",
      "r653",
      "r656",
      "r657",
      "r658",
      "r659",
      "r885",
      "r886"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, par value (in dollars per share)",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r302"
     ]
    },
    "syre_PreferredStockRemainsIssuedAndOutstandingPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "PreferredStockRemainsIssuedAndOutstandingPercentage",
     "presentation": [
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock issued and outstanding percentage",
        "label": "Preferred Stock Remains Issued and Outstanding Percentage.",
        "documentation": "Preferred stock remains issued and outstanding percentage."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, authorized (in shares)",
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r543"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, issued (in shares)",
        "label": "Preferred Stock, Shares Issued",
        "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r302"
     ]
    },
    "syre_PreferredStockSharesNotAutomaticallyConvertedOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "PreferredStockSharesNotAutomaticallyConvertedOutstanding",
     "presentation": [
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails",
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, not automatically converted, outstanding (in shares)",
        "label": "Preferred Stock, Shares Not Automatically Converted, Outstanding",
        "documentation": "Preferred Stock, Shares Not Automatically Converted, Outstanding"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://spyre.com/role/CondensedConsolidatedStatementsofChangesinConvertiblePreferredStockandStockholdersEquity",
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails",
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, outstanding (in shares)",
        "periodStartLabel": "Beginning balance, preferred stock (in shares)",
        "periodEndLabel": "Ending balance, preferred stock (in shares)",
        "label": "Preferred Stock, Shares Outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r543",
      "r561",
      "r886",
      "r887"
     ]
    },
    "us-gaap_PreferredStockTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockTextBlock",
     "presentation": [
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Preferred Stock and Stockholders' Equity",
        "label": "Preferred Stock [Text Block]",
        "documentation": "The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series A non-voting convertible preferred stock &amp; preferred stock shares authorized, issued, and outstanding, value",
        "label": "Preferred Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r472",
      "r648"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses and other current assets",
        "label": "Prepaid Expense and Other Assets, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r759"
     ]
    },
    "us-gaap_PrivatePlacementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrivatePlacementMember",
     "presentation": [
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails",
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Private Placement",
        "label": "Private Placement [Member]",
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfPrivatePlacement",
     "crdr": "debit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Proceeds from issuance of Series B non-voting convertible preferred stock in connection with private placement, net of placement and other offering costs",
        "label": "Proceeds from Issuance of Private Placement",
        "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "crdr": "debit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from employee stock option exercises and employee stock plan purchases",
        "label": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised",
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r8"
     ]
    },
    "syre_ProceedsFromRaisingCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "ProceedsFromRaisingCapital",
     "crdr": "debit",
     "presentation": [
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from raising capital",
        "label": "Proceeds From Raising Capital",
        "documentation": "Proceeds From Raising Capital"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
     "crdr": "debit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from maturities and sales of marketable securities",
        "label": "Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale",
        "documentation": "Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r134",
      "r135",
      "r783"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure",
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r699"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure, Table",
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r699"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeAxis",
     "presentation": [
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesNarrativeDetails",
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails",
      "http://spyre.com/role/FairValueMeasurementsSignificantInputsusedtoEstimatetheFairValueofDerivativeLiabilityDetails",
      "http://spyre.com/role/LicensingAgreementsDetails",
      "http://spyre.com/role/RelatedPartyTransactionsNarrativeDetails",
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Axis]",
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r283",
      "r284",
      "r285",
      "r286",
      "r312",
      "r320",
      "r347",
      "r348",
      "r349",
      "r357",
      "r390",
      "r436",
      "r445",
      "r461",
      "r498",
      "r500",
      "r508",
      "r533",
      "r534",
      "r592",
      "r593",
      "r594",
      "r595",
      "r600",
      "r606",
      "r607",
      "r625",
      "r630",
      "r634",
      "r641",
      "r642",
      "r646",
      "r647",
      "r650",
      "r654",
      "r790",
      "r793",
      "r828",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeMember",
     "presentation": [
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesNarrativeDetails",
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails",
      "http://spyre.com/role/FairValueMeasurementsSignificantInputsusedtoEstimatetheFairValueofDerivativeLiabilityDetails",
      "http://spyre.com/role/LicensingAgreementsDetails",
      "http://spyre.com/role/RelatedPartyTransactionsNarrativeDetails",
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Domain]",
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": [
      "r283",
      "r284",
      "r285",
      "r286",
      "r312",
      "r320",
      "r347",
      "r348",
      "r349",
      "r357",
      "r390",
      "r436",
      "r445",
      "r461",
      "r498",
      "r500",
      "r508",
      "r533",
      "r534",
      "r592",
      "r593",
      "r594",
      "r595",
      "r600",
      "r606",
      "r607",
      "r625",
      "r630",
      "r634",
      "r641",
      "r642",
      "r646",
      "r647",
      "r650",
      "r654",
      "r790",
      "r793",
      "r828",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850"
     ]
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract",
     "presentation": [
      "http://spyre.com/role/SegmentReportingSummaryofSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation of net loss",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
     "presentation": [
      "http://spyre.com/role/SegmentReportingTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Significant Segment Expenses",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
        "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r29"
     ]
    },
    "us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable",
     "presentation": [
      "http://spyre.com/role/SegmentReportingSummaryofSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment, Reconciliation of Other Items from Segments to Consolidated [Table]",
        "label": "Segment, Reconciliation of Other Items from Segments to Consolidated [Table]",
        "documentation": "Disclosure of information about reconciliation of other items from reportable segments to their consolidated amount. Excludes reconciliation of revenue, profit (loss), and assets."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r29"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r667",
      "r677",
      "r687",
      "r719"
     ]
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets",
      "http://spyre.com/role/CondensedConsolidatedStatementsofOperations",
      "http://spyre.com/role/CondensedConsolidatedStatementsofOperationsParenthetical",
      "http://spyre.com/role/LicensingAgreementsDetails",
      "http://spyre.com/role/RelatedPartyTransactionsExpensesrelatedtoRelatedPartywhichwereSettledinCashDetails",
      "http://spyre.com/role/RelatedPartyTransactionsNarrativeDetails",
      "http://spyre.com/role/RelatedPartyTransactionsRelatedPartyAccountsPayableDetails",
      "http://spyre.com/role/SegmentReportingSummaryofSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related and Nonrelated Parties [Domain]",
        "label": "Related and Nonrelated Parties [Domain]",
        "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r210",
      "r319",
      "r425",
      "r426",
      "r470",
      "r478",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r560",
      "r562",
      "r591"
     ]
    },
    "us-gaap_RelatedPartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyMember",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets",
      "http://spyre.com/role/CondensedConsolidatedStatementsofOperations",
      "http://spyre.com/role/CondensedConsolidatedStatementsofOperationsParenthetical",
      "http://spyre.com/role/LicensingAgreementsDetails",
      "http://spyre.com/role/RelatedPartyTransactionsExpensesrelatedtoRelatedPartywhichwereSettledinCashDetails",
      "http://spyre.com/role/RelatedPartyTransactionsNarrativeDetails",
      "http://spyre.com/role/RelatedPartyTransactionsRelatedPartyAccountsPayableDetails",
      "http://spyre.com/role/SegmentReportingSummaryofSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party",
        "label": "Related Party [Member]",
        "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family."
       }
      }
     },
     "auth_ref": [
      "r140",
      "r141",
      "r425",
      "r426",
      "r427",
      "r428",
      "r470",
      "r478",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r560",
      "r562",
      "r591"
     ]
    },
    "us-gaap_RelatedPartyTransactionAmountsOfTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionAmountsOfTransaction",
     "crdr": "debit",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofOperationsParenthetical",
      "http://spyre.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount of related party transaction",
        "label": "Related Party Transaction, Amounts of Transaction",
        "documentation": "Amount of transactions with related party during the financial reporting period."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r425"
     ]
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionAxis",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofOperationsParenthetical",
      "http://spyre.com/role/LicensingAgreementsDetails",
      "http://spyre.com/role/RelatedPartyTransactionsExpensesrelatedtoRelatedPartywhichwereSettledinCashDetails",
      "http://spyre.com/role/RelatedPartyTransactionsNarrativeDetails",
      "http://spyre.com/role/RelatedPartyTransactionsRelatedPartyAccountsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Axis]",
        "label": "Related Party Transaction [Axis]",
        "documentation": "Information by type of related party transaction."
       }
      }
     },
     "auth_ref": [
      "r425",
      "r426",
      "r842"
     ]
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionDomain",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofOperationsParenthetical",
      "http://spyre.com/role/LicensingAgreementsDetails",
      "http://spyre.com/role/RelatedPartyTransactionsExpensesrelatedtoRelatedPartywhichwereSettledinCashDetails",
      "http://spyre.com/role/RelatedPartyTransactionsNarrativeDetails",
      "http://spyre.com/role/RelatedPartyTransactionsRelatedPartyAccountsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Domain]",
        "label": "Related Party Transaction [Domain]",
        "documentation": "Transaction between related party."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://spyre.com/role/LicensingAgreementsDetails",
      "http://spyre.com/role/RelatedPartyTransactionsExpensesrelatedtoRelatedPartywhichwereSettledinCashDetails",
      "http://spyre.com/role/RelatedPartyTransactionsNarrativeDetails",
      "http://spyre.com/role/RelatedPartyTransactionsRelatedPartyAccountsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Line Items]",
        "label": "Related Party Transaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r210",
      "r567",
      "r568",
      "r571"
     ]
    },
    "syre_RelatedPartyTransactionNumberOfBoardSeats": {
     "xbrltype": "integerItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "RelatedPartyTransactionNumberOfBoardSeats",
     "presentation": [
      "http://spyre.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of board seats held by related party",
        "label": "Related Party Transaction, Number Of Board Seats",
        "documentation": "Related Party Transaction, Number Of Board Seats"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transactions [Abstract]",
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets",
      "http://spyre.com/role/CondensedConsolidatedStatementsofOperations",
      "http://spyre.com/role/CondensedConsolidatedStatementsofOperationsParenthetical",
      "http://spyre.com/role/LicensingAgreementsDetails",
      "http://spyre.com/role/RelatedPartyTransactionsExpensesrelatedtoRelatedPartywhichwereSettledinCashDetails",
      "http://spyre.com/role/RelatedPartyTransactionsNarrativeDetails",
      "http://spyre.com/role/RelatedPartyTransactionsRelatedPartyAccountsPayableDetails",
      "http://spyre.com/role/SegmentReportingSummaryofSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related and Nonrelated Parties [Axis]",
        "label": "Related and Nonrelated Parties [Axis]",
        "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r210",
      "r319",
      "r425",
      "r426",
      "r470",
      "r478",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r560",
      "r562",
      "r591",
      "r842"
     ]
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://spyre.com/role/RelatedPartyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transactions",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r422",
      "r423",
      "r424",
      "r426",
      "r429",
      "r517",
      "r518",
      "r519",
      "r569",
      "r570",
      "r571",
      "r589",
      "r590"
     ]
    },
    "syre_ReportableSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "ReportableSegmentMember",
     "presentation": [
      "http://spyre.com/role/SegmentReportingSummaryofSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reportable Segment",
        "label": "Reportable Segment [Member]",
        "documentation": "Reportable Segment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://spyre.com/role/SegmentReportingSummaryofSignificantSegmentExpensesDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://spyre.com/role/SegmentReportingSummaryofSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development, excluding compensation and share-based compensation",
        "label": "Research and Development Expense",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r358",
      "r608",
      "r620",
      "r851"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
     "crdr": "debit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofOperations",
      "http://spyre.com/role/RelatedPartyTransactionsExpensesrelatedtoRelatedPartywhichwereSettledinCashDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "label": "Research and Development Expense (Excluding Acquired in Process Cost)",
        "documentation": "Amount of expense for research and development. Excludes cost for computer software product to be sold, leased, or otherwise marketed, writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both, and write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r821"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofOperationsParenthetical",
      "http://spyre.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and Development Expense",
        "label": "Research and Development Expense [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date:",
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r668",
      "r678",
      "r688",
      "r720"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date",
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r669",
      "r679",
      "r689",
      "r721"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement does not require Recovery",
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r676",
      "r686",
      "r696",
      "r728"
     ]
    },
    "us-gaap_RestrictedCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedCash",
     "crdr": "debit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash",
        "label": "Restricted Cash",
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r756",
      "r765",
      "r852",
      "r854"
     ]
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "presentation": [
      "http://spyre.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents [Domain]",
        "label": "Cash and Cash Equivalents [Domain]",
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://spyre.com/role/NetLossPerShareWeightedAverageEquityInstrumentsExcludedfromCalculationofDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Unvested restricted stock units",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets",
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated deficit",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r84",
      "r476",
      "r505",
      "r507",
      "r516",
      "r544",
      "r648"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofChangesinConvertiblePreferredStockandStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Deficit",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r143",
      "r144",
      "r145",
      "r147",
      "r152",
      "r154",
      "r156",
      "r245",
      "r246",
      "r276",
      "r361",
      "r362",
      "r364",
      "r365",
      "r366",
      "r368",
      "r369",
      "r370",
      "r375",
      "r377",
      "r378",
      "r380",
      "r382",
      "r419",
      "r420",
      "r502",
      "r504",
      "r520",
      "r886"
     ]
    },
    "syre_RoyaltyStepDownPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "RoyaltyStepDownPercent",
     "presentation": [
      "http://spyre.com/role/LicensingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalty step-down percentage",
        "label": "Royalty Step-Down, Percent",
        "documentation": "Royalty Step-Down, Percent"
       }
      }
     },
     "auth_ref": []
    },
    "syre_RoyaltyTermExpirationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "RoyaltyTermExpirationPeriod",
     "presentation": [
      "http://spyre.com/role/LicensingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalty term expiration period",
        "label": "Royalty Term, Expiration Period",
        "documentation": "Royalty Term, Expiration Period"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Adopted",
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r737"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Terminated",
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r737"
     ]
    },
    "syre_SPY002LicenseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "SPY002LicenseAgreementMember",
     "presentation": [
      "http://spyre.com/role/LicensingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SPY002 License Agreement",
        "label": "SPY002 License Agreement [Member]",
        "documentation": "SPY002 License Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "syre_SPY003LicenseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "SPY003LicenseAgreementMember",
     "presentation": [
      "http://spyre.com/role/LicensingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SPY003 License Agreement",
        "label": "SPY003 License Agreement [Member]",
        "documentation": "SPY003 License Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "syre_SaleOfStockAggregateOfferingPrice": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "SaleOfStockAggregateOfferingPrice",
     "crdr": "credit",
     "presentation": [
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails",
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of stock, aggregate offering price",
        "label": "Sale of Stock, Aggregate Offering Price",
        "documentation": "Sale of Stock, Aggregate Offering Price"
       }
      }
     },
     "auth_ref": []
    },
    "syre_SaleOfStockAuthorizedAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "SaleOfStockAuthorizedAmount",
     "crdr": "credit",
     "presentation": [
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails",
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of stock, authorized amount",
        "label": "Sale of Stock, Authorized Amount",
        "documentation": "Sale of Stock, Authorized Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "crdr": "debit",
     "presentation": [
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails",
      "http://spyre.com/role/StockBasedCompensationNarrativeDetails",
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of stock, proceeds received",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "documentation": "Cash received on stock transaction after deduction of issuance costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails",
      "http://spyre.com/role/StockBasedCompensationNarrativeDetails",
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock [Domain]",
        "label": "Sale of Stock [Domain]",
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails",
      "http://spyre.com/role/StockBasedCompensationNarrativeDetails",
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares of common stock sold (in shares)",
        "verboseLabel": "Number of shares sold (in shares)",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails",
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of stock, price per share (in dollars per share)",
        "label": "Sale of Stock, Price Per Share",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "syre_SaleOfStockRemainingAuthorizedAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "SaleOfStockRemainingAuthorizedAmount",
     "crdr": "credit",
     "presentation": [
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails",
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of stock, remaining authorized amount",
        "label": "Sale of Stock, Remaining Authorized Amount",
        "documentation": "Sale of Stock, Remaining Authorized Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://spyre.com/role/AccruedandOtherCurrentLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued and Other Current Liabilities",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of accrued liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://spyre.com/role/NetLossPerShareWeightedAverageEquityInstrumentsExcludedfromCalculationofDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]",
        "label": "Antidilutive Security, Excluded EPS Calculation [Table]",
        "documentation": "Disclosure of information about security that could potentially dilute basic earnings per share (EPS) in future that was not included in calculation of diluted EPS."
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://spyre.com/role/NetLossPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-Average Equity Instruments Excluded from Calculation of Diluted Net Loss Per Share",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "presentation": [
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails",
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesEstimatedFairValueofCashEquivalentsandMarketableSecuritiesandtheGrossUnrealizedGainsandLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Securities, Available-for-Sale [Line Items]",
        "label": "Debt Securities, Available-for-Sale [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224"
     ]
    },
    "syre_ScheduleOfBalancesDueToAffiliatesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "ScheduleOfBalancesDueToAffiliatesTableTextBlock",
     "presentation": [
      "http://spyre.com/role/RelatedPartyTransactionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Accounts Payable",
        "label": "Schedule Of Balances Due To Affiliates [Table Text Block]",
        "documentation": "Schedule of balances due to affiliates."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
     "presentation": [
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated Fair Value of Cash Equivalents and Marketable Securities and the Gross Unrealized Gains and Losses",
        "label": "Cash, Cash Equivalents and Investments [Table Text Block]",
        "documentation": "Tabular disclosure of the components of cash, cash equivalents, and investments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "presentation": [
      "http://spyre.com/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-Based Compensation Expense",
        "label": "Share-Based Payment Arrangement, Cost by Plan [Table Text Block]",
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEarningsPerShareBasicByCommonClassTable",
     "presentation": [
      "http://spyre.com/role/NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earnings Per Share, Basic, by Common Class, Including Two-Class Method [Table]",
        "label": "Earnings Per Share, Basic, by Common Class, Including Two-Class Method [Table]",
        "documentation": "Disclosure of information about basic earnings per share by class of stock. Includes, but is not limited to, two-class method."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r26",
      "r160",
      "r164",
      "r166"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "presentation": [
      "http://spyre.com/role/StockBasedCompensationAssumptionsusedtoEstimatetheFairValueofStockOptionsGrantedDetails",
      "http://spyre.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "presentation": [
      "http://spyre.com/role/FairValueMeasurementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Assets and Liabilities Measured at Fair Value on Recurring Basis",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r825",
      "r826"
     ]
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "presentation": [
      "http://spyre.com/role/LicensingAgreementsDetails",
      "http://spyre.com/role/RelatedPartyTransactionsExpensesrelatedtoRelatedPartywhichwereSettledinCashDetails",
      "http://spyre.com/role/RelatedPartyTransactionsNarrativeDetails",
      "http://spyre.com/role/RelatedPartyTransactionsRelatedPartyAccountsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Table]",
        "label": "Related Party Transaction [Table]",
        "documentation": "Disclosure of information about related party transaction."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r45",
      "r567",
      "r568",
      "r571"
     ]
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock",
     "presentation": [
      "http://spyre.com/role/RelatedPartyTransactionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expenses related to Related Party which were Settled in Cash",
        "label": "Schedule of Related Party Transactions [Table Text Block]",
        "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock",
     "presentation": [
      "http://spyre.com/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Awards Granted",
        "label": "Schedule of Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value [Table Text Block]",
        "documentation": "Tabular disclosure of the total intrinsic value of options exercised (or share units converted), share-based liabilities paid, and the total fair value of shares vested during the year."
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://spyre.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r322",
      "r323",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://spyre.com/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assumptions used to Estimate the Fair Value of Stock Options Granted",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfStockByClassTable",
     "presentation": [
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock, Class of Stock [Table]",
        "label": "Stock, Class of Stock [Table]",
        "documentation": "Disclosure of information about stock by class. Includes, but is not limited to, common, convertible, and preferred stocks."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r80",
      "r82",
      "r83",
      "r84",
      "r117",
      "r118",
      "r119",
      "r176",
      "r302",
      "r303",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r512",
      "r513",
      "r514",
      "r515",
      "r630",
      "r748",
      "r766"
     ]
    },
    "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
     "presentation": [
      "http://spyre.com/role/NetLossPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation of Basic and Diluted Net Loss Per Share",
        "label": "Schedule of Weighted Average Number of Shares [Table Text Block]",
        "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit)."
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://spyre.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r662"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://spyre.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r664"
     ]
    },
    "us-gaap_SegmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentDomain",
     "presentation": [
      "http://spyre.com/role/SegmentReportingSummaryofSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Domain]",
        "label": "Segments [Domain]",
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r96",
      "r97",
      "r98",
      "r174",
      "r179",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r204",
      "r205",
      "r206",
      "r209",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r275",
      "r281",
      "r282",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r617",
      "r620",
      "r621",
      "r627",
      "r651",
      "r855",
      "r857",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://spyre.com/role/SegmentReporting"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r98",
      "r174",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r194",
      "r196",
      "r197",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r616",
      "r618",
      "r619",
      "r620",
      "r622",
      "r623",
      "r624"
     ]
    },
    "us-gaap_SegmentReportingOtherItemAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingOtherItemAmount",
     "crdr": "debit",
     "calculation": {
      "http://spyre.com/role/SegmentReportingSummaryofSignificantSegmentExpensesDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://spyre.com/role/SegmentReportingSummaryofSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other segment items",
        "label": "Segment Reporting, Other Segment Item, Amount",
        "documentation": "Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss)."
       }
      }
     },
     "auth_ref": [
      "r174",
      "r196",
      "r197",
      "r204",
      "r620"
     ]
    },
    "us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingOtherSignificantReconcilingItemLineItems",
     "presentation": [
      "http://spyre.com/role/SegmentReportingSummaryofSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment, Reconciliation of Other Items from Segments to Consolidated [Line Items]",
        "label": "Segment, Reconciliation of Other Items from Segments to Consolidated [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "syre_SeriesANonVotingConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "SeriesANonVotingConvertiblePreferredStockMember",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets",
      "http://spyre.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://spyre.com/role/CondensedConsolidatedStatementsofChangesinConvertiblePreferredStockandStockholdersEquity",
      "http://spyre.com/role/CondensedConsolidatedStatementsofOperations",
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails",
      "http://spyre.com/role/NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails",
      "http://spyre.com/role/NetLossPerShareWeightedAverageEquityInstrumentsExcludedfromCalculationofDilutedNetLossPerShareDetails",
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series A Non Voting Convertible Preferred Stock",
        "verboseLabel": "Series A Preferred Stock",
        "label": "Series A Non Voting Convertible Preferred Stock [Member]",
        "documentation": "Series A non voting convertible preferred stock."
       }
      }
     },
     "auth_ref": []
    },
    "syre_SeriesBNonVotingConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "SeriesBNonVotingConvertiblePreferredStockMember",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets",
      "http://spyre.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://spyre.com/role/CondensedConsolidatedStatementsofChangesinConvertiblePreferredStockandStockholdersEquity",
      "http://spyre.com/role/CondensedConsolidatedStatementsofOperations",
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails",
      "http://spyre.com/role/NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails",
      "http://spyre.com/role/NetLossPerShareWeightedAverageEquityInstrumentsExcludedfromCalculationofDilutedNetLossPerShareDetails",
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series B Non Voting Convertible Preferred Stock",
        "verboseLabel": "Series B Preferred Stock",
        "label": "Series B Non Voting Convertible Preferred Stock [Member]",
        "documentation": "Series B Non Voting Convertible Preferred Stock"
       }
      }
     },
     "auth_ref": []
    },
    "syre_ServiceBasedAwardsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "ServiceBasedAwardsMember",
     "presentation": [
      "http://spyre.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Service Based Awards",
        "label": "Service Based Awards [Member]",
        "documentation": "Service-based awards."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://spyre.com/role/SegmentReportingSummaryofSignificantSegmentExpensesDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://spyre.com/role/RelatedPartyTransactionsNarrativeDetails",
      "http://spyre.com/role/SegmentReportingSummaryofSignificantSegmentExpensesDetails",
      "http://spyre.com/role/StockBasedCompensationNarrativeDetails",
      "http://spyre.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "verboseLabel": "Share-based compensation",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "syre_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://spyre.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional number of shares available for issuance (in shares)",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Additional Number Of Shares Available For Grant",
        "documentation": "Share-based compensation arrangement by share-based payment award, additional number of shares available for grant."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://spyre.com/role/RelatedPartyTransactionsNarrativeDetails",
      "http://spyre.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vest period grant date",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r635"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice",
     "presentation": [
      "http://spyre.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price",
        "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://spyre.com/role/StockBasedCompensationAssumptionsusedtoEstimatetheFairValueofStockOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividend yield",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r348"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://spyre.com/role/StockBasedCompensationAssumptionsusedtoEstimatetheFairValueofStockOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected volatility",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r347"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://spyre.com/role/StockBasedCompensationAssumptionsusedtoEstimatetheFairValueofStockOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk-free interest",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r349"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://spyre.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r322",
      "r323",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://spyre.com/role/RelatedPartyTransactionsNarrativeDetails",
      "http://spyre.com/role/StockBasedCompensationStockAwardsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options granted (in shares)",
        "verboseLabel": "Grants (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r332"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://spyre.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding option awards (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r328",
      "r329"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease",
     "presentation": [
      "http://spyre.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares subject to options outstanding (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Period Increase (Decrease)",
        "documentation": "The increase or decrease in number of shares reserved for issuance under stock option agreements awarded under the plan that validly exist and are outstanding, including vested options."
       }
      }
     },
     "auth_ref": [
      "r801"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "presentation": [
      "http://spyre.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares issued (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period",
        "documentation": "Number of shares issued under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://spyre.com/role/StockBasedCompensationNarrativeDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Domain]",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://spyre.com/role/StockBasedCompensationStockAwardsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Grant Date Fair Value (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r332"
     ]
    },
    "us-gaap_ShareBasedCompensationAwardTrancheOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationAwardTrancheOneMember",
     "presentation": [
      "http://spyre.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-Based Payment Arrangement, Tranche One",
        "label": "Share-Based Payment Arrangement, Tranche One [Member]",
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period."
       }
      }
     },
     "auth_ref": []
    },
    "syre_ShareBasedPaymentArrangementSettlementOptionsCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "ShareBasedPaymentArrangementSettlementOptionsCash",
     "crdr": "debit",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofChangesinConvertiblePreferredStockandStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Cash settlement of stock option award",
        "label": "Share-Based Payment Arrangement, Settlement, Options, Cash",
        "documentation": "Share-Based Payment Arrangement, Settlement, Options, Cash"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "presentation": [
      "http://spyre.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting percentage",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage",
        "documentation": "Percentage of vesting of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r795"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "presentation": [
      "http://spyre.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based payment award, term",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r636"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://spyre.com/role/StockBasedCompensationAssumptionsusedtoEstimatetheFairValueofStockOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected term (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r346"
     ]
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://spyre.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Significant Accounting Policies",
        "label": "Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r138"
     ]
    },
    "syre_Spy001LicenseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "Spy001LicenseAgreementMember",
     "presentation": [
      "http://spyre.com/role/LicensingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SPY001 License Agreement",
        "label": "SPY001 License Agreement [Member]",
        "documentation": "SPY001 License Agreement."
       }
      }
     },
     "auth_ref": []
    },
    "syre_Spyre2023EquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "Spyre2023EquityIncentivePlanMember",
     "presentation": [
      "http://spyre.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Spyre 2023 Equity Incentive Plan",
        "label": "Spyre 2023 Equity Incentive Plan [Member]",
        "documentation": "Spyre 2023 equity incentive plan."
       }
      }
     },
     "auth_ref": []
    },
    "syre_SpyreTherapeuticsIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "SpyreTherapeuticsIncMember",
     "presentation": [
      "http://spyre.com/role/FairValueMeasurementsNarrativeDetails",
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Spyre Therapeutics, Inc.",
        "label": "Spyre Therapeutics, Inc. [Member]",
        "documentation": "Spyre Therapeutics, Inc."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementBusinessSegmentsAxis",
     "presentation": [
      "http://spyre.com/role/SegmentReportingSummaryofSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Axis]",
        "label": "Segments [Axis]",
        "documentation": "Information by business segments."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r96",
      "r97",
      "r98",
      "r110",
      "r174",
      "r179",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r204",
      "r205",
      "r206",
      "r209",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r275",
      "r278",
      "r281",
      "r282",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r617",
      "r620",
      "r621",
      "r627",
      "r651",
      "r855",
      "r857",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets",
      "http://spyre.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://spyre.com/role/CondensedConsolidatedStatementsofChangesinConvertiblePreferredStockandStockholdersEquity",
      "http://spyre.com/role/CondensedConsolidatedStatementsofOperations",
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails",
      "http://spyre.com/role/NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails",
      "http://spyre.com/role/StockBasedCompensationNarrativeDetails",
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Axis]",
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r117",
      "r118",
      "r119",
      "r139",
      "r160",
      "r164",
      "r166",
      "r168",
      "r176",
      "r177",
      "r244",
      "r288",
      "r291",
      "r292",
      "r293",
      "r297",
      "r298",
      "r302",
      "r303",
      "r306",
      "r307",
      "r309",
      "r408",
      "r512",
      "r513",
      "r514",
      "r515",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r543",
      "r564",
      "r586",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r748",
      "r766",
      "r774"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofChangesinConvertiblePreferredStockandStockholdersEquity",
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails",
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components [Axis]",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r57",
      "r60",
      "r61",
      "r109",
      "r129",
      "r130",
      "r131",
      "r143",
      "r144",
      "r145",
      "r147",
      "r152",
      "r154",
      "r156",
      "r175",
      "r245",
      "r246",
      "r276",
      "r311",
      "r361",
      "r362",
      "r364",
      "r365",
      "r366",
      "r368",
      "r369",
      "r370",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r382",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r481",
      "r502",
      "r503",
      "r504",
      "r520",
      "r586"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets",
      "http://spyre.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://spyre.com/role/CondensedConsolidatedStatementsofChangesinConvertiblePreferredStockandStockholdersEquity",
      "http://spyre.com/role/CondensedConsolidatedStatementsofOperations",
      "http://spyre.com/role/CondensedConsolidatedStatementsofOperationsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r143",
      "r144",
      "r145",
      "r175",
      "r420",
      "r462",
      "r511",
      "r531",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r543",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r562",
      "r565",
      "r566",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r586",
      "r655"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Cash Flows [Abstract]",
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Financial Position [Abstract]",
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Comprehensive Income [Abstract]",
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Stockholders' Equity [Abstract]",
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets",
      "http://spyre.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://spyre.com/role/CondensedConsolidatedStatementsofChangesinConvertiblePreferredStockandStockholdersEquity",
      "http://spyre.com/role/CondensedConsolidatedStatementsofOperations",
      "http://spyre.com/role/CondensedConsolidatedStatementsofOperationsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r143",
      "r144",
      "r145",
      "r175",
      "r210",
      "r420",
      "r462",
      "r511",
      "r531",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r543",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r562",
      "r565",
      "r566",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r586",
      "r655"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Price or TSR Estimation Method",
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r671",
      "r681",
      "r691",
      "r723"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "presentation": [
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails",
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares converted (in shares)",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r33",
      "r57",
      "r60",
      "r84",
      "r300"
     ]
    },
    "syre_StockIssuedDuringPeriodSharesExchangeOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "StockIssuedDuringPeriodSharesExchangeOfConvertibleSecurities",
     "presentation": [
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails",
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exchange of Series A non-voting convertible preferred stock into common stock (in shares)",
        "label": "Stock Issued During Period, Shares, Exchange of Convertible Securities",
        "documentation": "Stock Issued During Period, Shares, Exchange of Convertible Securities"
       }
      }
     },
     "auth_ref": []
    },
    "syre_StockIssuedDuringPeriodSharesOptionsExercisedAndEmployeeStockOwnershipPlan": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "StockIssuedDuringPeriodSharesOptionsExercisedAndEmployeeStockOwnershipPlan",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofChangesinConvertiblePreferredStockandStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock in connection with exercise of stock options and employee stock purchase plan (in shares)",
        "label": "Stock Issued During Period, Shares, Options Exercised And Employee Stock Ownership Plan",
        "documentation": "Stock Issued During Period, Shares, Options Exercised And Employee Stock Ownership Plan"
       }
      }
     },
     "auth_ref": []
    },
    "syre_StockIssuedDuringPeriodValueOptionsExercisedAndEmployeeStockOwnershipPlan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "StockIssuedDuringPeriodValueOptionsExercisedAndEmployeeStockOwnershipPlan",
     "crdr": "credit",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofChangesinConvertiblePreferredStockandStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock in connection with exercise of stock options and employee stock purchase plan",
        "label": "Stock Issued During Period, Value, Options Exercised And Employee Stock Ownership Plan",
        "documentation": "Stock Issued During Period, Value, Options Exercised And Employee Stock Ownership Plan"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "crdr": "credit",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofChangesinConvertiblePreferredStockandStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation expense",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r56",
      "r57",
      "r84"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets",
      "http://spyre.com/role/CondensedConsolidatedStatementsofChangesinConvertiblePreferredStockandStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL STOCKHOLDERS\u2019 EQUITY",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r60",
      "r61",
      "r78",
      "r545",
      "r561",
      "r587",
      "r588",
      "r648",
      "r661",
      "r767",
      "r788",
      "r840",
      "r886"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "STOCKHOLDERS\u2019 EQUITY",
        "label": "Equity, Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "syre_SublicensingFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "SublicensingFee",
     "crdr": "debit",
     "presentation": [
      "http://spyre.com/role/LicensingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sublicensing fee",
        "label": "Sublicensing Fee",
        "documentation": "Sublicensing Fee"
       }
      }
     },
     "auth_ref": []
    },
    "syre_SublicensingFeeOutstandingAndPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "SublicensingFeeOutstandingAndPayable",
     "crdr": "credit",
     "presentation": [
      "http://spyre.com/role/LicensingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sublicensing fee, outstanding and payable",
        "label": "Sublicensing Fee, Outstanding And Payable",
        "documentation": "Sublicensing Fee, Outstanding And Payable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails",
      "http://spyre.com/role/StockBasedCompensationNarrativeDetails",
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock [Axis]",
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tabular List, Table",
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r717"
     ]
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "crdr": "credit",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofChangesinConvertiblePreferredStockandStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Temporary Equity, Carrying Amount, Attributable to Parent",
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r288",
      "r291",
      "r292",
      "r293",
      "r297",
      "r298",
      "r355",
      "r474"
     ]
    },
    "us-gaap_TemporaryEquityParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityParOrStatedValuePerShare",
     "presentation": [
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series B non-voting convertible preferred stock, par value (in dollars per share)",
        "label": "Temporary Equity, Par or Stated Value Per Share",
        "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r30"
     ]
    },
    "us-gaap_TemporaryEquitySharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquitySharesOutstanding",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofChangesinConvertiblePreferredStockandStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance (in shares)",
        "periodEndLabel": "Ending balance (in shares)",
        "label": "Temporary Equity, Shares Outstanding",
        "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "syre_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "TemporaryEquityStockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofChangesinConvertiblePreferredStockandStockholdersEquity",
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails",
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Issuance of Series A/B non-voting convertible preferred stock in connection with private placement, net of financing costs (in shares)",
        "terseLabel": "Issuance of non-voting convertible preferred stock (in shares)",
        "label": "Temporary Equity, Stock Issued During Period, Shares, New Issues",
        "documentation": "Temporary Equity, Stock Issued During Period, Shares, New Issues"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityStockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofChangesinConvertiblePreferredStockandStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of Series A/B non-voting convertible preferred stock in connection with private placement, net of financing costs",
        "label": "Temporary Equity, Stock Issued During Period, Value, New Issues",
        "documentation": "Value of new stock classified as temporary equity issued during the period."
       }
      }
     },
     "auth_ref": []
    },
    "syre_TerminationNoticePeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "TerminationNoticePeriod",
     "presentation": [
      "http://spyre.com/role/LicensingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination notice period",
        "label": "Termination Notice Period",
        "documentation": "Termination Notice Period"
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://spyre.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title and Position [Axis]",
        "label": "Title and Position [Axis]"
       }
      }
     },
     "auth_ref": [
      "r781",
      "r841"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://spyre.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title and Position [Domain]",
        "label": "Title and Position [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Amount",
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r709"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Vs Peer Group",
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r716"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangement:",
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r736"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangements, by Individual",
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r738"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://spyre.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails",
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesEstimatedFairValueofCashEquivalentsandMarketableSecuritiesandtheGrossUnrealizedGainsandLossesDetails",
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesNarrativeDetails",
      "http://spyre.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://spyre.com/role/FairValueMeasurementsSignificantInputsusedtoEstimatetheFairValueofDerivativeLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instruments [Domain]",
        "label": "Financial Instruments [Domain]",
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r301",
      "r308",
      "r381",
      "r407",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r482",
      "r638",
      "r639",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r649",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r784",
      "r785",
      "r786",
      "r787",
      "r824",
      "r827",
      "r828",
      "r829",
      "r836",
      "r839"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adoption Date",
        "label": "Trading Arrangement Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r739"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Arrangement Duration",
        "label": "Trading Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r740"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration Date",
        "label": "Trading Arrangement Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r740"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r738"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title",
        "label": "Trading Arrangement, Individual Title"
       }
      }
     },
     "auth_ref": [
      "r738"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Available",
        "label": "Trading Arrangement, Securities Aggregate Available Amount"
       }
      }
     },
     "auth_ref": [
      "r741"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination Date",
        "label": "Trading Arrangement Termination Date"
       }
      }
     },
     "auth_ref": [
      "r739"
     ]
    },
    "syre_TwoThousandAndEighteenEquityInducementPlanAmendedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "TwoThousandAndEighteenEquityInducementPlanAmendedMember",
     "presentation": [
      "http://spyre.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2018 Equity Inducement Plan, Amended",
        "label": "Two Thousand And Eighteen Equity Inducement Plan, Amended [Member]",
        "documentation": "Two Thousand And Eighteen Equity Inducement Plan, Amended"
       }
      }
     },
     "auth_ref": []
    },
    "syre_TwoThousandAndEighteenEquityInducementPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "TwoThousandAndEighteenEquityInducementPlanMember",
     "presentation": [
      "http://spyre.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2018 Equity Inducement Plan",
        "label": "Two Thousand And Eighteen Equity Inducement Plan [Member]",
        "documentation": "2018 equity inducement plan."
       }
      }
     },
     "auth_ref": []
    },
    "syre_TwoThousandAndFifteenAndTwoThousandAndSixteenEquityIncentivePlanAndTwoThousandAndEighteenEquityInducementPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "TwoThousandAndFifteenAndTwoThousandAndSixteenEquityIncentivePlanAndTwoThousandAndEighteenEquityInducementPlanMember",
     "presentation": [
      "http://spyre.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2015 and 2016 and 2018 Equity Inducement Plan",
        "label": "Two Thousand And Fifteen And Two Thousand And Sixteen Equity Incentive Plan And Two Thousand And Eighteen Equity Inducement Plan [Member]",
        "documentation": "Two thousand and fifteen and two thousand and sixteen equity incentive plan and two thousand and eighteen equity inducement plan."
       }
      }
     },
     "auth_ref": []
    },
    "syre_TwoThousandAndFifteenEquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "TwoThousandAndFifteenEquityIncentivePlanMember",
     "presentation": [
      "http://spyre.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2015 Equity Incentive Plan",
        "label": "Two Thousand And Fifteen Equity Incentive Plan [Member]",
        "documentation": "Two thousand and fifteen equity incentive plan."
       }
      }
     },
     "auth_ref": []
    },
    "syre_TwoThousandAndSixteenEmployeeStockPurchasePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "TwoThousandAndSixteenEmployeeStockPurchasePlanMember",
     "presentation": [
      "http://spyre.com/role/StockBasedCompensationAssumptionsusedtoEstimatetheFairValueofStockOptionsGrantedDetails",
      "http://spyre.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2016 Employee Stock Purchase Plan",
        "verboseLabel": "2016 ESPP",
        "label": "Two Thousand And Sixteen Employee Stock Purchase Plan [Member]",
        "documentation": "Two thousand and sixteen employee stock purchase plan."
       }
      }
     },
     "auth_ref": []
    },
    "syre_TwoThousandAndSixteenEquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "TwoThousandAndSixteenEquityIncentivePlanMember",
     "presentation": [
      "http://spyre.com/role/StockBasedCompensationAssumptionsusedtoEstimatetheFairValueofStockOptionsGrantedDetails",
      "http://spyre.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2016 Equity Incentive Plan",
        "verboseLabel": "Stock Options Granted",
        "label": "Two Thousand And Sixteen Equity Incentive Plan [Member]",
        "documentation": "Two thousand and sixteen equity incentive plan."
       }
      }
     },
     "auth_ref": []
    },
    "syre_USBankingInstitutionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "USBankingInstitutionMember",
     "presentation": [
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "U.S. Banking Institution",
        "label": "U.S. Banking Institution [Member]",
        "documentation": "U.S. Banking Institution [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "presentation": [
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "US Government Agencies Debt Securities",
        "label": "US Government Agencies Debt Securities [Member]",
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB)."
       }
      }
     },
     "auth_ref": [
      "r612",
      "r631",
      "r853"
     ]
    },
    "us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "USGovernmentCorporationsAndAgenciesSecuritiesMember",
     "presentation": [
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails",
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesEstimatedFairValueofCashEquivalentsandMarketableSecuritiesandtheGrossUnrealizedGainsandLossesDetails",
      "http://spyre.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "U.S. government agency securities",
        "verboseLabel": "U.S. government agency securities",
        "label": "US Government Corporations and Agencies Securities [Member]",
        "documentation": "This category includes information about debt issued by US Government Corporations and Agencies. Investments in such US Government Corporations may include debt securities issued by the Government National Mortgage Association (Ginnie Mae) and by the Federal National Mortgage Association (Fannie Mae) and the Federal Home Loan Mortgage Corporation (Freddie Mac)."
       }
      }
     },
     "auth_ref": [
      "r853"
     ]
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "USTreasurySecuritiesMember",
     "presentation": [
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails",
      "http://spyre.com/role/CashEquivalentsandMarketableSecuritiesEstimatedFairValueofCashEquivalentsandMarketableSecuritiesandtheGrossUnrealizedGainsandLossesDetails",
      "http://spyre.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "U.S. government treasury securities",
        "label": "US Treasury Securities [Member]",
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years)."
       }
      }
     },
     "auth_ref": [
      "r612",
      "r631",
      "r633",
      "r638",
      "r853"
     ]
    },
    "syre_UnderwrittenOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://spyre.com/20250331",
     "localname": "UnderwrittenOfferingMember",
     "presentation": [
      "http://spyre.com/role/ConvertiblePreferredStockandStockholdersEquityNarrativeDetails",
      "http://spyre.com/role/TheCompanyandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underwritten Offering",
        "label": "Underwritten Offering [Member]",
        "documentation": "Underwritten Offering"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Security Market Price Change",
        "label": "Underlying Security Market Price Change, Percent"
       }
      }
     },
     "auth_ref": [
      "r735"
     ]
    },
    "us-gaap_VestingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VestingAxis",
     "presentation": [
      "http://spyre.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting [Axis]",
        "label": "Vesting [Axis]",
        "documentation": "Information by vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r820"
     ]
    },
    "us-gaap_VestingDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VestingDomain",
     "presentation": [
      "http://spyre.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting [Domain]",
        "label": "Vesting [Domain]",
        "documentation": "Vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r820"
     ]
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year",
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r705"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "calculation": {
      "http://spyre.com/role/NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofOperations",
      "http://spyre.com/role/NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average common stock outstanding, diluted (in shares)",
        "totalLabel": "Total diluted weighed average shares (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r159",
      "r168"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesIssuedBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesIssuedBasic",
     "calculation": {
      "http://spyre.com/role/NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://spyre.com/role/NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted-average shares outstanding (in shares)",
        "label": "Weighted Average Number of Shares Issued, Basic",
        "documentation": "This element represents the weighted average total number of shares issued throughout the period including the first (beginning balance outstanding) and last (ending balance outstanding) day of the period before considering any reductions (for instance, shares held in treasury) to arrive at the weighted average number of shares outstanding. Weighted average relates to the portion of time within a reporting period that common shares have been issued and outstanding to the total time in that period. Such concept is used in determining the weighted average number of shares outstanding for purposes of calculating earnings per share (basic)."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r21"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "calculation": {
      "http://spyre.com/role/NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://spyre.com/role/CondensedConsolidatedStatementsofOperations",
      "http://spyre.com/role/NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average common stock outstanding, basic (in shares)",
        "totalLabel": "Total basic weighed average shares (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r158",
      "r168"
     ]
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested",
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r703"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(f)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-13"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481142/505-10-45-2"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-10"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-5"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-1"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205/tableOfContent"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481573/470-10-45-12A"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/810/tableOfContent"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-6"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-6"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-6"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-7"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "808",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "808",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "808",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/808/tableOfContent"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-11"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/260/tableOfContent"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-22"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-23"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-26"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-11"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-2"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-11"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-14"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479130/326-30-45-1"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-5"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-7"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.E.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481839/830-10-45-9"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482014/830-20-35-3"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-12"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/850/tableOfContent"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481444/860-30-45-1"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "940",
   "SubTopic": "820",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3A"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column J))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column K))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-1"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-2"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "8",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-8"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479081/326-30-55-8"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "101",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481395/860-30-55-4"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r749": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r750": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r751": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r752": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r753": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r754": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r755": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r756": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r757": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r758": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r759": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r760": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r761": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r762": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r763": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r764": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r765": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r766": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r767": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r768": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r769": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r770": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r771": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r772": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r773": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r774": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r775": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r776": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18"
  },
  "r777": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r778": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r779": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r780": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r781": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r782": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/320/tableOfContent"
  },
  "r783": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-11"
  },
  "r784": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9"
  },
  "r785": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r786": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r787": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r788": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r789": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r790": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r791": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r792": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r793": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r794": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r795": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r796": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r797": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r798": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r799": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r800": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r801": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r802": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r803": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r804": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r805": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r806": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r807": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r808": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r809": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r810": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r811": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r812": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r813": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r814": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r815": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r816": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r817": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r818": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r819": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r820": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r821": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r822": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "15",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480123/805-50-15-3"
  },
  "r823": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r824": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r825": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r826": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r827": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r828": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r829": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r830": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r831": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r832": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r833": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r834": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r835": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r836": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r837": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r838": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r839": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r840": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r841": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r842": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r843": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r844": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r845": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r846": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r847": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r848": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r849": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r850": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r851": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r852": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r853": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-2"
  },
  "r854": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r855": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r856": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r857": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r858": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r859": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r860": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r861": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r862": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r863": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r864": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r865": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r866": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r867": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r868": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r869": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r870": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r871": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r872": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r873": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r874": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r875": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r876": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r877": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r878": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r879": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r880": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r881": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r882": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r883": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r884": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r885": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r886": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r887": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r888": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>85
<FILENAME>0001636282-25-000049-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001636282-25-000049-xbrl.zip
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MB-4Q<>,O%[_+U49_U0KNAY55E^$PV[W\_S[H:Z#N6J.<0GD77BS $]ZOIHJ
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MOFP<#Y!GM/5)SWJ1!J9/UBIR@G5:^VV53WP%U/S&#Y).PX=0_P!02P,$%
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MP>D2G1$#5($*&40[)>Z]4O-?J2&+EC_)J=Y6ISX(1*00M6NWS&0V=='G$BO
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MB!7EV!;<!Q??=TGJ^OG@;@J>09Z6YN&4']R5U]_5M7W'_5SP/U!+ P04
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MJHM,L"@;O]GE*R__M)_Q/:3C\/[3_P%02P,$%     @ )("H6DS#6# Y$P(
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MSX<;)QU6+N#TOKOE>>0]O[FBLP@1YG.R, 0ZX^@\Z<AW 8T<@<XX.HL0_!:
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M]4W^%/5Q8X/5Q(D:HM40-EY!J*BE805:#[S6BI(4.ZWF--D4)%:J=*I*+9\
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M#9F:6E\VUM6Z.0&IZ+$X^W<R"<P$)2BV4EY6F=,*,%^=H&:GY%M&0&87<Z#
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M09>@ZW !SRUPJ_/N=(P.83?J>(K[\AGO;X;N#6$0S/Z//15X'Y>UV2.D#ST
M.WCE(WP17%F(+\3^Q3XCG@U=!CQI;3K0!VI=Z[?;[8XN*_UF?R##;YG^!VNY
MA0\-IR;N&%R#2M^AY&>%#&!8E\1\(Q,7[:HX-8 4<=*GI%I(H^[GOG/131I"
M[-%#$;B52."G\03 "[AVR)CZX+FZ90D4Z&H@'K>[5U-9NHK+TM-4@E#LKD ^
M'3J$=B ;TK=X42"^1O/AAT5\W6"+>J!AO:'MP^MT]^/*_B[CC)G_,WEG-0.@
MUR89N_0R^O$I<AT,B_6"/?0I?%FH)!#>B\%(I$YP>X;\:BU ?Q@+#;\<WJ["
MK8OEZZU&M=%L)MZJ5>7$ZZM>)=>J2E/-]*K5U^NU'#O5V/0J?IW(U7'MM<YP
M9ZE90E@LD*M]QL7:J83MF1DHWP,#Y08-%*:=F9$B@7VRMSC-+A2.A2LR%:_A
MD0%H_Z4)W>93EN44R%4O4NSP1'-Q1#W!W(?-X:()?_4$&Z*>H)"JLY*J@]03
M;(AZ@H7*A#D85H.C"[6YT$%TD"': 1^W.Q=:)'8?Q9CD]=" K[8#?UJ2YCL.
MM;2)Y&&@WF2'6TA$QT4A#&.)PS*S'Y8Y%_4+)HB0VE<AL>,+)9;^/*/\K\2P
M<#*!0;E NFO?@7\?8%2V#I/-_>"9O"=,)<U:J2O7Q8F:)P.R#6MN1T*9C!NN
MN$99 6>--5NX.9PU?E@.A0__177I!4 4&B02X'E$G)\T7 *@,*D8GD&70A:I
M!+M@9XL<8/:84?TWVT2B1 )\;SU-:9U1F!4\67?Y4#1Q; U'T-KC*<P'0IE:
MZC;;R^E2HL+%24>L@V.;YSW8'2+8X;*P"GS7;1]GF*C?YQV,RX<NA==[*=5>
M@L:;::YLH;MF<*BHTMI%L^V!EWR'S(48"S'.P7S)4XX;3(X;RBYG]'$MQYQ8
M.&FVAG"0XRF2:@],<#67I-JV2*H]JZ3:(;%>0"P-2^)W&-/B?0LUA-FV _9K
M"$XV==S__EM;D5N?I)L_?<.;<#J@[.G!J_J;)#/[>:P0Z<A*LZK(G5PR?^M5
MI99\)WLVLE)KY=*G9E56L[UI_WUJ5.M*7EG;>?6I7NW(==&GC7U2JZV.PEF?
M>,1XJ]IJMD6?4O"NLV&SQ"XI\XU6FET):X,7^[< MMVR($VW*TASZ?2SZCO)
ME1Q494TEAY1[/&*NM#SG2!<AFWYZ,!8S:>YLJ_)[4/(Y9C6R6QM.GUB_U6 %
M7<Z L%\$87,F[%50A&O/Q((7./;;TAKN-H0KA$KM0?<Q9D/,0SM]Z?KW0 R]
M<FOQV;DK,C9PC3%]T3<!RE2@U#1_Y+/R"GPRGB4O\-FUN84)/KL8+)<(H3DS
MH;FF T,S/*$M\_:*,,^%3Y;'0\S_X+.+21'O-8ZCO+7CF&HO=A$,\:!BY&X[
MUW/8MEX$4@7UIU*0ZCS((9 CD".04S#D[+E9T7*/%YF0G%+RA9C$TJ@K5:1K
MJE&LN!P%J=,4,>'RP+%T(\]:O;JY?C/*-$K*3,F$8M7+Z73-4E>M+^\0R_N<
MN"RL.DJ^:#I^%>AHDQT!F%16= /ZXOY+X"AD3NYLX:;89KFN+-<7YFG/XMZJ
MAV\YF_(.IA7:K)6[-FMCK>>C*[.T7#PE19=ZS$7";9(2W #:')1@I]3ME-6$
ML]^W4X$9=(I0CSRIQ_9ZI 5+O*MT8S;,M6K!(3H)A8V$\A3*,S?EN0'22<IS
M&:M8TV*YKMU)*D<A+&<L+)U]6QHM!22IK*KULJ((@1("=>("I=;RF'U4D)GV
M\@'$0EJ$M' O+9EV=ZMIJS3D,!'5P>5M*>5ZP@&>>196%3(E9.J8,]"&4\)R
M$*1&J=N06^5V+:_2DON4I@VKF<<OA"!:B59<E1([<C'L=!KQUG5]7,_'C?]S
MA\$;%NI#BP:*\LWPAA)]IXYFN*QM>&+\&.^Z;-,]'8U->T)I>&OL.]J00&,@
MHK557)*#<[C3T9"5&%"6M/4V@RQNQ<5,I"I^%4P!7$$D0:1ME\O4%:=>NQ.'
M!I8USDM4CY=!#=?-@AGG)IR*])ZEWX03#WON_LT"@WQHC!]@VDDRNINEKMS)
M9^%,Z.YBZNX3XDFF&)&:7>A^)Z9/=Y:Y5JFKJCNG2 @D">D6/!$\*8[&77$<
MP?X5;ILGA7N:^R 8(RI]$A0F'8VIY09G.]%W_$U/>R_$+D[1R1Q,M$\E7LR4
M> %<021!)*$"3U4%GA!/\H@<S*V%K[!E6=CN"YI)5S$K*?-:>:?4;9?;C>7(
MG0 51Z 2@BYX(GARD"#"X71ON\:7[CW-1(PKX@XEEWJ>R4YB6,RQD,@;<721
M1R&BD*<5&1; %4021!(J\(Q5X GQ)-N>E;7Y"%/3]8%,T"#J.0X>2X4_GZ96
M4KA0AK93DN&*FX\32HQP<CKRV:-%2+#@B>!)SEIU;<Y!'DI5X42IGF9:P5?;
M@3\M2?,=AUK:1/* 0ZX9I!80_0_?]9!'(KM 1!)/*[HK@"N()(@D5. 9JT#!
M$\$33A8=U0W5#]@Q47,',@5''X7FZU5HO3ZC\1I\KF?ISS-3]E=B6-]LUX51
MN4"[^,KE'?7N!\_D/<GWP'H^>15+$"@3DG\F/,DQW>!(@E_G2/!/,__@A^50
M^/!?5)=>@$<2P&1$G)_4(WV32B[5@%.>D>ZD$K'^=@91R9.)% O@"B()(@D5
M>,8J4/!$\(03_V/;R,/,?OW--I$JD:=Q;SU-C=>,7D>CU*VWVYQLHQ;8$O)>
M$)X<(-ZP#W%O\B3NIYG> .273.#22NORA*)N(A(J>"+2)40F@"!2\8DD5"!_
M*E#P1/!$\.2L>))M?U$CY9DXX)0$3B7ZCYEWQ[? :ZR76ZWE0]DRGX8C4'-\
MU*0]2&DWT+3Y <UIIC-\(28>:^%*%>D[<;2AI,IE2:GA6?5;1!["(8?GZP2T
M6SYB9Z?3H#B1E:R%W)MY'PO?[I2Z:KV94Q0N)XX=(#:<IBNICB8[ %:+=G)9
MSB0IDM@FV44;9';WD\TZ-4S7:Y;K2EXUB(LCQ[NN\8@Y9@FOK;SGF X6!EC>
MPGKJT,RAIV(&$C-0#C/0!HG.80922MU.6>V<W_R3LY"+J6NGJ:N]'NA7[,3%
M5?-61LBKI6ZS5E9:9^L[B8E-3&Q'GM@VR'O2Q+8LR+C9:3DP*(18"+$0XD,(
M<6?OUFD#)+RLUM6R6JN=G: +:172FI^TUFMY3+E-L)W;BA!%(8I"%+=?.Z^G
M73S/80IMX11:DUMEI;8<Y,E<C%"(K!#94Q'93+;NWDU=S'1I*^6F? *&[H94
M&=UPQR:9X!CI:LD6K42KHK82 B!:G74K(0"BU5FW$@(@6IUU*R$ HM59MQ("
M(%J==2LA *+56;<2 B!:G74K(0"BU5FW$@(@6IUU*R$ HM59MQ("(%J==2LA
M *+56;<2 B!:G74K(0"BU5FW$@(@6IUU*R$ HM59MQ("(%J==2LF !?LC&3X
MKVZ\=C_#/U'KV,XRC5H>=<)M@-W/?0<?#GX?ZS'<H6?H<DVI:VTZT =J7>NW
MV^V.+BO]9G\@PV^9_D>52PG?"G?25=B&N<N*K.)6NT])/0C/CPX>"S?G 6%-
M,G;I9?3C4T17PV+[&=E#GT;$>3&L:*<??F"QIC1^+[C]Z<W0O>&E7*M5:S6V
M"S)42^&7P]M5N'6Q?%UI5NMU-?%6K2HG7E_UJGI5J=<SO6GU=47.]L2J/C6K
M<J?%69\:5;4EZ+2Y3VI5E3O<]:FM9I.60^ )]!5G?6I5V_6LWS[//L$DM.E-
M?)FV:VME-EI+[1(J)P13Y"'K!;02ZP4\#QU*I>_0;NA*-Y9.]?DC$^HI3M4Z
M ">BVV'?507HOA5W.M-FL5H!\MI* 3RR[0F>HJ[T16+FW9UM57ZW/>BS=&5;
MK'-H=TUK8TNLE$.:\]$VTB0=4;$NR.(;3H'>O77T9K>.1_-B$C8H@KMO8L$+
M'/LM^*WL1KBU)6]2.&0'H6H/NH]55HB9V6$\2/\>B*%7;BT^.W=%QH9'3&F^
M=P*4.X-2T_R1;Q*/ZGPRGATWSF?7Y@Y!Y[.+P8%HT@<\$NVCD)TSDYUK.C T
MPQ-*,V__S/9XG<3C]>'^P6<7@[)UJ3%Y>$=6WMJ1392D347O>/0 @K,OLMG^
MV4XO.1E2]4:V;WDI2)6-'!N\]2)22H#JV* J*CD$<HZ&G*,T.^(R0MI3G?D]
M7?F::G34ITZT6J"FD9M5H]Y2&G@OO)Q\.%A=65]\^9F.QK9#G$E@PJ8ZV+)3
MZLJ-Y4K+N_ D4\'QC'P\B8KB6<=<).0F%?G/!MLKXC@3&'LP4_0\SS'Z/LOO
M>;8? -&6E[&DN%*KE;KM>KG1V/EPQ^Q:9V_5_=<(VQ8*-$=SGG>$KM"M:LYG
M!BLUN=2MJ\N'!@O5*E1K;JIU VIW/HX![#,P$$!Y=I2=C[\^6>5Y)AJR?K"C
M:96:6NJJS7*M(=2G4)][5)\;()WF*#BEAJ>O[GQ633&4HQ"6,Q:6QMYMC4:I
MVVJJ9;DC"W$2XG3BXM3,8^YI@IU4V_D84B$M0EIX/RFT=:B30I5:"Z>A>KDN
MUW<X)U3(E) ISF>@]MX-NG80/*K)S<).45RM]2X<Z<OG6N^MZ_JXV"O9 VFZ
MYPB&7'D-MK]HL>U&X^G6%Q?1)AD6WK9H@-XWPQM"$^.5>-#4)!H=4<LK2Q;U
M\.4#PX+O!*]TO53Y%UM0E'?)7A&MZR0+MSMQZ-)",9(>N4;U:]\!,CQ #VT]
MB.+=T3=VRTV2;UP]5I;-SSPXD1B35;)Q,G%6XIV?29IZ!3-7+?PG\_-W8OHT
MQLYLNERN :^;[7([(5M@NW.9.3@'/<OS:U9*^=<>__VWMB(K2RP2@KF25&>!
M:0%< 5S^@"MX(G@B>")X(G@B>,)-,.;XI0-%*]'JM%J=YEZ7>/Q3"TK5K QN
MTG?J:(;+V@:-[#'>=25BZ1(=C4U[0FEX:^P[VI"X+!1JY9$'Q_W<DW>R7ZII
M.H%(IS=-)R.A( FWYQ>#$Y@^64SS#]R,2T^-VIJEI[5K3??!W'<33HIZS])O
MPBF0/7?_9E'''1KC!Y@ D]8HY%*WT<II/4J(7#%%[H1XDF6-L"%GESJV(IA1
MZ#*N&BJE;KVL=O+*CQ= $\(O>")X4@"%+*_8+W%DA:P602%S%70J1-(=0T:E
M3P O&'0:4\LE#*+T'7_3TTZ.$UD"15[5$2E; M,"TT(9"^ 6%K@GQ),\@BYS
M6VA6F/DLY/D%#;:KF+V6V9ZOE[KMLMK>N;25 )40=,$3P9/B*-]5 98#*M]&
M$90O5\&40F3P?+4=^-.2--]QJ*5-),^!EYE!0(7H?_BNAQL110J." N?5JA>
MI. (3)\AI@5P!7#Y Z[@B> ))ZY68T,)=W8*XMQY@\')?J$A?17:T<]H1@>?
MZUGZ\\RH_I48%IX!"*-R@79Q=^V.>O>#9_*>Y'XUL20!UPO99X\R(?G\\23/
M(,N1)+_%O>1S%74I1 K+#\NA\.&_J"Z9@ @)D#DBSD_*SOZ07*H!-CPCW3E;
M8O7T#(+%)Q/ %ZDL M-GB&D!7 %<_H K>")XLD>>9*IZO1QW65'U>I4;-K.I
M?[--I$_D;]U;3U.#.J/OU2YUF^WE$QK2E\86 !-"?UX\R23TRR$7#H2^P[70
M<Q5L*42*"_":15E$#HL("I]=H#YE,$6PBP]V"9Z(E!FA^P5P!4\$3P1/!$]V
MB*>I*5UK<(\"7QK=YJS;0I1:J5M7R^V$TZLSGQ_' 6IV1DI!SX&;&U?1D9\Z
MJ+0;\F7>D<]5I*@0:3E?B(G5C%VI(GTGCC:45+DL*36EOLNJ:.B!!]Q:/LHO
M=LQ?X9(=LE;+W' &_>+97D&A3-]S/6(A)9*D4"EUE;S*8*Z)U!^$R2<QH^1*
MD")A/LD&RP;X*^(X$QA[;P0$]7J>YQA]GZ4$/ML/( N6EWF24D$\&FJY7LMK
MWVY>VFS?RVUI3D_=,4%M PV20J[GI.PW9%,_1,>ALKWKJ71]'2VN97-+Z'JA
MZSG0]6E*-.QTQ+32"(Z8[BC+,G#:ROPP"OLLM')S/4JOV"$NJU1R1KPV2UVU
M66XJ':&RA<H^MCPDJ>P-PI"DLI=1CONS\CHGNL@*6<B@D,$M9+"U=[.I7>JV
M6HURI[GS+DHAI4)*3T9*LZTFME.NJ:2;,SMH&:J[I]@*2122>&Z2V-E!$K/-
MG&JMU&W7VF6EE4,VO!!5(:K%%]4LDMI<<3A@C@(J@^_94,I*<SG$<A*FK3@$
M7;02K4ZFE1 YT4JT$B(G6HE6I]M*B)QH)5H)D1.M1*O3;25$3K02K83(B5:B
MU>FV$B(G6HE60N1$*]'J=%L)D1.M1"LA<J*5:'6ZK83(B5:BE1 YT4JT.MU6
M0N1$*]%*B)QH)5J=;BLA<J*5:"5$3K02K4ZWE1 YT4JT$B(G6HE6I]M*B)QH
M)5H)D1.M1*O3;<5$[H*=Y@'_U8W7[F?X)VH](LZ+806%E92Q%Y53JK"J29<5
M6<5*3/%R2AJU/.KD4_I*KJ6J??4\I!+1-'L$7\1C2B3+]J@K$0<N6Y(!_7EQ
MB"F-B>-)]D#RAM2E0!E+IY9+D486JQ=%//AC8%C$TJ!+T'6X,(+1N-5IL:I%
MZH3=J",-QK9K8(&K2X>:Q#->Z:<W0_>&, A6GROV5%3$:O8(Z4,/?&_U(XML
M."[!Z_,$B?^+?<8B8(8NUY2ZUJ8#?:#6M7Z[W>[HLM)O]@<R_);I?]1Z*7IH
MZ$3]'I,76ND[E/RLD $,ZY*8;V3B(D[CU !2Q$F?DFHAC;J?^\Y%-VD(L4</
M1>!6(H&?QA, +^#:(6/J>X;FEJ5;2UL-Q.-V]VHJ2U=Q67J:2A"*W15QA])7
MTWYS.1W%AQ\6\74#>EX&I0%JPO;A=;K[<65_8_AJ,G@Q+3H3<U:3#CIMDK%+
M+Z,?GR(-;%BL$^RA3^&[0MV J%X\<@Z)$]R> ;Y:"T ?FDSAE\/;5;AUL7R]
M)5<[:O*M6E5.O+[J5;)2K;63'UGUJM77Z[5F?IU2U[YJ@YFYYG2- )?[K/?8
M2@76Y"J*T[%TBC26YZ%#J?0=V@U=Z094B<XT]/2DP[E1GCSK9F-9<U38AC-@
M>!FJ4E,:^0UTTRD[IT"N>A:PISVW]6"GF:8;YE7OZ3?IZ[?[?SU)7Q_OOTOW
M#S>/O>?;NU^EWM7S[>^WS[<W3UL=Q!../B<X;76J]QZZ5[0C;1=!D.Q#W%%/
M,FW7S5H(^.B5J=,-+W-EZN,5F$XWH&PG71_BH&M5 4^T7FZU<CBOH0"UW 7P
MBP#\@QSQKJHY'/&>$_*+;J(D,[VG_^&[7A"[\&S)H<!FS0#?W@JG+;R*OS6,
M:O@8^C LR1Y3AW@8@41NO!J>0=W+72R98YLJ^[)% O55XX[M[.2#2I\$8>'1
MF%HN0;%:R4,EV] 3]38G>FZG^7WA  D\H?,+4O$J1L3,6JY>ZK9!R>5UA 0'
M<_S9XV;36<3Y  ?/(X;I4<WK;/D]SY&<K 'N/HGSJM:OAL1ZH3A##XCA2*_$
M]"E;DOC]43(-TC=,PYMLI>,3Z,"SK.[FQ,W+ZJ_$L-!XO;>NH2^O;,GSUG(]
MQV=F$QBX#P[UR'MFZ6V6NDH9^K^#;;L&GOO0^&FLK1-"T5X<HO1P6D9,"]VA
MG8\ZS@DT15?VHH.B@\?N8-']2 QN$TT#A87Z$2P-&+\&P_$D^'-$G)\TS!2@
MFN^P,,$Y>)AY6A^]B+J]D0W#^HLY"O>#ZY#.;L_28;X8&?[(O;5>:1C+R6R+
MM-$6:=:5X\?9A/>YC^CL44#580:NPL&RQ4&#M['$J2B+%!M?=J:9>0=!S"VN
M]0/OI+%CPVAT5QHX]@BTLA>J8M37?U''!HKX8T#4CR?IV:'$]9V)],4PS87\
MM5/V%W-0V.[$H9<1S1]"DE_3OO<TG?L29*1>*W4;W)CTP@_<6^0O%3SB^G5@
MO%.]@O*9!!L9TZO:BJQ\X@0Z1;?$10</Y<MPYL($,5-W85G3=:GG2L32IW'3
MK9<XTQBJQW@^UUAXASN^@HW+;%EI3";H@YY#V#M'O_/6TM 6I-<T^.^M%1'T
M(:#GLT-TFM4EJ"NEKEJN);@$PN I*HXV^)I[ I**OJ4B\V(YYQKGXU*9.C[5
MV81H>T/JQ*=%$=+;,BLT4320SM]FQ.U9^CT2_#ZR36+W,@M-'9S-<J?3/GY
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M!:J(FG>6V&P6*D',&T"KMW#@._P0H/,+0!&/3.EZ 5R-B-4!4F-4,O#B++F
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MB27!@PN'&C!%6T-?$]6/H5,"?V3-'QWXVR;  $-?I#YY>F2D@T?+B+),_K8
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M3$?\8?V)CK8?8-;/E;$Y>/U&^;RB_A,<?0&SDB>59/H(>L"2!=&(@Q<'&74
MR<(5;9?CO3M\L1 6$X,2@&'.G:4CAE:0)YPB/AG[Z0'.1&1$VZ6:GYE'XRNX
MVQ"U)OP5!H7@JI5_ =4%8'>2UH0B"=WL'"+P5Y)?B/K4PL'@))DV = _8 ]U
M)N$9Y,ELBF&4B)P^-X6[B'$ SW" ^G)>]/CD)1HBJI!Q-]Y"*SPK49TXF @L
MF6'+*AY/I*@?WX!(T$F!.@7,[FHWG]UL@GIURJE(*.;-P$@(!?\%-":P/\D
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M_Y;B?S.]D';CORPOD/C?5OP_5Z>BD=XR':C1B2FM-&3D].E#"**9QD(5",+
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MS7)LVG$BR/)]-X=U)S.,ALV]?#2H^_)1@R_'O!6]G^_57*,'Z<Q",PC^0#+
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M4/#YX@B7&$J<56[UL"BAB?1$QFAN XU=L[CP>66]5A#0P,Z"1][<+UHJAGO
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MQI'*VHS**&149".]BXGFKUR(?WURF;T[><8P>K=%N3.HVM3>6\:",X_?&Z"
M-BU0U__R.G9%4[%/XF(IXU'%^EH^[>3!^8E?\"X5U+8RR\KZ]=T7^ZJ*=IJR
MB7QI*"YO#+$HWU2GPWQE5243MT3J'N+8*2NFN1!DT&\U4+7I1#7TR@+[;>W
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M7N9)=(F'\BZ.Y_"^H+5=<E-LWS_HYTDCVP5C3\_"7/C69K,070M"$*I)<2@
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M8XV^V;AO<S:#(BWKQ;T7=M7OYQ*(JN=$W<\?F;VA?,,C=4-RTP6?A6RD?WT
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MY=ELR0=E1.,/ HZ4.$1AA74>N&AV5D-V7D)^1E+2"* LX1PQFR8O\!(5T4:
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M:IZ%4,W3N,I:0JB75U%D264+GBKH/7>!GF/#_N2X%!5M=XZ*]KK)?)IJ+6^
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M#_NJ=N/NLW'K$X7X;Q0,85P$S&1.GDB8YA@5_ ^76R4/?Z00=SDYYCQ9)-<
MLT.+) OQU3^D"M-WUTJ20MT3$FO.79)2.K&W!,,LP3Q?XRU.J@NK(&IS78\G
MHWO=\HZX_XN+1B$8CKLGO<'H0DW&D_Y@-+RXN+@<=WO#L^&D"S]WU?]==I_I
MFV:I/:NI.AZF*OA\'$S@NWX(HIM@F2$9N-L!>^'N_8;;MN905X[VUGSSCG:\
M/I3])E=SK]?QW@8Q;! FD/\S\UZ%V:C(,M22V"1Z%0?1,@LS3!N_#N,@'L%K
MO9<)F)*YON:#RHHHITO>+51*O)(UDK>[?1=/DW2GY_P0YO#6T0:4^;])X64S
MRH$##8TIV6W3\N/RA@7.AB5%ZDW,IHU*FY;:34O,IB%>'%SV1Q&SG7(3YC-Z
M2A$'!=RLQO04%6?\$P4? _RU?0W8^;GB:@!^3T07Q$FN\/E2&@ O C\@]][X
M'I%!%Q>2SV#=_RK@]RJ-EG"NBP0N@76\!CO%ZYX<_\LD^_\T5W':WU,$#T]Y
M.X8QZ'=]#W-+WA$]]EGUN<^>>P$6+$01_A>?Z7SB!A_&'X0_6?HEY,WS%P]'
MQ7YIQ_ DKF+0!E'-WOS3[,U2!:GLQRLU4H0+*+LQP-U0WK/24V G)F&$X/IX
MW/CWWSH?.YZU*VE]8%S.@GBJ/ 28#/G;^&$??WX)C\"EJ&$*N[ST>N>\]QWO
M$^Y]A403N"OU%G <6?.IH^(+X)OAH\!/'!]'2?(9R=TYA7P6Y+ MUTETK;PT
MS#[S0H%XP>"'>W'IOI<5HQF>L'-CJJ;P2'P:[JCZLE CB0GB"?@X6P G:,)/
M^#S\QCR<T^6X6I4IPSWT.>9J4/!X9,GP#W@@*$OXF1\NW(57P[)@#?C/CG<%
MOY)'X:/G0;ST)F!0)ZDY>'QK/DO@E?('+U,Y;@J<%.P.K@V)KG?RX@-L@/>:
M+Z)?=5_ M2-=<U.[RSYM -R#Q*"_:4229AQ.)G!*X!XHE&EPBZGFT1>.539*
MPZ'09NJ%\T44PK^&2Q%1C2<GA\MW;B3.:+,TI"5]2RI?4,21RIB!Q8N"(Y].
M58;4A91V$V;*U[MTHV1OS&^*K/H;V)/JK_#IZ%'!"?EZ<^&+Y:\?,9RA?YTJ
MV#=*#]*O@0. F1<*7+41G.J;>-1A.N!ML((F*X89^'1!B@R7!Y^QS@GIXV:6
M1*JSJLXVM$<&SV[1@;VG-P2N1G\6(5N-2*KO4W7\5J53(#_>PHUT>?UW/&T!
MW;O8^^\B5EZO1_*P[X.^ 7:#KTWAQ%>^<U&D61'$.1(/"3<19-[5-%7$.D0Z
M[T',X#[)O4>.$'!WTMPDE/G<]YC2*DL"=B5.FR? ?@70Z%6V .+3*RN&I*2!
M;D$<@D*)@AL&DTV!_P*COIA004PD-[%+S4L1FH9]0*_\621A4'H!O.&77UZ6
M7A"!R,751F$P#",L-!SQ$UCHPB>(A5/_WE"+[^HN=U;W_888#:?,C. ,,52$
MP@I4W3 $)3^:Q4 D4_M^.AJ\!T2T[(+"%7E7BS2,O-X%[ZR'$VM8(X_AO(TD
M?J] I'K_"$ PQ?C%9#Z@Z'NK-(3OZR!,*43CV^K& MZ4T4?#]Y)>H.@621I-
M)ZA<HDBQ/%^D:-C!O@T5"59UK2+X#<EGC,%.D[ACW^2%N >3A!>-R]27'"SW
M?9JE23%EB^8J0[WIL >Q(IR* CW-.CZAP@[<3C#+T<2]95ME^[6!ZQP#%J!2
M 1E<.TV#>>8=85DF&P41L "935Q(\NQYQR,Q 23<=<6$^J+249C)XOABMM#@
M\6A4X!N%#8Q14GDM7#%4WA2C[ IU*9?F9E@UJ[\1+@'M[APX^&#\9;#,,(^4
ML5HP98K:EVRB9.VFN-8+&&AB\("!%*#Q@T89R  %=AK\E6.0%;?$%^;Y^/Y_
M3TZZ;*;\]2^7@],7 _S/V8MS>O\T18!K_EH?%R5$3H_"HAS<0J#(?RNJ&1XF
M8VW-PDWC8H05RTD:C<'55O1IL!.YHZ_1&J&""[ _?E=BS'DH ^1+6&23>Q,?
MPS.O0[1<R%QBTQ$D!7Q=D>+C<=-HC)BY&WX#SP3A /=[<'9@/B&WPT'U3@8#
MM%W)E*1#@I>B;10%X1SMBP0-5WA*QJ8DD)"Q];N#V\C(2B8Y=$?#W(5FC-^S
M9Y338\KY]$OWJB43(1/2_J?L#;84TF<*>?/+,2CLAR(1,.I!S'ND.291,(<U
M)& (#9,;%>'I**P9/'KVYJ=7X#>#=@2+0SS"1Z>>TVVH!_M!?I$3-N1 W1NH
M]LA5341DT\J8!X%8\AMLVW"L0+;,A+*D:42-J"E$/$)P71.X1N(\2$E,L-HC
M7UE'W3+Z9*:YCWX'_C'*2(J%X+/08"2"R7$[YQPV$6K)M6%G QL#'=BXLT-V
M?@ .V;MKE5Z'ZN9@3;_7)I[0;/Q1/Q$VK(838$ Z?SCS6; 023@$D19C:(&8
M*O V\@TFR8BB%$ T(D%P$3%&):8JEK!>67F@A0^\&A(O1>$U]5JAG0?RP15V
M132B^Z_1^0*'" SVHV>_8>@-R?5EFLS0=K/BY25(%]\)N(7S.8C^X[D"]PCI
M6JY$K0 2$(,I$WAL@JP6)[!T+=W J5$Y$C\XB,DH0LFC9>!22S]OA,4=Z%YF
ML*\<C5DD%.F"JW'[QN,4][*(YW 4L5)C"C;#)S*SS52!4C($WDOS62I?]^$*
MOFY$?6%+#"^A[(.=4!,\L1$8TEDP4?F2OO)[V,9QDN'?07* 7@A)">C$%=5K
M:U$]*M)4./XZ""/JI\)36/V8T)PCRA@2T$0W*@;Z5PK=>-0?-7>:8"K(4E*9
M(6XG[8D([DP9EX ]?FQY@YV>P@ZI10C,)2J&)/@L'(8YBV,448M9 +IMA*$U
M!60$JXHFQQ$&'>%![/?,04E-M&[1<O7U"'9I'J#K>3,+1]6K<*_'"KE"B28>
MI41/;;JPDB[L-:<+]SOS][@*IG[W N#@&&,Z0&(SX'Q0L:,/L9B#0G%&QH"7
MOD3A.R7VPU^/0C1NV/(1PI\H:ZH [X'QJ6+B:XH.3U+6\2"'8+/#+->1JXPE
M=\K4#KOT69'.3UVV/V:)/[\:2M)AG&#ZQXW_U"ZCQ%H=[TV,8C#4408*#-F7
MZ'!6C2B!55IABE*8]0>%N$"18=J!>16+F\,I+@>^"@2.,+5]LI'ECA$+@@$,
M2T>[%<:V-;_,\<@SCO.38P 2Z3J("GS5S4R1?G%>*0INB7&/X\J6)WCE,5KF
M3D<P_)R'"SBM51T#:T$=$,-!!G1(8/!A4L+1 M53='=(M R1#N5>QFS=HZA,
MFS9<2U"C2')4Q)J(0%R#Z)Z8#T,M0&8T6)E!K)(B\U# PKL"=D/^X. ?!B2C
M?&9B4AC%0?K0JP$-JS#'%F9SW"7'ND"5B@1'W<^L-N!3IW 3)P71JE^R77+G
M3 &(F]LLT_IT^>-:IO"U[[6I<K#F*8HQ4+3!^!I3P6"Q!-XB7"B\D+BAC@F\
M(XGQHQC2(7T3'LZ1*;08T5;5;79?N;]?VLH+<%=3^)9,,P>'$LE@01Y6T^4/
M=]EX::"LV?=P/O6R=/2W9]DR5<?H7IWT^]W_FW8[?RRFSY!G_O;LO6P/_ZIL
M>O3.3A9?[M+:?@9K_,+EC>%QEZJR#HV2MHQQ2W2GG&BJB?'XJ[ZQ\:)UC">P
M$0"DPM40K4^!-WY4*<#"V5S)"Z'$W:SXPWIM-F2%;VV(C7.1QAQ5$E*]HVD=
M2:]7K@/-.FQHPA?NHG]7:W>!%J"W$A\LH1"IDN!_K,0MQ'^36(ES;:_VVK7A
M$7K2C;/*8'6=#<OLNZ_NU[P:GXV1L2EK>^/>-'V7B=0T?8RD058#2O8K)W T
M\)K*5[+@6HTSR:>R$V/#:O#I<0*L.O++2^J;O:%J M,/!J1#!H/W42F]UVS4
M8,ARK%.M*SRC"P!T@<+MA4SS!+TMI^!AF!1Y0]"U,>Z5U6C\IS;ZZW6WG!B%
M@F&?",6EDM0!W7:P2AU-DSD0FJAU-5ZU+'TC9RC;.H.[L8*-;'M?_].$!9A>
MR3V"98Q=LX!T>C*-DF$!"_'^WK7>DNN]4\QA-<S0F$JK9HH;K8NCWUYRU.G5
M<^;&IB>&G%F'+Z1:KH)2]\Q513H)1B3ZV4+Q1BJ*,BD9,P](U13]!,4QI7DX
M38W3X-ZFOVP*# 0.24J<NZ2*()J K/0%I8@\+&S$$3YF^9^6I=W"[9-P\II=
MTX>*W^IN_B)5UY0NF;'GH9L_3+ZVM'Z2IV^OQB^OWAYWL2Q@GL!"BH@2 A@Z
MXZ B^"]HU454T$DW1A+RQHAEE"1C[QHOCDS !W;$V5.]"!9Y"W!*0K3Z\*"G
M14A?&RWGBUDR6I)ZU#5?].@,Z6#.\5"]V3EE&_S2IA."D]GH$(L(8&>'B(*D
ME^JN1><'FFB(:BS-SFBY'W)^&WRO8J2D+FV4%J&ATP;R\,F1E&,-L,V&PPUN
MMH:6_#$D[RTW?AIE7#@^EYGOE[=D2_ #YTVD@'[B''-'?!FX?,S 6;&@L\7X
M)&-=8834J2A 7EL$X#.B&]@LZ+_5&%S_*XO!/:T"T\0+)&D"/Z-9@&P*#_PW
MRUT='J*D'=J@Q8A3:\>S!-F>Y!C2-5H\(C["=$SEODN032"_,$TNKQHK4&KL
M5F9>!CP2!2GKPU$Y1HZQ0BSB7<8H.TD=@D^31.&_03T.:<ZYLVI]$$]9M0]+
M@E6GR4[6LOX<Y\F8%8!.'6E=NXB"#(%J0.:$8TJ/',5_.\5C1.Z5FG/V1U!L
M%G@:P1@WG&*E&;"-=Y2!6?PZG&*Z&<1Q_+<S+,6-T-A6C.2'37Z+YP=<.$86
MC<Y48YR: R>!-PG3#)=US#'KHV>OW_P#O)7W! +4Y2BIZ_F%NOZSZK64[R C
M2< GA["<,962C]0P.28#!FO'QOK:V)LI#",",X&L!IF+B7JN4@!EGG%-?>!A
M(BQ2QT$&)TLT,$XH*_CQ"HL.,%R:Q-JO"#C^NGKQV_+%_ F\#E9ONCTA \,$
MEXGWGIZ9%09C+&U'UJ>0/3K)9#Q,4.'!2N#1LR25.OK\)@$U;W\G]@N&4BD[
M:6TG$D)+7LTB#><8T(:%+Y*0ZQAU5I!D4251AFG%]_\4IYN!)--B6HJS/;MZ
MA7G'#'/@&)O+Q-MV7X,A#(GE4VL-+]F!J!R/68.;Y99BYBN+JC]6^-SK( TQ
MH@Q>-\@V;L? '0Q&6!2+S[)1&@\= EQ..6P/&T5'QD=$YE&(\>0;.ME(Y75!
MXP-AU3=H=(1STY- :HE9%JTU@P6*&_QK<LT%<E+ZA-01V$,$!RTHW_ V6'(+
M$5U:+.@(\>7HBB%@()P/QT_ACQWL[$'F<:SF4%:'I,Y6["M-RB;^518%M/X@
MD\=F&T5:L96OU [:WP!,]ABC^8]Z5!0?.7OQV/JPO#7= :)F/?OQ(XD([^BC
M56:]Y]ZQEL\WNC4L!R^,Z[N#48I0M5C61M*1M!RJ0Q*T]#LZ4R:3K@]?XLVG
M=.PFNU6YZ(PN>2Z4"#Q]G:0<A.?5@7N*C5DLZ"BT($!SQA\_5G,L9*?$YC5(
M#' CKBT0+TB4<3":<9E='&0)BIUE/,7JBHU8OJ6L[2GK_3]+5-5WJ,JQ=DGI
MJ@!=]TF!DHK[K2C'BW^%I\CIERI8')O7V- SZEYP\L]P)',)JO^_BQ.0:V"U
M#0,)("R2A<Z[PCO(4H0U^!R+I*K G"!1X1E*LMVHA>Q[_S/S>J?'\%!)W-L7
MHZON$9<<LS#CI&R8829"7 +M_]M\-II+_^J_/?[7V5OOX\M2YI3+>5I*W16E
MBA$R7L;P(K:,T-YS+?P!DF^&Q:4F[):,1@6L>T2=/968#2:;%M2FB!(T&:(-
MI1M+M4W*XA/N9?$GLK#? YFE/I=UJJY1NI&2LBB)L;%/+CB&.VW]%I9EH 8?
M%7DRF1RN1>/]I%E5HH1E"Z=4\2&19BT)**#%]D2O8@0B<_[VTM89PC_GX?BX
MJ9;U0/9*NZ$=[WU#S "H23;'%:-KP@C6[Q5W]Q42%6;*0!;?T:DUH;&F3'?/
MR73S-W7K$MW]L_X=$]V8(=>)[EYMHOM;#2$.#CJ$N(G*>PJ.[&&UF_@^Y8B'
MF+8HJG?$3'V'F>3E;.W7UHZ<]QZ I?K;UHX\ :5K>W3E9+*0*O$8^,+& 8_1
M C1&J%M?YQJA&\.LE"T0]S<I+_)BRV,>K!XS&+3R,9C J3OMT_,'J!0:;'3:
M6[!F"\A4*YI/6]&\ P$P6!$ B[(?P++YZ1C[M(:Q7]5R\^ AN/GTCG5_CU\Z
MTRN7SE!7ZR$7S+QV:^]ZMOOR1CEU>Y@5V*A.AL,H'). 77&+_%9*8C N7\SA
M];'">$68";K.<11^QB;6*3X0=E>7W.)66Q0-H*49.A;LF_+4JNWK9ACTZ:K#
MW<FE.AF*NB!:(.$#)1&%5J00QA10N'4'W#B1>; CUX'31&D+-*@@ C;D.AP7
M@2XWT77"X XEU]2HU7RM7:E4;LCO0X) 8*_?ART(J B3_^WUS0Z^^M"W&\@;
MA^LUI2V8+95,AUNWX?:_?5HI$-(%).#A3J>8+\%C#B@)A443J <$1Z54!N26
M>?#.E?<2B2K@^EFG5 0W"S[IPQ5<-X>OFW--ALWJ]<I-<#H35"(^+(%IK'^A
M[<7UP&:96L548>M;S-U?5"^;W,12B&,_5Z*^>,\XF"^DV;94ZR3E/HIJ<6)5
M@)D'1AQM+%7IWN!ZHU!=*[=JL_I)*XU]\V1,UJ-+E/I5;H<?[)L./OCV"=1S
M.2Y&@OS$?3_BNQ]N",<(M-W74;PK3(OV-=>2)M1),@(J"#!!B]%AS/7#KH0B
M3JF1QNU4)'8DP<@Z)0'QJ[/*P#?F9^Z8+89Q$"/Y.Z4:=8$3)XIXBG4"@]HZ
M 9[]APE2J21T^YZBS'0^PMHWZ7T$T:7[@SB8#=]+6=A4J>-)$HT;XT#HX<#3
M<JK+Y=([QD/41^A6D&_8!4:RH]0%YMM(/&9G@(:/\;\E6M&DP8U94FM >>Z<
MTM.__N-]5@G3GN$&G[K5%P?+//6U%WB.K]_\PVE$JTF7KZT:]PDL!S6S"D8S
MW1.W(N8D+ZRCKA*N(+B"?W* 66=W,Z578Q $UQ7GGX+=/4$T0JPX!6.%UZ.K
MP%?%+?4PZ@ OT&I]7#<S)L6'JYT<>NN;UOJF9P?MF^X;SVLU@:XI27M)-8G!
MB16^H)M>'W=)RWC!(@$##,WV(_0ZV91^\_I7S$*=$^IEJKC*.3;U02Q%"4Q1
MZJ2[(,#CA-ASP#]F.MPU]H[(>7U>#O]WO%?%=? YS(LII:2X)3,>S:AOF-B_
M;A6D$%_8>WWOP[OS\\N3;J\K9EX1A1EHLR$BXJ(_4=5+8#N@7G(Z8N\3.]VF
M!^_,<<8G4^]TCHW0 ^^ZYQU_A.\#NV,&FX#R];C;/3XY];I]N/&\-GO1OW@
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M#$1(@MC*SPEBHJ"YH^EM-"%G"&^54WTDU=X]*>OVRXX6=V_MNNHT>??\\B'
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MEPP66!URS$1>V@T[Z9SX2L^0UG-X^*,..)?[#H>-14NOV_.%.EX!C]/ H^Z
M?T7'31/)3GT]!:EAFK8=K%# ]Z3K:,F9N6T'0NM1VFXX<^5HRVT/5-XJM,TK
M$RB%369M"T&AE$R68!HNCX?P+AIM<I.DT?@8C &%@ 6CJ*"68#,M&FZ1/EK?
MFP=Q@5"@8,7[3DD+-H<@4A JA!ND&1"F41+FAFB=\6'XO:)EW)J7O_[E]+)?
M,]STR Q=I"WA\"\I@:,R+NIS'L =5L-\=IOJ^*"\-<&6F_-(>\/^T%%YWKH=
M AZJ:"S%(0[<9LV,<FK@*0VM#^;<^LS%'UFNP5%-%3H'@Q,?KDQ@)=RXG\]P
MC!=\9 2;-%FRO*!6A/_,]&[B$Y,A0L7R-*\J)^@=U'L:2B?L(LC):DB3#&>T
MH\@Y6(GSFY$,V.9$.0+:JII1[S><+9 =DP')P.J:A7D(S'>]7N>$6Q)AD5%(
M?Y!YT?!@!"?5:+IZ**_; ^^[%A*-1-0V%CP-3C_!C(M65C3+T=B#+.1H]8%=
MM2N=I"Y)EI$QGH.L @O=S!M<S-K _AX_5R_^N[ZW\GV\'AYYQ",<I6^-45.Y
M<$H;=60S=KS?F\1OKX8YDA@_ D6[^>KATOX89&'6?$[ 54S1N#HP/ITI9L$"
MGO&%FNN X[[K;7B .,\L6CJ"Q-G">QBC9[<9HQ=/;XR^3$.*.WA78,D4,<G
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M.=E=(5MZ%J\0-B>*/'A5BC<%HUD(/X]I1\ ]FCB_N9DI$DSZ,<Q7\C80)7D
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M J S6I8KE]C7"^-)Q(%@7(X7$!,0>!'"P#NP2\80S%,&!JKO+#^4D) !M/V
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M@Z/&8L[3Q&\1=!J@8>38\SKB%V*=-Q[F)(G"1*/Q<;<DVF,H8!VEF+EZ$,@
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M$^USS#;Z]<^2SC]$\!&8<UV$2U4T# @I\#U->LD=AB03ILF\ 3.%*]A\+P^
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MD+;UEZQ9D]FR*M_ML=^GCQRU0!LA1]&*W"GW5ZK4!C:+&1!P]+@>50*"2C\
M^/W4!'DFB#E7UQ@I&95$RG,-9BBM2]<RBDKF( &P3:KZ66J9<]4QTYU(S\Q/
MZ$C<G-!:/(9$R\32Z2[(VP^N"A3[BMW3</1#*K6:5(@)9#?S]W(:;!MN"P&A
ME;$GIOD(&MY3WS(567QM5B"#7J6$"/+*P= Z(DGG9ZJAS3W+[&CRQY)T1\73
M@^/+BVO?4PN$1W)O+:4'6\GH$(=L7!J^"QS1@Q"K.>FHL5<N*,EQJBQ=Y?2W
MC(92X/IX"7G+F(*C.&Y.4WG%@<?;QV5U$.MW@V74%[EB"82&EAW?O9  8=&
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M%\8/ZKAUY5^BX<C3PFW\+5(V7MBUP)JD))DAW@NQ7Y@./(4\AM"D.4BT!$H
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M!(+C&(\ "5+JF^AQ?FC.3@.&91KQ+%:<IVW4])'^44);7=9<M-2^N7N12+5
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M-&O>GU\@?XAA97*$*5A,6PP-S\<2N>?\$H-HN<>30RG,E=SDU)X:<@>T'5%
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M,L5R)HSY3U=VM<A=246:ZW5YW\G2EG6G92NJP])#B*KEG&."%:GS\C.'[6%
M*%M5MUMVSHX48;.L1Y(BCP@MX0 )O_K#[U=G0-M@]ZA5.?PK&-!P.J7Y Y3#
MM,!*M6O6+:?9>KGZ3RD#0_]K,#PO[6]M!HV-=?2N_H&JF'.,H(,6E Q=3Z*+
M[:#C%$_8621Y01Y'^P@J;BOP317T*+?P(TX,;(P$M&'+'@6N9<1>*L$45[*8
M&)\EQ^!2RVX'*CJ)QL/A^U5[)SUWZ6J.)*R:,_Y8HLM*=/_K8XGN^:/G JU@
M("C($8B2$XD2EHVP(H_A_TK"K[KC=)-J]J8D*0_7F_=4V$J[CC5-A]NN'U&
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M)'40HOT*(=!N]W+U']26&WZ]!XI2ZE7,V< <QN1=0UW2Q$64EHS3"_$)Y<$
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M?;Z&F$"BR)$G;?1:>A]S(&Z\3>P^4RUSG6B=9HX3T@>+3^1ECP?EB3>4F;R
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MF9#@J<(ER=(VB%4DI-/$KFM'S3E!EDB= WG#3%KIC-*;8L?(),SBW]GIQ;N
M=]5;V[WJR>(/+70<T>B:G ,_3]/4,40 G++.+W$"AN/833T52,&H(T_WCNF3
MA[Y'@Z^(61P<G2P+X0@,R0*]%O; "$:.U B^!ZY'/&1V%.RJ*V:XJV2G8G$,
M3@@B?9(=A3I!YC+.''K.KFZQCCH0" XJ@;SJ;PN_!([;@!>=6N;IM7W,T?#X
M:%W9ER2H[Z(6S -$'CT>$T1<RD[/$^#<^E(#QUL!8[&DBC@QG67F,A4KY(B;
M/9U&W!ZH'N8V-.05*C9L SW<#GUORLC+$XD)CI3LG"'6(B_MV!X&9YJ.TIKH
MW-7=MM=H-45YN(M%QX9ET^T@?6,B?>0PM>-0MJ.OP)!?>TCCZ:3467NB_Y;6
M7)4=D;1P0I/%ZD9:3I5L!K;$EZ#VAM595L'"?D?9"I3E5\N8WT<,V1I=&BM1
M+HY;C[7FR/E@I\.>_\#K@RM:.HX0 (T^&ED4\"W0G^P1V]6XH! 74XAL-$@?
M^A+"-0C:)'% ^3B,!HP]2$!$2F#Y*KT@E H2)[A);[ACO.DQQA0N!<!6S6.O
MW^Q$9RC@D/XF1YJA^_V$@8@S;-;"P/]:>/YKG_KAK%]L3P.?HI->KH!6GI:)
ML#:W5S N.&7YBS"\D7\FF*@.E(A.,28>DJ!4'K:9JMJ&7C8HKF.G+]ER8 BV
M/>R5!D&5GM("?7KP<$,.7LS:BMS &F$G;GS7TQ&TF"/K/CV7J4@7=8I0L=S4
M^,<Q8*4=8;9=40L*PKA)$=NYI"L9F'WP]")6?RC:PQ'#[<&06B:B*4==TH_.
MW'>!Y^)F/]!<=6YV4Z&5R$#I5L_8)E!-36A;5;HO"!P\RJ+E=[,RA@R@LS0M
M>C:J@C=^C_L>EV9.KUMR"I1?%;J\&?(N\F]!AD!F\%K(QW=:*'M^\(T5RAZY
M65JD-[!^IBG.V]DWZXK8]S:)SKS% +JI:GVRT3$FP:NP[>6%TG\@- SZ$.[N
M @MRU2NGZ^';KD*-)%\6:^X_UXYVK5D4:\ABU)A%\!LP_6,!/@:QS4\ J8!$
MR#T,(VS ;G(==Y,8).:IC *GTWE,;XEJ[M:P1K@B@=^H.69(W"9.E3KQ.]A3
M'(\2GX0.OFW JE/T!JK<V'/=,7\,-?)'/9<KH5.X,9K6/GL7/BCZ4!PF%2&E
MF]P6G+<C ;50:Y^L+P6T2E#8G!99PLWF[?7CN?P@V4\%V9)8XK.ECX3]WYO"
M$HWR(K<&*,AP*%(MA$>0ML/)'E^+4]CXC>U;U6Y.!^L31[?YN.9P#UZ43'OA
MZ*LZBQ)X]&E237"[[7A 'R:S@0>DUO;8@M_BB:ZA2! *E_,"W^;LW5Y28A:?
M<VL<]\3V:%_:]\2FS8)3_ 74*ZD)PN=& [\ >#A@YUX0E!#*?]8A\*H/[#'1
M7IHO2H+I@,ME8PN!]T!,!ND\^[]P?Q2+VCI'E4LI)I3@'(.((RPU[-6PT8;=
MP!1W+7),+4,#KIVO5&36)7L(.WJ<0K"_9P-N#))UK<.&')^9BCT&G1@2&@=)
M'P[ ",BJQ0.+'""(;'V#/)+X(GH:W;Z<([_ F("#W 'G=F%+?EV,'Z,R.!SI
MO+$N[J!\.H(CF\61]KI5UK#+E'KXD<K:J$!5_[QSY[N347HB<Z;QAF,'@]@*
MP(<WOZATN]@8+*TF2UZ?8D-5(+4G='W:E+(R-.H.70%4A5\'(D M:(#I90[Q
M\>5P=74U+I>&KJ5U#O=LT(M2BFZ/BD,2!Y-_P-3O>-CQF>C. 7M/UYGE.X,N
M%K%=GK5QAW[W@M/1,)_>08V* YW 9G EQ;G0ZOK*J\DA#8LOBFQSE/B.RXQP
M_C%ZD'JZ+^-L$4MW3(M,-8"B6R-J<"FTK3X,(!16.\+OGB0GK:6MTJ!BC9%J
M!KEYD;<AGR&#_/J%P'KJHD -I$E PCFR5G*2LJ_(^1F)G7)F232B](KAFLY/
MHS7GDWZ44M<#F=^ HJR#-M8:<$(S@;GUO@3!MY188B,W*RDNK8N!6]&=40D=
M05!\ A/O4:#P^\K4HIB.^ 5X:(EC1!?;;6!0[,N.GCU!LF($^1E2'4L0/HVG
M@_UD_ J:316CJOH'C)G]L!"+V\3!-#7)88.Y[%DC^ZQM(UH6DV-Z@A)W#$+;
MWI0M]24^11I0;Z*64EDI9E)8>;;&N8-5<E,BK 6/"[1%_G=)UP^[O/RN@\G[
M)XJDM#D9F# )LO A7J\G2FA*]DR$ "E+@V0_F%)Y%?9NBY1,L_D.:]E8E["C
M^JJUMI1T:+>_^'0%A,8^'\*0B]95XPRHR.U_IC-X25@YL]P)P.@S])4O?%#N
MR8[[JW9QY17X1H0V@Z**+[-4KVXJ_>CW"N@*[%;BC_#4?Y!Q?:4A/]R#!.^
MXB'-2(BJ9#5XB3&!O]UJH.P@1;$ZHE+O0S-?E,*Q++9W;/>=/23*ZAG:?KLU
MY0 08(DXY3V&KZ+#++^B3+%OQD!^BIN4JZGMRE4$FQ3)6VL^F%.#F2VT%BGX
M+K[$C%&&*XZH5DI*BN,AF!0W9DY6W=#Q*KM7H=9![2=*XD90O0&Z4;N.M+,<
MA32GYM>*_TDTE_P_[!PNC6]I\*4+UUOE.Z$Y4&# Z>JW+I"\=D:&P>B/<)4,
M*.Z[VE''^[J AJO9W'JO7ZG!V<<[.S/$H"#%""1U!E" (O5QC82,ZNV^_QP
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M)R;'[N; /PD</_87"*2N]VK;K_6^JYP,"2]-S8BYQ1"EKYA%'U>@:?K/.%]
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ML_8Q1KE5<J;4'65]'CQODB9_?Y(F@X/AT?C43)+)X=%X='IZ^B(9#$<GH\G
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MP/[W@?G?P?'S)]M1LFP:G'L=\N[\RSGJ\"QL9+Z.S3RYV4!RV?7A%LT'=3K
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M\&N?*RSRP4EJ^L?7JQ?_SN/K%X[?A8]*%>2_I>Y\0G*BN4B!.@Y4810B*,%
MFJ0((2A**9%>B]HK[9<(V-8TG#_I#0Z&9;9XB@GCN1!?I+QH5G.PG]S7U+[^
MVC4.Q^5T[IIO;U'L/<[Q+U$]^)K#M_,N-:E%7^RBCT$32"HCYJD48)P7X"5:
M.<:(8['V9.B [(S)+3T<@U>MU5CT7\W7G1&Z*H1]D>8I3]$ QQPY=Q)"LA$$
MLPH,]0Z48@;)D2[I8<!XC91[^CMX4DC:3O#U(IXE?.>'*V+:27;91A\L9*T5
M"(4AF/7:(FN)RDBI4Z&V_J\1L2U7OZ)(&S?;G\?]>#R=3]NNZ5.AU?,G.;I
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M,5_2M=]US=2?]M4>GQ8OW6RV.GT5[?<?KARDV979CR2EM18DHZH4>7M,'4@
M$DRTS$I%5.UQMP6Y8YK,WB7^=J7A:I"\<<!<D,IRU(2 <8*Q$;*/&*-JFS!:
MH0&L"R[G<H*)JITSWHO QQR@C/NR>N4@"%_V"Y8.]59Z4")GQS3AOGH_[X$'
MZ",[B H8K#D\[Z/?W0S/B_[,D>P]*94CL12R:D_!.RZAK*<R90.S8J<C\YZQ
MR"/[@@&@-HCF[IB5K:Z7+]ZUZ9<?_A]02P,$%     @ )("H6F"53;V,<
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M?-JGET4^A@+;9Y&/4<5^TH6'(/J61;Z5_A[/&]Y&^/NA!8LY6.,]\(*<D)D
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M-RWQCRE)]V+R/YC_DR1+L&_6\F+Z&A,M9%D3M1Y8EX@6A=0<C%G=!2#)/>H
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MX)%JQ7UQ8(R4FQ<K5G.,C+!Y>(^7RTE:D'-VTY_8YAB-%&0TF]IAG]R>4%@
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MK3%:ZDFI7Z;O+Y>+E03X37=YE*&HVJ[2"3JU@W3@&6W:KAH&EL5H;>LYE@_
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M^U#R(^=Z+QV/D6:/>%$M0GGQOHKO1;R8O VW@A3!6*VCSN!X,+19&?)D0Y+
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MV$;7.<\OPF+QHJR>_IEXG#.3 WF>HJ0"*M0,6*T9[4V^<)65E7?/WIW?S+5
MVEW<K#[WAX^KIUSY8HQH+A,3$ K2RZ4$TGM%^Z11,GL7:??5S?NQ;(:SKTN8
MW?6]^>9E-QD?R_W*M83^N[Y]T^6+^:J9P,K\UEEGRYD%EJP@[SU)\+4)5DE<
MDO\>A1*M;S8W@CE\W&-';<]Z2+V# ;,6V+7U-@1:I\C& [ .$]=HI, AM-A!
M^GLFB"+WW+-L07M1\[-2!*^,J8UW:R_[R(+Z_]O[MMZVCJ3;]_-?"NC[Y>4
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M<; XS.$PGC=;SN>!'E*(C_,P':8A3KY_Q+O,:1$O>1.SC2$!"RY5>]3.+LY
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MU"&>Z%\HJ N:UZ(*=9!GGE8,.L:L_3L;C9'",P>\($7[3E/,)V2] Y.$X8)
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M""$FD#Q)K5"HZ+O)/EV+\E<+%QP@[W:(_5K>-9[,!I^&L[IT_3I*PV_#-*>
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M$(Q5/,..WS!8;-0#S'<5'W=48'0S%BXY32LO30QN(9"UYZ [+>HAOQL@'Z#
M!LT_&]25EL$,Z\G 469;IN8>T&HG\/[N'_=Q6W= ?P4BSH-=DPN&83FFR$#4
MP#N9SZ 2Y'<E;LA:I>HCH!+N>AB>P9D,-,^#CPL-CI$,O/M5M#@CFR,NF6=-
M!F+H2D)LYHO!P03P(>!@.H'UQL6;R0 DAWED>_(@D:KR)*7W$()?]74SE^ZM
M% CHX]-WH4_)0# 1'_1'DPP2][<_F]Q,3^@%_=YR;ZB^> U#D%MID-RB\;0%
M ]$1AB="L&.8_9BY?1,HPJ[79&!J_:LJFZ\>\W?_@D]NO1_AW$Y/D=][VD4&
M]FWC&$C^HYQ@*)A'D6!P&0/U_RCXCX+_CH*>N T2WO^04Q?B5/M'\;(:V!:T
M^D9Z5!Z8],"9 )RD@I^!C\,>'*,A3:ZG]H6*J(H1"\V]A!'D*EH#BUI>'*^R
MG JSZ"X3IU8[+2UL_L1TH3V8$%M-E_XR'AZ2,/0B^1 T9#'G/L)G8HQO2'8L
MI.S96:M=VS/#^N]2WE49$Y4*MPB(3H)R'M[&()(,:/1*N(T,?C#QN6PFQS.;
M>_9L_N)8 !EX1?7Z]3UU_'T6.6O^@2.6&?+-*]&,5*1NDN5B2\/UDNPW>6_1
M#3/)!WEM\C9DV?<E3W,%%<B9E*@[.TCOY4\49"S*O+9?75]5QTKD'9N!*O#K
M,F2-U*.N%B+F(,<SN/3\;[S!SM:[E^.87@=EH$Q=JS_TA5RC(=K3?&&SJ7*;
MP*X[GYS.++(X(O+V_!89:$R1Z4309;0^QT==>MDE,_>!:V;+_>')N;V**.OW
MB%IPS.BO8U_5N>HXI)DO5$N^"1_7MML3.(C:FC^R#W__*$9:T0<GUPAC*VMU
M=V*W3TCL6PJ_)/LN,]-KZ>$W?1]AZC>)6VV<O,+Y_8_'XA^L!'.(3MJ.FJT0
MV.\UG&Q!%E=#YN,U1Y8'5BU0!'>;(D<D_CBR43#N!-ZUCB7GV[6R"AL0X!'R
MI[A\O9W;[\0,)Q)TJB)D.[<A)+YG.#@)S%2[?R*U3MAX'H:=#(  S^DGP'/6
MJK(C [;6L-EAK@R]X@UUPMF3DZ^(#*1]%*R&(6EFD/B>XLS_D#/0+*/_<DF(
ML*V\9+<!;89@C=&A8VN2> 40=!21@4W!*+RW::/3UD$"+P41(D%PPU,H+KE$
M )NH;,AL0VR0]=W5HLA.S/@*@?KM=P3EK=X(_Z-%3^X_D:?>WQ5 0_DGT:"A
M3#\,14?.96S#&,@ M-.'RS>J& 2S9& 'S7K\Z*PDX2SW7TWF;_Y3"0SO+?>'
M$A"FY8[]A8BU2O\!;9E)?&$X4XIW?N%A\$%F5OV)K$%$M0.M[:>&A7]H8HJ
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M<EJR)HU DD\BKF.DIZY"")QL+@W.G3D;_/#:L-B!LO)GM^)Q"=+O&-B5=FL
MMH.FG6-8'?0F/XF?#+SX2@;F%=DGQK &3IL26TBB?R$96'-;+^/4WE9SKDY\
MS$$L48,O<4Y8LC9!.-$%[LM\]>8O+3F\3$8,RK0?U#^TI@I\S7_XP,DO]D,8
MIXY@T@&L4]W[W2L@!NQR4\B3??1PML<-[_ IKN7)LECH7DY@:M T 5E[!CG]
M]A9D@_HU&>CJ-'T#AJ(&;#H:[T&JSR,#F5^["T60-^OD>I0U,;=C&I"UT&J(
MIWE3"CO.K?HPMC^FJ'W7DBA;XN/[IONXG@Q&9_6.0VYM:3'[DP$F!.O4,S1?
M:^;-"FFS(74G^C!/AT*QC9*2#G_JA]PN15];]@"*B=@.O"":\) $LGLT'K9F
M?I$9+R+W<.5(*18>,ODXMFFB2-(VW,U#)XS/+V#L:Y%65YXY[W&IQW%DX.@Q
MKXO.%\:(58H@C5JY-ZSH[6-WYO-,B3>T.5>IZ\/5T,-<ZJ&J':Y</'RQ7 1"
MVJ4I1UVZPP9PE:#Z EG8C>0/;7>F3<Z@@T@T%?CDJ66&N@V7/3=ZBTQ8I3A7
M>^(]FGUS.8O'V+>")L:H$#+$9PBNDDTNQQ!;Z@+7Q8,3.HWU7R-66=X\28K.
M"$@2I@DE=.+9I^:@AQ!FV.:'15/20X.?D)F[/IS7+>1^<6@ZR$5I)=QTP:]J
M8FPWPAU[01_>:#OIQ/1I^76P1M8Q#^#.W)RR"2=_(+, WV3E[7Y#H_O7_?3X
MX]]Z:"ZYCK(0TZLY$,9]!U6Z$9JV>5;OZRY_&M'>^V@<&WA-?Q; 2MO7(&^/
M#2%5>A!"<I&((]DJF1U7:Q9,.)R7@C6>!,P\9V++XS\-[-<\*S]'4"4#M-^P
MM6\/DEAQ:L43A>=$3.SO1A?6*;4I[]HS.!XHS;2J/%/M04P#*80)WOF&4Z5.
MT9AG27VP/FKXZ(9=M[3&R$Q&4K;N;B_.F@_@PU*<GJ\ZL3#2ND[<I:/^U$5C
MBW4##.4@#S) _[6>A"3P0[ IQ.S%MJ_0]\2\B(Z(-\25K<HU$L\&.@OA0 ;V
M=!#X/6#8!#)PC0Q<N:X(SDX8T:4W'T\Y??6#5[WB7(E<WTS>YD.VMGB>)%5\
M1,[+E&T,+)>0 <&)2:>M13LRD"5E<JF-HTE-L6.4(-&2!QD]YMOQE"1U"<]J
M3"R \EW&:XW5O_+C?HVZ$#PSIJK!]\'$ONF : 'RR#&M0&9]-4]T$<)Y6Q9/
MTTCB1FG=JZL0#.W1H9&=066K,"YR78A<B'Q.GW#Q6LO90P,S S5D8%,<"I"!
MXGMZ9*#[R>*ZRF3(@QQL5#V<W?[NDVTK5-;'3RHQ,3,"%]I1MP/,;![-M3TZ
M(N1.NGZQTL+PNKVE44W*H9XOE7)V'FG#REDC,G%SV':..>N+Q\)4DP+\-05,
M&V$ED%I>R:GF!CT6SQ*3'OY2;$365"O38X"E857AH,:)UW5JF=<8;8^?885+
MZ;B*-S;$M8NVRH1?GKY[[$E*9LKT]$ .@1DGUWA)=G<GB>O30K FJB.VNU-4
MB1OPBJJ\?2&(QM7F-,U9T8K3(M;S';'>U6AM#YD-Q[U#J+118?Q3;,^X:E7*
MT[RQ^6I.M?!#8@[BEUY<&(=(L E(*$^'7S.)*,9"FF$,50T&\U9B7=E.XLD9
MET^]!L:G'=6!J'/2HI\5T(.828]&'6\'9'.U6(_#.L/]"*OS*HJIQX,8BMGY
M+0#H_/3TM]8M\W%8S38D 'JPHEML72'B8M$7:(],3WKJV O)MHS4NLA,HGU]
MH6[0:2'Z!%3\F-?[8X<*^7*:_([B#296[J'*'$/2%@S--"<XBXY4PI?OJ@4Y
MC-T1%4$^"KIN'==+E6*_@J8E W528("MP; A.]%E[>@DNLW:MGUJ*7D$@4Z0
M_^ \2CD6$AAX/"I\2QZ@=CNDV8P>EH!M]:UY+&F#$?8M SGP?H 4>6NQ2<AH
MGVYI2H5DAY%6PAW#:ZC2@X3C&+PJP94(YL@]2((@9N@@-W1@ [X,45AJ;FU:
M&75J3GB%^=1\:Q.^H4],ML:W%U@N#,_%(,2S7T=J3+E$N$L!FTJ1YX(.%Q^"
M20<,\'-O-)*!N$@<D@AFX'D>=I!*!Z4+/MR&XJ\(ZYU:TO'@/[S=.(.P_2AL
M@#=YZ5)WI3=-_+I3?#*]1X[N_!<WKF^14&X$34_A;2?'4@R#^<L9;@5SUZI'
M*9?4#\3SR[?;%'D]'_X60.+QZX*RV<=PH I&+A1$+_0KJ#;L&PBA<7EQ^IAY
ME+[]NVH)OZ:3A$OX>\\]4Y \L@DC]'N6N2]\K7QD?)&>^X-%Y,E.=]EA4@>L
MY'US#7R9\BJ1L._= </5)^;/8"4%NL]>3GV+BE4!O'V[^BMGEZQUC(/4EZ$W
MH NF>D;C>F$HQA42"WY%'_MY>Y.D?$#9C>WYQW,?,P)&7O,G[5?3%5W4&X)M
MV'0M54I:3T'8[7"WO+-3PYROV[D%3);?7XTTQEH&<PM]"3Q-)]OA-\;'';S=
M.,:<$RY@ZAW:<;7')CE?0/7D$N,[)"O<\M: R 2&8=3BW),HO1*/\S0OCQSV
M>_SI8:.NI_==[W9D?'!)[D?VBB3;"*@,0@:;D@6.XL"#LN53# G$C_$'SM\X
MW_)!@#[+Z# 9X#LM^W@",M0S4159G&]?SL41E6_GW7OWJ[*3LSU[7R6M5U *
M=<VR*5,.0W.;5!- Z.QU9T@VUZ^HKGQ:)/$ERR[[Z=;;XF-/MF,UT97(*Z@#
MGVYA&-8MCT_>>"Q3I11V9VSU@_S^4UW+E?)D(,!X\H03@WH*JY_U&;\/<A=6
MG89C.^I1#&3@)G+/Q\MX)\T0U1#=\C=O>XZ\>*!\)WO&/<[-YVX)VZ%6WH1.
MTU[H<3S+N.1!3XA1>3="=&);9)WA((?'1N*U/;BW@C8QEXU9 I7'!]HPKU8(
M\>+<I)H38*"I-OJR;',3E,C _8'Q]Q%)W4[5G4GSW;:<J[TT+%NWC_CEWBS*
M?M&;K[H0)+JJID&8?E,>_V'2W&OJINW#=RYJ4XP%3'OX>[FV2S:@^&,3B^C[
M!O90 >Q,0H'5K0%#/9I;)BSONI1>1Q@[&=4*OV^2/N1K#^90,&L')7!)+N]U
MSK9[$>X9[UFT%!?-&%?=;P&B.$LRH*3J._;<R@ZSVX]=1SI;9HQIWL<F2O%U
MJ.+1Z93+#VCB6F6[(AODNP-S*L/R%1K-\[!"R_8^J<BZT<IN1;F,^0HH*J,A
M/E;BF3W;7C$RX*VFP'8ML%9^_L760%A?H:G1F_XR[?=JJT:RGS]V.,N$Y+\M
MO@%[*/A\H$2+[P,];^23(N-H U7V/.6?J['_Q8NN#X/52U;-P&%""Z@VA7HR
MDJ+<'@F#H"JX>@8=2 ;&4=AX?!ZZ'?78S=006E*'W#"">YNVW("O,$][]56?
M2 \5;3\!904STHM;*\SU8]1V5R85D@WMXSD7;!Y0Y#1A9$377$GT78[OTPBR
M2:S%$DZ=6]?CJ6%KK/ D]RT._83>J:^$#C@S008:*HR^-O__M/BS9V?-)O/_
MML4?JJV.;5&\&?->OPX20_E]5_<KB??#O4LZMGLVZ6CF=B%$MNT):A6XYF9Q
MLYH.C'8G\X9[P?&&YR^ =X/SKUNC]=*%E^%I,.I+L%I(2*.N.H%_V'-J>/B$
M_>K*QOV>G&[2&3R)^_X0OWU"7 "I(;;T 9+].BP"46WQ"'=12'R=\('K3*]#
MBB_<"$38,"C_IYL0=EOLHP1&M_?>HVK:+IH7WSQD".$-D"KPWYKPW84HMAK;
MYAAZ[[6MZ:G1$!3/ZBH6$<FN6IHAA#OLJX%VY6074^Q]>_)Y>B5OQTLRX(C>
MVS@I.40&#*NE9!+.R/95+2E0"5QOT$NZ.R+*2OKB8QI%JH$Q$R2G)!D\R^'[
M/9TT!JX';K"'ZF@UB09':!TXEV 4L(9.(P/V]BVWD;9P;DV%);52C8!:V,EW
MH1E1AC6F8<A:.=BT/BZ'B%0F ^G#U8Z/IE]N#BV1@9;),+_&%.MM/T\Y):Q3
M1*7D[H"T^0H>5KLOJ^K9P^J.1:-VG%?\KTV]*5+?$,=^B9M$1\9S</4GV.8/
MRB:WRQ82*_18KCRES:>6%NW"C&="5F&>ZJ3:6.1<CX7>$H0,"#'D( <B!D@!
M5F7RL"62_>(-1]071U^J;0>$%-8C"+I'&YGNJ:?2M1*<YA@XJ]=C'6B9<U=M
M6O^.K^@[RG.7LA>[$KY2>:?Z<*=,E;O#5,F)"*T/"@$<4Z>6W_9.G>9LMJ#_
M!AF9(FG0CFVP@E1O*+\-.9Y(!E;WXP/(@$4!,FF]5M>%]"$)#1(RX^L<Q##;
MKE52!QE@EG'B'L$WKO$>U [1+AEAE#)3<7)@>]8N6^]/'4]ST]!O1:A(:@93
MGA!5*>*%W9?S(DX#QUB1_/'NW8/Q,Z)9]\,K(R/W#I_+EU!ND1!E(-%+3;9'
MR-5"V;$$:4T>L\+I 5;:TZ:7V$\4=O"[M0TV7Z1[@0YXQ9OE<D=7XWFM];'+
M*BSR#B_7>(\[FCR[BMY9EX/KNJ,*^42)*0@:M"?\4H]8)>]$U?'5C0_V-R7'
MNY8;XKO/L%\V#J)E%SA12Q=9UG;3[PC^V+:T;$X0JTF/6[(IE>#CKNR*N[!&
MYZ,B0TFSC,: )V!:XAEB1&KLE#VKPEW=ZB"&;W(M8T!J$6[VEHDFVQA68*J>
M%CE)9'G-/B6MQ4J)O?-M%1AHOI*K?2B+\_UJ1F"2I7;V&LRTFA\!P<*:,?3Y
M5N9FEF&YB'9>EV:[^!/UQW$MT-6UTP)@:AQ[,$K3"^7TG#+%?LBF>MLS([49
M>N)E&I!Y;^A1OI_L-V8":T=#@AFJ;ME)X_7CK!#M7F17O5N$@%*C>CEV>=W&
M"F0WNQB[NCLFFT)RTX!1._K(U[-N+BURMA^EH_#[[E[)4H0*7C+Y$B'RBO,U
MQ #!BU<8%S>:@ 1*2BJR3+2_?1O!U&17)-3M,*II6=A9<I*M52!64S'6_BO:
MK&?Y*KX+>36^,RL6'ZAA,F1#+77HS>'#5L^<F\Y<Q>B3Z,A *P>6CABVA23%
MJ<.?)'XC)#BHDYHT86NY70EMAGDF2\;FE5'=< Z_#CYJ''.PK(Y$1QT?;[<C
M6CPS4&'1X>BGZZ]N&-(^.$?-Z1ISK]?T9+KGV_&$I<]G,??%UQU.JO4&'[ I
MSDY&T3Q[>%&WVQ65Y$\U3F65/]6Q'[(7#VDP&\ZSR9X?.)AF? TE(8BP@2T-
M3%5]GMX*^OC-].39QG=?NMM!EI \.%TLE"<09_%$3+$X)C9/K@TC+=+8J[NB
ML@Z?C*J%[2)X8C]LY_N8ODEA.199=96M[2FGB2F\.D1^6)-.?C$0)H6X/NYK
M5$,ZU5LI[DL#S;ONXE!^/JNR6V.PY4QT31XOMJYZF>B/T/0J0/!A>K[,V&5T
MK\L%CWA@S[=$O?!QM(5AC\] )?"Z[8;$M]601C$MDX4/^\X91%4)"([G03$+
MK*M%X>*7)V[UI@FYQ2&=W:8GA#A +EFRLI0Q@0FJAI3V*:K8V.?C"SOUSC9.
MBL5<3K*]IH0]]<TO\UX@'?LPB"Q*Y>HP+(L9]7='1;N_K/#>UV00]3H@=9H^
M5GK34?,TU:59V2Z""5:GHR$JI&(@V$'V;N?GWLG]LJNULVSA%0F6SQ*.1$N[
M'_J4N&D!YCL<&9!E)@/"*&*7Q?['8NHR.%DN7U@^I\3E3^^?H<J<EE#I%IYF
M9*"1M*\GO=M=''KJ=67/TA3#OG>'KP_IWXE,Y=A4VT,7/EGM2HS&3$\I<I,!
M2T?86J(94:K+[6D!0=8Z^Y8I<GB Q4S=P?4N;FE;FY;^BZD0=Z2NM'-*V6;C
MMNP\PP09&.Y0[>YZ]] F=\Q\MZ/F7L;%N)JU(L(Q+^/ZOAPA'R&G-XD]<7=B
M;0?(0'D"X5G.0]AB80[I43-<V*\!RME%N(SSVVBWZ+[M_DRV6_"1^0)'JZ)U
MPPO_6@N6)-:.-^A\,N @N2FG=P Y8*Y'%(FLODKT1TZ7CY&!P0-((N\N,5%[
M*H.BE=5S.01!;[WE'NRWNE$6O&W:IYM67%UKYGFR;@]G>@J.!@PI/M7M;DF-
MB68Z&W3#KW:4!ML1KB@U^<9]A6G^S,<7H^>*H1DV[/5J]-\GFZ(.$CT[&1!
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MTLM-<QSR(BL/+I["@Z)?.1#YS9]U@> E&G!XN@X)2I;0@%'WH0[=DK59L_N
M@^,.DO= PW7'P<F;![X.]R!9Z=<6OE__'HD[Y$N7>D)2;@LDD1=9%PS:0>KG
M(?52I30 +U>1%N7XS9UU4._!H/V:&/55+$L# CD)7=20D4 X0=^)!C28NNN(
M]=+#;C_*+0B2\M"EX]^EQM"89' %%!X,O:!_S" -N)L_]G/(F[Z+1WZ(,R =
M?(1!:LA\(/);#ZX_>PB&I/S?I0;?>U#$E7U3$;?6 _YG#U#\LRKAT!2>^1]B
M:!;LZI$K,L/0\JF5+Z,!FZT:?\Z:))7794VZY;L4FN218-B2$1F*ZP +%ZI$
MI;<LJ>1;2$#"^7\(XZF\R/JH%1EZT-4JKVDO^:E=ABY%K7"I0T$:X C]>11X
M$L:!G- BH*DL>6@P=/9I^D WU1;R?B.R+AITIP$'.>EUX V_CU47UT=AUORI
M/&]-.3V8"\"3" [TA#:A^:LJ.$[?]P -2&6JAX';UN:V)"V^&+6X"[)#D<J+
MJD>O<%7M_FD'D@-:"0?I3\_2 ,@2V?0!HR\/(1]"G;&>PHU3F*T%H6XUT%"W
M!E"3*;W)[T>353*OCSX-4(+B;!2..TK6@+KFK(>#,F7?XD:>L$R]8T0OKYHR
M0I^E=Z$:3VA  K0ON*((&50Q&M >@D.1>: YH@=F/.@##5XF"$DP<J%'@9V.
M6"=R;: 8\"0-X$1.'"9@OMD*QQFL]<?SO3^YHK0H>_C8>6B&[,C;D<'H)0EZ
MZ71&$@T@Z\!^[XVOOT/WFV.4J+SH^I&5S>K0,@GP0:XYYK?.9B:^.P8:.RL"
M-T]A3OGA!=T_>O.X;CPK0VZ%@C<<<H+B/YV0_GMWE6JRI-BU^6_ZPP7&?W;W
M3Z?_Y@39/_O[Z_3_7*>/+XT$#V_IN,AM3Q7JF+DH*C10)XL9>R8'T=!@&?DW
M="SV;WT1)C)73ABO\Y.]5U.$NRELZO;&<593,(JJGEE.HB13>8NX_02]]L6^
MD=$JIN_Z$Z=-0I^,IL7"E.9NC).5"NJB5K9I0MMG[89OR;T/ITOA@=%O90OH
MHB?WU(XS:VFNN4UA/ 7*BP=\MT,;OPUVY#M\2*[AA=+B;H++-_C ]SWQQKMA
MD-^D>PB>7Z4PPCO(#\B)!"]H1V'<@B([5[.&:I2L;;(&Y>/H/\108D<&(I:.
M5='+&K,9456M W7$UN#)_HP/BR._2W7)2NBZ@I5MUAS?AU1P\'M>_PIGFO\I
MAD8\BC.EPQGDMP'_BF96?Y?2@<,B(8<:@J)C&6W[-2QS^1LPV5N9<G--7O"K
MG%X2^@;]NMC#F%HH L6_3L/>;^ AT0JC^<\_V$K_@^L03J-?G@/A-"@,OP*@
M):%O" *:"=2_D/\#R3DAZ4B.M_J':R%S, @H=TTDTB]@^PZ:"@*12X;TJ]0"
MA"'4 4%%^ ]?07J5^NHP*]M2UK#?5]SQ.U#K>VQL\!V5K3TQ\G_PQ#?_VGU8
MA(9KAPY$_6*"[A\J"K1^ 6;(/V AA,LTH13;H4P(_CIJSZ6?N(R3#@O12X:^
M6W^JGZ\;6=E6P_5=?3[U>_QICJ^#9F^54$8-*;@#_PI4Z9-W$[2 YF:P#@9*
MK &GD8X? \!"O?OQ(SM4Z)W30>$:,$5/)'D=^@[[5G["/DZRTG+=_,JVX<U0
MYWS?W/,;,NV[^3V\46ZWH,[]0*NUSN%?.X?B DY6@!S@] .8SC_]B8OA! P-
M6.O_)PZ%]K(U9"SY'1E__@<RI@$X)(4'^3LT1E-#T/^GT!CQ!_K]#>S2D<>2
M(5GR)]K]K84.=[_;Q$;E98(0X\HVZB]NXN6LYX00\(^6?-)/:+8!VC*8<,$4
MGJA?!_%[4Y_/3_07 +F$@5!/#6F^@R;H?IOGWUJFJW\"6&A9U@70+[$Y/%J'
M^ J?KR/K;O^SQ7W8^ = AA8E3IL,8:(T5YSB#T3]M<7M1\N\+!VC?9TY).$Q
M50 *X_V$>"KS[%HD?6] ?6WPO&\\Z_ MKN'@"20[>N(1_2(R1H^O=..?#95O
M?V)+&;*L41!BZ3C]+K8U=@%- .(?#59#/Z$E#Y57L5YQ189^K=H/NO%;2_[<
M3_=#)(.5GTXW"G[0C8ZU)M0O37?_?.(?XK4NX+]TL?DWDU3_*:7C1AA=!9KE
M!Q^8^MD#VY]BJ <X78<?78?T&N3M^=D#_Q]2R$?((-32<?JU:@$&=+3^[*='
M%7\70OZG 9O@$\GT&](8XT;(.IZG?TX7 C2&0<(4K^]"&"%-4PC9H4[(HK+(
M0Q![[NG/2$#_)H,>AF]"_O*PY]Z?FEU^%T*:_82@L%&'DM!7U9=_JA[Y70C'
M'28K0S%Y X=8XW%\'WXA>6B<CB]=Z/--",&Z4!!:&H>7Z]#?2%[YSS52#ZV1
M4-#I5['L'R3K/TS!?A-#DXJH=UF1J?F7% SVAQ2:5#1$+I>,JN2^<[#0G[,*
M)\MB_BF- HU1$#B:0-&O;&,LI3N?]Z?SD7](H;@8^:KAW^!XOTDA_>BO&BR^
M:?!8^JF?+N6 3Z# [T(8(=U/!-D!AU(4BQ.=Y$W\F%M72%;SJPR.T_7=!\T>
M$N="YAZ$IG;PY]3B?Q?RH@GIU+6G_T$?OVJ&_R:#'B;OA_ Z _U*LZ^$L/1G
M'#1 <1 %ND'0E^D??!..PU"8Q7XGL_1AHGZCKG"<GN^_U$]'[3QKU/4?J@S^
M=VP6OL9F?VHGJ]'9[$_M)3^T\_VI"N($L&#$DCC]MC;&7OH,%:_-$-V-Z#]T
MT4->FC!/O0-C1V(3UR*X-]0:"GDZ/9&C\L;3R;+O+V0902?+/ZCV[.7O[(1N
MB1%N!+)$X-=QKC59KS6M,8B,'PP"#Z4<?3*=I[/1>?IWWB9#-T:1;LP:;>O\
M2=N0A"=4,61[("[J!VN+!2$,=Y _"/Z-M=G_8&UH\"2*$PZQ^I^D[2A9_5=F
M+E?\@[0AR-L1P:BEK> /&J7X1\L_B94<89%Z!_XKL2JHQZQPD?\EL7JP1JQ@
MOQ(K4SJQ^K>^0C#P_<MF_WZ%\-?I?YW^U^E_G?[7Z?]-G)XRB(/=RAUT1P>0
M-1CL]D<=O64T\:#7F.[)W6Z:'[=XF*SX2@A;>.6EB4H&KI<E;S#2X7L8\"_/
M+WZJD?)2-2;V!;U+R  KS0AG^A[%T #["4=GNP&EAQ@4;UCQ^"/ 2V14_(L1
M60D>@9S TZ\F'JF&>,"]"8:1B0* !@39$0LH(D8-R-7E#.2"*(S02B\HG1Y"
MO_78;ZF >N@Q)S*MBH$JB&I"+[G"-]. ^>$'-.#U=62]$MA'C93!PRFKG>@O
M'/X:U% ")VB+I%.Q!OIMQ6AOB$!LI7_S@AE%K.Q#W:4!R_-':<!'-6!Y1>X5
M')= AGB7+@\11J5,(LC!NG^-_&OD7R/_&OG7R+]&_D\ULE63GRQ.Y*RG^(T:
M]]3(>14UFW0.*E=,#BST,TM>F*@[LR _ZH3=;AQS1/3E.^:EE:]O>.8SX,OJ
M-1SQBB0$"=Z X/9BFO%S2:(!S"L#J)+Y_K+615SLG-.^P:B:?HP _?>I/^QI
M9T)W6*_[%T;]X30M"/[H>#']Z;H_O ;X4/BP?[HN_4^OK9M?,O7_W751?ZW\
M[VCE1S$&4!B/9 )?-)MV^RF!@XUQ'E2[A/2IR:PPQXB.%Q'4,R_@;\_NJN<X
M;2<IOD+Y^O:?*7P4PSX,UM=Y#AQ)QLL;U'G&BR'B<^W72[JYE.K8%+7I&CW<
M?NJ!^NXF#N:%?[&>_F?[_*^5_WE6XL7$*"E55FG3*[;I;L31YH'&DHQ64^[)
MOI#,+_Q'(P4:M[7H.(5O["J^'7!5>ZRZYNMI2CEX@]K%E=Y;V9.] Q'OHMP\
MG>2KS"-2,)H]R:PA-L.YE=W)]5<EQ2]N;O0*_K\OZ_RW2(U_C?SW&MF';O]Z
MQ\*_6GK_(SSPU\C_]XVT1F/A4"J'UWFH'4F'4GEC?!R4_W,=\%O=7"N.G$>_
M/6QT?Y=QH(CLN^/ZP,37$TI5AQK@17UA)7G(4]U.->I>J[JEE>5Q>'FUMKTC
M$CU6+<SI(Y?;"K4'5+FO;M17;V<J^Q^<H/Y:^5]J98$1B, ZG<)1;[EF.0PK
M]9+=W>1;+!72"]A<U1V,>0_7'#;.?W7Z^6L9A0^C .#Q]>R*]7GB(1S373]Q
M1])*9"S1HC%E0VEHO]/@\7:3U[623!Y[RE NDBY; QYQ[0IKNJ;'E/77YW^M
M_"^*7RWP% %C#KI3LBF%1/Z&%,U5NP>?D'5:I>DS2:IS"^2[-JNK09YV<PJ[
MWVD=6%DK!_+O^OX F/^_+>/\MTB+?XW\KS7R:=YY'Y_+:3>>E%_7RMN;>NBU
M5JU-\;K8/G^FQWSR_]^?U/S[^?OY3_QXZ<Z6$4<1E"2DG9-/<XU@49=+21A;
MF%[:;9-0??G7<=<CRG8Z1SS:W23@-HU8YR5#9;VQ:DX^VIG1398D('2))DGL
M30,&;3QU%24?M\N>L1'TFCN[D77"8WS?.9_0E4$J:S4-V*8["ELA=Z&77NP@
MH$ IHZ;Y8,0FI.T(MWV* G$YD"R7;8@?3'HX\[G:=N"=W=W^_J?WI"*?9%]T
MK11X&_V^G4D>AP1WRC1$K?>:VL0Y"J^KM!+CNZIXOFO6N7AU^J+,_%T%JV6;
MU2?Y-W7\4&9>B_4KP;<>$^^K51>0)1;M1T];G7G"QM1_S,\N\2R!WVZ_AMP"
M/Y65N*KMNP=LR_=B.$90*;#!WS32,2A%]RSU<FL5OKVP@...E-JOZ\S"%OWN
M[&@EY1E9'X^XC28<1=\>9J^,\Q$U;3C8V[NRG2E^Q\"5N(F#NL912^Z2D>N8
MLGG7=9!/TH" >H>*OO G!,PK3+ AOM^SV*-OX)%2ZW*XTJ*.'8?4X*WH>';M
M3R;/\Y#8W!&A&CY'DZMD6U B4>=!EV@.7\1<Q'[M\!=LZ>+WPL=%[,0ONA<X
M0#JUR8+M9,E5I0'PR\[4V ;KG945]B[]V@_D'R=C]4Z3K#H.W%.+&]\GL%(V
M.E);S3DZ7N>RV4O.NBAH:L2XQ+TLYLR&O'P5U([K4K[YX=J,/I%W0@'$+;2H
M.FSU,%GC!3$^H(3G9H;E[E"]3U:Q ZTOA]C?Q);T28;?TV;D9I99'#E+J4([
M.6I8KPQWD3P79R^D' Y%@ >52X=OW35YC6*2% E=Y 0E, TY%/[1K%!?[J["
M3N4VP8*J()M;;BX2&\YI'+OVEC.?OQ-]:8*!.%@+)YA$#=CA37(4$G"P(#%^
MHDD&^[8Q PV>^I7DCV^X+IW:JC?W,)!]0M5&\-R!T!5'DCLE'WUY1/BLKT$-
MF$Y(@S&:>7G6]7DW);BYXMH,C"+Q<UL?A"3B3XKJO=GQ\@I'6HT.Y+,=R#==
M7EG4AI8"BD)A02]Z@(&J!V^(6MU2HDB1CO&'*_ARTH -EI2GFC)65A9>!W!&
M060S5X< @[O7X1Q3\06LL?[O)"HN/$[9X_@<2EXKE#+TQ ?T0E,?'*3X8F@
MXR2EP%=T50*L;Q(J"[\^Y':RK'?GUI(R*P[F2^X7[Q4J2,?MVLAYP7%N!+R)
MJ.5<X:L11V(KFFE K"S#!TU6W^M@,MZE_T #@HNZ%3P(8_8:-RSNGHL]\K)+
M(3>]L>H*(2[(;H^34U5RO62FW*?Y]V54UA*\8@1**->7DZBJ3Q@.<<Q-O6V
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M$80?YFJ_F7E#EY&;*S;/81\^0GOG3-,HZ^/U^NJ 7"(!3N:S(:6#R?(?K3E
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M>'3ZH*'C\8I>.$Z\\U+-02>7S7WC=S4Y^B6E[WN>?/J^UM+?^S,-(/,ID>+
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M0>B2G)/::H-IQ2,AI\!2:-!:K;4?HQ-LKE]@=$5O]6?,=VLGHU?I9WJ/U<A
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M.;XFEA)(AT.)B%G79PZ:6WJ6^ AE$3OSVO#:C&..CN_7G?&(N+O!S$#AQ'@
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M0!J@.GRARRTAW-2>"DI3#AIV).DLTYM& UP?TH"U8Y&:2GNK1,NC*A7R%9!
M<O2&LN]3A+N$PHYG$].R_3],S[X?(NGGWCQ[P-62BE8<$3SDA"7EXZT@?\V9
M$U';='Y7F )$G*?/(?O15>MD8THF4N-^&R\^-6DQPM2R%4^^4)JQ&52O_D,^
M//=E8HQDMYO?Y,UD3[F]7]P54 ],ZK0V3AKOWS6O-U3778_?:JGF;"S=SCYV
MWYI4]NNU^]4ZW8KO-  \^R$O$#Z]UZ$E3:[V7]03N9S^IKF6?>@U4E-XZS@A
MUX62B'Z0$KPPV*U(.I%4@DE1Q[E\2QPGWW::?0O=_6ESYOT7]0IQ_B<%W)]1
M7A4SFUCNCOR9\YUTT*IA">G2=I484QQ^E[-!'5_<$7#^P6=9FOGY&,/?Q_',
MY=X[G\EP2BMZY=0\0 _*@UPT8/WJQ%;L_V^KA>!?&T(AE2V!,-@)J0E.HHJ%
MJ'88"A'XO9K&>E]]F%')C B,>,S[]'J=4GHK_OSNQT.[C3*D^&6LLE(G"F\[
M8&H_H:EG(&Y>0QA8SM8^C.TT8E)Z=6(U_:N-J&S&?<9)Q&7Z=*M3RI 0>TE8
M+_38EH8RW_D$OUIN]@VB6G3(]=_]AD-[O*/^(ZT1V21>ZFP8-RYAL=7<SM)0
M@H!,%=@0NVSYN]"D.S9'N/WLDV0>DUL+$M&LE80EXB!X_"U9D6!*C.^&LH'E
M[&5:V!F2L.DH;E^T(KCWYK?=)8_%>H:LSDAS.<![;XG*\FDQQ7&/&$<(0A\S
MRU&.CUNN:7JI<OU]#O9$HGHXGW0Z&I??"D1PXC%4-C6"8B^D/@73H3? WUD9
M8@OAWV@Z,V_D]5BU)=?MH>S=WPL?]I;+EZJ9%8$@BE!%^TND*IW8,: 6/DBI
M$7:>*E=4:$0(]X7]J>?QJBR</>>U72@N."?PNF&C*WEB_E_D$0VA X^+1\"#
M;MX*UY@@57"R  2KV)<V/>( PBK6VD2J?YU%UR":WVB-KZBD32U/O_)L"%P.
M_&OXLN*7N9R9FY><^Y5K#J]2 <9/"FA^U$+V]++4*0JZUM)C3"YUXGKMV#;6
M/)+KDVS\M78^A@[1#LU#.ALZ?A(<.U*D)EH2 L=JL)*>,*-%"O2U%BFRT_;&
M!<$G_[0??BS@CM4_.FMX#9; L3L\-*#S]"+\Q&R(%>9Z%N>%#6HGX;=WQ,[R
M*P>_%\%5*EO !0DNI7U&(ASL8NX;C&KC)&PI,3W>O!!F$<A9J:#CEWU:WSO#
M2L@F4'05L%LYV)H@2=%?&4@#F'Z"Q5C%RCU]TXJ?@2G2T7[^0CE.=PNH?U*(
M7\$-";M/]-D10)Z7O-E!U0)AX8;K-8T33B/IN8I?LWE_%@39I+O!2W]'&HY2
M/D,?<+-3O]$ #DQ/FURJ]]\/+QV]IFT^'7.:B69E85V\!5CHKC%?,F/>HPY2
MV=)(EB&'T[[A[>AC99K<;"8#N2\##*QO7&&SNNQ\:>V5R$ER8;'5V 84[Y ?
M8RA/..A$GP#[+M4TC/KHRSX*";3P=E<9ZGCX!;OP<>/C[0Z#)Z]T@/05:!6*
M+-A/]U$.0V'0J1UY 6_R%GXBQHTKEZMD<43@G?W2M<^[%U>TZD[8EVAAS7NM
M3C&N#4[2W>[..^I(WBD:\ 32(R86 NU3224^ZE++F+@V^;[HUBRCJ<Q'Y<KJ
M9T5Q2X)0LD \<9S0MQ5.7\ =*L^<4M=A/ED.-@WUIL[5Y[GD>Y)4!E6_Y^A[
M#B)6#81%5O5A'; 8=!4&=YID"DE&<R&E-Q.67FI>F?B-G^4W\D@Z([C'6I<U
M,W!_=G>KW$A=^P>KR)XUJ!),'H*2Z, 8%PO<&$(MO,/4P1,"D@SLS$!&[\_K
MP>EGB1/CKISC'Z)#)MU=)/W8JM*_GER8<,+O$+&4*L1E F/7!=MF$AU3>]P/
MGGY?5D;9(4OG_(!YUH?:N&>&_[ )^N36&,4HJF^C.K5#91O!QR]JMV..A9RW
MPZ^FE =:,IO6C6Q[5%56WY<R6V+K87=1$ORZ=(:[-GRB P*>@7>FI=&3/C=#
M"*J+JEX]KOG)52ET7TGI2OV-RI;X</G^+R*7AZQU"K@KU]ZU%!,_#+?);N8S
MD*\7D^6;M2 \*K$UCH&_LG22K_J]XZ_[:VC3+14,#4%Q#R0"> AX"D(6$(6Z
MZVBD<8<H![B@L,=GWSF52)J9:P@)15D/G.F1.9<^63XV]TM-=GMU#3Z5C0WZ
M1,A?@$21X64S4],;T[]?9P>?6U];/Z8KQQ,U]9)+K[*B-W]&CR@YAG*G ;%4
M40(\6=]%,;$E%.OK>FM43,&S/NW >/)O%;>Z%_MCESH:T#R/=J"#\?R_Y_.?
M8(A,273(\@ XF/ZWB_F_>$ +*ILR*3B$1#0FQ,?\R6?VDA(?+=M/8BTO%W>N
M:W@QEG&Q0#HQI%W$H*.BV7N7^S_O*IU801^QP<&6X3MC)RGYN \C"K%^LJUI
M'3DCEPCG.*J4DI(%3T:SZ)R<^(SL0^%M7E*U$>95((K WV6;)SBAJ8L<_+ A
MAJ@@>OGI]K2D?[4P^6$BL.U3R1[5&[&S@,'9X6%=^8P(UA/O"9X=6MFVKE(C
MV(9:.(_C*VQ@78H#QUW+F2@FP5ZC$^A3+;Y83E5B(CTW9SMN0M@7TFOF8#W3
M >,WNDX,_X8HXH3#N0QO#%GJ*C(S9<;D "2Z-\N2D(A+E Q#>="[JXU[B'S^
MD\.#,-.9WYE.M0U9QID_,_1/T\?N?'*#]6=H14.+:.D 5I5YS;'V>V^V\#B/
MR]7*8SSG>TLO19OW6HLJH*71"W7YNZ[ZS#3@[@1USM)U?V$0/)O= ><"H9>&
M_1!J2WT-E5^BQVV3K*M..<C:R)LW,XM*W&,#?OT/.T;0EY3PS,1^RGO]\Z1;
MU%$I<4+^DZU 7ZA%ZGB7];G-<ST"U'O!?&HZJ>;"?G(B?ZL[L.CP%N,*>]"N
MZS"O_K-579-'KK?RRBAN6*?PTG;?Y)E,\!KSZBIND1ZW3Q'RMU8(G:KQ&.X
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MOKX+(H8ZTKF(0;A_0/F$P&_\*W/A3DRXO:??L.-NG:=@)Q+R"]^ET[&0#O-
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MMAU2<H9WP9QC\S#E6M9K!=+/)EX,>$S=%*=*%:C#6T)JJZB^Y*SR$)L[8PQ
MC4K-BR^CY>7R;V\:<%MVI!.+;"M?2*P>F'8_!1"38T U=5OQA"K<]K/%9B#I
MD?M(@(-(-240V7(XIO/IC-/@M18U3:5N5KG8;O5?R9NOB>R.?\IR>9MSKTLI
M$&@+SSLG#DCPDER(?=\#;V]?_=LW_6$;8KY)%O6IUUQ?+QQR_)'J3"9IAA*$
M3T#XF\!+(%:O'- HZOZ8&;*X_*N?[BFG5*&HL=[HF^]-3M7ZM16H?6<=PSQB
M &8H1K3DP#+Y:QB"60D>NF7?B5+.C\/KA&FP3(NI_<4S$\VB=?7<QI#C0R]P
M!9,%SU$L0XQ,B9]"!(S2CS^=4%V<"#@-%87T ]+]66X/\AJP'XT^RO=^?$$8
M[!J&P(:1@@DQD72%>0-@4K7.F>?D9(.@M]>#9"S3K_WBX^Y6:;$3M:GE4!!#
MJXW].3G'5$^U6WT=14M2GU2.-H%ESI]WV,C,>2,W=(?0+EYNO/%+#/"[C_2&
M;.-!X:5/YTA](3O@N>=<5F]!E:VQE_+O!GJK];1,]_:<U/C!_=W]-&#U/0W,
M + -,@"9\LS%"$/[@C*CI3&?]*9V@8LNAX49D+/Q'<2IEZ4^;%OY[_DPTY,_
M-9;KT^UX?[\S[V?A8@68;:<QS;75&.&"E&!J2D(YTR<?GX"!"Q!M.K1<$F9K
M)A:_0$JNW-RE%KD-ZL8,^DWXY3QF&87W8*K,VT#\]#X&@%O="8*S>1[H=.=7
M>^W=V05G<M"@YVK*ISN#VR/I#^133;ZA? @+FQN$W-:&Y?(JYN(>K7]\N";>
M4-FWR+.!+;^Y0[;XSIUK"1=2.26D7DRM\L;_HPIL%4P]SV[-WJA[PTG1M"KV
M7FU%)3&]AN>$82[7RW@?04M> .N1V@#$=TW29-7$IH\*DSDDZT^>70IE4J<7
M"P[>/T6$'$7./5%K_0 <CSOS*0*L 5ZL0^R:P,49@.\^"-H)Z#KJNSS]YBI.
MD_;L% ,PG%EOSIQUFXE+0.Q&"YU_I E4_/"I]V1*T;=@G8W7 _P7+CH [IZ\
MP^^_SA9FL]E'Z+8DG_^3SXYC<EMIN\8;:&9J^J[Z(/C9++_)U?52([WQV^R%
M?RID_D>P^0&B"E'H-WS;52FL<XB?RZBIWG])B<%!II :B#&1^[[L7G3Q,>^]
M,,XR'V''K_6QTSF76S[$<;*(2/9\X 7A@JE\.XM3B?IB9*,.FWDYXGAP0VV*
M1Y&YA# )RO]-Z:P,V['A5U]=$U+]YM'E-"9G<4&\6*@Z/M'U<;'YF$&YH^']
MU_;CJYJ:<+LN"UN<A=FQ((75A%56J8\$3+NF,R?9$Z?*NV#"4]=@F.)Y7S?]
MQUNL\4?C[\72_'G%79>U-A4+/P"[%LC*A=2,9*:O_5[# -3=M?DYU8Z8]EC\
M$QO,/3M+_8L@V=F!M2I-'5"-?O1N+D'!]/SY/\'WZK]6J2>-2*SD*(H#D_!-
MO6P"E89XW*H<NYC\Y9947:#?R43Y;-EW%B?YC]3[C4>^)T+\0M2,LMK1P.'J
MK/3$;:5'TC5IGV0_NB5:ILFR)B1=8 /\R>K7>E.7#8>, =<&1^VA.,G^)@1T
M.M8YZU+%2*E+=42/SP,VDN'GQI>W.;M"I-(.8JB"64LV5(6%::]?[:1@*>N*
M)=.T41F.[WY>X- GW[?SK5S ^[,V@A1?)I&GG_I3ZR\ZGLC:+C85M1D 5>36
ML9.>*"]WK5<^.:ISHF*F83%&Y'?#:K[#/_8VVI!"""@#$)<C-1X /D&V,2$$
MQ=]3]M[:URE)>2*7>G6*?],TR/ER[.6%H71M)@]1IB7#5>FCF"K?"-1K7&%+
M"4K 4U\F6UV@;#[$U+)1D^.$DLNE>P&&+V']35)N\-"E7B:_\16DWB<N=% @
ML0O\:/%YJOKD]J1X2+GK\$Y CX]<!"RI8/EM]<>KP+2&4\19!N!*#I" 1BXB
M.'^B)4;O"QTZI[@?CRJ]<8[_S*M3P&_70V*V)BCGG> 3"RS;,)F\65N[D"3L
MX8+%Z';-Z8#GEVZ_>;SY<I,ESL2(*W1F_P-/LP%I9@2F2A$G^RXUDQ+#RVWG
ML?;Q,WJRW6]5WO^^$ZW4<M2N]>9NJ(3-6<+=#B0K9C%_'C"N:X0WCS[4S1S,
M#IH4#@I.JO02(BZ*(+?X2I\<#5R+3"CAR2[(IR4R *X80=A96C;,B1"&I\Z#
MB$;1@0[OI":5I;;QE[_<C# 5$/WK98'DM;A>D]G-D):A 7UI9K]?A=TD^^'7
M]A'/P<)3ADDW2WT1P8$%SM=%I3<]MZR:!@W]:[1YS[ .818+0%^0;0S =&[+
M(2@!QEWDO*:IG5YP\1=N9B;W2:K\FVWWJ+>BQ]H^B_N?^SWUZK'X;!ZQ]NL2
MTS>?VMHNP8O*U8_;F&A<77\@MQI]_*:! '^HO)M77DZ^R8XCT_X64\#\]%/D
MRCYK,HX827G*X7#0YQX<6.QD*O7$PJ.!<WDU*:ANK#F\F7(%/EC8#:D,:B8@
M6LY[-O";%CBL-3@&5QJG#QN=K#C'V\M<E(/4!D52GSQ]?1ETG&GB4O3C9%:\
M;SL(-!?2WC(O3G2:**_@N7VKW%/H()E?Y(*5O:5+KNZBS4]AZH7@5N"A#((I
M:PD93/^V9/6[;A%!EAO:<B+TCJY,M3( (M5@+OLYK?20 +# ^J2GXK.(_@J'
M,ZY)%Z#_1&058K'MKM#C-=7G9V;:XB5N=WRT.,G#QJ3O+!%LILY6_^N'&T["
M7=[L'?,*9'/\EG!KW62#1UR@\H4P/>U#DI%QV4H*%R?WJ:KC7V5/%+[2^@ <
M5)UQ(+41,[;.$@WHHF.+(*R*Z]=ZJ*2#3<6K7,B%R-5KE<#]H![6T%2$U"3(
MG^8Q :X ;8KCDJ=!5[T-0UV([!W*5UF$/I9MG=*ZO?A6^=FR:X^H:_03%BT1
M*RJ- 8A1@/DR !\+F3Z*SN.+^<V+>@@B&((3GSHW%CKWX9,!U=93Y_O7,Z/6
M7#ZWO'\PA#K)0M'\#]*&_P/_)%4%!&+S CZ#.*+.%.VFI*"I)C9<UH!&MRVF
MOCK][+ZG6](L1Z&)N+]ATG3;^_OF^F]8?J.8_G#O'W%LVG\"*#><58A!-?A$
MG3N5Q*-82[^'&=8C5UU,H9X&?')-,4%KR/=+ +]Q9#V<C_EL13HK599X/+VV
MX4$)?L[P6T?M%MZA(T?VE42)2&Z2UO>DUC=)[*(K=9A_V:WYEW0._]BMR5W7
M3MMY>?H?NS5V]_GT:O[LUIP9W!K&B'1QK!:!;M]F[\00;""_U?0<Z.U"H,-S
M4V^9#SR#9J-JD.,I*D.?R2C<3A3,_#/PA%.;:DVV$';;3ZR;TW+AE)KWT?<\
M2Z\A9O0Y<-7"2XSGT#2=TC(OU#RZJ>ZYLU6>[NUL)Q.AY)O.EILXH[6V.P'Z
M+DSR(6IN5A!4(&SD<HK)N+K1Q+9J!_;B:!][QJEKG]5D_6HW/P[U);T?9N]#
M$FQ\GX-YT6+T ;3X.%5F$<A-MKF3U5D[.>K\,%.]YOT07U63JVC(B,F=GA@?
MOS3V+ZA[M$CX7YY,<\4LOM,7)>9\1@Q?5-:QQZ3Y1\IG%,V?NT(?.W$R[$OY
M&)U+^!^WN"O)JI_(1FV:A_K9Q78ASR6M30*_YL<)\#LX=EB*X%]MSUWP2[@G
M]91U.4>:]I*N_.=P]8" VF0 /FV@!>NF<)CT6UZ'T+ZTJO3Q^5FG/+]S=2H.
M8:W9/;D_[@]>^0 <0$[7X=F[PH!)8G5=D",PS0;R._PSOT#EB=9A5*!B&#2K
MK,L$.#U]P]@JCU5Y)"O2&4F!P-QI!6!/4$Q0+=,5L#F1?0T)M#XOY(PU7&#"
M^WCERVE'$Z5=;26W$P[23^*>G/,_1%#8Z7UUB,K@EGKJV5+'M8-YN:9Q^?%
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MY?'4-B85YZ$NGOD4!_AO4.3NRM$<T9<BP\.A$$RR^1BNY8*^R0,]0<LG_>&
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M=1W+39R^%O;$(:R<??#\E)9^VF[P\ST]_0726/10R[WR1(^B*J <_5KB?0;
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M#%AW5Q5"=#UP.S.:[6@N@GE7O!9<4AQZ6_E4SLIQ%:<1A[G0Q(BWE++JO[#
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M$/_D=,ZYRX;JL7:8NQ.B1C<48 !8&8#13[<_Q2FN Z?_U<;$_RLXV_/?[QH
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MB<E-Y\XG*4!OO%\RB]';:KS0/=DVE1O=ER.3E8;VG)Z&%#32:'P;@5GX6T_
M/.1@J\G3=?4-,>;5Z5N+-;?'C"L^/BGB!%2P OB/&?^P42.8MQPPV0-:^*&^
M^/AR7<YAVR4A.V71S%/V-G[5E<4_VXL$9XSC3UW0CC$446B73C9P=DM-R#3[
M2>X=3M1.?2'7_]I3GXY0^T%C0Q^#SVEBFR+;ZP[AF,(\;^7Q-AW3;S*/(A8[
M96(%C0$[[*(0"V<!BBG\VQ?Z@)AZ1B)5;DE\W IM&E*V;9RTK7&O7^S271^\
MQOO$W"3HF+X, ]#Z?[#W7E%-?MV[:!05I5KH+2H@( )*EY:?TD' !DB-BH 8
M(0+2(5%1>D=0:I3> U)"C_0JO?<D(#624$(@(3GQ:H_]??N<O?<89^S_OO@N
MUMUZ9]XUYUQS/D_>->?2W#>&\IM@.3]E7H]L@[V(ON'M(V]RHLIA3%?Q3AK4
M]J0\,[]2-)0..$4'D!-QI:]F<%A0>UBUX,L8MHIYVPU>0=_#QP-%O*J=?EVV
M(DGC_'JR&];>&H>Z34)>ZK&\9,HC,N+OW9:-Q&L_-F4+O9Y7V!IEBSCHPJXL
MZ!?[!<2H]BCM3F[A*-R,0/,/%93VMY5^"OSIH<^(5= 7BAS^]E3!+,JO9Q)^
MSWL3[$$U)0NDHK?6"P+E"6^J1^_/:$,<2>M">M_%]<6GS;\F5H>KWKY6!.M!
MG]Y'OP>RKA(6T%[Y"V##0F-?L=$7/I$.8J_.V)U?E0SP][Q?Y-&QLUYH*C1B
M.Q^K3@8Q7O*0D-\6RV6U.;-0[8Z=+9:P*L4OU]@$>,5Y""=Z)K?P VHT[R"+
M);/J5B0DO%WY"M9B^SEC%P!#R\=UI52U9.,S\240_R<-J(])[*1@SG3][\^W
M8"60O3\+"]+&OM\^B(6<_2SFWOG=G(L- %@#X,&2@?>.$S7 .+F98D-RBF/!
M6OQ+Y=3D-%_2P:5^V0B;KXT_N70L)?I4#QNBXL%6$]5B.=E.NJK3E;N52^F1
M?RET:#A^.^59PJ[YQ"F;F!/R_.)W!HMH.>:Q9"G7D0WPA<8+.3;/;9;+X_N-
M]+87>KG/:/:[V@]2[L$ZY0-MB2]@BH20:M[00,N=<]2==:[^=Z<^JYWL7CK-
M#U@^,13CAPX&E0\TY08:5A%1#*MPZV*#C'H=ZT+XG%.7?\G#B_V<4LS#;)E0
M0G&W?[9,FZH\:N[NZ;1X4[&R2+A?*@OEH.J0O=Q5%Z%GHH717X.W%14ND@<K
MD:M@/=J\O=@/\#3$YN5OP^?C*Q41$[IN8L=4SY.:'O$598.DF./,/>2,8$O\
MNH\/>_ZK&ME1EYD/9=OBW6W2<D11@/P)YG<!3ZDHA[\M3<CQ9;8NJ981M"O6
M)A@[S9K9EM/CO_KN -VY'E[->1&K'5MZSY%?<GZFPTC>9-HM0&7K>@79C&13
M.5[MDETQNH E'9==>UH45YSD[# %P\=J%G<U/L.B!6@+]HJU!%1PWQJ(K:JN
MI6$L[Q1K%#!I[HU5C'P\1SJ/:,$1)Z[K9X9/!_BD(AT0LLCQI^J8IY?GPSET
M57X\=ZGH0V\W@[EDYPL)!OQMSJ6!B0SB/4K.H /N+)Z#+SE.T@&B#YAYYF8K
MN3Z79"6'+@+/:5UZ"3Q-Y85@T)PV7_'96B]&>_I1\G%,QE?^=#%- 0!+EL[@
M:[!NT _G2#K F0X0VE2;#/,2OK@SL6NJ[)Z7HC&B"E<"BFD8W/JD>:R*+-G,
MA//$_!Z>A0"3[97_,C/6;-(<42(87D4'5#"P9K4Q>F^Q\I &_L+4=Z BZ[F"
MVV9SUJRP'\YCQ 2YK:PZ"S0YW-T3BDA5=[WRS$/S:_\2S'S>UYGTF.@630&;
M$"V"]'6AG)KX^>Z:&+_HA6G7G'"]T?/W0MZ8#8YJ^EN.>S5N5#OR#O4JCC8D
M:" LR)!O5/'C# U+#)+#.LU.;58;#<U &4I_!;Z-F9^B ]X! *<#_W:I:41%
MEVF)#3RXUUWO(8V+*W$S!(:;4S\%E>)^L> Z1,X0>2)?$KN\"M8GE=TUVC]:
M)ES3O?&/&%M\.M,>DODX&NZ$N$0;^-MMB@YHU8?G+- !KX-BNVE]J5;*A_8P
M/ 5WS_F7K8,FIRF17];PVKZC*H58T\5X0'@*2>72;LL1 N)_G77?1R&'9PX5
ML,Y;*5@Z@!\V;FW6WB>CKQ-YIVJL:K8+59OY[.W#N8[?@*RK=5I67;_F7D0<
M#40DF.C-AYX:]0&I-S+3 5)R=71 >5XN'9"C,+D6'5B(04P_ZJA7P0>I=%CM
M"W,W:AR@?*[.W/ZM$N!8DR N>.^./'\+"'1O?QUL/E(L?JUT2BH/"5L=!*%0
M,YQ;O[! B?Y;QWF# ]/IKREW@[9=9^%"YD"R1!V*X8#N%3O*?N@9%7O80L,!
MF_.BVV ;]S;L%B$F!3?(N@$3F7"EC>:]NJG42%QE=OG#^9SCK&;8F>9_&/DR
MB(C <!0635-5R2EYZ\U"8WR'B-=ZNS6X$XV5K-_B.%2*I7 H(_=7]Y?=6A->
M!4YH3/R<!9*E+@4E/HND^)O,JODAG*$*Q,4&K4.D.;F.8DZ]0^3MTB<_(F2-
M=,[>#_&I"KI[:+Y@F*WG9["X<_6RQ09?1KZPNSE-$-:F)4WV)%)TB&%$GK3B
MM62%TOY=.Q/)YDR]X$O*@S>0\I7Q7R3<Y#U3)\E]%%YR]F,R PY=:.8GYPW^
M,^&,P'OH%O#>X2*WJ:F)+JL.F'\10MU_H^01_&K[>^HCPR.$/&W*_@SYT](\
MI,TC4)<8!9,91WY+P?$LA;F:6]TYRU*PG-FMM;VR%XHOI0.N!2P-'I%'07O)
M1JM:XK16-!=,HH6G#LL99NT3IO%\Y.P\5*/[]5+-B9BI"!V_!<^JJW(W_*XU
M;6-]?@KK8U>W\#F^O);HJE&J]C/H*]WY0A?7YE&V (7>XM=/;6KT_I!7ZKKF
M)Y\^@)'2TE=_ H'35)GC<$4Y[L76 YX9>X3[K0_RW+G0JNZ"=YEI7PL&7T]^
M#KQ-?D_1IDWPU&?F8@;/KXLP$]I59%[MM)WG$+I>H:-N?[?%SO#V@T'F:F_$
M.;AC;'BJV<=]SI.^NYUJ3M\).T%JV %V.>,;.]IB,64_0GT?K]CR "H B9WG
MRFQ:0!63G0P>2@?,U,M]A$FZI()"JOD5-,K#3[?@F^YW!J)^"N6\(YSQ+3R0
MW;<$-N6EBCRB\$P-YL$F#RQ\+%T+[&RBC:3<%M7SO>;X!PQ7PB0*-\%YU<2N
M%N 4J@-]"J8Q[9O79S/B!6=K3="6F'%,5I^^:.!=^?H"URD#CS.T?SH](%O^
M U6?<]_:B6%+6B,D2]C_SU/"_XS_7T:S&MF!<M57'1N2AHV]]*H^N0X*#\*!
MN/SBIP=9VI4AJ.'H[UD.P\P/_7X%1=J;4QCILD=MG [8\B0ZTW+4HB&F.>M:
M+]45D*R1R."TPM"TR%<SWAIT (V/%W-P?$;#F YX;T$'4)_'DI^"0Q?W^(AR
MM-,V=  QXL@B8G'S:^RJ<^%Q4PH=,'@(5((SR.K?,K^N<#CA^B*#K#Z@ ]A8
M"11:L,C?FLEB..T6V&A8?_(6<*"-$J! !R!VM%[][3+XMX+P3NS?"D)S-!W
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MYTF]<4P$NZ9@<)%Y8UJJD)W;2X=6FXL$!@D]E+)GH@/*=1:/U)I_T $??.F
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MPVU$CG(T?*JK&3+W5M/3E*B<""ERX27-Y*6]S7S!F^Q14F'47-1K(+H.9H*
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M)7KY@]H']4EU['8XC8,,5ZJRER*ZA6(*W9)23XWO2[I:WZ]E>VS0]H:?OZL
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M&][?;/(^>%R5T.J;%>:RT_DNY*$IGHC2\.YX31M!_]C^!&.G:@;;#7NQ/]_
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MQ3MSR5 DER/M6L]5#$[[O6CAECEK.JD3,B*#QU:A8LY>-7@6?E?,O<!<EPD
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M*'\%;WF'_!=KMX6"^*T>%Q5*L+CA_] !W;O$)S.^?'V<P5\45XAC&Y2"0Y^
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MBT(T-8M&, <JX5Q>XT97QK\GZ%>']Y6\_M'H>$?3SXQ6OFX?:A\D9'[CAIU
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M 9N]!W2 GJZ=::.TTYO[/BLF,+8T:^9FQC:_!5J>P(.VY/RH$XVL-!8\ Q&
MV^!'.TUTP'"\Y?]\QAD@36]D_\MR+_S$-IIPS^Q0J<&,PKH 5T*6;"X/DJ])
M4%/G\X\_;8-2)R>\< [HA2+_2H.M#Q&291<__)?7F_X7C\9BD@L#;_P]V3>U
MBAT\-O 2V+<FF+T#76H4QFR?WJR'%6-_<=Y#AW;"I'=EH$J2SY,4L.QW0E:<
M_I8P;ND^C$P.%[B;OJ%^5P8MNK!6ID+CU6_;/A)I5*(#@@/@--E8LAV0$[WF
M3YBDL3/L1JY'.H-6G!;-V^&#=4']6P7_"T]HIM,!2:'C[L#=/V!/]>O2T73
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M$:]S^ZYVOF?R\/C I:3S.%Z *7+2^&>M2[>(I]YF/YFCP/=RJJ!/,399JX>
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MES>:L30*4PRZ:X8H$2(>G<%/)RIP/$T:$,:]/DQJ'^)6AL%D0ZNR9C5ZO^C
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MG1HH]'E\"9CNV__K?0LJ/%KQ6>U-^N0[H3YT^4W*BY_(+*AJ0S+"5I]S)8B
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M*LI/#6+8+ EYSS<-&E/V@S:7X/+/9^;Z5;M+J&Z4."9J7BVE-M3>$LV9"!*
M@"P0EMR@'G_NTUVYGL;&2=O$AXL?C#\/0;=QK[?55#&-3;E8WZY9M;* E:G/
MKYM2AF>U0HL<12B3J>\P4V[)Y^BIG*]N[N440+FQ;FXH566;EN;)V]E"[H;+
M=_.C9SCSKE)8\;S5\<R&%!>$%@GU9?N\FR/2CH3THY-+QL^PL>936$-3>-5)
M7$O9?\_#K1+#NF$$C29!]LJ'-W;K6E(;9QU.A+WE=/2,H)Y, 8D^E0'QVJJN
MZ_J?@%0RP(A%GA]3LB,1_J8A PN<3N*'W1J;G66LG(6/HAN5>-2+=&C9AG<&
MYBMG76P8>;_S6Z^**)2^6S\W\O4_TR7R%&TAPJ'.*R0 &^$[CLYZPKNJ;O\8
M45?%^^,([NB^'^V951%]VG%2D8Z!S2"6Z4%4;J?]^_BGV7P?+2Q]M'GKKY?2
MX >O/X[[(9^Q/]'FJJ-.R%>114E&L8$8W<J][:<K-K,7BE+80YN<'K'>^11:
M[9,);<L237R?]"59W' 'XHWV3'8IN[3P]*UI:T5!PT^?F?E3EPZ,5ER+U#*L
M#M:IA5(5["(!7!;68"Y@#;>-_=[]C#_NO>O#2NX\#:U@&EB' 6@CC<R.]4D
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M<POZ^V?_9$CG$VQE6?2H#%0$%7"E=XP=4VJ1\\,YVRAZO*  <0Q,B*( Z+S
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MO/\43BAZCG!K5.T(3#?HYVL=I:DMI+++'2^FD;R?51P<:UGG.E>)NE?LANE
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M:V(*3+?2G?OWPK<F%?E<Y"-WZ<]YG7LYE;EQRB.XO=E]W21DK@NW<?+06?C
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M\,T!J%(!;8Q%VH,YS>+'4VS[^9>=]W6LJ.6O12SL?/&\U5+\M39'1[<@GS^
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M,:D$VQXVCH ^0:KUG-0)KI?DI-EFQ?%E#_M>W^CEL=YF?AK3Q_WB#'[* TO
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M\VLA@4'.^\N5!>?6SG.7&T_E*<T4?;#9#\CP2Z47/JER\PLT7\C@FQ([J*$
M\,)N)U"MY-M#<Y-C;;@ZEFG007:N4=7YC&YOESI[AEOBIH$1#H^'_C@S*J>6
M(Z]5B@3]X6DQPB CJB@ :]#H5?N34N1LU?82@^9ES)[U8KAA[WSN53P' ?R<
M%!?$;#';]!P?%'"),Q=W$M;F=4+M#?EA9.,H]516PV$K +]#IYHJ\Z;SL7,?
M1#7_=WP"RA5-NXR,F6(TL??95RZ\?L^3L$$LC(XOR>&[?\*H"C5DZQ*9S>F
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MRE,H /M)4 %A\3(%2'Q' 5HIP&'!AU.7<A**^S^VF(N8WB*ZG3[^$.=VH!1
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MW3&I</#M%\ES PA99RCF<8-> 6S$ /34S,YNU3KQ-O*X_^"[V>96P#Y>P?=
MM9WX'K8T]^<,7ZNG9& X2E1]\2B48+U82=F3YR=MS*Z:+[[ 5A$[G=3QZ,))
ML%/'DXMHR="T"8E%B?/XW/;,:F+%.XSE1JD$PUH2P]V5'R&[3%U6(IGZ5C&>
MN\&SK;J'SL1R/NS4LV;?;FMWHY;P%8V,J?M-4M:O!-W&8X*3J%_DN9YU/*6A
M>WR:W@+*&N+/#U55,\ZW7<]_/D+EW#C89FG=TE+HUD*BRL _XT#\A"W*EF6H
M8+_Y=^.V&N'>Z:F/GL"&KT*\)QFF;ZR#9I010ZZ"#^HG9%I4- >,5-*7A#W.
MAN;VKK,9+%RH_ Y#>RZ,1?2!(E.@&9RUC0G?QV>>N_Y<Y+7\R-;_1>W+V4^
M]^(<Y8[[FS:V)JQ[EP2M4W(F[K=#81?CO)?YS9"O.R':J#I71+07YKZ_SKY2
M8U):87C7DRK1I-K$E%T;:\A\NBNCD8WP;^S_5EC@GX=-31P37N,,".\-(C,/
M%? 19$!_PF33 =8;E%FB>A0*67H,P4*((@)_5L:RB!_^O:VA_U.7Z*%B&YB8
MA'3P7.!S79AC1=OIL@:(WW0XG1((K1>PT!^^E8VB*](B/XKE.U6N!RGT_ RC
MM?;W$FII]FWYY>NJ:CIZ:@6'0'7^OWTY52V+HEI3%;)7_!Y5^*R',2=U0WNE
M,R/+C0H^49D&>YX9.P&C;Y5UP7QFMCM?4ZZY8OF&7^5SPXQ (-OW6WSQ=2WS
MX_O.W\LU+KBAM"0ZQWN?/%:GWQ*<:/#Q!-?)]:X=X TZ$913I_/XF5PE5]V4
M>9'#O1N\%]KGZV]-^PNQ;J09++J')1 XB'"H6@Z*Q_6^8T-+FU.JZ*K**/4#
M[GG>DI/YC(,%R.F<=(JEG"](&:1Z;68Z43 M.'YM[*:2L#*O1,(4"^N7LPFO
M!+/ >@_].F'HD4,_'!R]]C77NK;2\5RI]:L%G2</'=5;GMB)W=Y?9!L,8!)&
M@?J9.-1DID9, P]%0;8BAXRY!LD@ZOCW>>C6]/%Z_5\^MGZ9G] E!-!9@.:9
M[]EY;WDUXCF_RLV"+><38S\XJT[<-;W;-TW6'MS+ PUJ+3\@G2&-&!'.83.:
M,-8!:FV-G\/7=;9R[UW5N5M2>S^<)^N<Y]N+2SCKB$VY^:F3V(#N.09O[=9H
M\^P IVN)/F4QNQ<%O 6K-RDA6Y<RZ$RT[R94*KB*MPYZ//3_(+\B#Q\8*G8
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M4-"F7..K0GWKE +1!7,4UJH#E?!VIW,ZSI_OO2[QG#=%+2Y36ECY49#)I^;
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MD];'V4;L+.,=7-W/\!\[AHD]:="YIB56T^M9SPP$[Q9B0R<4@&/4@F,/B)K
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M=P35FZD>?X>F'W:?HI[?,Z ]M[A[9A.M>]F,54&UEN+0;$OMY#;T$K$0\B0
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ME$!""8&T&_?=^]ZSUE[WW/T[]]RS]CGG_V%\R?N^8[8QQ_.,F3GGV-6#LM"
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MV/S(+P+/T(_R1<D^^=_"1[PDFSPU+S,<[OOX\)1PMC&YL5[Z="-)Z431^WL
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M%2B@GA"@ =KP&!#1ETXBEM=(BE06[2*HN$_HY+1-1W#I=2^_>:P+_IR'V8?
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M@RK_@2_RIDT/7H=X<-( \/G]JL0_B6UQ)&H$A V^F+OPKWEM_T9'XT6I/X6
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M27_SWM_6\]^:I/!7B_YJT7^L1;O(4&0-A"Q' P3NNH)Q\33@P0&O?# !@>4
MJSM>F:GK@QRLOENI,XQ=7!^-?Y67NZ.G)1:](R-[P;K8<#AI$T\1V!HST_4%
M:?SW/;]O_(SWBLO3XW&7;9. /SO&I3/"EY!AF^61K[3DOS]JDJVV[REL'7$9
M=?7\U1!7P"<\_&%U$-G#VWP];F6O/,:1%S>'JQAO,LI;#2Q@LG=<Z&*-UM2R
MOO>LE[SN/;TFU!^T4I<F&:;+^N>^I!>_M85U)7G3IEDLWIF_2C5(&;9]OA]7
M#3G1FNIAUQR%8(V(2*'^%+46*SN9G)VW\^$[U#:'6"29H3OA3WEP!9W=OBIY
M<D_*Y,)VH^,T<Q52'BQ=!XLJY1E8AW"1SZ('KANQV7?9262$\!_%^@3PWT_3
M%A"POG=3FQE?!,8U:('@W_?0Y62A&1J ]Z>\FR\4[&%S-%QC*[_YU-+JKKQ5
MY<3&V18Z_&]M?!3*K:])>YBD_>Z1K0%3R,5Q[<'1^*H34F6*YL1QW+[NF)R,
M$H<PT;G[<%J'FS"IUM7DU[FX6"RM>E%[PVVJ.;9^:MC!&8DO1F^6^J=/:&G@
M!K#]N,\SZ[S;ZD^2 .A^6?GM,5G_MT)OU]=?>VZ4YKD5?/GR.+E+,,QV"G'B
M_1$##4"JZF2Z5(G\2>)6AZ.J431N)<:_-$2V+_:M47/<\@U[=1U/IX1%C%94
MG1NK5-%T>KY+WH_^9_" HXGOQ/PS^"X?QVB_>U@ARM']60.,-VK+EFDAB<0N
M89EMF]8)(6#SJ&?@K5</W*9BUNC@J/,OX""=U41$H#75.Y.)S[>Z!&7+4&(?
MW/*-/UW/N#7(H,O).VMT1.'2H*Z_92O]DVO_T)(L0=ZUI,>5I!L0STL'[0M!
M.\HN0K5[,]F*HTJ:__J6PT0]7K&-*C".&:E!\/Q^;E(H:IZN,IV@,-B6Q!WA
MS.KWW'= 0<U..ANOUVEZ@BAQYQR>+[8ZY(A1I.P)]PR\O0"PF,;>(?K0?Z^T
MW^-UN>S2ES_&9<FE)^,I<%>_]YX>$^=\Z/G<N N F>Z3.B0G6;(@* 7,<9>8
MIULSN>R?>*6PYKCYZAMZ&\[-Q-Z[>>QJ[T=F75UN<R WIZFI;K1DI;$Q6]W^
M#F=^^K-WYV[&7?[V+0@ #"0_2HNU4]5QDTE<:/+5)6%IB)%?KO/(UH-Z3M[!
M[S/\&%75H9R/Q[#_0IK""(<SQG4>\8TQI??,&8T4(VX; $=,SZ0PC\5E_S]B
ML[2[G5=91<'LG07[GD"7QU%7W[_1$2OD%PT?L^G7$L5EQ* >(CE-E^ L'Z:'
M.HJ_,KK;J5]RKAX2>D'X#?I=^F-R?._,]YX UI<#@OW<<6:8@*.V^FU,(N_C
MYM-L3/6*@O-&VYSR([RY',9^XG4W:,#7,D3.$E49QQ?^9P?]$=OU!MFUCD^Y
MFQ7C.?SI\]I#:5)G<+[)8X_U/'=0Q[74W*D\^!-D=>)[U+W)L^>D-<TM2(TU
MO^N]([('%E!*L1A$M)88)1-J\ 2#C#93VHJ44-^#LZ<8=C<;2:W\/(..OK!9
MSX@:\T<Q4B<A;)C&VM1'WYPX!T+EJ@\JLI(T-1LX>\L6 JX/V?FX3,@?DH;R
M4O+.J"7,9/.:&H04^511K(?\@ZUX=O@ZP F"^VU#7!VX]:5XE5=:QM*='*EG
M*E9.""#,9B23OQ.4=O,G\CR<G,YCNSH?3W5G.PUN'#G:'>@R\L7=/$W%:W1J
M7\M#X$5Q>&;\?IY\9.F')E1_SI64#Y>:4M1Z!(]\^_88$#;02MMA[C2-%Q$E
M8I=L6T#D2T_C39B="Y<8D@7UWBE8"_-]PJ3_UG1'QC<]6P)/(SI3B>#6(8FW
MBV]=9HH\(C@)+RC?X8V_FTTMNI[SQ6@8+"*F)-'+O,I/EXRF] Z5$AZ&Y!XZ
MW&O,[N.PUF /EP3V1@LV[!J:YOOKWFK.*G.L<2&N7,5S$>^36_QVUC*,?Q!+
MR6RDLV2ERU?G-,*%OI"L\U2%F=]3N&%-\J&PT\1PS'ZL+%44:IJ8,SRY,J)Q
MQ4^,<^7B8 '1E#D;4MB^*$0#3E!9UU&G-8SY.A%QQ2N.RB"C[^(.NAXB?OG?
M=_>./]N<TN#(OV!24-D0WS2_M0OY=5-28(]/:@2I^0SZ!$OY0:T\.%O1_;*[
MHKLHYOW%H@2 ^=I1M3CI(:W;?[-)JI]Z@@Z.$L\P-( 430-6VZ=;9.CQBPG=
MUKJ"XJE=]DB*=%5Y-0WX_Q#&K5=.^Q9GC$7D][U]3ACF-S40VW_;257X3N;Y
M:/1I_; Y/=&)ZPK"-T2M,\?RX;N*%0%A35T8&_3>1/7"&>A#?%0QNMC:6-IZ
MHJS@\PNQZ5M^M[H4PG-$$:_\!Z4GL/2:9<%!*Z_%B(+J >#M$6/GSD\TH,5%
M<K>\"/RPG"A!F>P8XG.C7B&F!3YZ]LEM)';CBKK$Y<Z4\METM^- FNJ]XN27
M+)+YUJ"U^H>/S*PL?'+I'./>EJ9,< ;6"F_:#6*$N\Q<U3B;!W%WE/ZB[_^[
MH+K*(_]SYXVOZI'F34?//FES9F8Z(KU3A89OH/#EA-:[%IT6[C.+8<L=$GE+
M_:NM*9[''NH>QVY'@=JY70 "Z!.R.A KA$9-%;>NEZ]_E<4.?,O6C7KC>2U]
MT^%AJ.F)]W[?GONVB3/BE$MIP%$AXCK>R2+5A!B(M@_1I ^-L)AQJD63P^[L
MG<M($D%]4MD!?R+>WRT_$'^I;W(\&U1BC \FB!$+1%*4ZG?OVDVK;MY0SG#V
M$.J]\\Y;9[N!JT2A[[CHKIC2X4H^^4;J$O/&4K92-4>!@WNV@)?!#1FKTI\>
M#Y:E P[L5;6FRKN1TP*PBRJ),ILM=/[C1@/:C0(+/A#6BWFX2@M3=*]Q!B4&
MEJ#DF*^JKDCN61#@D?3QN$=A>7BW!"KY>#'XBM]+^#EIZ C+2+ZUM5_S6_M+
M.D\1W\!'J#] O-#3)0.%*DEDO5)]+\FZN 6K\4VY>P;B">]?=6]:O5'Q=D T
M'0T 5TVV+<3/7R'B%YL=MTSQV:F\Q9]ZGCQ9BH^10W-=0S6GM8Q<^_K0&MA<
M?JD^R4F2"#+I[P%5(SKF0&:1<I[.XT[IK@])E3+7^JRBV+6GPM17>$A5=P62
MY%0O^%F$-:73@)=Y(EZV!P7TGF:GO->2^HH_LM)*Y:_%,T<WG7]8T:6$S:K^
M+FS^]':/9^L1)Z&P2(NHL[&]W1JU)"I+';YAH;UTJ1"I'[P7C37]"'?M#3C:
MOMFFY=B^R'I/_UEY"=S=ARC5G8$SZLK(YL!]C 7%-ND^VG:<G;OE5%V3*K"-
MR_-/4.T]>FWPLLFU@R;8\$)-#Y9#9.&$6T-^TAM_F"U4_0,E?9;Q^\GZRS94
M:MS029E;4CI3[0H(ZWE,6GE9/H(HZ8/5Q4B#XJ?!'<T^MHT39,52F<]M/+NE
MBK:W*JICG!X8G'B:)CWZ:_"8--9TQH:0FDKP(II2<O)+S(D%-J^GW-PN;^K/
M>#_,BKY^RBE\_,V3Y$QR'27^?C!B&HFN[&Y\[5ZT''SQDN3VL984NO'5NY_^
M2@>+=)F#VFB3AC>GA[,M6>&<@C#+!Y^KBYRO8+P$&W=JVB]#$PY(:)\V>/Q"
M+2*N1M-PQCS#*GTXK6QO +;7>:K1[]-QUJE62?<+T\#O2V_I$6MZ,CYO<2%B
M0XN'K-\28M,Q\#RS)>WI:,V8?6[2G3?WWH3>^X+\E1C:]N.:P$$+]<\FWE6<
M+;6OP?)[-Y=1LR'![35'RY)Q*))X0HHL_8;^O&25MPY9-1\+/\=1,T4,XXDR
M(3FR=)1_1YN2F6Y7;-[Y&>WK4#CU[%FT?..3Z'^W7M-* SS+DY!<4'F2,7'?
M:+A%E%BL/RI;+G9'IB2@^/7]&'XQ\8O2D68IIHS-P2MD+A!5EP;$(O?V[M.
M]Z80"=@<:/LIF!.^3@!3).-J\OC[%4L^E!<<L)"/4V#5^)\%8;!CMD14)Y^Y
MYD?D>]U/CB8;C@;*K66SV;8_J.*9Y'@\JFLH'ES;TZ5?K7[5AS[SJB5]"XC>
M(T^$\TMT)&5[+6INVNDM+^XNVLRC:AT+M=Z2 .Y0+,D:F3?3.[MR/^68:,A3
MS&]CZ$\:P)0Q@BW3D@OJH^IWS-F[%I\QN?DT.DO%:78#5/IXT>F,EDB9W&3*
M4\CDMT+WL5L>0^&H:KT-L?R"!"\E^V :P'K?::S4_^VJ2VVB _:(Z]RIPJ^
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M[QOP5DT(6O H"Z6OH30U;L >_8%S$0V/N^'";58"LN.PH826!/C6S2,GL<]
M6X!H&W\M;B\1Y3$<@X-F5<@1 Y;]T^5N->?26R<. H_78,S#Q\;%+QB*%1U'
M;OR6G*C;\9@^ _1D92:U,1!5;2:O4@R/#1-W16:3[T4/MB2;]NXJK2=)&J\@
MNUOEELX H7Y@;NA=F[G-YH#TM1[[N /%CQ*/?VC*AA\H_=9= A;Y!IMFNGS9
M] _VBV"$.C@S6'5<#)G":#&4J8<"X)PK(*0B.6LX$87M.P/H5VY_M#0^4@A(
M,/3>IC)PX\K078TJ'VW<K>(K_[IX67:CC21J;$;AQX/6[W3Y#I(\9>4VS@"T
M"!?()5APTJJ:8I":2F+M7O8_X\*LUF6^"X [%4U+Z0Y)<@D)1!29/;.]60K5
M*:79'35 ?Y2C^31KQJI4F&F30>+"-?7WJ;]T0N8..3&VHC7ARS)D#CE]).X7
M<'HRP+(U3KZR%JNE7Y_H]+0@%-7BW_=P]G/EB=!LW/QU'[U;8N-IF,D:Q^4]
MXFW1[#)7LWO3+H2 &9N>GNYB>GXHA]:'O <7JC_?^+>+(5DTS98Z#)I-F?68
MIGPE2!)@SGS?@+_Z$$U9)XN$.-Q\9@+(HYR9_5GRT-C>WN$':>'--H6D:X/$
MA'-Q^T!!PH$;W(MU[D@O2B;40R/BFWZQWB6)J-GC_DAVFDB)7PI)*H*=9=;5
M*;KIOYJR-$+'_,J9'720$Z^K;S2-N=_@9K7I7>K%I[Q;;G;@7VOSQT>3.;B7
MP1%'015":69XUM@X]=YDU\2K.M;W4T67=V59[*%K6+H5;>2Y,'6H'4'-G7+,
MJ&RB?R8?3DC9/ MX^D;\SO89X.+-MCA**%5@(UBG74"Q6]SN4G-CZZTQFWD]
M'N?;:3\9>M+(/,E*FQGR5[/"W"TS?_\=U2DC"U(^D]GQ [^#U&1*/[ICQ^5[
M\WQS37X],:3A4#=3.GF?TG]]*%@+[DY^C$02^4C!+BS+^C[%T_.0J?H,!6@#
M@S56K\"$WPYYC_$/V[T$AE/C%1WL_!(PDJHTT2)5MBDH\GW\_L_'QGK.;NXC
M]R3X5J544N]VE7#*%I?]W5(:7_QP7,T>F/<$YQ3^IG([\\]FEDE64-J\H6>,
M+. T51=P54_HJ@%LVNM\:@D03:X6$%[6X45PNWVSPC4Q6LG6][^<^XH+0X$H
M;#KIL3G9E2BWS#?,K%4R]2HSN&?<[*XK:Z'W3Q'6QV81 ;0(.-BVH/AB6PD1
MBH-T!B_N#"[O7;'>3$$XNF;=:D%*\4H,.&5P^G]2 $U>MM>\YO5V-@Z6DF#\
MP4=9]?$AY +LP1\-L4 G=+<@[[C#^.&/A,B,NP]-!8S>AYI$>SY05]<*/(>M
MX=FTY>@N]6",3M;V4W0#H_.].9W\V<+R<WTNFA_1$R"D)>6X9B90>3<6:ZMW
MT/C+X(N(5YI>4E\)N2M+0T(IC3UK;SM+&4X&WA[K?*Y6/)^HKD0Z[<P.C9OX
M]P0O:ZCS<S<5R=BG<@_9-#FB[4"^-1_6!?SCGMRKRWO@G3X>G'N @Q)*B C\
M +;B/M\)5CXT"KS3:GB#N>OV]5N>%A"!SAKAZYM/R?:4,K5;YR"C HHZ(DG9
MOADRY,@5W[&/_*+EPGNO-==$F%9/B2[NA(^P/2JE<8T,PR'CR.(,KV9R>II=
MV4+2'[NZ"[]/EJ-)^ 90K+KJDV9R!E@J-(.X$W.62'E27PY:0/RYUN%,35G&
MX;MREMJ?7J*=]$M&0T8.(3&@I2]Y#/>EO U4A"M=\;VKO&< <+TV$E-*^]=4
M>$Y\V/4PF0,^*G@5M]A!;+O5)3^)7/YH>5][3-CT0YW&+XZ4-%HKH;"'/%5T
MA"JBS_(B$[5_9C?%H7"F!UI@-<NG_JVLWOO.R(UWUS1(%[V#<_J4AUZ<+Q@%
M]\*\)86*I)X,X+4Y'1[J%B5WNN:D!I2H<T=9.<5Z=&W5>0A4B\9J>>".5P)B
M6G0P/QNJKRUN-^)GXN,]T_10O^C6%F\"/GM>/-RX++FS%Y/7J/-6@XNL_QUG
MVNI1WA'B'BN"'.E@M\RO?_3 V_%JH- +49_V(=C/<^PZ/U(C,4 2;=^_'>3L
MX&.YG.%]0*0),KHJEBLK9S?=16,L?+7%,[KC:,; [7:O"6](0H&X-GW!#C@,
MT9 7WJ8>F$72Q*TF(6DGBG[8J&5%5KBP:U\WNY&JW:O/=/$"N3P'?XS=QM6U
M!Z_VOA<;)VMY>=R(<[EOY9LJ8C=.%\1JM548YXR57Z;0+2%VEC%\PS1$#S .
MNSI1S_LZ,]CDD^?/53T)[5X]#G>/] \O4P/N*O^L E/IAY:DN,:6I?9BAQ+D
MH &G$9-[02)V.3>TG@H;3^O=,519SPWGV>]*'_Y2?;]Z<)R0'(ZH1[[54#[Y
M1O1YEJINR'D@,KJ'V7=_Y'5 ^Y-)^6^ITEZ2Y,KP[!NJ(>;A&: Z1/4,H".O
M1WKF,GFN6ZC7+$S;<-90E]1Y+9>RGQY.V==^&-R1+3'J%7!0IKF^L-  Q+:>
M <2\/I\!T&TYYW<RJ[&8\[IHXZO?WNY2&@D;J*7BO/W[1'9J2Q7J4&E[QT:U
MCQ?851VNPM6Z(J4M(/.D8=3MG[1?8&.VY>=7+6*7;E_*(IY'M: S@##X+6A[
MX%P\-9-JSP >,ARV9X!.;EQT5]EN%H(@"^D/W_TIELDKKE&D34:TN08%82YI
MN%OHY6Y#SR6)AVCL51Z2N(2GK>=KI+19\9#SJKB>$<\#L=EHL"BJ.#!-JW[B
M\,>41_U@203.YM%R@:_PC;?582UZ>+GNW#O$FW!@!TDV,&S64(&1.7WGKN'"
MXX[+@^D7?SDB 7UKM$VT34.JRQ&YRL0 $AO9;,QO2-@4MY-1Q=5',ARU<KYG
MS8/Y(.1WG1\I_"/KH['IV,/>@K;FW-F59.)MF<X\9F*8@;3BQ%%ZXB^/D*^6
M!;,75=X-W\P0W+JB7KZ6S!4XJT6,)P41];LU!-L,=/1:Q^LSHGPO.=-?>_'P
M[[6'EP0CS.K/UXXBC+V@#U=MB1>VT%2H"2K]Z70L*^1DSJ;4GZC'?]$F]@BC
M3AN(2E0#?@T$4AE8"UQFU.O]_5FJ7=!Z;FR1NC-&[-^?*M'XW -XRB5->!DE
M%'%.?52^GPW2ETPC?L3K=R&NP&2D42N)#U_?X>QVB902&;VF^]AH\!Z "DAK
MKZI%J:.6"F<B)POPH/93]M^#+QHO^R7XLNDK:WM4"4,&FDK[<DV=#C+ON ?G
M-I'\8;+$Y*4]+B)\OL&&=W]/MS5LTL!R6CC.A4F:4U,D.:P;_T,P!_IO2IC=
M71N6%;Y[%QX3'J?]@=69_0%=U[A&-*->[^N&7X_6;0C_9[3>9:W&)#;@X9U[
M7'H7^A;FPKVVII6WH.L@HNA03V)Q./4VN+1>\FNOF^UF%>!>3(1/IE2N O:W
MSTSCL8VR]T?H[ZK@O@34TN<\AA;A2FN7$0&';F8:CC>)HI,*T9Y;-'HWW3LP
M0JP;!@% VC. *^("S+\U&XRCS$]457+ O<;\;C\VYN 9E+Z>_@VL9*\SEG6"
MZD35FX6UJ*Y4NHXMZ718#048M3"D+716Q3QG#Q.^,*#M/8\9OLYO]@'^"QE<
MF(?4BM]J?JERN=@KI#1[2'KB48_[VN1REM %I0NA>S-YM:;!EIV$I.UGP!EC
MP@=P3!Y_O?Z@\E$,^=;R=C_C9L %=CG->[+])54FL0" ^3J2\_AR-,DLD-&4
M^.0,P.I>W#)R_X(WX556@B0AULDH)R:E[F_N'$%DR0<B0IV"[ ?;LIT!OIM1
MW_.>UA$J\,Z=9P &HN H)+99!8K3DV,&@761UGJW(1]ZIY^%7I2=C38:7S*2
MY\JO8&WV#E"Z=/Z(4LA2T [Z,37#E'7@*^AMA1!/L?GDSK8$G$SR?9E86^XZ
M/$NT_)4C*8D-H/1+6EVAI7)Q0#G-.&L6D6\%U3OT9H5[YPP0E$]T7AH,]%D>
M*FJ1R&K=W>3BL&"'=O<\=Q=[-<>8]OWO)W0]HD-^+4CC$E3BEX4#GK/SLWKT
M=&422!:A\G'LB=K@HP*%58=MWMOY38F=_\,>Q4N.3(6L[P*%T'%6\-_[@3H8
MVLSX%LYRF>CZ\@S0K,J#1R/_M'KQ'EY(=C@&2U)F" .2NL_?RPR.;W>ME-LU
MI2L6IF?-RV^>^*N9$3I'=AI80F<H$T,5QM93#2V-8RIA?^JLM1.>$P9JZ*;0
M4O@G.J!O0]GNJDG1!6$^PZ>#=C;%6+<S@.CQRN*Q&^JPC'<%?AOQ,WX:,<6N
M<P88R9A8U%DJIH+V-0JDW)9QF9LV<"-ULR7!%,<"\G6<M_E,SZNZ35.T[,FK
MRR>VMYS]CT0^I5D'A(*<+;!D1 EQL6^F$"Z!O_#=8P?_+48J_]+.B^B""R,Z
MC+M! GL=D!/A-KHSP+=;F=28)UC)5)-;UPW$FI8G>\V^V+:X#,QAOY[.[.GO
M5J/_K??V.^B_MAVF^PW!/=T[D1L&G@'F0&< 0ZX)O#.9+8!J*-D-(4C,G0$V
M;7+@Z60G(K@0YD5TJP@4LVEJK1]M (O]SC;TU4,/?A2U*1IY#QLI43;N4%=!
M?X /(VJXWZ*<4+RVQ.PNE>H8C^K=P^,Q6W7+-?J;K/4I_;JLG='^]K8^">Q]
MQ<CHGM'BL-)'$';$7Z>5N32-B/PXR>[[($704E66:,E,<5?EB^@03KL?]4QT
M@P(=KZ;6Y]\S(=!RF^>L\V)QEF\9TN$1CLSEP?N.$A%F4?O0.C_.]W6)CQ44
M$GHK-$,5EK]]I\DU!#W2$(*IX_9Z9!@6B!X]*L]5>A/] 1D+KY,>]CN^>&A*
M5R!^R6P0_V]Y83CSUPH/YO6XETBI'R3UABLM[]1E;QS<.P/0#+>&,/,[\7YE
MM:OA-MUYN7)2E3P\/$N'645B^?!9VSV\?D4]N8D>4,&<XCY?G2R[A#KW%_0,
M%H7^,_2].L:0XKP+>_;C(#OUR^9))K ;]W6*%W1?:F_N?BT@?B'1P&X3/YYC
MU ;4&;%LH-BUX@4%1A?%"8ME?VM*+TK2O/$+>L">:ZA7_9!HAJ-[3-3')2&B
M+9TJ*[94F.)]>/5*P1QI[6GAK:RI\D]E?W5)!#F@BW@JG 0;!7-4]*K,D.^T
MI12F3VZ0&,\ /Z?(*N>!?QITF&M)::G.T.! =*C ^<B"Q,A\8I_V)-G$IW13
MMOZ/9DC :US-[?X 6J2I,%/PW>K2[;S[/<8]$PF;K]\M<W.6$N7P]I,'[:CZ
M@#BZV I$O?1KF+[\T&IEWT4L_,]+Y3. DY;R< %Z ]4-)HIG=E:>1]"#0.TW
M%)UN-)<;Y]?4.X5($G^1YU<+GDLSA>O'CG5(&@'HM(8:]9S0F,\ K[(_5),-
MBJTMMXVT;]A GGQXZ//-F6':U(Q&S=TX::*7+'.N37YD :)=U</R>&:='N[)
MO;4',$WO-!V^L"L>TO<?V]_K74*HF?E9N[-P7GG2#!O9:$3@Z(W>VT:O#>_H
M!PGFD$QA2JFORW)TNZ9@P^SY1\=V$$]$QW,-%E?!>T2/Y3, GXL_UIMZ/>/5
M7NI=?4:+,#@N^7$@6B/L4?!5U41-*GT?;F%OQ:\O">MW!N#:5)G+JH/>JTQ<
MK=6B[<@>$C2'>G=H^M(F3[85?T?&[2[HBB6*1FG=QO=_21]/N/9PZPK6PKZ.
M1Y\=S*Z3/X&P+4CP=<G+!'X#8FN6$6%PKG$U9LRTT]BACR]ZDK?^KMHVJV>^
M;N%CVIITIJ+G^T.Y$V])(=0I2QDL0S,HLH4+J2C(/>JL>,Q]?*T>XO)]QN%1
MR:)L?OFW08!>VN?V8;3@OS6 7I)Y\/ ?TL5N7$W+*9(>;Z2X]N\C?VY'9H@S
M)#L*,>%H?27/6?D,0-2#XOI,<:9Y#B4N[UR'&1>VN8XE3B/:C*--#D1T3*S?
MIIL ,$K#\BCT78;F[L*3O+F6GD%)<QR"* (BQY\!V$';6UUG@ >Y;?]0FD%_
M=^ WSX%Q!W$*YH17P']#:H<C04Z2ZOZSG3-1=0C!&A%90[_8_'>E"4HVN=9Z
MR6T^GPC5:L3J?]^6$CWPT2M<#1@!9RN\26-Q^9,Z,'/B?.VCPIN?9WCG/S#=
MWNK]FF3WB&<K??[$\@P@LT_'/9 R ],C.BCV@J>H'E<L4PCSFET9B:X\2_?Q
M(L:/"PFT&",B>G5Q)Q&_>09PS$M,=;5<R_.=>?EGL'";Z]6'7,Z%8D_3OM_)
M/ .?O+Z;[<C$M>@5P5B(QG[E\UTA;PH"H8;&-V<E]#S_='_QOB!1&"H;1!,.
MN198;$M).0.\EA&8IM1NF^.2XX_T+D'<PH U\N,?3AY7F.H&\+^0 X!IQ-Y:
MK!ZA I[EZ"H;AS1?U3>9FZ:4G?NQ!5H\76>(V7F 9JYV/\(&="LDOC@&VF=<
MJDLRJGT ZS%U8<@PF;IR:5W-; "$ P-/U$  Q)SF&<#@6)[P^P=)FGR-DD+E
M"?S1XR(VXS<Q*IUF.*ZFXY_V2S30QNB%UG.;G5^730)\QIG0O6< G,'\U753
M2B5,QN^BG%;1S*+-;Q-O3N:*=V$AES??.8^_76CE5_W\S6_BTLGKHQ";F( U
M,W4K*L/B&>"69#N"<"7[W#:8C>7A#! G]_=8$&CL,?6]NA^BWFS'8PDU [4>
M]8-PN 8?1?9^=)_\4Y7B=>G5P-#W#+9'?S^=LMHL=K"$JXBU@Z(;X5=QE G*
MVD?HG3J1F?<Q!^S"F:_?/[9^B=]')UIQ/PF\8H?NSCO)NMT&S<M8Q!E#3E02
M]:D=_HC3"]6C>=-\5(/DY4Q*:"7J\(*U61]X2N9\S6)I,2=DR(J40W>&Y?L_
M6NXC+ID*^*[&>Z$/ OG7T5F$,T"T!NTWHL.2#6-GEC5:D=<_V44@IP694"EW
MD^GBJLE#T .-]_8UON5VXD9)^,7=*SVE"G!A^']):6Y$L+7Q$)U7S@ 1NVIR
M*UA%DM7C[[ZI5A -\P#9NXZJ!8YV872:$!7RHW_?'9#O$=,Q.0$]EKD_5OKE
MF>WW]6=CL#)2IK<"[+N%H$Y"+_&IX-809[! 0N0K(X+!@N08\N22 W3N9) J
M@"%IG '^_+MG.>?\6:=*2A)B*"F'JLG3.C8XNJZ<Z_6$FCP2U'!L,LB="7G%
M>X/7S.G.9NN#W[):(5I:0?A>LV<)GV;KVBIKFXR(TR1&ZM@DL(Z[6\I[L4<!
M[=#5/*Y'N_WPNHN;<VSVH'=TZN43SM#UM?[?=T,6"4/G0X]\U783EQ,=W<82
MF&9L=2*=NG)@6Y<$E9&^1<<JBDO2OW<=PV/MDZN131PB,<'$B/.5UE#+QA2?
M@NW,2]F)^H\_6?V4 Z[X28S4G<\-L2;YWD 0E3X>!^EL?F\6X+7==FM_,1 Y
M*?.NV^L/9Y32OGJR[0GGKO[UT$H3>U>M _\-YT&1BC@4SA#!#C,FOEV2\N@!
M75/3"JEX=6Q\JRU>8%^G*<S]H.@J]QMQ^S)9KWUYN"?9\PR05G8>RRE)6='4
M3#U(<Q8\QZ70W&IJRK++T=&#MX>YH<5>:46+Q\2$!G"A_6+;<[P9F=UL.3F^
M30@J>+<%#;/@*BYS37,=TZ)=+8ET3#66E A_K6OSZ\&EM*3U2H?P7^+&U<\J
MT!(9/V\,2/\$6J"7@7TL)RK5YP0UM5F"V/1-)S5!1 /+J?3EN+Z>Q6ORR3RV
MT+8[\<83\GH-+OEA^^./:G^*IZ<_;!217A.ZJ-?G,]FTWV)SY\[7+3_-3]:-
M:F-4AM7\K4Q;)F)067NM0K)S2 #MY,1 K*-N@DCNG-9=,O3W&6 I#]10W"7S
M%G[QG+];G$6RKA9XP3S2GB>-ZK_US[4LZX8U.#V+-$](1"G_Y5\_+.X59!F!
M(99_G %8B/$&X:8CU07[55+2W!+;Z*TK2D()UQX(A4FN6IR?. -T^>O$T(IM
M8#YCR"RJ#C-^\ZX#J>GNQ_^$(+?H7KO5B-.JFUOSK>YBW$.^,$F2&W64"UB?
MUZ/O9O:X_GL#CIKI=.?.S(9;*B(G9U6"GC&U_0*:@?[O$OP]O%T1MP6L!87R
MB@ZG<XY+-UTWM6IZ2R>@XKRAI8G9FQ);!B6UT'TF:O,Q+C)N6JIW9]YMB[[C
MHE:UQ?FK5I\_ZM&C:K&\]SYOX_;: #":$80SZ#)X&<'B.M-;7/33_SBF^=?(
M$UR=1-3S>[T?C.O_HV5&47S/\K:=L'8J-'V'Y,H:_^P'B%_CG)A_3@324/L,
MSIE7OZ!Z?N!$KA.%,X!$:; 2WQ80.X=M\"^;<S/+-,LU.8XSOG)E*#\NJZ#]
M=BO@]J6+5U63&HYR'+/L-^V+Z,#Y_#=7&D!7J/_UE'_RB!(ZG>?Q5 !V8Z3%
MXFLG6B[0<,5"VOZ!'E==!)M>,L'R=NRA35^#KR#G?XH$+KF;&=C+%;P7?VO\
ML/69@"5/<4O#W?J:@5LF+Z3>2C8]$+KF->=7;47Y@GKE00\?#KZ<_08C*:"]
M]V1B_0W_U*S(!I^=?:VD"NZYX@.?<)L/"=Z5<47&3%68L=/]6]HC+GD >#NP
M$1'5=FFC&1E&]KO5DQ'I%T @J3_CX?5#IJ2;/DZYQCWS2)SV8<=\GW+9&0")
MQJ;DP^!CAXMT1)ZY>:*S81/U3\OXU[?YW+*1]_H:S"]?R=<FM;^LQ;</?R7*
M$>"4-(3K,#<$%':4&-#5G/761R':0:C^$<^^@]Z*5\*1^2QC;JA]'<AM+PK!
M@' &3B^PT ;*JBJIZ96[3N[;!(W%'EU?CGUIOZ]H\J 'P,.8L>0L^L/ASIV:
ME*R(=)V1G9:?Z,Q^Y#D6G,MA5L,9P#./TEI-\Z]'1?R<#2R@MKY&'&:HG"I2
MZ5F^S,T2 U:<:OL[1W>W.D<59_<S(\4" ,="AI_>)%L> Q-1WUBZ%I,AK#)D
MYQ5FY^[)X**_7CHB*FX3S8\N>95)T[1C1[3A[@T1-<]Q33E/TA4:4)?,)#WU
M!)S_6VXQXK_F[Q+ 6L2 KQL(QAT8_:5C<*'%!GXC94BX]/M=D8O7>L(B%^N=
M5;URY\O;X?^'[%UU1UHVG=</(X-\ Q=^;U5SR-*]=R+Z[U[;;UJ+U-A@LLN_
M+0+/,4L @=[).P5+P='0&36-&W^.!"16"_7?; =)%;Z*N<HY7BJA*ZRDWE']
ML>W_\,H5.*5F\V!.E^$@*8TU9:W&9,'SNUU-OH&:N)_'2-;^%KG>.,99WZK_
M:CB=KVWCI49\2W/:UN:V-6I'F.0;J+ILUN6'8^F6+$^\.0O.LO"=?Z;J(GUS
M_Z^#\.-M'F<F@0]A'&%\GQSROH%<(#/&Y]&[?:J^E7N%*[W$E=<L5NA[0I#"
MO7DK%=$.$>]R);%8[L3BN)/D9=1. 4F2.F;Y]4L)D1N"YXQM?,>7>'5AXX'P
M?.K=M,[?9N$#330"Y561NN!+I?:?3[A&'S?LV8J%P1<@#?YY)-W 9-UON'I%
M_65F.OA@^8<$-S\O45E2<%GD/[>50+!W*BS%J*54U+XNS.4,8#=R!BC$H]\A
M.AZV"..&E_JZDB_#E'$<EB&56UNR6[P)=P?7;1K[?[D>L[UL]-X%>&C6 YC?
M9)+9DKN.>0/:U1'&.18WQQLV_[F0>2%5R?[9TC$?LIH,0!N*/C\#U('\*_DV
M0XXI6GP'6R&56AQF_7S_O6S4_P\''([HL$!!/:Z167')T63:I4I#-[YN05$]
M=P\_21UQ+[>7$;?-Y_@+=%>C\/VLWWC$A ^OHFZBEI#PJ^-VQ+>XQ1ZXL4*:
M3]%P4:R)-]NK55DWAZG:H93MFE9FP LBA$I?@/]WVP?="G$L'Z;3-$H5B6>M
M%(UTOY6T63 E,H6&N__3H])K[ (2=S]B(;/G/4.C7,\ L[U[*\Y)A0;@YW\.
MC4O4MK)ORA5Z671%\-,TS/S#Q#R@2_,64A0L@Y5:XJ1D2K6)YWAWD.6NQM3U
M.WY$H*_4$$RMSP"5TFJM.?I>D!P$[K&-_^CLRG!WHN"#//>6$:'FR.2%_94\
MZ%OL1\SPGZ=T(WFXY]4SN<?M<-9O1,6E(*>F<XI(#)L=%G@G)=_Z/G%UQ]IG
MS7#QQU/E&> 7">B!PSF)?9HE0(A]N/6.8Q]*L56F[EB#E,7$L38R=4Z_51@T
M]Z L]'C&*F&E5?M49D:GXPS0L![;)E/<(<,6. M)?OY#!3:S&'$DCKWYM%?I
M9:S=_D&M$.?5%8!RAY+P3Q 4>.ZD..&29._1%GV\8@<(%QTXL/![DB\$2!+=
M[?L5>\L_EOQQOE#UXX>7_/POO)D!\/,K=!CN.7VC1,'%]&E.W$<V\5SM(,DM
MA9*N/!-[$.\)#95^&P_M!EY V(%XB'V=H*M'+#&G.[FJJ3V'0XI#!VS ;U9W
M/T9XZ?K?$%-C01U'<\Z1O8FM>#!&A\Q.@[F*Q =T0'!A@:F+EC6UR#%4;57]
MGNR$AR_: O8CTUDYZ)9-.U;U7D*X!1"GE9>HP5># \=3KT.V,@@:-S+-J=/?
M&K[[:;?H"<6)L3KOR7[@2-^.ON3\"1 $VC&J"'Q#R*"TR&B(PDSPZDGA&!0R
MNU*F4Q(J<G-E[7:$D=@'C.O)[?B8P:"DD;^'JB@G*.X,0&5(*WMUZH'M*'8%
M75UOA+#-3FT>V X6<<I*?TL;>-JX>.(JS+5 D1N"]\#<B1$H>NI5XFSO:\[L
M1R.[#5=&FO5$O.2T\W!B#*A$ -P>/BTH-8%R'Y[UZ4)<4+L7<C,0U(6LI*7T
M- T$;="W-JG'QM(\^@B$W1T>AI0+,N'@*>=#Z P&1]4SWC[$<C]IU-?7-]?F
M4OKS@L5G+K<P%2R*NGL.5'%M%]*LT6VWR4\G FRVKMJ-OFCYD!$0Q#-GPP;V
MUFH:M@5C3LO/%Z$?S/=<7>MA-]IPU=W BSK+PWS,ME IS<<66;W#_0=Q>E?L
M%UWGZP*49S_Y8R'Y#0?HON'I\F4FT!6X,)25+(E[XKK]Q=4,6B(3_;I[Q<Y#
M./9QKBV6U.8V_3OH,\O@N:T7D\'^7 )/TSW"]V0F^.:QNC[;SE2HLU*(=KM4
M%L_6SX?(5@L$*?7*+1;!?\!_(^K%HA$NPU'^5&5<0T:I7>&PCWQ95WD/OT]4
MXK?N"F\5C+J&*_GO^9B5R3=P8MU[C&3#S%X->MPYP-2U?+-RD1^28)Q\:R%Z
MY]I 8CT_$Z:*%EX2J-.A(4!$Y']-7G:CT<=-IB:-2D6E. M4,/SR_B6<^.AO
M;C'_G\L3<&E$AQ)B5>3?,O??UZE)\B0=2'P>SA!XHD<7A]A5/@,4) +.#1%M
M^3GN?\4A*;$9J%.;$$B#/+'R?_CU/L#( BY>TSJA)E<^[8($OAQWO[,6-8-Y
M(Y8N>>,**3,E2NBO][T>..0,T'61.KMXZ(4Z@6WGD>U#-:C$09(D69+RN;I2
M!BX4J('N#LC(P$)IN].&F%*Z]6YI/M[2$<E["N9<0>&,AF=D.E%UQSOH*N+]
M^\:!\3W!CT^Y,@NZ,3#__>X_/STQ9;TQNG3$O%? ;E-0/*K>J8!$"^^G<H3W
M6=;;RA$K"(AI0IC^3W?M+_XMK=VI_5RFL33B3D)L3ZKYW@*9X#_/ (Q4('7$
M5J6%.$+2A]GAL@T"_,<TERNMNDTSCA63$D/1K/6A71>Q,]]"%0$JHC2A_[$+
MU85XJSQ0;&D]0<VMTDK/S0VCG_UJQZV*6]"MLO;7I2GAW1]SNI>#8SKXKX%'
M%NN1W=6,\)X\.K(67N8A[FJR1I'(9&/JK'F?X*?CR$*)W)>E[%STK5,76?
M;1^;A4Q\=7M69BA9IP2F.ED/%-!9#I$O=@-V6J8WC-W6S?D2>N5#S.#)/R57
MZ0:\_J CJ/T0G-$YODXN*$^VR/Q'FS#R3=[$]ZSSFS5;O&$&HE\.5 98_:4G
M'ZY^NM@=[?Y6]H$&/R72S0T!1<SF'JP,)\(,"EZ=KK:2H%QMUQ.GW66<=/$,
MG3PO^MC*4@.X-2#_L'41XE#7$.ZJ0]=12P59]U$,MY"\&VVC&0$C,30DR&_
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M9 23D:6B%;\.O&< D?GM67Q18<@II/WGX=OIVS %,2#'[$VP:/K^4]T0\+A
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M"'%WLDYE>[PF(=BB WD"<M]MK^I5/L'CVR/1MS(G;;0MOY<<ADX>CQL/PZ>
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M=D,0>7\UV34SWHV6&>+STO:5><VUHR@)X83%I!<'EDXR (%ZEJ!9G^DNY*E
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M:7=FP.^1?]=16U=8]16O=YLL&8^3?1\GJ:.^TD%PHPKRMVD12*M_&>WMPL\
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M!D]L?DIX[ =JLU ).9!A-F@<5N*670WP>)6GHQ/]A.%9U,U[ =<_,NW@SE"
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MB $8_5\$([0_ M4#ATS )Y:'T4V_=KSUE$XF+B2)F2T<G3ZESY=%_+[_6UN
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M_4.',#"P.C*'J(&W6>25F[(T')-5%RN[\5DN0B0=_GS$SNR6G8E07TK7C.^
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M.D[DZHJM=+E/*QVENV.Z%P+&*RX5R[U5-YEZEYR9VD3N:V![55#G-G->J&K
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MU'<P6H54 /Z=XL=, <Y>BR??R/_GGH'#X[_ O\"_P+_ O\"_P+_ O\"_P+_
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M8&[G(CA@0!&.O]ND"N-D'R>_;H)X:]:&"5]B\A:66Q-?55UI:D(YPC^^#<@
M77NPW&JII+_!+8Y[,9Q4\+Z1CO6*9LT'A= F))AJ9F.35Q4Z8XBH!M-H(B1J
M!HE%- 94OY!>PE,= TU]8N ?.%+VH8UK*@>R@9S/ 1%+W.Z85IQSN'2]S<^4
M 9M<D43#1C4&.U'SZWX7$^6#(;]+\C-LNU/]-*./\(\)>L&8)A]>3<[7&6ZF
M,8G50XK/ZMX__G"8'P6D26#J\1YK?4V 8$K;Z+D_["N6'&@J<'ZW*D($'*A'
M?@;$-,\T#KP/RXIE$KKD<VPRN+BK9N'PB\1+E"'=(00%!OE3F0*CGKUW(/16
MUF'P]Y7[OW_>V53YZ?=!ZP[$Z'\4 =Z/]GM_I?W$4&Z26+&RO4F\5+<J3@(=
M;*/>8O*S+8AYSR67O0*&)2.Z4;/3&'17YFHP!LY@M37=P\GMI9G.+JYUOZUB
ML!E_\X=0M%IVI>=A^2*:':>Q/!+6+F\U,Q?0K4>9;JQ)*FPTJC>DZWM)HQ8U
MD4,/FQI.68[COH]UT^:H^7ZH>!EZ-=HZL&KF8^FSU@&N32.UD1_NHX_WIQBE
M1[0)]EC&#CA=%7(?)I@+=QB"Q0AV4ST-WBZ@PH-NWQ4M.;LP'0[EQ0HV@Y=Y
MT1),_R=-G_Z= _ ]H_NOL?"(DQ+IJ[WM<65H7[_^N'[6?_=X=XXX23LYA-P*
M&P)X!=$]$CUUU=,Y%W)'1#U[M>JOI>4-'4F%#Z:>JI0#ZS/A/CO>>ESZIQ-I
M+ORMM,5#=EX+ ;KM8NQ+%@Q8D:0R:H,6HL?)=GIP:MA YA1JMTZYF89M:5XF
MW\P2C&98O1BKNF57>*78$+R[2$D@?<5_?7V3K0N-<(66RI[YF^J2_MFA/$_<
MO*X(6YBFVB<&ETYB@+4>O>C)2A&L2E1AVGP?GX8BG52?ME./JT)63?]+A:1-
MFO4?BTV2ICX%*R-?^NPE7Y8_CGN:J;V3;_>$ZOC/E?_%//Y5#4VO-.Z9:&$#
MD3 0AM'/LO!>_8W62P\D-)W7K;3T^FTW]FAQR=.8A'"[7U.F*E$G(H<5MU=
M;0."[?:\/VFSA-9>M66:-S83V+%:BB5V02.1=O)OQSXFK;8R+]>X[_8R0L6$
M;QTEV<4+99JL[TAS;U-6=^0K;NF/^2JG@KV$$E;3\ZS!@YNHU[$$Y(I_3P*_
MC;7ZFY;47]TNGG?XOWY.LX_%'7X/\3T.?KMTB2)4W"T;T?(Z^IE<0/GZ0IMC
MDDC/U:$S&H*%]XN9J-()=PWHJ9"N2V2X&+?:.,$L^3CZ.^D:E3L-!^IEA8R!
M#]U1'%2^9S8)/TZV)GW[_VRW8PC_:[O=HQDY@^(G/!U'+S).DQ1*'BDJ\TTA
M/(O^/'+K=+)<C\M_]>D]3:C#AWN\NY -5!@(:^01 :9M%]FD*/^N1W+8;K>
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MYJ>/,$,7KKQJ;&JS3?"\75&D=P61ZLE'D_/T3Y8/T!?>J8!\U4).58S,5X-
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M(_><G8B*A'SKL383#R\*UU0#[UIC@D^#/^L^H^AP18&<.6T.#6\?RV]X_3F
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MJHQTH6EWWV %3:>3&OV-+_Y(&Z)UMF1BL4[(GA1H9P"GL :UW0]LW#4@/GE
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M-A,"_^^5G,=H? 4A'R>VO+1[#J!F "=,J[&FR4!_V=:JJM(Z\/K[/!HG8QY
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MRCQY&!&-6LY ,<%L<;26N$_KK2L_Z[5,GV>:9XC+2C^4NIW\U>HY_ZO[^Z\
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M.";LU^\8]+5%//MLHROT5\S=R8I?1D2S^J61-:F)NBBC8%KC[>PP#7(FB;?
MT->[<%.9KP$!5=HI?XKK:WE7ZE569D.;)2XTN0NL]X_5M%D^((B< [KZ81+2
MO67@-T*"U9/[E9;EO?:B.:T4^Y]7KX<K;(L(_P $(\M#J!!PQ4?0K&[(:"7A
MP_'>(QL'JP7"AS&),&<>\3':+**%=P%$'1ZI2/ X;MV!/NZS;Y$J5TNSS'I7
M+G&=PDFH)][:!-6(Q;:S;9W)]DK%+'"O/!F0M'.U3OW[MTZR3W?FMZ;>+N:^
MVSG NOFG&AWJ+L@>. OL1M6&I)1N+UXC5 ;AZ.]..P!;&Y/IQF8[+SG'ZH)/
M,[U:PY;#UP1D -HU_],+49$9J.7\1?9I3<__ZFA'-57R786N3U6A:MOB- SJ
MD]=7H"UQY0T_?W.Y2=8*,%](^6TQ5F=,WP/$ZB,BVB4)$*(R(>4)SC_<-X%A
MVS2@87U=0\N]RT8M1]CY==[=9,GDPJ2^70=)/0=;-(ECH+/E')  <J!2V,U%
MWM\GLJP0=ML91>N0%)=;DSWOW?-?2PF\K %<>$H/L)@X-J9?*=X=QQ7CF\AI
MV@*H#R0)+*WYA&)C>QIIJ(*@8)$&E]?1L?^RJ#3_D>>?]W0&7@N(/R37(Y6"
M^(-0LTL_Z],"QJS@F,M3TZ^X:#)%84Q,AY"3F]$ J4-9?!A!&,=M30V1:A<[
MF7$2S0HUU:\4Q\#DO.9.&N*\;T7W<IA?L&+:_G0A5^_/;->>VRH=RE;\&TL:
M:KE@#AV;1TX[66()8.GF.XTZ.6 W%$K$O>&#32?;S#78!0J^,N^2OQ&#^+<K
MA:9212HK88GP 86:NIX#N$)X7=(I$E/U$D4&(.Y-N4>^#E"AFW&:K9$#>LUI
M>IOR@LSJ?&2ZO%!-L14Q*J>#]-E=P'&%.6!1G=:"E,+B$1=HZ0SAW=B5O5L!
MOPKZ;^KR6EF&7WQGT0G&/@9=)ED36' [/4)\.(]N)/=F" ].,.:!-'D_PI<S
MRR*MI^WI. ^INI!IFU_UU5;83_J3JO_AF\9N_"KYRSX5SL/]DC8K^0*0#U+W
M?2:_=HE@.MBZ+,D+G<8?WJI<'Z;3)V$)'KB=5<2N^70.,%@H&/0T,+:R("#=
M**GR8\0'7+7XVX"_0,C;P!UP[81%9?B@()]=5P''ZFSBJK]/R!V8/N&$"J=C
M$%D6F23E_.**E>=CFBK%^@T4Y^N:L08"XF+IP?DI:&LR)YG*[%]G(F=1F!=3
M+>-]U $MYLY([NI,9I*966;2QH\F&QD.S_P$(/)*\MF_J$_\^*0JKO?]$K]&
M+2YA&44J8'E*G92QG7. W@"X]K.)E8,<W.:STP!$RE_ X1>'B4Y@+Y 1WFF-
M6DLDR%*ZB\\!C]:JYBE7HJA\L]'E'& ?-+)>?Y+-N=EFBXUA'*C]085I]H&#
M%[K&O\Q")74O:UT-N0MS)?#C^/%2A/5%%:QMW$" %V.S3%VVW64FK ['^_<-
M30![?7-'C6H>K^)Q_(5H2TW'ZO^+O?<.:_+[]@6#J" (2.\$*2(@($AO$94F
MTGM7 6DB32! (!3I)10!!0&E2 <10H?0BPI(1SH)2)>$$EY,")?ON?//G#-S
M9\Y]YLR=YYG?'^N_9+W[76OOM3Z?=^^U=EJ0G83?@B"/ RZX/U0)&"; H9B'
M7SGN!#S_\<YC[RC'\N;$;N/>H6"FIO-\2D7:C]!-*H6N,S,@&"NACK7O5**+
M2J=K<*4N&OJ\)!6F?"C5.,?EW;^1IL'SOD:GH+[/(1?:GRM_H*$DN&"8A'3&
MJ&S$J$K\TZI<]:ZM&Y[EJHZRM@=MB4S%]\_;_L615WR*/!0H'_\Q,U+$I,U#
MZ(@V%XLE@NCX=<J/DT7'S*0ARRAB"CWQ^KOI<TN#6@6%%S=U[DFJ> ^>91>T
MPI'+ [LS]<AFU J\2^C7Z29LF.#X#YN-=CC+-!OH'IEF3=/T7*WB4_?,^Z5<
M((?PBQ;JXF8KJQE<CD$Q*FMB:_JF24+8X2-_Q;TF;^:UZ2\+;^_<_<'BZ$<3
M$?K2.7U4YNS*F,7*(=NJZS>&DN&0XV6LP]O O WT*%%9"1]Q#OIT#CH'W9Z#
MGX/X9W8076!Z-QZ)B\3!'6#>1+"K*(?"]3M:FV;+?@\+UK_:0]XWS'SN!2)7
M)K.M8AY-Z!OO51=Y_59LGL1.*^G^S[F\P*C_7?_:T$NP"["?=H:S)PVH^)Z#
M].28"2?_!X?U0E@T28<26-0PN\GLZF9!/"']P__L!4__&1$>ZS_42NU/$DA^
M4%XZ)' $"AKC\I2.XW(9UUH3*4],T[]/417Z(;0;_B4;JJ<$CH7?V#73=>W,
M>3*V89-P/Y!AD [WEW;9"MWWO&Q5^'!TK36#K?GNV9N+62^-_> /N4&Z.5N9
M/1$N^[YPI)DE[$ P!8PYXNY G@PSF6] /^@^,=4T*CP'A?D)%%3^<_F-X?^P
M]^__UP0:,[ <<1+*V]*(0[UQ#);@<+5(O>Y(]KK\*M,&$'U5\=(UB@:5COCQ
M7&WC+&F]'[=$/M.65VGO #)3D%NPG!">#,)CUR]N+8\*+R@ARY'Z=8_94_U[
M-X5<!S=2O(+*E'&VGF_@KF5M$L&LT:3;6[[0 ,OHNR4&]'5J7IVE%.L+9+QK
M7Y1\Z!YO=MPAC7X!>JP:<?K1GJA5#EQ(S8\LKX@R);K6WV3'"O(*%!1\;8W6
M0%7IENS>ZFC2TE7%#[I,%2PUSI?N?8]3K%FDDCVQ84S^,%/&\WAL_?%.H^G6
M(MA9?_LT0U#O0R"ZHV_/B/N4<]SP8.%OH<[TT9[/K2P]%'*2SS@ZV#+S/MTG
M$=W T5A58;<6\X%]6BB?:+#9.)*3HCG;V>PPDDR24V^7C/!IDN=SF[4FX(#]
MWOL7_7!%/RX[)IHT0]7JZC\C==#IT_>^7U]/*LC;-BO^)@&R%[+"UM:?]7W,
M$M:_/:N3FGY<Z:!!GVZ]>6*V&?CS^Y>C\A$YGY-;>[>;ZB=?A^2U(S[ZT3P>
MU6YPS]DIO5,UN3+LS9M$@=83[6OS(QAL-5B5$/E)5+7I?4O\J4O,.J\=+NM1
M@NK(8FSRRKU "GQ-^=Q$,>RM+/1O3RZ8P:3XG3_BCFV*W'V]>997XJ@/:N>8
M\NZ2H>ND\^/_ZB5Q0GU7LL*=VJ:XG<%S 8;"3^^"4FWCG-DWZ,('8!,E,5'-
ME>N 1(Y,M]/K.^6WOU5G3?D8VWT-:@T,.:/.MDMPQ[Y>(&H!Q:];:A U<>[<
MHCZMC[SKGYGSRP^.^)?*<QW:RG5!HA5++OBO4!^8>T (7[G7JC-1=&HV179J
MD>C,2Q9^+.#\.;]G^1?^+Z;O&D8_]F\\%-'KI!8_P][0((^A#BL*SY,-H]6W
M<U]T<S='3MK.+QXU.JTYO7OA)F)0*.XZ9#GD\A:>1ET4W%$PILZ\ >;[?[2K
M]^D^P>0B3:AT\!&]@6,T@M/%:B9J3[K*>+?CB6+2U#>]#MO*NPTKF;N%OY-B
M>W@HM\91#VY7M\F*?&9Y]?H$&>>JXYL+^*[.YU,25;#]45"<3D#QEG^#L?+E
M=[\P<8;Q:63\(MXIM$I4FZ4%S8X+.2\_%L0+_Z>_9_PGA&S='BG7?YMT*72T
M0QXWY&?=?D_?^SEGRHP//7,3?].A[;V];*+#62+<$9)LSU/IAXH%4\,\/%?>
M5_Z9?Y)OUC0M\5+\E:.3MJ-IVI+0"S:7[XZ)F=SN>'W\A[/W,"6"&91VHIM'
M>-IO44@SXE3F*L=U;/>A5NQV^6^MHBL:!UZ@-?(Y)-P9%1;*?I8=RKI%NHS-
M61HMMM*1_KUCE"K0G*?-U2J=&!NO-6@8!1:IF0P+M2;Z7"3?0-+4">3Z<95^
M_T5LJ8(%?MHT.]BA*5P \DU0 7=[U^H-]4$/Q;M7?.A^W%>>J;AP&5.H-+=.
M=X<,8!WL9>4AY30C/3N[=LKP7"F*)_XK9<Z.9,U$X*?DW^PWLV4RA9D*^U?^
M.1MQ(RA"=!T2!L?JHJ*7ZP+Z8F'PE7,0/;1=A@V3QUBR9&<UY"P@57;UEN'+
M:E.]:;"J3T):X"#%1@V1<9]DY.1W#K)O.2&%JX36D:8,AKP)$K"G\;?G+!VQ
M_E_*."Y9OOOU! 3RDUF'4\!7<N$TI&M$GW1T=4P5\'F_5T)LH7_>H+4A^,D"
M!0.L[%5->!MFXVC$?9OZN[P,M?;>JT\Z":YC!9GL3%(M=[N,Z S4^,(@O/"5
MI',0FS(=MMHS(14ZT)<-B1:<U$AY63@EP7"UY6!XQ2]6DG.6W>'47.@WE[D2
MX17\FYFRRD4^RZ<Y!^VUAZ0&GH,NPP$:;_3^WG?7-LO/71N!WXM^;9<VE/I^
M$&5+[ P1&!RXVDZ.SB(R+J_.](W.71W%7*VM@A;,]S8TRLIINSOXO<QTJO(/
M?%IH7;=RZA P.J(G>9_EG_MO40>.YR"F<]!./]V92'3'!2")N 4?0@$;I'[_
M<]"XENC>:!*<\@B. /]SD0K9SHG<=) JDN&AMVP.GV!W^>!7F@N.36O@9]SO
MCCC+@CA!KH4.J=)-P>16:32M)BO]1 ]+=6\U*DM]^QKHRL/4Q_14_(;?Y0WE
MGQ3K^D3Z&I+>$H'4ES!ZQNUI7P#'FL!/)2%QJ)/K%_"DN!B"=_ZW>\YDSS(Z
M^'0PD&L[H2*3,MIW!"=^* XOUG\)])&2E$]>DEU\UZ_ZT@=:XPP<8\T?GA6$
M,NZ@Z&#:?J66+BT#J1NCQ8.I"Q(9RK[5_:_]V%W><I6MY,6DD!U0$.F-2;K.
M?1"\PB)\BR8)%D*@ ?9[4-079OFT='L2]JS: FJO=WC<:M8V+<XRS?3VVZQF
MP$V3W")8K^^ D>AQ)-[^+(LH2K@%4!A@$6\\CY,T==LGUZ8<LZRSA5\PM!D^
M,F%#)WK,4WDGKN4%D:V!V2\T9\*OJ,K"U%"X)"R.(@:IJ^'K&\(2&<QD8/MD
M0()?(%4;^>[ GWE(X%C@)\5W,-:JAL$U].[/T$ON06)'BGFI<-HZ;_? E_.%
MV;(<@>;&"_2#,L=Y63C,ZFBGYZSQROHYJ!=8;\8NU:S2@)^XRTQ8X94^ARC*
M2BKN"4>;ON(*\W([Z=<'A/1[))+RR #?E3-K4YS&^T* =CQ83)0@^Q<L@WG[
M@.WQ>,^M74I&MOG$_)?!=^POM8$A7;9"JV:UGR7BE,$E6[(MBO-N78Z!GQJ3
M^),6W]X^O!L__U:<,S7Y-OEA'F$%L<M)> 35TV=QR9./6>5>ZUNRE;5UXQ3&
M>&EUU36YDADGAE\C3XV<:T.1KHG6N-N!S[[(U%!#[<V;II7IO1U@GHX'<_*O
M;D:%-;9(,AXH.+"QKUVS#,[^NV]Y,1^DB5>G9%ZT-DPJ.Q59I]'-WCG6XJ ?
M\7[OL?3$GW!\A-H]!Q$DB(IG[XZHJR0ZK6Y,)&%$EY9M'D\LVC*/+$MI;) +
M4=TM% A/TP8=N_V_587R/R/$RP#N'"1(0*/.DH,V2!]>B9[\07'"W D<L&=
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MQXI2!TU-V07RPNBL_DK\^U&*[B!F2TC7SD$2/<&;1&><;#\KCDLBAX9K,'W
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M$+2P5_46BC0\MG?L8>C4?."8Y>J7:KZ>9)FL31YNK"T47/'>Q,/:FCNZBA
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M"?DS\3S@VO6[]+&+#R[1&3B^K//@1)Z#W$9C5.^TX,S#2 * DA:BMR7F34E
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M$F]W&QA=S6<&:NQ:Q#XON/NJ%5E*2WY"-IB:76MF8AUXQ^K+X!/=SHDQ3Q(
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MP33+-A7Q,:X-[F>TE)\.>1.\:)K3!%7^%G;<2[M+ WE!B+F(:37*]N@*.G+
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M$'KB,679^XG#T<\*<D%^MOW"XKN#72]\>B.455Q&Y%84^SP=^%HUR:Q 80&
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M/!6\'"%[I2Q>\Z5%GG2P>V*+.R:M5?#B+9ENE>[H*RCZR\714)&.PBX?''_
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M]\$M89=4VNB5G5O77QV]^IVJ8=*8;<!;]6^GBYF_AZ3>'JP3(UB5:5@_A??
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MTEO<MKKI._U!)=S$COG:JTBH3Y:WIL_A]RG$UO&!_*I/Y<%^.RP\\RK@=O(
MX5U+K*NPQ>U:G8%,96=^.E5=YM"U3; S,N4!(>)8*(5\-.5BU9S;ST U>="K
M:&'G!0Z"8NII=JYC'8,P6L)OX&[]1>;X/$VY%E?R=<PUBW=WN;8APD@LE)$L
M!>L.P+?1S3GYCI5W>%4-NMTT&)7K&GC.V)X8N8E@/=<[)*71"2W"2+QSKN-
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M#SOB]@Y%!;D,7^[PE8.?@7K-PMZ3C*S!E?.;A[ YT_))Z,T8V_#D.TOO=/K
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M"FW_/7XOZ:;@R+@I)93F )[8VN8I;EPNN>#LWPFE G,N05D7@3#,7WH5XY(
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MA138@@Q<UP.!;Q5Q4+>XRYO9]%,++*.V;:G^$E54H*Q'?M\$RL4[?E>$PIC
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MS=WXX[.._QY5N<_S0E+-(BV'M]\WBPM]M=&0OQ+)6SG]_]T#SM-_DH<WA;?
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MG;KA@RKWD%14E0.!.@@/[^-8S\? 8]_PWG8VU%C;6F$(7WFR'7BQ^_.. R6
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M=P]/U&-92X0[4N^JJ9YK08'X-RGE4-GK"C]ZX19ZU/DCP6F2FRY3M.T74^2
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MA+Y>2PB4]!#5BXN8\=(TSM^L/67H9.L;C.=1'E&?U6W(L3I$K.#,]Y<5Y^X
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M+0JQ=JWG?<.LH4K*8I4<<W7TYQ0LBXP2EXQFX>J/O01+<[^J2%7&H\F^$YQ
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M"^VS>A-]XZB-I]U^4=F(=P;M^G!I50J_LL'57:G!8\<T9LB1:M!?G'9_'WX
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MU/2F^5(=#P&(ES,JF5\<HDJ*\QG_R]#+])_CWW?R+%6>X(0+J23*;K:4A$,
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MA_QN1(P-8VT68>M_ZS'@;KF!C.^NG @186O?(TXAMGMX#(*&_BO+';:WXW>
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MY@/U&-3=\_>DF&7)[]"//4KFC?62E69V'9#<$O:B+\:YWQQ\^[>DAX...X&
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M ?.#%(,"D'2G4]J/5VF/^Z0^9?DEM[1L;T&+4_"4%HTDY2!LT!+[UB'D^*4
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M8VEN6'2-R>\P;3K'"T#4L3MO(CR.^$71 S\Y!))43!Z&$707&F0=V3$_'Z^
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M"N2V\5^^X-\]QFIGT984;<NWU>9)_K0*-+L_#O1BT[M>-[&@?7G<IH#"^'N
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MB"9X4K@P6&*M,4B=;M*3Z+<:*(Q3]!J:MY=_?I6-#>90*C2X%"F5:!5/ZK\
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M)(H1B30V_J$?.T*C$\S</>4U9=$]*ZEZV@KQ1F=-TYT1J*B?H^V7BM[,TR^
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M4C$GJ4&R\-H%/LK5R8S:-HP@.1)*U/Y<ZZI8@Q)_P+>LKF<K<27?\]#D.T6
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M#*!3[1UW0S>_3<$3S6MCF.G.J'N?+[E&XF0$W;D-<J,(G%2!.1$(8N!\A(;
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M16W% Q-0.P=8E046XWCIRU3)Y3_/P-V7O'^=M8:/DER&-9QP&(XU.7V.#*\
M^W WA6.%Z*7 ^J=MAX:ZCR+ <096>W1K1^G1"OV@3:1+4X),S>.T(6_7'; /
M6J310"+ANB*0RRGC>6<8GTERIS1E[O[W'43WKQ&;!)2D:@_^G$M?RZ6@_@Q0
MHK272ER2DX1>Y;'&U:[^\_)Q?@'!&M@BY-\&X94,:!2JTBT4?_+P0:,TQP>%
MZ6>U$4(N"ISUVI:?[R2WW'H[I T_H[T<K.EG*A?"<6>)$ZH!!T$-6,F-I-AQ
MNY&E">DMC3LN-R:2-:Z9RQ::PU[WK7]XWGOQ&R[0957=!5ZZM5@;HAC!G"3N
MWG7K:^Y+@#I ZH_4-A]Y&F?0B8XU7B/H8.<@0PB]+]-S=P(+-5&_"^),VUCS
M;HQ\@2B\YM"^WM53$K<W_[L;?YF\AE.?WL!P@#.LL\JPWW4$[RLT1AN*RBF\
M#0MZR+5 7\?S VUUS-[2CG*(M=%;?O_K%E1U=G]0=;\4&)G>;4%H3JN&1%PE
M).1]T:ZT7/-UXJ\+;_W%^U1 LH_GV1L#P+FUK^L/Y#+?&%N&&,/N BLLPI[Q
M$AE,=N]N\@.S_HH<BJ_,H=@XI[7%(A1C9(<Y;]-G[?%<X?F0F!7$U>O'M,5S
M;-A3=*4I?<WW<W7#K/P-[3OY]ZM4#4UONF>=<1\23%S ="5&@Y5JB:4-M9&E
M5<,.%S)RTD^^W%B]$J)%3>"SJ[MZ\;Z2::*RNL=["RR$,4@%[HDWP<KP(Y2(
M!F\WO5!\#VTT:EK$1LO+):*WML1J<9^3;S-9:Q[%'" 9>M!.5.[1R\3R3_DS
MY.Q7-,#CS ?:$>/S[LL*R;%GN]12!US@S^)>+>)]:( SJ7KFW5$($'F:*-8I
MPD$L_%)&=AM]C'J@,_8:-WXE6SQMSEC^KJPP9N:\W1VZ_)MU=B^&"8UX!VS)
MJ:1:24TVZ>!*+/0-[H+AE6-VV3>O1D>C&.Z[Z5 "FIPSZ;E:MUD'P"G&;+FA
M27X,3R:^H_7G#UR,,>B/+WHK\)A*4*(&#(\^.X-)J'H_HA@(AE7T7BP([_W)
M2'*ZH%U1+$G<^F7*F94$+P5.CU+U/;$TP/ZI'B'7)D9:WJ)53CZU< T2>W$<
MU0N]EM8*0IF'TO:QABF36U*L;=X\[<N::W7<Y_EGU"8U]:[W]TA!/W'Y^JK(
M3'$OT@!84&2+$N$D,<*+V5O_2LR<E;Y0[\Z=5-; O//@L5V[\$H!AW;EW@3G
MVBY8')3KU..S=JA9)>,VA$XT4U2W5T*<XCBC=9)"<"T#?<4W+75E_\1\FKEP
M<=)O0>8<Q7*D28^G.Y9ZB0S#JEW2X3)=:^%-:;=_!7YRQ:7G-F!'NP-E9)5G
MR5GV6%*Y,!N]*ZWG]&D7U0F, W&=8D&FUI 7$FAFY1BF76OB<F/>7KO^C IX
MI'WVH[ODP\1K-7<LCYWFY,AM1 F=DUR%TP2W-B=254? V5:ED'MOU9B@@"P?
MP^OMDL2?LEV^GJ[?5[WW_(+DV#C&I\J8!@BYV%NQ>] Y>*@A\_N VD:5.+53
MO._3B3*+16%5D,0,:&0U,))/K;P6/MQ/VJ[0/N#C:@NU)\@B7)\<7*QXHJ1$
M]W6^&AAUNA%&I.4<? K"!"_JG *GNJ(MYHK"O8HP&;PY4L^COG_A9RCQ,+"Q
MW&Z'1ED)D;?\2M>!A%YL#E_SM[01G3IB4>39L-J;$=KAB_;B]5$1JM0S>&$7
M2?EXI9GW/?$->>HO3HI>#0>IF",T8:PN7/T*;I]2SLJ(Y[QBGN4X*10#92VE
M\/LAKA<DDK)B#!+Z"2M43E>;0<ZM^:6;!*J;QHCOUHY&J5[6=MMQ]<93N(Y6
MW=CC3S?CK:\0ZQ)69Q6_"[ -?])=FHW[^_R*EC<@Z=HI!&K=I8X()I(4(TF1
M4_HK4RU].; <FYVXQHIL*K2GL7Q.S3AG)+R%(_OH0)*XZ2<1B73Z<1J)\>D8
M8'=X=91$B$K7VB5#(GAEUTH+XQ@ED=+ZY09B^#W/W^?)P# O]4 ];^:J &;T
MA-]-XS7I)-TKR7?UKFXZ>$H62WP!T(]4;TBFA&4L&5_5UTPRNL\3+<IU@>LQ
M ,U%=CVVA LM3G;#>"@W"4V5ZPV1$9N=LW-HNOA2R]K/"D9UKRNE5!CP;G<$
M%IOY%M,[ID&Q(*#W/-.ZKTF:N4_%:]>;$J-_. <J4I1?O^)@H1=HVX"R!O6
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M0?_QRX/!'S^WG":CB.?D3!I 1QD_2*'[1@/@GR$[)"GZIVB>25RA GZ=^F_
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MQ=+^Y52UOK=Y9QD'=%5Y.N"]I @R\AA"G;!23.]NV%@U6F\1'#F;>1*RO/3
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M8"M0MU-%PE#";V(V\I!J@"__\,MW:C]DY^*I"]OXA5R]VQ**1D'L48<<SC3
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M#% )'+6X)#<-;T0]#AG?!],N/TIJ_]#BX0EI2$A8MSWX']&RP)0B Q0'L6&
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M?10C2%,C37H\PK285]9H]RGMBUXB[JD[.+*9W A4D:TNPZ0575NR#6* .'D
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ME+RC_!$;A3=Z< !>JEE&"[E&VBJ3K7V1DKW(H9.D-:Z8% ;H;='=@RN6#;Q
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M#=Q?58=<D4?]//#T] +'Z*OY.YL)T1DF^LP5_P4+_ZU"UU<KY' &YQ#$:0<
M?\UNSR*J^VL9K8R/L@K#S>\*_[#[F*)2%@]J_,'\,8 !$D!U3B!4&*!2NT>'
MXCO\+X[.0V(0UA9CM7Z;?.F3KYVZ]:-VN_'S(ES)=U&W;HCR%7YK2'DA&?MS
M_B"*::/P9I(8+:[M,1A\N8%/KV6O"I\J?CFJ*TK]" B#6]9!'%I6-KLVS);P
M=P:H(>\81:[U*V"+@C_RSWYZ.4+5H^2=/JTQD[-@*\;$^!YSO!%;H4:^R\:?
MQ%M@]XJ,"P>(B'^]/'\1&I0Z] <W X=WWR3\*;)ZR/-C0?I(B<RQJL^1"W\T
M/ G9FX^380.DEZ;):XX%ZF(T(="B3/$YRNTI/FP_K5N]+:&^)YV5H-PILG95
MYF\-V->8[-?7S;-GNL4H+Y]0K'XNGQQW+ZC(_=$QZ7 ^0!TOIV!$T447W>E=
MPF>G;^75CLG/6YSSB'['>2=N=SC[_Z@Y'N\\JD*U,5V5&@6XJP9A7>"6O1=G
MOT<N3CEZ7+0XDB41<NIG"[,&Q3;%]LJ^C8\JT1NM=7*Y1J]9'N'CT7[/F%O/
MFYKPHONDZY1N?(BD0&Q8;+H.".%-T:.S[).Y9XI27>O<][6!\1:WM8FX*7@E
MT8EYG^LD&\XD\FL]C,[R]7#Y0A,H0IPA#>*4G,B*:M>U>Z1[%%1RI=[&--B!
M-:_)_>/Z78]8N<UB(J[E0.[OEN)=FN:CG_%9[B!);NA>I#D5.$O?'?CZWC#D
MIW[:W6>\ 9WO-P?=8:6'-(FS%7($V"=P'E(FPM%AI1B3#FAI5=7W( -[\+.T
MGTSQ^NVL5]319QU20=NI?_G]?P8#%5M2PMH46!"0(251U5;DN9(^+/N;Q8=+
M7E7W0N(WGMX8$]J6OIA%/ZX)/X09KM!=Y6(>U @=S0#EP U!>R?^883E/@!Q
MQ%$:[\S:K?L.+!<^Z7L<;%R#A$F3,SD_,$!.&+%+M225\NB4BC5>[S(%K1>?
M2L(U\=#^*RNPFP@. #G-@11=VO/_P6Q>W?WGD[17=4(2F"S&XR>/&".K-O4C
M;@.Y+O*KSXWD99,M<=,_%,7DGT#^D'P/96AO!&\V='\B,'"E>/O 2_/Z]"K@
MT[<"\=WS3]S%Z=8>&L!'.1_^=S)R;UC)!M)J]6+/*]?.-=?2I%826QOQ+*;C
MD_EQH=T5\X,$3W#8WON]A29.O@D?CCW=0U.QWSQR77G ^X149_1?G\<HZYYA
MY%2Z\_L&_JRE/EID]$<O+9<^!@ANQ "!EN\ZHH1ITNXS<KO"76$P++M'EHUJ
MWL_O5Q)&X ['<GFW+J$+G>CG!ERV12_]A].@?T5(,RQ<:3Q&_4%9U>"+2_SV
MPU6F%^-^-$07G#S?X#L,L:]=!RW?7\$<1SSTF!'>%?Z5IOU=WB-KLBKK]MB5
MA(%7"\<R>7%_Y%#N!Q0&2!E(_M/5M:$5FTJ40PC:ZS?-N#Y6-!+)O<H<,WQ;
M4]!$!P&A=%&_#=*$9_*+3R&> Z::F/!+3^/E1*$F7#9.Y96@JZT;(I]FG[VR
M/'H(A+<65O<IZH?XDK^!WZE!BMP>)Q62]<A(R=VRD\?]O:RXG&AI?)8$=T?A
MA6JK]TYY\5:J#3'^Q$15WE\]>I\CY<)__:M5 $9(TC3N9*KW,$V'" T7NU8S
M^#I"6?V[)]O^>(R;U?C%^"O/SY8T1V><@,^QH=CH;0W<0.?, 9C0G1--%_>I
M@)NC'%SX-O3* W72H2D2T5EOI%1%W[X]]DTD-HJ:<? .>1F,YWP$Q! Q)Q\A
MD("GY.J("E*H@G**W&UW3)]5M]2MQ9E6^_04Y$("E>D@LX&7IG[P54MN%+:X
M3H[0,)-*=,H$7!^4QZN&ZO>1XH\VN178/];VKXUZ,WN7>3G]$&6=BA>8L[\4
M.<<Q=_$(WE]'.P_U0V6=7HVC!SH/F0U!9H6]&:!'L/\J>TK _'MM;+;_+$ST
MSVZG,$UZ'WC##5)N<1!=DTQ/O92_:$CNP2LV-BB-U#F0,6U(MKX7"&T/ OO3
MY;T%DX;!AD:I6&O9PO8Q1%73B;O(=6=0&S!)424FAR O.5JYAFQU"?=P'A-)
M5N7D[8SEQ1R(0; O8J*.7+FDD72<:;>YN-N4=@](H<"T@<G/BWB^])Q'@#OB
MVQ]7(6',>:F:5K>#S(LO+ OB?NJ];P2MS+\ 7]F&AM)E@" B6]<HS6'&&-+,
MU]=>Z*J<''[BR_-7OO<^GZ2"U'Z;P.N+?HP$N[R!Z[@"4I%&)1A;[ *,GWY!
M>T93?JTP&[KF9'?QJL];R$(62MNZ09-29WMZH.^IJ7O>Q)R+2_D@*=E51]2@
M.$V#^_,$ @94#X_$ITVJFWCBAOYPRIW[_31H\==5O9T'D?/!OIBX(C%T94)#
MG%75&,I*025N'7P<H: 50X"M&6M;.J=^Y[^WB_&_NQ$Y!4BB:[GP=6'4VH.<
M.C#9H55,J!>A_7G9*F;%&%[ \F(F]/;I#K6)%._[U:O7!#HTX4N:WH]*R+^C
M_/*=J]PMG2KO5NSP*ZH,QBH+/I=>@@DZ,4!'UPX5)B<?C&9$.9R',S#^7(Z/
M[<_> E55E<55XU_9B26"48_M<)E=WC,D:/I0X1?^A;[CCYY)J\F)UPZ@X&AN
MQ+V!M60"<_.AQ3+X?-RYX>Q8SA+Y#+-P%5C1:9DW[%;T=CZ$W /FH<L]A45B
M>(HN*BVIH=@!2?;T!I8Y,2_A";O DYID?__-1CIG*8":.1!NL8+?V4,FPD4_
MLKLU?9&)Y'EY%F3"G%GX,^*IG3'N"4_=#BIV6DYP,YLL)^9![J%Z Y[D4"4M
M?G)A3 P^6GB7^W>-Z[WGB"HUC:/,V#?*/!8B"Q?0J2]7NRNWG^CP/#BYZ1H-
M+E\(I*N,M6MHYPA@K9$OMFM/;"@4"KQB-52;V<26:>9W0@B7@=K]RT0(O_4C
MQ$/ FQ]Z>JF/9%&"'B9>I&_?6&[<FJURWHN/7,X)=T=+C"CY0?JVE.X[/5R.
MO4_ M4%8:=9DVIN1X.U\EZ=M 1-/7AAP<Z67G=N-J__ NKC-?G/<H+2ZOKXZ
MMK]_\E19CR*3_N"II*=O0'(M2''DS^NVN406C2?D37,,H3AVU^Z;DR%3(6&E
M<G[Z3[5TKMAW]?QC!@>Y6%SP#L4'1>H)ZPG-L2L;;ZMYY.K^!?;8&\]V>V'_
MBQ]!QVG;9V@X")<, R *U8@\V)$_4P+ H5@)372[$OYF!;T9).>D2'CQ.RF>
M7Q \9]#8P^O7.L771W/Z/+$D1$UV*G#R9JNT-AHUMYSPRQ7UW[=(H/_&"6NP
M4?A@IYULA4;6L,8ZRG)KVIFAJO?DI^8B#39E!-23IU.I^.8"4:&/E<[3OF?0
M<N5:IA3FU1QB<0C7U 2";^1IVHWJB9=T42 W9CCQ54Y\2>VSS](KG<N-%FD
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M6@0$I(8J4B/2:^@@+0)"()00D-X2:1O23KR?MYSG?M[O>]_OC''&.#_.C\V
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M6F\8S_RN?&$I[19QM)2AW:O#J+-B@8^.K1:^#UWJ0(M,0M'AE8R(J(;P='
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ME@@]M_O(<'O2_\7:>T<U]7W[HJ&&CO1.1$!0JO2:8$% I*E($X)4Z2(M2DA
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M='>[JAG0_IY\)65KIR'BIG'#1'&C![SNO:6I?-PGC9\+UT=R:@3IH@S$+YZ
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M$G[F37V=WWKBY9'Y=3QJ36N]K/]X0$\M$KS]XT@?R%J-[6ZM/D56 "K+D*K
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M_<REN209Z)H6H36*[^0\SL1P >DKJ=T?]<[A(8*.B$]RIO&PVA),I%&@E^M
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MMRZL)OZ9E''I*\4E#P?Z/$8MT-QS= ^,ZHC\&%' 9P7>JR_3W8@!32C)DT]
M8G9+OYLT&V^_9S.A!WUW/U_>^D6V/^@G3=D*)/I1QXYUP-T2I/%$2'[TLBB%
M9]D>FRIR[QE#"H5F4'DX.4T^CEEN\ 8NLD?%9NEYO^2=$/TO49E:_>;GC$1O
M_&MSQ__N<)(FTI&F 6E"4Q\V-IIL301;3#3\H*T(<E6[6==K=[GJ6K_1^4Y"
M^%SCW/IR-X0!".]?)MP<P_+/]]KSOZYVN%STU414)S<GC"FY=MJ?I@NTFI0
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M#Y5- .;8V2)\0(P-.V<\A@-(VLYCFG%/,-G!T4<I#DF+Q)@;E;]PYN#L/-2
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M^AS-++Z$M8/(F5G_$CX2Q!$W( SYK475@UE?MY>_I@7_J!N8% !D]_GQ]IO
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MQ.E!:/AN,6S:3CX77?](6[)570$EY9/V&[9B8^R^WVN=AU8SR[$>' 5"&A@
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M?8>R/WS_\'?S437(E I?B&J0_6\46_>/=%(E%CP!6;KEL6L0X%U;U(<,F.
MK2Q5EXZ<Q2MW$TANV*<RIP09@,>MBG/;ZLP.Q[J388NFE!Z2W7/><N)$F-_T
M[R0MU$.-6U>^MIWQ=J8.VA(VY=]MID/Y"Z!0,/PV.:W,*7^V,F8P_M/(]V/E
MM45O/J0*PYH*LX3@EZUA?-J'0!SQ>+4G0A1$WB1WYY7[X>?-N_B\Z*O\IQ?H
MO0GR*>G0830HFT,5;*.?0%@%:(#E:$YMA:075OH1DN8B&S(_+IX6,7N[^QF
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MZ%%.]!NJ.+I>.G1B_G_U>BX+%BQ8_,\$E*?OO\  CG_(0 _CG1A 5KG75D&
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M3=_&/@CQX2IZ21.<KPUF:B2T3Y&6Z*X#]42_9)/;J4)56N=C>&^F_UWXJAJ
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MB:D W5L.BZL]B:X7TSX%FO_V#1#^[)QVKJ]>^[8C<G&W 3YJB/:&<QG[//K
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M.8L_\^V.E<($EB;C*]4&$]&/,-%MCS[!!>SF"+!H;6XP[\$0BI?B&$V*$'3
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M# ^^DTO5([Q-QL% $X9%LVDE%7Z/_![0AJ6\7FJO@K3#OQX)#SO!ZKBS6K^
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MJ$6V#( X0O;#SS1IH9@JZ*"G#TKQ0MZWMA!-[!;?>2BKSC!\;E-D5A^>:R%
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M7395K&R: O/*R@QA7\+D%A+)QX1:_1L.PS%6NL@ Y<CFUD<WG*]^AYO*N:>
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M'X )S=13I.$GT$DK7E!)]Z-*-;ZBP?73%0AL4+ O \C.^L1DM\P5C3?3:&(
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M-0*.&T7A0J32%CDU@@ITJ$46VY;$3M"O<CX\@O =)R?QTO+U?-S4)&]6[CP
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M)T8V".KLX?Y+4!]G;]T9G,!<I]IST2D[=0?, ',B,2Y==3^?M+0N(9?Z<*<
MY=(EM-28=)U) 10@R*3)]MFE[,;JAUGKX,\UK[[_7-P<[]0SV)$*DFJP@FJD
MX16[9G+"(;I%6XUJ'9;@:6W!^.A'FV6*Q5QG \Y.;A9U4 #<4T0UC'72HK+B
MC4F#,.W+"4_<&$P?[99QZ8\@A:4D'+XW9<_X3LM*#C>>WE80.& [UM]F7KR'
M8(Z^OYHH[JDK;\#,4?*U. NI^[.'?-8U7>9K@:Z))?PG%M]Q[L*4YI( 5K4
M1B4;YR=.<O2'U8) /7LSC$_P//FS''7DT8F]B-#D-K!SZY9@=!5M^*8^;:[
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MVRSONB3%L&4-;#' 691_F) IYCI_S\[>)C&?F_S<,;)\-5F$T]>V3+FM"V8
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M?*^<:1?+1;1:)A&*[HI/JNK'_!B+SQI86#P>Z9=)"?L6PV ;"H"/HJ;ZR0Q
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M6Q/CK8'D'JQPN>S-+(R.T(<-N29J[/BI TB!2O;<V-MC6S8EQ7U,/6OW5'B
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M%RN;&<]J-5IPY[G%\PKZ0P=E+LWEVX*WK[U6K?!&?@7./,5IX?T(QH%^LA0
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MPOS;%\'HD+M1&W,>\'I$EO-PP>1=,ZC@3[==YI/J-)EQZ[/7R&>? 6?Z3T!
M/%T&?H9CE&F'+(6G6[[$=KI% ="#HY'KYPIA"[PPHJZQ9U0V2U*L?*2LNN,]
MP8W?R?JD ZJW8"E8"2^$9 T010$ B*EY2+,*E<MX;DQQ3AN4_R-<7T8[O/*D
MP#1E(:=C.M_>\PS>[?S"SLB+IR=O?I:0QZ/WJR:YT:?#L&#036?X.#/> 'R)
M EC7_$U-]@R@]A(M@CQ1.D/='V.=QNCMWVD,?;#PE#Q61"P;]BID+;\)!:Y"
MK0S!177 :N;VK2^Y1!Y;Z@-5FGE, ?PV,^U!U1QOH^3;)1ZX9CS/>8F9S_41
M_KGTYLMWH7>:6K=FH^9IO;**PE&%42JI+MX27%LK?W0C!ES%+NM)AUC/G#A/
M+_@:J@5K3/QST6P'1@=S %\AVF":3W?*5RI2'(7VRV=.@*1KB<W]85"#P*%[
MUQ*ZZXZDIO07Y3ZIJ'5'0Q6#Y#VHJ0D8#^NM,+?]UJTGJ;V.+7&Z%RI6E6]4
M963YYV0B!G=)!Z>)+R]\/8A^5O] IG%FGT&F.YAN:.-Y;0$&M,B>DN*S4.YG
M$MSL?T4SGWSV2\R(7+&.BU3S1M''%YL4 %,-^&OZR6<UMA##WP@)ODI8T9PY
M4.<M-VA5.7'%V-4*I_CA0^JH["'JJNM]25#UD>L6WP^506^JICP1&)LT*8($
MX^,+%E27W%^%_]8-W@_'WY-K,WPJJFY9^G&L8[B4J"FRF:*<HTOZKB+NLGP>
M>V/^VKUI'SO:@"-ZYBTKO4Q"(/%A=6O#]]_P](;DF<>>@_:TA_#,]3*AR%R)
MA<2[A3KIQOAO&LO)Q,0*7RK?4"_@!]4H<;B^"LETQ<6>Y(=,FA12I]Z#9KF;
M0$],;:F;S-!T88P'>471M./#LRO]F+UM\JV#S5<M)D_)5I;#R /0(UG4;"PZ
M"Z=T/%ZS30$,#:9Y40#0Z=*242J5C[0H5()SS':'2KJO1@./9Y@MB+UYE6FF
M:MLS2IN?>=+[T1_2!V%)IVV%1&O,W<H:<WR/:KW_PHV7M_>V$IN:Y$;--]D;
M/T ="@;D#8_F+H;WK%Z"*HVB,W2"SB8I:MPXM!>\C)^XTI<_ @M?,U[(\,3[
MS1S%4P#&T*YA</*,9^<0IS.>0!>#:+JF:+DI<XW$,P4U&7=!UDQV71+W3%F2
M4,7MJXQ604\H@+28Z3*A5.,-P:!Q!?$KR&@+J8DMXM#HJ?A!D2X)01:=VCDX
MXKFDP0<=?1&A!!M51HQM(.N.XVQ:D1C<.U_01EC&%9B\9W"WN;L?XM.:,9KW
M%_!"W _@R=?0635(T%^?/LQU+_T6>'UT0L==4QZV^S':,WC3%S6[UCK)H[8;
M6S%=N6DDZJ#: __(O&&F0_LV<8KJ(<6,T?G8$UDJ9H?*J05",PF.1+&6GLSR
M/U- G4R&1')8.5G-S\)SAPLS]&QV.7!2Z\DAX<F\!@36_P#QYON173/P3]"X
M]("?5,*;=%(C!?#S\&7N-^?[CF7KQS-^!5M?VA&=C-=I?]N;\,GW9'--^%,
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M?SN=R;%R/H(P>9)C; A6QCOA%O%^<&LUU\#&PC<CM\'W3^>>7$M)L)"WI6L
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MEU!@LW*1\"[C ,=I@2B/Z@]K:AS1!Z4:LSDV/4$NMM?=#^ &R@XKCE<T(EA
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M/"O01Y!2V7O/U2BFWWUU<<)5Y\0X==K/2G+UAVGP"=(;W,&N>''.MJ((12;
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MU%!(*/U^*J9OK:S?S")3LN1BN,LWF@3AYWHH?JB3E+PP8;K?6?:\P<J#-;;
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M7Z<(QT2[9Q3,()N=FW[GBXKPWW6CIK  R9VP(*%EDF%:^,,05>ZH+WLL+_\
MCKS"Z F0((G"MO%O-DR<8K*=B ';6IA28D;"*N,R03('U8D_7';_&LC5':,%
M*;'-%RUB ?)40JJ9K7[&)+D\(M$G<0,??+'VE,%[%UA117W!Y1BQU]JOCT>[
M8F<V-Q[?A^ZY&Y=)Y_ Y.?E7ARWAR> &K[Q2]F1O!^<F]FMVP60(5O1KY_64
M%PGF-$3'S.KV"&V1[7E?^:7*$]'A0P9.*Z4C;$#9(;51:'J;^1+IZA;C4#CW
M(N32]?5K+7-:Y9""@$D]-Y&&H[A^T"#3-,33QLT,:H&_%OE;P9AZ@9;S ".E
M7]8'K+JB#^Z&@NBV0E-S9C).<EYCG2&0AX/.#G! P=#115B.BA5E]UH_;5DD
M/"*RY2"^%I4U994UCC\Z5PEV=95=.N1-M_P<-8G=^N@':2_*HVJ6J$(/.>T,
MH$N]DDXQ-NF6Q4;SS/$ SFF[%E70"265:1J.GYWFK8*1H>9K?"%,TSX08*CU
MKU,C]\WEFIJ[.7T38W;QVDYM*@[.DJQ2HU,@B4V=5N6XSZBP*=[VBHC=W,2\
M^:06/T[3 ^;)--NNU M8S0'K=/95[1M:V%F.H1YPRM"E"=5MK-[]FLD&*YMO
MB]DLFS(U7/'J&J.MM4)CV7PYLO5\6RQ61[8]JV8DX"$+,,8(=\-,%V#?(&&D
MVT^\F4=6.2X]=DZ3BGA]L&&ST/PV,Q0E,QA]NN?)ILB+<OP[. @*%$R&IBJP
MT7**;UP?#=$RL[P]2*Z2Z]Y4'.J<>!S-A:FS+9G$;#@A60!3T+;2Q/@'3J+;
MZ&1P<)G=WAI(Z9"QF$8+1;I@\C8?T2@E5LM*#$M>D)KK/;_0'Y'GGXFC7^H(
M-0 W^(HA7?VV<E<S,_H3B//X4SJGG:8"XIL3%Z2GQ%WXJM!C\HVHV/YY?!F^
MR?7"%6Q((@EH'DXRE%A>,(<6^# %PK)[XB@P]SISQ;I^4%((;X-=TPGO13]=
M?1?WB"?)A/?6/= U/V3LI1' E,OKA8ZGGORLBRY%"CM[^"?9S01O//+;%@NI
MMY'7JG@Y:T%B%&8UZ2(+\7]%5GIUTJ1/!$FV4(/?;B)@L.(V_K&=8Z8N"QN=
MP_ZD6)I80'/.UUD0E6_L #+C6,!9_*6Y?,DXTA\"3/E73OV=1Z" ] YTO7+'
M]RNJEP7P>#_Q%5,JBH2N;T3;L;UQIQ[L^J(*_OT?WK^+U0L$-S"DBKXSGL/?
MW-RW"5.U F^*<]&/;ZR[/+,28 %'\N,+,-N0HF<_XX^]/^L==2K]3"LT7 <O
MEN\M]TO)5.GW@O\N*_FAGW1FUPOS;M Z)T<AD$>4E&J^B"@6X'2];9AF?&RX
MYY_G+_)0^4R[-+R*2B>Q=Z(\/C!%+IK$21ZUU3V'YDM@(O+9?.Q\-W M(&WL
M6M\)?++3 OIPM.+:JHVQ?&&Y<XKKS2,_'Y#;%6=V$V@ONV''Y_'D6P&V\F@G
MGXOMBX0E I87?!-I_S2)#<?WDD<RV+_;69:)@K]4S-D(W2GS@?R!LU#XFA;Q
MLW(BFT7Q:AO.8%:_EW7GCMMR'?DW70Q959[,7K[BQ3LMD(U?B56C:M0TVIV\
MH_^)O?>.:NIKUT67@J+2!*4+44% $1"D2(WE!XB($9$N1$2DB4B3%A(5Z4U
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M!]X43D&/3E)O$I'QTW@Y9<O)W^?9(T)P.2HDHR/1!9@>4Y2M;*#KS1#$!>;
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M[D/P'ITU%CH@[DQ @[5M=.!K-4IUAW;Z8++LV>1Q.K#&AMX7ZF;I/J@<#UF
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M760)3ORI*=2)54VQ05#$/URK9RVS7S8?5;J]K/[Q?.2W&%)&W;/Z[&OW=5N
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M^UOU[<M#BP( KF>' 'XZV'Z&R&P*=A-2DCU721:AY[9!$AWP757H(DLJ1<I
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MKPI:VM6,'_W"/M[9W9BG VRN?NIXVZ(J[,B9_!KAGWUE[B'D/()+(Y;%,Z,
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M%P>DTWPQ,G.5Z0JI1^ZU2;C)%68]"E(-DMZ+ X>GKA$J9P2BZTX;)<FK/]F
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MB9:>@_X.X1X9- 1?M],_!,J%/^KN3Y%2W/;[<2;HS_PH?G95%V):R\250;7
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MOQ6.K"(%EA+?K3[]].1&GMR?@?D>K:OQ;PVO1,8H\4O.GOJ'6_@FO>\*G9@
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M-EE3"F6FZ&CH@3*+-T_Z%&0%72AW4H*V#$.5T:*WS[P28:63?*<&^]',7G1
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M.%FQT"3Z .)4T[<=Q0!P<Y&*T(UN?^IZ1H:9FYC%^?HG?+ZP2WF$EC8F2?B
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MV),S7VK/:4)<J<Q)%_2#"9SSFWC""]6@,R[>K7O%KD<_] :*G2B)I9!<EAA
M&(I@C@L=64CBB:H3P(#F3_"?OR3(W!X/;*>-SBR&8H5S/_(L<>)1:_$$DQGQ
M6P(A2'%''Y_21^?1/M"A]:'T3JX&42S@,ERP9X+Q "4I+E1[D%7^(MY=&%Z1
M)"347:ZME'P.57,V4?7:BM"#-G. 'KV(><T ["9!J<%7=.5),]"E[<5O*I3X
M?-0VU$GR5UK F1EGG;'FYFU=.15@58=OU_[O38*H?\?S:G!#F\H73+^;TL(
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M)BYN)YJ\WH:+^")W;Q&YDQR*%G?SYL9,)QM+;TF1Y;Z<)E/$7)CPBF-_?9X
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MOKOV!J-&133+VZ6Q?GUAZ%C*)PV5<JB[FZWMB3L_<R%)>6T?IP_<"%Y<13C
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M[Y_AKPSHVQC],(A\_EUA*Q;(5V]K-\4)__\)FXEC\M.Z:#*F'G]R<'64''N
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MI#2YGE+XH1;:\WB-+G"0@1O%2O25GB^--5QG3LSY?4GU =/N-*.7G); %'$
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MCZ1.?67C-SX517_%=+"1R&9U&T+K%,V0XLEFC>.W8L$,]LA[0[FR64)/LGT
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M!F4%Z3)E*IR5GH%<2*(@&70PT]4;T2Z!5C;W@>LHIF#L+.X#E/R]0U' [C[
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M-\+GI2V";FAFZ,TO!#C;F$%8$"V:[:NH]IXI71'PP_HA9VCD;H?EV^Q />G
M$UA<Q?S#+_(Z-FQ;NC9:/=G)!(DC6AW=Q>3 [VG%24[%BYNC3ZRM]\)B"$\K
MJRSE2XR5/RA].Q43/%(#H=P&\V(6](@8!F<1AA*U"F5*5OPXN 55YAG:43&K
MD1;0\W%@<=RL1C)P)8@GC+$4$]L' ^(^AZD/6LF>Y7I1MP+CG2C[M ^$21&7
M&:] W$Q,FC9Q$!3=S3=1=W5(6XOJ"$LU&RQ?-E,VCZ>"'^5\X.8QK1TY-FH
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M_*GZQ:\E@#L6HXOX'+QX/U6-)HBSM+\] !OYM:;1YIE7FE?U0UIVB[;<RKB
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M6 CC?"L$//(5IFPG4O<D36,@<^A4W6#QZINNL92E/\:B;&7?_1]+QY3,\
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M G=S--S$IUYWZ@6WO[C[=XD2G3Y#7'L_N\IJ.:":?LY/0=:R*L"^3BMLZN2
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MZ0;X<:4B_^K^K)H=!RV4D[+89G9DV0V%59=G@_0 H48)1C<"3,JM.=J8F>T
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MWRGLWJ7'HBZ89M1S,C*4%[)M_YDL&,PUK'8TR_Y*>>H:',=SZ\A='!CN$YA
MX1F=NY#;3 >T,1-=A$^%H$L",[U7T7ZS [56V\!2Z#SM*=&=8IF#>7P )$F"
M6UEWE+HK1O:I8UWC!ZJ:WO&96-]#G/5R#2=)@O&,F+@MEP4%?JLFD7"W$A<N
M_2_L]> R]ZI2V9F-WPI.XKL1T=0;0^"YQ!F^9/\Q^$6W"[-J/<08Z?RV8Q&^
M[D.J;";CXM^5Y=9="TD@:-2V\J5Z>T24K4AV5KA[E;LP&1%&!_SU\BYE/0=-
MP#!\R5W2B!8UILN:O:OW#3%**F9I$\:.J]NPG3ZD<",7#E#7W$!<S:?_UFK:
M"+\8F#4R![\STJ/89N@:95NY&>RH&V(:PH R?:05MP19O0&4XEUJ9\GY+LPO
MBX:FV3&FQ:V(6:7Y_9TF]5U?V2N!@5OO%PEE:4KL<L4*+:RI1%!03@N<3+Q%
M&BR8Z\'CVHW^-MF^.F&/W'[>T+3S&LGS"NT%%X55#H;.8OJVD]\,[0'O#5OD
MR^6A\57J]V3M&<(2(J8F!^6XJCZ6WR/&&/ LB9J(YS^SZ"[X&EJ]O\/KI@'"
M?74=';$YP4H,2D]PUK[9NE E_3GO\%3=(%HC^&X_D1JVP!E=6EL^3 ;5^(@Q
M?<+NER8(!M\F@-MM)MUPO*3(1P2^Z>I+,\)Q#]>V)>ZV2CD[22Q*((O*X='A
MQLS3<C<9+J+O'[F-7E&3P*["N/&@+J&(,FJ6?%WNND7$Q-[]^)5NCF_;\0_\
MODX5O/C]RN\ 5?7J3X$+_]#?I[9FSHR6Q4\AJZ9T%'K7NNVUZ8![%'1.\\01
M',@#"DP<'<J7K 5;5S/ZRZ!:-WY)#E"L'+X+9K>=%3D 2VQ]*\\U8GS!Y.!S
M:-D56#P=8-+SF%I@4*]^2)U0 Y;!5?MM32ZWM92C$7@68BRU81#AN?/Z^.LC
MIG9#WBEFH$M-0U@!Z@/W(J$<:4(MAG.X1K.!>2C2KPN]]N/L!3@XR9LW&!8A
M;-]"X5+N@!<>6.VTSU- L<3KE8Y5$-(C=SAN+\R:A1J;W,(>EL>/',_0E"Y7
M$VSU. 8(ZD^0]Z-IK];ORE^N^> 8H1]M?@,2%_WUF,M2*_Q5$0G1"JS>!><<
MRQ[A!^&2,*S^Q%4M2-E8^&F%\1K!W&_:-[$LZ\ITP(3/PG;:9P^:%*SF@?3-
M)#<(M\R;/L"OFQ19_K^'UDQ#L,1L_1UM/M*; MH44O35X'NXN*O)=Z_]J$^9
M!61"MG9)X2!B+@\H5GKO:$:F:NC:2_A@GG4L&;ZMLO U33_*Q@ ._@UV3A@/
ME-T%_Q%D0;!C!>O*.,G&]-M%:H%)BM/4D8_<JV,$A0_5U8\Z]@IMOO'"[TVF
M?WW,\G: W^+D0:F]48R-!,V!F A^Z(SJI8)I+ <ORF)VPBN^YT?V>I6GR&CB
M/7Z9+,C^&4BY&&^ZUR3E1.DD&V7V>7.T.T?[,TDW_E0'<2*8C^:P\NZP@X_@
METD'G+$E&?K6>%8S; "(^:G[5A;3UTO!R!^-(8S'.^!5"3ZJJ!++K$];]0/Y
M4MFSDMOZ2Y9:9V4T!QV6[7#%A2@D0UTF5^8DO[0^(46Z1[Z [L>PUNN9-+6I
M'Z[9@3+)UL&"P]%1($F2HQHWTX2OP-S:QC)?QU/\\&(S<*KK9X)U3GVOVB($
M._WXRE?";(17&#MV<Z*C^<.I4)B/G79$Q9/B\@W9R:#6U^-UJ="P/GR@A;QB
M_*KC#^F<_\&9ZEW."7%B#AZZ.?FYRW=!-KUIV!.B&BB7:-& +)RZ)?XL@$D^
MA.,45S1EXQ^Y6&Z2&A9*1NF M\_6LEF^6C&_D_-XN/TR*TT_R\K@T,PD/Q#F
MWL05;=MG83?.<4]J(XN/E.O&N U .G!2^P!,>.[0]^X5V8HWX;[R';AXQK'A
M7"2%[ZF+RCGEV6AK-F8W<1EV-QV]L_)AK[XJB6*3#&Z?._76P<[\I;NY^IZL
M8=^]'*?5)3XD V6?=T'+]KL?A(@=LQL:-L<:>OF[SR\FFKS0=89$;%<_?Z/+
M^_!_3[;Z_][V0;E_LGW@WH:(J^*O%0#G0]=(BD2C/O6,.P;_%[@S*W.,7496
MC<9M)TX+K862SB,7]?_]=:3LYME4/H9*,LLGT@&W;!0HYTP(N?]-]W_TL,8]
MK!Y2HZ:M"V>]G_[]'>@9Z,04'[E;HG+Q7\_F_J\;[# .X0@^ 2-W\!_3RKS@
MQW$;LC_[[5(>W@X7$%@,YXMDX#Y]?!<MQ!=,X?#"HT)R&BTDJ\U3QC>P:C^O
M=-SF^YW4[XJ+1;@HC">W ME ?#,;$R+\%>M<MCI"U8=ZNEAUIMA "\[-SV00
M3'_A,,PWQ+#]VG2WKQN"".MM:8UUW^UO /CV"!UZ34)H=^4+Z "HW^SQ-8@4
M&4 '=*L2^*GA";1W\2UW1XH.U$!.071 (O'5GHC-=ZDH7ZA&%BK$X_, '8#E
MHERG Y!V)G3 J4R*K Z6#J@XQ&+8-B8\*QP\"N6VD3Y\4V=V6*63U#@:!'X_
MXY"==$;)+91HBXP3*G\I"4KQVUO\(P'PLM:+?[G:_KN&^H68<* 9-T'H %2+
M)AU@L+6Q_Q1S@PYP23C2V(+2T/L[5*DZ%/0J[6H+<#FA89[S< )SL$7S!NM)
M_\EF'/%_4%;WQ-+"[^NB H]+V$*UKPP]8 (N*(316 BZS81UL0O]RTEFCF3]
ML:=[$'%!R.3?B#:,G);))UL2I#WC2QSLNF_!M(&;E$"/.)_4JC<4Y4OPVFK"
MZRW(Z=,N<"2XH4?,+6N>Q;Z,!YF]3[BM6K1_4>SW:$WZTQNN&CZ!2OMB/+VB
M(H982%KRQ$[QVAYE,X!S<Q2_T8KA;794?;-00KW=MFS9W,-9@1-QT[S2TSF9
M&']O]WH\7TO)OLXWVJD^M,CJ=><9L<'%P5*NF)2'5ED)%L\ETAS>=&N_7I7=
MM1_8#@&M"Y=8Y=4UA(_<_?+N3Z -6][+<UJ_(:-09CK $_NDH+4 MF-2WYQT
M\;SK!.SAMO:SV+^5UG\$T'90S\&<UJ@6)M^Q0U*F3->B4%%$<HI&&QFTYDLA
M>X9DZ<+,9FN1;=^W[I<4S_R8<^HV9/9'>MZTI:G,S0IB/,I,.H5".A/FR#>J
MV4&.5^0HFZ"1]<!PEKL)H$_)J[JP?;SY^KVIV@,0)S-V/%XF)[+2V\XV-8D.
M "?BX.-(7KEF!$%16\GXO<D7Y^LUA:G"+PTTSSLZ$@7,CC^7\Q,#\!^SE4C]
M\]K:)ZYW!:;[B+P0CSPL0Q;>#[F+TD"U()XR_+823!Q;16JRKMWUC;._5EMQ
M%P23@[DC;Z\PB46C\R!]%BDO8)[FJPE#52S5+T4*QEHW/"T//0ZH5ON]O*;0
M2W#N_TKKPM=-,2=!YW=B9SE],6=(7WY"G0-;&D)AQXJ'5N?I -;<,X[:T6%V
MCKPG2(($)AIS"('<AE8=>97%T^HO)MV_Y6EU]2#&)M-YL2FRV*!FB2TO5#'O
MQ<L;G6X'F42.>E*!(QYHA,=UX-CM5T&7\6M"P?P0GPZUR2T^_:2EQ,D54W(M
M3NIIK8%#0J[S?UF1X/_?-PP8,U<X<XZT0OC5<YL4A!]M%8HHF3\7->3K<5NX
M\))AT^N[T6Q:T1T.@CZ)H3^S!C WG3]Q=B2,<]*8W0BL[5"!5V14K!A?)A9]
M;H 0X'.FXZ?\1'*1L-SKN+%PJ70IH/3%\Y9<9/W37!-8D6N=%3I";__$S!>?
M!0!> <Q2_B>WH/[$$_63;Y/"B$](G&KQS2J.!:X:L4*I946UP^+^X8N)45[U
MZ]\6/^.8"K6E3ZW>D]T#SG=1+FQ@T[/-0%HD[R(7H_X=9=;VID>TT53IV$+B
M3-<19 C) 9[+!5;-MN-D-,%1M4)ROS\*0\^+KRV9? ZX&8L\M.UC&DCM#K8@
MV<S/QD$Y#[S.D"H'#'<XUV.$IFTZE-I^<=])?+&JP_F!%Q\$N96[$>@?54U"
M[9>0[8P[3=]ONR];/47D7KDX/ $@T0$T43!9E0[H^UR(F-O>H0/B3>D #B0U
M$['Z8 B,]_>G [ID-UFD3RTR&!*#56U.T@&W(S[3 6%-&-H-?8H&@NA!!WS6
M>4 'M$[/T@$BJ*\,II9 !\P/T@%57E06H4@:QS;CWB4@?HT.&*^CA?_)IL3D
MCZ"\1'_+>0T"TP&1)K1>S+ZT*Y"D^6?))P6!93CHY[/'O"J<%-%I.H#P@WPR
M^I^.U0+UE@Z8>X^IV@D-?I0+BS' E^T+E2<'L5/SRDKMU URO"]=?R1YCBTW
MK!55O/JO5_)_!#^6$"O^D7BW^T_BW2HZ($\)\B?Q[@AXUPTL"-Z\/X+8CW %
MT-QD(6VNPAW6U\0OSK1Q4BG6!YQG*-KUP\$*!=-?PHC#J:S,(V.@G?>'7>IK
M)(M],-M.V9=XYV!E@J$PDP%WWUD+IHNA3&?1\?$F5SI5M'-&?FX4Z/ (ZKFF
M9,P^#V%>,#H[V]YX?T1-Y.R21.>]:ZM8RKXD&CZJ+(SCF&W)W]13@S;.MBV2
M?P1%#Z/K"? /GDY-#2-R\TQBSY+OGC5!NTF2'PRKR%K^;FYL;*SC,!<*L!I2
M/7'QV4$K,"LD1%K=MQ$4&>5S5=5Y*(OY40E?TWKSZ.^?Q]+E3?/\KW'M.]%B
M?/C/26ZPFCCCF1\V4>(S?5T2Q7&2X''V[!#9  /=&]J)>$),<J7UQXZXN,Z"
M@#/Y>=QV=L8;O _:\K/UI$Z8<1A(U< 9PFMEZ(\#.>%-XU6:$L&C+GG1SII3
M4E/U!NU7C80J-EZK2R:_J? $[')X8,(WQ%C//'*3J@A=S;#-*$<W=-:45/9Z
MB^F=2V"Y &(6?"#,="8N*#_8^$D&]2GH1WSB.CFS4Z3Q3WF:%?8[S\_EOP]_
MH&@PQT(9I-: YSYSP:+E;.8/L6]KF@=$M,L+RJ=O)N?CGL=/B_"-TP%&YVYH
ME0/80F1I+%YD?5L84^L(E$.9=;1VI/D6%_)A$D]$-/9JD])D[V-]8%L\YPRJ
MY\S#3;Y;SZ4 )Y+<-A0_-BI%MYO;QQQ<_]CXES2J;V<<06-.%FO('2>E+PRE
M6^3,6UAJ*;G2S-Z<^ZZFR/G! +C;^T)?\/'+W.792:7YG4BT(&WP>"><HO1%
M/]]9->;QU_'.S7E_Z[;>'N[VM*<&$@<H>)I&G.NO.#6_U)V^[HY\/YAH") L
M3AL/Q&WBBE61(.19U-S&VMMT8F*KD%W1VK*^_(FG3/@;LD/L#=-0%\H+!BIX
M2@$3LC-]_.?.)K=:XRU@<XK-1!XUN_)20_WDS@=SB!>C2X?MG("-658*M CF
MT-X8G/&\JJ!["><ER>D>\5#=\?$M-O6+898#[4^J9#RSJ8-3'NJ:2#20$W[1
M&<S;#/Q"0F(A:T7.$V_ASY2D3OLY/@ZP>'A.)N"TT&K)KA2-N8>LC\.7+)2*
ML0[O6 5++;Q+.V/ V>T1_*+BGK;:1[U9,ZEPU*@KJ=2/:VY]]U60*%>Z(@.F
M-N^&_IF'Z&N,-RB[G0S'@<0@V>I,E,NJ*Z_>1-$!"89HT .WS>,]S@D>8A!^
M9^O*7),"&RGCT*SB:_40ST,#Y0\.\8\N=4D\YI'P5%VP6!3\+G)\,"_3&0<S
MR^Y.ONSK@,_=/(_HNS=*.TK_4X#WSP^]?_N!&@"_P^!-,..XN>70B:Y8^$52
MB4[E2L_> :O.U78$FVG,PP&URE"W!:^H=.BI+<]8,::!YJ#".V5A0>6N(P_.
MGB)7Z+MV(1]BU]8.]Z__W<X@CJI-DSH?.B>S+2I*[I__7MS0]?[6Y,&<TWX)
M]'$8+=0"<_@30]'5\23VP.*T%+M=,'*\+]^^1+_Y\3<G>G ?]83T;+:*6*9L
M@=:H)H5]4KKVJ-!%(RMK2EQJ1]G#N?P3HJJ9,%CC9Y89VI*Y+[%K\O46@Z;*
M0LG+4-HES#.&]<VJ*(56@L/,GUFE&"+V/JF#UY(#7R/N$1@DB3$]U>" 8$,\
M16@EO#E@(<O_7N;VU/BZA>>)[5)03^J3:<N3FM''.W-U;:+ .1-LEE)KX)G>
M@YGT@NI>WHF4J#VDHD5B'>\=:/.*@&DGJ&;WQA>-^$M)!:S3H.+IWOD+6;\6
MHJ51Z:K_PRVTW$+G0,\R9)T+L:XI_0GYCJPD!)F>.)C<U6*?DSUYHM,5>(8F
MMDY&3\^9L,UL"]O\.:7Q02SRRD!#BS[Q 4FEV&L/+4"R4WO-.;Y?_VEM[2L;
MG&]]WR*ZYNZ6U&'T=[R1/O$\B;,X(-L?VR0Q&TO-WE[F>+]6:1J?U3BZ7+>U
MA%? (DZ@5>73YY78:R,++76".-+J.)73]%,<GV[^TE'D/Y- F'LA>Y"^V-71
M"Y[S:DLX#^MYP"H]. =^7ON\:T)>8"M: ?KA>[?H61-7RF4",K8F(0HD,T31
M7V!=4Y%S>/BAH*$A9?=GT(GQF]]8U $ =;Z#&VHC,MW#'R>C!R$AB#F!H<J^
MCIP:\#S?"&)>5 @_L/WKW8HP8NL$:X#88T#*;*S3:0N[$,?!L7;IG!KY8-E2
MJU75B:ECN]\:VC^_"'CEA;]55/]E#A60"CL2DD^;"]3?)).52)G$E):1S6;9
MHE6_NF.SZ[^(&663V*O??T)>W3*M.W/14PK@"36USR]"M"JBU2W3=E]-"S]H
M_:8ZD<-&3KBFP+<WBN5\I['2!A9U$;N*WQJT=LUXU:;;JNEHGR <O]J3*MXW
MNL/9MA.5 >U 139RQNQ;R!6X$DN\A2K.Y'HF"#N0$K%7#A]!M3\\):C?N'+[
MET+/<[=S19YP[74@WF0VH='[B'+B:DG2*9MUBY<KHO@J;O!YV;0A\#.3."'7
MM,QYY#L1#SE:PM-!$<YG.-"TVZ%U]&YN]N@&'P-B?(#W E];IW]C3-5CT"("
M3P=T7/CKIAPQZ\*RUJF^CY_*'1[VJ6B+)"(*[,92/0JVKBG#M+V_BXSN&^AZ
M5JWY%C >\8V_:@_\\8?LL="0%O\\U7*9?'M0P=B #KA;%6]L\NC'8;G- VHV
MZ(+K#]T5K!>SK6B^#BC2W?+4ZJ0BF&7<J6_#B+I A#O-^?*14XO@G>#3OH_;
M$!$3ESP!P*H[?:_V=\>]29#K#-EJTDZX"G\(/C^2I.0IYU%BKS!?_=.,\U-9
M;O;\<0<-N*SP'-?Q0_9@Y\^I"6@P;S.X(:']@DBVW,'%0#H '3=(66[PT*<Q
M*^%'=,&/"5[16_%3G-4&'FJ]&^U7NNHV;+HTVK0GH7\%W0"F5D/6[//I@--1
M_4O35"1!_GCTRVSU&K.JMD_MLUX?H70*MY1-%/)KL,'@MMXF9_6:"6?/1CL*
MQWB(OFIKSQ:-DQ+>+;ZW'4WV^3,8(XI)9*8"+\GXMP]2(^A]0NWU4SZV: :H
M/(TE33[C3/;X-#OO_W3VT2DI,D8#!2YH\:QBNUI;&-XCW]7]"M+?F$[AP2UN
M9];3 6VLQ,)1H'9MT?,C7,[1).;>L@IP;'31,^UNYGQY(\D#LXIG/J(#7O-T
M8>Y-J!=S3^20^QJ@#IW.Y>0'5"1-V@5,(.,7.]+"/BI/B/X(B\_C_KC $$I;
MX')\WNSJ1/C?K,V9,5;B;<>[&A8_\BY7<:7J\EJ\]G*A@0B@I-;28/T2J[];
M6^O0:>#WK[34K-?V9R<T%]")59M(;HH=2Y&$GDI3T@?P9GHKI>178>FTNB'L
MDW:5$;4&KN[RY Z86R6R;8L.,'B&I /T9'UV1OZQ "U'V.WPP\1=:K8%G.E,
M=.K4'KEHLIAQ5!G=9FFK5?<%_1OD-'6\]^<H=6ZP<^7CYR;LLW&M%=X%Z@+[
M1Q+V8&@@8Q0D6?UVYV@ZP!FFTW:H(^4_GK8L<NSP"A5->AG=L40R\#+BS+##
M];6HT5@(15UUC$&P><@;S\![RY1O>-D_AFMC&._R9P^E(#*/X1%W(C6R,*=H
MV@?22RL8,^C>&O1#M87"E59,!0FS!]1*&&YAC+L#7^['&C"/X;?F'IM*&QF0
M%BLXG*/='#7YPO #QJ!S4(^]G9H633\?8M;U^%E4F@VJ!@[JM]1*9R$V'B5,
MW*46#2+F/LT":BZ>)!UXS'HNI&LX_H81NR,]X6\'@F]2FT'<,*=Y6EVY,UQA
M@*);/&'#7S7P.#7-YD-FU.#I4[&)#'TX=WITH84/210353Y"SM-TB+%KH$N4
MVZ,@&1C.C* ?M6-/MAAZKM@CSA.^R:6/+WX-,/T&8%E>S4&'7C>])_OL&:^I
M[@,@%-$*0KB6H-Z"0#5XBR8_SM #<FK,*]R;)Z_&S%)XOEEHFN^]B56%VP)'
MK6D^YM%?Q0MOH"J:U>B ,\:DIIS)6UXA!3 WF[O]IE\:JS](!K-Y7DT^TSV'
M3-]%O?]9V?!41J::NVEJA*>R"FPCC>K5YJ>Q;)7J5+O.LKM[4JU[+&#:FLHF
M.[,#3=.,*Y-S[XAT@!L,V'X!.D/F[;-=S)[,T")$XQW_;5_C>3,!M).#-NS'
MS!4@3]?H/O+Q0;F<CDUM'F3EZGP1_ 61[]^HL-6/E[)WO##+]8H4(\)9V^KM
M-@O<'5'I>-G#]"Y^?W:JZV=3]H[NBT"%+EP$_-(D]0.!M>WPY^SN+_:GT\@O
M 79'3&%#?N4COXXG3=\:N7CS#4G,&;!&0G]"E#]+4^YU\/3K\OW+5YG_67N!
M$=7B+PS6(ZDM@EG7]/B&:D)D%GY-3=VXVQX?#O$&S#T[%J)T,3BHU9_-?B3J
M3V!D)Y2F!"TW@^2&=XVTZ79FU4B:/IRBQ/V33B"*)^GR O"UF"J(CZ Y;E 4
MX[Q=9WEOH*MB+_Y>$>Y'$&0G'WZ;H?X/,+]7)FG?:I&_[AV+U%U'1:,VUZU'
M%%/,S/LVP*3+.YVR&^KR#@UX7+JRVZ7M(0FFT\^<#NT/U"@:N$4%"A4&I0/.
M*C*8< ;U,7Z4$M,(H0;JT@&?6 90UU<L2_;)T41OD![U#=@1*4CK!>.S&);1
M3CY=BC@Z!NJA9KX86.PFZU$G$[UI-=ZC+2$^NGR+HV5:NOH6055W2DL9<+CT
M[+_Z0_W?VD8PV2JA R3X']$!J"8OJH!L,O4UXG<F+(;6QOB$=[KLG/[SZ_;5
MB*G+&S3]J0$Z(,FU@!I,!_PV*2S,B=XUB?B?/J;U7]7^X_%@C)[L'I+XG@Y(
M+A^F S9VC.F @:# @UW<0D\_S9F<?9X."&&\O?WL"L_^4P8LODAZ_.\7^0N]
MKLX-R4G6-$9HQK@DYJ8)FBEJ)(;FB9V[N,BGPLM!' ;R!;^DOO.2\RSW14;^
MD'>?E#^6J'QJB4-<3IB!$BU7^NKN'3VR[#L <LZT9!<]\?TR73 3NGWA71?E
MS&L5\@DS%0^F^X0SC:W%+B,9*3+^Y[;GK,R MM=4-OM_%AB]'()0<.@>4A-/
M1&C!NX1JP[)-6@@=4&;RG64,CPL[P FYLCI^=E'+J.DYK]5D:45<:>)J2_!Y
M8_\!#]$?/."<"#(:+"_U*'^U5VSW5W4&'ZRV^(>9N[B @,!B+ OUK\'J'FVQ
M?CEWN8N5M29-[,UN0@K]-[^A#/GBCYM,39M<5T97;'6IZ=(#X2"7>VK#JW5T
M@/A2PFM,A;N]:&.8'6$UE$;4TA+2\D +9)8[>L;K'^I!IDLV6*11F676ODN]
MJG#]A)_>@JE0MZC46=W^P(LYT;*G>O_E*O*_VG]-(Y706/;H $F/0CI@S!5+
M!^BXDBV:2XCOJ5G[X(FP>;O1-\&W"M>%S-^.<MFQEJGD<I<F)D%V2DXV[U[C
MK/_$N5P93;U&BF'@67V")W*Y=\XKJM&X&AG@X=MC<-66<WLGH9<MY+OI/BJ-
M)HYHU4(X@R/@[AF16 \3L^K[B;Z?>(=24Q 7Q@PU$@Y3'C!%D?2[9J1(B$+6
M'592@@5^:?4&62\Y2*X4>3AP364?@TT@R3AM<>(/?\1[7;"!U?[0>CK:GG8%
M!*_\TIVP>#FXI-A%;8)OO]8Z-;43&<35GG9HJOSPKWV9;USFTJ<.W/XL2!/'
MFPNU0O"_+#$K^8<1.V$K:U[7!"B.J"*X"*+5&.R4$#5CIM.YB.6O1/2@WLG9
MX[Q&; 7TJ134-Q;I4\>)>%S,OH+06DDA+,AFL&;C++G.VG'*_SHP][/X05D@
MS3H8O.#AT*:1Y"HD5A:2,]MU*%]-3@\U/]8XK[\"U0]69T#9-%H?'<!.*<PA
M;-+$*Q/*4.\N&C)0J95MP&Q*Z&OPIVC97?]Y'.7"X<.8'Y%=&'8YSRI:Y2$V
MO9=C-H^'"4>E\AU(89$DF;K-@T4Z0$83Q3T+ ^T:G\%$E8K]A0QXNG<)&!,-
M.#Z.7M$2)(BW0;E*T>/S)CRKM,LUG?<G="F0>Z!\@45">?R_7OO^K8$NDL(9
M@-*/I(T?[9JYC(\OF,>(F!0Y"V7]2O65RP_/O+W;*GMG,[Q\*/5JY.G7WK%O
M!II+%OTI?)-SA^VH4!H('_^!<<>M(C<:<$BYQ,IS\^H(;UJ0RR6]EW7NMR.\
MDTZH_SJQ!OT(K$F@9*EUFI!%#I!4^8SFXM?:_%BP6+/5O#;'H,'@<HV-IKFL
M0-*4TN.D /!#MR)\^A;_HIQ#A[4JTELE\Y9O$!OWF5I J@N?,4?@W&C4J %^
MZ (I;MZ=C0YH'QFE _3E_!ZU6RS'FF4E()@R%H?OO4IU>3DM:[<U1N9<6*&\
M&T",.M,!6;#F=)OJ>KDJ6KF+!(.=IC+1>NS["3ZT.VO@C6K$KV95C"Z6PE30
M^=#[9VEC*]R#]@;ZC &LKL'YQF![BY(5Y:ZF/P@PSP'A$H0<,;S!9:C3I+#=
MJR/8 YH#QM\U.3I'8:""<FNGO<9R]Q^> @8,LF"=.^]R[T%&BMV'8UU=7LCR
MRLT_L?BD$+(';&2E"UK#G[#M*7SE22$HE>74W^\\R!\Y2\2O'SK8!^$3NOJ"
MY4GO<DCE(=R3[7+Y1L3W[@HBI7+23 ZJ9XU'L"?6<^OXJLB&EMT%\'X@SZ>4
MM"<+=KIU8GDJ/V,Y?^N&B#-,0PL>$]KLO8@07H5?Q<^\6]!,&YQKKHRQ'%QH
MW!VY(7CYRO*52:2JUF(Y4SX\\0:6,^RAZ]KES]W-<;6,Z5(/P[I,SLFQJ:I+
MKC]5VD<EH.6#;4;ARL%WAR@>*&J&]E/JHI.->JRWGKCN'?.'!M_,3+LE%I/<
M5L&D*^PKH?O(&*(8&QX:7@WDP'Z:.#LDT5\])F?M]B$4W76]<(K[NIA27Q.D
MF_>KLK0>2XU,<+DAGEFMRFEDAH/QW]G!SOBMMMHRGUQ2,4=L1D3VU[HA93%[
MSB&N+7M?\@/X$#=M<"(MKM@5Q#.X+VIC_&ZK=RGVUY8WLV:JR#7:A:E;=(!'
M"PR_?IR)!3$-:($9LC@B1$;7]++>IXV/:NE[.7Y:3U=U'HV.ZE=&FW7XRR3R
M;KSVWL64W7B G2\02@S/F[!VJ;=KX4POD_]2T1BQ/&,1L<!O)9[((2@@$LI9
MJ$(]'7R=8 /;F4>]I=Q;+S[N3'8I5$3== Q_=A$N!\6EPO?A/X^#,R";6_A?
M$T]G7&$^)E>%"R6GA8$1WB1(,E+WY:,0S]XKVSA#!C*D R8,%T,*-@_Q,9:$
MN(ZOZ(8PQY;43-5^;Y^_VJZ IT6J'+**QY;1M\^G&DCKNO82M6]'4Q0("5OA
MA,S.B9^-<:/MT/,NV[]3Z_IW\KZ^83J\\R)50*Q :BC;3?\6M1ZM ?,!.I+B
MBNXSN9'FFP[H@.SO,YB5D^@8,DL+6@7Q(;U:?XL*HP.VP&1]9TP5%/NA9@.?
MGM$QLJJ<I> GM![LORUN&]H[]MCW,>>*WAN&Q= E]>=Y\,?,3[_@P'@,?F"F
M S"*4KLH(6HNV'F'&SXPHU@]2M%AKXFJJK$Q=&,571!(O_SA]5/C98>DD)/Q
M;=G RR5;D-HZA62>PK+//10S4M5"0IS8M4:"0HSO#16Y>W!>8)JT.*Z'UZ#_
MO-.G0RF))&\MM7D[MT[K')?&LXDA9>O<+VLS?*MP5XYE3KJ@A6/N(:&#N:.>
M\F7*S[/._"9>*ZW*LQ*.%E<,'?NEJ OOA7?9RY-$BV JU="P 9N;(XFYLQ-3
MMY\.V>[O.5T]D;)"2JF,?7W]&^I3YU-TKM%+!IU*4HH-R%Y9JIZMP'5^=^\=
M#%8>_?G$W\/08\"!^LW?:5(0=67DE;8^MC%E EY6,.WBC_]HZ!; JB,#U+,
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M&35[,E96L(BV!7_/J)@7X9EX +(-G2EW>.UZBO\P[6HG@FM?ZK];8L$C$X
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M3N"+0O8U?G5\ @'7D2\@J)ABSW54IT!B]\.J/&B682=VB75T]P<X_0)Z2D7
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M6/C.]@X%<&,9X;T&F3 F1 S '?HC=HE(TY!*QI]BW!.P3P(;KC\[Q=TWA H
MUWO#WBBSWP&G'6V3.-?GS?(+Y-OBIN,R)[:O5_D>O>JL\VY.>5\NK!*JC&P1
M('2=E$I1 "XQ8 :K"7_?Y9:$%92WV#NIM;[R3P_NZI^59CAT6S_HA79!]%(7
M/ZP.-OC;&C16W?PP&0BT/LWV>TR6MP)=8(UT[U+EJQB\N3=YJ22BG\S0A=>Y
M#7;!H=^*6WM>KJJ-7?[[.0+US@EU=Y%H3@%(#Z@.;@7OVE$E]L);VZM/XB@
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M"$B,G"G\&?:H&Q)Y2%?AN-$Z@S-B?5.JT]D(JOMT]U>"7,P/@;\.-^ W33S
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M (+.*FT:=]HW05=BT/5GU9.DD7.\/"*=L06G7NT]@.4PME?Y)[);JH-QS'V
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M-,R\'^[/!1O:(T?L:T HDJYK3.(Y^5-:X:93U2M*9^">X>U *)R![UX&^AZ
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M&,D.1A*+&P1-JH.\P/GQ<ZEA,C,IQW&?>\7R;F:SOWUY]*0I#.^U"0=."3K
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M]<]OX4-.F*<%J^V:T5(0_)3P+Z7R81K@ZMB8>T7V9+J=!6WMR\J&!7\I]1C
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M!Q:#L")=TF5\<[VE(HXTX 6'Q?X%NE6\2PB>GA5-L""^'I!8Y,=L!%?CW+Y
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MV&XMN)H?@IG7G1%HX)JR+JY&E_\))<Z?3)H6&<+W"MJ=P7MOV/!J04SS!FA
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MFY%:SHVI(8@MD<\H-V_R\V!/52+@:OS%MF_M!AF2_X[HTQ^<&=#/= #SKHJ
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M?G0-N$;6N(-9=FF;9NNK#_K4FXV(U2T?V2D@V)<WO':(BOMQ321853BK7NF
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MGAMD3@;#E"D=2_7L&CG"C.AX"EM=Q)"5IP3-./$LH 6-[I[<L-"\P (P5UE
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M?'%'T!VP V4(OH6#.Y127]X7E7UEG4[552\*5VK/&'0+WSU9K"H*F+KN*$8
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MIE9W#OIV?8(R3]><("P.PI]XQ%[E3IQ6Z/8]LS$6_V ;:_[/(K%^3)(F)_A
M\^EWDPX:5N+2+#82(7 *+4%W;B GIA6VE4>MCWRJ6%]9/Q]Q_%EPD+[TV9B
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M_6P[<KHH\ZDNJNSD,HV8GQ7*7&^U%>"Y)S585OAQJ+K"OWAS:V=HD,E)?4S
MAJ=#@V^2TNMSD+$&J3]L72I/:/K_R,I5M1LWE:S*X OZ?[NP5@V-G#A:3XIM
M]A19JG&(%,[.GD^NK.A5W,-]ZI[&:PG2>4=1D:7\+I!JF6Y+(/A9P+)E_\^
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M)HVVLNRR/CM(5L\>ZRUP5<W]X9>6EAC;4%Y_Q!CT:C5 S !V"U2&6F_+H?;
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M:1#)_\T%)&$CJ!$FR_U]0+<T]O[P@OD]5HU/3;643#I>R ,)4ID>3YJM9N3
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M:P)VJZ/)=0D= SISD#,H!ZP31HH&'-.0"[C>F;;ZB\A9XI9_Q97N!GFN\7\
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MD4*2(VM0-*A9.\K]#<PX-YE#YX'M#8FC1IG/-7H4DC?7CC7U I:Y__=6@+/
M50$47K0Y-0^N32J85:IIL]5B%7-;J_?]XUOP)F?+_4'H0EO1V]<UOD(_I;LA
MN$[U12K_5P;I/.R-(.Q3'^>$JB$B&CD040AVF 3.4#9MWYA-OZ(?NVQZ_W4S
MZ_5[LK>8QM\ZSBD-_H?7 5&$8(:_+(;=(I7-087:"5<[3>+:U"<W2JN1N9J1
M3)J;YZY./9VPA"N$O?5%#S#BDBV/7AI+> EVLODRJ:K@<\(0D0X\P*BJT8&L
MW?WN?__2A0G/M1[!6'CS$.2Q7*(($ED"/VD3^.Q$O6WP P?EM('R/W=>_"1<
M6%3MO4& D+Q^UC*"'D\31@PIBJ+ ,3:%[UF>S)!E\KA3OG3$9GY]>MGT?\:9
MCV$PAG#HKB)$: J!K9U&!/7.F\;!=Y)W+T[K!]GP.VQE>ZHZ TQO66?^O?V#
MG$'\R__^UW^*'$ 4H::4T@%&S!:I/A(AIVG(%3,_J!0U=&10('+TI,N#N$?]
MZRGDXD6MU:7_,342S4_-@SB"(U%59V.(4&&7;#^K%*</7PO6(VDC8X[-$Y@U
M52?&7BJMF]T&S=6T>Y).HY&*:O:(*)I\/\S4]6V<G8WRY]K;)CKZKY'(NZ;+
M]M(?$<T7Z(!K\(EP4?%#-8.FJ&E;MVJF9W1@P/#5]D@^_ ]#$2/L>1A[?9WV
M:^IT7:*6T8U?#3+' 1MW4\M$G<9< 9JKU,X>N@SBC"%)(,,:V(*<BV$WAQ<(
M4_ELQXZFN E7#UQC?@E.D6P-&\QY^](LELJ3$RKM6N?^ 5DP;F5ET^K@X"[2
M>J2J\J%JCJZ0N3EP!'@*S)AG_#<X OPKT7C0P^$M["8*AUKSF5.I0*WM[2^F
M9%\=6ZEH/ N.9[M$<5O)H,PQ/C3^&,W5#([:=_'FG6N3>6HYV.E^.IP45+#]
MGJM3W6K.U=%,5W;MZ:=<2=050Z@YHODR36B4<IOZN>$49P'O/2N7&.4O^"]=
M 6$(GS\W^E0H1T.U,P_&F<X@)=I$.) Q<,45%:S#Y.D?7!&^-5:_$[A.WOM^
M!=OFEP!(3X9]0PY@(J$<,"T\HBE#/[SAO.-^0-1.(5;:R%4JV5_7V5DM2/CU
MPAND5/S,?4"Z\)\)O=INI'J&#JR2V B14SBT)ILS;O+6D\^#%/FC*/FRE7'N
M( ^3D*6A/\+D)_ 6<2GJ2[\BH]8@.G ,'+:K=M-"!*N[4&[X?.KZ<DKYS4-7
M0)Q,$H?YH4OB#3[$%I*[$\&!Z$A"XE9'[SX*$9E=&?S2F^[#*ISM-?'PNOV[
M<HU?H&T_^S"R-N5F+4F-4-\LKEC]YKVZ=M&1MN\%)]Y/"#AJ_SBACGJDM+AS
M&[1[JUCLVGGV/$>>7_TC''@IBY#@F:C6'[?TY;N#<)/J"^_JRH)=1E/^C/C\
M]1,[@RP/:A'/5A!2:&T_&&[.X!$:0G"F\ 43_?&0V"H4QRJ"F]9>XK)7X;HW
M/#V:$9]UDV#0UY69/%'TX%7\QY-SSW49CSAVT)N9^J[!"\\V"XW<,8E&N ]7
M(=E7GH4DU!#/YH+?:5:7ZXMX!#\M2KLOW\:49<#'1-K&-R.""FO>QR.6S*<8
MV]2,""BL^7CPKXF1I3<WJCG!D!]O*TAOIBC"=E/GOT F*QD+1>;#!^#?'YO.
MR(5?8P>7I?SIZL (TEC1%!-T9O\X.!--LER'K$U%0L+@;.R7$!6#-,<D^UM!
MY;M4KJK"DM9!S15(=U:*+I]E%^K<7UW<_3?^QG\Y+%-(*<02DOX,]1E9=Q@6
ME+>,+8G_P)9I_2Z\;>X3*KWD$1UH=8%Q,TAO2@X=F.XXF%*9_6!5R0^T=]E.
M?$@W$$U1CFKFVC^O+D>E>-+.(DGN7,_!.W=]H632-,484F1)T]^[]-NN]R9A
M.M$7&MG(/00SF94>'-AQ5SZNU=Y*%#L4-OGZ9;:^Y$N0#<666HAYO,D'[Y^Z
MD&S;G3?0<-Y-04SA6D*9J%$7KR$2<U[,:J>;+6QD&C*3!ZYZ%$/0ZVUM9,,K
M?SU:AML%W1G<>-(]=K$I-?:T =CWZ$-UIX$OZ!C*>5R(4<?4V?X=#O$QM)+=
MK=\:1BZ"I'E_UMQ1QZU@]HS]B0)F$45:F7EP+^;Z S6[,;Y*JO:JQ=?(GQU8
MMY[:3$<+(N&-9!)2Y]-1PWW+BB4Z4*;2*>;=+"?3*/JXKV7NE">[1;__JFAI
ML?H>_SZ*+ ?OAO-1,V%R'M7#OQ[#9;-.47/1!F^21I%O3O=>;N,"V(^'VDH5
MU(TH2V@^ML@^4;KV&.7S9Y\4AH_KP+"6)D^W3PD.:6KW*X].[8\EJQG0YE]C
MZ0">UXWYRDB5'-NJ\K-&9(C7A\?^WL=*-M8=+W<?3XPO5CN*R0;S!CH;$-+B
M_')7Z]Q+T?F3LMW%FZ>M';PV\A#[15O,Q$5JLB71DQ#QH>!]4#E)PC9 X*&>
M+-'T7(]MA7@NZ)R)Y%'0&4,MDFB_:FWPA=A^BK!\E&PA&444IGX>($;C)^I
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M&@5I$ -AMX@F\=WQC(G=UK3!UZ_D[!9IUR=^3O[ X:N!8D-FC/\-2ENW)+Y
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M@4HY@4);S(KM['I)P(+"9BKI%>.U.SW3;8?MM1L=)445#IYDH%W%-_T?LW3
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MKLUMCL3B45QHM]A;KMM>Y81A"G<B_DFQHMOUH1"I]]\#D6I[@3/B0?)GKZ/
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MS__ZGG-=N:[7Y3+XS/OSGOM]WZ_[_KS?KWL[JZM^9H+O56,XM;21]V<8'[4
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MAZ2%>/0EYEZ 90JVSV+^NSV%;?1F_"X1\1O!0CI'S@J4XNHIL5%(/3Y_^&*
MN.XB=.7YOM;0@BR%D<U&C5+,]\ /D:)A.K59\[B&YW8?]+4?1FN7W%]N]S0;
MT@0H:9A!7[(XN$5;GR@SS4.D_GJ@5YTNBL;5"5"\2]=?X1CC)LLPPEHZ 4JZ
M3KB:Y,>26KK(1P=&;=,J6M@37AAC/WZ'*IRC _:_F7]G_Z]JD?\>R IU=85K
M?@O]\'X&BXTZGWGCU]TXP5-=YY0F 2;)W*>83M3H<]J1TA+R%Z\)9@KO@()_
M.)-Q_';;X]68Q6UAWAIM%0LZ4-M2ZUV@%0'5PWDHCH9.@98'NCVGUXZ7X7\+
M"!Y-RU_<.^C"IZN;R-7;^05T9YA!+'"3M4GSU1 FLH?V8Z1=#]=$6/=6%%<'
ME:JZX^SG)S_76M4CUZ-=YF@L>>OK\E5CR2W)[9+?S&M)=C1V/6(SR6S3E*5)
MTU\WC4\'\LM HB_!_C$*D(/I,Z;^1YA=C:L@)HHBA(Q(I&8*?0B4$%YW]TO?
M[, B@RUTP>\FV*&3U3A.;:/>4<1\<_;P P7AB&'K._5)^2%5O&QB(@2)VWN8
MJ8G6-3:*/6$ (D;P?>2_KX*^<5>A>N=AI)W J9DW9SN_5!P,XJ7@8)X$](QB
M$H2%_ ;$A9!H56L$#\RXGAEZQR6\>#301&#'Q8QDPZ4+[B_B70<M[V_?YB#T
MK,#<0;$!CZ8(PZTE)Q7/9YZ@YE(MP[[C*^=_ME^=$Q"K.%2ZM/B7=YS?!\WK
M[]I6(+/"X-345X.0LV&Z P%FL2'16T,OIQVN47U>1@5?\WC5D&ECK^*"4:H7
M#A!H J+D$@:@+N4R1OVKOIA&$?B(#;ZUO^>^G_=]83^#O"JM2G4KX+CQ))-C
MX5WN)Y;O,XM'+*;BMQ8,WI0?+$P?_+"T#H$38)0$/B@C5/7B:Y9,6JTUKSXK
MMQ_UN,!59* ;8??YE_3YJ+LC&CMQ:S>PVV3$NL5#^"6<Q+023\Z1_L*Q'3M;
M[X*:V %PY1U']^0P/I 9V;C<QAEOD[*)&=&DF%!S?55-(=^:ERYMX+"3 V&C
M9E4=OXQ_)44'OCUZ57?F<.-GLC-1:R:WB"C4PE<_D"NF>0F?T1"$1*:_@TIV
MOMQ6>W)6Z<6+^)VP?I#LH$;ZY8Z%$XFO7FDI- ]%&[5=R.U>W%UXN>VPKTR$
M1/S5C4[^X _^JX.WE7*'[.!$Q$PIQE,X7S_.S%Y%RZ.S84'I)P62S74LFNNV
M+1RP/$R46@2NN1X=&695AKAO6^.E S?^D-F^>G@QK7WN!/+F\.]B"A=L1HVD
MV*IX@J+\$>W=^-ZCOB8W^6?X*U"FE05U/JX%["$GM"_?J@&-0LIZXGBKGSO4
M*\8_L5TT4&EN*;GTE,/OT\8M<\-2_9,Z7M.H2!2?*C@2Q]\@,_-1\?Z81Q#Q
M9[6LWWS;MNNCW*89]XO+ TQ4-8L;2#[B^9P9,XX%B%C?JO6&\:"\^,?J.L>T
MB^(L!A3+^(%_IA*E$S_L;F=>'QD?O1CL>3=&HWSUF/:]DR=DOR#$DMO+&$%*
MDF+/"&7VE -DC)_\3T<A=)-MXL/,.D)9\R ;=+,IXR4S=$QO"Y,5YD '#FIG
M?4LS8Z? +K)!I6HP!8^[^LLJNWI0DR(Z9*H-@VCQK^$FX\$G"E+ULQ+#0'>?
M[B1NPU*Y-@^,5)E6,=[E%,4M[8X#&?>IHBWE(^?<<A+Z)18^#Z^V-&>90T7B
M)F,)Y:WWR%W33](^0:BO8HL>.F]FP\10$U7P6Q3.?5U\"A>96?4C*7KJU%9X
MX.&CV<./3CB.21Q-?!Z1?!X\GL0SW.?_KQOI69[2^N@ DW\*WFX*4CPI$F3>
M^'US=.=FQJH_-??>TZ(;/)R++6EYHG(S*>1[\.:>7=$&)SH0;DL'B-E4WOP(
M")R:#KT)9:%U(F6'MM8XR0GV0SZJ=E*5F3KF+94\1F"Y2IYYB8_A>O^[;0[_
MWC'TE^2!OF'^;AS;Z!%%TA%"[/*#:?E0&\+$HX"/;N&W!N6E4JS.KNC#QH\L
MZVOTE(=K_+UU!RMV](S I] K\H5M[C,]G"TE]G:)MHN9LTVAWLOIBMVUU <9
M.D:=O 14*X,=BKP8[E:+H$EU>[IU)"@>^Q&78T@-?/06F6NS.[QHQ<-$;O)C
M?/KFY-9:CPI$QZ=U6V*]L0*&JT-[2K^2)844.^50&[G?]$/PYS 3Q8D(-:N*
MM'OJKZ.Q*M!1_$S.@(<.?++%V7KD@=!0=_@/!KM>[CZC&1NC<GA VRBN@AQK
M^]A^_-[9P+O'SZQ# ]\8J4L.]_Z/HBAAQ#U]9!.:%>I9^FJ@P?3EYU>(1V];
M,![WV+UJ11IZ,M*N:0GP/A(^<"@<I \@31&C--8'I88H.3)T.N %Z0I;LHCO
M5<3LQ9$KJ><.[T;#B^ZF,O@N#T3I>?,[QMUT>:;'62\2/B=/R(Q$T($.G"8U
MCV'+9Y#"C+\ZMC*3.3[3@>:6S&$Z[ 4"V1SL7#W46H;:M K?(DB0G,A>>^<7
MCMN0V5O.[UZI*K$KOV#@B5&H[%F3OF>3N%'MI/?[4$C1WXSA*QW UBY+3)F-
M,ML22 73<*ZE[',>F>NC34>?./UH-K!V\_[= 3TE' +K9YCO/(RBH3CE3@4Y
MGJ4#C>4H<C>8,(N+1F_J(%IHNU@Z,*.Z*\>XW0!42QJ-#]6[-0/:6QRF XD,
MBSMJ0KY!!RX.)T+72N&T<_#\ZO_[U^O$58$HW%Z?Z,"[GM:I&12(C&X5K,D[
M\ZIR#U)X<[VF$R8SFW35H&^\L?[?4+W3FH1@'L85/H.K&5?@G\1U>)5^M.94
M\&4FI\THX+-B ]MX4J@+\IU*-<:?9;GB%@>)M0G0R4>Y&MB&QPCG:6CLEHG]
M\:12VQZ7G676Q"M*:^AFW,U3>:#V;F8::Q;Q\O240>T,CM63X-,4KCWF<!;N
M@.&PWYJ!)H7#"" :&S_A^90IM:9\>JD4$V?;>E#3\/6E"L\O+;B1)S5TH#!Y
MB=8=WJ</W"*G-]<@)0D^I5.ONC.BJ0_K_?:4HY4,B$]I>HD<S)_:U3&1T*G/
M*';H[Q!B+'7+BPZT>VU:QP,[+21]:BSE])[(3\0K7TXO_+?J<3$3EQ>WV\\8
MSCZ[O+S>%[)3_F(^#U/P^V^9T4[6S#"%NW@2O<)<8G\;CXDM)&P_DOF<!2/,
MYG^_84,'>.*P^8%TP/-QY1;F%<-7? $+,(P3M,9'13>C>/)"I:%G!(<RNR2=
MQXU^QC(^7KXZ-NAD'!W@'UI736E'LGI=@ 3;3A/M14-D1A[IX![!EE=XF':D
M)M?(XBR/?!1X&V#$BU<J(X2K0R#/I;K4=)B-^J)GA">I<DN^D3B""1V(G#CT
MJQ97UR=-;'_/SG:<#K2^E;GDU//9Y^6MI2@U.:YD[-9''B#^)8]LQ)O#@,@A
M^7_1Z))&]DWL"W$_!%=;OP^:UO!>:P!/E^8[SESK=>!2**11>NN?./]\M^RF
MG:FZE<,8U,525--113X"'7 +@T>N&'7N.49\60R'V$6!?!"[UOM],"9C0Z0^
M?O(]%F8[H,JJ_M76YU%FF8[!=C8CDDVH[D;J RZ(BRUWR5K-(=*1OGY^P8<S
MG \E!O%?$BBR*; \.J=[Z)']"T#9[ !V?_Z):RG0=X;-./SE7L5D;3GOT)+\
ME00;;/?'35W_ RXMRBFK-7,DC!/#(RC2)/;/D*K8O1Y',5&,/_;G?[/N:N63
MNT\'4O.59FA4='DPI)SA*$W)5>S@Y1XALC(QZ*[/W(>(E0[[,Z!OH4CLGA)C
MA4$]P(1+4)&?CK)+J.-A6L7X69]TLZK<A4_SDA([NB2:0GCI@MF^V(QASX-<
MX$/R7EM0"*95J[-3G'V;K^9F,LW2\/[]D4*GCJOO]VKB@6["?$PUFN5W8,CY
MZ%<W?N/U7]R2\Q)BY3OA9$&1C0>8?\M=_G]E'9CGZ$#*!.$J- I7+5T$P;SV
MN(]P;SWGTE6*\-''IKEIKV8JEPO5A%2:=NR-R<U@!%!-H"V/M2+4D3"+=W55
M-Z_<7=)T;A,/.8T8>X#Z6!TNMY49#U"<S<CBJ+:98'%<DO;QFDBDL75HRTGM
MN]>7R<P8K12]I8[BL/TJBMBH9)=B,D3&1$7C5W_++B+IT=9&D5L'=0\SL'B*
MN1-R@/89QXYR&V7BCVR0]W8N44':[[;UK*W-"[NH=&\ 1BRW5NPW+1QQ?XNN
MB2^?1"F##@J2G\_44H[#)]?:5FYMV/46#D!$E]2N?+]<#^FH#&;[['QG9F[7
MH+-QD#3(,"^M ,8'I#:028S&M;/#L)WX=7)X!G%"5L&HQY&R!PL@;--8BZ<F
MV)<R-7.Q1)C-P%Q57?(OQ>4<63D^CL03]]9-OQG:PQ;V_7D7"IM"X=YNFL .
M)U:CCB/26T-^)06\\J0#(\2VHJ>!RL$ITC,?3\PK&+)48%Z?^H<1?J]K"A?E
MC12@:!%J'YYQSU[L:-FU>IM^</O$AF0RJ[64^R=F/U:V3\S2]9I_D^6 DML(
MH$]@<(,.-6EF@OT'.:9/;]WEV>6?=NF#^<^,$#U[9>=Z9V%Y#&Z7C>/>%_!N
MY!S,-DD!R-O6A.6'JWPA@_7P%MIB_8D1P^%@#.\0PU&@>$_VD&#)#>#0?AI4
M<'%B:=LI#>?*&'$';O\\,E<8*L#O^!(=X&I0>V7WN-$EVQO;-G-Z+=J/57VE
MLP<;KDKPI;$Q$7RG9DG;XW)U S3QVTKGUQ3-_;R<4WMWN'(Z?J^?A>3B O8/
M]( )JQE3.J+#QGTJ73K@RU@S!7:&L;+>@NOK,UF&'_+H^V<"@U!;\=P3(_N2
M&@FK#PK(Z3<&_3U40HL_Q)B>:GL_DN[)^5$H,03V%?6/8EAPRO(4@=^(FHWD
M7LAEZL6RKUPWK<@,OC9O/C*OE&F=&OGCC?H9W>F/FO\B=1*A;<>P"F^RZS0=
MX/72W.I):KC!V?XZ5'6SLM4[4,)80H/]:56$7>+PQ*8Y2RO\(&KR"0J$/$2Q
M(LRGJ*#Y$=ETP*)/@;/U_/"KB<^I\<I.-:U'SW:\Q-1Z_,W!TT)1D_D3 KBI
M .00\ARN%MWS7>6&P8/BQZ-97VJD[%^OEBL]ZZB*I[ZD5C?JR"S/[&D@JMJ(
M5RJ]((8_5*+5NQR[GSR*"%G>*92H2RK=^9)FF&V09N >*/7LZ6Q:2)H'\QCJ
M%C@B#=F'KHZ-UI8_(^W )X"KWHIIM[KS\F3A]86&Y4>AG7*[9ZV.Y#%%J .P
M3SB"$7RDV2P&>F@-(K[$URQ_O[U(M,]&A.C9ESX7L/!+R5-]L=%B-WS[/W$(
M ,9.[)_V!Q^&'$5T=7#G7U:15PC],?5XRC7#?,<"O?TBG\$*2YCWNXN/[7G
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MOZ^S9H#JCD*PVQW+Q#TVBA@UVY9]@A/A?QLB$>='!]B.5C?_VI:\^42=G<_
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MR.^@&!WH44V-H@,S=9@C5KZ/<A3PZ 87FV^W_0G>82JO/X<-X8K'D9'(SW2
M6YJ<04CK7BO:"#"5O5AL_P&<;?J&PP=98LG]LQ3V;K@-13!+LB@8TG8MYM>2
MJJVI8\]5+ELTHT&@)^&W89W.I]\$S/%6[EP-CT[F5BZ]>N3+-ESU;GZ\7.(.
MX:^VN3_X@S_X@_\-F.=QHT$D3#_.I>=!K>#O8V/DTFOR[GD+[]:EZ]IM#8'Y
MKL1CW8N7W^K=]-K9(,8F;*'!Y )+(OA1@ #6V_=ZG=?S#UTQ75T2PFGA+#=9
M ,87K ]-L* #^..^*;CJH49OG\1Q 4)_35QA>_DZ;]RC;*<?SZ2.!@59G%B6
MFZL'3N4W)E*?06_BXG%8\8Z2WX(NMFK1VBU"Y 0;9]Y*,4JS%-!0> ^B:\D5
MU:4+KH 23'%QS-.P95_";E!Z^*^4.[LBS?-:G%5/9\#;LQ=0DU:;8V%[>[RT
M+RPD/;)S"<*,=OQS XRTHH<]+16JYRVLK.(I=,;SXS?6I&#YT3Q,7LD_38),
MV[A,!<$L.@#-=3MM1] MW565.E!,%H]C?T_A-44IX8Y1O%!$B8Y<<:)CR2A6
MQ-<<;8%^,367^B)R6>UF*!/\>T];3XRM>[MOS+@8X6I50+AKD5=@^_=?WN>M
MXB<-C"3EE"L$F%G$HMAX=X*)I3368LQO4M4$18%8"!$;_?(;3[F O]>8</>9
MH:^;3<=' .G2YV#8FA(C*D>^.%V*YB3WZ'TDK-;Z=N$=.ZHSEG]/!/1.3CW)
MT$FZM\FTR;_LOG>3G$(R("?7%Z&?OR9?MW!)L.O=GO*18(F3Z&%7=LGPV9%%
MJ%(/(<#M]=!67Y;?XZ<(U.G;@@KE^]M\O_@C?KJX!$J\9'FLQY(*[\I!EM"!
M)@&H)_MK!>S$ \'NB6>W*R&5>7%"3SN=2$_Y?ZP>CQ91.KVF"WZS^5?O;EF?
M7]G)-PDF;+?@7_BM)7=9*'6VD"^EO@"_,@>UP@8"/H?!"!Q@;IKHDJ-@3JLT
M25A?26!][IK@^=W#5CTEG6\3=?0OE[GMBKZUBK<Y$W#F4HT9W+"  OIBHE5<
M^2'JUQFVDP&I]_O%9F&_AU>8IA/,!)%M#,: '>6'80>T64KMI?MS/I1)2YG5
M:;#T/H#GA+2G!^<MUH9X4T!>H9YR%U64.7@"U,5HXA^ZV6<R2_,H1\BIA%\(
MN$6_MM[4RN46,X=)U:(!TG>#.ID4^9R8J5&IV+O(%' LXM'IB]8I0^K/Y7+=
M8Z+M(>^BQSX4?VR<<YY4!/GE+4QLK8%I47(72A=(]SWKP[%%S<NYXU+Q^IWJ
MK@!7:H>%M=QB2>GU^'7#R>^FYY_M<M&!@QWU-?U;71^6WF>.X_M;AJNZY%[(
MRHYUO$^I$(!&!_<D4PSI %ML$I9ZWU/O-;PGL 05[7CA$Q*(),.X"+Z.N#XD
MN,Q:3?%.=G1U31;D1E,:MU_#2TATZOVE1'_IVO*5N?I<]9-)K[(-6%/;"ZN4
MU &F@71'E=?WAG-@ [3H3L+M'$'$9QW7J]F;E^4V4*DD%@KWS*6L;F)FQ>='
M@:-X UKY1E7*ISN4MO ,1Z\];8HBE W)OU"O,HGR_&HZMR.BO<TL1P>8S$MS
M]^Z/?Y1MU.*WL"H_+9_26=5@[S<2;=M+]G7]G8$3LC^5'S^K??:_@&?]@S_X
M@S_XA\"H4(L:)8P)Z204.7IZ+_B26OW5N "=@MRHF2XY$.V2"\8$DXJ;?(/_
MFFVV;#AC4]"I-JP97GIV&7<GKN<7-S@)0+)^J$[\^O7&T]DJ!O?R/)4? 6G[
M)['D=B[: /RX0@"&N^DD.72JUK#12@HY<3<X>0"\^IA=0SCZTV2=Q+;[E?XS
MFPZ:HV;]*TZ5%=@DIZ@AO)*PA4'!D3=Y3KH <"AL@A$UQLFNWH0.DA;AH,7H
M_\/>F8=#^;<-_Y)*BE3V=2JD+"E+)!DM0M*T,2&F4HD)J91ES$B170A%3%DB
MVR0DVTSV+139LPVR,V,9P\Q<USM^]_V\[WW?O]_]OO?[W,=SU.]YYH^/PS''
M->=\]_,\O]_K>YZ9R-B1MQT$.>X7"<.S(6$M,'FLO])X^M_%[9AK[E:B.5*0
MTP<'),,VT6L0VX)%WG\; *P[34+E?&L'%NKQ44_62H 8^$W$0YL=K)=8I4F;
M=52YR[V=Q+&]7XU"YWK?7XV'=UWIR>%+?8I>N4IH#*.K(,LEK:T&PQZ!<CU6
MJK0W86FX:]:?DWZ@+:)ZM6#'H_8=_N$ ,+&$TZSG6'E3RA/:8[H7>2R;/\_#
M*=>I8^]F]5LSLA]12<?G5(=L; T G)D0<@<%=RFRDJWQ=+=FFNZ(MCYV+*?8
M76PXU]@I%$$V=5WXR=F/KM#[JRV1%?T;T#+R[3-Z#<GCYLT/7!3."9^XS7/_
M,#!C)-1RY[X^!@<!ZT1R*5J/-#QA(I?Z:VR'E C?R]X<C<-?,/BDW,E(N"B[
M],1G7TE\_G((&2[I0-SU-.C%Y_O+Y#[5*)YO#YAHSZ$'U::>0P65CN>KBIA3
M\[UZ/9Z.7:$MWP5'RA^]3X,'R"48I^GR4CRKX%N9AX:D/0W>S6O@>,=%+9M2
MO=1O!>X>]!V9*ZM1TP[V/;NH#82O[!()OJU];]+$L=]9-ON-8TC&DU#^;]C&
M>RR8:]?A4,7 6Z>OA8@%BP#D>)OLT5#TF)[2-Z;6/D^EZ O@;M2/$&(&RU!S
M18$]\$91:S'&[:JN&9-CP]0W$5H5KT\^WY+*/6V$6&DZ_37LXVV$O"GV7J^;
M$]AQ_$-;]WI'O;MYIY,4LZ(EK;[$)X==\I3X0K]+W72);C9DJE2E)U6"ED:9
M/C<1>C3S;JQVB![N=R%T(':@Z@J8>_+LHURPX'"1>S1\W8F+I^^_ELOS2BBZ
M7S1=!'^UHN1/5Z5:F="[*#7ZU.BG]WL<S >'']VW[+M\OT'0,\-/?-;;8ZMU
M*=9Q]T?C:I,+JQ=*SOTN73,'#APX_"J@5@-#664V=DRA"$;J05[G$<\69O<A
M6 G$SX1XW,#K!(&8:@C(":LZK+>AI.MRJ^@Y8+-^?NRA:%F0>],9GOD*MA">
MA12&0O^Q-+"!M"&U@.NJWK:69[O'4AQWGH.OV<!4:LL8$J#+C59OT),#ZW5N
M/%)I,<FDZ_TP523O["_9HB[N^#UL9NJJ]]*<U9>.KK_7MLAJ/,6\)\@-=W7:
M:Q=0=^!M:O+!*=#-%@)",Y!=KLL/V4KO';UF'<%/EY]";!J1F)D9R>\]*BQ[
MS^5$EO!'9SN[YQ#0HP@PHQ,#(_KZK!K\7ZU>2[BX\\2CU6L)/&\UN%A[P(9-
M.[&?X1O,;5\8/EJX/?R2V7_U"3S+(^0R!D[II#A[,[4&%[F0QJTJF8 T$"B/
M8$47C/U<@S$$/O V0><CI7\* JZ\LMJ66JF3>?OTW7:QA\_#&--7F2%>,2@
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M>_$+3PFV&I]OGL60Q]@\JJ2US[Z]B0QG!5FTM-%8B=_?'8I\%[[A>S*#P!5
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M.4\,!%@WZ79L,[_PZZRJ2'\-!&S>N]!P1Y_QX,FL^:A,H=^9Y]Q==;1%1O.
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M,]6[KNX/!AMJ7_O(G6N6+3ZQ)CU-+D<;V(9F6P\WX2$2V2'46;(YV[/G]<M
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MI,,9)Q%Z*=DWG5_3$\X8=RR(6'F^$%MZYKAGSWC#VUNWQ9 M&F=XAIU#(6#
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M" *.-T. T@H* N3:$4&K2?CR$ ^92IGT2"NZ.TU%U/!]W!EB(=C3FCQW.?!
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M+#5I9,C/TDH?LP>6$KO1Y7(S@G6=#IY]>>WVD5<"P"\UG_Z=QEL]-R"DZ"I
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M9@;XLQ10] ?-MPG37C!I^R(V26-6@'  LU>"W)1N!UK<!$E[?XU?[5:$7K"
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M&#CQY4O%"]P^QG,=. 37G$!OH*C5Q,T0_LO @L@WP;F-\QY/L SSQ7ZLG.>
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MWS-"*];2G2D#OQ4NVM4^2/FU<!'2:E:49A<NGA,Q;+GZ5+UQ-%$7\;G\N_2
M ULG^BQ;>70Q[W9_%\7Y2 >E[QL/'<@5F?)<=FW(&G8E\F^U(0(,X<FE[[4A
MVI\GB.KLVI#8&KFM=L#(UXF$ZQSC/]LG_QW\%1&/[&"HH%T@WB%3HFQU<848
M=/LQ6'WD"7$@^S$?GCA6W*O1(.U">QPO0K*_>_$ANO_@.BV+'[UJQ>*O]!N:
M!9#Q5!Y(D&S=$.@8728VY#D-;G&N\.Q1 HOFQN;I[]-E5W8_NOM5^MJ'AXY2
M=_F".7Z^R_T;@-FK$%O_;WK+N$_X=9?K''N7"TGJ0A1L^[YC-HFE)\*4YR_6
MMV2K,<)?Z/PDF^]%%-_W/;\7401HW=\5PRZBD.\VXY0W4A]-M&K_Z<W&_]M-
MR8?Q=&$<3$VK!ZDR5K!"\UG"M'=%HMGU_9O8%5?_J[[_2)Y5C\SW^OZOQ=W"
M1NSZ_O<Y?/+ATH[?ID+V<]!)?TS_OVT&?D3]NAGX IPW"<15$GH\2>'370P\
MS-Y&?JO'0'BR -,2=CF&\@<6@&*78\CVU_MY/=SXUQ+D'_R#_S& ![!BA-%"
M?QJSGN\8"SAQ!3?QF? 0EN@<&)E!M"VE[A.^!B=\P?I3_J#1UE8GOU]BLTGO
M[7=I;3[R?E>(UE&VUX=> !NI:)AQO\4R'\Q.U2%)Z<R]+*!5A1+.7.]!@/J#
M5>'8VP6IC<SQP,)L4Y&)9R53NG6Q"9Q!:%!A+?TV5&39&7^B]%'+GJ;]G+()
MNG.ZB'>+?X-T] _^P3_X!__@'_R#?_ /_L%_"Q9J%-YA@]O,K?ZV<[48I2ZW
M,NTG5G$#MJ@3 EX]YWP<U$GGM@1QH@#Z!78=CC_BB+(56I/LFS-<>B-IVVIA
M:'67=NHI[OB&@O6? $S\:53T QQ=N&%X],N8"=DB-$^J<<4CH^SAR*L/?;+(
M<)V.IR06 "DTU 8%[-(8JQGDG3P0JE77]O5=H4*SNN+\2)P=M)C!W_U";MCS
M!D@VC[N)$O9\N8C;+#88;O6I:CVR.%(UPJO;9F]U'#7S?$-Y<-[&UKYCXJ\U
MFK9&BDH?Y7D3?_>(A!Z@\Q=+^W\OR#6!SJ9$7GW&?::0+;1@VX8KLM'H'!;S
M+6XK#JC+NAH2,_T42 _(X#_SA*!!(%&QO,AQ/4HX8\&5!30\@^4[$2W/ AYO
MJT<L?\*Q ,D,_E8KN85<)L*97,"\A1(!!P\1Z(%Q4'!.=?.J /H2"T 360!E
M$F (_7__P H!",4"N'RA:Y2SP\@P+;$<2*WN4 J1F>69?>3:=86R9P/.0D)I
M;IDS7&%7-^!*G_UY(__O!<)NT$4)DK.H17#2?2F>817B5:3>.%ZG+@/3L*E3
M!0D!LLG[A1TWOGDF]XV;]\:'D*"N)+!FM$*;!31C;[( LH42"T!D\/>NR@WS
M0S+@3.+((+&7*8RDRVX>IX#52$8:%3F=9G%3!R26?:(]*F ^/A!M]X"&^=,>
M'.XP(X-Y& *I7I!IOO]4K6>:B8Z\-5'./6&>]#9R+0MP3JM0Y[A/S@[1WAY)
M/Y;&Y-U+(7WU->;GKK\=<8[Y\?Z,1!B:Z8PEKRC%@0MC0RR +M0$#_8X)Y49
MN=),Y888PY[$L]2@0@HNRNY5W/F4TR5%]FV7G)[TB $$.67QA2F4_M_@DM@_
M7!B[P-U@"NU9KIR[H6QSWM8_C;DE!M-W+UBJQE!QU$)<*.#ZKJ/\7);+F_R'
M0W2P3P@R="_8,2L['.*?DCVK:9KGS(='+K2G7Q\9V!-_" N)XG3>PE&M$^WB
M_+"*I,1A((PQ2ZA?ZN:_KE@/[M1%%!9:C,R%L8 A/$:SJ"2FB 6$,27:\]X.
M2J;Y::=A+RBGZM+C1E"F]&TL]E5THE#*LR/9_LG:QJ2!QXI FH59<NUK)D)'
M.8D%!![76\[@?SO^(E"G( <*-RYN+\R=<C<]67)$>ENRE_RK#^%/I9[O#'^K
M>OV/;B"W4,#D0<!?0HQB.MU+.7N"K%3SUMLUEQ8DX)=G_,*Z;%CMWLV-)X2Z
MG->KI;_;DO/+]A53)F(W98Z)IL/_+?0="#$ S& K*A7[RH"^]>QPSLQ>VE%+
M2*ZNF"D99Y!RLJ3$H<WM2J0-Y9G<@LK+ \U9F-0?BO]^/@(&ZY6(8J3F2HF]
M2O3@X1G-FHA]R6$#?DI>ZA*_7-UQ4%WBPW-.*55R<RT64LBYZ9V6%@5RHI$=
M:/T7)[)F\WR3!?"T(T+VERL:G%?9159"4.-S%E#EAE$\,4A18B<JBVOJ)6'S
M=OA7*QZ"6+#E=#98Y::C6#M(V4]&A>:G7%4O"IT7Q+]MNH#4@>-D!G]/B=R"
M&HE %QZI+HF^>V0$%QZ8?<>(9_F!Q+!MCO;YAAT1]_AU/_K/?:F8@S1I1]!:
M$.,)/&<AWKI \,YE,S[5LH-N[_#-IH>$:^-90.4]QV(GSI;Q_U6G5A',R"!X
M--\<+/ CNFL9#3LM\0L<18[:MNJ6E/='W_99*V_ +'FS-*+"L2@DM')L9 Y2
M6!HIU1O"AFT^&D+QPTTJ[+PT?BG" K%,7J+3OTTQ>:TICV=%>OT-*J\=JV]/
M_K#4?>WS>9O\ &H&/_&$'*6M!HY<UG$1PLN;#[TCTZJ)T0!F267%PUV4!?0[
M!AQE[NCZ@N4&AUZ#&[2"GAW+@6I.=.A(7F@*4<PW+'^S,4C4CJ-KTHZS/1*@
M#40VD9LC54#1<=\'G3=>]$P%Z@T')"^OHJ>TMN!^R7V^8V$\R#SKYS.??_ ?
M!:&OR$+\#(*$ZO$C!8]%EYV5.O%BT/%5V\4=)N#U(WMY''. A(;;ITRU."<[
M(%XXXNYBY,@PGA"<3$X,5$]DDOUNIYO(&46<7[G^IECV7</+V#+$K#1FD6.4
M4(B:V3OB2?1JZ+*5H6"RI._85-1DULY0372DOJB?>K@): K^)B7]8+YDG[6Q
MT1+O,W?W2PG?OCF>'P[;*C]_6)TGX[J1-, %Z.D%EY)QS T"E(9AV?"ACB7S
M%CK?UJD238G 853QQ46%K:??FCY]=:G?]2,<2/@AV;$Z%M 39ZS1?,<[U\:S
MQOB&XCO2BNTP<8TA<$)48*1QAX<]CQ%P0.L4]Z<.JN<TG*2X>+I !W"S%>18
MA_=[,%;#FR-07E!JK'C7B 78>/"3O9+O7 V06PB>BWZ6P3_I>JQ+7LOD2;?+
MJMFH1EAJ\)H+Q/[>5T[?(MH/:L2W;SY"=UG"P$2P2@SIG!OC9]")V3C5%:-"
MO&#RPHE/[DK4]2%3#_XGI;G/IL(3WT0RM/X&M/O_@@I5.%L6@XW)T$UF=2#(
MC!.BFJ%A<LSEQ@(2%2C<C%N++( AN8>3'/;GHB$4(Y8%C$XQ^<'NWBP6,''.
MAR'=M3#! M9.03N'"5'8PN6;JMKK:BL223;F;98=11O>O+*NV_JX6KCAH$[U
MBW*CQB$Y 0;7WS#M_M?I$6%XE$\@W:U->YI)Y0VWT&H8).D*%-GSM'C>>JQ-
M(6W?L@FC4^IZ [/3^LG%.IH'6'5"2XYVN&=24HCLW3FP%TJZ*7!#+#C[7K_:
MA?U(Y=B6F^DZE\L<*4H-.AI=S-U0P5D*,E+5.,;5MCU;N=^V_Y"MOE8P  !;
M ?:?-2'[>Z)>.^R^_S A\,$)V.!_/(;XPN(KZO?%369_X/,<;PQ?ZW^>%MAJ
MGQH+2&83UL%T+G.P6 S3AA0^&46BU8/A%2+Q0VUEQ2M*.1,*/1)5]>W-QT6'
M2GEH%DR>1IH=6/V&[ SID8QGTO=2^"IF+@^O6WGI37T_/Z]AI";5KB]&FW2E
M_,K6D-[PP^\.SCL0_1AAL(I:5,45N0[C(&DU>FKQ(Q9P*1=V(3[7&:N??G#N
MO[ O.R_7TDG#YEO.<YN:2SD]U<O;U"PV;5&WTY.?_>C/ T@GMO#@46DH\ODY
MXN6YJG2^5N;F<3])O;&(G31,@;Q[N/7NX-=U#<[2^LV%YT</9/ _1'HT0WO#
M[U2HNEK%W:P0G4S!(" ?X:D 3X7&L*GSDZ*I;YU(4COT]Y\7)]CDDFW8'A;(
M J89-%GT24;VTH8ALFSXE8HW1>XI5GEM=^3S>D6)7_!<K^.2_ ZM5V]07;I-
MH MH#C<1GYJ,H-;5';Y0Z*K0NP]K,J#;W+658X6D%\Q'.\:L D5 AR#N#O3I
MC)IG_CXB<E,EXO7?6C>HB\V_H(0: B5[I$,V^>/2G3C'"3W;J$.4L>FTX;4V
M!TE%N'47?D&<(G?TA3<FJO=+RS(MC>.&Q<7YJD)$&-.0 <6Q!B6N(SG.5"8G
MK4YN5\S9EBIV55)&7.N,$KE$/%?ILF;T=N9EN3D4).TWHX"L9@$Q,>3!LX_B
MPNA.U>I"<4V>SYY@]S9H;=@J\OFP[ ?F#(#I^:^3(!91F$Y4$3>L-^R1M]4J
M]G8^4O0QNGGDZ03'Z]V,3O73?;M&E?%DW/-]FY1F+M'<_#FI)N2%"KRWJJ?P
MA>,H4_*G>S=GE-./EH5C]\DO^4[=+#P@@JL&B8+42$K.C#)ES4@=1J5=I_7P
M1]_D_5_=W2Y]/GXJ^R3W\\,.6J]E0M3G)/Q[+:'X$0G'.IV=Y<''K#MF,\M*
MWX$C\9]/<E_4 -0!0%TH7&\K!S6'O@7!-)4U80&OX)C)#"FB/4?=!LF&X(K6
M(S5F91<+6%W3-9OUTQ/^'Y(_91M]JQ231\B>ICSQ!5*NNMX[B13,'][X<5(Z
MW" BS-SR'/G+JQV9CM&;/]6WL  33 M61![#0=]&\8S#C5B.M+H]<,KK*8X8
MN[Q%I*#7.SHJO0?W;; !<Z@3(PTU65%,[WAN9P%6WXWVUG.8;31["4 < ,1Y
M *UK(\T"Z!,4U;$[:+,\VZG5_A&/]%6FG73,^,' />)<XAR5@+F04![)=,.4
MK09%*.PF:49QRJH3-[JY]WS/<?MD<^W0.+>$(,!HZ-0Z$Z'EN!OLXW4$L3*3
MS*S9@N?^=M77WS^^';,TFOCYG6A-P(&2C4&'7R"V((?B6( XG3^SZ9G3O).D
MJF%BD)73LD?*!1]BXJYU(Z\NF^HJZR(V=1T;0MRQE8:LAYOX!?U-+4M;?'JW
M#7+-I,WX+*WUMI<*?<GS2GJSWI7)5;WE\"7C<N6S!6_;BL2,K'BCC)\1#U^*
M/RDJ<7Y-IN1ZU3,A2'_"$): KTN9L22ME&D/GW;-I!M]&5Z0+0X?C3H=<C'X
MB9!LZ";.''5I@:IJ1@RJ:;D&<8<X6(V\H\$=7:9YC>KNJ%<:.]L?Z_OZ[(?]
M$J?#S,)]+FMV+3XF^PUC4BE/29YA6M>>KC-!7G@=2]EUG?=X[:61R\@(D8-8
M'Q6.[E8]?^Q,*N6+:4\;]1HE/,;M(]@K3%;(O_]FXTT?Y3LC;GX];]\;7!/-
MX(]!#F5BR:=I<VLF\02>"D&7ZE[KF]X:RW?R#)4<^OGR2GWO>94W[,&<.L:)
MGS_Q[9MK4X2'XNZ L:2/"<92PHZ7KY]/;)1>SD&A+KCXX;>E>#5Z^5V3,E99
M.. 8W_TU-6(TP4B:UJX"G+9]1.:F>E+F9@Z,<)(&UXQ_8_K?,_(+T@PP3[Z6
MSOEIK\B%H:&-!1>'Q+?3VG1A_B'NLKS=S3./CGK3ML2Y/-2VR%T2@4G0KCW.
M @;7A""5G'!O0:<X2+JA3BF4B2BG\(>K\B+OE$@DJ.!Y<W3)J :144)/HWOE
MIL<2][WJU[F2)H'EYAXD]2-E<!H[_#[?6ZY'E9_WPB^X%_X>7QN+2VPY#X+-
M>Z^JQP<,K>LC*&!H=#&HBA07A]A4&+<=TH=03L3HH!3?M:\,U?WM+]#S<T*1
M G>/(#_:8\+!*G'026YP/=JN74=HH,^CI<QL8XKO-4WQ8^!&^T;;FH^WQ=6>
MQR)/ZB(=_NI8YS_X!_]3H"!Z+887L9QP(F4!""B_<V2:^- JH*!ME'LC_NRK
M,!G4F3P9%O!D._.:5[JI#.$R8:@X7=U=::@K!"T3][KHD8?U,L 8G[E$/$+M
M]PZ?Y,)HM'"@GK  LOY@#[6I 2&(/D)1LRJT3C/ED?8E6IUXA\*?V' PMB=6
M53M0-"E\G]S"$X(O82B>R1<',X#7Z5'/7LPDUFKD,7-D K_:T_:P@ ;W\#%=
MA*.9A)?>*XI,%)@YF1R/FD@A:^=UO)QZ)Q/1GOMTTU"HP8@%K,.^$:@O(#G9
MZ06:KG]S)5;3<@*?]5+:*X&:\"QYC:GO?/\1%N"D&J"-B0&KW,JV2:90<BLQ
MLK'[P\^WC!;<O;$\0+SLAPC&K]>)E%M(#M$^2[6$WJE5$HB"E16J1F5I[FIG
MHVT?DCL3$(HD4.019>XFD9"E>G%2U-!>:D=L&"$IDIG  JZ@Q-5JXWJB2.%W
MKG@IU'7><)6H#<\U$;^\UW1XO)UCJO!OD.3_C\D_=5B)=WQ@_Y=!DZ["- G/
MD[[FKMKZ/8H[';AWW+MZ9,?B<.%X!C^2!80%098LX'A;%0N =A:Q@!%OL$:;
M+@^[BC-[^7PS>\>C9)%G#V<S"R"E,X7!5A4RR%SO#D+]"'(SR(L<?^ //V;M
M(0+=HWQ-)+  /\>1<!N[:*+%7HL50S'54,D$LADJ>G!3H8(A6A+R@I_+.]%%
M_9P(A5NVJ:0Y946$?TR^]OX.3WR-X1'FY-A<)&V0"C%>[&0D,=<-N"0K&["
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MIU-!!S%]LD&,NV)17'C!QS;K)@?."Q-G#C?=.Z/K?Y_^,77M%LOK1F=7;V;
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ML(LJN7#])W[ZQ/XCRI2HE8Q<M#9M-UWN+44RZ^N@:U=:WJ*)&$:2.B)Q\K"
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MP(A\(0B"'H>TH$0#^&SN[T_*T_I9_?HF-LCD[LQ(XZQ%C<?W/-;U3=H>/-G
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M%TPUSB4X:', 65- "-1C8;P#/-$?*YE#/N:FGGTTU8*H6Y@_..-QYKX(O"4
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MPKK7D#\MQH5FJ8*CG<<P<O6(1V N'3C7TPP!#^V,U?1%-NA2K.A IML4#^7
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MW20ZP/:1FK9>D* <L-N#)'R\XF'[@A0="(D.@<9[C.F)4;C 0 )"'<X>(&]
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MOR\L<RPEMZQ91,W@'%7VVNT>43EU0](>VB_3_F;9?\RPZ/\ER_YOP_Z+7<.
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MFU[Z+NUJ52G//@['W%?,$<WT:=,=]KG<%[B\P+(C'UX\((T\]^ZS]SI4)]*
MR<>HHY06T59M'K3?:Z\(>:UH^=RT9R7;(KJ $0&.I!?5IT67+RS@TR6XQ-O:
MBIX2J<ZW/HF;==8FXJN;A'$N4$Y8/$IETE]2B?2"&$I5V8\<=\(]5_[5Q8J^
MNT+W@(V$O:^C1/^30;I  P_C OYXQO[V>"JBU415A7HF T%^<F[XN$2?FZGU
MTQIUR92!QD%&OF?1'!J"&W'GA:M=SAQ*'3[M$Y"]ONE-17!$T&3[",J/'].M
M,V_JJ6MMR^HUB3*KZCJOWG0+8.*X -5%(AQY-#"0C! :TGBF179],7V;!CFK
MUXEZQ5)GE)&6GW@(E=&<8G4%EM)#FI!78E6LS8M65CFBGDQEUF&&P42#::L%
MI.R(?9>6MKT>PN0ICR+6%@Q-PWG5G354CX\%HQF0.)(X?:1Q^05\J@V([*&-
M4-)C\3Y$8(Q1T+H!]ZE,W PJ5-0_:?.U9L-H,XV,9>C()Q0,:+HK-S_?5]#.
M>#(<.CJ?79#P!;QJ*_)B?P@VH5;WH7;IZ$SW4/P>')SR\O!4 Y:N AX.8QG2
MTA>X0%Y85GNM-J&VO9HG]>3PN=B=(GRT',AQ=C)ZXFTF=%&R& )A8!RJJ?A'
M.V*B%;Q\DCR?"HJL8VN<HZ-MFW:D!FS.L?,ME+E "Q35_\[GS9N4CK=VV_)N
M9'V_*W4JD2V ^C**O*M&-__ B+M3(C/\/&$/3_+^%36>K6ZA1ZA!./6"#G0"
MDG"=BHDQ_&QFAW5528]U\D[BM;96N&4?)A0-"M!*U*XXM^K'K1[B%4HWDOC+
M.PS2GT1\4)AJ=&>G- ICAO/H\54XVHX5=S_=N][]22OJ*2)F@HM<8 #[$79S
MF:&):%F68*EFM6;S]6KTA3S1X7E^7"_$5])!(#)RAF\9\0"C@#2EX9OHJAK4
M,;*[\YCUCO>8#)$%&__'%*?VY&U(,:KY1CS2)NSYP "M8C>T89=*U#+\!9YJ
MC4FX/</92Q.*'ANB_-CAMKO"2Z-UP?02@B5G0-E.$VK5T6H*.M,T\\;-3NHE
MWY2FHLH,[T8\>J(R6ZN&4' $%ETL;1\_>+R6M'$RBOJG7O/NQC_83_$3!>-0
M=HZ9E5 ,RZ&@C821'#,>.4F^'O9VI]=D,B_( >@[P)MWFV4VT @9"4ON.'(G
ML[VLR*KQL-1UJR0AQR8X_!X#1G_+L((ME#!/PYT9B*Z^M:R('HUTK<,ZD]'Z
M!D0N@+6$=M?LBMKY4\F%A!(.ZT&"!:1E^%.TDNO)'RO!SX5YC,;.\EC)_,:_
M )X(ISI?'FLT"H,+MZ)]OGS>$4F#5^ F,3*PZ^@XHL*Z7:1-V[W=<TZW=IT<
M_:@@5 *$;;"D^B69B@R;G<E$MW7H6O> #4MFA/ZX'R7*D@^0 *8O#:@SU1NL
M/[N?U&F+=*!ND)9BJ-6?JAI5J),ORGH#[11RA$QOWPYXQ<AEPL+4*.IEMN0&
M+:;M:T##+4IOT1+:I=D,3S"!"EOL=@DK=X"TD+4>W[[L2KPY?'G#+ 1;CB?1
M\%)5[[$/UM:M%"XZ[P!,(77PUVAJ,UH /W,!SMP"F6NL&$.'"QQ[S06(?9:J
MGDP>SE"V)KN0>$&)DRR80;_D?9[ON<3];'*C->AR!9S/]Z8>T+:!=+8T#G$@
M-W\N-;SZF]3/D0]-"GPX5!Y2A\$W@7EPW9-DK^[7Z+>'^G/::,P_TSZ[VE/G
MU7IEZ*5><</;A5?0?);0&"6PJF>1"7$<J<X)A_VV^1'!@=L*U YER[8#CDD_
M&K@ /Y&=Q;*GM5#261KCN_NF:JGC&+6&1?;4\88O/&D >RF",/<*I-^NU.1S
M [%%L)C7)O>K8R\U=?4V1+1PE/O,M-YV>.8['_<,4 #4]\K#W$)R)!2Z;91R
M9O)X7_T3-^-A%(#%-),+I/W1 UL0@G)B?VR!-()_$]QCPH!S@2ME7" 7API$
M-U_'_YPT=&#R=/QM1^IO'O[_#(](6AP%^X C,)/B/W[P1V[O#:^GUN5_WA)3
MC2X%/:2-!$L<EJ=7/\2%&47H177Q^?A95/(,]UA=97QK=X%'K8D]\;G\T=5.
M+*C6UFV")[%;<%)V&B.,,F7 *$F8X B2BHO*I?%1LLW#GZ)K1_[-M%']-XK)
MHO0$.NKYW70+_8$KO;MJT0<T7E""UF1X9BLOP>*0%PO"\C[1/7;VE<I1[.JK
MY<]^;U#2UX=,>H22T,-9I.E$BUUV$R4&'M4?:>(.90O]K*9NH=)_U%A>M'?E
M''7"K[>!<E3ZTMQADOQV6^E(PKD"FD(.9!I#<6)E"^8F;PGO07&0(/5)D6\A
MTB$/N(!5"4J,,Z9T@2B&O@&7-C/^:84(WD'SVEYJ_* 9.XB/@>$T6]AV$P=>
MD5.PKB5O7[VUH>.NMZB]\;Q-P>^.@LER@1N03?/D1U"Z/GKA"QP/%2$@6K"0
M1$_V-AB;WVE"-_X'%_!#C$@[-5"_S]?@2A"+3ZMZQ:P5;0]MB7(>5%;AJ(28
M!2D2!1<]/FQXK16H.;N7[SI>&CU1P@56/+0MDEEMJ,Y9CP,]Z]\>",3F(4(.
MNK?M?JK7@17$[T%/5(Q+!$+)\@]P-5<]51:D*E.!6PH')S(!9AU'9)H+:-21
ML!L_.<\VE\'H+>0"J9LD*),7O7@>?AG=?) +^&)$Y^$58W%QB/7+VKA%8^?,
MB'!EA62U *\M<J,DF,=>(J]T-YJC>ER0'O)US-M^W1+[,H[R=:[JW9__D@/I
M669HF-T .30L]IFU8NXM"#E@&BJ#;H8NUSO2I.8O?J3M2/4C;"P'W5X\J/_:
M5.H8;<3,:8 (GAZ" ,E*V72L-A>HL" 4#PY6EKM,^Z64GS%8PSXS,P5[&_NQ
MGZ/MS(API=XY(IA,!\\><X]\4W<B-^&YFFH_SRCR!-@]:Y8A/,[$T7<X-E_N
MG>>-7JL@-=UEQ0N8K*3US7FF'*/.F:')= Z[W>W>&7@S!%(!/R[]M")G+*JE
MIA,UR+)BO[%09420;N:3#[-L?(=O#-P./U"2IJ:ODK.M/I-UE)UU8XEC &I(
MY8#+$C6-/\32%-2M\7K\F0![C/$C,L*DB:C@X=M."A'JN:F.,QY:/?XBWKV&
MHTW&\WG2DA>A'P+QC)CJL9M<H! [DW>Z@M/5%QAHAUBY=GGCWH2GD:<_%[B#
MNL##FD5_NLH\R06Z-EJAS*EYUO[#K""F]?#(%[/A]&1RK-&!%=AP]/ND-R]O
M:6WI#>/'H,^"\$H',4*L&\>PK/N((U'HR<=GA2@.+&D,Q:<5(H\B6(CWA6 4
MYUVR,;JOIH;'/.I3:B13><X%#>!O%U'Y."+Q7$ S8R*9B> "KSM17*#['TX:
M_M^"VW*K_?6-%@X_85U%7SKXG:NSG4[E3NG&LP\+.PBR\JV(>%4HXSS)CB@5
MELWP&S;/#$\;+7\NW%CO] =+A5W=*,,*I;4PX,U;U'[=@;%2(-4X43^I9LP2
MFD3$V;0F)Q)EL&OV=N2JM$(_E]W&QJZ?YK<?8TV;^:@8P(M!S>,P9D>Z@.&K
M'('&.MVV1VS7"5:9ZKFC?FBL9MO=Z7Q[T*]E'" @_=_/*'>/W!WA=9DN!S5>
M' U<WG2:UF5)Z;82MFPZ%EV^M_TTEK\[EVKS13GTI;3EC@*6S,=X=J&TYJ%V
MV/(DJH[3H5Z]0)IX'0[SXKS%:X*\OP@%3?N$J?SQLD_J2_#- ^G))"+\'>9#
MUZ/B>ANF+F/W2J]W6&>N4+:3>##F%, J!8,'SP6^C(^"95FIBPL<-5K_CC=,
M!DMZ6<_CDW]>ZAT[JIG3<8I!X8@V%!\E)P^OK,TN51\U''$-FE09\N:7;(M<
M?(\\7-<(7LC?]\C^I:1EIH9RAOR.=Z*VT'P &0A>Z;$F1_YYWIK#5,"Z&AU_
M#>:#5KY"X>RI0,]H_*W/?W"T^I"F3"L)?3KI:FV_NJ1K4=#'^X>Q_<DC<:UT
ME!+[E=D%PNTW:/_*Y\(;.[P3L@4 E"VZ>=]4*FQ$K>5DN7[>L/O-LV&(L0TP
MM4V\1Z^$9^\#^;HKG"WO;L.2LFFJ=NE8U/$FG[BF<Z=&XTF31WY?DG\U2S:O
M><,%OFCU;K[<9Z$V<;LZ,O3"5!3,A0MXZ6Z:)/.#(V(,90-.DUB6;&<R2]?>
M-/L^;3.!;<2.1]I>)>L.$3X%>AXYK5-,CG8O,'7;^]EH$R1  N=H(7'Q,#^A
MWL4]SII]^7KVE=/\*0D VP0<H7NC=L%,W;"@J93\R!6)/V\'K1# $&P^R@40
MV!VHKW#I2N@VAJ==+Z)XN7*YZM3&US])U<^:FB>"X#:H=E7)M&9X!2&V<O:H
M^/GO/SV7@8  ,F$!1ZVC/,?Y%85-?S)&[>S7N;JR*W.BZJ+!JWK)\2B8-IJT
M!I6'S;A1E]G,--:OF==NI!M(R8);\!M+#C1L#X(1BEB@<8$3WTZQ0)F3D,=1
M&6&:H7OT>_%@E\F%?*LY8!=]+0Y<H;1D[^AB!Z>Q M:FZ2:,'\6<;G@%>,%Z
M!';$U<4_\_X?=K(YN_5P7Z-YZ+*;%\&Q\& H3SC<QTC5RQ8PI%NJQG=4-O2^
MR9Q2/G?W,]D]]Z/F2Z<9+$M:B'.ZJQGN#%;LJSF0HG_\D[2_-ECG04?J1'_Y
MZHNA\X&!>MR?O0?<@P2C.(NERP4^7 ;S^##>&#]1 5^YG:G)CJ+\;8<M>@(#
M6[G.!<1 "2 '6S/.@>3._ 7L^7MBGV+T._6);;;Y6''&).W:M-T?OL.G.>=3
M,GP25Y<J-_A^&,%V^-8Z2<UME_LN^B8J9;TH$Q%OV E'#.E>S>BB:D43GR&-
MC/JKI<R21EXEV85JCI?Z<G8V=B/DIMI))=,>2?5*I6<M%E[7.#PD;A=ZLB;K
M]UG^*2NY2^?^0%WMOYIZ@YG")BKV0YK-92@I[VR2/Q/:X50'W>''3NPLSI[9
MX9M57E54FT?PC45]R;1$+6L'A>\&<!]05,%^QL_@Z9+)6X0_&!2Z@P.HL1V@
M,8T'J&,I"%G?>V=#$B1C7]F]ZK#($0785_J6<W]H!R[KC-KRTXI3/BR]\7)Z
MA!J>4Z:'TPZJJ7V^B5_*W"SBB/@PG4?#YC^MLHQH(:MV9'.%LB3R(DT]OLXW
MF>BK@,W'!R(V34 N2A $/<D>0&+!I.[SQ),10HY\+WC=;0)=&;!V#W\(3+Y/
MX"MGD&!Y<W<");+1&GPQGPF?A9?C[UN-M^()")&$X:Z[RD&*XKY\,[,:)ZW=
MHR'TI'T7'R8HGIDT%\9V.(@DCQC0WSP-RSHY8*2BW!+J'";\ZJ*DPRY+L\RX
M2VPP$?G#!WU:+TDA3V;/M];*CD KCH<?.M@HW+7_$,N7CWXF814QM$&)?<P\
MBC3J0SJ__IRO:5DMN:_KV0$>+Y8(UC:'-T%KPF%DA+[YPT)RGHH\PHA$T+MD
MYB0+70?=ENX/+@(0MVXAHNKM\&R/]=4CBUU&FZ X$"@&,[0P/MK6PVI^@L)^
MX";WC.I#G_M1B678YM$LWK%S!C--0^L2S8H(?4FF3@\X@\3*ZD34_C [2ZI3
MJXY*)1>0]W72WCA_TM9/L#?/D(=IQ-0>>0-R7FC+9X5K)MV!W93NMUJ09G0Y
MM(7(C[R$Z<B\=M+LJ,%F8FNI07)^ *I3RO#7**IL(\"W?3JZ9N&.U&*:L&[3
M-A[!$#I.+4?2XTM+UX27JO(?4ZXHS%I"WSW;D6:SC:_V[;V;A[ 97.!FU_ 0
MVAL3MWU\<$2'CBL\&3CQJ*I/SFG7/"F9GP&E_\G.63.BX? )ZSH&=OWRBTI(
M:R]13_.#II 2 -7,J\![6 :WN6\"FHC!Z2Y4TY2^?B-'SUGLH2[^>5\X\^CN
M$[#Z.IM[;*?N]<_KB&V7Y[Z;/2K5Z9U8HESQ%LH$^@M9,ZW1^O-XYL<IO '>
M'S^RVN&AS<"$4+,F7A4_*6G3NX\S==JLWE:SZ+8#6K&Q^"4\WZ)"]W'(7J.0
MS=ZN1<<EBZ$9"0!5TP//A)<O+[(I6&'6V4K&>=JW,P$Z5AU_9#:TI*E]>YH;
MU,=/F*E.,'/P)$$AXP%*#S]IF?K^F<BV.;.7S^.U:V%&5;Q,]=N %8,V-*YZ
M48#IB3S;SS*BGAYCH!WZ[")S2ZZ+*AT<"=6[2NS-H]DTP4<"FK?<:MOPCT.T
M5F_$^J6:/A1_GZ>>[ *PD:_Q1OB);"Y0O1&/VL7HL5!&6J<LX3:5OU;5O\#H
M6RM^5JL^Q=2DY[-S#8E#U21WL+#J1G^Q&$CJE3LD99<8DP-Q3[WPR'MP[\:A
M?!MG&?VG7^])PI,:Q?OQ <O#*P%8N3"T1T,WRT0[(WKO]-F4=S/O(1JE_JH'
MV65HKT[4]]76\_ZJ![K5TVY<6CE=G+KV>3-<AH?)8Q7$!418=U"[&6(VA#W5
M 79%67<B'M_E#[\M^=PC4HO<-?*8(RK[GF5 >XTT8@1<,4)(?:O5RBH<C,.E
M'Q+-\3'WY5O>J$DR%OW^OJ/,K/_9IGP!2X)=P_*^-CRY#(Z"W<=^.QDIMX[4
M@J?F-25=#^%57>VZ0^ED[[B6Y63C-*+8](FXL[5I05;7AP]:MAM80HMD+KKK
MGJ\:T-[94/',IRKC^)N$V\)&_O^?/,VPL&77XJ\VF-!?4X?ALX';7I%']G@B
M;C?%I)EC5 )6H8Y_F[\/[C&2?GTT,-(HK:H]=?3SSL-S)[\+8\?G]O*MSM-!
MSA>-P#?!)2$JC.$IK64I:^&^W*KK(KSZI.IW<\2OC<ELG)D\EL&D(VG6CTG/
M:@(]I@;?\/8_W:2W1>!D>#;]P,S8PW[9J,728FR&%H<-$,Y7][K:ILJ:W)P4
M3[06ZASU7,?6H_T<AH@M7* RKB6+*!%PMO 9P7CC>%Q\G)I0M='\A;-")),G
M8#+-Q"M9*/NO-K_.>F(M>%O._>#GCVZTE]!3=/20"4?$ 3L>1CE#LVD=B<HT
M*GJ<O+!VW2[NY?;/E[.'=FP1YI_)\(A?*CON7S63\.']#6$AA78]^ LN4.7#
MDOJ^VFZA74^+:WF<%6&$V4B;71$\\/VVK5L$879=AH<!+?@U5\<Q#<A\>,^\
MK2I/(B,P=TD\5G(YD3";O*##%)PEEH\_,WY7_$6PA"+6QAM0V+QO._]3:?,C
M!,+:/ZLOI_:N3;5Q8Y"-&!$Y\?Z+ 0F,(2Z@'M%.I O6<8$>'4MH+)YZVF'3
MK(L?/8)FRP5L</  ;.(%!B3OPF WN<"6-F&9#<@X6OVG0!!>H5%QE@N _QEQ
MS9E85MB\7"=";5M1ZC:;@E.L/8P,,)\[LU-16FX>,YDW\^@!MH^'YJIH94_R
MQIX6VWR NG >:)FZ49<RR'8.Y7-5!^$C7*#K</?!',CT"-FFC9@,P\G<K3V#
M#407V\A)!MXHR;C88 *$8WLQ# WT@G,X%6+UD98>GZ<7EGSIP1?C<KX79W<D
M08[#/6?0HJQ=I*QDV"GJ$N:J<?#44>"\^T4 :0[6O7WL1!]VKIDN)*'^2!;+
M^4U+F=IA"Z^=S_<#2P&KRJ3E=D0RM.(Z)I3$WB_&WCU^RS/ ]=OUP(9'9QUD
MV>*$?27(O=301Z6-/>\8B#.-F,.K&E%Z.9!6]!"$?IR10F-2[F)*YZOD+QVQ
M+^F=,ZF-?:=\H\9]4R_7W):MM;%[]=.1R*X'TU3RL;+97A?<ZXXDV5//.#BT
M;<_"'66CRKZ2:Q55\#H9+9P-R<F7CVI'?\9^BMK)^0:3QUR@YL>LCZ?M&(],
MRO=/;#;X+L(*2&/$T!"4KD4#GP)&@%-5XX_7U=Z7%Q<#AVQW7KDYG<F)QCT1
M<J )8(=P6H<05[A =O#>JY<S89_PPF$HJKM?XXZ^A5(#C+X";Q6JDF<5PI)&
MT.WKV2\YBF[^2G-8^E*]Y\=4.3?S&C[E;?=^*>GH/U =&YA*S?LZ.+Q$CL7.
MGF]_=D?9N94>E+4IB2RS M!F1 CJ #*<G;$0 A6?E2,,GW82_Z;3\*-.CY]Z
M=[7M+J8"LA!!(0YGD5?F577+&RM[AH/,U]F]^AD0-SZ&T^)X&17[275GO8E+
M>IPA<R0U>*H3N-X9.+,EAR$QX15^5;>&0-IB1CK[.DKE]6R*;ZUY$D:85_FR
M%'_'ZT*^S8O#>T$VM#<'TI',T*EF/5N. V,SBPO8.(V@J:>AFP8P@4@?,%1C
M&]5!8T;07SP8D5S@BA]^+22R&DQSS5P@S8#J-(!F*_CRS7W]"SS._BL#)@,F
M]']'D&$[L0QM NOEVWAPG$$V#>[IA3,TNU@9^$]<@"F0S)8HY)NY]Q>PYN^%
MPU Y_TSVJY6WZ3>]XGSW5/EDMG#&:,FL+2ASP^.9U4&SL9 NQ9M<(%D?O?@*
MV48>>5R'W0XW7UJN#"^I.3C;&?D-;HP,8_@%>[Y#WQC\U#OTC5/A^TW0G&IZ
M<:?9N82@)W],O&.]=XTX7/KF,BE^\N[,^S=I%X1>(V7[<47V]ZQZ*7ZW'Y8O
M?L;Z_>U7-S',#4?D=BI_MFPWAQ 6Y>&&;.G?IR)Q+_+XE7 L?3D1/]W-!8BU
M"TC=T$*/RQ7^C@H%0@IJLA56.T%CGOYM5>4K/-4Y>7/W/5WV0T\.;LUA04C4
MC=..%B<].]ZAD2K[Q]K."EZM:01#NX.58B[/^:3'!5RV##@B&UQ (X3:PFD.
MX *Y1@ JA#.*X0G!@)DTNK=1AZ$O%]>RXJ%.LQ+9^28O7=R&7RI@87D'*ZR'
M"_AB!Y//TZR?14B,-56N+%,><8%WF*NC;^X:K3ET8!YD.G0XQ!XA/%R__/3Q
MH-(AGZO/[W]F?HU08AWI-[M(@0X26ST,&)Z%ZMC<<<7HCKT[3P?AO#J.=]P#
MF!4<80)8TZ=;N<#Z#_2:F@>$>>LS2AW=;&VVCS1V---^O^U"8./WZ7W1)S55
M3)WJT<U*!(Y.1SQZ^ XLPXB,ICI*"*Y.$!8K2(CXT(,GQW<XWYAT+DN;TG F
M$+E B26T-%N>.I;\\(Z8"M0^YDIYQ2,KI=U1!P7"?1;#J=.G&5E42%OFF5P_
MF86!AVUJ.W65O6X7%+*TRAD7:9X@N9)#RN<SXJS[2VY>J[_O[4O.<,Y3CQP
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MN8C4KG9E<WO4 TXONLHF!G_=W/5T%<VJA#B$'?-,"KNJG:&FJ3EX"<O2TGV
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M]I3NUJS8ED/X#*W&+,A3LYK1(LBCE"=J9]W%+O==T1\9/$%[[6:,6AHOH.9
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MA!%-\W_,1"RAE_YG)K[.&0B<<SAJYQ;7!I&'"(>=FYL5S4JM<Q3Y.?W 4C6
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M."V:;[NS3C!JXEE)C!":[,6R8.Q'J$.H'@_#Z%6//JQG60UR=(YP>EM39,4
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M"N'*@PQU[1I;=V1MN)?<OIYNI2WC?YR($>LO(SMD*!CFJR(V8,O$!OKW62
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MGT<N>+<I[2FAM6@4\HO.V>1F!_LFT5+EPHH,8-+OW8=OA;@8.W"I?H3"2GT
M;5^0G;#X)JAT<C!PT2/ CW$*6X9CL &T+!8;8 (I0I5LK&41>D9%C6O"!%XH
MY2W*E24$ARM(=W0%HAAGICB,-?U+,I-A!V (#-8?8_6R+D;[U)G67D-ZJHT]
MJHXWB$7=CV2>Y"BX,POG*$OCR5K1/47Y8#ZVJO'.>NH0!';TAQ1&&DI2I9G6
M7N%861-5.JT\T)1R)CF_W:FD+FR^H7OD,W!>3\+G?]M//!:7C=\?.:*IOJB%
M"68X^^?=4D='+Y2]JE\[#;@^))>V-H^V\[%XGK.X[#F4U;>$/D))"Y]%'7+W
M<D0V>:MW[R9)1P. @75/1VD\.(V7Q5U_JFXUP[H/5.;/6=?UJ+M8.6N8/ISW
M793!4BFK0C; &2P?+>I:;8JI4TL)]'DU0186XJ%;/F+MJ3^496%UJDM3L[Y[
M.NOA32$+C?_N)320)V BH!..RLTK&M:O%1W>5QQP0C:EA[)"[<*95*5>M]SG
M.G26\'[@EL0@:*/XOFHK^L@X3;9YP<@WM>-9MD?:[=@A<'G@)/P3)=6NCF(8
MY=)5$"&,7?^@*"<E4]8K\P2GH)!@O97:5HP->RC;6OY*&7C?G)GHRP;H_F8#
MIL_$KM6@=W>2633U!T'ZZ7#-4GQ9H,G2]CCUA($4Z?USHV4[(#F/(\OIPQEL
M0%#D'-(5?-2!F31[JRK,-#WYEMP:8-EQ^D[#Y@;M[E%D+_0.A[BU^B*DR'NT
ME[_&LW_A]3ZO?YP;+A<*YB #O?_O 1]#.A31M*=* F<W!^TGY="2>I3Y*3.'
M*QML%,H1@:O(TAX2A'ZQ,J79#EO3O\9R*RSP=+SK(WVP$7*#-04L$VQ#CX93
M0WOAIN[H26RSY+<L\Z]?H?/M>K\BS2[V#-I4TBZR>(/("BTRTA5UPSI6!R/R
MM+B5/_1I"^E^VA>L"Z:=XDS>CI+[&G[3*8-A35ZU=8]I I6KET6 <HR>NM1S
MJ'I(%M35CIFXYGOUPBV)X>W7/_MV#-X=0W777V!6UY^'>5-[:4,$P2.,LP/(
M,O3IN$R-'QF6WI^E<3'GN=#]'  ^7<JHO\+\@"7L_R"^#=ORC1&8;@8E'03I
M*G*'<)X.&1]II%]>7N@X9>TEGMK19D("!4[58]%MX!$,M:">&0Y_6 0_3XO+
MZ?#XV@&[G=S/H=*&SF(-8G,R4!(:B&PT9_'0O)O\4L+>$._57ON.DUFZM#3K
MZR[9^]E+#RB.;+R^G\-M&O5KCSXU4JT!*W@RMC9!;?5[S,H45V8\0P\OOOE+
M;:/G/GX1LY8[ Q1&C''XL"P<C%\[ Q9<QIPF\D7H$JMUY]\%$+&WL!Y=!S=:
M4*7AD><*LMQ='UOS9BEPR_7R=*'(AMA=.3\V8+N/XPJUZ*%$U.L'%'QSS]$E
M2]R"\O:''VCQ4Y\.[4>H[W(NVM_!+-25AHN2VPH)*,E5+QIBS;B3SRPZ0@QK
MQB.\UYJU0DUA);I_NW=;Y5Q1IFU&8H#6^790(@#Q%-FHPM";/LQ2@!O1]/,=
M:I,O^P7;MLK"&_7D*/<]<22(!3,'-).1)D6N_RBRTRPC4XU)F_\PIRAU17=K
M8]Q7@?D>!"6)$JD)CWMDJJ0[)[X?YRXVK=+='D8VRK$DIV"A=I3PUB[;VZ3"
M6W+GRT*UQ6XEA.H!,Z=.#A#Z:P]\MQU7:3\YD',#HB?[A)'*V3VOD=$)!%[W
M;)J7>'78ZHY\/7GUL\VJYSODG#D>M-J&9(H,,1@PX*Q9,1V$&+!QO-Q?@+*(
M M>Y5)7R7_^9*WLP&)2QQQCB/*E-_\&4-+DE.I9D%:_FN1I[$3/K.$[ TLZJ
M-M19-EW>2\HBPK8FK3($53[V7?&%!TW,#M>+T%(I/"T@L@5VS%ZOGW$EIR.7
MYFH0],UK\\+/2'K4YRTY5P[ZSD6H7,X59!S_3?$4;^G*C=.H7GR';YDN :]-
MTV_";6@>7@6,ORBN5(7P80HA\&&^>O&%X OC>DPH59MHTR@ P@$!V^!PQ7R!
MPJDTY8#GA[A1OVSF!=<FZ==@L:S#JQ2D'1D479;ZBM"1$_2V)?B[_;X'@61%
M[CHV(.P4LP*TE(%A"9FRA-]-DTVQ8U$M,A?[?7N.KZ8@BJ]^6%5,V[RW^<EK
M.0[B.85L-$-P74M77W.\$ 9ME"$\/OU\OGC'^YW-3Z @]JEG-$<N422PNRMY
M;'W'D"Q<VY>Z"NNSTTSO%A^)2PLZ $"DTT1-:GL9DIG+>Z^LZRO*8OZ*E(HF
MZ&FJU]RQU9>O^ZK6]5>:U1T)B_/W]@:WN,@;#.%\@N]T"WB4VLW"^S$L=RP@
M'65>&)<CT*^<#7G(N%M.BZ-KV=KK>:E$6K3=U)%Z@\[5/04[BR-JA/BB^5>,
M)7!W*Z#NK\1W[; REYC>1!#CA.!L.<U#9?$.+0AYL>RE?4_R61F1VS,SP8K<
MU)S(79X&#CVZ"WE5?[K/J6H8#A8)#3!P'':;_!%TX8 _BG3J;XVSP.%P;>78
M9EF.DW,LA$7SWC>L5GMJ1" ;:E[-XQYG7*,'P77(V+8L\O F*5D"G_*PZ[/N
MHWQ7X&4M&]R?]D^CV2G \%\F'R5NV9V?O&)<SM&W>>8'AOVL9Z0H2EKW]'CG
M,[S9IMWX!%H#\8 -L"6%' CZ8\//,3^A$2"X=,RJ 09:Z-E,6%=63BCX!#@*
MX@7L"5*#8@[5'X*)V7\_BW0:0TUN]215,:%5@VI4R2_3?IU/6098%>0C($V1
M^H:\V"S; !2>,CTR:WQ&N/ZSVCAF?N3ND1&T S,3._.-#>!G7)W1'F$!GQ33
M\AVK]/F?M[U[Y<?O*O>R"P"O(4MG<KA22"3D3/!X@<0R?!8(KNOV<MAA"(]P
M4_0; +_YW[NR6%98FKSH&L?!3-&R6H#"#%,GN<LI'Y4?]\?<3NU02 MD)5JR
M>)<Y<-VP ;C=+\@4YV@Q&\ UY$0S);1:C66./C\ 2V8(?>2FJZ_ZBS,G4'L"
M@7X-J%TYEA3GH<[H/TT8.+BKHQR*W.X&,P\&:X)I<JZ,U$(\,TB!%0)=!-/^
M6F1\#@\!K:XRE)9Z_M,?!6E*+R9I(.).J,Y-^>*DB=O]!H*&X^\XY&@EMWEC
M]]B?8G^.1Y%+Q9!XR(DL6]!,=GM1!IYTX3FB?$^:?H$U#.&OO^P>8!BNHT14
M+!= #)B$V:<*1R=FC@5KR#V8V;-91+7T[-X*0>)_H;J#00_/(6?;IEE5Z-_"
MM$7.3NYS36;Q<LU<\TV"Z+8@-G.F=1")='$G-D#&FF.ANY#OT=U@VMG<M7$T
M+&33B(8A0&U5?4W%#$IO'MJ-U^PFL6BG@T&&A?V*,]$/>8L/2%[WP3VUD:9\
M\[ G&$9:T]Z47;[@GUWM@8X".:-H9VV:Z_0)S)A/%%$+&<GAIZ>/U@XH:5;*
MTBJE;"3IGLA&8X8"$1V.J3],@X 8<LD2$Z90+]_C);O&@:]BW+@3.0MM41M!
MV6PKMCWN@[P\DP&I(=UG TB6;,!?XAQOLKK!!C@+;RTRCN.H+X80QQAGJ_'P
M6VX>VPZ/S+V>2>:]2:IW8GY'SLO:@?Z43%K+# 8YE(%V]W$V?WL#R HYNVW>
MRP;,\>6R ?A:Y-ZA_,%_X.,;'$=W88W$(SJH6M*K2Q'?QU9$=?5K1&3NM=TB
M!FM.T\Y>3IYUL)FYX04[+?THR(3T(\E!")M:JL/L]H(D8,FO6?V@+4%:* =A
M.2"C$;DT;1;O)-GI;MBIHJG)9<MZKF-C-=]1WLN06S0>:@+-CW)FZDH9Y+B=
MEN;/W=_G7+<O<=$X$G((3.(8 3T.A@#M#.%IP[EO..L="Q(O?[O%-#&F"#WY
M)4J2F/F8SH%H^7M'*X8*/,][;"@O\N0FG\7\5G\6K!O(C&0#7-29GW1/C+DE
M>PJWU9RQ6R<"JT>O[*M__?>!'O0'-N"9Y_B39JH5N;7V\OGF;[34._P5PP4X
M7L.7.&-&>]6?&HMPST%U,,GMV?ILB:U.6\CI!2G?\<\^Z8)36DHSJ!$0B_>F
M*$F >)!L\^X<L1\.5M#RQTQTO(BL>O0K0*,\B*1W0,@F"=$W#;P$'L43TK*(
M=8]N>I[R$JA'N(N1 =+@2UPK/C8$9 QHAK-=8@S_HOOWEQ OXZ"5:YB!SA]\
M:8=G"P-CU[(Y,NXT]$S'(P=F3_1(,<R>B'NF?F-B,Z*#-R-9:I\I ('N,V^]
M8,I[^YW$Y3N-X=</=4,W<52.:H0DF9)=6T_ %!JH27MI.<6A5PDO=#*]&W#P
M7IZE1&&:?N;?SB=?IKG:Q5K7IRU0>ZZ(8)R'11A>D+SI8E%2<@YK..UPBK\'
M<0!NF1M+^^A.CC?GTK2V"%@(UOWX)U3P]P5G7I;__<GC=,%F".V, B/--01$
MPK*BU.EL "08^'?'@?[G9Q_\JT8!6F@50HZA^=T9##DL4*"JJ-_[_G KX D^
MC/&" FSD4SZ[#I(!$V95M;-2?]+-@DJ[$+;P9YR-^0AWH17[^^; 7+H]^<YI
M".ZKCW0T>"X6 UN]'_L:^P@T)DC]4%N!5S?Q+R+E/'A<-UATO=)RD"1;"/!"
M5AS,(!NS 6T6F":HLN,46*U^7'XNTF.RQE_/1W@NC:^84MC4J?#FQ+VFWQO9
M95&QW_0A!<B#;,!,K,Q1\J_A:E24^GBARRR@(_<6KUAXA:$='=R +<4VQX:-
M(4<85PC2&B:OBX:/MD9/?>WEF1-<XS"G Z<I'$E!G5B>$J/XE$!UI39OEC?=
M_RNP<OK4M0D<)H!90IY^JZQCGFF[DJ2Z8.]@(&<@,ZN);N.8#GQCD&P#2J96
M7B.$<6$8-);DLK)!UYV,[-!(#3;CN<_+U&'&GL16,--TY&5R2I1G@C=LK_%?
MF;V2+NCV'[&J_X&C=IKZEH81;9@.K3]#^1JW2\H>%X^761]M$%Y::_27X]IP
M%*>[P]7K:55T35B/7I]Q9X'IXVGGB,\'_-IG6.)_"NT>9QC26NFV\-NUV'[[
M^X-%ZU)KI?US[^74UF=/F6GVG*GAIDNQ>F=9]V!1+#; E UHM1E DHWJG*Z3
MP=$ZI@0'7]G^6@A7HCWI7JSBH0-6L8XW$46%+68927>=KQYZ& E@<*0V3(N9
M"5J<;H'L['FRSM8/<)3'A<%/RR#CB")9_K./AV1+X\=NWJSS<YXP%)N ;J&Z
M8^FKNY%6<?;K/T#Z>D?^(0$"L_C4V0"%OS*1(T= 3('\K636X4TVX(PG&<MJ
M=/K3!8,Q]H_TQ0C6#?\'A?;?9L2%S<OF0'NV/=]@QI(RY'_"L-;E-LO\-SR
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MO">?Q0^_C:6$E?N[!P:H#)V>JKSOE$(UWC6DNKW4/5\I'P-/UZ+CAX86\;?
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M)OVK!@4R+DG@$-PV\.ALFZY$/T"K=2B53P_'"Y$-I;G4?7VO]=F\,B 2P$*
M7"!CEAQI*N9IE:0KFYAZGKQH/WUO(NNYQH/J(Q<'0B&9(B"RK6HH&"I>,U!.
M6[_,Z)3.DP7=QV-8O: ?&\W ,=[E<F5[(TP%_J.'U@=HLM*2@1=$X0F$?*-'
MT.')B2X/BLSOX<GQ%WKGWJ_)?.H"^/.0OG!$3P\DJ0/T)0ARVW8Y9S[A[7-4
MGW-^['.U4GWZ3W>96BZ%1E2XHP*MD9AJDL^G#9N+4?QZO?"L1_<\3Q%TDO6G
M8)9BO2A<NPY3A9>"51%.A8^?YCW,$ B2IX3.!,6V;+P>H F:U>M*_G![K5:7
MPCU_<C^ 9U8/&!6@6P4D>=%A%9CL<;! 457>[E+J\_;O60G+.]"=7,-25D__
M.0\PXT>()G8CD7O/I@M;@EH3GD&-(N1K,+*.%-YX@T(OD8Z#WKW<.+N] ,YR
M?TT_<H*(:=O@88B3)UG%1 ^7L7YM33LGCP4TZB2WYMWN6^CFC7%[*F$8Z^[Y
M]L[4DHU&-3!L:PYVKI 8E^E_]//Z>^Y.FV%(A<(:E&)(36-^"Q_)BA<\J%SV
MQ'.T;2153FTL("WQMRIIFGYQ&5BR$Z$C3RB\L$@:Z,@MG73X,.;\_KRX+"5=
M<"B6=D8DP^\[ H<XGD9=L*_ZA3_9>3'IT?YP[C/UN=6U(6V3BU4IVK [SE\3
M0[['6IC^^4*YO_QOBA++?%GU1YOJ+E*K^QCZ1-60ZNYDPFMW7VC[F%B6?DC+
M-X!+L&X0LQ([DX60IFD0\GN.P$Y3I:&M.^X52F^-DL:$EUH_RE3JV#2@R.!I
M("RV!5DN$[87A@E\@=$(L76*?_E8_F-"HP[OMFHXEFQ2:-_,!O#[(B49M[\4
ME&N[C0X8/M6$+\8W8XTIL32%,B5/^CVWXI--AG!APQ\O#@ 03/S\-$-8G]H_
M5'LQ3[59=?^*9^[$NZ)"+^[$E(OOK>Z$QL5!<@,2.TH'BHJ$G#,C/@NFG\&F
M8<?..%&4J.T4_N3I&HVQS-TO>Q[ _F#Q#(8LC4($<]V'K8QY'D6ZCH<A+]QR
M.?[^H!__)@T_^*<KR_0XM%4$<E24@(U&+PY>HD]N2$_22\%"D>=/**0O9B/R
M:*!FJBRA+?HK\XMNT]A3M4O7] [<?B* !$%$OB83V #2)Z+8EGM*NRT-]3,Z
M<_;P0I'A@! 74T3IX)WF#'&A\E1"W35U4VYPC7YBTG[/KINWQUI#BJWK*_B/
M'+I09+BJ)ZKX'3)NAV2P ?;(Z7DV0 )44<8&[+(J_@91+W'1&O^A>HI/D8W.
M.3&>8X;Z;MDQYLQPX,2#D=WQ(J4MU-^G<@/V9/Y'0K6J:> 3D0K$L:'6KE^7
MZ86/<2D$[]\I+;0.BB..H/KZF:])=,G44Y!+A5.L>IW2)H;(T]8CQ+A>7YE@
M/I@-=1<C8:QWS8.4^IMF%B%3HT#;^#GU30T2NG/_SL92T"C]RJJ=3YJPFQ,6
M$^_1O ,].3E='BB-,(!YMMGA7A<ES1K7)_7K>7_0L9E EDR3I%5;W"#Z> >;
MNZ\,DY^3?NU>5;.?/6^9&U#L9YB+>DZ":Z==^%R5A:_6?9\9J=2F"S@;5N;+
ME=O!_'A:X^.NSD8-;6BOG6(8H5RK]-4DST'JQF?$I>$%*V>Q@834DO7G:9ZM
M]4CO#%\6I0"*$H.;E>,3C* >8I,7PO@/CX>:L0%A'_NQBR.L\O8G$,FG*K6>
M,@4_$,OF-L\$GZR\<QY6:'ZD-J*91S_W..T[:P=<N>6DT%K?NP3:&;#Q)[P<
MEC1\O=KYK#I9]T'Y%7!3[0_6@ 08ZL*(#@"%Z+B[S@;)JWK >J; QC_-X^WR
M918@$4UW\SL-CRZ02OV81R(C%0O F;R*.9?:L?Y#B)Q@H*,PW>$)-!NN6_&9
M25$;NTIQ[,R##DO<#UQ7,;<9F</_ E6 WUWJ.0&3:<*;UEP "S3?.NTA.S\>
MN=*LGU)@.8(;)7@EG@IM,96_G( /LD9=)!9:6J(LJI/\'S^Z%W\0)ER7E\ &
M''J6N@7JKG*AYU07W@(S3J6XX\2>[(U5:\I/L*);^G+#[SVYE-4IUB&7?"/S
M5[2@?:IA7:1S8M,^/@!T'17&!LALI2*YEY-$;"Y3\5-W%K:;# 3@?$<G5JZN
M;@B.[E"19-3;>JGEL;"Z[)O?ZGY!3]J6J.U*$'[)@A.-71N]<BQ#OEDD:7G[
MK&BW5GZ=2*(.H6O'ZRB7)&;]Z^4H4NZE<3)1SP\]7+;4IW@WI(ERK^T=R<Z[
M'0IRLP=?,& $0>M*:+(SRD)*UPAT[>>?0Q-P"T^R<1&UJH3E%)SACYA%"\L/
MK^[,@C9LWO289'J20;K9;WZ>W_AD^6%^RA2R?44<Y-X9]*C;<XT-X(/VI1M8
M0_//W#ZNV0I_X#,9:$GYTNB^KEP(GY55(6;M3WBU 4GG<R)NB,+QI9AP#WJS
M"/ Y.DWW+S=JDHQFK:DN^,*DU;59\:<OH':PMP,6=Z+1FU=_Z4(-#TM$"5Y3
MD(=BNG;<O/+2[C])C?(0Z_15-W0L3;W3[QHRY1)B+7XD?+]U@H%E$4C+ZLWG
MQP]B"U^TF:E^W-WSE3?+S,.8S6^,Y/Q> $<$)-9MKVH;>KRVG4;_"@C$3R92
M/(,1Q]&122ML0'- 00HHXJGW\Q A-L AM"G!\1-!,':/%<4W#NLTO$RQ!<5=
MW2MV==D>4T(?33KCV(^:"*R*-G*IQ$+#Y\UN!=9<%:E+V(7H+SU10I%1L9?
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MI%?ELKG%I)0S'8)LM:_X:<Z_F)J&3*9GM(.8#4^7*<K>^J+3]BZZ5"1U?5U
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MRAVY.EN\V9U9.)2DLEK[PR?,1I>A+T84LP<W*_G/UX5;F'WA:4CX<7;[(">
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M?^\M--G.,A^J1 J;#S/_.MSS9J\%9%)[C<>YP=SCI6"K7]I^)=K?L'F6=GI
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MUG5!38G77A4$A]/'(F);"XW!!UUR]GF8]#;K,,GEZU=:/X$"A[0X1?@6!IC
M6ZR#T.<P=B/%7H_F9YZ975#C$>?]K<;/F\G4.U7\D]=R1-_+Y\#VQ7.G:+7Z
M&_B\?5-4\\$$Z>@CK5]3[@MA+D7BH(7R.:1&W5OHZ1-?\\9Y#$LE;)0W%-P6
MSMO]831SNX-3>*C[HN36RV-XQV$ZC\U;TW4+-*3&5+GG:Y5.>/G<"K6LE9LD
MJE=3GV9M )S%22DESB1[XEKO4*-;9:QA8_P?"PMGJC^/>>(4<CXS9*A</M6Z
M2_BSHYDEV&:&9[C2I\HV/76=.XUI6C1N6#:#@FK>DU5O,9)%48M1/CC]4\'
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M(Y>D$[_* TT<'!<0TST'54,!=<,^,*$Y,+C[@\JRUXV&4.@D%P,0[T'G)"<
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M9]?6/4VT_36O$[OJ7[>/SVK.?D(?-ZL,_IS;7P2>\GJ655>5^.R0U[3"KW1
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MOR#6Y,.#)X]/KRN;UT_\P%3<")+;\/_RYWQ:*'0]9;ZS2[LD 6SZQNF,J7&
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ME_C3FW>/)U!&6O;&.47*WY-FZ.B^ZKR9RSN%\*'G!NU=*^QDA7P#1\M3?)K
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MX\GI3RE.8S^'#40Z2.V;>@Z1%20G^'B*=@/>F-0QD>)H=WUXWY7%"L)W/WS
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M[CRJ$6?'?O%M/50O87;0G;__C07 A=-E68#P2_[QS+ C2C0JNXWM_%^W41C
M.8*I9[NKR+#IC*3I]Q^>#$\KR*5<%[TL$X(V8IS]QZJQP1)_(X=*3?H;6=C_
MS*;JN>\$+.4>\P3L>_[Y/Q=F3.U0^#+<*G#6;! *HZPHT<)W[\@][7F%@+,
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M=%/1T[3R@5_8T<[G^ !GNU'>M-U4/&S=)P6XM7  2I-9<4QB?IBR?32S QG
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ML-HWVT,VX/.9P?WU"XQZ,+R !1B#-Y2;+:C5^Q;D%1PZZ\T3<15_NI?+CO8
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M9225O'JDH%79QG,F:0VF@VJ09,J:3/7$I&%"'Z48A%N/[6ON-%*0._-:2Q3
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MOF>IFMGM)!: U]';EUP^XR?AS\=_*PZ+94_>5TG&^088:OV"CZN7Y(B3@FC
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MS']WIR^-(4\@>^V%J84UY\_1A$@:-L:Y^_2WOHO#U_?*Z.H8>ZJC-7:P;)=
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MT95Y?[N\8MA;RU#)H?KF=S]ISOU,T/H(72"^=>?K(F$G-/FMI4G]2JJV\&&
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M:EA-.B3%3_LI>0\49, !M0.5ZUN6#\MOJ2JZ/>;_$9<G?11ZO?I?S>_W/..
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M,-M9\ERL=.W$DZ2W*)GX+]N?,<+THE#O\1T6(<@8E'H^$_Q9EXMY#F6DX'C
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M&$:QH(E64?5-\=ST1[^<DX64,T_*;&-"U4RDUO2;4G_N3AG;O[^)B[H5;K$
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MS\B/@0MO9E]/^QSIQ$71XH N)A#R)V?4$;M*H"V::@UVVLKO:C\(\IHPL=A
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MT8<9C[E[]R@':4V T8X^3/,E<S)X/9U:SRRU(;W3*9B+$3T?YH3:0<'G(O=
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MU>&Z)]K?^XC^XN@*=&W52TH[B!1D$#2"69(N43M C&@YLE(U/C$6+7SGD'(
M1UE.RLDD-VX'JHBO:0$M87I$,$F2.K)]\Y'BAA#6?.H-5N]K K-E[9$;"3X9
M!]!9<?)9KSFFQA#3M5;X29B9:$^*YZ*AK>9DX.VZH.D/TUAADD/H#PPSQID&
M8/M);)GI;;4N5C>H9N7DYHX+#W()U14N",T.;;.3P*J[D:X2F2SP9_6E2WR*
M2@ROC$Z)BR\^VL]F[_6*@./,>F,P1Y^RA@#G@!'2\^6Q\]<)$(F9\B%/3]3A
M,1P/H8?H0=(:;1P3*V?+*I"+Y'/Z]5&\@X0:A=VA(-! \L.7B=Q$B/&(&..^
MSZ];O'.:V=BN4"8ZYGBX#&2B*E@';#4'30RVEQD3?#\6"UR/$KDL6)/-7GLI
M7_"8U-\OX'V9KF[_>%(EF7Y%$S[?3>6A 7Y>@2][0-Y!_HYKYBY3'T]:<0A4
MJCY,]EN=4:!+A,<(Z29>,RE(!96E[S%<=TR PPYEISWGE**%_U31?ML/S'WF
M+3^ETHCC6GN^C5.EINMP@?)8/K;RX[MJD$)8\>['MFB5+5,;I94W2\+J(1(2
MH]52%K.9#N<F"?K0A1SG*9-Z5,*]+U_3&"^F:EHG9>+M5J99Z^!L,-'/@U7O
M\^R&625J2&V54]@8G.P0N#ZT1Q5("&]K6YA5B'4+<[=X7(2^U) 4(7%?5+N_
M<.,'#3!#7]%9@],T 'O;3/<9_J>VE=?.&&U=$*"B?I"U:^&GW=.$N)]'\4 :
MTK1!/FX]S&53YD-G]0<]O41(K]IM2--@7MRX<<@-Z!:'#9W8><'E?BE;8/O,
M-9VK5MI?<PI7J 6KW:M$Q9P8DL@-GPZ^MVNBU_?OKO7PW\D!/V$9G]%B[S1#
M)'Q:-W>VW_^2-+@"D8=)]<_7#+V[ZQ >N="TE7%H2)C%";;MM;\MN\GQ-"D-
M^R1N;LW.>J94T-=6[(32L=<R/;H^=DM?XM7YXOQ=EI]TW&UR/)UW<ZXDF(J9
MOXM?C*AMCQ<^)J5POH)AS6:K$<3[*T!\]LZ;U5AQA,2X7L7)\"X&1&F0-.,1
M]ILV12^HYZ;6@#Q5WQ26R:V6 YMFRSE-"KBG>>L+!L&LD=Y#[O90)V+=-4L4
MO)5RR>S5B7G3@4N-@),L5KC$WAO_!T*,_C?EE%<'D-U7)JH60O##/$PGO L+
M]!J\6#_\6U>%X5<-BY02'\J\R^>UG4J3F-IPP0_(C$Y-EY7/+FD'.ER<Y +M
M]#>QP%7_%$4;3)R;17:PCWT$<4U-3DXNQ\JFD7J<K[;G"QSKY60X!)>$TI?'
MB5U)7AE%MC,] R.R:6FV.;HK)C 9'+9);#@#Q,S&?A?3 ZMB%F9</X'L 1$E
MJC>,9ST,9]\0@V>Z[Q@:'?E^:3YI?=XIV>W.S<L=GJK@;K[(%O9XR%$R4P[,
MB.274^#&TZSV1OI"S5/[E$;O<<W7#)33%Z^X<W%*)!SYT,BY>M!%.$O)1<)=
M>Y_7VJ%*HX3Q1]5ROR9,;:::H:Q7M9!YKG\R,B<FFN;!/0A!T /$2PP0Y3RB
M?C//D!N9F#;;XW""?&,/F7<IF_TUFI.NWA0U6<F2^&.%=2YYOR;=1\J$5*0]
M6=M/K&QG'!;8Z\UPZ,0*//!@R0.PVYN:: $OD,WI ^4"NT)LF.LV;LOX 4:,
M6865="_85%P6%HP<0)?@-B.]9A#L*[7:V1='VL?47)^K;VBS@*Y;_0[KA?E2
MTD.%J/U!C_Q"%?J[?R9N&GE2[^51CQZ'-JLKTSGV>R)_[BHTT+MP:C+PCM"E
M,?R7.*&YAI <;8!S@']+AO_+7:BMI $JH:=]1#'A6MY= ."!BZ"1-?KSEV$I
M453="[5W@?=*VB0BS)F&^,JU ;#@.0Q1%-$$Y%WCX<M= :<I5Y_A%=TN>W-!
MO(S3%WF7R$SB)<M2,AV3YYI5U9,FOX,"??POO^WLN";B;;>@#>!:A/.#7"!'
MJ'U\X@27. 7?^K@GE=HO7WM3</(QN]\O,<[&RU"9Q7%RO?>LHW<I.K,3IQ9>
M3M9T,L5ES:*_XHR?5QE'9@%1_;[\)SY=D<(^%'%G$/ZUK]CP'X$._X;(IW]$
MN*+GH"M54RSN_N8'.WDO*S;6,MQL?]9H]QA(%F][;6B0C"%6J_N:_+BV6:F*
MG)A%;<!GSY?.Z-L>/B9^O[#[5R8+G4$CGXA?9@U[SZSZ=+4FVZA=U:R+=P2/
MW\UCN6H2 \I]\JLV@I&=SW>NWW;?)9]\F;@R"PH_'/@U-FGH#;UP)#C0 KVP
MR2 >!LFCFR'UI_9XUN:1H(:77>?3%.4N9K[YF7"/A)UO".DF,:V>!3*YIX7K
M1VZ([L-]YPH"1U-/J(8.2YELPZS3^M/XUUZ99[A370_IJP+Y%@3\6R]FF?S<
M\3SO IC:\&:IJ*NT<!Q7TJD3\V:&;W\V-]R_\?HCZBGGU"\_7W"SRRPP"K0L
M%0#?H%O(]D2B1>AY&B"[=(EZ%$3$0H81/M,8K 1P9X&R3*J(P4%&BUKY$E"!
MGUC'1S=3[>-3G5^A!RS"XBB2DR49WO/IEPF6?JHJ"7S7WK1W3AGK/LB-D6#7
M^UO[D[$N;.Y\[3ZOV#-![5!/ZN#4%['B;/KZ4>!3*IQKL>)J-I*SPO P >4^
M"^H$@Y>57\#N>\U!F%>L)DHNQQQ.B#/<\=OD;?/#-M]K&0S7WQ"V-'NLCRY<
MX#2QT?E[IXJ9DD.'$=M:]2Y_3G?""'D%Q!G"^5V%6(D4#\V&$NN5NQ6:V!J/
M;#(:19+%DYJM(A/09XCI-P>&K:B$[Q;VIQXKR[V2A\1Q(^C/)2HE?^H;M;@N
MD1)A6'&"[*T%K-0EQ!,=3X%FE ;@6Q1QLH)_B\RA8!6"1 /0 "/(#@C1#['!
ML4:?W\]+?^<.KZ(!7!.MX60V+UPV^P@-P!_:-\4F#1/]V(Y6'(A5K MG5=)7
M,^8B=I)X?J0#ORAFEE\-F!\13(V\<?+'];)2S'0&L$JMV)PD:S;$3W^<9<]X
M5)+*O(7WGX&T;["V!FT4Q 4]+6W6E]25=3XOD#7$<$@#_$^"P.8Z_DYVDS/P
M)@_,/!*F20-\5I@Z5$6/TU7I QJ@\RU1<@U$C5-@V'/ZGQQB4=(_ZEV9%<.L
ML+J#B$?+0UB)=GH77W>$/)$5TI#O!@0LQ6M>TO?&BVG<&=/7['21V(BV#HL+
M@]Q>5JV 9F@7K >T]D<*#PH7P"1%(O1YHSO%Q=!AE$R8NUB,[?%9G< *I_@W
M.$X_+@]7IKK^_R#O?RW>"*[02VX(%IC"X9?\)Z?,+S4U^75<AYP@SA$^XXMB
MD&7J[U"5GZ5O7_W(]@W],JS;%_-E/WK+2U.,!G \V*(@O(YZODIIWSXASK7C
M$:+#RGS,Z%Y&G<OZ+[6DF>(9^^A2KLO=$+LH@M<)ZK"=,J[AE^[&FO<C_OVD
M6L?/Y+5-X L,GP(FSD[0NLN)I+CNXCA2<74B:3CR"W1[M@%#,,)799TEIGIQ
M[V\CM9YEKR0'#3M<??5>^5*)@@?"T>*1#O?3#TTZWM@[Z*)E"J<)1")4[ ];
M5(IX,ZH!=P,- /&B2+Y&PO"8==*L47!;1F'>HR_(8S^Z+WHBW "DAY\Q,V_K
MP32 >BD(=PD>'I14S"IEW%P>J&-_15M?YV6&Q^Z.>MJP$_3-2_ZXMHCN!I]Q
MKG$VY?;PQQ>'/NON&Q.Q+CFA/:&7!E'O)-\*5W&TR:D!JY8 IXW/+:+?)?1P
M:0N9XF0'*HLMI5 :F461WN>BNF<%BJWQFOPIC:$7,FYL%=K)"^G+T@![*P@<
M<H\&.#Q&-R932&I#2#]!#[Z43+T7D@P\F,>DNNQ%_J1_/S0&V3F@?"-Z3C5.
M"J-2'6.-ZG7MXH1_9WO*K/6*:Y5""^H^$%BX(WN '0,Y1E(#91;NHZ[-5 ]N
MBIS.\[CAE]14L!=QR%ECP#E[ .T$,OSJD.BA/K87N[,QX6/BH3A 1-X#XI)7
M==?[REP\CXR "1]H $0 ?"MCT_CFCL3K.=Z:G4<]B.G#:K*XE?-Q> #H?4@E
M1(#,.W);4ZGJR-C9Q<^F?MOU!&1Y21@'7GC/DT/?7MPEA(Y;R\PV7\1(\)=\
MNV+OYNF<<"(]>?OJ?6!T-O.'3U[$V[OLAVPK4T1.Q)PN6<R*B7)\=XO,8HS_
MN)!N/_I.P5SY+R_F4<]*,5+#@ORIQ\2)_5W23<Z/^BVF<&]=@;O\@QC<Y=^!
M5;>K_NN%5^J.O:W4=H W.V7#^[SNT "-^30 'VA&K@^TK%P$GS:%QPM4K',[
M=W/1*0]SVG,:X'J#&@UP)(7L2@.\[-*:AGNLC*K#.P;^\S[.;POZ>>S\DGE/
M>.]<+QJ*^J>4\"'[3VN<G05'>.ZRGQZ5HJ;[RHI(34VBN?$=9 XZ\N-#?]@A
M0BT0+82XMOC:3F'V/NRR$2<#3K<%2!1)?*8N^<EZ*B#CT.O,P1GF,\I)C=]4
M!,Y"?%U5!=,C?(.-9(R>>WSRN*M[\G+_/;^2W7]<3\XB_ONC"\,'J+^)*S&D
M@Z #^A5E(H1NC<I_<W- "+N=->G6#7S D<WMJ?DZXU3(SZ68/8DYJN0GX^FZ
MJ6O';5P6]YH^)BQ'#]W+7=7,0# 2(6W]O\H_HU^);@-GJ1*K- #' 38.=K,R
MQ1C/F:YW^\8C3J<YE#5N$^4WQC:C?&KA[LS;K\@GA6QW)#X)+2W7?'J1)OU2
M7D#T5I[IF&_=Y*1N/C3K0E7? QGUC\E<WV5*0UA) L1#+YX S\,>QQ8K@<T.
MFPSBV0T>OLQO%;=W*@78.JXAJS$./M 9."NTTH:ZL=%OY;P1AS?D"(\0"JNK
M?]OYWHEX.Y+YI/I"MU7)8+_81+K#*/7\9%?I&K>F8,5#\<G*7PR3TK-U=?R7
MJM;T2K-M7[77W0\YY@UDVQU%%M5CD5AE'S41*1K@=F62[5Z 2RO=3NC]NPG:
M?R?L/)1\Q>6\OHW=@C%/D5<JO]0<)M&>KM;#\*URJN*^QV*B_8?/T))KTA;^
M:5<[]CY1;K:HJ@>%#+))_P!>QBR\. 2ZHZ3#ZGX2GS]TGO<@6[!LHD\1PV'B
M<X;!1=%.RHSKY*LBCMA2,D._[QK=Y/_85^+>Z5SJW.D\YQ#?D0 =FL/U)''&
MK!1:"1=_<PJ_#BQ0VL@QO2/=GBK%:>[X[X[)^-\6X''ZHK>7%H6,%MB?O&7T
M83RYH;*V&-YT6?K*+G!TA'3OM>Z9#MY QVN"S*O07[]=-\_W$4"0BX=#RYAK
M3\[)XF#NX_JR\]/!69+XHB8X"MR*>(9AAX%Q#:?=^B:1HXL1LP)&#$SB61-P
M*T"[=5=O-!R5?SGD,189/.MP1-YGF_\%9X@LI(0&P)FQ'0>R4)MYQFZL QUK
M*J(!C<OD633=!+VP(!\=TA0GNZ>T'7YY+^R:\9AD -$7,EEBS[R\5[I%O QN
M,XX&<FFJ ,/-_2J,"S^U7=DE642[??XEVV'CTXL"!+N0.=*L"W&(Z.0;[:,F
ML,]!+G#%0UN( K61!JAL6%K?QRD;#2KF\&(WE0V?],<!/OE+4+1#I/X\2ES&
MX&&I*@WIK;OU2?8H5'1AFLXUEH]R1J'WJ8- '+C4Y0Y>L2<5]Y'5=6-#1+:!
MLBZI\"1I0AL0^MD$D@AGI &F/T\J1+;Z?8;I5U=B!D5>"7<7C5]18] P"JT(
M8&\_!+="6-S0%_K+N&>;#[DRE,R9  D1SU3_Q$0D=_9_I^5XD6E)/CM21KXP
M'>4PI&[TR*#WR8QCQ'%@<\L(VA@')G/SS!U+^RJ0)68K8S)0[31356Z1WY&M
MDLT^+B'9"7+N'5-K0505/7N YPX3:S^7,#OZDR<>)R=K#1% *RX# 52A5<TK
M^*.(Y;38)):K[!<T -V (#8N(A(O3&5EP]/9?2N8??K;[H2\[@0I'UUAZ=@>
MG(GM@U0HD[G<9:(FQ0;),GB^2[Z4&^M'C704+;+E?%D335T9=S-BW*\E<;U>
ML' $6CT%<(*7E,F<[%06622,&9^*" _EFW3#\L7H&.T.-E=^DN;GU]-8&\=,
M(S!5NG%P5V2$5%G =T,5KZ9&Z+5;!J&/?#D9]FQ__R-_W*$M0?UUOE) *!]]
M5LN"YG?4Z3:-SIMW+9%3AV3 ;Y\PO',Q0)A*1]G+E1#,[C^8T\AE;:S*2BC%
M)U#RXXG^-YZ;WHW9[ K$2OQ#R(DU):4,6,RF/.%EC^R&W;M<]U=KJK8-OZ0%
M';7TA6KFP6U"])&=%,.6[?&BR;UU*W8+)!7BX 9WQ;*9DGHV'4[O=2Y+C/6Q
M.X\H0D/.&F=LK[1ZZ^0GNR>^A(%=9BEB:FNZQZS/([V[ Y4W>.>,*\>ULYO'
M7V8;7C ;9,HI Q."\6_ZGQ(&%JXXH,]?%E^X<=E:2S,K-SDM_TA]^BP-T.96
M#_QHX4;P^&*T)O*CGOQV'ERPEM&J>BK%!^Y-+3PZ.8QWB:V_+A.%6BL9%9$6
MNF&FD:[.\B%;LQ]'1;%'*03;ZK#O@9GKS>,#0.LK<_973)?333=3$BN1V8P9
M^S&WZ0H[__^SY"8VXQV!7B)R9<1?'DX:;8;:#.4'2:1;,"D,T7]N;3B5SQ!:
M#8V:OS]]64/>S@122I7!:2;.O9>V9K/KE[Z8Y)?6.,E4OF''4!K:$LJ?L<=O
M5)/!:K^?;*GO0,0.V.]<>G)I: )8YI1I&4F0+8JK3;;>=6FQLGOK\PFB[>9V
MUDB]%&6B*X)=45[OPGV!A-, [*:3BS?VP3^D'4VOWDW:=_>*@%1ZO=3DG>!?
M4S.OP3BQ#-@H[0&U@L E $[ \6/>#K(?:^<C.GJ]F4YWR+UHL1_.J<.8N.;&
M;+.__!L?P8SF-7CG53IG7'M%?5A7.Z=YU:U:M;JEP6Z@ASMK5J]1K\\Q2]M&
M4^2Q,W,7\WVI \@\[)9K61&5"Q$-6F8/H='G:"+1/%2$!LC6V*<RHH)^=7TE
MT_&ZC2Z9E$Y7M-_VID:-J2!%Y.$,D/IR>/=^@.XZ=J;!^'K]<#<ECA#3U_YQ
M4 ?L?5*?47%S;W&$.$HR9FN^M_W=.Z,2"S>G<Y4'(5?_)I#[5>@0YMS9Z=YF
M(VO+J/ST!?6:!^(GQVM$0B2Q;U\4BTR?RL?.[Y,YU>;@Y"O Z**6M$<K;MF5
MUN7F!V(B2YI[*PM$KU*P2;"49<,YGYZ.[ZIE.6+%Q1-V>G<.%MSNW E*AI>&
MOOKM/@Q5B8?JUN+$"IY@^5YKEWET924QQ*,.BFR7FD!1V"E6ZD4WU>'4CM%A
M%^WW#0]_*;-_1R_Q1UADG$+811:9"^#+21AM>Z)XVXBF&N[+>Z0;<M$2<DLT
MOC)+\@E&P:UM-.N2R=\I@RG9&RI+]L=!&N&GOI3/"=I)26.!Y^V_9A( IX*P
M]K-&3X!L 7#3X3+0D,5XIX\XZ4-!XK+DP0&E(%2&6$+X2J0!@J&%OXR*+8P"
M[ >OS(A\;-=;$L1K ;],529N2,WTCNFV#*Z.,0C=,Y7;V'KFG07%>I8)5WY)
M"[SS,_?&^N2SDRD0Z= F3(5&QSIF6EZHX(,HH>2#CI"7^(6SUQX]V.?:Q415
M59:YJB9D KM(MO6ON'=/%NA37!D7-X!4%D%<[LYL1-YTR<9#-=:?8J>O2QXQ
M=][MO0ZY8SG1!(=RM=7'*IRYY)MTZCI3#K(9/FY(.(9/7Y\+>3K';XW9@+,9
MJQG\/_;>.ZRI;=L;CJ*RL2%-%)"H@$@'I4F+R@9$!)06J1&1&@$5@0"!@ @H
M+0H""DH4!*0&I+>$7@2D":$'"+TFE!!(>^,^Y[SW[+//>\\]WW?O>^[W?/=Y
M,O_(>M:::\XUQQQC_,8<139_YYW,)1BWPGI\/?H+8C(.6^J4-1T20.QN L>
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MK_6&/S$!J:R="(\$E2TANDN 5H'(%L3O;P=-H8)4$#U $R8 FTZ#DAU6>IB
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M+@QEW+^6N&J@K?'I+KR4#*$I@AN-]\X\15(9%]EZ7=!J+ D827%ET7;!:R8
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M5+_,YI:L:)SA%_:SY9H7V?:D#\@?$(JTH@0P.'*I#A X@AB-$23I='K!4(;
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M*$KD>*4O]%+PA%GTLV.![K<\!.2-/I>\7KCY629WC(J?\D7F,<0IG#=(2B%
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MC1A5)_3,!$2V8 0RSU 7-HNET_D2VB67]8JM!<SNZ#SY+3_"7]D*1>3-I6&
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M$U1S;70/QPN"RH4Y,YRJ(>W8!HP*2_(%,P8$0+%/ X <%!#8T.#6!P/\VPW
M/?S%@CS9P_ENO<_3^I9LU9Z\B7.AC$X[(Y6 +^S4?I12=T>LLS/5'XB+NXA[
M+D)RL(7H5BZ2WI2HQ<CSGF9$>HC[[-INM!L6AB-L^WO6,0&Q DGUMJ;FU47'
M)/%W.YQZP^L$6U3 (PY$*(_V<+-;F:9:R2[A05 E7).>H2%!XIQ6>0$_DS4V
M?Z<O@^O9XS*/*Y(!N +P%*3>,ZH<=41+RG5"3K#@0N3]!T?Q,!5VK=*]X0P&
M#G7$LV34.IQDF],N>O-[A6?"BYFG*]#9Q[L/"S?MVI63:4:'2VP$9C73(C>
M%-:'0&PIC3 ,&7Q94\@1]:GY:.]E6\$;I#.U<QE/'Q\]?/PNPWQ6C<^D.I0:
M&V3IHRD;>3&/X[^]54:JC0EP 0K94'SU(HR+W>/L]@OKJ#JR]=4^P3RE9TH[
M1=PN_)"BT%'MLB(OD5]'W!5U/?,V3O_*3/\3/<V%S_F ;4A(D'IU+]S ,_,R
M?W'-O>@\F'9[&SIG7UO;#+@9<FSU00TI,>FH8>G$[7W F,!TS]/A$XH.B>:
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MPZS2(QA XY_ENB9@D?=NN[EQF8<?Y\L-E9\E<Z;,P'%\:@;2R=FU [6(J8+
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M #U30T<J^A[7$Y9AW/.Q^'W4V'[)2<SDW<"!-GM>UK(J0>4_S9=7Z==E9%3
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M3\=,]&]O,>XV231P C"9>>PN+JAW :#:, D;)D\S>Y6;^TA6_);[-87] 2G
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MA9E 21G:"_RC1X @X7\8-J?,&D&7"4RU:TF" R%,X$<C-J?@.QXZBJ,]SV_
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MST^='%LPEYQD8I<]:/=9$GOCYR!D+*5WX0=AA:#RV5^JYGM'C*;CTC NZO\
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M91'QU^!7D_0K*$LTIXF/->:OE+!\B=)/'(T#[MI]:J-RX0S92WR'K2)<S?E
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M(O<S&?J26(->:Z9&T-*96(V(NY69P\/$'F_5],Y>+]/YY]N0:W_ A!SVT5K
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M[WWNG:FR%3/[.6VF]6SVF]4QCLUMAHCTW&S16\:-$?V34UT_ENL>#=GY@?9
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M""7+T@T0%YB/+?/8?&2?EW40D&UB)V=\]=G5)VS>9")YAO.'^3H;C"3HRE/
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MI])=(-1-MBF 8<@QNX%?7SCO?R]'VL^ZD$9;>IAA=C7B%6ORP7IKJ)T[CD'
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MY 4=QY; -VU]JJ8K&K)4[E4-='8$X]_:"^B80D206H <HX"[[PA5T[$53<]
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M96OR'N2[U5>S4_8D!V5)M\MT/9JNA/Q7/ZAX:M74,8;1AK;/)X3^/^[L_,.
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M X7C&KKUH32Q\K--Q37PC7;R!LV2#$D+CZZDYY<?*-!^%W)K0O3K7Q&D,6.
MNY<E64]-+KW>L%6>9MB1Z^M1]^R8?;L:)!'GRXE'W\[#C86V.!HLOROD?&;Z
MY.K(/Q2P,3_&3_/;H6OL0)[:MF^#.B[VF91N@]Z.+ 4C-5E!W"83)0Z6?1/[
M-]R:5ET5,CMK==C^X6E3>3S[$(9[.;MR&^1Q'/H,UW=B,X()YF2O8\80% XS
MKF32+-BX=<"6(#5Q#E?H RHABOO,M)C(#3VJ8>%K*EPP@.P+;G71)1#Z+%K!
M2*P4]6L;5*5?[.V_OP:,=5^I>I4SE_%02&F\&E7%EN&-[#7R&$.M.4*X/O1&
M^ODA?]KP\?ME'^4F7Y@J1P:ZE[)LN6U3>SG8-9B2\Y-1O\ 8ST'-:Q>_;>C1
M#WSGR=Z;<<'//E7-J2:S$_K=]S=?ST@2J!G@S7+/?2!F&R3YR62O3P']@_;+
MS/[+#A9?YV-*QXT<)TE5!ANT8!;8[]#?K1LD\VK<:+E^T$F%?5\.STQ#2L-6
MEC9V-OKIV*C@9,C!L%INY/7KU;<7O3ZZ3WR95TOB[*XLQP_0/&MJX@[C4T,^
M!):)@Z_:":Z6L@S9MS#,F\ :(ECSK%NC[T-_+<W?II:IL-TI'/7UFAGNON/T
M(T;2P57?!_+76G^+:!W:'"_?L)5P81;RY. '*#&CAE48BOG_? Q65?NSH^UE
M;#=>>A;I_7-&-\H:N3&7],M]F=:3%V="H"= 6VID!%N<1<&WV8H[ 0]A C7I
MGZ>L9\=+BN4TL$:>_/V$*N#WHEH#6JY"+;OTG=O!KPNL;"HA@I--).<2=G/R
MUPOKK(*521L)-\V;PR0*\!Y3)@:LD4&8J)&.6@H*$I9L&IU]+EC3!'Y1F;SK
M#P]8@+CA1$_(YEF,,'KD.NPKNL:1_6JE)9T%@OYS!@K(4+8HM@TMC%+SX:K4
M#VG\CNGHU%9NR.H!'/_8ML.>;D#%48)AV,:0"HU0YYK<89_E4;X$^7GZ6W S
M#%!+9[_^E,RE<.\0W\ZQ"A9@K]"5@FPQ<"MO';@G?*>.#0:K&R;XC^PO_R74
M?=X();'E<Q9DMVND"4*_I2[CPO1DW8)-M!>Y%)QYI]D:.>VJU9;^1!;2KA6_
M%?^DSDPJ#^N&G.0CD15*>S[Y\#.^<X70+#/ B@Q-UQMFW)T(D:S--$\,4J?=
M&,^OWMB@W61$-,/DH5Y:!\-RFD(9?YTO/RZM _(>9M\\]YO@RI!B'\IS=0LX
M7P!_T/%Q>5.6>AN"F(/="+-ERGVG0Y?2T?0<V\$]K7-SO_#VKE?)(MU?E92J
M0:C;/"RAMPV:I1GQ@I;K)^X%XMO+VZ A7#]1EW@7"JA:)!-VLWW[C3P*_SKD
M2-;X_.V0?YOI0B):/?>W,R[DIV=Q]Y6KEDU7#287?_-V4?YW7GJ7<;O$UG&>
MB"894LTL]%AHLWF;RUZ]""O38"<YQ$MEF7-J"VY86B1+%'!D%O7?R5XU0"=H
MFOX+WFMZP%3^B%HU$DZ! <KS+6BP'\(7/I.7JG;^)=6KO)[432!'V EV8^C7
M$:D&X-8>DN@:<(^KZ7BE(NDL88S_KJSIU]LF_X.]-X^&^O__AD=B0LB^&U&I
M;"G[-E1(LD11MJF092S)&F/&+GLHBC()46)D7V?L*HGL6Q@C%,.,&&]F<4_?
M/^YS_3[?WW7?_USW[SKGOGY_/,^9<V;.G/=YO9_+X_%Z;G'VJQXT?IA-[2C*
M0S<3_J#FN7]KTR&F _==A?<S3J,ZI+<U2-*9I6$*-_(LO"42<K8VK8-M9>3>
M&F(>T6-P[H/"C"\%$F,T:/GL[1^_)B9.K7\6S']I,,O;)<A"\J<)LS+,V?.W
M4;]@]U$=QZ%+0[[0=54FGBOD[*(W,/F""C]RQ$6G=KPV?PWN63C+V7_:)M"%
M2#W&&,Q#KP^2=.8[\NJZ0S7?1>B/F''YP5[&3C!U[3ENH1JR=2UH<'\-PDAT
M"64>GM$!Z,E@]_S^;MT!:"@/VTQOQKGK>U *2:_>/BMVZO(]H5C1[#$SM-R$
M N0GUNTQC,_-B2D;ZBTS$1\_G#@CDBWC6\BAQPAB*:*:HSI,:4)4[;7 59V$
MM. /<,Y\[.?#R<6Q0R_3GTT@M,BP3MYI*C[]6>5 Z:\8QT^'<X5/R [Z] &2
MT>,OJ+;(3N0A>EE1PMK-VVIIWCRVUA^-^0W G-WIQH@ >1I_XJ)5G/_]C X#
MW>81M5WM3I<]MWTW3M 6%#BSTIX1!V&OI.G-\_R\4M??G\1>ZM; ;J5TZ*>C
M5#5\E8G939(JC)@AT1&7HVUK&E%Z0^E)296.'2H&M?!DUT!F_,TH]A303+5]
M>>Z\7N@ADP>Z;A.KI5WH1!V13AS'5%A$%^7ZU"V'U]9RUEQ/5)L^CN:!_I4H
MGD=]^DP:9+0IH[9575XQS_(ADY<Y,IW9A!ET6V<;!9R67[?",,8=&N+\:AUG
M(HR*C15M]H;9?K2N9'QIGI^$4>S&4>[,P._LI=/V5?/\U:\SA9$_+#U9?V8
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MB?YRV:5R(@?V&]9QI(?^'&N:JLXN9BBE^1=<&Z(^?\MMO__S4NK_"+'O136
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M-".Z6%&5:4'HA5"B%'Y0.*PGF-M(+3?BT9TFQ>&>5E\]58+8 .HB4I+,_HR
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MI,V.</1C":M\6W-1A_L-#5KW0/_*+#/-AY?I[B^B"7U$OI*P\RA>>FR7P^B
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MF/WQ=%=:C=1,PCI#:+M$D&7O)//)+@/S_M*80MH14BUNDB*LF%)F*K:UZ/:
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MI"YG$9QT/Q7_Y(GAG4AC!#>5224Z;%HABYM'ISSG^8.%OB.,Q!_G_.QP;S0
M).VK:?[,1XM%* "N"S-K+5 ^H[(U)58)W2O1_5B>.4]6\B8AI&(1EH"JJ\<<
MG28NE[Q;#6^/4>A_8=[H%&,(-5&G@\,4;!B3I/2TB$1;]9>6B([8K%AUX ()
MC/]61X4CQVQ^[X[;&'N@$/Z84J>GCU./<6P.XR*W^U7?_JK/2?G2P7\9NG 6
MO/V:2^T_:4$16L35E:[_ 1/521\ G>5 7P'GOH?NMC$M@9]VE]O>)X, A<6W
MV86H#BV<&_U>5\>NA682IHCCZ.ZMKXE:]P)6.2HU&1R:)-/+9&@TPHCLZ!*V
M\PKNW-18W=C0<EU6MGSI)<0E?*+A[V9RJ(>S(Z&APVN)1"S_+<YXKNEXN[#C
M";_F';K"UB4\.@-K@(",;F A8094^^]^E:)]&OF'CJKZM69FC$?ISJ<S(\8H
M2N0 Y.//!RC@%?G,PX<' Q1]9F22GB[%RP3 2M D*]141B^*A2:FOY*&,"_S
M%G^U'\_XDK/TV=^;A0$*O]\$!>15UE$5M!.)U\F[&=?S>_-:7EQ0YGK3N!>M
MOGOSWP\GOS(LVXS4D^\"%W_V-M>[[7[KBWNP@<?EN;E/)F<^ZVTI7C<I>?&<
M$ U+.@#5P;H'4Z#U*WU2@?B56!]EE=I(Z9_X#*N&!_S.:=VI5I $3]8=N<6<
M_ 7>Z7Y\0<V"I]YM+T6'Y$?^='10VMF%E6BT-VV3_@:UD-D Y64(SZXQP*-^
MP0/W>J;A^;HY$/7FF(=1/+!IK$GC$%(%V>-B4(UKJVLEU5=6BB'OW"3/R*4_
MHRI1A1C3!1!Z6>MQ[@];IAZ+,[=B?MRZX/8)!/ID4%H'8L+V;EC]YF.H.TY4
M.7Z1-1 :M_S4--#C@>AG[W#$>^3JCM#^(!E,&0.,\5!N3_N\MTWPLEMK*U]N
MR00]?2WC\=6)I+T)TT?^F"=91%Y8?%5W $K%2O[Z[+6X!QEHJHZ[X]*D5V^V
ML(@]"?R]0>P',&36/HW]T*1M+YIN89^,B'WU^?JQP3O<H,@DLBV#(P./3L4)
MJ*&DP^2N)X]TB<>:/@H45"XJ]],UI&"&(*R R6"[B\!($!<XR]S\2)QJ;:FB
MX<Y['#>"M92F2K+,Q+>IHK[74H-B4:%G0;/(NI&A?Z^;04-(]KS1FE@-P!5.
MX#XU9]Y"U# V*S)Z596:-;;/>R-X0+B_.UQ_.;>LO<%.,U--H).0:"(JQ_2:
M/9O *13QHS_)U#&_HT"Q*9,&???E#<?+)8<GO*P%+ /(8:_PDK=UI1V1K@%2
M8Q]6I;7OW?G2GKHC!-11@U =FL&;<=A33633KC8=9_..!L41_5I6L,6ON+4L
MWE.MN 45FB#KXF![+/W5J:)'Y:M/*KN'-Y WDQ(?!.2!Z,- 7;E7GDJ7E8#3
M[]UC,Y-I.L$AKV+>G=)H7VE2!^2HTIY]/;"ZS?@WW^^]\%T:=<X<0R[2^N2E
MV()A$@<@7]X45%UK#D.P.ODWM\[/1-I58G6GZ;I93^0>\[6,T1/]D8=7'X8-
M]@;$DPW>)M\;63)J[C[TZ,?L$T_632XMB[8/JJJSGY*+]Q=N_-O>W?^6_Y;_
M57+#7L1ZJG/$R5R23T7I1*J0Z6@>*"<9[X_5"A.P:HGP:KU9LE?V(.1'(:0
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M1\^^!HL:0R@>Q@*P8$6? +%S)M?T;L4?/WY0TQ U"AH7P19 J$OM A(.U%W
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MR,QZII_']:$ICNF)IU;C68)XKW#O3 V(_2+1:>T ?HH_W9F)I2M0,3V0REU
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MA;G'V"6'%L&6SG-T[;F"(EAIZ$<:1-Q'G-PJ?9#:TQ!D9..]"^C0:).-M*%
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M$'H0J9&$$@)I7SQSSLQYYYSOFIGWO69^S4[6CR2;S5[/<^][W6NMYZ%,4Y:
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M[L,;H2;*=^0PQ!!D8*;[XF9LG[Y*O11YY&;MT%=;@*3Y/PL9/$ !6CU;3K.
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M8-/;R6?K:^#<F<@D8F-L7N)D\*'92Y_8/AJ!T4NJ#'N7A@K>L_Q.^!DDF[#
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ME\<>O+7O=JN8U@UCO,7YQH!=]SZ/5/U\XO*+WUX)%"#.Y$_C_:;?,@4@L^-
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MJ;**8]GM*<(9%(^4>*DEA@>U'P^4C$>2U.].5?A\N3A?;-^XD_3S3(.E):]
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M0D)461Z'7Q4.IDW8 ^,M*0 OF?8UF6ERJCN:[]7GE.*4A:[\A$]-P;MS+A2
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MNDQM*49""&$4H%4[<&A&L&M,>^2*-%$'RVK^#'W69JZ:R8O'\*'-&E)'R<;
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MI;9@,9#JQ7CRF>FPK[(XZ MQ>_O-,=A@P(2SP#;8J?>W*<_ONX6Z 9:+'RB
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M>]&<$I^JSKE,*V@?0/V<(Y!/8%KNP9(S94<2RG[ ZRNG^4W1CB&O6 2AB:,
M)Q'U5.(>T:WL]ZOR+7,ZXX,ILY. 3>VVZ6\1 C?ZQ ZUZ=;]IK9'Q#=-!H>/
M,$5Q!SQNIK8E&&"+<>XS[P2''5C$V"N0R@SHEGF8,L"7%0]":U+!K^+[-GB
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MN7DN&-@XCM[KG,@M088E1[:]Z.?G&R[I#\V>%]0_-D7X;R0X@#40\OK1+YK
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MA*X>QP;W&V-I_7$B6$1SFO%2&Q@@Y^2572'U12I4PJAFNI_\T_:"2335YQ_
M_0$#A;NY[)SZ?:)O$G8K"-6W71AM/+?Z*^P1L5!F@B\JI"J?*(1M;3&8IR,J
MHD1P[]_(3FI,!\X9Z:5O6)L30@),SL[XM75SP2'G0TUFW:K1RNF@.H'Z>TF&
MJ?ZB\0*_2L**'B\9^ZR1;:^_S_J1]3]@^X_^9S#Q%0F^V_ "H5EJ?[WU]PS
M17#5^<N;!S],\N2L.3SFT^_+R1*D( CE&C/S<>.:X2J"S[SS%5^;]9]V:]1=
M+,WGO3;!&H,FA<-/.W^-+,Y<,-YK$Q])KY-UFO5-?[ X'YWL=S6CCK>-4U*3
M^3F'T%[FGO4IP#XH'31E&I/C3YNVS!92["-9H>KF>GM'_95%=^O(M>9"KML8
M9")Z]F&QES\+HN1K;/E5O9.BJWJ$8'-Y'\QT!Y#:Q7I$CC;@;DGV;VB=Q/BO
M.3R'RTGIV-K#G)U^9]8\!2EA\FVO@B,PVR'8:=1IV;^*<95,@5_Y!FG1_]Y
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MH\'4^+M[[++:M"6#-:'V.KI&U[XZ673__FU1'_$V(ZI0D>H3]#6>'=U/1^3
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M<'= 7['#[4<$>2UA4ON3TYKV^_DJJE9PU&6&0':L4(6CBZCGUV&<_W?_(/8
MHE_NXJYY'H^3X.OHS,%05D-K>G^VXWUT_Y8 !H%.Z/%EBI^[,?9UE2WTW1-
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M7.&J^TQ7HG5GN.B(EXCSBE6+0%KH0U"["#OU'+50YDBVD?'M0"<SA9M,?%W
M]N]\O/4_M?T(3^?F9$T@"R%,?%;/PR/N,RHV46)*(](WELU >63P+?10(F0
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M)/:TW*E+S&L!ES'.M:UDP=\OG"1[3F1#BDB&_@Q8"+.NBV4ZQ1A'BJ3R-NP
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M.\_[<5N\+QS(W2?FCCX-$;EFG179<):19=[]%R?QDU)?CH:J&I4I^FXHO[C
M&PC7RR-79MU&8Z>RJ&%K\B0T'[Q^!H!IJS![]XF?&W1FYKC:3G,J36W+)[]=
M#R2K(TNW/O!##^&W2ML#SVL 2TD]/*MG $UM&^K@A@,,% HY R*S(:)G0-@T
MJ$E:TJER/+L.B=R#)'&MQR830VHM01&2[$:6ZY( H]D\^H1% HIG4_[/E_Q_
M99P0A#;.N@,&5>1S9D<QX)\7._#052?;)>>M?Y:OBLR@@O'=JJ#A2*%<_GS[
MW!.L3K<.'9X"?)^?10FB]7&0CLV5B8^.)S'TY2[4;0ETV>*T.^<  4<].>8U
M'EY0"Q,_<8JY7EL,HA:VXSOCSVTR<0ZU?1KUW?JI.9[-)_8LB8RFM8ASR<.Z
M+8M*01O7A[&+QKBSPIFU0=0\@;NSP@$W\4EL5N9*\-=0Y6<:YETC=+F 3;(2
M3_[?7S67R/5R08! Y8;&FL/. &:+G+^_*<DFNP>? 6NZ RBL"17I$B4>R__U
M1RF'$'+03N])IN-C+MRL@^=ZW4 3WPMIYTOMIKW79 6.GP/T2A0RE^^\H 8N
MG5+\?4 +YE,5Y$^?TG('I"SHG;TNMN'W8*MAP&+TBKLO!W_(\KR@%&<09;#:
M-(.!#<5W=R35.@\C:)#%UD(/[W_*[+@Q_/5X2O>I6A)+,@VC1S#7\K/6H'B_
MD_T%2#Q5YUQ8"Q0G_>:S9I$958J$K.%;31/@:+HTZG>(Z6B+*,(1^Q4,R,6+
MZH3[27;X^AR_;#_"4L[4UY!'D2=_H^'(LM .,,>2O(F4+(@":R[<K2M-RU5J
MXAG3[39/Q?TL3TU8+. E\>\Y_?]-6KMS<80,O"JJ'.Z^" L7=BL7VG(QUAI5
M[/YDT=>;N!RVM,UY\;3'"!&8SW?X UFD;Q-[/38WD77QF>';,&6JHJN!,%Z8
M(P04O)Z,2S]ZWH25BE]PU7^$*VBVYXZK]'FY?)&#8?[GLUM;>^YMNISZ#IZ>
M#^8)?PI&EA+>>V<%02N;QH@"%>D/<=!H4535<D5=O,UH36^0\&+BRX1.JF0J
M2NI["9S: 0)Y>"K0\4\"#ZI=.1\OCRU(+[?W.<HOB'1E'86O_C"@RZ1"_IK1
MI<K ZX*0A?+H8:%,7N<>P\CG3^8360W(.V_W,G&M**RT,!(2%!E U*)]CV@\
MD1U',UWV#KO?R:<UU)67PP-O&?9GLQ?B$'>MCM\)Y13NOD!Q,-2$FB_<0B]8
M!A(5P?>8;?(SX$G32 OOAK7AKZLC!9$+88^%.QN?43.QFH_IO>CZ2;[?QD_1
MC;R-:A-",N&=< 9R1Q6E8*-.8]20_!V>5!_'RZH,%7HJ9G?Z?\35M5XVICL#
MZ W *V> BDXG!,\Q?@;L<?_9Z0;^A%']PS]0[+).,/1  J]$8H/8^#/@RMC<
M?P[F^GO_X'_TN,C;\%,B]3IVLQU=N]IA&724-A;%C\V*1,"D2GQ])7]5M,09
MQNL^JZBKO< NE8BU%EAQ\^4X"2%>_HA5(89E14#!.Q5GP)+<":IS[@M)AR,,
M3[5 G<70&6(%-%I!LD#QK;T][>!%SJNV]7I#5R+J7<R_?4V O(7/KX[?H)B'
M@)Z%;9"32TA>U'QWSQF0L'8&A-]",)P!.848*B*M"^HW?<L9\"%0$?C'/^+_
M?O/F[LE_U)B;72B7?O#:&=#>3\(++KCP3E&Z3>+MYM$J5 4ADTYO;U3KU;X[
M;U!ML1G?9:%/:AR>5(_;"([E,/ 0:ZQ"^*#(O(F&(#2]BTP<&GH2CR(/ZIGD
M0_<*X[S'?\;E"C.%O%5@'M@#%&G^D(PR$KR+$YQ'!R(L/X+)/0Q.IJ1Y'Q",
M-@2U-B5#KV5.RIKK2N8RY&3,,SVZD^0WYOK/:(W&'K=)P>@0% OE%QR3IG4*
MUB[9UKQU%IX2?(A39NJ,6394MBH24Z*0;>46S,Z&!,(6>K,H86N.8- 9$,(%
M):KD_@/)3XE1 $CQ#]W_<&<Y>NT_9,#RU#-@/A.-U=$)MZQ.;7OOWC4K,MKT
MN-#)2)$W_4&<,-O&Y(V'FJZN-ZSX:Q-V9L0]+W!0Q.41^\?BB7UGP!_F1=G,
M 1L\C-BXG$].<JY'A==+^!M&!K5NO\5$7<WN8;%V&S<.IOZF< !0K/Q/R[D;
M.[$DEG('[RYL/^ BR'>C&+9%%F0UK4=</.^JXWWW(#GS8[-_:DC4!K=0KO/<
M)C0J\N.IZD<EHW5H0?>.0:>4M.J25DF!MXN?K;C3V"+*W);7&6"W7K;-;+!G
M8=4@P2>A([72%J)@N(>'.'N2B:3@=3OKD>0CN1/[#LO_I"$$21JB<C&T(.>3
M)J:?R3$RWWSBAX1:UU7#&MW![ @9%U/U;PGQ[^J6K/_GUA#+9\#D,)%Z$[LY
M#^MVGSAM-SU?C8G^(8VABJ!_6ZSUT=Q,8:!31.C##)F6%\V4F\UR2$SH8C!D
MBP _ [K[)U#M:!X%?VQ?5P,QYY/)AB7D4+QXW<.Q\G["CYLIL^:5X9%](IL.
MH%[XN?HE!K)]*KRL_GPX@0[& ,-:6Y\!7[U0'6\5+Z &AG$49\!Y*1@^W!(U
MJ 0%_J%;_>]W>A\36,BP_]T&3)JK,<8SG2Y8;NV>2H$=&$BXY!G 8;%I*E-Y
MJG I?_E/_:U990IW@QHU&9,G,;>7Z'.CMA5)&+#M*A&"> @*ST/9-S+Y<9V7
M4M#93_Z$75N:?+HI=(3KW0@JY?@_ J];COZHXOO_HHJ;U/_+JEBZA1N\WK.0
M%:@@N4 G8A9Y,$/QL&:HU+;1UC'SQM4GB1G%14*&),_.7H8B'T"H_,^% ?X]
MXZZ< 7BF>)(IH25*$7\I,@PMUV5I#TAN:M\:-:LQ>H<)7M6+Y.PM#NXRL D\
M_S)0SGC]'(F?VRS_\#,YDI?DP84%H3Z9;Z 8O*\4.R4ZZ=_'=MQ(P9A_IHRD
M*=M\)V/W,K )JWE$\U\9&H.6.@-<LJ;\,>'1Q&M@R!$29%Z@,P +.)$=19LU
MO?QU-+T7?0'$9Q$."H48J6"/SX$'9$?L@6> <_]K%'/+S0U+>L0=S,&O)NN"
MYN\^<HA7[!K%SP*2,'81]UNEO3TACQ,MNBS#85B-OIM5<U/J6ZDWEZ?-UAI>
MZUU7GNS594QL6WI5/NWTKP.F!$N*7$J7Z^K>\M:&TB9I"9XST!5[DMP*O$S6
M&UM%X=F<%XURY^-#6MBP;&]]KN6"#3N.HI/,P4<I;=01F;U[6IS'C(D#"4J*
M@>@S(#@&^?.2>\3/2-$N;>%=%9=]U^TRN^I^V-Y>(H='CSF(WURCH^B\9!]5
M929LK3KBZNUZ_>A:VN1)KVT:9^Y=3FY-6DB1Y.]ZK#J1VAG;CZ':<L_9&!NM
MU<8)=*:1;[*E[<T^*'$6POG6X"(H?KMRT'&X]M7AQV]I] B2C(8>.%6D60+V
M+Z@>CB2O;SH2T 6J?$S"$S8:9:PO!^ZDL$W*EV2N!,*,'?X>X9,!1N*8.]#4
M>/9BL+(K+<]/.KRJKFFS<>)QAEI>*(?!N;^2E&BRDS0 /;P:KCJKPS*\10"'
MS*$]EN*!#NU4.T>X!HI]N\PH45;$$53WFM<F*!.#9D&Y0":3%R';[^8#=#I3
MD,PMV+$V"&2Z^\E-PO=AB> ;DXY_W4A3^@[SX;@B;1-R7$1QI#)?V%-.CAQ4
M9&W 03MF?(A,=&RCAU6_RY ]=VLF?O$E)KL,YEX6JL@(BD\O4^[)-EXE<3NC
M/E';OLOR2'8&M4X7BPS\^^'2F%51E[$_64*S^+82CRL.=?0&?(YEDNF/;W+.
M!U\Y6HOUV$N$:7UDL%]YPD?'1QLLQK+?]1)&@W+M#YKCDOQZX$Z%OS_L36=A
MO[?PN2'*F7/5Q=Y%\T7B.WKQ8[(UYWET& JK#8V<8T<Y"=MWH:NTP]\O-"N7
M5<LWQLJ;:"J.>32S<>D:XL<Q%WK<@,F$U[WX#TV;1)KPTVL(>4)*-23\Y SH
MN-^ '4EKG%:_GB*:G\'7MBPV?7]/_D'IN]M(*_%*+M^O5-N&K$OH+_:QWJ@(
M=*5.AR63\W[U;'61PZNAF>FZ#IWKK;2Q.^/3'MUF48?%_YJT%#T\BMBY#AWZ
M:>=9H;$_]4?7!AB^6#H97Z15CFPO6^$3T@'H=9SFRB-1[N7C/ABJ[0!,/ZUV
M'GQ.:Q OFMO*?,IS(ANTGZFR^O2\4EMZ'V-Q\'FI3+5%)9Z<!1WPAOO6]J(.
MHTAX >+Q\/GL_N7"J=(=EQR[GX!)822?[-W;TT?E'U3. R$)?I?PX23Y2$!V
MP\A1=EE!<N>.7[^>A,7QG' ]R<W22UEQ-1*.7?F*DV<(>L'1Y%1,?3'^+V.2
MIL-JO??OG.4EQ")XB=?WY[:^3)NL)S^U]TJYTS+ND7AL3!M-[!4& FS_?J+X
MM+\S/M*"$U29;];J:KG]:V$ ?[>0US]]HN/VT\^&9 9L=D)_6/H14)9&8M7Y
M0LMJV^-MSL5FG38>&D=W)!1^(?W]@XUI._GT'#$SR0X>''\R_PUURJ_?J6GS
M .07/",A5Y$'.3BIF%N,D,=!\/Q2<EZ8R0W+BJ=FOIZLT^S,:J^Q+Q,NE&N6
M_T"#5T7Q2= (]!%W]!F@.8K6_'L\K4L2_YVJ)+$\IXOB=UH!;_X!JI^SBG^R
M18G]<[0(VQ*X<2>:@5UGK.KCC^KEXG7V_8@\;F/$"S&FNY&K43D+<^!-Z:U%
M3#^#HQ_/6QS[MFE!H3?KVSSHN%^2;[+& J./9-WCE&=B&A0*:?@LD *[WVI9
MO;JMC8,:@.\P[Q2X%B[F?H3'!1B*9E=<Y*^-_"(NW"XF@EB1X>._<B!Y7-B6
M]<>3VEKVP= Q=[=0@F\QHFRQS(^#3SBK"/[:S=7B*C>\C1U<&]P>,G#P-$4!
MA/-_CQ;^!.4"3SM0= AYCW)XN?DP7C[7+.$?F7"VO L])= UB=[^DTU,.=3"
MT%7<I,@\5/T7'D;YXC8Y4]TI I0]KVMDR,G-I[R9 !F<^X,KE,\ ^RQN>-)=
M*@WP?4%-(?^'"T-[LRL_92]GG#.QB^2STJ&@?9GX)YNPO \59XE]9!D$92P]
MB+^(H,+UO/;2B6"3MA)^]/.TB\Y?N).+0]9!Y>OF[1=_T135"6=X6"*1/TBN
MH"&V<+X\3(%O$<;0@7GOHUXK55[<7D99<5Y15[[^FKZ3S=XKFST'BN%_=Z3H
M5Z0,<C2+!F9'T-+Z#$9CRD%UMT.93'^-,Z"R;*>I4X\U[EED:QM?F>!8R9]K
MOZ%H8(YT6EIH,'K!$M0H._B:>5$35N6VC:BRX@SC?4OVC:+,@8)Y071[$ M;
MS(HM1?#-QW.A7,&P#=EK4?VGUT_F/+OS,W93*)5#*?>0;[=-7X44.!RS5XX[
MCJ;HS_:MFFNYDW</?R,<\]JF3R^-1>&O$4*)5'A:7'5Y=!/C?-:6#L-D#_]C
M"Y2SY5-7$Y:2V*2?:YYY<>I#S233PHR:3R&A$]2E'H*OT]S)'>>C7O0_Z?O7
MA[1X$GH)7NB1P=6VAULA>R<#3K+[N3H_[RRNZ>^5C]& ^D2:B5.IS2PN1=HU
M"P%L3994:1DHM>*85U%+.]1G*U>4T1U%?VP4Q=9SK)+83TFQ$3\QJF4"LY\+
M$[7B8]->"!!J6Q89V2-^8YO)_=Q]QS(1BE5[H;/M^''>GH>MJ9]P!M24[2_H
MX%D+'X(^I]>>P.EU:#=2H0P' 9?7)FWW?-4?3498UZ:HB?D&?G#II;P2]:*7
M:_D@"^33V5HL ;4T<*)=I2B=5)U+R\6.:5=_AO(X:V-,"H']BIFK-/Z_77PI
M+P$$R;^)!'E-8<'$IJGK;%:1J3+JN0_SU+3IC-H750FW?'-N#H9>9=[@V\I=
M"-+*G'M463N,?HYBGYQ4YBZMDK[DI$Y[@Y%1=8GWW.-6B@'C<<D] 3RK,_%A
M>#?Z\+ 0M>XB0;9JB575^2V9Q8H:7_4^ _*D)$_(++-(RO0?>O\6QF$8H*);
M._1)Q-UM^8FP\ ?'@K<-5V]<^^L4H -\Y[:I3U7@L"-[\*7O(H1C]K?4('%G
MJ/LR5_KZUVO/0S4YK>-T5($D)<JQ)<LP!!_.C$C3<ZKR#2-LRS_01%'P0'@Y
MDTF[+-'Q_9Q=X&?"=E](TOC29SN:( -XUK;JJ9X%<A@-O8YSC\QM:<&ZOI]+
M+H CN7)<!M87>G8&CV0T;1ZG)CLC>G(,=17KL0)X-JV.,X 6(5  VK?/56[7
M1.8X#EYP_52*>%S-X"- N"C4N90B*Z3)G_12"?J)AQ,[FSX_1[?N1Q_OR!V7
MG#_99>OHS-#>1>O$R.)_#C!Z[XO>6L5%$]E)ZD2'!J],_$IL(T[7^I*$L&7X
M*(O/I>RO?:GKN_59#7)C>7]#&*R__U2#OH=3WZ; JF/4$A?[J>"5%C6@[>T:
M1^&#WS/"GW;YO+\;DRM 1<PC?&6LAD11?U&$$II0\^];;F)CQ^*1L'6BR&><
M)G$R_6DSEK"2<H7M*%[65G=%S01??8/31-^SA$>':JL<%-#9UH,Y[@8G2<[&
M/\_>;.%\)]'8*'P+>JN_=YP60NLKSU(D6"ESCO[V!8I%G4EG(DU7-MZ#\%X2
M0@[:MYFV9)'<>;/\N+RQ'\R3IB4,-FQ;,19V,I.-20IN_?RN,&W2N]\@J5(H
M(X(:Y"QVFA7ZDJ4YBC>!I^9JU=]+-C-3"[7:9]DKFWH?E:ED2T7%"P34_CW=
MJF,.:U ^N8,*A-%@L)9A;GFUN-KHG"3)^M"HNZ'Q,RFVSX?48%<9@Q5?4;)R
M_M8RP+JW6P;#L _G>-9>01GPG!AH5,LM<[%]_>JAPRGYDL]&Q(G1(8DX-;LG
MNK(N-F[[7 5WCF#;M22PBSL#PKIQW4$845#G#%A@(/8.QX9/H"M:IE96C)*1
MNU7JM;O6''?EQCK0U>PDEXC(63FO$]G"=P:TDQRMU]&G[%MS."'2+_^M%I_W
MWBS03>3(J<?*SFFAO$>W)W WFGBA \?7;L&)%8A!P#[!"U6'O G&%J\=3\R/
M<FBEC5^W%RL4O0O1[(?>4!C;N(N\@6HCC68# Y]FBE2!)6< M?V1.OX*#V\M
M:BMK:PZVW6B@2:S]82E:IKCH-[8=\*^/#()P%"HC"MKS,":'$^TE4^3'(L=:
MJ934Y!SX?)K&.R8U7>4K3X*5%#"UFV_ \FSGV9N@,\95L'VR,Q.*$_[U^F.!
MDT<&E__[O,Z>D+T="@6OZX$P*203B:!,B^;Z^JA(HH)CU?(5%RML'%^:<IR%
M<5UD\#,LJ^$7V6DYXY]SEYNH,"CPVNZV2<XLR-Z9FA;V5K+)]'WM),>5YBHQ
M,2U[KV*INFL<;C1WZDU>?>8XL)Q $VFNX"!'1N#;10@M<F  [.C$J%QV=?>^
MG7+\,/-NQ[&F8+&$IR"YQ@OZ3MNO_)E:&+MFC YX:VS;-4]U@8[\6 U;]MZ9
M+B:57<;ZN=4UGY05SWK5Q.@Z \I5IZ(_W_[=KHDM;BMS.))[^]':U9?\Z?TG
MS[:]:<7D7S@M&PU[@1+OI4:[)Q0:G9^D<"2@:(H R%?#M']M6']/X6I#\"J+
M<U,=7;/,0]Z:7@'^3W$KN7GO[\D^^ MQ.F'U+E*/VCSN] WTG:?L3\$3_O+N
M>/"&?=L<!_([JGHFO@<-62\X[9!NJ"ZHINO-N3TUIZ;;YRY[N2@QX;."C8;2
M-WTE>D(M>C[-3V"K$HOLP<""%$S*+)\Z&J?@-C0_-BF_:735W)[DOQ=J,R[U
MOF?EYVYJ5A-Z/OT,J&*K.%5%?F]PJ\#(%Z!Q//'^4I%%%F+;TA"FW+SP7S%Z
M777'KCV3+8R$*M1\OI_HMC'6HF>A/ C/73;IE/9KN=*)G,"'^")C$SQA9>>H
MI55)>P^:RJ7IID@2BF /8G]#^=;ZJ9BCJ72$:VQ\I&1TO7?S@^\5UN[\Q1&)
M&0>V43="R%I=.S+S*#;^[=F#_[K)D, 3!/28=PTXG*/#P["UX8>UQD8C5<UL
MDY/+(1EU8E?/7XFW\"V;_2>9_:$CBA1XB5]-]Q64 ["[[:D-1]MSDZF7KE6E
MFJQF211L[?D?2TX7O]8M)B_B .C/"?^3W%A8M (T&]Q7R5+%2446@-'J&25:
MA1NCB3-F7PU#;CHLG7O$02XFPWMI_$.@+$E7X.]BRSO,1<S%VWDX!_&"!3_N
MU"?UW_\<]9/]3?''A#RG[ H#Y4;.]J!Q8^6_/<G0__2BJU$WIO=HDJM/_J])
MSNT=!@7/[M8P-?V.FY3!$,I+%:J KS%>#-4&.>%#04@F-K7B#%@T0'4(_-F7
M_""-/0-(NL ?2I2T*%$%[,"7'7+J(0=FYEQ*0Y^\M*\./C!;/W%M,)MJSTNZ
MIQ9X*R8)SJU9>NMO89L?ZFO"]F8U1*YJSB<^4/"\86NKP*"\<<N4M)C8XU94
M&))QE 1BO$3#D<R#WK%=) Z3(#!-7HSM7,JZPR#U\N=+\U__).C2Q.(&-C-R
M,?;\YGT<3VPA&*+:,'44*V]0K97N6_/9>XXKN#3,\'EBFZY?U"_20I93(L2Q
MJ YY^70=*E#_/C:_]'NPR?S P9K+D#$%V3LK0UJ/;FVOJG_VR9Q8)!M<%//@
M7J8(-BP$\R8\8LQTF+>)>FYYG[4"-(H/Q9.H"=6,U\*N1!8Z7+)!>?9I5<5-
MLIY<!:B630_^<>:&AW2*8T9?TGZ>D,BB^2:OYI@Q/$[UKLK-^7AKHS]QT^TH
M2B(W"#%*-<#V!S;=69AY]/1W:L.C>'=G\579ONZ@>/VYYE=O_GNG"_POV)!.
M)*.C!W,^ Z*S*K.Z="XXG $0!;,SX,+1>]2'],:_4)6N(CY]JU_3:[69$_>*
M."CI!0^*T9=1\S5S>T\5R,X JTW4^L,JLK$G&W-8?3HMS=J1;?/"+W6A;E>]
MXCM,O&QI\T2D/2\L<N:!*B38I0OF8W,Q54@J0JZ"1,W1!P]W?T2#[Y<1"<+<
M*[L(1%+7 #Z*6L]$"UMZXHOM)VKVA**V6$FS^V"$ECX#YFM;S@V;*8/VBRRA
M?+]&-U8U4PP?-S@\$"KB.+S":=-#\'8""$K5#6$GHUSICGK^OHDV<4_&Q1H2
M$UKCLD/TQKI07Z1[S.T[T%AM* 0^(Z&UR^:<"1TJ<Q&6>"\WJ9G?X""25U,=
M(_0\W>'QA5<4RX:ONL\A0K%]'>B:\C\HAIHJZF WLI9XH7+8W>+[I';QS)J'
M;Z.1"JWNE)KF>%F(5\:>HA4)P'Z1,%ZRW!(\M4(X8..W#9VQ6IB41E^,EE;T
MU/M+R]Z1BH/>SWUI-,,T?_M2*#Q_M/),Q8UGZ\]N)$(#K#T5)8[YB49ZZ?"
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MD1&OB :O^)HZ!R@>.4?;5=C]7 [;H?O)G''N9H)<I1$L'#:?A&)IN0YOZ#,
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MQJ*3S4)Z3 O#&5WUIK9>.3Q@RH\C\EL\VGWT:Y]]F_E4<F/N@BL"AJ%&Z)>
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M^4P244JWK,WK%I_?W>P\ UP_>N^&F;IOM07@Y+N.D%?00TC^24LG4SS;Q>=
MK6:*]JRN%0N_->7J^[P!<KPG>!=+DJ L;&;_D<^P1+IH= ,L2CAT6A'R]LFD
MHW.=A51^150>G*8^==7J0>S$<TMK</_(%[3&:9EJ6W?SD&&/(ZL-0EU']PV&
M/V0^OI1T[_RS1P,F<7=_(').48A+H#EV?S[S(RZYS<.12 4FV_NZHS[ XSN&
M?)DWV/6?7O$2Y"2?__II2Y/VQ47HF]N*BZ=/$*8C1#9DMZ(8+K3-%=8)':<F
MWS(O/;<\H,%2G!G*G_Z*WJ,V\PW9_M@6&BO?"B/9>2=W)H09MC_$2X<>+XV]
M-KQFP1:N^27NPJ'V/=CA2<C;QRNW=CKM$WL3PU2R!ISVXB>,%YY"SZ'L461P
MQ1LILI^\ZM)VGRWLY/&X;(.].\Z_UO[#"S 6B0J5'@IJEKK-1VV,VMX4$N?U
M\E9@M55@"*#3405\6^)/91$26&)=0W-\2-6X^V!GQ#+GJ!0W32Y3L7H1>?/5
M?SF,(WDQ=%E1"-C'M888.U>87G7*SQ5)J_P/B30RE)YBU$M&L [1L$FJMC.
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M",*ZTCZ.>FM+R?_^9;'4Q]*8^^PTUWQ [57.Q;W%RVF_P(I3<;P\.+/ #>E
MWAY(UQL^D([3OK/8F#;KKZ9*0Z/%)4@8(%NE @Z!>#W2M(<[H)7E00CHXK9
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M YR:=/BST._F.0.B=".4/05B'-Z?]XBQ<N&F[29V0\(P64N-%JW]X\DL\9B
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M>OK@]J6YQLQ(^W;[05C3 8A9@M\N^8U'[^4%;!- ?[,&8,VB67KV-(\!:79
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MA0U08PM]GPZ<-)@G4G1#7H6_S<UM8'^8RIP]U)UJ!(:5$ @Y !VIP)2B/0Y
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M7^"2N,1ER2O7%964;ZBH:OVAK:.KIV]PW\S<PM+*VL;ID;.+JYN[A]\S_X#
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M++;/+61L(FV)[6SG.[O*V+W9F?UHN%_G!'@.0#1);5R1&N_\[=MY?_G9UO@
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MX+30+[CP8<*QK#8*5L$P^BYCW$TT=(MGMEP'@PHBS;<V$,@@T!+RY#PO"*^
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M?P>L:8[O+\##-#4J2=GJ4G!0ZSR/.T1 !G;!J"@H=5$:!\+K^CSC3326OX&
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MWT-[M4O\^2*ZA %BS=Y\OE-BDZ,N2Z2_I]HMC:VCF5'"J>A5L@C^&WZO65,
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MM)E=M5._JW+M.)8W/$[MC$GK^]S$C%?I 7-J-JOKP]4KK IA"C]:\I!OI"F
MAT^,DLA%;$/(Q]67.Y6S6NT"%LG^9_*C?&1^7[.?;WF\E:B4<]["_,.W2WR/
M6*,)WI7O[81S0_C4 T @H[$VPW3)&9>JX[Q?.,0,F&PD1R4Y4O1T%/EU"-$
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M -G&UK;S.%]@'>6T/4(>M]2(.;<RS;Q7@V3Q'N(^/>@A87KL<H[=LT/ 36Y
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MZ96$QY 9V:C6A\1DY2'N0193EFNFIMR <P%G]L217^[N&\PE4@RJNM$3+Z@
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MGRU^3+"6&>UN2N0=W+&B1U2G%2^0?G$\?$"J/?U4&5 E'""QW!T,P:53 8U
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MT=0?#<H19XB.7]'!X(LX1#[6SU+F^U@(RN/)I_&F%X_[)^3&([_><5TK)[O
M*K+83 ?2BFW+#;XH++K]-LOSS&;0-[6&.=Y&AK%4@%EMU,]!2-B-#I"6P'WB
MF3G*1;C-9YS[G'Y_AI-SLUM:C,/^H5.$KW.;T8&.Z,C+1Z*AZE*YWF4F1LQP
M+;Q9$M(GM>F3U"[B%KU*TY-2*H".W_6'X]C5W<7$MJ"WOP8<U<&<?2BSR2R0
M^?0/V#(TJ65*CM K/^[]D$=="5L4'V?VE3O1>/H9)!95R#1;@Z$C"?6H'\N$
MW3^[F--TD!P\W'E9M$1-[.CEJJ&G(E[KN&S;,6&7@H!P;KIKZP"! OV[Z8E1
M;Z:!2=ILIGC6_02UNB2"6<?.#LV%?-%PJZ1-]/-KZ*/YZ?8AKU<TQ6?8@UQK
MG*:INF);DC8A,LO[9!?WGH.(3KV>&0N[UDXYTU+_5K$=7(@0F4FHT2[OVST4
M@76J_N1(LWV3A[V>*D@*ZT]\5%49FB!I!5HK"%5=*NL[VD4FYG[LU>+XL/I_
M;_ Q%;#0B[X?>#'6K]"E^*M"=E-C6\3C!"&AL5=/W>L&/9_"U:B &"Z::4>;
M4$Q[AV1"2:)VV 23LO2]S/ND\I#933UCKM'[[U3-!DVJ>MJ /(T13Q0*]&CG
MONO^Y_UP&.9:)V?<TO?JW+?2Y9/WS*OZYU@U$L/MA\W=%E[-*B<E011=U.@M
M.=CI#F.PW9QPD5I"/A[2#&6&V'6_ :O'-5<W.E9[%A<23EI\*/YX10<T\A/L
M>6I,4;SCW<^U5(X6_TFB^A3AWAV":7;W#)K!RINQJ5AX]NP9*D"/\BOQ).MG
M-R<J(/3ET\"M&HVU)5T[0BF^<,ZNI5@%K(%L+"C#598)IN02GK7I??F:4/3K
MM+!7U,[9EJ>2(ZMTD6W/@7D45@+R 0X3^+Q\ ]D:![\V*.3#E+R[WS->._--
M//OBX<F>ZWB:U.XY]I!DC3-=:NZ8#HTAQ+91V&!J[C4I-[TNNR[(A9S[&,#_
M^)5G7$3$;(TX(:5YNO0G_ FY$BSLG=0&YOJ*/#%ES^NVG'Z^LI;YD84C\WNC
M#\["+RZ%W1R;F*&/<E-&WR? <,#9W"80K\,ME*!'-!<<4G%"Y'>4I#S<K_"0
MR^8$33.&;;Q[UP+\5;L!+J?;/?MON[>0^$(*)XITL1*#R\-@:83S.FXC?S^:
M8(@8W(=\.71[,;KOC.J<7K"!2$^2\582?W>KG?F.WT<JH!UXFS92[&F-+#34
M1"I5 TD!NUM'^]%4@";''@\0+[IL<\\6FID'N_-#H?8)2W:$+E.IC/DM08@Z
MOU>+DM8K79L4V7)F^44QBX(()OR(G;IYG_\SY,,C3)EGQ6&U+R_9"F)VU%9N
MOE@E8XE&W@ZJV#JD6X7L;8A27L&.KJ,7#ZQHD"A( W6K/N2R".:3^&$MD?!N
M5RZW= 'Z%[8MH0+^*8_HK94(7_YA-R_R7Q.$XCV*&0WQ(NG[JI4H6,']=DT_
MV BG_4A03,)CS4+.1!>'_5*+A]\%*LK%696?7'L3=A( < 'L<BAPC"%@OS8Z
M_)DVC"@WP*=IGJ2["7GD6X;NXR5-T;SHO/P,BLA/HD%K;J$J^0(:PH+/VINB
M]88+BC!-B6-K13ZG @ZO8L*I@'T)1]#1A36\.,;I#XWU21?&<COV(/J-3N=I
M+GGM',U)_&&3WVST7R/H!/XE\LJ1T ]:%S+3S"TNZLZ_57V?<R:(VT6JZ\P@
M Q$L-;CN-Q713%./O"L9'4K*#:_#+G]Z,P)5B?C!)L$A^6;\943>+OK7- $*
MXH L%Y*N40&-5<94P-S>D3P5<,*-"HBEGXDF\M/T9+]G!C1A</^!PAD%E^T$
M79&M0=%>;A,GC7-A!W/FS1]J];(G?^#EVUBM-,\VWG"CB&$<K,UDMTQ>*BZ<
MK7"C VP\6CI6@<'"X2940"8:3T\%G)G4H0*BAU&&=B\O#9C_@+GL*WZ?2U^Q
MMF&_/:Y8J,QGDMZ07&:5S<NM&IN7=:K>W"ZS7RLW1NY>F.'D(V(_Y700/KRM
M7I+\46$:Z!W:6G\!+QTM$R+MW%GRK< (P>I=LL&J=$->-GKA:SSSIY,32O05
MKD=(:"P(IV]$PS4HI;F#IBFD^POWZNN5Y%\[S"YQ2T@I[FKW$(QB(,^W#B51
MC)!UNED06:QWK:E6"RNFKB<,5* 4VEH?I\MU9+,XV7WPZDKW[;U-2*47*=$H
M&+4/P ,I\?9["Z97P?3X+K'XC _?M$9'^;D)2I^D/PXWF>%!X[P7Z%*(;DN>
M#08GNB@?A&>K9<X1'@+/,@:>W<_U6W+JWH\D55FXHFKJHJ9JYTH8LIV,+;:S
M2[?+FDWSOMF)]*YB2J-IUPI#[@-P!Y1X&,?>Y!^1=3C)?,YN\P.(%&[O^]\
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MJ]O:?-)#_PDU^=.Q(DAF'?WK0J YJ$ABXLBVXX-?V.QN_6-RW3R#MA8%%)_
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M&ZZKG_T@:^EC6]'2FDKG-[W2(6HV,[=(2$OP7M/=9ET< ]]GD ='*40B'.B
MT/U2<45OU'?OM$%?:HIHJUGUM4LYGM;EQ+F,W.C#BUK,8QG"<H>%(X-VB*<W
M4KM&U$RN^1\.O1P8<"3-WM/76\5J8K)SJ%<M_-CK'/EV(N"0\_."TB6!3(G!
MC>K/5TYX/@AD21[C1AG$C)2<VP^YINZRS-IFR\P(0:_]V*VH!>H^B1#T!SRM
MSJ[ T3SU<YN,6<+T+&'4@K>X<P'/,9<TG@"R0VT(4[!X((478LA@QT[L5-7;
M!+W4V-!G(@%B3RS3W*JF#'1W#<4:/EP0,7[W<P;>\NG8+>CV\\\W6Q[\D;/C
M.PC;IAR-V6< @:W) VMHY\:>I#B(8;&(VPR?=)*KJ>"@?FBZX&<ZL]@R]133
MKOE4@0YXK4;^K&-<67MI"R+9?OL#2_ )WZ+'TL%^W1)BO_1-2P0[;'Y"['[
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MN=9-JB":U$7.I55_Z&^RIE;0?^N?%A&V'.3U_Y>6R0>=7W[3OV$_Y[>7=[6
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ML?QT*3*R(YMMCN;0*:EGK)QZ8TBE0"(PQA_6#LKJKF]97O6U!V0.,+E3QS[
MA] ECU@5G2=7)?D1&0:>CV"RTP[QOIE5N<TF2]$JWP&6.$#FR,$&<$6NNS:M
MT/O(M:?!S1[.O[K-SN._;701)+ X3W=]]VMV!(^Z88Y;P\8<9L*YY10^DGYR
MEZ>,\H;C^,^PLV:V3LUCY5Z*>-MZGL$9P8&WL=LB0&'N6T!\)8=O9!]HOHWF
MI#N0T5VP9;,0TK3[A#Y/Q%)U(+[_1B-\Y\GX0.D'7Y.5BP\"#L=>%8,-^ST]
MN@]0?1@O]&!S)EV&<;,#Q%KIM?![^=VQPMB/"\'-\CEP>=&,G"BL"?_-CO@>
M.H2F=9!\!V:#=>&3IK8O$%8MTX5(#I^A"+7T,)V1CP[&^*$"Y_,W[A%\A5!,
M#>(L!MJ%?+</9.""'$2NX+H?3(,E$4[D$JMR*-B,7"-?3QG./"$0=^;*A8NG
M_1H2CX7CHDYAU\B0^%TY%$%HC*Y+?**Y:#G:,&,NVN0RD)AI]<W&Z%C607)J
M QIE64*RKD&.8%0J:8%=QE[8S&?!;U,T0JN+N"2S)_+";:7_)K$VU7.J3P^]
M#KE3T)1=M;!(&&RB1M69_AAD".I?&NR; >S"6[_V9@,T:&^3+-\D)OCI.E8-
MY^_I);IQ,<VD)?VQI:CB?*H?GO)#E@.ZNB,#WR!][5V<8R5%=XV@]@%!O7T@
M*8\.>?>VD#"U897V)RS\[D/$CH[+ SG-!<N9?2!*(CYL"%U@S9D9.XJ6*:+&
M-9(7,Q"NQ.L4SLUXT6;]ZNUG95<6-,N&%>%*&$P2M[%GQ1CL,BM<M8+>(]#.
M2MS9O(06TC.1XT6<FVC82?7A11B9E=:2=_KX/_<IOSR6?C)J?%LG4WIJ3^1R
M_O=W[PI8D])\9J!$#(Z_P40NO=B_*5::7)3U!E9-#R13-%R^6N,F?!]M92X\
M57<!Y0^$?S,\S@E38H^=']>;MQ.S:QS?W7,+#=7P==/8"EL6Z!,. 2X[2Y^(
M.X@6/8#%LS4/&.KV73,5J_&MVT\TA_51<[V][*C#2JPL L+LSC)QXJ\G_@%.
M(OJ6L[.+1WI').'+1+Y.V^DF"D=JE=$$!BF>%@:QF(C.5AY\S;K:EOA()D=.
M-2OC(]&LS8W92^M<@@FNS1FF@;)X*EH_U>C#CBS*M[Q]S)'EF*>YHQDT;V9Y
M.<L"@:Z)'3!&=OZ +?O,NFSCY21HQSBR:^'>)I/%B]W:BJF@1DP7HNCAS6]?
M.=59.N8NLU;3('M103DTSQYCUUYJ,PU*4>H@PRA'2Z*B^B+%.SQ?:W\H *D_
M-/\<;1S_7J?P9RU;3<&>#0)";D[#A)%G&X*?89G38WHX02OAZ:@D&>Q0^.F1
M B7EZ>.3/&%&O?9>S_%H%N:8(_T4[>6R5K)@,%-M_*KMAIK9'3[-[ST/!16?
ML'0E^K4[]WV<N2J2*K)U^[]<($M,8LN/]]%&.#+>Z_DDMR;?IU^\'@@EU288
MO_D1W%J;K6<RTJB9CP!QB1>".']=D<;:1_/>OJC21(L@5663'"3AZ7A*UXO@
M/Z69-YNZO[EDALE03E:\F<J8^3')EB9>NP *1%V*E:"\"YIS[>5+ \O3N,H&
M*#Q=494:L:ITDX3^@4HHAQ?)75WZ$(IZDBM/7\Y@6V>^![CGOF<'S^YL[>N8
M56]$ITR#>3YAO([5//*K@<>>T9B<?9][UB)4Y,J'507Y!VR)ZK. D =6C%'(
ME("?<R6#7SZ'^WX.D>496[0:W5:)*JB^ZLNE=,LHWP0;\8-/FQSKYWUM[Q2S
M*U:$!B&E(%PU*VO@"3PB$<0C/-WA$F+XJ!_QH-'NI$<(TI?X_)I)YY6$H9\:
M!\'*.=+NTL"Y\9K((Y;;/#P\;G/NVS65;J14X$- @+PJZTM31_97%/0<A)I2
M3SM^_5E0<43P+QP_W3U:] GQB9S3DZ<)WZ)+Q=TK'AR?R_W]K?O>:N_D!WT?
M4N"6#3%3C7J7\JL;G?P'F[],)+X^?D4Y'UZDS1-7'O+13X7;4,WP7(.@VA>M
MU%(!2G-6-KZ:CU24O8O+\#F*5?M<85 ?;'Q95*Q4>D)RH:JY?5PY1?#34W$-
MY?"GVYR#H7'A3$ZR7"K"E:+24^0#@R7CFK*27RYL:,A,#M96P)]?R/TA\^:X
M4@'TC.2;$,[!$A:_''=P/XUG3XDF1%1)_0F1G:.=L_UD&D@ZO-32WM H\'D^
M6$Q91U.IKJ#,72ES=EZ>_RB'B)7(-%V"YOH*KHL'2SC(0$6]32E3J5"#TE+-
M?'NW&X39%38%7_?X$[DP$ZSO(R-3](7_?:*$?RDM(RD$TS&F&(VS&ZPU]23?
M9G13>4(345=T7%+T1'F;]-6C*VEK&U\7::H<!=%OF+UH48W-\N  .YD:=U=F
M3(^BK0)=0)PIS$).3HQ5BIU=;&Y<K2;ADO^L^!S%'&$?[PR4-D3[-;-%?$EU
M,2B.YG:-R!$RZO!I-;M/56%4@HUH4"IJ@LE"CZK#3$7J)]6H-^(4_*&AEOZG
M?YBW@1+,7=249#H[S]J8.(TBE_((IJ.F%GMR\.BNN7L_ZS=BY5JQR4[U+H>"
MYFQ; C)G[VSY%P WDH,E/N:8O81 :Y,R*62$3'JW;'0VZ+?+V-R435DP6YB2
M^76+$S4ODAYJBZ]/IP'K8/7849^C8(ZN4*8II;" 6-C*7KV$0?_ZH7I*/5?3
M*P[D'Q_O"A:E0\DJO4/*80X=6+5Q4X=@+AZCMX]U.^QO@LZASMZ\*<Y+PAE"
M G#)3"G&ZP/P_@PMJZ^5+LI/*USNBG9U^1.0^L)@3?#4C;E90W.'8:5,D9N6
M"V.B2K?8@A;A6A:,A\BE-[&'R/L ?FW:?!3C5*D$E3Q6(G2C-*B%3W;PR2O3
ME"K6N I*$BD._&,*$H),),A0HE,QVJ_A.S9CC;@C'NE#WH0_EG$>YA['7 )O
M\G^I40 .V>BH L5MY")J%BV0,N4Y@^!<-M/J;A8]+TLB3)U5SK3IB) "YB-Z
M-_UR1_1_=_'AM;CI0?M 0A?\AP4EJTBVN=P#K\^W^?LW*EBIKNDPR(?DZ&ER
M1Y C7.?H\WB$V%,$W\'#'SUH?IVM_G=D[[\*'@^T;P!?X=\9*XT^?)_&F\LQ
M/RK4"P! ;!+"G5'.E$#PW VBQRQ[J71%BZFMGH-&&FRD"ITB*#I>J0DW])..
MK$8F[0/B&"'*\[/W_#H(*N,(A^>6)*/KXZM'KX7KB)KO]<]\Y67IB0UE?L3Q
M(?3W[)F+BPW*E10GFV:*%R'Y;B0[ZM%K/AWQ\JRMK0GQDIV86[TINAT+CP/9
M[E7NF3'[]@$>9.!(JK<NQ3#N1NVUB<;P4<(ZSXO7LS/EQOUU(&Z.SP(%FNX/
M=-D5/(59=C5\:0.]'H9=BSPAL2"*"/V.=VH5_H;F#LCE>IKV9(JCPXI:"$:*
MNK,/Y)O2&O>!J\=QE8#[%"1L)-Z#HZ LQ#BY>^'HU+Q'^I:HR0I2QSI=AXOW
M6G29J"7+8R"J%#JMYR.\Q@21MVIPE2&%=[*2(X'6^Q>;GGAS*2J9=-U/>+]3
M3'_#>(R\CD:!E0\,?16^W%=<FQ2FSR=N6[Y1G ?5S9P6_3Z;BHGG00[H<XB
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M1VY>;;FSS*E6S7*2PVPRJ;2@PLTKI+CR*VKG:=.[=TE5Q3&2HMPI:3RZ0AV
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M8ZPQ+.^?-_NG.CWM?>B6?2\QS2DO]I/-BXA;DU]_S^G2X()6JF97L6_0B62
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M2J8 78_3'&8LJQ?!7F=^%D<9OF/.NO=>A9PPKOO^EOA8#R*HX$['9>&F_C;
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MT*B/'YQ\>*4^B>[$3TCIGGB<O)BUU>,DE#KU4_IH:]!MMWNH%6W)I:K=Q?)
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M0,U%^IZ2N'_2W2TEA"H;^92_:4:G+L?:V[BFJ?)C(BFJ?L00!-]"$H<UI8X
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MT^_)T.]2UT5KEM!GD-,YZ+-8L9\9?E7!2J]JR%.6J9H73RJ'A;T^CL<>SXX
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M)XXF(LL6O&KNU[&,2-)FR:OQFL^\^,)SF^-MF,<VDP3M;TAG&A4XV7@YI[.
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MZESZ?G&CJ3.A\=FB'L=-KJ:O\%.H?O/8,_Z][,QG00R'%;B0BY_N>(Q'0&N
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M^TKU1KHW"^NP@ZKO?#]=%1NZHYWQ('*_\ LSU>!R)=(,&*&;(@VIT#S_:L0
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MEJ.?Q/OAD8RIHWY>Y0'HFUUE<_IXECLG+VN'[TF0HK2NU>DCX(6(_BC10Q7
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M\%W.1;DCW'R5R%O$[!14*Q?YD)@F086H?[8'X2"D05NSY-CK4IS4_:AB\E2
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MO235<LM.VS&P7JOK8ZVWL_]LX@Q/<81JB,A)QZP5:6F'K% T&)@8',J,KMV
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M=BY'PJDAB"A<'_ZX%L\\%YI<HDA9;-,I5;_PQO[B8FC?]F<0\N4AKV5GOF"
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M@6'1Z,JH/__M$[O__WZQ'<S]#U!+ P04    "  D@*A:N'NR_Q[\  !,$P$
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MFM^8M)H!4X6\/T%= ? 2\&3$P_S(&L30%FC5A_Y6^PM6ZV%!_G1R,U-1R?0
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M6)B"3[3(95F/TYIZG1-04]"@)7RM@/VGHSQ%[%UW*<MTHU\LP:Q]V'8C#-^
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MR! G+YF-WL7+^,M@%2U_Q/@0CD9OPFP.\:MW3%KTAX^4^8 ^WZ F5P JQ2O
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M&OFPPW8Q648[7S0@.\4!BP^4.:Q\IO_,)+IW-\*MI/7]KQU$1B7;1=1/4_\
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M\+\7!Q!--%WJ[Q;.24<&9O;>SJZ*>5G*7B_G'?7Q&RFJJ(=BJI-JI^]FD7R
MBCZ>4O_>&FITMV'J;][5 K-9WS]++BW(3 LFJ4EVAP:%3U3)%ZQ!K%X"% Z
M=U=G.M"FBP^S'>C+Z=H^\^>?XB?!]3X+\<^O]<Q\'C"HNH)2SN/[%%"/\6>!
M:0*5^.&-CY^+V32OJL11+@W)DD,(O'1S)9%%^I[P7F?I:K>CO*XAEAL*$#'(
ME6KH7HU(^7]W )-N=I(<.LAF-\LR2E)\;F8=5MRC"]YOPX7</\TEA)Q;""U
M(3WH)D!BFN0X'3W]GGUIF_^SY%?6]-0\)['LL6EFPHNVG_HE52I.%^'"3IXJ
M'1:3$3"Y@'*T%YUE1T.N7HN'GYQ!;WL&HZ]GPADH)X;W/-&D=(7B0WI0S(B-
M4J=&8CP&0O]K762ZN9AUU]*VJ+AB69^;#U^3_8TWD-JG[-CM8@LM]KG43P3S
MDJ>ZW)XDR<BS2"C=H 6(]L8))?C7_/F;J!0XQ?F*YK6O_0/I@8+H@)_IZ^Y
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M5Y#_\B#!,3ZL/6SO-<U(ZF3C>93W;K' KP744L<]%),K_GM= F69GB3RJ7<
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MC9UAY[-4D*_E4(C9X?XM+F8%@^DJK+DJPWBH9,D.JJDB0M&)<V?EZN;[JL&
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M"BO?ON?T6I*)4Q03>/9<U:#Y@T64IFF]B,:[D7@96<V<9[]W=":/=8E&K@$
M[*-*.,0 !0>2.^6Q@4BW+;B^S@NZ\V\DD.[&CIFL(!<^97[@ZO:.\1L=-+7/
M;FBLHX51714I(C[?8"3>JWQ%A-LUX"^M)<P=1S<1V3EQ#2 V/$U<5)C=U&R"
MP@-U^.RS<R"+C3YC@3%_5UH'!!C\LX8$%9H/>&C)05A0(!G&&:UPAK1H\1?Z
M"?]S:>QE!/*T6&8,)=;GRVFC>IX 6/Z&G["KC'K;/EN)XX XN>\+T9A!+H1"
MU_4Y96SL#\K"4%/'HY* =4S0D+"<!G?_:A35S@6CJZ-V#;OCU!BER/"OT:/'
M;BP%W0\B6=C6UK?S";&*L7U'G:5E8U<52+[$+/]SU>>I6)%K@+?2>N*/M[*E
M45\*AX6B'8_V<?:3AF,>'L5[O(U?U);;EM7.#9VO2MLF73OE,BSDT*YM]:]/
M\VBFEW7&WLE=?F[&'2ZS^$B):_9> ^Z\F9,3+9HHWX4/++V#/]MU:E(P$PD)
M"K]#Y+)>]5ZBJNQIR<_VNO-LBM'+YJRG*?(TU,:!^!T)6[VM9KQUG(US27V\
M8Z2#!F%O*/_@Y>56A)U//UQ<:PIU;<$-&8.D!<2.I.4N&WF/H:00;E);+U)V
MC\0L^;Z3ZI(8P);U#?\'F_(A]L5RK#<;5(%EY5 $/FKBBK15!P<8N ;TS]W$
M<60^$"*RMB_;^[;0T='RBX;@):-8 ]U$QUOMHX_+P/NTTD0<<7$)B8C(, A%
M&5BPY[B*:@6YC!=?-(,TC4U9PZ[8)*9;'^9]Q,</.HRWH*]%/XQWYYH=_T1S
M&BN6/G<JS!\K%ZY*.Y'^G5#ILK+E,(?,'2N-NDJ,@(C0)F3[^OD[U'[;%<!J
MLG2)VA,03]_W(HA;\Q;WA32VU.5TY'-+Y';!=D$OY['W QFO 9]\-:X!W0Q=
MF"S%O_\CM(0/Z?_'#]'@)=NO71'IM"0@YY]-5U5S2&M8UL>SZI3=MWG=\5]M
MDR@/^WX6!A%'E?;C[M?-PNKK"K=],^(:119%)QI7M+YH];]D1S0V/D].8PX5
M?(5QWX/Z04NQ2FC5](NX^5:!WN6K"*-]KS++]O3QP[T,S\<+VZ>5Q?84++99
MRNR$+H\88(4*/%I?>E#S R\=WK]BVOS::CY<-^U62*7B+?1AT=J+D^BUU&T-
MYKJXN,UVYE-%M$1=I86YD0:B7&Q,Z$5=ZW111W[/%-@+2:Z][8595TN0_S8G
M1/UQ5CTLB&29 X"W:R&!N8%S2O.EN&GT9DLIV'B=N),-=2F89WNNY"D.QW_K
M-\RF/Q#TUM>[.K\[$( ZZP.2PL&^O7"MSMC/\'01$]/0>E$1>RL-KLR/Z?P:
MG"D:,(&K\C<_3#51OUKG8 68 -PLOT1K^B=;7^^RP3&V+=/;]5F/TI\R20M6
M'861&00->('PO# 9O9-.)CK]8YI(G0@WI$%=ZRP3R0HCAZ^&4BZE>:?EUZ*V
M99/'I/;L0?)/;M#A7?QUR2!N3&C!]NO3"[5([W.Q*Q6A:T =1(]TV%&"/5UD
M) *^]HU!E#-T@\.!\S&*2;$;2(VQ&]+\<3P&4C&_96HNN*I'.*>^,F.\U+YB
MGO,F[2B3U5+%A^UE@72JK/-J60%%XC7 U7TA$4<%BNRB[WP [?V)^53L%\C8
MV7$3WPQ?H(&IGR23W_2-.(/X-Q_)M7]KZ[3F.)(T_+=5Y-?_3/%O/HS-2MWN
MHCA1OB<@/U55Y"23RG&;X^AA&]-:( >T?[J_DWQ2X6@LT)U3YU6XK^?^&,!'
M1C"K52'1^DU.<24)L4+;*XIM0X=_H73Q'XZ"#6;[DL-!00 3291PG!BI>!>K
M5R9?C]YY;2$8O?\2:>@PLM30KSO6DF9MN\BIU7>K,E_B8.C4'N66NY8?*IFE
M%GHB=.?Y*IPIKD8HHJ=YRNLRD\OG4B8)\<OH8[A+;0UO-_$@I1\P<;7V&A#=
M^5 -N> J?J4X<,]9XI"U,72=L.7R8=X&#?<"ME2XX+9QDWQEBNTU8 YP:[X)
M(A[P#/.:X421Q 3#NT/OT%7KXE;8'/S*RV%%7/?5Z4CY>A(/_N:^]:DV)K]Z
MFTWL:SM:K8]Q<<!7U-P"I+'F'"WXV8_RU?G+AG/W#SP_S6I>\+S\]$IHKC%9
MCN[K$,=Y0M27L91W2K^.-+##XD<Z,<P#\6C\ 4KG0%;,='E[5M$U8"$5K .:
M=JFTJ6,X"M,5/WXA7!!BK"ER.T'2%515]5C DD"]U HM,IJ@&'5Q\8-@YJ]9
MO2/8?Q:#0 :&_U;NL^"[-(8HM:(B^^BFQ#)?WR3W/,LBXYR<_@2*7$D6!,<$
MQR=;\7V#H\V&&VY#VG?Z.8L*LDS1ZP&UAYU!5M,.<MZS?$1\.Q;O8'[DV9'>
MM8')2\=/IV7UJ_CBG#U[E?;'IRMM?'&-H@?3+H0P9\>8FR\,L]SB4[=^%-[T
MS;*91JYE-$4D=ZM%?+\^YA,-;]"70@!>T"-GNJ7<A1[ID:*<S8.5RAN&_.Q?
MQ7QL0I<FD.<9B(E>5BU7<3Y6^I=SG[,UZV8.&RZU@'NI<H(O7Z5O/KO](0YQ
M%Q&7D%F-?ZJ&M@]N5T:.60!)54<#V/+8(%B]&Q^L=/U# RV[=,&!I*XV9X\G
MI&".F VB<&^AB/>;R<BK]_-])G95SH(YK7%' \R#1X7WC]J[GVI,D(:VE=SU
ML#"\%!_P1%)$,<U';<RXB>\Z.]-/"IQH DE@D5YK[,WG" ?;S(.'F682+)_[
M"\%*I#E!OD":SGL[%H+HU]E(4VCTQ7Q(R31^<?YI0'7>*'$RK>V3>;HC-T-X
MY5/[M)<B,=N!]\!TP,A DD3UV'YZ"UZ[MM:.;,,.(X)Y41W9,0[%I*BPP^16
MGK4[1Z!%^N=3;HH(HIF&"BBATZF$KZ'&5>2ZL^.AZR&;>A Y>;W>\PE^2Z/#
MGSX/ K-KY3E._;0$ JD=#@L=5VBFCA>8[&+F>_08ZF>N=B.((\1X+T.)7A9$
MDE'<_T%4^+?F4+/5?@H68ZP\:F <YDTV7PL[V/>ZU"4[2TWR><K S9Q-E**D
MR_@Q_*5:CO*ELM-%6"#+##^$*8.)=BZ[:$=F8'&G[6$-[H=K#2>E'Z?9N?UF
M4MU V/T"GQ$ N3M\"*=EO\Y]%9TU@4L:4]O+_8M=H]QOV#7S#;NVK.8[[<<L
MHW95,/3HR%Z9R,1V(4OD$"J]W*65?+S.E?6/ID!8!$\_&6)4R@O>/.IF9L_>
M!EJ0O;ES;?7F3DE<4I\26\4_<PXS,BA: C/-=]=JRJL@$FX,5+P@.JJ^:!:*
M6)B14UXW-\.N^)2>JK@;A/O$^4-F\%8F_[TA8KPCWWW)RIT5 #J@S5%F/E&<
MQ/MAA-^^BYR*?:G1-GK,]W:.+634CP&6+9,^^(3'CKL 9H#!0V:G8PS++, 1
M6B]EQ]AQ./B5M[F*N.;'.*K'C;81G(8$@AL&+]]V [/O^\'VR=>%J,"^0R$3
M_>]U>J\T>YM: _I-;!3N1^P<ZC;'QPCT,H,+TK[[&^/OO_SXJ#E$"69TE:.5
M#>&9SM8"$0^4B)T![1I1\EW)):8\:<'1-.$/9OLB1\HIFFD)F #G^NOTX>V,
ME9C5P?2S]UWA#[MFW6V3(3H5& K]#O3=&.-7O' +M>"/Z@_IG@0K6#"4VUV.
M3SC6!54F/MXST^!>L4PH#1Z^,!QADYMMMR6*EW-'[+K'6C!.>LN**M39NW-'
MAQEZQ$8+O*EW+F,C,C5U?O/+[RFX)45]F,>\8I?'8(IASI!*G8;P;=M3EG<>
M\""@!1%:[30.2H[UPD#7S.FV-"7F39".G1QYF]Y_WCC67U9D@SE>7/WY-7@P
MQ/SL*X B.^UL9+W=$!7;&RB&)@RN=LH2KX0WQI8+5CC[U/ DC7_5O)7)S.A-
M(OJ&#>_.^YNL+8C10"<.X.YCHA&7P'NC)4N."H+3#6,ZVDTUC3P7#E^[0@BB
M\_W^0+ZY)6=&,:1(=.,%@;(5'2D61=<.]RF1L(4_?5 *B.4U@(2PP1EMWP</
MFUM=R$A??&/,%9_O]>-SCEA-''Y^=@G>$'R%!,.,T(G$\;3/'\<Z%W=F"EJ%
M"PK^RN+C.1!4F/9@;15AYTQQD>59YPVR-%!"ZRSNXEQ'<:.2D8JGR""%+_^L
MUL,\&,@5V=-).>>],/\]5JLN_?>@3.< /XU_"H!ML[WKU!1UPVA"-N>\@2M.
M\/H)N3]YM=)64UW8.Z^3K@ 5T/JTO7D+YDF(I(.OV:[)A^>3^!$.G]FU%??+
M@G7JLD[(*31BGTQ6>OV&SIKT)I4/BM;CY9?O8N8RZ@56+ZX!HN6CZ2$AE]K7
M )_8$R$]%=K,D7]GJML3]QA%$8F[;[QHZ@RW\47.Z<M7+F9)[]OR#&\^Y;V'
M5IBW78J[RQ#WQPA(CJ/B[KW<5_'JHMKUA=.NC[X5<S4Q.D@GC>9\K/'8[''
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M>(YEA>XKWXJXSX!-3'4.0'1+R06]X_NFZ) 8DW\OD 9<IYI'00^FZ,TCG%E
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MW.PU@$1ZJEHU\_0!9?Z^@JE?("CKF7^3]6V<KI\TBV%6X'B5IV!+N1R<>T!
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M\/:D&.0"3S*R4O=E5.I+>_^R647OS//Y#;[E5H751\ ?$(3%SPRIG *(H_E
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MP8!)&S;4)V!*".,5H/-QNVB0S33,!$B&'X8@3@/-4C-+S-7^3NA7=EV&DRN
M8VW0T+4/OU2.7MM 5<G]H8__%^2*K$K_@$0@@2$BN.<SK7=#&$QG.29<8<&D
M2ZOT&<_T4^.N?W[3Q7PO[)F,G&$#D6\8XYW=8R*,0<]_^*Y.R#6G$#%,VE[M
M9<)JF_3@A=D!8?UOXN!BNE'RZGGV,@'4;XJ9!E9NFUG@)-10<E< 50),T@4U
M"83!Y[@XFN"<L.N*S1-@C0)'/,>$6_UEP?,9X5>_EETKV/QZ5\HM4PQMWNBR
MY\-*B->@M_ +"FRM!NMP!G_IIY>I(3-KVC<O$R[LAO#T=]X'IZ%>,KGB?3]R
M[:OP;=CU/GCC7U')@B>_CHGI!C%)(L.D0+6@G'74K0$?*B5U@DW@1X(B&9]T
MXJ8 48U-$6&>(2%?68-+"41.:>(/RL+D^T3=A;"SX2&D#L;R5C=^[73P56+
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M7:LTPHFC4S.=ORT@_-TU80U3+EM3%?GO)VA<4<7\]E$ D("Z=>QWD'_NV%/
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MUPI*"@ 6%A:0>/L'8.8!.0 '&_OWY[;@WG[P[N+AX>+B$>#CW[E+1$!$1$A
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MI;$F^A[NOJ[&<7+OVDHRU1XW/J+E+##&  ]V.'-UP*XN.@%+ER(8@*>-F35
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M@)*O\F%>VX3"9S41=_)6I=DK9Z[56J>+3ZJ3&@LH;*05"#' TL,00=!4)T^
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MV>57W5;J4Z!8-\$VP\MQZ^!.[U^ER]$F'K^@OPZ^^Y (O*RKCPQ=PEM'#F.
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M];=8,7V/YD.:56PW*2&PMW1C87,Q'-X9FS&@@O<_\!))?$D$$@>8J@D$[ U
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M;;JJ_DBQJ!K1A5VJ2(?QE[34ZPZAI-\'8IE3B8Y!V3<MLNOZ<.^;< QP+F?
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M(D2/=/(@?4MW9L=]&CF;]7F)"^!%8;3ZM9"7>!)#8]\$<I9>H8>9CY^CV#&
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MO<!_/&!>BL(?"X9L14$"\=7@R3L&&X=AYQ5SC\"KHQLKER[MM3JT.&S'H.$
MLU5B[Q6^Q90R6U-:TX')CF^58/,%X>4:SDU34?F':\X6)T1^"7_<U/.MM37!
MA<FKD453V8QN"EH?<%U-LE:6YK96ML(]]43XQ'I<^OQQ\*.5JCFR+$@^W&.,
M4*SFF2O1H"CM&C*YV(;<LC?BV)[E+Q2,MDM9N:IZ#6>[BQ7KRFMC<:WX(6?#
MCB3*@<J&LT^H_7; ?$TP3NW]U^L6K)RTHW=<HYN696/0],CP0GOJ<VI! V(Q
M6:<FZ NBQL_82J[)P%>I+0;FUX@#9:V$Y;&#QS4^N7T"1C619\,LC-657QK*
M'F!1J3>&*DC5-3.LV?63TC#1PN-K$9IOD2VKQE03_GS\1O7^CI('/!OT3;^J
M$J7OOA0,WBHQ@61,KPQY%\>8FD0RGUO3_M!,L7/K.UE2F%?J7S2XW"G;P0#P
MZ1S2A:W ,!-T_PEZ[*;I)A<=WB8M=CC6*;H%JPT2\(&JAZUQ=O_9D&V_R\>I
M 19-EY0LUGN25/2&BL!EN>PHA]AW"\6[P!LT>BNK:C2[-('6X9KZ7.UGKA<&
MD U"K='<N,]WZ"-^$R76-;40 X5"]T#[1TH9$C_[/22%T*->5ZZ&"K$L/+!Y
MU'23-)U^( %E2RJ#Z1&YRE(F5YO2+7G J3V0X;G)EQ);"?3# *^4B6V,6B8S
M/%%@Z3]S) 5^#?9%""Q5/_-<A4#4XDP>3 0Q&R)'E<\SY)M96 18!)58Q@Z[
M;R.+HT-8K*/(\4)?7$G/$EW \SJ$%V1U@6#U<%4YYNXI3T0HGY;0JY<M/^?X
M6ES4<)Z02NDTQ0;1[]*I?54CL-<Q>%+D;&-3WEGD7F2B^L3IT<>O6%D.ZB$R
MSUV;6+^OG_7>&&2TUG1T^M$J<W:5*!G#5'B6E$S$)K>*,YJ,57,'ENA+$#:]
MSN'IL,<(ZH@)8QV!0+. !&LGLV20*[U@!642S3U@_4RF_4;>E VEALS+0ZDB
M:^ 16R^4/SHZGMF&+:HXC?-(JCF]>?Z%/MKBDV7 VIW.QNJ /WS-\$#.ESFJ
M("7U@DB3L228@32:L\5&!0,D; <O5N>TQ(FA9?,P@%^KWPE[RS'EQ0MY"BV&
MKK_^Z5I1BFSAC_$W,6R.TWJ6="4W[XLQP%@X].:: BM/W@8#O+.#GJPX8X"@
M/N:?=,XHI"$&6*I]3D>A$WQ^)PL#R%!A@(M]]?_SVX ;Q3\F(1\K.:!?(!U9
M:LW7QI\R[E?&.8H.)(S$)AW+#+$9]^"#OFRK*&* NYO) 2]%3HINV913C*:Y
MB%I]"4R^Q66368R^O6-9]-<:J_@(_W\VO?!2'UP5A) 2(CL.IF_<8_$DH[1[
MYAJ]9*^627[XBT!*8^-_L?;E\5!V_?]3*D76LLN4+=E)R#9:A*2A[$N2["$)
M@V%$MK$5H<B^$[+O^S+9L^_;$"',6(=A_*[1?7?W/,]]/]_O[_?Z_3&OUU7.
M-=<Y[_-^O\\Y<\[G<T74&)?HOLLU$'TT4 /&&3WZZBA[[B%F\FW&]XJ/+<"D
M_7[E9Z2^6[D*J1#_LU3#0-X2G7,1I!G ZO2OEBK^]G0U4CY'3%K;;',<>75
MSB?X]1EREU-O9Y:EKR$9!?4X;,./4W[-UR_*Y[3RY/G0!6UCJ/AT"/I!(4&
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M?T'M?Y^HQO[:\I@7F\(1_ Z6%I>OV-H/39PD+LV(=3@;#9$2K?QP=5_IN>N
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M\/3SP-*#2(ITDOA-8MF](\J<+>ZK=[(#GH[!;5#*Q4.M?%4E^=YN!WH' 93
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M9-$88,]7?=AT;C33VEEZ@$M8'C\J(_K!EL:7F<808'GW.2.X.*X3LZS%,/0
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M:Z!( B99'B2X;C^W$0JTL/>IBO%1>+F6A2U^'/61&N'0OW>P=,=W[:-!"]#
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M8.[&='%28<+Y;M69!C>=$FC)XR;KQ@MKL*@4H5=5P$IHF>7H=:<NPE5!DMM
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M]"P@92Y2/^58F+]?051^:3YI\S CCE.MH-[CEK9$CK>BD?'0:04!/ME*-72
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MFF:*;.O#<=+\A6J+(BU=TQ-&K#;:;F(G1:&^O=]$.7/>G3^&ZZ(>@WVXJ F
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M'P=L#T=J/9)-8F%R/UA%&K2,.G,-,;J,G8Z$P@J= X4(C[]62J$M>:X,6P]
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M4#+J"@W=X\!=[;IZ6^=9<+W7:OW_1]M[1S7]/8NB$4'I37J5KD! .DI3.D1
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M .5!-BU):K:/R3!L7M?ZT'C+!WE^0Z//66,8^!!*/KZ'L==]B[,M,Q8'W[Y
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M-(.'>K21!X,]8>Z99#V%FZGN%?:XALI&.4]$-"2-(PCH)Q6471_DKUY7%MT
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M2!JI^KQ=K,GW5IY_\K]^78CJNT]D3J=JK*_-O<>NF=1*,]6!5*)R)44X?C(
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M-O/NP[LOKF8)NS@FXM?P[%EY[WVV"]N].XI-SO[:*U.#V!,1X,2B:?NF*(F
MYC:^!D>?B9T(318L"]>X!J]DS1<.%8W3W#1NX\/@[ADN/TV_H%U%D4_/QK['
MY)C6$^F#,9B-*AE99/9]K%3"*X42G&N*(?S'1A) DQ4R&)<=6E4P7ZD8\G N
MWK"KA3,1VH0*5>\U33G15)-<+E\T>!GQ0I8$E1['V0S\TAIE5(4OAL)</PB#
MR8XT>4UPP]HK+":UW]/IH43(ER*W!4#R@)C-TQNSM!9T2O?.1G9UU!/ZBQA
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M4$* ) R_YS__]YUGWO?#S'R9-6O-G;,_9)VR]CZ[7=<^]]7TU3* 1E--0PU
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MMDO)9QE2Y,($"FC*%SD6%S[H+5+4;0F$N%[>P&I[C:5R\D[E38AWH2/UA:\
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MRV4*\H;9M-EE]<?3<R;=.(TSB1O Q#($5D =UP<\NV96<\Y_8S,47$)]4JX
M']<-8,)BM+K4FK^EA3>.0B"9F^%@+GPF6!U=U:O?.'+HU62RQ_<BCS6TBOO^
M9UZWOKEX^=76"GQ.J\ .%TD0]9;9@PR/"FS\Q8*P_BH=]#YOW/,J;MDG_:\*
MV-V&28ROJ2@)X0J0Z-Y]!3@](R5\FNP.6C*FE>G2I7JJ>Y"DN9BSD/\!<G+7
MX/&N[>3#?:ZC1UVO4QR@ZC<CJPNT%X0@WHH!.WX%[<!/_F>]<>JOTA8Q\N3D
M1K=V]1IO*=O;910W#(BS\/-1&_0-%?2*S4#,L4+Y[==9Z:12ME7U\IZ,WG.;
MK_R\0BUW9$E)2<37/6-CQ[!::\!8*Q;4/(8 J)WB&[5O=+)WX6!PYSW^S0,?
ML@5S%*<[CL>[>/9PWL?_:@Y<V2VCMAIMUH#DS7^3:+\"W!Y)\$%2(22>,MM\
MXZ3>MOR:[&"$&TB%&RP5&3R*E_]AE%]8@(*7-9XL;=HM &V78E,)CT<.<=>=
M4G&!D,BJX?*1>Z"E0=ZG\N#5LCW&9MN"=+\=[7.QV?412ZV;L3R^SZ-Q>E,E
M0<F8:)1:H;C(J+<D@&P(_P5,NB9V!VP?O&N FH+G.AV;ZE(@F5+H5.Z2W"(S
M_4;=7-)^(/0;\6X[%[J6&CNKKT6.T8,>?+I!^&0L+2=%J)N=19YG*C&)=303
MO!_.=*O_,'=XL$]P_^MM30)QX/!=NY6 AS_.X8HX4?=YX7;_TR#?AL>=Y[^#
ML\(E3#RH)*,[L*,HQZXKP(UU;0G,N;N7HG9HI84YHTD>Z C@!?2>$#]=B:<V
MNYQ;5BRK+6B'D.05&=P=$\F5?\$;H,9RX;MHUCR V:H-=P]Y/-;'-!AA&-KS
M8O,^'PEU&_1W94%LD; Z+];=+H*\RZ3Q'#ZYZ?YV8\#%M3S^<AZ]-,U%T'R+
MN*X\X=>U:]1XP1 %VZ.^I@N2UE> "A7(UE;)0?'Z'V \07T8;8V+N[^%N >+
M0+B*Q1DW%D1MH!ZD>HPXF8$,(!OB7$[?/\VQ3;ZZVWL6-?PLH=[EJ&GM_9@N
M.J&7DOM^.!R4HQ3L2'QR R::7V#8?R)7KTZNT_K84%#H2 AF?GBD*+]\N.=;
MAGN%&D1$BM5^5P#F+P1/_9K[&97WZF-S^099[B;+DS79=A(4E%Z)$INZ#(L3
MJ9GAD_&E"-[Y?:9#G4)4^854L"T^HWXS#<^&=6?_@)-'-7_XQ*TM./E*3#N;
MH7?;DL,8$_9BPM?8,@XR]<=!^/7"\SQ*_?BI_3+8KN< @02G/-&LAXJ?,T,;
MUO;\@-A6J09(SXLP?:^,/6^[VR<4_&+M@[LFUGA-O1OOOA81EZD\SB&EN^'D
M;V&?K,KOG-&R[B;AO[[VZT;K,3Y'M%R80 H:TK(=X!Y?N&.QZ4)SC5'CDZS)
M" ,^CQLC>H=OJX*4N^"TFDV17,TO[$$75X"Z$KS0>]:X8EL1..[)UH>3=X*@
MTDD#C1Z,96GY_F[E#BOI'MTJATKGKG<1*'Y8<Y*#N.P3W"E9@\#TY5$[UUX)
MM3_:5;/SN@Q4#W<E" T%"EF.SRMX/IW+29,<23CLZ:SD_!6[;KQC"+[V[$V2
MRMH$4Y3EZEW,C.M!]C=[QP&UV (._V9HZE2LJ&B><^M0?E$,[W"E:;C,3GV3
M)IVNEH@48M!__L)Q>:FK7DD$K#@.5J5W(3D*89ALI'UN($:5H]AX=Z\#(05V
ME33'/45N6+AIZZ^$!SXO==E=FKZULX)C6OWI(^R:,\$+:A\BE@*]#R*#YH$A
M:TOGG,VJ5P ;(2B>=;*.-JW *I>QM^#+BDW('_1W$%APZL074G2828Y/ =NA
M5WMTV;#0KJA\K1+BC\2Z1)E.GR]+7TN$*BL=W%FF$H]&+45Q49\"PX*D6E&8
M_-':A1PAX9''^L_?L' $Q 8KMJ\B]!3HG.O^83=)!RHV[LQK[+<G()I8+<SB
M-4R^%@PE_ HP4_SA>]%DZ3+F45]UJ8[,HTQ.'XR/C\9]%VGWMHLEC!.Z;"E!
MB0(+T9^X[W1Z>W3?\<=%D]H&,=U\,IG&Z8-617R)DK053@V]<1#CY-&_TL+Y
M%A[./+V?:<BG,+@[I(P!4'@_N3#&\";F8KEH*_NTU5:,I\$%YTG6)-N.^XM\
MU3*01VG["OOSCJ(RCL=2%379E0SW7>MX^=I&XUUB2P9P,@7)<W,'E2<RGR V
M+0'=04QUD[6604O*:0=W%5N@,[&'X2S6CPY>A<9RRM@I''?[/6Y8AC*#F;'?
M+[SAZ=(+$L]3R#.D)"-('$P_2#SC>,;Y*QJOEMW ^WVB:=-8-VM%;W7/PEE[
ME:?@3F &0ZL/\J]?+)396@-+UJHX);7]7DR_3>M^6)<KB\R3HPZ;"N6:[[V7
M?*Q8MA?C8--+59R.">OF_NQB[MZ1A872]*]8#]U+@9SLSUN P<"(2P\+#>KV
M%Z-4C)9&))"/=6H$9Z$UZU#_LWC<DU6ADN&(D27MDMH251E,4*88^U/+.[_I
MP92_T]?F%)!OR1[J)YN8RBQE':(V;O<26[,\4Y-,<K)^5QZ-1RA26Z//]N1A
M6-T.7[F>GS!SER33MO%Y4_*W89C" 3]'3_=[]LO[_.R>GPV!=M!8)($>/0@-
M=1>ULB0U^=)-+^HA<G#[G"60^&Y-PH> UV5H \QW!\$I);Y[L31@X?1KU-[B
M!PL-8@ KCX%-LY?X@W$:;AAXQ<L'<H8=>T(\&3,S/>+I4SL2&0^5FY/V_#\4
MF-.%E$4,"AED$!C3QE'F\N9HI3)\"W ]X9I@8C@BK@ :!T+KD# S]Q@%5U_?
M95T*W0UUF(*'59%K9#_ @R(.^6:Q*W[3G62UM?Z_O^TWXHVY@WOD(D\],$A1
M:(#=QRF'_PKPC&$X EK=WN"CT%QP]]2**\,KZ:-KR7Y 2>"P ?]JP9Y+*4X&
MI=H;67:Z&^CT?D3#[WW=7SK6S9M?4N3;AI^0?;0XVTM<<UFZ@WLW6L:=3.@L
MJ:QJ_,25?/9P>OK4N'TX7]W_$KXF@TN\ K!?8T6RRVM5%A%/"#?Z1G%.* V#
M$'R9&^+S!^HM9]2I0V26M('!>QB'N<QOM'CWK#;_V(+8>+52!+Y2Z>;N[-_*
M8O#3X$,=;=:>#KZO=_B^6-"6/IO-(OMGT-[1^@;KN2RBLNH;6W,%H-CV-#=?
M6O++M$B-':"987OA86ARHC+"^?$:I]8@<5\@S-?X^==UUXJR9@CJ@QY](-!=
MHW<$GB\M5L0);Z9/,)];#^'Y(S3PH$QO]B1)[UQM9W,"2$FXN\MU"^((X=Q*
M6QB,FYSL,CZ+QM#*_U*K>0U(57WRQQ'^<1#,E.UBW,HUD8,8SW=QZ9N<>F)P
M*+HA^.)$UBYD&KD3T<UU_B!(]+I!JFX2HOQQ_5CCO-XRG XJ'BI1W>Y=,JO"
M [.,DPC?W4\S88W_6/0DJ5.VR/:A+5KZU'4!_^=D@&MZ>%45$^%8')CR&UC#
M\+8J(-VB)RZDX5M<,W%&$]RGQV4:X3)H8(*ROB8 5"#J3D:F_ARV5W!?']03
M%8JG@L\MU9[P>E*?!;!>M#8/KSGVMI NI_QTNPCU<&;-FWXPIP-_P]&V\T=W
MWFJFO7^+BDK6+KK$K-2=;<X>/*APS/+#3J!AS)#=W%E(VSH0<P#V0ZEC=*>4
M'KW3=_%E+0WB&L--A3-]G1[D^U- H>QF 5@2]9S@E"U77TMHYU!?AD0*GUS.
M8:7E _I>3IT]RGKY:9K[VPEO?&B\NO36(A^^4<&OY(GV@P&M45[^C8=W,JW?
MI\KKXH^$>H.X04T]G(^;ZR::+7TA?KPE@6E:]<TU<U],U'[=).8+'-VV&@26
MRJ5/LNKM!46$$) I0K.K&\SCOF<R069SA\CUP+!+F9U9>#=L)JDKDROSG']B
M+?I8M2[E0-DG9RY!H %0-V(OE,Y)1RP+^Z+T$"<V&7075+C%VMV=,;C\F?]8
MV')1L2R=HJIHF#/Y%+Y'[L*#DT=S]%O/]Q>?.\_L#)#1 A]8#S7;_7LO*$D)
M3?]HD%\WCY9H',O)M/W@M=]W*)8)_:N"$L(XHM43RFJ S-MG%\_E[&5V]AG^
MC)5.1S]K(K(3&I(]1PB>ZF(%^'$A"M>A:7E-_T^82T:O,>LY-ZLO/LCB"K#5
M:>7[3S>^ GQQ#(;LUBX10AALBW_G2ZM9LBE@[4ILZ^/IB_=U#+3&_@"7H9 C
M"C0<[W.=&R,.I8@Y];6\(Q?^-C..M=DY%=;6(F&1\.1I!YL^ DTNK7Q*^[89
M%*6+.+\%FB,TF4&V))"#0/8'*6MK_/&L[P]9!V<IK@#>;]\@L%L,I0][0#,-
M7M<<TW<%Y8564(TLTK-.?-#BRA&D[HLRQNBB2;OW6;P;8"LC4AK,I3)TR@Y?
MP;3D/#<0 O=B4]A#8J=T>X9G!KJL25BG, &1I]J<?@KUM6R&#ZMT7A@;G&D
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M/&!0D6D%'%K_N%"I\:]->B@X($>C;E=O/+V$>B44Q:2"L@<0M@_<+",:2]]
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MRZ]P_/#5RDH=Z@A>?Z^-%DGYR4BEJY 1!OT[M0*[FN6E?=M[YZSJXAYZ7$H
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MIHJ>K_';R4AR:6SV+F$X![W=E 48H;@YK"UN9]D5]+(NO\9_67!OKD."4U1
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M55'?ZN>M+Y<$.H:!ZB/GGYI:X_]/K[Z"7D+]NH^;XYY"[1.]F9!OC?K_<6_
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MH-2+U00K IH227&;=!I%%=,QTO."O-B%5O@#TTKC[9PG.:Q*9D2<97-[B9@
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MLF&"W@:*>![%/3-)E0>3,3TE-0WQU0?SG5P/W(A]P!_! #!70(=12&TM]=5
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M3.255Y MX%?P?/[&7MBJA73 QC-!4\HAD'YJT"/%2.W3QSR6,]=:6#]C$AG
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M?/6!.?#$N@J*5W8Y:X6\FV4=\_5%%S\/'/P6ULYKSMW+QUU-$9NW>2RIV1$
M_&K6'BQ[U"!:ZB'S/L H1^-8T.P?U,-44^G'>GMKS%4V_?#[ 'H1AUVT,=/J
MU1')>NF0DU]O\II%GN <AM[&)C;$YS#G92)IEG"9L'RN8NQAHX_._1B;5X';
M^D:1RJP]2'TF6YQO/HD<9 "2GD3-=?IXPYUGRU\#"LWS6U(BB]B^KR4\:]UZ
M&N4(7%.A$2*\$,8T+-8;-@E=X,'&-1OPG',>JC4+XM%W3#H1PJT1FCWW$&)R
M^I1:[[3%_)8ZJE5H6PJ.0[N?'"U(<8_@XPNSK0RR.4DP[D!RH+L:L*"&3&P
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M#Z>MQ*UT[7_D*W\WO?7IW8% W(%2AQ?J+EX=(VG/ITUA.=#J$*H@RAK\0CI
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M:E=#N#(K7A-4LEF76]B<%.N2T1IM\B@& ^QJQ]2.5M>Z\2X1'.PMN00)CG+
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MN%"MB../FR EH5[6%<.ZZ,_6,K5!@<(I2F_E7UT1%CQ0%S@2^X8$^UO EDR
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MKB'NG/_25*O-:@,*M>U??!T]O0L<GQ?G\;<ONS]RZ&4 Q'0X9%NDF0&T)#
M26!W5;4%A5<<@_Y2C60 T7QT752;=0GJASV% 1R 4+U9<1\Q+ S@T6M'9C^5
M[M+9H"#3>W*<9-I@4Y=-ZF$4Z1U?Q39ZCVT2-<[& 'Y<<"E[@!_9<@7%SF;X
M2#HY#^E\7[<22OTY;G[FR&Z'#8];:%^+^[$?=X.LOO R +OAY:J:D75_&8X-
MA=#>_*_'^'M[.[3DAK#'L?.O4%7+'59\4YCKH \)VB5S=#SG6DW]<&X-B;?8
M&%\UXO>R_OH?MYBT(H,W'H&3OPXBOS@0]*G"JFV[#*"B>V.M$&'^XY;WNU$-
M/X233Y6?69TE4/\XFY*MT[]Q2IB%HDT2ZII"M<-80I,[LXK]AA\:FT2:+;P1
M?&;F^G'7\)YQ#Z9W$U3D0YMHT =SJI;J"3 AZEG2G?=XMT-S?F:;ENG.#7[&
M9?Y.:8>-8A5;HB3<',1E+,0Q]YGSM10Y*!F9N9[XSF>*A_B =,PJS.^5XZ'(
MT]<UW$UC?Z3[%QZY=?;$VC*JDK:XN7Z.J>:QXTA%9Y?'33X+' =GTWOJM</6
M9:MN'6Z]A@YJ8;N1V;IV!I+KK@,.$BGXT>U@=U42+KY).TR6.V/_.R; 1X[U
M1]RSUF,-D:KVY>,/0<WMZ;[(LVWXD/8@N$J?</)J27Z,R0LPB'*<W@]C9P#>
M-IQKV:?!1=+J0#M2%MO\0O9S'4GDQ1?J(\!Y:7Y6-'CFVSTM'3'#9G\#IOF&
M$E[LKO=1_*R)R5:D@L(4$VEX0^Q*8ECA;,G8U9[!S9J&!+@.!\>DU(;2II;\
M"U< ^77->>DU_HO&@MWH#I>;YN5:MS_N[M\^MTON5Y8#?$48#MI[$_W0!QVX
M"EQGJ1=^ %WUQ<5VB&H<IAN>$+?S<BECR%1 A6!QY/F->Z8]>GM_G\7/0^I.
M1OG:3,,O@E*YJX*F[U=JR5D72LL6?D:673/+_GT=$OKN*>;T48^[-RJ]*F@?
ML/.9)R&5F!9K5#>*MRF$<'RG7\DF:*QTTUD^GOZUQ>J%J631A:G.I$:+PW8&
M\S_8BYCZZ0C]>.@P(22.KF2U !&#SZEE?-]J]<L?USN-<3[H^?+S.=63/^Z=
M2*T389978I/3>U#3*OTJB;>R\)?S713RS]6&U#F1_<:G[,NP+ CQ_.Q9G 6(
M(J7M_S85*2WM?[+5$ZZBYL#=303&HT#V]F9-9IF4(4?W1[L?!ZWUB[5.W;WO
MKF;UAP'<F=B+/EH;S:&L@$CY'JK@EGI/. K9!ZH2EJ.;%73[\!#)T(A.Z\/?
MBG-7/[L+0S;"_">H<&9;!V"$X#(\M*=(^36#0\61[]=$,^Y5-[__,//E2X>:
M_RT[N_-'G\\_:_UEC;Q/G\KY?(+>X:P12_+ ZS^IQ@?<_&@>8 BS%O]2\2)Z
M:\GRED7[4=GW=M@.;*@0NH"N0$74T?(9P'PZ4H54]E[R0JE5H;E748FO",^(
M?KE<0_0/$];H::2A[:%,JB 7P3P9J8C@([U@ ,G4*Z6A9?NX#K/#_D%?SL*_
M>J#7?]1T^C@]=DV[=^JKWC,*/VA.T$BF6, =D$JT H0FZ:H9G*L3W39E@]8(
M2GXLWB_AQ%,2I?((* K J[&',W%BN\3D:A1I@/9D@P'D/W7HSR%:XO9,8,+,
M6I6ZR@"&/BJS[D2XT@I,!$*]')J&JM%)V1Q#U5:GG:5>2VT*.+4;"1YOE\NS
MD'"4>?=D5!.$0V(@VTXF$ : O^+! +KA2[ I(3I'.E')==PHD.31;7*"%!]W
M<&1<\GN1KCXY<-HTS8E\J/I.5RA7AOS30Y:87DP<CF6:G$%[9QZ#%)GR#=[G
MF1W6%7/^F6A$MN<\ W^=D2B@PVYXC=?)5O24/.N^,,F\2Q-@^IFA':@ B&M'
M0H:#KOW1I?1?M:^MB2<%Q\]R-4;+3O7>SR>V[):A+XSK;@JNB(:7/4/!/ZV$
M/%,CCX]=5?MA(\5=G%>DTFLN&QL+R\ 1G?BX6N?1L0R A6KHIYLI.G6F?IB0
MY1H0E#0WI=6?JG,V)A 63.]$;?E #J/6'3\S@$'5,]*%C^CZ" ,2N5XC&8^&
MA,(ZPK\I#UD6^ACT5X^VJ3R5>!)8?X-%5BB50WC/1!=ADM"5USH4NME^G+ @
M^\B;I\0EF0%H?;R1XX5;\E<Q[9J97\(>^ULFV"U$\W$&\/ED(0,HL'4X2+GI
M[;R<Q/S)!QF%'T9Z1=;Y\(8N;.%*<.8/B\$JOL"  -Z-7E. _73WW1_L&W#$
M/?!^]G$9B0 (Z(:P@/5)GA[S:YZ G9K^N8E[0^[T9;8I]!%=RK$]@K I[-TL
M6OF*;!Y8ZLL_V;5!&_61,#5*/8@\2<=AB380+GH/E@-QG,  >$)?.XWYEU5?
M&PHZ.$)]ER+7JE8L?U3@(M_,J:EORTL0_2/[[.N#%/956*U#ZW.PD 0CV"0R
M:[ '=HGX>]Q2\+!?Y8&FN5MIJYXI%1]MTTHZ^[1E67?0[72Y(813?NLG[_""
M[,H/KMSM$84S\L0>@]MN'%=!R6("5@H,:0GW&3&RQJP@I3]+](^5ADF7N'+G
M9)NQ[F!Z!D Y2&HUCI>*)*&CE.J?>X\WZ(Y7.HK-/)LS-5*6/S(OG6:1C_[R
MB/X+\X#V"3J?W=#=A9DZ$/ 8)M2LXQ/NT%[X(D]T*Z>\_\/4IQR-P]PE/WX^
M+7BS(%_I!PV.,EDBHKHV$V "FLX#;<TFQ.[$LA'/Z5_[_=4SL716J728+I/W
M'!!AA( $6,6Z)";.Z$)QJ,<U$]FJ1SCO\:&IRQ[>2VJO%VY,6[+*G9IW6!S?
M""-VXS77:0L#7/U$)4+I^!/Y*_+C^OQSW493?AV7XH\+KLX*GIRM+Z]]H9UF
M\TWU-P, E;N3,48H9N..@EZ$E//+MF,XTY&R0 9@?*<\#/+Y=W<U$!Y"%<I9
MB&':WB,KV2I@W@)IR003P0I':HR%R4)[XR,2UD]$9^VOM67K,KT@6O?YJ-&)
MLI7F8\-'-EQF%;<,/SKNLS]Y08.3=LE\3%X-GD2.8@^C\.HD)@55TZ#M-;L/
M)KT-W--U/>X</F']RN["=1_>DY]B+@K:7%QLXH/\W8WS!E6[D1E;LE.T8\,S
M!YN<G$V]HL=C\.NC0VBK7/_C^E;ZMA=$]4@4DN"00)]$2>NA)Y?G9>H)6%[O
MK;5L>;6,<+\*EZ:>=!/+C NF;Q\G_7X0=3'Z6=8NIS(K"6Y%'-^H)"G-T_-(
M6Y#$J=&R=#CW[EI^6:U>_B[_69?^#$/E$=,J/]2+FDHVO(MJ3C6*J7UJS!HI
M=E3H>!560KR0E! W=S#'-E[O,<SE&Z3OQ;-[N6<&3_F]TYP]):'7BFJ]:F*
M\"$&I6Q&-['B7=;0K+Y(J1-@;$=-N'IG]Z2=TYTD"^O>=.$SW9#^^A!@CUM'
M&TX_O/L>H35DPK^VZRY($EI#GL)FL),4OHQ O3*^*0<<DT<K/3R'R&EBB[\U
MJR4,A.YNB%#LJ=ZT(JAO\D ,]$#02I-FP<KXU0GILUTKI?+U:0!R,%"]C8?4
M45+R28[2POI'%+CQKWO-:!06Y*"S9C1=/[0,)0E:V?'W!06&16J\RQUSXI0J
MCDB\9O5R$J9=RW9<7,+^R"Y5H&S).H3<2 K.0^"\F]+;,FNM58-TC'>RE_;?
M]N^-,ROG8$>,'BFDS2F&175B5;E_)EJ>C:\]D/J+=0,ZO4S^G$Z^"LKH]4L:
M1@R(P!U8;0;3 IOE[\=EXQ-(*LHKLZ]8YK.HFPGMV)JR J*)S90T4@5^[KS+
MG5%415>]P3<_X;?C!WJ4)JF?WS7/-89-.Z.(UU/"*?8@C*)%^X0O^$/55OCY
MBG[:G4O]6Z0-)-ZF%/D\U/QR#:3\<O+-GY@)YB!Q;V5/IQI"*Z\'T[0[@7M_
MB6B*L$G^#!H^",'D"X0.M.]R>7RBO3VKT')[5J3%M&V3I94U9; &$!?Y+2,$
M+A-QW</NY_#HQR8BI",UME*O/VZ_]9U:>?>(GSM5[D'U_3,SH4M8+6;5)HP/
MFR\P@*1@WY\N?1^<+JY,5%C)7@79 [XWV] 2Z "./HR3<,%O@?%_VILA#>41
ML_Y6BH9+U7$_'I-I8XKVR5*MG/<F%,[(0IJ1 N#7>3[(:OI*MAAI()YJ6>3R
ML]\KWY>\>]4\-K9>[KX9W\>\3IB$$<N\]2V<)4DS%:&/W["?9^5)+2Z>GAK0
M"$PIDHLW-C>=P_)#_32CH,26G"K].!<\-G'GT?<<T<I"7_VTK@#U#X)?I8H\
M+]C#GJ)X#]_/%WA#\>JV 16SP "R]6BS3FAL5\/O>M*5N^_'@[PW94Y6I_=[
MZG2$:+YT$QGX[OK[^.ZA4( 6G>29+9^AY"1W3\+M\CG6'ME=D7YPG) 9:R+9
MR9VM00J.PSLN,8!K^V,%/"_3:<-R&BA.\ 2=PYS41K&FH9ME9T*3?KO0-%L<
M]/7MZ0]?;MT=&[G\(]Y86.>B67C =@M$GMX'.Q#$)*_CF=V;$J&%!/W$S?GA
MNX*&;R\O=?N\#"LAS(WA0CT3 4OM%S?80EN59%G)$>[@ )'2UG#H==F:NP%Q
M#)WK>SY9^B(#<*B-F?H5G7;LV8PJB38$+Q@,ZC?L:+B079P/FUIM</MI95R]
M\[Q/5ZBK7>77ZL6*9SVR\^/X *JP'/G*"-1CKTD?WR_4:?"AD3CLGN%WMFWX
MVFT?=<V;G&GQ4^_OVWD:OG (.<N7P8-L1/ZWZ2[39S0X?4Y^J"Y5>:2Q\9XP
M2YHUTG 55NVP(4V)I-X?I1XE.KB];D6*55O>J:5(?RW7=E9E$Q/35_G@]ML)
M>7ZE#BB$ZR$[7%VZ@P+4A&33C@OG%?VZ]D1@SX$ [="<#"''T:*0VJM(#? Z
MO)A).-QK/J4KHC%[SOTO]9^%'1I33?DD\2HXC<6>_1V[%>DVZBY3H<D8JW;^
MW5X=R)S(? /!-9NZ6=5=E;>71.3/Z;@=:SC$.7&;M9";5W6; 9!=0(H'Y1*"
MG[B)+MF 5A9@S9.VVH,90*5KUZ+\F8G%^_K'?Y?4M_9@OL&8K-_J5@T19'K4
M-CU2.UXIOBGL?5BOQLW4"3G5HY3^@'L**;,V >DRH[M6"&<P$$4Y3#4E#;0:
M&U[^47602"X*Y,EX4=A]DVPUZ-_ZZ',7X"12(Y3Z[@ 'FR2P=X+\B#E48JF.
M((548?,(5GDWX"!VROUK4+*\6<.(!(?@Q0KLUX-UK4?!4U+)0/ 3M#BR/Z<V
MH17'-QM*P!&^%Q 2U0CPXA35RR2]V>WR=WMO:%F+;#91?+VOT6S*QMQ0XGD(
MW\0LPAQ\6VK%V9SG4>#LW'J<]?B1H48+]I%6R"(,H\M"8J<*H<C;S;2B*MK5
M-G>]U#&(S*^QM6"-TFOF,@7P.CFKQ53!\W?.M"*O?K%@?6J"*X%R@6+M[H=K
M*= $(^,";U&P^T7!Y(6[==MMRB+U__Y3./_$&8@Q$@?9@B,5&0"&QC0@ES->
M;*LC=B@(U-=2\#4=NXVB&3@[_*@"KEP0_D\-EG0"9@^81;6@MK7=(]SC_N>O
M_I^%RKS.1_4H]M'KE.@Q*K/7AJ _A6XS %<A!F JXA_%">K3N;B(-T *.;"2
M]/;MY_2KQ-O[,Q:K]:CRR^>OLN!8J DFT>(4=%,Q>W<SQQ!=/E0.1OQ0*\2T
M$<$G?'9]'QW:6CS[Y-K3>RU'8E,/'XJ"9J,.K[JKT\J,'A"OXJU'?O_P">S&
M3^L_\>R\.ZYCI;9N[!$7Q0#NST8L0S$PHEU G(/D^/II@K18VYBL*;ZCHBFI
MC8U2D_']_:CYC6>WFQ_[;OYKB\ XZ$31IEHE=)M(C319%Z_9DRN=6QH61ZO*
MSRT!I<<>;RP<)?]V718/7L@V*4W3S3J9>L'![*"3HR=_> Q3!WJ168DAZXDD
M,7SJ^]ND7!XE*]+8VS"YU_T/.AR<[SH$E[ \Z;(/75 K#'\!T0?^9)L\HF7Y
M,8";.2)4U-##G'@DW^A[TO=7'RU-TL.'?2NF>\B4G(&S_M)&38KSMZ^SR\F]
M<2A"7/S7]@HV,(' E>(\A8,1'V8*2MRN)BYN7YG., [NUK5[)+'L>X.WA5=U
M$N6E.;&,1ZW7!@0C!')[&@H(82$&77GZ4YH*9TPGL8#*3];J S%GY 4/ DAW
MY*A8.KT/2[P&1T'@&0],HD]B;F.ZCY4M97T_[[CLN9)A)@08VS[X#E]'3>>1
M">"Y0,IQL-::B$W9AHFN(56&7U\J'ZYJK,[R=(H?3_.$9?$_=BN7M;.XD@I?
MT9SB(L/ $,IE,)A'J3M+:3IKI-+)5W1(W']]LKRN6W;]GDX)YQONV&AWCGDL
M*(]N"3@T ==J<I<=_[W#)94LOKF3_"L_H\-:R.QVM)TP^IMM1[&!R5AKMS#+
M/(QH)BT<FH[WZJ(IY&N54J:<7P%?W8BN&BCN\414ZVFDM@^L?&#C] *$ V$'
M):8H;*OGN;G/Q,A5-,;?Q;R,,&L/Q0T_ASY,@UY!W89-++>B*GA?$U0UV7W#
MR06B]6HG7&OJ [E+4OCO-1I]]&C9^_X@>U:%;TJ5+ E:4FQ@BH4$&B<<Q2]_
M2Z#,1XB6M?[N5]D]^TL/I48_GQ)_QY<&G?^$JU%J1XL@N&T29+A(]ID+/#"G
MYMKLWVZB*QH;&W[X@!/J*H*O)]N =\LLB=T2L1:@]2>$'!/EDV#%L$MU6O?U
M,74&4/.A^M7%)BN]GP=D6[85Y5,>+TA]#COTY<_\)E6P<=ZFE0$(3L/[;A:'
MMMM6/[5B5A7'A9$0_K:%O+ KG9+:TK7%-_Z,<.XK+<#:C"$+W6T;J)9P6O].
M-KKT_-,9ZP\]B?<^5:C%>A@8Q#Z7OD;* D T_? K!L DKH4<BL0T ["4Q;R&
M_B_&?X4!K-<SR\"*;$E$%N.QAWT-Q@H\BF!OS_KHU>,SKJ?W61 _*.>QW(O]
MJ'1ZJ0X]N4;GV"2ND>%@Z4?$&6)7-2%YXPYY*L))=K2L-+^62^WQ^MEN_Y2G
MMAY+*]E5+'L[_WK41-42B%\H!"WG&S<U6QO4-Y]]=)-XI.T;TCM]>>D6$*_8
M<_"Q70OV3'QS'>W1-FYREWP1=) N&.C23!!K-A@=51H/.D6UN65&O>V79^*/
M^+AEADI,UI=@<2+8@'+H5I1P:/*U,?\FFX6>W]521?Z+%@'K,:H]BQ/*)Q]%
MIP6FP0WI1XJ(Y^CQ.8\AH'8Y _AI /QA*D=U-3)=!;0D)G?LJ\_6E.+W]+C>
MBQ9XZ/2S-3_4;KJ4FE]\R/%-#"^OZA@#N(V=1L_CF)1T"W=P%H[4'[I;'<#K
M'3@Q&QI9EDFYL!1]D2T5MUE#>Q</E(E[/CD2*11)T0#974'6?*K,>-5>T[EY
MFDX7EQ1J@\-\RCRMT>.YI;AU!7I36=JBBT-DWN3OW:YGJ:S$A,2%,0T/$B0Q
M+^FF;KA[]4<S<E3LTX);22>#5K8:M61O+"O)0OB96DHF0&$$==?:_G?PK!']
M2'.&&:O$G>R9='11*201NO7*Q89RY&$.32  ]CZ'!3J?@^5%>4&3]S$= 5RK
MV7(YCB,WZVLCC,\2)DL6+/.=Q(^9']!J/2.V=$JF6J:>R:.[8! &.2Q #:P;
M:[+-5D/;U8X>?!-BW];='R<@$"QUGV+QQ#/LU<\M9=9N['PU:@MN(LH RK^/
M,P"+@.)1U'PF9.L6BAO[6^GOWM2&;<Q4+!E&Q&S<GI>&MIEH8,=T-T[V745?
M3W43],Y]V?O,BM_.,\FT]NY UXFGIU?Y3(EB\V4)%$.$TH]F&=!_S?;+X$,4
MM"?GVC/YNH"384I^ZX^3[@U]%K_2(FTCS[KE1><P9 !*?80<"JLO:O_ZP< :
M&4WBP(8$)1*NC1R<4\@>:-/R#4]Y8[^;B?'Q\5DTS!>=WC)Z3#=-XTSKR[A;
MKK2]1@YG A!!-:!ET55](?Q&VJ6AN12G+S798Q9Z\&(?];:^8X;\Y=-YGL+B
M>PU>I5Y4)//WO1#BM/=&MX,(I?8X1^+2E_"YVQNX!/^%1V[8W5F%U/,S$14?
ME8J^?GW']PT+*B\NMZA#.V2XB84MKWGXG7_]F/U:O)HE]?IQF>?SMF-/9C(\
MM$V%WOR^830<FS:ZH[GQA0$HYX *#,#=1((!#/M@(L>P\R]0!_1LXHBABL.7
M1ZL<QVW15UZ[EC>F5!LF"IZ6.[S5)X7)3.28^)0GR\_R/2)  MG>S$7:7)_&
M#\2$8Q\CKNC'ZTKD9@S1_/WB]@3V8DY-T@<67UQ_^K'C!MXA.S\*\??L[2?:
M9_J14/-Y(QP? D[HUVPSJ$F,# STW1\=<FY_X*<:]LH2PNGFVL,I]$9$SKCY
M(;B\P,4WS47G=,-C08<*:1<K@P^O;QZD^IZU$BEWTM  H"WO;\ON7NM95=WD
M\:!SJ!+EG(FBT?CZ8Z2#7\;01\K-"5PN/1XC&E>6P\I/\^_9^>F(V&O[<PI[
MSCM\HO=#RB%MFY/6&(TFJ0^SL_"09X^5QO42.SL7S-_L^5Z_+F#9>E0DY(;7
M*7%@MV&OD?R;EH^X25&CRE61,'%&VAX$B_AW&2%+M'P.[U3>KQ9G.0ZV7,[+
MA#GOFU4BS/']FIW[//3$TA7R?MDS%)?+K)-;EWR2]\3-%\^)IDSR1QYDMIIE
MLPCU+"T'A5<#XPAH/C"@H^;IMZSN>.IL1>/QNUS>\K?^J'X8.O![,2F]$\%4
M36R^Q-^%Q<BA.5W2R==P=4R\W\/3&\NG39R;Q@5TM?:%'L\P@!:>R)LE_[JD
MP>*;+6N0TC2G-N1G]9O>6SDJ=W*"_MLS;K&;5C7P)=*-&#N/B:&SAAI F&[!
MM.;'P\?3WSP3U.6W^%G2G,0SGO4 _K<N ZP RQD(FMF#J"1=U$0MG9.=@.,-
M75J%\OI<T./CU=LA;>'C)+V7:E],T$:"XHVT%P2/*TF4PD 5_<ZW0N0<VCNZ
M-*B$S\[S6>!0>T=A<PB_MF8D-#?[_=,Q2S&5"0Y11T&3^X:2-#E: ?0F-@Y6
M?:%#C*XY]+MD!SS&;U[F/9P<@543/*M]V_,>QZFYE"=O/!3+F>(%5$+_?8-Z
M9H<509//<=4 ERAG;Z$7P.^JT#&&KPLX?D505_Z(/U<CVY/Y-U&('.:P> 2J
MFB03S>?)E87GY*=0C\[]$M,Q*X@QE]=Z[/3ED%_2\M@9PZ3M 1[Z'(Q;C0',
MY]B/ZX"UEC")2?",=PXQI7J(:QEK%5!9)DNANYSBP_K8%F)$=O63C13R0O^T
M.Z,3J.<^3*]):N0QP9Z8?1>Z>&Y$8#]VA/]PJPCI"0,@FD.CKH8^785K)A^M
MT F@=Z&O/YF*IO5W"9V$;I1%_F+MP<X_QO%HECR$),H8-T3G58PH5@^I>=XP
M?WF+3_YG>)3G(\\0;D-)$AH\5DA]JY^$6K_4P "&UB1I3XC0Z&V^^#F1880>
M/D4%=_Y'U:]')VM.%E?+N6/M+.4SY-,LY=,>P$R0?<S_P\8F 581@*[F$PLU
M=R:9Y16YKZ3YV%THG76Q.IRXF&378AX@,=L@O'RJU>BA+.L\#E0OI&:B69@&
MOIH!U%[]>Z_TW_$O1^*B=T8S@'<%YRAVR!84'Q:.$ETQ.4:*+R?XG=R]5$YA
MT_Z5:4\R&]Q+472T8GM4X[HMZW'$X3/U$FB51[4'K4NHQJ-E :7;;G;M%!.?
M];>B>(\6"7O/VSPMJ_D1MNQ+3/F"::VDFM&>0;VA'%-UJ<ON+BD:BO* 3*0Q
M@5UIMC.LD"H80HXBUJYODLX1V!\ACZ[:@N:42/5<JWZG1_S3L\Y&^/>OI@\<
M.S_0=^.VUF6+@16O]5&*(NA"-B8&)#X<.# +=UXFO\'Z>U>O?73*\D3[YC;9
MOKM^ZL@+C^^1Q7^N$L0Z-R<AY'?@V["/B&O$S)1F3K#T9]"HGKKD^2P)I7-5
M):3'GC<530]F )80[7<<J/DR7-5R#%T7?-UJ(D0TJ?8B6-GPEH[VDXL*>Q1K
M?#YLC<JE7C>$^799JK[8&V%]>H:F2TMBRH8A$^;DG2B_R0!R[;%'H'=Y4/,B
MRPE4UGF^R;&N/_:I0TN$!;LQQ?^+O?<.:O+KVH6CJ"BH"$@7@H*B=)$F)1$1
M$!$0:4J+"$@'D=X2%>DE@@(* B)=2J0K):$7$4(/'4+O))20GH/?S)DS<YXS
M<[[OS/N>WS/SO7]<DS]R)[GO[+W7NJZU]EJ[ZHNUBQ)'5!(O Q 4*Y)8C7P4
MD_-R0JX74L, 5,Z^V4;RAS 3 [%Z^^SK_$J1FVX>(Y;"!N^O](2M-2@ ?, 7
M\O'G:E]3=93>Y52GM]]<P[#E:07E?4U:U>[@>LEG,$C16/1%],+&.NDLGXM=
MLRZ&:&$9 #AY*27<U2\JS:&YW%+/'32OZ"5YZX*2-*YG[_Y]8V[E:4@1UYY2
M)YHH!FF&3 C8_,(<]+)LW,,+#EQ;,</1FFK2_$1VNL(M%*&4& _U(X_U-TH?
M%_*2EA;B@.-I\P)58]DN!:S/CVEE]WY%G]S:Y!&(P.S-3]EI=3RY!6AR;^XJ
M,Z:?$<,AC/&PS6R\J][HNU$Z-SZ\C>R0O]3T<C2?-=IX.&3UU]JGJ$VO=1#[
MT;>K4H_C1G-3S0<#BMO9)4Y1KB&^:Y=?\@,[1EP[LAE!R '<2J0\ZK23(O^U
MZ(+)-0NM=Q*>K@[.O G7[8S"38V:CK\&<X*?9\5^@#6#4"[HBP$Z\WE5$]JI
MP7R#OJKOHC/<%W69)J=?G[+A8'WU-:DB K# O#\[7T"]R#GGV HY9DV,88NR
M8(O>?G>6$ 0*APE.C_RI?Y7X,>X#M\$Q9\4W?:ZEM*]@>U0X U UDM$ 5<5-
M^6-&BRLP9M6)I3O/K%:<DF6?!H)%MJV2O#)=5_0%Z*<Q. &]D9/3O0Q 7'6
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M#!)([S838B7V?B?NKMBXF\VX4J8-#0:0;5<2.N:7(@ZG&VO?ASF1S 6#S1B
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M^62L=1<L!FJC*'+CO;_VW2TL[28$VCED:/NR.HNN?=5_&X5)]S,I#W5DGV8
M4E)DEH&4E0B:Q(:*1+[R]\19X_&<C.=KSF)_&AB /U0Z1DV@P.8/WB7HL503
MMJ'KSRLVA*85- _G;? EI:(ALY^@"TB$92,&:(ZM09 HV]UJ== ,Z>:;%6U>
M>/8ZF&5ORYO@B^O(^U62MO'@_?ZN_4S688_C_I7ZM84M9.20;4"&CJX-.(:.
MU%DI*\ 56__HT;QDOJK""US^&UL"/^B%6^*!X8NG/63<CJ:/Y JSY^*4^60=
M9A-3-K[CKD@?,M(8$/TC#5.#CS;LM4'8#J9//E5PYYY7#N(.:.B"4T\[N Y$
MR-T:T@XU X)RHJQ*.R!AE"R2$'M^B#TJC#74\=R1QX+*V7FN2Y0,@<2=+"*X
MG47+O2=\2+"=[*S1DG7(>9]SQMX"E]TOTU7-QLD^-(GD8?I9Y1YG<LP/!B#3
M_P:<&@AKJ:;]H290YEP]OD .UH.T,K.=BW20H_,"N0?1K3#QU7T8O^L,T):6
M43QC47CTI[O>N/$W2@0?1+HB<>91(>IB:5+7!((,7[2C3!>A"J!TO 1DT-)N
MBE9J'B8XN W.8C[(DU1).K3^L^[@50J<[M8-9  >4F0T:;EJ6K;5O@*N^H]!
M6U6M8LL-L(7J50N>+0%LX_WOD%;?O/M!5='+VN Y/?0:A,TYBZ_4OF6=F^-.
M<#<3,S"QN:Q>#Q\17S)GL7ZA,HOD>'F, 4AL?VG2K%/BOAK2)Q&YINZ@V]D+
M,P/M#U!-<P+>:#I/Y)4NPR)NF-3.J\2,(,(PXLT1IO6R<QC3[!!CO'GDW=+\
MRI<#,L<%PE;$ALY]@7*U2@I0)$EU4V"I5?0. Z! UQD;-D>K +<4"N_>72<_
MY-&=T=.Y68MA%J8_;V33).*Q@K8FNB%DMP+ZTQEM<P9 B \R^LLALD@H,M92
MHGU@AL?&(C-2RW3HP%+*3$;Q]S;K3P:@\<2;SE67$>],2P/IO^&M$_^T ?QW
M!%<G]5F_!]40AVA/,XW8"_;--[QT@U>T?E-9 [X#3,7O6(=S&:5*?DS5M# 5
MY$\L$APRW :+@\Y3'Z1CV=JDP&W.SVO_'G1PJ6;PYMVNWZ8_8.$_ N:1:SC(
M5CANLGV@(Y6_)!/8X,9TJIA=JWN#TO[;3KT;^&"9+@]M)RO!#R1*/5O]6UO)
M[:U\UVH3E2P>+NZ.7>HP%$U,I'<M8GKH<K1DZ%6BE'V*)QNRR.4S W!_T,HJ
M[CR%N8]Y1"OT8B:/H+/NA,X&5UX2'BCU(/FV^,3D.-DUAP1\O XKSVKU%'))
MG;E</5IMQYWG=;5/OK[>SBUOK)R=OO3C:^8I XE^)-B2%?P:*EUK'GC"PKA#
M2#/%#2!GZ W)1+'2I8BI<X=1\XV#'LL)HN]#B_63X1]>?L4F#V'X^-8E=M!Q
M4.$:/&1S9%[0Y<\RYE$_?83;X+[YG2:@UQ=SZ2O)%J;.13V?(9IMO;+*4T*W
M6,JY0O- #K\I+E7T6I 2+1ZV.%?%1E[P90!R=\W7SD&UB4IT#D/B?2D& ,M)
M'Z9/M0:"QV8<)[RJMB>7J&.37Q9J7)'#\H8):52P ZJ"^":4R6O)1B=D#5WH
M(5'+]XYP</'+8#_Y$D7T:8JT0D9 \_4\1^2.-<9;A/#._1Q2/N 'T;]'Q7""
M;B@F!/E<'C+]<\'S,XIW@8LL@<MO]V5[2[]0.7R%AQW]]6F[VN.X2+/:.[^;
M#KI$^8E#<ZA-[WDXUT9*;:;TCP]W<%1I(:>RTY;IK\_[B?L^"N)V>^;3&TH[
M>W-2\Y)L1[D6_[O[ W=,'\D"F+X>_UE^8-O#\LB_UGCE9Y9 9+(XKPK7[6GU
MV>ZK"&@)M9VXA4,>SGFVD=S=9IQ*+#1"<V>.^Y\^=-#>V<DY"_RJWAZ4U8&:
M:*5SSKZMNQ994!YF,2(R6188<KK-\21S51R3UP#4^$L:68:02X0XX$6P!D62
M]<^'JYSLAR6WV7";UH.7%W+$$P]8@LU7,"VSIV3:P%%!;)%"L(KV0FO)QP]/
M/2BX6K[SVFLG9CM;)>"[5Y%Q % OY;GL>!]WI@QW(Q542CX:#HA)J!+E/)5K
M:I=Z=V0+:3KMF9L;$[2?Y$7^"MXALVPP )Z>%T!9.-3]P87G!8^&DW.;*=W\
M-YL9@#=RP!9D_("\*_C\*L'")N/XQ-AXVP\-EO/L%Y^QD%SI+&=+0F2PIR;\
M8KN;W5Z>T6JBL2W9N(NCV>/B%D,B6 4E)T$%-OF8 3]=111Z^&]!":7?':.'
M]Z@9*+:NZA_/C=P1/RG=%,QA3B<))4<R ">9<".-!5%J8F7MO):Q8V+5&<EW
MII<NVHL>*B='#FCY 7&&LR1V-2,&P%;TB'+=K8#-91OD&.+D[#WD9BZHOXX$
M_X'Z#O&!MX ;Y1O&1>"#HHU&3,_[:5HFU=>[ -I)/B!EY*1K1CZ*F#!X)ZLI
M^HP=/?,>$ SEVJO=_("E>+*'!.)V;;0K-5U7;-R@&C[Q,<#FFJR61LNYT-P"
M@@3Q0_G#"+W8[N-?1<,M ^0,AYS!#_9FQPKH>J/I#("-/Y@L.;IVO?4")FLQ
MZ'V<4W^OF*%.(&Q-B?;TP',K#%OO'CRG7:\VX/ESR$*@Q[_IMVRB*>IX7$L#
M,_T, U#2R];&QN%\>7+S4.5)G0.ZI^ZVD09Y_@4B#^7"_(1^/*"KG 74E9-E
M?.48&=.=]2,O?3K$+?.>./>L;J;Y]/!;O)@0R8N,D0;.-)L8DL=P%:B9E]OB
MM\:5/.MD]M19"6TU^-EXZ+4UT%E<R[HYV6W"Q-S8F1!XX3-_8&I(P9NX*[2]
M-S&DO069YN"=M[M.W$&E4_[\F=E.&.-VMAO'9DR$/>=%+F5^7EN'&15C$<3K
M/%1X)B\#\,,5MCKZO6G>X49'C)D>7D794ZGX<>.E$U=R3F10:MUG#_;4ZPE'
MU"")M0"&64+3XQ2V#[# <D/J>VM5.DH:MF^+\$?(<%$#R97S1_Z:=Q[<+O/7
MWRVIO?P6<QWP_PL@;]**87.%X/,P1VN]1[B^2";B7@<AKA]MYW ]8?"WJ;)]
M9@@PP^!55(G&B9N:$&:7V5J>K4B*+EHB0*C3LFHPSYNW%@=Z(]()5%Y>L$^Z
M(8C^!%C$CS$1Z#%4*7CS;&W5L_66A7G\8O=2#<)GV@ \S!?D/>0IE%R?2Y^!
MU#!O+KTLZ)PP*"YT-NHNS\8C(G/?6'ZY4,N2^$NL7+KU_<O@U]") 0@/]&\_
M0A//" :@ZEI1/M'1NC:UR4:A,5%J:Q/AP#$^\^</E]W;E\Q];:_91W1%3TJZ
M;O'_1Z>W42HP)_?[Z[.":H[2KT3J$L9@D\IV5M! Q( +]3=>'CUO&#-S.=&
M)-.@^3)V)_UM+/EYHU5C\&!J(H$J!9P9+21KSP:C5D,W<,#6G%8PJX^RXE92
M ')(3' VD>R.N/.=')KF3% <+3^K<\*5 ^X 8%LRD^C]\BMW,20T**'ZJ4FH
MY0MP=!471O+^(^YED)WG:FA\('=M7OJ&?WBJ/?Y#K?^CUD*%[>J6@#WM73'K
MNU=;[OOU)/2.T<&#7YOP6SR/5*S7GLJ5ET\*JS<R "S[@@)FJ3K(A&617T$J
M*Y&0!PMJ1OENL.H.D-F\QFHP?S4V0V_K@H#S>?NX$.21H1[]R@:M;(@AC][&
MNN.[Y,[IVWAC@>PP^ZG03#\&X-[' W#3#,K08M]J);'KZ\F_<RMWHSGOV^O;
M\ LAMW#HZ.1X0J*'@R?)G87T.-1?^@S5M5=A9SSIC!(ROKA!AVC;J-]*IU@!
M^S&_C"RUJ^^[H>\F@#DCZ9>FD0?$K,L;L\PAEMC=7NGDJ\,2Z S[D &X%=LG
MZ)6&0S/<=M;W6SJ%3[0DP\*6.R.!<",(S,R@%JLNT);X<7B_QW** ;A8_K9U
M=5IGSK6"=Q1Y]1"H$3G/_Q[6".]U@OJLPYCWT[]:] 5N0GZ@/V4EKAR4Z9D0
M]4J?+)52,S3 :Q_</;M1'4@*GGES,ANR'2J]O:+W?I<=G@%<A'J.-J#;(,?4
M3+.W@P-$1N: [2]FP33<2Y@D)L_P4M8$!5W:XB4J9O\])(\.PQDFI#["B[V;
MNI%";F+#?E!EFPLHI<DL<!=XAC?6O#T -Z#J84/PP<8D<HNKKM $81SKU:KI
MQ6=,+.+ZXY+%5B5H>4WOY%M-!D!*"IX"N]RY9ITYRD'\%GJ\ [LA,VM,R@$_
M))9GS]HZWGH"IBE:]Y#*8,F^9BK)^07 SX[>YP:#VK"HY,"^(IQ=L?,$?% U
M[V]-'%7B(Q(G$^5SX^RWOA>LZ(P7DRA@:B+)F."SA/M!KN&HQ7U_2LID %Q]
MU>-:+)US:SZ^$@W_+4O5\@N2Z4#PK-;?72\-/C+&*?Z%5]$+AR@+DIX^,7'^
MW-6&FCK* \0IU>HIG07,05FM'K'7_=K(L*3HN\.DZ5IXUQR].@[7NUWV<EXN
M6C\89PS!>&_0V A?*$4E3JBG;O9'-R?  ,0@[O4CY0+T(&/E+@,3?V9W?^,"
MI4B9;'.N\[T2[1.@ZC?.A7<'@:07*W9T':[R P0HX+Y?^>Y87.3YZ9(Y!J L
MCE)S(RE@]/ZTO3;?V0)ANCR9"'N YR[*KME2-:HK![U_^!LL[&5= \=3VB=L
M1M*6SSVX255Z%,< S.J%624U=X=(KX2;"Y<"L;W@5BKZ>R&"JQ_FG*$X)^Y"
MMFY//TP9?U=TT-P,+ U2C,0+M-J(F%).5;J*9)$<1$BO8+-28585.8\%<MI*
MW[1A&8!H9A*B:>UZ[D977HG!A7_<^O^; *% ^U9&U<^GBHP>L)V!Z-D5/_D^
ME1K.E9%M=NJ.W'G97VX)4$C0_G?7;UUQ"=D#$2P_ND0&RS@6DY(1=CELIH]*
M6<K$K4I5U;,220P !4P?X4>%4P-V%DJ#'X_XJ*XV1";-FW^R ,V9/<K,T)BX
M%3;+B_AA3_N*%-#*CR7@:V*>B:B:;5E */L@Z.PT@HN81V%9RQ0>+AAN 'XO
MB]B[Z3]4EB/CP9MDT&'S"%890>A\L&=*>Z,6O/)L WJ)W7'GS#:KW=HB V!!
M6)<4NERT]XH$_/8\^_V+BB=P]\V,:K/:-5>R4Z!Y)_J2,Y@#)+%AL1WNY+Z_
M$:D5]W%LB.M1_N/&6/8LF\\K"H34Z!"P+Q8R-K.BB]04W$)$<EV+CV"Y?>>I
MX4\Q8/@SZB5:3)7GL75"W6RT ON\X(/Q=^\G<BVEGK\,>'[FVEUE$66^3=<I
M^A6B)IUSAVG#1I "&0-7E:;-;H$@GY=6D%-Q-#D)->UK'S-4?.B\D\8?%/ID
M?<7"6VVMUP:=:W8&>S!:A_N@8_\BL4)F<:X$508@7 ?/;(@'4Z_.3J <=(TW
M4>-(@RU\A2/LRUC'YOX6Y+ZY(JA*PO1Q_G9)H)5^0NLR;]=(JUZ:^ VWT=K0
MP>TCW1S8V?T%U0XF70/)'!$X]15Z5!!UC?:) 5AL#%"BH]CHL4$T<;Q9- -P
M1BE"(1[81U$BA'\9S?3KI4,^A?N[=_7=^F)OWI=U%O8<1C074A]HT#NZ-(L
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M;*S9SM7B:/-=97 ?,NC;+X?((_*P,/H;EUS]LG*WG\*C22S 0MC=+?5?3#N
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M[!-M0U80*YKDQ3]W4<PA*Z*[BOF?*)=HL)_J;4,DW?=F=]+@BZU%ZB=PKZ&
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ML4@L/Y$&_(Z*LM:E72?_/X3G/^NY> 8#K]YL@C1#QP?D^TX,J("N7;+07^2
M!2I @T!"X:;X*7+"'HB:YZF*%SMK00WC)4E[KF2AS^2 T\=2(FPBYAMK(#U
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MHUT5<I[HZ^FZTFB&YNT[.<%,DU#;HXAM24CL///X]PISK6_/X"%;MVC)>[7
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M'^$B,O&B!QS$!R=R&Y 9V!5\2FD#:Z%#771[DB?S6;&G-CW,OZVO9EREX^@
M&.%CTA%EVYO.;Y+8X=/E7ERM.'=/Z.4L4*46JZIQ H26*P<=%#31L'$@<OH_
M!1K#?C6)$!B#H9C46/J'<:^3OGE7W:F]NO7Q[NS%3SRN:2G'D1T4EI$&[P5S
MT[847 9JV!UJ?!\IK%E.9QFG4;?UXKKU58F+4BN@\RAK=#"H8J L?QW!U"
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MW7PW(DP :#PZ(G=X5EG<_FW/2:.&;RP>J5+S(V:=->6:,=_[!)M5:.<&6)G
M-A#*OT4%>--P-]SW4EP<&J(M&'[I]O7UC''-KB/ZMO]OYX:\68/U_S7#_YH%
MWBD4&]Q9D#MC(6W/([:XVA9W-#'..@I]:69[3]%.[D%G@\J)E+UTZN_A[971
MG/6;J8=E*Z/R8J1^;^>PIDO$BK;,WXZ@DR=S\*6J\-U'^S.'*(WC^8CU$,$<
MS[&#?-M'A;+JNZ*@7<4K<9P"'#S&/-I_NQJH0^R)D<W'3!%CT?K/:^K\7FF
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M^B!_$X]8^)G(R^;XYN?&=,((5U]^Y;:"_.'K'Q%S?B@QZVW^Z)R'0GN%M2B
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M< &^$A-(NCKTW+%LX%C>YL-Q+0<3DTBS4::_,$E6N[K8X?"9Z&6P=B_Z^ C
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MA#>NK?LI\,ROK:==$LK@CURF=[M@1)\AZUFG0WV:[,%_'V VE-E]C7!T#10
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MXZ((;2BKMIG/]V<35560N'C&!9>\#5-P[&3]W*;$:?+D%&L1MC[6H7#$,_#
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MXAVS,N2%W 8++2-=\9BCR]2^L&L>"XQG&SL(K,=6!TB)5_Z\<15(.NVTBV1
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M?%WT6 &(;A<9FDT%;^?WW16]JY@%O ?LP9%[!PA/;2BG5;TRCC,HA.1O6!/
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ME[\?\>?>@U^7M(WVRI#!JI8V(5L_&5  OWW,6'M)MEQT" !;4@$-3-J5QR%
M!G0EDG52==^SOB9]#(@Q&Z(BGQ'69LXIDWHAW*GD6.Z%E!(5)Y$!$1M_ GK"
M59_I]\ZR>E[!12=%:&1!!EM*W37J4 ;3-!&!1_R^M["PT6NNA%I5=[F=<D/9
M[$.UE&O**>@R ^OA!-U<8T.C)DM[A#NO9^/Y0\ -O<O(FQF&@QZ)5=L&7RQ$
MN*^]4E67T*.BDA=.?Z&E]?\J^.W9:NIY"V8'SZ1#^6N=D(9F1@V.I:12[4&9
MG*2G11'J3J>J _1>!:CIWK[Q_N=]Y#(]B@N.*?(5/3I''IUF7\1[?+5)0+W;
MLWOH SR+]WA\?T.YQ\_.Z6)9G(M0M$.8PL-.?E:&:Q.,M !.,*8#S@9>]L5&
MDK7@N-QU\K&/Y'F8H*_4L8\D%]03W7B@9P9"Y\M8SQS[2 HYFJB+7ET\+WOV
M'>.7%^BT8[MWNWHNZ:OVBJ=F1S+)0N_'JB,\&R3#<!NFX"8X7G2K"1J,8%&4
MP#  :?&%PT?-/ 6%,2</&.P6U(5VQ![T!&N,,;QU//,]!5AK]3>.W?XW2F #
M4 ZM8&R)HG35C#6S^IPHNA]1TAE 0A"YZ(B'-X@++E!IV'0D(GB*_W>_22[$
M3VMP8WT"*;ZW#4O7<)L"Z(F#RYJ;_10D=2+V)DAT4A1 M,_I6@J (#B8G1J"
MB^SYSTHET5?')=+FV>P?G*GB_;J9->B#_K3F+3;&CPF$?N;]-$\3")HS*WZR
MIW6-Z7E?2I(S\&I3+D+[MH"ZJMFPM->N<2ECDV#N??E;>[G2 !WA@&N"5O./
MEIM.:2F' .;<_#BT)"&2DMVTGO9KZ_#6LETHRQGW!O<16.B59;_(.H<_./;,
M^/>BQ?/Q7@4'D%<,JD,QU20E58#;$WWQ5/SK\8VW"Q6J?2^4]-<V3.\6O3S)
MY]]^\34'];E/1:@%#_6%R'\)U'DK6HF=#N?PBQOS/QF3VM,K6^H-\L9DIP M
M,Y"*V.DPH8&;XY-Q<>@4^P(0/F1K8U.P.N!EP/#]D1>27_QOG_MGB>QV/-=(
MLYI7C?JUU8W79YD%OJT_AZ,]L),V>#B]/=9,4"<30!(KID/LVA_3\DW#<_3R
M5*>^).PJN^%$U@=R1K=B5 <O#+)F!\Y[/?8[L0!9,8,BC^%F<XV,ULW9KB]T
M4<HJN\\:B&L;N1%6YE7!J0DR<3>Y7KB=9-ED<E?AO$4T2B8Q'K! 'N1H^/4<
M$D!G^J &^- 9CW?$.W7#S2L53#V)SZ<,>HY0'KM("1SG.CK?8#-&O3Y()[),
M!R@,Z8D%?RH<>6[=Y6&^;&5YRVA,8QL%WJ&RGB&THFB^IX560F:BR\N?- ^"
MGAU>GR&[Q?ZJK,WNE#+I\[A#73L,_K2IQ#24SMG'M?DL8E:**)GR[! MD>LK
MWNO&^.EK="MDRQAU7-Q:6!U2V:D]FC"0]QC1("J@GDOD0U5T&9@VN==%:R^@
M]MB[ZY#O:T'"&_$)[L"IN^Z@9M_,^M?IBK_L>JJ;-:UMO*__R+UD$ZP!APZW
MA:_ .<M]?F>HQ* @>M1H_T?U[3+;=?'>1$@,.>':+K$-K_<S9R8<J#]A.3!K
MR$LVNJOXC00N<#K,:OCXZEOB+_UM9_#65S+;EII/'H_+C"U1DPJ:J'=/-5C5
M2_CR7%,SVUYG6(1)S[8!67MFEI]9Y7)I[-MMX3(J38_DB^Q$9/FJX6@_3!F;
MEC<B:17*)^#*J#_*;U];TD^3[G%/K47__DM^F^E_D]^.G]-B-?A>,7B!&;[P
M):O+H7U8,NO69@3])Z/!^LN)KMHC+.U[J25RD#S8;Q1 A]0 :BT==<B-5$$J
MXJE+IE#/0PJ@,)I*DRWJF.MA%;A+JS#=" K .X\L<IS1,>2[\*\.*O_)1K>@
MWS9-^#V^"7$42'V=SZ)[>JBK]<H40.>+>CX*8$*6 KC7 <TM^Z=,YG]&TV\#
MLU$ ,PD40&EA*=(3T99\PY@DJ?7P<$YO$+GIUF3W*KI;4$/PW,@3TQ\^,_HC
M0_A8W%SS-#MJ)A-4SE$Z _^MWI<?0UB,:&4('N-7'N/ZU.I@?YHI/BJXE?T3
M+7U:H/2)+7=XR1:1E0)X-(0J?8H/S2H?GDGS"+W;VCP'N']?!5V,],/[44%B
M$_[4S#2[IT.KLD#)4'I]OT/!GIWRW-&SA?==;*%B=A%A-1]!=T7GC+?P%\'-
MEW<[A,KPP9B\\-O"CZ>,?=[/6I)7/HB>5=I'9)B27I.O^VJ08N#6S:0DV*4S
M<WUN"OZV=I9.(@EQ^K]G8!)&CYIDZ9\XQ3,%7'@#('G_#=9$\]>B+/*O5(_]
MVR;F65(]!3"?XPDG?T<=&1D=^N^_I$;/,S/(0RSHD%6_:[IB@ :G<P>P+:V-
M:+6V7948_<B.9YCY0@VZ;Q%$K[S19GC5 +D&D;*(V(9@E. $P8'_6LC]%7;E
MZV.82RUZ?[\Q>:R>+=JUIR7I)[Q1L,G)*,<H?WV/?6THJ6"Y:,W=XHH:FJ_M
M/%\.!4 /V ZYVOHUJR=C4JFNT2X*?E%)O5S_U^V8/4RPY TT1UZ/?AC\!IE=
M1P7-%'I:1*Y"Q)_40RYW*^]92P F5B\.P6!(KJU-I64:/P/)M\QWYEDT36"1
MA<K)C5><]PDKD\H(C.FKQ^E]^5%%KL\^--4!E(^?MTS:SWU--=$5^*F#D.I0
M/3WCMT:-[WM:G,T<U?.&[]<_JW<S^&'(%\M%6U.2-:WC#)+2HAZJ7&E@G_;T
M:-6VX17?HF]RZ06KPK'2)P;Z_LFSJ.-KQ.S-"(-A@Y%G48-G82EHFEG(FWHV
M'"WAW(\5C^.@Y\YXE#5)$NVUR@M;  6,3,5ZE_&O:*0M]AP+O"X$'O0[B._=
M#[H_3_J!*GSRAU33SP),AV^=SL.J8KGO4FIW$6FNX#?(BER%4,_"KU99P<+!
M@=Q"CSJI?V9RPP5ZKFJKMR>OZ5?<):)H,/*BJQ0 BR\#-KFN;J[$[AJF:D?,
M^&G/T1?DBIGNK,-HEUE_ET;ZA$K>=[G3D%B)^8<#!/2K&](+PVU]SW;"Q/V.
MLTU+Q?-ENI/&]P:E>?UIT\R=S"4.+,,*89_7\+I75Z>?^-R(CJ[^%7;_[#JK
M*ZZN6C04;[?Q159Y^[P03,EF@VU_Q.;AM94O-W.PH>JU$\/1D*=+*3I_*.:*
MR,%&&I9.V"7PXH]>V8439/'HTCYCM;*YP:VL2"1D SI(($@HJF*X;SK4#103
MF9F;\ ),KM[ZK>)WIVVFQYH\ZZ; DZ@]4(;W7&Y[ +_*U]5\22#&9#$'NW5G
MR+G[A7@Z>+M_A&"YO7*HESQ\#C_KYN<<X# W0$A;@X]:MKB3K^$U;=WL3F*%
M9*7N-KK1B)U^KD\7M7,"\<@6G=<%MO#C  *)H'XQNRYI)\5I*7,7"S6Y6X?H
M''27?D5Y[+<J?.;+CKVQJ1Y[2X=:*D3_OG/W?X!NZ'^F ?^RQ :FZTM=A#]V
M^,I1 )4.Y.!HE*[5WSW]]*]JR%807L2R#<@,:P&7T353 $$(U@R><S:<+"M9
M!LG"VQN;XL*?GX"Y#=)9I1R6;WY5Y(L<7<4O[?=2 &_M\)K[N4.0D-WNW_&R
M;<E&+3?3^ 3<Z@XOG[B'F^=?3;D<=?_6]PNO'P&4IG;V4_$*YFE)CQU"ZAE-
MP?8X^;7A?"YX:5"'<E,"\3O.H45)='^8>L]THL0@\=1)- \P:+-L3TNEXX7L
MHY&>2_.E)5&QCS759)]^8/UZ*Y<#CKU' 81NVSR[5FLY\\F5-,_[WEY"*-[>
M4]GPF_87]VD\>AFX;GM$BU?8OU-44U=6&],\)35X\:R9+?KZ^V(.%:]']QB\
MK.Z?)/XP>!/S&@ X=/Z[ET1+[!]0 UMY*@4PP@[>=2W?@ZZ/4P&A2 -HGRGR
M$-T)KV@CQA9PDK]38TM:!C(/;+%%N*!\F@(H>@4?KONB?I0DM2LV3K['!8;V
M)<?\.E7I_5\MJGJY-L8HOU#81A V,X_GR]D]U/\,-=3*FM1PD'\5Q7R:G#96
M%UA,5,4LEW?97X^_#_80V54>/+&P^R3^9O_HA*+4A8@GMU[*_,'[[/F:T6]3
M%K:.'+"U42K)W@O.7(U9WOGXM%41,VL/EE Q+;!8/13S_N@3?\:1#KBV;O7;
M0L&@_H?\XIOSX$_[,C).'!4>\I?F?LNX?\MS_"L%H%R.-IA6S;XK%%RZFI6+
M4+G-\2>>OUHK-R=;.FKG^_L'5\/J$C\_50^G]A@U)"^=&C=CUGETN%Z]_ZQM
M$M-^Y+0QZ\[=MCV!P-=*:B$9&6L<8RVH1#OAK:T+F/C5JQO_DD(V_?J!C7)1
M][>;4Z+9O/DNY]VHL4F6RB$/, 56M7'*[N$*+N0(#W4*P!>TK.H=P.Z4<]E7
M;"4MN"#((T,X,JY6"TO3?"BP(M:O9#'A4CTX"VD![@K7KF[_G(-46EU+B1MS
MFVF39'N&YSG*+=V+!*[4GZ^X;J/'<= '=[=J,E_V@;&/,[Z(;RWTXP"!<_A%
M6\FVZF1H%);$OIOU'F5!HM,6%XYW<TKO]&)9Z@[=5HS\6=O4##WAJ_]URU-\
M;B@%.EOZ"D7".L+%J%&/;:E4.3#0]ATR-0F1C, "Y5,SJLN36]W?+G*++^KX
M\[7K!LW87%U6LIU^0GUUFC^#O(*_X#ZU.S,2Q!@E!7*U)@7P-6%7GG XW1R?
M0]!3(*TB\8AC]YD7CO]1GN]_6OM_+.](MP0ALB62Z2\5$.EQ]$1)O*7TS2G1
M(_F>O+7':B5)2B\ ;8SW1Z'2.<R&;^CS/YV,UI^ SR0JB^*FP\ O-VX>S)Y'
M"Z$I@++"SBG/-\*<G'';MQ+DGG1UJ0<_R %=8Z5Y _U2S]#["G8%WF FHR3;
M&B7>'8QK+3A*3%<0XDC%%)SU'])X>R+B'4@%6K%[ @<GLJNW3I^K%<0"M2"!
MPPE$EZZ<C.&< BL&V<]91M_K+18]ZZV:-!:2VL($:89KF\AGJ,SD%#-:6=IV
M#5LZ:]H)]4Q*\2JS<[%)FQ:S,9SYK'8BZI$4+<!>]]6VY'3:CZ\?WTH"3_(0
MP3B/P-TM?PH JZ\E>A_[A&5T)6?.3NA27>[L+;UUX_(?-GD'NK ^R1G'%',N
MKA3@!,_?O8!SYIA>/1@.I0">/J&BD7[T$*+4@_@!<1(^<A.\!KT"FUKGG9V*
M.#%OE8,X(HG[&1_)YD#?*)^F([\II@",]IU FZZ1O:4.A+-/27 U;RTV;;,;
MA.7_!HX_$3H+9FHIO%/EQ-\/C(9 S3?,;%T<Q+]L,;:;QS)S:_E<>NZ9V.2T
M%G<T<,;=?QZ^!2^QHOF1G=5S,JY4\?'7B'NW7MJG?OXU>=C<M(3%'RK*'M=S
MTCF8;YADRQKQ;QT(@0ZZ@*NBE;GH,5_Y=\HF>>0UYER_[-^4)'1#=2*O;+>C
MO*4&X7NY&XX'>A7REV8_//C@'"VA1HTCL0/6/(/>T7:O+GWGRT)6IC!=_6-_
M"Y?6(2"5AAOS5NEF<P20MID_9HOS3IY=H.\=CQ5$+!F!,7-2!?BHLC?B/5H+
M:,?M[H2V]%FNZI.VM+=,FYW%WA>&<1O\RE(R_PLA&@W8 $M.G&5PH<UXYN##
M>6 1=E,YJ )C]G)68A1U=U!3(\/4Q%I2X)[E01_LWCS,;:U,+RKGEJ_86EHH
M,HC,-D:LGUN L/B>PND%5-\_7N%!+1:C\*.9&;(A4KFZ/.&/J[D9C]RC/.!W
M]&1L8H&GPP,<?U60SL#&EGDK71*7D!]0&Z__ZD:XK]4A#S?I_HJ9[(X1'/H&
MQ\2^ZQ ,MJB[>.2;(+,[]BKIGA1L7R(+?*QG"0VN9\#G-5V8]P%N,% Y?MRP
MR ^N/=&#H 73(N1#'ZGE(D(R)TNZI>7HLN/@H^]Y[(*,M\[OL>DMY?H98SG)
M&LE)%(#I)0J@M]N;WVOI.Y0@[.U!<HVG %1DEMUV]E#!$CK;^1Y'0U <^ <5
M-;3_0\]0_#T;^*^DS<K_HM;_KZ#0'600!0 B G'"\)(5HQ].-L8A_/('!U)+
MMQIS;L'Q9V26RYW?I6Q<,O<>O(I9ZC"Z)M%][&WA_\>11(C<KR6E;BD+-('>
MU<HXVNV-5_J.YRWW]%BS8'2!EJ]8$1@NP>C38^'<>@GO("HGWA1\FA4,2BV'
MO]WL,<('X Z^HQA?>,ITN[.CM!%%1O[2%,#=O"045DS_D]:1-U$QXFY>IF>(
M+OG0J"%R^"G\ 9[#T,Q+0(,_/:K#PEU.#/(8XO([,C704$UTRJYTSYN/_TT6
M@]['=-*K^BV\R K4'VP+#:R7KM8TV,OLOY;^-(>C@.7U#?#&? K10+\H/?2B
M:-H?\%^D$=$%F0%^"1Y[>- @OX (4%3U/!#@KGUVJK946>M=&.SQ&>IH>_&%
MI==2D.O\]JSD$%=5OX^KHLGX.UV>A_6T6N.>J#YRT/03;55/D<4[?PIRG#BI
M60H@H/Z<=;#7K/@]XUK4JOA%WJ5$?O>4=868UTJV2TDZ9'J6+!4%)H4&??U'
M2T'5@QRT@J2A< H@R;<%E]6F#V=1%K8];!DL$+)S$])K[XYBHV\QUQY/V1B,
M]D&+I*_(5N]GV&6M#)="H2:W(G@]S];4"'RG/_26<[O<(%]=NJ^("KC^9%G-
MLZ5;N'#/6J)ZW*-J7R^1&KQ.#[R,4OLZ4Y-GM=-E;,-P _0F')SD=P&+GKT9
MC]-I="=?Z)NK#FGT<%6M#1-<> @$1 T*D/)V?J[MZ^ +K"TJ(#-'@<&O+SRO
M>JLAQ[W <;=I>Q]91Z;QU)MK -/57DF;;+0KQ)08B@2\8>*+9A7,H?O*. ]R
MM/7GUF1Z>*;/>[JNY_,L(X=.8%.K)^V7Q&_1B_T]W03^/6HXD</^J0-/0&7@
M37Z^U*&= @Z&8SFF*8!(='\Y?L[L&PT3A*6[IW\ZYX!/ZB/&!6*W]Y$T96PX
M[D,!1!WJ8//VL[&(EBUV('!Y#%9JY_G4)U+R\'2T4EY86'Z^2T^&CSC,B]R$
MVC:)(3=4@(XNP0+UN,:N?]6/YC78\?0_H2[>ZD,/8HI!FV&H+.G$SG%&G2[4
M]Q$ICW@)&]\R@/?0'RC/2QPQC]"+[CQMI'BKO<'ZR1*VT&AZ?Q=[JAG77 T.
MIKG?H&97@(MVH@"4UI:0X\9DS>$,"L#,??I03#_8&K[-6D;%LAU4Z$I_:'2+
M7BJ#NVX,;-:%MY1H?IJCGXV03DU$%T2./+B<6F]%?/?/DMLFOJ(R9@3Q-YS#
M=_C8Q?$YE#^LSR[=IL(1RO^@#S[/G:M>]HS$H?6F09'C6E9*3YJO!/7Z\=&V
MKV/CQ+MX+S?A/)Z ! J@"7W?_,M<_-FN\""EBJ)#5^0@D^V] :)&^N2*=WEX
M?5;F9.NSRM+:X)<A+Y1TH]XP K\B/]0>YZ7C20A%.S\G#^MT6X%S<19B72DV
MJH*,WK$:<;K:ZRDG1A[1]2!843,5')%IIL9$9;R'<\*7$#TJ9&8Q/1_!&EG[
M-/02.?DY!?!@!XH7!GX'LQ-]2:F%,'E\VP:GD5J4CQ)AT!Y-ONN=_J:(-8R%
MV^6"8, SKJVV$?)OU/=0)_?4TZ/>;AX\1"N:88M>1IH-EG(_U3@5??+]]>7K
M=TXRWUD"/[/R%DC") GT:/2+B9?57?MY*7"L\^>E$"YSFA/:;( 4[Q.W.;/_
M_KO+;\ .8(*8D27I#?7E^DKUARF TC;BART:"F#D*I!$6W^?5$L!S!=;(_9/
M4;&=NA;4!-8#WE:I!5*!7C9XEV??"7P,W%S@A+,SU'$7MBM_.;76?&?FOPLA
M:%H$N$TM0/)G.7!T=*61*F9.0@Z,81$9O^2C:>L2JGK8/4W=K+J[*QD\TZ+&
M[BS[+=/\S,YX:362=T5/YVWZ4W^-7]CM[*11B]>9D)<303L"LU5,ZEH(]4I]
M/06IC['P'J,-ZYB[\2Q_-FG>-75S^!Y(!64KU%Z#>*,+I?3ZYOL7SZEIWH5T
MD@8/>49[]QH\4\_\%.'GI5(GDC=@[$^/7( $XE/G[CWC_C&<OL.M&.FVFV]T
MF08M/:DWKE>Q8Y<^53>([?0[G1<[S^.>H1SO6CI>W\:O;B$06"=X!\=?7\7!
M1M"G5_8TV-D32'TML_P_0!A_B:@Z P+B<R#[R?$.BD%DXU.CYRF -V$\VXAS
ML!_9X_.]Y8^36NJVY_UHD'NT=6,A8^Q9$(PE# 0*;H(S>[M/\GDTPIFG/?4;
M;E;;IYUK\6",MM=U;#H5?))EPS2<3<\Y)L;94MPHHESC2=S&!/4?8_XA17+_
M"'C[%^IYT+]DUW^Y\OD.?BK,<>V\?]'R?,3T#:0QWN[(@#I-,=.Q]F.11"&>
MYX#4'CUATUQ:@(94G=/(BPAY_4'P.0K@.>(4OB.KMG?*@6'5^=SQ"9:Z;Q;*
MQ3%MX,FG2GD+D&!0R71D/0^A@G5%W:!_0&3CT,SBMI*A4QTLW7RJ_AM7V,VK
MBM%'GX^203*=+KDVX<90PLLT GC;0[D2;WOT$L_9)L[^+4?44^>Q2Z3$HZ=/
M1<:> BB ^D9TC?&$JM=O6B=SI"69.H1><1MXOY4/(;JO-!2B,5NM#EQ$B4^R
M0>4UH<:^F[9RP,_V%(#!N"".2WFORU@T=#BF(D;1!$X[D+3T%B&ZO@>%40!^
M/4,AH@N@0%1%7&2NM%ZR=/^X6E*E?,!K:[O#O1=RKB"MO5U4H*]I*KY'RU3E
M[I"XF_%-*B[Z5A($.+PII[/N:-N<%Y2G>K1,7..-,Y<\>*5Z,QZ&@+76P71\
MGP^7@]E\[^.8*W+&3<:5-N;#STT(7F&A^2;#6W-2%Q0 RQ_4Y^B=NML[<2^F
M<=I;CDT2D2WSC?-<4;_S0EV/BM!/#LAC-WYECTMV&PX-!+^V1>@Z!OL2)HW'
M6Z.=.QS21N_9(]/?8SI_^ZTUJ_BY]_Z)R R_%?,C!:),43^XU!QK%B7$U1#M
M\TR(A%K(>WGD;K,N#:>W2@95)OM)J _LCFX"#--+R^\GW)9ZW7+[IZ3W84*,
M$8XC%E.CXY)GHY?PLO(DH2(F7[/-S""D5DTR\R)LH7_=(6&I\LO/:E>3-/8R
MG;5IK5'"UI&A+W"@GAE?\S!1!2@0E*\N],&X?>''.;4G]U_'1%>ZGD_V$A1A
MQ^AN3I=7M-:!9[?"\NUVU:S+M'CD+@9B A4)?/Z"V8H!A+.,>^/)>W-3'-B?
M7^<D6*P/A6-/5 U*9!H\"_..&4S^[B92=!+=CYD8XJJN02!?/D8RUG\I+AS0
M--X?1N^4%\+2B+SH+!RX$7'&)OY2\N+<[V\RW>6N80 6Q/LBN,+.$L4+F!%?
M08PI2.5U8)!6:4B? :/]Z3<N>[=ZYHSV<#'6'>7%Q*/W'RV-G+.PWS96'%-#
MKC+^5L4;&29 4U89?89HAQFQ" ]1=+;I%16D>7M:HH&NW&V( )K;(@@0U2F
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MRN\=KV<!;C++"=HL1]VIN])]? Z>XYN[&EPH(#I#!4+K'W^Q.+:&H+\RSI0
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M?W0Y@>^X:9!GL2)#&> _GF>_:W:O;]32O,/1-576Z(PQ^$41MS([5BS/*EF
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MNZG=>PN4Q!8GU8IGWP/!WHZ+$H+Q>E%=I);R_@\2\?RQC-\%(XRXR>Z6MAI
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M(?98'5%[/2-/J$19/WN/?=(1 5/7A/]?:^V+RIP) =0LE7@RFZ>[5+L8YY<
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MZYHR,@(F,ZKZF[+Q;X/U6BU<G,B^F/W1,5/4V[LUHP-3R+W[<5(4Z4X@:+V
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M %C)("1I#D=6X($/2@_!<5 %&B!80 5%+$#W):Q,J1Q+]/!^BV%_42\HGN0
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M 8V$"^(AP:4D8;H[&&CRD>ZL1;4KK5;Y@;O6>8Q%TSW/9PJAS-+.7CFP>>+
ME7/A"?KS+*"[YM_+%Z'QV;Q1A)9:8A:NV*@15_,TL_/5:_=7TWK")NPA>1D7
M]3_E";1GY2YRQC%TPB^OM.G=$3G^X/J!E&KN /,%\UB5:+ [DBA]+*=H6LG6
MSZ/76C#H[*[I!HF[7UZK4/'C! UXE4K26A0QVH$?7C?'?Y<H?SZL,'(]B5R*
MMZ8>I@&.]=W84+G=#]\]Y*HUIHJ>?$UWC&<A%T(_AVA/TXW4&J1! Y[6$FX*
M;IAYU.$^ET,#+/4-8ZZV+*YF7*<S:+=(NI 464>PN'5.Q$_?4C=8R#R!JB*9
M)-)A[4?@8 #CI$G6A$1B@+8T^2!^[RD!FGYKL.)>>-P"5/:W_GF,*082DX,S
MA4ZRP)VVN()N-M2]U"4@#\UIE7EX-A..BH?""K<@1#[  )]C\H4&N)M.D3JM
M5&,]O[M:E1&.>7&]YYX=.FVR.%[&/H>3WD40Q0PZ+FA*DB[[I;3Z/ASH7A Y
M0VB;!E5/J>(.[W)EK%^B'F["#9)-\*5=VAJ-\:]B+PX?++N!!J^JR<,>[O_P
M_,A)&ED6E8^E"BA064/&X/CE(FN_-QK8.1^]> S'"=%621\:$#)P:(M\3*S;
MH!."TD-$V:4$:8,&R[%Q]EE5G_ID8,Z#L-N[OMAB' 7&1W<&&6\DJS_L5KU#
M=CSO>AR,V,]S!2X@T+\(X7!5G<,-S^%N"L7"B:3*$4WWKU4*GT0_3MXMBJI-
M.>2V4TME_4 #3M]<0.Y3A^FQYHTZ@(<03XT6N^23N8@Y):[\BI86DVN5_5J?
M-KG/%U@_MLQ   "+^&@A#<"9NVC>Q4<W<N#0&*U^Q,&^K?'J!C3VINM>=UY*
M[[;0_4?7+.O,WM=L,R^]BL)/==H*$17+R>>&/)I;,12OZR:7;CH;<<\PF;QF
M _U8SODMX2L[3A%23/]>?=.#9+44#/*9YLU7Q9/-$@;>#U&6\B$*+@_GE&4
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M0W>0C?R-;-S^-()HR]9^EX"!/YF" 3,=J/^GX5 0TM&HK^2(,P_U+DY3"4N
MUI^>]YB3*3K-E37V/3FB<4A6(EJ)6+H>8US5SOV#ZS]E'H"K LGUL)7A4MGW
M<V@A!+X><J^7(I[Q!N[&8&DZR3I=>^^52:Z^R'OUO^2I".-:SY$.L_NBMRVE
MAL^>3&KLRY$3I8U#7 Z:2B\%SP6O\<P0+ES=,,T>78\H9NQB?OO@C=Z:N4U,
M#C*_.*@<=S1L'$BP2JWQYM^(\T?S^*(V6]I:YPI-U+Z*6UZ-1'%R6ZW%+.9J
MS >T=C1DG/C.N\O_>STV ,F%=G\+AY"NO4-Y.0GUD)^6>XL>!$5J.DP\L[O_
MX$+2YF-9EY!2KMD-;;4NR?$H$3BL!7#%L5V %AYF!O.THA1;6WOC6/RR_+YH
MC_*$6/;??6GS5B-RM=B,H@-_YASCQ#WS^][T:%_D.V\SKS8L DN?M"UQ;/=;
MHE[HH/0-WWC;9B*G:7AR7=>OES7#C1KNXY$7O;M&^M<8D5[2JZG%[JXZ6Z6K
MYT$S96B6063+UT8BVS)]BZ!50/IQ##+KXTU8F!W"!H^O&3TKNZ^;$WXGE^%6
M%)Y2$D8L!SY2[MC#N0#72EB1S;2?Q'RK*"N[Y[/QG[0WLQ&Z#JA3S_K;5K.9
M!.</# \E"NRVZLV<%2<H3S9@H7BM2J(,+U5A 7U#PWK::X'?DMC50VT25;DY
MQ<G^QC1[Q42'$?HYBH'J1&8;F5"VZ%JD@[U+3RNA^ >$JR:CYB[+2A41TG!/
MP@; RJT7.0V_<^6$:#[\C^?_7_\PMQ.9["352X+$_/8-??#9CVJ"\+@,"TIE
M'X7F2?%Z[^EI'NA;1)^K[HT.FK."Q+6F[K,#)GKSBM+2OXPH*_H-'K-N ?O>
M/]ZD/3!\M]HY\$=/9&%$Y 05)(AL(_4".%2,OX99@]0!=G"<ZYG]=:]KN<VM
MC/H,*KOA(*^*E28>;'-;68V7<J#S3DBH,L^$N\;GBFQ[U8_)*;&FQ:PO'ZJ%
ME%OV^"H;H;N-PFZMK_/F^N+-IZY82GA'GQ,C@DZMOQP/LN8FQ6'X%X>=&5:@
MA4<O?E!Y$1I-$H?&/YL?I-0]DO?+D%-^_/+\KX%]QWJENN_2@RE?HFX ?S?P
MH4-][+"&KZMKF$H[S?YVSK"HP%_WUN+: [GY!D8#XV9*2'VC%M1[0-@)MEU:
M]4K4R[%JSB#9\J'WI1W\3)#>/\9>!L8LI/ZKG!EE*9+*PUV;3GRDK[5U#A<^
M>QUFKWWH'+52N!6VUU\A;YCR$[*\113;$.H5'"%T*D  O1GHN\<I*WL(K]6W
MVAO=+L&^0Y?IPJT[_V"?A[@\W-V^_B\$2\8"'\F7[ !??+<DC6%@D:X\=PM5
MWD*?>B]W(]W6IJ D^X92V1XH6_;G16A/M>\MD?_6[_\^&M$>!$\X+XX6.,Q[
M[NN=RJ6)</*/E0X] 54''%']^6P/R&?:*93$1A@^!@GT\MO >GTO44[)N!=<
M;:588^4:.XTIAQ)65D2AVND;+;/-G*'6=^YSF9],\1,8<33<8VB*>;=4;$&(
M.*NP].!G"[3S,.-V>:=8M%;+J>[[S]00(Y+ISK@NX"]F*/3(8M4K_9WM]O/3
M1\J@=YZFON8!Q"<X)>50C+KS1;CQ.]CX@)IN:^VV/.!JUI,X4630&>+EV^MR
MNM'M;C%(_Z9LL46S3I>:X7^04C(?*"'S&@ F.%_K$;OE?(JRR7T/&RZ%C$^[
M237G!/,>JQV=]&LPEY7>"\6O9),7OWR]]O@'6@6N^U^H2^]\\Y-=:_"9G.ZS
MJ%R4_O]FTYNES;7VVVJ:A]4A([X^N.RO3X5TKN:Y_F'0YKV.4@48R'Z(#/ %
M'[3CK80@YOUKA2J^4?.'Z>,"_\CTN02[/TD+^>:4;EQ5\BJGJ^N\)'A4^.8L
M]0(^TGJ8OR7]8E'52L_<]]3.MNL?0:$2KX6K.E$7J(_\N:F")XYR9/+9W_UG
MG41?R_0<;V?'HW47;79PH79M]*E1:N!J\^JM-G6L9![@2NBQP B?G6F=@ ZU
M"W/-H3C6'85WEBO;AIK>NGQ(%-?VX;Z\EA%>6I7>\J_21O]W(Z @P#XY8 .'
M&-(T&6E>.@9Y*]:.""II(;(]0K.L/2/KTTY/?"95U5/Y@?(GY'Q\;SIAA;EW
M+'\:J33[B5,@+#<%[?Y>/H&)B4$D+J:PP=K/+[:K)V,AY2 S]1@D9#)XTCU4
M"*FG(:EK_0UAA>C9V7.@]2&&:"'))CW.MGXI0PO_M<<IM]":Y=?Y_]S!@ZED
ML&!^/X);XQ0N(E* 8G<T(O<!I8Q%HQJ'XQ%A[:[^']:?Y_ZKI',[R_7WG_U/
M9W<B4H35X_"90U/LL!K"O]-K^S% .N[[SU=L6<J/]U:'67%$U8$=DTC0[O4&
M2=S4L$&4%%SN,]I>*9>6]+?"_WHC10_YY6U6[D-:;7%- J5<H'%2WA&<K'''
M'0^YN!N^7GDET636MZ*[XR5K;H:BU/#%+1#Y?LEWR9U PY3-*"ZJ3ARA/;IE
MBAN[-%5MNZL%71D(N),S;NO(721X>N#NXTOI0SF.P0*>FK___:5GN;^4G@,V
M>Y6!1:+S*;OM%6FX/)?Q+=1A_7I0 Z_L'WO&54ZB>N;JSI1P]8F)<WI]_X^+
M_]=[*5E1TP@PIM\1K-V1J*-U=4ZQ1-MFP/VPKYFMRR"2 E919Y2EVDY=EI:0
M<+LV8^W1,/T?V'"RQ^UGW"#*9 C+ 0AH^5X;:1YM;E076?LLSYH9CI)\O!([
M*=]QD)CA5;$^V',"?1W@^&,01VL?V%OK9NJC$QC&&VE*F$+5!=+OAK=57I;2
M^*V;KO3NE,G9Q(G%C(A=_K:T2QUF9HX.+/9>3V^(Q2J<H*?47DPQ2 WI3>B]
M %#L@5S<=#V4SH8FW?_F8,"Y$Q[7;=SX//DB0!25T/#=EB_U;,MG^:5>\U^S
M/'$,\@2G+1R#3M$%'&$UOBJ[!WH:2I]M_M#U"G\LB48MC'*I1\Z6=!!5+UQ;
M>UG4U*UY->5=I:-)9.7RJL.*@&3!&P/Q-NF.X9$[-XI9<9L>#-6&A-Y;<+=9
M+8Z!-WK!7H'OO OWJ.%^1:[>C#M5(99?,M?,.@)CPRXSOB@*N1/A'7Z6RTHB
M'7TG$&_"#%4;*<T-;'"RP7[4X'<O;#8*OOI.DC/>2M4UYN5%^6+^NTK;#?[X
MJ>16&3Z8A/Y":R0C@M5;^?V?9B_E6Q/2[9^TK:22 J//G=653]FY#BI#;QS&
M !/^)#"^=3&E:C8#)18XY'LV$[D9UK 7J[SG\^1N^YKJ2H9\UOJ.M<6&5T@H
MK]+HV%=/<P/?5#]965-##P855;[^G9F2D@;)VJ7V_RBODRTQ,X-I$,*OP4'Z
ML7B//M=-%@R8$E_$HOL:AV,R:$4"43H&:U%[X25*A:O6'?\#H/_)PO\_3U8H
M;KL4LOI;[?\:X/\[R.<#;X@=6I>I&F2FE ;IB=5PR^+\JTM:4ZK1?RZ%7%S[
MI#UY4C/A?XX^7RQ+(?2R4N_E$S!#TBPCS5[.2YDUN@>IX)8PNETRWZ-];.?8
M6_\NV6Y!HB+VW[S3/O=?!A@-5)-3'P#V$?A()<(,T6Q!P^@MIFIG(00X55+"
M7;)$FS?%Y4S]%J*I:X[\ET8T.!,2,W" *^GGL/#-CG;EYSM6 0ZICRD:7QDV
MC9?40V495%0FGX5;RL1!.,2!1M*X#MD':WTHNIN%+L/L"2/RRG0MU0\; FH$
M?J3Y850FU-4=K*T;L=/_JXS_WP.>2_[Y,(Z0OQ=/:A_@?>S@%1Y2$OC.Z>[*
M1?#-J-Y[KMOSG^F8KK6-%T_)F0-KWE:1)@/MGQ9D)!@CSMD'^3"J\USXE<OD
M/0I(=&.<VZI'3HBC*5FZ1=WSE[Z)Y\;-1.$_[?GTOXH>ASD2.-0HB@'NVI9)
M%Y_)^QR,ZSQ5%GQ-PB<\<!+RI3!XQU&=OC].ODT_!A7DDR1-V\DR>R;D*0+W
M+W)5P9O7,U8[4Q\%GY<T]/\]V_)1E++^NZB2:@/\H1CL6O]%#LY6P20&K'XJ
M\!1FU'/*K^WM8H("LA%KVHS/L^\HQI%,!L/K%[_+DB5M6Q)L@U&7%&E$.88N
MSWSFW?*./]>.U)-0!K2"DVG.3! 6H)52Y:$(PIJD;M>,SPOE/&5YYBU.1O&4
MD:.*U8??7T,B%A7-K;H-#S\;E?FM&6B=H7H#R;5 ]<@&"SSB;'K?L/2M 90"
M[8Y.'>]-G7@I=E\1/HZF\ERI\[%5:.BA*VE_9(H;_HSLD6X_JF9QYTFM7A6
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MH']!@1C1!E5NTFL$V CMHS()""&T,HE"2*@N ZHVA@TDLB*J;HKVCU7&#&+
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MSH04#(BXQMTO#Z[&/UFW\KA? ?PDLAJQ#:-X=@^UN ';JN6B=[_B_ 5V[5Y
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M2\YCE-Z-@[&(MS,6 T'Z+CH2FJ>FINJBM_^V31;](V,U<(],_I ;P3J*5")
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M)R*WB.R2^?'(X%$4!^<WMT*.;WPZ&[O4G6FGTD@0\*KF33O1OA+NZ\$>)2(
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MBN[Q*1OL%YG;VKWW_1TX<9WT%,!>NM[YB/8;1 G#*:1V"5 ^RD@GR_+"+32
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M$1W2-)\@07(*AA>:6OTV)#BQ+X514XWZG7[=?#,BV.?9O9ZP'_%'(02O7XA
M;]Q*7X>1&5?'XU(?9+^8%ZMJ-%U0Z^A9Z+72I>*TXY27DS5]_& U#XITO\S$
M@2X(:H$+'GV0S+QUY[/3O6\5ORD>4]")4\CU=S7+IR0XZJHF?Y _.)2(L>)6
MOF6.*-4%7A!P:Q/FQ+F\4A6)F/8G'F5'+@'(AI67K_@%/ZY4$Z]1Y^# 89VW
M)]N?G%HBK6<;Z"P'YXV2C.OII/0RL,^="J-%'F0D^,MRK6HN@04/<.W"YZSP
MOA!NU!2$37HB7OE.)R'CDTQLE<\WU/RU(F:SMK;$*1WNVXJT9FIJ*G)CELEJ
MC8^=&RQ,=C*Z6#H?($%$3)082NR/Z8,XJ B.9F8ZJKCTD]I<K2P(GG$[B<)+
M1?4M/;U+.;!/W!X,(=16HEB1PE_#=P?!5"U=,^+OI T9TVGO<_^D=#(4"N.P
M S&M(/S#45?/)TXV!\Z$^Y09YI&>N%4M-O9:*Z>I)>4\5P'%KN [L9H\5]ZM
MIG:3Y8JT (I$FKX0VB[GW<3&3KD9?#VO]LOVV(/3,9TWDAQ74AK_)8:VI:P+
M*#TZW'B':VHLU,%[3UR G)+9D1X$2!_W[C62=O,4Z8D33CW6];#CAH$&HEB3
MC\T@23E?@D#_QG8_N;63%_$:R;H.IOM-S35P]J'4;(G5W,9+[0MZ)95Z OFK
M4Q[X2?1^>%;8Y0B.["0C#'R?]3&CLQ"OKL9.I"M>Y9R"'M)PP<:&1HC=FW@J
MTNO\$9PF%)JUEG5"TO]772RV8K_%#/HKZ>#!P;_)._!$>Z_8A9W&HBV;1?^)
M=_:U_]D!Z_]]\.2%=;("5MB&P09/[)C4J7*P\^\US)"[T/L)2<&,6VJN7F/=
MW9O%ED1T6+U$+!]G.^$X5OI@YB"HH].WKNT6OH)3P_;&N_ K0S>;/I?Z!\6-
MV'#WK($G25>PV6#P;S8;O2G19VBX:]5$C38;3(H)G:JKJ>0R=IBW2+-^WE7Y
MK=P2P3>Z-O1+?4\XE^-#[+=;@AX?0Q:K7W_*2C,MX2G[FQ #%?AD"KP"O.CN
M3M&1+S<43%M'&H*%PFBS08-4P@*=.MYYM.>4@,#Z3E9.+OB[S63>\]ON'QPR
M+$X?N)&-^BU1'&$]Y(]85_6U=E_50I,'(+56O7H<VU/;"M7A>*$9NY#[FORY
M+KXIL=_L-59?I@:FRN]:QI8 ZFJ3[=)06*G3=Z>E>Y&5<^-CR'<O7ZF0N5,)
M"Z>,ZWIG+7S*DPKZ6FO&T]57'67)!>A@-PJ %T^Y=#/L72) 69K> B#.>(U1
M="3OJ9'*YRV"\U+P;/H4IUB5M:/=PP%M@:L<M@SJY'OTS@,L5<><8TBE_SQ?
M)(H[6870F"5=>4N>SZ")65-B'"VJ?;F*\J_D&"MZJ"+Q11\\'RC44\A-W1,<
M<Q?.X*G-*5OE%O$(<F"=FGRR^E=$Q+A_%LI>L&W)#*>UVGIKZ2CFWEAI<T^,
M,_'A]?;]P<F(&0:PZ;HT>%$5"XO$^\I)8RC-S*J*X4+%_8F>T-3W1<^K8@4T
M3.\-:RA2K:=8-CQ1MF]\;7O"%U*.)"?PM5RJC3;AR=_P.H29=HI]P_3YK,*7
M^W][1'FD@H^PL930>>T-/0K'"Q!#NU0P%H_ZCG$\'B[S=*_39"-PW.-.28^^
MJ\ 7Z%/9>L?[7JUD(0&5PAZ1V5NS%!!X?2'$7JS(2P'?R/CO-5E$,S+'07XW
M9X8/3* /6X=1F0)FJM,V==_%4C4V:NR=C%SJI,+-:USK:N2%*WU8]/W8H.[S
M1U! WJ'R N2,7C>3:-C=O]H^W0ZZ ,VS>?,I->):N2&+%Z!N4W@423O?S%&-
M5Z _+3OQ^2S<7=+SAKP@1.I.JL(-_:4.^CCDU%]Q@X4Q B;:9Y<*"-&=E(XW
MJ)TZ )B6EE8U7Z7D7U'3%,RA+[K,%1U;I")@@\V+Y!(;3,-:/#@5[\7]W!5*
MF! =^/7JR[BIFKW@&_WY!E_IYVV<>L93;K[X6\=/.Q/&[(+(EO4X_!Y-MJ:_
M;M$0X,]5(?>KJ+X"D#V\7"W>"HQPT+604&]T<*R<4W\;OF,1ZV\]JBE<IA3]
M\)J/M+[_U]X6)56L5>2A7DPK/.EO_83B@*E;G:FI54-_5VOLF]#/";+CCVN]
MC& /+-/G])_L7#&'1Z+ @&J/LL0\5+]@BTQWKJ'6[%FN8FR<KK:[8+_Y(/U.
M3B1EVA_O1?TG"^'M21M'VL 37YS#_ ^";.Y2_+?->YC;H8W>>?RP]/G&%:,J
M_4=I9F2:?[U05P$C;$B4@"$?Y]3@A[-R'S@<G"=:8I)L.)JP\ ?!P3?;_P=2
M2]F#?V&5:=)"4,JVTKZ1WJNG\,@X)^U'><P%B*ZYVOI3GG13LU<5FA<+></'
M0."KK/IC2A'/ENU=135P,B :Q?F(@HK\21S_E?>@+Q3T(HK8XVXP""E"O';>
MA-6C5RUT-IKD$,ZX\]-.,H/60#_G"^UGN6<*UP_NWOX5W#M2\T.9_RP5Q0B4
M]K_8SLH,KQ2:*7T[(H*&$@;_ZFI+._$_TOQ!:C^N*N\-H2!QKENQ.//=))Q'
MTJ=]P9@]<? XFM*HD=;_<O=VO']&,U7[EXB>0WG\[<(L,W/S\J]&[Q#H(T/
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MR?* >\.6ZSH5&VHC$HS\08QC7M3WL#HX!TQ$#YBT8:&5FLQQMW#><F3S9WB
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M&&O;-2 JQ?U1_!4OC2:$<LB*#@IY.SK[)O8&\R"[\58E@V>^:$6LV@50*&0
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M'];=.5?H#N3\A/4__8FK]_UFHOYM*TLZF2KR5<MC;,9[/HRZ;NT8*3KP^.]
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M&6L:D39?Z:PW6$/XE]IH@N=3LN#WTU=O?76Q/[:('\S:*2W8$TX&XS(QU%U
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MH&1@K8N'8?4Q>MWNK+L*C</NQ;KWP<>_?Q6%XBY$H$U[U1</<&)Z.'#!3H<
MYB3S';S=:]AM+?@%S</&Z.<=LFBCH82H5]H4TAMN021L#YKNI9^G)Q>"@*LZ
MU.A;$>Z5.'^#IM_'S7]H-Y;JQ*GNI$S3+-XEJP(.6L.9>I#1\VLMX'<@:XA3
M68_?B"N%A$6#^@2^R+5D=@4QWEEOWXY"1IQU-KC$EXZ70)F>3*/-33\KV43%
M6Z@]-5UD^7/?<,P[<C0 V9M,"S4;U&Y68KG,!JEB!17FL@RJ<"DDTU,Q/ >B
MC=6LG)W^U6526EFM>WH-?NK($'+L3!B623G>##-3[E[AE/I(V=-E[D:,X:L
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M"9,%"<F4"N>5;YAE&Q<'T8"N:I[I$%XH=3^8J>TY.I<8)1,7(FVYI%ECX?R
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MT>).(/RD([OD?[%V7@%-=%&<#P("T@2DERB@(DB17A-%Z2("2B\*"-)%6H!
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M)GU^'&S.SZUL;+4!3Q;[Z=VX7@Y- "C2PC1J'/XEX=NLF>(OQ6M#4R\,",E
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M2/?_V&CF5+V7X/B%R$0@OB2$86GTX>99>FUC\IO6LM9/]51_%\^J]YW>LI*
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MK;W:-6;ZW0O M0-5+8PD@\T.G5,EP>J@S9"%ZF^H(.DK8$4)*.:^'B68381
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M1M4^;+;YD!/*CQO<J_-"'R9JF6;WM_X;7\%F:MQ:K.+KN\)2FUMPX*'&^QK
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M+L07MWTI1MNL93 T_34?\@ SU?UYR;)SRGEE,N.W7C2]!#SP[L6F,>2MO[@
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M^^[Y$'M\_B^?LG9K\<SPDR#74KEFH;K/Y2MAHM2O:@\_4FZL>6S0P /_\0X
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MS8.BAKR=.UIW3G22'W!G;D:J)P6>]@?;:@C\/GGTLPU^BQ#1 ^,AV1(%ER!
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MUVYH.+HW][[%)#H]9)HLZGF5/!&B/&U(:K%\YJJ(4KQ5(GA=J_E8AF Z;LL
M!1(UH/P$_V]_5ICWZFU9(3"SVFA#PU*NR6 )YS73])  H7&N5! !OV^K2_[5
M==6!@,.>0^_+(;[VSM5:32@CS[_^C&T["_(OEM;-65_SU#V)MWQ;N9_?%$;U
MKB]<5F.[_"J 5#X];6]G%5#DW0.B)H\A,\-4%3!+QGW_AG=@UTG6#/&E+G'T
MMQLW%)_\R7FPJ-VM^/SJ#;;U+KK+C#L%9&B7[V+VT9=$*-^):6)5Q*E.%AY)
MX$>4:S[KX!F9 BEMW0VUZ@,7E3@R0"_/OX300%!H@4R<O?E,I6,SSJ1".$(W
M=>> VZF=]D>]QWCURZ=):RJ?WRMU;S8;1%[BQ"4,'2YL];ZS(*@\_7TZ+Q=)
M?(E/*S-@"5;>(U4.+[\7>_-2B0EQGB<=LI$/KP]<\A 8<[;?[(H _H_VSNL=
MKC[J^R--M C1VTC(K9-$E(3,1$0/@BA1(SK1B3:,$MT0W$Q"F$0)H@Q&;Z-+
M]!(E2J:H46>0R<:8/.[W>O^$]^ ]> Y^>Y_]#M:URN=[[;77HJ,ZX7^HVI"E
M^KG3@1AB!]I!^O7XHV^K5O;R KH&UWP=-;:_7)*/UAD@0;OD!(*Y*5*SU.N>
M177Y*C-FZZ-3V9M7U?*-KD4<?EM%+8)Z=RDKL]/_/CO1A#R&=2VC?]@]([ML
M#^#AE]T:?7]!I$G#9G^JCRJ8]0.NOB]TMHY"OKX>%V(TEVGMG1@ G\<047%B
M)$C[1\!;=Q+]KY6M1_XKE964]*:WF1!EVO;#XY<=$P4YI;-J?B*K.+Z(L?L'
M[B@Z59EBBX8R BO](E.EE7$.471QPT'JI"&\EQW='=?IHV)>&#$=P4LV1W1<
M]N@0(KU^?UI6X>[,PVP+>[J3/&R6WJ@]V,[M;4V=WOK7>#W(L/K(-&<7MD7.
MI+A]ASTG!76V&,9Z$R?;K/#_-B#UFISG$:)&7ZJ78J*?<\8X[(F/&6MQWD3N
M.)#_4::J?*E*Q@O>BT?ZHW\=:%$2KP8Z[:^]-E->=DU#FZ+1&Y^_W&VX%JW*
MO;R^O1I.!N-3,PD($:OF)K)0E+1Y-M]GM,_^B/\=*:F0V@_5<DT?#B_(/50F
M_P5Q!;M0RH%RO*!ZC^7ON,R"'S<+1=$N#YI:IQ/ TDYOAI-XEL7^./!N_3%<
M>&;$AS@?[8*D#6.O[$5P4EE)V'@%/8W::4]"AMY7TXG!$5&TR+FSXJ%$]]90
MS0)7OQY#M2&?Q^<7$K"7?L6;?J_G?R>2P^;+H?+"_(#WS#*0?>'.>T?M\K93
M&H;R:VM2R*756VU,A'=4;GS>^1ZRIT3QG)HC8P#$VKV9ZHOJ;W0M^%BXCHJV
M8U0U*:9-V''2A(-+]!79W#-DLE-W5(WK*)]J6E?\3%;B6+.J0RA5 Y1LX#;K
M &NL979<0LSSR'"T7EXUH_5'%7/?C:H[\3\P\^UF21U!$2]#3"M"_G2ZM;GB
MF.\FP\&_/(N!_!'(D&_+F@1M_"H(XY7XSBGNCGQ>)^5&FQUE,]J.#]Z-!OPO
MK%TB*R5PCZ3?<TR]Q98KV'GP!][IL9FSC^.&7162 U;Q?T$)YO='%[Q9YH>8
M[]^K7Q3-ZHT9.0A"-"W&\[,N"ASTI&0@Y3D*=^=(>7H]X'H#= $J/@/>#?7\
M% *WAW/U2$K7+D1AW@HTW0R_P;+WLV4L$57+@Z2X3=*$ ,4UZ(Z^$.6!I51R
MFW!'"^/6]8A/00S\H!66+PR=(^'W-*"NQTSI@1#YV;JQ>2P1&;M'O5?A-@^.
ME1:MRY9*+M>Q5^+NL3^=DY*/E8VP3I.&+;Z57"LCR0ULG;!O0%D.QUB/;&\V
MM3%]L0RO6@PQ"O^BDQ)G*.\0D!S[TN?AP 76:O&2'?!CH9&@VPO=%#@I 7Q%
MTU:*M?J,5\J,E:0C[++O_>Z#!?[7D8RMPW6V"ZUW_KPVH:I2'ASNY1AFXTZT
MP%QU%JTVN=/X0-MU@;<3W>A:FK(8P(\8R_QO5%@,E/TLT3\!LHAIW):RK>6;
M9HR>"AI-\4Z_!W#!W?',R4V2B,$8ICE?F[^@[3!2B0V@3\K6,^2P3#9D=[?,
MZB\,X\[)J,5<36X>S[IGT>-CH!2Z8MXT86#B=Y'S6M=_.[@A_Y#021WBP9B^
MXY>_0M&)]0W9\]=4_>_,7W=.6T.\HSOI;AJ-,-#2A0A2;Y.5J I*O88)MM>G
MN(;T<D8%Y1ZGEZ2J2S_\YX^IV<U[">!W$J?K@N2] ./UT ["8!WDT0R-G>H*
M\)/U^FRO QHN14!FS\]_6CP6$."GZ2)7G_36$(K2(H?GQ$\O7_"1:@'$2 ?$
MW9)E]66[I)_B.1/$A#XG@K[01G&&XU7;@)1MOSL^#/X?V''BG(>"'$N:TQ6,
M#/*K*#HJ%&@^,S"E@!R'N113; ?(]85&#X54Z/G$N<HLLZY6>*Q)Q1U%I]=$
M=1Z./"/CNN62L8P1MX'D 3@]<2IP"'R-$VD\_IN!D_X#-&$WN(O7Y85ZM%)U
MEV!$S5D6#VJ/_5H!(Y"0G6"^-O/E(4,>V#,ROZN9V?6.$<*#2]L#%U)">:D-
MDIOR;WD_9-SKQ._ !  7HK[<,JX/+0 @#17=RL<NYJ?28,8A#>G1K:04W151
M5456VP</9I(,/!=AI4=C%"0@LNQ]+7B]&\4.X<=9:1!QK/TSQ%%R=-&$XEZ+
MX5"&:.#UZLM>'U-A6[U09KBKW+QQ.+<:D%6\$7&%E)>U$H24L1?UOKM*QVN3
MJ1ODZ7S^7UO_.?/YNR:F?(]\GDBMX>;E\/&I"JR)?/1]X-A9LQH H]^@:,ZE
M].H+TLBI)AHGH?S:F"=5\:T:YV$6)UMF<HNDWGL+8,@,4".O4[*GZ[98DU _
M.IA(-A5##_ISBX939D5?TSDBQ:J8.KA%(PTY?T%4@0=50"XE'3 /\RP*L6.%
M@1U$D^\O/N92052((!QDL&FRN+RFSJV^< 8-NSK'?6&T[.EG&M@=S!%Q"2CI
M"=7_\M.]\6D_Y2WRV9*H7U'DI9>@T6''M_?01@48@]'5^D"']3,J-L?C$F#<
M7*W+K$+=UP8LMRK8-9UT$,5%#T6-Z,WLOYJ*72"5Y6N\A 4 \F1^7:#=DVQ'
MD&X(XMO.?M1C/"EG8^0U[B!08RH<^U#-2;C@;3@DMP"==^!_;;#2815]&1"C
M1 &5RRSRQD!:Q0">]8H;)G%!@S1"2+*:A$;E2PAL*Z\'Q,=TKZ<K[5PD.1 5
MT'U+4D1L=UQ]ZRRQCHN[Q6:A@&'<A7Y=LJ+HZF7I(D[C!QVH_^M#E0X$<"+X
M/-85G,;7^ ;=%NCTN:]$JZP_TS74LU>*);;9Z< E\X[@2EDGXZ0B9XOC)0IT
MW@2?AE#56$8SPW0!CS!O^I0Z<<OQ^:7J9\V1R.MJWDB:I?;EEW2L71?,)P*,
M=H3RU;8GR''UI!)*S&FQ;$4 /#%&CP2-^93U3VO=Y*IF6&51 (-HL]>R_T7Z
M#^P@M.9T!_.6.;:>M6?)<D'#"A[?P3J.J"S"N2:4HAP32D66L)$OU[T@!O6'
M^AQAF@()1W]!77 6JBGKCCZ9E2A44Q!B:?4K_5<+/_\[BT5QMEUA^IL,MP-]
ML/ M.]5@. &[(U%$-6@'HDIA"A,P0V)B[JVE+<O8MG+'>W0O'K=I/*3KQ*?/
M[?L?LVHP%MK031F6+>/.P73(J%[N>2Q5!LJXT<&'25*F]9R^%PYZ_\WS:,%7
M' 2Z'_6G%3\;#9,"7$YTJ-R8[VVLA#RY'NC<K.4;I!WIWY^Z55TH]_?G0EH[
M-N58K@6A&\6+QSPV(#;U9\"70[L K!.\4R,D@C&]U=\J/,S3C_AL5OMZGQQ_
MNKBTHF)]Y+Z=;F_G!HKT33K38;C8^WO=WF]J+8,+OEL&9QI_KU+@GVO[GI7U
M[HW-Z)NRP7[^:-_6V1OM_4DWE:06.9X97CA]3^,!<KL[)(%/Q#'N7\G%FQW_
MS,Q;N3XA#P^YQN9 <Q1?T.\Q+M\[NB<H#@21!GIQI.\X-LCUX/@G5C*R'LH!
M[>R:^?>8:T"Y2Z86_ZX)1[PH^?,A:*!]0B]O\R1><AP8@?!00P!6,G]_)O7.
M1)TW1[!_;^-8!+]1CD+8:V=G7A9I_>8@MOY581?><BP3C9%J:SCO_Q"((7-8
M>3"<(F]E[(^ZF@G>UWQN)#/SH"N58Z6VC/??E<Q,.[N),W5A'Z:P"'P>(( '
MT!>IZN22WCU&"[<>BQF%W%)43VA>[QV9D3C3RI4KM1<O^-VRX?$\5*X:(, [
ML0D=$*"LA*H+3#PH4LI1_@M*A,97"%I*N6RU)W'9LHJL.8LR?Q"GW[24N)_"
M>3=-F#3;B^;;1-6E):ERPHO=&O*O3AV6_F92:=K_XX>\77 4ZR09]<[Z:C%G
M=<QF>$2-ZCU\.W>WO[O_+S,I3_^R186EG1X5'9G>^-;6C-XKD2Z,RB#&A5+/
M!\GFF[#5,TQ']L%)"U 2"NX$[Q,[3:?8[;#6:= PWQ8:AW!8='@3.IAL'A>P
MQQ?L;3Q>'Q;8.A5X6>AG\+M ,YZOAR*E#Q+HZ]TGU#-?[[,CTI!8%W ,[1X0
MY+'L'4N3G429 -[!LM>>S'#MGG]7?%%(7N@OZ+9ZN0O_K0HPQAFCRD)(2X-C
M/K^'QK0I$2K%B'*QGFOIAZV_ZB]OKT4))GNFV_1KZJAHAHBQI-#]+N:,F&B?
M4$TNA(2<E3[N/JZ.&V1X+VM":$%):IN^^\R-!S=).4[-H(N(HZ/^WB[>_JXA
M=GU_&E_S:3&$X_D(89E0J4*,+9+7GLDY':U^:_!UV(+A<17/\H/;G?BS^"XK
M+1X]_K1/@1B0!K9+B'E6!+N^A#8=>,FO_%M C&J0G]5<]HE,KH:4'A\7KRC7
M:Q;$(IBX5D1BF=VY3@!?^ 6Y7 >$$X8,MQ>>53>2.?O+>",UDS@=;Q4BI2\Q
M**]$:Z]S_O;D."T,^^0G&_\-?AYR 3@A[+V)4'+E6T4MK,]^RJH;T7&)E"V4
M[[F#\61]MS^,@HFOM6=2'$G.&-(?O%VLZ@,B$[3:@^O6()+KI[M.]?L5^X/K
MDL$O@L4J0V,YBI5D!GA*MV'+)!2^ _L9Y@=,? '2M-B"[?J$U3UN-R7V#3]N
M\JVWJ*564A\&5CETTEB ]1.%^9_!)MVV@I,TD> '7J*Y^CEAP/:NC.FWEU6"
MW]DR=$!".L('4;\K.<*TOM_C5E_?BX)>5'WN1N:W!LK(DL01JM.7+HI*N)*A
M2N7AB6_C*KV8S!NC+F7>FXD.J<F$M%XL+Y"Y?$9!#$":SM1V0.6%'MG<!^\<
MI*L']T/TI4)26M]?4^[.;^;<^HWX"$"U2"-KZ)#/%EJ>0>76N:U;*=D9(;Z1
MS]]E1EXZ=V@TSFA@WMZ3/5.#L;UXHDB5(RM%1MR .4\K[,AO<T&NDYEP;AE'
M9!U*PI-99O[+O6CVZSV@D%\S[90D73/](,E9-Y0PC/<4234Z0^QYH=T#L_H?
MI"VU-NQWZKWWQ$#YQ2./R*A&V>^V%1^]4MAF%7[:PJ3(C[$-B+0T;KVQ6)%Q
M1*X[V#4YL:%I8747M^C?*/3[4)#3J]!K95\T^'2]=XS7@C;%!X]:FZQ;);W^
M5#P4[AU!Y]'@.AVTSDYXIE)Z]-9%]9IME\4,C75B!V8:1+38-CEYO?E#>K7#
MV1E^TX# MT(P5WW[T3'2P$?*^5,=1<+Z*+/O+^ARA A,&OA6"7L,F'K;HW\
MB<^VA/BP'ZR0_UX11<S%COKY:7>]QL?TSLM&D6>)Z%[$>5.RCV%<Q+6)E8/B
MB4.$R4BN\:N86K/$K^(^]*(OKD5EIA]6<MI.4,2RP+>I-@"<+-<#KWN-(D,[
M(_CKR#!V5]P/Y'W8[(3E7<_F5'\1D-:B<$I^X?G*T+2$-C6R(CC)EA,ST:90
MHH^W*O<YGOGD*WGZ>=(.M:*V+NN;<,36:#)64CRAET-I <N],Q\Z@S0NV!.2
MX8Y@T!E>T! E0/\#$T,KIO9_]G<\5^+=^XL*M0<_@B6NJ(W)7EX7V[POH6G]
M2?P S$'U IS()\MQN84>?*CXPSRY$SZ:Q#95SCZ,(U/%1>XN1B6!]O1<+,OH
M\@"Z&B@G8!,5O.<7.CL4&Z<82#-YG_X;P'F7?)YC5&P^5FD7&A[R5.N!QY)K
M.27-X]K7M'MMLY";8OU#,G=P/<<>5'F/.W_XAK2Q[GJ(U$<7#S"(+OICS/>#
MQ5 %#C//;!B6N/4:L#_Q >QZ:U%R.N3^C&/1S*NW9#/=GE&65A>B%C/"GMDU
MH")I$C!C;]9@>!<-[.G0[9L>\D4T-(7K\]I#P,)J.-W*]:DA**7ZP3.'^0YY
MF%@-\ U?=E<EMV3*^T:.R@CT6:R2CI,_[Z!NH8CR"EOZ6T-A?.J 7MPF3K\N
MZ7A53LXAEBOL'7$_^_FYR-%K8JYB8EX&\BDY4_DSR&=:,KMGU@;@_= ZK=@
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MG5<U)#*>;2[\(L[]Q**V**_4N:FG.,8OA-[4('/_)MLO37]/N;'F-7^ZRBA
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M=@6,^3-R@1EU:T?]J09M'OFEIK\S57/;>\T3_P7_(DR*8',9 N ;Z-6*%M7
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M&!1!75"66H[O5?Z\FNNV4TSXF*/J5I:742KKIEHOH5"&_KU>,GWWCW\P*"0
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M.8(D0%[/&HA _HL$^&.I21 =88:.OL+ B61;4$(E7#,/YB8Q< #Z??,?^/_
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M0.^[5'W871FXQK@WO@SD &>L*E<&FM2X5&U$W7W/$3$F?,?T;6=BJOS^6Q)
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M@'I"]6F$"V$:(6E.5LR$%ZT]L0X!GV^*4Y.[;<Q7YJ:EZ_(=% "KD<42T08
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M^T!),,=<P^!,AXAL8D]A8R_L3/=*R!KH+\MU,:;GU!J!3P?@#ACGGRG]V')
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M2_G?O5?FIZ$$62+'@A;RO/X10'L8ZQF@B*ZW&.%6>F;7\[?F]1WAWOSO\G_
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M-</(@3\PX&J.@B2D)W[KN%,NNCXYW,4F:LCP"#'_\:28>&Z+TRP+2\JKD($
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M:+LN>Y4)>LD$D2#K#J/="L+X7^>[BUFL9O;J__B4HW.^0;"]?_+T.#9;0@G
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M77V-D?C:<C@]OQG>F6/!2";<F Z_;O?EZ_PW(A]X]^<3Z/YJBFW=:N?MF;X
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M]V\]/<5"-8;U/O]T\+PR*R-A?_G+F[<)0@);(__:%W4W9YX6+DN-WL^9KK2
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M;RG MSNR.#<>X8PS>&OJ1)2X;^!R3L,@A8NCB25I:A/&N#'!:"&<P7<O GW
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M>\\4]02?V ?S04YLS)]L'-Z?<\9]BG O"DQU7Q>?85>8*]ZKQ#'EK:7$%9\
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MZ[4ZHN&#2PYU=SW1,-S,4:+'3NZ@[3??$'GC_.[+E=Z;-4Q-!!83XH4&\N-
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MC:_&$R3;&Z59U&"DEYUY"H?:4M#H.:K4[KWD;NE#9#O8,2JZ]QYC)+"RNN5
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ML*4@W_GC%M!>^'BMEH)?:IDO;>PR?FDX/:QWK9@^_X25+5*HSL$YKPEO6Q3
MT(]>PHC#3&"B^;2'E-!O[I,K#,T"3][OREH+]S/0 +O;^VI%@*>B,MESK0T]
M593O>X/JGQ@K[GEJ'LXZ1L4S[ (ZNEY(3;OM]N!"-AU4E[D*3W8F/X(;HA]H
M5TCT?_0FIO06]7?&D;/;,'4L$<TBB\$V"C;&O7=S%'9-?$IW+9/T025M(O)9
ME'DZ*-(>=_YM0>J@70K$7N(+LZ.=]PV19V W<EH;YK-73+/E8K#FO<.1SA<:
M==J#NTJ:&H;^$</O\-C<>DGQ5C5S(WV]S(-I.?7<6FD6O2G8F5'>_=7&5K*U
M#?3^R X4^SY7..W<//E&Z',%VTSH>][((++_>ET0A)"^?@6L[V1ZB!]THH,Z
M:RLO,$RX+- 3>KCT$?F[6Q.*?5-[3W@0)Z.$W,Q]C01^E?./V8\A)+//!&E"
M_P2#&QF*ZR%M1+8#G(A?6XE&.3_I(+\-699=)1D,/HBP.O'NU_VZ@T^8MYCK
MH#("8YZN^('_N.,LD-@S)L" N3C#_3X&KB/+B>R)M.VL>#JH.@LQ J8,,$*V
M[,/=)DMSV'FEPU-6M#E;MA$BR7Y17W];HP.I\?"O>G+\>/W8WX2C^/ [,MV(
MGW(:TF9(J[9L1AYX/($1RSXS.E-$",H=#N!-Z:"Y4RC:5\N&13CF=-*]K_.5
M 7\,?^MJ(]NU:SRGAZ)9*$>PHW\=$?M/=7>:"(2T\\R]))K&BB*D0,=%K$S(
M'J<8 <S_&120!+<7TWXG%4F2)PRIIQX$WU'Q:NL>_3I!453]FSX[RE6O*%9#
M"V.H7D"]]+=(;Z1KWO[57]KKC_V0)*O]8@PV9X%9G#S-,8O9L579[[9A=$(F
MJ,FV<BG009A@E7TWVPD."B8,S/6Z(I^V0G-.J:/PB#-&]J%)%V*DO$P';:6S
M(=MOU.P<"N]7T;;3O9&DVR0 :4<'A7G30=^B/23)!^:,*.;VL)Z!Y"!A57Z
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MWKRVI'6)T%(2.(4<QEVB)"]Z24?\"C;_>?7^X<#Z"6HG;2(57?SWAOP;B!M
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M![!QX&KT9B+1XLP"3(^=\>'24G3XRM?DXCF''E]/H2O7]:N;DQV[3T6PQOV
MN'@?*M%JCDZ(T , ZP"L?*#K4[@2PE\8C6,^)$T>-^CO/\>6\2Q(Y$VHOL03
MUH>:?<G3O_#<82@/BVCPB4JNI3!=N9+UY^Y9276!I2TB39PW7LV=3TU-.=G]
MO/M))FM$W"2C%N6X-(/&8SM?#/'#K;M59N&IO3<<ADQ"O+=@94\-N8[KSW7(
MVFQ?;?') C$<1G^;FGG?JAWW4))JJ6J-5%+\><[SBX+7^_37>VRGC2?;%0Y9
M90:R5^\RHUP!(12(SVZ3\VK55>JN#WX]Q&DNO5-5%9Z2LI(K(A8\-0YE^1T/
M/HW@ 5"E;L&(6?-L_SR; 4^G9RN+BU)>V5(*08[YK#*5:M!+J$YCK"=*@/EY
M4OQT/3DIK1#J $1Z-=B[QY\/7^K?^63)GWG^3\[@Y75]<.X 36W]<#,_ /E2
M,%0D$)4Q<@"JF$+(E17V?&(M\^31YG9PYM]=V[Q' $^/W0;Z""%0PE0,P@Q&
M89]T.S^VFWSZ\_>?JS(G_RI=J3_=U(&@0+4':);V")\8;,_VK'6/]@6TYOX"
M:^<^IR'//;KT!.G> >B(->8]Q!$*."D*DF0B/76/:L:I#\7L#)QSRV1*)%G*
MRZ2NS!VOEWR]-&$&0G[XM^2HH.C>[5DHH6]S[52*<C>8ISAZS,I-8,B_=DSH
MUF-3BK"&2ELPJ0(4',)/1'%@/88B#D#B=!NF,%DY/NWA9.K,MO"$1^6Y[AOW
MU;Q2U44%'=1R87.',=682*UX(4@7D"<,OLN\I_BR/N"7B8?H'P_BZ":[5)&^
M^KX]],W26>R*&OKD 6A3C)N9:F^]_NU>6GHE]5"$7]3_&^J_AB+R"9_B>]#D
MBL/P2,=N;6"VAC83G&@6*[_H\Z@!BY:L76V\'@]\KJ-=/;['#.^Z13+3L6_^
M-,$<>C394L<WMZ;F;/W5*7W@%]IV^_O_M%KX/VW9%T@B'A)ZEQ54U1Y:X] \
M0&:WIG#'E$>%!ZGZW6SQS$AG2M^B;M4?G^3!4L/:)2?74=^715FUJ'L-AR8<
M*I5_(>'K_TEKY::. CI$Y03HL4TB.3/&HU63"#T%T\B5^M0X(>+Y+LU.P-DD
MZ1AG!E?JL?Y*(RWQ/]"_3_Q9/1F39+S=_:+>])M[\S[%*FMJ%IG=G179J.0<
M$8!\F/?42DLD12^/-8>12U>CQ!.+MV0(R3$00;H+_@:ZJ]E_*S<]#[BZKU78
MHGE,P/J5?,/G(V7/^UX_E%V>$J2]@'3P [LHPI-#D1F-7^(Y #G;H;H;<)+M
M7Y97J! >S:](CU_3EJCI9!M&BC?$E4L \C*7EX),)D75-FM,">.^/KI!S_AU
MS2MG2N<Y!T?6_AJUD;*:38;A%UM(*80KRMV+$B_GIM?)[J>-K$QC5V\X\FH)
M'1,VZTOID)+2RN../!PP"/(T@_%>]W#L8X&]Z#AQ*8KFG,6T7YL;=#.0>P4[
MH/38025M_/E19-G46E\G.&E1;Q1Q#5\&%?F>R\F<;@3>EL)%K.RE3&[DLHJ]
M?MY-'94[RRGY[&O'BHW?!C1O]U]*PK!';1T*V@MEE$!FC[WI <@DMXD;D/&F
MOX5V86CL7PY A;S#'".U_U]EUT2&_[Y<B!G" !??!30@+S%R%.JX1.Y3E#+]
MB2(EE;M7A&:\ZHX-S408"$S>:PN3>!PM4Y+'C?V)4=ST7"2NPK>VAIT+T[L^
M,DSP]U,^UQA5)E0F:,K_?5Q-8FHYJ8X\U"?.SLA N=M?)>$<SI$%NW)N*NH"
M+EV+LBUNE5LS7L1?#^5UJEE[GP?U)]3/3S71;S *=1_C[;D[]?B!$&*=/=2<
MS!^%.=QOX:JDAXVW)3B^-;YUOA[.JUOU3NUD*ES^%3?6%1-:@?5*CEDZT\I!
MTUE'<E</^W&+TN_"5IHG_&6?9/5W//@\\GG$L%7 1=9&7J6/<_"YML6L&C45
MJ*'I3B.4R&(KS/1R8+MG:B]EB.BIC&O0],&Y';\JK*BGJ7Q^Y0E8UE'OWL8K
M%FKZ%J,^V\NEI3%N\K2^ZBT"WYGA)^,S0U(IT/2EVJD^;C#=AA&-E'F ,"!O
MK:)1A ,0K]NKZ0UK;>G!9/$:]SVAI,?>E^>3-,0Z>-E7,##O61PQN0,=WUS\
MDBF=? K F*,[ AU4Q[ $D?K4F0KA63G1.96GCM^O*WVX]D7:0K0$1,N-H^^3
MH5LAE.*K!Z!(09*%\#Q@_8#LW9-HZ=<]O!LO)-D\BICB/%->9/3+YY7-7Z2S
M/Y[K 9/*2AY^Z\4UU9Y7"3[U"P\EO4(L1$^A3H!:#!%#X&[O,RAOQ25J).Z6
M<]_,<T3-H(;'^M8&U&A=TUJP&:&V\* N$A?NL/!.R]S"I_,W'?9@[-G\H-K=
MZ09#/BNCL/\\PW0555O<$S\4ACU"=R8-<.DI6OVZ5DV[9>5;H_!<XS?T3=(S
M39?DFZ UK!MFAH.PMF7_87H6/MA/U&%  J?]0[3O\$\T>K>^CY%\_>K4)-N3
M)X^F< X7& DHIZ49J+V]*=&BN\*X.U##Z[S%R7G[GDNIJN\B4SGAW2_!U+C2
M[9X@[Y<H5XM$<$-#C)*?F1.I(4KO]/=JDY4#T!/#9Y.\YL6 $RL7I&@JN^'F
M=ZSC 6BZ@<"LH3U"V)+!21)Z5ZK('BIU!7M>Y,+N\HVW8CSDCBB(/*]>+<O^
M&+X-9DZ1B:A5A-YX.;>N23UM_Z#+B>=U),DJ,2!)\(1^Q[H-A%?O&,!!XK31
M3*1+Y@,%T]X"Q?=K3>@YP%+#,Y*.-<3 /B"[:/;[K&<EVLE;K#"QW(1-@%QR
M/TZ=Q9+O5"@()#X13Y'J\H7O$?9B$>K>I=\^#)6[30GP_+#"OU6TM9EA*PO7
M<U9,^;P^&:HGP2AHA9"-\9I]W"\=6!H8Z%;^\FNDLA$WZ=UZ-Q';I_ /_277
M6AA>05*%(78$\(PU_@ 4BC!TQ@"^!&S4KKW[E_@YZ(S;2-^EZZ5W+4,_?W:$
M"-.S&:58)WL8 =RW';[(W0945<(_K/5D#GBS8UZ(Q-9V>9U+1NA_[7[7Z'5B
MYP/6_'!6L3,1EHRWM1B>F1]H'G_O&+,RBY,CWS[FR]NQ61VU]DO>:WBR^_WO
M6T;_YJH[!R#FB6L7&HB8.7F">+HS>>X.D%WXW=;)H3V"OR7[Q?KYE &C[:K7
MLCS7[:2*)[&WY4D6LQA20Y_%S!0I*HRH*-.5*:X#*/IX\=(L1CS8,NO'/)T]
M1R]FW,FI+* 7IY_WSSME3!4%.LDX*V"B'+BXAC?/(4.(6XD%;QK"9RPK*YA6
M*:R;5O<2DQM>]6NR]AA07C!/;!&P+]%\K=;X,G2T=GV^3Y[[/;=1>QQ*^/PW
MD70%OO<=E]=ML#6HJ%9OF@5SX1YR>!\3K@Z)7N0:\1M[7&Q0;N38V.[+VG59
M0N!LJI$"^\C+VR9?,"/'+[5HB>5L200ZI7X33D7=!-&] 4^:\31S_ !$ON\=
M)7YY;-<TY\A"VB;4J?FM,Z+/S3=C'G16!WN3D87Y"HE_U?=WL;<LX&F*454Q
M%0&Y*,O*O*)4MKOSCT.P9Y[]+JP4P4%/XLD'H&3UG)"'EP+U0[)$T0L"JQ9?
M=ZD76K)*S^<FK4XX'3.Y^'S5REYQY\^A2E:.U0[LCJ$;[0<DEGW'&4\J77K;
MBWDT&46TJ6IVK=DC>9 99%C!U.^79&9R8,G R2D>.\D44NB1%>.[+%)Y:^3*
M0$)#4IVR:!]18+Q5^B/\UGI66V_VD1_9:B@^^)R_P"@JX,_EH4(WX$??W?%#
MBF]8\%"]_H.4XO';IW:T9 TXHH3 B3PUJ;?NYPO=C\N8$NQL5ZZGM">IZ^B\
MB%%\.W-FZP1?NW9*.'P('%;Q8Q4IXAJ(%".;ISN%2+XH(1Z= AW[-=@9-G>9
MOE%4K".G+A;7+6M4G@Z)U/SWC/JN25V?]P#J;ASN]KA37>L;5E&%<M,CSU3"
MAG2MMC2R)CZL'#>4D7Y"/2%;*=+G($U1BB6*\0X85]<VUXX7[-RJD4\[DV1R
M62JQ"4(^8Z[R/,!PI/#BZ'(\C9ZT&G?3-NWTA^SS\;P9 <?R6T1/W%@UR51I
M;EQ/U\KC&+%!*E&2T/@<+>4ZB)9GEH$XX*0<)9'RSF_=5EBO]%13X1QTKCS^
M:-=QJ5_6,,\KQ\4^-MDW-0MK^]ZV%-Z#WEWANW/WZ7\(UJ$L[TY:<U/4;"@"
M:!<GF2CIA@Q"I<#Q/#]>\+O0BDV6C=]4C#BCJ%T/GDWP;(_5C*RKX+QSUW;L
M[LO-#->?H,^.83L?G^'.XI.#=_]Z<[&Q/Z70I*Q]M4Z.=O'.Q]FI8GONHA+,
M5W1,)K1V:8O+.Q_([()]-"Y2N#LG[ZH=,S9J9+U<+63MLR;2]-TP)!*_E$P5
MAL31I<@#]QNP+11EJGVK<"21"1C"):^.- DI("DN@RP;\Q$\X:71I1?-BF6W
MO3*TUQ]]=)2[^/K*EHB;5^J/(;\/<?)#NN3_,O'^%QI&D9$O 93ZD)F7@"N,
M0U5RW&7.2?'PQ^D+<YLT*/(O[F\Y;^BP\;(UZ-R0*9G_4&707OA0P#U9:Q%T
MK>(E@T#JT*F;O-2@4.>D8YU6"RU!)-8B$] 9??%[9"@Q>DN2,#2;UH7E;E?3
M#/?TJ_ U;<?6>9X"+]I?.J::TG"[_X%-%(A_\'@GQ@M8J("S$O?BI1GO6N\4
MN]L6+L7NRJF_B'A:<JZZ+NEVJ=H-.UFF>^57^>?L<$SR 0B?J^V]N5Z)\,N\
M1ZZOH9PZ !'5H]#R;M2ET[D270M1,^<;=AJ=ZF(DLR54)/RE9K$P2/0!2(#.
M2B'A(.+MW'#D4F\F-4L>\'U('L?4F\9?DTL7US,XK\(4?66)M#H:"?*!<OV]
M4Q]RXFKPEB1Y!WH:R.Q%JE(X8I65,W&!PE6QNS2=I?-!%4IG57)(766>G7TE
M;"$1E/B>=@UR<M36!3)WN!-EL<4?GK'DB+YGIB<"CVNYM'.S?^EB.JNKD'2O
M_#(D6MNE#ST[]?<]I21(+)H[DV =2F?5G4VLS'FV4HG9MM=07L0]AFM=_ B2
M6I5)+L#"%.\1J6ARTJIR>+!B.X9D-S,Y;NJCJQ(2Q6ZM_"S<RM*%31:46_%.
MU#%4=XRPM-7V$1Z!@X@0*<:A*((H!=M5)J>L+G9![-;#V86PD]42IJ$17H@/
MW/W/SHH'L1I3'S#*=/UIU]WK?:$(G6$_Y9,/U[N '[:HA I_^3>F'VOO#+C'
MG4_XY)33P2_%9LU/TZ1K4(;"D,?I5\F3%>33U\I_")CY!OD0N07LH$,DD2_7
M%-9]595_AMW57TAG802>^8H08N0@'I<BI\5Y@;1BA. G!IHN16!<) [=J:H=
M5W3V=#3AF; >J/_SC%-ROL-E@.,\'L3] 04;$G!-17[%"BJ<L1E;! "7NR]M
M*T:% ADYO0M-@YN4I+KX Q#;U@$H31ZP/  ]FH'L?K#]A9UMH2H#UH5T10!#
M.;=DW +EQQ6Y:Q,?9O^YR?E>9*!E8*%!Y,]<@O6'OZ\3"F+$(_ES#T SHV#Z
MFXQ0O83_]07VF6)>!XG>S6R+&G8X-LUQ[<+7(SZYN8WT]0H_5H>XJ%$3Y[K8
MM81K:K+*9ST[+7QR?ZM+_(_R-[2@,6#^5B%R4>_L7B_RX@A='O9\];+TI')^
M_0.;D^EFRUX2 ?QZ\121KMQSY#1X\4V*4DH)X,93$.(XN2^GR&^]?4;6,T\9
MD:LS]0XY%E_H  _N'91C"A<GJNZL<U(NJJ=.]1\].G!N62\@G0U3,L3_)P3V
M;/AP7K28,NO-MWAE:X%,8?B'C9MO3(H>ZC\PVC"+.S*W\JCK%UWF\B,0QR9'
M*%(>KDPLS/DV%8&PSH<7+4YT^W[)7S)^?LYI6*-7QS<BX??'12%@ZC#R]N;*
MMI&7HNF>! :L6^!%^TB1V_YKM8>&M83JN&XR7-=G$:N+\*@7. #5!?:H Z<4
MK&\>,GGE *_H2&I(]I:=R.;:'E0Y)UG&FX*LZX:S("0%(FB<$%QG0;*X1B/.
M6AN:21WC?H/UH)D/H;UTA[!TG:I>5];?JXW*,6A6NA3E7H\X)X4C9E.Z=4(7
MC/17%+?Y^23&0$LV4+64I=?)040JCCY,V>O=3J!"N)':"--/0!W&%M7%0;E@
M)G5SA%\29ATZ_U).XYYOGI5^Z;N3&@:**1M6$,%V!3H_T$.IP7&3/.\1%;)0
M. U*>K@[N7?1*._(DZLQ>0KZ+2EG22?R4U7U];X#^>0!W %(2/=H&:#98Y4<
M0F!8"NBTP%?A#R;L'SX>C@*KRN&I&%4*:M."G-^[>&ZLKN+:C7')MMI1J6'H
MIG#=M^I%F][W=SG#1)+5]5FC-D)%)%B@W/0K (4DXLV#'+!PH>F[YVJT41:K
M1!?ER+LU<R94U:&S?Q'5N451:C(9:VSOY<-2H/[,&=M:I@CC'=T>8PO_L498
M?)\_QV@>LVV08#*X?^*?2/R)E^<1'U;+8//+.^G-C^R#LI4C.;\C>2=KES:3
MC\/U3#"["^;VMG9NNT5!)U-O-CCC)!2>/Y\FA+#_I:M,CJ<^!];Q=F V^(L>
M@78-<9'6D+MSM\=:[TE/8IQ\I%:*!>7DTI]/;S=$DL*2E1FOF>J:?<I'Z8\H
MT7U#IW&>;H]%K9HQN"VCA?=5(YM6?*\LSI]J*5![=6,PF%]H(0['>+U,AO1Y
MS[&TJ\!M *<.<7#U:-$P'4(PY<QV]3?S-#H J>X01S6^NO+E?+0.X#E.>*ZO
M%T')W*PC6W1A.1 F'^"KU$VX\=V6!NS$;PL^>,9*089-S([I_(#2_2.@$\<X
MKG#=9^0PCS,'4V&+4A1CG,Z6<F]@9@!T1C,UT:<NLJ;F&6K$TL%XY\.C L^?
M@JQA<?F'%)0#<"I$W =<"%>T:7T.8+)>O@M1/N2:J3=_=:+RG:8DK6/U[S39
M5#,N2ZRYG=7"O$4H4GQ[M(=PJ%E81[!F.)VK$'%U1%=-=.>0IMP\6C/N*+&"
M-+]5)IJZU?E9IY?%%K2W'04YBGJRS8IP'GU/7HKULQLZNZZIBG(" M9ZGE(N
MS45[--;7!;U1>+O)(I&0P -];(U#59DU;(X<@$[2R&_Q4%:T /%S1BM-DXJE
M3JY\9F/2OOZJJ>4F].K9[I.(#=&_,?R(*Y.[*.[YN9D?#<,B\$HEYU3U!!66
M;#_47Y*^"8&]\ JY'G-WQ1E-[&,13D*(I+_%EF31'.?FSU_TJA8]+#1X'-/?
MB) FK;?+H+J.J'/=@$=L17WM]7:>/K;\Y1WC&U;/9R\(,[H49:M41<""O@>;
M8W4%;>L2J^>^7:E-O9'J^<>RP>07[WTED^VLO9I;'[7\))4]BE9&%W1^[JH6
MZ\'6G8H/N=&:6?A_]K"O%&8]&Y!=^'#^QYY ?;.[S/9JF_\-2PNPEA=HK<T>
M<X%1UBZX 19&N7B+ C*X;4_QFG*;/P(509(W&F)YVI^"7OU57 >":_8.S7!0
MS8&IM06S$KA+5]9X$V0V5WA2L0+LP[R0H)*8].+U4!OB';8:VXV>D>^QC8Y'
MLB!\R=$Q7RE!OM.+[@'/[!]>+WZ6..KB6M"K_?/>]Z/P*WN;AB3EB,!1=#R4
ML]4_Y$/^DQ_M'*T-C=<MMGF6!_IH/?)M@ O9FGJ!LM UMX2PI:R]W![J]Z";
M\K?5]VZ_O<N>X+00"4(.TG4FU!6]"0>@*'4Q-ZEDF];1+2]E*]'_B[7WC&HR
MZM9%@Z!(%^E2@H"@TJ1W B)=B* T*5&*@)$F+4)(0 2D2U<4$.DB1'HG]*(B
M':2&A-X3*08(R<5OW[O/V?O;^^[OC'%^)",9>?.NL=::ZYG/L^9ZYWS&UFPT
M<KY=F#>ZAT[@8#FG1G\[Y$S33O$:X,EYN%.0]9C@1%'Z_)S?:Z>DM#P+1UMX
M=%@DOYS#WWS"AJ-PT *(:3U( 7,8F>12.&-K,[=KM;=@<"8MOG=ZWF/6IU7(
M($ 6=L,1RC!3)!,1HU4]N?].A756>I#-B7?19T]O\>2;]D>65^J/SY:$)Y$6
M9Q!Q F-S:"5PQ)DKI@67N!T^?V]#2'5QDKFI%"'F5>"!.$-$_/WOR'C5HBA-
M(&SCYR'R=>/ %J'[19&-+F>VD/7T'4;X0-NVWD^N<O$WA#];4 +PT.#KI*<F
ME]M#2 \HLF[HIQB^IZ:H6Q%5>!1C]:,VX\GJS =2\W$N2"%HEW2Y=V$#IG_H
M-5I.,EM(RH,U,CD2DCULC7]+Y^E4WS@_IDQSF;;6C7K[\U^W:UI=?>^<7\&9
M!B?U$+LI@!L?B*YGY&(-N9^\@3:%[O$N<I$*?;$YI^&Y%,"(\>=3E7^W.&8E
M+"I:W1:G3+H-M\$:D&Y.!+5T%V968*Y-SGS)$+#HG[[0<02ZNN38=',1P6L/
MV]D 7:( .OQ=/DTU/OU#EX]T_"[RTD3=J?]%W7XJ:29TL2#@P;^=S#!Y\JO@
MM0A5]@43W]9+DPK\#XT/QB1<JV=NN#%6I%V0&PK1/_A<Y5YE,/H\-G.*;=.!
M>;1FV\M@7"IOSK=03=TA2CCWF(]U1SP@!JK8+:$MR(B7=;=O$KUA:FXDN5;+
M;_" S]F57_P#/J&A^.D(I#S72:-PREC+):Y8)CM\ U0&&6\V=,_#K!]F,$5+
M.U_/V2*,G;A2$XJ^[3HNZ_GDB.[VY8G%/4[L85U[#W,[RA@QS45*C\6L;0J-
M=G$J99ZN9 @PC5>*5RQ^.*">]3F::+F\_M'"T.;YC.[>GAQ<-W>&F*'3,BH5
M^;@QK@><NZ5?KPR*<(6#\' $+;ZF,#VN\F[#BV4S<J7.& 4@J!%:GM#<V,/"
MO:::$5TNM>NEH&:=F%*H\U7Q-RE*&=BF?+Q2';_,Q9LE_V)C).V:?'K"8.G,
M,040&L3<DFM#S##,,1T3VBM[ E#=7].F00A]_D6LNET_AJZ4].>U:HU[2^[E
MC=^L?JYXV",N;D"(Z'TMW[0)M69\.-=\LXR]UVWO8CM(ZVE.:/,Y/WO+3=LQ
M)\CVBT^V 8_:P\Q(+\@$7FT*(' ^X4'*_6"6J>OW/T"_#3QKQD# <HVSLGHO
M^'4E?<KXSUC-0;R5_=CN50]%B_9(]70[/D&>7;)H([' ,,]0^%'?@NS7->TU
MJ(I>KZ01/-U]#M$2-6PP->TM&_RDN;<3S:Z0R HK^3(855195?6N#,5C_3V:
MKFWI>AOWX-!H'%\*--?OZX&XGGGD,.9^)2%YHW(-Q9S(&MQ@+87'!DB;/P<[
M8.+=UY/M!HIF6I8<=(>U5WHN"BHA=!VM-Z=?D6\U5B7W8.7;W@ME?;H:B!)9
M/:.#VIOVDI>'1;K-\3&%([N(QC1I!5LHPWL#L521.E.G:##ADAP9\:EL0JH&
MR\L?=#R_LS:P:KOX7>;; REFWS ,Z%MMB9J-]4^[#Z5IFV/B6<0P7'0S#Y9?
MQ^;E#XS"I])JK<5E"6J9PWN&FFV3NG:37=&/HMJ"-NV^)-).\=OI86UIG%XB
M6M3V/Q=Y^O\H+[?@WGL0YQ%<#2\H@]\'XC_88SH+RM_YE,X,T!N)7./X1B6L
MU_:R\M$2L RF.]@^53CFTM TD6?LFO$C_05'?LKC9U5LX^]3#A2FH0(B7T?@
MVM#SN+=#MDT\\[)FIMH6M!_%:/<Y^*XLQV5JS)<^>M+ZH>N:K>^[*XJ.!EJ
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M.7I;X)V"PO/,U+F&]/(^;*ZI=808L+)\<";&I-.'9[5<?*^T)P=O0<?2/B<
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M$2!F1&F\L2U!,Z7(7;6VB"_],/TP<WGCH4V3B:SN.^< "WKJE)=Z/G%[6KQ
M.J0;. K(+T]XL0#A=D<(405JM#2W>SH"]T<XNZ(I@'-F=KO;3H3OMJ<Y9-99
M8FRG _-8LQ>.9]66ETD)7)OL8FAO_ZKJ8OOCRZ]4>D72[.*6X-%8#%&4-AIQ
M'5;I]1K"!K<H@(EUF7<Y5X\@N*SUB_2A-VCRJK'/?]#Q7#54I@!L(%XDJB$2
M%)L3CF ;00AMW-H@RU=677IJ-63D8C-G'1&RK.UXW].01TPT5),!+]WICI!!
M_$!77\@I6&^5'FM5@'5\X[]O-P[7_MA?H!TL:[RB[_H$%59Q6Y6J7:U=F9O!
M%QMX.-F+2<!43AXJO5+7Q9YX12" R4"V>:CJ@PDS6SL&-RQGW\^\8,[8CV2N
MP2>]ZR;L5/C);9N3ZYM7O#HQ,?/J7K&M4@U5"9UFXX.12_5>7QMI7FC^L$*H
M-\/K>TW'-T'_2$(P&($\9/Y'$H+RIL,V"B#%@GA&NAS+SU J?] NBL161[Z+
MPEJ=ACM3 "/1;M1KTW\WKL170[QP[(KH&G(&5I0@]MK19G^WAE]4^<-4=:Z6
M0\#B]YN&8LHL/?I&QT*-4+/#F\Q_5JRNJ<4GP?NF CEF91J"$GWL,&&ZWVTP
M&@,'W9N28V]*LL*FBPVX%]%!ZZ4?\" 2#$(!3)[VDB.L)=_ZZ^M;MXH2:%J!
M">.+7Y.)X.M12TE64&"CR@$YK<9N-QZ].'J7 O@:CR9'W GDJV7AK_"Z.)=N
MGW_DC"KZV6QU&^UGI4&@2H.+!=='K&@6 7\/0W/->;1IA=E#4J6*Q!>R5"=^
M4@!=3#2L71A/YV_EFO<^:QT[9VYL?L#GD!#$<'('TQEG+_/S,_9.:-=U)N98
MO]<>7FZ-'+,_NL,5UU_%L/DAY.9!W,BL3:<$X:*H/^-PY"S[L6N+N+L/QI;S
M;-WJ_(=MO]*2IP'3&N_G[+\OS10JJ= LBO%_'G\"RR/KMMPGM^13 $,F"O79
MW64@L[KQ+XN--2D#=2D[K1<'E7<MGT:&40""DFKDEKRSRW0AN3M4NNS_*T#T
M?R4 1'7W]_T?EY]!Y+@Q"3[KF2'L@-X($1>IF&[3!U]_LA1_,AAQOB$DGKOQ
M199),P9@D@=PBKFE@DN/ >R!SN@\M2"Q1?.]&FRR)YLILT?E,0;+[_Y%??]-
MB9!93;B36WN/GBF+_& 8B)G$A =W"K=ITE9GCXQ\,Y02.]%^<2WSB3"\\ALF
MY-=BCA:@#6!5-*F6A^R;PTD7H,FA3S/,Y'*G57 I3RD /\2#C9MZ8J8?S!*?
M/KQ.=8OV[/U_"^ 6^)99V\SKNVLLR=CUQR>IA0ZDA(4=E%;__X?/. @9V/'!
M;J\H553DLV;CSS#-P\UOR1C;X?PI7ZC(\_R8;R&RH:Q);PSZ!@)J<,C:C%AU
MR!EV(G$7&A; U6+191(ZV@J?O3(O_GA=911^TL^:%%4X>_B1A3,#]V>;X42\
M9P+# 9?2E".!7C_SXB8: 3+3FNV5[*;]GC$7>*ME*. @M*W44 @77*,8AEP
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M4JA(_(*]9GQN3NZD/I7J#8=J,NQ$ZF]BJ13<8&@S./B,= 80 W'&2.:GH\2
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M=,.:;)/5E,F,+XM*QY:-?W#MN=NB+M3GZ[MT1J&MYF)<9'S][T ]Y&[9@!6
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M8:KR@3OC0]&=*-*/!L=F3#FF&1;>*#E$UL'VA0M>2BA9_>U;73,Z\#GQ7+,
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MO?0AYAF[ J&?-#QLK/\_/+/[?ZO<^SC4,.,P2@/][$Q *(G8JF\[3:D1?]-
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M*\SB;![YE6\]L]7O;^YF3'JN@SHR178GM&,BL^[_R6-BYO\=%'<%L30Y$)(
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M:ME"O6R#%KU*X9\J@CO$3TE;JY.B-)"WSFMZ6 \'7+8GZV#U#W/C/X:>SZ'
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M(#IO?;& IF7>:ORGN<E/5<,RHA'UT]9)OR_?4; \15SFH/:XHSK0%>="2=J
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M25<B*[.^B>W53C*V0<9461FKT*!/5W+8EU!BM&U7!RV&KCTA+\9=HO1+2TT
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MG&SQ(#VWMO(6Z;-+;AXJ9 LO9&.U.-](?Z2V>YOL>R<-MVQ(,=P7#%A^C,]
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MHHIG%32+?UI4IA5;KVM1?/T&Y'EKTK>S^X@I90BW]AO,#"U6(&M'1)#VKX*
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MCRK]J8Q[3??E+\ NQ,EE4)>9O+]_(DOPA#]:9:8Y((-DR]=#90S\L0O7@T!
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MU"4J';),4QVJ-5M'H&2/'@?;VS39HQFZ$$[A 07+/R))!5H7?STR%Q'&^PL
MQ7-:1F2/G5';I@#][/J.>6!CND?RFW\!'^H[#U,]BZCX,D*$RSPE,HR W-9#
M\4D*E1,6KB0U+$6"7O&^C-#]2[6=0%;G7KKVF6 9R(%ZX]POL+[&C,2X]!''
M\O*'#(>-T3WMB>P)KC6F^,PMDO#XQ_$X[S&X*).F3<KH6X6I0_[FCOE?:\K
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MK8];T2$]2IQ-TZ^R@5?W?HJV29$7K(Z7*-9[2+6Y7$RRX'&2%;_]3"%3OLZ
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M.6S8*5S%+"R2(2&8'##<&.<Y-5S]Q<O8\^\,Z3-X\^+WQ?N+74[[2],\G3=
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M!T1&*%L KE0-QSF6_P #-<T>?2_%UM>:=J7Q!AUJ?6KY;DO;V-UY\'V9[99
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MTMDBNBU;X%RZ/X\\%^)O"MU<3/HAO$GMO$&O7]VKQ36S1J(_.:;9B01DX"Y
MZ\ 5=XD6D9G@?0#\8/%'Q&UO5-;\00Z9#K;Z/I4&E:_>V44*6T21RR*D,JH2
MTN\Y(/*UV/P!\4ZEXN^&-E=ZM.UY>V]U>:>UZX :Z6WN9(5E. !EA&"<<9S7
M*?#'P1\3_ 7PYLO",=KX6LKE1,9O$4>J7%U(LTLCR23BU:TC5VW.<*TH'3)(
M&#Z/H?@Q? ?P[C\.>%2(Y+&R>&QDOI"VZ8@D22M@Y+2'<Q ZD\=JF5MBH]SP
M+PG\0O /BS4O'FO>,OB1<6<@UVZ@T[2;7Q==V+1V=NJQ)Y=I;SHS-(T;N $+
M,6& 2>9/AAXY\9:;J'VSQ'%X@U>Y\,^#K476C(S-=7-Y=W4AMQ+"" TX@BB#
M,PRI=]V.37M_P;\!R?#'X6^&O#$\Z7-WIUHJ7,T9)1YB2\K*2 2"[-@D X[5
MYUXJ^!.O>(F\7W\TVEWUWJ_B>QU7^R[N:065]IUK'%'':7!\MMN=KN?DD7<%
MR#S5<T7="L]&;5U\>I_!^H:S8^.= AT:[L-&CUM$T;4#J(FC>8P"'YHH2)C*
M451@JV[[XP:EU/XUZMX%M=1O/'G@Z;1;&WTT:A!<Z/<OJ222&18Q9NWDQ*ER
MSR1!%!96W-\X"Y/GD7[+6K7D_C74!8^$_"EWJ,>F2:/IWA^)A:6\EI</.4G(
MAC+B1EAS(J@\GY?D7=VWCKX6^,/BUX9UJV\37FC66Z2TFTSP_;@WE@LEO*)2
MUS,\4<DOFD>6RA55$QA7;)*M />+[?&C5/#6H367C7PS;^'KB31+G6[+['JG
MVQ)4ME#7$$K&*,1RH'C/R[T(+8;@;N.^#/Q:U_PGX,^']E\0+&2*+7=*N=0B
MUVXU-KFXW1Q&ZD^TQ%!Y:F(N4VO(0$"L$/ CUC]G#5-:\.^+UL-$\$>"-0U;
M3AI-E9Z!91[((G9?M$TEX+:.5W>,N@C5%0 #.XMN7?U/X+>(/B-&EOXPGTS2
M[+3]!O-%T^'1)7GW2W,!@ENWWQQA"(^%B&X#<V7/%/W;![Q?TOXXZM,/">J:
MIX0_LGPMXHO4LM.O&U#S+Z-I0QMVN+;R@L:R!0?EE<KO7<!SCH/C!XTO_#&D
MZ3I>AO$GB7Q%J$>DZ<\H#"!F#/+<%?XA%&COC!!(4'K7.:7\-_&/B"[\%6WB
MV31;31/"C0W21:3<2SR:G=Q1&.*63?%&($7)?RP9,L0"WRY-SXJ1_8?BQ\(M
M6G^6PBU*]L'EZA)I[.00Y]-Q0J#ZL!WJ=+Z#UL8/Q$\()X/T;6-7\3>.O$%I
MX4TK28[72(K+6;J"\^UMN\R661&#74SL(1&KEE'S )SSZ7\+;KQ#??#CPU<>
M*XO)\2RZ?"^H)L"$3%!NRHX5L]0. <X Z5YMJ7P^^(&H?%R[\6:EI7AKQ-8V
M+[/#EC>:[<6L>G)C#3&(64@:=_[^X[1\J],UZ#J'PQTG6KRZOKZ?6EN;R%XY
M[>'Q#?\ V4;XRC!8/-$0&"<8C'.&P#S0[6LQK?0\>\9?$CQ#\0OC)\/=*\+W
M\]AX+_MN027UHY3^V#:Q/)<[6!&;9&"1'M([/U" MZ)\']=O;OQ+\3-%O+NX
MOETGQ&_V:6XD9RD,\$,XB!))"HTCA1T"[0  *Y#4/@OX>^&'C33_ !G/?7]C
MX*\*Z(T-E9R>(=0FDAN3+'A(XWE(\LQQQQ"$-B0L%*'"UK?#?^U/ >E6EUJ>
MG1GQ1X[\0RZE>:;)<%);.)TZ#"MO,$,408?*NXGY@2-S=FM"5>^IZYJK7BZ7
M>-IRQ/J A<VZSY\LR;3L#8YVYQG':OF?P7J4VL6NBZ=%XK\1>'OCC"8[Z]T;
MQ?J-W%;7Y$KBZ1+8YMI;=E2<QM:IE55&!0J:^@O'WAN]\7>$M0TG3=:N?#M_
M.$,&I6N[? ZNK@X5E)4[=K+N&5)&>:X35O!?C?XD7OA6+Q99>'-%L=#U*WUI
M[C2+^>]GN+F @HB+);Q"!&R^YMTAV_)CYBPF+5BI;G!+X\\&>)/BU\29/&/Q
M!?0=.TF[M]*TW3/^$NGTDJT4.ZYD$,-Q&6W22;=Q!SY>!SD54L]:\6>#? 'A
M_P")$^HZ]<:#H^LW8N+#5)YFGN/#\TQ2*>>-SEIHE*2*S#>4^\:]C^!WP_U'
MX<^ QI^MW%O>:]>7UWJ6HW%K(SQ23SS/(2I95) !49('2M'XN^&M8\9_#+Q+
MH&@7-M9ZKJED]E'<7;,L<:R#8Y)56.=A;&!UQTZBN97MT%RNUSP35?B;XJ\8
M?:/B#HM]=:7IFH7T/A3P3ITDDBV]U-/,(Y-4N(LA9 %\PQJX*@)DKDAJO_$;
MQO?_ +/?BRXL-&U+5->^V>&'G%OKNI37N=0^V06UM-F0MY8=IVW)'L0[1@+M
MKU;QY\+YM1\(^%=/\-O;V]WX5OK.^TV&]9E@E^SH8Q%(R*2H:-F&X*<'!VG&
M*Y'Q%\"=<\>1Z[XBUV^T^U\:W3V;:9#:M)-8Z?'9W!GA@,C*KR"1_FD?8N-P
M"K\F6:E'KL*S^8Z.SU3X9_%/X?:;_P )!K7B"[\06NI'6([Z^>:*YEAB27S8
M87;R[?$C;0L01 KA2.!@^&/BGQMXP^/GBT>(8H]%TC1=(M8;?0K6\,WDR7+>
M9NN"/D><+#_!E45PJLV69NM\+^!]:OOB%/XW\6+IUOJ45A_9>FZ9I<SW,-I"
MS!Y9&FDCC9Y9&"CA%"J@'S$DFW\.? M_X7\0>.=8U2XAN;SQ!K!NXC"Q;R[5
M(8XH(VRHPP"$D#(&[@GK4W5AV98^)FBW.LZ7:EM<U/2-$M)OM.IPZ)!.U]?1
M*IVPQ20'S8P7VLWE*78+M!4$Y\,\)^.M?UZSTWPIHFO7G]D>*O$M]#I.K75V
MT^HVFC6T8DN1YCEI%E,FZ-/.S+&)1N"E1M]R\4V_CFU\36VH^&Y=*U326M3!
M<:'JT[6867=N6XCN(X)6)P=IC*[< $$'.?/=(^!WB+PC=^'?$NGW>F:SXLM;
M[5+_ %.WNI'L[.Y>_"&98G6.1HQ&T4.TE&W!6SM+9!%JVH2O?0Y76O'&L^#?
M'WB;X<>'=:OQ)J.I:+8Z9=ZE=2:A-IIN8II+QUDG+L^V*W#JCL0&D';Y:[[P
M0)?!_P <M4\&V>K:KJFCGP[;ZH\>KZC-?R07'GO%E9)69E#JH)3.W*Y &3G.
M3X%Z[8W&F^,8K[3]0^(L>M-K=YY[/#83^9;FU:T1PCR)'' P5'*L2R9*C?A>
MU^'/@/4-#USQ)XH\0S6LWB7Q!+'YT=B2UO9VT0*P6\;LJL^T,S,Y5=S,3M48
M%.35A).YSGC?]H'_ (0GQ5JGA>;P^]YXE<V@\.Z=#=8.M>>64D,8\0B)D?S&
M.X*H#9Y KT'Q'!XAU#P7?PZ//9Z1XGFLV6WGD)GM[:X*X#9*C>JL>"5&<#*]
MJ\KG^$?C?5/B19_$2_U331XAL+Y;:RTB*YE-A!I)5UFBWF(,T[E_,+E/O1HO
M"BO0_BQI_B[5_ FI6'@:[L=.\17(6*&]OY6C2!"PWNI6-SOVY"_+@$@]L&7;
M2Q2OK<\[\)V]QX6^..F>%] \0:YXBM[316D\5MJFHRWT4,QV?9),RNWD32'S
M6,4>T%"IV8"FNN\=?%+4_#_Q T#P?H/AO_A(=5U6SN+UY)+PVT-G'&R*KRL(
MW(1F<C.,C:  Q(%+\'/"&J> =%_L2?PYH^BZ?&#-]IL-:FU"YO+AC^\EG:2U
MAW.W4ODD\#  &(+SX?\ B&3Q]XY\40W=D+J]T&#1] 'FNIMRHFD=IB$^4--(
MARNX[4^@IZ7U#6VARN@?M*W^K:+X2U^[\(QZ9X>US5ET1KJ750TL=P3*#+%&
M(MLEN#$1YC/&W#GR\!2RZW^TEJFG^';'Q18^"CJ'A35[Z/3]'O#J8CN;F221
M8XY)(?*(BA<[]K!W8@)E%W_+"WP(DT?PW\,=,U"X@?PSX+TRZ?4U@,LD\]TU
MJ8A)#&L9+ %YV'\62H"FO/?!NK:EXXO_ (-^!-,UKPSXB\/^&YH;ZZU#P[<R
M73O;V<)%J]TA1?L;L1&/*+.6<MRHC(:^6+U2(O):,^B_C!)XFA^&FOR>#E=_
M$BV^;18PAD^\-^P/\N_9NVYXW8KRGP9KVBS:EI^I^"_&&M13:&)#XL\->,=2
MOI;W[)Y =G-M=%FCF1S%AX]D;;I%W-@"O6/B1X<\0:[8Z7<^&=6&FZOI=\EZ
MD%Q+(EK?H$=6MI]ASL8/G.&VLJG:<8/,M\.=;\=^/--\0^,[#1=+M]*L+JR@
ML='O);R2[7SY.Q2.%_5(H9 M>P@CLF8OQA*9#!\I+9:Q)$66,5EG, C9C0DQ
M(2:[[#*,/9E!DF0=!L.,B&09BI&)M^]_\/[X_O#^<'^_SSW/?<XYS[G/7=]0
M%K0U0"0(-CX_#ZX*'.YX2F%+:H99(]HR%DTX?BR(@KCA]"TA),9UO-DEG+P1
M'M*=6C7BP9$%OZ#A+Z)48.=]HKU)Y\-.E)T>NGE-6JQU2D>&C6*[!)T5U_65
M-/N3_?N%N_\AFYK2*;!628 80-!T2;B'&?T!)X327T2">'TCW_ :C\T'SYH(
M1Q8'1/)655[W\)2;'E?F+>K<[G@6>/:,-*&?*ES0S<-,)(8'D['[-F_FIJ%#
M"$/; .W\4 OUGX%?(.**;W4*]TXBL<G&"D@T2Y*V$6A8X#GKRLRN[/,N7_L3
MQ G3_H]H<"#0P15/) GG>5\6KAA\;)D@Y,I0("<>2;!N3>)M@OHD[@TD*C9U
M_-ON")*HUISK&D%3R[)G+C\9M:HN?_JP:T.:VV-+P&4*2^NHET!RTS320)<4
MTO[4Q3WFV9MJ3T,+=Y&TG9*\DDLM0I-[KO((-(QFJ^P*7C4*ZFDO[*KVZ1:8
MV-R HVXO18+)=QAR:V7HEJQ2Z+G39]K84BWE!%2TT,O+L#>RM4+7?2)5G!-3
M.UWJO"DKN&(FG!CG/.$O%Y&[J5'G^JEW2G@17O#P9:Y4$K=$$5"E4?F<ESDQ
M2BE:P(<J%Z-&$S%P67V7L".)T=XX*P?&JN!/*6UZ7- .3 3RWPV#D^"Q>804
M8UE? _H3JB#C7DM)Q>P,149$Q2K8/FVPB_:<*/=)$OFPHQA8Q^V1]^F2VQWP
M/%X1LX?.O_N5Q6:,ID&:;3SZL*(Y0Q7<$VA8'CE\1!;KS<N? >![9G49UM8K
M'CQ".;%[WW,4QM+EH>H?S;:/"EEA["Z.Z*V=RYIK'C<3,TO6"2-9I#;<JL@1
M/P9P1)U8E^'[C>-R_K&[U@1%(HB\I1^D7J<OK&4YAQ&$ !ZWSE45QTTLOSME
MMXWI>2_"Y+[UO[3-SW/T-T8$F%<T50M77R&TM!WZT6&,FPT='.;GK1/2$EP6
M@F/R][GVT?_0-%:=0@4PH'2IJ7+U8&;PHW>C]E:B-FHU]EP*F6%"\7SO41:/
ME&KN^)L>5F<PS$D"J[ASZLO,N#"ZD23MC_?>DM7$+^OJ(2C7IJM+UM\67[ ]
MY#3RNJ>='$5&S.][,U-ED1?>TXY(?LQ0F(_?:ZOSQ1K4[*Y5#8F0*8V5//J\
ME2EZF=-'NR&Z2Z-'0*2U'7EIU W,N)]?Z0*)]+KXOFJ.,ER!?[ZRP'VRU_)N
MO$J<-)M*.KMP2"1G+4:3\3VY'J5"DTGLEB2#(KG&0^H%X7&DK^L7)S=UE+(K
MW P8_X5E9'U*:Y?!/35,U;/Y:T"^R<"0KA6C0(S"CK=(?YC@CE'0G6:&%+4$
M[JO]JJ\HEK82B67K[%=.-[Z]RR-0< Q(-&GZN_6,Y44SS-4UC/C+30Q76*ZM
M J.Y_[9LK@YIUUQ1SCA)22D:!+"Q+N!@Y=]R>HK_X%2\%\YUNC$T_AOKYI^9
M<_5V!;5D6FN(^.XM9^ /H:& N>M+1TYS=?.)C:&@!_P;;JZ3(1HQ1VK,,H[W
M-8YZ^4!B[Q3#!W%"; /FN>.N+X"56X',B[7A/@.OL(L-[M4G1K&]WR:G@B+H
M4DZ^85LLBRI@0[XG\,9CGDO"G;!LL8#DT^SR&A,[MMS%K+,,#9;<'PWBW_OK
M5O_0YK3L$@73J8ZN^W=2#&-T1,9('J<%$_KW[0.I#FSV <H'Q2K:*K>FFC62
M"R68V"5#-.+>U^ 1GM1U(Y%9JPD%O$-9<VHP6=M/6?'B/65!TX_"?$.[FIHH
M*#.9P6W']%[,=Q$9U?$&W0S.MQX.J6/ELH8ZPS*<P#@M@[2<C+T-YY\\<^7?
M<.PLB&*B+@:@1LV5B=&U<8I81U^WD9VPJ1D77\8[H-ZK"BYG?=&2>8&;W_R&
M,-9G1B/H.!'D"?IIV,8O&3XWZTIGRK=J4.P\G<!59-F+3[MIV<^A/>/BK#J\
M)<ULG^V1/DU&04(3H)'*GZ #R3=Y\OD;3)\^A0"B='=Q<2A86#F.%XDAY0VD
MX6&A]/YUUPX8]/M8<_Z3#0JDMK8V)Q0*5_4+]D(#E9^_Z$LWCF=F+Z9&)QNS
MD5D:089.Q*J901]_ 818*E\V(^/U^?./O,3JKTP9\S%Q])=?^<X/EWK?SY%0
MV\3".&)4LW(K.I[-#@>N6"[M3'H @<J2IZ:Q5TZ\=&HIR=XJ&G)>E]A/9$EN
M[]*EZ^M]+M$U!'S; SK?6:^];Z(U=?CI5E&^?R+=:D$-=[LCAT2OZMZXPU G
M1&_#CT3/M1]5^]90??3V)<!8>*1JZ*V9KA]$X29HK'Q!:3)!NUUT[AAPZ59U
M^MX033&)]8 J@6?,Y3D[Z2?4@CJ@+A)TB,UO6LR;P[OEEE^O"^H%9JBS=)[G
MGOTJP<N^N)6BKC/"SG0C(9P@V[BXL@0'8&,F1#W$P^_$S,%HIT_#*8!V%;[C
M%8\P8*4NN<EP(?D]OPG-<77/8'@X9>[) CQVUJY#^R#Z02QX9B]6K^!3S6#K
MXZ>EKQEQ'YV8<:1H:92XT4!BH2T7,WS]KF5M2'";>]A;[\IEKQR%G0\M6FR'
M+8,/SVYE*?NZ+7$2-X+HI:'2XH>/N_,74W/XZB \FP3RDPH57['3S?(/12.V
MYL!W>80*34@+O%&*/_[W,VIQ*-(<G&EX_U"]&13^<L_NAX@FJQ&<6=;T*L^"
M?;B7$7ONQ8"0I"/B$O4(7/_!R XZ(HW\,W1C4I?7JZ=%T(GH$?+6U3HB]6N=
M^E("_;X7DBSP2.2"X657>@F#/+!A3W2]P)C"E3+!1D[D7HE'X=E[18@J24L'
M'8U+\98)MM2-T\WA4@,*E_7#^8@;^K=&489G\\/>/#F2C!WAISBL8D="3I
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MY!@@6[JFFD/&ZE?>A<E:.+B#,T7M*8^Q5S@+LIUF29DH1686W87C:L@"_ZH
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M[S!DDJ(6RNN3/!E&Z5WE9L.RA,L4T\8;)X>; C<YG-]5/V@PT9?#M35T+?G
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ML;+A0%L]4^>:9FUT[8X9:[JJ37YN3S(8\ZP1R'X&Z&WS\A*)7_=7)OYJ-<Z
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MQ&?L;O@ E%:,&# 8YTQZ56+P95Y-3R['"1SX8@/M(K=,G>][N58IG&W6 A,
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M QO*T:&A;]D$RGN9J\HB&$0ON8]P&OJ6'Y5NDWLT=WH_8Y2A7T>[*AGV_TG
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MZK6Q4A!_L,]GY(S.A*BMU7Q-807EZ]S',T G$_J%ST**F]P*$]0N][3O/S!
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M;F['2_2,PJJ-R/<%S1P;EK!,927J ^JK7CX2J&165C59M[N.;CZ,Z1 CA X
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MXI+U['SGQQ]MMDM!$C3K$415[6NVOK?+TM+Z+93T&^?:QLG5T)&P%;?2#-N
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MV.[,4R0RAL>$51CPA56*I)4)_G "J$=T@J*!O)AGX$2Z$G7_/$(,7:#2 K]
M35P 8G,CJD@' 0J%#H^R\A;_Y-^Y=@@KLHNA[OSWZ9^L<MI]9.:DJ('EWGI2
M7E9>?DQCG7R=E7Z<JA=^?KMG<M1SU[<S[B>A&.RY?%@9[IT_-;MH^S%1WDSU
M."@#N0!/W\$DZ&B?ML]$,,E*F17BT_-[E2Y#TLWI_!8Z3]2V?>?R!V>ZR=A?
M='O]Q;+TNZ4ZXUAPQNO*%4SBUW8\)@;3-!5#D^#3$_1RH*0>NC?6JF?GU#GU
M4KY_ZKG%\.[,*WS(E1^#L#SHT^-<NA#LM[!B7-;"%LN?=4I+V G@CJO+G,^3
M'EO-PJ?IO$2G+U^M&U^>/_OP!!!G0[7",'M0+06BJQ6A#"\LRT=]G^5>5)&O
MC ]+[ZHY2K^QL93ZFU4B08:P0)=>#]N9/:C&. ^42PMUF#\G'&NZ^2C+;F]
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MECVR+RVBG.?<D!S4(G-*@T&K+H=^^S":U-9VTE:H;-USHL^"13QH^]UPX@F
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M);L.#1$>Q\A/<H[?0G84QZOD+[M6E=FS?[GX;A&(IE^%2I'@/</G_D+ O6+
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M,'6:2M&YY7$;.EX+(D"N <*5,H19[C\32MA"@DT^:L]:F$-K(8*S^Y73*>
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M^[VL<YV$:4>SDO:6H_$X5D\'YMCPH2F'9SEEG;Z^FL'GE@@&;-WOSFI>>L5
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MK>7G)?#O??MN[QB?%I6_0RU.-1<O'G<".+I]Q2;GJ?]P?[$_:]_"7HWG@]Y
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MBX%8%_/\2ZO"+TSOCUH[Q!WG&PJ$8*C"?'78<V3#[KQ$WPWEFP_H2A@E>U"
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M?7C,2-89H&@,C%'<4Z9PV%&?(/I!!_O%9X!U;W::/]K_R:U6[(?SG0%2'J[
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M"9-J1889-?J[R;Q.O.D8[]' .-YZ@2;UVAK/,"!(@&,/LN5 '.H#L;=9X 5
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M%"_7KY_HW&WJ-C1P"+X*KMDAJ5LS>@C^*1WL5.>#B-ICBAN.<EI/N*@##8'
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MQS5+XK90U.>E+/@>Q$\B>!L-/00]P%&2YAMMVYNWAR^ANXQMD(V(A]O(R#,
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M$S@#2&5]"%X9ZF<'Y%:CW]YF^@M@MVH)_6\I/JO9-T;XX%!!R>8 U[D%#W'
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M<:L?AE14C')6?R@S )Z; .$L9?=#_CH:S1#>^R5.A/[2I8N/V$HR<;/V@78
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MM%]:)^NH;1^/)WW%C#JDR.H:->ESEJ^S[V*P,Z1W8K":W@#ST%:%8NCI^EI
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M-"BPW5)Y8^_OSSOXU[>#MN>GUP'^GQ&3DLI$!*H4>&!/4K[4:5F7=,@@M[)
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M$O$0S?0HG((S&.CV"DG=OD],Q1A>!B;Z>9@[V,! ]!W_V0CQ<9!^^1WM)R4
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MPQ@LW3-*J[S51]U$NE\7H Z9X2\<45:N6W'_Y N).53;GL]LR\@+C_Y.T=8
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M7(_3OQ/'SYVF)0+(I$D?JB$XHVE5J#E<U<2^6G4_9\%9Z=)E44FT>C$YZ75
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M<-G%^\<U;-HT_>P8N8^G/@;CV'O:#/K8D;7LXT.8<C8)"B/KVSUZKJN9HU0
MA%BJ6H,RZYVEQ]%_MJ<?RA<.K1@@4L'#?ZV?GB."J6'I[&UXOYZ%A1D=VW;>
M"6_5/_;9O=_"!4>5SQ9#.\O=0Q$XXYR0 -K/I#2?XATNT]KT\&'<LD'^B)HS
MI><+G8/[[;[X$SV^NOUEH?-H$@^AM ^9$%V9:D::04S+CSQTE\2)!_O$9=:G
M$&Q;Z>\X+:IF\LD8!?_,J<[*V<W*)\S=FZP#-KP*:&]$IF2QI,DNW%_KYXC7
M 055OU\#*)>K%S9C)EC>>!=I^)3EF)>>C?J1^.S/E"Y%M&;C)8;=32\A9?4:
MCC-QGZ^V7="X.7SV>'8!O?04%=]_SEX>I&T#[@:^MZ+H A$,0#^T+\WX?48/
M>[ PXNQ1N].IP^B*DA.92V!,^"9?72(2EG1I:Y=6/:#D2HB4<[W[&N9G>E<C
M\IPM$8XJA-28^#L$"^H]R/'BXYL)=B\\E5+ 9E,05"]92>04#&DH9'L='URN
M6%?\=\K] J"7(A]W['%0,6U#!TW%(78K4? ;6Q< ZM>[[$8'P3SJP^G #*_&
M,#5WGFSWH4-BQ:^M:,!A)<%_<W?<HHB0<//Y1]U_3!>V<P&0;"L6O,1M3O#P
M(2LC4<^?F@D H7>)O+NV>L[6? ;\U8V>S<)@S7O>5)2>YQ?;0E.]]EK)U48L
MC=RE%7$R7%C2OCKT \']#$!P0B7T5(:?SH4<<<<8DG6EIF_DO;4OT7,3:4XG
M#2Y/<RP"6$3KC;4HE'.I5W"'P'D$*9J\G\0<<,DW!:;@Z(V5FN<?^S1NCFQ<
M24+@XK>;^BLTAB!&YISVN)Q[4R2);3@CAAV$2]Q6>:0BO_Y]&.04K9,H_07=
MH+PI?P5#>^DH%,\SV+3OX^F>8;-* E5+UE8K0!/.Y9<'E,_3IW_2]UAJQ;J]
MN3Q S)^^ 'S%VZUBP.]/V:-)PC"Y?O.NS3._+H\5[8*_GM@8UT5GGH4YH-(0
MUVIB/)3>^CPK4!!#:X]Q+/26:I_"4^LDW)NMMWEN6'U?7&R=)C"NVFDSVT.3
M[\D*SF1E/D]+!*,60DZCCSLN[E"G)P;\^>9.N$.Q.UP>AA<.732GZ#XM-)J&
M]S=8[=2-_:I!CWV0-X0^;+&UWFUNB*B] %#9[+9>:>]]V9F+],7]-4K9_RTV
MTBX#[U1JY5S]7#L=J%YDYZPAT(!_31)G9Y]*RY6S&7$[@?X O!EZ':H3; RV
M OQ&H#= -?!S%NH$XJTC"$F[8.!?FD>@$_[!Z]9JK=L_@0:L=0'@JSMB]<AA
M)C'_AK"+$T'02NIDMLCR^9WC',?4(9!+O2?>#;7NZ<_[FZQ'Z%\\[L>*K4L[
M"+L[= E?GE-X?_F_MOP#'4*DM-_HC ;OC*?''/!W'?8"P-I^^<><:DK0K[#W
M-AG<KCIS3Q-VJ_^Z;EH/"B6(4,0-RJI&NT=K,+W2D")\1L%YMJ]>]D+G3G"S
MTV?)7U5^3+U*7QK_MC^U\91^1=;#3:+R.%.HD,,S&:7\DD,OF>\'P/LKK:"7
M9@5&.'Z8OQ^HZR/^)J]5O80F<Y7LG'VV#=IS :A9>4^T9LO@);0O%!+JZ;FZ
MUQ==+P!1[PV;Y/IE-DM(=7VPL^.;!%>\8(\&PVQ=^$S<?GB=6+DY^$#JGE2.
M1X#[RV7%K*%-F8Y5ZOXV@%?B_S#BCVIPA@UO=<Y+.%W^]*WV'YC)GV?DFSD2
MPE5*8E,T>&8TR>9(ZM!)A,-*F!*\YO(Z=>:..>0GE;;1'(\@.=N%/B,>L+]"
M!X /QA1^&KU']$&=@S B[P+OHVTM'GJ7>X$;IR2)D?,BR?*NW-C7/+QE;]X^
MH1@S^)<;9=V7ZKD]K_=3L#N]@I[T<(J"R+)S[/(J$(UGN\]._'/IB?Q,%_Z>
MI[3'X>#ANZV,:'7F[G3W+_)8@3Y:C851U[%U;:Z^C 2O.AU#_]GD,RF"F/9Y
MMELP]8+D)26X8=O;-E,3V30R.K#IO]:3$;"?6-5/QG)EX[)+R2^CSJ>/*XPO
MKTD>YM!M(_PN7S+@[128R')R_(KF"B&!7X0#B$MPR=S\)TY7ZN%U=QM0.>S;
MJ<B(W.9(I)0:NU3(]X,*WX3= 1[59ZZ81Z&'I,^1\#-6HO)TZ_W\'1/)\N,E
MT5=?5UQ1U!< INJ^J3<+8\NJB#:L)J]YQPH2BJ[$"D)+%P.5\2)$H2=;4CQ^
MY<?<&9#;WVB>O(!-^=Y36AJ5&0D(#]P\NT7J;X;LIF'H/Y2BL=I[@7(8L9C;
MM6>J[^PPT_>IQ=_I2Y/M^3ERD)%=;8_]WZ;"TL<%.G]'$DJ[$4"-F]O2\MF2
MN/@VX8*PHNL"02K<!E!+X[L<#$8O_84D*>@1%/Q41W"DH&7KM 8G0>RQE#@#
M++^'2_%SL;RX45SM86%F&B]9Q9,SF?)*EN#1 %!4JW89),O+<JJVS1,F69=%
M-6K16Y GKV7*>Q ^_3F.]9U*Q TR,EN1N&!V*]B9UHQ\D+E)NZ*2G/6BI00B
ME7DKJ;LJ'\;[1/'!!Z&AE+75/;PFWZ6PH1U# Z,A+*UD*&57HDC!!>#EUFE\
M>BETTW*K08[2WHNU??T)R+ORAZMQO_J([7F\]T(YL*-=ZD?;S'[=3BF$??M'
M^_?BNV]CWE6'-@V&R.T" ,\ @$IM@C^N?:7#W*H]7[&RB!!C.[.LU#93=Q^8
M):J-C&:3?Z!M-'XG=$#=T)H QQUTHT<*:MP+%VT6;Q67+&X?9"1]*ZNIWS#M
M (JJRR7OO2(K^9_+UAD(>"A]-$DD4!1G5^I^O$^S/6<5OIS_7$KQ),<I])'1
MHRRA!._O]4K7OJ[QF#?, ?'LZ/+"GKM_TJR-VB<4@OAVL.F^Y075E-AO=XQ^
M\%KR6EJ\J_@.+KP:<A<TWR6#/H=B4L/$PPHC6Q4P"F'Z#>*6$OSI@TC40G^2
M!Y>^>(;YUP@JZ=PK(U D'^)[,'*%7NH(Q++DDJ)2$(.AKWZUP]3M_)SE5K?C
M#*>4F/](NXX:6I.*0J,*!0]_0R S.%/,*M\V7K+9EBIQ:0Z?2Q8Z_;9WM>K+
M%UP^5<B-+M<;N<]H3)?<T:,Y%40]7$.<2&.3H6[WK-^QV;B.^4"BY$C3QT9!
MH82:6XN,,S79TE=F_\T$ZRB$19XW8.6XB*!=:@?[NK&JT]@\S5\[_CSJ17TD
MVZ-'23PI*?? UU"B*+J"]K@*\TNO1R^N9HK9IR1$;& VQ!"T(VK'55U/=04-
M&*/"UI@T*02O>6GRFO[_2]?Y^V%OY^YD\Q.4,#!Y,-,BS**_T&;,R\^!JJV[
MYV.+OT>-!^<+@,0[S5%I_TJCLA7F5T\(^=T!%7&>!]JN14@#)[$>31]+ACRQ
MCSIO8#]SZ5-?8S'X.:*<;NC1 AP+IG9I)B=5%EO8!!Z?3"*1"T(RHY%1S$KN
MM_I^2C QT2VKRQT[)/Y9D.*%O;B56)M !TO:!$^QZ4H*U"/CJVX+9179A*C2
MT(68+1?C@ :MN,HP[Q8)^Z<31\ ;)7&"-C6P]AGZO4>2'"KR;A7O(\SN%8;%
MAL8GH\>Z1T#HPLB%1S^R-X[U*X1:6]K;WAPNV>AY'OS4)!,Z!EQ^KFCR&OYK
M(^B^J6YK+24K\V*]R3OWQJS_6FQL[/&(OC8@4!\:A$&$D1C/2X^4U<R+8,F]
M9FP?E_I+%^_TO4@KR[C.,>T:Q9!9<ACKJ2\T<P&(33>LW)U33!#I7G"<<)PA
MRA1W%JEG,+@51%]+4AUH^KM'1G:V03YZF*+PYSWHNC<]EAXX!A.9=B6^CF(K
M=O)\VKM>=HLI*N0&N<6FT-F+'][T\T-Z57XJQVWEL!&3AZD/:FW=+'Y9S?]D
M48.N?V5[P:J5>*+<+Z')0Q%.O%T0*$B8P46O=,WN%%H3:K2F\^>>1?)#1FC,
M:K3]I<=&9&OT"NY1,VI0HLRG%#:"R0CL]B@$D^5.JA6I"O/V7+'+4.RAZPN]
M+\ZS\1,U_<"4F,:J"/&6/4]&G>T_@_]V<J6?I !-S]KLH8\()OLQO?<'"F*V
M73$HMG,^^.)F6%=>E3P8KS7LL :K'@JKL[@J9]=I!\>;H.OS5E4ON2JT^7HE
M713&G=9NP,_!P\_%S75#7^"5X[M7W?DLWJ_7+5A?WA^]P<\)!!"U2FRE8HE*
MI2Y^7-/MG+-K4^5'U%TT!PN?+ 69I,F\BER_-V?2K*W-253 4C'DE5@H:NG.
MF7%M-4X;FY)_['KG9XV^YT0O-V4%1\@5&HL[-*&QR<FART1E@D<IC,RPR7&F
M[,@0:C&3\W2VDF\B/]YVE9Q?Z^;!,?KJGB.*9RU;'):,+DL_Z:VD@ VXSW+4
M4D,7?&MDF!P/)YXRS/_UQ?Y1'@'X>?^/]&?/'!8A_--@:@0?C4J@U:'DKPH?
MPSYJ!U" <>G09Y[W/P<ZA'PJ[(_MYNK<60*OX.R**[9EMT][1]+>EFYUT*O^
MC:=FN,NK0D<>X+#>U%R3#?!-$WRYM)48.R>,\^M@"I0@..7"S*QGIE].\4MG
M?(OM$QJJ>2GY6..D'.#[KX\ 8\>Z8Z0^\''AVM/\T1*/I^Y-Y"-JN++VAT^2
M(IOBU#Y$*.8^Z_=^GQP/&/A9@W&N<X_*X6W50JWA;U6BE[B[V_GJ$%I?%X/2
M+2LE'3+%*U!,0UP=,IQ_*7T7N4-4$;$(NI>$8I2__(W*U,>^+77-A\MR_.?#
M [<Y?N[4\+Z=58IK9X-%K_8W\$GC(!]>RTM870 >V@H^27@ZE7Y ::_K%V'Z
M-$56*'9(Q-@T[%EH[#CYV/QJ/U=DCWN8!N><C[/QJFG*;8E]2<&$(<N"=^;O
M]*\FM#1]E0CM& E0\(+0!E([X<8ZTJ7"=QV2,"N&#0SG7U^[IQU8KKWV:/I2
MP^.14I'R_^8"J%$_P;/W4,.10]TJ=M^+D9:$.R?@:=KL!/NF;"^FO@<G=)I_
MJWONB':0"27!4)6M01A'@CT&%'L!P'W:_FCC'"S:](Z6T^&2*L*/7=O^UD(=
MPS@<O77A2ON1;ARB"Q#-G16ZE[/M$C"3/H/ *NVOELM6=7FQ*9]&&:[39LO4
MC&\J="P'CZK4#A7!7*28D2+=6?=M58[ZDDZ]%'Y+@)#"=?K$\7?L&>)>G,_*
M!NEOAE!DP5HP(E%Y!"^\W"I+L.@T%MB)W!V YFN+G)+]LC+@&KOV8Y5NLC#M
MK/M0C/6.)@?(SCR,$';L/J/@B*>(1.$5RH#T@=JE!94ESDS.O7N__D8)S>+!
M&^$6ZZ_Z=ON&67Y0?-1M?7+EB5TK?GYTMJIL3HR;(S^QOE3C[C44BCG>PV1"
M$WCK-X*-=)/ WH&HU6G#C!B/F>$I(BB0XA*N]@*#/S,,MYC(#E5*&5/N2KR#
MH6C!#+ ,N_.<NC&ZVO;;,ZTF= WHI8>8 UI'=S6%\_(?C988E/^=SI<F7&AE
M&]%^C:1@,J0+!%>']8E9J=L*5NLRH)'9?0LCC:S]H-$?@C/<78T>FM2XMM,\
M6^[@@R?KF;43CGPTL2</Y?ASKE!.33FN*]'3^SW9NRR:A9PJWXN')Q;@OY03
MVZJ/:VIG)*2<]'(U?!# U[*;G8[$YTDGD6<Z3ZW<5VAVY7L\Y3;!>J_$[-''
MAV'&!/I>.Y&)\F JV. %H)>KH(0$RMD];<_PN_OV@=R"@1?E.W5$\\'P<PT;
MMVLI QLM[E2DL8!AE<+WJ;W9HG7XZU&H,^@'>6OK(/F%X3%Q"?=-FY\.;W8_
MJO9=O4/3(L,+@)!=GC\760>\CMSANUT_0Y1"%7S^(R9:NTH[^LB510=C(B;V
MUT.5'QF3N39.T7C)8UZXLW:C;/4($G\("I/O=7V*]V2L)>FV?*4D!Y6I/U)N
M:_NR6IO4JD1D^+EP/\\6B?&5BQO4@5L!_L*U\"?1@5JX2!1;).A#I?U,H.LE
M5B$V[]\W)]UPK7!SN/'K?$'OV=/%UI(:U\Y.5A_$A_9;N/92###"MUUX6B0Q
MT.2[<TK R%"45'F9NX SGYR8U.CV\T0S'?(0CR2]D8!'H)KUC1P<HH.++Z>R
M&XIQ)[<5WLLHU7=\&;I&*>XI]''_6A_>4("!A_&C%J;4]I+*1E3E[9BG)T0]
MNQ0@.T:SKD<]LQ+>!RFS4]9%>@(67/=&& P[-@Q'VN+-0P!J.WTYC&I&N+&>
M;$6"^W.,X4/LRR;<SJO3^CS1QM8?D<9-Z<LPXJQ->_?KT=BS+_Z-HRS/-6X%
MZN!U.TLO #P$$7T\W_> $S$T/M_%JNSKWN9C5X,G;'(,>X7PU.$BH-^PQXF.
MV/@^PO%<MY=-0_)276!>">$K6CP*%^^7.,]>%PM2LY!Y>W<U?,W1P9)/UW4L
M159IB0,P W?$WN_G@L2ZJ=EB+$3PCUOKKZX83^S2MJHX5WVQL9+W&! *CQY5
MZUM<4=1#/2'?OV*[;4=)V"J%T1EZ/9WSMHYC4G\QOL-^:^.M\X."VRP/=3!Q
MW<^C.D>E[Y8AD-T]$ 8UI:^_S>U8I['RZK0^!D+3%7V;K9GJ72*)''W3QI3B
M:Y>.>5.PYI(^3UE/!CJ7P+I[FY?BZS#<0Z*UOQ'5NU:32&IOX0]4!WJ]:0,O
M##PZR&*S@+&02Z_\'47XHW?IE1T0=:V'V7+\/7+BX1Z)<VYR"_)7-DDB&1:$
M-/Q0;S9S3$]S0Z1\ C7!=_!4>*)"8TQHKL'3!O/_M'>E[U"X_WHT:HH8^U@R
M4YFT&"1;PB#9DB79R50("1$9&5MJ['NI*$OXJH3L2].(&4:+;&.L&3-C"6'&
M.IDQCM^[<YWKG!>_\^Y<UWEQ_P7/_;D_]WU]GN?YN!S9=]W3TGN?^JJX@I30
M*B.9';Q7AK#Z ^^F?NVIJ519J5LU%DX.4TH3"*JQBD WJ=Z%/4Q]'R^(;']R
M@FD$E%R$:K&OTI6JH2CTI_9HA9J^,&4GBPPS,IV\/HO#.C,BH(<RX37/<M4U
M2K(=]BQ:*D7#H&ZR;"J7V; 2BS'Q+UL8T\H<0_1^&-&<@-2HR^B1S*<3D_C+
M"K'M$P3Y@X U%+9MCS&L$GLFZE%#AM@=1U5__RHA'[N!$U+ALJD4V7AG(J??
MM(>#H1R4"#S?-7F*:4,,$N?N=8)8O/R"AP*Y\H%VDG!=A=] BO^GC4$5>GT<
MAFA[+>+5Y1FMZ2[01:-U9>W-(#(&[#G%J3Z SA-$B?DZ;N5N:8]UQC4GV''<
M_XE\GGU^.K5"8[I;JQ%T1=32AZ.] )6L8]XNH66(M0<PP&!DT>"="\_B\L:O
MNOV5<NO,AF?)A%_.ZBY#S9P"'<TRA,;0#!(]%%FD9)P:<T^"B'E/_8+>+]Z[
MX]I0VB$XOABI>OJ&\9DS3Q&!$G6*%*3MW*S.!G5TC=A:5>;-4 4ORC[=[NE]
M@C%&9@F7A-?WZK<]E^B7N?P>&^;2*-5E_<7:0O'CAUV C[PE81,O.Q1J(^Y&
M8D0I\M9LF\G5&JN;3;-K,+\DFHOD,^'N;YE_K\G.A1_=HA["'_G.G#,F>^+)
M3LZ4C2C3 #?[MG3P<9TJ^)AP]Y;:)8=+)OM?T$PM=#3XQO^;L<G_#%0A3#+&
M5S6M!KVRF9M#0*H-:A2",2I-->2C-:T#=A&!_%G?9D7^2CNNYL,?W6^2GM,/
M;X\9$Z<3J?4@0J5@U_9DRCM?I!XS%:_@IB0'.^J76AI@DEGC(W<_>Q+G*<&W
M>:0 T4<;+NF;IH2R-UK$?UAI5I5 $*^X'7K+"O$_=>U[Z4(J^L$:M\D?AIVS
M8?7_% P6-?O6FKU0^$EOX0_L.B<4?0%-8J0GT5%)'B=WBBJ%J[63ZJFRAMMR
MQN76FSW%;O% WKK*%[@=BI\Y6EV&/V-!1R52F5=M^']Q+[ \\FGYGRUI=NZ=
M%1YN@C73FC.#T0OG#'W@U>ZQQ>GGB\!]KJ1AW,TBMD-E5U/E?*M.<\#'%$[S
MU!KXS8K"R7D/=8X,UY=ULLLFP96 KA]S]^?!*('U;OF<@YM&Z)MW#SD\/)Q>
M%)S'[(W=!8 P0AQSC.U.44-&BJM0>1+7V)ONEB9[, RK$KJD==81N"^'D_DU
M8;)91X??JP_TB]5=>[SU;.C-S&\A!S?*G3KQBJP,[ND]/RW-MF(J=3ZH&V7G
MVQ5:UK%,&T(UX358M<_]$7R%"$GQ6$#7><DY XDV_XP4J@ /R@UF?IYL^V>A
M0(LI-)MZ%W?5_T:2/!'2)/#D1.R,PY<)8?VHM\#U6\EL[#!CJ[/W49N,2CTX
MT77Y&2, N?AE>%(9*Z1MS3GV*-*7\$)D.M=Q>M^HOM+]*3#1)@T)W\MR^-/H
M?!)4@HQ3HON?#CN$4Y5_T90W)%!G)OFA11D1>_A<8P2_ ( CD,P=8NMS?#$/
M6</I>DIT'0V+(*YX%3JNOF5]9O 6=F!RN >]10CU6H-ZCQVRP]&P2M>(A;!H
M@P57@Z5#]$H@21;YN@2C28'J!F@MFEEXM22)7G_CQR=]O72*$:S_I0C<+]7Z
M1$7LP#,IG_VYY[ZH\Y'CJ)+*T0]\74EIW"C.+;8/:=-#U>K"L!/;QX]^:IU6
M;KHHB<NL:/CHV7LNF].K<'[)M?#0'MM3 CAG%G8!<CA/EH))^D]T$$*C!SEG
MPG>LQ6TM2.+GK;^EG@UDTR+@TY4<0U@,Q1-=8IJ^^JV_P5^R%7\XX*CV*2@C
M:')U6.=N>%<PZC52E/V7%4XG)? ,,/H4W%6$G1]>2/9S>G44;;VF]9*7LD:T
M:7 -XW!RSYK0>&NJ/0H0AA)A(SF;5VHHJJ$KHN,+#QUF>NKK_$0$\^6" :?Y
M[:8^*H 0!Y4+?('KK<G<I<:=]TA-#ZYDT)@\QH(VS0S?7'0F39G4'+"I51YM
M)+C[W'N5Z09\)/#J?O(DF7<.$\+.8KDQ"EY.467GHR%]7$B9RYW&W*VQB^Y7
M7)U//#7^E'IZ=3SX!A'33-+@VRJ[5D=!:,KE?X^T'(^L2-$6=>\\_'X%F'G0
M"3!C??"\?EJ$TY\Y5O8N@-[TAT0+2FQ])?KZ,L<B\M.+I;[W]5G/'<=PC!-@
MZ 9+E5"8 M5E0OY<9U*[HH6&E!$8?Y82::MN86N+TH&>S?4?3WSQ48\A4F[\
M2KB>;]O[W1W'AYJI6V-/R%):ML>R_?-?\@=WE52HBP&@LW4,UO.$629GL7\Q
M[VZ>K%#/N\J)VR. X!R5!QN,2@R0%4E/(*:@A'F#U(.\8^@$&Y;+ $98L]+
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M1'&&W5!](43[R?HGP5E/?D>*TI$[1?NT5M357X5Y+AG"(J^B9'[O AI/$@V
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M=Q$8@MO)C):AWBD0).=?QF$Y'1>N/(0^U\>7Z%U!,%)-LRP:2'G[,NB]#UO
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M;+JQZ;UYVOVWJ&\73P<T_WT&%'L0&Z*&,KGZ7S;0_C_^KP&V._H?4$L#!!0
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MP$CFC(Q,NV+; !O'L93@Z(!(^Z%F@M^F*3$(K?[9\7Q!:]S[/;O70FYN[.Q
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MH?I9(;ZZI'O&_&J^/JD_OHXZN\O*O2KZI&O[F*A@0-QNI1C !?)[),^3[Q7
M\H:VV=3>(EAZRG214]'W:4;.3+&R[,G\_C+8Y?ZY--5D,+=Y:"L%HP16A*Y5
M1:[J?R,74\SARF3%<H=UI\O$T(^II4,%4X./,G'6EJ.YCPS/E=0\801KTX80
MP@V@6#"RKWM3!R2"@=!.BG$XKF="/O7K13S>>DHT:OJ0G]M[E<G'>7X*O'5
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M]F6%E'],:AM<GH1=VACU8C63@VL(!2-<7H<>APW\,6;974J??0VXZ2A40('
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M;,8LB&]:BW'2NWMT._70BH6!RDT.I-5B=!N[OU_/E'0]RV1V_=CLM2J&M&>
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MD2LSW\X4V@I(FSJ^)_BCOY$KU5Y6EBM\0YD>_J]//=&O@!$@0A+KXMEI^"5
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MG'Y<K>NO<Y*C4<%>MLHCDZ$><#WWO@291,$))7$N9VF23'==T6?_/BC_)FG
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M_.X5^I=T.I^6J&ER\AJ\2R$\$F=PYX6$0<"AF,99(-_2!466@6FED-J$Y35
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M7*?$RV<GU95>5G*O3D 2\.=UEY$QS;D&XY9FJ,,%_JZ;#:6,!$:PRU24X.#
M"1$JI/+#,_F0.!->^[>43K?G;KGV*[G^-];>PZW)_]L2C:(B2!&E(T2E2Q6D
M""$1D2Y=>A.0&GH-$(B"]"8@H*!$0'KO':1&0(AT 2D)O2?4 "%<OF=^]]PS
M9^[,/?/,??*\?T ^[W[W6FM_]EX[FE!\!+MD1"FPF5XDJ[<6+:Q+?61E&"2/
M8$12KE<\\30>$'@?&V*VH_%+RK4/=?_RHU FLZCAUA5025U*C5B7H]<QN_[_
MWZ8Q T@L2,!JL9QR8XYC_ 5*<VS[>TW#&6B0*HM=A9OK.8N1?3CY_=_DZ L
M(YC7J8DWWJ=49O[(9J(ED.IE4=-AB\$-MK^]^?=_SN#$:Y80%-MF6EMW"V!G
M&-(E<MZDC211$2(ZZIC2R_*+2P\27,XS\I2?E OZ)KYW67[6&?+*$_7M:I,_
MQ-8R=H[9:*N%_$R7@%0=SF$V1= 3@E'=3 #?JUCSN'<[M$[;8 ;2KWH2-;ZV
M/A9N@U?O!=Z!*T/O]C@UE?:;.M8UCZ=D"O ][[U7S" X$_\XUOJMW%";# %Z
M1KU1UUYY >B&A)#$QP_&F_"2Q?X%'06./*K8>A$NW9EF<I4!^B0&.YVWSWZX
M>H)[LM^")7$B6WYXIE[2DS1S AZ+H-W47I^C:\)9)-ICC/+EN5N[7>B/_:A%
MF;\N6N=JT_==LV%^VG[S F!] 8AN,HP!TZ_/TX&@F%8;S&KG9ZX&W%: 4 G>
MB34VU[=S\AU)I5N![87S%!DYUP[09?@9A]29%>Q,FV!Y)D48[6$UC(9@:,8.
MUEX'NEANJ?M7*35&,8H(C:<=Y[9\[;Z=Z;H?UUC>IS4UC[5,V(8XH&F@332%
MB )"OL%8=GVS_W?_=-)3+DO)IWU/O>]?]1IU>"VOK;R%0!47#P#?GVY- .D.
M+@#OTZ!+SOCX0A<W#[?\%5C'/'N7H/(OEDA7JU ^S@_7X8IG%%-9Y[5MW'U2
MD3675-],.(H+B4OZ8ZI Q1K3,I%;EJVB&G?ML]#>';!K7NNO=CK65\6*O:>6
M>P9$E8^NHQ!EA^QHW'\_K(I#1@(I?2RO;J(7$R*<AN<$F-J&;5CB,3)UW>Q>
M?0*$LIM76Z>CE[NM,%%QN3FF$DW!RKGO4.,#&T]')T14%;<O47\#=1=7CZU+
MQJLK24G:;TWB%LP=]T3%GL^U;01*[8$,72R$\.H+VX=E97#HPE.:#*P111+4
MZ"T%3*:>78IC 3=O\1)(19(D1&#!A3PI['EI^1N^OVO2&(]5'XG:VNJ]2S[?
M+>A MS. WJP-:G>7!^:8JA.1WH$,>T5&19Z]RR/GTX3LN8H@I,^T)6_A#OVD
M?J*QL8( %8/5!^5<BF;KW5ZB5WV>X_@F\A',LIOV;;ID(S8&:GZ;)\Q#(JZG
M;V^L1G"=2^U;6;#VBXB=4QIJX:]XV1X@)>N\&KXM;G7=8SN$VE1+OH*/F0QP
M'>1[HDFN8!$C%0'2$&ZDR9,8Y+8+IQ :AE39"E1.,:^>\R9_FMP'&6H>%?O8
M+UEP&:JMU^D[7 !\B5Y[2; CK@G2Z(O<PGVZ_K].0VV,!W;SR3$&ICW@XZU?
M%P!J0K4*WB=ZSI$)-_\\X,1EG[>:?UFKDB&B0!5K!%*UL>*HM7O8$N\O+^/!
M?97^QP7 %#V_B5);(JKB;@@$KHP3[Q9J8+X:RS_DFVV)V(U_JAWTU *\[:E-
M=)B BR]N/^I"27[HD/Q2K>#A ]V_4U7$X%GD001\\75K3NQCYBV1$.^V8Q#=
M$/WU<&$GZ:/I4D#Q9HZ)I?(Q4F&ZI'*FN_IG]<LBLI^%%>(V23<TP9\+G>+C
MRAQ)#RK5!\7VV#8-U[F$F8-HLXY XQL_3B/[Q:(]_)1#X,J$X053K9C@JZHM
M^GE*T_I'6>PX1]2I;%#JBZY3^+S(1&NSTD0)7#%WQLG$=LQP@HF/*QS+^#>)
M?X?:/+OV2PY7DJG_!> 'G\!^]5'1968.DHH!/W5D70TGRKODF<(V35+9B@-_
M?HTK[:MK:$Y]Q;DK<,M1<S16G&^(QO! LV41BR0F ,G;MYR0%X"7Z:7>"W@&
MT7W/O.T<8AA7^E@&IOWR&*F(L@3E;#CHC(IU+B*O:_G3(=\=VZ]3TZI<;UXK
M_]H9C)_J\7?K%B'P(CL@0/\D94P^KF=QZ3RGZ_C&7ZK5[\K>"LE3<L7K,@+,
M6('GFAX9&O$_B7\)K6=RA.8CNS9</?%A>PV];\5@D=*T1<SBK>YH ;]7B'G,
MU.*CQFFC%]]8 '+089OSW';'\O=MIO!G!"G:6.]XVJ/\,+-J,8^S3FMQ/G8M
MOL^+^28G;B1*!MP,:I@T$M!66.C8%)^;NTE+Z5"OW;GW''_R^N9=EBMCX?WN
MJB>5^V](,<&]8 :\5DB[W?R-=8['ZI$2!:\_9)A6O9S U90,OSA98GC>SG^6
M<^M=75OH7;XN:LU2"^-&?^/SC1D?L?AMSG<X7B)]QL)JC##CJ&'S&)&E( @5
M85(MR]!QO_PSG?OC^/+Z?6Q;'"XA 22UN W9GF.=/)@-'@5\KIEI6-5'V]1\
M =JL&UN "5(+;M':GXBF&#E>2UG?DLG4R-'[EPG9S,V20,&PGQ +6?@,H2YW
M:Z\A,I000C%'Q1Q4M/ES+)BHZN/*!_OB!Q\-DYW9-<MH+P!7+7-$YI3_T!MV
M:^':CWX0GB9BW(#KEO1/"@CQHZ;3]5JQ02L9U^Q)S<A-=5HB_:U>)-74:T(?
MSM0<M^307^4TK2MN6J<)UKE/Z7_P:?4$J?/E A#*#5$N_[O5E=&XCR(RL%X
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MY&ZDIVR?_AP(OWT!R%F1M)4&E2DIVSP#%HHJL)<\[J*"TC\N>!$O05GT[36
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ML:=GCNFIL=-Q7](4-">$2.A )XX5GKW\!-XW,9U52PLAXA;QC+IQ,A,(^PN
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ME7>I6RV$59O;&.-G/];?M9PUZUCIN:=^\V]B$77);I+*"8QA$U$%Z9''NV%
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M"P-?0MS%WVTB*R<[V&T6M#H^'23<04.EHB5<U';-QU.[(';A*RL:V_3&2T6
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M4>AO*]VEM)BUU1\HNJ7\L(5UZ )@<?[I\'WE&&N0&^;P;T/(&E6?7?<J\U;
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MMO^':(^;FKA[:?]XHR%B-<%-9 .5\_P5 V1.RGM>L5Z@CH00D"W5&HOFRZX
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M%I*'(.)ES^MD/GA,OP57_%M8M@E>\JTDN!<!A4O#!%=ZX8[58I[]=LZI3KT
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MHM_N&.@O_W='W]P7:JC?]\S>#?#!>$*]Q4S41R_<3Q!P?OT2!V"30=T T)@
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M>/+,LQ;?G0^_WCGD2(EOSZ$R4K= =BY'ZP_4Y-E;,[A\W7?,/K(4W]"3R'\
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M^XOPFRHJ+;Y0WUVS_BW27HA=:VZ"Z<.=^/01^U'&[WIJ/\D'_[ HQ#:/!K8
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M3W\\,XY;L(X.VELEW_FV1@/.FZQKSM\9T\A*>#@E=J<,%KY3H7$LE2WM'?_
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M-35Y70Y:^@YZV\.V!SA]<0K ONS !+PO&W$G]P4-?\*]O+9^^/0QG)=\SN2
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M$<EAC&A)*.Q1%H=]6.DD"+6A*18V"OYF(&TT378\J"'K(FSLP:;C[;XT=[%
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MG-+$#'Q.!M$;7Q$-Y\T=#/ K</./<_74H)8,+'TZ]LK\;N!:WK*#+4LD*I+
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M65OF[@N0/KN=6]-8=KKEG9YIB%/Y$8NUSB+=F$,M6KB -4MO8B'A9#)+#IR
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M\#E3=I=YZ]QV,_OW?Y E%H/TM ,:*>&_(,?5;J8V*M;R]2[H_!J] 2I KIK
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M/DC14Z0EO?J9L_8\>JD!)YZUQ028PB12;J>^^3]6Y5\F**+0OR -_/+[CY9
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M7"J@2_Q,LJ7F(0=1$6!\^BB2U FI0CU7;9#\].__!^*KY...]@@,E*O^<50
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M8IBF;QGX6"-&HZ2,6.::M'.<^2] -#YSW<7+$W*3"F"4TZ$"4. KR$6EKU0
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M=XBLAC(Z 9G8Y-S*8++3I\F+V^:4/K4K1F* /4&L]D@:WN ]YD)-'WJZ&+>
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MY6+2.SODHH]@X"H4TNH-'6Y5M5'M?=/(GOZD?$34ST:'O3NYR'+DE'M6REL
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M05%P5B(BHB+$7)<2Z^52I;L^/#%],WE"9_N71*WS-LM/J.Z]DSIG?9 V0PR
MVV:\'1=EEIAVCY(Q-\N\+,Q)^1!_/H,C,M#'J\ 5??S*!YF>Q"IEM6Q U#!
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M.??,AWS8*7N_Y7G6L]:[5][M2D8\F 0W%K953]SI@KR>_NM0R*O&.XU):?F
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M,L-O>7?J'ZO;]__JQ/WGZE/Y),K]8/Y8G6(60Q=2T'E4"'IX_,JK[C7<9]K
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M90A9CJ$#$9E)1'4KLZ=6.=RK$3"B"T.-JXO3_N7?/Y.=C51&72+V()^<"N3
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M^&>$P9(=F(TJ1/;!0U\^0RK@M259V'2J]T###SUSY.5VE5,2TP(#7,A8/3W
M _=LVN_**!Z8\_6:,7PCB;Z>\](ZSUJ.XJ^KS*+6J[QFPXFL?^Z"HT"7XUJ=
M+6\W6!(6]5L.,>-[/.G'(ZC5G,%>]:J:> !^M$.!5I'L"8G>/"#[W,O4&S,8
MIL:XBALSIQ:#_0KTG+V?RUP^/G B6Y6Z'S38.%\<?UI7/W;U^\.X1KRL:)/Q
MVZV^X4-KMZ74@(%DV,3&,GHVLQMZ&<GS8E'.I8MZPXFALY9<8#3N.E[Q4";
M?W=0ZMV*2;;H3(GJM7Z-_CY.FG7AFM%.;?CB: 3%N @V9M?O4T(NMIIZJ.JM
M5!*QXB/^,,X\NF/97WLX6"X419V LK>)W":,)CE+_ !=7<_F2< G1>?X%?UN
MT (-!H@G,D?_LGVJ]\!_J='CN*OK*'V#G_4]2EP.+C%9YU,G-\ET[5'QV@>S
M\RS"[:'"WX%V!&&.M2-'U>;#V/,UZYG].8J;#@7B-'_[OE6TNTPEP=N#&.*
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M0T,16 S>89ISXT?.W _E_YQN,OYLJZK(P3?Z=N:\T%95=UI @X/XASWG*#V
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M%@# XD*=T!0\C 7#, FA&F-WJ^K/:L-%]U#IZCFV?ED>51\E9M]N=X55'>$
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MS2]U-5-UL%A1[E#'5V+AO+3^B[P1W<O9(>5K3."?\(XIZ'EDP*+"UD>/@U-
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M.M; 2*_J3;/!'NC^!16,K%^WJE[;F33^%",=E:17?3  S=(VP,7..ZSPABB
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M+H5X5>H5 ]B_)0S_;(S" <O&Z<NN3H&VL7P!FH)ZNY;2A5FG^>.MV1SS-@*
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M <WT[&?GF[8)-+=(+%=;P(!4[I-[:1._>ZKFY3PR;'Z.NL[C6AS&@8Q086H
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MQR2WN>P3#8@T 7PCY)Z'0FB4Q(SS/?6""S0KCS>7)K<272,\ATMZSP#-D#/
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M#WBON'>AGCW&_0SM5EPQ(_?L-O4-$A^29ZN*/\RH_ME#]NS6GJSP3D2']I9
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ML[$*Y]CM'?,A2[24B%D5/4&C<);QT9M=\^R8-5MQH@R:C#P1)X(6#K<8<FW
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M_'@U/_>88I/)$K _+?&A@?@1G042ZA]#"_JQW!\J?? _VOONJ*:Z;=\-**"
M%.DM("!\(&*A2$M0I(D8E2H(41$IH8BT "&A2)$6 1$%-2(H*DUZ#YT@2$?
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M-4V3 CI&1/4$Y4+"=!]D;NC'=M),KW,JE;V 036[ 8T0"56OHV=L)V>,<>Z
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M<EX6J* =G2_?W.,,QM5@=^^4USO'*2B[4PWR2TW5NO+<DCB1'>HEZMPX@*K
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M.J!P($!; %>S6#FH[ ?A6^B#3_"2G6J+C 1[EK[9U)6(HWG,'P>NG%%@F?O
MF^5O=#TQYZ#-K8AY5Z5WE*0C)4)QJXEU!ZZZG>'IVO+C$(N_=6;F_;G%X8+
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MW1&J5?AMN+'8MMEO6NQ9QT[GK&V4^'+WC7H^@,H5[&$ ]Q!X67O_O&@KIYL
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MUQY[/VXN WSI0 GHU[+GPL9!2)]0/!2PUS(W:&&8)D'K[7=749_OF0M)O=.
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MH1##]X4:E-P](P99RWC=UDA$.K^E^+H=^FYKY/.;J_.5,S]%PUL#0:>$OY=
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MY9>V?N?S6GSL_7?*B<QW81[T?$2$2<X0Q"@-8$C"D$912'VD%?@Z#,:Q'+=
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M*Y@)CIFH>56QY5^+#>C1 9<[/@XP CN4?G3,2)VV?FX9:MCA[]6'6?6,G?Q
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MJQ!H2>9'0<TJ["I$OY9RI7=.'E5WVK"4[I3CL8?2&!&8\$PX $F.88X# N.
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MTBAMH35OXJ5E9KY)U;2]OF'$6YP+O8DNY^%<\3OAY]>82*B?RD=<K!8Q1GE
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M;+!5GZ4+?MX*+D/FO*GQ,EWGNZ@"DYD<M3!E"L(6- MS$B(,HR G$&5)#G&
MA9T1>%G@A7Z:4?J.Y5\#5!T;*QM8X$D":]M4TG*YQ%4-9)Y1V[)RKKFBT]NF
MIA*_C\W0]#E=%H#U6]R2\-T6?AU@\_=9\35$]%^YU.L PQW7>!V":! RO1E8
MOX,NRE_7TA"^XA]*@< MPTV]\+,XPCS.89K+X8!^[LE!T1B&E*4L8QY)0_56
MQ<I@7?N7+4"9+Y=+D,) %3#! UM2J2 V'MF3NNNIR52%4)X35NDIU)L]SW2
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MZ31@NW;86I#2/]CKP@&:'09Z_I@.6]6<+4?,TC0\CC>8Z!&1/+Q3X)JV<V1
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MMQ7A.A;-6U9)#_4#6(E3X+ELX]ABQYY9U132!WT2'Q6K9*_F?L[U$Z[ <]N
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M2WDRX7IG@PG-VB[D*$V67,?#,&9U&4?)?.TJCC]LTM, UP\RT/^,ES*O5JB
M7W#U#];(_,M=(MWN<_010T&0(9BPF,IV!P2F/O%AFE$<>-QC-%226!/@K@59
M8 ,&Z+3GY ZA83ZKOI ;,5O!DG3(0DV5\-UQ3Z?]@CLN&C9ED-QD VY*M^=Q
MQ\UZB]2/MGHUF+%@O(.#YIHS]G4PHW:_VX/A&F8&U%?VQV!&>U6NQ%])5XC9
M3FQ_Z?[<I<CB*,+$"P+HLU#.V(TQS-(DA5G& A:DF,21ULP1700<:^L;1@3H
MY0LXI^53TU_^?2T;\-^LV?YLAS#8QUC/,M/FO9K1YI*C>LI;8'*<5V>@PP/\
MWO_?25F&*3,L&8+:X&>U$4V9\]I\-%['3&>]+K/HZ[(6 ?4\#Y-<:"4N5!.6
MJHF2!'+?PWF,>)IS+;?O"!S'&DA6ERUE==DV]^L,T+[RS$9JV#'N_?_4?5MS
MXSBRYE]!Q$;L=D<8L[R )+C[Y+)=/8Y37?:ZW#W1.P\*W.C2&9GR2+*K?7[]
M B0E43<2"8%T[XDY72X7@<S\R$P B;S8&1</F,!LR&$:U\4Z$<^?E>B1RI,Q
M.$5E5)WO$75?M?L>=TQO-8%?QCZT#YY5Y'&>%P$UVPNCS$:1)=8'P!C'3*HT
MC#,N8<$!)RF-[+YQJ,IP&B0[5?4B^GD.',^%&WHE\I4J>9+.N!F/?>(>)"[V
M#G!45_5D9GU0+_.%6>*K<*%OTZ=R6DP%,_]@))K.3,EBS<#VK%PD6H.#,, I
MS0M,$B8Q%YG"O.",DHQ'40*K%>S(R,#*WK!U@3;T-UG(=31<Q42=I=P\NS0M
MZ$UA/[TSDG5?!6</K_/KL;0C(X .O$,<#6^XB3H3+%\6S)6-<0W<F6 =V+]S
MY_.06/:/Z>I[U4K0W(%]G[X\SF_TL6CUWE2 "S)&*<]R'-% 6T1)N+:(5/]'
MRHBDF5(9M7-TPVD/; 2/I6B!*N^YP-GCRAX6))C1<L'GO"0V.TE]IK?U4/RX
MQ#<[*#I3XBRG\)(L=^)^O<J4^:I^5/^RG$1)6L1Q4> X$ DF0:@W5KF)_(H9
M)S2BB22@LY(+$R,&=S4I=9?_TS:I[E@$V,MB^J:7?Q/357NH+E"IJD;3Q;34
ME.HIEU!7KM/[L]M^#?U6@%;L(!.O*UBHXNH"&3]PS=A@F7D@6(9)T[-CX2-S
M]D @]23PP>9R""%XF+^SF:&C7J[G/TR?!7,S,XF")$MBDF&2)@$FO& X9S+&
M(LBIS'C.HM@J=Z^#QM!73#51;:/4"Y::K''E&KKLR;*N31<^/3LB/U+#;,9:
M8$,0&XH7J*%YOKB V_CSQ7:[='<0'W;'WBU8YU7ZB:'CW9AW\[YS,=[SZ+F%
M%M?E 9OJ@'6KI[NBCFFL"L>U+L&-J0D$P2Q23!LA%NH#7%+@, M41FC*X]BJ
M1_597 Q_$[[G6_G$EE-1G6#\5T*$H&_IMAH:4Z#/JE7/<,W0IGW#MJ]8T[)J
MG$J%#L!X+T8(X>&#Z@TZP'2ZI*#+9/ <O:9V&*0N<VO(T#?<H$+,;5&Z-?\,
M*6"ZO"ZGYZ^B\A&VG=+HVO.,ECQWA/EVRMRQ?X9]T5)-)[6SI>J(R82IQWG-
M5NRJKL<PB?-0D:0(<2A(B FE M,LYSB((QD0R4/*F8T>]!$:6#%JTJA%&QGB
MJ*%NIS.]8'4KD4\(8%KE*KVUHMF*UJ%Y>HI:\_0/6\WKG7@45;05;ZV;UL_#
MEY\'M5Q?15_/U?+K?/5@HHX7:ETE'5RRUG[&P;?%&T:0U)R@<KY"BYJ73=U]
M^]4-@%3_XC<,2,##?@L?PT05//NPA\\ A6CALCLML  RHZV_<-';R[/#:+>C
M]NZ!\J[HN9VMVFBO;^\?Y^V[^VJ;/*%2'[FS0. XB00F1<HQ$S3$42PHC;.<
MA<QJT1^(O_\O8DXJ3H'A)K[?H]UQ_@/?#O"@/\:+ 1_Z!X+/DSO -W>C.@H&
M@G;?A3 4&7C,RR:!NPI&Y2SF2G")69&EIIAB@7/".)9*J#0K8GTR$[81+3LS
M#VQ M[4)H#63=^7ON7 Y1RJ8X;$6"!15<I3Y,V)&=N<;+2+DJ!CM>(_C#YS1
MU)7WMY;G1WL<-HW:'HR?<'F_N1J<J)S30*@ QYPI3.(PQ+R0,989"P0G-)8<
MUL!I""X'5MIU2T#HC>FP;\;R0N*C\0;N8PPON&K#N==8>LLQXN^H_5S#-:HX
MOJC_0.MW5K.^N?SL>G=N?6*'PM9GHUCO/([?*78HF(^VBAV,F&.Z='-=<Z<-
M$#/SKW=8$\Y)$LJ8X8#IO1"1,L4YC0@N@B 3J2HRRD"I#B<I#7TYL[F*G*\I
MHV5#&IC>?!(K.WOI!0&8S=L*OR&Z.:-YS$GN$\Q7\O%).N-F&?>)>Y!.W#O
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M7"@EJ[K"Z[:L=\5]W4_U?MU.=1($@L4B*K"B<8$)4Q)39NK@T2C+XB(/L[R
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M3)."TCB/[.J0#PVS4S7R#=#C(6IQWAX0)>#J!?L.79(5H? !CN\#PNAVK-_
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M*X1OG FL94#'N50<:LXHM?AE,7]]N5TN7[4M^@QOC=PQQ<"6T%!&%6G4T+Y
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MQ?^RF"];@=N_L&GYR93J4X_LSTF:A"HE+,19*/26+9,4TYR:7AUQ$'/*5$9
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MY;#1W#" 7C8< .+5>Z'KUF[O@,"TNX5%0QI5M-'](%@ @OE]8N(6W7\.-K"
M?UM9.S, >B<9+R7 5IZ=' 'K06<Y\K[.5W^HU;72=N-YJN>'IP=:S/713C_-
M&-*<H2UK3@[ TUB!W()>8/+L+#Q$:(!6W1 ,SO4MGB;P$1['7G%/^"'[QSFV
MLEHWS6FBH)>3B*M Z/_@-,LCXWN4F$8!P2DGC*J8TB)5D]5\Q69V)Y0#"B ;
ML*%C_84_FB%HVZ>I:5D%]",>XF)W%CE+6I@J;TBM(]@]5/+J%<-7UZF#^<=M
M-'5*O(/>4B<?=#A+;,LJ7LW+-[583?E,W6M U6*A9!5BV00 /,[O%],W_=/]
MC(DJ3>&W\H5-97V3HVU#%&0JC+'>Z(28B$)@&JL LR0D">%Q(*E]'1-?7 V\
MM->D$'NN>\ROPU)6\VW$MBF?JA;&V?T)E?,2O\TK[1!;L=#+6JXF!'Q:FG\N
ME:C6OA_3U7?]2"6C*8M;"PG8YGM[PQ9'HX]X;S #U:YKV^(1;9BL \C1P_9=
M-HRB#:<7J'GQD.M:O^\"<#3[B'?B=H0;\]W CGR^,>P\&GHC-MX1TC<^.T=-
M[Y,[9K(>SYG:9NU]>M\^TB3U5:'4&S_@I1;DN2X^;)9N4Z3L][EFO/(,/FBV
M)T*),.(DP'E<=>TP_3NDY)B'L9 TH;E@H$SX$7@>>(E=$T5O&ZK K-017IO=
M-OPO]C)@ZV8[8W4WD&?+/^+OQVO$&R%V8O9:@M2YKM4KWLJ"C# ><UO'0]Y7
MINL('(^;]SK>*SC(@AV1M-O2<EN*A=+4KU7]YVVY.>,U^6W;6BE)SB,J4LQC
M(3")8XD9C1(<$1I'*>$L3C+("F%/>NC@J^_F=2S-Z6?K)V%5=8HJ@FC67*'I
MHQ2PG@H 73M#/@QFP'-,PP/Z:<W%SP:ZK?]EG0 [1+$5. ">S"* \*C6#0[(
MOI%RF,'-UNPU7MIKRV1* /PPFVW]]RN]NYZNOLR7RTDN%8D20G&BJKYR <,L
M(TK_E6<B3)2)_X18'1<F!K8_58.S=@,YMM/@;%DU.&-KSJH\<E'QAF::.9A%
M<GH'=K9I:&1A5LJN:]P.J#5;Z$L7J&"#=0XJGDR7$PNC&K%S0-HW9V?-!;\R
MOE?SZHH%F/RQ-VQ@"W-_<X?JBZ"S<C[V9>V_W3U#3)BZNTD(NJ4](8O3A>S^
M7*/=O9X0HGW->NJ1,^,_OVQWT;_J;<:K5KZ[\L$HJDG1UR>@Z?*W<LY-&0VC
MK[?ER^O*E (JA1Y5O<TK-A.F4Z/^\6$^FVD--D>E240R%?$PQ(G,,TQ$5N"\
MB H<*DH*&J6I2D%%>@;G>&!EWSH[+E!+!+26 6F]V$B!*C&,ZWHK"*HD0;NB
MF/2*C3#HGT8<U,CC&N,ZV!=AMU_Y2[UGF+7["[UB]SC>H6'W'0L\&+\?$T\\
M-/PG8Y(')^Q2*9R94G7-A8XI-&#Z#;RNOL\7I@Y=<_.99440*Y[CC,<!)GF2
M8BH%Q:E(61PF21:%5C4!K"D.O% 8%LR%Y[*N6[98LX'8AH\FP !2EML&28O[
M?-_X .\<&FB:DFX;#M"6!?@5O!4TD#+FGB%RK&U^/E3 JN< L;M+H=M,-&)]
M=(!<NT73(0-=^Y>W[[Q;E^'UCTMCB<UG,XDE38.42<PY$Y@HF>!<%!R+@D4Q
MTQ8T38&MR.T(#WU%L*&&N%F@H&W!+=&SV[@.@0GPM+T;%G/1CIE9_Z4"J^+#
M9P=NF.3>FFE;DAVY+S8,C,,6U\#QYY9AOQ1B\:ID:_^WUU(HIGF>A$&&HS F
MVG@PCBG+!(XSRJ."IES_Q:VV>A_I@<U'0[ZZ3;Q;?5<+=*5WNR9 H<61:\GS
M7ECMK,HP8 &W7>O"\GH_L<:L?;X=HE>3N_S>2XOW$OZ@>N&V@)PN FX]@W,4
MP_Q9?=,[URJJXDM32[Q.,8^8S'@0ZBT(-<5CB@CG5.E3&TV)C)*4\ 3D'NR@
M-?1Y;4W3J$?-!EJ3OT"?V*RZR7)).^_"S\YZ>$(%:"Y\ .(2@M GJK^8@Y.4
MQ@XRZ!/Y2%1![Q#W"E*?KV^O;LO*=]2<F\.(9DE*$ZR*@F)2I *S4$8X2A-!
MI H)*:P2SSNI#'W*J,H8&:IH6I,%^5^Z ;+3X[/%AFEP2^*&HC=?@95$'JLN
M'=(8O:[223&/54XZ_;"CBZ .7UPVGHAUZ'S5O6.2)(7("[T(IV$<8\(R@FF8
M%EC0/,F*C/$L!.WLNX@-?9>^#O!'[*GZK][3SZL]_;S0YZDZQ4JS 701=*%G
MZ1;PA G0%=!0W;@ -\TMZH9.'@__%O+Y.O!WD1KWD&\A],'!WF:,JQ]P+I22
MR\^:T2J<QM1;6YE8FW>]R=^+M=E&X4P*5L2D4 4N9*I/]D6F,,N*$ >\B&06
MLTCE5IU7S^1C:-/0<(7,>T3/-4/FW&ILA GCJ[3D>5N0<.E8UM'U-=CZ%P<'
M%^IN;.-:73C4E1UKI@RH%N%^/MV09P'DS2OIQL7(3LJSH#KT69XWW=F-PYIV
M+/J@H:*<%CC1[)B&#C&F@J>8\EQ%*2N"(@)ERQU0&/P^8]NQRKF=EU5K&B\2
M @\5+>$\=GOIE<1_*ZTQ.[/TBM?1"NNLOBDFYK )!*D<3I81M*TA RM+0\DR
M]V=?G&[U.$,2F%(T1+QYPTXP[A0-VYYGM$C8(\RWHV"/_;/C!=AZ$ZYDW8ZJ
M;FM9Q4(=3Q"<A E/HSPF.,ST(9GPA&#&I&E0SC,F$AG3")1J!V=A<%>V9@CS
M*E=7M .VF_)$P+LP.,)VB]:PN &=W74[R9J;BW7T9V\[7U;HUV/". LU77GM
M5.(.CJ^+,S@#XUZ@.0-T<)'F/I-#,.2OTW)N=M2WI?YTU')EZBLNEM^G+]L:
MBY_>OVH,YN5*XZ&G>:H?^;N:R=OR\?MT4?=LFL1I'&F;)7%,*,5$A!'.N4RQ
MHGEF+N%8D=E'3'IC:V@OP(8=<S"=K[E$WS4;)E%V91A!+X830/"@OY?2;?H^
M#FK@?J9A$:UY1!LF6W57T:=WM,MG\Q@RG.JQJ.*U:N?V,6\#$._Y(6_%+2AT
M\W:FZ[>SU8-M]613M:/<?3OU8\=TY6^>PD>]H]@98^J/VGB!J-X1VHE6]3^[
MPQ+WV[=/K/R7GOJV7*[TOLA\W(T[@^8RH DM,"MBO69%BF":F? 1H9*<LD0$
MPFKOW4-GX$7HM[]]^QMJ:*,6<8"-Z\#(8@GQ(SEL33@E=+\3""0]P&3[0<'-
M!KNC 3.H_3)V6LB.X>.9O'X9=FR8Q>,^XNSK(]\VE'\2RSB+\UCA-(\S;9M8
MB%G*"4YESFE4J#A6H%BV;G*#WY;M%!^]:*<=_:37_F7%SL_GA-H? &A[ >8+
M%N@]UUY8?7/FW](>*I3^E(R#!- ?$/O L/E3@G<'RY\<!?=\?]9RS$ME$AS?
MU.+]^E4]SIOJRG?%35G,%W6T":"V!&#*@56\X02M64'R59G:J0TWYGS<XN<"
M7) " EZ_'WX@W& VP#-D('^^ P!._GX(G='N QR$;]\7N S_\(H:VQR1,.0!
MU^\(QS(PN<TBPWF6<AP0F<HL*8I8NC5B\\CDT'?BVS* UZHJYCM]4^X).H.\
M)KO]RT>##[1X@Q2S&#17:$B _WIE*SXH_VA(D <L3N&CU^Q-J4^5[S?/:O&D
MJ?ZRF/]8?3>W.ZQ\GZ1)1&A!8LRX:3L;I1'F:11B:DI0J")7*K"Z4^FA,["Q
MK2FC-6E4TT8-<?MNM%U(=1M+C_+#[)VCZ*!^M1:".;6N[9IWM"ZV%L*U&]K:
M/.[@0KY6;VHV?S%[.A-9_:"FS_Q5ZX'Y1:N38:J5-<S#"!<DYUC_12NN3$/,
M2)RDE)&@D%8N&P#-@56WQ425Z8 6;38NUO<[ %^K)9067F?_ ,%TNXV-80 ]
M[&+CU"W3$AZ 6]H_3&XN:@]PP7S5,,$[_=:64XWGPX;)MN//!@YUL);W;,'T
M^?CR::'J?-"I,$?C7Z<SM5SI<_,Z9Z6Y8HDHXS0-<QQ'Q.2+Y#GF12AQ$.N7
MD$L6J=B^I1>,]L#6LR&.-MP # $01 M[.1PT0,]WS<<6%7,4K(':\((VJ68.
MUWE Z "V=#@(W6PJ"$I/9M4-@T[S"IQR/#/K)NN.N76<PLU=V#K1;DZYU].E
MF,W-Z7;"DXSF4NFM:93IXV18))A%08+#F*B<"EH(!0HU[B8WL'&M*T#/7%UV
M/5#9.=_\ 0 SH2VZ.PV/MK3]^;_L9/3DR>HA-JI/RD[P?>^2Y2C'] +U9(S%
M@WJ9+TS/#F!'F5/#A_M0&XIH0W*01C%]<OF*03]%9MQ(\QYA#^+)^Y[WL,/_
M]LJ7ZM^O^J?'^:5IIG0I_OTZ74Y;@52!$C)2A<))3B),1)QB%L@$)U)$:9XF
M+)6)\RZ_G_[ B]&6 7-_6[& 6CR<L7FU@-9A[^\7L+/W_SWP^3@$6.!XQD'
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M=#7A0B1Q9IH@!2HUG9 $9I(I++,\"6D4\SA@$!7K)SFT?V-+T&3Z&(HPQ;,
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M*XT:9F%",%$QQU0F 2YXH?*@"+. QS9J?##ST/[Q-2UDB-DIZ*'TW>IXEDS
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MFY1>2@.OUU?S<C4MGXS1G?/9]*G^O.N0*OW#\W2FEBNM"Y!@ND[@+%9M7W
M;UKJM>AQCCXI9 C751.<BE]U(@!I)^L)"<<6LC4BJSGB"KT81%XK1-B:!5]K
MM(V8W;UBNR88L3^LA1R[/6%M!KCY.*[58OI6U=!N=?S^JH5X72RJKY '!261
MP(*;(O=%$&&>Y1E6A"N1% DK<@'Q:O30&]I//2]Q0PE=_?Z 9@T/[S#?11]H
M=MX*CU# 3-B6,%I3?K] 6\K^7!.6(GIR1O11&]7]8"GZOL/!=I@_C^8_IJOO
MOY5SOE2+-Q-"4E^2F5U3*33].K_ %*E9Z W )[:<+C<?S3>U6LUJG\@D3T2D
M>%'@H#"&0B5ZDR.2'"="1C**TR0ET:2L2@++Q_.\H'XXMM*OO-:O [ZM=:WI
MV0VL'S?@>W+WI(X(^]E7[RVVT0_--VHSWES,HUW6+]"&>51Q?]&VCBT)AO7<
M^D5Y0#>O)T8_W"?L%W ;![)GBJ[U4RZEU-JTO)\O5VSV?Z<O5W.I)ADADD92
MX(RF^L JP@*S1'"<2<Z$D'E 9 JKHG*,S,#;O*;,2$/Y M6TD2:.#'5H496C
M0'7;47_BPVR@J^0.E5:Z!#NCWLK1:4>NNM(EVF'ME<ZG7;RDR_]7W;?^-JXC
M^7[?OT+ O=@[ Y@#4:)>.\ "Z71ZMH$^G=Q.SAD,S@>#S[1G'#DK.>G._O67
MU,.6;5DF*4HY]\.<22<RJ^HG5[%8K$<[54.E&E[]7)6ZN;8]'YU8TSH4O8]<
M+O"TRIO0I_SU?^CGVO9)K1,*'B6P:>1W2%;O=T7=66CWK%R6D=S3]68,W)X5
MYC!.>_XQ\RVN::OY!@/RL));YC(1(10APT!0'P.$?*(&=F*0<57$C(,@941W
M8SM>?&(EJVBH^P88_(G\N6W-JAFSZ 7C\N8U1D0SM3*5SFBK.B>&U09ULMAL
MV](Y,;J;T=EG;'O)5A4F*L^JKGH061!E!"4@XD$&$.&^U)T$ @2C$*9)R*5B
MF360/20P^0W&/AUUX?UO_R^^[T/O&1?>JZ+^5P_Y_L*O_]>F5N*7[?=-L?H?
M5>U6Y;3^HK(]_OU_P=C_:P@7GHHP5XD]'SFM+D</_H3^ZL7^(DBB113#W9+R
M:?7;*%GX0=C^=E4G(ZH_;CIMRFR(+CRYX#-7O;OY^NU\Z%WOI>M%"\:\2C-C
MT1;'U6^QS;.OT'/9[;9?'&<M;H^6G[FO;;]PI\ULSSQG><^PNW2]%=TK\F:&
M[[5TGLLJC[.Z4VRC9KOIC# 32<@@ BPA*4"9-#XDA1G@<:J:#^*0(*-9N^/8
MF=A4581!W;6C(=V=LV8]*'/D.]"\U9@-63/+X0!4\^L/)UBXNAT9Q\R\ER=.
M@#NY6W&SJJ4_A<OO5SE3_Z<:%TBGHUI\>XV+0DU<J/=;G_EQ DFF[!R53I8T
M=EF6"I"E'"8\05E,C(K^M*A.[7FIF3'*8:D&[? ]&X:^B1: F@Z+:U@,O9@6
MD>J'#@<+#ZL9.S43KLIWK81VY>MHT9S7 3*!X<0K,OJPJX9(M]OOO+BB5&6!
ME-(NJ4N#):<9A)' ((D# 5#((2""Q?(\AN014*0B"LQ;CEPD.WD\L3+%ZERV
M??-P0UO^\TU_HJXACGH6PSTZ9B;C3(.CB@FOY<*[NX"3@[Y&0V)/UM&HE^@[
M]S(: N)R%Z/!3YM?&EQ_SQ\_YY_45>.M4)W.6?XH[=2O^6NY9;O1IG\K\BW[
MG-\5Q3\*PY&^U@0F-AC_X+@ *K\7J)^\Z^_*H5>:T2G"4IG:!Y-SJSX.=?'G
M7;':%)[Z;.D]?)>[KW3_O&ZK>+5-2REYN1T(,3A\'Y<O/69Y%6;6:=:WX'C8
M\6@XK6YD[*G.=F\S&ICN[<[XQ2Q2\Q]^;!Z^;UY*^>V1M&ZJQF4\K[^%GW/V
M0JNC_YW\*K<U=@PR2F(?<$A"@+A @.!(@#3U:8@2P=)$:[J2%?6)+67@P[35
MP#UY3]$W2%DWAG38GDT.E.%=U(^-U[+B25Z\EIDSP-G4YQDC:% (,"62=L4!
MU;>.U^"M]N ]RX=<E078"CU8*F"\Z'SE [;R'I046"\R,O&XD]7<9,2QVZ-D
MMY/4N,/,N ]ONVRXZS4NRZ9# $S\.",( LXC*H_#(04XB1"(>10AG\B_Z=WO
MS\;QQ.:^XWF1MWTFJU=Q,+9GPV1O4>\P_H=Z-V8[S,C78I]B/#54KC.-)^/W
M?1*.IX;_;-[QY(3M-@3]X>.[^\<()G&:I E@*4( Q0*"3/583F(.61!&:22$
MB84W9V'JBY*K^__R/GVY_?N]]^G;[2_>I\]?K[Y>?_[Z-^_J^N'S;Y\?/M_<
MFQEL"Y3U+/"TV)F95,E+?9'2<J,LZY\40]+C_+.WX\G;,S7);:\])HYLIP4#
MLQI#>X".K=N(E<QCJ_\H;G+61"Z.(Q77KP7[1W$<SS +K=JN/T=DE<LSL&8,
M[UK%_^2/501PZRZ4:@W_Y4CJ',A;!%(G ]UQY'0L?%:!4VNBL\5-Q\+2#9N.
M7LNRKZW*@JERI;IY,IUTJ0]O^T>:1)GJR]ETGN]\ >]XL=JPXPNP)81",$YB
M(,_E\K@N/3B0T4P /XC]+*+$3Q V:H8[-<=SY/R57OE"_JG&.FPWWJ:9Z-!-
M"+9O\SKY"]7S&_]0K\G,-'<3" ^:/'6S"*7GV9MHJ$18M$,Z%ET#O?!J0;R>
M&WZ'[6CGPMU5#]O)^9VW\>U<\)]TRYV-L-U&<R>_+KR0'DRGYH#"B*48,\ C
M @&B80(R)/\3T Q12'$<0:U+N $:4QMS"96:W>/EFQR\;E3G+$]^4Z2KMEVI
M_@//+4=-=_1_QT_/?SWY[4D1RJ*I$UD<%XHLZAH6LRVA#WH](SX24#.SNR,V
M<=''@%".;%H?A5FMT("(QW9CZ%$[35?EG<6*JCSKWAS*_M\V1[F48,$C+(!(
M,@10R!!(0YH GD4D\K$@:8I,3,(89N;*EC[.#;:\LQF%NYX]F M-,\,Q DAC
MX^$" 4=69A0KLYHC%Z =VRTG:]H9N)NGY_7FC?/*8C;Z0[ :!1GX(&18GG)]
MG(*44#6X%M$X"7F<ID;=\WIH3&R.6HKU[FMF>OH0T;,H(^4T,Q2'(DXPI6E
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M/-5>YT79U7(-/&)1,*MT%>=O5SFK"@-NQ9U\>VW-WY?=C+8@]/T(B@ D+(8
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MG#4B/2'$Q]'L*4G9;0I5^MD5I<4+[TY=N'XI5 ^>99J$(@XQ 8RF*IN$AH#
M0+IO01@G/DZCE*4F]GV8W,2FNJ'K;1039A;W DQZQM.=\&9VL"ZL::4_2")I
M:+NS5WHR.C(]%XC-:D7T!#\V")J?LFQD6XU3Z<DU6?J)X(S%*9!>FU3K.$H
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MCWO[HHGW'^+VY1*O_Q_=OFC"[O;V19>H;?N#3ZLU+UH?<!DD2>('/ $)BRE
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M__EO[6_D?XAT+__SW_X?4$L#!!0    ( "2 J%K>N':<PYP  !E6!P 5
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MVR@9M_=3>R UX'<'J'EXA&G0PG)O(P1F.:@B#&E;*4 :*6U*:+)HW0O_N('
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MZ]C*HP2-JUF:X>*N;FDGA.Y4RAT7.M1F1,O_Q'7M]'*C0=,!.F;')Q\YS?
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M -N3[_B2-E2E*(&+W,-"10CS)(N(F"B,!-:L[E2G_]P-+T=K']),ZF^8CAK
MW.^3V7PQ6=V^F\$W89/>%4%O^VS9J_CJ]OU\YO/H^/D4/G.U^95+KBWX?)C
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M3T^ ZB/6VA' E[_F7[[.;Y9VEHNY?YFD58PS^-O#?_\\^3O_^Z;:Z-TLWUZ
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M8(&TCA91Q;B5U&.5<&&+>B;)E0?DUDY[/*.^6X7WV^W&70__N?OA'8_D4I!
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M+.>EO>U.A-4-[L<#6GFM- "UW72'32,_HHCV@2"K+4&<J8 ,HQX)'C6EN<O
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M6DS<S?JM^Y?Y:SN=;L<(7<S"OVSNE[5:7CJ'\^@IC9AA(@?!&NF8#/).8@A
MDJ6A-!+/(+=R6\'QP/E<*FS@*#VY#S_<K)8K.\N%P-O-: W(S1.D=8Y^O35(
M!TM1H(YSJKDFJ?1[T%X$5N[+5\E<GJ6FX1@L5AITA+GMY=LC'B\#@R@K*(JL
MHN")!!S@2" 4>:*YL-['\O.X>I)8MT;M^7%81%4-(/&@Y"Z-$5I",(\$YVHC
M,*-D0-1[8:T+WN'2C<8.$E*WB&Q$5)TO]@9.TGTFMGOB4M,0E6 6*2:R,<81
M61,PPL8E+$U,Y;NT'R&E$W[43X"?(:)OKG7L7M')GN7=C7A:KA8WZXJGS9.M
M&++@P37U-]-M+<O8Y3LC$5:TON<YA#=Z 1! %@<1492P2[B,$1E&P#":Z 6A
M1E!=.LTU?@'0Q6PU"5G&D^_Q<_0WB\EJ$N_4D2OZ\N.PF]6VZF^?H$UBE&*6
MG^4FA#UC>5XS1E90@B3#C@F0C$NE[]7+<M!6!G$0XHZ7#CV[BAOP!<[D^=7M
MX0^L"R68XM9ZYE#RA"".#1R4D7J4HF/&:B:2+7WQ-B([K=0V/3]*YVU"IMG=
M<V^P83#!<,L#$OG^"P))@ZS+AHFJ@#7E2;+2(R6>HJDNCIL!3R=0#]1D \A\
M, -SD_S=WM6S/&I36XN,5;EO"-;()>V1X2X:IRV-O'1.ZB@Q+6)QJ,Z/360\
M2P%-W!-]BN!F3?*XDS4S?\PFJ^6GSW]LV;'182L"11"C:L1C$L@9GMMKI:AI
M)!J\K\)X.DE0W8O(43%53A'U2_\^VH7-D?#N.FK7-LOH*+0("&)X">*)%#DG
M@!/,C<5!48Z[58P>_G[=B\!1P%%*FB^MMMA'3JVG&$[[_%Q$8X%LD@$11P*G
M@2=ANTW/'J.V>+2;N_$@-*;\ZYN;OG6O24$@Q$E$R1D07H*_::PEPDQ'%1.S
M1*L>Z"I;:3S:?=S8Z!I'_DTX26<&-C^N%V2P24AJD69Y-HG6 6D"-IM'F:\(
M?&#%[XQ+T=Y*G>I+3Y$, T,#4>>9?&^;#G$,Y\BZ@X?,#7N)S%,>B44QJ>@Q
MA$_8E[Z'+$)XB]'LV)@K"_P! *A_&[K^]C+Z__MJ_OW_B3YL/K\>'?IE<@WL
MO9DL_72^O%G$AT0?NL1\@.3[']V V(<?V#V\0L_;R,'$GWF)"$M=;E:Y7B_Q
MXPP9*H[C7QQHU.Y_\/?9MTG^Z!=@^Q7\\#]%R'S\U2H6Y$E=['9Y)XE4/(8>
MT!=77^>AL+[VOEG%W1FFK</2:$17$ &$U>)Z%GZ9VJLBFGKXQ2I)GT%Z.BB)
M1K24=_SKV3(LRJEI[Y-5,BN#K=]C632BJ/^9__6#OK(6\,BGJR0M!BGNM&PJ
M*_#N3)U<@[,\7V1?^4\[/7N[G?INE4K=7JKK()46-M[R-;C)\<O\CMSUXYMR
MN^^)[U>IF.V_!;M)J5E]CJ3&3MK3C6JO$:6]FX7)]TFXL=-UM=8YBMK[5-V@
M[+3,YT\)H/96FDY_T+6[A#UK$QWZ8#4-'9'YO)L 6LC8KO<__/(3FV904O7!
MM^L&RYUVT4FA-*"LPX-(+O*5_]7Z%?#RU>V/W_EH;_._K9GYP=$L?)S:V;UR
MP+(Z'X7$NGGU@V#H-"*FC&8: -[Q KZRZ&FT4'!4[7:M&VP(#IM>B-]@>;_I
M0_PI/UI:?K[X]'D46#R]7MV+YV>$1V?1U_;[#AVZX AE#LL'4;L/=X&!&<W'
M&!Q&[<FE!=7],0N+Z>W5O0K[Z]7Y>COXU4ZF'=?7VBF1M*"RMW\O_,?%Q!?8
M7S\^U4DY#=Q(/F*^!8W\FFMQW]A5_,5.%G_:Z4T!U1SX9B<=-7 />5P<E97U
M<&??_OZ?U1I*K[_.KC[Z\\S>$Y_NI+JZ5Y/=A--J&<[;Q?J^8*02G,=?+U)^
M\P31!4IO\AB1[W%Q^R$]6NL1& ;AOM,"9VS9[5=WRYR?G#_XP6IYQ3[ZN;]9
M3XFELI'-CY>V+?7S&7!VDO[0]ZKIZZ3<YYV$\+_Z^F04[Z2K4OZY./GGXJ27
M;M[/9^_CO(12'GZIWD7C*5G/GV"\H7,EPB>O)[.US+)]+7; //IP-:,VU#/H
M(J;:)N_J:K5EZNQLT\-/52L ':JMPZ*HK)\=03,[O5U.EF5JFXY^M%HQZ)F^
M]U'Q5-;>Y]5_/B[\A\67Y>+M<C6YMINKI7)5\IT6J%8I.E2K?<166</WVMD6
M-*7'OUJM='2H+I\44#L'X/OYZM_Q[J2.I<JXNRQ0K9*TP&'YI-@J:_@7^.A\
M%G><EK@0/?+):A6E0[5X6C1MZ>W-3?PR?_MWONO/8Y%F:;[P:]?Z7&/;9YUJ
ME]V%--Q%B VJ_<_)?+I]OOP_\^OX.K]87MS^9O\:0_<G%ZMW<5X2 5WDV2 ,
M@./_WMCI)$W\EOHO]N]7<1;39'5VL<2@!>M=U9>$0U>YM@4),&-3.]L2_.[Z
M6^Y*# RXR72RNBWCNPU;L5YM0"%0])-L.Q%821?OQ&?K%1 4",+:]/4.$%@X
MCM[_;"<E-I7K>EI&#=T*S.,2XL)/\;\WD\6=72ECE'LLTTG)3:6^^LNPU2J@
MC]_'J@!Z^.4BU3\GB"U0^?/1WOZ9^RU!M'5M9SZ6+OSI\OTS]C4(Y_Q:G[N/
M5+MP[:&%^SMRG_O:%T)_1[]N]?4:S,35?'%[=NG(X2_64].^O.<=F:^=2)Y.
M]\F;Q$)%),<_7*_ZZJ0JYOWD4EEU'^.\@)Y^?*5F3<G3LIZ?8+Q^D0^0]+Z(
M.O:_5>\M=$^E'!'"/[6*SWG2_%.?^$]]8C_=A/_ORWP=CY^[/1Y^J5H9U:G=
M<9#9V@J83N_(*K,U]C]7[U@_*.YY%]YK*^7J:K5^M31;SOZTL'D_WUQ?;_)6
MR]7LBYO^,E]<?)NZZ;\7)736>[6:GMHQC<T+B*\!M6>:@<7EY^_^]7)52+L'
M/UK3L^NHQ%/"J!W\E-;38!V-L]&>DOZ\FR@:T=+'Q:*XHO:_66\_#=#5$8'4
MSM+]=W5[\=<B+#.)!51UZ'OU.BQW,GLG1-"*<D9V1_JL4R^/=T)-A[3Y8GR0
M!XSE:1A7X$%]^K98A<<LE-ZAW9:K]TBSI\Y[2["RZO^]>#L+O^1V%Q_2'1._
M+F:9\-??%^'?BWR7'F97%[/PQ^S[<A4* &#PHFUL_7[ZG9<3=F6LY/#JW6Q+
M_SZE^_R L_'O18GS?/BJ;1B-P6@Y6]R5X?(G,'CU9G40[\ '_/@.]@5@TG^U
M:DYA&7@,%F\[5N1B^2%MV?B0U@B^8Z,P.@8O6NV99W$;,DC8M<N8=X1OZ)V%
MQ^?FQO#],@UKWE[/9V'Y9@%_*86<0B14>UA:!D=E%5$956^^A[#\L/BP^KIX
MN\CC_<*'V1TW[U?YW_]:?DI3G]GZLIIF >7!'J4@56+]:H];R^"IH IJ#\6)
M-M?%G7V5>?\[U0Z=4Q>9!QBMG>C=4ENF5OKQU^I56YQ7?MG:LY/7\\]Q&OTJ
MABV&SGYQ<OB+]>[_A^GKI%QJEY<!*>&N%NM#2A,/W_UE5F:O/?WU>B9PF"X[
MRZNVS8QQ\>MB?O/MW7)Y4U"CI[Y;S?<=:D>?EE%MB_HU]^X/=X26TN*I[U;S
M.(=:UZ=E5'TOSK_,5W9:XOG>_K>J=4D9O.<.RJ*^AB[\ZL9.I[<?[2044M2A
M3U;KAS)<7R<D4[NF*E^Y X7KJ+&0:3SVS6IM3@8J[@G9U'8[=P7]%]^OBMG&
MHQ^MUZ%DJ)?YA'@:TMZ:LGL6HJ02#WV[7GN1 KH\(:P63.D=J<4-ZM$OUVL,
M<HY=?4I0U>M\;B:KVSS:9"-*"&^NUR/<WDP2$!.!VU+:[;E4O3XA ]4]3)2U
MP\8],_/G<GV(K(>_?9U/0<J?5J4BR7Y+U6LQ,CAW-T24S>G_?5R]F_GY=:$<
M>J<%ZG4:*:;KXV)K3L./DLQC:?K$0ITTWE3N:( 8*VO^@/G)G&^37V64WG6-
M3OIN*?O44WC-;?(/JZ]Q,?+^/KQ&)U6WE+CJ*;S:N]JZFZE=_#99K@I>=1__
M:B=UMI3.>E) M17XV+*<FPDY\LE.U0HM);-.BZ9ZYG]G_,LK\*EO=])D2ZFL
MCL*JJ-+=?/([Q_VW^?)4O=:0,? /O]U)B:TDL$Z*I[JWL^=YG[O]#GZPD[I:
M2D"=$DOM#K79H<H<%5+8H>]UTE=+":,30FDAQ5]DJMG]#W524$M9GD-BJ.Z$
MS,\NE=Q]HY,^6LK![#'?1IGWV>KH6Z]*6TJ3-%BF.I_]"H[+EK W<>D7D_4U
M3*$ZU:<_WTF)+25 NHNL^KD4)IDN.^68?O_!7:GKYZ>^WDFS+>5".@NL]K$V
M6\Y>S=(J/R$J5G]\Y)N=W@2TE!5Y0CC5*PA^O/XJ5RIP^)N=5-=2&N0)X;0Z
M?>#=;#D!87Y9V/7DR<4BUTWGJ0I[&8 S1Q&<6*;(7(*N;!084O!HJ4>P&-CL
M]^AGS\E WWWN59YD<_YX@H,?K-@)]RE=/,@YGQ!&[9N".]+.?DNZ]ZEJNCDI
M[8-::>AUZ<5T>L"6E&F7>_S##>CJ1.?<)P7R3^?U6GOHGR[L_W1A[Y?16BVF
M7^+B>ODA?5D$P%<9;_[$9ZOMH7X^PM."J>XI9*I*3&Y\^*5J[^?[^G 'V&]%
M)5\FJ[/=ZP>?JO80?J!2'@B@LE8^W4PCP4Z0[-6$^;=5#+],[=59ZCGVS6J/
MW/OIZ0F1U$_GCZ&S$Y^M]JJ]G]J>%DP3!G!-5WX$8U<EC."#SU5[T3[$$!X2
M1$/&\,OB>K8J:POO?;+:6_;AIO"Q0-JRA(44=ORKU9ZQGV4'FU/;+F!87$\V
M0^$+6<+]+]9[N3[$&AZ11Q.Z>OOWM\FBI*KV/ECO7?H031V61A.*>G.S(:R
MBNX^5>^5^1#E[$N@";5\COYF,5E-XO+BZNKBNYU,SW[?<.*[]=Z)#U'82=F\
MC.O@C_/IQ ,#'Q=S/^)U\(-E1K@./LY&\>O@^TL]PDB!>^'#WS_KTF3[^7#_
MTZ5B[Z>_WLC5\4F]/;QIZ2BOZI=AA^A\/U]M22V3[^^^2B/I_S/U?$)^XUOT
M[0_R'\XNX__[?_W_4$L! A0#%     @ )("H6D$4OM^L!P  #R4  !@
M         ( !     '-P>7)E+3(P,C4P,S,Q>&5X,S$R+FAT;5!+ 0(4 Q0
M   ( "2 J%K_WR-LX@0  #48   8              "  >('  !S<'ER92TR
M,#(U,#,S,7AE>#,R,2YH=&U02P$"% ,4    "  D@*A:-]YXVJ8'   &)0
M%P              @ 'Z#   <W!Y<F4M,C U,#,S,7AE>#,Q,2YH=&U02P$"
M% ,4    "  D@*A:3,-8,#D3 @ [ZQ0 $0              @ '5%   <WER
M92TR,#(U,#,S,2YH=&U02P$"% ,4    "  D@*A:?0@XWP$2  "<P   $0
M            @ $]* ( <WER92TR,#(U,#,S,2YX<V102P$"% ,4    "  D
M@*A:8/B0D_47  !VWP  %0              @ %M.@( <WER92TR,#(U,#,S
M,5]C86PN>&UL4$L! A0#%     @ )("H6F"53;V,<   @!<% !4
M     ( !E5(" '-Y<F4M,C R-3 S,S%?9&5F+GAM;%!+ 0(4 Q0    ( "2
MJ%IBV=KW)%0$ %J:!0 4              "  53# @!S>7)E+3(P,C4P,S,Q
M7V<Q+FIP9U!+ 0(4 Q0    ( "2 J%I$:=1;T>8! $ $ @ 5
M  "  :H7!P!S>7)E+3(P,C4P,S,Q7V<Q,"YJ<&=02P$"% ,4    "  D@*A:
M=,#JD>AH!0#C^0@ %0              @ &N_@@ <WER92TR,#(U,#,S,5]G
M,3$N:G!G4$L! A0#%     @ )("H6A;,,HLF.0, /%$$ !4
M ( !R6<. '-Y<F4M,C R-3 S,S%?9S$R+FIP9U!+ 0(4 Q0    ( "2 J%H8
MO)+R>/(  'P< 0 5              "  2*A$0!S>7)E+3(P,C4P,S,Q7V<Q
M,RYJ<&=02P$"% ,4    "  D@*A:-DYIZQKH   +%0$ %0
M@ '-DQ( <WER92TR,#(U,#,S,5]G,30N:G!G4$L! A0#%     @ )("H6O.Z
M12!2\@  0!H! !4              ( !&GP3 '-Y<F4M,C R-3 S,S%?9S$U
M+FIP9U!+ 0(4 Q0    ( "2 J%JX>[+_'OP  $P3 0 4              "
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M              "  3P*'P!S>7)E+3(P,C4P,S,Q7V<Y+FIP9U!+ 0(4 Q0
M   ( "2 J%K2&G=O%.P  ,H]"0 5              "  =S 'P!S>7)E+3(P
M,C4P,S,Q7VQA8BYX;6Q02P$"% ,4    "  D@*A:WKAVG,.<   95@< %0
M            @ $CK2  <WER92TR,#(U,#,S,5]P<F4N>&UL4$L%!@     8
- !@ /P8  !E*(0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>syre-20250331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:syre="http://spyre.com/20250331"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="syre-20250331.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
        </entity>
        <period>
            <instant>2025-05-02</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesANonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesANonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:PreferredStockExcludingSeriesAAndBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:PreferredStockExcludingSeriesAAndBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesANonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesANonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesANonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesANonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesANonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesANonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">syre:SpyreTherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-22</startDate>
            <endDate>2023-06-22</endDate>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:CommonStockAndSeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-11</instant>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-20</instant>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-20</startDate>
            <endDate>2024-03-20</endDate>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-20</instant>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-20</startDate>
            <endDate>2024-03-20</endDate>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">syre:ConversionOfSeriesANonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesANonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-23</startDate>
            <endDate>2024-04-23</endDate>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">syre:AssetAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesANonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-22</instant>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-23</startDate>
            <endDate>2024-04-23</endDate>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesANonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-25</instant>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">syre:ConversionOfSeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-14</startDate>
            <endDate>2024-05-14</endDate>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">syre:ConversionOfSeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-14</startDate>
            <endDate>2024-05-14</endDate>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">syre:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-06</instant>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">syre:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-06</instant>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">syre:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">syre:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">syre:UnderwrittenOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-20</startDate>
            <endDate>2024-11-20</endDate>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-29</startDate>
            <endDate>2024-11-29</endDate>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">syre:UnderwrittenOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-20</instant>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">syre:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-06</instant>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">syre:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
        </entity>
        <period>
            <startDate>2015-03-10</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">syre:ContingentValueRightLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">syre:ContingentValueRightLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">syre:ContingentValueRightLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">syre:ContingentValueRightLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">syre:ContingentValueRightLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">syre:ContingentValueRightLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">syre:ContingentValueRightLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">syre:ContingentValueRightLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">syre:ContingentValueRightLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">syre:MeasurementInputProabilityOfSuccessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">syre:ContingentValueRightLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">syre:MeasurementInputProabilityOfSuccessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">syre:ContingentValueRightLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">syre:MeasurementInputReimbursementRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">syre:ContingentValueRightLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">syre:MeasurementInputReimbursementRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">syre:ContingentValueRightLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">syre:ContingentValueRightLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">syre:ContingentValueRightLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">syre:ContingentValueRightLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">syre:ContingentValueRightLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">syre:USBankingInstitutionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:SPY003LicenseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-11</instant>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:Spy001LicenseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-14</instant>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:SPY002LicenseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-14</instant>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:SPY003LicenseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-11</startDate>
            <endDate>2024-10-11</endDate>
        </period>
    </context>
    <context id="c-168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:SPY002LicenseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-14</startDate>
            <endDate>2024-05-14</endDate>
        </period>
    </context>
    <context id="c-169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:ParagonAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:SPY002LicenseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:ParagonAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:ParagonAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:ParagonAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:ParagonAgreementLicenseMilestonePaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:ParagonAgreementLicenseMilestonePaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">syre:ParagonTherapeuticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:ParagonAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">syre:FairmountFundsManagementLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:ParagonAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:AppointOfBoardMembersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:ParagonAgreementLicenseMilestonePaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:ParagonAndLicenseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:ParagonAndLicenseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:ParapyreLiabilityLicenseAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:ParapyreLiabilityLicenseAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-01</instant>
        </period>
    </context>
    <context id="c-185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:ParagonAgreementSubsequentToAssetAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">syre:ParapyreOptionObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">syre:ParapyreOptionObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:ConsultingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-22</startDate>
            <endDate>2023-11-22</endDate>
        </period>
    </context>
    <context id="c-190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:ConsultingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-22</instant>
        </period>
    </context>
    <context id="c-191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:ConsultingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-22</startDate>
            <endDate>2023-11-22</endDate>
        </period>
    </context>
    <context id="c-192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:ConsultingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:ConsultingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">syre:ParapyreWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">syre:A2024ParapyreOptionObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">syre:ParapyreWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">syre:A2024ParapyreOptionObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">syre:ParapyreWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesANonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-22</instant>
        </period>
    </context>
    <context id="c-198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesANonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-23</startDate>
            <endDate>2024-04-23</endDate>
        </period>
    </context>
    <context id="c-199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesANonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-24</instant>
        </period>
    </context>
    <context id="c-200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-11</startDate>
            <endDate>2023-12-11</endDate>
        </period>
    </context>
    <context id="c-201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-18</startDate>
            <endDate>2024-03-18</endDate>
        </period>
    </context>
    <context id="c-202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:CommonStockAndSeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-20</instant>
        </period>
    </context>
    <context id="c-203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">syre:ConversionOfSeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syre:SeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">syre:ConversionOfSeriesBNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">syre:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">syre:TwoThousandAndFifteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">syre:TwoThousandAndSixteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-01-01</startDate>
            <endDate>2016-12-31</endDate>
        </period>
    </context>
    <context id="c-210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">syre:TwoThousandAndSixteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-01</instant>
        </period>
    </context>
    <context id="c-211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">syre:TwoThousandAndSixteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-01</instant>
        </period>
    </context>
    <context id="c-212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">syre:TwoThousandAndSixteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">syre:TwoThousandAndEighteenEquityInducementPlanAmendedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">syre:TwoThousandAndEighteenEquityInducementPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">syre:ServiceBasedAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">syre:TwoThousandAndFifteenAndTwoThousandAndSixteenEquityIncentivePlanAndTwoThousandAndEighteenEquityInducementPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">syre:AssetAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">syre:Spyre2023EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-22</startDate>
            <endDate>2023-06-22</endDate>
        </period>
    </context>
    <context id="c-217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">syre:TwoThousandAndSixteenEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">syre:A2016ESPPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">syre:TwoThousandAndSixteenEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">syre:TwoThousandAndSixteenEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">syre:A2016ESPPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">syre:AegleaEmployeesAndDirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">syre:TwoThousandAndSixteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">syre:TwoThousandAndSixteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">syre:TwoThousandAndSixteenEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">syre:TwoThousandAndSixteenEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syre:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syre:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syre:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-232">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syre:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-233">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syre:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-234">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syre:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-235">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-236">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-237">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-238">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-239">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-240">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-241">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">syre:ParapyreWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-242">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">syre:ParapyreWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-243">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">syre:ParagonAgreementSubsequentToAssetAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="segment">
        <measure>syre:segment</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="bank">
        <measure>syre:bank</measure>
    </unit>
    <unit id="seat">
        <measure>syre:seat</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-27">0001636282</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-28">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:AmendmentFlag contextRef="c-1" id="f-29">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-30">2025</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-31">Q1</dei:DocumentFiscalPeriodFocus>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-243" decimals="-5" id="f-781" unitRef="usd">0</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <syre:RoyaltyStepDownPercent contextRef="c-172" decimals="3" id="f-782" unitRef="number">0.33</syre:RoyaltyStepDownPercent>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-219" decimals="-5" id="f-783" unitRef="usd">0</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <dei:DocumentType contextRef="c-1" id="f-1">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="c-1" id="f-2">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2025-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-4">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-37722</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-6">SPYRE THERAPEUTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-7">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-8">46-4312787</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-9">221 Crescent Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-1" id="f-10">Building 23</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine3 contextRef="c-1" id="f-11">Suite 105</dei:EntityAddressAddressLine3>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-12">Waltham</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-13">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-14">02453</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-15">617</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-16">651-5940</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-17">Common Stock, $0.0001 Par Value Per Share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-18">SYRE</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-19">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-20">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-21">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityFilerCategory contextRef="c-1" id="f-22">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-23">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-24">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="c-1" id="f-25">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-2" decimals="INF" id="f-26" unitRef="shares">60353561</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-3" decimals="-3" id="f-32" unitRef="usd">48493000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-3" id="f-33" unitRef="usd">89423000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-3" decimals="-3" id="f-34" unitRef="usd">516327000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-4" decimals="-3" id="f-35" unitRef="usd">513665000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-3" decimals="-3" id="f-36" unitRef="usd">4948000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-4" decimals="-3" id="f-37" unitRef="usd">5386000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-3" decimals="-3" id="f-38" unitRef="usd">569768000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-4" decimals="-3" id="f-39" unitRef="usd">608474000</us-gaap:AssetsCurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-3" decimals="-3" id="f-40" unitRef="usd">10000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-4" decimals="-3" id="f-41" unitRef="usd">10000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c-3" decimals="-3" id="f-42" unitRef="usd">569778000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-4" decimals="-3" id="f-43" unitRef="usd">608484000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c-5" decimals="-3" id="f-44" unitRef="usd">3689000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-6" decimals="-3" id="f-45" unitRef="usd">666000</us-gaap:AccountsPayableCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-46" unitRef="usd">42810000</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-47" unitRef="usd">25080000</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities contextRef="c-3" decimals="-3" id="f-48" unitRef="usd">21631000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities contextRef="c-4" decimals="-3" id="f-49" unitRef="usd">27711000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="c-7" decimals="-3" id="f-50" unitRef="usd">2548000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="c-8" decimals="-3" id="f-51" unitRef="usd">603000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-52" unitRef="usd">70678000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-53" unitRef="usd">54060000</us-gaap:LiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent contextRef="c-3" decimals="-3" id="f-54" unitRef="usd">16490000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent contextRef="c-4" decimals="-3" id="f-55" unitRef="usd">36620000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="c-3" decimals="-3" id="f-56" unitRef="usd">87168000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-4" decimals="-3" id="f-57" unitRef="usd">90680000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-3" id="f-58" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-4" id="f-59" unitRef="usd" xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-9"
      decimals="INF"
      id="f-60"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-10"
      decimals="INF"
      id="f-61"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-10" decimals="INF" id="f-62" unitRef="shares">1086341</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-9" decimals="INF" id="f-63" unitRef="shares">1086341</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="c-10" decimals="INF" id="f-64" unitRef="shares">346045</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-9" decimals="INF" id="f-65" unitRef="shares">346045</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-10" decimals="INF" id="f-66" unitRef="shares">346045</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued contextRef="c-9" decimals="INF" id="f-67" unitRef="shares">346045</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue contextRef="c-9" decimals="-3" id="f-68" unitRef="usd">146425000</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-10" decimals="-3" id="f-69" unitRef="usd">146425000</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-11"
      decimals="INF"
      id="f-70"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-12"
      decimals="INF"
      id="f-71"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-12" decimals="INF" id="f-72" unitRef="shares">271625</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-11" decimals="INF" id="f-73" unitRef="shares">271625</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="c-11" decimals="INF" id="f-74" unitRef="shares">16667</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-12" decimals="INF" id="f-75" unitRef="shares">16667</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued contextRef="c-12" decimals="INF" id="f-76" unitRef="shares">16667</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-11" decimals="INF" id="f-77" unitRef="shares">16667</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue contextRef="c-12" decimals="-3" id="f-78" unitRef="usd">9395000</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-11" decimals="-3" id="f-79" unitRef="usd">9395000</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-13"
      decimals="INF"
      id="f-80"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-14"
      decimals="INF"
      id="f-81"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-13" decimals="INF" id="f-82" unitRef="shares">8642034</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-14" decimals="INF" id="f-83" unitRef="shares">8642034</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-13" decimals="INF" id="f-84" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued contextRef="c-13" decimals="INF" id="f-85" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-14" decimals="INF" id="f-86" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued contextRef="c-14" decimals="INF" id="f-87" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue contextRef="c-14" decimals="-3" id="f-88" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-13" decimals="-3" id="f-89" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-90"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-91"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-3" decimals="INF" id="f-92" unitRef="shares">400000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-4" decimals="INF" id="f-93" unitRef="shares">400000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-94" unitRef="shares">60275561</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-3" decimals="INF" id="f-95" unitRef="shares">60275561</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-4" decimals="INF" id="f-96" unitRef="shares">60257023</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-4" decimals="INF" id="f-97" unitRef="shares">60257023</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue contextRef="c-3" decimals="-3" id="f-98" unitRef="usd">13000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-4" decimals="-3" id="f-99" unitRef="usd">13000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-3" decimals="-3" id="f-100" unitRef="usd">1343300000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-4" decimals="-3" id="f-101" unitRef="usd">1334223000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-3" decimals="-3" id="f-102" unitRef="usd">682000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-4" decimals="-3" id="f-103" unitRef="usd">180000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-3" decimals="-3" id="f-104" unitRef="usd">-1017205000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-4" decimals="-3" id="f-105" unitRef="usd">-972432000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c-3" decimals="-3" id="f-106" unitRef="usd">482610000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-107" unitRef="usd">517804000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-3" decimals="-3" id="f-108" unitRef="usd">569778000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-4" decimals="-3" id="f-109" unitRef="usd">608484000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost contextRef="c-1" decimals="-3" id="f-110" unitRef="usd">41623000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost contextRef="c-15" decimals="-3" id="f-111" unitRef="usd">34928000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-1" decimals="-3" id="f-112" unitRef="usd">11944000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-15" decimals="-3" id="f-113" unitRef="usd">12846000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses contextRef="c-1" decimals="-3" id="f-114" unitRef="usd">53567000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-15" decimals="-3" id="f-115" unitRef="usd">47774000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-3" id="f-116" unitRef="usd">-53567000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-15" decimals="-3" id="f-117" unitRef="usd">-47774000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeNet contextRef="c-1" decimals="-3" id="f-118" unitRef="usd">6493000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet contextRef="c-15" decimals="-3" id="f-119" unitRef="usd">4432000</us-gaap:InvestmentIncomeNet>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-120" unitRef="usd">2286000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-15" decimals="-3" id="f-121" unitRef="usd">-483000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-122" unitRef="usd">8779000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-15" decimals="-3" id="f-123" unitRef="usd">3949000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-124" unitRef="usd">-44788000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-15" decimals="-3" id="f-125" unitRef="usd">-43825000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-126" unitRef="usd">-15000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-15" decimals="-3" id="f-127" unitRef="usd">32000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-128" unitRef="usd">-44773000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-15" decimals="-3" id="f-129" unitRef="usd">-43857000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-16"
      decimals="2"
      id="f-130"
      unitRef="usdPerShare">-23.95</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-16"
      decimals="2"
      id="f-131"
      unitRef="usdPerShare">-23.95</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-17"
      decimals="2"
      id="f-132"
      unitRef="usdPerShare">-28.93</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-17"
      decimals="2"
      id="f-133"
      unitRef="usdPerShare">-28.93</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c-16"
      decimals="INF"
      id="f-134"
      unitRef="shares">346045</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c-16"
      decimals="INF"
      id="f-135"
      unitRef="shares">346045</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c-17"
      decimals="INF"
      id="f-136"
      unitRef="shares">437037</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c-17"
      decimals="INF"
      id="f-137"
      unitRef="shares">437037</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-18"
      decimals="2"
      id="f-138"
      unitRef="usdPerShare">-23.95</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-18"
      decimals="2"
      id="f-139"
      unitRef="usdPerShare">-23.95</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-19"
      decimals="2"
      id="f-140"
      unitRef="usdPerShare">-28.93</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-19"
      decimals="2"
      id="f-141"
      unitRef="usdPerShare">-28.93</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c-18"
      decimals="INF"
      id="f-142"
      unitRef="shares">16667</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c-18"
      decimals="INF"
      id="f-143"
      unitRef="shares">16667</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c-19"
      decimals="INF"
      id="f-144"
      unitRef="shares">166261</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c-19"
      decimals="INF"
      id="f-145"
      unitRef="shares">166261</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-20"
      decimals="2"
      id="f-146"
      unitRef="usdPerShare">-0.60</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-20"
      decimals="2"
      id="f-147"
      unitRef="usdPerShare">-0.60</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-21"
      decimals="2"
      id="f-148"
      unitRef="usdPerShare">-0.72</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-21"
      decimals="2"
      id="f-149"
      unitRef="usdPerShare">-0.72</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c-20"
      decimals="INF"
      id="f-150"
      unitRef="shares">60265932</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c-20"
      decimals="INF"
      id="f-151"
      unitRef="shares">60265932</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c-21"
      decimals="INF"
      id="f-152"
      unitRef="shares">36512662</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c-21"
      decimals="INF"
      id="f-153"
      unitRef="shares">36512662</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-22" decimals="-3" id="f-154" unitRef="usd">2500000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-23" decimals="-3" id="f-155" unitRef="usd">17100000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-24" decimals="-3" id="f-156" unitRef="usd">300000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-25" decimals="-3" id="f-157" unitRef="usd">300000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-158" unitRef="usd">-44773000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-15" decimals="-3" id="f-159" unitRef="usd">-43857000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="c-1" decimals="-3" id="f-160" unitRef="usd">14000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="c-15" decimals="-3" id="f-161" unitRef="usd">16000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-1" decimals="-3" id="f-162" unitRef="usd">488000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-15" decimals="-3" id="f-163" unitRef="usd">-681000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-1" decimals="-3" id="f-164" unitRef="usd">-44271000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-15" decimals="-3" id="f-165" unitRef="usd">-44522000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-26" decimals="-3" id="f-166" unitRef="shares">346000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-26" decimals="-3" id="f-167" unitRef="usd">146425000</us-gaap:StockholdersEquity>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-27" decimals="-3" id="f-168" unitRef="shares">17000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-27" decimals="-3" id="f-169" unitRef="usd">9395000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-28" decimals="-3" id="f-170" unitRef="shares">60257000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-28" decimals="-3" id="f-171" unitRef="usd">13000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-29" decimals="-3" id="f-172" unitRef="usd">1334223000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-30" decimals="-3" id="f-173" unitRef="usd">180000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-31" decimals="-3" id="f-174" unitRef="usd">-972432000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-175" unitRef="usd">517804000</us-gaap:StockholdersEquity>
    <syre:StockIssuedDuringPeriodSharesOptionsExercisedAndEmployeeStockOwnershipPlan contextRef="c-32" decimals="-3" id="f-176" unitRef="shares">19000</syre:StockIssuedDuringPeriodSharesOptionsExercisedAndEmployeeStockOwnershipPlan>
    <syre:StockIssuedDuringPeriodValueOptionsExercisedAndEmployeeStockOwnershipPlan contextRef="c-33" decimals="-3" id="f-177" unitRef="usd">335000</syre:StockIssuedDuringPeriodValueOptionsExercisedAndEmployeeStockOwnershipPlan>
    <syre:StockIssuedDuringPeriodValueOptionsExercisedAndEmployeeStockOwnershipPlan contextRef="c-1" decimals="-3" id="f-178" unitRef="usd">335000</syre:StockIssuedDuringPeriodValueOptionsExercisedAndEmployeeStockOwnershipPlan>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-33" decimals="-3" id="f-179" unitRef="usd">8859000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-1" decimals="-3" id="f-180" unitRef="usd">8859000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <syre:ShareBasedPaymentArrangementSettlementOptionsCash contextRef="c-33" decimals="-3" id="f-181" unitRef="usd">117000</syre:ShareBasedPaymentArrangementSettlementOptionsCash>
    <syre:ShareBasedPaymentArrangementSettlementOptionsCash contextRef="c-1" decimals="-3" id="f-182" unitRef="usd">117000</syre:ShareBasedPaymentArrangementSettlementOptionsCash>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="c-34" decimals="-3" id="f-183" unitRef="usd">14000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="c-1" decimals="-3" id="f-184" unitRef="usd">14000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-34" decimals="-3" id="f-185" unitRef="usd">488000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-1" decimals="-3" id="f-186" unitRef="usd">488000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:NetIncomeLoss contextRef="c-35" decimals="-3" id="f-187" unitRef="usd">-44773000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-188" unitRef="usd">-44773000</us-gaap:NetIncomeLoss>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-36" decimals="-3" id="f-189" unitRef="shares">346000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-36" decimals="-3" id="f-190" unitRef="usd">146425000</us-gaap:StockholdersEquity>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-37" decimals="-3" id="f-191" unitRef="shares">17000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-37" decimals="-3" id="f-192" unitRef="usd">9395000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-38" decimals="-3" id="f-193" unitRef="shares">60276000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-38" decimals="-3" id="f-194" unitRef="usd">13000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-39" decimals="-3" id="f-195" unitRef="usd">1343300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-40" decimals="-3" id="f-196" unitRef="usd">682000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-41" decimals="-3" id="f-197" unitRef="usd">-1017205000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-3" decimals="-3" id="f-198" unitRef="usd">482610000</us-gaap:StockholdersEquity>
    <us-gaap:TemporaryEquitySharesOutstanding contextRef="c-42" decimals="-3" id="f-199" unitRef="shares">150000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="c-42" decimals="-3" id="f-200" unitRef="usd">84555000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-43" decimals="-3" id="f-201" unitRef="shares">437000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-43" decimals="-3" id="f-202" unitRef="usd">184927000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-44" decimals="-3" id="f-203" unitRef="shares">36057000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-44" decimals="-3" id="f-204" unitRef="usd">10000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-45" decimals="-3" id="f-205" unitRef="usd">763191000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-46" decimals="-3" id="f-206" unitRef="usd">302000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-47" decimals="-3" id="f-207" unitRef="usd">-764414000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-48" decimals="-3" id="f-208" unitRef="usd">184016000</us-gaap:StockholdersEquity>
    <syre:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues contextRef="c-49" decimals="-3" id="f-209" unitRef="shares">122000</syre:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues contextRef="c-49" decimals="-3" id="f-210" unitRef="usd">168850000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <syre:StockIssuedDuringPeriodSharesOptionsExercisedAndEmployeeStockOwnershipPlan contextRef="c-50" decimals="-3" id="f-211" unitRef="shares">572000</syre:StockIssuedDuringPeriodSharesOptionsExercisedAndEmployeeStockOwnershipPlan>
    <syre:StockIssuedDuringPeriodValueOptionsExercisedAndEmployeeStockOwnershipPlan contextRef="c-51" decimals="-3" id="f-212" unitRef="usd">4390000</syre:StockIssuedDuringPeriodValueOptionsExercisedAndEmployeeStockOwnershipPlan>
    <syre:StockIssuedDuringPeriodValueOptionsExercisedAndEmployeeStockOwnershipPlan contextRef="c-15" decimals="-3" id="f-213" unitRef="usd">4390000</syre:StockIssuedDuringPeriodValueOptionsExercisedAndEmployeeStockOwnershipPlan>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-51" decimals="-3" id="f-214" unitRef="usd">8385000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-15" decimals="-3" id="f-215" unitRef="usd">8385000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="c-52" decimals="-3" id="f-216" unitRef="usd">16000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="c-15" decimals="-3" id="f-217" unitRef="usd">16000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-52" decimals="-3" id="f-218" unitRef="usd">-681000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-15" decimals="-3" id="f-219" unitRef="usd">-681000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:NetIncomeLoss contextRef="c-53" decimals="-3" id="f-220" unitRef="usd">-43857000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-15" decimals="-3" id="f-221" unitRef="usd">-43857000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquitySharesOutstanding contextRef="c-54" decimals="-3" id="f-222" unitRef="shares">272000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="c-54" decimals="-3" id="f-223" unitRef="usd">253405000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-55" decimals="-3" id="f-224" unitRef="shares">437000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-55" decimals="-3" id="f-225" unitRef="usd">184927000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-56" decimals="-3" id="f-226" unitRef="shares">36629000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-56" decimals="-3" id="f-227" unitRef="usd">10000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-57" decimals="-3" id="f-228" unitRef="usd">775966000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-58" decimals="-3" id="f-229" unitRef="usd">-363000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-59" decimals="-3" id="f-230" unitRef="usd">-808271000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-60" decimals="-3" id="f-231" unitRef="usd">152269000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-232" unitRef="usd">-44773000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-15" decimals="-3" id="f-233" unitRef="usd">-43857000</us-gaap:NetIncomeLoss>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-3" id="f-234" unitRef="usd">8859000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-15" decimals="-3" id="f-235" unitRef="usd">13835000</us-gaap:ShareBasedCompensation>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax contextRef="c-1" decimals="-3" id="f-236" unitRef="usd">2400000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax contextRef="c-15" decimals="-3" id="f-237" unitRef="usd">-430000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments contextRef="c-1" decimals="-3" id="f-238" unitRef="usd">2642000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments contextRef="c-15" decimals="-3" id="f-239" unitRef="usd">2423000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <syre:InterestProceedsDebtSecurities contextRef="c-1" decimals="-3" id="f-240" unitRef="usd">530000</syre:InterestProceedsDebtSecurities>
    <syre:InterestProceedsDebtSecurities contextRef="c-15" decimals="-3" id="f-241" unitRef="usd">0</syre:InterestProceedsDebtSecurities>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade contextRef="c-1" decimals="-3" id="f-242" unitRef="usd">3023000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade contextRef="c-15" decimals="-3" id="f-243" unitRef="usd">2210000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities contextRef="c-1" decimals="-3" id="f-244" unitRef="usd">-5998000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities contextRef="c-15" decimals="-3" id="f-245" unitRef="usd">8151000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayable contextRef="c-1" decimals="-3" id="f-246" unitRef="usd">1945000</us-gaap:IncreaseDecreaseInOtherAccountsPayable>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayable contextRef="c-15" decimals="-3" id="f-247" unitRef="usd">-6507000</us-gaap:IncreaseDecreaseInOtherAccountsPayable>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-1" decimals="-3" id="f-248" unitRef="usd">-462000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-15" decimals="-3" id="f-249" unitRef="usd">381000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-3" id="f-250" unitRef="usd">-40994000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-15" decimals="-3" id="f-251" unitRef="usd">-28542000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities contextRef="c-1" decimals="-3" id="f-252" unitRef="usd">71383000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities contextRef="c-15" decimals="-3" id="f-253" unitRef="usd">47750000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt contextRef="c-1" decimals="-3" id="f-254" unitRef="usd">71444000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt contextRef="c-15" decimals="-3" id="f-255" unitRef="usd">152713000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-3" id="f-256" unitRef="usd">-61000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-15" decimals="-3" id="f-257" unitRef="usd">-104963000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="c-1" decimals="-3" id="f-258" unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="c-15" decimals="-3" id="f-259" unitRef="usd">169205000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities contextRef="c-1" decimals="-3" id="f-260" unitRef="usd">0</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities contextRef="c-15" decimals="-3" id="f-261" unitRef="usd">1430000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <syre:PaymentForDeferredOfferingCosts contextRef="c-1" decimals="-3" id="f-262" unitRef="usd">93000</syre:PaymentForDeferredOfferingCosts>
    <syre:PaymentForDeferredOfferingCosts contextRef="c-15" decimals="-3" id="f-263" unitRef="usd">0</syre:PaymentForDeferredOfferingCosts>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions contextRef="c-1" decimals="-3" id="f-264" unitRef="usd">335000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions contextRef="c-15" decimals="-3" id="f-265" unitRef="usd">4390000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <syre:PaymentForSettlementOfShareBasedPaymentArrangement contextRef="c-1" decimals="-3" id="f-266" unitRef="usd">117000</syre:PaymentForSettlementOfShareBasedPaymentArrangement>
    <syre:PaymentForSettlementOfShareBasedPaymentArrangement contextRef="c-15" decimals="-3" id="f-267" unitRef="usd">0</syre:PaymentForSettlementOfShareBasedPaymentArrangement>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-3" id="f-268" unitRef="usd">125000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-15" decimals="-3" id="f-269" unitRef="usd">172165000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-1" decimals="-3" id="f-270" unitRef="usd">0</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-15" decimals="-3" id="f-271" unitRef="usd">-4000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-3" id="f-272" unitRef="usd">-40930000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-15" decimals="-3" id="f-273" unitRef="usd">38656000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-3" id="f-274" unitRef="usd">89423000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-48" decimals="-3" id="f-275" unitRef="usd">189215000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-3" decimals="-3" id="f-276" unitRef="usd">48493000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-60" decimals="-3" id="f-277" unitRef="usd">227871000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <syre:DeferredOfferingCostsUnpaidAmount contextRef="c-1" decimals="-3" id="f-278" unitRef="usd">69000</syre:DeferredOfferingCostsUnpaidAmount>
    <syre:DeferredOfferingCostsUnpaidAmount contextRef="c-15" decimals="-3" id="f-279" unitRef="usd">0</syre:DeferredOfferingCostsUnpaidAmount>
    <syre:IssuanceOfConvertiblePreferredStockRelatedToPrivatePlacementUnpaidAmount contextRef="c-1" decimals="-3" id="f-280" unitRef="usd">0</syre:IssuanceOfConvertiblePreferredStockRelatedToPrivatePlacementUnpaidAmount>
    <syre:IssuanceOfConvertiblePreferredStockRelatedToPrivatePlacementUnpaidAmount contextRef="c-15" decimals="-3" id="f-281" unitRef="usd">355000</syre:IssuanceOfConvertiblePreferredStockRelatedToPrivatePlacementUnpaidAmount>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-3" decimals="-3" id="f-282" unitRef="usd">48493000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-60" decimals="-3" id="f-283" unitRef="usd">227552000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCash contextRef="c-3" decimals="-3" id="f-284" unitRef="usd">0</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash contextRef="c-60" decimals="-3" id="f-285" unitRef="usd">319000</us-gaap:RestrictedCash>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-3" decimals="-3" id="f-286" unitRef="usd">48493000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-60" decimals="-3" id="f-287" unitRef="usd">227871000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="c-1" id="f-288">The Company and Basis of Presentation&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Spyre Therapeutics, Inc., formerly Aeglea BioTherapeutics, Inc. (&#x201c;Spyre&#x201d; or the &#x201c;Company&#x201d;), is a clinical stage biotechnology company focused on developing next generation therapeutics for patients living with inflammatory bowel disease and other immune-mediated diseases. The Company was formed as a Limited Liability Company in Delaware on December 16, 2013 under the name Aeglea BioTherapeutics Holdings, LLC and was converted from a Delaware LLC to a Delaware corporation on March 10, 2015. On November 27, 2023, the Company completed its corporate rebranding, changing the name of the Company to Spyre Therapeutics, Inc. The Company operates in one segment and has its principal offices in Waltham, Massachusetts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 22, 2023, the Company acquired, in accordance with the terms of the Agreement and Plan of Merger (the "Acquisition Agreement"), the assets of Spyre Therapeutics, Inc. (&#x201c;Pre-Merger Spyre&#x201d;), a privately held biotechnology company advancing a pipeline of antibody therapeutics with the potential to transform the treatment of inflammatory bowel disease through a research and development option agreement (as amended, the "Paragon Agreement") with Paragon Therapeutics, Inc. ("Paragon") and Parapyre Holding LLC (&#x201c;Parapyre&#x201d;) (the "Asset Acquisition"). The Asset Acquisition was accomplished through a two-step reverse triangular merger whereby Aspen Merger Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of the Company ("First Merger Sub"), merged with and into Pre-Merger Spyre, which existed at the time the Acquisition Agreement was entered into, and became a wholly owned subsidiary of the Company in accordance with the terms of the Acquisition Agreement. Immediately following this merger, Pre-Merger Spyre merged with and into Sequoia Merger Sub II, LLC, a Delaware limited liability company and a wholly subsidiary of the Company (&#x201c;Second Merger Sub&#x201d;), in accordance with the terms of the Acquisition Agreement and Pre-Merger Spyre ceased to exist. Subsequently, Aeglea BioTherapeutics, Inc. was renamed Spyre Therapeutics, Inc. and is a different entity than Pre-Merger Spyre, which ceased to exist upon merging with Second Merger Sub.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Asset Acquisition, a non-transferable contingent value right ("CVR") was distributed to stockholders of record of the Company as of the close of business on July 3, 2023 (the "Legacy Stockholders"). Holders of the CVRs will be entitled to receive cash payments from proceeds received by the Company for a three-year period related to the disposition or monetization of its legacy assets for a period of one-year following the closing of the Asset Acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 20, 2024, the Company completed a private placement of Series B non-voting convertible preferred stock, par value of $0.0001 per share ("Series B Preferred Stock") (convertible on a 40 to 1 basis) (the &#x201c;March 2024 PIPE&#x201d;) to a group of investors. The Company sold 121,625 shares of Series B Preferred Stock at $1,480 per share. The net proceeds from this offering were approximately $168.9 million after deducting placement and offering costs of $11.2 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 23, 2024, the Company entered into an exchange agreement with Fairmount Healthcare Fund II L.P. (the &#x201c;Stockholder&#x201d;), pursuant to which the Stockholder agreed to exchange an aggregate of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;90,992&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; shares of Series A non-voting convertible preferred stock, par val&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ue of $0.0001 per share ("Se&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ries A Preferred Stock"), par value of  for an aggregate of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,639,680&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; shares of the Company's common stock (the &#x201c;April 2024 Exchange&#x201d;). The common stock issued in connection with the April 2024 Exchange was issued without registration under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;) in reliance on the exemption from registration contained in Section 3(a)(9) of the Securities Act. The April 2024 Exchange closed on April 25, 2024, with &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;346,045&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; shares of Series A Preferred Stock remaining outstanding following the April 2024 Exchange.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 14, 2024, the Company's stockholders approved the issuance of its common stock upon conversion of the Company's Series B Preferred Stock to common stock. A total of 254,958 shares of Series B &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Preferred Stock automatically converted to 10,198,320 shares of common stock; 16,667 shares of Series B Preferred Stock did not automatically convert and remained outstanding as of March&#160;31, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 6, 2024, the Company filed a new shelf registration statement on Form S-3 that was declared effective by the SEC for the potential offering, issuance and sale by the Company of up to $500.0&#160;million of its common stock, preferred stock, debt securities, warrants and/or units consisting of all or some of these securities. Concurrent with the filing of the shelf-registration statement, the Company entered into a sales agreement, dated September 6, 2024, with TD Securities (USA) LLC (&#x201c;TD Cowen&#x201d;) ("Sales Agreement"), as its sales agent, pursuant to which the Company may issue and sell shares of its common stock for an aggregate offering price of up to $200.0&#160;million under an at-the-market (&#x201c;ATM&#x201d;) offering program included in the shelf registration. During the year ended December 31, 2024, the Company sold an aggregate of 777,432 shares of common stock under the ATM at an average price per share of $26.935, resulting in aggregate net proceeds of approximately $20.5 million after deducting $0.4 million in commissions paid to TD Cowen as sales agent and other offering costs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 18, 2024, the Company entered into an underwriting agreement (the "Underwriting Agreement") with Jefferies LLC, Goldman Sachs &amp;amp; Co. LLC, Evercore Group L.L.C. and Guggenheim Securities, LLC as representatives of the several underwriters (collectively, the "Underwriters"), pursuant to which the Company sold an aggregate of 8,366,250 shares of its common stock, inclusive of 1,091,250 shares pursuant to the full exercise of the Underwriters' over-allotment option, at a public offering price per share of $27.50, resulting in net proceeds of approximately $215.9&#160;million after deducting approximately $14.2&#160;million of underwriting discounts and other offering costs (the "November 2024 Offering"). The November 2024 Offering closed on November 20, 2024 and the over-allotment option was exercised in full on November 26, 2024 and closed on November 29, 2024. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2025, the Company filed a new shelf registration statement on Form S-3 (the "February 2025 Shelf Registration Statement") that was declared effective by the SEC for the potential offering, issuance and sale of up to $500.0&#160;million of shares of common stock, preferred stock, debt securities, warrants and/or units consisting of all or some of these securities. Concurrent with the effectiveness of the February 2025 Shelf Registration Statement, the offering of unsold securities under a previous shelf registration statement on Form S-3 (File No. 333-281975), which was initially filed with the SEC on September 6, 2024 and became effective on September 18, 2024, was deemed terminated pursuant to Rule 415(a)(6) under the Securities Act. The February 2025 Shelf Registration Statement contains a sales agreement prospectus supplement covering the offering, issuance and sale by the Company of up to $179.1&#160;million of shares of common stock that may be issued and sold under the Sales Agreement in connection with the ATM offering program. No shares were sold under the ATM offering program during the three months ended March 31, 2025.  As of March 31, 2025, $179.1&#160;million remained available for sale under the Sales Agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Liquidity&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is a clinical stage biotechnology company with a limited operating history, and due to its significant research and development expenditures, the Company has generated operating losses since its inception and has not generated any revenue from the commercial sale of any products. There can be no assurance that profitable operations will ever be achieved, and, if achieved, whether profitability can be sustained on a continuing basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since its inception and through March&#160;31, 2025, the Company has funded its operations by raising an aggregate of approximately $1.3&#160;billion of gross proceeds from the sale and issuance of convertible preferred stock and common stock, pre-funded warrants, the collection of grant proceeds, and the licensing of its product rights for commercialization of pegzilarginase in Europe and certain countries in the Middle East. As of March&#160;31, 2025, Spyre had an accumulated deficit of $1.0&#160;billion, and cash, cash equivalents, and marketable securities of $564.8&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on its current operating plans, the Company has sufficient resources to fund operations for at least one year from the issuance date of these financial statements with existing cash, cash equivalents, and marketable securities. The Company will need to secure additional financing in the future to fund additional research and development, and before a commercial drug can be produced, marketed and sold. If the Company &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;is unable to obtain additional financing or generate license or product revenue, the lack of liquidity could have a material adverse effect on the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States (&#x201c;U.S. GAAP&#x201d;) as defined by the Financial Accounting Standards Board and include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Unaudited Interim Financial Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The interim condensed consolidated financial statements included in this Quarterly Report on Form 10-Q are unaudited. The unaudited interim financial statements have been prepared on the same basis as the annual financial statements and reflect, in the opinion of management, all adjustments of a normal and recurring nature that are necessary for a fair statement of the Company&#x2019;s financial position as of March&#160;31, 2025, and its results of operations for the three months ended March&#160;31, 2025 and 2024, changes in convertible preferred stock and stockholders&#x2019; equity for the three months ended March&#160;31, 2025 and 2024, and cash flows for the three months ended March&#160;31, 2025 and 2024. The results of operations for the three months ended March&#160;31, 2025, are not necessarily indicative of the results to be expected for the year ending December&#160;31, 2025 or for any other future annual or interim period. The December&#160;31, 2024 balance sheet was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP for complete financial statements. These financial statements should be read in conjunction with the audited financial statements included in the Company&#x2019;s Form 10-K for the year ended December&#160;31, 2024 (the "Annual Report") as filed with the SEC on February 27, 2025.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="c-1"
      decimals="INF"
      id="f-289"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <syre:AssetAcquisitionStockholderPaymentPeriod contextRef="c-61" id="f-290">P3Y</syre:AssetAcquisitionStockholderPaymentPeriod>
    <syre:AssetAcquisitionCashPaymentThresholdPeriod contextRef="c-61" id="f-291">P1Y</syre:AssetAcquisitionCashPaymentThresholdPeriod>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="c-62"
      decimals="4"
      id="f-292"
      unitRef="usdPerShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:PreferredStockConvertibleConversionRatio contextRef="c-63" decimals="0" id="f-293" unitRef="number">40</us-gaap:PreferredStockConvertibleConversionRatio>
    <syre:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="c-64"
      decimals="INF"
      id="f-294"
      unitRef="shares">121625</syre:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-65"
      decimals="2"
      id="f-295"
      unitRef="usdPerShare">1480</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-66" decimals="-5" id="f-296" unitRef="usd">168900000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-66" decimals="-5" id="f-297" unitRef="usd">11200000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="c-67"
      decimals="INF"
      id="f-298"
      unitRef="shares">90992</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-68"
      decimals="4"
      id="f-299"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <syre:StockIssuedDuringPeriodSharesExchangeOfConvertibleSecurities
      contextRef="c-69"
      decimals="INF"
      id="f-300"
      unitRef="shares">3639680</syre:StockIssuedDuringPeriodSharesExchangeOfConvertibleSecurities>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c-70"
      decimals="INF"
      id="f-301"
      unitRef="shares">346045</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="c-71"
      decimals="INF"
      id="f-302"
      unitRef="shares">254958</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="c-72"
      decimals="INF"
      id="f-303"
      unitRef="shares">10198320</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <syre:PreferredStockSharesNotAutomaticallyConvertedOutstanding
      contextRef="c-12"
      decimals="INF"
      id="f-304"
      unitRef="shares">16667</syre:PreferredStockSharesNotAutomaticallyConvertedOutstanding>
    <syre:SaleOfStockAuthorizedAmount contextRef="c-73" decimals="-5" id="f-305" unitRef="usd">500000000</syre:SaleOfStockAuthorizedAmount>
    <syre:SaleOfStockAggregateOfferingPrice contextRef="c-74" decimals="-5" id="f-306" unitRef="usd">200000000</syre:SaleOfStockAggregateOfferingPrice>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c-75"
      decimals="INF"
      id="f-307"
      unitRef="shares">777432</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-76"
      decimals="3"
      id="f-308"
      unitRef="usdPerShare">26.935</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-75" decimals="-5" id="f-309" unitRef="usd">20500000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-75" decimals="-5" id="f-310" unitRef="usd">400000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c-77"
      decimals="INF"
      id="f-311"
      unitRef="shares">8366250</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c-78"
      decimals="INF"
      id="f-312"
      unitRef="shares">1091250</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-79"
      decimals="2"
      id="f-313"
      unitRef="usdPerShare">27.50</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-77" decimals="-5" id="f-314" unitRef="usd">215900000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-77" decimals="-5" id="f-315" unitRef="usd">14200000</us-gaap:PaymentsOfStockIssuanceCosts>
    <syre:SaleOfStockAuthorizedAmount contextRef="c-73" decimals="-5" id="f-316" unitRef="usd">500000000</syre:SaleOfStockAuthorizedAmount>
    <syre:SaleOfStockAggregateOfferingPrice contextRef="c-80" decimals="-5" id="f-317" unitRef="usd">179100000</syre:SaleOfStockAggregateOfferingPrice>
    <syre:SaleOfStockRemainingAuthorizedAmount contextRef="c-81" decimals="-5" id="f-318" unitRef="usd">179100000</syre:SaleOfStockRemainingAuthorizedAmount>
    <syre:ProceedsFromRaisingCapital contextRef="c-82" decimals="-8" id="f-319" unitRef="usd">1300000000</syre:ProceedsFromRaisingCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-3" decimals="-8" id="f-320" unitRef="usd">-1000000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:MarketableSecurities contextRef="c-3" decimals="-5" id="f-321" unitRef="usd">564800000</us-gaap:MarketableSecurities>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c-1" id="f-322">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States (&#x201c;U.S. GAAP&#x201d;) as defined by the Financial Accounting Standards Board and include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c-1" id="f-323">Summary of Significant Accounting Policies&lt;div style="margin-top:18pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These interim condensed consolidated financial statements have been prepared in accordance with U.S. GAAP and SEC instructions for interim financial information, and should be read in conjunction with the Company's Annual Report. Significant accounting policies and other disclosures normally provided have been omitted since such items are disclosed in the Company's Annual Report. The Company uses the same accounting policies in preparing quarterly and annual financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There have been no significant changes from the significant accounting policies and estimates disclosed in the Notes titled &#x201c;1. The Company and Basis of Presentation&#x201d; and "2. Summary of Significant Accounting Policies&#x201d; of the Company's Annual Report.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There have been no recent accounting pronouncements or changes in accounting pronouncements during the three months ended March&#160;31, 2025 that are of significance or potential significance to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Not Yet Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the Financial Accounting Standards Board&#x2019;s ("FASB") issued Accounting Standards Update 2023-09 ("ASU 2023-09"), Income Taxes (Topic 740): Improvements to Income Tax Disclosures. ASU 2023-09 expands disclosures in an entity&#x2019;s income tax rate reconciliation table and disclosures regarding taxes paid both in the U.S. and foreign jurisdictions. This update is effective for fiscal years beginning after December 15, 2024. ASU 2023-09 will have no impact on the Company&#x2019;s consolidated financial condition or results of operations. The Company is currently evaluating the impact to its income tax disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2024, the Financial Accounting Standards Board issued Accounting Standards Update 2024-03 ("ASU 2024-03") Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses to require more detailed information about specified categories of expenses (purchases of inventory, employee compensation, depreciation, amortization, and depletion) included in certain expense captions presented on the face of the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;income statement. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and for interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. The amendments may be applied either (1) prospectively to financial statements issued for reporting periods after the effective date of this ASU or (2) retrospectively to all prior periods presented in the financial statements. The Company is currently evaluating the impact ASU 2024-03 will have on its disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-324">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There have been no recent accounting pronouncements or changes in accounting pronouncements during the three months ended March&#160;31, 2025 that are of significance or potential significance to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Not Yet Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the Financial Accounting Standards Board&#x2019;s ("FASB") issued Accounting Standards Update 2023-09 ("ASU 2023-09"), Income Taxes (Topic 740): Improvements to Income Tax Disclosures. ASU 2023-09 expands disclosures in an entity&#x2019;s income tax rate reconciliation table and disclosures regarding taxes paid both in the U.S. and foreign jurisdictions. This update is effective for fiscal years beginning after December 15, 2024. ASU 2023-09 will have no impact on the Company&#x2019;s consolidated financial condition or results of operations. The Company is currently evaluating the impact to its income tax disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2024, the Financial Accounting Standards Board issued Accounting Standards Update 2024-03 ("ASU 2024-03") Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses to require more detailed information about specified categories of expenses (purchases of inventory, employee compensation, depreciation, amortization, and depletion) included in certain expense captions presented on the face of the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;income statement. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and for interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. The amendments may be applied either (1) prospectively to financial statements issued for reporting periods after the effective date of this ASU or (2) retrospectively to all prior periods presented in the financial statements. The Company is currently evaluating the impact ASU 2024-03 will have on its disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="c-1" id="f-325">Fair Value Measurements&lt;div style="margin-top:18pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures and reports certain financial instruments as assets and liabilities at fair value on a recurring basis. The following tables set forth the fair value of the Company&#x2019;s financial assets and liabilities at fair value on a recurring basis based on the three-tier fair value hierarchy (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;46,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;46,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 15.4pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. government treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;223,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;223,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 15.4pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;72,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;72,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 15.4pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;147,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;147,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 15.4pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;72,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;72,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total financial assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;270,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;292,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;563,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CVR liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;59,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;59,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;59,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;59,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;65,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;65,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. government treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;227,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;227,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;86,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;86,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 15.4pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;165,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;165,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 15.4pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;56,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;56,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total financial assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;293,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;308,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;601,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CVR liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;61,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;61,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;61,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;61,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures the fair value of money market funds and U.S. government treasury securities on quoted prices in active markets for identical assets or liabilities. The Level 2 assets include U.S. government agency securities, commercial paper and corporate bonds, and are valued based on quoted prices for similar assets in active markets and inputs other than quoted prices that are derived from observable market data. The Company evaluates transfers between levels at the end of each reporting period. There were no transfers between Level 1, Level 2, or Level 3 during the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;CVR Liability &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Asset Acquisition, a non-transferable CVR was distributed to the Legacy Stockholders. Holders of the CVR will be entitled to receive certain cash payments from proceeds received by &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the Company for a three-year period, if any, related to the disposition or monetization of the Company&#x2019;s legacy assets for a period of one year following the closing of the Asset Acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the CVR liability was determined using the probability weighted discounted cash flow method to estimate future cash flows associated with the sale of the legacy assets. Analogous to a dividend being declared/approved in one period and paid out in another, the liability was recorded at the date of approval, June 22, 2023, as a common stock dividend, returning capital to the Legacy Stockholders. Changes in fair value of the liability will be recognized as a component of Other income (expense), net in the consolidated statement of operations and comprehensive loss in each reporting period. The liability value is based on significant inputs not observable in the market such as estimated cash flows, estimated probabilities of regulatory success, and discount rates, which represent a Level 3 measurement within the fair value hierarchy. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The significant inputs used to estimate the fair value of the CVR liability were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:78.748%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Estimated cash flow dates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;08/28/25 - 06/22/26&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Estimated probability of success&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;72% - 100%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Estimated reimbursement rate compared to reimbursement target&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;49% - 100%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Risk-adjusted discount rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.78% - 7.90%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in fair value between December&#160;31, 2024 and March&#160;31, 2025 was a $2.4&#160;million decrease, primarily driven by changes in the likelihood of achievement of certain milestones and an increase in risk-adjusted discount rates, partially offset by  time value of money adjustments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents changes in the CVR liability for the periods presented (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.718%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.082%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;CVR Liability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning balance as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;61,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of the CVR liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Ending Balance as of March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;59,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="c-1" id="f-326">The following tables set forth the fair value of the Company&#x2019;s financial assets and liabilities at fair value on a recurring basis based on the three-tier fair value hierarchy (in thousands):&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;46,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;46,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 15.4pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. government treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;223,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;223,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 15.4pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;72,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;72,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 15.4pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;147,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;147,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 15.4pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;72,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;72,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total financial assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;270,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;292,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;563,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CVR liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;59,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;59,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;59,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;59,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;65,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;65,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. government treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;227,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;227,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;86,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;86,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 15.4pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;165,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;165,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 15.4pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;56,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;56,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total financial assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;293,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;308,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;601,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CVR liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;61,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;61,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;61,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;61,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-83" decimals="-3" id="f-327" unitRef="usd">46800000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-84" decimals="-3" id="f-328" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-85" decimals="-3" id="f-329" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-86" decimals="-3" id="f-330" unitRef="usd">46800000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-87" decimals="-3" id="f-331" unitRef="usd">223500000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-88" decimals="-3" id="f-332" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-89" decimals="-3" id="f-333" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-90" decimals="-3" id="f-334" unitRef="usd">223500000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-91" decimals="-3" id="f-335" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-92" decimals="-3" id="f-336" unitRef="usd">72730000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-93" decimals="-3" id="f-337" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-94" decimals="-3" id="f-338" unitRef="usd">72730000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-95" decimals="-3" id="f-339" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-96" decimals="-3" id="f-340" unitRef="usd">147450000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-97" decimals="-3" id="f-341" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-98" decimals="-3" id="f-342" unitRef="usd">147450000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-99" decimals="-3" id="f-343" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-100" decimals="-3" id="f-344" unitRef="usd">72647000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-101" decimals="-3" id="f-345" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-102" decimals="-3" id="f-346" unitRef="usd">72647000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-103" decimals="-3" id="f-347" unitRef="usd">270300000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-104" decimals="-3" id="f-348" unitRef="usd">292827000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-105" decimals="-3" id="f-349" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-106" decimals="-3" id="f-350" unitRef="usd">563127000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-107" decimals="-3" id="f-351" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-108" decimals="-3" id="f-352" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-109" decimals="-3" id="f-353" unitRef="usd">59300000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-110" decimals="-3" id="f-354" unitRef="usd">59300000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-103" decimals="-3" id="f-355" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-104" decimals="-3" id="f-356" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-105" decimals="-3" id="f-357" unitRef="usd">59300000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-106" decimals="-3" id="f-358" unitRef="usd">59300000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-111" decimals="-3" id="f-359" unitRef="usd">65902000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-112" decimals="-3" id="f-360" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-113" decimals="-3" id="f-361" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-114" decimals="-3" id="f-362" unitRef="usd">65902000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-115" decimals="-3" id="f-363" unitRef="usd">227244000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-116" decimals="-3" id="f-364" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-117" decimals="-3" id="f-365" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-118" decimals="-3" id="f-366" unitRef="usd">227244000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-119" decimals="-3" id="f-367" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-120" decimals="-3" id="f-368" unitRef="usd">86681000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-121" decimals="-3" id="f-369" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-122" decimals="-3" id="f-370" unitRef="usd">86681000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-123" decimals="-3" id="f-371" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-124" decimals="-3" id="f-372" unitRef="usd">165130000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-125" decimals="-3" id="f-373" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-126" decimals="-3" id="f-374" unitRef="usd">165130000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-127" decimals="-3" id="f-375" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-128" decimals="-3" id="f-376" unitRef="usd">56448000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-129" decimals="-3" id="f-377" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-130" decimals="-3" id="f-378" unitRef="usd">56448000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-131" decimals="-3" id="f-379" unitRef="usd">293146000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-132" decimals="-3" id="f-380" unitRef="usd">308259000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-133" decimals="-3" id="f-381" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-134" decimals="-3" id="f-382" unitRef="usd">601405000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-135" decimals="-3" id="f-383" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-136" decimals="-3" id="f-384" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-137" decimals="-3" id="f-385" unitRef="usd">61700000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-138" decimals="-3" id="f-386" unitRef="usd">61700000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-131" decimals="-3" id="f-387" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-132" decimals="-3" id="f-388" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-133" decimals="-3" id="f-389" unitRef="usd">61700000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-134" decimals="-3" id="f-390" unitRef="usd">61700000</us-gaap:LiabilitiesFairValueDisclosure>
    <syre:AssetAcquisitionStockholderPaymentPeriod contextRef="c-61" id="f-391">P3Y</syre:AssetAcquisitionStockholderPaymentPeriod>
    <syre:AssetAcquisitionCashPaymentThresholdPeriod contextRef="c-61" id="f-392">P1Y</syre:AssetAcquisitionCashPaymentThresholdPeriod>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock contextRef="c-1" id="f-393">The significant inputs used to estimate the fair value of the CVR liability were as follows:&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:78.748%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Estimated cash flow dates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;08/28/25 - 06/22/26&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Estimated probability of success&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;72% - 100%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Estimated reimbursement rate compared to reimbursement target&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;49% - 100%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Risk-adjusted discount rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.78% - 7.90%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:DerivativeLiabilityMeasurementInput contextRef="c-139" decimals="2" id="f-394" unitRef="number">0.72</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput contextRef="c-140" decimals="2" id="f-395" unitRef="number">1</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput contextRef="c-141" decimals="2" id="f-396" unitRef="number">0.49</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput contextRef="c-142" decimals="2" id="f-397" unitRef="number">1</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput contextRef="c-143" decimals="4" id="f-398" unitRef="number">0.0778</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput contextRef="c-144" decimals="4" id="f-399" unitRef="number">0.0790</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="c-145" decimals="-5" id="f-400" unitRef="usd">-2400000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="c-1" id="f-401">&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents changes in the CVR liability for the periods presented (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.718%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.082%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;CVR Liability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning balance as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;61,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of the CVR liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Ending Balance as of March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;59,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-146" decimals="-3" id="f-402" unitRef="usd">61700000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="c-145" decimals="-3" id="f-403" unitRef="usd">-2400000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements contextRef="c-145" decimals="-3" id="f-404" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-147" decimals="-3" id="f-405" unitRef="usd">59300000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock contextRef="c-1" id="f-406">Cash Equivalents and Marketable Securities&lt;div style="margin-top:18pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the estimated fair value of the Company&#x2019;s cash equivalents and marketable securities and the gross unrealized gains and losses (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amortized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gains&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Losses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Estimated&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;46,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;46,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;46,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;46,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;147,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;147,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;72,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;72,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. government treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;222,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;223,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.68pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;72,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;72,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;515,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;516,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amortized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gains&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Losses &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Estimated&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;65,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;65,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;21,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;21,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;87,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;87,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;143,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;143,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;56,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;56,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. government treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;227,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(296)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;227,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.68pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;86,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;86,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;513,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(493)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;513,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the available-for-sale securities in an unrealized loss position for which an allowance for credit losses has not been recorded as of March&#160;31, 2025 and December&#160;31, 2024, aggregated by major security type and length of time in a continuous unrealized loss position:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.506%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.964%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="border-bottom:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Less Than 12 Months&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;12 Months or Longer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Losses &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Losses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Losses &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;36,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;36,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. government treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;32,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;32,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;23,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;23,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;105,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;105,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="border-bottom:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Less Than 12 Months&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;12 Months or Longer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Losses &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Losses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Losses &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;67,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;67,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;42,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;42,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. government treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;126,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(296)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;126,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(296)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;249,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(493)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;249,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(493)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluated its securities for credit losses and considered the decline in market value to be primarily attributable to current economic and market conditions and not to a credit loss or other factors. Additionally, the Company does not intend to sell the securities in an unrealized loss position and does not expect it will be required to sell the securities before recovery of the unamortized cost basis. As of March&#160;31, 2025 and December&#160;31, 2024, an allowance for credit losses had not been recognized. Given the Company's intent and ability to hold such securities until recovery, and the lack of significant change in credit risk of these &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;investments, the Company does not consider these marketable securities to be impaired as of March&#160;31, 2025 and December&#160;31, 2024. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The financial instruments that potentially subject the Company to a concentration of credit risk consist principally of cash deposits. Accounts at each of our two U.S. banking institutions are insured by the Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;) up to $250,000 per depositor. As of March&#160;31, 2025 and December&#160;31, 2024, cash deposits at the Company's U.S. banking institutions exceeded the FDIC limits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no realized gains or losses on marketable securities for the three months ended March&#160;31, 2025 and 2024. Interest on marketable securities is included in interest income. Accrued interest receivable on available-for-sale debt securities as of March&#160;31, 2025 and December&#160;31, 2024, was $3.4 million and is reflected in Prepaid expenses and other current assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the contractual maturities of the Company&#x2019;s marketable securities at estimated fair value (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;March 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Due in one year or less&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;367,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;338,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Due in 1 - 2 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;149,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;175,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;516,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;513,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may sell investments at any time for use in current operations even if they have not yet reached maturity. As a result, the Company classifies marketable securities, including securities with maturities beyond twelve months as current assets.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock>
    <us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock contextRef="c-1" id="f-407">&lt;div style="margin-top:18pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the estimated fair value of the Company&#x2019;s cash equivalents and marketable securities and the gross unrealized gains and losses (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amortized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gains&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Losses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Estimated&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;46,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;46,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;46,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;46,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;147,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;147,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;72,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;72,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. government treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;222,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;223,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.68pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;72,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;72,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;515,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;516,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amortized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gains&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Losses &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Estimated&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;65,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;65,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;21,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;21,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;87,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;87,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;143,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;143,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;56,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;56,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. government treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;227,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(296)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;227,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.68pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;86,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;86,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;513,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(493)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;513,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-148" decimals="-3" id="f-408" unitRef="usd">46800000</us-gaap:CashEquivalentsAtCarryingValue>
    <syre:CashEquivalentsUnrealizedGains contextRef="c-148" decimals="-3" id="f-409" unitRef="usd">0</syre:CashEquivalentsUnrealizedGains>
    <syre:CashEquivalentsUnrealizedLosses contextRef="c-148" decimals="-3" id="f-410" unitRef="usd">0</syre:CashEquivalentsUnrealizedLosses>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-148" decimals="-3" id="f-411" unitRef="usd">46800000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-3" decimals="-3" id="f-412" unitRef="usd">46800000</us-gaap:CashEquivalentsAtCarryingValue>
    <syre:CashEquivalentsUnrealizedGains contextRef="c-3" decimals="-3" id="f-413" unitRef="usd">0</syre:CashEquivalentsUnrealizedGains>
    <syre:CashEquivalentsUnrealizedLosses contextRef="c-3" decimals="-3" id="f-414" unitRef="usd">0</syre:CashEquivalentsUnrealizedLosses>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-3" decimals="-3" id="f-415" unitRef="usd">46800000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-149" decimals="-3" id="f-416" unitRef="usd">147448000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-149" decimals="-3" id="f-417" unitRef="usd">26000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-149" decimals="-3" id="f-418" unitRef="usd">24000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-149" decimals="-3" id="f-419" unitRef="usd">147450000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-150" decimals="-3" id="f-420" unitRef="usd">72618000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-150" decimals="-3" id="f-421" unitRef="usd">49000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-150" decimals="-3" id="f-422" unitRef="usd">20000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-150" decimals="-3" id="f-423" unitRef="usd">72647000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-151" decimals="-3" id="f-424" unitRef="usd">222942000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-151" decimals="-3" id="f-425" unitRef="usd">638000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-151" decimals="-3" id="f-426" unitRef="usd">80000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-151" decimals="-3" id="f-427" unitRef="usd">223500000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-152" decimals="-3" id="f-428" unitRef="usd">72673000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-152" decimals="-3" id="f-429" unitRef="usd">94000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-152" decimals="-3" id="f-430" unitRef="usd">37000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-152" decimals="-3" id="f-431" unitRef="usd">72730000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-3" decimals="-3" id="f-432" unitRef="usd">515681000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-3" decimals="-3" id="f-433" unitRef="usd">807000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-3" decimals="-3" id="f-434" unitRef="usd">161000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-3" decimals="-3" id="f-435" unitRef="usd">516327000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-153" decimals="-3" id="f-436" unitRef="usd">65902000</us-gaap:CashEquivalentsAtCarryingValue>
    <syre:CashEquivalentsUnrealizedGains contextRef="c-153" decimals="-3" id="f-437" unitRef="usd">0</syre:CashEquivalentsUnrealizedGains>
    <syre:CashEquivalentsUnrealizedLosses contextRef="c-153" decimals="-3" id="f-438" unitRef="usd">0</syre:CashEquivalentsUnrealizedLosses>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-153" decimals="-3" id="f-439" unitRef="usd">65902000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-154" decimals="-3" id="f-440" unitRef="usd">21832000</us-gaap:CashEquivalentsAtCarryingValue>
    <syre:CashEquivalentsUnrealizedGains contextRef="c-154" decimals="-3" id="f-441" unitRef="usd">6000</syre:CashEquivalentsUnrealizedGains>
    <syre:CashEquivalentsUnrealizedLosses contextRef="c-154" decimals="-3" id="f-442" unitRef="usd">0</syre:CashEquivalentsUnrealizedLosses>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-154" decimals="-3" id="f-443" unitRef="usd">21838000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-4" decimals="-3" id="f-444" unitRef="usd">87734000</us-gaap:CashEquivalentsAtCarryingValue>
    <syre:CashEquivalentsUnrealizedGains contextRef="c-4" decimals="-3" id="f-445" unitRef="usd">6000</syre:CashEquivalentsUnrealizedGains>
    <syre:CashEquivalentsUnrealizedLosses contextRef="c-4" decimals="-3" id="f-446" unitRef="usd">0</syre:CashEquivalentsUnrealizedLosses>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-4" decimals="-3" id="f-447" unitRef="usd">87740000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-154" decimals="-3" id="f-448" unitRef="usd">143265000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-154" decimals="-3" id="f-449" unitRef="usd">104000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-154" decimals="-3" id="f-450" unitRef="usd">77000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-154" decimals="-3" id="f-451" unitRef="usd">143292000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-155" decimals="-3" id="f-452" unitRef="usd">56471000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-155" decimals="-3" id="f-453" unitRef="usd">25000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-155" decimals="-3" id="f-454" unitRef="usd">48000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-155" decimals="-3" id="f-455" unitRef="usd">56448000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-156" decimals="-3" id="f-456" unitRef="usd">227155000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-156" decimals="-3" id="f-457" unitRef="usd">385000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-156" decimals="-3" id="f-458" unitRef="usd">296000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-156" decimals="-3" id="f-459" unitRef="usd">227244000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-157" decimals="-3" id="f-460" unitRef="usd">86616000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-157" decimals="-3" id="f-461" unitRef="usd">137000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-157" decimals="-3" id="f-462" unitRef="usd">72000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-157" decimals="-3" id="f-463" unitRef="usd">86681000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-4" decimals="-3" id="f-464" unitRef="usd">513507000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-4" decimals="-3" id="f-465" unitRef="usd">651000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-4" decimals="-3" id="f-466" unitRef="usd">493000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-4" decimals="-3" id="f-467" unitRef="usd">513665000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock contextRef="c-1" id="f-468">&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the available-for-sale securities in an unrealized loss position for which an allowance for credit losses has not been recorded as of March&#160;31, 2025 and December&#160;31, 2024, aggregated by major security type and length of time in a continuous unrealized loss position:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.506%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.964%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="border-bottom:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Less Than 12 Months&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;12 Months or Longer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Losses &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Losses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Losses &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;36,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;36,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. government treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;32,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;32,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;23,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;23,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;105,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;105,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="border-bottom:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Less Than 12 Months&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;12 Months or Longer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Losses &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Losses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Losses &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;67,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;67,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;42,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;42,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. government treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;126,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(296)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;126,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(296)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;249,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(493)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;249,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(493)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months contextRef="c-149" decimals="-3" id="f-469" unitRef="usd">36057000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss contextRef="c-149" decimals="-3" id="f-470" unitRef="usd">24000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger contextRef="c-149" decimals="-3" id="f-471" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss contextRef="c-149" decimals="-3" id="f-472" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition contextRef="c-149" decimals="-3" id="f-473" unitRef="usd">36057000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss contextRef="c-149" decimals="-3" id="f-474" unitRef="usd">24000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months contextRef="c-150" decimals="-3" id="f-475" unitRef="usd">13129000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss contextRef="c-150" decimals="-3" id="f-476" unitRef="usd">20000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger contextRef="c-150" decimals="-3" id="f-477" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss contextRef="c-150" decimals="-3" id="f-478" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition contextRef="c-150" decimals="-3" id="f-479" unitRef="usd">13129000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss contextRef="c-150" decimals="-3" id="f-480" unitRef="usd">20000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months contextRef="c-151" decimals="-3" id="f-481" unitRef="usd">32810000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss contextRef="c-151" decimals="-3" id="f-482" unitRef="usd">80000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger contextRef="c-151" decimals="-3" id="f-483" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss contextRef="c-151" decimals="-3" id="f-484" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition contextRef="c-151" decimals="-3" id="f-485" unitRef="usd">32810000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss contextRef="c-151" decimals="-3" id="f-486" unitRef="usd">80000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months contextRef="c-152" decimals="-3" id="f-487" unitRef="usd">23154000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss contextRef="c-152" decimals="-3" id="f-488" unitRef="usd">37000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger contextRef="c-152" decimals="-3" id="f-489" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss contextRef="c-152" decimals="-3" id="f-490" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition contextRef="c-152" decimals="-3" id="f-491" unitRef="usd">23154000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss contextRef="c-152" decimals="-3" id="f-492" unitRef="usd">37000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months contextRef="c-3" decimals="-3" id="f-493" unitRef="usd">105150000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss contextRef="c-3" decimals="-3" id="f-494" unitRef="usd">161000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger contextRef="c-3" decimals="-3" id="f-495" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss contextRef="c-3" decimals="-3" id="f-496" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition contextRef="c-3" decimals="-3" id="f-497" unitRef="usd">105150000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss contextRef="c-3" decimals="-3" id="f-498" unitRef="usd">161000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months contextRef="c-154" decimals="-3" id="f-499" unitRef="usd">67200000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss contextRef="c-154" decimals="-3" id="f-500" unitRef="usd">77000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger contextRef="c-154" decimals="-3" id="f-501" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss contextRef="c-154" decimals="-3" id="f-502" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition contextRef="c-154" decimals="-3" id="f-503" unitRef="usd">67200000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss contextRef="c-154" decimals="-3" id="f-504" unitRef="usd">77000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months contextRef="c-155" decimals="-3" id="f-505" unitRef="usd">42916000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss contextRef="c-155" decimals="-3" id="f-506" unitRef="usd">48000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger contextRef="c-155" decimals="-3" id="f-507" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss contextRef="c-155" decimals="-3" id="f-508" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition contextRef="c-155" decimals="-3" id="f-509" unitRef="usd">42916000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss contextRef="c-155" decimals="-3" id="f-510" unitRef="usd">48000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months contextRef="c-156" decimals="-3" id="f-511" unitRef="usd">126588000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss contextRef="c-156" decimals="-3" id="f-512" unitRef="usd">296000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger contextRef="c-156" decimals="-3" id="f-513" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss contextRef="c-156" decimals="-3" id="f-514" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition contextRef="c-156" decimals="-3" id="f-515" unitRef="usd">126588000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss contextRef="c-156" decimals="-3" id="f-516" unitRef="usd">296000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months contextRef="c-157" decimals="-3" id="f-517" unitRef="usd">12560000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss contextRef="c-157" decimals="-3" id="f-518" unitRef="usd">72000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger contextRef="c-157" id="f-519" unitRef="usd" xsi:nil="true"/>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss contextRef="c-157" id="f-520" unitRef="usd" xsi:nil="true"/>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition contextRef="c-157" decimals="-3" id="f-521" unitRef="usd">12560000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss contextRef="c-157" decimals="-3" id="f-522" unitRef="usd">72000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months contextRef="c-4" decimals="-3" id="f-523" unitRef="usd">249264000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss contextRef="c-4" decimals="-3" id="f-524" unitRef="usd">493000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger contextRef="c-4" decimals="-3" id="f-525" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss contextRef="c-4" decimals="-3" id="f-526" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition contextRef="c-4" decimals="-3" id="f-527" unitRef="usd">249264000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss contextRef="c-4" decimals="-3" id="f-528" unitRef="usd">493000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss contextRef="c-158" decimals="INF" id="f-529" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss contextRef="c-159" decimals="INF" id="f-530" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <syre:ImpairmentOfMarketableSecurities contextRef="c-160" decimals="INF" id="f-531" unitRef="usd">0</syre:ImpairmentOfMarketableSecurities>
    <syre:ImpairmentOfMarketableSecurities contextRef="c-161" decimals="INF" id="f-532" unitRef="usd">0</syre:ImpairmentOfMarketableSecurities>
    <syre:NumberOfDomesticBankingInstitutions contextRef="c-3" decimals="INF" id="f-533" unitRef="bank">2</syre:NumberOfDomesticBankingInstitutions>
    <us-gaap:CashFDICInsuredAmount contextRef="c-162" decimals="INF" id="f-534" unitRef="usd">250000</us-gaap:CashFDICInsuredAmount>
    <us-gaap:MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments contextRef="c-161" decimals="INF" id="f-535" unitRef="usd">0</us-gaap:MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments>
    <us-gaap:MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments contextRef="c-163" decimals="INF" id="f-536" unitRef="usd">0</us-gaap:MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments>
    <us-gaap:InterestReceivable contextRef="c-158" decimals="-5" id="f-537" unitRef="usd">3400000</us-gaap:InterestReceivable>
    <us-gaap:InterestReceivable contextRef="c-159" decimals="-5" id="f-538" unitRef="usd">3400000</us-gaap:InterestReceivable>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock contextRef="c-1" id="f-539">&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the contractual maturities of the Company&#x2019;s marketable securities at estimated fair value (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;March 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Due in one year or less&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;367,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;338,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Due in 1 - 2 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;149,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;175,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;516,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;513,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue contextRef="c-3" decimals="-3" id="f-540" unitRef="usd">367106000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue contextRef="c-4" decimals="-3" id="f-541" unitRef="usd">338442000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <syre:DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOne contextRef="c-3" decimals="-3" id="f-542" unitRef="usd">149221000</syre:DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOne>
    <syre:DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOne contextRef="c-4" decimals="-3" id="f-543" unitRef="usd">175223000</syre:DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOne>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-3" decimals="-3" id="f-544" unitRef="usd">516327000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-4" decimals="-3" id="f-545" unitRef="usd">513665000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <syre:AccruedAndOtherCurrentLiabilitiesTextBlock contextRef="c-1" id="f-546">Accrued and Other Current Liabilities &lt;div style="margin-top:18pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued and other current liabilities consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;March 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued contracted research and development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;19,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued professional and consulting fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total accrued and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;21,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;27,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</syre:AccruedAndOtherCurrentLiabilitiesTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="c-1" id="f-547">&lt;div style="margin-top:18pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued and other current liabilities consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;March 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued contracted research and development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;19,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued professional and consulting fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total accrued and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;21,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;27,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedSalariesCurrent contextRef="c-3" decimals="-3" id="f-548" unitRef="usd">1561000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedSalariesCurrent contextRef="c-4" decimals="-3" id="f-549" unitRef="usd">5688000</us-gaap:AccruedSalariesCurrent>
    <syre:AccruedContractedResearchAndDevelopmentCosts contextRef="c-3" decimals="-3" id="f-550" unitRef="usd">19078000</syre:AccruedContractedResearchAndDevelopmentCosts>
    <syre:AccruedContractedResearchAndDevelopmentCosts contextRef="c-4" decimals="-3" id="f-551" unitRef="usd">20861000</syre:AccruedContractedResearchAndDevelopmentCosts>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="c-3" decimals="-3" id="f-552" unitRef="usd">621000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="c-4" decimals="-3" id="f-553" unitRef="usd">661000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-554" unitRef="usd">371000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-555" unitRef="usd">501000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities contextRef="c-3" decimals="-3" id="f-556" unitRef="usd">21631000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities contextRef="c-4" decimals="-3" id="f-557" unitRef="usd">27711000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock contextRef="c-1" id="f-558">Licensing Agreements&lt;div style="margin-top:18pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 12, 2023, December 14, 2023, and June 5, 2024, the Company exercised the Option available under the Paragon Agreement with respect to the SPY001, SPY002, and SPY003 research programs, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 14, 2024, the Company and Paragon entered into (i) a license agreement (the &#x201c;SPY001 License Agreement&#x201d;), pursuant to which Paragon granted the Company a royalty-bearing, world-wide, exclusive license to develop, manufacture, commercialize or otherwise exploit certain antibodies and products targeting &#x3b1;4&#xdf;7 integrin and (ii) a license agreement (the &#x201c;SPY002 License Agreement&#x201d;), pursuant to which Paragon granted the Company a royalty-bearing, world-wide, exclusive license to develop, manufacture, commercialize or otherwise exploit certain antibodies and products targeting TL1A, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 11, 2024, the Company and Paragon entered into a license agreement (as amended, the "SPY003 License Agreement", and together with the SPY001 License Agreement and the SPY002 License Agreement, the "License Agreements"), pursuant to which Paragon granted the Company a royalty-bearing, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;world-wide, exclusive license to develop, manufacture, commercialize or otherwise exploit certain antibodies and products targeting IL-23 in the field of IBD.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 24, 2025, the SPY003 License Agreement was amended and restated to, among other things, clarify each party's rights and obligations with respect to license exclusivity and patent prosecution.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the terms of each License Agreement, the Company is obligated to pay Paragon up to $22.0 million based on specific development, regulatory and clinical milestones for the first product under each agreement, respectively, that achieves such specified milestones, including a milestone payment of $3.0 million upon the first dosing of a human patient in a Phase 2 trial. In addition, the following summarizes other key terms of each License Agreement:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt"&gt;Paragon will provide the Company with an exclusive license (such license, with respect to the SPY003 License Agreement only, being limited to the field of IBD) to its patents covering the related antibody, the method of use and its method of manufacture.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt"&gt;Paragon will not conduct any new campaigns that generate anti-&#x3b1;4&#xdf;7 or anti-TL1A monospecific antibodies in any field or anti-IL-23 monospecific antibodies in the field of IBD, in each case for at least 5 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt"&gt;The Company will pay Paragon a low single-digit percentage royalty for single antibody products and a mid single-digit percentage royalty for products containing more than one antibody from Paragon.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt"&gt;There is a royalty step-down of 1/3rd if there is no Paragon patent in effect during the royalty term.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt"&gt;The royalty term ends on the later of (i) the last-to-expire licensed patent or Company patent directed to the manufacture, use or sale of a licensed antibody in the country at issue or (ii) 12 years from the date of first sale of a Company product. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt"&gt;Agreement may be terminated on 60 days&#x2019; notice by the Company; on material breach without cure; and to the extent permitted by law, on a party&#x2019;s insolvency or bankruptcy.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt"&gt;With respect to the SPY002 License Agreement only, on a product by product basis, the Company will pay sublicensing fees of up to approximately $20 million upon the achievement of mostly commercial milestones.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes the expense associated with each milestone when the achievement of the milestone is deemed probable. During the three months ended March&#160;31, 2025, the Company recognized expense of $2.5 million related to Paragon license milestone payments recorded within Research and development expenses in the accompanying condensed statement of operations. There was no such expense for the three months ended March&#160;31, 2024. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March&#160;31, 2025 and 2024, there were no cash milestone payments to Paragon. As of March&#160;31, 2025 and December 31, 2024, there were $2.5 million and nil, respectively, of Paragon license milestone payments outstanding and payable to Paragon. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Additionally, there were no expenses recognized related to sublicensing fees for the three months ended March&#160;31, 2025 and 2024. For the three months ended March&#160;31, 2025 and 2024, the Company made sublicensing fees payments to Paragon totaling $0.5 million and nil, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2025 and December 31, 2024, nil and $0.5 million in sublicensing fees were outstanding and payable to Paragon, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <syre:AmountToBePaidUnderAgreement contextRef="c-164" decimals="-5" id="f-559" unitRef="usd">22000000.0</syre:AmountToBePaidUnderAgreement>
    <syre:AmountToBePaidUnderAgreement contextRef="c-165" decimals="-5" id="f-560" unitRef="usd">22000000.0</syre:AmountToBePaidUnderAgreement>
    <syre:AmountToBePaidUnderAgreement contextRef="c-166" decimals="-5" id="f-561" unitRef="usd">22000000.0</syre:AmountToBePaidUnderAgreement>
    <syre:PaymentOfMilestone contextRef="c-167" decimals="-5" id="f-562" unitRef="usd">3000000.0</syre:PaymentOfMilestone>
    <syre:PaymentOfMilestone contextRef="c-168" decimals="-5" id="f-563" unitRef="usd">3000000.0</syre:PaymentOfMilestone>
    <syre:PaymentOfMilestone contextRef="c-168" decimals="-5" id="f-564" unitRef="usd">3000000.0</syre:PaymentOfMilestone>
    <syre:CampaignTimelineMinimumTerm contextRef="c-169" id="f-565">P5Y</syre:CampaignTimelineMinimumTerm>
    <syre:RoyaltyTermExpirationPeriod contextRef="c-169" id="f-566">P12Y</syre:RoyaltyTermExpirationPeriod>
    <syre:TerminationNoticePeriod contextRef="c-169" id="f-567">P60D</syre:TerminationNoticePeriod>
    <syre:SublicensingFee contextRef="c-170" decimals="-5" id="f-568" unitRef="usd">20000000</syre:SublicensingFee>
    <syre:LicenseAgreementMilestoneExpenseAmountRecognized contextRef="c-169" decimals="-5" id="f-569" unitRef="usd">2500000</syre:LicenseAgreementMilestoneExpenseAmountRecognized>
    <syre:LicenseAgreementMilestoneExpenseAmountRecognized contextRef="c-171" decimals="-5" id="f-570" unitRef="usd">0</syre:LicenseAgreementMilestoneExpenseAmountRecognized>
    <syre:LicenseAgreementMilestonePayments contextRef="c-171" decimals="INF" id="f-571" unitRef="usd">0</syre:LicenseAgreementMilestonePayments>
    <syre:LicenseAgreementMilestonePayments contextRef="c-169" decimals="INF" id="f-572" unitRef="usd">0</syre:LicenseAgreementMilestonePayments>
    <syre:LicenseAgreementMilestonePaymentsOutstandingAndPayable contextRef="c-172" decimals="-5" id="f-573" unitRef="usd">2500000</syre:LicenseAgreementMilestonePaymentsOutstandingAndPayable>
    <syre:LicenseAgreementMilestonePaymentsOutstandingAndPayable contextRef="c-173" decimals="-5" id="f-574" unitRef="usd">0</syre:LicenseAgreementMilestonePaymentsOutstandingAndPayable>
    <syre:SublicensingFee contextRef="c-169" decimals="-5" id="f-575" unitRef="usd">0</syre:SublicensingFee>
    <syre:SublicensingFee contextRef="c-171" decimals="-5" id="f-576" unitRef="usd">0</syre:SublicensingFee>
    <syre:PaymentForSublicensingFee contextRef="c-169" decimals="-5" id="f-577" unitRef="usd">500000</syre:PaymentForSublicensingFee>
    <syre:PaymentForSublicensingFee contextRef="c-171" decimals="-5" id="f-578" unitRef="usd">0</syre:PaymentForSublicensingFee>
    <syre:SublicensingFeeOutstandingAndPayable contextRef="c-174" decimals="-5" id="f-579" unitRef="usd">0</syre:SublicensingFeeOutstandingAndPayable>
    <syre:SublicensingFeeOutstandingAndPayable contextRef="c-175" decimals="-5" id="f-580" unitRef="usd">500000</syre:SublicensingFeeOutstandingAndPayable>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="c-1" id="f-581">Related Party Transactions&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Paragon and Parapyre each beneficially own less than 5% of a class of the Company's voting securities through their respective holdings of the Company's common stock. Fairmount Funds Management LLC ("Fairmount") beneficially owns more than 5% of a class of the Company's voting securities, has two seats on the Board (held by Peter Harwin and Tomas Kiselak) and beneficially owns more than 5% of Paragon. Fairmount appointed Paragon's board of directors and has the contractual right to approve the appointment of &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;any executive officers of Paragon. Parapyre is an entity formed by Paragon as a vehicle to hold equity in Spyre in order to share profits with certain employees of Paragon and will not perform any substantive role under the Paragon Agreement other than to receive warrants granted to Parapyre under the Paragon Agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is the summary of expenses related to the Paragon Agreement and License Agreements, which are ultimately settled in cash (in millions) and recorded within Research and development in the consolidated statement of operations for the periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.629%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:27pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reimbursable costs under the Paragon Agreement&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;License Agreements milestone and sublicensing fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total related party expense (excludes stock-based compensation)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is the summary of Related party accounts payable and other current liabilities (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;March 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reimbursable costs under the Paragon Agreement&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;License Agreements development milestone liability (see Note 6)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total related party accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Paragon Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Asset Acquisition, the Company assumed the rights and obligations of Pre-Merger Spyre under the Paragon Agreement. Spyre is obligated to compensate Paragon for its services performed under each research program based on the actual costs incurred with mark-up costs pursuant to the terms of the Paragon Agreement. Spyre was also obligated under the Paragon Agreement to issue Parapyre annual equity grants of warrants in accordance with the Parapyre Option Obligation (as defined below). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 12, 2023, December 14, 2023, and June 5, 2024, the Company exercised the Option available under the Paragon Agreement with respect to the SPY001, SPY002 and SPY003 research programs, respectively. Please refer to Note 6 for additional information on the License Agreements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 14, 2024, the Company, Paragon and Parapyre entered into a second amended and restated antibody discovery and option agreement that amends and restates that certain amended and restated antibody discovery and option agreement, dated September 29, 2023, by and between Paragon, Parapyre and Spyre Therapeutics, LLC, in order to, among other things, (i) replace the Company&#x2019;s subsidiary with the Company as a party to the agreement and (ii) amend certain terms related to the SPY003 research program, including without limitation, (a) establishing an SPY003 antibody selection process pursuant to which the Company and Paragon shall alternate in turn to select a project antibody to be included and excluded, respectively, from the Company&#x2019;s rights under its option to license certain intellectual property rights related to SPY003 from Paragon until all project antibodies under the SPY003 research program have been selected; (b) reducing the development costs invoiced to the Company for the SPY003 research program incurred from and after April 1, 2024 through completion of the SPY003 antibody selection process by 50%; (c) requiring Paragon to reimburse the Company for 50% of the development costs for the SPY003 research program incurred prior to April 1, 2024; provided, that Paragon receives rights to at least one SPY003 project antibody following completion of the SPY003 antibody selection process; (d) obligating the Company to exercise its option to license the intellectual property rights to SPY003 project antibodies and technology following the completion of the SPY003 antibody selection process; and (e) establishing a license agreement term sheet for the SPY003 research program with substantially similar milestone payment terms and royalty payment terms as the SPY001 License Agreement. Please refer to Note 6 for additional disclosures. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March&#160;31, 2025 and 2024, the Company recognized de minimis and $17.1 million, respectively, expenses related to services provided by Paragon, of which nil and $5.4 million, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;respectively, of related stock-based compensation expense were recorded as Research and development expenses in the consolidated statements of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March&#160;31, 2025 and 2024, the Company made payments totaling $0.1 million and $18.2 million respectively, in connection with the Paragon Agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Parapyre Option Obligation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the Paragon Agreement, the Company agreed to issue Parapyre an annual equity grant of warrants, on the last business day of each of the years ended December 31, 2023 and December 31, 2024, to purchase 1% of the then outstanding shares of the Company's common stock, on a fully diluted basis, during the term of the Paragon Agreement (the "Parapyre Option Obligation"). See Note 9 for disclosures related to the Parapyre Option Obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Paragon License Agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 6 for disclosures related to the License Agreements entered into with Paragon.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Mark McKenna Option Grant&lt;/span&gt;&lt;/div&gt;On February 1, 2024, the Board appointed Mark McKenna as a Class I director. Mr. McKenna and the Company are parties to a consulting agreement, pursuant to which Mr. McKenna agreed to continue to provide consulting services as an independent contractor to the Company, with an effective date of August 1, 2023 (the &#x201c;Vesting Commencement Date&#x201d;). As compensation for Mr. McKenna&#x2019;s consulting services, on November 22, 2023, he was granted non-qualified stock options to purchase 477,000 shares of the Company&#x2019;s common stock under the 2016 Plan (as defined in Note 8) with an exercise price of $10.39 per share, which vest as to 25% on the one year anniversary of the Vesting Commencement Date and thereafter vest and become exercisable in 36 equal monthly installments, subject to Mr. McKenna&#x2019;s continued service to the Company through each applicable vesting date. For the three months ended March&#160;31, 2025 and 2024, the Company recognized $0.3&#160;million in stock-based compensation expense related to Mr. McKenna's consulting agreement.</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners contextRef="c-176" decimals="2" id="f-582" unitRef="number">0.05</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners contextRef="c-177" decimals="2" id="f-583" unitRef="number">0.05</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <syre:RelatedPartyTransactionNumberOfBoardSeats contextRef="c-178" decimals="0" id="f-584" unitRef="seat">2</syre:RelatedPartyTransactionNumberOfBoardSeats>
    <syre:MinorityInterestOwnershipPercentageByNoncontrollingOwnersHeldInThirdParty contextRef="c-177" decimals="2" id="f-585" unitRef="number">0.05</syre:MinorityInterestOwnershipPercentageByNoncontrollingOwnersHeldInThirdParty>
    <us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock contextRef="c-1" id="f-586">&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is the summary of expenses related to the Paragon Agreement and License Agreements, which are ultimately settled in cash (in millions) and recorded within Research and development in the consolidated statement of operations for the periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.629%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:27pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reimbursable costs under the Paragon Agreement&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;License Agreements milestone and sublicensing fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total related party expense (excludes stock-based compensation)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost contextRef="c-169" decimals="-5" id="f-587" unitRef="usd">0</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost contextRef="c-171" decimals="-5" id="f-588" unitRef="usd">11700000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost contextRef="c-174" decimals="-5" id="f-589" unitRef="usd">2500000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost contextRef="c-179" decimals="-5" id="f-590" unitRef="usd">0</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost contextRef="c-180" decimals="-5" id="f-591" unitRef="usd">2500000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost contextRef="c-181" decimals="-5" id="f-592" unitRef="usd">11700000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <syre:ScheduleOfBalancesDueToAffiliatesTableTextBlock contextRef="c-1" id="f-593">&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is the summary of Related party accounts payable and other current liabilities (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;March 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reimbursable costs under the Paragon Agreement&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;License Agreements development milestone liability (see Note 6)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total related party accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</syre:ScheduleOfBalancesDueToAffiliatesTableTextBlock>
    <us-gaap:AccountsPayableOtherCurrent contextRef="c-172" decimals="-5" id="f-594" unitRef="usd">0</us-gaap:AccountsPayableOtherCurrent>
    <us-gaap:AccountsPayableOtherCurrent contextRef="c-173" decimals="-5" id="f-595" unitRef="usd">100000</us-gaap:AccountsPayableOtherCurrent>
    <us-gaap:AccountsPayableOtherCurrent contextRef="c-182" decimals="-5" id="f-596" unitRef="usd">2500000</us-gaap:AccountsPayableOtherCurrent>
    <us-gaap:AccountsPayableOtherCurrent contextRef="c-183" decimals="-5" id="f-597" unitRef="usd">500000</us-gaap:AccountsPayableOtherCurrent>
    <us-gaap:AccountsPayableOtherCurrent contextRef="c-7" decimals="-5" id="f-598" unitRef="usd">2500000</us-gaap:AccountsPayableOtherCurrent>
    <us-gaap:AccountsPayableOtherCurrent contextRef="c-8" decimals="-5" id="f-599" unitRef="usd">600000</us-gaap:AccountsPayableOtherCurrent>
    <syre:DevelopmentCostReductionPercentage contextRef="c-184" decimals="2" id="f-600" unitRef="number">0.50</syre:DevelopmentCostReductionPercentage>
    <syre:DevelopmentCostReimbursementPercentage contextRef="c-185" decimals="2" id="f-601" unitRef="number">0.50</syre:DevelopmentCostReimbursementPercentage>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-186" decimals="-5" id="f-602" unitRef="usd">17100000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:ShareBasedCompensation contextRef="c-187" decimals="-5" id="f-603" unitRef="usd">0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-188" decimals="-5" id="f-604" unitRef="usd">5400000</us-gaap:ShareBasedCompensation>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-169" decimals="-5" id="f-605" unitRef="usd">100000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-171" decimals="-5" id="f-606" unitRef="usd">18200000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <syre:CommonStockSharesOutstandingPercentageAvailableToPurchaseOnADilutedBasis contextRef="c-172" decimals="2" id="f-607" unitRef="number">0.01</syre:CommonStockSharesOutstandingPercentageAvailableToPurchaseOnADilutedBasis>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c-189"
      decimals="-3"
      id="f-608"
      unitRef="shares">477000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="c-190"
      decimals="2"
      id="f-609"
      unitRef="usdPerShare">10.39</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="c-191" decimals="2" id="f-610" unitRef="number">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-191" id="f-611">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-189" id="f-612">P36M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-192" decimals="-5" id="f-613" unitRef="usd">300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-193" decimals="-5" id="f-614" unitRef="usd">300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:PreferredStockTextBlock contextRef="c-1" id="f-615">Convertible Preferred Stock and Stockholders&#x2019; Equity&lt;div style="margin-top:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Parapyre Warrants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2024, the Company settled its obligations under the Parapyre Option Obligation by issuing Parapyre 848,184 warrants to purchase the Company's common stock at an exercise price of $23.28.  As of March&#160;31, 2025, a total of 1,532,591 warrants with a weighted-average exercise price of $22.49 had been issued to Parapyre under the Parapyre Option Obligation.  As of March 31, 2025, none of the warrants issued under the Parapyre Option Obligation have been exercised and all remain outstanding. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Series A Non-Voting Convertible Preferred Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the Company's Certificate of Designation of Preferences, Rights and Limitations of the Series A Non-Voting Convertible Preferred Stock (the "Series A Certificate of Designation"), holders of Series A Preferred Stock are entitled to receive dividends on shares of Series A Preferred Stock equal to, on an as-if-converted-to-common stock basis, and in the same form as, dividends actually paid on shares of common stock. Except as provided in the Series A Certificate of Designation or as otherwise required by law, the Series A Preferred Stock does not have voting rights. However, as long as any shares of Series A Preferred Stock are outstanding, the Company will not, without the affirmative vote of the holders of a majority of the then outstanding shares of the Series A Preferred Stock: (a) alter or change adversely the powers, preferences or rights given to the Series A Preferred Stock, or alter or amend the Series A Certificate of Designation, amend or repeal any provision of, or add any provision to, the Company&#x2019;s Certificate of Incorporation or its Bylaws, or file any articles of amendment, certificate of designations, preferences, limitations and relative rights of any series of preferred stock, if such action would adversely alter or change the preferences, rights, privileges or powers of, or restrictions provided for the benefit of the Series A Preferred Stock, regardless of whether any of the foregoing actions will be by means of amendment to the Certificate of Incorporation or by merger, consolidation, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;recapitalization, reclassification, conversion or otherwise, (b) issue further shares of Series A Preferred Stock or increase or decrease (other than by conversion) the number of authorized shares of Series A Preferred Stock, (c) prior to the stockholder approval of the conversion of the Series A Preferred Stock into shares of common stock in accordance with Nasdaq Stock Market Rules (the &#x201c;Series A Conversion Proposal&#x201d;) or at any time while at least 30% of the originally issued Series A Preferred Stock remains issued and outstanding, consummate (x) any Fundamental Transaction (as defined in the Series A Certificate of Designation) or (y) any merger or consolidation of the Company with or into another entity or any stock sale to, or other business combination in which our stockholders immediately before such transaction do not hold at least a majority of our capital stock immediately after such transaction or (d) enter into any agreement with respect to any of the foregoing. The Series A Preferred Stock does not have a preference upon any liquidation, dissolution or winding-up of the Company. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 23, 2024, in connection with the April 2024 Exchange, the Stockholder agreed to exchange an aggregate of 90,992 shares of Series A Preferred Stock for an aggregate of 3,639,680 shares of the Company's common stock. This exchange was recorded as a reclassification between Series A Preferred Stock and common stock based on the historical per-share contributed capital amount, inclusive of any forward-contract valuation adjustments, of the Series A Preferred Stock. Following the April 2024 Exchange, 346,045 shares of Series A Preferred Stock remained outstanding and are convertible into 13,841,800 common shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Series B Non-Voting Convertible Preferred Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the Company's Certificate of Designation of Preferences, Rights and Limitations of Series B Non-Voting Convertible Preferred Stock (as amended, the "Series B Certificate of Designation"), holders of Series B Preferred Stock are entitled to receive dividends on shares of Series B Preferred Stock equal to, on an as-if-converted-to-common stock basis, and in the same form as, dividends actually paid on shares of common stock. Except as provided in the Series B Certificate of Designation or as otherwise required by law, the Series B Preferred Stock does not have voting rights. However, as long as any shares of Series B Preferred Stock are outstanding, the Company will not, without the affirmative vote of the holders of a majority of the then outstanding shares of the Series B Preferred Stock, alter or change adversely the powers, preferences or rights given to the Series B Preferred Stock, or alter or amend the Series B Certificate of Designation, amend or repeal any provision of, or add any provision to, the Company&#x2019;s Certificate of Incorporation or its Bylaws, or file any articles of amendment, certificate of designations, preferences, limitations and relative rights of any series of preferred stock, if such action would adversely alter or change the preferences, rights, privileges or powers of, or restrictions provided for the benefit of the Series B Preferred Stock, regardless of whether any of the foregoing actions will be by means of amendment to the Certificate of Incorporation or by merger, consolidation, recapitalization, reclassification, conversion or otherwise. The Series B Preferred Stock does not have a preference upon any liquidation, dissolution or winding-up of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 18, 2024, in connection with the March 2024 PIPE, the Company filed a certificate of amendment to its Series B Certificate of Designation to increase the number of authorized shares of Series B Preferred Stock from 150,000 to 271,625.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 20, 2024, as part of the March 2024 PIPE, the Company completed a private placement of 121,625 shares of Series B Preferred Stock at $1,480.00 per share in exchange for net proceeds of approximately $168.9&#160;million, after deducting placement agent fees and offering costs of $11.2&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 14, 2024, the Company's stockholders approved the issuance of common stock upon the conversion of all issued and outstanding Series B Preferred Stock into shares of common stock in accordance with the Nasdaq Stock Market Rules (the "Series B Conversion Proposal"), among other matters, at its 2024 annual meeting of stockholders. As a result of the approval of the Series B Conversion Proposal, all conditions that could have required cash redemption of the Series B Preferred Stock were satisfied. Since the Series B Preferred Stock is no longer redeemable, the associated balances of the Series B Preferred Stock were reclassified from mezzanine equity to permanent equity during the second quarter of 2024. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following stockholder approval of the Series B Conversion Proposal, each share of Series B Preferred Stock automatically converted into 40 shares of common stock, subject to certain limitations, including that a holder of Series B Preferred Stock is prohibited from converting shares of Series B Preferred Stock into shares of common stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;own more than a specified percentage (established by the holder between 0% and 19.9%) of the total number of shares of common stock issued and outstanding immediately after giving effect to such conversion. 254,958 shares of Series B Preferred Stock automatically converted to 10,198,320 shares of common stock; 16,667 shares of Series B Preferred Stock did not automatically convert and remain outstanding as of March&#160;31, 2025 due to beneficial ownership limitations. This conversion was recorded as a reclassification between Series B Preferred Stock and common stock based on the historical per-share contributed capital amount of the Series B Preferred Stock. The remaining outstanding Series B Preferred Stock is convertible into 666,680 common shares as of March&#160;31, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;September 2024 ATM Facility&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 6, 2024, the Company filed a new shelf registration statement on Form S-3 that was declared effective by the SEC for the potential offering, issuance and sale of up to $500.0&#160;million of the Company's common stock, preferred stock, debt securities, warrants and/or units consisting of all or some of these securities. Concurrent with the filing of the shelf-registration statement, the Company entered into the Sales Agreement, pursuant to which the Company may issue and sell up to $200.0&#160;million of shares of common stock under an ATM offering program included in the registration statement. During the twelve months ended December 31, 2024, the Company sold an aggregate of 777,432 shares of common stock under the ATM offering program at an average price per share of $26.935 resulting in net proceeds of $20.5 million, after deducting sales agent commissions and other offering costs of $0.4 million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2025, the Company filed a new shelf registration statement on Form S-3 that was declared effective by the SEC for the potential offering, issuance and sale of up to $500.0&#160;million of the Company's common stock, preferred stock, debt securities, warrants and/or units consisting of all or some of these securities. Concurrent with the effectiveness of the February 2025 Shelf Registration Statement, the offering of unsold securities under the previous shelf registration statement on Form S-3 (described above), was deemed terminated pursuant to Rule 415(a)(6) under the Securities Act. The February 2025 Shelf Registration Statement contains a prospectus supplement covering the offering, issuance and sale by the Company of up to $179.1&#160;million of shares of common stock that may be issued and sold under the Sales Agreement in connection with the ATM program. No shares were sold under the ATM program during the three months ended March 31, 2025. As of March 31, 2025, $179.1&#160;million remained available for sale under the Sales Agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;November 2024 Underwritten Offering&lt;/span&gt;&lt;/div&gt;On November 18, 2024, the Company entered into the Underwriting Agreement with the Underwriters, pursuant to which the Company sold an aggregate of 8,366,250 shares of common stock, at a public offering price per share of $27.50, resulting in net proceeds of approximately $215.9&#160;million after deducting approximately $14.2&#160;million of underwriting discounts and other offering costs. The November 2024 Offering closed on November 20, 2024 and the over-allotment option was exercised in full on November 26, 2024 and closed on November 29, 2024.</us-gaap:PreferredStockTextBlock>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-194"
      decimals="INF"
      id="f-616"
      unitRef="shares">848184</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-194"
      decimals="2"
      id="f-617"
      unitRef="usdPerShare">23.28</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-195"
      decimals="INF"
      id="f-618"
      unitRef="shares">1532591</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-195"
      decimals="2"
      id="f-619"
      unitRef="usdPerShare">22.49</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <syre:ClassOfWarrantOrRightNumberOfSecuritiesExercised
      contextRef="c-196"
      decimals="INF"
      id="f-620"
      unitRef="shares">0</syre:ClassOfWarrantOrRightNumberOfSecuritiesExercised>
    <syre:PreferredStockRemainsIssuedAndOutstandingPercentage contextRef="c-197" decimals="2" id="f-621" unitRef="number">0.30</syre:PreferredStockRemainsIssuedAndOutstandingPercentage>
    <syre:StockIssuedDuringPeriodSharesExchangeOfConvertibleSecurities
      contextRef="c-198"
      decimals="INF"
      id="f-622"
      unitRef="shares">90992</syre:StockIssuedDuringPeriodSharesExchangeOfConvertibleSecurities>
    <syre:StockIssuedDuringPeriodSharesExchangeOfConvertibleSecurities
      contextRef="c-69"
      decimals="INF"
      id="f-623"
      unitRef="shares">3639680</syre:StockIssuedDuringPeriodSharesExchangeOfConvertibleSecurities>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c-199"
      decimals="INF"
      id="f-624"
      unitRef="shares">346045</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockConvertibleSharesIssuable
      contextRef="c-199"
      decimals="INF"
      id="f-625"
      unitRef="shares">13841800</us-gaap:PreferredStockConvertibleSharesIssuable>
    <syre:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="c-200"
      decimals="INF"
      id="f-626"
      unitRef="shares">150000</syre:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <syre:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="c-201"
      decimals="INF"
      id="f-627"
      unitRef="shares">271625</syre:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <syre:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="c-64"
      decimals="INF"
      id="f-628"
      unitRef="shares">121625</syre:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-65"
      decimals="2"
      id="f-629"
      unitRef="usdPerShare">1480</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-66" decimals="-5" id="f-630" unitRef="usd">168900000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-66" decimals="-5" id="f-631" unitRef="usd">11200000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PreferredStockConvertibleConversionRatio contextRef="c-202" decimals="0" id="f-632" unitRef="number">40</us-gaap:PreferredStockConvertibleConversionRatio>
    <syre:BeneficialHoldersOwnedPercentage contextRef="c-203" decimals="0" id="f-633" unitRef="number">0</syre:BeneficialHoldersOwnedPercentage>
    <syre:BeneficialHoldersOwnedPercentage contextRef="c-204" decimals="4" id="f-634" unitRef="number">0.199</syre:BeneficialHoldersOwnedPercentage>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="c-205"
      decimals="INF"
      id="f-635"
      unitRef="shares">254958</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="c-206"
      decimals="INF"
      id="f-636"
      unitRef="shares">10198320</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <syre:PreferredStockSharesNotAutomaticallyConvertedOutstanding
      contextRef="c-12"
      decimals="INF"
      id="f-637"
      unitRef="shares">16667</syre:PreferredStockSharesNotAutomaticallyConvertedOutstanding>
    <us-gaap:PreferredStockConvertibleSharesIssuable
      contextRef="c-12"
      decimals="INF"
      id="f-638"
      unitRef="shares">666680</us-gaap:PreferredStockConvertibleSharesIssuable>
    <syre:SaleOfStockAuthorizedAmount contextRef="c-73" decimals="-5" id="f-639" unitRef="usd">500000000</syre:SaleOfStockAuthorizedAmount>
    <syre:SaleOfStockAggregateOfferingPrice contextRef="c-74" decimals="-5" id="f-640" unitRef="usd">200000000</syre:SaleOfStockAggregateOfferingPrice>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c-75"
      decimals="INF"
      id="f-641"
      unitRef="shares">777432</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-76"
      decimals="3"
      id="f-642"
      unitRef="usdPerShare">26.935</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-75" decimals="-5" id="f-643" unitRef="usd">20500000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-75" decimals="-5" id="f-644" unitRef="usd">400000</us-gaap:PaymentsOfStockIssuanceCosts>
    <syre:SaleOfStockAuthorizedAmount contextRef="c-73" decimals="-5" id="f-645" unitRef="usd">500000000</syre:SaleOfStockAuthorizedAmount>
    <syre:SaleOfStockAggregateOfferingPrice contextRef="c-80" decimals="-5" id="f-646" unitRef="usd">179100000</syre:SaleOfStockAggregateOfferingPrice>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c-207"
      decimals="INF"
      id="f-647"
      unitRef="shares">0</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <syre:SaleOfStockRemainingAuthorizedAmount contextRef="c-81" decimals="-5" id="f-648" unitRef="usd">179100000</syre:SaleOfStockRemainingAuthorizedAmount>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c-77"
      decimals="INF"
      id="f-649"
      unitRef="shares">8366250</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-79"
      decimals="2"
      id="f-650"
      unitRef="usdPerShare">27.50</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-77" decimals="-5" id="f-651" unitRef="usd">215900000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-77" decimals="-5" id="f-652" unitRef="usd">14200000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c-1" id="f-653">Stock-Based Compensation&lt;div style="margin-top:18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2015 Equity Incentive Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2015, the Company adopted the 2015 Equity Incentive Plan (&#x201c;2015 Plan&#x201d;), administered by the board of directors, and provides for the Company to sell or issue shares of common stock or restricted common stock, or to grant incentive stock options or nonqualified stock options for the purchase of common stock, to employees, members of the board of directors and consultants of the Company. The Company granted options under the 2015 Plan until April 2016 when it was terminated as to future awards, although it continues to govern the terms of options that remain outstanding under the 2015 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2025, a total of 952 shares of common stock are subject to options outstanding under the 2015 Plan and will become available under the 2016 Equity Incentive Plan (&#x201c;2016 Plan&#x201d;) to the extent the options are forfeited or lapse unexercised.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2016 Equity Incentive Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2016 Plan became effective in April 2016 and serves as the successor to the 2015 Plan. Under the 2016 Plan, the Company may grant stock options, stock appreciation rights, restricted stock awards, restricted stock units, performance awards, and stock bonuses. The 2016 Plan, as amended, provides for an automatic increase in the number of shares reserved for issuance thereunder on January 1 of each year for the remaining term of the plan equal to (a) 5.0% of the number of issued and outstanding shares of common stock &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(including such shares issuable pursuant to the exercise or conversion, as applicable, of any outstanding pre-funded warrants and nonvoting convertible preferred stock) on December 31 of the immediately preceding year, or (b) a lesser amount as approved by the board each year (the &#x201c;Evergreen Provision&#x201d;). As a result of the Evergreen Provision, on January 1, 2025 and 2024, an additional 3,814,905 and 3,023,650 shares, respectively, became available for issuance under the 2016 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2025, the 2016 Plan had 11,007,869 shares available for future issuance, of which 4,817,317 shares were subject to outstanding option awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2018 Equity Inducement Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2018 Equity Inducement Plan (&#x201c;2018 Plan&#x201d;) became effective in February 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of 2024, the Company amended the 2018 Plan to increase the number of shares of common stock reserved for issuance by 1,000,000. After this amendment and as of March&#160;31, 2025, the 2018 Plan had 6,856,811 shares available for future issuance, of which 6,300,368 shares were subject to outstanding option awards and restricted unit awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Service-based awards granted under the 2018 Plan, 2016 Plan, and 2015 Plan generally vest over four years and expire after ten years, although awards have been granted with vesting terms less than four years. Under the 2016 Plan and 2018 Plan, the Company may grant stock-based awards with service conditions (&#x201c;service-based&#x201d; awards), performance conditions (&#x201c;performance-based&#x201d; awards), and market conditions (&#x201c;market-based&#x201d; awards). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Spyre 2023 Equity Incentive Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June&#160;22, 2023, in connection with the Asset Acquisition, the Company assumed the Amended and Restated Spyre 2023 Equity Incentive Plan (the "2023 Plan") and its outstanding and unexercised stock options, which were converted to options to purchase 2,734 shares of common stock. The acquisition-date fair value of these grants will be recognized as an expense on a pro-rata basis over the vesting period. As of March 31, 2025 none of the stock options under the 2023 Plan remained outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s stock awards granted under all equity incentive and inducement plans for each of the periods indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.515%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:42.022%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.353%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.769%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.353%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.774%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Grants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Grants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,897,917&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;21.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,044,658&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Parapyre Option Obligation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2024, the Company settled its obligations under the Parapyre Option Obligation by issuing Parapyre 848,184 warrants to purchase the Company's common stock at an exercise price of $23.28.  As of March&#160;31, 2025, a total of 1,532,591 warrants with a weighted-average exercise price of $22.49 had been &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;issued to Parapyre under the Parapyre Option Obligation.  As of March 31, 2025 none of the warrants issued under the Parapyre Option Obligation have been exercised and all remain outstanding. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March&#160;31, 2024, $5.4 million was recognized as stock compensation expense related to the Parapyre Option Obligation. There are no ongoing obligations under the Parapyre Option Obligation as of January 1, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2016 Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Company&#x2019;s 2016 Employee Stock Purchase Plan (&#x201c;2016 ESPP&#x201d;), the Company issued and sold 16,877 and 2,330 shares during the three months ended March&#160;31, 2025 and 2024, respectively. The aggregate cash proceeds were $0.3 million and de minimis for the three months ended March&#160;31, 2025 and 2024, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-based Compensation Expense&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total stock-based compensation expense recognized from the Company&#x2019;s equity incentive plans, 2018 Plan, 2016 ESPP and Parapyre Option Obligation during the periods presented was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.748%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.869%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.869%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.408%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total stock-based compensation expense &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-top:9pt;padding-left:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;For the three months ended March&#160;31, 2024, $5.4 million was recognized as stock compensation expense related to the Parapyre Option Obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Of the total $13.8 million of stock-based compensation expense for the three months ended March&#160;31, 2024, $2.9 million is related to legacy Aeglea employees and directors who had been terminated as of the end of the period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:9pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the weighted-average Black-Scholes option pricing model assumptions used to estimate the fair value of stock options granted under the Company's equity incentive plans, and the shares purchasable under the 2016 ESPP during the periods presented: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.484%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.537%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.696%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock Options Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.03&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.03&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;76%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;105%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Risk-free interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.46%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.88%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2016 ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;69%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;98%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Risk-free interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.23%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.31%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease
      contextRef="c-208"
      decimals="INF"
      id="f-654"
      unitRef="shares">952</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease>
    <syre:AnnualPercentageOfAdditionalSharesWhichEqualsToIssuedAndOutstandingShares contextRef="c-209" decimals="3" id="f-655" unitRef="number">0.050</syre:AnnualPercentageOfAdditionalSharesWhichEqualsToIssuedAndOutstandingShares>
    <syre:ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalNumberOfSharesAvailableForGrant
      contextRef="c-210"
      decimals="INF"
      id="f-656"
      unitRef="shares">3814905</syre:ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalNumberOfSharesAvailableForGrant>
    <syre:ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalNumberOfSharesAvailableForGrant
      contextRef="c-211"
      decimals="INF"
      id="f-657"
      unitRef="shares">3023650</syre:ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalNumberOfSharesAvailableForGrant>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c-212"
      decimals="INF"
      id="f-658"
      unitRef="shares">11007869</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-212"
      decimals="INF"
      id="f-659"
      unitRef="shares">4817317</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <syre:CommonStockCapitalSharesReservedForFutureIssuanceIncreasedAmount
      contextRef="c-213"
      decimals="INF"
      id="f-660"
      unitRef="shares">1000000</syre:CommonStockCapitalSharesReservedForFutureIssuanceIncreasedAmount>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c-214"
      decimals="INF"
      id="f-661"
      unitRef="shares">6856811</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-214"
      decimals="INF"
      id="f-662"
      unitRef="shares">6300368</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-215" id="f-663">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="c-215" id="f-664">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-215" id="f-665">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <syre:OutstandingAndUnexercisedStockOptions
      contextRef="c-216"
      decimals="INF"
      id="f-666"
      unitRef="shares">2734</syre:OutstandingAndUnexercisedStockOptions>
    <us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock contextRef="c-1" id="f-667">&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s stock awards granted under all equity incentive and inducement plans for each of the periods indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.515%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:42.022%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.353%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.769%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.353%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.774%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Grants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Grants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,897,917&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;21.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,044,658&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="c-1" decimals="INF" id="f-668" unitRef="shares">1897917</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-669"
      unitRef="usdPerShare">21.45</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c-15"
      decimals="INF"
      id="f-670"
      unitRef="shares">1044658</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-15"
      decimals="2"
      id="f-671"
      unitRef="usdPerShare">26.50</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-194"
      decimals="INF"
      id="f-672"
      unitRef="shares">848184</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-194"
      decimals="2"
      id="f-673"
      unitRef="usdPerShare">23.28</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-195"
      decimals="INF"
      id="f-674"
      unitRef="shares">1532591</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-195"
      decimals="2"
      id="f-675"
      unitRef="usdPerShare">22.49</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <syre:ClassOfWarrantOrRightNumberOfSecuritiesExercised
      contextRef="c-196"
      decimals="INF"
      id="f-676"
      unitRef="shares">0</syre:ClassOfWarrantOrRightNumberOfSecuritiesExercised>
    <us-gaap:ShareBasedCompensation contextRef="c-188" decimals="-5" id="f-677" unitRef="usd">5400000</us-gaap:ShareBasedCompensation>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c-217"
      decimals="INF"
      id="f-678"
      unitRef="shares">16877</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod contextRef="c-218" decimals="0" id="f-679" unitRef="shares">16877</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c-219"
      decimals="INF"
      id="f-680"
      unitRef="shares">2330</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-217" decimals="-5" id="f-681" unitRef="usd">300000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock contextRef="c-1" id="f-682">&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total stock-based compensation expense recognized from the Company&#x2019;s equity incentive plans, 2018 Plan, 2016 ESPP and Parapyre Option Obligation during the periods presented was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.748%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.869%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.869%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.408%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total stock-based compensation expense &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-top:9pt;padding-left:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;For the three months ended March&#160;31, 2024, $5.4 million was recognized as stock compensation expense related to the Parapyre Option Obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Of the total $13.8 million of stock-based compensation expense for the three months ended March&#160;31, 2024, $2.9 million is related to legacy Aeglea employees and directors who had been terminated as of the end of the period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:9pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-220" decimals="-3" id="f-683" unitRef="usd">3512000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-221" decimals="-3" id="f-684" unitRef="usd">6857000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-222" decimals="-3" id="f-685" unitRef="usd">5347000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-223" decimals="-3" id="f-686" unitRef="usd">6978000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-1" decimals="-3" id="f-687" unitRef="usd">8859000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-15" decimals="-3" id="f-688" unitRef="usd">13835000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensation contextRef="c-188" decimals="-5" id="f-689" unitRef="usd">5400000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-15" decimals="-5" id="f-690" unitRef="usd">13800000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-224" decimals="-5" id="f-691" unitRef="usd">2900000</us-gaap:ShareBasedCompensation>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="c-1" id="f-692">&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the weighted-average Black-Scholes option pricing model assumptions used to estimate the fair value of stock options granted under the Company's equity incentive plans, and the shares purchasable under the 2016 ESPP during the periods presented: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.484%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.537%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.696%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock Options Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.03&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.03&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;76%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;105%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Risk-free interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.46%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.88%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2016 ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;69%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;98%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Risk-free interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.23%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.31%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-225" id="f-693">P6Y10D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-226" id="f-694">P6Y10D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c-225" decimals="2" id="f-695" unitRef="number">0.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c-226" decimals="2" id="f-696" unitRef="number">1.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-225" decimals="4" id="f-697" unitRef="number">0.0446</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-226" decimals="4" id="f-698" unitRef="number">0.0388</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c-225"
      decimals="INF"
      id="f-699"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c-226"
      decimals="INF"
      id="f-700"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-227" id="f-701">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-228" id="f-702">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c-227" decimals="2" id="f-703" unitRef="number">0.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c-228" decimals="2" id="f-704" unitRef="number">0.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-227" decimals="4" id="f-705" unitRef="number">0.0423</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-228" decimals="4" id="f-706" unitRef="number">0.0531</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c-227"
      decimals="INF"
      id="f-707"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c-228"
      decimals="INF"
      id="f-708"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c-1" id="f-709">Segment Reporting&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates under a single operating and reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated diseases. The Company's Chief Operating Decision Maker ("CODM") is the Company's Chief Executive Officer. The Company's CODM uses consolidated Net loss as the measure of segment profit or loss and uses consolidated Total Assets as reported on the balance sheet as the measure of segment assets. The Company's CODM compares Net loss against budgeted and/or forecasted amounts to track the Company's financial performance against expectations and to inform, along with development timelines and scientific and commercial considerations, their decisions regarding resource allocations to fund the Company's development of its pipeline. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table sets forth the significant expenses provided to the CODM on a regular basis (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.545%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.807%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.408%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.143%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development, excluding compensation and stock-based compensation &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2) (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;33,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other segment items &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4,628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(255)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;44,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;43,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reconciliation of net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Adjustments and reconciling items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Consolidated net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;44,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;43,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Includes $0.3 million and $5.7 million in related party expenses for the three months ended March 31, 2025 and 2024, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Includes non-clinical study, clinical trial, and manufacturing expenses. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Includes $2.5 million and $11.7 million in related party expenses for the three months ended March 31, 2025 and 2024, respectively. &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt; Includes general and administrative expenses such as audit, legal, and other professional fees, interest income, and other expense, net.</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock contextRef="c-1" id="f-710">&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table sets forth the significant expenses provided to the CODM on a regular basis (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.545%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.807%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.408%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.143%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development, excluding compensation and stock-based compensation &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2) (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;33,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other segment items &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4,628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(255)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;44,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;43,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reconciliation of net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Adjustments and reconciling items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Consolidated net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;44,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;43,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Includes $0.3 million and $5.7 million in related party expenses for the three months ended March 31, 2025 and 2024, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Includes non-clinical study, clinical trial, and manufacturing expenses. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Includes $2.5 million and $11.7 million in related party expenses for the three months ended March 31, 2025 and 2024, respectively. &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt; Includes general and administrative expenses such as audit, legal, and other professional fees, interest income, and other expense, net.</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <us-gaap:CompensationExpenseExcludingCostOfGoodAndServiceSold contextRef="c-229" decimals="-3" id="f-711" unitRef="usd">6991000</us-gaap:CompensationExpenseExcludingCostOfGoodAndServiceSold>
    <us-gaap:CompensationExpenseExcludingCostOfGoodAndServiceSold contextRef="c-230" decimals="-3" id="f-712" unitRef="usd">4174000</us-gaap:CompensationExpenseExcludingCostOfGoodAndServiceSold>
    <us-gaap:ShareBasedCompensation contextRef="c-229" decimals="-3" id="f-713" unitRef="usd">8859000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-230" decimals="-3" id="f-714" unitRef="usd">13835000</us-gaap:ShareBasedCompensation>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-229" decimals="-3" id="f-715" unitRef="usd">33551000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-230" decimals="-3" id="f-716" unitRef="usd">26103000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-229" decimals="-3" id="f-717" unitRef="usd">-4628000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-230" decimals="-3" id="f-718" unitRef="usd">-255000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:NetIncomeLoss contextRef="c-229" decimals="-3" id="f-719" unitRef="usd">-44773000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-230" decimals="-3" id="f-720" unitRef="usd">-43857000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-231" decimals="-3" id="f-721" unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-232" decimals="-3" id="f-722" unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-233" decimals="-3" id="f-723" unitRef="usd">-44773000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-234" decimals="-3" id="f-724" unitRef="usd">-43857000</us-gaap:NetIncomeLoss>
    <us-gaap:ShareBasedCompensation contextRef="c-235" decimals="-5" id="f-725" unitRef="usd">300000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-236" decimals="-5" id="f-726" unitRef="usd">5700000</us-gaap:ShareBasedCompensation>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-235" decimals="-5" id="f-727" unitRef="usd">2500000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-236" decimals="-5" id="f-728" unitRef="usd">11700000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:EarningsPerShareTextBlock contextRef="c-1" id="f-729">Net Loss Per Share&lt;div style="margin-top:18pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company computes net loss per share of common stock, Series A Preferred Stock, and Series B Preferred Stock using the two-class method required for multiple classes of common stock and other participating securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The two-class method is an earnings (loss) allocation method under which earnings (loss) per share is calculated for each class of common stock. The Company has determined that the Series A Preferred Stock and Series B Preferred Stock do not have preferential rights when compared to the Company's common stock and therefore it must allocate losses to these other classes of common stock, as illustrated in the table below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted net loss per share is computed by dividing the net loss by the weighted-average number of shares and pre-funded warrants outstanding during the period, without consideration of potential dilutive securities. The pre-funded warrants are included in the computation of basic net loss per share as the exercise price is negligible and they are fully vested and exercisable. For periods in which the Company generated a net loss, the Company does not include potential shares of common stock in diluted net loss per share when the impact of these items is anti-dilutive. The Company has generated a net loss for all periods &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;presented, therefore diluted net loss per share is the same as basic net loss per share since the inclusion of potential shares of common stock would be anti-dilutive.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted net loss per share of common stock, Series A Preferred Stock, and Series B Preferred Stock (in thousands, except share and per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:38.596%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.445%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.445%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.445%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.445%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.445%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Series A Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Series B Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Common&lt;br/&gt;Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Series A Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Series B Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Common&lt;br/&gt;Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Net loss per share, basic and diluted:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Numerator&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Allocation of losses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(8,288)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(399)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(36,086)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(12,642)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4,810)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(26,405)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Denominator&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Weighted-average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;346,045&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;16,667&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;60,265,932&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;437,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;166,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;36,262,662&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Weighted-average pre-funded warrants outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;250,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Number of shares used in per share computation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;346,045&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;16,667&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;60,265,932&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;437,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;166,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;36,512,662&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Net loss per share, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(23.95)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(23.95)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(0.60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(28.93)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(28.93)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(0.72)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following weighted-average equity instruments were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive for the periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.121%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:65.320%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.951%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.538%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.951%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.540%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options to purchase common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,866,235&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,200,918&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unvested restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22,622&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;61,253&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding Parapyre warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,532,591&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;684,407&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c-1" id="f-730">&lt;div style="margin-top:18pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company computes net loss per share of common stock, Series A Preferred Stock, and Series B Preferred Stock using the two-class method required for multiple classes of common stock and other participating securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The two-class method is an earnings (loss) allocation method under which earnings (loss) per share is calculated for each class of common stock. The Company has determined that the Series A Preferred Stock and Series B Preferred Stock do not have preferential rights when compared to the Company's common stock and therefore it must allocate losses to these other classes of common stock, as illustrated in the table below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted net loss per share is computed by dividing the net loss by the weighted-average number of shares and pre-funded warrants outstanding during the period, without consideration of potential dilutive securities. The pre-funded warrants are included in the computation of basic net loss per share as the exercise price is negligible and they are fully vested and exercisable. For periods in which the Company generated a net loss, the Company does not include potential shares of common stock in diluted net loss per share when the impact of these items is anti-dilutive. The Company has generated a net loss for all periods &lt;/span&gt;&lt;/div&gt;presented, therefore diluted net loss per share is the same as basic net loss per share since the inclusion of potential shares of common stock would be anti-dilutive.</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock contextRef="c-1" id="f-731">&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted net loss per share of common stock, Series A Preferred Stock, and Series B Preferred Stock (in thousands, except share and per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:38.596%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.445%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.445%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.445%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.445%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.445%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Series A Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Series B Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Common&lt;br/&gt;Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Series A Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Series B Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Common&lt;br/&gt;Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Net loss per share, basic and diluted:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Numerator&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Allocation of losses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(8,288)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(399)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(36,086)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(12,642)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4,810)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(26,405)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Denominator&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Weighted-average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;346,045&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;16,667&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;60,265,932&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;437,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;166,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;36,262,662&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Weighted-average pre-funded warrants outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;250,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Number of shares used in per share computation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;346,045&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;16,667&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;60,265,932&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;437,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;166,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;36,512,662&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Net loss per share, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(23.95)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(23.95)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(0.60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(28.93)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(28.93)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(0.72)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock>
    <us-gaap:NetIncomeLoss contextRef="c-16" decimals="-3" id="f-732" unitRef="usd">-8288000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-18" decimals="-3" id="f-733" unitRef="usd">-399000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-20" decimals="-3" id="f-734" unitRef="usd">-36086000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-17" decimals="-3" id="f-735" unitRef="usd">-12642000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-19" decimals="-3" id="f-736" unitRef="usd">-4810000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-21" decimals="-3" id="f-737" unitRef="usd">-26405000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic contextRef="c-16" decimals="0" id="f-738" unitRef="shares">346045</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic contextRef="c-18" decimals="0" id="f-739" unitRef="shares">16667</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic contextRef="c-20" decimals="0" id="f-740" unitRef="shares">60265932</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic contextRef="c-17" decimals="0" id="f-741" unitRef="shares">437037</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic contextRef="c-19" decimals="0" id="f-742" unitRef="shares">166261</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic contextRef="c-21" decimals="0" id="f-743" unitRef="shares">36262662</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants contextRef="c-16" decimals="0" id="f-744" unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants contextRef="c-18" decimals="0" id="f-745" unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants contextRef="c-20" decimals="0" id="f-746" unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants contextRef="c-17" decimals="0" id="f-747" unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants contextRef="c-19" decimals="0" id="f-748" unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants contextRef="c-21" decimals="0" id="f-749" unitRef="shares">250000</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-16" decimals="0" id="f-750" unitRef="shares">346045</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-16" decimals="0" id="f-751" unitRef="shares">346045</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-18" decimals="0" id="f-752" unitRef="shares">16667</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-18" decimals="0" id="f-753" unitRef="shares">16667</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-20" decimals="0" id="f-754" unitRef="shares">60265932</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-20" decimals="0" id="f-755" unitRef="shares">60265932</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-17" decimals="0" id="f-756" unitRef="shares">437037</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-17" decimals="0" id="f-757" unitRef="shares">437037</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-19" decimals="0" id="f-758" unitRef="shares">166261</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-19" decimals="0" id="f-759" unitRef="shares">166261</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-21" decimals="0" id="f-760" unitRef="shares">36512662</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-21" decimals="0" id="f-761" unitRef="shares">36512662</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-16"
      decimals="2"
      id="f-762"
      unitRef="usdPerShare">-23.95</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-16"
      decimals="2"
      id="f-763"
      unitRef="usdPerShare">-23.95</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-18"
      decimals="2"
      id="f-764"
      unitRef="usdPerShare">-23.95</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-18"
      decimals="2"
      id="f-765"
      unitRef="usdPerShare">-23.95</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-20"
      decimals="2"
      id="f-766"
      unitRef="usdPerShare">-0.60</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-20"
      decimals="2"
      id="f-767"
      unitRef="usdPerShare">-0.60</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-17"
      decimals="2"
      id="f-768"
      unitRef="usdPerShare">-28.93</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-17"
      decimals="2"
      id="f-769"
      unitRef="usdPerShare">-28.93</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-19"
      decimals="2"
      id="f-770"
      unitRef="usdPerShare">-28.93</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-19"
      decimals="2"
      id="f-771"
      unitRef="usdPerShare">-28.93</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-21"
      decimals="2"
      id="f-772"
      unitRef="usdPerShare">-0.72</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-21"
      decimals="2"
      id="f-773"
      unitRef="usdPerShare">-0.72</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="c-1" id="f-774">&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.121%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:65.320%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.951%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.538%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.951%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.540%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options to purchase common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,866,235&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,200,918&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unvested restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22,622&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;61,253&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding Parapyre warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,532,591&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;684,407&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-237"
      decimals="INF"
      id="f-775"
      unitRef="shares">1866235</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-238"
      decimals="INF"
      id="f-776"
      unitRef="shares">3200918</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-239"
      decimals="INF"
      id="f-777"
      unitRef="shares">22622</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-240"
      decimals="INF"
      id="f-778"
      unitRef="shares">61253</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-241"
      decimals="INF"
      id="f-779"
      unitRef="shares">1532591</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-242"
      decimals="INF"
      id="f-780"
      unitRef="shares">684407</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c-1" id="f-784">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-1" id="f-785">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c-1" id="f-786">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c-1" id="f-787">false</ecd:NonRule10b51ArrTrmntdFlag>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#f-110"
          xlink:label="f-110"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-111"
          xlink:label="f-111"
          xlink:type="locator"/>
        <link:footnote id="fn-1" xlink:label="fn-1" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Includes $2.5 million and $17.1 million in related party expenses for the three months ended March&#160;31, 2025 and 2024, respectively.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-110"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-111"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-112"
          xlink:label="f-112"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-113"
          xlink:label="f-113"
          xlink:type="locator"/>
        <link:footnote id="fn-2" xlink:label="fn-2" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Includes $0.3 million in related party expenses for the three months ended March&#160;31, 2025 and 2024.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-112"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-113"
          xlink:to="fn-2"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
